PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cinque, L; Forrester, A; Bartolomeo, R; Svelto, M; Venditti, R; Montefusco, S; Polishchuk, E; Nusco, E; Rossi, A; Medina, DL; Polishchuk, R; De Matteis, MA; Settembre, C				Cinque, Laura; Forrester, Alison; Bartolomeo, Rosa; Svelto, Maria; Venditti, Rossella; Montefusco, Sandro; Polishchuk, Elena; Nusco, Edoardo; Rossi, Antonio; Medina, Diego L.; Polishchuk, Roman; De Matteis, Maria Antonietta; Settembre, Carmine			FGF signalling regulates bone growth through autophagy	NATURE			English	Article							ENDOPLASMIC-RETICULUM; CRE RECOMBINASE; CHONDROGENESIS; PROCOLLAGEN; EXPRESSION; CELLS	Skeletal growth relies on both biosynthetic and catabolic processes(1,2). While the role of the former is clearly established, how the latter contributes to growth-promoting pathways is less understood. Macroautophagy, hereafter referred to as autophagy, is a catabolic process that plays a fundamental part in tissue homeostasis(3). We investigated the role of autophagy during bone growth, which is mediated by chondrocyte rate of proliferation, hypertrophic differentiation and extracellular matrix (ECM) deposition in growth plates(4). Here we show that autophagy is induced in growth-plate chondrocytes during post-natal development and regulates the secretion of type II collagen (Col2), the major component of cartilage ECM. Mice lacking the autophagy related gene 7 (Atg7) in chondrocytes experience endoplasmic reticulum storage of type II procollagen (PC2) and defective formation of the Col2 fibrillary network in the ECM. Surprisingly, post-natal induction of chondrocyte autophagy is mediated by the growth factor FGF18 through FGFR4 and JNK-dependent activation of the autophagy initiation complex VPS34-beclin-1. Autophagy is completely suppressed in growth plates from Fgf18(-/-) embryos, while Fgf18(+/-) heterozygous and Fgfr4(-/-) mice fail to induce autophagy during post-natal development and show decreased Col2 levels in the growth plate. Strikingly, the Fgf18(+/-) and Fgfr4(-/-) phenotypes can be rescued in vivo by pharmacological activation of autophagy, pointing to autophagy as a novel effector of FGF signalling in bone. These data demonstrate that autophagy is a developmentally regulated process necessary for bone growth, and identify FGF signalling as a crucial regulator of autophagy in chondrocytes.	[Cinque, Laura; Forrester, Alison; Bartolomeo, Rosa; Svelto, Maria; Venditti, Rossella; Montefusco, Sandro; Polishchuk, Elena; Nusco, Edoardo; Medina, Diego L.; Polishchuk, Roman; De Matteis, Maria Antonietta; Settembre, Carmine] Telethon Inst Genet & Med TIGEM, I-80078 Pozzuoli, NA, Italy; [Cinque, Laura; Forrester, Alison; Bartolomeo, Rosa; Svelto, Maria; Settembre, Carmine] Dulbecco Telethon Inst, I-80078 Pozzuoli, NA, Italy; [Forrester, Alison; Svelto, Maria; Settembre, Carmine] Univ Naples Federico II, Dept Med & Translat Sci, Med Genet Unit, I-80131 Naples, Italy; [Rossi, Antonio] Univ Pavia, Biochem Unit, Dept Mol Med, I-27100 Pavia, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Naples Federico II; University of Pavia	Settembre, C (corresponding author), Telethon Inst Genet & Med TIGEM, Via Campi Flegrei 34, I-80078 Pozzuoli, NA, Italy.	settembre@tigem.it	Rossi, Antonio/E-9935-2012; Medina, Diego/AAC-9622-2020; De Matteis, Maria Antonietta/AHE-5161-2022; Settembre, Carmine/AIA-9170-2022; Forrester, Alison Ruth/ABC-2636-2021; Venditti, Rossella/AAT-4281-2020	Medina, Diego/0000-0002-7347-2645; De Matteis, Maria Antonietta/0000-0003-0053-3061; Forrester, Alison Ruth/0000-0003-3352-9173; Venditti, Rossella/0000-0002-1884-6501; Polishchuk, Roman/0000-0002-7698-1955; Cinque, Laura/0000-0002-8497-3939; SETTEMBRE, Carmine/0000-0002-5829-8589	Italian Telethon Foundation [TCP12008]; Marie Curie European Reintegration Grant [PCIG13-GA-2013-618805]; STAR/Banco di Napoli; Italian Ministry of Research [FIRB RBFR13LH4X]	Italian Telethon Foundation(Fondazione Telethon); Marie Curie European Reintegration Grant(European Commission); STAR/Banco di Napoli; Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR))	We thank A. Ballabio, G. Karsenty, A. Auricchio, M. Sandri and G. Diez Roux for critical reading of the manuscript. We thank L. Staiano and C. Lanzara for technical support. We thank A. Carissimo for statistical analysis. We thank N. Mizushima, D. Ornitz and J. Seavitt for sharing mouse lines used in this work. This work was supported by grants from the Italian Telethon Foundation (TCP12008), Marie Curie European Reintegration Grant (PCIG13-GA-2013-618805), STAR/Banco di Napoli and the Italian Ministry of Research (FIRB RBFR13LH4X) to C.S.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Houck SA, 2014, MOL CELL, V54, P166, DOI 10.1016/j.molcel.2014.02.025; Ishida Y, 2011, METHOD ENZYMOL, V499, P167, DOI 10.1016/B978-0-12-386471-0.00009-2; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; King KB, 2003, J CELL BIOCHEM, V89, P992, DOI 10.1002/jcb.10571; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Lotz MK, 2011, NAT REV RHEUMATOL, V7, P579, DOI 10.1038/nrrheum.2011.109; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moore EE, 2005, OSTEOARTHR CARTILAGE, V13, P623, DOI 10.1016/j.joca.2005.03.003; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Settembre C, 2008, GENE DEV, V22, P2645, DOI 10.1101/gad.1711308; Shapiro IM, 2014, AUTOPHAGY, V10, P7, DOI 10.4161/auto.26679; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Srinivas V, 2009, CELL CYCLE, V8, P391, DOI 10.4161/cc.8.3.7545; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961; Venditti R, 2012, SCIENCE, V337, P1668, DOI 10.1126/science.1224947; Vuppalapati KK, 2015, J BONE MINER RES, V30, P2249, DOI 10.1002/jbmr.2575; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wilsman NJ, 1996, J ORTHOP RES, V14, P927, DOI 10.1002/jor.1100140613	30	131	141	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					272	+		10.1038/nature16063	http://dx.doi.org/10.1038/nature16063			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26595272				2022-12-28	WOS:000366053300043
J	Hoffmann, NA; Jakobi, AJ; Moreno-Morcillo, M; Glatt, S; Kosinski, J; Hagen, WJH; Sachse, C; Muller, CW				Hoffmann, Niklas A.; Jakobi, Arjen J.; Moreno-Morcillo, Maria; Glatt, Sebastian; Kosinski, Jan; Hagen, Wim J. H.; Sachse, Carsten; Mueller, Christoph W.			Molecular structures of unbound and transcribing RNA polymerase III	NATURE			English	Article							TRANSCRIPTION TERMINATION; CRYSTAL-STRUCTURE; ELECTRON-MICROSCOPY; ELONGATION COMPLEX; ACTIVE-SITE; SUBCOMPLEX; INITIATION; SUBUNIT; RESOLUTION; VISUALIZATION	Transcription of genes encoding small structured RNAs such as transfer RNAs, spliceosomal U6 small nuclear RNA and ribosomal 5S RNA is carried out by RNA polymerase III (Pol III), the largest yet structurally least characterized eukaryotic RNA polymerase. Here we present the cryo-electron microscopy structures of the Saccharomyces cerevisiae Pol III elongating complex at 3.9 angstrom resolution and the apo Pol III enzyme in two different conformations at 4.6 and 4.7 angstrom resolution, respectively, which allow the building of a 17-subunit atomic model of Pol III. The reconstructions reveal the precise orientation of the C82-C34-C31 heterotrimer in close proximity to the stalk. The C53-C37 heterodimer positions residues involved in transcription termination close to the non-template DNA strand. In the apo Pol III structures, the stalk adopts different orientations coupled with closed and open conformations of the clamp. Our results provide novel insights into Pol III-specific transcription and the adaptation of Pol III towards its small transcriptional targets.	[Hoffmann, Niklas A.; Jakobi, Arjen J.; Moreno-Morcillo, Maria; Glatt, Sebastian; Kosinski, Jan; Hagen, Wim J. H.; Sachse, Carsten; Mueller, Christoph W.] European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Jakobi, Arjen J.] European Mol Biol Lab, Hamburg Unit, D-22607 Hamburg, Germany; [Moreno-Morcillo, Maria] Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomputing Programme, Madrid 28029, Spain; [Glatt, Sebastian] Jagiellonian Univ, Malopolska Ctr Biotechnol, Gronostajowa 7A str, PL-30387 Krakow, Poland	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Centro Nacional de Investigaciones Oncologicas (CNIO); Jagiellonian University	Sachse, C (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	carsten.sachse@embl.de; christoph.mueller@embl.de	Sachse, Carsten/H-2727-2012; Müller, Christoph W/I-7420-2012; Sachse, Carsten/AAY-9384-2020; Glatt, Sebastian/AAS-1230-2020; Kosinski, Jan/V-8540-2019	Sachse, Carsten/0000-0002-1168-5143; Müller, Christoph W/0000-0003-2176-8337; Sachse, Carsten/0000-0002-1168-5143; Glatt, Sebastian/0000-0003-2815-7133; Kosinski, Jan/0000-0002-3641-0322; Hagen, Wim/0000-0001-6229-2692; Moreno Morcillo, Maria/0000-0003-4603-2529; Hoffmann, Niklas Alexander/0000-0002-0891-0581; Jakobi, Arjen/0000-0002-7761-2027; Moreno Morcillo, Maria/0000-0001-7928-3338	Marie-Sklodowska-Curie fellowships [FP7-PEOPLE-2011IEF301002, PIEF-GA-2012-331285]; EMBL International PhD program; EMBL Interdisciplinary Postdoc Program (EIPOD) under Marie Curie COFUND actions [PCOFUND-GA-2008-229597]; ERC Advanced Grant [ERC-2013-AdG340964-POL1PIC]	Marie-Sklodowska-Curie fellowships; EMBL International PhD program; EMBL Interdisciplinary Postdoc Program (EIPOD) under Marie Curie COFUND actions; ERC Advanced Grant	We thank Y. Sadian, H. Grotsch and R. Wetzel for help in Pol III purification. We are grateful to F. Thommen and M. Wahlers for set-up and maintenance of the high-performance computational environment of RELION. We acknowledge F. Schur, S. Fromm, C. Bertipaglia, M. Beck and G. Hofhaus for helpful advice regarding sample preparation and image processing. We also thank the 'Fermentation et culture de microorganisms' (IFR88, CNRS, Marseille). M. M.-M. and A.J.J. were supported by Marie-Sklodowska-Curie fellowships (FP7-PEOPLE-2011IEF301002, PIEF-GA-2012-331285). N.A.H. acknowledges support by the EMBL International PhD program, A.J.J. and J.K. by postdoctoral fellowships from the EMBL Interdisciplinary Postdoc Program (EIPOD) under Marie Curie COFUND actions (PCOFUND-GA-2008-229597) and C.W.M. by an ERC Advanced Grant (ERC-2013-AdG340964-POL1PIC).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Arimbasseri AG, 2014, TRANSCR-AUSTIN, V5, DOI 10.4161/trns.27369; Arimbasseri AG, 2015, MOL CELL, V58, P1124, DOI 10.1016/j.molcel.2015.04.002; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Barnes CO, 2015, MOL CELL, V59, P258, DOI 10.1016/j.molcel.2015.06.034; Boguta M, 2013, BBA-GENE REGUL MECH, V1829, P376, DOI 10.1016/j.bbagrm.2012.11.004; Brun I, 1997, EMBO J, V16, P5730, DOI 10.1093/emboj/16.18.5730; Bui KH, 2013, CELL, V155, P1233, DOI 10.1016/j.cell.2013.10.055; Carter R, 2010, MOL BIOL EVOL, V27, P1035, DOI 10.1093/molbev/msp316; Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; DiMaio F, 2013, PROTEIN SCI, V22, P865, DOI 10.1002/pro.2267; Ehara H, 2011, PROTEIN SCI, V20, P1558, DOI 10.1002/pro.682; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel C, 2013, NATURE, V502, P650, DOI 10.1038/nature12712; Fernandez-Tornero C, 2007, MOL CELL, V25, P813, DOI 10.1016/j.molcel.2007.02.016; Fernandez-Tornero C, 2013, NATURE, V502, P644, DOI 10.1038/nature12636; Fernandez-Tornero C, 2010, EMBO J, V29, P3762, DOI 10.1038/emboj.2010.266; Ferri ML, 2000, MOL CELL BIOL, V20, P488, DOI 10.1128/MCB.20.2.488-495.2000; Geiger SR, 2010, MOL CELL, V39, P583, DOI 10.1016/j.molcel.2010.07.028; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Hu HL, 2015, MOL CELL BIOL, V35, P2831, DOI 10.1128/MCB.00263-15; Iben JR, 2011, NUCLEIC ACIDS RES, V39, P6100, DOI 10.1093/nar/gkr182; Jasiak AJ, 2006, MOL CELL, V23, P71, DOI 10.1016/j.molcel.2006.05.013; JIANG JS, 1994, J MOL BIOL, V243, P100, DOI 10.1006/jmbi.1994.1633; Jun SH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6132; Kassavetis GA, 2010, J BIOL CHEM, V285, P2695, DOI 10.1074/jbc.M109.074013; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Khoo SK, 2014, MOL CELL BIOL, V34, P551, DOI 10.1128/MCB.00910-13; Kosinski J, 2015, J STRUCT BIOL, V189, P177, DOI 10.1016/j.jsb.2015.01.014; Kosinski J, 2013, BIOINFORMATICS, V29, P953, DOI 10.1093/bioinformatics/btt062; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Landrieux E, 2006, EMBO J, V25, P118, DOI 10.1038/sj.emboj.7600915; Lane LA, 2011, STRUCTURE, V19, P90, DOI 10.1016/j.str.2010.11.009; Lefevre S, 2011, NAT STRUCT MOL BIOL, V18, P352, DOI 10.1038/nsmb.1996; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Moreno-Morcillo M, 2014, ACTA CRYSTALLOGR D, V70, P2570, DOI 10.1107/S1399004714015788; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plaschka C, 2015, NATURE, V518, P376, DOI 10.1038/nature14229; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Rijal K, 2013, NUCLEIC ACIDS RES, V41, P139, DOI 10.1093/nar/gks985; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Ross A. W., INT TABLES CRYSTALLO, P259; Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088; Sainsbury S, 2015, NAT REV MOL CELL BIO, V16, P129, DOI 10.1038/nrm3952; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; SHAABAN SA, 1995, MOL CELL BIOL, V15, P1467; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Svetlov V, 2013, BBA-GENE REGUL MECH, V1829, P20, DOI 10.1016/j.bbagrm.2012.08.009; THUILLIER V, 1995, EMBO J, V14, P351, DOI 10.1002/j.1460-2075.1995.tb07009.x; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Vannini A, 2010, CELL, V143, P59, DOI 10.1016/j.cell.2010.09.002; Wang ZX, 1997, GENE DEV, V11, P1315, DOI 10.1101/gad.11.10.1315; Werner M, 2009, CURR OPIN STRUC BIOL, V19, P740, DOI 10.1016/j.sbi.2009.10.005; White RJ, 2008, TRENDS GENET, V24, P622, DOI 10.1016/j.tig.2008.10.003; WHITEHALL SK, 1994, J BIOL CHEM, V269, P2299; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu CC, 2012, P NATL ACAD SCI USA, V109, P19232, DOI 10.1073/pnas.1211665109; Wu CC, 2011, MOL CELL BIOL, V31, P2715, DOI 10.1128/MCB.05151-11	73	120	122	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					231	+		10.1038/nature16143	http://dx.doi.org/10.1038/nature16143			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26605533	Green Accepted			2022-12-28	WOS:000366053300034
J	Wang, C; Yosef, N; Gaublomme, J; Wu, C; Lee, Y; Clish, CB; Kaminski, J; Xiao, S; Horste, GMZ; Pawlak, M; Kishi, Y; Joller, N; Karwacz, K; Zhu, C; Ordovas-Montanes, M; Madi, A; Wortman, I; Miyazaki, T; Sobel, RA; Park, H; Regev, A; Kuchroo, VK				Wang, Chao; Yosef, Nir; Gaublomme, Jellert; Wu, Chuan; Lee, Youjin; Clish, Clary B.; Kaminski, Jim; Xiao, Sheng; Horste, Gerd Meyer Zu; Pawlak, Mathias; Kishi, Yasuhiro; Joller, Nicole; Karwacz, Katarzyna; Zhu, Chen; Ordovas-Montanes, Maria; Madi, Asaf; Wortman, Ivo; Miyazaki, Toru; Sobel, Raymond A.; Park, Hongkun; Regev, Aviv; Kuchroo, Vijay K.			CD5L/AIM Regulates Lipid Biosynthesis and Restrains Th17 Cell Pathogenicity	CELL			English	Article							ANTI-INTERLEUKIN-17 MONOCLONAL-ANTIBODY; ROR-GAMMA-T; T(H)17 CELLS; TGF-BETA; TRANSCRIPTIONAL NETWORK; RECEPTOR; DIFFERENTIATION; INDUCTION; LIGANDS; OBESITY	Th17 cells play a critical role in host defense against extracellular pathogens and tissue homeostasis but can induce autoimmunity. The mechanisms implicated in balancing "pathogenic" and "non-pathogenic" Th17 cell states remain largely unknown. We used single-cell RNA-seq to identify CD5L/AIM as a regulator expressed in non-pathogenic, but not in pathogenic Th17 cells. Although CD5L does not affect Th17 differentiation, it is a functional switch that regulates the pathogenicity of Th17 cells. Loss of CD5L converts non-pathogenic Th17 cells into pathogenic cells that induce autoimmunity. CD5L mediates this effect by modulating the intracellular lipidome, altering fatty acid composition and restricting cholesterol biosynthesis and, thus, ligand availability for Rorgt, the master transcription factor of Th17 cells. Our study identifies CD5L as a critical regulator of the Th17 cell functional state and highlights the importance of lipid metabolism in balancing immune protection and disease induced by T cells.	[Wang, Chao; Wu, Chuan; Lee, Youjin; Xiao, Sheng; Horste, Gerd Meyer Zu; Pawlak, Mathias; Kishi, Yasuhiro; Joller, Nicole; Karwacz, Katarzyna; Zhu, Chen; Ordovas-Montanes, Maria; Madi, Asaf; Kuchroo, Vijay K.] Harvard Univ, Evergrande Ctr Immunol Dis, Sch Med, Boston, MA 02115 USA; [Wang, Chao; Wu, Chuan; Lee, Youjin; Xiao, Sheng; Horste, Gerd Meyer Zu; Pawlak, Mathias; Kishi, Yasuhiro; Joller, Nicole; Karwacz, Katarzyna; Zhu, Chen; Ordovas-Montanes, Maria; Madi, Asaf; Kuchroo, Vijay K.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Yosef, Nir; Gaublomme, Jellert; Clish, Clary B.; Madi, Asaf; Wortman, Ivo; Park, Hongkun; Regev, Aviv; Kuchroo, Vijay K.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Gaublomme, Jellert; Park, Hongkun] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Gaublomme, Jellert; Park, Hongkun] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Yosef, Nir] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Sobel, Raymond A.] Stanford Univ, Sch Med, Palo Alto Vet Adm Hlth Care Syst, Stanford, CA 94305 USA; [Sobel, Raymond A.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Miyazaki, Toru] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Lab Mol Biomed Pathogenesis, Tokyo 1130033, Japan; [Regev, Aviv] MIT, Howard Hughes Med Inst, Cambridge, MA 20140 USA; [Regev, Aviv] MIT, David H Koch Inst Integrat Canc Res, Dept Biol, Cambridge, MA 20140 USA; [Yosef, Nir; Kaminski, Jim] Univ Calif Berkeley, Ctr Computat Biol, Berkeley, CA 94720 USA; [Kishi, Yasuhiro] Mitsubishi Tanabe Pharma Corp, Yokohama, Kanagawa 2250002, Japan	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; University of California System; University of California Berkeley; Stanford University; Stanford University; University of Tokyo; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; Mitsubishi Tanabe Pharma Corporation	Regev, A (corresponding author), Broad Inst MIT & Harvard, 415 Main St, Cambridge, MA 02142 USA.	aregev@broadinstitute.org; vkuchroo@evergrande.hms.harvard.edu	Horste, Gerd Meyer zu/O-9549-2016; Clish, Clary/AAB-7124-2019; Clish, Clary B/ABB-9374-2021; Wang, Chao/GYD-5103-2022; Park, Hongkun/R-9842-2019; Joller, Nicole/G-7897-2015; Wu, Chuan/H-6379-2013	Horste, Gerd Meyer zu/0000-0002-4341-4719; Clish, Clary B/0000-0001-8259-9245; Wang, Chao/0000-0003-3084-6093; Park, Hongkun/0000-0001-9576-8829; Joller, Nicole/0000-0003-1996-1672; Sobel, Raymond/0000-0002-0477-9002; Wu, Chuan/0000-0003-2288-353X; Miyazaki, Toru/0000-0003-3842-4362; Pawlak, Mathias/0000-0002-4533-398X; Madi, Asaf/0000-0003-3441-3228	Klarman Cell Observatory at the Broad Institute; HHMI; Koch Institute Support (core) Grant from the National Cancer Institute [P30-CA14051]; Evergrande Center for Immunologic diseases [NS030843, AI039671, NS076410, AI056299]; Crohn's and Colitis Foundation of America; National Multiple Sclerosis Society [TA-3059-A-2]; US National Institutes of Health [4R00AI110649]; Multiple Sclerosis Society of Canada; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI110649, P01AI056299, P01AI045757, P01AI039671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS076410, R01NS030843, R37NS030843, R29NS030843] Funding Source: NIH RePORTER	Klarman Cell Observatory at the Broad Institute; HHMI(Howard Hughes Medical Institute); Koch Institute Support (core) Grant from the National Cancer Institute; Evergrande Center for Immunologic diseases; Crohn's and Colitis Foundation of America; National Multiple Sclerosis Society(National Multiple Sclerosis Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Sclerosis Society of Canada; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful for Mary Collins, Patrick Burkett, and Alan Saghatelian for critical reading of the manuscript. We thank Leslie Gaffney for assistance with preparation of figures. We thank the Broad Metabolomics Platform for the metabolite profiling experiments. This project was supported by the Klarman Cell Observatory at the Broad Institute (A.R. and H.P.), HHMI (A.R.), in part by the Koch Institute Support (core) Grant P30-CA14051 from the National Cancer Institute, the Evergrande Center for Immunologic diseases (VKK), grant numbers NS030843, AI039671, NS076410, and AI056299, and the Crohn's and Colitis Foundation of America (V.K.K.). C. Wu was supported by a Career Transition Award from the National Multiple Sclerosis Society (TA-3059-A-2) and US National Institutes of Health (4R00AI110649). C. Wang was supported by an endMS Postdoctoral Fellowship from the Multiple Sclerosis Society of Canada. During the course of the research, V.K.K. had an ownership interest in Tempero Pharmaceuticals, a company that was working in the area of Treg-Th17 biology and developing treatments for autoimmune diseases in areas related to this research. V.K.K.'s ownership ended in October 2014. V.K.K.'s interests were reviewed and managed by the Brigham and Women's Hospital and Partners HealthCare in accordance with their conflict of interest policies.	Ahmed M, 2010, CYTOKINE GROWTH F R, V21, P449, DOI 10.1016/j.cytogfr.2010.10.005; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Baeten DLP, 2013, NAT MED, V19, P824, DOI 10.1038/nm.3268; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Gaffen SL, 2011, IMMUNOL RES, V50, P181, DOI 10.1007/s12026-011-8226-x; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Guglani L, 2010, CURR OPIN HIV AIDS, V5, P120, DOI 10.1097/COH.0b013e328335c2f6; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Jhun JY, 2012, EXP MOL MED, V44, P424, DOI 10.3858/emm.2012.44.7.047; Jin LH, 2010, MOL ENDOCRINOL, V24, P923, DOI 10.1210/me.2009-0507; Kleinewietfeld M, 2013, SEMIN IMMUNOL, V25, P305, DOI 10.1016/j.smim.2013.10.009; Konkel JE, 2011, TRENDS MOL MED, V17, P668, DOI 10.1016/j.molmed.2011.07.002; Kurokawa J, 2010, CELL METAB, V11, P479, DOI 10.1016/j.cmet.2010.04.013; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee Y, 2014, J CLIN IMMUNOL, V34, pS56, DOI 10.1007/s10875-014-0040-5; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martinez VG, 2014, CELL MOL IMMUNOL, V11, P343, DOI 10.1038/cmi.2014.12; Mathews JA, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00440; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Monk JM, 2013, J NUTR, V143, P1501, DOI 10.3945/jn.113.178178; Monk JM, 2012, J NUTR, V142, P117, DOI 10.3945/jn.111.147058; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Patel DD, 2013, ANN RHEUM DIS, V72, P116, DOI 10.1136/annrheumdis-2012-202371; Pe'er D., 2002, BIOINFORMATICS, V18, P258; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Santori FR, 2015, CELL METAB, V21, P286, DOI 10.1016/j.cmet.2015.01.004; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Soroosh P, 2014, P NATL ACAD SCI USA, V111, P12163, DOI 10.1073/pnas.1322807111; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Xiao S, 2014, IMMUNITY, V40, P477, DOI 10.1016/j.immuni.2014.04.004; Xu JN, 2009, J IMMUNOL, V182, P6226, DOI 10.4049/jimmunol.0900123; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	57	236	252	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6								10.1016/j.cell.2015.10.068	http://dx.doi.org/10.1016/j.cell.2015.10.068			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26607793	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000366044800006
J	Edelman, ER; Weber, BN				Edelman, Elazer R.; Weber, Brittany N.			Tenuous Tether	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Edelman, Elazer R.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Edelman, Elazer R.; Weber, Brittany N.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Edelman, Elazer R.; Weber, Brittany N.] Harvard Univ, Sch Med, Boston, MA USA	Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Edelman, ER (corresponding author), MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA.							Laennec RTH, 1838, AUSCULTATION MEDIATE; Solomon SD, 2014, NEW ENGL J MED, V370, P1083, DOI 10.1056/NEJMp1311944	2	11	11	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2015	373	23					2199	2201		10.1056/NEJMp1509625	http://dx.doi.org/10.1056/NEJMp1509625			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5LM	26630141				2022-12-28	WOS:000365743100003
J	Jin, WF; Tang, QS; Wan, MM; Cui, KR; Zhang, Y; Ren, G; Ni, B; Sklar, J; Przytycka, TM; Childs, R; Levens, D; Zhao, KJ				Jin, Wenfei; Tang, Qingsong; Wan, Mimi; Cui, Kairong; Zhang, Yi; Ren, Gang; Ni, Bing; Sklar, Jeffrey; Przytycka, Teresa M.; Childs, Richard; Levens, David; Zhao, Keji			Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples	NATURE			English	Article							CHROMATIN ACCESSIBILITY; SUPER-ENHANCERS; EXPRESSION; GENE; SEQ; PATTERNS; IDENTITY; DISTINCT; REVEALS; DIFFERENTIATION	DNase I hypersensitive sites (DHSs) provide important information on the presence of transcriptional regulatory elements and the state of chromatin in mammalian cells(1-3). Conventional DNase sequencing (DNase-seq) for genome-wide DHSs profiling is limited by the requirement of millions of cells(4,5). Here we report an ultrasensitive strategy, called single-cell DNase sequencing (scDNase-seq) for detection of genome-wide DHSs in single cells. We show that DHS patterns at the single-cell level are highly reproducible among individual cells. Among different single cells, highly expressed gene promoters and enhancers associated with multiple active histone modifications display constitutive DHS whereas chromatin regions with fewer histone modifications exhibit high variation of DHS. Furthermore, the single-cell DHSs predict enhancers that regulate cell-specific gene expression programs and the cell-to-cell variations of DHS are predictive of gene expression. Finally, we apply scDNase-seq to pools of tumour cells and pools of normal cells, dissected from formalin-fixed paraffin-embedded tissue slides from patients with thyroid cancer, and detect thousands of tumour-specific DHSs. Many of these DHSs are associated with promoters and enhancers critically involved in cancer development. Analysis of the DHS sequences uncovers one mutation (chr18: 52417839G> C) in the tumour cells of a patient with follicular thyroid carcinoma, which affects the binding of the tumour suppressor protein p53 and correlates with decreased expression of its target gene TXNL1. In conclusion, scDNase-seq can reliably detect DHSs in single cells, greatly extending the range of applications of DHS analysis both for basic and for translational research, and may provide critical information for personalized medicine.	[Jin, Wenfei; Tang, Qingsong; Cui, Kairong; Zhang, Yi; Ren, Gang; Zhao, Keji] NHLBI, Syst Biol Ctr, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Wan, Mimi; Sklar, Jeffrey] Yale Univ, Dept Pathol, Sch Med, New Haven, CT 06520 USA; [Zhang, Yi; Ni, Bing] Peoples Liberat Army, Mil Med Univ 3, Inst Immunol, Chongqing 400038, Peoples R China; [Ren, Gang] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China; [Przytycka, Teresa M.] Natl Lib Med, Computat Biol Branch, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20892 USA; [Childs, Richard] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; [Levens, David] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Yale University; Army Medical University; Northwest A&F University - China; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zhao, KJ (corresponding author), NHLBI, Syst Biol Ctr, Div Intramural Res, NIH, Bldg 10, Bethesda, MD 20892 USA.	zhaok@nhlbi.nih.gov	t, lf/AAJ-4924-2020; Levens, David/C-9216-2009; Jin, Wenfei/V-9944-2019; Jin, Wenfei/H-5330-2011	Levens, David/0000-0002-7616-922X; Jin, Wenfei/0000-0002-0028-3739; Jin, Wenfei/0000-0002-0028-3739; Przytycka, Teresa/0000-0002-6261-277X; Ni, Bing/0000-0002-4297-5346; REN, GANG/0000-0001-9690-5995	Division of Intramural Research, National Heart, Lung, and Blood Institute; Intramural Research Program of National Library of Medicine; Center for Cancer Research of the National Cancer Institute of the National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIASC009144] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002345, ZIAHL005801, ZICHL006058] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM200887] Funding Source: NIH RePORTER	Division of Intramural Research, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural Research Program of National Library of Medicine; Center for Cancer Research of the National Cancer Institute of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank J. Cooper and B. Z. Stanton for reading the manuscript, the National Heart, Lung, and Blood Institute DNA Sequencing Core Facility for sequencing the libraries and the National Heart, Lung, and Blood Institute Flow Cytometry Core facility for sorting the cells. The work was supported by Division of Intramural Research, National Heart, Lung, and Blood Institute (to K.Z.), Intramural Research Program of National Library of Medicine (to T.M.P.) and the Center for Cancer Research of the National Cancer Institute (to D.L.) of the National Institutes of Health.	Andersen KM, 2009, J BIOL CHEM, V284, P15246, DOI 10.1074/jbc.M900016200; Beige G., 2003, GENE CHROMOSOME CANC, V47, P56; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Buenrostro J. D., 2015, NATURE, V523, P436; Chiappetta G., 2003, EUR J CANCER, V44, P1015; Crawford G. E., 2010, COLD SPRING HARB PRO; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Emerling BM, 2013, CELL, V155, P844, DOI 10.1016/j.cell.2013.09.057; Gemoll T, 2011, CELL MOL LIFE SCI, V68, P3261, DOI 10.1007/s00018-011-0628-3; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hu GQ, 2013, NAT IMMUNOL, V14, P1190, DOI 10.1038/ni.2712; Hu GQ, 2013, CELL STEM CELL, V12, P180, DOI 10.1016/j.stem.2012.11.003; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kraushaar DC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r121; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lin CQ, 2013, CELL, V152, P144, DOI 10.1016/j.cell.2012.12.015; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Lui WO, 2005, ONCOGENE, V24, P1467, DOI 10.1038/sj.onc.1208135; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Ni P, 2014, CURR CANCER DRUG TAR, V14, P850, DOI 10.2174/1568009614666141028094612; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Sasagawa Y, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r31; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Sheffield NC, 2013, GENOME RES, V23, P777, DOI 10.1101/gr.152140.112; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	39	203	235	2	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					142	+		10.1038/nature15740	http://dx.doi.org/10.1038/nature15740			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26605532	Green Accepted			2022-12-28	WOS:000365606000065
J	Zhang, X; Davidson, EA; Mauzerall, DL; Searchinger, TD; Dumas, P; Shen, Y				Zhang, Xin; Davidson, Eric A.; Mauzerall, Denise L.; Searchinger, Timothy D.; Dumas, Patrice; Shen, Ye			Managing nitrogen for sustainable development	NATURE			English	Article							ENVIRONMENTAL KUZNETS CURVE; ECONOMIC-GROWTH; CROPPING SYSTEMS; FOOD SECURITY; AGRICULTURE; HYPOTHESIS; MANAGEMENT; EMISSIONS; CHINA; TOOL	Improvements in nitrogen use efficiency in crop production are critical for addressing the triple challenges of food security, environmental degradation and climate change. Such improvements are conditional not only on technological innovation, but also on socio-economic factors that are at present poorly understood. Here we examine historical patterns of agricultural nitrogen-use efficiency and find a broad range of national approaches to agricultural development and related pollution. We analyse examples of nitrogen use and propose targets, by geographic region and crop type, to meet the 2050 global food demand projected by the Food and Agriculture Organization while also meeting the Sustainable Development Goals pertaining to agriculture recently adopted by the United Nations General Assembly. Furthermore, we discuss socio-economic policies and technological innovations that may help achieve them.	[Zhang, Xin; Mauzerall, Denise L.; Searchinger, Timothy D.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Zhang, Xin] Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA; [Davidson, Eric A.] Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD 21532 USA; [Mauzerall, Denise L.] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA; [Dumas, Patrice] Ctr Cooperat Int Rech Agron Dev CIRAD, F-75116 Paris, France; [Dumas, Patrice] CIRED, F-94736 Nogent Sur Marne, France; [Shen, Ye] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA	Princeton University; Princeton University; University System of Maryland; University of Maryland Center for Environmental Science; Princeton University; CIRAD; AgroParisTech; Ecole des Ponts ParisTech; UDICE-French Research Universities; Universite Paris Saclay; University System of Georgia; University of Georgia	Zhang, X (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA.	xzhang@al.umces.edu; edavidson@umces.edu	Zhang, Xin/K-8264-2016; Davidson, Eric A/K-4984-2013; Mauzerall, Denise L/I-5977-2013; Zhang, Xin/AGA-7371-2022	Zhang, Xin/0000-0003-1619-1537; Davidson, Eric A/0000-0002-8525-8697; Mauzerall, Denise L/0000-0003-3479-1798; Zhang, Xin/0000-0003-1619-1537	programme in Science, Technology, and Environmental Policy at the Woodrow Wilson School at Princeton University; United States Department of Agriculture [2011-67003-30373]; National Oceanic and Atmospheric Administration, United States Department of Commerce [NA14OAR4320106]	programme in Science, Technology, and Environmental Policy at the Woodrow Wilson School at Princeton University; United States Department of Agriculture(United States Department of Agriculture (USDA)); National Oceanic and Atmospheric Administration, United States Department of Commerce	We thank G. M. Grossman, Mark W. Watson, G. Chow, Z. Shi, O. Torres-Reyna and Y. Wang for their advice on economic data analysis. We thank E. Shevliakova, F. Gonzalez Taboada and D. R. Kanter for comments. This study was supported by the programme in Science, Technology, and Environmental Policy at the Woodrow Wilson School at Princeton University, the United States Department of Agriculture (grant 2011-67003-30373), and the National Oceanic and Atmospheric Administration, United States Department of Commerce (award NA14OAR4320106). The statements, findings, conclusions, and recommendations are those of the authors and do not necessarily reflect the views of the National Oceanic and Atmospheric Administration, the US Department of Commerce, or the US Department of Agriculture. This is Scientific Contribution number 5080 of the University of Maryland Center for Environmental Science Appalachian Laboratory.	Al-Mulali U, 2015, ENERG POLICY, V76, P123, DOI 10.1016/j.enpol.2014.11.019; Alam M. S., 2013, INT J EC FINANCE, V5, P86; Alexandratos N., 2012, 1203 ESA FAO, DOI DOI 10.1016/S0264-8377(03)00047-4; [Anonymous], 2000, AGRIC RESOUR ECON RE, DOI DOI 10.1017/S1068280500001416; [Anonymous], 2020, WORLD DEV IND; Arrow K, 1995, ECOL ECON, V15, P91, DOI 10.1016/0921-8009(95)00059-3; Avnery S, 2011, ATMOS ENVIRON, V45, P2284, DOI 10.1016/j.atmosenv.2010.11.045; Billen G, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/2/025001; Bodirsky BL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4858; Bouwman L, 2013, P NATL ACAD SCI USA, V110, P20882, DOI 10.1073/pnas.1012878108; Brock WA, 2005, HANDB ECON, V22, P1749; Brouwer F, 1998, NUTR CYCL AGROECOSYS, V52, P303, DOI 10.1023/A:1009783302364; Cassman KG, 2003, ANNU REV ENV RESOUR, V28, P315, DOI 10.1146/annurev.energy.28.040202.122858; Chow GC, 2014, PAC ECON REV, V19, P1, DOI 10.1111/1468-0106.12048; Cole M.A., 1997, ENVIRON DEV ECON, V2, P401, DOI DOI 10.1017/S1355770X97000211; Conant RT, 2013, GLOBAL BIOGEOCHEM CY, V27, P558, DOI 10.1002/gbc.20053; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; David MB, 2015, J ENVIRON QUAL, V44, P368, DOI 10.2134/jeq2014.01.0036; Davidson EA, 2014, CURR OPIN ENV SUST, V9-10, P1, DOI 10.1016/j.cosust.2014.07.003; Davidson EA, 2015, J ENVIRON QUAL, V44, P305, DOI 10.2134/jeq2015.02.0078; de Vries W, 2013, CURR OPIN ENV SUST, V5, P392, DOI 10.1016/j.cosust.2013.07.004; Diao XD, 2009, J CLEAN PROD, V17, P541, DOI 10.1016/j.jclepro.2008.09.007; Dinda S, 2004, ECOL ECON, V49, P431, DOI 10.1016/j.ecolecon.2004.02.011; Drinkwater LE, 1998, NATURE, V396, P262, DOI 10.1038/24376; Erisman JW, 2008, NAT GEOSCI, V1, P636, DOI 10.1038/ngeo325; Ferguson RB, 2015, J ENVIRON QUAL, V44, P449, DOI 10.2134/jeq2014.02.0085; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Griffis TJ, 2013, GLOBAL BIOGEOCHEM CY, V27, P746, DOI 10.1002/gbc.20066; GROSSMAN GM, 1995, Q J ECON, V110, P353, DOI 10.2307/2118443; He J, 2012, ECOL ECON, V76, P49, DOI 10.1016/j.ecolecon.2012.01.014; Heffer P., 2013, ASSESSMENT FERTILIZE; Heffer P., 2009, ASSESSMENT FERTILIZE; Herridge DF, 2008, PLANT SOIL, V311, P1, DOI 10.1007/s11104-008-9668-3; Hickman JE, 2015, J GEOPHYS RES-BIOGEO, V120, P938, DOI 10.1002/2015JG002913; Hickman JE, 2011, CURR OPIN ENV SUST, V3, P370, DOI 10.1016/j.cosust.2011.08.001; Howard C. M., 2011, EUROPEAN NITROGEN AS, DOI [10.1017/CBO9780511976988, DOI 10.1017/CBO9780511976988]; IFA, 2009, GLOB 4R NUTR STEW FR; Jayanthakumaran K, 2012, ENERG POLICY, V42, P450, DOI 10.1016/j.enpol.2011.12.010; Jayne TS, 2013, AGR ECON-BLACKWELL, V44, P547, DOI 10.1111/agec.12073; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Ju XT, 2007, ENVIRON POLLUT, V145, P497, DOI 10.1016/j.envpol.2006.04.017; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Lassaletta L, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/105011; Lassaletta L, 2014, BIOGEOCHEMISTRY, V118, P225, DOI 10.1007/s10533-013-9923-4; Leadership Council of the Sustainable Development Solutions Network (SDSN), 2015, IND MON FRA IN PRESS; Li YX, 2013, J ENVIRON QUAL, V42, P972, DOI 10.2134/jeq2012.0465; Liu JG, 2010, P NATL ACAD SCI USA, V107, P8035, DOI 10.1073/pnas.0913658107; MacDonald GK, 2012, GLOBAL CHANGE BIOL, V18, P1904, DOI 10.1111/j.1365-2486.2012.02653.x; MacDonald GK, 2011, P NATL ACAD SCI USA, V108, P3086, DOI 10.1073/pnas.1010808108; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Muller-Furstenberger G, 2007, ECOL ECON, V62, P648, DOI 10.1016/j.ecolecon.2006.08.005; Mulla DJ, 2013, BIOSYST ENG, V114, P358, DOI 10.1016/j.biosystemseng.2012.08.009; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Newell Price JP, 2011, INVENTORY MITIGATION; Osmond DL, 2015, J ENVIRON QUAL, V44, P382, DOI 10.2134/jeq2014.02.0091; Panayotou T, 1993, 238 INT LAB ORG TECH; Perez MR, 2015, J ENVIRON QUAL, V44, P402, DOI 10.2134/jeq2014.07.0304; Pesaran MH, 2001, J APPL ECONOMET, V16, P289, DOI 10.1002/jae.616; Powell JM, 2015, J ENVIRON QUAL, V44, P336, DOI 10.2134/jeq2014.07.0299; Powell JM, 2010, ENVIRON SCI POLICY, V13, P217, DOI 10.1016/j.envsci.2010.03.007; Reay DS, 2012, NAT CLIM CHANGE, V2, P410, DOI 10.1038/NCLIMATE1458; Robertson GP, 2013, BIOGEOCHEMISTRY, V114, P41, DOI 10.1007/s10533-012-9802-4; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Sanchez PA, 2005, LANCET, V365, P442, DOI 10.1016/S0140-6736(05)17834-9; Sawyer J., 2006, CONCEPTS RATIONALE R; Schoumans OF, 2014, SCI TOTAL ENVIRON, V468, P1255, DOI 10.1016/j.scitotenv.2013.08.061; Searchinger T., 2013, CREATING SUSTAINABLE; Setiyono TD, 2011, AGRON J, V103, P1276, DOI 10.2134/agronj2011.0053; Shi WM, 2009, NUTR CYCL AGROECOSYS, V83, P73, DOI 10.1007/s10705-008-9201-3; Singh AP, 2015, ENVIRON DEV SUSTAIN, V17, P1509, DOI 10.1007/s10668-015-9618-1; Snyder CS, 2014, CURR OPIN ENV SUST, V9-10, P46, DOI 10.1016/j.cosust.2014.07.005; Song ML, 2013, ENERG POLICY, V57, P14, DOI 10.1016/j.enpol.2012.04.036; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Stern DI, 2004, WORLD DEV, V32, P1419, DOI 10.1016/j.worlddev.2004.03.004; Stevens CJ, 2009, CRIT REV ENV SCI TEC, V39, P478, DOI 10.1080/10643380801910017; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; van Beek CL, 2003, NUTR CYCL AGROECOSYS, V67, P233, DOI 10.1023/B:FRES.0000003619.50198.55; van Grinsven HJM, 2012, BIOGEOSCIENCES, V9, P5143, DOI 10.5194/bg-9-5143-2012; van Grinsven HJM, 2015, J ENVIRON QUAL, V44, P356, DOI 10.2134/jeq2014.03.0102; Van Groenigen JW, 2010, EUR J SOIL SCI, V61, P903, DOI 10.1111/j.1365-2389.2009.01217.x; Wagner M., 2015, EC THEORY; Wagner M, 2008, RESOUR ENERGY ECON, V30, P388, DOI 10.1016/j.reseneeco.2007.11.001; Wagner M, 2015, J APPL ECONOMET, V30, P948, DOI 10.1002/jae.2421; Weber C, 2015, J ENVIRON QUAL, V44, P391, DOI 10.2134/jeq2014.02.0089; Yang L, 2014, ENV SCI ENG, P1, DOI DOI 10.1016/j.tra.2014.08.001; Zhang X, 2015, J ENVIRON QUAL, V44, P312, DOI 10.2134/jeq2014.03.0129; Zhou MH, 2014, ENVIRON RES LETT, V9, DOI [10.1088/1748-9326/9/10/105009, 10.1155/2014/943537]	90	1067	1141	142	1408	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					51	59		10.1038/nature15743	http://dx.doi.org/10.1038/nature15743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26595273	Green Submitted			2022-12-28	WOS:000365606000048
J	Hansen, O; Seger, B; Vesborg, PCK; Chorkendorff, I				Hansen, Ole; Seger, Brian; Vesborg, Peter C. K.; Chorkendorff, Ib			A quick look at how photoelectrodes work	SCIENCE			English	Editorial Material							PROTECTION LAYER; WATER; PHOTOANODES; EVOLUTION; DEVICE; TIO2; SI		[Hansen, Ole] Tech Univ Denmark, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark; [Seger, Brian; Vesborg, Peter C. K.; Chorkendorff, Ib] Tech Univ Denmark, Dept Phys, Ctr Individual Nanoparticle Funct, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Hansen, O (corresponding author), Tech Univ Denmark, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark.	ole.hansen@nanotech.dtu.dk	Hansen, Ole/C-4480-2011; Seger, Brian J/G-2433-2011; Vesborg, Peter C. K./A-4980-2010; Chorkendorff, Ib/C-7282-2008	Hansen, Ole/0000-0002-6090-8323; Seger, Brian J/0000-0002-0036-095X; Vesborg, Peter C. K./0000-0002-3761-4212; Chorkendorff, Ib/0000-0003-2738-0325				FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Hu S, 2014, SCIENCE, V344, P1005, DOI 10.1126/science.1251428; Jaramillo TF, 2007, SCIENCE, V317, P100, DOI 10.1126/science.1141483; Kemppainen E, 2015, ENERG ENVIRON SCI, V8, P2991, DOI 10.1039/c5ee02188j; Khaselev O, 1998, SCIENCE, V280, P425, DOI 10.1126/science.280.5362.425; McCrory CCL, 2013, J AM CHEM SOC, V135, P16977, DOI 10.1021/ja407115p; Mei B, 2015, J PHYS CHEM C, V119, P15019, DOI 10.1021/acs.jpcc.5b04407; Mei B, 2014, J PHYS CHEM LETT, V5, P3456, DOI 10.1021/jz501872k; Seger B, 2014, ENERG ENVIRON SCI, V7, P2397, DOI 10.1039/c4ee01335b; Vojvodic A, 2015, NATL SCI REV, V2, P140, DOI 10.1093/nsr/nwv023; Yang Y, 2015, SCIENCE, V350, P1061, DOI 10.1126/science.aad3459	11	6	6	1	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1030	1031		10.1126/science.aad6060	http://dx.doi.org/10.1126/science.aad6060			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY5BJ	26612935				2022-12-28	WOS:000366422600021
J	Hoag, H				Hoag, Hannah			Molecular biology: Marked progress	NATURE			English	Editorial Material							CARCINOMA IN-SITU; BREAST-CANCER; DIAGNOSIS; RISK											Afghahi A, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0623-y; Blancato J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087610; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Esserman L, 2014, ANN INTERN MED, V160, P511, DOI 10.7326/M14-0435; Kerlikowske K, 2010, JNCI-J NATL CANCER I, V102, P627, DOI 10.1093/jnci/djq101; Marks JR, 2015, CANCER EPIDEM BIOMAR, V24, P435, DOI 10.1158/1055-9965.EPI-14-1178; Narod SA, 2015, JAMA ONCOL, V1, P888, DOI 10.1001/jamaoncol.2015.2510; Rakovitch E, 2015, BREAST CANCER RES TR, V152, P389, DOI 10.1007/s10549-015-3464-6	8	5	5	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					S114	S115		10.1038/527S114a	http://dx.doi.org/10.1038/527S114a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26580160	Bronze			2022-12-28	WOS:000365356800005
J	Rammig, A; Mahecha, MD				Rammig, Anja; Mahecha, Miguel D.			ECOLOGY Ecosystem responses to climate extremes	NATURE			English	Editorial Material							SEMIARID ECOSYSTEMS; CARBON-CYCLE; VARIABILITY		[Rammig, Anja] Tech Univ Munich, TUM Sch Life Sci Weihenstephan, D-85354 Freising Weihenstephan, Germany; [Mahecha, Miguel D.] Max Planck Inst Biogeochem, D-07745 Jena, Germany	Technical University of Munich; Max Planck Society	Rammig, A (corresponding author), Tech Univ Munich, TUM Sch Life Sci Weihenstephan, D-85354 Freising Weihenstephan, Germany.	anja.rammig@tum.de; mmahecha@bgc-jena.mpg.de	Mahecha, Miguel D/F-2443-2010	Mahecha, Miguel D/0000-0003-3031-613X; Rammig, Anja/0000-0001-5425-8718				Ahlstrom A, 2015, SCIENCE, V348, P895, DOI 10.1126/science.aaa1668; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Holmgren M, 2006, FRONT ECOL ENVIRON, V4, P87, DOI 10.1890/1540-9295(2006)004[0087:ECESAA]2.0.CO;2; Isbell F, 2015, NATURE, V526, P574, DOI 10.1038/nature15374; Ma XL, 2015, J GEOPHYS RES-BIOGEO, V120, P2036, DOI 10.1002/2015JG003144; Poulter B, 2014, NATURE, V509, P600, DOI 10.1038/nature13376; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Richardson AD, 2013, AGR FOREST METEOROL, V169, P156, DOI 10.1016/j.agrformet.2012.09.012; Seneviratne S., 2012, SPECIAL REPORT WORKI, P109; UN, 2011, GLOB DRYL UN SYST WI	10	17	18	3	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					315	+		10.1038/527315a	http://dx.doi.org/10.1038/527315a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26581288				2022-12-28	WOS:000365356800043
J	[Anonymous]				[Anonymous]			When Science Is a Family Tradition	CELL			English	News Item																			0	0	0	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1049	1050						2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26590411	Bronze			2022-12-28	WOS:000366044700002
J	Barry, MJ; Hayes, JH				Barry, Michael J.; Hayes, Julia H.			Evaluating an Elevated Screening PSA Test	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROSTATE-SPECIFIC ANTIGEN; CANCER		[Barry, Michael J.] Massachusetts Gen Hosp, Dept Med, Div Gen Internal Med, Boston, MA 02114 USA; [Barry, Michael J.] Harvard Univ, Sch Med, Boston, MA USA; [Hayes, Julia H.] Dana Farber Canc Inst, Dept Hematol Oncol, Brighton, MA USA; [Hayes, Julia H.] St Elizabeths Med Ctr, Brighton, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; St. Elizabeth's Medical Center	Barry, MJ (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Gen Internal Med, 50 Staniford St,Ste 802, Boston, MA 02114 USA.	mbarry@partners.org						Ankerst DP, 2014, UROLOGY, V83, P1362, DOI 10.1016/j.urology.2014.02.035; ChoosingWisely, PSA BLOOD TEST PROST; Cooperberg MR, 2015, JAMA-J AM MED ASSOC, V314, P80, DOI 10.1001/jama.2015.6036; Gulati R, 2013, ANN INTERN MED, V158, P145, DOI 10.7326/0003-4819-158-3-201302050-00003; Hayes JH, 2014, JAMA-J AM MED ASSOC, V311, P1143, DOI 10.1001/jama.2014.2085; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; Thompson IM, 2014, JAMA-J AM MED ASSOC, V312, P995, DOI 10.1001/jama.2014.9680; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P66, DOI 10.1001/jama.294.1.66; Vickers AJ, 2011, J NATL CANCER I, V103, P462, DOI 10.1093/jnci/djr028; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162	10	5	5	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2015	314	19					2073	2074		10.1001/jama.2015.12614	http://dx.doi.org/10.1001/jama.2015.12614			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW1PR	26575065				2022-12-28	WOS:000364764200024
J	Borniger, JC				Borniger, Jeremy C.			Leaping into the unknown	SCIENCE			English	Editorial Material									Ohio State Univ, Neurosci Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Borniger, JC (corresponding author), Ohio State Univ, Neurosci Program, Columbus, OH 43210 USA.		Borniger, Jeremy/AAQ-5049-2020	Borniger, Jeremy/0000-0002-5419-0271					0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					882	882		10.1126/science.350.6262.882	http://dx.doi.org/10.1126/science.350.6262.882			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW3MS	26564857				2022-12-28	WOS:000364897000063
J	Horton, R				Horton, Richard			Public health research in the UK: the era of implementation	LANCET			English	Editorial Material												richard.horton@lancet.com							0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV	2015	386			2			S1	S1		10.1016/S0140-6736(15)00754-0	http://dx.doi.org/10.1016/S0140-6736(15)00754-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	VE7ZI	26572070				2022-12-28	WOS:000440368400001
J	Finn, AV; Virmani, R				Finn, Aloke V.; Virmani, Renu			The clinical challenge of disappearing stents	LANCET			English	Editorial Material							CORONARY; SCAFFOLD		[Finn, Aloke V.] Emory Univ, Sch Med, Atlanta, GA USA; [Virmani, Renu] CVPath Inst, Gaithersburg, MD 20878 USA	Emory University; CVPath Institute	Virmani, R (corresponding author), CVPath Inst, Gaithersburg, MD 20878 USA.	rvirmani@cvpath.org						Cassese S, 2015, LANCET; Ellis SG, 2015, NEW ENGL J MED, V373, P1905, DOI 10.1056/NEJMoa1509038; Gori T, 2016, EUR HEART J, V37, P2040, DOI 10.1093/eurheartj/ehv581; Koppara T, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.115.002427; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Navarese EP, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2014-000064; Onuma Y, 2011, CIRCULATION, V123, P779, DOI 10.1161/CIRCULATIONAHA.110.971606; Onuma Y, 2010, EUROINTERVENTION, V6, P447, DOI 10.4244/EIJ30V6I4A76; Otsuka F, 2014, CIRC-CARDIOVASC INTE, V7, P330, DOI 10.1161/CIRCINTERVENTIONS.113.000990; Puricel S, 2015, J AM COLL CARDIOL, V65, P791, DOI 10.1016/j.jacc.2014.12.017; Raber L, 2015, J AM COLL CARDIOL, V66, P1901, DOI 10.1016/j.jacc.2015.08.853; Sabate M, 2016, EUR HEART J, V37, P229, DOI 10.1093/eurheartj/ehv500; Serruys PW, 2015, LANCET, V385, P43, DOI 10.1016/S0140-6736(14)61455-0	13	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2016	387	10018					510	512		10.1016/S0140-6736(15)00978-2	http://dx.doi.org/10.1016/S0140-6736(15)00978-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3PV	26597772				2022-12-28	WOS:000369835800009
J	Neumann, PJ; Cohen, JT				Neumann, Peter J.; Cohen, Joshua T.			Measuring the Value of Prescription Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Neumann, Peter J.; Cohen, Joshua T.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Ctr Evaluat Value & Risk Hlth, Boston, MA 02111 USA	Tufts Medical Center	Neumann, PJ (corresponding author), Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Ctr Evaluat Value & Risk Hlth, Boston, MA 02111 USA.							Abboud C, 2013, BLOOD, V121, P4439, DOI 10.1182/blood-2013-03-490003; [Anonymous], 2015, NY TIMES; DiJulio B, 2015, KAISER HLTH TRACKING	3	106	107	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2015	373	27					2595	2597		10.1056/NEJMp1512009	http://dx.doi.org/10.1056/NEJMp1512009			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CZ8UH	26580666				2022-12-28	WOS:000367374100003
J	Young, RC				Young, Robert C.			Value-Based Cancer Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TOP 5 LIST; CLINICAL ONCOLOGY; AMERICAN SOCIETY		[Young, Robert C.] RCY Med, Philadelphia, PA 19118 USA		Young, RC (corresponding author), RCY Med, Philadelphia, PA 19118 USA.		young, robert/AAJ-3362-2020					Medicine Io, 2013, DELIVERING HIGH QUAL; Porter ME, 2013, HARVARD BUSINESS REV; Schnipper LE, 2015, J CLIN ONCOL, V33, P2563, DOI 10.1200/JCO.2015.61.6706; Schnipper LE, 2013, J CLIN ONCOL, V31, P4362, DOI 10.1200/JCO.2013.53.3943; Schnipper LE, 2012, J CLIN ONCOL, V30, P1715, DOI 10.1200/JCO.2012.42.8375	5	61	62	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2015	373	27					2593	2595		10.1056/NEJMp1508387	http://dx.doi.org/10.1056/NEJMp1508387			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CZ8UH	26580243				2022-12-28	WOS:000367374100002
J	Heisler, M; Baker, E; McKay, D				Heisler, Michele; Baker, Elise; McKay, Donna			Attacks on Health Care in Syria - Normalizing Violations of Medical Neutrality?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Heisler, Michele] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Heisler, Michele] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Heisler, Michele; Baker, Elise; McKay, Donna] Phys Human Rights, New York, NY USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Heisler, M (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA.		Heisler, Michele/B-5774-2015	Heisler, Michele/0000-0002-6889-2063	NIDDK NIH HHS [P30 DK092926] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		International Committee of the Red Cross, SUMM GEN CONV 1949 T; Physicians for Human Rights, AN CRIS MAP ATT HLTH; Physicians for Human Rights, 2015, AL AB CAS STUD HLTH; Sengupta Somini, 2015, NY TIMES	4	32	32	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2015	373	26					2489	2491		10.1056/NEJMp1513512	http://dx.doi.org/10.1056/NEJMp1513512			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CZ7SG	26580838	Green Accepted			2022-12-28	WOS:000367299700002
J	Hunter, NL; O'Callaghan, KM; Califf, RM				Hunter, Nina L.; O'Callaghan, Kathryn M.; Califf, Robert M.			Engaging Patients Across the Spectrum of Medical Product Development View From the US Food and Drug Administration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hunter, Nina L.; O'Callaghan, Kathryn M.] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA; [Califf, Robert M.] US FDA, Off Med Prod & Tobacco, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); FDA Center for Tobacco Products (CTP)	Califf, RM (corresponding author), US FDA, 10903 New Hampshire Ave,Bldg 1,Room 2314, Silver Spring, MD 20993 USA.	robert.califf@fda.hhs.gov						Gallin EK, 2013, ACAD MED, V88, P1220, DOI 10.1097/ACM.0b013e31829ed2a7; Hunter NL, FDAS PATIENT PREFERE; O'Callaghan K, LISTENING PATIENTS V; US Food and Drug Administration, STUD MARK YOUR DEV; US Food and Drug Administration, DRAFT GUID PAT PREF; US Food and Drug Administration, GUID IND FDA STAFF	6	42	43	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2015	314	23					2499	2500		10.1001/jama.2015.15818	http://dx.doi.org/10.1001/jama.2015.15818			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4PV	26584067				2022-12-28	WOS:000366391500011
J	Linari, M; Brunello, E; Reconditi, M; Fusi, L; Caremani, M; Narayanan, T; Piazzesi, G; Lombardi, V; Irving, M				Linari, Marco; Brunello, Elisabetta; Reconditi, Massimo; Fusi, Luca; Caremani, Marco; Narayanan, Theyencheri; Piazzesi, Gabriella; Lombardi, Vincenzo; Irving, Malcolm			Force generation by skeletal muscle is controlled by mechanosensing in myosin filaments	NATURE			English	Article							X-RAY-DIFFRACTION; SARCOMERE-LENGTH DEPENDENCE; VERTEBRATE STRIATED-MUSCLE; STRUCTURAL-CHANGES; THICK-FILAMENT; CROSS-BRIDGES; ACTIVE FORCE; FIBERS; CONTRACTION; FROG	Contraction of both skeletal muscle and the heart is thought to be controlled by a calcium-dependent structural change in the actin-containing thin filaments, which permits the binding of myosin motors from the neighbouring thick filaments to drive filament sliding(1-3). Here we show by synchrotron small-angle X-ray diffraction of frog (Rana temporaria) single skeletal muscle cells that, although the well-known thin-filament mechanism is sufficient for regulation of muscle shortening against low load, force generation against high load requires a second permissive step linked to a change in the structure of the thick filament. The resting (switched 'OFF') structure of the thick filament is characterized by helical tracks of myosin motors on the filament surface and a short backbone periodicity(2,4,5). This OFF structure is almost completely preserved during low-load shortening, which is driven by a small fraction of constitutively active (switched 'ON') myosin motors outside thick-filament control. At higher load, these motors generate sufficient thick-filament stress to trigger the transition to its long-periodicity ON structure, unlocking the major population of motors required for high-load contraction. This concept of the thick filament as a regulatory mechanosensor provides a novel explanation for the dynamic and energetic properties of skeletal muscle. A similar mechanism probably operates in the heart.	[Linari, Marco; Brunello, Elisabetta; Reconditi, Massimo; Caremani, Marco; Piazzesi, Gabriella; Lombardi, Vincenzo] Univ Florence, Dept Biol, Physiol Lab, I-50019 Florence, Italy; [Linari, Marco; Reconditi, Massimo] UdR Firenze, Consorzio Nazl Interuniv Sci Fis Mat, I-50019 Florence, Italy; [Fusi, Luca; Irving, Malcolm] Kings Coll London, Randall Div, London SE1 1UL, England; [Fusi, Luca; Irving, Malcolm] Kings Coll London, BHF Ctr Res Excellence, London SE1 1UL, England; [Narayanan, Theyencheri] European Synchrotron Radiat Facil, F-38043 Grenoble, France	University of Florence; University of London; King's College London; University of London; King's College London; European Synchrotron Radiation Facility (ESRF)	Lombardi, V (corresponding author), Univ Florence, Dept Biol, Physiol Lab, I-50019 Florence, Italy.	vincenzo.lombardi@unifi.it		Brunello, Elisabetta/0000-0003-3167-4828; Narayanan, Theyencheri/0000-0003-1957-1041; LINARI, MARCO/0000-0001-6512-4897; RECONDITI, MASSIMO/0000-0001-5065-924X; Caremani, Marco/0000-0001-9128-7227; Fusi, Luca/0000-0003-3992-0114	Ente Cassa di Risparmio di Firenze [2010.1402]; FIRB-Futuro in Ricerca project [RBFR08JAMZ]; MIUR-PRIN project (Italy) [2010R8JK2X]; MRC (UK); ESRF; MRC [G0601065] Funding Source: UKRI; Medical Research Council [G0601065] Funding Source: researchfish	Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); FIRB-Futuro in Ricerca project(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); MIUR-PRIN project (Italy); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRF; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Dolfi and J. Gorini for electronic and mechanical engineering support and P. Panine for assistance at the beamline. We thank ESRF for beamtime, and Ente Cassa di Risparmio di Firenze 2010.1402, FIRB-Futuro in Ricerca project RBFR08JAMZ, MIUR-PRIN project 2010R8JK2X (Italy), MRC (UK) and ESRF for financial support.	Bennett PM, 1996, J MOL BIOL, V259, P896, DOI 10.1006/jmbi.1996.0367; Brunello E, 2006, J PHYSIOL-LONDON, V577, P971, DOI 10.1113/jphysiol.2006.115394; Brunello E, 2014, J PHYSIOL-LONDON, V592, P3881, DOI 10.1113/jphysiol.2014.276196; CAPUTO C, 1994, J PHYSIOL-LONDON, V478, P137, DOI 10.1113/jphysiol.1994.sp020237; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; HASELGROVE JC, 1975, J MOL BIOL, V92, P113, DOI 10.1016/0022-2836(75)90094-7; HUXLEY HE, 1967, J MOL BIOL, V30, P383, DOI 10.1016/S0022-2836(67)80046-9; Huxley H, 2006, J MOL BIOL, V363, P743, DOI 10.1016/j.jmb.2006.08.075; Irving T, 2011, BIOPHYS J, V100, P1499, DOI 10.1016/j.bpj.2011.01.059; Jung HS, 2008, MOL BIOL CELL, V19, P3234, DOI 10.1091/mbc.E08-02-0206; Linari M, 2000, P NATL ACAD SCI USA, V97, P7226, DOI 10.1073/pnas.97.13.7226; Linari M, 2007, BIOPHYS J, V92, P2476, DOI 10.1529/biophysj.106.099549; LOMBARDI V, 1984, J MUSCLE RES CELL M, V5, P503, DOI 10.1007/BF00713257; Luther PK, 2011, P NATL ACAD SCI USA, V108, P11423, DOI 10.1073/pnas.1103216108; Muhle-Goll C, 2001, J MOL BIOL, V313, P431, DOI 10.1006/jmbi.2001.5017; Narayanan T, 2001, NUCL INSTRUM METH A, V467, P1005, DOI 10.1016/S0168-9002(01)00553-8; Pfuhl M, 2012, J MUSCLE RES CELL M, V33, P83, DOI 10.1007/s10974-012-9291-z; Piazzesi G, 2007, CELL, V131, P784, DOI 10.1016/j.cell.2007.09.045; Reconditi M, 2004, NATURE, V428, P578, DOI 10.1038/nature02380; Reconditi M, 2014, J PHYSIOL-LONDON, V592, P1119, DOI 10.1113/jphysiol.2013.267849; Reconditi M, 2011, P NATL ACAD SCI USA, V108, P7236, DOI 10.1073/pnas.1018330108; ROME E, 1973, NATURE-NEW BIOL, V244, P152, DOI 10.1038/newbio244152a0; Stewart MA, 2010, P NATL ACAD SCI USA, V107, P430, DOI 10.1073/pnas.0909468107; Woodhead JL, 2005, NATURE, V436, P1195, DOI 10.1038/nature03920; Yagi N, 2003, BIOPHYS J, V84, P1093, DOI 10.1016/S0006-3495(03)74925-X	25	159	159	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					276	+		10.1038/nature15727	http://dx.doi.org/10.1038/nature15727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26560032	Green Submitted			2022-12-28	WOS:000366053300044
J	Stuart-Smith, RD; Edgar, GJ; Barrett, NS; Kininmonth, SJ; Bates, AE				Stuart-Smith, Rick D.; Edgar, Graham J.; Barrett, Neville S.; Kininmonth, Stuart J.; Bates, Amanda E.			Thermal biases and vulnerability to warming in the world's marine fauna	NATURE			English	Article							CLIMATE-CHANGE; RANGE SHIFTS; OXYGEN LIMITATION; CONTINENTAL-SCALE; BIODIVERSITY; TEMPERATURE; ECOSYSTEMS; TOLERANCE; CONSERVATION; DIVERSITY	A critical assumption underlying projections of biodiversity change associated with global warming is that ecological communities comprise balanced mixes of warm-affinity and cool-affinity species which, on average, approximate local environmental temperatures. Nevertheless, here we find that most shallow water marine species occupy broad thermal distributions that are aggregated in either temperate or tropical realms. These distributional trends result in ocean-scale spatial thermal biases, where communities are dominated by species with warmer or cooler affinity than local environmental temperatures. We use community-level thermal deviations from local temperatures as a form of sensitivity to warming, and combine these with projected ocean warming data to predict warming-related loss of species from present-day communities over the next century. Large changes in local species composition appear likely, and proximity to thermal limits, as inferred from present-day species' distributional ranges, outweighs spatial variation in warming rates in contributing to predicted rates of local species loss.	[Stuart-Smith, Rick D.; Edgar, Graham J.; Barrett, Neville S.; Kininmonth, Stuart J.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7001, Australia; [Kininmonth, Stuart J.] Stockholm Univ, Stockholm Resilience Ctr, SE-10691 Kraftriket Stockholm, Sweden; [Bates, Amanda E.] Univ Southampton, Ocean & Earth Sci, Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England	University of Tasmania; Stockholm University; NERC National Oceanography Centre; University of Southampton	Stuart-Smith, RD (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7001, Australia.	rstuarts@utas.edu.au	Kininmonth, Stuart/N-9299-2013; Edgar, Graham/AAY-3797-2020; Bates, Amanda E./ABD-6874-2021; Stuart-Smith, Rick D/M-1829-2013; Stuart-Smith, Rick/I-5214-2019; Barrett, Neville S/J-7593-2014	Kininmonth, Stuart/0000-0001-9198-3396; Edgar, Graham/0000-0003-0833-9001; Bates, Amanda E./0000-0002-0198-4537; Stuart-Smith, Rick D/0000-0002-8874-0083; Stuart-Smith, Rick/0000-0002-8874-0083; Barrett, Neville S/0000-0002-6167-1356	Ian Potter Foundation; CoastWest; National Geographic Society; Conservation International; Wildlife Conservation Society Indonesia; Winston Churchill Memorial Trust; Australian-American Fulbright Commission; ASSEMBLE Marine	Ian Potter Foundation; CoastWest; National Geographic Society(National Geographic Society); Conservation International; Wildlife Conservation Society Indonesia; Winston Churchill Memorial Trust; Australian-American Fulbright Commission; ASSEMBLE Marine	We thank the many Reef Life Survey (RLS) divers who participated in data collection and provide ongoing expertise and commitment to the program, University of Tasmania staff including J. Berkhout, A. Cooper, M. Davey, J. Hulls, E. Oh, J. Stuart-Smith and R. Thomson. Development of RLS was supported by the former Commonwealth Environment Research Facilities Program, and analyses were supported by the Australian Research Council, Institute for Marine and Antarctic Studies, and the Marine Biodiversity Hub, a collaborative partnership supported through the Australian Government's National Environmental Science Programme. Additional funding and support for field surveys was provided by grants from the Ian Potter Foundation, CoastWest, National Geographic Society, Conservation International, Wildlife Conservation Society Indonesia, The Winston Churchill Memorial Trust, Australian-American Fulbright Commission, and ASSEMBLE Marine.	Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Bates AE, 2015, DIVERS DISTRIB, V21, P13, DOI 10.1111/ddi.12263; Bates AE, 2014, NAT CLIM CHANGE, V4, P62, DOI 10.1038/NCLIMATE2062; Beaugrand G, 2015, NAT CLIM CHANGE, V5, P695, DOI [10.1038/NCLIMATE2650, 10.1038/nclimate2650]; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Burrows MT, 2014, NATURE, V507, P492, DOI 10.1038/nature12976; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Cheung WWL, 2013, NATURE, V497, P365, DOI 10.1038/nature12156; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Deutsch C, 2015, SCIENCE, V348, P1132, DOI 10.1126/science.aaa1605; Devictor V, 2008, P ROY SOC B-BIOL SCI, V275, P2743, DOI 10.1098/rspb.2008.0878; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Edgar GJ, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.7; Edgar GJ, 2009, MAR ECOL PROG SER, V388, P51, DOI 10.3354/meps08149; Figueira WF, 2009, MAR ECOL PROG SER, V384, P231, DOI 10.3354/meps08057; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Garcia Molinos J, 2015, NATURE CLIM CHANGE; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Hiddink JG, 2008, GLOBAL CHANGE BIOL, V14, P453, DOI 10.1111/j.1365-2486.2007.01518.x; Jablonski D, 2013, P NATL ACAD SCI USA, V110, P10487, DOI 10.1073/pnas.1308997110; Kellermann V, 2012, P NATL ACAD SCI USA, V109, P16228, DOI 10.1073/pnas.1207553109; Kordas RL, 2011, J EXP MAR BIOL ECOL, V400, P218, DOI 10.1016/j.jembe.2011.02.029; Lima FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1713; MAGNUSON JJ, 1979, AM ZOOL, V19, P331; Mumby PJ, 2014, CURR OPIN ENV SUST, V7, P22, DOI 10.1016/j.cosust.2013.11.021; Nguyen KDT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029340; Okey TA, 2015, OCEAN COAST MANAGE, V106, P35, DOI 10.1016/j.ocecoaman.2015.01.009; Pacifici M, 2015, NAT CLIM CHANGE, V5, P215, DOI 10.1038/NCLIMATE2448; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Sunday JM, 2015, ECOL LETT, V18, P944, DOI 10.1111/ele.12474; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; Victor DG, 2014, NATURE, V514, P30, DOI 10.1038/514030a; Watson JEM, 2013, NAT CLIM CHANGE, V3, P989, DOI [10.1038/NCLIMATE2007, 10.1038/nclimate2007]; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Zografou K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087245	44	122	122	4	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					88	+		10.1038/nature16144	http://dx.doi.org/10.1038/nature16144			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26560025				2022-12-28	WOS:000365606000053
J	Black, M; Bhattacharya, S; Philip, S; Norman, JE; McLernon, DJ				Black, Mairead; Bhattacharya, Siladitya; Philip, Sam; Norman, Jane E.; McLernon, David J.			Planned Cesarean Delivery at Term and Adverse Outcomes in Childhood Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHILDREN BORN; SECTION; RISK; ASSOCIATION; MODE; MICROBIOTA; BIRTH; METAANALYSIS; MORTALITY; DISEASE	IMPORTANCE Planned cesarean delivery comprises a significant proportion of births globally, with combined rates of planned and unscheduled cesarean delivery in a number of regions approaching 50%. Observational studies have shown that offspring born by cesarean delivery are at increased risk of ill health in childhood, but these studies have been unable to adjust for some key confounding variables. Additionally, risk of death beyond the neonatal period has not yet been reported for offspring born by planned cesarean delivery. OBJECTIVE To investigate the relationship between planned cesarean delivery and offspring health problems or death in childhood. DESIGN, SETTING, AND PARTICIPANTS Population-based data-linkage study of 321 287 term singleton first-born offspring born in Scotland, United Kingdom, between 1993 and 2007, with follow-up until February 2015. EXPOSURES Offspring born by planned cesarean delivery in a first pregnancy were compared with offspring born by unscheduled cesarean delivery and with offspring delivered vaginally. MAIN OUTCOMES AND MEASURES The primary outcome was asthma requiring hospital admission; secondary outcomes were salbutamol inhaler prescription at age 5 years, obesity at age 5 years, inflammatory bowel disease, type 1 diabetes, cancer, and death. RESULTS Compared with offspring born by unscheduled cesarean delivery (n = 56 015 [17.4%]), those born by planned cesarean delivery (12 355 [3.8%]) were at no significantly different risk of asthma requiring hospital admission, salbutamol inhaler prescription at age 5 years, obesity at age 5 years, inflammatory bowel disease, cancer, or death but were at increased risk of type 1 diabetes (0.66% vs 0.44%; difference, 0.22%[95% CI, 0.13%-0.31%]; adjusted hazard ratio [HR], 1.35 [95% CI, 1.05-1.75]). In comparison with children born vaginally (n = 252 917 [78.7%]), offspring born by planned cesarean delivery were at increased risk of asthma requiring hospital admission (3.73% vs 3.41%; difference, 0.32% [95% CI, 0.21%-0.42%]; adjusted HR, 1.22 [95% CI, 1.11-1.34]), salbutamol inhaler prescription at age 5 years (10.34% vs 9.62%; difference, 0.72%[95% CI, 0.36%-1.07%]; adjusted HR, 1.13 [95% CI, 1.01-1.26]), and death (0.40% vs 0.32%; difference, 0.08%[95% CI, 0.02%-1.00%]; adjusted HR, 1.41 [95% CI, 1.05-1.90]), whereas there were no significant differences in risk of obesity at age 5 years, inflammatory bowel disease, type 1 diabetes, or cancer. CONCLUSIONS AND RELEVANCE Among offspring of women with first births in Scotland between 1993 and 2007, planned cesarean delivery compared with vaginal delivery (but not compared with unscheduled cesarean delivery) was associated with a small absolute increased risk of asthma requiring hospital admission, salbutamol inhaler prescription at age 5 years, and all-cause death by age 21 years. Further investigation is needed to understand whether the observed associations are causal.	[Black, Mairead; Bhattacharya, Siladitya; McLernon, David J.] Univ Aberdeen, Div Appl Hlth Sci, Aberdeen AB25 2ZD, Scotland; [Philip, Sam] NHS Grampian, Diabet Res Unit, Aberdeen, Scotland; [Norman, Jane E.] Univ Edinburgh, Tommys Ctr Maternal & Fetal Hlth, Edinburgh, Midlothian, Scotland	University of Aberdeen; University of Edinburgh	Black, M (corresponding author), Univ Aberdeen, Div Appl Hlth Sci, Aberdeen Matern Hosp, Room 3 Dugald Baird Ctr,Cornhill Rd, Aberdeen AB25 2ZD, Scotland.	mairead.black@abdn.ac.uk	Philip, Sam/AAE-3349-2021; McLernon, David/D-5167-2012	Norman, Jane/0000-0001-6031-6953; Black, Mairead/0000-0002-6841-8601; Philip, Sam/0000-0001-6164-211X; McLernon, David/0000-0001-8905-2429	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	Dr Black was funded by the Wellcome Trust as part of a personal research training fellowship.	Administrative Data Liaison Service (ADLS), PRESCR INF SYST; Blustein J, 2013, INT J OBESITY, V37, P900, DOI 10.1038/ijo.2013.49; Bruce A, 2014, INFLAMM BOWEL DIS, V20, P1217, DOI 10.1097/MIB.0000000000000075; Cardwell CR, 2008, DIABETOLOGIA, V51, P726, DOI 10.1007/s00125-008-0941-z; Hall MH, 1999, LANCET, V354, P776, DOI 10.1016/S0140-6736(05)76016-5; Information Services Division (ISD) Scotland, 2011, BIRTHS SCOTT HOSP 20; Information Services Division (ISD) Scotland, SCOTT CANC REG DAT A; Information Services Division (ISD) Scotland, 2010, DAT QUAL ASS ASS MAT; Information Services Division (ISD) Scotland, 2012, ASS SMR01 DAT 2010 2; Information Services Division (ISD) Scotland, 2010, PRIM ON BOD MASS IND; Information Services Division (ISD) Scotland, DAT DICT MOD DEL BAB; Jakobsson HE, 2014, GUT, V63, P559, DOI 10.1136/gutjnl-2012-303249; Kaplan JL, 2011, PEDIATR RES, V69, P465, DOI 10.1203/PDR.0b013e318217638a; Khashan AS, 2014, PEDIATRICS, V134, pE806, DOI 10.1542/peds.2014-0819; Kuhle S, 2015, OBES REV, V16, P295, DOI 10.1111/obr.12267; MacDorman MF, 2006, BIRTH-ISS PERINAT C, V33, P175, DOI 10.1111/j.1523-536X.2006.00102.x; Magnus MC, 2011, AM J EPIDEMIOL, V174, P1275, DOI 10.1093/aje/kwr242; McLoone P., 2004, CARSTAIRS SCORES SCO; Menacker F, 2006, SEMIN PERINATOL, V30, P235, DOI 10.1053/j.semperi.2006.07.002; Momen NC, 2014, BJOG-INT J OBSTET GY, V121, P1343, DOI 10.1111/1471-0528.12667; O'Callaghan M, 2013, OBSTET GYNECOL, V122, P1169, DOI 10.1097/AOG.0000000000000020; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Ponsonby AL, 2009, INFLAMM BOWEL DIS, V15, P858, DOI 10.1002/ibd.20842; Roduit C, 2009, THORAX, V64, P107, DOI 10.1136/thx.2008.100875; Ronca AE, 2006, BEHAV NEUROSCI, V120, P1308, DOI 10.1037/0735-7044.120.6.1308; Rook GAW, 2015, BRAIN RES, V1617, P47, DOI 10.1016/j.brainres.2014.04.004; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Rubin D., MULTIPLE IMPUTATION, P114; Salminen S, 2004, GUT, V53, P1388, DOI 10.1136/gut.2004.041640; Schlinzig T, 2009, ACTA PAEDIATR, V98, P1096, DOI 10.1111/j.1651-2227.2009.01371.x; Scottish Care Information Diabetes Collaboration (SCI-Diabetes), SCI DIAB FEAT BEN; Sevelsted A, 2015, PEDIATRICS, V135, pE92, DOI 10.1542/peds.2014-0596; Smith GCS, 2004, ARCH DIS CHILD, V89, P956, DOI 10.1136/adc.2003.045971; Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Villar J, 2007, BRIT MED J, V335, P1025, DOI 10.1136/bmj.39363.706956.55; World Health Organization, WORLD HLTH STAT 2013	38	102	103	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2015	314	21					2271	2279		10.1001/jama.2015.16176	http://dx.doi.org/10.1001/jama.2015.16176			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX2GT	26624826	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000365515700019
J	Limb, M				Limb, Matthew			The lung study promising a breath of fresh air in research world	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												limb@btinternet.com						GSK, CLIN TRIALS MEET REA; New JP, 2014, THORAX, V69, P1152, DOI 10.1136/thoraxjnl-2014-205259	2	1	1	3	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2015	351								h6343	10.1136/bmj.h6343	http://dx.doi.org/10.1136/bmj.h6343			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX4TP	26613902				2022-12-28	WOS:000365693500002
J	Baker, M				Baker, Monya			ANTIBODY ANARCHY: A CALL TO ORDER	NATURE			English	Editorial Material													, Pathology Services Core/CEZ-2246-2022					[Anonymous], 2015, NATURE METHODS, V12, P373; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Bradbury A, 2015, NATURE, V518, P27, DOI 10.1038/518027a; Conze T, 2010, GLYCOBIOLOGY, V20, P199, DOI 10.1093/glycob/cwp161; Marcon E, 2015, NAT METHODS, V12, P725, DOI [10.1038/NMETH.3472, 10.1038/nmeth.3472]; Pauly D., 2015, F1000RESEARCH; Saper CB, 2003, J COMP NEUROL, V465, P161, DOI 10.1002/cne.10858; Vasilevsky NA, 2013, PEERJ, V1, DOI 10.7717/peerj.148; Wu WW, 2009, MOL CELL PROTEOMICS, V8, P245, DOI 10.1074/mcp.M800171-MCP200	9	82	84	1	45	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					545	551		10.1038/527545a	http://dx.doi.org/10.1038/527545a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26607547	Bronze			2022-12-28	WOS:000365352500057
J	Canup, R				Canup, Robin			PLANETARY SCIENCE The Moon's tilt for gold	NATURE			English	Editorial Material							ACCRETION; EARTH; DISK		[Canup, Robin] Southwest Res Inst, Planetary Sci Directorate, Boulder, CO 80302 USA	Southwest Research Institute	Canup, R (corresponding author), Southwest Res Inst, Planetary Sci Directorate, Boulder, CO 80302 USA.	robin@boulder.swri.edu		Canup, Robin/0000-0002-2342-3458				Bottke WF, 2010, SCIENCE, V330, P1527, DOI 10.1126/science.1196874; GOLDREIC.P, 1966, REV GEOPHYS, V4, P411, DOI 10.1029/RG004i004p00411; Ida S, 1997, NATURE, V389, P353, DOI 10.1038/38669; Pahlevan K, 2015, NATURE, V527, P492, DOI 10.1038/nature16137; Touma J, 1998, ASTRON J, V115, P1653, DOI 10.1086/300312; Walker RJ, 2009, CHEM ERDE-GEOCHEM, V69, P101, DOI 10.1016/j.chemer.2008.10.001; Ward WR, 2000, NATURE, V403, P741, DOI 10.1038/35001516	7	0	0	1	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					455	456		10.1038/527455a	http://dx.doi.org/10.1038/527455a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26607541				2022-12-28	WOS:000365352500033
J	Howes, LM; Casey, AR; Asplund, M; Keller, SC; Yong, D; Nataf, DM; Poleski, R; Lind, K; Kobayashi, C; Owen, CI; Ness, M; Bessell, MS; Da Costa, GS; Schmidt, BP; Tisserand, P; Udalski, A; Szymanski, MK; Soszynski, I; Pietrzynski, G; Ulaczyk, K; Wyrzykowski, L; Pietrukowicz, P; Skowron, J; Kozlowski, S; Mroz, P				Howes, L. M.; Casey, A. R.; Asplund, M.; Keller, S. C.; Yong, D.; Nataf, D. M.; Poleski, R.; Lind, K.; Kobayashi, C.; Owen, C. I.; Ness, M.; Bessell, M. S.; Da Costa, G. S.; Schmidt, B. P.; Tisserand, P.; Udalski, A.; Szymanski, M. K.; Soszynski, I.; Pietrzynski, G.; Ulaczyk, K.; Wyrzykowski, L.; Pietrukowicz, P.; Skowron, J.; Kozlowski, S.; Mroz, P.			Extremely metal-poor stars from the cosmic dawn in the bulge of the Milky Way	NATURE			English	Article							GALACTIC BULGE; HIGH-RESOLUTION; CHEMICAL ABUNDANCES; LINE FORMATION; 1ST STARS; EVOLUTION; PARAMETERS; SPECTRA; HALO; II.	The first stars are predicted to have formed within 200 million years after the Big Bang(1), initiating the cosmic dawn. A true first star has not yet been discovered, although stars(2-4) with tiny amounts of elements heavier than helium ('metals') have been found in the outer regions ('halo') of the Milky Way. The first stars and their immediate successors should, however, preferentially be found today in the central regions ('bulges') of galaxies, because they formed in the largest over-densities that grew gravitationally with time(5,6). The Milky Way bulge underwent a rapid chemical enrichment during the first 1-2 billion years(7), leading to a dearth of early, metal-poor stars(8,9). Here we report observations of extremely metal-poor stars in the Milky Way bulge, including one star with an iron abundance about 10,000 times lower than the solar value without noticeable carbon enhancement. We confirm that most of the metal-poor bulge stars are on tight orbits around the Galactic Centre, rather than being halo stars passing through the bulge, as expected for stars formed at redshifts greater than 15. Their chemical compositions are in general similar to typical halo stars of the same metallicity although intriguing differences exist, including lower abundances of carbon.	[Howes, L. M.; Asplund, M.; Keller, S. C.; Yong, D.; Nataf, D. M.; Kobayashi, C.; Owen, C. I.; Bessell, M. S.; Da Costa, G. S.; Schmidt, B. P.; Tisserand, P.] Australian Natl Univ, Res Sch Astron & Astrophys, Canberra, ACT 2601, Australia; [Casey, A. R.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Poleski, R.; Udalski, A.; Szymanski, M. K.; Soszynski, I.; Pietrzynski, G.; Ulaczyk, K.; Wyrzykowski, L.; Pietrukowicz, P.; Skowron, J.; Kozlowski, S.; Mroz, P.] Univ Warsaw Observ, PL-00473 Warsaw, Poland; [Poleski, R.] Ohio State Univ, Dept Astron, Columbus, OH 43210 USA; [Lind, K.] Uppsala Univ, Div Astron & Space Phys, Dept Phys & Astron, SE-75120 Uppsala, Sweden; [Kobayashi, C.] Univ Hertfordshire, Sch Phys Astron & Math, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England; [Ness, M.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Tisserand, P.] Univ Paris 06, Sorbonne Univ, F-75014 Paris, France; [Tisserand, P.] CNRS, Inst Astrophys Paris, UMR 7095, F-75014 Paris, France; [Pietrzynski, G.] Univ Concepcion, Dept Astron, Concepcion, Chile; [Ulaczyk, K.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England	Australian National University; University of Cambridge; University of Warsaw; Warsaw University Observatory; University System of Ohio; Ohio State University; Uppsala University; University of Hertfordshire; Max Planck Society; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universidad de Concepcion; University of Warwick	Howes, LM (corresponding author), Australian Natl Univ, Res Sch Astron & Astrophys, Canberra, ACT 2601, Australia.	louise.howes@anu.edu.au	Poleski, Radoslaw/AAM-7565-2021; Skowron, Jan/M-5186-2014; Szymański, Michał K/H-6951-2018; Szymański, Michał Krzysztof/X-5627-2019; Mroz, Przemek/ABH-9105-2020; Kozlowski, Szymon/G-4799-2013	Poleski, Radoslaw/0000-0002-9245-6368; Skowron, Jan/0000-0002-2335-1730; Szymański, Michał K/0000-0002-0548-8995; Szymański, Michał Krzysztof/0000-0002-0548-8995; Kozlowski, Szymon/0000-0003-4084-880X; Pietrzynski, Grzegorz/0000-0002-9443-4138; Ulaczyk, Krzysztof/0000-0001-6364-408X; Pietrukowicz, Pawel/0000-0002-2339-5899; Schmidt, Brian/0000-0002-8538-9195; Casey, Andrew/0000-0003-0174-0564; Udalski, Andrzej/0000-0001-5207-5619; Kobayashi, Chiaki/0000-0002-4343-0487; Yong, David/0000-0002-6502-1406; Schmidt, Brian/0000-0001-6589-1287; Asplund, Martin/0000-0002-5804-3682; Wyrzykowski, Lukasz/0000-0002-9658-6151; Da Costa, Gary/0000-0001-7019-649X; Tisserand, Patrick/0000-0003-4237-0520; Nataf, David/0000-0001-5825-4431; Bessell, Michael/0000-0001-7801-1410; Howes, Louise/0000-0003-0117-0231; Lind, Karin/0000-0002-8892-2573; Soszynski, Igor/0000-0002-7777-0842; Mroz, Przemek/0000-0001-7016-1692; Ness, Melissa/0000-0001-5082-6693	Collaborative Research Infrastructure Strategy of the Australian Federal Government; Australian Research Council [FL110100012, DP120101237, DP150103294]; European Union FP7 programme through ERC [320360]; NSC, Poland [2014/14/A/ST9/00121]; STFC [ST/M001008/1, ST/M000958/1] Funding Source: UKRI	Collaborative Research Infrastructure Strategy of the Australian Federal Government; Australian Research Council(Australian Research Council); European Union FP7 programme through ERC; NSC, Poland; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This paper includes data gathered with the 6.5-m Magellan Telescopes located at Las Campanas Observatory, Chile. Australian access to the Magellan Telescopes was supported through the Collaborative Research Infrastructure Strategy of the Australian Federal Government. L.M.H. and M.A. were supported by the Australian Research Council (FL110100012). A.R.C. acknowledges support from the European Union FP7 programme through ERC grant number 320360. Research on metal-poor stars with SkyMapper is supported through Australian Research Council Discovery Projects grants DP120101237 and DP150103294 (principal investigator G.S.D.C.). The OGLE project received funding from the NSC, Poland (MAESTRO grant 2014/14/A/ST9/00121 to A.U.).	Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Barklem PS, 2007, ASTRON ASTROPHYS, V466, P327, DOI 10.1051/0004-6361:20066686; Barklem PS, 2000, ASTRON ASTROPHYS, V363, P1091; Bernstein RA, 2003, P SOC PHOTO-OPT INS, V4841, P1694, DOI 10.1117/12.461502; Bovey J., 2015, GALPY; Bromm V, 2009, NATURE, V459, P49, DOI 10.1038/nature07990; Casagrande L, 2006, MON NOT R ASTRON SOC, V373, P13, DOI 10.1111/j.1365-2966.2006.10999.x; Casey A. R., 2014, PREPRINT; de Laverny P, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219330; Feltzing S, 1999, ASTROPHYS SPACE SCI, V265, P337, DOI 10.1023/A:1002188616863; Frebel A, 2007, MON NOT R ASTRON SOC, V380, pL40, DOI 10.1111/j.1745-3933.2007.00344.x; Perez AEG, 2013, ASTROPHYS J LETT, V767, DOI 10.1088/2041-8205/767/1/L9; Greif TH, 2012, MON NOT R ASTRON SOC, V424, P399, DOI 10.1111/j.1365-2966.2012.21212.x; Gustafsson B, 2008, ASTRON ASTROPHYS, V486, P951, DOI 10.1051/0004-6361:200809724; Howes LM, 2014, MON NOT R ASTRON SOC, V445, P4241, DOI 10.1093/mnras/stu1991; Jacobson HR, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/2/171; Karlsson T, 2013, REV MOD PHYS, V85, P809, DOI 10.1103/RevModPhys.85.809; Keller SC, 2007, PUBL ASTRON SOC AUST, V24, P1, DOI 10.1071/AS07001; Keller SC, 2014, NATURE, V506, P463, DOI 10.1038/nature12990; Kelson D., 2014, MIKE PIPELINE; Lind K, 2012, MON NOT R ASTRON SOC, V427, P50, DOI 10.1111/j.1365-2966.2012.21686.x; Lind K, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201016095; Lind K, 2009, ASTRON ASTROPHYS, V503, P541, DOI 10.1051/0004-6361/200912221; Ness M, 2014, ASTROPHYS J LETT, V787, DOI 10.1088/2041-8205/787/2/L19; Nomoto K, 2003, PROG THEOR PHYS SUPP, P44, DOI 10.1143/PTPS.151.44; Norris JE, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/25; Placco VM, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/1/21; Poleski R, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/76; Robin AC, 2003, ASTRON ASTROPHYS, V409, P523, DOI 10.1051/0004-6361:20031117; Ryde N, 2010, ASTRON ASTROPHYS, V509, DOI 10.1051/0004-6361/200912687; Salvadori S, 2010, MON NOT R ASTRON SOC, V401, pL5, DOI 10.1111/j.1745-3933.2009.00772.x; Schlaufman KC, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/1/13; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Sharp R., 2006, P SOC PHOTO-OPT INS, V6269, P1; Sneden C., 2012, ASTROPHYSICS SOURCE; Tumlinson J, 2007, ASTROPHYS J, V664, pL63, DOI 10.1086/520930; Tumlinson J, 2010, ASTROPHYS J, V708, P1398, DOI 10.1088/0004-637X/708/2/1398; Umeda H, 2002, ASTROPHYS J, V565, P385, DOI 10.1086/323946; Yong D, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/26	46	72	72	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					484	+		10.1038/nature15747	http://dx.doi.org/10.1038/nature15747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26560034	Green Submitted, Green Accepted			2022-12-28	WOS:000365352500040
J	Pahlevan, K; Morbidelli, A				Pahlevan, Kaveh; Morbidelli, Alessandro			Collisionless encounters and the origin of the lunar inclination	NATURE			English	Article							EARTH-MOON SYSTEM; FAST-SPINNING EARTH; GIANT IMPACT; EARLY EVOLUTION; ACCRETION; DISK; DYNAMICS; ORBIT; MARS	The Moon is generally thought to have formed from the debris ejected by the impact of a planet-sized object with the proto-Earth towards the end of planetary accretion(1,2). Models of the impact process predict that the lunar material was disaggregated into a circumplanetary disk and that lunar accretion subsequently placed the Moon in a near-equatorial orbit(3-6). Forward integration of the lunar orbit from this initial state predicts a modern inclination at least an order of magnitude smaller than the lunar value-a long-standing discrepancy known as the lunar inclination problem(7-9). Here we show that the modern lunar orbit provides a sensitive record of gravitational interactions with Earth-crossing planetesimals that were not yet accreted at the time of the Moon-forming event. The currently observed lunar orbit can naturally be reproduced via interaction with a small quantity of mass (corresponding to 0.0075-0.015 Earth masses eventually accreted to the Earth) carried by a few bodies, consistent with the constraints and models of late accretion(10,11). Although the encounter process has a stochastic element, the observed value of the lunar inclination is among the most likely outcomes for a wide range of parameters. The excitation of the lunar orbit is most readily reproduced via collisionless encounters of planetesimals with the Earth-Moon system with strong dissipation of tidal energy on the early Earth. This mechanism obviates the need for previously proposed (but idealized) excitation mechanisms(12,13), places the Moon-forming event in the context of the formation of Earth, and constrains the pristineness of the dynamical state of the Earth-Moon system.	[Pahlevan, Kaveh; Morbidelli, Alessandro] Univ Cote Azur, Observ Cote Azur, Lab Lagrange, F-06304 Nice 4, France	UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur	Pahlevan, K (corresponding author), Univ Cote Azur, Observ Cote Azur, Lab Lagrange, CNRS Blvd Observ CS 34229, F-06304 Nice 4, France.	pahlevan@oca.eu		Pahlevan, Kaveh/0000-0002-6770-0568	Henri Poincare Fellowship at the Observatoire de la Cote d'Azur (OCA); OCA; City of Nice, France; European Research Council Advanced Grant ACCRETE [290568]	Henri Poincare Fellowship at the Observatoire de la Cote d'Azur (OCA); OCA; City of Nice, France; European Research Council Advanced Grant ACCRETE(European Research Council (ERC))	This research was carried out as part of a Henri Poincare Fellowship at the Observatoire de la Cote d'Azur (OCA) to K.P. The Henri Poincare Fellowship is funded by the OCA and the City of Nice, France. A.M. thanks the European Research Council Advanced Grant ACCRETE (no. 290568).	Alemi A., 2006, BA, V38, P491; Bottke WF, 2010, SCIENCE, V330, P1527, DOI 10.1126/science.1196874; Cameron A. G. W., 1976, LUNAR PLANET SCI C, V7; Canup RM, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0175; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; Canup RM, 2004, ANNU REV ASTRON ASTR, V42, P441, DOI 10.1146/annurev.astro.41.082201.113457; Canup RM, 2012, SCIENCE, V338, P1052, DOI 10.1126/science.1226073; Collins BF, 2008, ASTRON J, V136, P2552, DOI 10.1088/0004-6256/136/6/2552; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; GOLDREIC.P, 1966, REV GEOPHYS, V4, P411, DOI 10.1029/RG004i004p00411; Ida S, 1997, NATURE, V389, P353, DOI 10.1038/38669; KAULA WM, 1964, REV GEOPHYS, V2, P661, DOI 10.1029/RG002i004p00661; Marchi S, 2012, EARTH PLANET SC LETT, V325, P27, DOI 10.1016/j.epsl.2012.01.021; MIGNARD F, 1981, MOON PLANETS, V24, P189, DOI 10.1007/BF00910608; Morbidelli A, 2012, EARTH PLANET SC LETT, V355, P144, DOI 10.1016/j.epsl.2012.07.037; Nimmo F., 2014, 45 LUN PLAN SCI C, P1459; Raymond SN, 2013, ICARUS, V226, P671, DOI 10.1016/j.icarus.2013.06.019; Salmon J, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/83; Spurzem R, 2009, ASTROPHYS J, V697, P458, DOI 10.1088/0004-637X/697/1/458; THOMPSON C, 1988, ASTROPHYS J, V333, P452, DOI 10.1086/166760; TOUMA J, 1994, ASTRON J, V108, P1943, DOI 10.1086/117209; Touma J, 1998, ASTRON J, V115, P1653, DOI 10.1086/300312; Ward WR, 2000, NATURE, V403, P741, DOI 10.1038/35001516; WETHERILL GW, 1967, J GEOPHYS RES, V72, P2429, DOI 10.1029/JZ072i009p02429; Wieczorek MA, 2012, SCIENCE, V335, P1212, DOI 10.1126/science.1214773; Wisdom J, 2015, ICARUS, V256, P138, DOI 10.1016/j.icarus.2015.02.025; YODER CF, 1981, ICARUS, V47, P1, DOI 10.1016/0019-1035(81)90088-9; Zahnle KJ, 2015, EARTH PLANET SC LETT, V427, P74, DOI 10.1016/j.epsl.2015.06.058	30	21	21	0	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					492	+		10.1038/nature16137	http://dx.doi.org/10.1038/nature16137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26607544	Green Submitted			2022-12-28	WOS:000365352500042
J	Whitmarsh, F; Hoskins, B; McCoy, D				Whitmarsh, Flora; Hoskins, Brian; McCoy, David			Climate science: frequently asked questions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Whitmarsh, Flora; Hoskins, Brian] Univ London Imperial Coll Sci Technol & Med, Grantham Inst Climate Change, London, England; [McCoy, David] Queen Mary Univ London, Dept Primary Care & Publ Hlth, London, England	Imperial College London; University of London; Queen Mary University London	McCoy, D (corresponding author), Queen Mary Univ London, Dept Primary Care & Publ Hlth, London, England.	d.mccoy@qmul.ac.uk						Holland PR, 2012, NAT GEOSCI, V5, P872, DOI [10.1038/ngeo1627, 10.1038/NGEO1627]; IPCC, 2013, CLIMATE CHANGE 2022; Lewis N, 2015, CLIM DYNAM, V45, P1009, DOI 10.1007/s00382-014-2342-y; Lichter M, 2011, J COASTAL RES, V27, P757, DOI 10.2112/JCOASTRES-D-10-00072.1; McCoy D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5178; Royal Society US National Academy of Sciences, 2014, CLIM CHANG EV CAUS; Sigmond M, 2010, GEOPHYS RES LETT, V37	7	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2015	351								h6216	10.1136/bmj.h6216	http://dx.doi.org/10.1136/bmj.h6216			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX4SX	26604084				2022-12-28	WOS:000365691700006
J	Nudo, RJ				Nudo, Randolph J.			REHABILITATION Boost for movement	NATURE			English	Editorial Material							STIMULATION; PLASTICITY; BEHAVIOR		[Nudo, Randolph J.] Univ Kansas, Med Ctr, Dept Rehabil Med, Landon Ctr Aging, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Nudo, RJ (corresponding author), Univ Kansas, Med Ctr, Dept Rehabil Med, Landon Ctr Aging, Kansas City, KS 66160 USA.	rnudo@kumc.edu						Angeli CA, 2014, BRAIN, V137, P1394, DOI 10.1093/brain/awu038; Guggenmos DJ, 2013, P NATL ACAD SCI USA, V110, P21177, DOI 10.1073/pnas.1316885110; Hebb Donald O., 1949, ORG BEHAV; Jackson A, 2006, NATURE, V444, P56, DOI 10.1038/nature05226; Lucas TH, 2013, J NEUROSCI, V33, P5261, DOI 10.1523/JNEUROSCI.4683-12.2013; McPherson JG, 2015, P NATL ACAD SCI USA, V112, P12193, DOI 10.1073/pnas.1505383112; Mushahwar VK, 1998, ANN NY ACAD SCI, V860, P531, DOI 10.1111/j.1749-6632.1998.tb09096.x; Nishimura Y, 2013, NEURON, V80, P1301, DOI 10.1016/j.neuron.2013.08.028; Rebesco JM, 2011, PROG BRAIN RES, V192, P83, DOI 10.1016/B978-0-444-53355-5.00006-3; SHATZ CJ, 1992, SCI AM, V267, P61, DOI 10.1038/scientificamerican0992-60	10	6	6	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					314	315		10.1038/527314a	http://dx.doi.org/10.1038/527314a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26581287				2022-12-28	WOS:000365356800042
J	Fihn, SD				Fihn, Stephan D.			In hospitalized patients, the Hospital-patient One-year Mortality Risk score predicted 1-year mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Fihn, Stephan D.] Dept Vet Affairs, Seattle, WA USA		Fihn, SD (corresponding author), Dept Vet Affairs, Seattle, WA USA.		Fihn, Stephan/ABA-1040-2020					Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Wang L, 2013, MED CARE, V51, P368, DOI 10.1097/MLR.0b013e31827da95a	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					JC13	JC13		10.7326/ACPJC-2015-163-10-013	http://dx.doi.org/10.7326/ACPJC-2015-163-10-013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26571255				2022-12-28	WOS:000365746400014
J	Gould, J				Gould, Julie			Non-profit organizations: Scientists on a mission	NATURE			English	Editorial Material																			0	0	0	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					265	266		10.1038/nj7577-265a	http://dx.doi.org/10.1038/nj7577-265a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VB5XJ	26565047	Bronze			2022-12-28	WOS:000415917700012
J	Maillard, I; Saltiel, AR				Maillard, Ivan; Saltiel, Alan R.			METABOLISM Inflammation keeps old mice healthy	NATURE			English	Editorial Material							VISCERAL ADIPOSE-TISSUE; REGULATORY T-CELLS; PPAR-GAMMA; REG CELLS; FAT; ACCUMULATION; OBESITY; AGE		[Maillard, Ivan] Univ Michigan, Inst Life Sci, Div Hematol Oncol, Ann Arbor, MI 48109 USA; [Maillard, Ivan] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Maillard, Ivan] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Saltiel, Alan R.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Diego	Maillard, I (corresponding author), Univ Michigan, Inst Life Sci, Div Hematol Oncol, Ann Arbor, MI 48109 USA.	imaillar@umich.edu; asaltiel@ucsd.edu	Saltiel, Alan/L-3632-2019	Saltiel, Alan/0000-0002-9726-9828; Maillard, Ivan/0000-0003-1312-6748				Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Cipolletta D, 2015, P NATL ACAD SCI USA, V112, P482, DOI 10.1073/pnas.1423486112; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Kolodin D, 2015, CELL METAB, V21, P543, DOI 10.1016/j.cmet.2015.03.005; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Lumeng CN, 2011, J IMMUNOL, V187, P6208, DOI 10.4049/jimmunol.1102188; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001	13	4	4	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					44	46		10.1038/nature15648	http://dx.doi.org/10.1038/nature15648			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26580010				2022-12-28	WOS:000365606000044
J	Tittensor, DP				Tittensor, Derek P.			ECOLOGY Ecosystem vulnerability to ocean warming	NATURE			English	Editorial Material							CLIMATE-CHANGE		[Tittensor, Derek P.] United Nations Environm Programme World Conservat, Cambridge CB3 0DL, England; [Tittensor, Derek P.] Dalhousie Univ, Halifax, NS, Canada	Dalhousie University	Tittensor, DP (corresponding author), United Nations Environm Programme World Conservat, Cambridge CB3 0DL, England.	derek.tittensor@unep-wcmc.org	Tittensor, Derek P./AAV-1117-2021	Tittensor, Derek P./0000-0002-9550-3123				[Anonymous], 2015, CLIMATE CHANGE 2014; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Fernandes JA, 2013, GLOBAL CHANGE BIOL, V19, P2596, DOI 10.1111/gcb.12231; Harfoot MBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001841; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Rosenzweig C, 2014, GLOBAL ENVIRON CHANG, V28, P395, DOI 10.1016/j.gloenvcha.2014.05.003; Secretariat of the Convention on Biological Diversity, 2014, GLOB BIOD OUTL, V4; Stuart-Smith RD, 2015, NATURE, V528, P88, DOI 10.1038/nature16144; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484	9	3	3	2	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					43	44		10.1038/nature16314	http://dx.doi.org/10.1038/nature16314			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26560035				2022-12-28	WOS:000365606000043
J	Vermeij, G				Vermeij, Geerat			How Victoria's fishes were knocked from their perch	SCIENCE			English	Editorial Material							JAWS		[Vermeij, Geerat] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Vermeij, G (corresponding author), Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA.	gjvermeij@ucdavis.edu						Galis F, 1998, TRENDS ECOL EVOL, V13, P1, DOI 10.1016/S0169-5347(97)01239-1; Hulsey CD, 2006, EVOLUTION, V60, P2096, DOI 10.1111/j.0014-3820.2006.tb01847.x; LIEM KF, 1973, SYST ZOOL, V22, P425, DOI 10.2307/2412950; McGee MD, 2015, SCIENCE, V350, P1077, DOI 10.1126/science.aab0800; Sterrer W., 1992, Evolution and Cognition, V1, P101; VANVALEN L, 1975, EVOLUTION, V29, P87, DOI 10.1111/j.1558-5646.1975.tb00816.x; Vermeij GJ, 2013, ANNU REV EARTH PL SC, V41, P1, DOI 10.1146/annurev-earth-050212-124123; VERMEIJ GJ, 2010, EVOLUTIONARY WORLD A	8	0	0	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1038	1038		10.1126/science.aad7032	http://dx.doi.org/10.1126/science.aad7032			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY5BJ	26612940				2022-12-28	WOS:000366422600026
J	Rouyer, F; Chatterjee, A				Rouyer, Francois; Chatterjee, Abhishek			CIRCADIAN CLOCKS A receptor for subtle temperature changes	NATURE			English	Editorial Material							IONOTROPIC GLUTAMATE RECEPTORS; DROSOPHILA BRAIN; ENTRAINMENT; RHYTHMS; NEURONS; CYCLES; BLIND		[Rouyer, Francois; Chatterjee, Abhishek] Univ Paris Saclay, Univ Paris 11, CNRS, Inst Neurosci Paris Saclay, F-91190 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Rouyer, F (corresponding author), Univ Paris Saclay, Univ Paris 11, CNRS, Inst Neurosci Paris Saclay, F-91190 Gif Sur Yvette, France.	francois.rouyer@inaf.cnrs-gif.fr	Rouyer, François/L-9043-2018	Rouyer, François/0000-0001-5641-397X; Chatterjee, Abhishek/0000-0002-0274-0577				Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Chen C, 2015, NATURE, V527, P516, DOI 10.1038/nature16148; Das A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134213; Frank DD, 2015, NATURE, V519, P358, DOI 10.1038/nature14284; Green EW, 2015, P NATL ACAD SCI USA, V112, P8702, DOI 10.1073/pnas.1506093112; Kaneko H, 2012, CURR BIOL, V22, P1851, DOI 10.1016/j.cub.2012.08.006; Lee Y, 2013, J NEUROSCI, V33, P6716, DOI 10.1523/JNEUROSCI.4237-12.2013; Liu WW, 2015, NATURE, V519, P353, DOI 10.1038/nature14170; Picot M, 2009, J NEUROSCI, V29, P8312, DOI 10.1523/JNEUROSCI.0279-08.2009; Roessingh S., 2015, J BIOL RHYTHMS; Sehadova H, 2009, NEURON, V64, P251, DOI 10.1016/j.neuron.2009.08.026; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106; Wolfgang W, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0959	16	2	2	0	28	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					449	451		10.1038/nature16316	http://dx.doi.org/10.1038/nature16316			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26580008				2022-12-28	WOS:000365352500029
J	Creutzig, F; Jochem, P; Edelenbosch, OY; Mattauch, L; van Vuuren, DP; McCollum, D; Minx, J				Creutzig, Felix; Jochem, Patrick; Edelenbosch, Oreane Y.; Mattauch, Linus; van Vuuren, Detlef P.; McCollum, David; Minx, Jan			Transport: A roadblock to climate change mitigation?	SCIENCE			English	Editorial Material									[Creutzig, Felix; Mattauch, Linus; Minx, Jan] Mercator Res Inst Global Commons & Climate Change, D-10829 Berlin, Germany; [Creutzig, Felix; Mattauch, Linus] Tech Univ Berlin, D-10623 Berlin, Germany; [Jochem, Patrick] KIT, D-76131 Karlsruhe, Germany; [Edelenbosch, Oreane Y.; van Vuuren, Detlef P.] PBL Netherlands Environm Assessment Agcy, NL-3720 AH Bilthoven, Netherlands; [van Vuuren, Detlef P.] Univ Utrecht, Dept Geosci, Copernicus Inst Sustainable Dev Geosci, NL-3584 CS Utrecht, Netherlands; [McCollum, David] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Minx, Jan] Hertie Sch Governance, D-10117 Berlin, Germany	Technical University of Berlin; Helmholtz Association; Karlsruhe Institute of Technology; Utrecht University; International Institute for Applied Systems Analysis (IIASA)	Creutzig, F (corresponding author), Mercator Res Inst Global Commons & Climate Change, D-10829 Berlin, Germany.	creutzig@mcc-berlin.net	van Vuuren, Detlef P./A-4764-2009; Jochem, Patrick/Q-8828-2019; Creutzig, Felix/B-8691-2016; Minx, Jan C/AAC-5948-2019	van Vuuren, Detlef P./0000-0003-0398-2831; Jochem, Patrick/0000-0002-7486-4958; Creutzig, Felix/0000-0002-5710-3348; Minx, Jan C/0000-0002-2862-0178; McCollum, David/0000-0003-1293-0179				Creutzig F, 2016, TRANSPORT REV, V36, P341, DOI 10.1080/01441647.2015.1079277; Creutzig F, 2014, URBAN CLIM, V10, P63, DOI 10.1016/j.uclim.2014.09.003; Dulac J., 2013, GLOBAL LAND TRANSPOR; Girod B, 2012, ENERG POLICY, V45, P152, DOI 10.1016/j.enpol.2012.02.008; Jochem P, 2015, TRANSPORT RES A-POL, V78, P68, DOI 10.1016/j.tra.2015.05.007; Mattauch L, 2016, TRANSPORT RES D-TR E, V45, P64, DOI 10.1016/j.trd.2015.08.006; National Research Council, 2013, TRANS ALT FUELS VEH; Nykvist B, 2015, NAT CLIM CHANGE, V5, P329, DOI 10.1038/nclimate2564; Pietzcker RC, 2014, ENERGY, V64, P95, DOI 10.1016/j.energy.2013.08.059; Schwanen T, 2011, TRANSPORT RES A-POL, V45, P993, DOI 10.1016/j.tra.2011.09.005; Sims R, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P599; Sperling D., 2009, 2 BILLION CARS; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P33; Winkler SL, 2014, ENVIRON SCI TECHNOL, V48, P6453, DOI 10.1021/es405651p	14	221	222	9	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					911	912		10.1126/science.aac8033	http://dx.doi.org/10.1126/science.aac8033			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW4IP	26586747	Green Accepted, Green Submitted			2022-12-28	WOS:000364955200022
J	Kim, HF; Ghazizadeh, A; Hikosaka, O				Kim, Hyoung F.; Ghazizadeh, Ali; Hikosaka, Okihide			Dopamine Neurons Encoding Long-Term Memory of Object Value for Habitual Behavior	CELL			English	Article							PRIMATE SUPERIOR COLLICULUS; VENTRAL TEGMENTAL AREA; MONKEY CAUDATE NEURONS; BASAL GANGLIA CIRCUITS; NIGRA PARS RETICULATA; SUBSTANTIA-NIGRA; PARKINSONS-DISEASE; FUNCTIONAL-PROPERTIES; PROJECTION NEURONS; VISUAL RESPONSES	Dopamine neurons promote learning by processing recent changes in reward values, such that reward may be maximized. However, such a flexible signal is not suitable for habitual behaviors that are sustained regardless of recent changes in reward outcome. We discovered a type of dopamine neuron in the monkey substantia nigra pars compacta (SNc) that retains past learned reward values stably. After reward values of visual objects are learned, these neurons continue to respond differentially to the objects, even when reward is not expected. Responses are strengthened by repeated learning and are evoked upon presentation of the objects long after learning is completed. These `` sustain-type'' dopamine neurons are confined to the caudal-lateral SNc and project to the caudate tail, which encodes long-term value memories of visual objects and guides gaze automatically to stably valued objects. This population of dopamine neurons thus selectively promotes learning and retention of habitual behavior.	[Kim, Hyoung F.; Ghazizadeh, Ali; Hikosaka, Okihide] NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA; [Kim, Hyoung F.] Inst Basic Sci, CNIR, Suwon 440746, South Korea; [Kim, Hyoung F.] Sungkyunkwan Univ, Dept Biomed Engn, Suwon 440746, South Korea; [Hikosaka, Okihide] NIDA, Intramural Res Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Institute for Basic Science - Korea (IBS); Sungkyunkwan University (SKKU); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Kim, HF (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	hyoung.f.kim@gmail.com			Intramural Research Program at the National Institutes of Health, National Eye Institute; NATIONAL EYE INSTITUTE [ZIAEY000415] Funding Source: NIH RePORTER	Intramural Research Program at the National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank M. Yasuda for discussions and D. Parker, I. Bunea, M.K. Smith, G. Tansey, A.M. Nichols, T.W. Ruffner, J.W. McClurkin, and A.V. Hays for technical assistance. This research was supported by the Intramural Research Program at the National Institutes of Health, National Eye Institute.	Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Bayley PJ, 2005, NATURE, V436, P550, DOI 10.1038/nature03857; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Comoli E, 2003, NAT NEUROSCI, V6, P974, DOI 10.1038/nn1113; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; DENIAU JM, 1982, EXP BRAIN RES, V47, P105; Fernandez-Ruiz J, 2001, P NATL ACAD SCI USA, V98, P4196, DOI 10.1073/pnas.061022098; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P542, DOI 10.1152/jn.1972.35.4.542; Goldstein RZ, 2009, TRENDS COGN SCI, V13, P372, DOI 10.1016/j.tics.2009.06.004; GOTO S, 1989, ANN NEUROL, V26, P766, DOI 10.1002/ana.410260613; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P780, DOI 10.1152/jn.1989.61.4.780; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Hikosaka O, 2013, TRENDS COGN SCI, V17, P434, DOI 10.1016/j.tics.2013.07.001; Ikeda T, 2003, NEURON, V39, P693, DOI 10.1016/S0896-6273(03)00464-1; Ikeda T, 2007, J NEUROPHYSIOL, V98, P3163, DOI 10.1152/jn.00975.2007; Kim HF, 2015, BRAIN, V138, P1776, DOI 10.1093/brain/awv134; Kim HF, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00120; Kim HF, 2013, NEURON, V79, P1001, DOI 10.1016/j.neuron.2013.06.044; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Moody TD, 2010, BEHAV NEUROSCI, V124, P1, DOI 10.1037/a0018414; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; RICHFIELD EK, 1987, J COMP NEUROL, V262, P446, DOI 10.1002/cne.902620308; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1986, J NEUROPHYSIOL, V56, P1439, DOI 10.1152/jn.1986.56.5.1439; Seger CA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00066; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1023/A:1022633531479; TAYLOR JR, 1986, PSYCHOPHARMACOLOGY, V90, P390; TEPPER JM, 1995, J NEUROSCI, V15, P3092; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; West AR, 2002, J NEUROSCI, V22, P294, DOI 10.1523/JNEUROSCI.22-01-00294.2002; Yamamoto S, 2013, J NEUROSCI, V33, P11227, DOI 10.1523/JNEUROSCI.0318-13.2013; Yamamoto S, 2012, J NEUROSCI, V32, P11005, DOI 10.1523/JNEUROSCI.0828-12.2012; Yasuda M, 2015, J NEUROPHYSIOL, V113, P1681, DOI 10.1152/jn.00674.2014; Yasuda M, 2012, J NEUROSCI, V32, P16917, DOI 10.1523/JNEUROSCI.3438-12.2012; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	45	80	80	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1165	1175		10.1016/j.cell.2015.10.063	http://dx.doi.org/10.1016/j.cell.2015.10.063			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26590420	Green Accepted, Bronze			2022-12-28	WOS:000366044700015
J	Militz, H; Hungerer, C				Militz, Helga; Hungerer, Christine			Treponema pallidum - The Great Imitator	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Militz, Helga; Hungerer, Christine] BG Trauma Ctr Murnau, Murnau, Germany		Militz, H (corresponding author), BG Trauma Ctr Murnau, Murnau, Germany.	h.militz@haut-murnau.de							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2015	373	21					2069	2069		10.1056/NEJMicm1501265	http://dx.doi.org/10.1056/NEJMicm1501265			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW4JN	26580999				2022-12-28	WOS:000364957700012
J	Yeap, LS; Hwang, JK; Du, Z; Meyers, RM; Meng, FL; Jakubauskaite, A; Liu, MY; Mani, V; Neuberg, D; Kepler, TB; Wang, JH; Alt, FW				Yeap, Leng-Siew; Hwang, Joyce K.; Du, Zhou; Meyers, Robin M.; Meng, Fei-Long; Jakubauskaite, Agne; Liu, Mengyuan; Mani, Vinidhra; Neuberg, Donna; Kepler, Thomas B.; Wang, Jing H.; Alt, Frederick W.			Sequence-Intrinsic Mechanisms that Target AID Mutational Outcomes on Antibody Genes	CELL			English	Article							CLASS SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; REGION; DELETIONS; TRANSCRIPTION; ACCUMULATION; INSERTIONS; HOTSPOTS	In activated B lymphocytes, AID initiates antibody variable (V) exon somatic hypermutation (SHM) for affinity maturation in germinal centers (GCs) and IgH switch (S) region DNA breaks (DSBs) for class-switch recombination (CSR). To resolve long-standing questions, we have developed an in vivo assay to study AID targeting of passenger sequences replacing a V exon. First, we find AID targets SHM hot-spots within V exon and S region passengers at similar frequencies and that the normal SHM process frequently generates deletions, indicating that SHM and CSR employ the same mechanism. Second, AID mutates targets in diverse non-Ig passengers in GC B cells at levels similar to those of V exons, definitively establishing the V exon location as "privileged" for SHM. Finally, Peyer's patch GC B cells generate a reservoir of V exons that are highly mutated before selection for affinity maturation. We discuss the implications of these findings for harnessing antibody diversification mechanisms.	[Yeap, Leng-Siew; Hwang, Joyce K.; Du, Zhou; Meyers, Robin M.; Meng, Fei-Long; Jakubauskaite, Agne; Liu, Mengyuan; Mani, Vinidhra; Wang, Jing H.; Alt, Frederick W.] Harvard Univ, Sch Med, Boston Childrens Hosp, Howard Hughes Med Inst,Program Cellular & Mol Med, Boston, MA 02115 USA; [Yeap, Leng-Siew; Hwang, Joyce K.; Du, Zhou; Meyers, Robin M.; Meng, Fei-Long; Jakubauskaite, Agne; Liu, Mengyuan; Mani, Vinidhra; Wang, Jing H.; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Neuberg, Donna] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Kepler, Thomas B.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02215 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Boston University	Alt, FW (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Howard Hughes Med Inst,Program Cellular & Mol Med, 300 Longwood Ave, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu	Wang, Jing Hong/M-7813-2015	Wang, Jing Hong/0000-0003-4343-2527; Meyers, Robin/0000-0002-1802-7231; Meng, Feilong/0000-0003-0333-6872	NIH [R01AI077595, 5UM1AI100645, R21AI110777-01A1, R21CA184707-01A1, R01CA166325-01A1, F30AI114179-01A1]; Dana Farber/Harvard Cancer Center Core Grant [5P30 CA006516]; Boettcher Foundation Webb-Waring Biomedical Research Award; Cancer League of Colorado; American Society of Hematology Scholar Award; NATIONAL CANCER INSTITUTE [R21CA184707, R01CA166325, P30CA006516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077595, UM1AI100645, R37AI077595, R21AI110777, F30AI114179] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Farber/Harvard Cancer Center Core Grant; Boettcher Foundation Webb-Waring Biomedical Research Award; Cancer League of Colorado; American Society of Hematology Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Dr. Kefei Yu for the RMCE exchange plasmid, Klaus Rajewsky for the J<INF>H</INF> targeting construct, Pei-Yi Huang and Yuko Fujiwara for generating the chimeras, Kenneth Ketman and Natasha Barteneva for help with FACS sorting, and Garnett Kelsoe for helpful discussions. This work was supported by NIH grants (R01AI077595 and CHAVI-ID 5UM1AI100645 to F.W.A.; R21AI110777-01A1, R21CA184707-01A1, and R01CA166325-01A1 to J.H.W.). J.K.H. was supported by an NIH grant (F30AI114179-01A1). D.N. is supported by a Dana Farber/Harvard Cancer Center Core Grant (5P30 CA006516). J.H.W. is also supported by a Boettcher Foundation Webb-Waring Biomedical Research Award, an American Society of Hematology Scholar Award, and the Cancer League of Colorado. F.W.A. is an investigator and Z.D. is a postdoctoral fellow of the Howard Hughes Medical Institute. L.S.Y. was a Cancer Research Institute postdoctoral fellow, and F.-L.M. is a Lymphoma Research Foundation postdoctoral fellow.	Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; BETZ AG, 1993, IMMUNOL TODAY, V14, P405, DOI 10.1016/0167-5699(93)90144-A; BETZ AG, 1993, P NATL ACAD SCI USA, V90, P2385, DOI 10.1073/pnas.90.6.2385; Briney BS, 2012, GENES IMMUN, V13, P523, DOI 10.1038/gene.2012.28; Buerstedde JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001831; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Chahwan R, 2012, SEMIN IMMUNOL, V24, P293, DOI 10.1016/j.smim.2012.05.005; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dorner T, 1997, J IMMUNOL, V158, P2779; GONZALEZFERNANDEZ A, 1993, P NATL ACAD SCI USA, V90, P9862, DOI 10.1073/pnas.90.21.9862; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; Hackney JA, 2009, ADV IMMUNOL, V101, P163, DOI 10.1016/S0065-2776(08)01005-5; Han L, 2011, P NATL ACAD SCI USA, V108, P11584, DOI 10.1073/pnas.1018726108; Hwang JK, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0037-2014; Kepler TB, 2014, CELL HOST MICROBE, V16, P304, DOI 10.1016/j.chom.2014.08.006; Lanning Dennis K, 2005, Discov Med, V5, P393; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Maul RW, 2014, J EXP MED, V211, P2297, DOI 10.1084/jem.20131512; Maul RW, 2010, IMMUNOL RES, V47, P113, DOI 10.1007/s12026-009-8142-5; Maul RW, 2010, ADV IMMUNOL, V105, P159, DOI 10.1016/S0065-2776(10)05006-6; Meng FL, 2014, CELL, V159, P1538, DOI 10.1016/j.cell.2014.11.014; Mostoslavsky R, 2004, CELL, V118, P539, DOI 10.1016/j.cell.2004.08.023; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muramatsu Masamichi, 2007, Adv Immunol, V94, P1, DOI 10.1016/S0065-2776(06)94001-2; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rouaud P, 2013, J EXP MED, V210, P1501, DOI 10.1084/jem.20130072; Saribasak H, 2012, SEMIN IMMUNOL, V24, P287, DOI 10.1016/j.smim.2012.05.002; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Storb U, 2014, ADV IMMUNOL, V122, P253, DOI 10.1016/B978-0-12-800267-4.00007-9; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wei LR, 2015, P NATL ACAD SCI USA, V112, pE728, DOI 10.1073/pnas.1500788112; WEISS U, 1992, EUR J IMMUNOL, V22, P511, DOI 10.1002/eji.1830220233; Wesemann DR, 2013, NATURE, V501, DOI 10.1038/nature12496; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Yang Shu Yuan, 2007, Adv Immunol, V94, P109, DOI 10.1016/S0065-2776(06)94004-8; YELAMOS J, 1995, NATURE, V376, P225; Zarrin AA, 2004, NAT IMMUNOL, V5, P1275, DOI 10.1038/ni1137; Zheng SM, 2015, CELL, V161, P762, DOI 10.1016/j.cell.2015.03.020	45	104	107	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1124	1137		10.1016/j.cell.2015.10.042	http://dx.doi.org/10.1016/j.cell.2015.10.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26582132	Green Accepted, Bronze			2022-12-28	WOS:000366044700012
J	Siegel, D				Siegel, David			In uncontrolled hypertension, a pharmacist-prescribing intervention reduced blood pressure at 6 months	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Siegel, David] VA North Calif Hlth Care Syst, Mather, CA USA		Siegel, D (corresponding author), VA North Calif Hlth Care Syst, Mather, CA USA.							Alberta College of Pharmacists, WHAT DRUGS CAN PHARM; Alberta College of Pharmacy, ADD PRESCR AUTH; Nwankwo Tatiana, 2013, NCHS Data Brief, P1; Shireman TI, 2015, CIRCULATION, V132, P75, DOI 10.1161/CIRCULATIONAHA.115.017395; Zillich AJ, 2015, AM J MED, V128, DOI 10.1016/j.amjmed.2014.11.027	5	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					JC7	JC7		10.7326/ACPJC-2015-163-10-007	http://dx.doi.org/10.7326/ACPJC-2015-163-10-007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26571261				2022-12-28	WOS:000365746400008
J	Jurecic, A; Marchalik, D				Jurecic, Ann; Marchalik, Daniel			Examining empathy	LANCET			English	Editorial Material									[Jurecic, Ann] Rutgers State Univ, Dept English, New Brunswick, NJ 08901 USA; [Marchalik, Daniel] Georgetown Univ, Sch Med, Dept Urol & Literature & Med Track, Washington, DC 20007 USA	Rutgers State University New Brunswick; Georgetown University	Jurecic, A (corresponding author), Rutgers State Univ, Dept English, New Brunswick, NJ 08901 USA.	ann.jurecic@rutgers.edu		Marchalik, Daniel/0000-0002-6912-1252					0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2015	386	10004					1618	1618		10.1016/S0140-6736(15)00540-1	http://dx.doi.org/10.1016/S0140-6736(15)00540-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CU0HS	26595622				2022-12-28	WOS:000363197500015
J	McMahon, KW; McCarthy, MD; Sherwood, OA; Larsen, T; Guilderson, TP				McMahon, Kelton W.; McCarthy, Matthew D.; Sherwood, Owen A.; Larsen, Thomas; Guilderson, Thomas P.			Millennial- scale plankton regime shifts in the subtropical North Pacific Ocean	SCIENCE			English	Article							COMMUNITY STRUCTURE; CARBON; PATTERNS; GYRE; SEA; PHYTOPLANKTON; DELTA-C-13; NITROGEN; RATIOS; EXPORT	Climate change is predicted to alter marine phytoplankton communities and affect productivity, biogeochemistry, and the efficacy of the biological pump. We reconstructed high-resolution records of changing plankton community composition in the North Pacific Ocean over the past millennium. Amino acid-specific delta C-13 records preserved in long-lived deep-sea corals revealed three major plankton regimes corresponding to Northern Hemisphere climate periods. Non-dinitrogen-fixing cyanobacteria dominated during the Medieval Climate Anomaly (950-1250 Common Era) before giving way to a new regime in which eukaryotic microalgae contributed nearly half of all export production during the Little Ice Age (similar to 1400-1850 Common Era). The third regime, unprecedented in the past millennium, began in the industrial era and is characterized by increasing production by dinitrogen-fixing cyanobacteria. This picoplankton community shift may provide a negative feedback to rising atmospheric carbon dioxide concentrations.	[McMahon, Kelton W.; McCarthy, Matthew D.; Guilderson, Thomas P.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [McMahon, Kelton W.; Guilderson, Thomas P.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Sherwood, Owen A.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Larsen, Thomas] Univ Kiel, Leibniz Lab Radiometr Dating & Stable Isotope Res, D-24118 Kiel, Germany; [Guilderson, Thomas P.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of Colorado System; University of Colorado Boulder; University of Kiel; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	McMahon, KW (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA.	kemcmaho@ucsc.edu	Larsen, Thomas/D-3105-2012	Larsen, Thomas/0000-0002-0311-9707; McMahon, Kelton/0000-0002-9648-4614; SHERWOOD, OWEN/0000-0003-1055-3162	National Oceanic and Atmospheric Administration's National Undersea Research Program; National Geographic Society [7717-04]; U.S. Department of Energy [DE-AC52-07NA27344]; NSF [OCE-1061689]; The Future Ocean, a program - German Research Foundation	National Oceanic and Atmospheric Administration's National Undersea Research Program(National Oceanic Atmospheric Admin (NOAA) - USA); National Geographic Society(National Geographic Society); U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); The Future Ocean, a program - German Research Foundation	All methods, additional figures, and source data are available in the supplementary materials. K.W.M., T.P.G., and M.D.M. conceived the project. K.W.M. prepared samples, performed bulk and compound-specific delta<SUP>13</SUP>C analyses, and wrote the manuscript. O.A.S. and T.L. assisted in data analysis and commented on the manuscript. T.P.G. and M.D.M. supervised this project, discussed the results, and commented on the manuscript. We thank M. Hanson, S. Fauque, and J. Liu for assistance in the laboratory. This work would not have been possible without the captain and crew of the research vessel Kaimikai-o-Kanaloa and the pilots and engineers of the Hawaii Undersea Research Laboratory's Pisces IV and V submersibles. We also thank three anonymous reviewers for valuable feedback on the manuscript. Funding for sample collection was provided by the National Oceanic and Atmospheric Administration's National Undersea Research Program and the National Geographic Society (grant 7717-04). A portion of this work was performed under the auspices of the U.S. Department of Energy (grant DE-AC52-07NA27344). The majority of the work presented here was funded by NSF (grant OCE-1061689). T.L. was supported by The Future Ocean, a program funded by the German Research Foundation.	Boyd PW, 1999, DEEP-SEA RES PT I, V46, P63, DOI 10.1016/S0967-0637(98)00066-1; Close HG, 2013, P NATL ACAD SCI USA, V110, P12565, DOI 10.1073/pnas.1217514110; Corno G, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003730; Deutsch C, 2014, SCIENCE, V345, P665, DOI 10.1126/science.1252332; Dore JE, 2008, PROG OCEANOGR, V76, P2, DOI 10.1016/j.pocean.2007.10.002; EPPLEY RW, 1973, LIMNOL OCEANOGR, V18, P534, DOI 10.4319/lo.1973.18.4.0534; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; Guilderson TP, 2013, BIOGEOSCIENCES, V10, P6019, DOI 10.5194/bg-10-6019-2013; Hays GC, 2005, TRENDS ECOL EVOL, V20, P337, DOI 10.1016/j.tree.2005.03.004; Karl DM, 2012, P NATL ACAD SCI USA, V109, P1842, DOI 10.1073/pnas.1120312109; Karl DM, 1999, ECOSYSTEMS, V2, P181, DOI 10.1007/s100219900068; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1449, DOI 10.1016/S0967-0645(00)00149-1; Kim IN, 2014, SCIENCE, V346, P1102, DOI 10.1126/science.1258396; Larsen T, 2015, BIOGEOSCIENCES, V12, P4979, DOI 10.5194/bg-12-4979-2015; Larsen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073441; Mann ME, 2009, SCIENCE, V326, P1256, DOI 10.1126/science.1177303; Martiny AC, 2013, NAT GEOSCI, V6, P279, DOI [10.1038/NGEO1757, 10.1038/ngeo1757]; McMahon KW, 2013, OCEANOGR MAR BIOL, V51, P327; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Quay P, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB004003; Richardson TL, 2007, SCIENCE, V315, P838, DOI 10.1126/science.1133471; Scharek R, 1999, DEEP-SEA RES PT I, V46, P1051, DOI 10.1016/S0967-0637(98)00102-2; Schiff JT, 2014, MAR CHEM, V166, P82, DOI 10.1016/j.marchem.2014.09.008; Scott JH, 2006, ASTROBIOLOGY, V6, P867, DOI 10.1089/ast.2006.6.867; Sherwood OA, 2014, NATURE, V505, P78, DOI 10.1038/nature12784; Teng YC, 2014, NAT GEOSCI, V7, P895, DOI 10.1038/NGEO2303; Trouet V, 2009, SCIENCE, V324, P78, DOI 10.1126/science.1166349	29	59	62	3	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1530	1533		10.1126/science.aaa9942	http://dx.doi.org/10.1126/science.aaa9942			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26612834				2022-12-28	WOS:000366591100059
J	Rivero-Calle, S; Gnanadesikan, A; Del Castillo, CE; Balch, WM; Guikema, SD				Rivero-Calle, Sara; Gnanadesikan, Anand; Del Castillo, Carlos E.; Balch, William M.; Guikema, Seth D.			Multidecadal increase in North Atlantic coccolithophores and the potential role of rising CO2	SCIENCE			English	Article							OCEAN; PHYTOPLANKTON; CALCIFICATION; PATTERNS	As anthropogenic carbon dioxide (CO2) emissions acidify the oceans, calcifiers generally are expected to be negatively affected. However, using data from the Continuous Plankton Recorder, we show that coccolithophore occurrence in the North Atlantic increased from similar to 2 to more than 20% from 1965 through 2010. We used random forest models to examine more than 20 possible environmental drivers of this change, finding that CO2 and the Atlantic Multidecadal Oscillation were the best predictors, leading us to hypothesize that higher CO2 levels might be encouraging growth. A compilation of 41 independent laboratory studies supports our hypothesis. Our study shows a long-term basin-scale increase in coccolithophores and suggests that increasing CO2 and temperature have accelerated the growth of a phytoplankton group that is important for carbon cycling.	[Rivero-Calle, Sara; Gnanadesikan, Anand; Del Castillo, Carlos E.] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; [Rivero-Calle, Sara] Johns Hopkins Univ, Appl Phys Lab, Baltimore, MD 21218 USA; [Del Castillo, Carlos E.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Balch, William M.] Bigelow Lab Ocean Sci, East Boothbay, ME USA; [Guikema, Seth D.] Univ Michigan, Dept Ind & Operat Engn, Ann Arbor, MI 48109 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Bigelow Laboratory for Ocean Sciences; University of Michigan System; University of Michigan	Rivero-Calle, S (corresponding author), Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA.	sara.rivero@jhu.edu; gnanades@jhu.edu	Del Castillo, Carlos/N-2601-2013; Rivero-Calle, Sara/M-2197-2019; Gnanadesikan, Anand/A-2397-2008	Rivero-Calle, Sara/0000-0002-7538-0429; Gnanadesikan, Anand/0000-0001-5784-1116	Johns Hopkins University; Applied Physics Laboratory; NSF (Division of Ocean Sciences); NASA (Ocean Biology and Biogeochemistry Program);  [NSF-1149460]; NERC [SAH01001, NE/H01702X/1] Funding Source: UKRI; Natural Environment Research Council [NE/I030062/1, NE/H01702X/1, SAH01001] Funding Source: researchfish	Johns Hopkins University(Johns Hopkins University); Applied Physics Laboratory; NSF (Division of Ocean Sciences)(National Science Foundation (NSF)); NASA (Ocean Biology and Biogeochemistry Program)(National Aeronautics & Space Administration (NASA)); ; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank D. Johns, the Sir Alister Hardy for Ocean Science (SAHFOS) Associated External Researcher fund, and everyone involved in the CPR survey. We thank the Johns Hopkins University and the Applied Physics Laboratory for financial support and B. Zaitchik, D. Waugh, J. Dunne, and three anonymous reviewers for helpful comments. Funding for S.D.G. was from NSF-1149460. Support for W.B. came from NSF (Division of Ocean Sciences) and NASA (Ocean Biology and Biogeochemistry Program). CPR data used in this study can be obtained from SAHFOS upon request.	Antia AN, 2001, GLOBAL BIOGEOCHEM CY, V15, P845, DOI 10.1029/2000GB001376; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cubillos JC, 2007, MAR ECOL PROG SER, V348, P47, DOI 10.3354/meps07058; Edwards M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057212; Francois R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001722; Gnanadesikan A, 2014, J MARINE SYST, V133, P39, DOI 10.1016/j.jmarsys.2013.10.003; Hannisdal B, 2012, GLOBAL CHANGE BIOL, V18, P3504, DOI 10.1111/gcb.12007; HAYS GC, 1995, J MAR BIOL ASSOC UK, V75, P503, DOI 10.1017/S0025315400018361; Hovland EK, 2013, MAR ECOL PROG SER, V484, P17, DOI 10.3354/meps10277; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Lohbeck KT, 2012, NAT GEOSCI, V5, P346, DOI [10.1038/ngeo1441, 10.1038/NGEO1441]; Matrai P, 2007, J MARINE SYST, V67, P83, DOI 10.1016/j.jmarsys.2006.10.001; MCINTYRE A, 1967, DEEP-SEA RES, V14, P561, DOI 10.1016/0011-7471(67)90065-4; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Richardson AJ, 2006, PROG OCEANOGR, V68, P27, DOI 10.1016/j.pocean.2005.09.011; Riebesell U, 2009, P NATL ACAD SCI USA, V106, P20602, DOI 10.1073/pnas.0813291106; Rost B, 2003, LIMNOL OCEANOGR, V48, P55, DOI 10.4319/lo.2003.48.1.0055; Rost B, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P99; Smith HEK, 2012, P NATL ACAD SCI USA, V109, P8845, DOI 10.1073/pnas.1117508109; Smyth TJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019735; Takahashi T, 2009, DEEP-SEA RES PT I, V56, P2075, DOI 10.1016/j.dsr.2009.07.007; Winter A, 2014, J PLANKTON RES, V36, P316, DOI 10.1093/plankt/fbt110	24	81	82	6	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2015	350	6267					1533	1537		10.1126/science.aaa8026	http://dx.doi.org/10.1126/science.aaa8026			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY7LY	26612836	Bronze			2022-12-28	WOS:000366591100060
J	Liu, GW; Yong, MYJ; Yurieva, M; Srinivasan, KG; Liu, J; Lim, JSY; Poidinger, M; Wright, GD; Zolezzi, F; Choi, H; Pavelka, N; Rancati, G				Liu, Gaowen; Yong, Mei Yun Jacy; Yurieva, Marina; Srinivasan, Kandhadayar Gopalan; Liu, Jaron; Lim, John Soon Yew; Poidinger, Michael; Wright, Graham Daniel; Zolezzi, Francesca; Choi, Hyungwon; Pavelka, Norman; Rancati, Giulia			Gene Essentiality Is a Quantitative Property Linked to Cellular Evolvability	CELL			English	Article							NUCLEAR-PORE COMPLEX; ANEUPLOIDY; GENOME; EVOLUTION; IDENTIFICATION; DELETION; PRIORITIZATION; REARRANGEMENTS; CYTOKINESIS; ADAPTATION	Gene essentiality is typically determined by assessing the viability of the corresponding mutant cells, but this definition fails to account for the ability of cells to adaptively evolve to genetic perturbations. Here, we performed a stringent screen to assess the degree to which Saccharomyces cerevisiae cells can survive the deletion of similar to 1,000 individual "essential" genes and found that similar to 9% of these genetic perturbations could in fact be overcome by adaptive evolution. Our analyses uncovered a genome-wide gradient of gene essentiality, with certain essential cellular functions being more "evolvable" than others. Ploidy changes were prevalent among the evolved mutant strains, and aneuploidy of a specific chromosome was adaptive for a class of evolvable nucleoporin mutants. These data justify a quantitative redefinition of gene essentiality that incorporates both viability and evolvability of the corresponding mutant cells and will enable selection of therapeutic targets associated with lower risk of emergence of drug resistance.	[Liu, Gaowen; Yong, Mei Yun Jacy; Liu, Jaron; Lim, John Soon Yew; Wright, Graham Daniel; Rancati, Giulia] ASTAR, Inst Med Biol IMB, Singapore 138648, Singapore; [Liu, Gaowen; Rancati, Giulia] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Yurieva, Marina; Srinivasan, Kandhadayar Gopalan; Poidinger, Michael; Zolezzi, Francesca; Pavelka, Norman] ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore; [Choi, Hyungwon] Natl Univ Singapore NUS, Saw Swee Hock Sch Publ Hlth, Singapore 117549, Singapore; [Choi, Hyungwon] Natl Univ Hlth Syst, Singapore 117549, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore	Pavelka, N (corresponding author), ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore.	norman_pavelka@immunol.a-star.edu.sg; giulia.rancati@imb.a-star.edu.sg	Yurieva, Marina/V-2432-2018; Choi, Hyungwon/S-8824-2019; Pavelka, Norman/G-4577-2018	Choi, Hyungwon/0000-0002-6687-3088; Pavelka, Norman/0000-0003-4542-9970; Kandhadayar, Gopalan Srinivasan/0000-0003-4387-8502; Poidinger, Michael/0000-0002-1047-2277; Wright, Graham/0000-0003-2362-1312; Yurieva, Marina/0000-0002-5761-0382; Rancati, Giulia/0000-0003-0835-0139	A<SUP>star</SUP>STAR Investigatorship award [1437a00119, 1437a00117]; Singapore Ministry of Education Tier 2 Grant [R-608-000-088-112]	A<SUP>star</SUP>STAR Investigatorship award; Singapore Ministry of Education Tier 2 Grant(Ministry of Education, Singapore)	Authors thank Rong Li, Dmitry Ivanov, and Simonetta Piatti for reagents; Andrea Chew, Josephine Lum, and Agatha Susila for technical assistance; Steve Chai (Bitplane/Oxford Instruments) for assistance with Imaris; Brian Burke, Maybelline Giam, Zhihao Tan, Barbara Knowles, and Neil McCarthy (Insight Editing London) for critically reading the manuscript; Valerie Doye, Dirk Gorlich, and Hema Chung for useful discussions and sharing unpublished results. G.R. is supported by A<SUP>star</SUP>STAR Investigatorship award 1437a00119. N.P. is supported by A<SUP>star</SUP>STAR Investigatorship award 1437a00117. H.C. is supported by a Singapore Ministry of Education Tier 2 Grant R-608-000-088-112.	Aitchison JD, 2012, GENETICS, V190, P855, DOI 10.1534/genetics.111.127803; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], NUCL ACIDS RES, V40, pD700; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bergmiller T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002803; Chen GB, 2012, BIOESSAYS, V34, P893, DOI 10.1002/bies.201200069; Chen GB, 2012, NATURE, V482, P246, DOI 10.1038/nature10795; Chug H, 2015, SCIENCE, V350, P106, DOI 10.1126/science.aac7420; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Fang G, 2005, MOL BIOL EVOL, V22, P2147, DOI 10.1093/molbev/msi211; Forche A, 2011, MBIO, V2, DOI 10.1128/mBio.00129-11; Gerdes S, 2006, CURR OPIN BIOTECH, V17, P448, DOI 10.1016/j.copbio.2006.08.006; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Giaever G, 2014, GENETICS, V197, P451, DOI 10.1534/genetics.114.161620; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Harcombe WR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-106; Harris MA, 2013, BIOINFORMATICS, V29, P1671, DOI 10.1093/bioinformatics/btt266; Hodge CA, 2010, J CELL SCI, V123, P141, DOI 10.1242/jcs.055046; Hu WQ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030024; Hwang YC, 2009, MOL BIOSYST, V5, P1672, DOI [10.1039/b900611g, 10.1039/B900611G]; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Judson N, 2000, NAT BIOTECHNOL, V18, P740, DOI 10.1038/77305; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; Kops AD, 2001, EMBO J, V20, P4183, DOI 10.1093/emboj/20.15.4183; Lees JA, 2010, NAT STRUCT MOL BIOL, V17, P1292, DOI 10.1038/nsmb.1917; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Nagai K, 2003, EMBO J, V22, P3479, DOI 10.1093/emboj/cdg337; Ni M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001653; Pavelka N, 2010, CURR OPIN CELL BIOL, V22, P809, DOI 10.1016/j.ceb.2010.06.003; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Ponder RG, 2005, MOL CELL, V19, P791, DOI 10.1016/j.molcel.2005.07.025; Rancati G, 2008, CELL, V135, P879, DOI 10.1016/j.cell.2008.09.039; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Ryan CJ, 2013, GENOME BIOL EVOL, V5, P1049, DOI 10.1093/gbe/evt074; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/NMETH.2212, 10.1038/nmeth.2212]; Saitoh Y, 2005, TRAFFIC, V6, P502, DOI 10.1111/j.1600-0854.2005.00295.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Sharma S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097100; Sherman F., 1974, METHODS YEAST GENETI; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Szamecz B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001935; Teng X, 2013, MOL CELL, V52, P485, DOI 10.1016/j.molcel.2013.09.026; Tolliday N, 2003, MOL BIOL CELL, V14, P798, DOI 10.1091/mbc.E02-09-0558; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Vernon M, 2008, GENETICS, V179, P237, DOI 10.1534/genetics.107.086603; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu P, 2011, SCI REP-UK, V1, DOI 10.1038/srep00125; Yona AH, 2012, P NATL ACAD SCI USA, V109, P21010, DOI 10.1073/pnas.1211150109; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zhu J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002719	62	88	88	6	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6					1388	1399		10.1016/j.cell.2015.10.069	http://dx.doi.org/10.1016/j.cell.2015.10.069			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26627736	Bronze			2022-12-28	WOS:000366044800003
J	Liu, JF; Bai, Y; Wang, S; Justham, S; Lu, YJ; Gu, WM; Liu, QZ; Di Stefano, R; Guo, JC; Cabrera-Lavers, A; Alvarez, P; Cao, Y; Kulkarni, S				Liu, Ji-Feng; Bai, Yu; Wang, Song; Justham, Stephen; Lu, You-Jun; Gu, Wei-Min; Liu, Qing-Zhong; Di Stefano, Rosanne; Guo, Jin-Cheng; Cabrera-Lavers, Antonio; Alvarez, Pedro; Cao, Yi; Kulkarni, Shri			Relativistic baryonic jets from an ultraluminous supersoft X-ray source	NATURE			English	Article							DISCOVERY; NOVAE; DISKS	The formation of relativistic jets by an accreting compact object is one of the fundamental mysteries of astrophysics. Although the theory is poorly understood, observations of relativistic jets from systems known as microquasars (compact binary stars)(1,2) have led to a well established phenomenology(3,4). Relativistic jets are not expected to be produced by sources with soft or supersoft X-ray spectra, although two such systems are known to produce relatively low-velocity bipolar outflows(5,6). Here we report the optical spectra of an ultraluminous supersoft X-ray source (ULS7,8) in the nearby galaxy M81 (M81 ULS-1; refs 9, 10). Unexpectedly, the spectra show blueshifted, broad H alpha emission lines, characteristic of baryonic jets with relativistic speeds. These time-variable emission lines have projected velocities of about 17 per cent of the speed of light, and seem to be similar to those from the prototype microquasar SS 433 (refs 11, 12). Such relativistic jets are not expected to be launched from white dwarfs(13), and an origin from a black hole or a neutron star is hard to reconcile with the persistence of M81 ULS-1's soft X-rays(10). Thus the unexpected presence of relativistic jets in a ULS challenges canonical theories of jet formation(3,4), but might be explained by a long-speculated, supercritically accreting black hole with optically thick outflows(14-20).	[Liu, Ji-Feng; Bai, Yu; Wang, Song; Justham, Stephen; Lu, You-Jun; Guo, Jin-Cheng] Chinese Acad Sci, Natl Astron Observ, Key Lab Opt Astron, Beijing 100012, Peoples R China; [Liu, Ji-Feng; Justham, Stephen; Lu, You-Jun] Univ Chinese Acad Sci, Coll Astron & Space Sci, Beijing 100049, Peoples R China; [Gu, Wei-Min] Xiamen Univ, Dept Astron, Xiamen 361005, Fujian Province, Peoples R China; [Liu, Qing-Zhong] Chinese Acad Sci, Purple Mt Observ, Key Lab Dark Matter & Space Astron, Nanjing 210008, Jiangsu, Peoples R China; [Di Stefano, Rosanne] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Cabrera-Lavers, Antonio; Alvarez, Pedro] Inst Astrofis Canarias, E-38200 San Cristobal la Laguna, Tenerife, Spain; [Cabrera-Lavers, Antonio; Alvarez, Pedro] Univ La Laguna, Dept Astrofis, E-38205 San Cristobal la Laguna, Tenerife, Spain; [Cao, Yi; Kulkarni, Shri] CALTECH, Dept Astron, Pasadena, CA 91125 USA	Chinese Academy of Sciences; National Astronomical Observatory, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Xiamen University; Chinese Academy of Sciences; Nanjing Institute of Astronomical Optics & Technology, NAOC, CAS; Purple Mountain Observatory, CAS; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Instituto de Astrofisica de Canarias; Universidad de la Laguna; California Institute of Technology	Liu, JF (corresponding author), Chinese Acad Sci, Natl Astron Observ, Key Lab Opt Astron, 20A Datun Rd, Beijing 100012, Peoples R China.	jfliu@nao.cas.cn	Bai, Yu/E-2902-2016	Bai, Yu/0000-0002-4740-3857	Chinese Academy of Sciences [XDB09000000]; 973 Program [2014CB845705]; National Science Foundation of China [NSFC-11333004/11425313]; W.M. Keck Foundation	Chinese Academy of Sciences(Chinese Academy of Sciences); 973 Program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); W.M. Keck Foundation(W.M. Keck Foundation)	We thank K. Blundell, R. Narayan, Z. Li, T. Wang, F. Yuan, X. Fang, J. Irwin, T. Maccarone and D. Swartz for helpful discussions. We acknowledge support from the Chinese Academy of Sciences (grant XDB09000000), from the 973 Program (grant 2014CB845705), and from the National Science Foundation of China (grants NSFC-11333004/11425313). This work is based partly on observations made with the Gran Telescopio Canarias, installed in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias, on the island of La Palma. Some of the data were obtained at the W.M. Keck Observatory, which is operated through a scientific partnership among the California Institute of Technology, the University of California and the National Aeronautics and Space Administration. This Observatory was made possible through the financial support of the W.M. Keck Foundation.	ABRAMOWICZ MA, 1988, ASTROPHYS J, V332, P646, DOI 10.1086/166683; Bai Y, 2015, ASTROPHYS J LETT, V802, DOI 10.1088/2041-8205/802/2/L27; Becker CM, 1998, ASTROPHYS J, V506, P880, DOI 10.1086/306272; Blundell KM, 2007, ASTRON ASTROPHYS, V474, P903, DOI 10.1051/0004-6361:20077924; Di Stefano R, 2004, ASTROPHYS J, V609, P710, DOI 10.1086/421318; Di Stefano R, 2003, ASTROPHYS J, V592, P884, DOI 10.1086/375858; Di Stefano R, 2010, ASTRON NACHR, V331, P205, DOI 10.1002/asna.200911328; Fender RP, 2004, MON NOT R ASTRON SOC, V355, P1105, DOI 10.1111/j.1365-2966.2004.08384.x; FREEDMAN WL, 1994, ASTROPHYS J, V427, P628, DOI 10.1086/174172; Gu WM, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/71; HASINGER G, 1989, ASTRON ASTROPHYS, V225, P79; IBEN I, 1982, ASTROPHYS J, V259, P244, DOI 10.1086/160164; Jiang YF, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/2/106; Kahabka P, 1997, ANNU REV ASTRON ASTR, V35, P69, DOI 10.1146/annurev.astro.35.1.69; King AR, 2003, MON NOT R ASTRON SOC, V345, P657, DOI 10.1046/j.1365-8711.2003.06980.x; Liu JF, 2008, ASTROPHYS J SUPPL S, V177, P181, DOI 10.1086/587551; Liu J, 2008, ASTROPHYS J LETT, V674, pL73, DOI 10.1086/529071; Livio M, 2001, ASTR SOC P, V224, P225; MARGON B, 1984, ANNU REV ASTRON ASTR, V22, P507; Migliari S, 2006, MON NOT R ASTRON SOC, V366, P79, DOI 10.1111/j.1365-2966.2005.09777.x; Mirabel IF, 1998, NATURE, V392, P673, DOI 10.1038/33603; NOMOTO K, 1982, ASTROPHYS J, V253, P798, DOI 10.1086/159682; Ohsuga K, 2005, ASTROPHYS J, V628, P368, DOI 10.1086/430728; PACZYNSKY B, 1980, ASTRON ASTROPHYS, V88, P23; Paredes J. M., 2003, CONTRIBUTIONS SCI, V2, P303; Sadowski A., 2015, PREPRINT; Schilizzi R. T., 2007, PRELIMINARY SPECIFIC; Shen RF, 2015, MON NOT R ASTRON SOC, V447, pL60, DOI 10.1093/mnrasl/slu183; Southwell KA, 1996, ASTROPHYS J, V470, P1065, DOI 10.1086/177931; Swartz DA, 2002, ASTROPHYS J, V574, P382, DOI 10.1086/340926; Vittone A., 1983, Astronomy & Astrophysics Supplement Series, V53, P109	32	30	31	0	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					108	+		10.1038/nature15751	http://dx.doi.org/10.1038/nature15751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26605521	Green Submitted			2022-12-28	WOS:000365606000057
J	Blumenstock, J; Cadamuro, G; On, R				Blumenstock, Joshua; Cadamuro, Gabriel; On, Robert			Predicting poverty and wealth from mobile phone metadata	SCIENCE			English	Article							SELECTION	Accurate and timely estimates of population characteristics are a critical input to social and economic research and policy. In industrialized economies, novel sources of data are enabling new approaches to demographic profiling, but in developing countries, fewer sources of big data exist. We show that an individual's past history of mobile phone use can be used to infer his or her socioeconomic status. Furthermore, we demonstrate that the predicted attributes of millions of individuals can, in turn, accurately reconstruct the distribution of wealth of an entire nation or to infer the asset distribution of microregions composed of just a few households. In resource-constrained environments where censuses and household surveys are rare, this approach creates an option for gathering localized and timely information at a fraction of the cost of traditional methods.	[Blumenstock, Joshua] Univ Washington, Informat Sch, Seattle, WA 98195 USA; [Cadamuro, Gabriel] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [On, Robert] Univ Calif Berkeley, Sch Informat, Berkeley, CA 94720 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Berkeley	Blumenstock, J (corresponding author), Univ Washington, Informat Sch, Seattle, WA 98195 USA.	joshblum@uw.edu	Blumenstock, Joshua/ADN-3685-2022	Blumenstock, Joshua/0000-0002-1813-7414	NSF [1025103]; Institute for Money, Technology, and Financial Inclusion [2010-2366]; Gates Foundation [OPP1106936]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Institute for Money, Technology, and Financial Inclusion; Gates Foundation(Bill & Melinda Gates Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We received approval for this study from the University of Washington Human Subjects Division (protocol 44933) and the University of California Committee for Protection of Human Subjects (protocol 200949). We thank N. Eagle for providing access to the mobile phone records, Y. Yao for research assistance, S. Kumaran and the faculty and students at the Kigali Institute of Science and Technology for help in coordinating the phone survey, and N. Musaninkindi and the Rwandan National Institute of Statistics for assistance with DHS data. J.B. is supported by the NSF (Doctoral Dissertation Award 1025103); the Institute for Money, Technology, and Financial Inclusion (grant 2010-2366); and the Gates Foundation (grant OPP1106936). We do not have any real or apparent conflicts of interest. Mobile phone data were supplied by an anonymous service provider in Rwanda and are not available for distribution. All other data and code, including all intermediate data needed to replicate these results and apply these methods in other contexts, are available through the Inter-university Consortium for Political and Social Research (http://doi.org/10.3886/E50592V2).	Abelson B, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P1563, DOI 10.1145/2623330.2623335; [Anonymous], 2014, MOB EC 2014; Blumenstock JE, 2012, INF TECHNOL INT DEV, V8, P1; Blumenstock JE, 2012, INFORM TECHNOL DEV, V18, P107, DOI 10.1080/02681102.2011.643209; Breiman L., 1984, CLASSIFICATION REGRE; Candia J, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/22/224015; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; de Montjoye YA, 2015, SCIENCE, V347, P536, DOI 10.1126/science.1256297; Deville P, 2014, P NATL ACAD SCI USA, V111, P15888, DOI 10.1073/pnas.1408439111; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Elbers C, 2003, ECONOMETRICA, V71, P355, DOI 10.1111/1468-0262.00399; Fields G. S., 1989, World Bank Research Observer, V4, P167, DOI 10.1093/wbro/4.2.167; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Frias-Martinez V, 2012, P 5 INT C INF COMM T, P76; GHOSH M, 1994, STAT SCI, V9, P55, DOI 10.1214/ss/1177010647; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Jerven M., 2013, POOR NUMBERS WE ARE; Jerven M., 2014, DAT DEV ASS PAP; King G, 2011, SCIENCE, V331, P719, DOI 10.1126/science.1197872; Kuznets S, 1955, AM ECON REV, V45, P1; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lu X, 2013, SCI REP-UK, V3, DOI 10.1038/srep02923; Ministry of Planning, 2010, DEM HLTH SURV 2010; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Wang W, 2015, INT J FORECASTING, V31, P980, DOI 10.1016/j.ijforecast.2014.06.001; Wesolowski Amy, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.0177e7fcf52217b8b634376e2f3efc5e; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	29	286	299	7	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1073	1076		10.1126/science.aac4420	http://dx.doi.org/10.1126/science.aac4420			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY5BJ	26612950				2022-12-28	WOS:000366422600039
J	Appleby, J				Appleby, John			Pay in the NHS: who earns what?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Appleby, John] Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						Benedikt CF, 2013, FUTURE EMPLOYMENT SU; Health and Social Care Information Centre, 2015, GP EARN EXP TIM SER; Health and Social Care Information Centre, 2015, NHS STAFF EARN EST J; Health and Social Care Information Centre, DENT EARN EXP 2013 1; Health and Social Care Information Centre, 2015, NHS STAFF EARN EST M; HM Treasury, 2010, SPEND REV 2010; Office for National Statistics, 2010, ANN SURV HOURS EARN; Office of National Statistics, ANN SURV HOURS EARN; Timmins N, 2015, PRIME MINISTERS PAY	9	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2015	351								h6250	10.1136/bmj.h6250	http://dx.doi.org/10.1136/bmj.h6250			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX4TL	26612086				2022-12-28	WOS:000365693100003
J	Zuckerman, DM; Jury, NJ; Silcox, CE				Zuckerman, Diana M.; Jury, Nicholas J.; Silcox, Christina E.			21st Century Cures Act and similar policy efforts: at what cost?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GAMMA-SECRETASE INHIBITOR; BAPINEUZUMAB; COGNITION; DIMEBON; TRIAL		[Zuckerman, Diana M.; Jury, Nicholas J.; Silcox, Christina E.] Natl Ctr Hlth Res, Washington, DC 20036 USA		Zuckerman, DM (corresponding author), Natl Ctr Hlth Res, 1001 Connecticut Ave NW, Washington, DC 20036 USA.	dz@center4research.org		Jury, Nicholas/0000-0002-4233-117X				Altucher J., 2009, WALL STREET J; Alzheimer's Association, LAT MED MEM LOSS; [Anonymous], 2012, REUTERS; [Anonymous], 2015, ALZHEIMERS DEME 0712; [Anonymous], 2003, FORTUNE; Bachurin S, 2001, ANN NY ACAD SCI, V939, P425; Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Bezprozvanny I, 2010, DRUG NEWS PERSPECT, V23, P518, DOI 10.1358/dnp.2010.23.8.1500435; Doody RS, 2008, LANCET, V372, P207, DOI 10.1016/S0140-6736(08)61074-0; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Fleisher AS, 2008, ARCH NEUROL-CHICAGO, V65, P1031, DOI 10.1001/archneur.65.8.1031; Humpel C, 2011, TRENDS BIOTECHNOL, V29, P26, DOI 10.1016/j.tibtech.2010.09.007; IMS Health, 2014, MED US SHIFT COSTS H; Kim C, 2015, JAMA INT MED; Liu EC, 2015, NEUROLOGY, V85, P692, DOI 10.1212/WNL.0000000000001877; Makuch RW, 2014, THER INNOV REGUL SCI, V48, P362, DOI 10.1177/2168479013517103; Nussbaum A., 2011, BLOOMBERG; Pollack A., 2010, NY TIMES; Pollack A., 2007, NY TIMES; Pollack A, 2015, NY TIMES, pB2; RIGGS BL, 1990, NEW ENGL J MED, V322, P802, DOI 10.1056/NEJM199003223221203; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Rocchi Angela, 2013, Cost Eff Resour Alloc, V11, P31, DOI 10.1186/1478-7547-11-31; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Siemers ER, 2006, NEUROLOGY, V66, P602, DOI 10.1212/01.WNL.0000198762.41312.E1	26	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2015	351								h6122	10.1136/bmj.h6122	http://dx.doi.org/10.1136/bmj.h6122			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX4SR	26597099				2022-12-28	WOS:000365691100001
J	Boivin, MJ; Kakooza, AM; Warf, BC; Davidson, LL; Grigorenko, EL				Boivin, Michael J.; Kakooza, Angelina M.; Warf, Benjamin C.; Davidson, Leslie L.; Grigorenko, Elena L.			Reducing neurodevelopmental disorders and disability through research and interventions	NATURE			English	Review							CAREGIVER TRAINING-PROGRAM; EARLY-CHILDHOOD DIARRHEA; MIDDLE-INCOME COUNTRIES; INFANT HYDROCEPHALUS; APOLIPOPROTEIN E4; CEREBRAL MALARIA; CHILDREN; OUTCOMES; DISEASE; KONZO	We define neurodevelopment as the dynamic inter-relationship between genetic, brain, cognitive, emotional and behavioural processes across the developmental lifespan. Significant and persistent disruption to this dynamic process through environmental and genetic risk can lead to neurodevelopmental disorders and disability. Research designed to ameliorate neurodevelopmental disorders in low-and middle-income countries, as well as globally, will benefit enormously from the ongoing advances in understanding their genetic and epigenetic causes, as modified by environment and culture. We provide examples of advances in the prevention and treatment of, and the rehabilitation of those with, neurodevelopment disorders in low-and middle-income countries, along with opportunities for further strategic research initiatives. Our examples are not the only possibilities for strategic research, but they illustrate problems that, when solved, could have a considerable impact in low-resource settings. In each instance, research in low-and middle-income countries led to innovations in identification, surveillance and treatment of a neurodevelopmental disorder. These innovations have also been integrated with genotypic mapping of neurodevelopmental disorders, forming important preventative and rehabilitative interventions with the potential for high impact. These advances will ultimately allow us to understand how epigenetic influences shape neurodevelopmental risk and resilience over time and across populations. Clearly, the most strategic areas of research opportunity involve cross-disciplinary integration at the intersection between the environment, brain or behaviour neurodevelopment, and genetic and epigenetic science. At these junctions a robust integrative cross-disciplinary scientific approach is catalysing the creation of technologies and interventions for old problems. Such approaches will enable us to achieve and sustain the United Nations moral and legal mandate for child health and full development as a basic global human right.	[Boivin, Michael J.] Michigan State Univ, Coll Osteopath Med, Dept Psychiat, 965 Fee Rd,East Fee Hall Room 225, E Lansing, MI 48824 USA; [Boivin, Michael J.] Michigan State Univ, INPEP, E Lansing, MI 48824 USA; [Kakooza, Angelina M.] Makerere Univ, Dept Pediat & Child Hlth, Sch Med, Coll Hlth Sci, Kampala, Uganda; [Warf, Benjamin C.] Boston Childrens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Davidson, Leslie L.] Columbia Univ, Med Ctr, Coll Phys & Surg, Dept Epidemiol,Mailman Sch Publ Hlth, New York, NY 10032 USA; [Davidson, Leslie L.] Columbia Univ, Med Ctr, Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; [Grigorenko, Elena L.] Yale Univ, Dept Epidemiol & Publ Hlth, Dept Psychol, Yale Child Study Ctr, New Haven, CT 06520 USA	Michigan State University; Michigan State University College of Osteopathic Medicine; Michigan State University; Makerere University; Harvard University; Boston Children's Hospital; Columbia University; Columbia University; Yale University	Boivin, MJ (corresponding author), Michigan State Univ, Coll Osteopath Med, Dept Psychiat, 965 Fee Rd,East Fee Hall Room 225, E Lansing, MI 48824 USA.	boivin@msu.edu	Grigorenko, Elena/V-2418-2019		Fogarty International Center	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The authors declare no competing financial interests. Financial support for publication has been provided by the Fogarty International Center.	Abubakar A., 2013, NEUROPSYCHOLOGY CHIL, P181, DOI [10.1007/978-1-4614-6834-9_9, DOI 10.1007/978-1-4614-6834-9_9]; Abubakar A, 2008, EARLY HUM DEV, V84, P613, DOI 10.1016/j.earlhumdev.2008.02.003; Abubakar A, 2010, J CHILD PSYCHOL PSYC, V51, P652, DOI 10.1111/j.1469-7610.2009.02193.x; Abubakar A, 2009, DEV MED CHILD NEUROL, V51, P968, DOI 10.1111/j.1469-8749.2009.03333.x; Alwan A, 2003, NAT REV GENET, V4, P61, DOI 10.1038/nrg978; [Anonymous], 2017, 2013 UNAIDS REP GLOB; [Anonymous], 2002, A56326 UN; [Anonymous], WORLD MAL REP; Banea J. P., 2015, African Journal of Food Science, V9, P43; Bangirana P, 2013, NEUROPSYCHOLOGY CHIL, P277, DOI DOI 10.1007/978-1-4614-6834-9_1; Baral S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-482; Boivin MJ, 2007, PEDIATRICS, V119, pE360, DOI 10.1542/peds.2006-2027; Boivin MJ, 2013, J PEDIATR-US, V163, P1409, DOI 10.1016/j.jpeds.2013.06.055; Boivin MJ, 2013, J DEV BEHAV PEDIATR, V34, P269, DOI 10.1097/DBP.0b013e318285fba9; Boivin MJ, 2013, PEDIATRICS, V131, pE1231, DOI 10.1542/peds.2012-3011; Boivin MJ, 2009, PROG BRAIN RES, V178, P113, DOI 10.1016/S0079-6123(09)17808-1; Bradbury JH, 2011, FOOD CHEM TOXICOL, V49, P539, DOI 10.1016/j.fct.2010.04.049; Braithwaite EC, 2015, EPIGENETICS-US, V10, P408, DOI 10.1080/15592294.2015.1039221; Brett ZH, 2015, INT J BEHAV DEV, V39, P150, DOI 10.1177/0165025414538557; Cliff J, 1997, TROP MED INT HEALTH, V2, P1068, DOI 10.1046/j.1365-3156.1997.d01-178.x; Couper J, 2002, SAMJ S AFR MED J, V92, P549; Croen LA, 2008, AUTISM RES, V1, P130, DOI 10.1002/aur.14; DeBoer MD, 2012, NUTR REV, V70, P642, DOI 10.1111/j.1753-4887.2012.00543.x; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Elder JP, 2014, J HEALTH COMMUN, V19, P25, DOI 10.1080/10810730.2014.940477; Farnsworth SK, 2014, J HEALTH COMMUN, V19, P67, DOI 10.1080/10810730.2014.941519; Fernald LC, 2003, EUR J CLIN NUTR, V57, P1458, DOI 10.1038/sj.ejcn.1601710; Foltz JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066419; Gluckman P, 2006, DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, P1, DOI 10.2277/ 0521847435; Gregory KE, 2011, J PERINAT NEONAT NUR, V25, P158, DOI 10.1097/JPN.0b013e3182169346; Guerrant DI, 1999, AM J TROP MED HYG, V61, P707, DOI 10.4269/ajtmh.1999.61.707; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; Guerrant RL, 2000, J INFECT DIS, V182, pS134, DOI 10.1086/315924; Guerrant RL, 1999, ADV EXP MED BIOL, V473, P103; Guo DX, 2014, SCI CHINA LIFE SCI, V57, P88, DOI 10.1007/s11427-013-4593-y; Idro R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002540; John CC, 2008, PEDIATRICS, V122, pE92, DOI 10.1542/peds.2007-3709; Kiwanuka J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072775; Koura KG, 2013, J DEV BEHAV PEDIATR, V34, P486, DOI 10.1097/DBP.0b013e31829d211c; Kubota T, 2015, J DEV ORIG HLTH DIS, V6, P96, DOI 10.1017/S2040174415000057; Kulkarni AV, 2013, J NEUROSURG-PEDIATR, V12, P334, DOI 10.3171/2013.7.PEDS12637; Kvalsvig J. D., 2013, NEUROPSYCHOLOGY CHIL, P37; Laughton B, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18603; Li LL, 2011, J NEUROSURG-PEDIATR, V7, P73, DOI 10.3171/2010.9.PEDS10162; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; McCall CE, 2011, J LEUKOCYTE BIOL, V90, P439, DOI 10.1189/jlb.0211075; Mendenhall E, 2014, SOC SCI MED, V118, P33, DOI 10.1016/j.socscimed.2014.07.057; Mitter SS, 2012, CLINICS, V67, P11, DOI 10.6061/clinics/2012(01)03; Murgatroyd C, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2014.140; National Institutes of Health, 2014, NIH SPONS STUD ID SU; Nelson R, 2012, AM J NURS, V112, P17, DOI 10.1097/01.NAJ.0000423494.77404.42; Nemoda Z, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.32; Noble KG, 2015, NAT NEUROSCI, V18, P773, DOI 10.1038/nn.3983; Oria RB, 2005, PEDIATR RES, V57, P310, DOI 10.1203/01.PDR.0000148719.82468.CA; Oria RB, 2007, MED HYPOTHESES, V68, P1099, DOI 10.1016/j.mehy.2006.09.036; Perroud N, 2014, WORLD J BIOL PSYCHIA, V15, P334, DOI 10.3109/15622975.2013.866693; Reichman NE, 1998, FAM PLANN PERSPECT, V30, P182, DOI 10.2307/2991681; Schiff SJ, 2012, J NEUROSURG-PEDIATR, V10, P161, DOI 10.3171/2012.5.PEDS11557; Sejvar JJ, 2013, LANCET NEUROL, V12, P166, DOI 10.1016/S1474-4422(12)70321-6; Sinclair D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006086.pub3; Sirois PA, 2013, PEDIATR INFECT DIS J, V32, P648, DOI 10.1097/INF.0b013e318284129a; Stone SSD, 2014, J NEUROSURG-PEDIATR, V14, P439, DOI 10.3171/2014.7.PEDS14152; Swartz L, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.23433; Thankachan P, 2010, EUR J CLIN NUTR, V64, P1101, DOI 10.1038/ejcn.2010.126; Thaver D, 2009, PEDIATR INFECT DIS J, V28, pS3, DOI 10.1097/INF.0b013e3181958755; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; TYLLESKAR T, 1993, J NEUROL NEUROSUR PS, V56, P638, DOI 10.1136/jnnp.56.6.638; TYLLESKAR T, 1994, NEUROLOGY, V44, P959, DOI 10.1212/WNL.44.5.959; UN General Assembly, 2012, POL DECL HIGH LEV M; UNICEF, 2013, STATE WORLDS CHILDRE; Warf BC, 2005, J NEUROSURG, V102, P1, DOI 10.3171/ped.2005.102.1.0001; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P502, DOI 10.3171/2011.8.PEDS11221; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P509, DOI 10.3171/2011.8.PEDS11163; Warf BC, 2010, WORLD NEUROSURG, V73, P296, DOI 10.1016/j.wneu.2010.02.009	74	55	56	0	28	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					S155	S160		10.1038/nature16029	http://dx.doi.org/10.1038/nature16029			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW9ZN	26580321	hybrid			2022-12-28	WOS:000365356800010
J	Cottler, LB; Zunt, J; Weiss, B; Kamal, AK; Vaddiparti, K				Cottler, Linda B.; Zunt, Joseph; Weiss, Bahr; Kamal, Ayeesha Kamran; Vaddiparti, Krishna			Building global capacity for brain and nervous system disorders research	NATURE			English	Review							MIDDLE-INCOME COUNTRIES; HEALTH RESEARCH; EATING-DISORDERS; INTERNET; INTERVENTIONS; BURDEN; DISABILITY; DISEASES; WORLD; PREVALENCE	The global burden of neurological, neuropsychiatric, substance-use and neurodevelopmental disorders in low-and middle-income countries is worsened, not only by the lack of targeted research funding, but also by the lack of relevant in-country research capacity. Such capacity, from the individual to the national level, is necessary to address the problems within a local context. As for many health issues in these countries, the ability to address this burden requires development of research infrastructure and a trained cadre of clinicians and scientists who can ask the right questions, and conduct, manage, apply and disseminate research for practice and policy. This Review describes some of the evolving issues, knowledge and programmes focused on building research capacity in low-and middle-income countries in general and for brain and nervous system disorders in particular.	[Cottler, Linda B.; Vaddiparti, Krishna] Univ Florida, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Cottler, Linda B.; Vaddiparti, Krishna] Univ Florida, Coll Med, Gainesville, FL USA; [Zunt, Joseph] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Weiss, Bahr] Vanderbilt Univ, Dept Psychol & Human Dev, Nashville, TN 37235 USA; [Kamal, Ayeesha Kamran] Aga Khan Univ, Int Cerebrovascular Translat Clin Res Training Pr, Fogarty Int Ctr, Stroke Serv,Sect Neurol,Dept Med,NIH, Karachi, Pakistan	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Washington; University of Washington Seattle; Vanderbilt University; Aga Khan University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Cottler, LB (corresponding author), Univ Florida, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA.	lbcottler@ufl.edu	Zunt, Joseph/ABD-2886-2021	cottler, linda/0000-0001-5643-8536	FIC/NIMH/NIH [D43TW009120, D43TW009089, D43TW008660]; Fogarty International Center; National Institute on Drug Abuse of the National Institutes of Health [D43 TW009120]; FOGARTY INTERNATIONAL CENTER [D43TW009120, D43TW008660, D43TW009089] Funding Source: NIH RePORTER	FIC/NIMH/NIH; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute on Drug Abuse of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The authors were supported in part by the following grants: FIC/NIMH/NIH D43TW009120, Indo-US Training Program on Non-Communicable Diseases Across the Lifespan; FIC/NIMH/NIH D43TW009089, Increasing Mental Health Research Infrastructure in Southeast Asia; and FIC/NINDS/NIH D43TW008660, International Cerebrovascular Translational Clinical Research Training Program. Research reported in this publication was supported by the Fogarty International Center and the National Institute on Drug Abuse of the National Institutes of Health under Award Number D43 TW009120. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aardoom JJ, 2013, INT J EAT DISORDER, V46, P539, DOI 10.1002/eat.22135; Brouwer W, 2011, J MED INTERNET RES, V13, P23, DOI 10.2196/jmir.1639; Chin JH, 2014, NEUROLOGY, V83, P349, DOI 10.1212/WNL.0000000000000610; Cottler LB, 2014, LANCET GLOB HEALTH, V2, pE592, DOI 10.1016/S2214-109X(14)70290-6; Crutzen R, 2011, HEALTH EDUC BEHAV, V38, P49, DOI 10.1177/1090198110372878; Davies CA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-52; Dolemeyer R, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-207; ESSENCE on Health Research, 2014, ESSENCE GOOD PRACT D, V31; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Kahn JG, 2010, HEALTH AFFAIR, V29, P254, DOI 10.1377/hlthaff.2009.0965; Katikireddi SV, 2004, BRIT MED J, V328, P1190, DOI 10.1136/bmj.328.7449.1190; Lansang MA, 2004, B WORLD HEALTH ORGAN, V82, P764; Luabeya MK, 2013, NEUROLOGY, V80, P1806, DOI 10.1212/WNL.0b013e3182918c5e; Martinez-Perez B, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2600; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nuyens Y, 2007, B WORLD HEALTH ORGAN, V85, P319, DOI 10.2471/BLT.06.032375; Ogundahunsi OAT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003380; Organization WH, 2006, NEUR DIS PUBL HLTH C, DOI 10.1001/archneurol.2007.19; Ormel J, 2008, BRIT J PSYCHIAT, V192, P368, DOI 10.1192/bjp.bp.107.039107; Pang T, 2003, B WORLD HEALTH ORGAN, V81, P815; Pew Research Center, 2014, EM NAT EMBR INT MOB; Pinkerton RC, 2011, AM J TROP MED HYG, V85, P893, DOI 10.4269/ajtmh.2011.11-0159; Ruktanonchai CW, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-39; Smith DG, 2012, ACAD MED, V87, P1511, DOI 10.1097/ACM.0b013e31826d30d5; Stinson J, 2009, J PEDIATR PSYCHOL, V34, P495, DOI 10.1093/jpepsy/jsn115; Task force on the principles of commmunity engagement, 2011, PRINC COMM ENG, V197; Thornicroft G, 2012, HARVARD REV PSYCHIAT, V20, P13, DOI 10.3109/10673229.2012.649117; Toma J. D, 2010, BUILDING ORG CAPACIT, V280; Uthman OA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006340; van Beugen S, 2014, J MED INTERNET RES, V16, P251, DOI 10.2196/jmir.2777; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; WHO, 2020, MENT HLTH ATL 2011; World Health Organization, 2012, WHO STRAT RES HLTH	34	12	12	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					S207	S213		10.1038/nature16037	http://dx.doi.org/10.1038/nature16037			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW9ZN	26580329	Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000365356800018
J	Praetorius, SK; Mix, AC; Walczak, MH; Wolhowe, MD; Addison, JA; Prahl, FG				Praetorius, S. K.; Mix, A. C.; Walczak, M. H.; Wolhowe, M. D.; Addison, J. A.; Prahl, F. G.			North Pacific deglacial hypoxic events linked to abrupt ocean warming	NATURE			English	Article							SANTA-BARBARA BASIN; OXYGEN MINIMUM ZONE; BENTHIC FORAMINIFERA; ORGANIC-MATTER; NORDIC SEAS; WATER; SURFACE; SEDIMENTS; CLIMATE; TEMPERATURE	Marine sediments from the North Pacific document two episodes of expansion and strengthening of the subsurface oxygen minimum zone (OMZ) accompanied by seafloor hypoxia during the last deglacial transition(1-4). The mechanisms driving this hypoxia remain under debate(1-11). We present a new high-resolution alkenone palaeotemperature reconstruction from the Gulf of Alaska that reveals two abrupt warming events of 4-5 degrees Celsius at the onset of the Bolling and Holocene intervals that coincide with sudden shifts to hypoxia at intermediate depths. The presence of diatomaceous laminations and hypoxia-tolerant benthic foraminiferal species, peaks in redox-sensitive trace metals(12,13), and enhanced N-15/N-14 ratio of organic matter(13), collectively suggest association with high export production. A decrease in O-18/O-16 values of benthic foraminifera accompanying the most severe deoxygenation event indicates subsurface warming of up to about 2 degrees Celsius. We infer that abrupt warming triggered expansion of the North Pacific OMZ through reduced oxygen solubility and increased marine productivity via physiological effects; following initiation of hypoxia, remobilization of iron from hypoxic sediments could have provided a positive feedback on ocean deoxygenation through increased nutrient utilization and carbon export. Such a biogeochemical amplification process implies high sensitivity of OMZ expansion to warming.	[Praetorius, S. K.; Mix, A. C.; Walczak, M. H.; Wolhowe, M. D.; Prahl, F. G.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Addison, J. A.] US Geol Survey, Menlo Pk, CA 94025 USA	Oregon State University; United States Department of the Interior; United States Geological Survey	Praetorius, SK (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA.	spraetorius@carnegiescience.edu		Walczak, Maureen/0000-0002-4123-6998; Addison, Jason/0000-0003-2416-9743	NSF [AGS-0602395, OCE-1204204]; NSF; USGS Cimate and Land Use Change Research and Development Program; Volcano Science Center; Directorate For Geosciences [1502754, 1357529, 1204204] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); USGS Cimate and Land Use Change Research and Development Program; Volcano Science Center; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank J. Padman for assistance with faunal counts, K. Brewster for assistance with alkenone sample preparation and analysis, and A. Guiheneuf for preliminary alkenone measurements and faunal assemblage data. This work was supported by NSF grants AGS-0602395 (Project PALEOVAR, A.C.M.) and OCE-1204204 (A.C.M. and F.G.P.), and an NSF graduate research fellowship for S.K.P.; J.A.A. was supported by the USGS Cimate and Land Use Change Research and Development Program and the Volcano Science Center.	Addison JA, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2011PA002161; Adkins JF, 1997, PALEOCEANOGRAPHY, V12, P337, DOI 10.1029/97PA00379; Barron JA, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000768; Barron JA, 2009, MAR MICROPALEONTOL, V72, P176, DOI 10.1016/j.marmicro.2009.04.006; Behl RJ, 1996, NATURE, V379, P243, DOI 10.1038/379243a0; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Bemis BE, 1998, PALEOCEANOGRAPHY, V13, P150, DOI 10.1029/98PA00070; Bendle J, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000741; BENSON BB, 1984, LIMNOL OCEANOGR, V29, P620, DOI 10.4319/lo.1984.29.3.0620; BERNHARD JM, 1991, BIOGEOCHEMISTRY, V15, P127; BERNHARD JM, 1986, J FORAMIN RES, V16, P207, DOI 10.2113/gsjfr.16.3.207; BOYD P, 1995, DEEP-SEA RES PT I, V42, P619, DOI 10.1016/0967-0637(95)00017-Z; Brickley PJ, 2004, DEEP-SEA RES PT II, V51, P229, DOI 10.1016/j.dsr2.2003.06.003; Chang AS, 2015, PALEOCEANOGRAPHY, V30, P77, DOI 10.1002/2014PA002681; Christie W.W, 2003, LIPID ANAL ISOLATION, V3rd; Conley DJ, 2009, HYDROBIOLOGIA, V629, P21, DOI 10.1007/s10750-009-9764-2; Crusius J, 2004, GEOLOGY, V32, P633, DOI 10.1130/G20508.1; Davies MH, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002051; Davies-Walczak M, 2014, EARTH PLANET SC LETT, V397, P57, DOI 10.1016/j.epsl.2014.04.004; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Fitzsimmons JN, 2014, P NATL ACAD SCI USA, V111, P16654, DOI 10.1073/pnas.1418778111; Hendy IL, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000965; HERMELIN JOR, 1990, MAR GEOL, V91, P1, DOI 10.1016/0025-3227(90)90130-C; Hill TM, 2006, QUATERNARY SCI REV, V25, P2835, DOI 10.1016/j.quascirev.2006.03.012; Hoffmann LJ, 2006, LIMNOL OCEANOGR, V51, P1217, DOI 10.4319/lo.2006.51.3.1217; Hofmann AF, 2011, DEEP-SEA RES PT I, V58, P1212, DOI 10.1016/j.dsr.2011.09.004; INGALL E, 1994, GEOCHIM COSMOCHIM AC, V58, P2571, DOI 10.1016/0016-7037(94)90033-7; Jaccard SL, 2012, NAT GEOSCI, V5, P151, DOI [10.1038/ngeo1352, 10.1038/NGEO1352]; Jorissen FJ, 2007, DEV MARINE GEOL, V1, P263, DOI 10.1016/S1572-5480(07)01012-3; KAIHO K, 1994, GEOLOGY, V22, P719, DOI 10.1130/0091-7613(1994)022<0719:BFDOIA>2.3.CO;2; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Kemp AES, 2013, PROG OCEANOGR, V119, P4, DOI 10.1016/j.pocean.2013.06.004; Kienast SS, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000650; Kohfeld KE, 2011, QUATERNARY SCI REV, V30, P3350, DOI 10.1016/j.quascirev.2011.08.007; Kuehn H, 2014, CLIM PAST, V10, P2215, DOI 10.5194/cp-10-2215-2014; Lam PJ, 2013, NAT GEOSCI, V6, P622, DOI [10.1038/NGEO1873, 10.1038/ngeo1873]; Lopes C, 2015, P NATL ACAD SCI USA, V112, P332, DOI 10.1073/pnas.1410480111; Marcott SA, 2014, NATURE, V514, P616, DOI 10.1038/nature13799; Mix AC, 1999, GEOPH MONOG SERIES, V112, P127; Moffitt SE, 2014, PALEOCEANOGRAPHY, V29, P44, DOI 10.1002/2013PA002483; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Okazaki Y, 2010, SCIENCE, V329, P200, DOI 10.1126/science.1190612; Parnell AC, 2008, QUATERNARY SCI REV, V27, P1872, DOI 10.1016/j.quascirev.2008.07.009; Praetorius SK, 2014, SCIENCE, V345, P444, DOI 10.1126/science.1252000; Prahl FG, 2010, GEOCHIM COSMOCHIM AC, V74, P131, DOI 10.1016/j.gca.2009.09.027; Prahl FG, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000853; PRAHL FG, 1995, PALEOCEANOGRAPHY, V10, P763, DOI 10.1029/95PA01394; PRAHL FG, 1988, GEOCHIM COSMOCHIM AC, V52, P2303, DOI 10.1016/0016-7037(88)90132-9; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Robinson RS, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001702; Rontani JF, 2013, ORG GEOCHEM, V59, P95, DOI 10.1016/j.orggeochem.2013.04.005; Rontani JF, 2008, ORG GEOCHEM, V39, P34, DOI 10.1016/j.orggeochem.2007.10.003; Rosell-Mele A, 1999, PALEOCEANOGRAPHY, V14, P770, DOI 10.1029/1999PA900037; Schilt A, 2010, EARTH PLANET SC LETT, V300, P33, DOI 10.1016/j.epsl.2010.09.027; Schlitzer R., 2000, EOS T AGU, V81, P45, DOI DOI 10.1029/00E000028; Schmitt J, 2012, SCIENCE, V336, P711, DOI 10.1126/science.1217161; Schmittner A, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001384; Schmittner A, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002953; Scholz F, 2014, NAT GEOSCI, V7, P433, DOI [10.1038/NGEO2162, 10.1038/ngeo2162]; Stabeno PJ, 2004, CONT SHELF RES, V24, P859, DOI 10.1016/j.csr.2004.02.007; Sverdrup H.U., 1953, J CONSEILCONSEIL PER, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; Takeda S., 2011, AQUA BIOSCIENCE MONO, V4, P41, DOI DOI 10.5047/ABSM.2011.00402.0041; Thomson RE, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006280; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Walinsky SE, 2009, CONT SHELF RES, V29, P1565, DOI 10.1016/j.csr.2009.04.006; Wang MY, 2010, J MARINE SYST, V79, P258, DOI 10.1016/j.jmarsys.2008.11.028; ZHANG J, 1995, GEOCHIM COSMOCHIM AC, V59, P107, DOI 10.1016/0016-7037(95)91550-D	68	97	98	10	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					362	+		10.1038/nature15753	http://dx.doi.org/10.1038/nature15753			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26581293				2022-12-28	WOS:000365356800053
J	Carpenter, CR				Carpenter, Christopher R.			The Richmond Agitation Sedation Scale was accurate for detecting delirium in older patients in the ED	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							EMERGENCY-DEPARTMENT		[Carpenter, Christopher R.] Washington Univ, St Louis, MO 63130 USA	Washington University (WUSTL)	Carpenter, CR (corresponding author), Washington Univ, St Louis, MO 63130 USA.		Carpenter, Christopher R./E-3720-2013	Carpenter, Christopher R./0000-0002-2603-7157				American College of Emergency Physicians American Geriatrics Society Emergency Nurses Association, 2014, ANN EMERG MED, V63, pe7, DOI DOI 10.1016/J.ANNEMERGMED.2014.02.008; Han JH, 2015, J HOSP MED, V10, P694, DOI 10.1002/jhm.2478; Han JH, 2009, ACAD EMERG MED, V16, P193, DOI 10.1111/j.1553-2712.2008.00339.x; LaMantia MA, 2014, ANN EMERG MED, V63, P551, DOI 10.1016/j.annemergmed.2013.11.010; Siddiqi N, 2007, COCHRANE DB SYST REV, V2	5	0	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					JC10	JC10		10.7326/ACPJC-2015-163-10-010	http://dx.doi.org/10.7326/ACPJC-2015-163-10-010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26571252				2022-12-28	WOS:000365746400011
J	Ludvigsson, JF; Strom, P; Lundholm, C; Cnattingius, S; Ekbom, A; Ortqvist, A; Feltelius, N; Granath, F; Stephansson, O				Ludvigsson, Jonas F.; Strom, Peter; Lundholm, Cecilia; Cnattingius, Sven; Ekbom, Anders; Ortqvist, Ake; Feltelius, Nils; Granath, Fredrik; Stephansson, Olof			Maternal vaccination against H1N1 influenza and offspring mortality: population based cohort study and sibling design	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREGNANT-WOMEN; PRETERM BIRTH; FETAL-DEATH; SAFETY; OUTCOMES; RISK; IMMUNIZATION; DELIVERY; VIRUS	Study question What is the mortality in offspring of mothers who had influenza A(H1N1) pdm09 vaccination during pregnancy? Methods This was a prospective population based cohort study in seven healthcare regions in Sweden based on vaccinations taking place between 2 October 2009 and 26 November 2010. H1N1 vaccination data were linked with pregnancy and birth characteristics and offspring mortality data in 275 500 births (of which 1203 were stillbirths) from 137 886 mothers. Of these offspring, 41 183 had been exposed to vaccination with Pandemrix, a monovalent AS03 adjuvanted H1N1 influenza vaccine, during fetal life. A primary comparison group consisted of pregnancies of women who were not vaccinated during the same calendar period. In a second comparison, non-exposed siblings of infants prenatally exposed to vaccination were used as controls. Cox regression was used to estimate hazard ratios for stillbirth, early neonatal mortality (days 0-6 after birth), and subsequent mortality (beginning on day 7) in vaccinated versus non-vaccinated women, adjusting for mother's age at delivery, body mass index, parity, smoking, country of birth, and disposable income and for sex of offspring. Study answer and limitations The results of this study suggest that AS03 adjuvanted H1N1 vaccination during pregnancy does not affect the risk of stillbirth, early neonatal death, or later mortality in the offspring. During follow-up, 1172 stillbirths, 380 early neonatal deaths, and 706 deaths thereafter occurred. Compared with general population controls, this corresponded to adjusted hazard ratios of 0.83 (95% confidence interval 0.65 to 1.04) for stillbirth, 0.71 (0.44 to 1.14) for early neonatal death, and 0.97 (0.69 to 1.36) for later death. When siblings were used as controls, adjusted hazard ratios were 0.88 (0.59 to 1.30) for stillbirth, 0.82 (0.46 to 1.49) for early neonatal death, and 0.78 (0.52 to 1.19) for later death. Limitations of the study include lack of data on miscarriage before gestational week 22, inability to ascertain which mothers had pandemic flu during pregnancy, and lack of data on factors influencing the decision to vaccinate during pregnancy. What this study adds H1N1 vaccination during pregnancy is not associated with adverse fetal outcome or offspring mortality, including when familial factors are taken into account.	[Ludvigsson, Jonas F.; Strom, Peter; Lundholm, Cecilia] Karolinska Inst, Dept Med Epidemiol, S-10401 Stockholm, Sweden; [Ludvigsson, Jonas F.] Orebro Univ Hosp, Dept Paediat, Orebro, Sweden; [Cnattingius, Sven; Ekbom, Anders; Granath, Fredrik; Stephansson, Olof] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, S-10401 Stockholm, Sweden; [Ortqvist, Ake] Karolinska Inst, Dept Med, Unit Infect Dis, S-10401 Stockholm, Sweden; [Ortqvist, Ake] Stockholm Cty Council, Dept Communicable Dis Control & Prevent, Stockholm, Sweden; [Feltelius, Nils] Med Product Agcy, Uppsala, Sweden; [Stephansson, Olof] Karolinska Hosp & Inst, Dept Womens & Childrens Hlth, Karlskrona, Sweden	Karolinska Institutet; Orebro University; Karolinska Institutet; Karolinska Institutet; Stockholm County Council; Medical Products Agency; Karolinska Institutet; Karolinska University Hospital	Ludvigsson, JF (corresponding author), Karolinska Inst, Dept Med Epidemiol, S-10401 Stockholm, Sweden.	jonasludvigsson@yahoo.com	Ludvigsson, Jonas F/A-8560-2012	Ludvigsson, Jonas F/0000-0003-1024-5602; Stephansson, Olof/0000-0003-1528-4563; Strom, Peter/0000-0002-1631-806X; Lundholm, Cecilia/0000-0002-6546-3650	Swedish Research Council (Medicine) [2010-4202]; Swedish Council for Working Life and Social Research [FAS: 2010-0923]	Swedish Research Council (Medicine)(Swedish Research Council); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This project was supported by grants from the Swedish Research Council (Medicine, 2010-4202) and the Swedish Council for Working Life and Social Research (FAS: 2010-0923).	Anell A, 2015, NEW ENGL J MED, V372, P1, DOI 10.1056/NEJMp1411430; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P261; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Beau AB, 2014, VACCINE, V32, P1254, DOI 10.1016/j.vaccine.2014.01.021; Chambers CD, 2013, VACCINE, V31, P5026, DOI 10.1016/j.vaccine.2013.08.097; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Dodds L, 2012, J OBSTET GYNAECOL CA, V34, P714, DOI 10.1016/S1701-2163(16)35336-1; Fell DB, 2015, BJOG-INT J OBSTET GY, V122, P17, DOI 10.1111/1471-0528.12977; Fell Deshayne B, 2012, Am J Public Health, V102, pe33, DOI 10.2105/AJPH.2011.300606; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Haberg SE, 2013, NEW ENGL J MED, V368, P333, DOI 10.1056/NEJMoa1207210; Heikkinen T, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.007; Huang WT, 2014, VACCINE, V32, P6463, DOI 10.1016/j.vaccine.2014.09.054; Huang WT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023049, 10.1371/journal.pone.0023829]; Kallen B, 2012, BJOG-INT J OBSTET GY, V119, P1583, DOI 10.1111/j.1471-0528.2012.03470.x; Lin TH, 2012, VACCINE, V30, P2671, DOI 10.1016/j.vaccine.2012.02.008; Ludvigsson JF, 2013, EUR J EPIDEMIOL, V28, P579, DOI 10.1007/s10654-013-9813-z; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Luteijn JM, 2014, HUM REPROD, V29, P809, DOI 10.1093/humrep/det455; Mackenzie IS, 2012, BRIT J CLIN PHARMACO, V73, P801, DOI 10.1111/j.1365-2125.2011.04142.x; Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI 10.1056/NEJMoa1401480; Medical Products Agency, 2009, BEN RISKS VACC PAND; Moro PL, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.047; Omon E, 2011, VACCINE, V29, P9649, DOI 10.1016/j.vaccine.2011.10.034; Oppermann M, 2012, VACCINE, V30, P4445, DOI 10.1016/j.vaccine.2012.04.081; Pasternak B, 2012, BMJ-BRIT MED J; Pasternak B, 2012, JAMA-J AM MED ASSOC, V308, P165, DOI 10.1001/jama.2012.6131; Persson I, 2014, J INTERN MED, V275, P172, DOI 10.1111/joim.12150; Richards JL, 2013, CLIN INFECT DIS, V56, P1216, DOI 10.1093/cid/cit045; Rubinstein F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f393; Sammon CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051734; Tavares F, 2011, VACCINE, V29, P6358, DOI 10.1016/j.vaccine.2011.04.114; Trotta F, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3361; Van der Maas N, 2015, BJOG; World Health Organization, 2015, BMI CLASSIFICATION; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	37	33	33	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 16	2015	351								h5585	10.1136/bmj.h5585	http://dx.doi.org/10.1136/bmj.h5585			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XU	26572546	Green Published, hybrid			2022-12-28	WOS:000365352300001
J	Sallan, L; Galimberti, AK				Sallan, Lauren; Galimberti, Andrew K.			Body-size reduction in vertebrates following the end-Devonian mass extinction	SCIENCE			English	Article							COPES RULE; ATMOSPHERIC OXYGEN; EVOLUTION; DIVERSITY; PATTERNS; DIVERSIFICATION; BOTTLENECK; RECOVERY	Following the end-Devonian mass extinction (359 million years ago), vertebrates experienced persistent reductions in body size for at least 36 million years. Global shrinkage was not related to oxygen or temperature, which suggests that ecological drivers played a key role in determining the length and direction of size trends. Small, fast-breeding ray-finned fishes, sharks, and tetrapods, most under 1 meter in length from snout to tail, radiated to dominate postextinction ecosystems and vertebrae biodiversity. The few large-bodied, slow-breeding survivors failed to diversify, facing extinction despite earlier evolutionary success. Thus, the recovery interval resembled modern ecological successions in terms of active selection on size and related life histories. Disruption of global vertebrate, and particularly fish, biotas may commonly lead to widespread, long-term reduction in body size, structuring future biodiversity.	[Sallan, Lauren] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Galimberti, Andrew K.] Kalamazoo Coll, Dept Biol, Kalamazoo, MI 49006 USA	University of Pennsylvania; Kalamazoo College	Sallan, L (corresponding author), Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA.	Isallan@sas.upenn.edu	Sallan, Lauren/H-7041-2012; Sallan, Lauren/AGZ-1308-2022	Sallan, Lauren/0000-0002-4441-1456; Sallan, Lauren/0000-0002-4441-1456	University of Pennsylvania, Kalamazoo College; University of Michigan; Michigan Society of Fellows	University of Pennsylvania, Kalamazoo College; University of Michigan(University of Michigan System); Michigan Society of Fellows	We thank G. Hunt for assistance with methods; N. Sheldon for advice on climate models; and T. Kailing, D. Rabosky, M. Friedman, J. Clarke, S. Giles, N. Heim, M. Brazeau. and three anonymous reviewers for discussions. We also thank the University of Pennsylvania, Kalamazoo College, the University of Michigan, and the Michigan Society of Fellows for support. All data are available in the supplementary materials.	Barnett LAK, 2009, MAR BIOL, V156, P301, DOI 10.1007/s00227-008-1084-y; Berner RA, 2009, AM J SCI, V309, P603, DOI 10.2475/07.2009.03; Choo B, 2014, SCI REP-UK, V4, DOI 10.1038/srep05242; Dahl TW, 2010, P NATL ACAD SCI USA, V107, P17911, DOI 10.1073/pnas.1011287107; Friedman M, 2012, PALAEONTOLOGY, V55, P707, DOI 10.1111/j.1475-4983.2012.01165.x; Frobisch NB, 2013, P NATL ACAD SCI USA, V110, P1393, DOI 10.1073/pnas.1216750110; Harries PJ, 2009, PALAEOGEOGR PALAEOCL, V284, P4, DOI 10.1016/j.palaeo.2009.08.021; Heim NA, 2015, SCIENCE, V347, P867, DOI 10.1126/science.1260065; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; Jablonski D, 2002, P NATL ACAD SCI USA, V99, P8139, DOI 10.1073/pnas.102163299; Knouft JH, 2003, AM NAT, V161, P413, DOI 10.1086/346133; Lamsdell JC, 2010, BIOL LETTERS, V6, P265, DOI 10.1098/rsbl.2009.0700; Lee MSY, 2014, SCIENCE, V345, P562, DOI 10.1126/science.1252243; Lockwood R, 2005, PALEOBIOLOGY, V31, P578, DOI 10.1666/0094-8373(2005)031[0578:BSEEAT]2.0.CO;2; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; Long JA, 2015, NATURE, V517, P196, DOI 10.1038/nature13825; Payne JL, 2013, EVOLUTION, V67, P816, DOI 10.1111/j.1558-5646.2012.01807.x; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Ponge JF, 2013, ECOL EVOL, V3, P1113, DOI 10.1002/ece3.505; RAUP DM, 1979, SCIENCE, V206, P217, DOI 10.1126/science.206.4415.217; Romano C., 2014, BIOL REV, DOI [10.1111/brv.12161, DOI 10.1111/BRV12161]; Royer D.L., 2004, GSA TODAY, V14, P4, DOI DOI 10.1130/1052-5173(2004)014; Sallan LC, 2012, P ROY SOC B-BIOL SCI, V279, P2025, DOI 10.1098/rspb.2011.2454; Sallan LC, 2011, P NATL ACAD SCI USA, V108, P8335, DOI 10.1073/pnas.1100631108; Sallan LC, 2010, P NATL ACAD SCI USA, V107, P10131, DOI 10.1073/pnas.0914000107; STANLEY SM, 1975, P NATL ACAD SCI USA, V72, P646, DOI 10.1073/pnas.72.2.646; STANLEY SM, 1973, EVOLUTION, V27, P1, DOI 10.1111/j.1558-5646.1973.tb05912.x; Stanley SM, 2010, P NATL ACAD SCI USA, V107, P19185, DOI 10.1073/pnas.1012833107; Van Valkenburgh B, 2004, SCIENCE, V306, P101, DOI 10.1126/science.1102417; Wagner PJ, 2014, P NATL ACAD SCI USA, V111, P16419, DOI 10.1073/pnas.1406304111; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399	31	56	56	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					812	815		10.1126/science.aac7373	http://dx.doi.org/10.1126/science.aac7373			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW3MS	26564854				2022-12-28	WOS:000364897000044
J	Raynal, A				Raynal, Anne			PERSONAL VIEW Occupational medicine is in demise	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												occdoc@doctors.org.uk						[Anonymous], 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1503; Black C., 2008, WORKING HLTH TOMORRO; Greenberg M, 2006, AM J IND MED, V49, P54, DOI 10.1002/ajim.20233; Hackitt J, 2015, 40 YEARS STRENGTHS G; Health and Safety Executive, 2015, COSTS BRIT WORKPL FA; Health and Safety Executive, PUBL REG CONV; Kloss D, 2007, OCCUP MED-OXFORD, V57, P234, DOI 10.1093/occmed/kqm027; Leckie A, 2015, OCCUP MED-OXFORD, V65, P426, DOI 10.1093/occmed/kqv117; Leigh D., 2015, DISCLOSURE LETTER FR; O'Reilly N, 2015, OCCUP HLTH, V67, P3; Pilkington A, SURVEY USE OCCUPATIO; Poole CJM, 2007, CLIN MED, V7, P362, DOI 10.7861/clinmedicine.7-4-362; Raynal A, 2006, OCCUP HLTH REV, P124; Rigby M, PREVENTIVE SERVICES; Shilling R., 1989, OCCUPATIONAL HLTH PR, P1	15	13	13	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2015	351								h5905	10.1136/bmj.h5905	http://dx.doi.org/10.1136/bmj.h5905			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW4FX	26561457				2022-12-28	WOS:000364947900006
J	Dhaliwal, HS; Sekhon, GS; Rai, N; Nampoothiri, RV				Dhaliwal, Harpal S.; Sekhon, G. S.; Rai, Nitish; Nampoothiri, Ram V.			An unusual medical cause of abdominal pain diagnosed by urological abnormalities	LANCET			English	Editorial Material									[Dhaliwal, Harpal S.] GTBS C Hosp, Dept Gastroenterol & Hepatol, Ludhiana 141002, Punjab, India; [Sekhon, G. S.] GTBS C Hosp, Dept Rheumatol, Ludhiana, Punjab, India; [Rai, Nitish; Nampoothiri, Ram V.] Postgrad Inst Med Educ & Res, Dept Med, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Dhaliwal, HS (corresponding author), GTBS C Hosp, Dept Gastroenterol & Hepatol, Ludhiana 141002, Punjab, India.	hsdhaliwalpgi@yahoo.com		Dhaliwal, Harpal S./0000-0001-8252-4876					0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2016	387	10030					E25	E25		10.1016/S0140-6736(15)00806-5	http://dx.doi.org/10.1016/S0140-6736(15)00806-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK6SS	26584736	Bronze			2022-12-28	WOS:000375056100001
J	Centor, RM				Centor, Robert M.			Acute Uncomplicated Diverticulitis: What to Do Until We Have Better Data	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Centor, Robert M.] Univ Alabama, Sch Med Huntsville Reg Med Campus, Huntsville, AL 35899 USA	University of Alabama System; University of Alabama Huntsville	Centor, RM (corresponding author), UAB Huntsville Reg Med Campus, 301 Governors Dr, Huntsville, AL 35801 USA.	rcentor@uab.edu						Chabok A, 2012, BRIT J SURG, V99, P532, DOI 10.1002/bjs.8688; Isacson D, 2015, INT J COLORECTAL DIS, V30, P1229, DOI 10.1007/s00384-015-2258-y; Stollman N, 2015, GASTROENTEROLOGY	3	4	4	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2016	164	2					120	+		10.7326/M15-2499	http://dx.doi.org/10.7326/M15-2499			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB0CI	26584216				2022-12-28	WOS:000368175800016
J	Abdula, N; Macharia, J; Motsoaledi, A; Swaminathan, S; VijayRaghavan, K				Abdula, Nazira; Macharia, James; Motsoaledi, Aaron; Swaminathan, Soumya; VijayRaghavan, Krishnaswamy			National action for global gains in antimicrobial resistance	LANCET			English	Editorial Material									[Abdula, Nazira] Govt Mozambique, Minist Hlth, Maputo, Mozambique; [Macharia, James] Govt Kenya, Minist Hlth, Nairobi, Kenya; [Motsoaledi, Aaron] Dept Hlth, Pretoria, South Africa; [Swaminathan, Soumya] Govt India, Dept Hlth Res, New Delhi, India; [VijayRaghavan, Krishnaswamy] Govt India, Dept Biotechnol, New Delhi, India	Department of Biotechnology (DBT) India	Abdula, N (corresponding author), Govt Mozambique, Minist Hlth, Maputo, Mozambique.	soumyas@trcchennai.in						Ardal C, 2016, LANCET, V387, P296, DOI 10.1016/S0140-6736(15)00470-5; Dar OA, 2016, LANCET, V387, P285, DOI 10.1016/S0140-6736(15)00520-6; Gelband H, 2015, AMR CONTROL 2015 CON, P98; Ghid P., 2015, SITUATION ANAL RECOM; [Government of India Ministry of Health and Family Welfare], 2015, HLTH MIN LAUNCH KAYA; [Government of India Ministry of Health and Family Welfare], 2015, MEAS CONT DEATHS ANT; [Government of South Africa Department of Health], 2014, ANT RES NAT STRAT FR; Laxminarayan R., 2015, WOUND HEAL S AFRICA; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Mendelson M, 2016, LANCET, V387, P188, DOI 10.1016/S0140-6736(15)00547-4; Travasso C, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4440; Wasserman S, 2014, BEHALF S AFRICAN ANT; WHO, 2015, DRAFT GLOB ACT PLAN; Winters C, 2011, SAMJ S AFR MED J, V101, P556	14	15	17	1	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2016	387	10014					E3	E5		10.1016/S0140-6736(15)00668-6	http://dx.doi.org/10.1016/S0140-6736(15)00668-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA8LF	26603924				2022-12-28	WOS:000368055500002
J	Gunderson, EP; Hurston, SR; Ning, X; Lo, JC; Crites, Y; Walton, D; Dewey, KG; Azevedo, RA; Young, S; Fox, G; Elmasian, CC; Salvador, N; Lum, M; Sternfeld, B; Quesenberry, CP				Gunderson, Erica P.; Hurston, Shanta R.; Ning, Xian; Lo, Joan C.; Crites, Yvonne; Walton, David; Dewey, Kathryn G.; Azevedo, Robert A.; Young, Stephen; Fox, Gary; Elmasian, Cathie C.; Salvador, Nora; Lum, Michael; Sternfeld, Barbara; Quesenberry, Charles P., Jr.		Study Women Infant Feeding Type 2	Lactation and Progression to Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus	ANNALS OF INTERNAL MEDICINE			English	Article							GLUCOSE-TOLERANCE; WOMEN; PREGNANCY; RISK; ADIPONECTIN; METABOLISM; PROLACTIN; DURATION; SWIFT; ADAPTATION	Background: Lactation improves glucose metabolism, but its role in preventing type 2 diabetes mellitus (DM) after gestational diabetes mellitus (GDM) remains uncertain. Objective: To evaluate lactation and the 2-year incidence of DM after GDM pregnancy. Design: Prospective, observational cohort of women with recent GDM. (ClinicalTrials.gov: NCT01967030) Setting: Integrated health care system. Participants: 1035 women diagnosed with GDM who delivered singletons at 35 weeks' gestation or later and enrolled in the Study of Women, Infant Feeding and Type 2 Diabetes After GDM Pregnancy from 2008 to 2011. Measurements: Three in-person research examinations from 6 to 9 weeks after delivery (baseline) and annual follow-up for 2 years that included 2-hour, 75-g oral glucose tolerance testing; anthropometry; and interviews. Multivariable Weibull regression models evaluated independent associations of lactation measures with incident DM adjusted for potential confounders. Results: Of 1010 women without diabetes at baseline, 959 (95%) were evaluated up to 2 years later; 113 (11.8%) developed incident DM. There were graded inverse associations for lactation intensity at baseline with incident DM and adjusted hazard ratios of 0.64, 0.54, and 0.46 for mostly formula or mixed/inconsistent, mostly lactation, and exclusive lactation versus exclusive formula feeding, respectively (P trend = 0.016). Time-dependent lactation duration showed graded inverse associations with incident DM and adjusted hazard ratios of 0.55, 0.50, and 0.43 for greater than 2 to 5 months, greater than 5 to 10 months, and greater than 10 months, respectively, versus 0 to 2 months (P trend = 0.007). Weight change slightly attenuated hazard ratios. Limitation: Randomized design is not feasible or desirable for clinical studies of lactation. Conclusion: Higher lactation intensity and longer duration were independently associated with lower 2-year incidences of DM after GDM pregnancy. Lactation may prevent DM after GDM delivery.	[Gunderson, Erica P.; Lo, Joan C.; Sternfeld, Barbara; Quesenberry, Charles P., Jr.] Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; Permanente Med Grp Inc, Oakland, CA USA; [Dewey, Kathryn G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	Kaiser Permanente; Permanente Medical Groups; University of California System; University of California Davis	Gunderson, EP (corresponding author), Kaiser Permanente No Calif, Div Res, Cardiovasc & Metab Condit Sect, 2000 Broadway, Oakland, CA 94612 USA.	Erica.Gunderson@.kp.org		Walton, David/0000-0002-8461-2551; Ferrara, Assiamira/0000-0002-7505-4826	National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050625] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092924] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Child Health and Human Development.	Albright AL, 2013, AM J PREV MED, V44, pS346, DOI 10.1016/j.amepre.2012.12.009; Asai-Sato M, 2006, ENDOCR J, V53, P555, DOI 10.1507/endocrj.K06-026; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Brandebourg T, 2007, DIABETES OBES METAB, V9, P464, DOI 10.1111/j.1463-1326.2006.00671.x; Butte NF, 2005, PUBLIC HEALTH NUTR, V8, P1010, DOI 10.1079/PHN2005793; Butte NF, 1998, J NUTR, V128, p381S, DOI 10.1093/jn/128.2.381S; Butte NF, 1997, J CLIN ENDOCR METAB, V82, P585, DOI 10.1210/jc.82.2.585; Centers for Disease Control and Prevention (CDC), BREASTF US CHILDR BO; Chasan-Taber L, 2004, MED SCI SPORT EXER, V36, P1750, DOI 10.1249/01.MSS.0000142303.49306.0D; DeSisto CL, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130415; Dewey KG, 2004, ADV EXP MED BIOL, V554, P91; Drynda R, 2015, HORM METAB RES, V47, P64, DOI 10.1055/s-0034-1395691; Gavin JR, 2000, DIABETES CARE, V23, pS4; Gunderson EP, 2007, OBSTET GYNECOL, V109, P729, DOI 10.1097/01.AOG.0000252831.06695.03; Gunderson EP, 2014, METABOLISM, V63, P941, DOI 10.1016/j.metabol.2014.04.006; Gunderson EP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-952; Gunderson EP, 2012, DIABETES CARE, V35, P50, DOI 10.2337/dc11-1409; Gunderson EP, 2010, DIABETES, V59, P495, DOI 10.2337/db09-1197; Jager S, 2014, DIABETOLOGIA, V57, P1355, DOI 10.1007/s00125-014-3247-3; KJOS SL, 1993, OBSTET GYNECOL, V82, P451; KNOPP RH, 1985, J CLIN ENDOCR METAB, V60, P542, DOI 10.1210/jcem-60-3-542; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Liu B, 2010, DIABETES CARE, V33, P1239, DOI 10.2337/dc10-0347; Martin JE, 2014, MATERN CHILD NUTR, V10, P496, DOI 10.1111/j.1740-8709.2012.00437.x; Matias SL, 2014, AM J CLIN NUTR, V99, P115, DOI 10.3945/ajcn.113.073049; McClure CK, 2011, OBESITY, V19, P2205, DOI 10.1038/oby.2011.185; McManus RM, 2001, METABOLISM, V50, P715, DOI 10.1053/meta.2001.23304; METZGER BE, 1993, DIABETES CARE, V16, P1598, DOI 10.2337/diacare.16.12.1598; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; Neville CE, 2014, INT J OBESITY, V38, P577, DOI 10.1038/ijo.2013.132; Qureshi I. A., 1999, Annals Academy of Medicine Singapore, V28, P217; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ramos-Roman MA, 2011, HORM METAB RES, V43, P593, DOI 10.1055/s-0031-1284353; REBUFFESCRIVE M, 1985, J CLIN INVEST, V75, P1973, DOI 10.1172/JCI111914; Rifas-Shiman SL, 2001, PUBLIC HEALTH NUTR, V4, P249, DOI 10.1079/PHN200061; Schwarz EB, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2010.03.016; Section on Breastfeeding, 2012, Pediatrics, V129, pe827, DOI 10.1542/peds.2011-3552; Sparling YH, 2006, BIOSTATISTICS, V7, P599, DOI 10.1093/biostatistics/kxj028; Stuebe AM, 2011, DIABETES, V60, P1277, DOI 10.2337/db10-0637; Stuebe AM, 2010, J WOMENS HEALTH, V19, P941, DOI 10.1089/jwh.2009.1660; Stuebe AM, 2005, JAMA-J AM MED ASSOC, V294, P2601, DOI 10.1001/jama.294.20.2601; Tigas S, 2002, J CLIN ENDOCR METAB, V87, P302, DOI 10.1210/jc.87.1.302; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Villegas R, 2008, DIABETOLOGIA, V51, P258, DOI 10.1007/s00125-007-0885-8; Ziegler AG, 2012, DIABETES, V61, P3167, DOI 10.2337/db12-0393	46	138	148	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2015	163	12					889	+	I36	10.7326/M15-0807	http://dx.doi.org/10.7326/M15-0807			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4BS	26595611	Green Accepted			2022-12-28	WOS:000366354200014
J	McGlynn, EA; McDonald, KM; Cassel, CK				McGlynn, Elizabeth A.; McDonald, Kathryn M.; Cassel, Christine K.			Measurement Is Essential for Improving Diagnosis and Reducing Diagnostic Error A Report From the Institute of Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[McGlynn, Elizabeth A.] Kaiser Permanente Ctr Effectiveness & Safety Res, Pasadena, CA 91101 USA; [McDonald, Kathryn M.] Stanford Univ, Ctr Hlth Policy, Palo Alto, CA 94304 USA; [McDonald, Kathryn M.] Stanford Univ, Ctr Primary Care & Outcomes Res, Palo Alto, CA 94304 USA; [Cassel, Christine K.] Natl Qual Forum, Washington, DC USA	Kaiser Permanente; Stanford University; Stanford University	McGlynn, EA (corresponding author), Kaiser Permanente Ctr Effectiveness & Safety Res, 100 S Los Robles,Third Floor, Pasadena, CA 91101 USA.	elizabeth.a.mcglynn@kp.org						[Anonymous], ANN BENCHM REP 2014; Carayon P, 2007, HDB HUMAN FACTORS ER; McDonald KM, 2013, ANN INTERN MED, V158, P381, DOI 10.7326/0003-4819-158-5-201303051-00004; National Academies of Sciences Engineering and Medicine, IMPR DIAGN HLTH CAR; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; Singh H, 2012, BMJ QUAL SAF, V21, P93, DOI 10.1136/bmjqs-2011-000304	6	57	57	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2015	314	23					2501	2502		10.1001/jama.2015.13453	http://dx.doi.org/10.1001/jama.2015.13453			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4PV	26571126				2022-12-28	WOS:000366391500012
J	Mitchell, A; Wei, P; Lim, WA				Mitchell, Amir; Wei, Ping; Lim, Wendell A.			Oscillatory stress stimulation uncovers an Achilles' heel of the yeast MAPK signaling network	SCIENCE			English	Article							CELLULAR INFORMATION; SCAFFOLD; KINASE; PATHWAYS; HOG; SPECIFICITY; ACTIVATION; PROTEINS; DYNAMICS	Cells must interpret environmental information that often changes over time. In our experiment, we systematically monitored the growth of yeast cells under various frequencies of oscillating osmotic stress. Growth was severely inhibited at a particular resonance frequency, at which cells show hyperactivated transcriptional stress responses. This behavior represents a sensory misperception: The cells incorrectly interpret oscillations as a staircase of ever-increasing osmolarity. The misperception results from the capacity of the osmolarity-sensing mitogen-activated protein kinase (MAPK) network to retrigger with sequential osmotic stresses. Although this feature is critical for coping with natural challenges, such as continually increasing osmolarity, it results in a trade-off of fragility to non-natural oscillatory inputs that match the retriggering time. These findings demonstrate the value of non-natural dynamic perturbations in exposing hidden sensitivities of cellular regulatory networks.	[Mitchell, Amir; Wei, Ping; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Mitchell, Amir; Lim, Wendell A.] UCSF, Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA; [Wei, Ping] Peking Univ, Ctr Quantitat Biol, Sch Life Sci, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Wei, Ping] Peking Univ, Peking Tsinghua Ctr Life Sci, Sch Life Sci, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Lim, Wendell A.] UCSF, HHMI, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Peking University; Peking University; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Wei, P (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	pwei@pku.edu.cn; lim@cmp.ucsf.edu	Mitchell, Amir/AAS-1148-2020	Mitchell, Amir/0000-0001-9376-3987	NIH [R01 GM55040, R01 GM62583, PN2 EY016546, P50 GM081879]; NSF Synthetic Biology Engineering Research Center (SynBERC); HHMI; MOST [2015CB910300]; National Natural Science Foundation of China [31470819]; Peking-Tsinghua Center for Life Sciences; Program for Breakthrough Biomedical Research Postdoctoral Research Award (UCSF); NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062583, R01GM055040, P50GM081879] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Synthetic Biology Engineering Research Center (SynBERC); HHMI(Howard Hughes Medical Institute); MOST; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking-Tsinghua Center for Life Sciences; Program for Breakthrough Biomedical Research Postdoctoral Research Award (UCSF); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Youk, R. Almeida, S. Coyle, and M. Thomson for insightful discussions. This work was supported by NIH grants R01 GM55040, R01 GM62583, PN2 EY016546, and P50 GM081879; the NSF Synthetic Biology Engineering Research Center (SynBERC); and HHMI (to W.A.L.). This work was also supported in part by MOST grant 2015CB910300, National Natural Science Foundation of China grant 31470819, and Peking-Tsinghua Center for Life Sciences (to P.W.). A.M. is a European Molecular Biology Organization Fellow (ALTF 419-2010) and the recipient of a Program for Breakthrough Biomedical Research Postdoctoral Research Award (UCSF).	Alon U., 2006, INTRO SYSTEMS BIOL D; Behar M, 2013, CELL, V155, P448, DOI 10.1016/j.cell.2013.09.018; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Elion EA, 2001, J CELL SCI, V114, P3967; Furukawa K, 2013, MOL MICROBIOL, V88, P5, DOI 10.1111/mmi.12174; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; Wei P, 2012, NATURE, V488, P384, DOI 10.1038/nature11259; Zalatan JG, 2012, SCIENCE, V337, P1218, DOI 10.1126/science.1220683	17	59	61	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1379	1383		10.1126/science.aab0892	http://dx.doi.org/10.1126/science.aab0892			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26586187	Green Accepted			2022-12-28	WOS:000366162400043
J	Amani, M; Lien, DH; Kiriya, D; Xiao, J; Azcatl, A; Noh, J; Madhvapathy, SR; Addou, R; Santosh, KC; Dubey, M; Cho, K; Wallace, RM; Lee, SC; He, JH; Ager, JW; Zhang, X; Yablonovitch, E; Javey, A				Amani, Matin; Lien, Der-Hsien; Kiriya, Daisuke; Xiao, Jun; Azcatl, Angelica; Noh, Jiyoung; Madhvapathy, Surabhi R.; Addou, Rafik; Santosh, K. C.; Dubey, Madan; Cho, Kyeongjae; Wallace, Robert M.; Lee, Si-Chen; He, Jr-Hau; Ager, Joel W., III; Zhang, Xiang; Yablonovitch, Eli; Javey, Ali			Near-unity photoluminescence quantum yield in MoS2	SCIENCE			English	Article							MONOLAYER MOS2; LAYER; HETEROSTRUCTURES; TRANSITION; DYNAMICS; DEFECTS; BANDGAP; STRAIN; STATES; WS2	Two-dimensional (2D) transition metal dichalcogenides have emerged as a promising material system for optoelectronic applications, but their primary figure of merit, the room-temperature photoluminescence quantum yield (QY), is extremely low. The prototypical 2D material molybdenum disulfide (MoS2) is reported to have a maximum QY of 0.6%, which indicates a considerable defect density. Herewe report on an air-stable, solution-based chemical treatment by an organic superacid, which uniformly enhances the photoluminescence and minority carrier lifetime of MoS2 monolayers by more than two orders of magnitude. The treatment eliminates defect-mediated nonradiative recombination, thus resulting in a final QY of more than 95%, with a longest-observed lifetime of 10.8 0.6 nanoseconds. Our ability to obtain optoelectronic monolayers with near-perfect properties opens the door for the development of highly efficient light-emitting diodes, lasers, and solar cells based on 2D materials.	[Amani, Matin; Lien, Der-Hsien; Kiriya, Daisuke; Madhvapathy, Surabhi R.; Yablonovitch, Eli; Javey, Ali] Univ Calif Berkeley, Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Amani, Matin; Lien, Der-Hsien; Kiriya, Daisuke; Xiao, Jun; Madhvapathy, Surabhi R.; Ager, Joel W., III; Zhang, Xiang; Yablonovitch, Eli; Javey, Ali] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Lien, Der-Hsien; He, Jr-Hau] King Abdullah Univ Sci & Technol, Comp Elect & Math Sci & Engn Div, Thuwal 239556900, Saudi Arabia; [Lien, Der-Hsien; Lee, Si-Chen] Natl Taiwan Univ, Inst Elect Engn, Dept Elect Engn, Taipei 10617, Taiwan; [Xiao, Jun; Zhang, Xiang] Univ Calif Berkeley, Natl Sci Fdn Nanoscale Sci & Engn Ctr, Berkeley, CA 94720 USA; [Azcatl, Angelica; Noh, Jiyoung; Addou, Rafik; Santosh, K. C.; Cho, Kyeongjae; Wallace, Robert M.] Univ Texas Dallas, Dept Mat Sci & Engn, Richardson, TX 75080 USA; [Dubey, Madan] US Army Res Lab, Sensors & Electron Devices Directorate, Adelphi, MD 20723 USA; [Zhang, Xiang] King Abdulaziz Univ, Dept Phys, Jeddah 21589, Saudi Arabia	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; King Abdullah University of Science & Technology; National Taiwan University; National Science Foundation (NSF); University of California System; University of California Berkeley; University of Texas System; University of Texas Dallas; United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); King Abdulaziz University	Javey, A (corresponding author), Univ Calif Berkeley, Elect Engn & Comp Sci, Berkeley, CA 94720 USA.	ajavey@eecs.berkeley.edu	He, Jr-Hau/Y-2620-2019; Wallace, Robert M/A-5283-2008; Lien, Der-Hsien/GYD-6547-2022; Addou, Rafik/C-8992-2013; Javey, Ali/B-4818-2013; Zhang, Xiang/F-6905-2011; KC, Santosh/H-2765-2019; He, Jr-Hau/B-5141-2011	He, Jr-Hau/0000-0003-1886-9241; Wallace, Robert M/0000-0001-5566-4806; Lien, Der-Hsien/0000-0001-6774-2074; Addou, Rafik/0000-0002-5454-0315; Javey, Ali/0000-0001-7214-7931; KC, Santosh/0000-0003-4650-3722; He, Jr-Hau/0000-0003-1886-9241; Lee, Si-Chen/0000-0002-3788-2030; Xiao, Jun/0000-0003-4248-8190; Zhang, Xiang/0000-0002-3272-894X	Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division of the U.S. Department of Energy [DE-AC02-05Ch11231]; Center for Low Energy System Technology (LEAST), one of six centers - STARnet phase of the Focus Research Program (FCRP), a Semiconductor Research Corporation program - Microelectronics Advanced Research Corporation; Defense Advanced Research Projects Agency; Samsung; NSF Center for Energy Efficient Electronics Science (E3S); KAUST; U.S. Army Research Lab Director's Strategic Initiative program on interfaces in stacked 2D atomic layers and materials	Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division of the U.S. Department of Energy(United States Department of Energy (DOE)); Center for Low Energy System Technology (LEAST), one of six centers - STARnet phase of the Focus Research Program (FCRP), a Semiconductor Research Corporation program - Microelectronics Advanced Research Corporation; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Samsung(Samsung); NSF Center for Energy Efficient Electronics Science (E3S); KAUST(King Abdullah University of Science & Technology); U.S. Army Research Lab Director's Strategic Initiative program on interfaces in stacked 2D atomic layers and materials	We thank F. R. Fischer for in-depth discussions on surface chemistry and A. B. Sachid for analysis of the electrical measurements. M.A., J.X., J.W.A., X.Z., and A.J. were funded by the Director, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division of the U.S. Department of Energy, under contract no. DE-AC02-05Ch11231. A. A., J.N., R. A., S.KC, R.M.W., and K.C. were funded by the Center for Low Energy System Technology (LEAST), one of six centers supported by the STARnet phase of the Focus Research Program (FCRP), a Semiconductor Research Corporation program sponsored by Microelectronics Advanced Research Corporation and Defense Advanced Research Projects Agency. D.K. acknowledges support from Samsung, E.Y. acknowledges support from the NSF Center for Energy Efficient Electronics Science (E<SUP>3</SUP>S), J.-H.H. acknowledges support from the baseline fund of KAUST, and M.D. acknowledges support from the U.S. Army Research Lab Director's Strategic Initiative program on interfaces in stacked 2D atomic layers and materials.	Addou R, 2015, ACS NANO, V9, P9124, DOI 10.1021/acsnano.5b03309; Addou R, 2015, ACS APPL MATER INTER, V7, P11921, DOI 10.1021/acsami.5b01778; Azcatl A, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4869149; Berkelbach TC, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.045318; Britnell L, 2013, SCIENCE, V340, P1311, DOI 10.1126/science.1235547; Chernikov A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.076802; Desai SB, 2014, NANO LETT, V14, P4592, DOI 10.1021/nl501638a; Fang H, 2014, P NATL ACAD SCI USA, V111, P6198, DOI 10.1073/pnas.1405435111; Hill HM, 2015, NANO LETT, V15, P2992, DOI 10.1021/nl504868p; Iribarren A, 1998, PHYS REV B, V58, P1907, DOI 10.1103/PhysRevB.58.1907; Korn T, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3636402; LANDSBERG PT, 1970, PHYS STATUS SOLIDI, V41, P457, DOI 10.1002/pssb.19700410202; Liu Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6246; Lu CP, 2014, NANO LETT, V14, P4628, DOI 10.1021/nl501659n; Mai C, 2014, NANO LETT, V14, P202, DOI 10.1021/nl403742j; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Mak KF, 2012, NAT NANOTECHNOL, V7, P494, DOI [10.1038/nnano.2012.96, 10.1038/NNANO.2012.96]; McDonnell S, 2014, ACS NANO, V8, P2880, DOI 10.1021/nn500044q; Nayak AP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4731; Noh JY, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.205417; Park YS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.187401; SCHNITZER I, 1993, APPL PHYS LETT, V62, P131, DOI 10.1063/1.109348; Tongay S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02657; Wang F, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245424; Wang HN, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.165411; Wang HN, 2015, NANO LETT, V15, P339, DOI 10.1021/nl503636c; Wu SF, 2015, NATURE, V520, P69, DOI 10.1038/nature14290; Xia FN, 2014, NAT PHOTONICS, V8, P899, DOI [10.1038/nphoton.2014.271, 10.1038/nphoton.2010.271]; Yuan L, 2015, NANOSCALE, V7, P7402, DOI 10.1039/c5nr00383k	29	807	822	45	766	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1065	1068		10.1126/science.aad2114	http://dx.doi.org/10.1126/science.aad2114			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY5BJ	26612948				2022-12-28	WOS:000366422600037
J	Khoshnood, B; Loane, M; de Walle, H; Arriola, L; Addor, MC; Barisic, I; Beres, J; Bianchi, F; Dias, C; Draper, E; Garne, E; Gatt, M; Haeusler, M; Klungsoyr, K; Latos-Bielenska, A; Lynch, C; McDonnell, B; Nelen, V; Neville, AJ; O'Mahony, MT; Queisser-Luft, A; Rankin, J; Rissmann, A; Ritvanen, A; Rounding, C; Sipek, A; Tucker, D; Verellen-Dumoulin, C; Wellesley, D; Dolk, H				Khoshnood, Babak; Loane, Maria; de Walle, Hermien; Arriola, Larraitz; Addor, Marie-Claude; Barisic, Ingeborg; Beres, Judit; Bianchi, Fabrizio; Dias, Carlos; Draper, Elizabeth; Garne, Ester; Gatt, Miriam; Haeusler, Martin; Klungsoyr, Kari; Latos-Bielenska, Anna; Lynch, Catherine; McDonnell, Bob; Nelen, Vera; Neville, Amanda J.; O'Mahony, Mary T.; Queisser-Luft, Annette; Rankin, Judith; Rissmann, Anke; Ritvanen, Annukka; Rounding, Catherine; Sipek, Antonin; Tucker, David; Verellen-Dumoulin, Christine; Wellesley, Diana; Dolk, Helen			Long term trends in prevalence of neural tube defects in Europe: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOLIC-ACID FORTIFICATION; CONGENITAL-MALFORMATIONS; FOOD FORTIFICATION; SPINA-BIFIDA; PREGNANCY; ANOMALIES; EXPOSURE; IMPACT	STUDY QUESTION What are the long term trends in the total (live births, fetal deaths, and terminations of pregnancy for fetal anomaly) and live birth prevalence of neural tube defects (NTD) in Europe, where many countries have issued recommendations for folic acid supplementation but a policy for mandatory folic acid fortification of food does not exist? METHODS This was a population based, observational study using data on 11 353 cases of NTD not associated with chromosomal anomalies, including 4162 cases of anencephaly and 5776 cases of spina bifida from 28 EUROCAT (European Surveillance of Congenital Anomalies) registries covering approximately 12.5 million births in 19 countries between 1991 and 2011. The main outcome measures were total and live birth prevalence of NTD, as well as anencephaly and spina bifida, with time trends analysed using random effects Poisson regression models to account for heterogeneities across registries and splines to model non-linear time trends. SUMMARY ANSWER AND LIMITATIONS Overall, the pooled total prevalence of NTD during the study period was 9.1 per 10 000 births. Prevalence of NTD fluctuated slightly but without an obvious downward trend, with the final estimate of the pooled total prevalence of NTD in 2011 similar to that in 1991. Estimates from Poisson models that took registry heterogeneities into account showed an annual increase of 4% (prevalence ratio 1.04, 95% confidence interval 1.01 to 1.07) in 1995-99 and a decrease of 3% per year in 1999-2003 (0.97, 0.95 to 0.99), with stable rates thereafter. The trend patterns for anencephaly and spina bifida were similar, but neither anomaly decreased substantially over time. The live birth prevalence of NTD generally decreased, especially for anencephaly. Registration problems or other data artefacts cannot be excluded as a partial explanation of the observed trends (or lack thereof) in the prevalence of NTD. WHAT THIS STUDY ADDS In the absence of mandatory fortification, the prevalence of NTD has not decreased in Europe despite longstanding recommendations aimed at promoting peri-conceptional folic acid supplementation and existence of voluntary folic acid fortification.	[Khoshnood, Babak] Maternite Port Royal, Ctr Biostat & Epidemiol, Obstet Perinatal & Pediat Epidemiol Res Team, INSERM U1153, F-75014 Paris, France; [Loane, Maria; Dolk, Helen] Univ Ulster, Inst Nursing Res, Ctr Maternal Fetal & Infant Res, EUROCAT Cent Registry, Newtownabbey, North Ireland; [de Walle, Hermien] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, EUROCAT Northern Netherlands Registry, Groningen, Netherlands; [Arriola, Larraitz] CIBER Epidemiol & Salud Publ CIBERESP, Inst BIO Donostia Basque Govt, Publ Hlth Div Gipuzkoa, San Sebatian, Spain; [Addor, Marie-Claude] CHU Vaudois, Serv Genet Med Maternite, Lausanne, Switzerland; [Barisic, Ingeborg] Childrens Univ Hosp Zagreb, Clin Hosp Sisters Mercy, Zagreb, Croatia; [Beres, Judit] Dept Hungarian Congenital Abnormal Registry & Sur, Natl Inst Hlth Dev, Budapest, Hungary; [Bianchi, Fabrizio] Gabrielle Monasterio Fdn, CNR Inst Clin Physiol, Pisa, Italy; [Dias, Carlos] Inst Nacl Saude Dr Ricardo Jorge, Lisbon, Portugal; [Draper, Elizabeth] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Garne, Ester] Hosp Lillebaelt, Kolding, Denmark; [Gatt, Miriam] Dept Hlth Informat & Res, Guardamangia, Malta; [Haeusler, Martin] Med Univ Graz, Graz, Austria; [Klungsoyr, Kari] Univ Bergen, Norwegian Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway; [Klungsoyr, Kari] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Latos-Bielenska, Anna] Univ Med Sci, Dept Med Genet, Poznan, Poland; [Lynch, Catherine] HSE South, Dept Publ Hlth, Lacken, Kilkenny, Ireland; [McDonnell, Bob] Hlth Serv Execut, Dublin, Ireland; [Nelen, Vera] Prov Inst Hyg, Antwerp, Belgium; [Neville, Amanda J.] Univ Ferrara, Ctr Clin & Epidemiol Res, Registro IMER IMER Registry Emilia Romagna Regist, I-44100 Ferrara, Italy; [O'Mahony, Mary T.] Hlth Serv Execut South, Dept Publ Hlth, Dublin, Ireland; [Queisser-Luft, Annette] Johannes Gutenberg Univ Mainz, Childrens Hosp, Univ Med Ctr, Birth Registry Mainz Model, D-55122 Mainz, Germany; [Rankin, Judith] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Rissmann, Anke] Univ Magdeburg, Fac Med, Malformat Monitoring Ctr Saxony Anhalt, D-39106 Magdeburg, Germany; [Ritvanen, Annukka] Natl Inst Hlth & Welf, Helsinki, Finland; [Rounding, Catherine] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England; [Sipek, Antonin] Thomayer Univ Hosp, Dept Med Genet, Natl Registry Congenital Anomalies Czech Republ, Prague, Czech Republic; [Tucker, David] Publ Hlth Wales, Swansea, W Glam, Wales; [Verellen-Dumoulin, Christine] Inst Rech Sci Pathol & Genet, Ctr Human Genet, Charleroi, Belgium; [Wellesley, Diana] Southampton Univ Hosp, Fac Med, Southampton, Hants, England; [Wellesley, Diana] Wessex Clin Genet Serv, Southampton, Hants, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Ulster University; University of Groningen; Basque Government; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Zagreb; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Instituto Nacional de Saude Dr. Ricardo Jorge; University of Leicester; Medical University of Graz; Norwegian Institute of Public Health (NIPH); University of Bergen; University of Bergen; University of Ferrara; Johannes Gutenberg University of Mainz; Newcastle University - UK; Otto von Guericke University; Finland National Institute for Health & Welfare; University of Oxford; Thomayer Hospital; University of Southampton	Khoshnood, B (corresponding author), Maternite Port Royal, Ctr Biostat & Epidemiol, Obstet Perinatal & Pediat Epidemiol Res Team, INSERM U1153, F-75014 Paris, France.	babak.khoshnood@inserm.fr	Khoshnood, Babak/N-9096-2017; Draper, Elizabeth S/I-6304-2018; Draper, Elizabeth/S-6874-2019; Bianchi, Fabrizio/F-7900-2015; Klungsøyr, Kari/ABC-6147-2020; Barisic, Ingeborg/A-7314-2016; Barisic, Ingeborg/HDN-8784-2022; Dias, Carlos/I-6335-2012	Draper, Elizabeth S/0000-0001-9340-8176; Draper, Elizabeth/0000-0001-9340-8176; Bianchi, Fabrizio/0000-0002-3459-9301; Klungsøyr, Kari/0000-0003-2482-1690; Dias, Carlos/0000-0002-0206-5874; Loane, Maria/0000-0002-1206-3637; Khoshnood, Babak/0000-0002-4031-4915	European Public Health Commission, EUROCAT Joint Action [2010 22 04]	European Public Health Commission, EUROCAT Joint Action	The study was funded by the European Public Health Commission, EUROCAT Joint Action 2011-2013 (grant No 2010 22 04). The funding body had no role in study design, analysis, or reporting.	[Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; Bestwick JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089354; Botto LD, 1999, NEW ENGL J MED, V341, P1509, DOI 10.1056/NEJM199911113412006; Boyd PA, 2008, BJOG-INT J OBSTET GY, V115, P689, DOI 10.1111/j.1471-0528.2008.01700.x; Busby A, 2005, BMJ-BRIT MED J, V330, P574, DOI 10.1136/bmj.330.7491.574; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Dunlap Beth, 2011, J Exp Clin Assist Reprod, V8, P2; EUROCAT Folic Acid Working Group, 2009, EUROCAT SPEC REP PRE; Flynn MAT, 2008, P NUTR SOC, V67, P381, DOI 10.1017/S0029665108008720; Garne E, 2005, ULTRASOUND OBST GYN, V25, P6, DOI 10.1002/uog.1784; Greenlees R, 2011, BIRTH DEFECTS RES A, V91, pS51, DOI 10.1002/bdra.20775; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; Hoey L, 2007, AM J CLIN NUTR, V86, P1405, DOI 10.1093/ajcn/86.5.1405; Honein MA, 2001, JAMA-J AM MED ASSOC, V285, P2981, DOI 10.1001/jama.285.23.2981; Jentink J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6581; Jentink J, 2010, PHARMACOEPIDEM DR S, V19, P803, DOI 10.1002/pds.1975; Jentink J, 2010, NEW ENGL J MED, V362, P2185, DOI 10.1056/NEJMoa0907328; Khoshnood B, 2011, BIRTH DEFECTS RES A, V91, pS16, DOI 10.1002/bdra.20776; Lelong N, 2011, J GYNECOL OBST BIO R, V40, P42, DOI 10.1016/j.jgyn.2010.07.007; Loane M, 2011, BIRTH DEFECTS RES A, V91, pS23, DOI 10.1002/bdra.20779; Mladovsky P, 2009, OBSERVAOTRY STUDIES, V19, P76; Oakley GP, 2009, ANN EPIDEMIOL, V19, P226, DOI 10.1016/j.annepidem.2009.01.016; Oakley GP, 2004, BRIT MED J, V329, P1376, DOI 10.1136/bmj.329.7479.1376; Rankin J, 2005, ARCH DIS CHILD-FETAL, V90, pF374, DOI 10.1136/adc.2003.047902; Royston P, 2000, STAT MED, V19, P1831, DOI 10.1002/1097-0258(20000730)19:14<1831::AID-SIM502>3.0.CO;2-1; Sauerbrei W, 2007, STAT MED, V26, P5512, DOI 10.1002/sim.3148; Tort J, 2013, BJOG-INT J OBSTET GY, V120, P1661, DOI 10.1111/1471-0528.12414	27	142	145	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2015	351								h5949	10.1136/bmj.h5949	http://dx.doi.org/10.1136/bmj.h5949			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX4SX	26601850	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000365691700002
J	Mervis, J				Mervis, Jeffrey			FUNDING NIH program fails to launch blacks in biotech	SCIENCE			English	News Item																			0	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					896	896		10.1126/science.350.6263.896	http://dx.doi.org/10.1126/science.350.6263.896			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW4IP	26586739				2022-12-28	WOS:000364955200012
J	Macilwain, C				Macilwain, Colin			Time to cry out for academic freedom	NATURE			English	Editorial Material												cfmworldview@googlemail.com							0	1	1	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					277	277		10.1038/527277a	http://dx.doi.org/10.1038/527277a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW9ZN	26581256	Bronze			2022-12-28	WOS:000365356800022
J	Springer, J				Springer, Jason			Optimized extracorporeal shock-wave therapy improved pain and functioning in chronic plantar fasciitis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TRIAL		[Springer, Jason] Univ Kansas, Sch Med, Kansas City, KS USA	University of Kansas; University of Kansas Medical Center	Springer, J (corresponding author), Univ Kansas, Sch Med, Kansas City, KS USA.			Badgett, Robert/0000-0003-2888-3303				Buchbinder R, 2002, JAMA-J AM MED ASSOC, V288, P1364, DOI 10.1001/jama.288.11.1364; Chang KV, 2012, ARCH PHYS MED REHAB, V93, P1259, DOI 10.1016/j.apmr.2012.02.023; Emdin C, 2015, JAMA INTERN MED, V175, P304, DOI 10.1001/jamainternmed.2014.6924; Mardani-Kivi M, 2015, J FOOT ANKLE SURG	4	5	5	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					JC8	JC8		10.7326/ACPJC-2015-163-10-008	http://dx.doi.org/10.7326/ACPJC-2015-163-10-008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26571262				2022-12-28	WOS:000365746400009
J	Spalding, MD; Brown, BE				Spalding, Mark D.; Brown, Barbara E.			Warm-water coral reefs and climate change	SCIENCE			English	Editorial Material							GREAT-BARRIER-REEF; OCEAN ACIDIFICATION; PHASE-SHIFTS; RESILIENCE; RECOVERY; DECLINE; MORTALITY; DRIVEN; COVER	Coral reefs are highly dynamic ecosystems that are regularly exposed to natural perturbations. Human activities have increased the range, intensity, and frequency of disturbance to reefs. Threats such as overfishing and pollution are being compounded by climate change, notably warming and ocean acidification. Elevated temperatures are driving increasingly frequent bleaching events that can lead to the loss of both coral cover and reef structural complexity. There remains considerable variability in the distribution of threats and in the ability of reefs to survive or recover from such disturbances. Without significant emissions reductions, however, the future of coral reefs is increasingly bleak.	[Spalding, Mark D.] Univ Siena, Dept Phys Earth & Environm Sci, Global Ocean Team, Nat Conservancy, I-53100 Siena, Italy; [Spalding, Mark D.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Brown, Barbara E.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Brown, Barbara E.] Univ Highlands & Islands, Environm Res Inst, Thurso KW14 7EE, Scotland	University of Siena; University of Cambridge; Newcastle University - UK; UHI Millennium Institute	Spalding, MD (corresponding author), Univ Siena, Dept Phys Earth & Environm Sci, Global Ocean Team, Nat Conservancy, Plan dei Mantellini 44, I-53100 Siena, Italy.	mspalding@tnc.org	Spalding, Mark/GVU-0739-2022; Brown, Barbara/AAT-7991-2021	Spalding, Mark/0000-0001-9456-4533				Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Brown BE, 2015, MAR BIOL, V162, P479, DOI 10.1007/s00227-014-2596-2; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burke L., 2011, REEFS RISK REVISITED; Chong-Seng KM, 2014, CORAL REEFS, V33, P449, DOI 10.1007/s00338-014-1137-2; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Edwards CB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.1835; Fenner D, 2014, MAR POLLUT BULL, V84, P9, DOI 10.1016/j.marpolbul.2014.04.049; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Johns KA, 2014, CORAL REEFS, V33, P553, DOI 10.1007/s00338-014-1148-z; Kerry JT, 2015, CORAL REEFS, V34, P41, DOI 10.1007/s00338-014-1232-4; Kwiatkowski L, 2015, NAT CLIM CHANGE, V5, P777, DOI [10.1038/nclimate2655, 10.1038/NCLIMATE2655]; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; McClanahan TR, 2004, MAR BIOL, V144, P1239, DOI 10.1007/s00227-003-1271-9; McPhaden MJ, 2015, NAT CLIM CHANGE, V5, P791, DOI 10.1038/nclimate2775; Mumby PJ, 2014, CONSERV LETT, V7, P176, DOI 10.1111/conl.12047; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Perry CT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2409; Putnam HM, 2015, J EXP BIOL, V218, P2365, DOI 10.1242/jeb.123018; Randall CJ, 2015, NAT CLIM CHANGE, V5, P375, DOI 10.1038/nclimate2530; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Rinkevich B, 2014, CURR OPIN ENV SUST, V7, P28, DOI 10.1016/j.cosust.2013.11.018; Sheppard CRC, 2008, MAR ECOL PROG SER, V362, P109, DOI 10.3354/meps07436; Spalding M. D., 2001, WORLD ATLAS CORAL RE; van Oppen MJH, 2015, P NATL ACAD SCI USA, V112, P2307, DOI 10.1073/pnas.1422301112	29	138	141	32	650	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					769	771		10.1126/science.aad0349	http://dx.doi.org/10.1126/science.aad0349			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW3MS	26564846				2022-12-28	WOS:000364897000033
J	Chang, AJ; Ortega, FE; Riegler, J; Adison, DVM; Krasnow, MA				Chang, Andy J.; Ortega, Fabian E.; Riegler, Johannes; Adison, Daniel V. M.; Krasnow, Mark A.			Oxygen regulation of breathing through an olfactory receptor activated by lactate	NATURE			English	Article							RAT CAROTID-BODY; MITOCHONDRIAL RESPIRATORY-CHAIN; GLOMUS CELLS; CHEMORECEPTOR DISCHARGE; ODORANT RECEPTORS; GENE-EXPRESSION; SENSORY NEURONS; CRE RECOMBINASE; LEIGH-SYNDROME; I CELLS	Animals have evolved homeostatic responses to changes in oxygen availability that act on different timescales. Although the hypoxia-inducible factor (HIF) transcriptional pathway that controls long-term responses to low oxygen (hypoxia) has been established(1), the pathway that mediates acute responses to hypoxia in mammals is not well understood. Here we show that the olfactory receptor gene Olfr78 is highly and selectively expressed in oxygen-sensitive glomus cells of the carotid body, a chemosensory organ at the carotid artery bifurcation that monitors blood oxygen and stimulates breathing within seconds when oxygen declines(2). Olfr78 mutants fail to increase ventilation in hypoxia but respond normally to hypercapnia. Glomus cells are present in normal numbers and appear structurally intact, but hypoxia-induced carotid body activity is diminished. Lactate, a metabolite that rapidly accumulates in hypoxia and induces hyperventilation(3-6), activates Olfr78 in heterologous expression experiments, induces calcium transients in glomus cells, and stimulates carotid sinus nerve activity through Olfr78. We propose that, in addition to its role in olfaction, Olfr78 acts as a hypoxia sensor in the breathing circuit by sensing lactate produced when oxygen levels decline.	[Chang, Andy J.; Ortega, Fabian E.; Krasnow, Mark A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Chang, Andy J.; Ortega, Fabian E.; Krasnow, Mark A.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Riegler, Johannes] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Adison, Daniel V. M.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Krasnow, MA (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	krasnow@stanford.edu	Madison, Daniel/F-9341-2017	Madison, Daniel/0000-0002-0718-5373	Stanford University Dean's Postdoctoral Fellowship; National Institutes of Health (NIH) Career Development Program [K12 RFA-HL-07-004]; Helen Hay Whitney Postdoctoral Fellowship; NIH Pediatric Research Loan Repayment Program; Howard Hughes Medical Institute Gilliam Fellowship; NIH [MH065541, NS069375]; Harold and Leila Y. Mathers Charitable Foundation; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL089989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER	Stanford University Dean's Postdoctoral Fellowship; National Institutes of Health (NIH) Career Development Program; Helen Hay Whitney Postdoctoral Fellowship; NIH Pediatric Research Loan Repayment Program; Howard Hughes Medical Institute Gilliam Fellowship(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harold and Leila Y. Mathers Charitable Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Fish for technical assistance: D. Riordan for assistance with RNA sequencing and analysis; L. He, B. Dinger, and S. Fidone for instruction on carotid body dissection: A. Gourine for instruction on carotid sinus nerve recordings; H. Matsunami for plasmids and advice about OR activity assays; A. Olson for assistance with two photon imaging; R. Yu and K. Deisseroth for mouse strains; D. Cornfield and D. Bernstein for equipment: and P. Harbury and members of our laboratory for discussions and comments on the manuscript. This work was supported by Stanford University Dean's Postdoctoral Fellowship, National Institutes of Health (NIH) K12 RFA-HL-07-004 Career Development Program, Helen Hay Whitney Postdoctoral Fellowship, and NIH Pediatric Research Loan Repayment Program (A.J.C.), Howard Hughes Medical Institute Gilliam Fellowship (F.E.O.), NIH MH065541 and Harold and Leila Y. Mathers Charitable Foundation (D.V.M.), NIH NS069375 (Stanford Neuroscience Microscopy Service), and the Howard Hughes Medical Institute (M.A.K.).	Anickhov SV, 1963, PHARM CAROTID BODY C; Balbir A, 2007, AM J PHYSIOL-LUNG C, V292, pL704, DOI 10.1152/ajplung.00383.2006; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Bozza T, 2009, NEURON, V61, P220, DOI 10.1016/j.neuron.2008.11.010; Buckler KJ, 2015, PFLUG ARCH EUR J PHY, V467, P1013, DOI 10.1007/s00424-015-1689-1; Buckler KJ, 2013, J PHYSIOL-LONDON, V591, P3549, DOI 10.1113/jphysiol.2013.257741; Buckler KJ, 1997, J PHYSIOL-LONDON, V498, P649, DOI 10.1113/jphysiol.1997.sp021890; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Conzelmann S, 2000, EUR J NEUROSCI, V12, P3926, DOI 10.1046/j.1460-9568.2000.00286.x; DRORBAUGH JE, 1955, PEDIATRICS, V16, P81; Flegel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055368; Fleischer J, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.009.2009; Ganfornina MD, 2005, J PHYSIOL-LONDON, V566, P491, DOI 10.1113/jphysiol.2005.088815; Gautier H, 1996, J APPL PHYSIOL, V81, P521, DOI 10.1152/jappl.1996.81.2.521; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gourine AV, 2005, J PHYSIOL-LONDON, V568, P715, DOI 10.1113/jphysiol.2005.095968; Halestrap AP, 2013, COMPR PHYSIOL, V3, P1611, DOI 10.1002/cphy.c130008; Hardarson T, 1998, J APPL PHYSIOL, V84, P411, DOI 10.1152/jappl.1998.84.2.411; HUCKABEE WE, 1958, J CLIN INVEST, V37, P264, DOI 10.1172/JCI103605; Izal-Ancarate A, 2008, RESP PHYSIOL NEUROBI, V161, P95, DOI 10.1016/j.resp.2007.12.008; Kang N, 2012, BMB REP, V45, P612, DOI 10.5483/BMBRep.2012.45.11.232; KIRSCH JR, 1983, STROKE, V14, P971, DOI 10.1161/01.STR.14.6.971; Kline DD, 2005, J NEUROSCI, V25, P3389, DOI 10.1523/JNEUROSCI.4556-04.2005; Kline DD, 2002, P NATL ACAD SCI USA, V99, P821, DOI 10.1073/pnas.022634199; KNOWLES SE, 1974, BIOCHEM J, V142, P401, DOI 10.1042/bj1420401; Kumar ME, 2014, SCIENCE, V346, P827, DOI 10.1126/science.1258810; Kumar P, 2012, COMPR PHYSIOL, V2, P141, DOI 10.1002/cphy.c100069; Lee LY, 1996, J APPL PHYSIOL, V81, P2349, DOI 10.1152/jappl.1996.81.6.2349; Lindeberg J, 2004, GENESIS, V40, P67, DOI 10.1002/gene.20065; LOPEZBARNEO J, 1988, SCIENCE, V241, P580, DOI 10.1126/science.2456613; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marina N, 2015, HYPERTENSION, V65, P775, DOI 10.1161/HYPERTENSIONAHA.114.04683; MATSUURA S, 1973, J PHYSIOL-LONDON, V235, P57, DOI 10.1113/jphysiol.1973.sp010378; MONTIBLOCH L, 1993, BRAIN RES, V622, P119, DOI 10.1016/0006-8993(93)90810-A; MOORE SJ, 1991, TOXICOL APPL PHARM, V109, P412, DOI 10.1016/0041-008X(91)90004-X; Pardal R, 2007, CELL, V131, P364, DOI 10.1016/j.cell.2007.07.043; Peng YJ, 2010, P NATL ACAD SCI USA, V107, P10719, DOI 10.1073/pnas.1005866107; Piruat JI, 2004, MOL CELL BIOL, V24, P10933, DOI 10.1128/MCB.24.24.10933-10940.2004; Piskuric NA, 2012, J PHYSIOL-LONDON, V590, P2121, DOI 10.1113/jphysiol.2012.229468; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; POKORSKI M, 1983, AM J PHYSIOL, V244, pR652, DOI 10.1152/ajpregu.1983.244.5.R652; Pronicka E, 2001, J INHERIT METAB DIS, V24, P707, DOI 10.1023/A:1012937204315; Quintana A, 2012, J CLIN INVEST, V122, P2359, DOI 10.1172/JCI62923; REMESY C, 1980, REPROD NUTR DEV, V20, P1339, DOI 10.1051/rnd:19800725; RIGUAL R, 1991, J PHYSIOL-LONDON, V433, P519, DOI 10.1113/jphysiol.1991.sp018441; ROSDAHL H, 1993, J PHYSIOL-LONDON, V471, P637, DOI 10.1113/jphysiol.1993.sp019920; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Schwarzkopf TM, 2013, EXP BIOL MED, V238, P84, DOI 10.1258/ebm.2012.012261; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shirahata M, 2013, RESP PHYSIOL NEUROBI, V185, P20, DOI 10.1016/j.resp.2012.05.017; Stettner GM, 2011, MITOCHONDRION, V11, P413, DOI 10.1016/j.mito.2010.12.011; Streller T, 2002, FASEB J, V16, P1277, DOI 10.1096/fj.02-0166fje; Tan ZY, 2007, CIRC RES, V101, P1009, DOI 10.1161/CIRCRESAHA.107.154377; Trapp S, 2011, EXP PHYSIOL, V96, P451, DOI 10.1113/expphysiol.2010.055848; van der Schier Rutger, 2014, F1000Prime Rep, V6, P79, DOI 10.12703/P6-79; Weber M, 2002, J NEUROSCI RES, V68, P176, DOI 10.1002/jnr.10164; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Wolever TMS, 1997, METABOLISM, V46, P805, DOI 10.1016/S0026-0495(97)90127-X; Yokoyama T, 2013, HISTOCHEM CELL BIOL, V140, P147, DOI 10.1007/s00418-012-1066-5; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120	66	162	163	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					240	+		10.1038/nature15721	http://dx.doi.org/10.1038/nature15721			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26560302	Green Submitted, Green Accepted			2022-12-28	WOS:000364396700046
J	Ardal, C; Outterson, K; Hoffman, SJ; Ghafur, A; Sharland, M; Ranganathan, N; Smith, R; Zorzet, A; Cohn, J; Pittet, D; Daulaire, N; Morel, C; Rizvi, Z; Balasegaram, M; Dar, OA; Heymann, DL; Holmes, AH; Moore, LSP; Laxminarayan, R; Mendelson, M; Rottingen, JA				Ardal, Christine; Outterson, Kevin; Hoffman, Steven J.; Ghafur, Abdul; Sharland, Mike; Ranganathan, Nisha; Smith, Richard; Zorzet, Anna; Cohn, Jennifer; Pittet, Didier; Daulaire, Nils; Morel, Chantal; Rizvi, Zain; Balasegaram, Manica; Dar, Osman A.; Heymann, David L.; Holmes, Alison H.; Moore, Luke S. P.; Laxminarayan, Ramanan; Mendelson, Marc; Rottingen, John-Arne			International cooperation to improve access to and sustain effectiveness of antimicrobials	LANCET			English	Article							RESEARCH-AND-DEVELOPMENT; GLOBAL HEALTH TREATIES; PUBLIC-HEALTH; RESISTANCE; AGREEMENT; FRAMEWORK; DRUGS	Securing access to effective antimicrobials is one of the greatest challenges today. Until now, efforts to address this issue have been isolated and uncoordinated, with little focus on sustainable and international solutions. Global collective action is necessary to improve access to life-saving antimicrobials, conserving them, and ensuring continued innovation. Access, conservation, and innovation are beneficial when achieved independently, but much more effective and sustainable if implemented in concert within and across countries. WHO alone will not be able to drive these actions. It will require a multisector response (including the health, agriculture, and veterinary sectors), global coordination, and financing mechanisms with sufficient mandates, authority, resources, and power. Fortunately, securing access to effective antimicrobials has finally gained a place on the global political agenda, and we call on policy makers to develop, endorse, and finance new global institutional arrangements that can ensure robust implementation and bold collective action.	[Ardal, Christine; Daulaire, Nils; Rottingen, John-Arne] Norwegian Inst Publ Hlth, N-0403 Oslo, Norway; [Outterson, Kevin] Boston Univ, Sch Law, Boston, MA 02215 USA; [Outterson, Kevin; Dar, Osman A.; Heymann, David L.] Chatham House Ctr Global Hlth Secur, London, England; [Hoffman, Steven J.] Univ Ottawa, Global Strategy Lab, Fac Law, Ottawa, ON, Canada; [Hoffman, Steven J.; Rottingen, John-Arne] Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Ghafur, Abdul] Apollo Hosp, Madras, Tamil Nadu, India; [Sharland, Mike] St Georges Univ, Pediat Infect Dis Res Grp, London, England; [Ranganathan, Nisha] Worldwide Antimalarial Resistance Network, Oxford, England; [Smith, Richard] Fac Publ Hlth & Policy, London, England; [Heymann, David L.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Zorzet, Anna] Uppsala Univ, Uppsala, Sweden; [Zorzet, Anna] ReAct Act Antibiot Resistance, Uppsala, Sweden; [Cohn, Jennifer; Balasegaram, Manica] Access Campaign, Med Sans Frontieres, Geneva, Switzerland; [Cohn, Jennifer] Univ Penn, Div Infect Dis, Philadelphia, PA 19104 USA; [Pittet, Didier; Morel, Chantal] Univ Hosp Geneva, Fac Med, Geneva, Switzerland; [Pittet, Didier] WHO Collaborating Ctr Patient Safety, Geneva, Switzerland; [Morel, Chantal] Univ London London Sch Econ & Polit Sci, LSE Hlth, London WC2A 2AE, England; [Rizvi, Zain] Yale Univ, Sch Law, New Haven, CT 06520 USA; [Dar, Osman A.; Heymann, David L.] Publ Hlth England, London, England; [Holmes, Alison H.; Moore, Luke S. P.] Univ London Imperial Coll Sci Technol & Med, Natl Inst Hlth, Res Unit Healthcare Associated Infect, Res Hlth Protect, London, England; [Holmes, Alison H.; Moore, Luke S. P.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, London, England; [Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC USA; [Laxminarayan, Ramanan] Princeton Environm Inst, Princeton, NJ USA; [Laxminarayan, Ramanan] Publ Hlth Fdn India, New Delhi, India; [Mendelson, Marc] Univ Cape Town, Groote Schuur Hosp, Dept Med, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [Rottingen, John-Arne] Univ Oslo, Fac Med, Inst Hlth & Soc, Oslo, Norway	Norwegian Institute of Public Health (NIPH); Boston University; University of Ottawa; Harvard University; Harvard T.H. Chan School of Public Health; St Georges University London; Worldwide Antimalarial Resistance Network (WWARN); University of London; London School of Hygiene & Tropical Medicine; Uppsala University; Doctors Without Borders; University of Pennsylvania; University of Geneva; World Health Organization; University of London; London School Economics & Political Science; Yale University; Public Health England; Imperial College London; Imperial College London; Princeton University; Public Health Foundation of India; University of Cape Town; University of Oslo	Rottingen, JA (corresponding author), Norwegian Inst Publ Hlth, N-0403 Oslo, Norway.	john-arne.rottingen@fhi.no	Laxminarayan, Ramanan/ABD-5050-2021; Moore, Luke S P/Q-1012-2018; Morel, Chantal M/R-8243-2017	Moore, Luke S P/0000-0001-7095-7922; Morel, Chantal M/0000-0003-3984-9741; Hoffman, Steven/0000-0002-2064-3711; sharland, mike/0000-0001-8626-8291; Mendelson, Marc/0000-0001-6668-3893; Holmes, Alison/0000-0001-5554-5743; Outterson, Kevin/0000-0003-2513-3216	Canadian Institutes of Health Research; Research Council of Norway; Trudeau Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Research Council of Norway(Research Council of Norway); Trudeau Foundation	There was no funding to write this manuscript. However, travel and accommodation to attend author meetings were paid jointly by the Center for Disease Dynamics, Economics & Policy and the Norwegian Institute of Public Health. SJH is financially supported by the Canadian Institutes of Health Research, Research Council of Norway, and the Trudeau Foundation. The opinions expressed are those of the authors and do not reflect the views of any of the authors' institutions.	Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; [Anonymous], 2008, INT HLTH REG; [Anonymous], 2014, REV ANTIMICROBIAL RE; Bewley-Taylor D, 2012, INT J DRUG POLICY, V23, P72, DOI 10.1016/j.drugpo.2011.08.003; Dar OA, 2015, LANCET; European Commission, 2005, IP051687 EUR COMM; Food and Agriculture Organization World Health Organization World Organisation for Animal Health, 2011, STRENGTH LAB CAP RES; Frenk J, 2013, NEW ENGL J MED, V368, P936, DOI 10.1056/NEJMra1109339; Ghafur A, 2014, INDIAN J MED MICROBI, V32, P221, DOI 10.4103/0255-0857.129053; GlaxoSmithKline, 2013, GLAXOSMITHKLINE AW 2; Godoy M, 2014, NATL PUBLIC RAD 0219; Grogan K, 2013, PHARMATIMES ONL 1105; Hoffman SJ, 2015, AM J PUBLIC HEALTH, V105, P1523, DOI 10.2105/AJPH.2015.302726; Hoffman SJ, 2015, AM J PUBLIC HEALTH, V105, P26, DOI 10.2105/AJPH.2014.302085; Hoffman SJ, 2015, B WORLD HEALTH ORGAN, V93, P66, DOI 10.2471/BLT.15.152710; Hoffman SJ, 2012, B WORLD HEALTH ORGAN, V90, P854, DOI 10.2471/BLT.12.109827; Holmes AH, 2015, LANCET; Innovative Medicines Initiative, 2014, NEW DRUGS FOR BAD BU; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Joint Programming Initiative on Antimicrobial Resistance, 2014, 1 JPIAMR TRANSN CALL; Kelly L., 2004, MULTILATERAL FUND IM; Kesselheim AS, 2010, HEALTH AFFAIR, V29, P1689, DOI 10.1377/hlthaff.2009.0439; Konberg B, 2014, FUGURE NORDIC COOPER; Laxminarayan R, 2015, LANCET; Mendelson M, 2015, LANCET; Molzon JA, 2011, CLIN PHARMACOL THER, V89, P503, DOI 10.1038/clpt.2011.10; Moon S, 2014, PUBLIC HEALTH, V128, P167, DOI 10.1016/j.puhe.2013.08.014; Nesta, 2014, ANT CAN WE PREV RIS; O'Brien M, 2013, LANCET ONCOL, V14, pE176, DOI 10.1016/S1470-2045(12)70343-1; O'Neill J, 2015, THE TIMES LONDO 0421; Outterson K, 2014, NEW BUSINESS MODELS; Outterson K, 2015, HEALTH AFFAIR, V34, P277, DOI 10.1377/hlthaff.2014.1003; Republic of South Africa, 2014, ANT RES NAT STRAT FR; Silverglade BA, 2000, FOOD DRUG LAW J, V55, P517; The White House, 2015, NAT ACT PLAN COMB AN; The White House, 2014, NAT STRAT COMB ANT B; Transatlantic Task Force on Antimicrobial Resistance (TATFAR), 2014, TATFAR PROGR REP 201; US Food and Drug Administration, 2013, PHAS CERT ANT US FAR; WHO, 2005, CONT ANT RES WHO POL; WHO, 2014, 6725 WHO; WHO, 2001, WHO GLOB STRAT CONT; WHO, 1998, WHA5117 WHO; WHO, 2014, A6739 WHO; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; WHO Regional Office for South-East Asia, 2010, REG STRAT PREV CONT; Woolhouse M, 2014, NATURE, V509, P555, DOI 10.1038/509555a; World Health Organization, 2013, EB13432 WHO; World Health Organization, 2010, FRAM ACT INT ED COLL; World Health Organization, 2016, ANTIMICROBIAL RESIST	49	94	95	0	28	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2016	387	10015					296	307		10.1016/S0140-6736(15)00470-5	http://dx.doi.org/10.1016/S0140-6736(15)00470-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA9LQ	26603920	Green Published			2022-12-28	WOS:000368130700036
J	Saxton, RA; Knockenhauer, KE; Wolfson, RL; Chantranupong, L; Pacold, ME; Wang, T; Schwartz, TU; Sabatini, DM				Saxton, Robert A.; Knockenhauer, Kevin E.; Wolfson, Rachel L.; Chantranupong, Lynne; Pacold, Michael E.; Wang, Tim; Schwartz, Thomas U.; Sabatini, David M.			METABOLISM Structural basis for leucine sensing by the Sestrin2-mTORC1 pathway	SCIENCE			English	Article							RAG GTPASES; SIGNAL INTEGRATION; AMINO-ACIDS; MTORC1; SESTRINS; ACTIVATION; PROTEIN; SUFFICIENCY; RAGULATOR; MECHANISM	Eukaryotic cells coordinate growth with the availability of nutrients through the mechanistic target of rapamycin complex 1 (mTORC1), a master growth regulator. Leucine is of particular importance and activates mTORC1 via the Rag guanosine triphosphatases and their regulators GATOR1 and GATOR2. Sestrin2 interacts with GATOR2 and is a leucine sensor. Here we present the 2.7 angstrom crystal structure of Sestrin2 in complex with leucine. Leucine binds through a single pocket that coordinates its charged functional groups and confers specificity for the hydrophobic side chain. A loop encloses leucine and forms a lid-latch mechanism required for binding. A structure-guided mutation in Sestrin2 that decreases its affinity for leucine leads to a concomitant increase in the leucine concentration required for mTORC1 activation in cells. These results provide a structural mechanism of amino acid sensing by the mTORC1 pathway.	[Saxton, Robert A.; Knockenhauer, Kevin E.; Wolfson, Rachel L.; Chantranupong, Lynne; Pacold, Michael E.; Wang, Tim; Schwartz, Thomas U.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Saxton, Robert A.; Wolfson, Rachel L.; Chantranupong, Lynne; Pacold, Michael E.; Wang, Tim; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Saxton, Robert A.; Wolfson, Rachel L.; Chantranupong, Lynne; Pacold, Michael E.; Wang, Tim; Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Saxton, Robert A.; Wolfson, Rachel L.; Chantranupong, Lynne; Pacold, Michael E.; Wang, Tim; Sabatini, David M.] Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Saxton, Robert A.; Wolfson, Rachel L.; Chantranupong, Lynne; Pacold, Michael E.; Wang, Tim; Sabatini, David M.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Sabatini, DM (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sabatini@wi.mit.edu	Schwartz, Thomas/K-9029-2017; Schwartz, Thomas/ABA-1770-2021	Schwartz, Thomas/0000-0001-8012-1512; Schwartz, Thomas/0000-0001-8012-1512; /0000-0002-1446-7256; Saxton, Robert/0000-0001-9777-8270; Wang, Timothy/0000-0001-5730-3019	Navitor Pharmaceuticals; National Institute of General Medical Sciences from the National Institutes of Health [P41 GM103403]; NIH-ORIP HEI grant [S10 RR029205]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NIH [T32GM007287, R01CA103866, AI47389, T32 GM007753, F30 CA189333, F31 CA180271, F31 CA189437]; U.S. Department of Defense [W81XWH-07-0448]; MIT Whitaker Health Sciences Fund; Sally Gordon Fellowship of the Damon Runyon Cancer Research Foundation [DRG-112-12]; Department of Defense Breast Cancer Research Program Postdoctoral Fellowship [BC120208]; NATIONAL CANCER INSTITUTE [F30CA189333, F31CA189437, F31CA180271, P30CA014051, R01CA103866] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389, R37AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, P41GM103403, T32GM007287] Funding Source: NIH RePORTER	Navitor Pharmaceuticals; National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NIH-ORIP HEI grant; DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); MIT Whitaker Health Sciences Fund; Sally Gordon Fellowship of the Damon Runyon Cancer Research Foundation; Department of Defense Breast Cancer Research Program Postdoctoral Fellowship(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D.M.S. is a founder, a member of the Scientific Advisory Board, a paid consultant, and a shareholder of Navitor Pharmaceuticals, which is targeting for therapeutic benefit the amino acid sensing pathway upstream of mTORC1. We thank all members of the Sabatini and Schwartz laboratories for helpful insights. We also thank Cell Signaling Technologies for providing many antibodies. This work is based on research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences from the National Institutes of Health (P41 GM103403). The Pilatus 6Mdetector on 24-ID-C beamline is funded by a NIH-ORIP HEI grant (S10 RR029205). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. This work was supported in part by the NIH Predoctoral Training Grant T32GM007287. This work has also been supported by grants from NIH (R01CA103866 and AI47389) and the U.S. Department of Defense (W81XWH-07-0448) to D.M.S. Fellowship support was provided by NIH to R.L.W. (awards T32 GM007753 and F30 CA189333), L.C. (F31 CA180271), and T.W. (F31 CA189437). T.W. is also supported by an award from the MIT Whitaker Health Sciences Fund. M.E.P. is supported by the Sally Gordon Fellowship of the Damon Runyon Cancer Research Foundation (award DRG-112-12) and a Department of Defense Breast Cancer Research Program Postdoctoral Fellowship (award BC120208). D.M.S. is an investigator of the Howard Hughes Medical Institute. Coordinates and structure factors for the x-ray crystal structures of Sestrin2 have been deposited in the Protein Data Bank (PDB) with accession code 5DJ4.	Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Duran RV, 2012, EMBO REP, V13, P121, DOI 10.1038/embor.2011.257; Efeyan A, 2013, BIOCHEM SOC T, V41, P902, DOI 10.1042/BST20130063; Fox Heather L., 1998, American Journal of Physiology, V275, pC1232; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Greiwe JS, 2001, AM J PHYSIOL-ENDOC M, V281, pE466, DOI 10.1152/ajpendo.2001.281.3.E466; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Koshkin A, 2003, J BIOL CHEM, V278, P29502, DOI 10.1074/jbc.M303747200; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lynch CJ, 2000, J CELL BIOCHEM, V77, P234, DOI 10.1002/(SICI)1097-4644(20000501)77:2<234::AID-JCB7>3.0.CO;2-I; NAIR KS, 1992, AM J PHYSIOL, V263, pE928, DOI 10.1152/ajpendo.1992.263.5.E928; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Parmigiani A, 2014, CELL REP, V9, P1281, DOI 10.1016/j.celrep.2014.10.019; Peng M, 2014, CELL, V159, P122, DOI 10.1016/j.cell.2014.08.038; Potier M, 2009, CURR OPIN CLIN NUTR, V12, P54, DOI 10.1097/MCO.0b013e32831b9e01; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Woo HA, 2009, ANTIOXID REDOX SIGN, V11, P739, DOI 10.1089/ARS.2008.2360; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	29	250	263	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268					53	58		10.1126/science.aad2087	http://dx.doi.org/10.1126/science.aad2087			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ8QM	26586190	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000367364200039
J	Slaymaker, IM; Gao, LY; Zetsche, B; Scott, DA; Yan, WX; Zhang, F				Slaymaker, Ian M.; Gao, Linyi; Zetsche, Bernd; Scott, David A.; Yan, Winston X.; Zhang, Feng			Rationally engineered Cas9 nucleases with improved specificity	SCIENCE			English	Article							GENOME-EDITING SPECIFICITY; CRISPR RNA; SEED SEQUENCE; TARGET DNA; ENDONUCLEASE; RECOGNITION; COMPLEX; SYSTEMS	The RNA-guided endonuclease Cas9 is a versatile genome-editing tool with a broad range of applications from therapeutics to functional annotation of genes. Cas9 creates double-strand breaks (DSBs) at targeted genomic loci complementary to a short RNA guide. However, Cas9 can cleave off-target sites that are not fully complementary to the guide, which poses a major challenge for genome editing. Here, we use structure-guided protein engineering to improve the specificity of Streptococcus pyogenes Cas9 (SpCas9). Using targeted deep sequencing and unbiased whole-genome off-target analysis to assess Cas9-mediated DNA cleavage in human cells, we demonstrate that "enhanced specificity" SpCas9 (eSpCas9) variants reduce off-target effects and maintain robust on-target cleavage. Thus, eSpCas9 could be broadly useful for genome-editing applications requiring a high level of specificity.	[Slaymaker, Ian M.; Gao, Linyi; Zetsche, Bernd; Scott, David A.; Yan, Winston X.; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Slaymaker, Ian M.; Zetsche, Bernd; Scott, David A.; Zhang, Feng] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Slaymaker, Ian M.; Zetsche, Bernd; Scott, David A.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Slaymaker, Ian M.; Gao, Linyi; Zetsche, Bernd; Scott, David A.; Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Yan, Winston X.] Harvard Univ, Sch Med, Grad Program Biophys, Boston, MA 02115 USA; [Yan, Winston X.] Harvard Univ, Sch Med, Harvard MIT Div Hlth Sci & Technol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	zhang@broadinstitute.org	Huang, ZhiXin/H-5123-2017; Macrae, Rhiannon/AAX-1536-2020	Huang, ZhiXin/0000-0003-0705-1970; Gao, Alex/0000-0002-3579-0327	Simons Center for the Social Brain; National Institute of General Medical Sciences [T32GM007753]; Paul and Daisy Soros Fellowship; National Institutes of Health through NIMH [5DP1-MH100706, 1R01MH110049]; NIDDK [5R01DK097768-03]; National Science Foundation; Keck Foundation; New York Stem Cell Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Merkin Foundation; Vallee Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313, T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH110049, DP1MH100706] Funding Source: NIH RePORTER	Simons Center for the Social Brain; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Paul and Daisy Soros Fellowship; National Institutes of Health through NIMH; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science Foundation(National Science Foundation (NSF)); Keck Foundation(W.M. Keck Foundation); New York Stem Cell Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Merkin Foundation; Vallee Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Dahlman for helpful discussions and a critical review of the manuscript; F. A. Ran, R. J. Platt, and J. Joung for experimental assistance; and the entire Zhang laboratory for support and advice. I.S. is supported by the Simons Center for the Social Brain. W.X.Y. is supported by T32GM007753 from the National Institute of General Medical Sciences and a Paul and Daisy Soros Fellowship. F.Z. is supported by the National Institutes of Health through NIMH (5DP1-MH100706 and 1R01MH110049) and NIDDK (5R01DK097768-03), a Waterman Award from the National Science Foundation, the Keck, New York Stem Cell, Damon Runyon, Searle Scholars, Merkin, and Vallee Foundations, and B. Metcalfe. F.Z. is a New York Stem Cell Foundation Robertson Investigator. I.S., L.G., B.Z., and F.Z. are inventors on provisional patent application 62/181,453 applied for by the Broad Institute and MIT that covers the engineered CRISPR proteins described in this manuscript. Plasmid DNA encoding eSpCas9(1.0) and eSpCas9(1.1) are available from Addgene under a Universal Biological Material Transfer Agreement with the Broad Institute and MIT. F.Z. is a founder and scientific advisor for Editas Medicine and a scientific advisor for Horizon Discovery. Further information about the protocols, plasmids, and reagents can be found at the Zhang laboratory website (www.genome-engineering.org).	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149	20	1419	1626	15	469	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268					84	88		10.1126/science.aad5227	http://dx.doi.org/10.1126/science.aad5227			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ8QM	26628643	Green Accepted, Green Submitted			2022-12-28	WOS:000367364200048
J	Curry, MP; O'Leary, JG; Bzowej, N; Muir, AJ; Korenblat, KM; Fenkel, JM; Reddy, KR; Lawitz, E; Flamm, SL; Schiano, T; Teperman, L; Fontana, R; Schiff, E; Fried, M; Doehle, B; An, D; McNally, J; Osinusi, A; Brainard, DM; McHutchison, JG; Brown, RS; Charlton, M				Curry, M. P.; O'Leary, J. G.; Bzowej, N.; Muir, A. J.; Korenblat, K. M.; Fenkel, J. M.; Reddy, K. R.; Lawitz, E.; Flamm, S. L.; Schiano, T.; Teperman, L.; Fontana, R.; Schiff, E.; Fried, M.; Doehle, B.; An, D.; McNally, J.; Osinusi, A.; Brainard, D. M.; McHutchison, J. G.; Brown, R. S., Jr.; Charlton, M.		ASTRAL-4 Investigators	Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATITIS-C VIRUS; GENOTYPE 1; RANDOMIZED-TRIAL; INFECTION; COMBINATION; RIBAVIRIN; DISEASE	BACKGROUND As the population that is infected with the hepatitis C virus (HCV) ages, the number of patients with decompensated cirrhosis is expected to increase. METHODS We conducted a phase 3, open-label study involving both previously treated and previously untreated patients infected with HCV genotypes 1 through 6 who had decompensated cirrhosis (classified as Child-Pugh-Turcotte class B). Patients were randomly assigned in a 1: 1: 1 ratio to receive the nucleotide polymerase inhibitor sofosbuvir and the NS5A inhibitor velpatasvir once daily for 12 weeks, sofosbuvir-velpatasvir plus ribavirin for 12 weeks, or sofosbuvir-velpatasvir for 24 weeks. The primary end point was a sustained virologic response at 12 weeks after the end of therapy. RESULTS Of the 267 patients who received treatment, 78% had HCV genotype 1, 4% genotype 2, 15% genotype 3, 3% genotype 4, and less than 1% genotype 6; no patients had genotype 5. Overall rates of sustained virologic response were 83% (95% confidence interval [CI], 74 to 90) among patients who received 12 weeks of sofosbuvir-velpatasvir, 94% (95% CI, 87 to 98) among those who received 12 weeks of sofosbuvir-velpatasvir plus ribavirin, and 86% (95% CI, 77 to 92) among those who received 24 weeks of sofosbuvir-velpatasvir. Post hoc analysis did not detect any significant differences in rates of sustained virologic response among the three study groups. Serious adverse events occurred in 19% of patients who received 12 weeks of sofosbuvir-velpatasvir, 16% of those who received 12 weeks of sofosbuvir-velpatasvir plus ribavirin, and 18% of those who received 24 weeks of sofosbuvir-velpatasvir. The most common adverse events were fatigue (29%), nausea (23%), and headache (22%) in all patients and anemia (31%) in the patients receiving ribavirin. CONCLUSIONS Treatment with sofosbuvir-velpatasvir with or without ribavirin for 12 weeks and with sofosbuvir-velpatasvir for 24 weeks resulted in high rates of sustained virologic response in patients with HCV infection and decompensated cirrhosis.	[Curry, M. P.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [O'Leary, J. G.] Baylor Univ, Med Ctr, Dallas, TX USA; [Lawitz, E.] Univ Texas Hlth Sci Ctr San Antonio, Texas Liver Inst, San Antonio, TX 78229 USA; [Bzowej, N.] Ochsner Med Ctr, New Orleans, LA USA; [Muir, A. J.] Duke Univ, Durham, NC USA; [Fried, M.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Korenblat, K. M.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Fenkel, J. M.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Reddy, K. R.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Flamm, S. L.] Northwestern Univ, Chicago, IL 60611 USA; [Schiano, T.] Mt Sinai Hosp, New York, NY 10029 USA; [Teperman, L.] NYU, Sch Med, New York, NY USA; [Brown, R. S., Jr.] Weill Cornell Med Coll, New York, NY USA; [Fontana, R.] Univ Michigan, Ann Arbor, MI 48109 USA; [Schiff, E.] Univ Miami, Miami, FL USA; [Doehle, B.; An, D.; McNally, J.; Osinusi, A.; Brainard, D. M.; McHutchison, J. G.] Gilead Sci Inc, Foster City, CA 94404 USA; [Charlton, M.] Intermt Med Ctr, Salt Lake City, UT USA	Harvard University; Beth Israel Deaconess Medical Center; Baylor University; Baylor University Medical Center; University of Texas System; University of Texas Health San Antonio; Ochsner Health System; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Washington University (WUSTL); Jefferson University; University of Pennsylvania; Northwestern University; Icahn School of Medicine at Mount Sinai; New York University; Cornell University; University of Michigan System; University of Michigan; University of Miami; Gilead Sciences; Intermountain Healthcare; Intermountain Medical Center	Curry, MP (corresponding author), Beth Israel Deaconess Med Ctr, 110 Francis St,Suite 7, Boston, MA 02215 USA.	mcurry@bidmc.harvard.edu	Vargas, Hugo E./K-1562-2019	Vargas, Hugo E./0000-0002-7802-688X; Fenkel, Jonathan/0000-0003-4612-8416	Gilead Sciences	Gilead Sciences(Gilead Sciences)	Funded by Gilead Sciences; ASTRAL-4 ClinicalTrials.gov number, NCT02201901.	Afdhal N, 2014, 49 ANN M EUR ASS STU; [Anonymous], 2015, SOV SOF TABL US PREC; Charlton M, 2015, GASTROENTEROLOGY, V149, P649, DOI 10.1053/j.gastro.2015.05.010; Cheng G, 2013, 48 ANN M EUR ASS STU; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Deterding K, 2015, ALIMENT PHARM THER, V42, P889, DOI 10.1111/apt.13343; Doehle B, 2013, 64 ANN M AM ASS STUD; Dyson J.K., 2015, J HEPATOL; Everson GT, 2015, ANN INTERN MED, V163, P818, DOI 10.7326/M15-1000; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Fink SA, 2011, NAT REV GASTRO HEPAT, V8, P285, DOI 10.1038/nrgastro.2011.57; Forns X, 2015, HEPATOLOGY, V61, P1485, DOI 10.1002/hep.27681; Foster GR, 2015, NEW ENGL J MED, V373, P2608, DOI 10.1056/NEJMoa1512612; Foster GR, 2013, 48 ANN M EUR ASS STU; Harvoni (ledipasvir and sofosbuvir) tablets, HARV LED SOF TABL EU; Harvoni (ledipasvir-sofosbuvir) tablets, 2015, HARV LED SOF TABL US; Lawitz E, 2015, J VIRAL HEPATITIS, V22, P1011, DOI 10.1111/jvh.12435; Manns M, 2015, 50 ANN M EUR ASS STU; Modi AA, 2015, LIVER TRANSPL; Pianko S, 2015, ANN INTERN MED, V163, P809, DOI 10.7326/M15-1014; Poordad F, 2015, J HEPATOL, V62, pS261, DOI 10.1016/S0168-8278(15)30154-9; Reddy KR, 2015, 50 ANN M EUR ASS STU; Saxena V, 2015, HEPATOLOGY, V62, P715, DOI 10.1002/hep.27922	23	547	578	6	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2015	373	27					2618	2628		10.1056/NEJMoa1512614	http://dx.doi.org/10.1056/NEJMoa1512614			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ8UH	26569658	Bronze			2022-12-28	WOS:000367374100007
J	Tashima, KT; Smeaton, LM; Fichtenbaum, CJ; Andrade, A; Eron, JJ; Gandhi, RT; Johnson, VA; Klingman, KL; Ritz, J; Hodder, S; Santana, JL; Wilkin, T; Haubrich, RH				Tashima, Karen T.; Smeaton, Laura M.; Fichtenbaum, Carl J.; Andrade, Adriana; Eron, Joseph J.; Gandhi, Rajesh T.; Johnson, Victoria A.; Klingman, Karin L.; Ritz, Justin; Hodder, Sally; Santana, Jorge L.; Wilkin, Timothy; Haubrich, Richard H.		A5241 Study Team	HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors A Randomized, Controlled Trial	ANNALS OF INTERNAL MEDICINE			English	Article							ANTIRETROVIRAL REGIMENS; INFECTION; RITONAVIR; EFFICACY; SAFETY; MORTALITY; RALTEGRAVIR; 2ND-LINE; ADULTS; NORTH	Background: Nucleoside reverse transcriptase inhibitors (NRTIs) are often included in antiretroviral regimens in treatment-experienced patients in the absence of data from randomized trials. Objective: To compare treatment success between participants who omit versus those who add NRTIs to an optimized antiretroviral regimen of 3 or more agents. Design: Multicenter, randomized, controlled trial. (ClinicalTrials.gov: NCT00537394) Setting: Outpatient HIV clinics. Participants: Treatment-experienced patients with HIV infection and viral resistance. Intervention: Open-label optimized regimens (not including NRTIs) were selected on the basis of treatment history and susceptibility testing. Participants were randomly assigned to omit or add NRTIs. Measurements: The primary efficacy outcome was regimen failure through 48 weeks using a noninferiority margin of 15%. The primary safety outcome was time to initial episode of a severe sign, symptom, or laboratory abnormality before discontinuation of NRTI assignment. Results: 360 participants were randomly assigned, and 93% completed a 48-week visit. The cumulative probability of regimen failure was 29.8% in the omit-NRTIs group versus 25.9% in the add-NRTIs group (difference, 3.2 percentage points [95% CI, -6.1 to 12.5 percentage points]). No significant between-group differences were found in the primary safety end points or the proportion of participants with HIV RNA level less than 50 copies/mL. No deaths occurred in the omit-NRTIs group compared with 7 deaths in the add-NRTIs group. Limitation: Unblinded study design, and the study may not be applicable to resource-poor settings. Conclusion: Treatment-experienced patients with HIV infection starting a new optimized regimen can safely omit NRTIs without compromising virologic efficacy. Omitting NRTIs will reduce pill burden, cost, and toxicity in this patient population.	[Tashima, Karen T.] Brown Univ, Alpert Med Sch, Miriam Hosp, Providence, RI 02906 USA; [Smeaton, Laura M.; Ritz, Justin] Harvard Univ, TH Chan Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [Gandhi, Rajesh T.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Fichtenbaum, Carl J.] Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA; [Andrade, Adriana] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA; [Eron, Joseph J.] Univ N Carolina, Div Infect Dis, Chapel Hill, NC USA; [Johnson, Victoria A.] Birmingham Vet Affairs Med Ctr, Birmingham, AL 35233 USA; [Klingman, Karin L.] NIAID, Therapeut Res Program, HIV Res Branch, Bethesda, MD 20892 USA; [Hodder, Sally] W Virginia Univ, Sch Med, Morgantown, WV 26506 USA; [Santana, Jorge L.] Univ Puerto Rico, San Juan, PR 00936 USA; [Wilkin, Timothy] Weill Cornell Med Coll, Ctr Special Studies HIV AIDS, New York, NY 10065 USA; [Haubrich, Richard H.] Gilead Sci Inc, Foster City, CA 94404 USA	Brown University; Lifespan Health Rhode Island; Miriam Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; University System of Ohio; University of Cincinnati; Johns Hopkins University; Johns Hopkins Medicine; University of North Carolina; University of North Carolina Chapel Hill; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); West Virginia University; University of Puerto Rico; Cornell University; Gilead Sciences	Tashima, KT (corresponding author), Brown Univ, Alpert Med Sch, Miriam Hosp, 164 Summit Ave, Providence, RI 02906 USA.	ktashima@lifespan.org	Johnson, Victoria/GVU-7127-2022	Ritz, Justin/0000-0001-6307-4849; Fichtenbaum, Carl/0000-0002-6778-7253	National Institute of Allergy and Infectious Diseases; Boehringer Ingelheim; Janssen; Merck; ViiV Healthcare; Roche; Monogram Biosciences (LabCorp); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069419, UM1AI068634, UM1AI069412, UM1AI069423, U01AI068636, U01AI069419, UM1AI069415, UM1AI068636, UM1AI069513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Boehringer Ingelheim(Boehringer Ingelheim); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); ViiV Healthcare; Roche(Roche Holding); Monogram Biosciences (LabCorp); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institute of Allergy and Infectious Diseases, Boehringer Ingelheim, Janssen, Merck, ViiV Healthcare, Roche, and Monogram Biosciences (LabCorp).	Achhra AC, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-33; Allavena C, 2009, HIV CLIN TRIALS, V10, P337, DOI 10.1310/hct1005-337; [Anonymous], 2014, SELZ MAR; Boyd MA, 2013, LANCET, V381, P2091, DOI 10.1016/S0140-6736(13)61164-2; Clotet B, 2007, LANCET, V369, P1169, DOI 10.1016/S0140-6736(07)60497-8; Di Biagio A, 2013, CURR HIV RES, V11, P179, DOI 10.2174/1570162X113119990036; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Imaz A, 2011, J ANTIMICROB CHEMOTH, V66, P358, DOI 10.1093/jac/dkq432; Justice AC, 2013, JAIDS-J ACQ IMM DEF, V62, P149, DOI 10.1097/QAI.0b013e31827df36c; Katlama C, 2009, AIDS, V23, P2289, DOI 10.1097/QAD.0b013e3283316a5e; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; McComsey GA, 2011, J INFECT DIS, V203, P1791, DOI 10.1093/infdis/jir188; Miller CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095061; Neuhaus J, 2010, AIDS, V24, P697, DOI 10.1097/QAD.0b013e3283365356; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2015, GUID US ANT AG HIV 1; Paton NI, 2014, NEW ENGL J MED, V371, P234, DOI 10.1056/NEJMoa1311274; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Sabin C, 2014, TOP ANTIVIR MED, V22, P382; Tashima KT, 2015, HIV CLIN TRIALS, V16, P147, DOI 10.1179/1945577115Y.0000000001; Yazdanpanah Y, 2009, CLIN INFECT DIS, V49, P1441, DOI 10.1086/630210	21	14	14	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2015	163	12					908	+		10.7326/M15-0949	http://dx.doi.org/10.7326/M15-0949			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4BS	26595748	Green Accepted			2022-12-28	WOS:000366354200016
J	Mouginot, J; Rignot, E; Scheuchl, B; Fenty, I; Khazendar, A; Morlighem, M; Buzzi, A; Paden, J				Mouginot, J.; Rignot, E.; Scheuchl, B.; Fenty, I.; Khazendar, A.; Morlighem, M.; Buzzi, A.; Paden, J.			Fast retreat of Zachariae Isstrom, northeast Greenland	SCIENCE			English	Article							ICE-SHEET; CONTINENTAL-SHELF; GLACIER; BENEATH; DYNAMICS; CAVITY; WATER	After 8 years of decay of its ice shelf, Zachariae Isstrom, a major glacier of northeast Greenland that holds a 0.5-meter sea-level rise equivalent, entered a phase of accelerated retreat in fall 2012. The acceleration rate of its ice velocity tripled, melting of its residual ice shelf and thinning of its grounded portion doubled, and calving is now occurring at its grounding line. Warmer air and ocean temperatures have caused the glacier to detach from a stabilizing sill and retreat rapidly along a downward-sloping, marine-based bed. Its equal-ice-volume neighbor, Nioghalvfjerdsfjorden, is also melting rapidly but retreating slowly along an upward-sloping bed. The destabilization of this marine-based sector will increase sea-level rise from the Greenland Ice Sheet for decades to come.	[Mouginot, J.; Rignot, E.; Scheuchl, B.; Morlighem, M.; Buzzi, A.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Rignot, E.; Fenty, I.; Khazendar, A.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Paden, J.] Univ Kansas, Ctr Remote Sensing Ice Sheets, Lawrence, KS 66045 USA	University of California System; University of California Irvine; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Kansas	Mouginot, J (corresponding author), Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA.	jmougino@uci.edu	Rignot, Eric/A-4560-2014; Fenty, Ian/AAP-9569-2021; Mouginot, Jeremie/G-7045-2015; Morlighem, Mathieu/O-9942-2014	Rignot, Eric/0000-0002-3366-0481; Mouginot, Jeremie/0000-0001-9155-5455; Morlighem, Mathieu/0000-0001-5219-1310	NASA [NNX13AI84A, NNX14AB93G, NNX13AD53A, NNX15AD55G]; NSF [ANT-0424589]	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	This work was performed under NASA grants NNX13AI84A (E.R.), NNX14AB93G (E.R.), NNX13AD53A (J.P.), and NNX15AD55G (M.M.), and NSF grant ANT-0424589 (J.P.). The work of I.F., A.K., and E.R. was carried at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. We gratefully acknowledge European Space Agency, Canadian Space Agency, Japan Aerospace Exploration Agency, Agenzia Spaziale Italiana, National Aeronautics and Space Administration, and Deutsches Zentrum fur Luft- und Raumfahrt e.V. for providing SAR data and Polar Space Task Group for coordination of SAR acquisitions.	Beszczynska-Moller A, 2012, ICES J MAR SCI, V69, P852, DOI 10.1093/icesjms/fss056; Cochran JR, 2012, J GLACIOL, V58, P540, DOI 10.3189/2012JoG11J033; Csatho BM, 2014, P NATL ACAD SCI USA, V111, P18478, DOI 10.1073/pnas.1411680112; de Steur L, 2014, DEEP-SEA RES PT I, V92, P26, DOI 10.1016/j.dsr.2014.05.018; Fahnestock M, 2001, SCIENCE, V294, P2338, DOI 10.1126/science.1065370; Fettweis X, 2013, CRYOSPHERE, V7, P469, DOI 10.5194/tc-7-469-2013; Holland PR, 2008, J CLIMATE, V21, P2558, DOI 10.1175/2007JCLI1909.1; Holliday NP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032675; James TD, 2014, NAT GEOSCI, V7, P594, DOI 10.1038/NGEO2204; Joughin I, 2014, CRYOSPHERE, V8, P209, DOI 10.5194/tc-8-209-2014; Khan SA, 2014, NAT CLIM CHANGE, V4, P292, DOI [10.1038/nclimate2161, 10.1038/NCLIMATE2161]; Mauritzen C, 2011, PROG OCEANOGR, V90, P62, DOI 10.1016/j.pocean.2011.02.010; Mayer C, 2000, GEOPHYS RES LETT, V27, P2289, DOI 10.1029/2000GL011514; MEIER MF, 1987, J GEOPHYS RES-SOLID, V92, P9051, DOI 10.1029/JB092iB09p09051; Morlighem M, 2014, NAT GEOSCI, V7, P418, DOI [10.1038/NGEO2167, 10.1038/ngeo2167]; Munchow A, 2014, J GLACIOL, V60, P489, DOI 10.3189/2014JoG13J135; Orvik KA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015002; Pollard D, 2015, EARTH PLANET SC LETT, V412, P112, DOI 10.1016/j.epsl.2014.12.035; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; Rignot E, 2012, ANN GLACIOL, V53, P257, DOI 10.3189/2012AoG60A136; Rignot E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051634; Rignot E, 2001, J GEOPHYS RES-ATMOS, V106, P34007, DOI 10.1029/2001JD900071; Schauer U., 2008, ARCTIC SUBARCTIC OCE, P65, DOI DOI 10.1007/978-1-4020-6774-7_4; Wilson NJ, 2015, GEOPHYS RES LETT, V42, P7648, DOI 10.1002/2015GL064944; Xu Y, 2013, GEOPHYS RES LETT, V40, P4648, DOI 10.1002/grl.50825	25	125	128	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1357	1361		10.1126/science.aac7111	http://dx.doi.org/10.1126/science.aac7111			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26563135	Green Submitted			2022-12-28	WOS:000366162400038
J	Kim, C; Nevitt, MC; Niu, JB; Clancy, MM; Lane, NE; Link, TM; Vlad, S; Tolstykh, I; Jungmann, PM; Felson, DT; Guermazi, A				Kim, Chan; Nevitt, Michael C.; Niu, Jingbo; Clancy, Mary M.; Lane, Nancy E.; Link, Thomas M.; Vlad, Steven; Tolstykh, Irina; Jungmann, Pia M.; Felson, David T.; Guermazi, Ali			Association of hip pain with radiographic evidence of hip osteoarthritis: diagnostic test study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							KNEE OSTEOARTHRITIS; PREVALENCE; MRI; DEFINITIONS; RELIABILITY; RISK; DISCORDANCE; ATTENDERS; COMMUNITY; ARTHRITIS	Study question Is there concordance between hip pain and radiographic hip osteoarthritis? Methods In this diagnostic test study, pelvic radiographs were assessed for hip osteoarthritis in two cohorts: the Framingham Osteoarthritis Study (community of Framingham, Massachusetts) and the Osteoarthritis Initiative (a multicenter longitudinal cohort study of osteoarthritis in the United States). Using visual representation of the hip joint, participants reported whether they had hip pain on most days and the location of the pain: anterior, groin, lateral, buttocks, or low back. In the Framingham study, participants with hip pain were also examined for hip pain with internal rotation. The authors analysed the agreement between radiographic hip osteoarthritis and hip pain, and for those with hip pain suggestive of hip osteoarthritis they calculated the sensitivity, specificity, positive predictive value, and negative predictive value of radiographs as the diagnostic test. Study answer and limitations In the Framingham study (n=946), only 15.6% of hips in patients with frequent hip pain showed radiographic evidence of hip osteoarthritis, and 20.7% of hips with radiographic hip osteoarthritis were frequently painful. The sensitivity of radiographic hip osteoarthritis for hip pain localised to the groin was 36.7%, specificity 90.5%, positive predictive value 6.0%, and negative predictive value 98.9%. Results did not differ much for hip pain at other locations or for painful internal rotation. In the Osteoarthritis Initiative study (n=4366), only 9.1% of hips in patients with frequent pain showed radiographic hip osteoarthritis, and 23.8% of hips with radiographic hip osteoarthritis were frequently painful. The sensitivity of definite radiographic hip osteoarthritis for hip pain localised to the groin was 16.5%, specificity 94.0%, positive predictive value 7.1%, and negative predictive value 97.6%. Results also did not differ much for hip pain at other locations. What this study adds Hip pain was not present in many hips with radiographic osteoarthritis, and many hips with pain did not show radiographic hip osteoarthritis. Most older participants with a high suspicion for clinical hip osteoarthritis (groin or anterior pain and/or painful internal rotation) did not have radiographic hip osteoarthritis, suggesting that in many cases, hip osteoarthritis might be missed if diagnosticians relied solely on hip radiographs.	[Kim, Chan; Niu, Jingbo; Clancy, Mary M.; Felson, David T.] Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02116 USA; [Kim, Chan] Boston Univ, Sch Med, Dept Rheumatol, Boston, MA 02116 USA; [Nevitt, Michael C.; Tolstykh, Irina] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Lane, Nancy E.] Univ Calif Davis, Dept Rheumatol, Davis, CA 95616 USA; [Link, Thomas M.] Univ San Francisco, Dept Rheumatol, San Francisco, CA 94117 USA; [Vlad, Steven] Tufts Med Ctr, Dept Rheumatol, Boston, MA USA; [Jungmann, Pia M.] Tech Univ Munich, Dept Diagnost & Intervent Radiol, D-80290 Munich, Germany; [Felson, David T.] NIHR Manchester Biomed Res Unit, Manchester, Lancs, England; [Guermazi, Ali] Boston Univ, Sch Med, Dept Radiol, Boston, MA 02116 USA	Boston University; Boston University; University of California System; University of California San Francisco; University of California System; University of California Davis; University of San Francisco; Tufts Medical Center; Technical University of Munich; Boston University	Kim, C (corresponding author), Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, 650 Albany St,Room X200, Boston, MA 02116 USA.	bevochan@bu.edu	Link, Thomas M. M/E-7522-2012	Kim, Chan/0000-0001-7533-6148; Felson, David/0000-0002-2668-2447; Jungmann, Pia/0000-0003-2198-3678	National Institutes of Health (NIH) [AR47785, AG18393]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [BAA-NHLBI-AR-10-06]; NIH, a branch of Department of Health and Human Services [N01-AR-2-2258, N01-AR-2-2259, N01-AR-2-2260, N01-AR-2-2261, N01-AR-2-2262]; Merck Research Laboratories; Novartis Pharmaceuticals; GlaxoSmithKline; Pfizer; National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH [HHSN268201000019C]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [N01AR022261, P60AR047785, N01AR022260, N01AR022258, N01AR022259, N01AR022262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018393] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH, a branch of Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Research Laboratories(Merck & Company); Novartis Pharmaceuticals(Novartis); GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was Supported by the National Institutes of Health (NIH AR47785, AG18393, and AR47785), National Institute of Arthritis and Musculoskeletal and Skin Diseases (BAA-NHLBI-AR-10-06). The Osteoarthritis Initiative is a public-private partnership comprised of five contracts (N01-AR-2-2258; N01-AR-2-2259; N01-AR-2-2260; N01-AR-2-2261; N01-AR-2-2262) funded by the NIH, a branch of the Department of Health and Human Services, and conducted by the Osteoarthritis Initiative Study Investigators. Private funding partners include Merck Research Laboratories, Novartis Pharmaceuticals, GlaxoSmithKline, and Pfizer. Private sector funding for the Osteoarthritis Initiative is managed by the Foundation for the NIH. This project was also funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, under Contract No HHSN268201000019C. This manuscript was prepared using, in part, an Osteoarthritis Initiative public use dataset and does not necessarily reflect the opinions or views of the Osteoarthritis Initiative investigators, the NIH, or the private funding partners.	ALTMAN R, 1991, ARTHRITIS RHEUM, V34, P505, DOI 10.1002/art.1780340502; Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; Arden NK, 2009, ARTHRITIS RHEUM-US, V60, P1052, DOI 10.1002/art.24382; Arden NK, 1999, ARTHRITIS RHEUM, V42, P1378, DOI 10.1002/1529-0131(199907)42:7<1378::AID-ANR11>3.0.CO;2-I; Barbour KE, 2015, ARTHRITIS RHEUMATOL, V67, P1798, DOI 10.1002/art.39113; Bedson J, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-116; Birrell F, 2005, RHEUMATOLOGY, V44, P337, DOI 10.1093/rheumatology/keh458; Birrell F, 2005, ANN RHEUM DIS, V64, P95, DOI 10.1136/ard.2003.018788; Birrell F, 2003, BRIT J GEN PRACT, V53, P26; Birrell F, 2001, RHEUMATOLOGY, V40, P506, DOI 10.1093/rheumatology/40.5.506; Birrell F, 2000, ANN RHEUM DIS, V59, P857, DOI 10.1136/ard.59.11.857; Conrozier T, 1997, OSTEOARTHR CARTILAGE, V5, P17, DOI 10.1016/S1063-4584(97)80028-3; Conrozier T, 1999, OSTEOARTHR CARTILAGE, V7, P295, DOI 10.1053/joca.1998.0203; CROFT P, 1994, J RHEUMATOL, V21, P591; CROFT P, 1990, AM J EPIDEMIOL, V132, P514, DOI 10.1093/oxfordjournals.aje.a115687; Duncan R, 2011, AGE AGEING, V40, P752, DOI 10.1093/ageing/afr105; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Gossec L, 2009, OSTEOARTHR CARTILAGE, V17, P182, DOI 10.1016/j.joca.2008.06.009; Guermazi A, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5339; Hannan MT, 2000, J RHEUMATOL, V27, P1513; Hayashi D, 2014, OSTEOARTHR CARTILAGE, V22, P76, DOI 10.1016/j.joca.2013.10.007; Jacobsen S, 2004, ACTA ORTHOP SCAND, V75, P713, DOI 10.1080/00016470410004085; Keenan AM, 2006, ARTHRIT RHEUM-ARTHR, V55, P757, DOI 10.1002/art.22239; Kim C, 2014, ARTHRITIS RHEUMATOL, V66, P3013, DOI 10.1002/art.38795; Kotlarz H, 2009, ARTHRITIS RHEUM-US, V60, P3546, DOI 10.1002/art.24984; Kumar D, 2015, J ORTHOP RES, V33, P527, DOI 10.1002/jor.22781; Lane NE, 2007, NEW ENGL J MED, V357, P1413, DOI 10.1056/NEJMcp071112; Lane NE, 1999, J RHEUMATOL, V26, P849; Lane NE, 2004, ARTHRITIS RHEUM-US, V50, P1477, DOI 10.1002/art.20213; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lee S, 2015, J MAGN RESON IMAGING, V41, P1549, DOI 10.1002/jmri.24722; Lequesne MG, 1998, ANN RHEUM DIS, V57, P676, DOI 10.1136/ard.57.11.676; Misra D, 2015, J GERONTOL A-BIOL, V70, P337, DOI 10.1093/gerona/glu102; Nevitt MC, 1996, ANN RHEUM DIS, V55, P652, DOI 10.1136/ard.55.9.652; Pope DP, 2003, ANN RHEUM DIS, V62, P322, DOI 10.1136/ard.62.4.322; Reijman M, 2004, ANN RHEUM DIS, V63, P1427, DOI 10.1136/ard.2003.016477; Reijman M, 2004, ANN RHEUM DIS, V63, P226, DOI 10.1136/ard.2003.010348; Roemer FW, 2011, OSTEOARTHR CARTILAGE, V19, P946, DOI 10.1016/j.joca.2011.04.003; Xu L, 2013, SKELETAL RADIOL, V42, P1421, DOI 10.1007/s00256-013-1675-7	39	89	91	3	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2015	351								h5983	10.1136/bmj.h5983	http://dx.doi.org/10.1136/bmj.h5983			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX9EY	26631296	Green Published, hybrid			2022-12-28	WOS:000366009000002
J	Watts, G				Watts, Geoff			Lawrence Gostin: legal activist in the cause of global health	LANCET			English	Biographical-Item																		GOSTIN L, PUBLICATION LIST	1	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 28	2015	386	10009					2133	2133		10.1016/S0140-6736(15)00992-7	http://dx.doi.org/10.1016/S0140-6736(15)00992-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8YW	26615325	Bronze			2022-12-28	WOS:000365992600018
J	Boone, C; Andrews, BJ				Boone, Charles; Andrews, Brenda J.			The indispensable genome	SCIENCE			English	Editorial Material							SACCHAROMYCES-CEREVISIAE GENOME; CANCER-CELLS; GENES		[Boone, Charles] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada	University of Toronto; University of Toronto	Boone, C (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada.	charlie.boone@utoronto.ca; brenda.andrews@utoronto.ca						Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Hughes TR, 2004, CURR OPIN MICROBIOL, V7, P546, DOI 10.1016/j.mib.2004.08.015; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Lee AY, 2014, SCIENCE, V344, P208, DOI 10.1126/science.1250217; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Pal C, 2001, GENETICS, V158, P927; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	14	9	9	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1028	1029		10.1126/science.aad7925	http://dx.doi.org/10.1126/science.aad7925			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY5BJ	26612934				2022-12-28	WOS:000366422600020
J	McGee, MD; Borstein, SR; Neches, RY; Buescher, HH; Seehausen, O; Wainwright, PC				McGee, Matthew D.; Borstein, Samuel R.; Neches, Russell Y.; Buescher, Heinz H.; Seehausen, Ole; Wainwright, Peter C.			A pharyngeal jaw evolutionary innovation facilitated extinction in Lake Victoria cichlids	SCIENCE			English	Article							ADAPTIVE RADIATION; DIVERSIFICATION; ECOLOGY; FISH	Evolutionary innovations, traits that give species access to previously unoccupied niches, may promote speciation and adaptive radiation. Here, we show that such innovations can also result in competitive inferiority and extinction. We present evidence that the modified pharyngeal jaws of cichlid fishes and several marine fish lineages, a classic example of evolutionary innovation, are not universally beneficial. A large-scale analysis of dietary evolution across marine fish lineages reveals that the innovation compromises access to energy-rich predator niches. We show that this competitive inferiority shaped the adaptive radiation of cichlids in Lake Tanganyika and played a pivotal and previously unrecognized role in the mass extinction of cichlid fishes in Lake Victoria after Nile perch invasion.	[McGee, Matthew D.; Neches, Russell Y.; Wainwright, Peter C.] Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA; [McGee, Matthew D.; Neches, Russell Y.; Wainwright, Peter C.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [McGee, Matthew D.; Seehausen, Ole] Univ Bern, Inst Ecol & Evolut, CH-3012 Bern, Switzerland; [McGee, Matthew D.; Seehausen, Ole] Swiss Fed Inst Aquat Sci & Technol, Eawag, Dept Fish Ecol & Evolut, CH-6047 Kastanienbaum, Switzerland; [Borstein, Samuel R.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Buescher, Heinz H.] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland	University of California System; University of California Davis; University of California System; University of California Davis; University of Bern; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Tennessee System; University of Tennessee Knoxville; University of Basel	McGee, MD (corresponding author), Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA.	mcgee.matthew@gmail.com	Seehausen, Ole/C-8272-2011; Borstein, Samuel/Q-1476-2015	Seehausen, Ole/0000-0001-6598-1434; Borstein, Samuel/0000-0002-7258-141X; Neches, Russell/0000-0002-2055-8381	Tanzania Fisheries Research Institute; NSF [IOS-0924489, DEB-0717009, DEB-061981]; SNSF [31003A_144046]; Sloan Foundation	Tanzania Fisheries Research Institute; NSF(National Science Foundation (NSF)); SNSF(Swiss National Science Foundation (SNSF)); Sloan Foundation(Alfred P. Sloan Foundation)	We thank R. Bireley, J. Clifton, L. DeMason, R. Robbins, D. Schumacher, W. Wong, O. Selz, A. Taverna, M. Kayeba, M. Haluna, and the Lake Victoria Species Survival Program for facilitating access to live and preserved specimens; the Tanzania Fisheries Research Institute for support and the Tanzania Commission for Science and Technology for research permits to O.S.; and R. Grosberg, D. Schluter, T. Schoener, D. Strong, M. Turelli, and G. Vermeij for manuscript comments. Funding was provided by NSF grants IOS-0924489, DEB-0717009, and DEB-061981 to P.C.W. and SNSF grant 31003A_144046 to O.S. R.Y.N. was supported by a Sloan Foundation grant to J. Eisen. All live animal protocols comply with UC Davis Guidelines for Animal Care and Use. Data are archived in Dryad.	Alfaro ME, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-255; Brawand D, 2014, NATURE, V513, P375, DOI 10.1038/nature13726; Coulter G. W., 1991, LAKE TANGANYIKA ITS; CRACRAFT J, 1990, EVOLUTIONARY INNOVATIONS, P21; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Givnish Thomas J., 1998, P281; Givnish TJ, 2000, EVOLUTION, V54, P1915; Greenwood P. H., 1981, HAPLOCHROMINE FISHES; Heard Stephen B., 1995, Historical Biology, V10, P151; Hodges SA, 1995, P ROY SOC B-BIOL SCI, V262, P343, DOI 10.1098/rspb.1995.0215; Hunter JP, 1998, TRENDS ECOL EVOL, V13, P31, DOI 10.1016/S0169-5347(97)01273-1; LIEM KF, 1973, SYST ZOOL, V22, P425, DOI 10.2307/2412950; Maia R, 2013, P NATL ACAD SCI USA, V110, P10687, DOI 10.1073/pnas.1220784110; Mayr E., 1963, ANIMAL SPECIES EVOLU; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; Pfennig D. W., 2012, EVOLUTIONS WEDGE COM; Rabosky DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089543; Rabosky DL, 2013, ANNU REV ECOL EVOL S, V44, P481, DOI 10.1146/annurev-ecolsys-110512-135800; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; VAN OIJEN MJP, 1982, NETH J ZOOL, V32, P336, DOI 10.1163/002829681X00374; van Rijssel JC, 2013, EVOL ECOL, V27, P253, DOI 10.1007/s10682-012-9596-9; Vermeij GJ, 2007, PALEOBIOLOGY, V33, P469, DOI 10.1666/06061.1; Vermeij GJ, 2012, EVOL ECOL, V26, P357, DOI 10.1007/s10682-010-9458-2; Vermeij GJ, 2001, BIOL J LINN SOC, V72, P461, DOI 10.1006/bijl.2001.0524; WAINWRIGHT PC, 1987, J ZOOL, V213, P283, DOI 10.1111/j.1469-7998.1987.tb03704.x; Wainwright PC, 2012, SYST BIOL, V61, P1001, DOI 10.1093/sysbio/sys060; WITTE F, 1992, ENVIRON BIOL FISH, V34, P1, DOI 10.1007/BF00004782	29	43	43	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1077	1079		10.1126/science.aab0800	http://dx.doi.org/10.1126/science.aab0800			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY5BJ	26612951				2022-12-28	WOS:000366422600040
J	Inra, CN; Zhou, BO; Acar, M; Murphy, MM; Richardson, J; Zhao, ZY; Morrison, SJ				Inra, Christopher N.; Zhou, Bo O.; Acar, Melih; Murphy, Malea M.; Richardson, James; Zhao, Zhiyu; Morrison, Sean J.			A perisinusoidal niche for extramedullary haematopoiesis in the spleen	NATURE			English	Article							STEM-CELLS; BONE-MARROW; TRANSGENIC MICE; PROGENITOR CELLS; CRE RECOMBINASE; SELF-RENEWAL; NG2 CELLS; EXPRESSION; RECEPTOR; MOUSE	Haematopoietic stresses mobilize haematopoietic stem cells (HSCs) from the bone marrow to the spleen and induce extramedullary haematopoiesis (EMH). However, the cellular nature of the EMH niche is unknown. Here we assessed the sources of the key niche factors, SCF (also known as KITL) and CXCL12, in the mouse spleen after EMH induction by myeloablation, blood loss, or pregnancy. In each case, Scf was expressed by endothelial cells and Tcf21(+) stromal cells, primarily around sinusoids in the red pulp, while Cxcl12 was expressed by a subset of Tcf21(+) stromal cells. EMH induction markedly expanded the Scf-expressing endothelial cells and stromal cells by inducing proliferation. Most splenic HSCs were adjacent to Tcf21(+) stromal cells in red pulp. Conditional deletion of Scf from spleen endothelial cells, or of Scf or Cxcl12 from Tcf21(+) stromal cells, severely reduced spleen EMH and reduced blood cell counts without affecting bone marrow haematopoiesis. Endothelial cells and Tcf21(+) stromal cells thus create a perisinusoidal EMH niche in the spleen, which is necessary for the physiological response to diverse haematopoietic stresses.	[Inra, Christopher N.; Zhou, Bo O.; Acar, Melih; Murphy, Malea M.; Zhao, Zhiyu; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Inra, Christopher N.; Zhou, Bo O.; Acar, Melih; Murphy, Malea M.; Zhao, Zhiyu; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Childrens Res Inst, Dallas, TX 75390 USA; [Richardson, James] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Morrison, SJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.	sean.morrison@utsouthwestern.edu	Morrison, Sean/ABD-5326-2021	Murphy, Malea/0000-0001-7071-6862; Morrison, Sean/0000-0003-1587-8329	Leukemia and Lymphoma Society; National Institutes of Health National Heart, Lung, and Blood Institute [HL097760]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097760] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	S.J.M. is a Howard Hughes Medical Institute Investigator, the Mary McDermott Cook Chair in Pediatric Genetics, the director of the Hamon Laboratory for Stem Cells and Cancer, and a Cancer Prevention and Research Institute of Texas Scholar. B.O.Z. was supported by a fellowship from the Leukemia and Lymphoma Society. We thank N. Loof and the Moody Foundation Flow Cytometry Facility, K. Correll and M. Gross for mouse colony management, and E. Olson and J. Mendell for providing Cre lines. This work was supported by the National Institutes of Health National Heart, Lung, and Blood Institute (HL097760).	Abdel-Wahab OI, 2009, ANNU REV MED, V60, P233, DOI 10.1146/annurev.med.60.041707.160528; Acar M, 2015, NATURE, V526, P126, DOI 10.1038/nature15250; Acharya A, 2011, GENESIS, V49, P870, DOI 10.1002/dvg.20750; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Becker Klaus, 2013, Cold Spring Harb Protoc, V2013, P743, DOI 10.1101/pdb.prot076521; BENNETT M, 1968, BLOOD, V32, P908, DOI 10.1182/blood.V32.6.908.908; Burberry A, 2014, CELL HOST MICROBE, V15, P779, DOI 10.1016/j.chom.2014.05.004; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Cheshier SH, 2007, STEM CELLS DEV, V16, P707, DOI 10.1089/scd.2007.0017; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Cuttler AS, 2011, GENESIS, V49, P673, DOI 10.1002/dvg.20769; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; FOWLER JH, 1968, DEV BIOL, V18, P331, DOI 10.1016/0012-1606(68)90045-6; FREEDMAN MH, 1981, AM J HEMATOL, V11, P271, DOI 10.1002/ajh.2830110307; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johns JL, 2012, VET PATHOL, V49, P508, DOI 10.1177/0300985811432344; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Lowell CA, 1996, BLOOD, V87, P1780; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Miwa Y, 2013, PATHOLOGY, V45, P408, DOI 10.1097/PAT.0b013e3283613dbf; Morita Y, 2011, EXP HEMATOL, V39, P351, DOI 10.1016/j.exphem.2010.12.008; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Nakada D, 2014, NATURE, V505, P555, DOI 10.1038/nature12932; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; TAVASSOLI M, 1973, BLOOD, V42, P267, DOI 10.1182/blood.V42.2.267.267; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wendling O, 2009, GENESIS, V47, P14, DOI 10.1002/dvg.20448; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	39	148	157	4	45	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					466	+		10.1038/nature15530	http://dx.doi.org/10.1038/nature15530			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26570997	Green Accepted			2022-12-28	WOS:000365352500037
J	Maheswaran, S; Haber, DA				Maheswaran, Shyamala; Haber, Daniel A.			CELL FATE Transition loses its invasive edge	NATURE			English	Editorial Material							STEM-CELLS; CANCER; PROGRESSION; EMT		[Maheswaran, Shyamala; Haber, Daniel A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Maheswaran, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA.	maheswaran@helix.mgh.harvard.edu; dhaber@mgh.harvard.edu						Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Clark AG, 2015, CURR OPIN CELL BIOL, V36, P13, DOI 10.1016/j.ceb.2015.06.004; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Rumman M, 2015, STEM CELLS, V33, P2903, DOI 10.1002/stem.2056; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	11	25	26	0	31	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					452	453		10.1038/nature16313	http://dx.doi.org/10.1038/nature16313			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26560026				2022-12-28	WOS:000365352500031
J	deBronkart, D				deBronkart, Dave			Patient commentary: Empowered patients aren't belittled by doctors' titles	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												dave@epatientdave.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2015	351								h6355	10.1136/bmj.h6355	http://dx.doi.org/10.1136/bmj.h6355			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX4TG	26608739				2022-12-28	WOS:000365692600023
J	Kaafarani, HMA				Kaafarani, Haytham M. A.			Tension Pneumoperitoneum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kaafarani, Haytham M. A.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Kaafarani, HMA (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	hkaafarani@mgh.harvard.edu							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2015	373	21					E24	E24		10.1056/NEJMicm1500045	http://dx.doi.org/10.1056/NEJMicm1500045			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW4JN	26581011				2022-12-28	WOS:000364957700001
J	Zhao, Z; Nelson, AR; Betsholtz, C; Zlokovic, BV				Zhao, Zhen; Nelson, Amy R.; Betsholtz, Christer; Zlokovic, Berislav V.			Establishment and Dysfunction of the Blood-Brain Barrier	CELL			English	Review							AMYLOID-BETA-PEPTIDE; THYROID-HORMONE TRANSPORTER; GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; VASCULAR DEVELOPMENT; CEREBROSPINAL-FLUID; IDENTIFIES VARIANTS; CNS ANGIOGENESIS; PERICYTE LOSS	Structural and functional brain connectivity, synaptic activity, and information processing require highly coordinated signal transduction between different cell types within the neurovascular unit and intact blood-brain barrier (BBB) functions. Here, we examine the mechanisms regulating the formation and maintenance of the BBB and functions of BBB-associated cell types. Furthermore, we discuss the growing evidence associating BBB breakdown with the pathogenesis of inherited monogenic neurological disorders and complex multifactorial diseases, including Alzheimer's disease.	[Zhao, Zhen; Nelson, Amy R.; Zlokovic, Berislav V.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA; [Zhao, Zhen; Nelson, Amy R.; Zlokovic, Berislav V.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Betsholtz, Christer] Rudbeck Lab, Dept Immunol Genet & Pathol, S-75185 Uppsala, Sweden	University of Southern California; University of Southern California	Zlokovic, BV (corresponding author), Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA.	zlokovic@usc.edu	zhao, zhen/A-2080-2012; Nelson, Amy R./HCH-3772-2022	zhao, zhen/0000-0001-8967-5570; Nelson, Amy R./0000-0003-2025-1408	NIA NIH HHS [R01 AG039452, RF1 AG039452, P50 AG005142, R01AG039452, R01AG023084, R01 AG023084] Funding Source: Medline; NINDS NIH HHS [R01NS090904, R01NS034467, R01 NS090904, R01 NS034467] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034467, R01NS090904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023084, R01AG039452, P50AG005142, RF1AG039452] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alakbarzade V, 2015, NAT GENET, V47, P814, DOI 10.1038/ng.3313; Alkan A, 2007, J CHILD NEUROL, V22, P655, DOI 10.1177/0883073807303219; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Andreone BJ, 2015, ANNU REV NEUROSCI, V38, P25, DOI 10.1146/annurev-neuro-071714-033835; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bading JR, 2002, J DRUG TARGET, V10, P359, DOI 10.1080/10611860290031831; Baeten KM, 2011, DEV NEUROBIOL, V71, P1018, DOI 10.1002/dneu.20954; Baloyannis SJ, 2012, J NEUROL SCI, V322, P117, DOI 10.1016/j.jns.2012.07.010; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Benarroch EE, 2014, NEUROLOGY, V82, P1374, DOI 10.1212/WNL.0000000000000328; Betsholtz C, 2015, NAT GENET, V47, P699, DOI 10.1038/ng.3348; Betsholtz C, 2014, NATURE, V509, P432, DOI 10.1038/nature13339; Blinder P, 2013, NAT NEUROSCI, V16, P889, DOI 10.1038/nn.3426; Bray N, 2015, NAT REV DRUG DISCOV, V14, P14, DOI 10.1038/nrd4522; Capri Y, 2013, HUM MUTAT, V34, P1018, DOI 10.1002/humu.22331; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Cirrito JR, 2005, J CLIN INVEST, V115, P3285, DOI 10.1172/JCI25247; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Deane R, 2012, J CLIN INVEST, V122, P1377, DOI 10.1172/JCI58642; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Drouin-Ouellet J, 2015, ANN NEUROL, V78, P160, DOI 10.1002/ana.24406; Dumitrescu AM, 2004, AM J HUM GENET, V74, P168, DOI 10.1086/380999; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Fischer A, 2013, TRENDS MOL MED, V19, P302, DOI 10.1016/j.molmed.2013.02.004; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; Guemez-Gamboa A, 2015, NAT GENET, V47, P809, DOI 10.1038/ng.3311; Hagan N, 2015, SEMIN CELL DEV BIOL, V38, P7, DOI 10.1016/j.semcdb.2014.12.006; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Halliday M. R., 2015, J CEREB BLOOD FLOW M; Halliday MR, 2013, JAMA NEUROL, V70, P1198, DOI 10.1001/jamaneurol.2013.3841; Hammer C, 2014, MOL PSYCHIATR, V19, P1143, DOI 10.1038/mp.2013.110; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Henshall TL, 2015, ARTERIOSCL THROM VAS, V35, P409, DOI 10.1161/ATVBAHA.114.304849; Hultman K, 2013, J CEREBR BLOOD F MET, V33, P1251, DOI 10.1038/jcbfm.2013.76; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Keller A, 2013, NAT GENET, V45, P1077, DOI 10.1038/ng.2723; Kersseboom S, 2013, MOL ENDOCRINOL, V27, P801, DOI 10.1210/me.2012-1356; Korczyn AD, 2015, NAT REV NEUROL, V11, P319, DOI 10.1038/nrneurol.2015.61; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Kuo DS, 2012, HUM MOL GENET, V21, pR97, DOI 10.1093/hmg/dds346; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; Legati A, 2015, NAT GENET, V47, P579, DOI 10.1038/ng.3289; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lin L, 2015, NAT REV DRUG DISCOV, V14, P543, DOI 10.1038/nrd4626; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Miller DS, 2015, ADV CANCER RES, V125, P43, DOI 10.1016/bs.acr.2014.10.002; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Montine TJ, 2014, NEUROLOGY, V83, P851, DOI 10.1212/WNL.0000000000000733; Nakagomi T, 2015, STEM CELLS, V33, P1962, DOI 10.1002/stem.1977; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; O'Driscoll MC, 2010, AM J HUM GENET, V87, P354, DOI 10.1016/j.ajhg.2010.07.012; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Parikh I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091242; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Raven EP, 2013, J ALZHEIMERS DIS, V37, P127, DOI 10.3233/JAD-130209; Sagare A, 2007, NAT MED, V13, P1029, DOI 10.1038/nm1635; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Sasaki A, 2015, NEUROGENETICS, V16, P265, DOI 10.1007/s10048-015-0451-3; Saunders NR, 2013, MOL ASPECTS MED, V34, P742, DOI 10.1016/j.mam.2012.11.006; Sengillo JD, 2013, BRAIN PATHOL, V23, P303, DOI 10.1111/bpa.12004; Snyder HM, 2015, ALZHEIMERS DEMENT, V11, P710, DOI 10.1016/j.jalz.2014.10.008; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sosa MAG, 2010, AM J PATHOL, V176, P353, DOI 10.2353/ajpath.2010.090482; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Sweeney MD, 2015, J CEREBR BLOOD F MET, V35, P1055, DOI 10.1038/jcbfm.2015.76; Tallquist MD, 2003, PLOS BIOL, V1, P288, DOI 10.1371/journal.pbio.0000052; Tam SJ, 2012, DEV CELL, V22, P403, DOI 10.1016/j.devcel.2011.11.018; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; Tietz S, 2015, J CELL BIOL, V209, P493, DOI 10.1083/jcb.201412147; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Wang C, 2012, NAT GENET, V44, P254, DOI 10.1038/ng.1077; Wang D, 2000, HUM MUTAT, V16, P224, DOI 10.1002/1098-1004(200009)16:3<224::AID-HUMU5>3.0.CO;2-P; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966; Winkler EA, 2013, ACTA NEUROPATHOL, V125, P111, DOI 10.1007/s00401-012-1039-8; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Yamamoto H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7429; Yao Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4413; Yates PA, 2014, NEUROLOGY, V82, P1266, DOI 10.1212/WNL.0000000000000285; Zhao Z, 2015, NAT NEUROSCI, V18, P978, DOI 10.1038/nn.4025; Zhao Z, 2014, NEURON, V82, P728, DOI 10.1016/j.neuron.2014.05.012; Zhou YL, 2014, DEV CELL, V31, P248, DOI 10.1016/j.devcel.2014.08.018; Zhou YL, 2014, J CLIN INVEST, V124, P3825, DOI 10.1172/JCI76431; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zlokovic BV, 2013, JAMA NEUROL, V70, P440, DOI 10.1001/jamaneurol.2013.2152; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Zlokovic BV, 2010, J NEUROCHEM, V115, P1077, DOI 10.1111/j.1471-4159.2010.07002.x; ZLOKOVIC BV, 1995, PHARM RES-DORDR, V12, P1395, DOI 10.1023/A:1016254514167; ZLOKOVIC BV, 1985, BRAIN RES, V336, P125, DOI 10.1016/0006-8993(85)90423-8; Zonneveld HI, 2014, NEUROLOGY, V82, P698, DOI 10.1212/WNL.0000000000000150	111	792	826	21	268	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1064	1078		10.1016/j.cell.2015.10.067	http://dx.doi.org/10.1016/j.cell.2015.10.067			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26590417	Bronze, Green Accepted			2022-12-28	WOS:000366044700008
J	Egan, JM				Egan, Josephine M.			Targeting Stem Cells in Chronic Myeloid Leukemia with a PPAR-gamma Agonist	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NIA, Diabet Sect, Lab Clin Invest, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Egan, JM (corresponding author), NIA, Diabet Sect, Lab Clin Invest, NIH, Baltimore, MD 21224 USA.							Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Prost S, 2008, J CLIN INVEST, V118, P1765, DOI 10.1172/JCI33037; Prost S, 2015, NATURE, V525, P380, DOI 10.1038/nature15248; Rousselot PRL, 2012, 54 ASH ANN M EXP ATL	5	8	8	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2015	373	20					1973	1975		10.1056/NEJMcibr1511276	http://dx.doi.org/10.1056/NEJMcibr1511276			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV7IL	26559576				2022-12-28	WOS:000364445500015
J	Kogleck, L				Kogleck, Larissa			STRENGTH IN NUMBERS	NATURE			English	Editorial Material																			0	0	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					S50	S51		10.1038/527S50a	http://dx.doi.org/10.1038/527S50a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VB5XJ	26560451	Bronze			2022-12-28	WOS:000415917700002
J	Chavala, SH; Williamson, JF; Postel, EA				Chavala, Sai H.; Williamson, Jennifer F.; Postel, Eric A.			Embolic central retinal artery occlusion after subcutaneous auricular steroid injection	LANCET			English	Editorial Material									[Chavala, Sai H.; Williamson, Jennifer F.] Univ N Carolina, Dept Ophthalmol, Chapel Hill, NC USA; [Postel, Eric A.] Duke Univ, Dept Ophthalmol, Durham, NC USA; [Chavala, Sai H.] Univ N Texas, Hlth Sci Ctr, North Texas Eye Res Inst, Ft Worth, TX 76107 USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of North Texas System; University of North Texas Health Science Center	Chavala, SH (corresponding author), Univ N Texas, Hlth Sci Ctr, North Texas Eye Res Inst, Ft Worth, TX 76107 USA.	sai.chavala@unthsc.edu			NATIONAL EYE INSTITUTE [K08EY021171, R01EY025667] Funding Source: NIH RePORTER; NEI NIH HHS [K08-EY021171, R01-EY025667] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))			0	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2016	387	10034					2235	2235		10.1016/S0140-6736(15)00980-0	http://dx.doi.org/10.1016/S0140-6736(15)00980-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN1IZ	26631356				2022-12-28	WOS:000376820800033
J	Bagley, N; Koller, C				Bagley, Nicholas; Koller, Christopher			Transparency and the Supreme Court-Can Employers Refuse to Disclose How Much They Pay for Health Care?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bagley, Nicholas] Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA; [Koller, Christopher] Milbank Mem Fund, New York, NY USA	University of Michigan System; University of Michigan	Bagley, N (corresponding author), Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA.							Anderson GF, 2003, HEALTH AFFAIR, V22, P89, DOI 10.1377/hlthaff.22.3.89; Kaiser Family Foundation, 2015, EMPL HLTH BEN SURV	2	1	1	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2015	373	27					1	3		10.1056/NEJMp1513895	http://dx.doi.org/10.1056/NEJMp1513895			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CZ8UH	26605801				2022-12-28	WOS:000367374100004
J	Gaublomme, JT; Yosef, N; Lee, Y; Gertner, RS; Yang, LV; Wu, C; Pandolfi, PP; Mak, T; Satija, R; Shalek, AK; Kuchroo, VK; Park, H; Regev, A				Gaublomme, Jellert T.; Yosef, Nir; Lee, Youjin; Gertner, Rona S.; Yang, Li V.; Wu, Chuan; Pandolfi, Pier Paolo; Mak, Tak; Satija, Rahul; Shalek, Alex K.; Kuchroo, Vijay K.; Park, Hongkun; Regev, Aviv			Single-Cell Genomics Unveils Critical Regulators of Th17 Cell Pathogenicity	CELL			English	Article							T(H)17 CELLS; MOLECULAR SIGNATURE; MULTIPLE-SCLEROSIS; FLOW-CYTOMETRY; SELF-RENEWAL; T-CELLS; RNA-SEQ; GENERATION; DIFFERENTIATION; IDENTIFICATION	Extensive cellular heterogeneity exists within specific immune-cell subtypes classified as a single lineage, but its molecular underpinnings are rarely characterized at a genomic scale. Here, we use single-cell RNA-seq to investigate the molecular mechanisms governing heterogeneity and pathogenicity of Th17 cells isolated from the central nervous system (CNS) and lymph nodes (LN) at the peak of autoimmune encephalomyelitis (EAE) or differentiated in vitro under either pathogenic or nonpathogenic polarization conditions. Computational analysis relates a spectrum of cellular states in vivo to in-vitro-differentiated Th17 cells and unveils genes governing pathogenicity and disease susceptibility. Using knockout mice, we validate four new genes: Gpr65, Plzp, Toso, and Cd5l (in a companion paper). Cellular heterogeneity thus informs Th17 function in autoimmunity and can identify targets for selective suppression of pathogenic Th17 cells while potentially sparing non-pathogenic tissueprotective ones.	[Gaublomme, Jellert T.; Yosef, Nir; Lee, Youjin; Satija, Rahul; Shalek, Alex K.; Kuchroo, Vijay K.; Park, Hongkun; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Gaublomme, Jellert T.; Gertner, Rona S.; Park, Hongkun] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Gaublomme, Jellert T.; Gertner, Rona S.; Park, Hongkun] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Yosef, Nir] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Yosef, Nir] Univ Calif Berkeley, Ctr Computat Biol, Berkeley, CA 94720 USA; [Lee, Youjin; Wu, Chuan; Kuchroo, Vijay K.] Harvard Univ, Sch Med, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Lee, Youjin; Wu, Chuan; Kuchroo, Vijay K.] Brigham & Womens Hosp, Harvard Inst Med, Boston, MA 02115 USA; [Yang, Li V.] E Carolina Univ, Brody Sch Med, Dept Internal Med, Dept Anat & Cell Biol, Greenville, NC 27834 USA; [Pandolfi, Pier Paolo] Harvard Univ, Canc Res Inst, Dept Med & Pathol,Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr,Med Sch, Boston, MA 02215 USA; [Mak, Tak] Princess Margaret Hosp, Ontario Canc Ctr, Toronto, ON M5G 2M9, Canada; [Satija, Rahul] New York Genome Ctr, New York, NY 10013 USA; [Satija, Rahul] NYU, Ctr Genom & Syst Biol, New York, NY 10012 USA; [Shalek, Alex K.] MIT, Inst Med Engn & Sci, Cambridge, MA 02142 USA; [Shalek, Alex K.] MIT, Dept Chem, Cambridge, MA 02142 USA; [Shalek, Alex K.] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA 02139 USA; [Shalek, Alex K.] Harvard Univ, Boston, MA 02139 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Regev, Aviv] MIT, Dept Biol, David H Koch Inst Integrat Canc Biol, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of North Carolina; East Carolina University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; New York University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Park, H (corresponding author), Broad Inst MIT & Harvard, 415 Main St, Cambridge, MA 02142 USA.	hongkun_park@harvard.edu; aregev@broadinstitute.org	t, lf/AAJ-4924-2020; Satija, Rahul/AAF-9564-2019; Park, Hongkun/R-9842-2019; Shalek, Alex/Y-2434-2019; Wu, Chuan/H-6379-2013	Park, Hongkun/0000-0001-9576-8829; Shalek, Alex/0000-0001-5670-8778; Yang, Li/0000-0002-8654-4927; Wu, Chuan/0000-0003-2288-353X; Pandolfi, Pier Paolo/0000-0002-5352-5295	Klarman Cell Observatory at the Broad Institute; NIH [P50 HG006193, NS030843, AI039671, NS076410, AI056299, 4R00AI110649]; Koch Institute Support (core) grant from the National Cancer Institute [P30-CA14051]; National MS Society, New York; Crohn's and Colitis Foundation of America; National Multiple Sclerosis Society [TA3059-A-2]; NIH NSRA grant [F32 HD075541]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD075541] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671, P01AI056299, R00AI110649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS030843, P01NS076410, R37NS030843, R01NS030843] Funding Source: NIH RePORTER	Klarman Cell Observatory at the Broad Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Koch Institute Support (core) grant from the National Cancer Institute; National MS Society, New York; Crohn's and Colitis Foundation of America; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH NSRA grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J.E. Coligan for providing Toso<SUP>-/-</SUP> mice; J. Shuga for scientific discussions; D. Kozoriz, T. Rogers, and M. Tam for assistance with cell sorting; T.J. Diefenbach for assistance with the Imagestream system; C. Wu for help with EAE experiments; O. Rozenblatt-Rosen, E. Shefler, J. Lee, and C. Guiducci for project management; the Broad Genomics Platform for all sequencing work; and L. Gaffney for help with artwork. Work was supported by the Klarman Cell Observatory at the Broad Institute (A.R., H.P., and V.K.K.), an NIH grant P50 HG006193 (A.R. and H.P.), and by the Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute (A.R.). V.K.K. was supported by NIH grants NS030843, AI039671, NS076410, AI056299, National MS Society, New York, and Crohn's and Colitis Foundation of America. C.W. was supported by a Career Transition Award from the National Multiple Sclerosis Society (TA3059-A-2) and NIH grant 4R00AI110649. R.S. was supported by NIH NSRA grant F32 HD075541. A.R. is an Investigator of the Howard Hughes Medical Institute. During the course of the research, V.K.K. had an ownership interest in Tempero Pharmaceuticals, a company that was working in the area of Treg-Th17 biology and developing treatments for autoimmune diseases in areas related to this research. V.K.K.'s ownership ended in October 2014. V.K.K.'s interests were reviewed and managed by the Brigham and Women's Hospital and Partners HealthCare in accordance with their conflict of interest policies. A.R. is a paid consultant for Driver Group and a member of the SAB of ThermoFisher Scientific and Syros Pharmaceuticals. A.R.'s interests were reviewed and managed by the Broad Institute according to its conflict of interest policies.	Antebi YE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001616; Aust G, 2005, EUR J ENDOCRINOL, V152, P635, DOI 10.1530/eje.1.01892; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Blaschitz C, 2010, J CLIN IMMUNOL, V30, P196, DOI 10.1007/s10875-010-9368-7; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; De Rosa SC, 2001, NAT MED, V7, P245, DOI 10.1038/84701; Dolfi DV, 2008, J IMMUNOL, V180, P2912, DOI 10.4049/jimmunol.180.5.2912; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Fischer MT, 2013, BRAIN, V136, P1799, DOI 10.1093/brain/awt110; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gilmore Thomas D, 2011, Genes Cancer, V2, P695, DOI 10.1177/1947601911421925; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Hernandez-Santos N, 2012, CELL HOST MICROBE, V11, P425, DOI 10.1016/j.chom.2012.04.008; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; Hitoshi Y, 1998, IMMUNITY, V8, P461, DOI 10.1016/S1074-7613(00)80551-8; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Holzer U, 2013, HUM IMMUNOL, V74, P693, DOI 10.1016/j.humimm.2013.02.002; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kryczek I, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002949; Lang KS, 2013, P NATL ACAD SCI USA, V110, P2593, DOI 10.1073/pnas.1222264110; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Mahad DJ, 2003, SEMIN IMMUNOL, V15, P23, DOI 10.1016/S1044-5323(02)00125-2; Miaw SC, 2000, IMMUNITY, V12, P323, DOI 10.1016/S1074-7613(00)80185-5; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; Nakae S, 2007, J LEUKOCYTE BIOL, V81, P1258, DOI 10.1189/jlb.1006610; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rocha PP, 2010, DEVELOPMENT, V137, P2723, DOI 10.1242/dev.053660; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Tsuzuki S, 2013, STEM CELLS, V31, P236, DOI 10.1002/stem.1277; Wang C, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.068; Wang HK, 2014, NAT IMMUNOL, V15, P667, DOI 10.1038/ni.2890; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981	53	350	368	7	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6								10.1016/j.cell.2015.11.009	http://dx.doi.org/10.1016/j.cell.2015.11.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26607794	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000366044800005
J	Devereaux, PJ; Sessler, DI				Devereaux, P. J.; Sessler, Daniel I.			Cardiac Complications in Patients Undergoing Major Noncardiac Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PERIOPERATIVE MYOCARDIAL-INFARCTION; CORONARY-ARTERY REVASCULARIZATION; ANESTHESIA-RELATED MORTALITY; ELECTIVE VASCULAR-SURGERY; ABDOMINAL AORTIC-ANEURYSM; PROSPECTIVE COHORT; RANDOMIZED-TRIALS; UNITED-STATES; BETA-BLOCKADE; OPEN REPAIR		[Devereaux, P. J.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Devereaux, P. J.] McMaster Univ, Hamilton, ON, Canada; [Devereaux, P. J.] McMaster Univ, Dept Clin Epidemiol, Hamilton, ON L8S 4L8, Canada; [Sessler, Daniel I.] McMaster Univ, Dept Biostat & Med, Hamilton, ON, Canada; [Sessler, Daniel I.] Cleveland Clin, Inst Anesthesiol, Dept Outcomes Res, Cleveland, OH USA	McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University; Cleveland Clinic Foundation	Devereaux, PJ (corresponding author), Hamilton Gen Hosp, Populat Hlth Res Inst, David Braley Cardiac Vasc & Stroke Res Inst, Perioperat Med & Surg Res Unit, Rm C1-116,237 Barton St E, Hamilton, ON L8L 2X2, Canada.	philipj@mcmaster.ca	Sessler, Daniel/D-3504-2011; Devereaux, PJ/AAF-2862-2019; Devereaux, PJ/AAY-1757-2021	Sessler, Daniel/0000-0001-9932-3077; Devereaux, PJ/0000-0003-2935-637X				Acedillo RR, 2013, ANN SURG, V258, P901, DOI 10.1097/SLA.0000000000000244; Angeli Fabio, 2010, Ther Adv Cardiovasc Dis, V4, P109, DOI 10.1177/1753944710361731; Bartels K, 2013, ANESTHESIOLOGY, V119, P1474, DOI 10.1097/ALN.0000000000000022; BAXEVANIS CN, 1994, CLIN IMMUNOL IMMUNOP, V71, P82, DOI 10.1006/clin.1994.1055; Beattie WS, 2008, ANESTH ANALG, V106, P1039, DOI 10.1213/ane.0b013e318163f6a9; Beattie WS, 2012, CAN J ANESTH, V59, P1013, DOI 10.1007/s12630-012-9782-9; Beattie WS, 2001, ANESTH ANALG, V93, P853, DOI 10.1097/00000539-200110000-00010; Beattie WS, 2006, ANESTH ANALG, V102, P8, DOI 10.1213/01.ane.0000189614.98906.43; Beloosesky Y, 2007, J GERONTOL A-BIOL, V62, P420, DOI 10.1093/gerona/62.4.420; Biccard B, 2015, ANESTH ANALG, V120, P543, DOI 10.1213/ANE.0000000000000598; Bickler SW, 2008, LANCET, V372, P90, DOI 10.1016/S0140-6736(08)60924-1; Botto F, 2014, ANESTHESIOLOGY, V120, P564, DOI 10.1097/ALN.0000000000000113; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; CHERNOW B, 1987, ARCH INTERN MED, V147, P1273, DOI 10.1001/archinte.147.7.1273; Chuang D, 2005, ANZ J SURG, V75, P813, DOI 10.1111/j.1445-2197.2005.03530.x; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; CRUICKSHANK AM, 1990, CLIN SCI, V79, P161, DOI 10.1042/cs0790161; Darvish-Kazem S, 2009, CAN J CARDIOL B, V25B, P158; Davis C, 2013, CAN J ANESTH, V60, P855, DOI 10.1007/s12630-013-9988-5; Desborough JP, 2000, BRIT J ANAESTH, V85, P109, DOI 10.1093/bja/85.1.109; DETSKY AS, 1986, J GEN INTERN MED, V1, P211, DOI 10.1007/BF02596184; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Devereaux PJ, 2014, NEW ENGL J MED, V370, P1504, DOI 10.1056/NEJMoa1401106; Devereaux PJ, 2014, NEW ENGL J MED, V370, P1494, DOI 10.1056/NEJMoa1401105; Devereaux PJ, 2012, JAMA-J AM MED ASSOC, V307, P2295, DOI 10.1001/jama.2012.5502; Devereaux PJ, 2011, ANN INTERN MED, V154, P523, DOI 10.7326/0003-4819-154-8-201104190-00003; Dimick JB, 2003, J AM COLL SURGEONS, V196, P671, DOI 10.1016/S1072-7515(03)00122-4; DRIPPS RD, 1961, JAMA-J AM MED ASSOC, V178, P261, DOI 10.1001/jama.1961.03040420001001; Etchells E, 2002, J VASC SURG, V36, P534, DOI 10.1067/mva.2002.126563; Fleisher LA, 2008, LANCET, V371, P1813, DOI 10.1016/S0140-6736(08)60662-5; Fleisher LA, 2014, CIRCULATION, V130, pE278, DOI 10.1161/CIR.0000000000000106; FLINN WR, 1984, J VASC SURG, V1, P888, DOI 10.1067/mva.1984.avs0010888; Ford MK, 2010, ANN INTERN MED, V152, P26, DOI 10.7326/0003-4819-152-1-201001050-00007; Foucrier A, 2014, ANESTH ANALG, V119, P1053, DOI 10.1213/ANE.0000000000000302; FRANK SM, 1993, ANESTHESIOLOGY, V78, P468, DOI 10.1097/00000542-199303000-00010; GILL NP, 1992, BRIT J ANAESTH, V68, P471, DOI 10.1093/bja/68.5.471; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; GOLDMAN MD, 1993, J AM GERIATR SOC, V41, P703, DOI 10.1111/j.1532-5415.1993.tb07457.x; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Greenstein AJ, 2007, J VASC SURG, V46, P1138, DOI 10.1016/j.jvs.2007.08.026; Grigoryan KV, 2014, J ORTHOP TRAUMA, V28, pE49, DOI 10.1097/BOT.0b013e3182a5a045; Gualandro DM, 2012, ATHEROSCLEROSIS, V222, P191, DOI 10.1016/j.atherosclerosis.2012.02.021; Gupta PK, 2011, CIRCULATION, V124, P381, DOI 10.1161/CIRCULATIONAHA.110.015701; Hawn MT, 2013, JAMA-J AM MED ASSOC, V310, P1462, DOI 10.1001/jama.2013.278787; Jorgensen ME, 2014, JAMA-J AM MED ASSOC, V312, P269, DOI 10.1001/jama.2014.8165; Kamel H, 2012, CIRCULATION, V126, P207, DOI 10.1161/CIRCULATIONAHA.112.094326; Kavsak PA, 2011, CLIN BIOCHEM, V44, P1021, DOI 10.1016/j.clinbiochem.2011.05.017; Kazaure HS, 2013, JAMA SURG, V148, P14, DOI 10.1001/jamasurg.2013.671; Kristensen SD, 2014, EUR HEART J, V35, P2383, DOI 10.1093/eurheartj/ehu282; Kumar R, 2001, J GEN INTERN MED, V16, P507, DOI 10.1046/j.1525-1497.2001.016008507.x; LANDESBERG G, 1993, LANCET, V341, P715, DOI 10.1016/0140-6736(93)90486-Z; Le Manach Y, 2005, ANESTHESIOLOGY, V102, P885, DOI 10.1097/00000542-200505000-00004; Lederle FA, 2009, JAMA-J AM MED ASSOC, V302, P1535, DOI 10.1001/jama.2009.1426; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Leuvan Chris H Van, 2008, Crit Care Resusc, V10, P111; Levy M, 2011, ANESTHESIOLOGY, V114, P796, DOI 10.1097/ALN.0b013e31820ad503; Li G, 2009, ANESTHESIOLOGY, V110, P759, DOI 10.1097/ALN.0b013e31819b5bdc; Lienhart A, 2006, ANESTHESIOLOGY, V105, P1087, DOI 10.1097/00000542-200612000-00008; Mackey WC, 2006, J VASC SURG, V43, P533, DOI 10.1016/j.jvs.2005.11.013; MANGANO DT, 1990, NEW ENGL J MED, V323, P1781, DOI 10.1056/NEJM199012273232601; MANGANO DT, 1991, J AM COLL CARDIOL, V17, P843, DOI 10.1016/0735-1097(91)90863-5; MANGANO DT, 1992, JAMA-J AM MED ASSOC, V268, P233, DOI 10.1001/jama.268.2.233; MANGANO DT, 1992, ANESTHESIOLOGY, V76, P342, DOI 10.1097/00000542-199203000-00004; MCDANIEL MD, 1984, J VASC SURG, V1, P261, DOI 10.1067/mva.1984.avs0010261; McFalls EO, 2008, EUR HEART J, V29, P394, DOI 10.1093/eurheartj/ehm620; McFalls EO, 2004, NEW ENGL J MED, V351, P2795, DOI 10.1056/NEJMoa041905; McFalls EO, 1999, CONTROL CLIN TRIALS, V20, P297, DOI 10.1016/S0197-2456(99)00004-5; McGain F, 2008, MED J AUSTRALIA, V189, P380, DOI 10.5694/j.1326-5377.2008.tb02083.x; MOLLER JT, 1993, ANESTHESIOLOGY, V78, P445, DOI 10.1097/00000542-199303000-00007; Rodseth RN, 2014, J AM COLL CARDIOL, V63, P170, DOI 10.1016/j.jacc.2013.08.1630; ROSENFELD BA, 1993, ANESTHESIOLOGY, V79, P435, DOI 10.1097/00000542-199309000-00005; Sabate S, 2011, BRIT J ANAESTH, V107, P879, DOI 10.1093/bja/aer268; Semel ME, 2012, SURGERY, V151, P171, DOI 10.1016/j.surg.2011.07.021; Sheth T, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1907; Siddiqui NF, 2012, CAN MED ASSOC J, V184, P1237, DOI 10.1503/cmaj.110895; Sprung J, 2003, ANESTHESIOLOGY, V99, P259, DOI 10.1097/00000542-200308000-00006; Sun Z, 2015, ANESTH ANALG, V121, P709, DOI 10.1213/ANE.0000000000000836; Torborg A, 2014, SAMJ S AFR MED J, V104, P619, DOI [10.7196/SAMJ.7654, 10.7196/samj.7654]; Udeh BL, 2014, ANESTHESIOLOGY, V121, P36, DOI 10.1097/ALN.0000000000000233; UDELSMAN R, 1987, J CLIN ENDOCR METAB, V64, P986, DOI 10.1210/jcem-64-5-986; van Waes JAR, 2013, CIRCULATION, V127, P2264, DOI 10.1161/CIRCULATIONAHA.113.002128; VISION Pilot Study Investigators, 2011, Open Med, V5, pe193; Weber M, 2013, EUR HEART J, V34, P853, DOI 10.1093/eurheartj/ehs445; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Wijeysundera DN, 2014, CIRCULATION, V130, P2246, DOI 10.1161/CIR.0000000000000104; Wijeysundera DN, 2012, CIRCULATION, V126, P1355, DOI 10.1161/CIRCULATIONAHA.112.102715; Wijeysundera DN, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5526	87	201	220	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2015	373	23					2258	2269		10.1056/NEJMra1502824	http://dx.doi.org/10.1056/NEJMra1502824			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5LM	26630144				2022-12-28	WOS:000365743100009
J	Appleby, J				Appleby, John			UK's health and social care spending plans: more of the same?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Appleby, John] Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	jappleby@kingsfund.org.uk						Calkin S, 2015, LOCAL GOVT CHRO 1124; Department of Health, ANN REP ACC 2014 15; Department of Health, ANN REP ACC 2012 13; Department of Health, RES ACC 2009 10; Department of Health, RES ACC 2010 11; Department of Health, ANN REP ACC 2011 12; HM Treasury, JUN 2010 BUDG; HM Treasury, CM9162; Institute for Fiscal Studies, 2015, HLTH SPEND; Monitor, NHS FDN TRUSTS CONS; Monitor NHS Trust Development Authority, 2015, NHS PROV Q PERF REP; Monitor NHS Trust Development Authority, 2015, NHS PROV Q PER REP Q; NHS Trust Development Authority, 2014, SERV FIN PERF REP PE; NHS Trust Development Authority, 2015, PAP D NHS TRUST SERV; NHS Trust Development Authority, SERV FIN PERF REP PE; NHS Trust Development Authority, SERV FIN PERF OUTT R; Office for Budget Responsibility, 2015, EC FISC OUTL	17	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2015	351								h6458	10.1136/bmj.h6458	http://dx.doi.org/10.1136/bmj.h6458			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX4TP	26613903				2022-12-28	WOS:000365693500010
J	Bisson, JI; Cosgrove, S; Lewis, C; Roberts, NP				Bisson, Jonathan I.; Cosgrove, Sarah; Lewis, Catrin; Roberts, Neil P.			Post-traumatic stress disorder	BMJ-BRITISH MEDICAL JOURNAL			English	Review							COGNITIVE-BEHAVIORAL THERAPY; 3,4-METHYLENEDIOXYMETHAMPHETAMINE-ASSISTED PSYCHOTHERAPY; TRAUMATIC EVENTS; PTSD; SYMPTOMS; TRIAL; COMORBIDITY; NIGHTMARES; PRAZOSIN		[Bisson, Jonathan I.; Cosgrove, Sarah; Lewis, Catrin; Roberts, Neil P.] Cardiff Univ, Sch Med, Div Psychol Med & Clin Neurosci, Cardiff CF10 3AX, S Glam, Wales	Cardiff University	Bisson, JI (corresponding author), Cardiff Univ, Sch Med, Div Psychol Med & Clin Neurosci, Cardiff CF10 3AX, S Glam, Wales.	BissonJI@cardiff.ac.uk						Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P5, DOI 10.1111/j.1600-0047.2004.00325.x; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2004, PRACT GUID TREATM PA; Australian Centre for Posttraumatic Mental Health, 2007, AUSTR GUID TREATM AD; Barrera TL, 2013, CLIN PSYCHOL REV, V33, P24, DOI 10.1016/j.cpr.2012.09.005; Bastos MH, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007194.pub2; Bisson JI, 2013, EPIDEMIOL PSYCH SCI, V22, P205, DOI 10.1017/S2045796013000164; Bisson JI, 2007, BMJ-BRIT MED J, V334, P789, DOI 10.1136/bmj.39162.538553.80; Bisson JI, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub4; Bisson JI, 2010, BRIT J PSYCHIAT, V196, P69, DOI 10.1192/bjp.bp.109.066266; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Brewin CR, 2010, PSYCHOL MED, V40, P2049, DOI 10.1017/S0033291710000206; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Cloitre M, 2011, J TRAUMA STRESS, V24, P615, DOI 10.1002/jts.20697; Ferry F, 2010, EC IMPACT POSTTRAUMA; Ford JD., 2009, TREATING COMPLEX TRA; Gartlehner G, 2013, AHRQ PUBLICATION; Gupta MA, 2013, INT REV PSYCHIATR, V25, P86, DOI 10.3109/09540261.2012.736367; Health Technology Assessment database, 2011, COMP EFF PSYCH TREAT; Hetrick SE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007316.pub2; Hoskins M, 2015, BRIT J PSYCHIAT, V206, P93, DOI 10.1192/bjp.bp.114.148551; Inter-Agency Standing Committee (IASC), 2007, AM PSYCHOL ASS, DOI [DOI 10.1037/E518422011-002, 10.1037/e518422011-002]; Ivarsson D., 2014, INTERNET INTERV, V1, P33, DOI [10.1016/j.invent.2014.03.002, DOI 10.1016/J.INVENT.2014.03.002]; James EL, 2015, PSYCHOL SCI, V26, P1201, DOI 10.1177/0956797615583071; Jonas DE, 2013, COMP EFFECTIVENESS R, V92; Kar N, 2011, NEUROPSYCH DIS TREAT, V7, P167, DOI 10.2147/NDT.S10389; Karstoft KI, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0399-8; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kliem S, 2013, BEHAV RES THER, V51, P753, DOI 10.1016/j.brat.2013.08.005; Krystal JH, 2011, JAMA-J AM MED ASSOC, V306, P493, DOI 10.1001/jama.2011.1080; Leucht S, 2012, BRIT J PSYCHIAT, V200, P97, DOI 10.1192/bjp.bp.111.096594; Litz BT, 2007, AM J PSYCHIAT, V164, P1676, DOI 10.1176/appi.ajp.2007.06122057; Maercker A, 2013, LANCET, V381, P1683, DOI 10.1016/S0140-6736(12)62191-6; McManus S, 2008, ADULT PSYCHIAT MORBI; Mithoefer MC, 2013, J PSYCHOPHARMACOL, V27, P28, DOI 10.1177/0269881112456611; Mithoefer MC, 2011, J PSYCHOPHARMACOL, V25, P439, DOI 10.1177/0269881110378371; Muldoon OT, 2012, POLIT PSYCHOL, V33, P259, DOI 10.1111/j.1467-9221.2012.00874.x; National Collaborating Centre for Mental Health, 2005, POSTTR STRESS DIS PT; Raskind MA, 2007, BIOL PSYCHIAT, V61, P928, DOI 10.1016/j.biopsych.2006.06.032; Raskind MA, 2013, AM J PSYCHIAT, V170, P1003, DOI 10.1176/appi.ajp.2013.12081133; Roberts NP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006869.pub2; Roberts NP, 2015, CLIN PSYCHOL REV, V38, P25, DOI 10.1016/j.cpr.2015.02.007; Roberts NP, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007944.pub2; Rose S, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000560; Sareen J, 2007, PSYCHOSOM MED, V69, P242, DOI 10.1097/PSY.0b013e31803146d8; Schnun PP, 2007, HDB PTSD SCI PRACTIC; Sijbrandij M, 2015, LANCET PSYCHIAT, V2, P413, DOI 10.1016/S2215-0366(14)00121-7; Spence J, 2011, DEPRESS ANXIETY, V28, P541, DOI 10.1002/da.20835; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Stein MB, 2002, AM J PSYCHIAT, V159, P1777, DOI 10.1176/appi.ajp.159.10.1777; Tanielian TL, 2009, INVISIBLE WOUNDS WAR; van Emmerik AAP, 2013, PSYCHOTHER PSYCHOSOM, V82, P82, DOI 10.1159/000343131; White J, 2015, Epidemiol Psychiatr Sci, V24, P249, DOI 10.1017/S2045796014000110; WHO (World Health Organization), 2013, WHO GUID COND SPEC R; Williams R, 2014, PRINCIPLES RESPONDIN; World Health Organization, 1992, ICD 10 CLASS MENT BE, DOI DOI 10.1002/1520-6505(2000)9:5%3C201::AID-EVAN2%3E3.3.CO;2-P	56	128	129	1	53	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2015	351								h6161	10.1136/bmj.h6161	http://dx.doi.org/10.1136/bmj.h6161			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX4TL	26611143	Green Published			2022-12-28	WOS:000365693100002
J	Lichten, M				Lichten, Michael			Putting the breaks on meiosis	SCIENCE			English	Editorial Material							MEIOTIC RECOMBINATION; INITIATION		NCI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lichten, M (corresponding author), NCI, Bethesda, MD 20892 USA.	mlichten@helix.nih.gov	Lichten, Michael/C-5795-2013	Lichten, Michael/0000-0001-9707-2956	NATIONAL CANCER INSTITUTE [ZIABC005268] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Auton A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003984; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; Choi KH, 2013, NAT GENET, V45, P1327, DOI 10.1038/ng.2766; de Massy B, 2013, ANNU REV GENET, V47, P563, DOI 10.1146/annurev-genet-110711-155423; Lam I, 2015, SCIENCE, V350, P932, DOI 10.1126/science.aad0814; Lesecque Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004790; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; Singhal S, 2015, SCIENCE, V350, P928, DOI 10.1126/science.aad0843; Webster MT, 2012, TRENDS GENET, V28, P101, DOI 10.1016/j.tig.2011.11.002	10	9	9	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					913	913		10.1126/science.aad5404	http://dx.doi.org/10.1126/science.aad5404			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW4IP	26586748				2022-12-28	WOS:000364955200023
J	Sessolo, M; Bolink, HJ				Sessolo, Michele; Bolink, Henk J.			Perovskite solar cells join the major league	SCIENCE			English	Editorial Material							HYSTERESIS		[Sessolo, Michele; Bolink, Henk J.] Univ Valencia, Inst Ciencia Mol, Paterna 46980, Spain	University of Valencia	Bolink, HJ (corresponding author), Univ Valencia, Inst Ciencia Mol, Paterna 46980, Spain.	henk.bolink@uv.es	Sessolo, Michele/P-8911-2014; Bolink, Henk/L-7618-2014	Sessolo, Michele/0000-0002-9189-3005; Bolink, Henk/0000-0001-9784-6253				Chen W, 2015, SCIENCE, V350, P944, DOI 10.1126/science.aad1015; Ellmer K, 2012, NAT PHOTONICS, V6, P808, DOI [10.1038/NPHOTON.2012.282, 10.1038/nphoton.2012.282]; Green MA, 2015, PROG PHOTOVOLTAICS, V23, P805, DOI 10.1002/pip.2637; Heo JH, 2015, ENERG ENVIRON SCI, V8, P1602, DOI 10.1039/c5ee00120j; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Malinkiewicz O, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201400345; Razza S, 2015, J POWER SOURCES, V277, P286, DOI 10.1016/j.jpowsour.2014.12.008; Seo J, 2014, ENERG ENVIRON SCI, V7, P2642, DOI 10.1039/c4ee01216j; Snaith HJ, 2014, J PHYS CHEM LETT, V5, P1511, DOI 10.1021/jz500113x; Vak D, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201401539; Yang MJ, 2015, ADV MATER, V27, P6363, DOI 10.1002/adma.201502586; Yang WS, 2015, SCIENCE, V348, P1234, DOI 10.1126/science.aaa9272; You J., 2015, NAT NANO, DOI [10.1038/nnao.2015.230, DOI 10.1038/NNAO.2015.230]	13	49	50	7	292	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					917	917		10.1126/science.aad5891	http://dx.doi.org/10.1126/science.aad5891			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW4IP	26586751				2022-12-28	WOS:000364955200026
J	Underwood, E				Underwood, Emily			NEUROSCIENCE A faster, brighter picture of brain cells in action	SCIENCE			English	News Item																			0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					895	895		10.1126/science.350.6263.895	http://dx.doi.org/10.1126/science.350.6263.895			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW4IP	26586738				2022-12-28	WOS:000364955200011
J	Edwards, N				Edwards, Nigel			THE BEST POLICY Commissioning's identity crisis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Edwards, Nigel] Nuffield Trust, London, England		Edwards, N (corresponding author), Nuffield Trust, London, England.	nigel.edwards@nuffieldtrust.org.uk						Carter P, 2015, REV OPERATIONAL PROD; Jupp B, 2015, VIEWPOINT RECONSIDER	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2015	351								h6008	10.1136/bmj.h6008	http://dx.doi.org/10.1136/bmj.h6008			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XX	26581217				2022-12-28	WOS:000365352600004
J	Hirsch, C				Hirsch, Calvin			A balance retraining exercise program reduced injurious falls in at-risk older community-dwelling women	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Hirsch, Calvin] Univ Calif Davis, Davis, CA 95616 USA	University of California System; University of California Davis	Hirsch, C (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.							Butt DA, 2013, OSTEOPOROSIS INT, V24, P2649, DOI 10.1007/s00198-013-2369-7; Centers for Disease Control and Prevention, 2015, STEADL MATERIALS FOR; Gillespie L. D., 2012, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD007146; Greenwood-Hickman MA, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.140574; Orces CH, 2014, INJURY PREV, V20, P421, DOI 10.1136/injuryprev-2014-041268	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					JC2	JC2		10.7326/ACPJC-2015-163-10-002	http://dx.doi.org/10.7326/ACPJC-2015-163-10-002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26571256				2022-12-28	WOS:000365746400003
J	Stocker, TF				Stocker, Thomas F.			The silent services of the world ocean	SCIENCE			English	Editorial Material								The most recent comprehensive assessment carried out by the Intergovernmental Panel on Climate Change has concluded that "Human influence on the climate system is clear," a headline statement that was approved by all governments in consensus. This influence will have long-lasting consequences for ecosystems, and the resulting impacts will continue to be felt millennia from now. Although the terrestrial impacts of climate change are readily apparent now and have received widespread public attention, the effects of climate change on the oceans have been relatively invisible. However, the world ocean provides a number of crucial services that are of global significance, all of which come with an increasing price caused by human activities. This needs to be taken into account when considering adaptation to and mitigation of anthropogenic climate change.	[Stocker, Thomas F.] Univ Bern, Inst Phys, Climate & Environm Phys, Bern, Switzerland; [Stocker, Thomas F.] Univ Bern, Oeschger Ctr Climate Change Res, Bern, Switzerland	University of Bern; University of Bern	Stocker, TF (corresponding author), Univ Bern, Inst Phys, Climate & Environm Phys, Bern, Switzerland.	stocker@climate.unibe.ch						Cai WJ, 2015, NAT CLIM CHANGE, V5, P849, DOI [10.1038/nclimate2743, 10.1038/NCLIMATE2743]; Cheung WWL, 2013, NATURE, V497, P365, DOI 10.1038/nature12156; Christensen JH, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1217; Church J. A, 2013, CLIMATE CHANGE 2013, DOI DOI 10.1017/CBO9781107415324; Gattuso JP, 2015, SCIENCE, V349, DOI 10.1126/science.aac4722; Hanna E, 2013, NATURE, V498, P51, DOI 10.1038/nature12238; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Joughin I, 2014, SCIENCE, V344, P735, DOI 10.1126/science.1249055; Kossin JP, 2014, NATURE, V509, P349, DOI 10.1038/nature13278; Le Quere C, 2015, EARTH SYST SCI DATA, V7, P47, DOI 10.5194/essd-7-47-2015; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Ng B, 2015, SCI REP-UK, V5, DOI 10.1038/srep11697; Plattner GK, 2008, J CLIMATE, V21, P2721, DOI 10.1175/2007JCLI1905.1; Portner HO, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P411; Rhein M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P255; Roemmich D, 2015, NAT CLIM CHANGE, V5, P240, DOI [10.1038/NCLIMATE2513, 10.1038/nclimate2513]; Schmidtko S, 2014, SCIENCE, V346, P1227, DOI 10.1126/science.1256117; Slangen ABA, 2014, CLIMATIC CHANGE, V124, P317, DOI 10.1007/s10584-014-1080-9; Srokosz MA, 2015, SCIENCE, V348, DOI 10.1126/science.1255575; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Steinacher M, 2013, NATURE, V499, P197, DOI 10.1038/nature12269; Stocker T. F., 2013, OCEAN CIRCULATION CL, P3, DOI DOI 10.1016/B978-0-12-391851-2.00001-5; Stocker TF, 1997, NATURE, V388, P862, DOI 10.1038/42224; Stocker TF, 2013, SCIENCE, V339, P280, DOI 10.1126/science.1232468; Watson RA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8365; Zemp M, 2015, J GLACIOL, V61, P745, DOI 10.3189/2015JoG15J017	26	25	25	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					764	765		10.1126/science.aac8720	http://dx.doi.org/10.1126/science.aac8720			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW3MS	26564844				2022-12-28	WOS:000364897000031
J	Wells, T				Wells, Thomas			SPOT DIAGNOSIS Nail changes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wells, Thomas] Western Gen Hosp, Dept Oncol, Weston Super Mare BS23 4TQ, Somerset, England		Wells, T (corresponding author), Western Gen Hosp, Dept Oncol, Weston Super Mare BS23 4TQ, Somerset, England.	thomas.wells@nhs.net							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 13	2015	351								h6072	10.1136/bmj.h6072	http://dx.doi.org/10.1136/bmj.h6072			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW4HA	26567121				2022-12-28	WOS:000364950900008
J	Zhang, T				Zhang, Tian			More efficient together	SCIENCE			English	Editorial Material							CARBON-DIOXIDE; CONVERSION; CO2; CHEMICALS; FUELS		Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2970 Horsholm, Denmark	Technical University of Denmark	Zhang, T (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2970 Horsholm, Denmark.	zhang@biosustain.dtu.dk	Zhang, Tian/N-4696-2015	Zhang, Tian/0000-0003-3840-4839	Novo Nordisk Fonden [NNF13OC0004665] Funding Source: researchfish; NNF Center for Biosustainability [Bioelectrochem. Systems] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability		Blankenship RE, 2011, SCIENCE, V332, P805, DOI 10.1126/science.1200165; Jhong HR, 2013, CURR OPIN CHEM ENG, V2, P191, DOI 10.1016/j.coche.2013.03.005; Jourdin L, 2014, J MATER CHEM A, V2, P13093, DOI 10.1039/c4ta03101f; Li H, 2012, SCIENCE, V335, P1596, DOI 10.1126/science.1217643; Liu C, 2015, NANO LETT, V15, P3634, DOI 10.1021/acs.nanolett.5b01254; Liu HM, 2015, ANGEW CHEM INT EDIT, V54, P11545, DOI 10.1002/anie.201504933; Lovley DR, 2013, CURR OPIN BIOTECH, V24, P385, DOI 10.1016/j.copbio.2013.02.012; Meng XG, 2014, ANGEW CHEM INT EDIT, V53, P11478, DOI 10.1002/anie.201404953; Nevin KP, 2010, MBIO, V1, DOI 10.1128/mBio.00103-10; Nichols EM, 2015, P NATL ACAD SCI USA, V112, P11461, DOI 10.1073/pnas.1508075112; O'Brien PG, 2014, ADV SCI, V1, DOI 10.1002/advs.201400001; Parlevliet David, 2014, Aquat Biosyst, V10, P4, DOI 10.1186/2046-9063-10-4; Torella JP, 2015, P NATL ACAD SCI USA, V112, P2337, DOI 10.1073/pnas.1424872112; Tremblay PL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00201	14	41	43	6	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					738	739		10.1126/science.aad6452	http://dx.doi.org/10.1126/science.aad6452			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW3MS	26564832				2022-12-28	WOS:000364897000018
J	Lafkas, D; Shelton, A; Chiu, C; Boenig, GD; Chen, YM; Stawicki, SS; Siltanen, C; Reichelt, M; Zhou, MJ; Wu, XM; Eastham-Anderson, J; Moore, H; Roose-Girma, M; Chinn, Y; Hang, JQ; Warming, S; Egen, J; Lee, WP; Austin, C; Wu, Y; Payandeh, J; Lowe, JB; Siebel, CW				Lafkas, Daniel; Shelton, Amy; Chiu, Cecilia; Boenig, Gladys de Leon; Chen, Yongmei; Stawicki, Scott S.; Siltanen, Christian; Reichelt, Mike; Zhou, Meijuan; Wu, Xiumin; Eastham-Anderson, Jeffrey; Moore, Heather; Roose-Girma, Meron; Chinn, Yvonne; Hang, Julie Q.; Warming, Soren; Egen, Jackson; Lee, Wyne P.; Austin, Cary; Wu, Yan; Payandeh, Jian; Lowe, John B.; Siebel, Christian W.			Therapeutic antibodies reveal Notch control of transdifferentiation in the adult lung	NATURE			English	Article							STEM-CELLS; CLARA CELLS; MOUSE MODEL; AIRWAY; REPAIR; REGENERATION; MAINTENANCE; MECHANISMS; RECEPTORS; SYSTEM	Prevailing dogma holds that cell-cell communication through Notch ligands and receptors determines binary cell fate decisions during progenitor cell divisions, with differentiated lineages remaining fixed(1). Mucociliary clearance(2,3) in mammalian respiratory airways depends on secretory cells (club and goblet) and ciliated cells to produce and transport mucus. During development or repair, the closely related Jagged ligands (JAG1 and JAG2) induce Notch signalling to determine the fate of these lineages as they descend from a common proliferating progenitor(4-8). In contrast to such situations in which cell fate decisions are made in rapidly dividing populations(9,10), cells of the homeostatic adult airway epithelium are long-lived(11-13), and little is known about the role of active Notch signalling under such conditions. To disrupt Jagged signalling acutely in adult mammals, here we generate antibody antagonists that selectively target each Jagged paralogue, and determine a crystal structure that explains selectivity. We show that acute Jagged blockade induces a rapid and near-complete loss of club cells, with a concomitant gain in ciliated cells, under homeostatic conditions without increased cell death or division. Fate analyses demonstrate a direct conversion of club cells to ciliated cells without proliferation, meeting a conservative definition of direct transdifferentiation(14). Jagged inhibition also reversed goblet cell metaplasia in a preclinical asthma model, providing a therapeutic foundation(15). Our discovery that Jagged antagonism relieves a blockade of cell-to-cell conversion unveils unexpected plasticity, and establishes a model for Notch regulation of transdifferentiation.	[Lafkas, Daniel; Shelton, Amy; Siltanen, Christian; Siebel, Christian W.] Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA; [Chiu, Cecilia; Chen, Yongmei; Stawicki, Scott S.; Wu, Yan] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Boenig, Gladys de Leon; Payandeh, Jian] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Reichelt, Mike; Eastham-Anderson, Jeffrey; Austin, Cary; Lowe, John B.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Zhou, Meijuan; Wu, Xiumin; Lee, Wyne P.] Genentech Inc, Dept Translat Immunol, San Francisco, CA 94080 USA; [Moore, Heather; Egen, Jackson] Genentech Inc, Dept Discovery Immunol, San Francisco, CA 94080 USA; [Roose-Girma, Meron; Warming, Soren] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Chinn, Yvonne; Hang, Julie Q.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Siebel, CW (corresponding author), Genentech Inc, Dept Discovery Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	csiebel@gene.com	Warming, Soren/ABD-5729-2021; Lafkas, Daniel/AAI-8718-2021	Lafkas, Daniel/0000-0001-7395-476X; Warming, Soren/0000-0002-5721-0741; Egen, Jackson/0000-0003-2053-0837				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPH SYST; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanc E., 2011, BUSTER VERSION 2 11; Chalouni C., 2014, JOVE-J VIS EXP, V89, P51332; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chilvers M A, 2000, Paediatr Respir Rev, V1, P27, DOI 10.1053/prrv.2000.0009; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Guha A, 2012, P NATL ACAD SCI USA, V109, P12592, DOI 10.1073/pnas.1204710109; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Huntzicker EG, 2015, HEPATOLOGY, V61, P942, DOI 10.1002/hep.27566; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Koch U, 2013, DEVELOPMENT, V140, P689, DOI 10.1242/dev.080614; Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lee CV, 2004, J IMMUNOL METHODS, V284, P119, DOI 10.1016/j.jim.2003.11.001; Liang WC, 2007, J MOL BIOL, V366, P815, DOI 10.1016/j.jmb.2006.11.021; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Martin C, 2014, DRUGS, V74, P1073, DOI 10.1007/s40265-014-0235-3; Misaghi S, 2013, P NATL ACAD SCI USA, V110, P15770, DOI 10.1073/pnas.1221661110; Mori M, 2015, DEVELOPMENT, V142, P258, DOI 10.1242/dev.116855; Morimoto M, 2012, DEVELOPMENT, V139, P4365, DOI 10.1242/dev.083840; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Pardo-Saganta A, 2015, NATURE, V523, P597, DOI 10.1038/nature14553; Pardo-Saganta A, 2015, CELL STEM CELL, V16, P184, DOI 10.1016/j.stem.2015.01.002; Pardo-Saganta A, 2013, AM J RESP CELL MOL, V48, P364, DOI 10.1165/rcmb.2012-0146OC; Rawlins E. L., 2008, AM J PHYSIOL-LUNG C, V295, pL231; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Roy MG, 2014, NATURE, V505, P412, DOI 10.1038/nature12807; Shin YS, 2009, ALLERGY ASTHMA IMMUN, V1, P10, DOI 10.4168/aair.2009.1.1.10; Veta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070221; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Watson JK, 2015, CELL REP, V12, P90, DOI 10.1016/j.celrep.2015.06.011; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Xing YM, 2012, STEM CELLS, V30, P946, DOI 10.1002/stem.1059; You Y., 2012, METHOD MOL BIOL, V945, P123, DOI DOI 10.1007/978-1-62703-125-7_; Zhang SB, 2013, DEV DYNAM, V242, P678, DOI 10.1002/dvdy.23965; Zheng DH, 2014, AM J RESP CELL MOL, V50, P595, DOI 10.1165/rcmb.2013-0327OC	44	134	136	5	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					127	+		10.1038/nature15715	http://dx.doi.org/10.1038/nature15715			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26580007				2022-12-28	WOS:000365606000062
J	Talcott, JA				Talcott, James A.			Prostate Cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; RADICAL PROSTATECTOMY; ANDROGEN-DEPRIVATION; FOLLOW-UP; VITAMIN-E; RADIOTHERAPY; RISK; PREVENTION; MORTALITY; THERAPY						Talcott, James/CAG-8759-2022					Aizer AA, 2014, J ONCOL PRACT, V10, P107, DOI 10.1200/JOP.2013.000902; Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Bill-Axelson A, 2008, J NATL CANCER I, V100, P1144, DOI 10.1093/jnci/djn255; Bill-Axelson A, 2014, NEW ENGL J MED, V370, P932, DOI 10.1056/NEJMoa1311593; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502; Bolla M, 2012, LANCET, V380, P2018, DOI 10.1016/S0140-6736(12)61253-7; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Crook JM, 2012, NEW ENGL J MED, V367, P895, DOI 10.1056/NEJMoa1201546; D'Amico AV, 2002, INT J RADIAT ONCOL, V54, P436, DOI 10.1016/S0360-3016(02)02940-1; Fowler FJ, 2000, JAMA-J AM MED ASSOC, V283, P3217, DOI 10.1001/jama.283.24.3217; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Holmberg Lars, 2012, Journal of the National Cancer Institute Monographs, P230, DOI 10.1093/jncimonographs/lgs025; Horwitz EM, 2008, J CLIN ONCOL, V26, P2497, DOI 10.1200/JCO.2007.14.9021; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Hussain M, 2013, NEW ENGL J MED, V368, P1314, DOI 10.1056/NEJMoa1212299; Jones CU, 2011, NEW ENGL J MED, V365, P107, DOI 10.1056/NEJMoa1012348; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Klotz L, 2015, J CLIN ONCOL, V33, P272, DOI 10.1200/JCO.2014.55.1192; Lane JA, 2014, LANCET ONCOL, V15, P1109, DOI 10.1016/S1470-2045(14)70361-4; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Magnan S, 2015, JAMA ONCOL, V1, P1261, DOI 10.1001/jamaoncol.2015.2895; Messing EM, 1999, NEW ENGL J MED, V341, P1781, DOI 10.1056/NEJM199912093412401; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Resnick MJ, 2013, NEW ENGL J MED, V368, P436, DOI 10.1056/NEJMoa1209978; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smith MR, 2009, NEW ENGL J MED, V361, P745, DOI 10.1056/NEJMoa0809003; Sweeney CJ, 2015, NEW ENGL J MED, V373, P737, DOI 10.1056/NEJMoa1503747; Talcott JA, 2010, JAMA-J AM MED ASSOC, V303, P1046, DOI 10.1001/jama.2010.287; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Thompson IM, 2013, NEW ENGL J MED, V369, P603, DOI 10.1056/NEJMoa1215932; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Tosoian JJ, 2015, J CLIN ONCOL; WALSH PC, 1984, BRIT J UROL, V56, P694, DOI 10.1111/j.1464-410X.1984.tb06149.x; Widmark A, 2009, LANCET, V373, P301, DOI 10.1016/S0140-6736(08)61815-2; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Yuen KK, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006250	43	2	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	2015	163	11							ITC1	10.7326/AITC201512010	http://dx.doi.org/10.7326/AITC201512010			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX7FB	26618297				2022-12-28	WOS:000365866500003
J	Moon, S; Sridhar, D; Pate, MA; Jha, AK; Clinton, C; Delaunay, S; Edwin, V; Fallah, M; Fidler, DP; Garrett, L; Goosby, E; Gostin, LO; Heymann, DL; Lee, K; Leung, GM; Morrison, JS; Saavedra, J; Tanner, M; Leigh, JA; Hawkins, B; Woskie, LR; Piot, P				Moon, Suerie; Sridhar, Devi; Pate, Muhammad A.; Jha, Ashish K.; Clinton, Chelsea; Delaunay, Sophie; Edwin, Valnora; Fallah, Mosoka; Fidler, David P.; Garrett, Laurie; Goosby, Eric; Gostin, Lawrence O.; Heymann, David L.; Lee, Kelley; Leung, Gabriel M.; Morrison, J. Stephen; Saavedra, Jorge; Tanner, Marcel; Leigh, Jennifer A.; Hawkins, Benjamin; Woskie, Liana R.; Piot, Peter			Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola	LANCET			English	Article							VIRUS DISEASE EPIDEMIC; SEPTEMBER 2014; HEALTH; OUTBREAK; LESSONS; GOVERNANCE; FUND		[Moon, Suerie; Jha, Ashish K.; Leigh, Jennifer A.; Woskie, Liana R.] Harvard Univ, Harvard Global Hlth Inst, Boston, MA 02115 USA; [Moon, Suerie; Jha, Ashish K.; Leigh, Jennifer A.; Woskie, Liana R.] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Moon, Suerie] Harvard Univ, Kennedy Sch, Boston, MA 02115 USA; [Sridhar, Devi] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Pate, Muhammad A.] Duke Global Hlth Inst, Durham, NC USA; [Clinton, Chelsea] Bill Hillary & Chelsea Clinton Fdn, New York, NY USA; [Delaunay, Sophie] Medecins Sans Frontieres, New York, NY USA; [Edwin, Valnora] Campaign Good Governance, Freetown, Sierra Leone; [Fallah, Mosoka] Act Contre La Faim Int, Monrovia, CA, Liberia; [Fidler, David P.] Indiana Univ, Maurer Sch Law, Bloomington, IN USA; [Garrett, Laurie] Council Foreign Relat, New York, NY USA; [Goosby, Eric] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Gostin, Lawrence O.] Georgetown Univ, Washington, DC USA; [Heymann, David L.] Chatham House, London, England; [Lee, Kelley] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Leung, Gabriel M.] Univ Hong Kong, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Morrison, J. Stephen] Ctr Strateg & Int Studies, Washington, DC 20006 USA; [Saavedra, Jorge] AIDS Healthcare Fdn, Mexico City, DF, Mexico; [Tanner, Marcel] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Hawkins, Benjamin; Piot, Peter] London Sch Hyg & Trop Med, London WC1, England	Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; University of Edinburgh; Duke University; Indiana University System; Indiana University Bloomington; University of California System; University of California San Francisco; Georgetown University; Simon Fraser University; University of Hong Kong; Centre for Strategic & International Studies; University of Basel; Swiss Tropical & Public Health Institute; University of London; London School of Hygiene & Tropical Medicine	Moon, S (corresponding author), Harvard Global Hlth Inst, Cambridge, MA 02138 USA.	smoon@hsph.harvard.edu	Lee, Kelley/AAE-1588-2019	Lee, Kelley/0000-0002-3625-1915; Leung, Gabriel/0000-0002-2503-6283; Moon, Suerie/0000-0001-8504-1212; Woskie, Liana/0000-0002-7451-6849	Rockefeller Foundation	Rockefeller Foundation	We thank Julio Frenk for initial discussions that led to the creation of the Panel, and Robert Marten and the Rockefeller Foundation for supporting the London meeting of the Panel, and research and dissemination efforts. We are grateful to Emily Anne Robinson for research and organisational support for the Boston meeting, and to Zoe Mark Lyon for research support.	Abramowitz SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003706; African Risk Capacity, AFR RISK CAP INS MEC; [Anonymous], 2009, REPORT REV COMMITTEE; [Anonymous], 2014, SPEC REPR UN SECR GE; [Anonymous], 2015, MANO RIVER UNION POS; [Anonymous], 2015, REUTERS; Balasegaram M, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001831; Belluz J., 2014, WHY WE FAIL STOPPING; Bogner P, 2006, NATURE, V442, P981, DOI 10.1038/442981a; Borio L, 2015, NEW ENGL J MED, V373, P993, DOI 10.1056/NEJMp1508708; Brechot C, 2015, NATURE, V524, P7, DOI 10.1038/524007a; Bristol N, 2015, POWER STRAIGHT TALK; Cheng M, 2015, INVESTIGATION BUNGLI; Cheng M., 2015, EMAILS UN HLTH AGENC; Clift C., 2014, WHATS WHO FINAL REPO; Commission on Information and Accountability for Women's and Children's Health, 2011, KEEP PROM MEAS RES; Crampton T., 2003, WHO CRITICIZES CHINA; Doctors Without Borders Canada/Medecins Sans Frontieres (MSF) Canada, 2014, EB W AFR EP OUT CONT; Fidler DP, 2011, JAMA-J AM MED ASSOC, V306, P200, DOI 10.1001/jama.2011.960; Financial Tracking Service, 2014, APP EB VIR OUTBR OV; Financial Tracking Service, 2015, EB VIR OUTBR OV NEED; Fink S., 2014, NY TIMES; Frenk J, 2013, NEW ENGL J MED, V368, P936, DOI 10.1056/NEJMra1109339; Frontline PBS, 2015, OUTBR INS TROUBL EAR; Garrett L, 2015, CUBA COULD STOP NEXT; Garrett L., 2015, EBOLA REV 1 2; Garrett L., 2015, EBOLAS LESSONS WHO M; Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918; Gettleman J, 2014, NY TIMES; Gostin LO, 2014, LANCET, V384, pE49, DOI 10.1016/S0140-6736(14)61345-3; Grabowski A, 2015, LOSING TRACK MEANS L; Green A, 2014, LANCET, V384, P740, DOI 10.1016/S0140-6736(14)61428-8; Grepin KA, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h376; HAYDEN EC, 2015, NATURE, V524, P146; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Heymann DL, 2015, LANCET, V385, P1884, DOI 10.1016/S0140-6736(15)60858-3; Heymann DL, 2003, BROWN J WORLD AFF, V10, P85; Implementation of the International Health Regulations, 2015, REPORT IMPLEMENTATIO; Inter-Agency Standing Committee Working Group, 2012, PR120440787 INT STAN; Jambawai M., 2014, ARFICA REV; Kamradt-Scott A, 2015, SAVING LIVES CIVIL M; Lee Kelley, 2008, WHO; Liu J, 2015, NATURE, V524, P27, DOI 10.1038/524027a; MacDougall C., 2015, NY TIMES; Medecins Sans Frontieres, 2015, PUSH LIM YEAR LARG E; Mirkovic K, 2014, MMWR-MORBID MORTAL W, V63, P873; Moon S., 2014, DEMONSTRATION FINANC; Naimah JKP, 2014, MSF ADDRESSES UN SEC; Najjar-Pellet J, 2013, EMERGING HLTH THREAT, V6, DOI [10.3402/ehtj.v6i0.19960, DOI 10.3402/EHTJ.V6I0.19960]; Nierle T, 2014, EBOLA FAILURES INT O; Oleribe OO, 2015, CLIN MED, V15, P54, DOI 10.7861/clinmedicine.15-1-54; ONeill J, 2015, REV ANTIMICROBIAL RE; Plotkin SA, 2015, NEW ENGL J MED, V373, P297, DOI 10.1056/NEJMp1506820; Pollack A, 2014, OPTING EBOLA DRUG IL; Pope AE, 2015, UNITING SEOUL EXTING; Samb S., 2014, WHO SAYS GUINEA EBOL; Save the children, 2015, WAK CALL LESS EB WOR; Shuaib F, 2014, MMWR-MORBID MORTAL W, V63, P867; Sridhar D, 2014, OVERSEEING GLOBAL HL; Steenhuysen J., 2014, EXCLUSIVE US EBOLA R; UN Global Ebola Response, 2015, INT EB REC C JUL 9 1; UN Office of the Special Envoy on Ebola, 2015, RES RES 3; WHO, 2015, RESP HLTH EM; WHO, 2014, ETH CONS US UNR INT; WHO, 2015, STAT 5 M IHR EM COMM; WHO, 2014, PAND INFL PREP FRAM; WHO, 2015, EB R D EFF VACC THER; WHO, 2015, STAT 4 M IHR EM COMM; WHO, 2014, STAT 3 M IHR EM COMM; WHO Consultative Expert Working Group on Research and Development: Financing and Coordination, 2012, RES DEV MEET HLTH NE; WHO (World Health Organization), 2015, REP EB INT ASS PAN J; World Bank, 2015, WORLD BANK DOCUMENT; World Bank Group, 2015, PREP NEXT OUTBR; World Health Organization, 2014, STAT 2 M IHR EM COMM; World Health Organization, 2014, STAT 1 M IHR EM COMM; World Health Organization, 2015, EB SIT REP 17 JUN 20; World Health Organization, 2015, GROUND ZER GUIN OUTB; World Health Organization, 2015, WHO EB SIT REP; World Health Organization (WHO), 2016, INT HLTH REG 2005; World Health Organization (WHO), 2015, PROP PROGR BUDG 2016; Yale Global Health Justice Partnership and American Civil Liberties Union, 2015, FEAR POL EB QUAR HUR; Yozwiak NL, 2015, NATURE, V518, P477, DOI 10.1038/518477a	82	299	301	4	69	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 28	2015	386	10009					2204	2221		10.1016/S0140-6736(15)00946-0	http://dx.doi.org/10.1016/S0140-6736(15)00946-0			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX8YW	26615326	Green Published, hybrid			2022-12-28	WOS:000365992600032
J	Gandhi, KJK				Gandhi, Kamal J. K.			The best decision I ever made	SCIENCE			English	Editorial Material								What prompts a person to make a decision that will change their life forever? For me, it was being born a female in a developing country, India. I had a happy childhood filled with warm memories and a supportive family, but because I was a girl, it seemed that I had fewer rights than boys and couldn't have the freedoms and education they were offered. My future was to marry a man as arranged by my parents, rather than have a full career. But I wanted something different. After spending a glorious summer at a youth World Wildlife Fund camp in Mudumalai National Park in the mountains of the Western Ghats when I was 13 years old, I decided that I wanted to be an ecologist to study and preserve nature.	[Gandhi, Kamal J. K.] Univ Georgia, Daniel B Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Gandhi, KJK (corresponding author), Univ Georgia, Daniel B Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	SciCareerEditor@aaas.org		Gandhi, Kamal/0000-0001-6217-5859					0	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1122	1122		10.1126/science.350.6264.1122	http://dx.doi.org/10.1126/science.350.6264.1122			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY5BJ	26612954				2022-12-28	WOS:000366422600048
J	Yang, Y; Gu, J; Young, JL; Miller, EM; Turner, JA; Neale, NR; Beard, MC				Yang, Ye; Gu, Jing; Young, James L.; Miller, Elisa M.; Turner, John A.; Neale, Nathan R.; Beard, Matthew C.			Semiconductor interfacial carrier dynamics via photoinduced electric fields	SCIENCE			English	Article							SURFACE RECOMBINATION VELOCITY; PHOTOCATHODIC H-2 EVOLUTION; TERAHERTZ SPECTROSCOPY; EXCITON DISSOCIATION; HYDROGEN-PRODUCTION; WATER; TIO2; ELECTROMODULATION; NANOCRYSTALS; LAYER	Solar photoconversion in semiconductors is driven by charge separation at the interface of the semiconductor and contacting layers. Here we demonstrate that time-resolved photoinduced reflectance from a semiconductor captures interfacial carrier dynamics. We applied this transient photoreflectance method to study charge transfer at p-type gallium-indium phosphide (p-GaInP2) interfaces critically important to solar-driven water splitting. We monitored the formation and decay of transient electric fields that form upon photoexcitation within bare p-GaInP2, p-GaInP2/platinum (Pt), and p-GaInP2/amorphous titania (TiO2) interfaces. The data show that a field at both the p-GaInP2/Pt and p-GaInP2/TiO2 interfaces drives charge separation. Additionally, the charge recombination rate at the p-GaInP2/TiO2 interface is greatly reduced owing to its p-n nature, compared with the Schottky nature of the p-GaInP2/Pt interface.	[Yang, Ye; Gu, Jing; Young, James L.; Miller, Elisa M.; Turner, John A.; Neale, Nathan R.; Beard, Matthew C.] Natl Renewable Energy Lab, Chem & Nanosci Ctr, Golden, CO 80401 USA; [Young, James L.] Univ Colorado, Mat Sci & Engn Program, Boulder, CO 80309 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University of Colorado System; University of Colorado Boulder	Yang, Y (corresponding author), Natl Renewable Energy Lab, Chem & Nanosci Ctr, Golden, CO 80401 USA.	ye.yang@nrel.gov; matt.beard@nrel.gov	Beard, MATTHEW C/E-4270-2015; Yang, Ye/D-5675-2015	Beard, MATTHEW C/0000-0002-2711-1355; Miller, Elisa/0000-0002-7648-5433; Yang, Ye/0000-0003-2827-3572; Neale, Nathan/0000-0001-5654-1664	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy, through the Solar Photochemistry Program [DE-AC36-08GO28308]; NSF Graduate Research Fellowship [DGE 1144083]	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy, through the Solar Photochemistry Program; NSF Graduate Research Fellowship(National Science Foundation (NSF))	This work was supported by the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy, through the Solar Photochemistry Program under contract no. DE-AC36-08GO28308 to the National Renewable Energy Laboratory. J.L.Y. acknowledges NSF Graduate Research Fellowship Grant no. DGE 1144083. The U.S. government retains-and the publisher, by accepting the article for publication, acknowledges that the U.S. government retains-a nonexclusive, paid-up, irrevocable, worldwide license to publish or reproduce the published form of this work, or allow others to do so, for U.S. government purposes.	ASPNES DE, 1972, PHYS REV LETT, V28, P168, DOI 10.1103/PhysRevLett.28.168; Beard MC, 2002, J PHYS CHEM B, V106, P7146, DOI 10.1021/jp020579i; BENNETT BR, 1990, IEEE J QUANTUM ELECT, V26, P113, DOI 10.1109/3.44924; Chen ZB, 2010, J MATER RES, V25, P3, DOI 10.1557/JMR.2010.0020; EMANUELSSON P, 1994, APPL PHYS LETT, V64, P2849, DOI 10.1063/1.111445; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Hu S, 2014, SCIENCE, V344, P1005, DOI 10.1126/science.1251428; Huang YS, 1998, APPL PHYS LETT, V73, P214, DOI 10.1063/1.121759; Khaselev O, 1998, SCIENCE, V280, P425, DOI 10.1126/science.280.5362.425; Kippenberg T, 1999, PHYS REV B, V60, P4446, DOI 10.1103/PhysRevB.60.4446; Kita T, 2003, J APPL PHYS, V94, P6487, DOI 10.1063/1.1623327; Klimov VI, 2007, ANNU REV PHYS CHEM, V58, P635, DOI 10.1146/annurev.physchem.58.032806.104537; Knowles KE, 2013, J PHYS CHEM C, V117, P10229, DOI 10.1021/jp400699h; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Marcinkevicius S, 2012, AIP ADV, V2, DOI 10.1063/1.4768670; Pollak FH, 2001, SURF INTERFACE ANAL, V31, P938, DOI 10.1002/sia.1131; Sabbah AJ, 2000, J APPL PHYS, V88, P6954, DOI 10.1063/1.1316047; Schultes FJ, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4847635; Seger B, 2013, RSC ADV, V3, P25902, DOI 10.1039/c3ra45966g; Seger B, 2013, J AM CHEM SOC, V135, P1057, DOI 10.1021/ja309523t; Shah J., 1999, ULTRAFAST SPECTROSCO; SHEN H, 1990, PHYS REV B, V42, P7097, DOI 10.1103/PhysRevB.42.7097; SHEN H, 1995, J APPL PHYS, V78, P2151, DOI 10.1063/1.360131; Tisdale WA, 2010, SCIENCE, V328, P1543, DOI 10.1126/science.1185509; Tvrdy K, 2011, P NATL ACAD SCI USA, V108, P29, DOI 10.1073/pnas.1011972107; Ulbricht R, 2011, REV MOD PHYS, V83, P543, DOI 10.1103/RevModPhys.83.543; VODOPYANOV KL, 1992, PHYS REV B, V46, P13194, DOI 10.1103/PhysRevB.46.13194; Yang Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8961; Yang Y, 2014, COORDIN CHEM REV, V263, P229, DOI 10.1016/j.ccr.2013.11.013	30	88	91	17	283	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1061	1065		10.1126/science.aad3459	http://dx.doi.org/10.1126/science.aad3459			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY5BJ	26612947				2022-12-28	WOS:000366422600036
J	Brady, PC; Gilerson, AA; Kattawar, GW; Sullivan, JM; Twardowski, MS; Dierssen, HM; Gao, M; Travis, K; Etheredge, RI; Tonizzo, A; Ibrahim, A; Carrizo, C; Gu, YL; Russell, BJ; Mislinski, K; Zhao, SL; Cummings, ME				Brady, Parrish C.; Gilerson, Alexander A.; Kattawar, George W.; Sullivan, James M.; Twardowski, Michael S.; Dierssen, Heidi M.; Gao, Meng; Travis, Kort; Etheredge, Robert Ian; Tonizzo, Alberto; Ibrahim, Amir; Carrizo, Carlos; Gu, Yalong; Russell, Brandon J.; Mislinski, Kathryn; Zhao, Shulei; Cummings, Molly E.			Open-ocean fish reveal an omnidirectional solution to camouflage in polarized environments	SCIENCE			English	Article							LIGHT-FIELD; INVISIBILITY; REFLECTANCE; WATERS; MIRROR; CLEAR	Despite appearing featureless to our eyes, the open ocean is a highly variable environment for polarization-sensitive viewers. Dynamic visual backgrounds coupled with predator encounters from all possible directions make this habitat one of the most challenging for camouflage. We tested open-ocean crypsis in nature by collecting more than 1500 videopolarimetry measurements from live fish from distinct habitats under a variety of viewing conditions. Open-ocean fish species exhibited camouflage that was superior to that of both nearshore fish and mirrorlike surfaces, with significantly higher crypsis at angles associated with predator detection and pursuit. Histological measurements revealed that specific arrangements of reflective guanine platelets in the fish's skin produce angle-dependent polarization modifications for polarocrypsis in the open ocean, suggesting a mechanism for natural selection to shape reflectance properties in this complex environment.	[Brady, Parrish C.; Travis, Kort; Etheredge, Robert Ian; Mislinski, Kathryn; Zhao, Shulei; Cummings, Molly E.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Gilerson, Alexander A.; Tonizzo, Alberto; Ibrahim, Amir; Carrizo, Carlos; Gu, Yalong] CUNY City Coll, Opt Remote Sensing Lab, New York, NY 10031 USA; [Kattawar, George W.; Gao, Meng] Texas A&M Univ, Dept Phys & Astron, College Stn, TX 77843 USA; [Kattawar, George W.; Gao, Meng] Texas A&M Univ, Inst Quantum Sci & Engn, College Stn, TX 77843 USA; [Sullivan, James M.; Twardowski, Michael S.] Florida Atlantic Univ, Harbor Branch Oceanog Inst, Ft Pierce, FL 34946 USA; [Dierssen, Heidi M.; Russell, Brandon J.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	University of Texas System; University of Texas Austin; City University of New York (CUNY) System; City College of New York (CUNY); Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Harbor Branch Oceanographic Institute Foundation; State University System of Florida; Florida Atlantic University; University of Connecticut	Brady, PC (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.		Ibrahim, Amir/D-3103-2017	Ibrahim, Amir/0000-0002-3290-056X	Office of Naval Research Multi-University Research Initiative [N000140911054]; NSF Division of Ocean Sciences [1130793]; Division Of Ocean Sciences [1130793] Funding Source: National Science Foundation	Office of Naval Research Multi-University Research Initiative; NSF Division of Ocean Sciences(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	All experiments were approved by the University of Texas animal care committee (under Institutional Animal Care and Use Committee protocols AUP-2009-00022 and AUP-2015-00026). This research was supported by Office of Naval Research Multi-University Research Initiative grant N000140911054 to M.E.C., H.M.D., J.S., A.A.G., and G.W.K.; and NSF Division of Ocean Sciences grant 1130793 to M.E.C. and G.W.K. The data are deposited though the Dryad Digital Repository (10.5061/dryad.gt37j).	Brady PC, 2013, P NATL ACAD SCI USA, V110, P9764, DOI 10.1073/pnas.1222125110; Calabrese GM, 2014, P NATL ACAD SCI USA, V111, P13397, DOI 10.1073/pnas.1321368111; Cermak MJ, 2002, BIOL BULL, V203, P241, DOI 10.2307/1543419; Cronin TW, 2001, J EXP BIOL, V204, P2461; DENTEN EJ, 1970, PHILOS T ROY SOC B, V258, P285, DOI 10.1098/rstb.1970.0037; Gilerson AA, 2013, APPL OPTICS, V52, P8685, DOI 10.1364/AO.52.008685; Haag JM, 2013, OPT EXPRESS, V21, P3603, DOI 10.1364/OE.21.003603; Handegard NO, 2012, CURR BIOL, V22, P1213, DOI 10.1016/j.cub.2012.04.050; Johnsen S, 2003, INTEGR COMP BIOL, V43, P580, DOI 10.1093/icb/43.4.580; Johnsen S, 2014, LIMNOL OCEANOGR, V59, P1839, DOI 10.4319/lo.2014.59.6.1839; Johnsen S, 2014, ANNU REV MAR SCI, V6, P369, DOI 10.1146/annurev-marine-010213-135018; Jordan TM, 2012, NAT PHOTONICS, V6, P759, DOI [10.1038/nphoton.2012.260, 10.1038/NPHOTON.2012.260]; Kamermans M, 2011, PHILOS T R SOC B, V366, P742, DOI 10.1098/rstb.2010.0211; Marshall Justin, 2011, P186; MOREL A, 1995, J GEOPHYS RES-OCEANS, V100, P13143, DOI 10.1029/95JC00531; PANKHURST NW, 1982, J FISH BIOL, V21, P279, DOI 10.1111/j.1095-8649.1982.tb02833.x; PARRISH JK, 1992, ENVIRON BIOL FISH, V34, P257, DOI 10.1007/BF00004771; Roberts NW, 2011, PHILOS T R SOC B, V366, P627, DOI 10.1098/rstb.2010.0206; SABBAH S, 2005, RECENT RES DEV EXPT, P123; Sabbah S, 2007, J OPT SOC AM A, V24, P2049, DOI 10.1364/JOSAA.24.002049; Schittny R, 2014, SCIENCE, V345, P427, DOI 10.1126/science.1254524; Waterman TH, 2006, BIOL REV, V81, P111, DOI 10.1017/S1464793105006883; You Y, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007278; You Y, 2011, APPL OPTICS, V50, P4873, DOI 10.1364/AO.50.004873; Zhao SL, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1390	25	45	45	3	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					965	969		10.1126/science.aad5284	http://dx.doi.org/10.1126/science.aad5284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW4IP	26586762				2022-12-28	WOS:000364955200046
J	Pennisi, E				Pennisi, Elizabeth			Crystalline eyes of chitons inspire materials scientists	SCIENCE			English	News Item																			0	0	1	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					899	899		10.1126/science.350.6263.899	http://dx.doi.org/10.1126/science.350.6263.899			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW4IP	26586742				2022-12-28	WOS:000364955200015
J	Baingana, F; al'Absi, M; Becker, AE; Pringle, B				Baingana, Florence; al'Absi, Mustafa; Becker, Anne E.; Pringle, Beverly			Global research challenges and opportunities for mental health and substance-use disorders	NATURE			English	Review							MIDDLE-INCOME COUNTRIES; RANDOMIZED CONTROLLED-TRIAL; PSYCHIATRIC-DISORDERS; SCALE-UP; KNOWLEDGE TRANSLATION; SYSTEMATIC ANALYSIS; ANXIETY DISORDERS; DUAL DIAGNOSIS; DEPRESSION; SERVICES	The research agenda for global mental health and substance-use disorders has been largely driven by the exigencies of high health burdens and associated unmet needs in low-and middle-income countries. Implementation research focused on context-driven adaptation and innovation in service delivery has begun to yield promising results that are improving the quality of, and access to, care in low-resource settings. Importantly, these efforts have also resulted in the development and augmentation of local, in-country research capacities. Given the complex interplay between mental health and substance-use disorders, medical conditions, and biological and social vulnerabilities, a revitalized research agenda must encompass both local variation and global commonalities in the impact of adversities, multi-morbidities and their consequences across the life course. We recommend priorities for research - as well as guiding principles for context-driven, intersectoral, integrative approaches - that will advance knowledge and answer the most pressing local and global mental health questions and needs, while also promoting a health equity agenda and extending the quality, reach and impact of scientific enquiry.	[Baingana, Florence] Makerere Univ, Sch Publ Hlth, POB 7072, Kampala, Uganda; [al'Absi, Mustafa] Univ Minnesota, Sch Med, DMRI, 311-1035 Univ Dr, Duluth, MN 55812 USA; [Becker, Anne E.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 03115 USA; [Pringle, Beverly] NIMH, Off Res Dispar & Global Mental Hlth, Bethesda, MD 20892 USA	Makerere University; University of Minnesota System; University of Minnesota Duluth; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Baingana, F (corresponding author), Makerere Univ, Sch Publ Hlth, POB 7072, Kampala, Uganda.	kamayonza@gmail.com		Becker, Anne/0000-0001-9129-6510	BRAIN R21 grant [R21DA024626]; Grand Challenges Canada [GMH 0094-04];  [R01DA016351];  [R01DA027232]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016351, R01DA027232, R21DA024626] Funding Source: NIH RePORTER	BRAIN R21 grant; Grand Challenges Canada(CGIAR); ; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank J. Dewit, A. Garton, Y. Bodenstein and J. Nguyen at the National Institute of Mental Health for construction of the interactive map. M. A. was supported in part by the following grants: R01DA016351 and R01DA027232, and a BRAIN R21 grant (R21DA024626). F. B. was supported in part by Grand Challenges Canada Grant GMH 0094-04. We are grateful to B. Good for his insightful review and suggestions.	al'Absi M, 2005, PSYCHOPHARMACOLOGY, V181, P107, DOI 10.1007/s00213-005-2225-3; al'Absi M., 2007, STRESS ADDICTION BIO; al'Absi M, 2014, PSYCHONEUROENDOCRINO, V49, P253, DOI 10.1016/j.psyneuen.2014.07.018; [Anonymous], 2008, CLOS GAP GEN HLTH EQ; Araya R, 2006, AM J PSYCHIAT, V163, P1379, DOI 10.1176/appi.ajp.163.8.1379; Balachova T, 2012, ADDICTION, V107, P109, DOI 10.1111/j.1360-0443.2011.03569.x; Becker A. E., 2014, PSYCHIAT PRESENT PRO; Bloom DE, 2011, GLOBAL EC BURDEN NON; Bruckner TA, 2011, B WORLD HEALTH ORGAN, V89, P184, DOI 10.2471/BLT.10.082784; Charlson FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110208; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Copeland J, 2014, WORLD PSYCHIATRY, V13, P198, DOI 10.1002/wps.20133; de Jong JTVM, 2014, TRANSCULT PSYCHIATRY, V51, P806, DOI 10.1177/1363461514557995; Degenhardt L, 2014, DRUG ALCOHOL REV, V33, P4, DOI 10.1111/dar.12088; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Dobbins M, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-61; Drew N, 2011, LANCET, V378, P1664, DOI 10.1016/S0140-6736(11)61458-X; Eaton J, 2011, LANCET, V378, P1592, DOI 10.1016/S0140-6736(11)60891-X; Edmondson D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038915; Fricchione GL, 2012, HARVARD REV PSYCHIAT, V20, P47, DOI 10.3109/10673229.2012.655211; Goldner EM, 2014, CAN J PSYCHIAT, V59, P160, DOI 10.1177/070674371405900308; Grimsrud A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005552; Huang JTJ, 2008, MOL PSYCHIATR, V13, P1118, DOI 10.1038/sj.mp.4002108; Jacob KS, 2014, LANCET, V383, P1433, DOI 10.1016/S0140-6736(13)62382-X; Karpyak VM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.103; Kerry Vanessa B, 2013, J Glob Health, V3, P020406, DOI 10.7189/jogh.03.020406; Kessler RC, 2004, BIOL PSYCHIAT, V56, P730, DOI 10.1016/j.biopsych.2004.06.034; Khantzian EJ, 1997, HARVARD REV PSYCHIAT, V4, P231, DOI 10.3109/10673229709030550; Kieling C, 2011, LANCET, V378, P1515, DOI 10.1016/S0140-6736(11)60827-1; Kleinman A, 2009, LANCET, V374, P603, DOI 10.1016/S0140-6736(09)61510-5; Kohrt BA, 2014, INT J EPIDEMIOL, V43, P365, DOI 10.1093/ije/dyt227; Lee AA, 2014, PSYCHOSOMATICS, V55, P343, DOI 10.1016/j.psym.2013.12.015; Ludwig J, 2012, SCIENCE, V337, P1505, DOI 10.1126/science.1224648; Lund C, 2008, SAMJ S AFR MED J, V98, P444; Mackenzie J., 2014, GLOBAL MENTAL HLTH P; Mello MM, 2013, NEW ENGL J MED, V369, P1651, DOI 10.1056/NEJMhle1309073; Mendenhall E, 2014, SOC SCI MED, V118, P33, DOI 10.1016/j.socscimed.2014.07.057; Mimiaga M. J., 2014, J ACQ IMMUN DEF SYND, V68, P329; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; National Institute of Mental Health, 2013, GRAND CHALL GLOB MEN; Ovretveit J, 2007, ROUTL HEALTH MANAG, P129; Patel V, 2007, BRIT J PSYCHIAT, V190, P77, DOI 10.1192/bjp.bp.106.025692; Patel V, 2014, TRANSCULT PSYCHIATRY, V51, P777, DOI 10.1177/1363461514524473; Patel V, 2011, BRIT J PSYCHIAT, V199, P459, DOI 10.1192/bjp.bp.111.092155; Peedicayil J, 2008, BRIT J PHARMACOL, V155, P795, DOI 10.1038/bjp.2008.254; Phillips MR, 2013, LANCET, V381, P1964, DOI 10.1016/S0140-6736(13)61177-0; Quello Susan B, 2005, Sci Pract Perspect, V3, P13; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Razzouk D, 2010, HEALTH POLICY, V94, P211, DOI 10.1016/j.healthpol.2009.09.009; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Schwarz E, 2008, BRIT J PHARMACOL, V153, pS133, DOI 10.1038/sj.bjp.0707658; Sung YH, 2013, BEHAV BRAIN RES, V246, P154, DOI 10.1016/j.bbr.2013.02.028; Thornicroft G, 2012, HARVARD REV PSYCHIAT, V20, P13, DOI 10.3109/10673229.2012.649117; Tsai AC, 2014, ACAD PSYCHIATR, V38, P426, DOI 10.1007/s40596-014-0092-0; UNODC, 2014, WORLD DRUG REP 2014; van Emmerik-van Oortmerssen K, 2012, DRUG ALCOHOL DEPEN, V122, P11, DOI 10.1016/j.drugalcdep.2011.12.007; van Ginneken N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009149.pub2; Vassileva J, 2007, DRUG ALCOHOL DEPEN, V86, P287, DOI 10.1016/j.drugalcdep.2006.06.015; Volkow ND, 2004, BIOL PSYCHIAT, V56, P714, DOI 10.1016/j.biopsych.2004.07.007; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; WHO, 2010, ATLAS SUBST US RES P; World Health Organization, 2010, WHO MHGAP INT GUID M; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization and Calouste Gulbenkian Foundation, 2014, INT RESP MENT DIS OT; World Health Organization (WHO), 2010, MENT HLTH DEV TARG P; Wright S, 2000, SOC PSYCH PSYCH EPID, V35, P297, DOI 10.1007/s001270050242; Wu CY, 2010, J AM ACAD NURSE PRAC, V22, P694, DOI 10.1111/j.1745-7599.2010.00565.x	71	62	63	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					S172	S177		10.1038/nature16032	http://dx.doi.org/10.1038/nature16032			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW9ZN	26580324	Green Accepted, hybrid			2022-12-28	WOS:000365356800013
J	Eisenstein, M				Eisenstein, Michael			Medicine: Eyes on the target	NATURE			English	Editorial Material							METASTATIC BREAST-CANCER; PERTUZUMAB PLUS TRASTUZUMAB; CHEMOTHERAPY; DOCETAXEL; PHASE-2; SAFETY; TRIAL											Bachelot T, 2013, LANCET ONCOL, V14, P64, DOI 10.1016/S1470-2045(12)70432-1; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Gianni L, 2012, LANCET ONCOL, V13, P25, DOI 10.1016/S1470-2045(11)70336-9; Giuliano M, 2015, CLIN CANCER RES, V21, P3995, DOI 10.1158/1078-0432.CCR-14-2728; Modi S, 2011, CLIN CANCER RES, V17, P5132, DOI 10.1158/1078-0432.CCR-11-0072; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Schneeweiss A, 2013, ANN ONCOL, V24, P2278, DOI 10.1093/annonc/mdt182; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Slamon DJ, 2015, J CLIN ONCOL, V33; Swain SM, 2014, ANN ONCOL, V25, P1116, DOI 10.1093/annonc/mdu133; Tefferi A, 2015, MAYO CLIN PROC, V90, P996, DOI 10.1016/j.mayocp.2015.06.001	11	7	8	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					S110	S112		10.1038/527S110a	http://dx.doi.org/10.1038/527S110a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26580159	Bronze			2022-12-28	WOS:000365356800004
J	Liebi, M; Georgiadis, M; Menzel, A; Schneider, P; Kohlbrecher, J; Bunk, O; Guizar-Sicairos, M				Liebi, Marianne; Georgiadis, Marios; Menzel, Andreas; Schneider, Philipp; Kohlbrecher, Joachim; Bunk, Oliver; Guizar-Sicairos, Manuel			Nanostructure surveys of macroscopic specimens by small-angle scattering tensor tomography	NATURE			English	Article							X-RAY-SCATTERING; COLLAGEN FIBER ORIENTATION; COMPUTED-TOMOGRAPHY; SCANNING SAXS; BONE; SPECTROSCOPY; MICROSCOPY	The mechanical properties of many materials are based on the macroscopic arrangement and orientation of their nanostructure. This nanostructure can be ordered over a range of length scales. In biology, the principle of hierarchical ordering is often used to maximize functionality, such as strength and robustness of the material, while minimizing weight and energy cost. Methods for nanoscale imaging provide direct visual access to the ultrastructure (nanoscale structure that is too small to be imaged using light microscopy), but the field of view is limited and does not easily allow a full correlative study of changes in the ultrastructure over a macroscopic sample. Other methods of probing ultrastructure ordering, such as small-angle scattering of X-rays or neutrons, can be applied to macroscopic samples; however, these scattering methods remain constrained to two-dimensional specimens(1-4) or to isotropically oriented ultrastructures(5-7). These constraints limit the use of these methods for studying nanostructures with more complex orientation patterns, which are abundant in nature and materials science. Here, we introduce an imaging method that combines small-angle scattering with tensor tomography to probe nanoscale structures in three-dimensional macroscopic samples in a non-destructive way. We demonstrate the method by measuring the main orientation and the degree of orientation of nanoscale mineralized collagen fibrils in a human trabecula bone sample with a spatial resolution of 25 micrometres. Symmetries within the sample, such as the cylindrical symmetry commonly observed for mineralized collagen fibrils in bone(8-10), allow for tractable sampling requirements and numerical efficiency. Small-angle scattering tensor tomography is applicable to both biological and materials science specimens, and may be useful for understanding and characterizing smart or bio-inspired materials. Moreover, because the method is non-destructive, it is appropriate for in situ measurements and allows, for example, the role of ultrastructure in the mechanical response of a biological tissue or manufactured material to be studied.	[Liebi, Marianne; Menzel, Andreas; Kohlbrecher, Joachim; Bunk, Oliver; Guizar-Sicairos, Manuel] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Georgiadis, Marios] ETH, Inst Biomech, CH-8093 Zurich, Switzerland; [Schneider, Philipp] Univ Southampton, Bioengn Sci Res Grp, Fac Engn & Environm, Southampton SO17 1BJ, Hants, England	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Southampton	Liebi, M (corresponding author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.	marianne.liebi@psi.ch; manuel.guizar-sicairos@psi.ch	Schneider, Philipp/AAP-6133-2021; Kohlbrecher, Joachim/C-8790-2011; Liebi, Marianne/A-3821-2015; Guizar-Sicairos, Manuel/AAB-3793-2019; Guizar-Sicairos, Manuel/I-4899-2013; Menzel, Andreas/C-4388-2012; Bunk, Oliver/B-7602-2013	Schneider, Philipp/0000-0001-7499-3576; Kohlbrecher, Joachim/0000-0001-5879-6943; Liebi, Marianne/0000-0002-5403-0593; Guizar-Sicairos, Manuel/0000-0002-8293-3634; Guizar-Sicairos, Manuel/0000-0002-8293-3634; Menzel, Andreas/0000-0002-0489-609X; Bunk, Oliver/0000-0001-6563-4053; Georgiadis, Marios/0000-0003-0733-4559	ETH Research Grant [ETH-39 11-1]	ETH Research Grant	We thank M. Holler and J. Raabe for their help in sample preparation and A. Diaz, F. Schaff and M. Bech for discussions. M.G. was supported by the ETH Research Grant ETH-39 11-1. The vertebral specimen was provided by W. Schmolz, Department for Trauma Surgery, Innsbruck Medical University, Innsbruck, Austria.	Alvarez-Murga M, 2012, J APPL CRYSTALLOGR, V45, P1109, DOI 10.1107/S0021889812041039; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bi X, 2005, OSTEOARTHR CARTILAGE, V13, P1050, DOI 10.1016/j.joca.2005.07.008; BUNGE HJ, 1969, J APPL CRYSTALLOGR, V2, P116, DOI 10.1107/S0021889869006704; Bunk O, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123016; Currey JD, 2002, BONES STRUCTURE MECH; Feldkamp JM, 2009, PHYS STATUS SOLIDI A, V206, P1723, DOI 10.1002/pssa.200881615; Fratzl P, 1997, J APPL CRYSTALLOGR, V30, P765, DOI 10.1107/S0021889897001775; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Georgiadis M, 2015, BONE, V71, P42, DOI 10.1016/j.bone.2014.10.002; Giannini C, 2014, J APPL CRYSTALLOGR, V47, P110, DOI 10.1107/S1600576713030215; Giannini C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00435; Gourrier A, 2010, J APPL CRYSTALLOGR, V43, P1385, DOI 10.1107/S0021889810035090; Granke M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058043; Grenander U., 1981, ABSTRACT INFERENCE; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Heidelbach F, 1999, J APPL CRYSTALLOGR, V32, P841, DOI 10.1107/S0021889899004999; Holler M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03857; Howells MR, 2009, J ELECTRON SPECTROSC, V170, P4, DOI 10.1016/j.elspec.2008.10.008; Hubbell JH., 1995, TABLES XRAY MASS ATT; Jensen TH, 2011, NEUROIMAGE, V57, P124, DOI 10.1016/j.neuroimage.2011.04.013; Jensen TH, 2011, PHYS MED BIOL, V56, P1717, DOI 10.1088/0031-9155/56/6/012; Kraft P, 2009, J SYNCHROTRON RADIAT, V16, P368, DOI 10.1107/S0909049509009911; Ludwig W, 2008, J APPL CRYSTALLOGR, V41, P302, DOI 10.1107/S0021889808001684; Malecki A, 2014, EPL-EUROPHYS LETT, V105, DOI 10.1209/0295-5075/105/38002; MARTIN RB, 1989, J BIOMECH, V22, P419, DOI 10.1016/0021-9290(89)90202-9; Pabisch S, 2013, METHOD ENZYMOL, V532, P391, DOI 10.1016/B978-0-12-416617-2.00018-7; Rauch EF, 2010, Z KRIST-CRYST MATER, V225, P103, DOI 10.1524/zkri.2010.1205; RIGGS CM, 1993, ANAT EMBRYOL, V187, P239; Rinnerthaler S, 1999, CALCIFIED TISSUE INT, V64, P422, DOI 10.1007/PL00005824; ROE RJ, 1965, J APPL PHYS, V36, P2024, DOI 10.1063/1.1714396; Schneider P, 2010, BONE, V47, P848, DOI 10.1016/j.bone.2010.07.026; Schroer CG, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2196062; Seidel R, 2012, BIOINSPIR BIOMIM NAN, V1, P123, DOI 10.1680/bbn.11.00014; Thibault P, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/6/063004; Tinti G, 2015, J INSTRUM, V10, DOI 10.1088/1748-0221/10/03/C03011; Zhao Q, 2004, PHILOS T R SOC A, V362, P2407, DOI 10.1098/rsta.2004.1447	37	129	130	4	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					349	+		10.1038/nature16056	http://dx.doi.org/10.1038/nature16056			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26581291	Green Accepted			2022-12-28	WOS:000365356800050
J	Sydeman, WJ; Poloczanska, E; Reed, TE; Thompson, SA				Sydeman, William J.; Poloczanska, Elvira; Reed, Thomas E.; Thompson, Sarah Ann			Climate change and marine vertebrates	SCIENCE			English	Review							NORTH-SEA; EVOLUTIONARY RESPONSES; BREEDING PERFORMANCE; ENVIRONMENTAL-CHANGE; POPULATION-DYNAMICS; PHENOLOGICAL CHANGE; PLASTIC RESPONSES; FISH POPULATIONS; EMPEROR PENGUIN; SHIFTS	Climate change impacts on vertebrates have consequences for marine ecosystem structures and services. We review marine fish, mammal, turtle, and seabird responses to climate change and discuss their potential for adaptation. Direct and indirect responses are demonstrated from every ocean. Because of variation in research foci, observed responses differ among taxonomic groups (redistributions for fish, phenology for seabirds). Mechanisms of change are (i) direct physiological responses and (ii) climate-mediated predator-prey interactions. Regional-scale variation in climate-demographic functions makes range-wide population dynamics challenging to predict. The nexus of metabolism relative to ecosystem productivity and food webs appears key to predicting future effects on marine vertebrates. Integration of climate, oceanographic, ecosystem, and population models that incorporate evolutionary processes is needed to prioritize the climate-related conservation needs for these species.	[Sydeman, William J.; Thompson, Sarah Ann] Farallon Inst Adv Ecosyst Res, Petaluma, CA 94952 USA; [Sydeman, William J.] Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA; [Poloczanska, Elvira] Commonwealth Sci & Ind Res Org, Ecosci Precinct, Brisbane, Qld 4102, Australia; [Poloczanska, Elvira] Univ Queensland, Global Change Inst, St Lucia, Qld 4072, Australia; [Reed, Thomas E.] Natl Univ Ireland Univ Coll Cork, Sch Biol Earth & Environm Sci, Cork, Ireland; [Thompson, Sarah Ann] Univ Washington, Climate Impacts Grp, Seattle, WA 98195 USA	University of California System; University of California Davis; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; University College Cork; University of Washington; University of Washington Seattle	Sydeman, WJ (corresponding author), Farallon Inst Adv Ecosyst Res, Petaluma, CA 94952 USA.	wsydeman@faralloninstitute.org		poloczanska, elvira/0000-0001-8470-0925; Reed, Thomas/0000-0002-2993-0477	NSF [OCE-1434732]; European Research Council [ERC-STG-2014-639192-ALH]; Irish Government's Beaufort Marine Research Award in Fish Population Genetics	NSF(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission); Irish Government's Beaufort Marine Research Award in Fish Population Genetics	We thank J. Piatt, E. Hazen, and B. Black for reviewing earlier versions of the manuscript, and K. Kuletz and P. Gienapp for clarifying statements. W.J.S. and SAT. were supported under NSF award OCE-1434732. T.E.R. was supported by the European Research Council (ERC-STG-2014-639192-ALH) and the Irish Government's Beaufort Marine Research Award in Fish Population Genetics.	AEBISCHER NJ, 1990, NATURE, V347, P753, DOI 10.1038/347753a0; Anderson JJ, 2013, ECOL MODEL, V264, P83, DOI 10.1016/j.ecolmodel.2013.03.009; Asch RG, 2015, P NATL ACAD SCI USA, V112, pE4065, DOI 10.1073/pnas.1421946112; Bailleul F, 2013, ECOL EVOL, V3, P2535, DOI 10.1002/ece3.656; Ballerini T, 2009, OECOLOGIA, V161, P253, DOI 10.1007/s00442-009-1387-9; Barbraud C, 2006, P NATL ACAD SCI USA, V103, P6248, DOI 10.1073/pnas.0510397103; Barbraud C, 2001, J AVIAN BIOL, V32, P297, DOI 10.1111/j.0908-8857.2001.320402.x; Batianoff GN, 2010, PAC SCI, V64, P73, DOI 10.2984/64.1.073; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bonduriansky R, 2012, EVOL APPL, V5, P192, DOI 10.1111/j.1752-4571.2011.00213.x; Boyd PW, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P133; Brander K, 2010, J MARINE SYST, V79, P389, DOI 10.1016/j.jmarsys.2008.12.015; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Burthe S, 2012, MAR ECOL PROG SER, V454, P119, DOI 10.3354/meps09520; Burthe SJ, 2014, MAR ECOL PROG SER, V507, P277, DOI 10.3354/meps10849; Chambers LE, 2014, INT J BIOMETEOROL, V58, P603, DOI 10.1007/s00484-013-0711-6; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Crawford RJM, 2008, AFR J MAR SCI, V30, P189, DOI 10.2989/AJMS.2008.30.1.20.470; Croxall JP, 2002, SCIENCE, V297, P1510, DOI 10.1126/science.1071987; Crozier LG, 2014, EVOL APPL, V7, P68, DOI 10.1111/eva.12135; Crozier LG, 2011, AM NAT, V178, P755, DOI 10.1086/662669; Cullen JM, 2009, MAR ECOL PROG SER, V378, P269, DOI 10.3354/meps07881; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Dalleau M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046920; Deutsch C, 2015, SCIENCE, V348, P1132, DOI 10.1126/science.aaa1605; Donelson JM, 2012, NAT CLIM CHANGE, V2, P30, DOI 10.1038/NCLIMATE1323; Donnelly A, 2011, INT J BIOMETEOROL, V55, P805, DOI 10.1007/s00484-011-0426-5; Drinkwater KF, 2006, PROG OCEANOGR, V68, P134, DOI 10.1016/j.pocean.2006.02.011; DUNLOP J N, 1986, Records of the Western Australian Museum, V12, P389; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Engelhard GH, 2014, GLOBAL CHANGE BIOL, V20, P2473, DOI 10.1111/gcb.12513; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Field JC, 2013, DEEP-SEA RES PT II, V95, P37, DOI 10.1016/j.dsr2.2012.09.006; Fincham JI, 2013, J SEA RES, V75, P69, DOI 10.1016/j.seares.2012.07.004; Fischbach AS, 2007, POLAR BIOL, V30, P1395, DOI 10.1007/s00300-007-0300-4; Forcada J, 2008, GLOBAL CHANGE BIOL, V14, P2473, DOI 10.1111/j.1365-2486.2008.01678.x; Francis RC, 1998, FISH OCEANOGR, V7, P1, DOI 10.1046/j.1365-2419.1998.00052.x; Frederiksen M, 2013, GLOBAL CHANGE BIOL, V19, P364, DOI 10.1111/gcb.12072; Fuentes MMPB, 2016, MITIG ADAPT STRAT GL, V21, P209, DOI 10.1007/s11027-014-9590-3; Garcia Molinos J., 2015, NATURE CLIMATE CHANG, DOI [10.1038/nclimate2769, DOI 10.1111/GCB]; Gleason JS, 2009, ARCTIC, V62, P405; Greenslade P, 2008, J INSECT CONSERV, V12, P333, DOI 10.1007/s10841-008-9157-2; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Hamann M, 2003, CRC MAR BIOL SER, P135; Hawkes LA, 2007, GLOBAL CHANGE BIOL, V13, P923, DOI 10.1111/j.1365-2486.2007.01320.x; Hazen EL, 2013, NAT CLIM CHANGE, V3, P234, DOI 10.1038/NCLIMATE1686; Hiddink JG, 2008, GLOBAL CHANGE BIOL, V14, P453, DOI 10.1111/j.1365-2486.2007.01518.x; Hoegh-Guldberg O, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1655; Hollowed AB, 2013, ICES J MAR SCI, V70, P1023, DOI 10.1093/icesjms/fst081; Hoover C, 2013, ECOL MODEL, V264, P143, DOI 10.1016/j.ecolmodel.2013.01.010; Hsieh CH, 2008, CAN J FISH AQUAT SCI, V65, P947, DOI 10.1139/F08-017; Huber V, 2014, EARTH SYST DYNAM, V5, P399, DOI 10.5194/esd-5-399-2014; Inchausti P, 2003, J AVIAN BIOL, V34, P170, DOI 10.1034/j.1600-048X.2003.03031.x; IPCC, 2013, CLIMATE CHANGE 2022; Iverson SA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3128; Jenouvrier S, 2005, ECOLOGY, V86, P2889, DOI 10.1890/05-0514; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; Jenouvrier S, 2014, NAT CLIM CHANGE, V4, P715, DOI 10.1038/NCLIMATE2280; Kaschner K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019653; Kitaysky AS, 2000, J ANIM ECOL, V69, P248, DOI 10.1046/j.1365-2656.2000.00392.x; Kopp M, 2014, EVOL APPL, V7, P169, DOI 10.1111/eva.12127; Kovach RP, 2015, GLOBAL CHANGE BIOL, V21, P1821, DOI 10.1111/gcb.12829; Kuletz KJ, 2014, DEEP-SEA RES PT II, V109, P282, DOI 10.1016/j.dsr2.2014.05.006; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Lehodey P, 2015, DEEP-SEA RES PT II, V113, P246, DOI 10.1016/j.dsr2.2014.10.028; Lopez-Sepulcre A, 2012, BEHAVIOURAL RESPONSES TO A CHANGING WORLD: MECHANISMS AND CONSEQUENCES, P3; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; McKinney MA, 2013, GLOBAL CHANGE BIOL, V19, P2360, DOI 10.1111/gcb.12241; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; Munday PL, 2013, ECOL LETT, V16, P1488, DOI 10.1111/ele.12185; MURPHY R.C., 1936, OCEANIC BIRDS S AM, V2; Myers RA, 1998, REV FISH BIOL FISHER, V8, P285, DOI 10.1023/A:1008828730759; Neeman N, 2015, J EXP MAR BIOL ECOL, V462, P113, DOI 10.1016/j.jembe.2014.10.019; Nye JA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1420; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; O'Connor MI, 2012, GLOBAL ECOL BIOGEOGR, V21, P693, DOI 10.1111/j.1466-8238.2011.00713.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Poloczanska ES, 2009, ADV MAR BIOL, V56, P151, DOI 10.1016/S0065-2881(09)56002-6; Radovich J., 1961, Fishery Bulletin Sacramento, V112, P1; Reed TE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020380; Reed TE, 2009, J ANIM ECOL, V78, P376, DOI 10.1111/j.1365-2656.2008.01503.x; Reusch TBH, 2014, EVOL APPL, V7, P104, DOI 10.1111/eva.12109; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Rogers LA, 2008, OIKOS, V117, P1578, DOI 10.1111/j.0030-1299.2008.16758.x; Saikkonen K, 2012, NAT CLIM CHANGE, V2, P239, DOI [10.1038/NCLIMATE1430, 10.1038/nclimate1430]; Sandvik H, 2005, J ANIM ECOL, V74, P817, DOI 10.1111/j.1365-2656.2005.00981.x; Schindler DE, 2015, FRONT ECOL ENVIRON, V13, P257, DOI 10.1890/140275; Sgro CM, 2011, EVOL APPL, V4, P326, DOI 10.1111/j.1752-4571.2010.00157.x; Shoji J, 2011, ICES J MAR SCI, V68, P1165, DOI 10.1093/icesjms/fsr059; Slater L, 2009, J BIOGEOGR, V36, P465, DOI 10.1111/j.1365-2699.2008.02050.x; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Stewart JS, 2014, GLOBAL CHANGE BIOL, V20, P1832, DOI 10.1111/gcb.12502; Stine AR, 2009, NATURE, V457, P435, DOI 10.1038/nature07675; Stramma L, 2012, NAT CLIM CHANGE, V2, P33, DOI 10.1038/NCLIMATE1304; Sundby S, 2008, ICES J MAR SCI, V65, P953, DOI 10.1093/icesjms/fsn085; Sydeman WJ, 2013, GLOBAL CHANGE BIOL, V19, P1662, DOI 10.1111/gcb.12165; Sydeman WJ, 2009, MAR ECOL PROG SER, V393, P185, DOI 10.3354/meps08382; Taning A. V., 1953, INT COMM NW ATLANTIC, P69; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; Thuiller W, 2013, ECOL LETT, V16, P94, DOI 10.1111/ele.12104; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Wanless S, 2008, MAR ECOL PROG SER, V370, P263, DOI 10.3354/meps07712; Watanuki Y, 2012, MAR ECOL PROG SER, V454, P183, DOI 10.3354/meps09627; Waugh SM, 2015, CONDOR, V117, P147, DOI 10.1650/CONDOR-14-141.1; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Williams Stephen E, 2008, PLoS Biol, V6, P2621, DOI 10.1371/journal.pbio.0060325; Wolf SG, 2010, GLOBAL CHANGE BIOL, V16, P1923, DOI 10.1111/j.1365-2486.2010.02194.x; Wood KR, 2010, INT J CLIMATOL, V30, P1269, DOI 10.1002/joc.1973; Yemane D, 2014, REV FISH BIOL FISHER, V24, P463, DOI 10.1007/s11160-014-9357-7; Zeidberg LD, 2007, P NATL ACAD SCI USA, V104, P12946, DOI 10.1073/pnas.0702043104	114	134	138	12	401	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					772	777		10.1126/science.aac9874	http://dx.doi.org/10.1126/science.aac9874			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW3MS	26564847				2022-12-28	WOS:000364897000034
J	[Anonymous]				[Anonymous]			INDUSTRIAL-STRENGTH BONDS	NATURE			English	Editorial Material																		Carpenter ML, 2013, AM J HUM GENET, V93, P852, DOI 10.1016/j.ajhg.2013.10.002; Cywes-Bentley C, 2013, P NATL ACAD SCI USA, V110, pE2209, DOI 10.1073/pnas.1303573110; Kofuku Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2046; Pertuze JA, 2010, MIT SLOAN MANAGE REV, V51, P83; Pushp A, 2013, NAT PHYS, V9, P505, DOI [10.1038/nphys2669, 10.1038/NPHYS2669]; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Trastoy J, 2014, NAT NANOTECHNOL, V9, P710, DOI [10.1038/NNANO.2014.158, 10.1038/nnano.2014.158]; Visani C, 2012, NAT PHYS, V8, P539, DOI 10.1038/nphys2318	8	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					S76	S79		10.1038/527S76a	http://dx.doi.org/10.1038/527S76a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RC	26560455				2022-12-28	WOS:000364396700004
J	Daims, H; Lebedeva, EV; Pjevac, P; Han, P; Herbold, C; Albertsen, M; Jehmlich, N; Palatinszky, M; Vierheilig, J; Bulaev, A; Kirkegaard, RH; von Bergen, M; Rattei, T; Bendinger, B; Nielsen, PH; Wagner, M				Daims, Holger; Lebedeva, Elena V.; Pjevac, Petra; Han, Ping; Herbold, Craig; Albertsen, Mads; Jehmlich, Nico; Palatinszky, Marton; Vierheilig, Julia; Bulaev, Alexandr; Kirkegaard, Rasmus H.; von Bergen, Martin; Rattei, Thomas; Bendinger, Bernd; Nielsen, Per H.; Wagner, Michael			Complete nitrification by Nitrospira bacteria	NATURE			English	Article							AMMONIA-OXIDIZING BACTERIUM; COMPLETE GENOME SEQUENCE; 16S RIBOSOMAL-RNA; IN-SITU; OXIDATION-KINETICS; HIGH-ACCURACY; SP-NOV; EVOLUTION; SOIL; ARCHAEA	Nitrification, the oxidation of ammonia via nitrite to nitrate, has always been considered to be a two-step process catalysed by chemolithoautotrophic microorganisms oxidizing either ammonia or nitrite. No known nitrifier carries out both steps, although complete nitrification should be energetically advantageous. This functional separation has puzzled microbiologists for a century. Here we report on the discovery and cultivation of a completely nitrifying bacterium from the genus Nitrospira, a globally distributed group of nitrite oxidizers. The genome of this chemolithoautotrophic organism encodes the pathways both for ammonia and nitrite oxidation, which are concomitantly expressed during growth by ammonia oxidation to nitrate. Genes affiliated with the phylogenetically distinct ammonia monooxygenase and hydroxylamine dehydrogenase genes of Nitrospira are present in many environments and were retrieved on Nitrospira-contigs in new metagenomes from engineered systems. These findings fundamentally change our picture of nitrification and point to completely nitrifying Nitrospira as key components of nitrogen-cycling microbial communities.	[Daims, Holger; Pjevac, Petra; Han, Ping; Herbold, Craig; Palatinszky, Marton; Vierheilig, Julia; Wagner, Michael] Univ Vienna, Div Microbial Ecol, Dept Microbiol & Ecosyst Sci, A-1090 Vienna, Austria; [Lebedeva, Elena V.; Bulaev, Alexandr] Russian Acad Sci, Biotechnol Res Ctr, Winogradsky Inst Microbiol, Moscow 119071, Russia; [Albertsen, Mads; Kirkegaard, Rasmus H.; Nielsen, Per H.] Aalborg Univ, Dept Chem & Biosci, Ctr Microbial Communities, DK-9220 Aalborg, Denmark; [Jehmlich, Nico; von Bergen, Martin] UFZ Helmholtz Ctr Environm Res, Dept Prote, D-04318 Leipzig, Germany; [von Bergen, Martin] UFZ Helmholtz Ctr Environm Res, Dept Metabol, D-04318 Leipzig, Germany; [Rattei, Thomas] Univ Vienna, Div Computat Syst Biol, Dept Microbiol & Ecosyst Sci, A-1090 Vienna, Austria; [Bendinger, Bernd] Hamburg Univ Technol, DVGW Forsch Stelle TUHH, D-21073 Hamburg, Germany	University of Vienna; Research Center of Biotechnology RAS; Russian Academy of Sciences; Aalborg University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Vienna; Hamburg University of Technology	Wagner, M (corresponding author), Univ Vienna, Div Microbial Ecol, Dept Microbiol & Ecosyst Sci, Althanstr 14, A-1090 Vienna, Austria.	wagner@microbial-ecology.net	Palatinszky, Márton/ABB-2723-2020; Bulaev, Aleksandr/O-2455-2013; von Bergen, Martin/D-7960-2011; Han, Ping/P-5401-2019; Palatinszky, Marton/D-9876-2011; Vierheilig, Julia/AAP-2143-2020; Han, Ping/F-2360-2017; Pjevac, Petra/ABE-9919-2021; Daims, Holger/I-8410-2012; Jehmlich, Nico/D-9041-2015; Nielsen, Per Halkjær/T-6796-2018; Herbold, Craig W./S-4397-2018; Rattei, Thomas/F-1366-2011; Wagner, Michael/A-7801-2011; Pjevac, Petra/AAW-8737-2020; Palatinszky, Marton/HGB-7938-2022; Jehmlich, Nico/B-5403-2009; Vierheilig, Julia/ABC-1593-2021; Albertsen, Mads/T-7358-2018	Bulaev, Aleksandr/0000-0001-7914-9817; von Bergen, Martin/0000-0003-2732-2977; Han, Ping/0000-0001-6025-1651; Palatinszky, Marton/0000-0002-3627-085X; Han, Ping/0000-0001-6025-1651; Pjevac, Petra/0000-0001-7344-302X; Daims, Holger/0000-0002-4195-0913; Jehmlich, Nico/0000-0002-5638-6868; Nielsen, Per Halkjær/0000-0002-6402-1877; Herbold, Craig W./0000-0003-3479-0197; Rattei, Thomas/0000-0002-0592-7791; Wagner, Michael/0000-0002-9778-7684; Pjevac, Petra/0000-0001-7344-302X; Palatinszky, Marton/0000-0002-3627-085X; Jehmlich, Nico/0000-0002-5638-6868; Kirkegaard, Rasmus Hansen/0000-0003-3349-3617; Valeeva, Aygul V./0000-0002-9968-9586; Vierheilig, Julia/0000-0002-9764-7534; Albertsen, Mads/0000-0002-6151-190X	European Regional Development Funds (EFRE-Europe funds Saxony); Helmholtz Association; Austrian Science Fund (FWF) [P27319-B21, P25231-B21]; European Research Council Advanced Grant [NITRICARE 294343]; Danish Council for Independent Research [DFF-4005-00369]; Innovation Fund Denmark (EcoDesign); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER	European Regional Development Funds (EFRE-Europe funds Saxony); Helmholtz Association(Helmholtz Association); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council Advanced Grant(European Research Council (ERC)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Innovation Fund Denmark (EcoDesign); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank T. K. Lee and M. Steinberger for help with PCR analyses, N. V. Grigor'eva and M. Pogoda for assistance with culture maintenance, N. A. Kostrikina for assistance with electron microscopy, K. Kitzinger for support with FISH analyses, M. Mooshammer for help with chemical analyses, R. Hatzenpichler for designing probe Nmir1009, K. Eismann for help with proteome sample preparation, B. Scheer for help with mass spectrometer maintenance, Purena GmbH (Wolfenbuttel, Germany) for cooperation, N. Chernyh and J. Rosenthal for taking samples, and H. Koch and E. Bock for discussion. The authors are grateful for using the analytical facilities of the Centre for Chemical Microscopy (ProVIS) (Helmholtz Centre for Environmental Research), which is headed by H. Richnow (Department of Isotope Biochemistry) and supported by European Regional Development Funds (EFRE-Europe funds Saxony) and the Helmholtz Association. P.P. and H.D. were supported by the Austrian Science Fund (FWF) projects P27319-B21 and P25231-B21 (to H.D.). M.P., J.V., P.H., and M.W. were supported by the European Research Council Advanced Grant project NITRICARE 294343 (to M.W.). M. A., R. H. K., and P.H. N. were supported by the Danish Council for Independent Research, DFF-4005-00369 and Innovation Fund Denmark (EcoDesign).	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Altmann D, 2003, ENVIRON MICROBIOL, V5, P798, DOI 10.1046/j.1469-2920.2003.00469.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Angel R., 2012, PROTOC EXCH; Angel R, 2012, ISME J, V6, P847, DOI 10.1038/ismej.2011.141; Arp D., 2006, MICROBE, V1, P229; Arp DJ, 2007, ANNU REV MICROBIOL, V61, P503, DOI 10.1146/annurev.micro.61.080706.093449; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benson DA, 2015, NUCLEIC ACIDS RES, V43, pD30, DOI 10.1093/nar/gku1216; Bergmann DJ, 2005, APPL ENVIRON MICROB, V71, P5371, DOI 10.1128/AEM.71.9.5371-5382.2005; Berube PM, 2012, J BACTERIOL, V194, P3448, DOI 10.1128/JB.00133-12; Bock E., 2001, PROKARYOTES HDB BIOL, P457; Boetzer M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-211; Chain P, 2003, J BACTERIOL, V185, P2759, DOI 10.1128/JB.185.9.2759-2773.2003; Costa E, 2006, TRENDS MICROBIOL, V14, P213, DOI 10.1016/j.tim.2006.03.006; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Daims H, 2001, APPL ENVIRON MICROB, V67, P5273, DOI 10.1128/AEM.67.11.5273-5284.2001; Daims H, 2009, COLD SPRING HARB PRO, V2009, pt5253; Daims H, 2005, MOL MICROBIAL ECOLOG, P213; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Dupont CL, 2012, ISME J, V6, P1186, DOI 10.1038/ismej.2011.189; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EHRICH S, 1995, ARCH MICROBIOL, V164, P16; Foesel BU, 2008, FEMS MICROBIOL ECOL, V63, P192, DOI 10.1111/j.1574-6941.2007.00418.x; Gregor I., 2014, PREPRINT; Gruber-Dorninger C, 2015, ISME J, V9, P643, DOI 10.1038/ismej.2014.156; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hackl T, 2014, BIOINFORMATICS, V30, P3004, DOI 10.1093/bioinformatics/btu392; Heinrich Reinhart, 1996, REGULATION CELLULAR; Hood-Nowotny R, 2010, SOIL SCI SOC AM J, V74, P1018, DOI 10.2136/sssaj2009.0389; Hovanec TA, 1998, APPL ENVIRON MICROB, V64, P258; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; KANDELER E, 1988, BIOL FERT SOILS, V6, P68, DOI 10.1007/BF00257924; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Klotz MG, 2008, ENVIRON MICROBIOL, V10, P3150, DOI 10.1111/j.1462-2920.2008.01733.x; Klotz MG, 2008, FEMS MICROBIOL LETT, V278, P146, DOI 10.1111/j.1574-6968.2007.00970.x; Klotz MG, 2006, APPL ENVIRON MICROB, V72, P6299, DOI 10.1128/AEM.00463-06; Koch H, 2015, P NATL ACAD SCI USA, V112, P11371, DOI 10.1073/pnas.1506533112; Koch H, 2014, SCIENCE, V345, P1052, DOI 10.1126/science.1256985; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lebedeva EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080835; Lebedeva EV, 2011, FEMS MICROBIOL ECOL, V75, P195, DOI 10.1111/j.1574-6941.2010.01006.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; Maixner F, 2006, ENVIRON MICROBIOL, V8, P1487, DOI 10.1111/j.1462-2920.2006.01033.x; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Martiny AC, 2005, APPL ENVIRON MICROB, V71, P8611, DOI 10.1128/AEM.71.12.8611-8617.2005; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Mobarry BK, 1996, APPL ENVIRON MICROB, V62, P2156, DOI 10.1128/AEM.62.6.2156-2162.1996; Norton JM, 2008, APPL ENVIRON MICROB, V74, P3559, DOI 10.1128/AEM.02722-07; Nowka B, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiu031; Nowka B, 2015, APPL ENVIRON MICROB, V81, P745, DOI 10.1128/AEM.02734-14; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Palatinszky M, 2015, NATURE, V524, P105, DOI 10.1038/nature14856; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Pester M, 2014, ENVIRON MICROBIOL, V16, P3055, DOI 10.1111/1462-2920.12300; Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x; Pfeiffer T, 2004, AM NAT, V163, pE126, DOI 10.1086/383593; Prosser JI, 2012, TRENDS MICROBIOL, V20, P523, DOI 10.1016/j.tim.2012.08.001; Purkhold U, 2000, APPL ENVIRON MICROB, V66, P5368, DOI 10.1128/AEM.66.12.5368-5382.2000; *R PROJ, 2013, R LANG ENV STAT COMP; Radajewski S, 2002, MICROBIOL-SGM, V148, P2331, DOI 10.1099/00221287-148-8-2331; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; RITTMANN BE, 1994, WATER SCI TECHNOL, V30, P1; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Schramm A, 1999, APPL ENVIRON MICROB, V65, P3690; Schramm A, 1998, APPL ENVIRON MICROB, V64, P3480; Sorokin DY, 2012, ISME J, V6, P2245, DOI 10.1038/ismej.2012.70; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stein LY, 2007, ENVIRON MICROBIOL, V9, P2993, DOI 10.1111/j.1462-2920.2007.01409.x; Stoecker K, 2006, P NATL ACAD SCI USA, V103, P2363, DOI 10.1073/pnas.0506361103; Suwa Y, 2011, J BACTERIOL, V193, P5047, DOI 10.1128/JB.05521-11; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Ushiki N, 2013, MICROBES ENVIRON, V28, P346, DOI 10.1264/jsme2.ME13042; Vallenet D, 2013, NUCLEIC ACIDS RES, V41, pE636, DOI 10.1093/nar/gks1194; van Eck K Griess-Romijn, 1966, 105642 NEN; van Kessel M. A. H. J., 2015, NATURE; Watson M, 2015, BIOINFORMATICS, V31, P114, DOI 10.1093/bioinformatics/btu590; WATSON SW, 1986, ARCH MICROBIOL, V144, P1, DOI 10.1007/BF00454947; Widdel F., 1980, THESIS; Winkler MKH, 2012, APPL MICROBIOL BIOT, V94, P1657, DOI 10.1007/s00253-012-4126-9; Winogradsky S., 1892, ARCH SCI BIOL ST PET, V1, P87; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041	92	1175	1304	106	1440	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					504	+		10.1038/nature16461	http://dx.doi.org/10.1038/nature16461			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26610024	Green Accepted			2022-12-28	WOS:000366991900042
J	Bach, PB; Pearson, SD				Bach, Peter B.; Pearson, Steven D.			Payer and Policy Maker Steps to Support Value-Based Pricing for Drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bach, Peter B.] Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, New York, NY 10021 USA; [Pearson, Steven D.] Inst Clin & Econ Review, Boston, MA USA	Memorial Sloan Kettering Cancer Center	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, 1275 York Ave,POB 44, New York, NY 10021 USA.	bachp@mskcc.org						Anderson JL, 2014, J AM COLL CARDIOL, V63, P2304, DOI 10.1016/j.jacc.2014.03.016; [Anonymous], 2013 COMP PRIC REP V; Bach PB, 2009, NEW ENGL J MED, V360, P626, DOI 10.1056/NEJMhpr0807774; Cherny NI, 2015, ANN ONCOL, V26, P1547, DOI 10.1093/annonc/mdv249; Dusetzina SB, 2014, J CLIN ONCOL, V32, P306, DOI 10.1200/JCO.2013.52.9123; Keehan SP, 2015, HEALTH AFFAIR, V34, P1407, DOI 10.1377/hlthaff.2015.0600; Loftus P., 2015, WALL STREET J	7	62	63	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 15	2015	314	23					2503	2504		10.1001/jama.2015.16843	http://dx.doi.org/10.1001/jama.2015.16843			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4PV	26619354				2022-12-28	WOS:000366391500013
J	Eisenstein, M				Eisenstein, Michael			Disease: Closing the door on HIV	NATURE			English	Editorial Material							T-CELLS											Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662	2	3	3	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					S8	S9		10.1038/528S8a	http://dx.doi.org/10.1038/528S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26630600	Bronze			2022-12-28	WOS:000365606000004
J	Holtkamp, W; Kokic, G; Jager, M; Mittelstaet, J; Komar, AA; Rodnina, MV				Holtkamp, Wolf; Kokic, Goran; Jaeger, Marcus; Mittelstaet, Joerg; Komar, Anton A.; Rodnina, Marina V.			Cotranslational protein folding on the ribosome monitored in real time	SCIENCE			English	Article							EXIT TUNNEL; NMR-SPECTROSCOPY; DYNAMICS	Protein domains can fold into stable tertiary structures while they are synthesized on the ribosome. We used a high-performance, reconstituted in vitro translation system to investigate the folding of a small five-helix protein domain-the N-terminal domain of Escherichia coli N5-glutamine methyltransferase HemK-in real time. Our observations show that cotranslational folding of the protein, which folds autonomously and rapidly in solution, proceeds through a compact, non-native conformation that forms within the peptide tunnel of the ribosome. The compact state rearranges into a native-like structure immediately after the full domain sequence has emerged from the ribosome. Both folding transitions are rate-limited by translation, allowing for quasi-equilibrium sampling of the conformational space restricted by the ribosome. Cotranslational folding may be typical of small, intrinsically rapidly folding protein domains.	[Holtkamp, Wolf; Kokic, Goran; Jaeger, Marcus; Mittelstaet, Joerg; Rodnina, Marina V.] Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany; [Komar, Anton A.] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA; [Komar, Anton A.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA	Max Planck Society; University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University	Rodnina, MV (corresponding author), Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany.	rodnina@mpibpc.mpg.de	Rodnina, Marina V./AAD-4667-2019	Rodnina, Marina V./0000-0003-0105-3879; Komar, Anton/0000-0003-4188-0633	Max Planck Society; Deutsche Forschungsgemeinschaft [FOR1805]; Human Frontier Science Program [RGP0024-2010]; Max Planck Institute of Biophysical Chemistry (Gottingen)	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program); Max Planck Institute of Biophysical Chemistry (Gottingen)	We thank W. Wintermeyer for critically reading the manuscript, and O. Geintzer, S. Kappler, T. Wiles, M. Zimmermann, T. Uhlendorf, and A. Bursy for expert technical assistance. Supported by the Max Planck Society, Deutsche Forschungsgemeinschaft grant FOR1805 (M.V.R.), and Human Frontier Science Program grant RGP0024-2010 (M.V.R. and A.A.K.). Data described in this manuscript can be found in the supplementary materials. A.A.K. acknowledges the support of Max Planck Institute of Biophysical Chemistry (Gottingen) during his sabbatical stay in fall 2013.	Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Chen HM, 2010, J AM CHEM SOC, V132, P7244, DOI 10.1021/ja100500k; Doose S, 2009, CHEMPHYSCHEM, V10, P1389, DOI 10.1002/cphc.200900238; Eichmann C, 2010, P NATL ACAD SCI USA, V107, P9111, DOI 10.1073/pnas.0914300107; Gloge F, 2014, CURR OPIN STRUC BIOL, V24, P24, DOI 10.1016/j.sbi.2013.11.004; Han Y, 2012, P NATL ACAD SCI USA, V109, P12467, DOI 10.1073/pnas.1208138109; Hsu STD, 2007, P NATL ACAD SCI USA, V104, P16516, DOI 10.1073/pnas.0704664104; Kaiser CM, 2011, SCIENCE, V334, P1723, DOI 10.1126/science.1209740; Keil B., 1992, SPECIFICITY PROTEOLY, V331, P201, DOI DOI 10.1007/978-3-642-48380-6; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Kosolapov A, 2009, NAT STRUCT MOL BIOL, V16, P405, DOI 10.1038/nsmb.1571; Kubelka J, 2006, J MOL BIOL, V359, P546, DOI 10.1016/j.jmb.2006.03.034; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Marme N, 2003, BIOCONJUGATE CHEM, V14, P1133, DOI 10.1021/bc0341324; Mittelstaet J, 2013, J AM CHEM SOC, V135, P17031, DOI 10.1021/ja407511q; Nilsson OB, 2015, CELL REP, V12, P1533, DOI 10.1016/j.celrep.2015.07.065; O'Brien EP, 2011, J AM CHEM SOC, V133, P513, DOI 10.1021/ja107863z; Pechmann S, 2013, MOL CELL, V49, P411, DOI 10.1016/j.molcel.2013.01.020; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Yang Z, 2004, J MOL BIOL, V340, P695, DOI 10.1016/j.jmb.2004.05.019; Zhang G, 2011, CURR OPIN STRUC BIOL, V21, P25, DOI 10.1016/j.sbi.2010.10.008	22	131	132	3	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1104	1107		10.1126/science.aad0344	http://dx.doi.org/10.1126/science.aad0344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY5BJ	26612953				2022-12-28	WOS:000366422600047
J	Fischer, KR; Durrans, A; Lee, S; Sheng, JT; Li, FH; Wong, STC; Choi, HJ; El Rayes, T; Ryu, SH; Troeger, J; Schwabe, RF; Vahdat, LT; Altorki, NK; Mittal, V; Gao, DC				Fischer, Kari R.; Durrans, Anna; Lee, Sharrell; Sheng, Jianting; Li, Fuhai; Wong, Stephen T. C.; Choi, Hyejin; El Rayes, Tina; Ryu, Seongho; Troeger, Juliane; Schwabe, Robert F.; Vahdat, Linda T.; Altorki, Nasser K.; Mittal, Vivek; Gao, Dingcheng			Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance	NATURE			English	Article							CANCER-CELLS; MIR-200 FAMILY; STEM-CELLS; BREAST; EXPRESSION; PLASTICITY; RESISTANCE; INDUCTION; THERAPY; MODEL	The role of epithelial-to-mesenchymal transition (EMT) in metastasis is a longstanding source of debate, largely owing to an inability to monitor transient and reversible EMT phenotypes in vivo. Here we establish an EMT lineage-tracing system to monitor this process in mice, using a mesenchymal-specific Cre-mediated fluorescent marker switch system in spontaneous breast-to-lung metastasis models. We show that within a predominantly epithelial primary tumour, a small proportion of tumour cells undergo EMT. Notably, lung metastases mainly consist of non-EMT tumour cells that maintain their epithelial phenotype. Inhibiting EMT by overexpressing the microRNA miR-200 does not affect lung metastasis development. However, EMT cells significantly contribute to recurrent lung metastasis formation after chemotherapy. These cells survived cyclophosphamide treatment owing to reduced proliferation, apoptotic tolerance and increased expression of chemoresistance-related genes. Overexpression of miR-200 abrogated this resistance. This study suggests the potential of an EMT-targeting strategy, in conjunction with conventional chemotherapies, for breast cancer treatment.	[Fischer, Kari R.; Durrans, Anna; Lee, Sharrell; Choi, Hyejin; El Rayes, Tina; Ryu, Seongho; Altorki, Nasser K.; Mittal, Vivek; Gao, Dingcheng] Cornell Univ, Weill Cornell Med Coll, Dept Cardiothorac Surg, 1300 York Ave, New York, NY 10065 USA; [Fischer, Kari R.; Durrans, Anna; Lee, Sharrell; Choi, Hyejin; El Rayes, Tina; Mittal, Vivek; Gao, Dingcheng] Cornell Univ, Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Fischer, Kari R.; Durrans, Anna; Lee, Sharrell; Choi, Hyejin; El Rayes, Tina; Ryu, Seongho; Altorki, Nasser K.; Mittal, Vivek; Gao, Dingcheng] Cornell Univ, Weill Cornell Med Coll, Neuberger Berman Lung Canc Ctr, New York, NY 10065 USA; [Fischer, Kari R.; Choi, Hyejin; El Rayes, Tina] Cornell Univ, Weill Cornell Med Coll, Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA; [Sheng, Jianting; Li, Fuhai; Wong, Stephen T. C.] Houston Methodist Hosp, Houston Methodist Res Inst, Dept Syst Med & Bioengn, Houston, TX 77030 USA; [Wong, Stephen T. C.] Houston Methodist Hosp, Methodist Canc Ctr, Houston, TX 77030 USA; [Ryu, Seongho] Soonchunhyang Univ, Soonchunhyang Inst Medi Bio Sci SIMS, Cheonan Si 31151, Chungcheongnam, South Korea; [Troeger, Juliane; Schwabe, Robert F.] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Troeger, Juliane; Schwabe, Robert F.] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA; [Vahdat, Linda T.] Cornell Univ, Weill Cornell Med Coll, Dept Med 1, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; Soonchunhyang University; Columbia University; Columbia University; Cornell University	Mittal, V (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Cardiothorac Surg, 1300 York Ave, New York, NY 10065 USA.	vim2010@med.cornell.edu; dig2009@med.cornell.edu	Schwabe, Robert/AAY-6506-2021; Gao, Dingcheng/P-5889-2019; Choi, Hyejin/ABC-5099-2020; El Rayes, Tina/R-8202-2017; Choi, Hyejin/ABC-4915-2020	Choi, Hyejin/0000-0002-4884-2747; El Rayes, Tina/0000-0002-9935-388X; Choi, Hyejin/0000-0002-4884-2747	US Department of Defense CDMRP LCRP [LC110643]; NIH [1 F31 CA186510-01]; National Cancer Institute [U54 CA149196-05]; WCMC Meyer Cancer Center Pilot Funding; Neuberger Berman Foundation Lung Cancer Research Center; Arthur and Myra Mahon Donor-Advised Fund; Liz Claiborne and Art Ortenberg Foundation; Douglas AMP; Katherine McCormick Family Foundation; R. AMP; M. Goldberg Family Foundation; P. AMP; C. Collins Fund; Eliot Stewart 'Wren' Fund; William and Shelby Modell Family Foundation Trust; Division of Thoracic Surgery; NATIONAL CANCER INSTITUTE [R01CA135417, F31CA186510, U01CA188388, U54CA149196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008539] Funding Source: NIH RePORTER	US Department of Defense CDMRP LCRP; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); WCMC Meyer Cancer Center Pilot Funding; Neuberger Berman Foundation Lung Cancer Research Center; Arthur and Myra Mahon Donor-Advised Fund; Liz Claiborne and Art Ortenberg Foundation; Douglas AMP; Katherine McCormick Family Foundation; R. AMP; M. Goldberg Family Foundation; P. AMP; C. Collins Fund; Eliot Stewart 'Wren' Fund; William and Shelby Modell Family Foundation Trust; Division of Thoracic Surgery; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the US Department of Defense CDMRP LCRP (LC110643). K.F. is supported by a fellowship from the NIH (1 F31 CA186510-01). V.M. was supported by the National Cancer Institute sub-award (U54 CA149196-05) and WCMC Meyer Cancer Center Pilot Funding. This work was also supported by funds from The Neuberger Berman Foundation Lung Cancer Research Center; the Arthur and Myra Mahon Donor-Advised Fund; the Liz Claiborne and Art Ortenberg Foundation; the Douglas & Katherine McCormick Family Foundation, the R. & M. Goldberg Family Foundation; the P. & C. Collins Fund; the Eliot Stewart 'Wren' Fund; the William and Shelby Modell Family Foundation Trust; and generous funds donated by patients in the Division of Thoracic Surgery to N.K.A. The funding organizations played no role in experimental design, data analysis or manuscript preparation.	Bastid J, 2012, CANCER METAST REV, V31, P277, DOI 10.1007/s10555-011-9344-6; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Cabezon T, 2007, INT J CANCER, V121, P1433, DOI 10.1002/ijc.22850; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Diessner J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.115; Dumont N, 2008, P NATL ACAD SCI USA, V105, P14867, DOI 10.1073/pnas.0807146105; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; Gao DC, 2012, CANCER RES, V72, P1384, DOI 10.1158/0008-5472.CAN-11-2905; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gunasinghe NPAD, 2012, CANCER METAST REV, V31, P469, DOI 10.1007/s10555-012-9377-5; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Lau CK, 2009, CLIN CANCER RES, V15, P3462, DOI 10.1158/1078-0432.CCR-08-2127; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Okada H, 1997, AM J PHYSIOL-RENAL, V273, pF563, DOI 10.1152/ajprenal.1997.273.4.F563; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; RUSSO JE, 1988, CANCER RES, V48, P2963; Scheel C, 2011, INT J CANCER, V129, P2310, DOI 10.1002/ijc.26311; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; von Minckwitz G, 2007, EXPERT OPIN PHARMACO, V8, P485, DOI 10.1517/14656566.8.4.485; Xiao ZM, 2015, BIOTECHNOL APPL BIOC, V62, P401, DOI 10.1002/bab.1193; Xue CS, 2003, CANCER RES, V63, P3386; Yamada D, 2013, EUR J CANCER, V49, P1725, DOI 10.1016/j.ejca.2012.12.002; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zhang YH, 2012, MODERN PATHOL, V25, P178, DOI 10.1038/modpathol.2011.167	35	1205	1247	4	260	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					472	+		10.1038/nature15748	http://dx.doi.org/10.1038/nature15748			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26560033	Green Accepted			2022-12-28	WOS:000365352500038
J	Heeney, JL				Heeney, Jonathan L.			EBOLA Hidden reservoirs	NATURE			English	Editorial Material							VIRUS-DISEASE		[Heeney, Jonathan L.] Univ Cambridge, Lab Viral Zoonot, Cambridge CB3 OES, England	University of Cambridge	Heeney, JL (corresponding author), Univ Cambridge, Lab Viral Zoonot, Cambridge CB3 OES, England.	jlh66@cam.ac.uk		Heeney, Jonathan/0000-0003-2702-1621	Wellcome Trust [100891] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 2015, NURSING STAND, V30, P8; Baggi F. M., 2014, EUROSURVEILLANCE; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Borchert M, 2002, TROP MED INT HEALTH, V7, P902, DOI 10.1046/j.1365-3156.2002.00945.x; Clark DV, 2015, LANCET INFECT DIS, V15, P905, DOI 10.1016/S1473-3099(15)70152-0; Deen G.F., 2015, N ENGL J MED; Gulland A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4336; MARTINI GA, 1969, T ROY SOC TROP MED H, V63, P295, DOI 10.1016/0035-9203(69)90001-7; Mate S. E., 2015, N ENGL J MED; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]; Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291; SMITH DH, 1982, LANCET, V1, P816	13	19	20	0	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					453	455		10.1038/527453a	http://dx.doi.org/10.1038/527453a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26607539	Bronze			2022-12-28	WOS:000365352500032
J	Soluyanov, AA; Gresch, D; Wang, ZJ; Wu, QS; Troyer, M; Dai, X; Bernevig, BA				Soluyanov, Alexey A.; Gresch, Dominik; Wang, Zhijun; Wu, QuanSheng; Troyer, Matthias; Dai, Xi; Bernevig, B. Andrei			Type-II Weyl semimetals	NATURE			English	Article							FERMION SEMIMETAL	Fermions-elementary particles such as electrons-are classified as Dirac, Majorana or Weyl. Majorana and Weyl fermions had not been observed experimentally until the recent discovery of condensed matter systems such as topological superconductors and semimetals, in which they arise as low-energy excitations(1-6). Here we propose the existence of a previously overlooked type of Weyl fermion that emerges at the boundary between electron and hole pockets in a new phase of matter. This particle was missed by Weyl(7) because it breaks the stringent Lorentz symmetry in high-energy physics. Lorentz invariance, however, is not present in condensed matter physics, and by generalizing the Dirac equation, we find the new type of Weyl fermion. In particular, whereas Weyl semimetals-materials hosting Weyl fermions-were previously thought to have standard Weyl points with a point-like Fermi surface (which we refer to as type-I), we discover a type-II Weyl point, which is still a protected crossing, but appears at the contact of electron and hole pockets in type-II Weyl semimetals. We predict that WTe2 is an example of a topological semimetal hosting the new particle as a low-energy excitation around such a type-II Weyl point. The existence of type-II Weyl points in WTe2 means that many of its physical properties are very different to those of standard Weyl semimetals with point-like Fermi surfaces.	[Soluyanov, Alexey A.; Gresch, Dominik; Wu, QuanSheng; Troyer, Matthias] Swiss Fed Inst Technol, Theoret Phys & Stn Zurich Q, CH-8093 Zurich, Switzerland; [Wang, Zhijun; Bernevig, B. Andrei] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Dai, Xi] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China	Swiss Federal Institutes of Technology Domain; ETH Zurich; Princeton University; Chinese Academy of Sciences; Institute of Physics, CAS	Soluyanov, AA (corresponding author), Swiss Fed Inst Technol, Theoret Phys & Stn Zurich Q, CH-8093 Zurich, Switzerland.	soluyanov@itp.phys.ethz.ch	Wang, Zhijun/O-8015-2014; Gresch, Dominik/AAS-7509-2021; Dai, Xi/HCG-9886-2022; Troyer, Matthias/B-7826-2008; Wu, QuanSheng/AAL-3118-2021; Soluyanov, Alexey A./Q-1904-2019; Wu, QuanSheng/Q-2316-2016; Dai, Xi/C-4236-2008	Wang, Zhijun/0000-0003-2169-8068; Troyer, Matthias/0000-0002-1469-9444; Wu, QuanSheng/0000-0002-9154-4489; Soluyanov, Alexey A./0000-0003-3539-1024; Wu, QuanSheng/0000-0002-9154-4489; Dai, Xi/0000-0002-2396-0966; Gresch, Dominik/0000-0002-0150-0424	Microsoft Research; Swiss National Science Foundation through the National Competence Center in Research MARVEL; European Research Council through ERC Advanced Grant SIMCOFE; ARO MURI [W911NF-12-1-0461]; NSF CAREER [DMR-0952428]; NSF MRSEC [DMR-0819860]; Packard Foundation; Keck grant; National Natural Science Foundation of China; 973 program of China [2011CBA00108, 2013CB921700]; Chinese Academy of Sciences [XDB07020100];  [ONR-N00014-11-1-0635]	Microsoft Research(Microsoft); Swiss National Science Foundation through the National Competence Center in Research MARVEL; European Research Council through ERC Advanced Grant SIMCOFE(European Research Council (ERC)); ARO MURI(MURI); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Packard Foundation(The David & Lucile Packard Foundation); Keck grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); 	A.A.S., D.G., QS.W. and M.T. acknowledge the support of Microsoft Research, the Swiss National Science Foundation through the National Competence Center in Research MARVEL and the European Research Council through ERC Advanced Grant SIMCOFE. Z.W. and B.A.B. acknowledge the support of ARO MURI W911NF-12-1-0461, ONR-N00014-11-1-0635, NSF CAREER DMR-0952428, NSF MRSEC DMR-0819860, the Packard Foundation and a Keck grant. X.D. is supported by the National Natural Science Foundation of China, the 973 program of China (no. 2011CBA00108 and no. 2013CB921700) and the "Strategic Priority Research Program (B)" of the Chinese Academy of Sciences (no. XDB07020100).	Ali MN, 2014, NATURE, V514, P205, DOI 10.1038/nature13763; BROWN BE, 1966, ACTA CRYSTALLOGR, V20, P268, DOI 10.1107/S0365110X66000513; Hosur P, 2013, CR PHYS, V14, P857, DOI 10.1016/j.crhy.2013.10.010; Huang SM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8373; Huang XC, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031023; Lv BQ, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031013; NIELSEN HB, 1983, PHYS LETT B, V130, P389, DOI 10.1016/0370-2693(83)91529-0; NIELSEN HB, 1981, NUCL PHYS B, V185, P20, DOI 10.1016/0550-3213(81)90361-8; Pletikosic I, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.216601; Silaev MA, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.214511; Soluyanov AA, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.235401; Volovik GE, 2014, JETP LETT+, V98, P753, DOI 10.1134/S002136401324020X; Volovik G. E., 2009, UNIVERSE HELIUM DROP; Wan XG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205101; Weng HM, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.011029; Weyl H, 1929, Z PHYS, V56, P330, DOI 10.1007/BF01339504; Xiong J., 2015, PREPRINT; Xu G, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.186806; Xu SY, 2015, SCIENCE, V349, P613, DOI 10.1126/science.aaa9297; Yu R, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075119; Zhang C., 2015, PREPRINT; Zyuzin AA, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.115133	23	1615	1641	48	985	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					495	498		10.1038/nature15768	http://dx.doi.org/10.1038/nature15768			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26607545	Green Submitted			2022-12-28	WOS:000365352500043
J	Srivastava, R				Srivastava, Ranjana			Nourishment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Srivastava, Ranjana] Monash Hlth, Melbourne, Vic, Australia		Srivastava, R (corresponding author), Monash Hlth, Melbourne, Vic, Australia.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2015	373	22					2100	2101		10.1056/NEJMp1508201	http://dx.doi.org/10.1056/NEJMp1508201			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9YT	26605927				2022-12-28	WOS:000365354800004
J	Romano, M; Cifelli, RL				Romano, Marco; Cifelli, Richard L.			100 years of continental drift	SCIENCE			English	Editorial Material							SUPER-EARTHS		[Romano, Marco] Univ Roma La Sapienza, Dipartimento Sci Terra, I-00185 Rome, Italy; [Cifelli, Richard L.] Sam Noble Museum, Norman, OK 73072 USA	Sapienza University Rome	Romano, M (corresponding author), Univ Roma La Sapienza, Dipartimento Sci Terra, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	marco.romano@uniroma1.it; rlc@ou.edu	Romano, Marco/G-9300-2016	Romano, Marco/0000-0001-7629-3872				Bosellini A., 1978, TETTONICA PLACCHE GE; Bullard E., 1965, PHILOS T R SOC LON A, VA258, P6; DIETZ RS, 1970, SCI AM, V223, P30, DOI 10.1038/scientificamerican1070-30; Frankel H.R., 2012, CONTINENTAL DRIFT CO; Greene M. T., 2015, A WEGENER SCI EXPLOR; SCOTESE C. R., 2001, ATLAS EARTH HIST, V1; Simpson GG, 1943, AM J SCI, V241, P1, DOI 10.2475/ajs.241.1.1; Stamenkovi V., 2013, ASTROPHYS J, V748, P1; Stein C, 2013, EARTH PLANET SC LETT, V361, P448, DOI 10.1016/j.epsl.2012.11.011; Tackley PJ, 2013, ICARUS, V225, P50, DOI 10.1016/j.icarus.2013.03.013; van der Gracht W. A, 1928, THEORY CONTINENTAL D; Wegener A, 1911, THERMODYNAMIK ATMOSP; Wegener A, 1915, ENTSTEHUNG KONTINENT	13	15	15	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					915	916		10.1126/science.aad6230	http://dx.doi.org/10.1126/science.aad6230			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW4IP	26586750				2022-12-28	WOS:000364955200025
J	John, CC; Carabin, H; Montano, SM; Bangirana, P; Zunt, JR; Peterson, PK				John, Chandy C.; Carabin, Helene; Montano, Silvia M.; Bangirana, Paul; Zunt, Joseph R.; Peterson, Phillip K.			Global research priorities for infections that affect the nervous system	NATURE			English	Review							COMPUTERIZED COGNITIVE REHABILITATION; CIRCUMSPOROZOITE PROTEIN; CEREBRAL MALARIA; CYTOMEGALOVIRUS-INFECTION; TUBERCULOUS MENINGITIS; PLASMODIUM-FALCIPARUM; UGANDAN CHILDREN; NATIONAL CAUSES; BURDEN; MORTALITY	Infections that cause significant nervous system morbidity globally include viral (for example, HIV, rabies, Japanese encephalitis virus, herpes simplex virus, varicella zoster virus, cytomegalovirus, dengue virus and chikungunya virus), bacterial (for example, tuberculosis, syphilis, bacterial meningitis and sepsis), fungal (for example, cryptococcal meningitis) and parasitic (for example, malaria, neurocysticercosis, neuroschistosomiasis and soil-transmitted helminths) infections. The neurological, cognitive, behavioural or mental health problems caused by the infections probably affect millions of children and adults in low-and middle-income countries. However, precise estimates of morbidity are lacking for most infections, and there is limited information on the pathogenesis of nervous system injury in these infections. Key research priorities for infection-related nervous system morbidity include accurate estimates of disease burden; point-of-care assays for infection diagnosis; improved tools for the assessment of neurological, cognitive and mental health impairment; vaccines and other interventions for preventing infections; improved understanding of the pathogenesis of nervous system disease in these infections; more effective methods to treat and prevent nervous system sequelae; operations research to implement known effective interventions; and improved methods of rehabilitation. Research in these areas, accompanied by efforts to implement promising technologies and therapies, could substantially decrease the morbidity and mortality of infections affecting the nervous system in low-and middle-income countries.	[John, Chandy C.] Indiana Univ Sch Med, Dept Pediat, Ryan White Ctr Pediat Infect Dis & Global Hlth, Indianapolis, IN 46202 USA; [Carabin, Helene] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Dept Biostat & Epidemiol, Oklahoma City, OK 73104 USA; [Montano, Silvia M.] US Naval Med Res, Dept Bacteriol, Unit 6, Lima, Peru; [Bangirana, Paul] Makerere Univ, Dept Psychiat, Coll Hlth Sci, Kampala, Uganda; [Zunt, Joseph R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Peterson, Phillip K.] Univ Minnesota, Div Infect Dis & Int Med, Minneapolis, MN 55455 USA	Indiana University System; Indiana University Bloomington; University of Oklahoma System; University of Oklahoma Health Sciences Center; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); Makerere University; University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities	John, CC (corresponding author), Indiana Univ Sch Med, Dept Pediat, Ryan White Ctr Pediat Infect Dis & Global Hlth, Indianapolis, IN 46202 USA.	chjohn@iu.edu	Zunt, Joseph/ABD-2886-2021; John, Chandy/GNP-8431-2022	John, Chandy/0000-0002-1634-1411	Fogarty International Center; National Institutes of Health [R01 NS055349, D43 NS078280, R25 TW009345, R21 NS077466, R01 NS064901, R01 NS55627]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055627, R21NS077466, R01NS064901, R01NS055349] Funding Source: NIH RePORTER	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors' work was supported by the Fogarty International Center and by National Institutes of Health grants R01 NS055349 (C.C.J.), D43 NS078280 (C.C.J.), R25 TW009345 (J.R.Z., C.C.J.), R21 NS077466 (H.C.), R01 NS064901 (H.C.), and R01 NS55627 (J.R.Z.). We are grateful to D. Gilden for his insightful review and suggestions.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; ALARCON F, 1992, STROKE, V23, P1563, DOI 10.1161/01.STR.23.11.1563; Ances BM, 2007, SEMIN NEUROL, V27, P86, DOI 10.1055/s-2006-956759; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS62, DOI 10.1038/sj.jp.7211273; Bangirana P, 2014, CLIN INFECT DIS, V59, P336, DOI 10.1093/cid/ciu293; Bangirana P, 2009, J DEV BEHAV PEDIATR, V30, P310, DOI 10.1097/DBP.0b013e3181b0f01b; Baud O, 2013, HAND CLINIC, V112, P1109, DOI 10.1016/B978-0-444-52910-7.00030-1; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Birbeck GL, 2010, LANCET NEUROL, V9, P1173, DOI 10.1016/S1474-4422(10)70270-2; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Boivin MJ, 2013, J PEDIATR-US, V163, P1409, DOI 10.1016/j.jpeds.2013.06.055; Boivin MJ, 2010, NEUROPSYCHOLOGY, V24, P667, DOI 10.1037/a0019312; Boulware DR, 2014, NEW ENGL J MED, V370, P2487, DOI 10.1056/NEJMoa1312884; Brouwer MC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004405.pub4; Bruckner TA, 2011, B WORLD HEALTH ORGAN, V89, P184, DOI 10.2471/BLT.10.082784; Carabin H, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001152; Cobbs CS, 2002, CANCER RES, V62, P3347; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Coyle Christina Marie, 2013, Handb Clin Neurol, V114, P271, DOI 10.1016/B978-0-444-53490-3.00022-4; DeBiasi RL, 2002, J INFECT DIS, V186, P1547, DOI 10.1086/345375; Deckers N, 2010, TRENDS PARASITOL, V26, P137, DOI 10.1016/j.pt.2009.12.008; Desalermos A, 2012, EXPERT OPIN PHARMACO, V13, P783, DOI 10.1517/14656566.2012.658773; Dutta K., 2014, NEUROINFLAMMATION NE, P309, DOI [10.1007/978-1-4939-1071-7_15, DOI 10.1007/978-1-4939-1071-7_15]; Engle PL, 2011, LANCET, V378, P1339, DOI 10.1016/S0140-6736(11)60889-1; Falusi O, 2002, CLIN INFECT DIS, V35, P1414, DOI 10.1086/344462; Ferrari TCA, 2011, LANCET NEUROL, V10, P853, DOI 10.1016/S1474-4422(11)70170-3; Finkelstein JL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000158; Fleury A, 2003, NEUROEPIDEMIOLOGY, V22, P139, DOI 10.1159/000068748; Fooks AR, 2014, LANCET, V384, P1389, DOI 10.1016/S0140-6736(13)62707-5; Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005; GOOD MF, 1988, P NATL ACAD SCI USA, V85, P1199, DOI 10.1073/pnas.85.4.1199; Gray KJ, 2007, EMERG INFECT DIS, V13, P223, DOI 10.3201/eid1302.060680; Guerrant RL, 2013, NAT REV GASTRO HEPAT, V10, P220, DOI 10.1038/nrgastro.2012.239; HOFFMAN SL, 1986, NEW ENGL J MED, V315, P601, DOI 10.1056/NEJM198609043151001; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Insinga RP, 2005, J GEN INTERN MED, V20, P748, DOI 10.1111/j.1525-1497.2005.0150.x; Iregbu Kenneth C, 2006, Afr Health Sci, V6, P151; Jarvis JN, 2007, AIDS, V21, P2119, DOI 10.1097/QAD.0b013e3282a4a64d; John CC, 2008, PEDIATRICS, V122, pE92, DOI 10.1542/peds.2007-3709; Kayange N, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-39; Kleinschmidt-DeMasters BK, 2001, ARCH PATHOL LAB MED, V125, P770; Kvalsvig Jane, 2013, Handb Clin Neurol, V114, P369, DOI 10.1016/B978-0-444-53490-3.00029-7; LaBeaud AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-1; Lengeler C, 2004, COCHRANE DB SYST REV, V2; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; McGrath N, 1997, J NEUROL NEUROSUR PS, V63, P321, DOI 10.1136/jnnp.63.3.321; Mehar V, 2013, J Neonatal Perinatal Med, V6, P165, DOI 10.3233/NPM-1367312; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nankabirwa J, 2013, AM J TROP MED HYG, V88, P1102, DOI 10.4269/ajtmh.12-0633; Ochoa-Reparaz J, 2011, ANN NEUROL, V69, P240, DOI 10.1002/ana.22344; Peterson P. K., 2014, NEUROINFLAMMATION NE; Richard SA, 2014, J NUTR, V144, P965, DOI 10.3945/jn.113.187161; RICHTER RW, 1961, NEUROLOGY, V11, P553, DOI 10.1212/WNL.11.7.553; Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151; Seale AC, 2013, PEDIATR RES, V74, P73, DOI 10.1038/pr.2013.207; Spudich S, 2014, SEMIN NEUROL, V34, P5, DOI 10.1055/s-0034-1372336; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Strode C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001619; Swanson EC, 2013, PEDIATR CLIN N AM, V60, P335, DOI 10.1016/j.pcl.2012.12.008; Tan IL, 2012, LANCET NEUROL, V11, P605, DOI 10.1016/S1474-4422(12)70098-4; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites GE, 2013, LANCET NEUROL, V12, P999, DOI 10.1016/S1474-4422(13)70168-6; van de Beek D, 2012, LANCET, V380, P1623, DOI 10.1016/S0140-6736(12)61808-X; Waiswa P, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-213; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; WALKER CLF, 2012, PLOS ONE, V7, DOI DOI 10.1371/JOURNAL.PONE.0047908; Whitley R., 2014, INFECT CENTRAL NERVO, P137; WHO, 2020, MENT HLTH ATL 2011; WHO World Health Organisation STD Statistics, 2001, GLOB PREV INC SEL CU; World Health Organization, 2015, NUMB PEOPL ALL AG	72	79	82	1	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					S178	S186		10.1038/nature16033	http://dx.doi.org/10.1038/nature16033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26580325	Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000365356800014
J	Schaff, F; Bech, M; Zaslansky, P; Jud, C; Liebi, M; Guizar-Sicairos, M; Pfeiffer, F				Schaff, Florian; Bech, Martin; Zaslansky, Paul; Jud, Christoph; Liebi, Marianne; Guizar-Sicairos, Manuel; Pfeiffer, Franz			Six-dimensional real and reciprocal space small-angle X-ray scattering tomography	NATURE			English	Article							COMPUTED-TOMOGRAPHY; COLLAGEN ORIENTATION; BONE; MYELIN; SAXS; NANOSTRUCTURE; COMPOSITE; DENTIN; BRAIN	When used in combination with raster scanning, small-angle X-ray scattering (SAXS) has proven to be a valuable imaging technique of the nanoscale(1), for example of bone, teeth and brain matter(2-5). Although two-dimensional projection imaging has been used to characterize various materials successfully, its three-dimensional extension, SAXS computed tomography, poses substantial challenges, which have yet to be overcome. Previous work(6-11) using SAXS computed tomography was unable to preserve oriented SAXS signals during reconstruction. Here we present a solution to this problem and obtain a complete SAXS computed tomography, which preserves oriented scattering information. By introducing virtual tomography axes, we take advantage of the two-dimensional SAXS information recorded on an area detector and use it to reconstruct the full three-dimensional scattering distribution in reciprocal space for each voxel of the three-dimensional object in real space. The presented method could be of interest for a combined six-dimensional real and reciprocal space characterization of mesoscopic materials with hierarchically structured features with length scales ranging from a few nanometres to a few millimetres-for example, biomaterials such as bone or teeth, or functional materials such as fuel-cell or battery components.	[Schaff, Florian; Jud, Christoph; Pfeiffer, Franz] Tech Univ Munich, Lehrstuhl Biomed Phys, Dept Phys, D-85748 Garching, Germany; [Schaff, Florian; Jud, Christoph; Pfeiffer, Franz] Tech Univ Munich, Inst Med Tech, D-85748 Garching, Germany; [Bech, Martin] Lund Univ, Dept Med Radiat Phys, Clin Sci, S-22185 Lund, Sweden; [Zaslansky, Paul] Charite, Julius Wolff Inst, D-13353 Berlin, Germany; [Liebi, Marianne; Guizar-Sicairos, Manuel] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Pfeiffer, Franz] Tech Univ Munich, Klinikum Rechts Isar, Inst Diagnost & Interventionelle Radiol, D-81675 Munich, Germany	Technical University of Munich; Technical University of Munich; Lund University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Technical University of Munich	Schaff, F (corresponding author), Tech Univ Munich, Lehrstuhl Biomed Phys, Dept Phys, D-85748 Garching, Germany.	florian.schaff@tum.de; martin.bech@med.lu.se; franz.pfeiffer@tum.de	Schaff, Florian/L-9379-2019; Bech, Martin/K-4331-2012; Liebi, Marianne/A-3821-2015; Guizar-Sicairos, Manuel/I-4899-2013; zaslansky, paul/AAB-7322-2021; Guizar-Sicairos, Manuel/AAB-3793-2019	Schaff, Florian/0000-0003-2144-851X; Bech, Martin/0000-0001-9109-7175; Liebi, Marianne/0000-0002-5403-0593; Guizar-Sicairos, Manuel/0000-0002-8293-3634; zaslansky, paul/0000-0002-8714-4992; Guizar-Sicairos, Manuel/0000-0002-8293-3634	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP); DFG Gottfried Wilhelm Leibniz program; DFG (German Research Foundation) [SPP1420]; TUM Graduate School; TUM Institute for Advanced Studies (TUM-IAS)	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP)(German Research Foundation (DFG)); DFG Gottfried Wilhelm Leibniz program(German Research Foundation (DFG)); DFG (German Research Foundation)(German Research Foundation (DFG)); TUM Graduate School; TUM Institute for Advanced Studies (TUM-IAS)	The SAXS experiments were performed at the cSAXS beamline of the Swiss Light Source (SLS) at the Paul Scherrer Institut (PSI), Villigen, Switzerland. We are grateful for travel support that was granted by the EU access program CALIPSO. We acknowledge financial support through the DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP) and the DFG Gottfried Wilhelm Leibniz program. P.Z. is grateful for funding of the DFG (German Research Foundation) through SPP1420. F.S. and C.J. thank the TUM Graduate School for support of their studies. F.P. acknowledges support through the TUM Institute for Advanced Studies (TUM-IAS). We thank A. Fehringer for developing the GPU projectors used for the reconstruction.	Boote C, 2004, J STRUCT BIOL, V146, P359, DOI 10.1016/j.jsb.2003.12.009; Bossa N, 2015, CEMENT CONCRETE RES, V67, P138, DOI 10.1016/j.cemconres.2014.08.007; Bunk O, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123016; De Felici M, 2008, PHYS MED BIOL, V53, P5675, DOI 10.1088/0031-9155/53/20/007; Dierolf M, 2010, NATURE, V467, P436, DOI 10.1038/nature09419; Dinapoli R, 2011, NUCL INSTRUM METH A, V650, P79, DOI 10.1016/j.nima.2010.12.005; Eikenberry EF, 2003, NUCL INSTRUM METH A, V501, P260, DOI 10.1016/S0168-9002(02)02044-2; Falzon G, 2007, PHYS MED BIOL, V52, P6543, DOI 10.1088/0031-9155/52/21/014; Feldkamp J., 2009, THESIS TU DRESDEN; Feldkamp JM, 2009, PHYS STATUS SOLIDI A, V206, P1723, DOI 10.1002/pssa.200881615; Fratzl P, 1997, J APPL CRYSTALLOGR, V30, P765, DOI 10.1107/S0021889897001775; Fratzl P, 1996, CALCIFIED TISSUE INT, V58, P341, DOI 10.1007/BF02509383; Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g; Gaiser S, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0004-8; Jensen TH, 2011, NEUROIMAGE, V57, P124, DOI 10.1016/j.neuroimage.2011.04.013; Jensen TH, 2011, PHYS MED BIOL, V56, P1717, DOI 10.1088/0031-9155/56/6/012; Kieffer J, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/20/202012; Kinney JH, 2001, CALCIFIED TISSUE INT, V69, P31, DOI 10.1007/s00223-001-0006-5; Marten A, 2010, BIOMATERIALS, V31, P5479, DOI 10.1016/j.biomaterials.2010.03.030; Meek KM, 2009, PROG RETIN EYE RES, V28, P369, DOI 10.1016/j.preteyeres.2009.06.005; Moger CJ, 2007, OSTEOARTHR CARTILAGE, V15, P682, DOI 10.1016/j.joca.2006.12.006; Rinnerthaler S, 1999, CALCIFIED TISSUE INT, V64, P422, DOI 10.1007/PL00005824; Schroer CG, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2196062; Sidky EY, 2006, J X-RAY SCI TECHNOL, V14, P119; Stribeck N, 2008, MACROMOLECULES, V41, P7637, DOI 10.1021/ma8015322; Stribeck N, 2006, MACROMOL CHEM PHYS, V207, P1139, DOI 10.1002/macp.200600147	26	103	103	5	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					353	+		10.1038/nature16060	http://dx.doi.org/10.1038/nature16060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26581292				2022-12-28	WOS:000365356800051
J	Snieckus, V				Snieckus, Victor			Richard Heck (1931-2015) OBITUARY	NATURE			English	Biographical-Item									[Snieckus, Victor] Queens Univ, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Snieckus, V (corresponding author), Queens Univ, Kingston, ON K7L 3N6, Canada.	victor.sniekus@chem.queensu.ca						HECK R, PUBLICATION LIST	1	2	2	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					306	306		10.1038/527306a	http://dx.doi.org/10.1038/527306a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26581284	Bronze			2022-12-28	WOS:000365356800036
J	Woolston, C				Woolston, Chris			Untitled	NATURE			English	Editorial Material															Medipolis Proton Therapy and Research Center, a part of the Medipolis Medical Research Institute	Medipolis Proton Therapy and Research Center, a part of the Medipolis Medical Research Institute	We are pleased to acknowledge the financial support of the Medipolis Proton Therapy and Research Center, a part of the Medipolis Medical Research Institute, in producing this Outlook. As always, Nature retains sole responsibility for all editorial content.		0	99	103	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					S101	S101		10.1038/527S101a	http://dx.doi.org/10.1038/527S101a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VB6BM	26580154	Bronze			2022-12-28	WOS:000416343000001
J	Cole, TB				Cole, Thomas B.			Columbarium Architecture (Museum of Disappearing Buildings)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2015	314	19					2006	2007		10.1001/jama.2014.12091	http://dx.doi.org/10.1001/jama.2014.12091			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW1PR	26575047				2022-12-28	WOS:000364764200001
J	Dyer, O				Dyer, Owen			BRIEFING Tasers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												owen_dyer@hotmail.com						[Anonymous], 2012, STATEMENT MED IMPLIC; Azadani PN, 2011, AM HEART J, V162, P533, DOI 10.1016/j.ahj.2011.05.025; Bui ET, 2009, CAN MED ASSOC J, V180, P625, DOI 10.1503/cmaj.081364; Dawes DM, 2014, FORENSIC SCI MED PAT, V10, P9, DOI 10.1007/s12024-013-9510-y; Han JS, 2009, CAN J EMERG MED, V11, P90; Healy P., 2012, NBC S CAROLINA  0328; Hinchey PR, 2009, PREHOSP EMERG CARE, V13, P532, DOI 10.1080/10903120903144890; Ho JD, 2011, FORENSIC SCI INT, V204, P50, DOI 10.1016/j.forsciint.2010.05.003; Kroll MW, 2009, J FORENSIC LEG MED, V16, P173, DOI 10.1016/j.jflm.2008.12.012; National Institutes of Justice, 2011, SPECIAL REPORT; Payne-James J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c853; White MD, 2014, J EXP CRIMINOL, V10, P267, DOI 10.1007/s11292-013-9197-9; Zipes DP, 2014, CIRCULATION, V129, P101, DOI 10.1161/CIRCULATIONAHA.113.005504	13	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 17	2015	351								h6070	10.1136/bmj.h6070	http://dx.doi.org/10.1136/bmj.h6070			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XV	26577942				2022-12-28	WOS:000365352400002
J	Berta-Thompson, ZK; Irwin, J; Charbonneau, D; Newton, ER; Dittmann, JA; Astudillo-Defru, N; Bonfils, X; Gillon, M; Jehin, E; Stark, AA; Stalder, B; Bouchy, F; Delfosse, X; Forveille, T; Lovis, C; Mayor, M; Neves, V; Pepe, F; Santos, NC; Udry, S; Wunsche, A				Berta-Thompson, Zachory K.; Irwin, Jonathan; Charbonneau, David; Newton, Elisabeth R.; Dittmann, Jason A.; Astudillo-Defru, Nicola; Bonfils, Xavier; Gillon, Michael; Jehin, Emmanuel; Stark, Antony A.; Stalder, Brian; Bouchy, Francois; Delfosse, Xavier; Forveille, Thierry; Lovis, Christophe; Mayor, Michel; Neves, Vasco; Pepe, Francesco; Santos, Nuno C.; Udry, Stephane; Wuensche, Anael			A rocky planet transiting a nearby low-mass star	NATURE			English	Article							THERMAL PHASE CURVES; M-DWARFS; STELLAR ACTIVITY; PROPER-MOTION; METALLICITIES; SEARCH; CALIBRATION; LUMINOSITY; SYSTEMS; KEPLER	M-dwarf stars-hydrogen-burning stars that are smaller than 60 per cent of the size of the Sun-are the most common class of star in our Galaxy and outnumber Sun-like stars by a ratio of 12:1. Recent results have shown that M dwarfs host Earth-sized planets in great numbers(1,2): the average number of M-dwarf planets that are between 0.5 to 1.5 times the size of Earth is at least 1.4 per star(3). The nearest such planets known to transit their star are 39 parsecs away(4), too distant for detailed follow-up observations to measure the planetary masses or to study their atmospheres. Here we report observations of GJ 1132b, a planet with a size of 1.2 Earth radii that is transiting a small star 12 parsecs away. Our Doppler mass measurement of GJ 1132b yields a density consistent with an Earth-like bulk composition, similar to the compositions of the six known exoplanets with masses less than six times that of the Earth and precisely measured densities(5-11). Receiving 19 times more stellar radiation than the Earth, the planet is too hot to be habitable but is cool enough to support a substantial atmosphere, one that has probably been considerably depleted of hydrogen. Because the host star is nearby and only 21 per cent the radius of the Sun, existing and upcoming telescopes will be able to observe the composition and dynamics of the planetary atmosphere.	[Berta-Thompson, Zachory K.] MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Berta-Thompson, Zachory K.; Irwin, Jonathan; Charbonneau, David; Newton, Elisabeth R.; Dittmann, Jason A.; Stark, Antony A.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Astudillo-Defru, Nicola; Bouchy, Francois; Lovis, Christophe; Mayor, Michel; Pepe, Francesco; Udry, Stephane] Univ Geneva, Observ Geneve, CH-1290 Sauverny, Switzerland; [Bonfils, Xavier; Delfosse, Xavier; Forveille, Thierry; Wuensche, Anael] Univ Grenoble Alpes, IPAG, F-33000 Grenoble, France; [Bonfils, Xavier; Delfosse, Xavier; Forveille, Thierry; Wuensche, Anael] CNRS, IPAG, F-38000 Grenoble, France; [Gillon, Michael; Jehin, Emmanuel] Univ Liege, Inst Astrophys & Geophys, B-4000 Liege, Belgium; [Stalder, Brian] Univ Hawaii Manoa, Inst Astron, Honolulu, HI 96822 USA; [Bouchy, Francois] Univ Aix Marseille 1, CNRS, Lab Astrophys Marseille, UMR 6110, F-13388 Marseille 13, France; [Neves, Vasco] Univ Fed Rio Grande do Norte, Dept Fis, BR-59072970 Natal, RN, Brazil; [Santos, Nuno C.] Univ Porto, Inst Astrofis & Ciencias Espaco, CAUP, P-4150762 Oporto, Portugal; [Santos, Nuno C.] Univ Porto, Fac Ciencias, Dept Fis & Astron, P-4169007 Oporto, Portugal	Massachusetts Institute of Technology (MIT); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Geneva; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); Centre National de la Recherche Scientifique (CNRS); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); University of Liege; University of Hawaii System; University of Hawaii Manoa; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Universidade Federal do Rio Grande do Norte; Universidade do Porto; Universidade do Porto	Berta-Thompson, ZK (corresponding author), MIT, Kavli Inst Astrophys & Space Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	zkbt@mit.edu	Santos, Nuno C/E-9957-2011	Santos, Nuno C/0000-0003-4422-2919; Berta-Thompson, Zachory/0000-0002-3321-4924; udry, Stephane/0000-0001-7576-6236; Pepe, Francesco/0000-0002-9815-773X; Neves, Vasco/0000-0002-8297-4372; Stark, Antony/0000-0002-2718-9996; Bonfils, Xavier/0000-0001-9003-8894; Astudillo-Defru, Nicola/0000-0002-8462-515X; Gillon, Michael/0000-0003-1462-7739	David and Lucile Packard Fellowship for Science and Engineering; National Science Foundation; John Templeton Foundation; Belgian Fund for Scientific Research; MIT Torres Fellowship for Exoplanet Research; French Agence Nationale de la Recherche; European Research Council; CNPq/BJT Post Doctorate fellowship; INCT INEspaco; Portuguese National Science Foundation (FCT); COMPETE program	David and Lucile Packard Fellowship for Science and Engineering(The David & Lucile Packard Foundation); National Science Foundation(National Science Foundation (NSF)); John Templeton Foundation; Belgian Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); MIT Torres Fellowship for Exoplanet Research; French Agence Nationale de la Recherche(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); CNPq/BJT Post Doctorate fellowship; INCT INEspaco; Portuguese National Science Foundation (FCT)(Portuguese Foundation for Science and Technology); COMPETE program	We thank the staff at the Cerro Tololo Inter-American Observatory for assistance in the construction and operation of MEarth-South; J. Winn and J. Berta-Thompson for comments on the manuscript; S. Seager and A. Zsom for conversations that improved the work; L. Delrez for her independent analysis of the TRAPPIST data; and J. Eastman, D. Dragomir and R. Siverd for their efforts to observe additional transits. The MEarth Project acknowledges funding from the David and Lucile Packard Fellowship for Science and Engineering, and the National Science Foundation, and a grant from the John Templeton Foundation. The opinions expressed here are those of the authors and do not necessarily reflect the views of the John Templeton Foundation. The development of the PISCO imager was supported by the National Science Foundation. HARPS observations were made with European Southern Observatory (ESO) Telescopes at the La Silla Paranal Observatory. TRAPPIST is a project funded by the Belgian Fund for Scientific Research, with the participation of the Swiss National Science Foundation. Z.K.B.-T is funded by the MIT Torres Fellowship for Exoplanet Research. X.B., X.D., T.F. and A.W. acknowledge the support of the French Agence Nationale de la Recherche and the European Research Council. M.G. and E.J. are FNRS Research Associates. V.N. acknowledges a CNPq/BJT Post Doctorate fellowship and partial financial support from the INCT INEspaco. N.C.S. acknowledges the support from the Portuguese National Science Foundation (FCT) as well as the COMPETE program.	Akeson RL, 2013, PUBL ASTRON SOC PAC, V125, P989, DOI 10.1086/672273; Ambikasaran S., 2014, PREPRINT; Astudillo-Defru N, 2015, ASTRON ASTROPHYS, V575, DOI 10.1051/0004-6361/201424253; Ballard S., 2014, PREPRINT; Benedict GF, 1998, ASTRON J, V116, P429, DOI 10.1086/300420; Berta ZK, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/5/145; Bonfils X, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201014704; Bouchy F, 2001, ASTRON ASTROPHYS, V374, P733, DOI 10.1051/0004-6361:20010730; Boyajian TS, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/112; Charbonneau D, 2009, NATURE, V462, P891, DOI 10.1038/nature08679; Claret A, 2012, ASTRON ASTROPHYS, V546, DOI 10.1051/0004-6361/201219849; Delfosse X, 2000, ASTRON ASTROPHYS, V364, P217; Dittmann JA, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/2/156; Dotter A, 2008, ASTROPHYS J SUPPL S, V178, P89, DOI 10.1086/589654; Dressing CD, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/1/45; Dressing CD, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/95; Dumusque X, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/2/154; EGGEN OJ, 1979, ASTROPHYS J SUPPL S, V39, P89, DOI 10.1086/190566; Feltzing S., 2008, PHYS SCR, V2008, pT133; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Gibson NP, 2012, MON NOT R ASTRON SOC, V419, P2683, DOI 10.1111/j.1365-2966.2011.19915.x; GOLDREICH P, 1966, ICARUS, V5, P375, DOI 10.1016/0019-1035(66)90051-0; Goodman J, 2010, COMM APP MATH COM SC, V5, P65, DOI 10.2140/camcos.2010.5.65; Hartman JD, 2015, ASTRON J, V149, DOI 10.1088/0004-6256/149/5/166; Hawley SL, 1997, ASTRON J, V113, P1458, DOI 10.1086/118363; Haywood RD, 2014, MON NOT R ASTRON SOC, V443, P2517, DOI 10.1093/mnras/stu1320; Howard AW, 2013, NATURE, V503, P381, DOI 10.1038/nature12767; Irwin J. M., 2015, CAMBR WORKSH COOL ST, V18, P767; Irwin J, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/1/56; Jao WC, 2005, ASTRON J, V129, P1954, DOI 10.1086/428489; Kiraga M, 2007, ACTA ASTRONOM, V57, P149; Koll DDB, 2015, ASTROPHYS J, V802, DOI 10.1088/0004-637X/802/1/21; Kreidberg L, 2014, NATURE, V505, P69, DOI 10.1038/nature12888; Leggett SK, 2001, ASTROPHYS J, V548, P908, DOI 10.1086/319020; Lopez ED, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/1; Mamajek EE, 2008, ASTROPHYS J, V687, P1264, DOI 10.1086/591785; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; Mann AW, 2015, ASTROPHYS J, V804, DOI 10.1088/0004-637X/804/1/64; Mann AW, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/6/160; Mann AW, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/2/52; Mayor M., 2003, MESSENGER, V114, P20; Morton TD, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/1/10; Motalebi F, 2015, ASTRON ASTROPHYS, V584, DOI 10.1051/0004-6361/201526822; Muirhead P. S., 2015, ASTROPHYS J, V801, P18; Muirhead PS, 2015, ASTROPHYS J, V801, DOI 10.1088/0004-637X/801/1/18; Muirhead PS, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/2/144; Newton ER, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/2/85; Newton ER, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/1/20; Pecaut MJ, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/1/9; Pepe F, 2013, NATURE, V503, P377, DOI 10.1038/nature12768; Rogers LA, 2015, ASTROPHYS J, V801, DOI 10.1088/0004-637X/801/1/41; Selsis F, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201116654; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Stalder B, 2014, PROC SPIE, V9147, DOI 10.1117/12.2054933; Tokovinin A, 2013, PUBL ASTRON SOC PAC, V125, P1336, DOI 10.1086/674012; Walkowicz LM, 2009, ASTRON J, V137, P3297, DOI 10.1088/0004-6256/137/2/3297; West AA, 2008, ASTRON J, V135, P785, DOI 10.1088/0004-6256/135/3/785; Winters JG, 2015, ASTRON J, V149, DOI 10.1088/0004-6256/149/1/5; Zeng L, 2013, PUBL ASTRON SOC PAC, V125, P227, DOI 10.1086/669163	64	158	159	1	21	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					204	+		10.1038/nature15762	http://dx.doi.org/10.1038/nature15762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26560298	Green Submitted			2022-12-28	WOS:000364396700038
J	Gray, AL; Wirtz, VJ; M'tHoen, EF; Reich, MR; Hogerzeil, HV				Gray, Andy L.; Wirtz, Veronika J.; M'tHoen, Ellen F.; Reich, Michael R.; Hogerzeil, Hans V.			Essential medicines are still essential	LANCET			English	Editorial Material									[Gray, Andy L.; Wirtz, Veronika J.; M'tHoen, Ellen F.; Reich, Michael R.; Hogerzeil, Hans V.] Lancet Commiss Essential Med Policies, Mexico City, DF, Mexico; [Gray, Andy L.] Univ KwaZulu Natal, Sch Hlth Sci, Durban, South Africa; [Wirtz, Veronika J.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Reich, Michael R.] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [M'tHoen, Ellen F.; Hogerzeil, Hans V.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands	University of Kwazulu Natal; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; University of Groningen	Hogerzeil, HV (corresponding author), Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands.	h.v.hogerzeil@umcg.nl	Wirtz, Veornika/AAG-9712-2019; Gray, Andrew/F-2104-2013	Gray, Andrew/0000-0001-7815-8180; 't Hoen, Ellen/0000-0003-4477-6866; Wirtz, Veronika J./0000-0002-0863-8768				[Anonymous], 2014, LANCET, V384, P1642, DOI 10.1016/S0140-6736(14)62017-1; [Anonymous], 2015, NY TIMES; [Anonymous], 2013, WHO TECHN REP SER, V985; Hogerzeil HV, 2004, BRIT MED J, V329, P1169, DOI 10.1136/bmj.329.7475.1169; Manikandan S, 2015, J PHARMACOL PHARMACO, V6, P123, DOI 10.4103/0976-500X.162008; Moucheraud C, 2015, B WORLD HEALTH ORGAN, V93, P693, DOI 10.2471/BLT.14.149914; van de Ven N, 2015, HEPATOLOGY, V61, P1174, DOI 10.1002/hep.27641; WHO, 2015, WHO TECH REP SER, V994, P1; WHO, 2002, WHO TECHN REP SER, V914, P14; WHO, 2005, WHO TECHN REP SER, V933; WHO, 2015, PAT SIT KEY PROD TRE; World Health Organization, 2015, 19 WHO MOD LIST ESS; World Health Organization, 2012, PROP INCL TRAST WHO; World Trade Organization, 2006, PHARM PAT TRIPS AGR	14	21	24	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2015	386	10004					1601	1603		10.1016/S0140-6736(15)00514-0	http://dx.doi.org/10.1016/S0140-6736(15)00514-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU0HS	26595616				2022-12-28	WOS:000363197500005
J	Dagres, N; Hindricks, G				Dagres, Nikolaos; Hindricks, Gerhard			Pulmonary pressure, telemedicine, and heart failure therapy	LANCET			English	Editorial Material							IMPLANTABLE ELECTRONIC DEVICES; RHYTHM ASSOCIATION; EUROPE		[Dagres, Nikolaos; Hindricks, Gerhard] Herzzentrum Leipzig, Dept Electrophysiol, D-04289 Leipzig, Germany	Heart Center Leipzig GMBH	Hindricks, G (corresponding author), Herzzentrum Leipzig, Dept Electrophysiol, D-04289 Leipzig, Germany.	Gerhard.Hindricks@medizin.uni-leipzig.de						Abraham W. T., 2015, LANCET; Abraham WT, 2011, LANCET, V377, P658, DOI 10.1016/S0140-6736(11)60101-3; Bohm M., 2015, 2015 EUR SOC CARD C; Chaudhry SI, 2010, NEW ENGL J MED, V363, P2301, DOI 10.1056/NEJMoa1010029; Dagres N, 2013, EUR HEART J, V34, P1964, DOI 10.1093/eurheartj/eht109; Desai AS, 2010, NEW ENGL J MED, V363, P2364, DOI 10.1056/NEJMe1011769; Hernandez-Madrid A, 2014, EUROPACE, V16, P129, DOI 10.1093/europace/eut414; Hindricks G, 2014, LANCET, V384, P583, DOI 10.1016/S0140-6736(14)61176-4; Mairesse GH, 2015, EUROPACE, V17, P814, DOI 10.1093/europace/euu390; Parthiban N, 2015, J AM COLL CARDIOL, V65, P2591, DOI 10.1016/j.jacc.2015.04.029; Varma N, 2015, J AM COLL CARDIOL, V65, P2601, DOI 10.1016/j.jacc.2015.04.033	11	7	7	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 30	2016	387	10017					408	410		10.1016/S0140-6736(15)00808-9	http://dx.doi.org/10.1016/S0140-6736(15)00808-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DC1OX	26560248				2022-12-28	WOS:000368986800006
J	Morris, JM; Roberts, CL; Bowen, JR; Patterson, JA; Bond, DM; Algert, CS; Thornton, JG; Crowther, CA				Morris, Jonathan M.; Roberts, Christine L.; Bowen, Jennifer R.; Patterson, Jillian A.; Bond, Diana M.; Algert, Charles S.; Thornton, Jim G.; Crowther, Caroline A.		PPROMT Collaboration	Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial	LANCET			English	Article							LOW-BIRTH-WEIGHT; PREMATURE RUPTURE; PRELABOR RUPTURE; WEEKS GESTATION; INDUCTION; INFANTS; SEPSIS; COUNT	Background Preterm pre-labour ruptured membranes close to term is associated with increased risk of neonatal infection, but immediate delivery is associated with risks of prematurity. The balance of risks is unclear. We aimed to establish whether immediate birth in singleton pregnancies with ruptured membranes close to term reduces neonatal infection without increasing other morbidity. Methods The PPROMT trial was a multicentre randomised controlled trial done at 65 centres across 11 countries. Women aged over 16 years with singleton pregnancies and ruptured membranes before the onset of labour between 34 weeks and 36 weeks and 6 days weeks who had no signs of infection were included. Women were randomly assigned (1: 1) by a computer-generated randomisation schedule with variable block sizes, stratified by centre, to immediate delivery or expectant management. The primary outcome was the incidence of neonatal sepsis. Secondary infant outcomes included a composite neonatal morbidity and mortality indicator (ie, sepsis, mechanical ventilation >= 24 h, stillbirth, or neonatal death); respiratory distress syndrome; any mechanical ventilation; and duration of stay in a neonatal intensive or special care unit. Secondary maternal outcomes included antepartum or intrapartum haemorrhage, intrapartum fever, postpartum treatment with antibiotics, and mode of delivery. Women and caregivers could not be masked, but those adjudicating on the primary outcome were masked to group allocation. Analyses were by intention to treat. This trial is registered with the International Clinical Trials Registry, number ISRCTN44485060. Findings Between May 28, 2004, and June 30, 2013, 1839 women were recruited and randomly assigned: 924 to the immediate birth group and 915 to the expectant management group. One woman in the immediate birth group and three in the expectant group were excluded from the primary analyses. Neonatal sepsis occurred in 23 (2%) of 923 neonates whose mothers were assigned to immediate birth and 29 (3%) of 912 neonates of mothers assigned to expectant management (relative risk [RR] 0.8, 95% CI 0.5-1.3; p=0.37). The composite secondary outcome of neonatal morbidity and mortality occurred in 73 (8%) of 923 neonates of mothers assigned to immediate delivery and 61 (7%) of 911 neonates of mothers assigned to expectant management (RR 1.2, 95% CI 0.9-1.6; p=0.32). However, neonates born to mothers in the immediate delivery group had increased rates of respiratory distress (76 [8%] of 919 vs 47 [5%] of 910, RR 1.6, 95% CI 1.1-2.30; p=0.008) and any mechanical ventilation (114 [12%] of 923 vs 83 [9%] of 912, RR 1.4, 95% CI 1.0-1.8; p=0.02) and spent more time in intensive care (median 4.0 days [IQR 0.0-10.0] vs 2.0 days [0.0-7.0]; p<0.0001) compared with neonates born to mothers in the expectant management group. Compared with women assigned to the immediate delivery group, those assigned to the expectant management group had higher risks of antepartum or intrapartum haemorrhage (RR 0.6, 95% CI 0.4-0.9), rapartum fever (0.4, 0.2-0.9), and use of postpartum antibiotics (0.8, 0.7-1.0), and longer hospital stay (p<0.0001), but a lower risk of caesarean delivery (RR 1.4, 95% CI 1.2-1.7). Interpretation In the absence of overt signs of infection or fetal compromise, a policy of expectant management with appropriate surveillance of maternal and fetal wellbeing should be followed in pregnant women who present with ruptured membranes close to term.	[Morris, Jonathan M.; Roberts, Christine L.; Bowen, Jennifer R.; Patterson, Jillian A.; Bond, Diana M.; Algert, Charles S.] Northern Sydney Local Hlth Dist, Perinatal Res, Kolling Inst, St Leonards, NSW, Australia; [Morris, Jonathan M.; Roberts, Christine L.; Bowen, Jennifer R.; Patterson, Jillian A.; Bond, Diana M.; Algert, Charles S.] Univ Sydney, Sydney Med Sch Northern, St Leonards, NSW 2065, Australia; [Bowen, Jennifer R.] Royal N Shore Hosp, Dept Neonatol, St Leonards, NSW 2065, Australia; [Thornton, Jim G.] Univ Nottingham, Sch Clin Sci, City Hosp, Div Obstet & Gynaecol, Nottingham NG7 2RD, England; [Crowther, Caroline A.] Womens & Childrens Hosp, Robinson Inst, Adelaide, SA, Australia; [Crowther, Caroline A.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand	University of Sydney; Kolling Institute of Medical Research; University of Sydney; Royal North Shore Hospital; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; Robinson Research Institute; University of Auckland	Morris, JM (corresponding author), Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, St Leonards, NSW 2065, Australia.	jonathan.morris@sydney.edu.au	Patterson, Jillian/A-7384-2015; Thornton, Jim/B-8336-2008; Kothari, Alka/G-2013-2018	Thornton, Jim/0000-0001-9764-6876; Kothari, Alka/0000-0002-9816-3734; Bond, Diana/0000-0002-9452-4707; Algert, Charles/0000-0003-2525-9361	Australian NHMRC [358378, 1009898]; Women's and Children's Hospital Foundation, Adelaide; University of Sydney; NHMRC [APP1021025]; UK National Institute for Health Research through Comprehensive Clinical Research Network; Australian National Health and Medical Research Council; Women's and Children's Hospital Foundation; MRC [G9533539] Funding Source: UKRI; Medical Research Council [G9533539] Funding Source: researchfish	Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Women's and Children's Hospital Foundation, Adelaide; University of Sydney(University of Sydney); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); UK National Institute for Health Research through Comprehensive Clinical Research Network; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Women's and Children's Hospital Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Australian National Health and Medical Research Council, the Women's and Children's Hospital Foundation, and The University of Sydney.; This study was funded by the Australian NHMRC Project Grants (IDs: 358378 and 1009898). Start-up funds were provided by the Women's and Children's Hospital Foundation, Adelaide. Bridging support was provided by The University of Sydney. CLR was supported by a NHMRC Senior Research Fellowship (#APP1021025). Additionally, we acknowledge the support of the UK National Institute for Health Research, through the Comprehensive Clinical Research Network. We thank Kate Levett, the original trial coordinator for PPROMT; Samantha Lain for help with study design and funding acquisition; and Bithi Roy for her assistance with sepsis adjudication. We also thank members of the data monitoring committee-Peter Davis and Judy Simpson-and posthumously acknowledge the contributions of Charles Chen to the interim analysis. We thank the collaborators and their hospitals around the world who contributed this trial, and the women who participated in this study.	Alexander JM, 1996, SEMIN PERINATOL, V20, P369, DOI 10.1016/S0146-0005(96)80003-6; Algert CS, PRETERM PRELABOUR RU; [Anonymous], 2013, Obstet Gynecol, V122, P918, DOI 10.1097/01.AOG.0000435415.21944.8f; ARIAS F, 1982, OBSTET GYNECOL, V60, P277; Brown HK, 2014, INT J EPIDEMIOL, V43, P802, DOI 10.1093/ije/dyt251; Buchanan S, 2004, AUST NZ J OBSTET GYN, V44, P400, DOI 10.1111/j.1479-828X.2004.00256.x; Buchanan SL, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004735.pub3; COX SM, 1995, OBSTET GYNECOL, V86, P875, DOI 10.1016/0029-7844(95)00303-9; GONEN R, 1989, OBSTET GYNECOL, V74, P347; Guida JD, 2003, PEDIATRICS, V111, P1411, DOI 10.1542/peds.111.6.1411; Hannah ME, 1996, NEW ENGL J MED, V334, P1005, DOI 10.1056/NEJM199604183341601; Healy AJ, 2004, AM J OBSTET GYNECOL, V190, P1479, DOI 10.1016/j.ajog.2004.02.036; Kenyon S, 2013, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD001058.PUB3; Lain SJ, 2013, J PEDIATR-US, V163, P1014, DOI 10.1016/j.jpeds.2013.04.051; Lee J, 2009, J PERINAT MED, V37, P53, DOI 10.1515/JPM.2009.036; McGowan JE, 2011, PEDIATRICS, V127, P1111, DOI 10.1542/peds.2010-2257; MERCER BM, 1993, AM J OBSTET GYNECOL, V169, P775, DOI 10.1016/0002-9378(93)90004-3; Morris Jonathan M, 2006, BMC Pregnancy Childbirth, V6, P9, DOI 10.1186/1471-2393-6-9; Morris JM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.082; Naef RW, 1998, AM J OBSTET GYNECOL, V178, P126, DOI 10.1016/S0002-9378(98)70638-6; NELSON LH, 1985, OBSTET GYNECOL, V66, P55; Ottolini MC, 2003, PEDIATR INFECT DIS J, V22, P430, DOI 10.1097/00006454-200305000-00008; PHILIP AGS, 1980, PEDIATRICS, V65, P1036; Philip AGS, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.1.e4; Raju TNK, 2006, PEDIATRICS, V118, P1207, DOI 10.1542/peds.2006-0018; Ramsey PS, 2004, AM J OBSTET GYNECOL, V191, P1497, DOI 10.1016/j.ajog.2004.08.005; Royal College of Obstetrics and Gynaecology, 2010, GREEN TOP GUID; SPINNATO JA, 1987, OBSTET GYNECOL, V69, P196; Tajik P, 2014, BJOG-INT J OBSTET GY, V121, P1263, DOI 10.1111/1471-0528.12889; Teune MJ, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.07.015; van der Ham DP, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.024; van der Ham DP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001208; vanHeerden J, 1996, S AFR MED J, V86, P264	33	90	100	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 30	2016	387	10017					444	452		10.1016/S0140-6736(15)00724-2	http://dx.doi.org/10.1016/S0140-6736(15)00724-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC1OX	26564381	Green Accepted			2022-12-28	WOS:000368986800033
J	Ainsworth, C				Ainsworth, Claire			AGRICULTURE A new breed of edits	NATURE			English	Editorial Material							MOSQUITO											Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009; Smidler AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074511; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937	4	11	13	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					S15	S16		10.1038/528S15a	http://dx.doi.org/10.1038/528S15a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26630594				2022-12-28	WOS:000365606000008
J	Rauen, T; Eitner, F; Fitzner, C; Sommerer, C; Zeier, M; Otte, B; Panzer, U; Peters, H; Benck, U; Mertens, PR; Kuhlmann, U; Witzke, O; Gross, O; Vielhauer, V; Mann, JFE; Hilgers, RD; Floege, J				Rauen, Thomas; Eitner, Frank; Fitzner, Christina; Sommerer, Claudia; Zeier, Martin; Otte, Britta; Panzer, Ulf; Peters, Harm; Benck, Urs; Mertens, Peter R.; Kuhlmann, Uwe; Witzke, Oliver; Gross, Oliver; Vielhauer, Volker; Mann, Johannes F. E.; Hilgers, Ralf-Dieter; Floege, Juergen		Stop-IgAN Investigators	Intensive Supportive Care plus Immunosuppression in IgA Nephropathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LONG-TERM; ACE-INHIBITORS; CORTICOSTEROIDS; TRIAL; REMISSION; THERAPY; OUTCOMES; CHILDREN	BACKGROUND The outcomes of immunosuppressive therapy, when added to supportive care, in patients with IgA nephropathy are uncertain. METHODS We conducted a multicenter, open-label, randomized, controlled trial with a two-group, parallel, group-sequential design. During a 6-month run-in phase, supportive care (in particular, blockade of the renin-angiotensin system) was adjusted on the basis of proteinuria. Patients who had persistent proteinuria with urinary protein excretion of at least 0.75 g per day were randomly assigned to receive supportive care alone (supportive-care group) or supportive care plus immunosuppressive therapy (immunosuppression group) for 3 years. The primary end points in hierarchical order were full clinical remission at the end of the trial (protein-to-creatinine ratio < 0.2 [with both protein and creatinine measured in grams] and a decrease in the estimated glomerular filtration rate [eGFR] of < 5 ml per minute per 1.73 m(2) of body-surface area from baseline) and a decrease in the eGFR of at least 15 ml per minute per 1.73 m(2) at the end of the trial. The primary end points were analyzed with the use of logistic-regression models. RESULTS The run-in phase was completed by 309 of 337 patients. The proteinuria level decreased to less than 0.75 g of urinary protein excretion per day in 94 patients. Of the remaining 162 patients who consented to undergo randomization, 80 were assigned to the supportive-care group, and 82 to the immunosuppression group. After 3 years, 4 patients (5%) in the supportive-care group, as compared with 14 (17%) in the immunosuppression group, had a full clinical remission (P = 0.01). A total of 22 patients (28%) in the supportive-care group and 21 (26%) in the immunosuppression group had a decrease in the eGFR of at least 15 ml per minute per 1.73 m(2) (P = 0.75). There was no significant difference in the annual decline in eGFR between the two groups. More patients in the immunosuppression group than in the supportive-care group had severe infections, impaired glucose tolerance, and weight gain of more than 5 kg in the first year of treatment. One patient in the immunosuppression group died of sepsis. CONCLUSIONS The addition of immunosuppressive therapy to intensive supportive care in patients with high-risk IgA nephropathy did not significantly improve the outcome, and during the 3-year study phase, more adverse effects were observed among the patients who received immunosuppressive therapy, with no change in the rate of decrease in the eGFR. (Funded by the German Federal Ministry of Education and Research; STOP-IgAN ClinicalTrials.gov number, NCT00554502.)	[Rauen, Thomas; Eitner, Frank; Floege, Juergen] Rhein Westfal TH Aachen, Div Nephrol & Clin Immunol, D-52057 Aachen, Germany; [Fitzner, Christina; Hilgers, Ralf-Dieter] Rhein Westfal TH Aachen, Dept Med Stat, D-52057 Aachen, Germany; [Eitner, Frank] Bayer Pharma, Kidney Dis Res, Wuppertal, Germany; [Sommerer, Claudia; Zeier, Martin] Heidelberg Univ, Dept Nephrol, D-69115 Heidelberg, Germany; [Otte, Britta] Univ Hosp Muenster, Dept Nephrol Hypertens & Rheumatol, Internal Med D, Munster, Germany; [Panzer, Ulf] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Peters, Harm] Charite Univ Med Berlin, Dept Nephrol, Charite Campus Mitte, Berlin, Germany; [Peters, Harm] Charite Univ Med Berlin, Dieter Scheffner Ctr Med Educ, Charite Campus Mitte, Berlin, Germany; [Benck, Urs] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Med 5, Mannheim, Germany; [Mertens, Peter R.] Univ Magdeburg, Dept Nephrol & Hypertens Diabet & Endocrinol, D-39106 Magdeburg, Germany; [Kuhlmann, Uwe] Cent Hosp Bremen, Medi Clin 3, Bremen, Germany; [Witzke, Oliver] Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany; [Gross, Oliver] Univ Med Ctr Goettingen, Clin Nephrol & Rheumatol, Gottingen, Germany; [Vielhauer, Volker] Klinikum Ludwig Maximilians Univ, Med Klin & Poliklin 5, Nephrol Zentrum, Munich, Germany; [Mann, Johannes F. E.] Munich Gen Hosp, Dept Nephrol Hypertens & Rheumatol, Munich, Germany	RWTH Aachen University; RWTH Aachen University; Bayer AG; Bayer Healthcare Pharmaceuticals; Ruprecht Karls University Heidelberg; University of Munster; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Otto von Guericke University; University of Duisburg Essen; University of Gottingen; University of Munich	Floege, J (corresponding author), Rhein Westfal TH Aachen, Div Nephrol & Clin Immunol, Pauwelsstr 30, D-52057 Aachen, Germany.	juergen.floege@rwth-aachen.de	Fitzner, Christina/H-6431-2013; Gross, Oliver/AAR-3936-2021; Schena, Francesco P/K-6982-2016; Mann, Johannes/AAI-8803-2020; Rauen, Thomas/GLR-8682-2022; Hilgers, Ralf-Dieter/C-7090-2013; Mertens, Peter/AAI-7310-2020; Peters, Harm/AAE-5643-2019; George, Britta/AAL-2031-2021	Gross, Oliver/0000-0002-8390-8852; Schena, Francesco P/0000-0001-7927-5207; Hilgers, Ralf-Dieter/0000-0002-5945-1119; Banas, Bernhard/0000-0003-2076-2195; Peters, Harm/0000-0003-1441-7512; George, Britta/0000-0001-5430-5086	German Federal Ministry of Education and Research	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Funded by the German Federal Ministry of Education and Research	[Anonymous], 1999, STAT MED, V18, P1905; [Anonymous], 2012, KIDNEY INT S, V2, P142; Ballardie FW, 2002, J AM SOC NEPHROL, V13, P142, DOI 10.1681/ASN.V131142; Coppo R, 2007, J AM SOC NEPHROL, V18, P1880, DOI 10.1681/ASN.2006040347; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; Eitner F, 2010, NAT REV NEPHROL, V6, P252, DOI 10.1038/nrneph.2010.31; Eitner F, 2008, J NEPHROL, V21, P284; Floege J, 2013, NAT REV NEPHROL, V9, P320, DOI 10.1038/nrneph.2013.59; Floege J, 2011, AM J KIDNEY DIS, V58, P992, DOI 10.1053/j.ajkd.2011.05.033; Kanno Y, 2000, CLIN NEPHROL, V54, P360; Kim JK, 2012, CLIN J AM SOC NEPHRO, V7, P427, DOI 10.2215/CJN.04820511; Levey AS, 2014, AM J KIDNEY DIS, V63, P820, DOI 10.1053/j.ajkd.2013.12.006; Lv JC, 2008, NEPHROL DIAL TRANSPL, V23, P2868, DOI 10.1093/ndt/gfn161; Lv JC, 2013, J AM SOC NEPHROL, V24, P2118, DOI 10.1681/ASN.2012101017; Lv JC, 2009, AM J KIDNEY DIS, V53, P26, DOI 10.1053/j.ajkd.2008.07.029; Manno C, 2009, NEPHROL DIAL TRANSPL, V24, P3694, DOI 10.1093/ndt/gfp356; Nam KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101935; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Parikh SV, 2015, COMPREHENSIVE CLIN N, P931; Phillips A, 2002, PHARM STAT, V12, P255; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Pozzi C, 2004, J AM SOC NEPHROL, V15, P157, DOI 10.1097/01.ASN.0000103869.08096.4F; Pozzi C, 1999, LANCET, V353, P883, DOI 10.1016/S0140-6736(98)03563-6; Pozzi C, 2010, J AM SOC NEPHROL, V21, P1783, DOI 10.1681/ASN.2010010117; Praga M, 2003, J AM SOC NEPHROL, V14, P1578, DOI 10.1097/01.ASN.0000068460.37369.DC; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; Ruggenenti P, 2008, J AM SOC NEPHROL, V19, P1213, DOI 10.1681/ASN.2007090970; Shima Y, 2013, PEDIATR NEPHROL, V28, P71, DOI 10.1007/s00467-012-2294-6; Tang SCW, 2010, KIDNEY INT, V77, P543, DOI 10.1038/ki.2009.499; Tesar V, 2015, J AM SOC NEPHROL, V26, P2248, DOI 10.1681/ASN.2014070697; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Yoshikawa N, 1999, J AM SOC NEPHROL, V10, P101; Yoshikawa N, 2006, CLIN J AM SOC NEPHRO, V1, P511, DOI 10.2215/CJN.01120905	33	342	364	1	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2015	373	23					2225	2236		10.1056/NEJMoa1415463	http://dx.doi.org/10.1056/NEJMoa1415463			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5LM	26630142	Bronze, Green Published			2022-12-28	WOS:000365743100006
J	Marais, R				Marais, Richard			Christopher Marshall (1949-2015)	SCIENCE			English	Biographical-Item									[Marais, Richard] Univ Manchester, CRUK Manchester Inst, Manchester M20 4BX, Lancs, England	University of Manchester	Marais, R (corresponding author), Univ Manchester, CRUK Manchester Inst, Manchester M20 4BX, Lancs, England.	richard.marais@cruk.manchester.ac.uk			Cancer Research UK [17240, 19279] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		MARSHALL C, PUBLICATION LIST	1	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1040	1040		10.1126/science.aad8404	http://dx.doi.org/10.1126/science.aad8404			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY5BJ	26612942				2022-12-28	WOS:000366422600028
J	Conroy, C; van Dokkum, PG; Choi, J				Conroy, Charlie; van Dokkum, Pieter G.; Choi, Jieun			Ubiquitous time variability of integrated stellar populations	NATURE			English	Article							LONG-PERIOD VARIABLES; ASYMPTOTIC GIANT BRANCH; GRAVITATIONAL LENSING EXPERIMENT.; OGLE-III CATALOG; MAGELLANIC CLOUDS; MIRA VARIABLES; AGB STARS; M87; EVOLUTION; PROJECT	Long-period variable stars arise in the final stages of the asymptotic giant branch phase of stellar evolution. They have periods of up to about 1,000 days and amplitudes that can exceed a factor of three in the I-band flux. These stars pulsate predominantly in their fundamental mode(1-3), which is a function of mass and radius, and so the pulsation periods are sensitive to the age of the underlying stellar population(4). The overall number of long-period variables in a population is directly related to their lifetimes, which is difficult to predict from first principles because of uncertainties associated with stellar mass-loss and convective mixing. The time variability of these stars has not previously been taken into account when modelling the spectral energy distributions of galaxies. Here we construct time-dependent stellar population models that include the effects of long-period variable stars, and report the ubiquitous detection of this expected 'pixel shimmer' in the massive metal-rich galaxy M87. The pixel light curves display a variety of behaviours. The observed variation of 0.1 to 1 per cent is very well matched to the predictions of our models. The data provide a strong constraint on the properties of variable stars in an old and metal-rich stellar population, and we infer that the lifetime of long-period variables in M87 is shorter by approximately 30 per cent compared to predictions from the latest stellar evolution models.	[Conroy, Charlie; Choi, Jieun] Harvard Univ, Dept Astron, Cambridge, MA 02138 USA; [van Dokkum, Pieter G.] Yale Univ, Dept Astron, New Haven, CT 06511 USA	Harvard University; Yale University	Conroy, C (corresponding author), Harvard Univ, Dept Astron, Cambridge, MA 02138 USA.	cconroy@cfa.harvard.edu		Choi, Jieun/0000-0002-8822-1355				Baltz EA, 2004, ASTROPHYS J, V610, P691, DOI 10.1086/382071; Bird S, 2010, ASTRON ASTROPHYS, V524, DOI 10.1051/0004-6361/201014876; Blakeslee JP, 2009, ASTROPHYS J, V694, P556, DOI 10.1088/0004-637X/694/1/556; Conroy C, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/71; Davidge TJ, 2004, ASTROPHYS J, V607, pL25, DOI 10.1086/421771; Ferrarese L, 2003, ASTROPHYS J, V599, P1302, DOI 10.1086/379349; Fliri J, 2006, ASTRON ASTROPHYS, V445, P423, DOI 10.1051/0004-6361:20042223; FOX MW, 1982, ASTROPHYS J, V259, P198, DOI 10.1086/160160; GOULD A, 1995, ASTROPHYS J, V455, P44, DOI 10.1086/176554; Groenewegen MAT, 2005, ASTRON ASTROPHYS, V443, P143, DOI 10.1051/0004-6361:20053131; Ita Y, 2004, MON NOT R ASTRON SOC, V353, P705, DOI 10.1111/j.1365-2966.2004.08126.x; Kormendy J, 2009, ASTROPHYS J SUPPL S, V182, P216, DOI 10.1088/0067-0049/182/1/216; Kuntschner H, 2010, MON NOT R ASTRON SOC, V408, P97, DOI 10.1111/j.1365-2966.2010.17161.x; Marigo P, 2008, ASTRON ASTROPHYS, V482, P883, DOI 10.1051/0004-6361:20078467; Peng EW, 2009, ASTROPHYS J, V703, P42, DOI 10.1088/0004-637X/703/1/42; Rejkuba M, 2003, ASTRON ASTROPHYS, V406, P75, DOI 10.1051/0004-6361:20030683; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; Smith BJ, 2002, ASTRON J, V123, P948, DOI 10.1086/338647; Soszynski I, 2013, ACTA ASTRONOM, V63, P21; TONRY J, 1988, ASTRON J, V96, P807, DOI 10.1086/114847; Tonry JL, 2001, ASTROPHYS J, V546, P681, DOI 10.1086/318301; van Dokkum PG, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/1/56; Villaume A, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/1/82; Waters CZ, 2009, ASTROPHYS J, V693, P463, DOI 10.1088/0004-637X/693/1/463; WOOD PR, 1983, ASTROPHYS J, V272, P99, DOI 10.1086/161265; Wood PR, 1996, MON NOT R ASTRON SOC, V282, P958, DOI 10.1093/mnras/282.3.958	28	6	6	0	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					488	+		10.1038/nature15731	http://dx.doi.org/10.1038/nature15731			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26570999	Green Submitted			2022-12-28	WOS:000365352500041
J	Cox, B; Beard, P				Cox, Ben; Beard, Paul			IMAGING TECHNIQUES Super-resolution ultrasound	NATURE			English	Editorial Material							ACOUSTIC SUPERRESOLUTION; MICROBUBBLES		[Cox, Ben; Beard, Paul] UCL, Dept Med Phys & Biomed Engn, London WC1E 6BT, England	University of London; University College London	Cox, B (corresponding author), UCL, Dept Med Phys & Biomed Engn, Mortimer St, London WC1E 6BT, England.	b.cox@ucl.ac.uk		Cox, Ben/0000-0001-7296-4093				Christensen-Jeffries K, 2015, IEEE T MED IMAGING, V34, P433, DOI 10.1109/TMI.2014.2359650; Couture O, 2011, IEEE INT ULTRA SYM, P1285, DOI 10.1109/ULTSYM.2011.6293576; Desailly Y, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826597; Errico C, 2015, NATURE, V527, P499, DOI 10.1038/nature16066; Viessmann OM, 2013, PHYS MED BIOL, V58, P6447, DOI 10.1088/0031-9155/58/18/6447	5	23	26	1	58	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					451	452		10.1038/527451a	http://dx.doi.org/10.1038/527451a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26607538				2022-12-28	WOS:000365352500030
J	Smith, JM				Smith, Jeanette M.			The Harvest Moon	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2015	314	20					2114	2115		10.1001/jama.2014.12105	http://dx.doi.org/10.1001/jama.2014.12105			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XQ	26599171				2022-12-28	WOS:000365351900001
J	Vyazovskiy, VV				Vyazovskiy, Vladyslav V.			Mapping the birth of the sleep connectome	SCIENCE			English	Editorial Material							NON-REM SLEEP; EEG; DEPRIVATION; STATES		Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	University of Oxford	Vyazovskiy, VV (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	vladyslav.vyazovskiy@dpag.ox.ac.uk		Vyazovskiy, Vladyslav/0000-0002-4336-6681	Wellcome Trust [098461, 106174, 98461/Z/12/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ACHERMANN P, 1993, BRAIN RES BULL, V31, P97, DOI 10.1016/0361-9230(93)90016-5; BEERSMA DGM, 1990, ELECTROEN CLIN NEURO, V76, P114, DOI 10.1016/0013-4694(90)90209-3; BENINGTON JH, 1994, AM J PHYSIOL, V266, pR1992, DOI 10.1152/ajpregu.1994.266.6.R1992; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; Endo T, 1997, PSYCHIAT RES, V66, P97, DOI 10.1016/S0165-1781(96)03029-6; Fort P, 2009, EUR J NEUROSCI, V29, P1741, DOI 10.1111/j.1460-9568.2009.06722.x; Franken P, 2002, J SLEEP RES, V11, P17, DOI 10.1046/j.1365-2869.2002.00275.x; Hayashi Y, 2015, SCIENCE, V350, P957, DOI 10.1126/science.aad1023; Landolt HP, 2002, NEUROPSYCHOPHARMACOL, V27, P462, DOI 10.1016/S0893-133X(02)00322-6; Lee SH, 2012, NEURON, V76, P209, DOI 10.1016/j.neuron.2012.09.012; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032	11	2	2	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					909	910		10.1126/science.aad6489	http://dx.doi.org/10.1126/science.aad6489			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW4IP	26586746				2022-12-28	WOS:000364955200021
J	Fang, CF; Ma, MJ; Zhan, BD; Lai, SM; Hu, Y; Yang, XX; Li, J; Cao, GP; Zhou, JJ; Zhang, JM; Wang, SQ; Hu, XL; Li, YJ; Wang, XX; Cheng, W; Yao, HW; Li, XL; Yi, HM; Xu, WD; Jiang, JF; Gray, GC; Fang, LQ; Chen, EF; Cao, WC				Fang, Chun-Fu; Ma, Mai-Juan; Zhan, Bing-Dong; Lai, Shi-Ming; Hu, Yi; Yang, Xiao-Xian; Li, Jing; Cao, Guo-Ping; Zhou, Jing-Jing; Zhang, Jian-Min; Wang, Shuang-Qing; Hu, Xiao-Long; Li, Yin-Jun; Wang, Xiao-Xiao; Cheng, Wei; Yao, Hong-Wu; Li, Xin-Lou; Yi, Huai-Ming; Xu, Wei-Dong; Jiang, Jia-Fu; Gray, Gregory C.; Fang, Li-Qun; Chen, En-Fu; Cao, Wu-Chun			Nosocomial transmission of avian influenza A (H7N9) virus in China: epidemiological investigation	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TO-PERSON TRANSMISSION; A(H7N9) VIRUS; HUMAN INFECTION; FAMILY CLUSTER; LIVE POULTRY; RISK-FACTORS; FERRETS; SHANGHAI; PROVINCE; ZHEJIANG	STUDY QUESTION Can avian influenza A (H7N9) virus be transmitted between unrelated individuals in a hospital setting? METHODS An epidemiological investigation looked at two patients who shared a hospital ward in February 2015, in Quzhou, Zhejiang Province, China. Samples from the patients, close contacts, and local environments were examined by real time reverse transcriptase (rRT) polymerase chain reaction (PCR) and viral culture. Haemagglutination inhibition and microneutralisation assays were used to detect specific antibodies to the viruses. Primary outcomes were clinical data, infection source tracing, phylogenetic tree analysis, and serological results. STUDY ANSWER AND LIMITATIONS A 49 year old man (index patient) became ill seven days after visiting a live poultry market. A 57 year old man (second patient), with a history of chronic obstructive pulmonary disease, developed influenza-like symptoms after sharing the same hospital ward as the index patient for five days. The second patient had not visited any poultry markets nor had any contact with poultry or birds within 15 days before the onset of illness. H7N9 virus was identified in the two patients, who both later died. Genome sequences of the virus isolated from both patients were nearly identical, and genetically similar to the virus isolated from the live poultry market. No specific antibodies were detected among 38 close contacts. Transmission between the patients remains unclear, owing to the lack of samples collected from their shared hospital ward. Although several environmental swabs were positive for H7N9 by rRT-PCR, no virus was cultured. Owing to delayed diagnosis and frequent hospital transfers, no serum samples were collected from the patients, and antibodies to H7N9 viruses could not be tested. WHAT THIS STUDY ADDS Nosocomial H7N9 transmission might be possible between two unrelated individuals. Surveillance on patients with influenza-like illness in hospitals as well as chickens in live poultry markets should be enhanced to monitor transmissibility and pathogenicity of the virus.	[Fang, Chun-Fu; Zhan, Bing-Dong; Lai, Shi-Ming; Cao, Guo-Ping; Zhang, Jian-Min; Wang, Shuang-Qing; Hu, Xiao-Long] Quzhou Ctr Dis Control & Prevent, Quzhou, Peoples R China; [Ma, Mai-Juan; Hu, Yi; Yang, Xiao-Xian; Li, Jing; Zhou, Jing-Jing; Li, Yin-Jun; Yao, Hong-Wu; Li, Xin-Lou; Jiang, Jia-Fu; Fang, Li-Qun; Cao, Wu-Chun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Secur, Beijing 100071, Peoples R China; [Wang, Xiao-Xiao; Cheng, Wei; Chen, En-Fu] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Yi, Huai-Ming] Changshan Cty Ctr Dis Control & Prevent, Changshan, Peoples R China; [Xu, Wei-Dong] Kecheng Dist Peoples Hosp, Quzhou, Peoples R China; [Gray, Gregory C.] Duke Univ, Med Ctr, Global Hlth Inst, Div Infect Dis, Durham, NC USA; [Gray, Gregory C.] Duke Univ, Med Ctr, Nicholas Sch Environm, Durham, NC USA	Beijing Institute of Microbiology & Epidemiology; Zhejiang Provincial Center for Disease Control & Prevention; Duke University; Duke University	Cao, WC (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Secur, Beijing 100071, Peoples R China.	caowc@bmi.ac.cn	Li, Jing/AAE-6038-2019; Fang, Li-Qun/GWD-0296-2022; Gray, Gregory C./ABF-1298-2020; li, xinlou/ABF-8578-2021	Gray, Gregory/0000-0002-4628-5908; Li, Jing/0000-0002-6860-6135; Ma, Mai-Juan/0000-0002-8105-462X; Li, Yi-Ju/0000-0001-6996-4834	Program of International Science and Technology Cooperation of China [2013DFA30800]; Basic Work on Special Program for Science and Technology Research [2013FY114600]; National Natural Science Foundation of China [81402730]; Special Program for Prevention and Control of Infectious Diseases in China [2013ZX10004218]; US National Institutes of Health [1R01-AI108993]; Zhejiang Province Major Science and Technology Program [2014C03039]; Quzhou Science and Technology Program [20111084]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108993] Funding Source: NIH RePORTER	Program of International Science and Technology Cooperation of China; Basic Work on Special Program for Science and Technology Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Program for Prevention and Control of Infectious Diseases in China; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zhejiang Province Major Science and Technology Program; Quzhou Science and Technology Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Program of International Science and Technology Cooperation of China (2013DFA30800), Basic Work on Special Program for Science and Technology Research (2013FY114600), National Natural Science Foundation of China (81402730), Special Program for Prevention and Control of Infectious Diseases in China (2013ZX10004218), US National Institutes of Health (1R01-AI108993), Zhejiang Province Major Science and Technology Program (2014C03039), and Quzhou Science and Technology Program (20111084). The funding bodies had no role in study design, data collection and analysis, preparation of the manuscript, or the decision to publish.	Bao CJ, 2013, NEW ENGL J MED, V368, P2337, DOI 10.1056/NEJMc1306100; Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; Ding H, 2014, BMC INFECT DIS, V14, P3846; FluTrackers, 2015, FLUTRACKERS 2013 15; Gao HN, 2014, INT J INFECT DIS, V29, P254, DOI 10.1016/j.ijid.2014.10.029; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; He Y, 2014, EMERG INFECT DIS, V20, P1565, DOI 10.3201/eid2009.131243; Hu J, 2014, EUROSURVEILLANCE, V19, P23, DOI 10.2807/1560-7917.ES2014.19.25.20838; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Liu B, 2014, CLIN INFECT DIS, V59, P787, DOI 10.1093/cid/ciu423; Liu T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-98; Liu W, 2014, J VIROL, V88, P13344, DOI 10.1128/JVI.01777-14; Ma MJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07588; Mao HY, 2015, J CLIN VIROL, V63, P18, DOI 10.1016/j.jcv.2014.11.034; Mounts AW, 1999, J INFECT DIS, V180, P505, DOI 10.1086/314903; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Wang LP, 2014, EMERG INFECT DIS, V20, P1296, DOI 10.3201/eid2008.131821; Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9; World Health Organization, 2014, REAL TIM RT PCR PROT; World Health Organization, 2013, SER DET AV INFL A H7; Wu P, 2014, EMERG INFECT DIS, V20, P1891, DOI 10.3201/eid2011.140556; Xiao XC, 2014, EUROSURVEILLANCE, V19, P14, DOI 10.2807/1560-7917.ES2014.19.25.20837; Yi LN, 2015, J CLIN MICROBIOL, V53, P22, DOI 10.1128/JCM.02322-14; Yu HJ, 2007, EMERG INFECT DIS, V13, P1061, DOI 10.3201/eid1307.061557; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	27	27	28	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2015	351								h5765	10.1136/bmj.h5765	http://dx.doi.org/10.1136/bmj.h5765			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9YA	26586515	hybrid, Green Published			2022-12-28	WOS:000365352900001
J	Koch, S; Acebron, SP; Herbst, J; Hatiboglu, G; Niehrs, C				Koch, Stefan; Acebron, Sergio P.; Herbst, Jessica; Hatiboglu, Gencay; Niehrs, Christof			Post-transcriptional Wnt Signaling Governs Epididymal Sperm Maturation	CELL			English	Article							GLYCOGEN-SYNTHASE KINASE-3; CELL-CYCLE CONTROL; BETA-CATENIN; TERMINAL DIFFERENTIATION; PROTEIN STABILIZATION; GSK3; PHOSPHORYLATION; ACTIVATION; PATHWAY; MICE	The canonical Wnt signaling pathway is of paramount importance in development and disease. An emergent question is whether the upstream cascade of the canonical Wnt pathway has physiologically relevant roles beyond beta-catenin-mediated transcription, which is difficult to study due to the pervasive role of this protein. Here, we show that transcriptionally silent spermatozoa respond to Wnt signals released from the epididymis and that mice mutant for the Wnt regulator Cyclin Upsilon-like 1 are male sterile due to immotile and malformed spermatozoa. Posttranscriptional Wnt signaling impacts spermatozoa through GSK3 by (1) reducing global protein poly-ubiquitination to maintain protein homeostasis; (2) inhibiting septin 4 phosphorylation to establish a membrane diffusion barrier in the sperm tail; and (3) inhibiting protein phosphatase 1 to initiate sperm motility. The results indicate that Wnt signaling orchestrates a rich post-transcriptional sperm maturation program and invite revisiting transcription-independent Wnt signaling in somatic cells as well.	[Koch, Stefan; Acebron, Sergio P.; Herbst, Jessica; Niehrs, Christof] DKFZ ZMBH Alliance, Div Mol Embryol, D-69120 Heidelberg, Germany; [Hatiboglu, Gencay] Heidelberg Univ, Dept Urol, D-69120 Heidelberg, Germany; [Niehrs, Christof] Inst Mol Biol, D-55128 Mainz, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Institute of Molecular Biology (IMB)	Niehrs, C (corresponding author), DKFZ ZMBH Alliance, Div Mol Embryol, D-69120 Heidelberg, Germany.	niehrs@dkfz-heidelberg.de		Koch, Stefan/0000-0003-3579-4229	Deutsche Forschungsgemeinschaft (DFG) [SFB 873]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Expert technical support by the DKFZ core facilities for flow cytometry, transgenics, light microscopy, electron microscopy, and the central animal laboratory is gratefully acknowledged. We thank X. Huang and Y. Zhang for Lcn5-CreERT2 mice, D. Baumann for Cela2a;Kras mice, N. Soshnikova for APC<SUP>min</SUP> mice, and W. Becker and L. Leyns for reagents. This work was supported by the Deutsche Forschungsgemeinschaft (DFG), SFB 873.	Acebron SP, 2014, MOL CELL, V54, P663, DOI 10.1016/j.molcel.2014.04.014; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Boyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029764; Braun RE, 1998, SEMIN CELL DEV BIOL, V9, P483, DOI 10.1006/scdb.1998.0226; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Das DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063603; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Davidson G, 2009, DEV CELL, V17, P788, DOI 10.1016/j.devcel.2009.11.006; Fuchs Y, 2013, SCIENCE, V341, P286, DOI 10.1126/science.1233029; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Hadjihannas MV, 2012, EMBO REP, V13, P347, DOI 10.1038/embor.2012.12; Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huang YL, 2015, P NATL ACAD SCI USA, V112, P5732, DOI 10.1073/pnas.1423533112; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Kikuchi A, 2011, INT REV CEL MOL BIO, V291, P21, DOI 10.1016/B978-0-12-386035-4.00002-1; Kim H, 2015, CELL REP, V11, P1151, DOI 10.1016/j.celrep.2015.04.048; Kim NG, 2009, P NATL ACAD SCI USA, V106, P5165, DOI 10.1073/pnas.0810185106; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Kissel H, 2005, DEV CELL, V8, P353, DOI 10.1016/j.devcel.2005.01.021; Kwitny S, 2010, BIOL REPROD, V82, P669, DOI 10.1095/biolreprod.109.079566; Li Q, 2005, J BIOL CHEM, V280, P2831, DOI 10.1074/jbc.M405680200; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Matsuda T, 2005, J BIOMED MATER RES A, V73A, P125, DOI 10.1002/jbm.a.30260; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Mikolcevic P, 2012, MOL CELL BIOL, V32, P868, DOI 10.1128/MCB.06261-11; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Platts AE, 2007, HUM MOL GENET, V16, P763, DOI 10.1093/hmg/ddm012; Ploper D, 2015, P NATL ACAD SCI USA, V112, pE420, DOI 10.1073/pnas.1424576112; Rivas B, 2014, GENESIS, V52, P328, DOI 10.1002/dvg.22742; Salinas PC, 2007, TRENDS CELL BIOL, V17, P333, DOI 10.1016/j.tcb.2007.07.003; Sharma S, 2013, NATURE, V499, P238, DOI 10.1038/nature12229; Sipila P, 2009, REPRODUCTION, V137, P379, DOI 10.1530/REP-08-0132; Sitz JH, 2008, NEUROSCIENCE, V157, P596, DOI 10.1016/j.neuroscience.2008.09.034; Somanath PR, 2004, J ANDROL, V25, P605; Stolz A, 2015, EMBO REP, V16, P490, DOI 10.15252/embr.201439410; Sullivan R, 2007, ASIAN J ANDROL, V9, P483, DOI 10.1111/j.1745-7262.2007.00281.x; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Toure A, 2007, HUM MOL GENET, V16, P1783, DOI 10.1093/hmg/ddm117; Tsukiyama T, 2012, NEUROSCI LETT, V512, P48, DOI 10.1016/j.neulet.2012.01.062; Turner TT, 2008, J ANDROL, V29, P237, DOI 10.2164/jandrol.107.004119; Valenta T, 2011, GENE DEV, V25, P2631, DOI 10.1101/gad.181289.111; Vijayaraghavan S, 1996, BIOL REPROD, V54, P709, DOI 10.1095/biolreprod54.3.709; Vincan E, 2008, CLIN EXP METASTAS, V25, P657, DOI 10.1007/s10585-008-9156-4; Vinyoles M, 2014, MOL CELL, V53, P444, DOI 10.1016/j.molcel.2013.12.010; Wang K, 2013, MOL HUM REPROD, V19, P57, DOI 10.1093/molehr/gas051; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Xie SS, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104034; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yang J, 2015, MOL GENET GENOM MED, V3, P40, DOI 10.1002/mgg3.111; Yeung C.-H., 2002, EPIDIDYMIS MOL CLIN, P417, DOI DOI 10.1007/978-1-4615-0679-9_24; Zi ZZ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005485	58	120	121	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1225	1236		10.1016/j.cell.2015.10.029	http://dx.doi.org/10.1016/j.cell.2015.10.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26590424	Bronze			2022-12-28	WOS:000366044700020
J	Zeevi, D; Korem, T; Zmora, N; Israeli, D; Rothschild, D; Weinberger, A; Ben-Yacov, O; Lador, D; Avnit-Sagi, T; Lotan-Pompan, M; Suez, J; Mahdi, JA; Matot, E; Malka, G; Kosower, N; Rein, M; Zilberman-Schapira, G; Dohnalova, L; Pevsner-Fischer, M; Bikovsky, R; Halpern, Z; Elinav, E; Segal, E				Zeevi, David; Korem, Tal; Zmora, Niv; Israeli, David; Rothschild, Daphna; Weinberger, Adina; Ben-Yacov, Orly; Lador, Dar; Avnit-Sagi, Tali; Lotan-Pompan, Maya; Suez, Jotham; Mahdi, Jemal Ali; Matot, Elad; Malka, Gal; Kosower, Noa; Rein, Michal; Zilberman-Schapira, Gili; Dohnalova, Lenka; Pevsner-Fischer, Meirav; Bikovsky, Rony; Halpern, Zamir; Elinav, Eran; Segal, Eran			Personalized Nutrition by Prediction of Glycemic Responses	CELL			English	Article							POSTPRANDIAL BLOOD-GLUCOSE; GUT MICROBIOME; METABOLIC SYNDROME; LOAD VALUES; INDEX; TOLERANCE; OBESITY; ASSOCIATION; METAGENOME; ACCURATE	Elevated postprandial blood glucose levels constitute a global epidemic and a major risk factor for prediabetes and type II diabetes, but existing dietary methods for controlling them have limited efficacy. Here, we continuously monitored week-long glucose levels in an 800-person cohort, measured responses to 46,898 meals, and found high variability in the response to identical meals, suggesting that universal dietary recommendations may have limited utility. We devised a machine-learning algorithm that integrates blood parameters, dietary habits, anthropometrics, physical activity, and gut microbiota measured in this cohort and showed that it accurately predicts personalized postprandial glycemic response to real-life meals. We validated these predictions in an independent 100-person cohort. Finally, a blinded randomized controlled dietary intervention based on this algorithm resulted in significantly lower postprandial responses and consistent alterations to gut microbiota configuration. Together, our results suggest that personalized diets may successfully modify elevated postprandial blood glucose and its metabolic consequences.	[Zeevi, David; Korem, Tal; Rothschild, Daphna; Weinberger, Adina; Ben-Yacov, Orly; Lador, Dar; Avnit-Sagi, Tali; Lotan-Pompan, Maya; Matot, Elad; Malka, Gal; Kosower, Noa; Rein, Michal; Bikovsky, Rony; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-7610001 Rehovot, Israel; [Zeevi, David; Korem, Tal; Rothschild, Daphna; Weinberger, Adina; Ben-Yacov, Orly; Lador, Dar; Avnit-Sagi, Tali; Lotan-Pompan, Maya; Matot, Elad; Malka, Gal; Kosower, Noa; Rein, Michal; Bikovsky, Rony; Segal, Eran] Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel; [Zmora, Niv; Suez, Jotham; Mahdi, Jemal Ali; Zilberman-Schapira, Gili; Dohnalova, Lenka; Pevsner-Fischer, Meirav; Elinav, Eran] Weizmann Inst Sci, Dept Immunol, IL-7610001 Rehovot, Israel; [Zmora, Niv] Tel Aviv Sourasky Med Ctr, Internal Med Dept, IL-6423906 Tel Aviv, Israel; [Zmora, Niv; Halpern, Zamir] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Res Ctr Digest Tract & Liver Dis, IL-6423906 Tel Aviv, Israel; [Israeli, David] Kfar Shaul Hosp, Jerusalem Ctr Mental Hlth, Day Care Unit, IL-9106000 Jerusalem, Israel; [Israeli, David] Kfar Shaul Hosp, Jerusalem Ctr Mental Hlth, Lab Imaging & Brain Stimulat, IL-9106000 Jerusalem, Israel; [Halpern, Zamir] Tel Aviv Sourasky Med Ctr, Digest Ctr, IL-6423906 Tel Aviv, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Elinav, E (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-7610001 Rehovot, Israel.	eran.elinav@weizmann.ac.il; eran.segal@weizmann.ac.il	Elinav, Eran/ABE-8881-2020; Segal, Eran/AAF-4855-2019; Korem, Tal/D-4155-2018; Suez, Jotham/AAZ-5433-2020	Elinav, Eran/0000-0002-5775-2110; Korem, Tal/0000-0002-0609-0858; Suez, Jotham/0000-0003-3836-972X; Zeevi, David/0000-0002-6492-6078; Dohnalova, Lenka/0000-0002-2761-2547; Rothschild, Daphna/0000-0002-0872-8624; Segal, Eran/0000-0002-6859-1164	Weizmann Institute of Science; Ministry of Science, Technology, and Space, Israel; Foulkes Foundation; Yael and Rami Ungar, Israel; Leona M. and Harry B. Helmsley Charitable Trust; Gurwin Family Fund for Scientific Research; Crown Endowment Fund for Immunological Research; Benoziyo Endowment Fund for the Advancement of Science; European Research Council (ERC); Israel Science Foundation (ISF); ERC; ISF	Weizmann Institute of Science; Ministry of Science, Technology, and Space, Israel(Ministry of Science, Technology and Space (MOST), Israel); Foulkes Foundation; Yael and Rami Ungar, Israel; Leona M. and Harry B. Helmsley Charitable Trust; Gurwin Family Fund for Scientific Research; Crown Endowment Fund for Immunological Research; Benoziyo Endowment Fund for the Advancement of Science; European Research Council (ERC)(European Research Council (ERC)European Commission); Israel Science Foundation (ISF)(Israel Science Foundation); ERC(European Research Council (ERC)European Commission); ISF(Israel Science Foundation)	We thank the Segal and Elinav group members for fruitful discussions; Keren Segal, Yuval Dor, Tali Raveh-Sadka, Michal Levo, and Leeat Keren for fruitful discussions and critical insights to the manuscript; Guy Raz and Ran Chen for website development; Shira Zelber-Sagi for discussions; and Noya Horowitz for writing and submitting documents for review by IRBs. This research was supported by the Weizmann Institute of Science. T.K., D.Z., and D.R. are supported by the Ministry of Science, Technology, and Space, Israel. T.K. is supported by the Foulkes Foundation. E.E. is supported by Yael and Rami Ungar, Israel; Leona M. and Harry B. Helmsley Charitable Trust; the Gurwin Family Fund for Scientific Research; Crown Endowment Fund for Immunological Research; estate of Jack Gitlitz; estate of Lydia Hershkovich; the Benoziyo Endowment Fund for the Advancement of Science; John L. and Vera Schwartz, Pacific Palisades; Alan Markovitz, Canada; Cynthia Adelson, Canada; estate of Samuel and Alwyn J. Weber; Mr. and Mrs. Donald L. Schwarz, Sherman Oaks; grants funded by the European Research Council (ERC); the Israel Science Foundation (ISF); E.E. is the incumbent of the Rina Gudinski Career Development Chair. E.S. is supported by a research grant from Jack N. Halpern, and Mr. and Mrs. Donald L. Schwarz and by grants from the ERC and the ISF.	American Diabetes Association, 2015, Diabetes Care, V38 Suppl, pS31, DOI 10.2337/dc15-S008; American Diabetes Association, 2015, Diabetes Care, V38 Suppl, pS20, DOI 10.2337/dc15-S007; Atkinson FS, 2008, DIABETES CARE, V31, P2281, DOI 10.2337/dc08-1239; Bailey TS, 2014, DIABETES TECHNOL THE, V16, P277, DOI 10.1089/dia.2013.0222; Bansal N, 2015, WORLD J DIABETES, V6, P296, DOI 10.4239/wjd.v6.i2.296; Bao JS, 2011, DIABETES CARE, V34, P2146, DOI 10.2337/dc11-0567; Blaak EE, 2012, OBES REV, V13, P923, DOI 10.1111/j.1467-789X.2012.01011.x; Carpenter D, 2015, HUM MOL GENET, V24, P3472, DOI 10.1093/hmg/ddv098; Cavalot F, 2011, DIABETES CARE, V34, P2237, DOI 10.2337/dc10-2414; Conn JW, 1936, J CLIN INVEST, V15, P665, DOI 10.1172/JCI100818; CUNNINGHAM KM, 1989, BRIT J NUTR, V61, P285, DOI 10.1079/BJN19890116; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dodd H, 2011, AM J CLIN NUTR, V94, P992, DOI 10.3945/ajcn.111.012138; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Everard A, 2014, ISME J, V8, P2116, DOI 10.1038/ismej.2014.45; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gallwitz B, 2009, DIABETES CARE, V32, pS322, DOI 10.2337/dc09-S331; GIBBS EM, 1995, J CLIN INVEST, V95, P1512, DOI 10.1172/JCI117823; Greenwood DC, 2013, DIABETES CARE, V36, P4166, DOI 10.2337/dc13-0325; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Hastie T., 2008, ELEMENTS STAT LEARNI; Himsworth HP, 1934, J PHYSIOL-LONDON, V81, P29, DOI 10.1113/jphysiol.1934.sp003113; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Israeli Center for Disease Control, 2014, HLTH 2013; JENKINS DJA, 1981, AM J CLIN NUTR, V34, P362, DOI 10.1093/ajcn/34.3.362; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Korem T, 2015, SCIENCE, V349, P1101, DOI 10.1126/science.aac4812; Kristo AS, 2013, NUTRIENTS, V5, P1071, DOI 10.3390/nu5041071; Lamkin DM, 2009, CANCER-AM CANCER SOC, V115, P1021, DOI 10.1002/cncr.24126; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Nishida T, 2006, AM J GASTROENTEROL, V101, P70, DOI 10.1111/j.1572-0241.2005.00307.x; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Riccardi G, 2000, BRIT J NUTR, V83, pS143; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Santacruz A, 2009, OBESITY, V17, P1906, DOI 10.1038/oby.2009.112; Schwingshackl L, 2013, NUTR METAB CARDIOVAS, V23, P699, DOI 10.1016/j.numecd.2013.04.008; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vega-Lopez S, 2007, DIABETES CARE, V30, P1412, DOI 10.2337/dc06-1598; Vrolix R, 2010, CONTEMP CLIN TRIALS, V31, P5, DOI 10.1016/j.cct.2009.08.001; WOLEVER TMS, 1986, AM J CLIN NUTR, V43, P167, DOI 10.1093/ajcn/43.1.167; World Health Organization, 2008, GLOB HLTH OBS DAT RE; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071108	57	1207	1271	31	346	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1079	1094		10.1016/j.cell.2015.11.001	http://dx.doi.org/10.1016/j.cell.2015.11.001			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26590418	Bronze			2022-12-28	WOS:000366044700009
J	Ross, AGP				Ross, Allen G. P.			PERSONAL VIEW Richer countries should help poorer ones plan for the next pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SURVEILLANCE		[Ross, Allen G. P.] Griffith Univ, Trop Med & Global Hlth, Nathan, Qld 4111, Australia	Griffith University	Ross, AGP (corresponding author), Griffith Univ, Trop Med & Global Hlth, Gold Coast Campus, Nathan, Qld 4111, Australia.	a.ross@griffith.edu.au						Childs JE, 2009, MT SINAI J MED, V76, P421, DOI 10.1002/msj.20133; Gostin LO, 2015, LANCET, V385, P1902, DOI 10.1016/S0140-6736(15)60644-4; Heymann DL, 2015, LANCET, V385, P1884, DOI 10.1016/S0140-6736(15)60858-3; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Katz R, 2010, GLOB HLTH GOV, VIII, P2; Quinn SC, 2014, BIOSECUR BIOTERROR, V12, P263, DOI 10.1089/bsp.2014.0032; Ross AGP, 2015, INT J INFECT DIS, V38, P89, DOI 10.1016/j.ijid.2015.07.016; Vernet G, 2014, EMERG INFECT DIS, V20, P434, DOI [10.3201/eid2003.121157, 10.3201/EID2003.121157]	8	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 17	2015	351								h6156	10.1136/bmj.h6156	http://dx.doi.org/10.1136/bmj.h6156			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XV	26578443				2022-12-28	WOS:000365352400005
J	Wang, CL; Graham, DJ; Kane, RC; Xie, DQ; Wernecke, M; Levenson, M; MaCurdy, TE; Houstoun, M; Ryan, Q; Wong, S; Mott, K; Sheu, TC; Limb, S; Worrall, C; Kelman, JA; Reichman, ME				Wang, Cunlin; Graham, David J.; Kane, Robert C.; Xie, Diqiong; Wernecke, Michael; Levenson, Mark; MaCurdy, Thomas E.; Houstoun, Monica; Ryan, Qin; Wong, Sarah; Mott, Katrina; Sheu, Ting-Chang; Limb, Susan; Worrall, Chris; Kelman, Jeffrey A.; Reichman, Marsha E.			Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FERRIC GLUCONATE COMPLEX; ADVERSE DRUG EVENTS; HEMODIALYSIS-PATIENTS; SYSTEMATIC ANALYSIS; ANEMIA; FERUMOXYTOL; THERAPY; DEXTRAN; SUCROSE; DISEASE	IMPORTANCE All intravenous (IV) iron products are associated with anaphylaxis, but the comparative safety of each product has not been well established. OBJECTIVE To compare the risk of anaphylaxis among marketed IV iron products. DESIGN, SETTING, AND PARTICIPANTS Retrospective new user cohort study of IV iron recipients (n = 688 183) enrolled in the US fee-for-service Medicare program from January 2003 to December 2013. Analyses involving ferumoxytol were limited to the period January 2010 to December 2013. EXPOSURES Administrations of IV iron dextran, gluconate, sucrose, or ferumoxytol as reported in outpatient Medicare claims data. MAIN OUTCOMES AND MEASURES Anaphylaxiswas identified using a prespecified and validated algorithm defined with standard diagnosis and procedure codes and applied to both inpatient and outpatient Medicare claims. The absolute and relative risks of anaphylaxis were estimated, adjusting for imbalances among treatment groups. RESULTS A total of 274 anaphylaxis cases were identified at first exposure, with an additional 170 incident anaphylaxis cases identified during subsequent IV iron administrations. The risk for anaphylaxis at first exposure was 68 per 100 000 persons for iron dextran (95% CI, 57.8-78.7 per 100 000) and 24 per 100 000 persons for all nondextran IV iron products combined (iron sucrose, gluconate, and ferumoxytol) (95% CI, 20.0-29.5 per 100 000), with an adjusted odds ratio (OR) of 2.6 (95% CI, 2.0-3.3; P <.001). At first exposure, when compared with iron sucrose, the adjusted OR of anaphylaxis for iron dextran was 3.6 (95% CI, 2.4-5.4); for iron gluconate, 2.0 (95% CI 1.2, 3.5); and for ferumoxytol, 2.2 (95% CI, 1.1-4.3). The estimated cumulative anaphylaxis risk following total iron repletion of 1000mg administered within a 12-week period was highest with iron dextran (82 per 100 000 persons, 95% CI, 70.5-93.1) and lowest with iron sucrose (21 per 100 000 persons, 95% CI, 15.3-26.4). CONCLUSIONS AND RELEVANCE Among patients in the US Medicare nondialysis population with first exposure to IV iron, the risk of anaphylaxis was highest for iron dextran and lowest for iron sucrose.	[Wang, Cunlin; Graham, David J.; Mott, Katrina; Reichman, Marsha E.] US FDA, Div Epidemiol 1, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD 20903 USA; [Kane, Robert C.; Houstoun, Monica; Ryan, Qin; Limb, Susan] US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20903 USA; [Xie, Diqiong; Levenson, Mark] US FDA, Off Biostat, Ctr Drug Evaluat & Res, Silver Spring, MD 20903 USA; [Wernecke, Michael; MaCurdy, Thomas E.; Wong, Sarah; Sheu, Ting-Chang] Acumen LLC, Burlingame, CA USA; [Mott, Katrina] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Limb, Susan] Genentech Inc, San Francisco, CA 94080 USA; [Worrall, Chris; Kelman, Jeffrey A.] Ctr Medicare & Medicaid Serv, Washington, DC USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Harvard University; Harvard T.H. Chan School of Public Health; Roche Holding; Genentech; Centers for Medicare & Medicaid Services	Wang, CL (corresponding author), US FDA, Div Epidemiol 1, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20903 USA.	cunlin.wang@fda.hhs.gov		Sheu, Ting-Chang/0000-0002-5839-030X	Centers for Medicare & Medicaid Services; US Food and Drug Administration	Centers for Medicare & Medicaid Services; US Food and Drug Administration	This study was funded through an intraagency agreement between the Centers for Medicare & Medicaid Services and the US Food and Drug Administration.	Agresti A, 2003, CATEGORICAL DATA ANA; Albaramki J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007857.pub2; Auerbach M, 2010, HEMATOL-AM SOC HEMAT, P338, DOI 10.1182/asheducation-2010.1.338; Bailie GR, 2012, AM J HEALTH-SYST PH, V69, P310, DOI 10.2146/ajhp110262; Bailie GR, 2000, AM J KIDNEY DIS, V35, P1, DOI 10.1016/S0272-6386(00)70294-0; Bailie GR, 2005, NEPHROL DIAL TRANSPL, V20, P1443, DOI 10.1093/ndt/gfh820; Barton JC, 2000, AM J MED, V109, P27, DOI 10.1016/S0002-9343(00)00396-X; Chertow GM, 2006, NEPHROL DIAL TRANSPL, V21, P378, DOI 10.1093/ndt/gfi253; Faich G, 1999, AM J KIDNEY DIS, V33, P464, DOI 10.1016/S0272-6386(99)70183-6; Fishbane S, 2003, AM J KIDNEY DIS, V41, pS18, DOI 10.1016/S0272-638(03)00373-1; Fishbane S, 1996, AM J KIDNEY DIS, V28, P529, DOI 10.1016/S0272-6386(96)90463-1; Fletes R, 2001, AM J KIDNEY DIS, V37, P743, DOI 10.1016/S0272-6386(01)80123-2; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Kosch M, 2001, NEPHROL DIAL TRANSPL, V16, P1239, DOI 10.1093/ndt/16.6.1239; Macdougall IC, 2014, CLIN J AM SOC NEPHRO, V9, P705, DOI 10.2215/CJN.05320513; Michael B, 2002, KIDNEY INT, V61, P1830, DOI 10.1046/j.1523-1755.2002.00314.x; Pai AB, 2012, J BLOOD MED, V3, P77, DOI 10.2147/JBM.S29204; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Silverstein SB, 2004, AM J HEMATOL, V76, P74, DOI 10.1002/ajh.20056; Simons FER, 2010, J ALLERGY CLIN IMMUN, V125, pS161, DOI 10.1016/j.jaci.2009.12.981; Singh A, 2008, AM J KIDNEY DIS, V52, P907, DOI 10.1053/j.ajkd.2008.08.001; Triggiani M, 2008, CLIN EXP IMMUNOL, V153, P7, DOI 10.1111/j.1365-2249.2008.03714.x; Tukey J., 1953, REPRINTED COLLECTED, V1, P165; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Walsh Kathleen E, 2013, Pharmacoepidemiol Drug Saf, V22, P1205, DOI 10.1002/pds.3505; Wysowski DK, 2010, AM J HEMATOL, V85, P650, DOI 10.1002/ajh.21794	26	139	144	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2015	314	19					2062	2068		10.1001/jama.2015.15572	http://dx.doi.org/10.1001/jama.2015.15572			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW1PR	26575062	Bronze			2022-12-28	WOS:000364764200021
J	Trevan, T				Trevan, Tim			Rethink biosafety	NATURE			English	Editorial Material												timtrevan@biosafety.co						[Anonymous], 2010, BUSINESSWEEK; Centers for Disease Control and Prevention ( CDC), 2014, REP POT EXP ANTHR; Chassin MR, 2011, HEALTH AFFAIR, V30, P559, DOI 10.1377/hlthaff.2011.0076; Fouchier RAM, 2013, NATURE, V493, P609, DOI 10.1038/nature11858; HOLLAND D, 2014, IMPLEMENTING CULTURE; Oye KA, 2014, SCIENCE, V345, P626, DOI 10.1126/science.1254287; [No title captured]; [No title captured]	8	12	12	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					155	158		10.1038/527155a	http://dx.doi.org/10.1038/527155a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RC	26560283	Bronze			2022-12-28	WOS:000364396700017
J	Lane, R				Lane, Richard			Yusuf Hamied: leader in the Indian generic drug industry	LANCET			English	Biographical-Item																			0	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2015	386	10011					2385	2385		10.1016/S0140-6736(15)00839-9	http://dx.doi.org/10.1016/S0140-6736(15)00839-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY3EE	26603926				2022-12-28	WOS:000366290400017
J	Doudna, J				Doudna, Jennifer			Perspective: Embryo editing needs scrutiny	NATURE			English	Editorial Material									[Doudna, Jennifer] Univ Calif Berkeley, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Doudna, J (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	doudna@berkeley.edu							0	23	24	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					S6	S6		10.1038/528S6a	http://dx.doi.org/10.1038/528S6a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26630598	Bronze			2022-12-28	WOS:000365606000002
J	Maxmen, A				Maxmen, Amy			Three technologies that changed genetics	NATURE			English	Editorial Material																			0	3	3	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					S2	S3		10.1038/528S2a	http://dx.doi.org/10.1038/528S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26630596	Bronze			2022-12-28	WOS:000365606000075
J	Peng, YQ; Gillis-Smith, S; Jin, H; Trankner, D; Ryba, NJP; Zuker, CS				Peng, Yueqing; Gillis-Smith, Sarah; Jin, Hao; Traenkner, Dimitri; Ryba, Nicholas J. P.; Zuker, Charles S.			Sweet and bitter taste in the brain of awake behaving animals	NATURE			English	Article							GUSTATORY STIMULI; MIMETIC RESPONSES; MAMMALIAN SWEET; REACTIVITY TEST; UMAMI TASTE; RECEPTORS; RATS; REPRESENTATION; CIRCUIT; NEURONS	Taste is responsible for evaluating the nutritious content of food, guiding essential appetitive behaviours, preventing the ingestion of toxic substances, and helping to ensure the maintenance of a healthy diet. Sweet and bitter are two of the most salient sensory percepts for humans and other animals; sweet taste allows the identification of energy-rich nutrients whereas bitter warns against the intake of potentially noxious chemicals(1). In mammals, information from taste receptor cells in the tongue is transmitted through multiple neural stations to the primary gustatory cortex in the brain(2). Recent imaging studies have shown that sweet and bitter are represented in the primary gustatory cortex by neurons organized in a spatial map(3,4), with each taste quality encoded by distinct cortical fields(4). Here we demonstrate that by manipulating the brain fields representing sweet and bitter taste we directly control an animal's internal representation, sensory perception, and behavioural actions. These results substantiate the segregation of taste qualities in the cortex, expose the innate nature of appetitive and aversive taste responses, and illustrate the ability of gustatory cortex to recapitulate complex behaviours in the absence of sensory input.	[Peng, Yueqing; Gillis-Smith, Sarah; Jin, Hao; Traenkner, Dimitri; Zuker, Charles S.] Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; [Peng, Yueqing; Gillis-Smith, Sarah; Jin, Hao; Traenkner, Dimitri; Zuker, Charles S.] Columbia Univ Coll Phys & Surg, Dept Biochem, New York, NY 10032 USA; [Peng, Yueqing; Gillis-Smith, Sarah; Jin, Hao; Traenkner, Dimitri; Zuker, Charles S.] Columbia Univ Coll Phys & Surg, Dept Mol Biophys, New York, NY 10032 USA; [Peng, Yueqing; Gillis-Smith, Sarah; Jin, Hao; Traenkner, Dimitri; Zuker, Charles S.] Columbia Univ Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Traenkner, Dimitri; Zuker, Charles S.] HHMI Janelia Farm Res Campus, Ashburn, VA 20147 USA; [Ryba, Nicholas J. P.] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Zuker, CS (corresponding author), Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA.	nick.ryba@nih.gov; cz2195@cumc.columbia.edu		Ryba, Nicholas/0000-0002-2060-8393	National Institute of Drug Abuse [DA035025]; Intramural Research Program of the National Institutes of Health, National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035025] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Intramural Research Program of the National Institutes of Health, National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We particularly thank H. Fischman and R. Lessard for suggestions, and members of the Zuker laboratory for comments. We also thank D. Salzman, K. Scott, and R. Axel for discussions. This research was supported in part by a grant from the National Institute of Drug Abuse (DA035025) to C.S.Z., and the Intramural Research Program of the National Institutes of Health, National Institute of Dental and Craniofacial Research (to N.J.P.R.). C.S.Z. is an investigator of the Howard Hughes Medical Institute and a Senior Fellow at Janelia Farms Research Campus, Howard Hughes Medical Institute.	Accolla R, 2007, J NEUROSCI, V27, P1396, DOI 10.1523/JNEUROSCI.5188-06.2007; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Calu DJ, 2010, NEURON, V68, P991, DOI 10.1016/j.neuron.2010.11.019; Chen XK, 2011, SCIENCE, V333, P1262, DOI 10.1126/science.1204076; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; Gardner MPH, 2014, J NEUROSCI, V34, P13000, DOI 10.1523/JNEUROSCI.1820-14.2014; Graham DM, 2014, J NEUROSCI, V34, P7398, DOI 10.1523/JNEUROSCI.0213-14.2014; GRILL HJ, 1978, BRAIN RES, V143, P281, DOI 10.1016/0006-8993(78)90569-3; GRILL HJ, 1978, BRAIN RES, V143, P263, DOI 10.1016/0006-8993(78)90568-1; Guo ZCV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088678; Halpern B.P., 1977, DRINK BEHAV, P1, DOI [10.1007/978-1-4684-2319-8_1, DOI 10.1007/978-1-4684-2319-8_1]; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nieh EH, 2015, CELL, V160, P528, DOI 10.1016/j.cell.2015.01.003; Reilly S, 1996, BEHAV NEUROSCI, V110, P737, DOI 10.1037/0735-7044.110.4.737; Simon SA, 2006, NAT REV NEUROSCI, V7, P890, DOI 10.1038/nrn2006; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Spector Alan C, 2005, Behav Cogn Neurosci Rev, V4, P143, DOI 10.1177/1534582305280031; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; YAMAMOTO T, 1984, PROG NEUROBIOL, V23, P273, DOI 10.1016/0301-0082(84)90007-8; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	27	123	126	3	102	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					512	+		10.1038/nature15763	http://dx.doi.org/10.1038/nature15763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26580015	Green Accepted			2022-12-28	WOS:000365352500047
J	Kaiser, J				Kaiser, Jocelyn			WHAT DOES A DISEASE DESERVE?	SCIENCE			English	Editorial Material																			0	4	4	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					900	902		10.1126/science.350.6263.900	http://dx.doi.org/10.1126/science.350.6263.900			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW4IP	26586743				2022-12-28	WOS:000364955200016
J	Staerk, L; Lip, GYH; Olesen, JB; Fosbol, EL; Pallisgaard, JL; Bonde, AN; Gundlund, A; Lindhardt, TB; Hansen, ML; Torp-Pedersen, C; Gislason, GH				Staerk, Laila; Lip, Gregory Y. H.; Olesen, Jonas B.; Fosbol, Emil L.; Pallisgaard, Jannik L.; Bonde, Anders N.; Gundlund, Anna; Lindhardt, Tommi B.; Hansen, Morten L.; Torp-Pedersen, Christian; Gislason, Gunnar H.			Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EXPERT CONSENSUS DOCUMENT; FOUNDATION TASK-FORCE; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; TRIPLE THERAPY; FOCUSED UPDATE; NSAID USE; ASPIRIN; RISKS; MANAGEMENT	Study question What are the risks of all cause mortality, thromboembolism, major bleeding, and recurrent gastrointestinal bleeding associated with restarting antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation? Methods This Danish cohort study (1996-2012) included all patients with atrial fibrillation discharged from hospital after gastrointestinal bleeding while receiving antithrombotic treatment. Restarted treatment regimens were single or combined antithrombotic drugs with oral anticoagulation and antiplatelets. Follow-up started 90 days after discharge to avoid confounding from use of previously prescribed drugs on discharge. Risks of all cause mortality, thromboembolism, major bleeding, and recurrent gastrointestinal bleeding were estimated with competing risks models and time dependent multiple Cox regression models. Study answer and limitations 4602 patients (mean age 78 years) were included. Within two years, 39.9% (95% confidence interval 38.4% to 41.3%, n=1745) of the patients had died, 12.0% (11.0% to 13.0%, n=526) had experienced thromboembolism, 17.7% (16.5% to 18.8%, n=788) major bleeding, and 12.1% (11.1% to 13.1%, n=546) recurrent gastrointestinal bleeding. 27.1% (n=924) of patients did not resume antithrombotic treatment. Compared with non-resumption of treatment, a reduced risk of all cause mortality was found in association with restart of oral anticoagulation (hazard ratio 0.39, 95% confidence interval 0.34 to 0.46), an antiplatelet agent (0.76, 0.68 to 0.86), and oral anticoagulation plus an antiplatelet agent (0.41, 0.32 to 0.52), and a reduced risk of thromboembolism was found in association with restart of oral anticoagulation (0.41, 0.31 to 0.54), an antiplatelet agent (0.76, 0.61 to 0.95), and oral anticoagulation plus an antiplatelet agent (0.54, 0.36 to 0.82). Restarting oral anticoagulation alone was the only regimen with an increased risk of major bleeding (1.37, 1.06 to 1.77) compared with non-resumption of treatment; however, the difference in risk of recurrent gastrointestinal bleeding was not significant between patients who restarted an antithrombotic treatment regimen and those who did not resume treatment. What this study adds Among patients with atrial fibrillation who experience gastrointestinal bleeding while receiving antithrombotic treatment; subsequent restart of oral anticoagulation alone was associated with better outcomes for all cause mortality and thromboembolism compared with patients who did not resume treatment. This was despite an increased longitudinal associated risk of bleeding.	[Staerk, Laila; Olesen, Jonas B.; Pallisgaard, Jannik L.; Bonde, Anders N.; Gundlund, Anna; Lindhardt, Tommi B.; Gislason, Gunnar H.] Copenhagen Univ Hosp Herlev & Gentofte, Dept Cardiol, DK-2900 Hellerup, Denmark; [Staerk, Laila; Lip, Gregory Y. H.] Univ Birmingham, Ctr Cardiovasc Sci, Birmingham City Hosp, Birmingham, W Midlands, England; [Fosbol, Emil L.; Hansen, Morten L.] Copenhagen Univ Hosp, Dept Cardiol, Rigshosp, Copenhagen, Denmark; [Torp-Pedersen, Christian] Aalborg Univ, Inst Hlth Sci & Technol, Aalborg, Denmark; [Gislason, Gunnar H.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Gislason, Gunnar H.] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Gislason, Gunnar H.] Danish Heart Fdn, Copenhagen, Denmark	University of Birmingham; Rigshospitalet; University of Copenhagen; Aalborg University; University of Copenhagen; University of Southern Denmark	Staerk, L (corresponding author), Copenhagen Univ Hosp Herlev & Gentofte, Dept Cardiol, Kildegaardsvej 28, DK-2900 Hellerup, Denmark.	Lailastaerk@gmail.com	Gislason, Gunnar/B-7561-2009; Pallisgaard, Jannik Langtved/S-9546-2019	Gislason, Gunnar/0000-0002-0548-402X; Pallisgaard, Jannik Langtved/0000-0002-8072-3318; Fosbol, Emil/0000-0002-2048-4167; Bonde, Anders Nissen/0000-0001-6794-8726	Boehringer-Ingelheim; Novo Nordisk Fonden [NNF12OC1015957] Funding Source: researchfish	Boehringer-Ingelheim(Boehringer Ingelheim); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by a grant from Boehringer-Ingelheim. The sponsor had no influence on the study design, interpretation of results, or the decision to submit the manuscript for publication.	Abraham NS, 2010, J AM COLL CARDIOL, V56, P2051, DOI 10.1016/j.jacc.2010.09.010; Alberts MJ, 2012, LANCET NEUROL, V11, P1066, DOI 10.1016/S1474-4422(12)70258-2; Bhatt DL, 2008, J AM COLL CARDIOL, V52, P1502, DOI 10.1016/j.jacc.2008.08.002; Camm AJ, 2012, EUR HEART J, V33; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; CHOUDARI CP, 1995, GUT, V36, P483, DOI 10.1136/gut.36.4.483; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cunningham A, 2011, PHARMACOEPIDEM DR S, V20, P560, DOI 10.1002/pds.2109; Delaney JA, 2007, CAN MED ASSOC J, V177, P347, DOI 10.1503/cmaj.070186; Gaist D, 1997, BRIT J CLIN PHARMACO, V43, P429, DOI 10.1046/j.1365-2125.1997.00582.x; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Hearnshaw SA, 2011, GUT, V60, P1327, DOI 10.1136/gut.2010.228437; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Kumler T, 2008, EUR J HEART FAIL, V10, P658, DOI 10.1016/j.ejheart.2008.05.006; Lamberts M, 2012, CIRCULATION, V126, P1185, DOI 10.1161/CIRCULATIONAHA.112.114967; Lau JYW, 2013, LANCET, V381, P2033, DOI 10.1016/S0140-6736(13)60596-6; Lip GYH, 2008, BRIT MED J, V336, P614, DOI 10.1136/bmj.39351.706586.AD; Lip GYH, 2015, JAMA-J AM MED ASSOC, V313, P1950, DOI 10.1001/jama.2015.4369; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Man-Son-Hing M, 2002, ARCH INTERN MED, V162, P541, DOI 10.1001/archinte.162.5.541; Mukamal KJ, 2005, CIRCULATION, V112, P1736, DOI 10.1161/CIRCULATIONAHA.105.547844; Olesen JB, 2015, EUROPACE, V17, P187, DOI 10.1093/europace/euu225; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Olesen JB, 2011, THROMB HAEMOSTASIS, V106, P739, DOI 10.1160/TH11-05-0364; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Qureshi W, 2014, AM J CARDIOL, V113, P662, DOI 10.1016/j.amjcard.2013.10.044; Riva N, 2012, INT J CLIN PRACT, V66, P2, DOI 10.1111/j.1742-1241.2011.02828.x; Sam C, 2004, AM J CARDIOL, V94, P947, DOI 10.1016/j.amjcard.2004.06.038; Schmidt M, 2014, CLIN EPIDEMIOL, V6, P155, DOI 10.2147/CLEP.S59156; Sung JJY, 2010, ANN INTERN MED, V152, P1, DOI 10.7326/0003-4819-152-1-201001050-00179; Witt DM, 2012, ARCH INTERN MED, V172, P1484, DOI 10.1001/archinternmed.2012.4261	34	104	105	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 16	2015	351								h5876	10.1136/bmj.h5876	http://dx.doi.org/10.1136/bmj.h5876			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XU	26572685	Green Published, hybrid			2022-12-28	WOS:000365352300002
J	Dijk, DJ; Skeldon, AC				Dijk, Derk-Jan; Skeldon, Anne C.			BIOLOGICAL RHYTHMS Human sleep before the industrial era	NATURE			English	Editorial Material							ELECTRIC LIGHT		[Dijk, Derk-Jan] Univ Surrey, Surrey Sleep Res Ctr, Guildford GU2 5XH, Surrey, England; [Skeldon, Anne C.] Univ Surrey, Dept Math, Guildford GU2 7XP, Surrey, England	University of Surrey; University of Surrey	Dijk, DJ (corresponding author), Univ Surrey, Surrey Sleep Res Ctr, Guildford GU2 5XH, Surrey, England.	d.j.dijk@surrey.ac.uk; a.skeldon@surrey.ac.uk		Skeldon, Anne/0000-0001-6387-4766				Czeisler C, 2013, NATURE, V497, pS13, DOI 10.1038/497S13a; Daan S, 2013, J BIOL RHYTHM, V28, P403, DOI 10.1177/0748730413514357; de la Iglesia HO, 2015, J BIOL RHYTHM, V30, P342, DOI 10.1177/0748730415590702; Moreno CRC, 2015, SCI REP-UK, V5, DOI 10.1038/srep14074; Roenneberg T, 2013, NATURE, V498, P427, DOI 10.1038/498427a; Santhi N, 2012, J PINEAL RES, V53, P47, DOI 10.1111/j.1600-079X.2011.00970.x; Skeldon A. C., 2015, SLEEP MED REV; van der Vinne V, 2014, P NATL ACAD SCI USA, V111, P15256, DOI 10.1073/pnas.1413135111; Wright KP, 2013, CURR BIOL, V23, P1554, DOI 10.1016/j.cub.2013.06.039; Yetish G, 2015, CURR BIOL	10	3	3	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					176	177		10.1038/527176a	http://dx.doi.org/10.1038/527176a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RC	26560297				2022-12-28	WOS:000364396700032
J	Rigby, PWJ; Weiss, RA				Rigby, Peter W. J.; Weiss, Robin A.			Chris Marshall (1949-2015) Obituary	CELL			English	Biographical-Item									[Rigby, Peter W. J.] Inst Canc Res, Chester Beatty Labs, Div Canc Biol, London SW3 6JB, England; [Weiss, Robin A.] UCL, Div Infect & Immun, London WC1E 6BT, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; University College London	Rigby, PWJ (corresponding author), Inst Canc Res, Chester Beatty Labs, Div Canc Biol, Fulham Rd, London SW3 6JB, England.	peter.rigby@icr.ac.uk; r.weiss@ucl.ac.uk							0	1	1	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1177	1178		10.1016/j.cell.2015.08.050	http://dx.doi.org/10.1016/j.cell.2015.08.050			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26606761	Bronze			2022-12-28	WOS:000361247900001
J	Gelband, H; Sankaranarayanan, R; Gauvreau, CL; Horton, S; Anderson, BO; Bray, F; Cleary, J; Dare, AJ; Denny, L; Gospodarowicz, MK; Gupta, S; Howard, SC; Jaffray, DA; Knaul, F; Levin, C; Rabeneck, L; Rajaraman, P; Sullivan, T; Trimble, EL; Jha, P				Gelband, Hellen; Sankaranarayanan, Rengaswamy; Gauvreau, Cindy L.; Horton, Susan; Anderson, Benjamin O.; Bray, Freddie; Cleary, James; Dare, Anna J.; Denny, Lynette; Gospodarowicz, Mary K.; Gupta, Sumit; Howard, Scott C.; Jaffray, David A.; Knaul, Felicia; Levin, Carol; Rabeneck, Linda; Rajaraman, Preetha; Sullivan, Terrence; Trimble, Edward L.; Jha, Prabhat		Dis Control Priorities-Canc	Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition	LANCET			English	Review							UNIVERSAL HEALTH COVERAGE; CERVICAL-CANCER; BREAST-CANCER; DEATHS; MORTALITY; INDIA; CARE; BEVACIZUMAB; RESOURCE; SMOKERS	Investments in cancer control-prevention, detection, diagnosis, surgery, other treatment, and palliative care-are increasingly needed in low-income and particularly in middle-income countries, where most of the world's cancer deaths occur without treatment or palliation. To help countries expand locally appropriate services, Cancer (the third volume of nine in Disease Control Priorities, 3rd edition) developed an essential package of potentially cost-effective measures for countries to consider and adapt. Interventions included in the package are: prevention of tobacco-related cancer and virus-related liver and cervical cancers; diagnosis and treatment of early breast cancer, cervical cancer, and selected childhood cancers; and widespread availability of palliative care, including opioids. These interventions would cost an additional US$20 billion per year worldwide, constituting 3% of total public spending on health in low-income and middle-income countries. With implementation of an appropriately tailored package, most countries could substantially reduce suffering and premature death from cancer before 2030, with even greater improvements in later decades.	[Gelband, Hellen] Ctr Dis Dynam Econ & Policy, Washington, DC 20005 USA; [Sankaranarayanan, Rengaswamy; Bray, Freddie] Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France; [Gauvreau, Cindy L.; Dare, Anna J.; Jha, Prabhat] Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Sullivan, Terrence] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Horton, Susan] Univ Waterloo, Waterloo, ON N2L 3G1, Canada; [Anderson, Benjamin O.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Cleary, James] Univ Wisconsin, Madison, WI USA; [Denny, Lynette] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Gospodarowicz, Mary K.; Jaffray, David A.] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Gupta, Sumit] Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Howard, Scott C.] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Knaul, Felicia] Harvard Univ, Cambridge, MA 02138 USA; [Levin, Carol] Univ Washington, Seattle, WA 98195 USA; [Rabeneck, Linda] Canc Care Ontario, Toronto, ON, Canada; [Rajaraman, Preetha; Trimble, Edward L.] NCI, Bethesda, MD 20892 USA	World Health Organization; International Agency for Research on Cancer (IARC); University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Waterloo; Fred Hutchinson Cancer Center; University of Wisconsin System; University of Wisconsin Madison; University of Cape Town; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Tennessee System; University of Tennessee Health Science Center; Harvard University; University of Washington; University of Washington Seattle; Cancer Care Ontario; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gelband, H (corresponding author), Ctr Dis Dynam Econ & Policy, Washington, DC 20005 USA.; Jha, P (corresponding author), Univ Toronto, Toronto, ON M5B 2C5, Canada.	gelband@cddep.org; prabhat.jha@utoronto.ca	Harding, Richard/G-9729-2012; Trimble, Edward/J-9647-2019	Trimble, Edward/0000-0001-5028-0598; Jaffray, David/0000-0001-7378-7543; Gupta, Sumit/0000-0003-1334-3670; Ginsburg, Ophira/0000-0002-1384-2675; Horton, Susan/0000-0002-9243-4767; Knaul, Felicia/0000-0002-0512-4788; Bray, Freddie/0000-0002-3248-7787	Bill & Melinda Gates Foundation; US National Cancer Institute; Canadian Institutes of Health Research [126347]; Centre for Global Health Research	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Centre for Global Health Research	We thank George Alleyne for helpful comments on an earlier draft. The Bill & Melinda Gates Foundation provides financial support for the Disease Control Priorities Network project, of which this volume is a part. We received funding from the US National Cancer Institute, Canadian Institutes of Health Research (grant 126347), and Centre for Global Health Research.	Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Anderson BO, 2011, LANCET ONCOL, V12, P387, DOI 10.1016/S1470-2045(11)70031-6; Anderson BO., 2015, CANC DIS CONTROL PRI, V3, P45; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Bray F., 2014, PLANNING DEV POPULAT; Bray F, 2015, DIS CONTROL IN PRESS; Brown ML, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P569; Chen ZM, 2015, LANCET, V386, P1447, DOI 10.1016/S0140-6736(15)00340-2; Cleary J, 2015, DIS CONTROL IN PRESS; Dare AJ, 2015, DIS CONTROL IN PRESS; Dare AJ, 2015, LANCET GLOB HEALTH, V3, pE646, DOI 10.1016/S2214-109X(15)00079-0; Dedes KJ, 2009, EUR J CANCER, V45, P1397, DOI 10.1016/j.ejca.2008.12.016; Denny L, 2015, DIS CONTROL IN PRESS; Dikshit R, 2012, LANCET, V379, P1807, DOI 10.1016/S0140-6736(12)60358-4; Dowsett M, 2015, LANCET, V386, P1341, DOI 10.1016/S0140-6736(15)61074-1; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Foley KM, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P981; Gelband H, 2015, DIS CONTROL IN PRESS; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Gospodarowicz MK, 2015, DIS CONTROL IN PRESS; Goss PE, 2013, LANCET ONCOL, V14, P391, DOI 10.1016/S1470-2045(13)70048-2; Groopman JD, 2008, ANNU REV PUBL HEALTH, V29, P187, DOI 10.1146/annurev.publhealth.29.020907.090859; Gupta S, 2015, DIS CONTROL IN PRESS; Gupta S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001656; Hamid SA, 2014, APPL HEALTH ECON HEA, V12, P421, DOI 10.1007/s40258-014-0100-2; Hewitt M., 2005, CANC PATIENT CANC SU; Hill C, 2013, IMPACT AUGMENTATION; Horton S, 2015, DIS CONTROL IN PRESS; IARC, 2012, IARC MONGR EV CARC R, V100; IARC, 1994, IARC MONGR EV CARC R, V61; Ilbawi AM, 2013, WORLD J SURG, V37, P1208, DOI 10.1007/s00268-013-1977-x; Institute for Health Metrics and Evaluation, 2012, FIN GLOB HLTH 2012 E; International Agency for Research on Cancer (IARC), 2020, GLOBOCAN, V419, P1; Jaffray DA, 2015, CANC DIS CONTROL PRI, V3; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jamison DT, 2011, MUCH HAVE GLOBAL PRO, P207; Jamison DT, 2015, LANCET; Jha P., 2009, CHOOSING HLTH ENTITL; Jha P, 2015, DIS CONTROL IN PRESS; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; Jha P, 2015, LANCET, V385, P918, DOI 10.1016/S0140-6736(15)60464-0; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; John RM, 2011, TOB CONTROL, V20, P349, DOI 10.1136/tc.2010.040089; Knaul F, 2015, DIS CONTROL IN PRESS; Mallath MK, 2014, LANCET ONCOL, V15, pE205, DOI 10.1016/S1470-2045(14)70115-9; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Metzger ML, 2003, LANCET, V362, P706, DOI 10.1016/S0140-6736(03)14228-6; Mock CN, 2015, LANCET, V385, P2209, DOI 10.1016/S0140-6736(15)60091-5; Monteiro CA, 2007, B WORLD HEALTH ORGAN, V85, P527, DOI 10.2471/BLT.06.039073; Montero AJ, 2012, BREAST CANCER RES TR, V132, P747, DOI 10.1007/s10549-011-1919-y; Musgrove P, 1996, PUBLIC PROVATE ROLES; Lan NH, 2013, GLOBAL HEALTH ACTION, V6, P32, DOI 10.3402/gha.v6i0.18872; Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9; OECD, 2013, OECD HLTH POL STUD C; Ozawa S, 2012, VACCINE, V31, P96, DOI 10.1016/j.vaccine.2012.10.103; Peabody JW, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1293; Piot P, 2013, NEW ENGL J MED, V368, P2210, DOI 10.1056/NEJMra1201533; PONTEN J, 1995, INT J CANCER, V60, P1, DOI 10.1002/ijc.2910600102; Pramesh CS, 2014, INDIAN J MED PAEDIAT, V35, P226, DOI 10.4103/0971-5851.142040; Rabeneck L, 2015, DIS CONTROL IN PRESS; Rao Seshadri S, 2015, KARNATAKAS ROADMAP I; Ringborg U, 2003, ACTA ONCOL, V42, P357, DOI 10.1080/02841860310010826; Rodgers M, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI [10.3310/hta15100, 10.3310/hta15suppl1/01]; Sankaranarayanan R, 2015, DIS CONTROL IN PRESS; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Seya Marie-Josephine, 2011, J Pain Palliat Care Pharmacother, V25, P6, DOI 10.3109/15360288.2010.536307; Shisana O, 2006, SAMJ S AFR MED J, V96, P814; Shulman L., 2011, CLOSING CANC DIVIDE; Sloan F.A., 2007, I MED US COMMITTEE C; Smith MA, 2010, J CLIN ONCOL, V28, P2625, DOI 10.1200/JCO.2009.27.0421; Sullivan T, 2015, DIS CONTROL IN PRESS; Tappenden P, 2007, HEALTH TECHNOL ASSES, V11, P1; The World Bank, WORLD BANK DEV IND 2; Trimble EL, 2015, DIS CONTROL IN PRESS; Union for International Cancer Control (UICC), GLOB TASK FORC RAD C; United Nations Department of Economic and Social Affairs, TRANSF OUR WORLD 203; UNPD, 2012, WORLD POP PROSP 2012; US Preventive Services Task Force, 2012, FIN REC STAT PROST C; Van Walbeek Corne, 2005, Promot Educ, VSuppl 4, P25; Varmus H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002321; Verguet S, 2015, LANCET GLOB HEALTH, V3, pE206, DOI 10.1016/S2214-109X(15)70095-1; WHO, 2000, WORLD HLTH REP 2000; WHO, 2011, SCAL ACT NONC DIS MU; WHO Immunization Practices Advisory Committee, 2011, FIN M REP REC 12 13; World Health Organization, 2015, HLTH STAT INF SYST G; World Health Organization, 2001, MACR HLTH INV HLTH E; World Health Organization-WHO, 2013, WHO REP GLOB TOB EP	88	110	113	2	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 21	2016	387	10033					2133	2144		10.1016/S0140-6736(15)00755-2	http://dx.doi.org/10.1016/S0140-6736(15)00755-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6HC	26578033	Bronze			2022-12-28	WOS:000376450800037
J	Ledford, H				Ledford, Heidi			Epigenetics: The genome unwrapped	NATURE			English	Editorial Material																			0	10	10	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					S12	S13		10.1038/528S12a	http://dx.doi.org/10.1038/528S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26630592	Bronze			2022-12-28	WOS:000365606000006
J	Joelving, F				Joelving, Frederik			CONFLICTS OF INTEREST India's "health camps": the drug rep will see you now	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												fcjoelving@gmail.com						Abbot India, CORP SOC RESP POL; Abbott India, ABB IND ANN REP 2014; Abbott India, TRANSF LIV CONT CAR; Abbott India, YOUR EXP OUR PROM AN; Abbott India, CIT REP 2010 2011; Abbott India, ABB IND ANN REP 2010; [Anonymous], 2015, FREE HLTH CHECK CAMP; [Anonymous], 2014, INDIAN EXPRESS; [Anonymous], 2013, BUSINESS STANDA 0510; [Anonymous], 2015, SANGAI EXPRESS; English E, 2015, DIABETOLOGIA, V58, P1409, DOI 10.1007/s00125-015-3599-3; IMS Health, 2015, MARK REFL REP; McGettigan P, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001826; Rugge JB, 2015, ANN INTERN MED, V162, P35, DOI 10.7326/M14-1456; Varma S., 2014, TIMES INDIA	15	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2015	351								h6413	10.1136/bmj.h6413	http://dx.doi.org/10.1136/bmj.h6413			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX9EY	26631261				2022-12-28	WOS:000366009000004
J	Molina, G; Weiser, TG; Lipsitz, SR; Esquivel, MM; Uribe-Leitz, T; Azad, T; Shah, N; Semrau, K; Berry, WR; Gawande, AA; Haynes, AB				Molina, George; Weiser, Thomas G.; Lipsitz, Stuart R.; Esquivel, Micaela M.; Uribe-Leitz, Tarsicio; Azad, Tej; Shah, Neel; Semrau, Katherine; Berry, William R.; Gawande, Atul A.; Haynes, Alex B.			Relationship Between Cesarean Delivery Rate and Maternal and Neonatal Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREGNANCY OUTCOMES; INCOME COUNTRIES; PERINATAL HEALTH; GLOBAL SURVEY; SECTION	IMPORTANCE Based on older analyses, the World Health Organization (WHO) recommends that cesarean delivery rates should not exceed 10 to 15 per 100 live births to optimize maternal and neonatal outcomes. OBJECTIVES To estimate the contemporary relationship between national levels of cesarean delivery and maternal and neonatal mortality. DESIGN, SETTING, AND PARTICIPANTS Cross-sectional, ecological study estimating annual cesarean delivery rates from data collected during 2005 to 2012 for all 194 WHO member states. The year of analysis was 2012. Cesarean delivery rates were available for 54 countries for 2012. For the 118 countries for which 2012 data were not available, the 2012 cesarean delivery rate was imputed from other years. For the 22 countries for which no cesarean rate data were available, the rate was imputed from total health expenditure per capita, fertility rate, life expectancy, percent of urban population, and geographic region. EXPOSURES Cesarean delivery rate. MAIN OUTCOMES AND MEASURES The relationship between population-level cesarean delivery rate and maternal mortality ratios (maternal death from pregnancy related causes during pregnancy or up to 42 days postpartum per 100 000 live births) or neonatal mortality rates (neonatal mortality before age 28 days per 1000 live births). RESULTS The estimated number of cesarean deliveries in 2012 was 22.9 million (95% CI, 22.5 million to 23.2 million). At a country-level, cesarean delivery rate estimates up to 19.1 per 100 live births (95% CI, 16.3 to 21.9) and 19.4 per 100 live births (95% CI, 18.6 to 20.3) were inversely correlated with maternal mortality ratio (adjusted slope coefficient, -10.1; 95% CI, -16.8 to -3.4; P = .003) and neonatal mortality rate (adjusted slope coefficient, -0.8; 95% CI, -1.1 to -0.5; P < .001), respectively (adjusted for total health expenditure per capita, population, percent of urban population, fertility rate, and region). Higher cesarean delivery rates were not correlated with maternal or neonatal mortality at a country level. A sensitivity analysis including only 76 countries with the highest-quality cesarean delivery rate information had a similar result: cesarean delivery rates greater than 6.9 to 20.1 per 100 live births were inversely correlated with the maternal mortality ratio (slope coefficient, -21.3; 95% CI, -32.2 to -10.5, P < .001). Cesarean delivery rates of 12.6 to 24.0 per 100 live births were inversely correlated with neonatal mortality (slope coefficient, -1.4; 95% CI, -2.3 to -0.4; P = .004). CONCLUSIONS AND RELEVANCE National cesarean delivery rates of up to approximately 19 per 100 live births were associated with lower maternal or neonatal mortality among WHO member states. Previously recommended national target rates for cesarean deliveries may be too low.	[Molina, George; Lipsitz, Stuart R.; Shah, Neel; Semrau, Katherine; Berry, William R.; Gawande, Atul A.; Haynes, Alex B.] Brigham & Womens Hosp, Ariadne Labs, Boston, MA 02115 USA; [Molina, George; Lipsitz, Stuart R.; Shah, Neel; Semrau, Katherine; Berry, William R.; Gawande, Atul A.; Haynes, Alex B.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Molina, George; Haynes, Alex B.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Weiser, Thomas G.; Esquivel, Micaela M.; Uribe-Leitz, Tarsicio] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [Lipsitz, Stuart R.] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA 02115 USA; [Azad, Tej] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Shah, Neel] Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Stanford University; Harvard University; Brigham & Women's Hospital; Stanford University; Harvard University; Beth Israel Deaconess Medical Center	Haynes, AB (corresponding author), Ariadne Labs, 401 Pk Dr,Third Floor East, Boston, MA 02215 USA.	tweiser@stanford.edu; abhaynes@mgh.harvard.edu	Weiser, Thomas G/AAC-4609-2022; Molina, George/ABC-5038-2021	Weiser, Thomas G/0000-0002-3118-3888; Azad, Tej/0000-0001-7823-4294; Semrau, Katherine/0000-0002-8360-1391; Esquivel, Micaela/0000-0003-1892-6533				Althabe F, 2006, BIRTH-ISS PERINAT C, V33, P270, DOI 10.1111/j.1523-536X.2006.00118.x; [Anonymous], 1985, LANCET, V2, P436; [Anonymous], DAT OECD; [Anonymous], WHO REG OFF EUR; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Carroll RJ, 2006, MESUREMENT ERROR NON; Central Intelligence Agency, WORLD FACTB COUNT RL; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Declercq E, 2011, BIRTH-ISS PERINAT C, V38, P99, DOI 10.1111/j.1523-536X.2010.00459.x; Kozhimannil KB, 2013, HEALTH AFFAIR, V32, P527, DOI 10.1377/hlthaff.2012.1030; Kyu HH, 2013, INT J EPIDEMIOL, V42, P781, DOI 10.1093/ije/dyt081; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; McClure EM, 2007, INT J GYNECOL OBSTET, V96, P139, DOI 10.1016/j.ijgo.2006.10.010; MEHTA CR, 1995, STAT MED, V14, P2143, DOI 10.1002/sim.4780141908; Organization for Economic Co-operation and Development iLibrary, HLTH CAR GLANC HLTH; Program DHS, DEM HLTH; Ronsmans C, 2006, LANCET, V368, P1516, DOI 10.1016/S0140-6736(06)69639-6; Shah A, 2009, INT J GYNECOL OBSTET, V107, P191, DOI 10.1016/j.ijgo.2009.08.013; Solheim KN, 2011, J MATERN-FETAL NEO M, V24, P1341, DOI 10.3109/14767058.2011.553695; Stanton CK, 2006, STUD FAMILY PLANN, V37, P41, DOI 10.1111/j.1728-4465.2006.00082.x; Stanton CK, 2005, B WORLD HEALTH ORGAN, V83, P449; UNICEF, MAT HLTH DEL CAR CES; United Nations, MILL DEV GOALS 2015; United Nations Statistics Division, WORLD STAT PCK; United States Bureau of Labor Statistics, INFL CLC; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Volpe FM, 2011, REV PANAM SALUD PUBL, V29, P303, DOI 10.1590/S1020-49892011000500001; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Wilmoth JR., 2012, STAT POLITICS POLICY, V3, DOI 10.1515/2151-7509.1038; World Bank, WORLD DEV IND; World Health Organization, 1994, IND MON MAT HLTH GOA, P20; World Health Organization, 2010, WORLD HLTH STAT 2010, P88; World Health Organization, GLOB HLTH OBS DAT RE; Ye JF, 2014, BIRTH-ISS PERINAT C, V41, P237, DOI 10.1111/birt.12104	34	300	314	3	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2015	314	21					2263	2270		10.1001/jama.2015.15553	http://dx.doi.org/10.1001/jama.2015.15553			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX2GT	26624825	Bronze, Green Published			2022-12-28	WOS:000365515700018
J	Simakov, O; Kawashima, T; Marletaz, F; Jenkins, J; Koyanagi, R; Mitros, T; Hisata, K; Bredeson, J; Shoguchi, E; Gyoja, F; Yue, JX; Chen, YC; Freeman, RM; Sasaki, A; Hikosaka-Katayama, T; Sato, A; Fujie, M; Baughman, KW; Levine, J; Gonzalez, P; Cameron, C; Fritzenwanker, JH; Pani, AM; Goto, H; Kanda, M; Arakaki, N; Yamasaki, S; Qu, J; Cree, A; Ding, Y; Dinh, HH; Dugan, S; Holder, M; Jhangiani, SN; Kovar, CL; Lee, SL; Lewis, LR; Morton, D; Nazareth, LV; Okwuonu, G; Santibanez, J; Chen, R; Richards, S; Muzny, DM; Gillis, A; Peshkin, L; Wu, M; Humphreys, T; Su, YH; Putnam, NH; Schmutz, J; Fujiyama, A; Yu, JK; Tagawa, K; Worley, KC; Gibbs, RA; Kirschner, MW; Lowe, CJ; Satoh, N; Rokhsar, DS; Gerhart, J				Simakov, Oleg; Kawashima, Takeshi; Marletaz, Ferdinand; Jenkins, Jerry; Koyanagi, Ryo; Mitros, Therese; Hisata, Kanako; Bredeson, Jessen; Shoguchi, Eiichi; Gyoja, Fuki; Yue, Jia-Xing; Chen, Yi-Chih; Freeman, Robert M., Jr.; Sasaki, Akane; Hikosaka-Katayama, Tomoe; Sato, Atsuko; Fujie, Manabu; Baughman, Kenneth W.; Levine, Judith; Gonzalez, Paul; Cameron, Christopher; Fritzenwanker, Jens H.; Pani, Ariel M.; Goto, Hiroki; Kanda, Miyuki; Arakaki, Nana; Yamasaki, Shinichi; Qu, Jiaxin; Cree, Andrew; Ding, Yan; Dinh, Huyen H.; Dugan, Shannon; Holder, Michael; Jhangiani, Shalini N.; Kovar, Christie L.; Lee, Sandra L.; Lewis, Lora R.; Morton, Donna; Nazareth, Lynne V.; Okwuonu, Geoffrey; Santibanez, Jireh; Chen, Rui; Richards, Stephen; Muzny, Donna M.; Gillis, Andrew; Peshkin, Leonid; Wu, Michael; Humphreys, Tom; Su, Yi-Hsien; Putnam, Nicholas H.; Schmutz, Jeremy; Fujiyama, Asao; Yu, Jr-Kai; Tagawa, Kunifumi; Worley, Kim C.; Gibbs, Richard A.; Kirschner, Marc W.; Lowe, Christopher J.; Satoh, Noriyuki; Rokhsar, Daniel S.; Gerhart, John			Hemichordate genomes and deuterostome origins	NATURE			English	Article							PTYCHODERA-FLAVA; PHYLOGENETIC ANALYSES; REGULATORY LANDSCAPE; CHORDATE ORIGINS; EVOLUTION; ORGANIZATION; DATABASE; IDENTIFICATION; EXPRESSION; GENES	Acorn worms, also known as enteropneust (literally, 'gut-breathing') hemichordates, are marine invertebrates that share features with echinoderms and chordates. Together, these three phyla comprise the deuterostomes. Here we report the draft genome sequences of two acorn worms, Saccoglossus kowalevskii and Ptychodera flava. By comparing them with diverse bilaterian genomes, we identify shared traits that were probably inherited from the last common deuterostome ancestor, and then explore evolutionary trajectories leading from this ancestor to hemichordates, echinoderms and chordates. The hemichordate genomes exhibit extensive conserved synteny with amphioxus and other bilaterians, and deeply conserved non-coding sequences that are candidates for conserved gene-regulatory elements. Notably, hemichordates possess a deuterostome-specific genomic cluster of four ordered transcription factor genes, the expression of which is associated with the development of pharyngeal 'gill' slits, the foremost morphological innovation of early deuterostomes, and is probably central to their filter-feeding lifestyle. Comparative analysis reveals numerous deuterostome-specific gene novelties, including genes found in deuterostomes and marine microbes, but not other animals. The putative functions of these genes can be linked to physiological, metabolic and developmental specializations of the filter-feeding ancestor.	[Simakov, Oleg; Rokhsar, Daniel S.] Grad Univ, Okinawa Inst Sci & Technol, Mol Genet Unit, Onna, Okinawa 9040495, Japan; [Simakov, Oleg] Heidelberg Univ, Dept Mol Evolut, Ctr Organismal Studies, D-69115 Heidelberg, Germany; [Kawashima, Takeshi; Hisata, Kanako; Shoguchi, Eiichi; Gyoja, Fuki; Baughman, Kenneth W.; Satoh, Noriyuki] Grad Univ, Okinawa Inst Sci & Technol, Marine Genom Unit, Onna, Okinawa 9040495, Japan; [Marletaz, Ferdinand] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Jenkins, Jerry; Schmutz, Jeremy] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Koyanagi, Ryo; Fujie, Manabu; Goto, Hiroki; Kanda, Miyuki; Arakaki, Nana; Yamasaki, Shinichi] Grad Univ, Okinawa Inst Sci & Technol, DNA Sequencing Sect, Onna, Okinawa 9040495, Japan; [Mitros, Therese; Bredeson, Jessen; Wu, Michael; Rokhsar, Daniel S.; Gerhart, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Yue, Jia-Xing; Putnam, Nicholas H.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77005 USA; [Chen, Yi-Chih; Su, Yi-Hsien; Yu, Jr-Kai] Acad Sinica, Inst Cellular & Organism Biol, Taipei 11529, Taiwan; [Freeman, Robert M., Jr.; Peshkin, Leonid; Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Sasaki, Akane; Tagawa, Kunifumi] Hiroshima Univ, Grad Sch Sci, Marine Biol Lab, Onomichi, Hiroshima 7220073, Japan; [Hikosaka-Katayama, Tomoe] Hiroshima Univ, Gene Sci Div, Nat Sci Ctr Basic Res & Dev, Hiroshima 7398527, Japan; [Sato, Atsuko] Marine Biol Assoc UK, Lab, Plymouth PL1 2PB, Devon, England; [Levine, Judith; Gonzalez, Paul; Fritzenwanker, Jens H.; Lowe, Christopher J.] Stanford Univ, Dept Biol, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Cameron, Christopher] Univ Montreal, Dept Sci Biol, Montreal, PQ H3C 3J7, Canada; [Pani, Ariel M.] Univ N Carolina, Chapel Hill, NC 27599 USA; [Qu, Jiaxin; Cree, Andrew; Ding, Yan; Dinh, Huyen H.; Dugan, Shannon; Holder, Michael; Jhangiani, Shalini N.; Kovar, Christie L.; Lee, Sandra L.; Lewis, Lora R.; Morton, Donna; Nazareth, Lynne V.; Okwuonu, Geoffrey; Santibanez, Jireh; Chen, Rui; Richards, Stephen; Muzny, Donna M.; Worley, Kim C.; Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Gillis, Andrew] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Humphreys, Tom] Univ Hawaii, Inst Biogenesis Res, Honolulu, HI 96822 USA; [Fujiyama, Asao] Natl Inst Genet, Mishima, Shizuoka 4113540, Japan; [Rokhsar, Daniel S.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA	Okinawa Institute of Science & Technology Graduate University; Ruprecht Karls University Heidelberg; Okinawa Institute of Science & Technology Graduate University; University of Oxford; HudsonAlpha Institute for Biotechnology; Okinawa Institute of Science & Technology Graduate University; University of California System; University of California Berkeley; Rice University; Academia Sinica - Taiwan; Harvard University; Harvard Medical School; Hiroshima University; Hiroshima University; Marine Biological Association United Kingdom; Stanford University; Universite de Montreal; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; University of Cambridge; University of Hawaii System; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Simakov, O (corresponding author), Grad Univ, Okinawa Inst Sci & Technol, Mol Genet Unit, Onna, Okinawa 9040495, Japan.	oleg.simakov@oist.jp; norisky@oist.jp; dsrokhsar@gmail.com; jgerhart@berkeley.edu	Jenkins, Jerry/ABE-6479-2020; Yue, Jia-Xing/H-5592-2019; Simakov, Oleg/AAV-2494-2020; Schmutz, Jeremy/N-3173-2013; Simakov, Oleg/G-4572-2015; Tagawa, Kunifumi/G-2856-2019; Marlétaz, Ferdinand/H-3018-2019; Su, Yi-Hsien/F-2910-2014; Yu, Jr-Kai/H-4822-2019; Satoh, Nori/C-4123-2009; Putnam, Nicholas/B-9968-2008	Jenkins, Jerry/0000-0002-7943-3997; Yue, Jia-Xing/0000-0002-2122-9221; Simakov, Oleg/0000-0002-3585-4511; Schmutz, Jeremy/0000-0001-8062-9172; Simakov, Oleg/0000-0002-3585-4511; Tagawa, Kunifumi/0000-0001-5634-9373; Marlétaz, Ferdinand/0000-0001-8124-4266; Yu, Jr-Kai/0000-0001-8591-0529; Satoh, Nori/0000-0002-4480-3572; Koyanagi, Ryo/0000-0002-9694-0288; Freeman, Robert/0000-0003-1463-9748; Worley, Kim/0000-0002-0282-1000; Fritzenwanker, Jens/0000-0002-5201-4100; Putnam, Nicholas/0000-0002-1315-782X; Gillis, Andrew/0000-0003-2062-3777; Richards, Stephen/0000-0001-8959-5466; Rokhsar, Daniel/0000-0002-8704-2224; Lowe, Christopher/0000-0002-7789-8643; Bredeson, Jessen/0000-0001-5489-8512; Peshkin, Leonid/0000-0002-6420-848X	MEXT; OIST, Japan; USPHS [HD42724, HD37277]; NASA [FDNAG2-1605, NNX13AI68G]; FP7/ERC grant [268513]; Molecular Genetics Unit of the Okinawa Institute of Science and Technology Graduate University; Marine Genomics Unit of the Okinawa Institute of Science and Technology Graduate University; Academia Sinica; Ministry of Science and Technology, Taiwan; NIH [R01HD073104]; National Human Genome Research Institute, National Institutes of Health [U54 HG003273]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD073104, T32HD055164] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037277, R01HD042724] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); OIST, Japan; USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NASA(National Aeronautics & Space Administration (NASA)); FP7/ERC grant; Molecular Genetics Unit of the Okinawa Institute of Science and Technology Graduate University; Marine Genomics Unit of the Okinawa Institute of Science and Technology Graduate University; Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The Ptychodera flava genome project was supported by MEXT and OIST, Japan. This research was supported by USPHS grant HD42724 and NASA grant FDNAG2-1605 to J.G.; USPHS grant HD37277 to M.W.K.; NASA - NNX13AI68G to C.L. F.M. was funded by FP7/ERC grant [268513]. O.S. and D.S.R, and T.K. and N.S. were supported by the Molecular Genetics Unit and Marine Genomics Unit of the Okinawa Institute of Science and Technology Graduate University, respectively. Y.-H.S. and J.-K.Y. are supported by Academia Sinica and Ministry of Science and Technology, Taiwan. L.P. was supported by NIH grant R01HD073104. The Saccoglossus kowalevskii genome project was supported by a grant from the National Human Genome Research Institute, National Institutes of Health (U54 HG003273) to R.A.G.	Aberer AJ, 2013, EXAML EXASCALE MAXIM; Agassiz A., 1873, Mem Am Ac, Vix, P421; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateson W, 1885, Q J MICROSC SCI, V25, P81; Bateson W., 1886, Q J MICROSC SCI, V26, P535; Baughman KW, 2014, GENESIS, V52, P952, DOI 10.1002/dvg.22840; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Brown FD, 2008, GENESIS, V46, P605, DOI 10.1002/dvg.20471; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Cameron RA, 2006, J EXP ZOOL PART B, V306B, P45, DOI 10.1002/jez.b.21070; Cannon JT, 2014, CURR BIOL, V24, P2827, DOI 10.1016/j.cub.2014.10.016; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chen SH, 2014, MAR GENOM, V15, P35, DOI 10.1016/j.margen.2014.04.010; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgecombe GD, 2011, ORG DIVERS EVOL, V11, P151, DOI 10.1007/s13127-011-0044-4; Freeman R, 2012, CURR BIOL, V22, P2053, DOI 10.1016/j.cub.2012.08.052; Gerhart J, 2005, CURR OPIN GENET DEV, V15, P461, DOI 10.1016/j.gde.2005.06.004; Giacopuzzi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044193; Gillis JA, 2012, P ROY SOC B-BIOL SCI, V279, P237, DOI 10.1098/rspb.2011.0599; Gonzalez P, 2009, BIOL J LINN SOC, V98, P898, DOI 10.1111/j.1095-8312.2009.01332.x; Halanych KM, 1995, MOL PHYLOGENET EVOL, V4, P72, DOI 10.1006/mpev.1995.1007; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Harduin-Lepers A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-258; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Holland ND, 2015, NATURE, V520, P450, DOI 10.1038/nature14433; Hyman L. H., 1959, INVERTEBRATES SMALLE, VV; Ikuta T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-129; Irimia M, 2012, GENOME RES, V22, P2356, DOI 10.1101/gr.139725.112; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Kaul-Strehlow S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-53; Kokubu C, 2009, NAT GENET, V41, P946, DOI 10.1038/ng.397; Kovalevskij A. O., 1866, MEMOIRES ACAD IMPERI; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lee AP, 2011, MOL BIOL EVOL, V28, P1205, DOI 10.1093/molbev/msq304; Lowe CJ, 2006, PLOS BIOL, V4, P1603, DOI 10.1371/journal.pbio.0040291; Lowe CJ, 2015, NATURE, V520, P456, DOI 10.1038/nature14434; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Royo JL, 2011, P NATL ACAD SCI USA, V108, P14186, DOI 10.1073/pnas.1109037108; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marinic M, 2013, DEV CELL, V24, P530, DOI 10.1016/j.devcel.2013.01.025; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Metschnikoff V.E., 1881, ZOOL ANZ, V4, P139; Ogasawara M, 1999, DEVELOPMENT, V126, P2539; PARDOS F, 1988, ACTA ZOOL-STOCKHOLM, V69, P1, DOI 10.1111/j.1463-6395.1988.tb00895.x; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Range R, 2007, DEVELOPMENT, V134, P3649, DOI 10.1242/dev.007799; Range R, 2011, DEV BIOL, V357, P440, DOI 10.1016/j.ydbio.2011.07.005; Romiguier J, 2014, NATURE, V515, P261, DOI 10.1038/nature13685; Ruiz-Trillo I, 2004, MOL PHYLOGENET EVOL, V33, P321, DOI 10.1016/j.ympev.2004.06.002; Ruppert EE, 1999, INVERTEBR BIOL, V118, P202, DOI 10.2307/3227061; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Santagati F, 2003, GENETICS, V165, P235; Santagati F, 2001, MAMM GENOME, V12, P232, DOI 10.1007/s003350010267; Simakov O., 2013, NATURE; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Srivastava M, 2014, CURR BIOL, V24, P1107, DOI 10.1016/j.cub.2014.03.042; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Swalla BJ, 2008, PHILOS T R SOC B, V363, P1557, DOI 10.1098/rstb.2007.2246; Tagawa K, 2014, ZOOL SCI, V31, P414, DOI 10.2108/zs130262; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wang SH, 2009, MOL CELL ENDOCRINOL, V313, P57, DOI 10.1016/j.mce.2009.08.024; Wang W, 2007, MOL BIOL EVOL, V24, P784, DOI 10.1093/molbev/msl205	68	142	144	5	91	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					459	+		10.1038/nature16150	http://dx.doi.org/10.1038/nature16150			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26580012	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000365352500036
J	Verma, SB				Verma, Shyam B.			Topical corticosteroid misuse in India is harmful and out of control	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Verma, Shyam B.] Nirvan Skin Clin, Vadodara 390009, Gujarat, India		Verma, SB (corresponding author), Nirvan Skin Clin, Vadodara 390009, Gujarat, India.	skindiaverma@gmail.com						Coondoo Arijit, 2014, Indian Dermatol Online J, V5, P416, DOI 10.4103/2229-5178.142483; Malik V., 2010, LAWS RELATING DRUGS, P409; National Psoriasis Foundation, WHATS TOPS TOP STER; Saraswat A, 2011, INDIAN J DERMATOL VE, V77, P160, DOI 10.4103/0378-6323.77455; Saraswat A, 2010, INDIAN J DERMATOL VE, V76, P225, DOI 10.4103/0378-6323.62959; Verma SB, 2014, INDIAN J DERMATOL VE, V80, P201, DOI 10.4103/0378-6323.132246; World Bank, RUR POP TOT POP	7	18	18	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2015	351								h6079	10.1136/bmj.h6079	http://dx.doi.org/10.1136/bmj.h6079			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX4TG	26608450				2022-12-28	WOS:000365692600004
J	Lipchik, RJ				Lipchik, Randolph J.			After treating unprovoked PE with VKAs for 6 months, warfarin for 18 more months reduced a composite of VTE or major bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lipchik, Randolph J.] Med Coll Wisconsin, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Lipchik, RJ (corresponding author), Med Coll Wisconsin, Milwaukee, WI 53226 USA.							Agnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Prandoni P, 2007, HAEMATOLOGICA, V92, P199, DOI 10.3324/haematol.10516	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					JC6	JC6		10.7326/ACPJC-2015-163-10-006	http://dx.doi.org/10.7326/ACPJC-2015-163-10-006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26571260				2022-12-28	WOS:000365746400007
J	Santos, RD				Santos, Raul D.			ACC/AHA guidelines determining statin eligibility better predicted CVD than ATP-III guidelines	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Santos, Raul D.] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil	Universidade de Sao Paulo	Santos, RD (corresponding author), Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil.		Santos, Raul/A-1170-2010	Santos, Raul/0000-0002-9860-6582				Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Whelton SP, 2012, CIRC-CARDIOVASC QUAL, V5, P601, DOI 10.1161/CIRCOUTCOMES.112.965566	3	0	0	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					JC11	JC11		10.7326/ACPJC-2015-163-10-011	http://dx.doi.org/10.7326/ACPJC-2015-163-10-011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26571253				2022-12-28	WOS:000365746400012
J	Gerya, TV; Stern, RJ; Baes, M; Sobolev, SV; Whattam, SA				Gerya, T. V.; Stern, R. J.; Baes, M.; Sobolev, S. V.; Whattam, S. A.			Plate tectonics on the Earth triggered by plume-induced subduction initiation	NATURE			English	Article							MANTLE PLUMES; MELT; CRUST; ORIGIN; GEODYNAMICS; EMPLACEMENT; EXTRACTION; BASALT; MODELS; GROWTH	Scientific theories of how subduction and plate tectonics began on Earth-and what the tectonic structure of Earth was before this-remain enigmatic and contentious(1). Understanding viable scenarios for the onset of subduction and plate tectonics(2,3) is hampered by the fact that subduction initiation processes must have been markedly different before the onset of global plate tectonics because most present-day subduction initiation mechanisms require acting plate forces and existing zones of lithospheric weakness, which are both consequences of plate tectonics(4). However, plume-induced subduction initiation(5-9) could have started the first subduction zone without the help of plate tectonics. Here, we test this mechanism using high-resolution three-dimensional numerical thermomechanical modelling. We demonstrate that three key physical factors combine to trigger self-sustained subduction: (1) a strong, negatively buoyant oceanic lithosphere; (2) focused magmatic weakening and thinning of lithosphere above the plume; and (3) lubrication of the slab interface by hydrated crust. We also show that plume-induced subduction could only have been feasible in the hotter early Earth for old oceanic plates. In contrast, younger plates favoured episodic lithospheric drips rather than self-sustained subduction and global plate tectonics.	[Gerya, T. V.] ETH, Dept Earth Sci, CH-8092 Zurich, Switzerland; [Stern, R. J.] Univ Texas Dallas, Geosci Dept, Richardson, TX 75083 USA; [Baes, M.; Sobolev, S. V.] GFZ German Res Ctr Geosci, D-14473 Potsdam, Germany; [Sobolev, S. V.] Univ Potsdam, Inst Earth & Environm Sci, D-14476 Potsdam, Germany; [Whattam, S. A.] Korea Univ, Dept Earth & Environm Sci, Seoul 136701, South Korea	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Texas System; University of Texas Dallas; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; University of Potsdam; Korea University	Gerya, TV (corresponding author), ETH, Dept Earth Sci, Sonneggstr 5, CH-8092 Zurich, Switzerland.	taras.gerya@erdw.ethz.ch	Stern, Robert/N-8344-2019; Whattam, Scott/AAX-1462-2021; Gerya, Taras/V-2330-2019; Sobolev, Stephan V/G-3813-2011	Stern, Robert/0000-0002-8083-4632; Whattam, Scott/0000-0001-9193-9002; Gerya, Taras/0000-0002-1062-2722; Sobolev, Stephan V/0000-0002-3382-4028; Baes, Marzieh/0000-0003-4703-8674	ERC ITN project ZIP; SNF project Swiss-AlpArray; SNF [200021_149252]; ETH [ETH-37_11-2]; SNF short scientific visits program	ERC ITN project ZIP; SNF project Swiss-AlpArray; SNF; ETH(ETH Zurich); SNF short scientific visits program	This study was co-funded by the ERC ITN project ZIP (T.V.G.), the SNF project Swiss-AlpArray (T.V.G.), the SNF grant 200021_149252 (T.V.G.), the ETH grant ETH-37_11-2 (T.V.G.) and a SNF short scientific visits program (R.J.S.). Simulations were performed on the ETH-Zurich Brutus cluster and on the GFZ-Potsdam cluster. Open-source software ParaView (http://www.paraview.org) was used for 3D visualization.	Barnes SJ, 2014, LITHOSPHERE-US, V6, P80, DOI 10.1130/L356.1; Bercovici D, 2014, NATURE, V508, P513, DOI 10.1038/nature13072; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; Campbell IH, 2001, GEOL S AM S, P5; Champion DC, 2007, DEV PREC G, V15, P369, DOI 10.1016/S0166-2635(07)15043-X; Clauser C., 1995, ROCK PHYS PHASE RELA, VVolume 3, P105, DOI DOI 10.1029/RF003P0105; Condie KC, 2006, GEOPHYS MONOGR SER, V164, P47, DOI 10.1029/164GM05; Connolly JAD, 2005, EARTH PLANET SC LETT, V236, P524, DOI 10.1016/j.epsl.2005.04.033; Connolly JAD, 2009, NATURE, V462, P209, DOI 10.1038/nature08517; Dhuime B, 2012, SCIENCE, V335, P1334, DOI 10.1126/science.1216066; Dymkova D, 2013, GEOPHYS RES LETT, V40, P5671, DOI 10.1002/2013GL057798; Eldholm O., 2000, GEOPHYS MONOGR SER, V121, P309; Gerya TV, 2011, J METAMORPH GEOL, V29, P7, DOI 10.1111/j.1525-1314.2010.00904.x; Gerya T. V., 2010, INTRO NUMERICAL GEOD, DOI 10.1017/9781316534243; Gerya TV, 2007, PHYS EARTH PLANET IN, V163, P83, DOI 10.1016/j.pepi.2007.04.015; Gerya TV, 2013, PHYS EARTH PLANET IN, V214, P35, DOI 10.1016/j.pepi.2012.10.007; GUDMUNDSSON A, 1990, TECTONOPHYSICS, V176, P257, DOI 10.1016/0040-1951(90)90073-H; Gudmundsson A, 2002, J VOLCANOL GEOTH RES, V116, P279, DOI 10.1016/S0377-0273(02)00226-3; Gurnis M, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000681; Hansen VL, 2007, GEOLOGY, V35, P1059, DOI 10.1130/G24202A.1; Herzberg C, 2010, EARTH PLANET SC LETT, V292, P79, DOI 10.1016/j.epsl.2010.01.022; Herzberg C, 2009, NATURE, V458, P619, DOI 10.1038/nature07857; Hess P.C., 1989, ORIGIN IGNEOUS ROCKS; Hoernle K, 2004, GEOLOGY, V32, P697, DOI 10.1130/G20574.1; Ito K., 1971, GEOPHYS MONOGR SER, V14, P303, DOI DOI 10.1029/GM014P0303; Jellinek AM, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000144; Katz RF, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000433; Katz RF, 2006, NATURE, V442, P676, DOI 10.1038/nature05039; Katz RF, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003282; KELEMEN PB, 1995, NATURE, V375, P747, DOI 10.1038/375747a0; Keller T, 2013, GEOPHYS J INT, V195, P1406, DOI 10.1093/gji/ggt306; Korenaga J, 2013, ANNU REV EARTH PL SC, V41, P117, DOI 10.1146/annurev-earth-050212-124208; Mei S, 2002, EARTH PLANET SC LETT, V201, P491, DOI 10.1016/S0012-821X(02)00745-8; MORGAN JP, 1995, J GEOPHYS RES-SOL EA, V100, P8045, DOI 10.1029/94JB02887; Morris GA, 2000, J PETROL, V41, P43, DOI 10.1093/petrology/41.1.43; Moyen JF, 2012, GEOLOGY, V40, P451, DOI 10.1130/G322894.1; Nair R, 2008, GEOLOGY, V36, P583, DOI 10.1130/G24773A.1; Nikolaeva K, 2008, PHYS EARTH PLANET IN, V171, P336, DOI 10.1016/j.pepi.2008.06.026; Olsson JR, 2011, NAT GEOSCI, V4, P865, DOI [10.1038/ngeo1308, 10.1038/NGEO1308]; Pedersen R, 2007, J VOLCANOL GEOTH RES, V162, P73, DOI 10.1016/j.jvolgeores.2006.12.010; Puchtel IS, 1999, GEOCHIM COSMOCHIM AC, V63, P3579, DOI 10.1016/S0016-7037(99)00111-8; Ranalli G., 1995, RHEOLOGY EARTH; Rey PF, 2014, NATURE, V513, P405, DOI 10.1038/nature13728; RUBIN AM, 1993, EARTH PLANET SC LETT, V119, P641, DOI 10.1016/0012-821X(93)90069-L; SANDWELL DT, 1992, SCIENCE, V257, P766, DOI 10.1126/science.257.5071.766; Schmeling H, 2008, PHYS EARTH PLANET IN, V171, P198, DOI 10.1016/j.pepi.2008.06.028; Schmidt MW, 1998, EARTH PLANET SC LETT, V163, P361, DOI 10.1016/S0012-821X(98)00142-3; Schutt DL, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2003JB002950; Sigmundsson F, 2010, NATURE, V468, P426, DOI 10.1038/nature09558; Smithies RH, 2005, EARTH PLANET SC LETT, V231, P221, DOI 10.1016/j.epsl.2004.12.026; Sobolev SV, 2011, NATURE, V477, P312, DOI 10.1038/nature10385; Stern RJ, 2004, EARTH PLANET SC LETT, V226, P275, DOI 10.1016/j.epsl.2004.08.007; Turcotte D.L., 2002, GEODYNAMICS, DOI DOI 10.1002/GJ.987; Ueda K, 2008, PHYS EARTH PLANET IN, V171, P296, DOI 10.1016/j.pepi.2008.06.032; van Dinther Y, 2013, J GEOPHYS RES-SOL EA, V118, P1502, DOI 10.1029/2012JB009479; Van Kranendonk MJ, 2010, AM J SCI, V310, P1187, DOI 10.2475/10.2010.01; Vogt K, 2012, PHYS EARTH PLANET IN, V192, P1, DOI 10.1016/j.pepi.2011.12.003; Whattam SA, 2015, GONDWANA RES, V27, P38, DOI 10.1016/j.gr.2014.07.011; Willbold M, 2009, EARTH PLANET SC LETT, V279, P44, DOI 10.1016/j.epsl.2008.12.029; Wyman DA, 2002, PRECAMBRIAN RES, V115, P37, DOI 10.1016/S0301-9268(02)00005-0	60	214	231	26	234	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					221	+		10.1038/nature15752	http://dx.doi.org/10.1038/nature15752			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26560300				2022-12-28	WOS:000364396700042
J	Dar, OA; Hasan, R; Schlundt, J; Harbarth, S; Caleo, G; Dar, FK; Littmann, J; Rweyemamu, M; Buckley, EJ; Shahid, M; Kock, R; Li, HL; Giha, H; Khan, M; So, AD; Bindayna, KM; Kessel, A; Pedersen, HB; Permanand, G; Zumla, A; Rottingen, JA; Heymann, DL				Dar, Osman A.; Hasan, Rumina; Schlundt, Jorgen; Harbarth, Stephan; Caleo, Grazia; Dar, Fazal K.; Littmann, Jasper; Rweyemamu, Mark; Buckley, Emmeline J.; Shahid, Mohammed; Kock, Richard; Li, Henry Lishi; Giha, Haydar; Khan, Mishal; So, Anthony D.; Bindayna, Khalid M.; Kessel, Anthony; Pedersen, Hanne Bak; Permanand, Govin; Zumla, Alimuddin; Rottingen, John-Arne; Heymann, David L.			Exploring the evidence base for national and regional policy interventions to combat resistance	LANCET			English	Article							JUDICIOUS ANTIBIOTIC USE; ANTIMICROBIAL RESISTANCE; STREPTOCOCCUS-PNEUMONIAE; DEVELOPING-COUNTRIES; SURVEILLANCE; STRATEGIES; TRIAL; IMPLEMENTATION; STEWARDSHIP; INFECTIONS	The effectiveness of existing policies to control antimicrobial resistance is not yet fully understood. A strengthened evidence base is needed to inform effective policy interventions across countries with different income levels and the human health and animal sectors. We examine three policy domains-responsible use, surveillance, and infection prevention and control-and consider which will be the most effective at national and regional levels. Many complexities exist in the implementation of such policies across sectors and in varying political and regulatory environments. Therefore, we make recommendations for policy action, calling for comprehensive policy assessments, using standardised frameworks, of cost-effectiveness and generalisability. Such assessments are especially important in low- income and middle-income countries, and in the animal and environmental sectors. We also advocate a One Health approach that will enable the development of sensitive policies, accommodating the needs of each sector involved, and addressing concerns of specific countries and regions.	[Dar, Osman A.; Heymann, David L.] Publ Hlth England, London, England; [Dar, Osman A.; Heymann, David L.] Chatham House, Ctr Global Hlth Secur, London SW1Y 4LE, England; [Hasan, Rumina] Aga Khan Univ, Karachi, Pakistan; [Schlundt, Jorgen] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore; [Harbarth, Stephan] Univ Hosp Geneva, Geneva, Switzerland; [Harbarth, Stephan] Fac Med, Geneva, Switzerland; [Caleo, Grazia] Med Sans Frontieres, London, England; [Dar, Osman A.; Giha, Haydar; Bindayna, Khalid M.] Arabian Gulf Univ, Manama, Bahrain; [Littmann, Jasper] Univ Kiel, Kiel, Germany; [Rweyemamu, Mark] Sokoine Univ Agr, Southern African Ctr Infect Dis Surveillance, Morogoro, Tanzania; [Buckley, Emmeline J.; Khan, Mishal; Kessel, Anthony; Heymann, David L.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Shahid, Mohammed] Aligarh Muslim Univ, Jawaharlal Nehru Med Coll & Hosp, Aligarh, Uttar Pradesh, India; [Kock, Richard] Univ London Royal Vet Coll, London, England; [Khan, Mishal] Res Alliance Advocacy & Dev, Karachi, Pakistan; [So, Anthony D.] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA; [So, Anthony D.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Pedersen, Hanne Bak; Permanand, Govin] WHO Reg Off Europe, Copenhagen, Denmark; [Zumla, Alimuddin] UCL, London, England; [Zumla, Alimuddin] Univ Coll Hosp NHS Trust, Natl Inst Hlth Res Biomed Res Ctr, London, England; [Rottingen, John-Arne] Norwegian Inst Publ Hlth, Oslo, Norway; [Rottingen, John-Arne] Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Rottingen, John-Arne] Univ Oslo, Inst Hlth & Soc, Fac Med, Oslo, Norway	Public Health England; Aga Khan University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Geneva; University of Geneva; Doctors Without Borders; Arabian Gulf University; University of Kiel; Sokoine University of Agriculture; University of London; London School of Hygiene & Tropical Medicine; Aligarh Muslim University; University of London; University of London Royal Veterinary College; Duke University; Duke University; World Health Organization; University of London; University College London; University of London; University College London; Norwegian Institute of Public Health (NIPH); Harvard University; Harvard T.H. Chan School of Public Health; University of Oslo	Dar, OA (corresponding author), Chatham House, Ctr Global Hlth Secur, London SW1Y 4LE, England.	osman.dar@phe.gov.uk	ZUMLA, Alimuddin/ABA-8208-2020; Schlundt, Joergen/AAH-9976-2020; Bindayna, Khalid/GLQ-8847-2022	ZUMLA, Alimuddin/0000-0002-5111-5735; Bindayna, Khalid/0000-0002-6222-4128; Bak Pedersen, Hanne/0000-0002-1251-0716; Buckley, Emmeline/0000-0002-8949-3643; Kock, Richard/0000-0002-6561-3209; Permanand, Govin/0000-0002-5624-4421	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Aarestrup Frank M, 2012, Emerg Infect Dis, V18, pe1, DOI 10.3201/eid/1811.120453; Aarestrup FM, 2010, AM J VET RES, V71, P726, DOI 10.2460/ajvr.71.7.726; Ahuja V, 2004, TROP ANIM HEALTH PRO, V36, P247, DOI 10.1023/B:TROP.0000016831.75454.2c; Aidara-Kane A., 2014, TACKLING ANTIMICROBI; Allegranzi B, 2013, LANCET INFECT DIS, V13, P843, DOI 10.1016/S1473-3099(13)70163-4; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Amabile-Cuevas CF, 2010, ANTIMICROBIAL RESISTANCE IN DEVELOPING COUNTRIES, P3, DOI 10.1007/978-0-387-89370-9_1; [Anonymous], 2013, ON HLTH CONC BRING T; [Anonymous], 2014, FINANCIAL TIMES; [Anonymous], WAT PARTN PROGR; [Anonymous], 2011, LIVE TD         0330; Baertlein L, 2015, REUTERS; Belongia EA, 1998, BRIT MED J, V317, P668, DOI 10.1136/bmj.317.7159.668; Belongia EA, 2001, PEDIATRICS, V108, P575, DOI 10.1542/peds.108.3.575; Bushnell G, 2013, INT J INFECT DIS, V17, pE325, DOI 10.1016/j.ijid.2012.11.025; Catley A, 2004, REV SCI TECH OIE, V23, P225, DOI 10.20506/rst.23.1.1476; Catley A, 2001, PREV VET MED, V49, P95, DOI 10.1016/S0167-5877(01)00171-4; Cheng AC, 2012, EMERG INFECT DIS, V18, P1453, DOI 10.3201/eid1809.111515; Coenen S, 2014, J ANTIMICROB CHEMOTH, V69, P529, DOI 10.1093/jac/dkt385; Crowther-Gibson P, 2012, ANTIMICROB AGENTS CH, V56, P5088, DOI 10.1128/AAC.06463-11; Dagan R, 2009, CLIN MICROBIOL INFEC, V15, P16, DOI 10.1111/j.1469-0691.2009.02726.x; Danish Veterinary and Food Administration, 2012, YELL CARD IN ANT; Datema TAM, 2012, INT J TUBERC LUNG D, V16, P704, DOI 10.5588/ijtld.11.0701; Davey P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub3; De Boeck H, 2012, EMERG INFECT DIS, V18, P1019, DOI 10.3201/eid1806.111214; Earnshaw S, 2014, EUROSURVEILLANCE, V19, P10, DOI 10.2807/1560-7917.ES2014.19.41.20928; ECDC, 2020, ANN REPORT EUROPEAN; EMA, 2011, TRENDS SAL VET ANT A; Eng JV, 2003, EMERG INFECT DIS, V9, P1128; Eurosurveillance editorial team, 2012, EUROSURVEILLANCE, V17, P20314; Fatkenheuer G, 2015, LANCET, V385, P1146, DOI 10.1016/S0140-6736(14)60660-7; Finkelstein JA, 2008, PEDIATRICS, V121, pE15, DOI 10.1542/peds.2007-0819; GAVI Alliance, COUNTR EL POL; Gerber JS, 2013, JAMA-J AM MED ASSOC, V309, P2345, DOI 10.1001/jama.2013.6287; Grasswitz TR, 2004, VET PHARM IND AFRICA; Grave K, 2006, PREV VET MED, V77, P306, DOI 10.1016/j.prevetmed.2006.01.010; Grave K, 2014, J ANTIMICROB CHEMOTH, V69, P2284, DOI 10.1093/jac/dku106; Grundmann H, 2011, DRUG RESIST UPDATE, V14, P79, DOI 10.1016/j.drup.2011.02.007; Hammerum AM, 2007, EMERG INFECT DIS, V13, P1632, DOI 10.3201/eid1311.070421; Harbarth S, 2001, CLIN INFECT DIS, V33, P1462, DOI 10.1086/322677; Hennessy TW, 2002, CLIN INFECT DIS, V34, P1543, DOI 10.1086/340534; Heuer OE, 2009, CLIN INFECT DIS, V49, P1248, DOI 10.1086/605667; Holloway K, 2011, TROP MED INT HEALTH, V16, P368, DOI 10.1111/j.1365-3156.2010.02696.x; Huttner B, 2014, CLIN MICROBIOL INFEC, V20, P954, DOI 10.1111/1469-0691.12803; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Jack A, 2013, FINANCIAL TIMES; Kariuki S, 2006, INT J ANTIMICROB AG, V28, P166, DOI 10.1016/j.ijantimicag.2006.05.026; Katakweba A.A.S., 2012, LIVEST RES RURAL DEV, V24; Khan MS, 2015, HEALTH POLICY PLANN, V30, P1289, DOI 10.1093/heapol/czu137; Komolafe O O, 2003, Malawi Med J, V15, P63; Kummerer K, 2004, J ANTIMICROB CHEMOTH, V54, P311, DOI 10.1093/jac/dkh325; Little P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1606; Luoto J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001469; Mandal J, 2012, EMERG INFECT DIS, V18, P1326, DOI 10.3201/eid1808.111686; Marti E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078906; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V60, pI63, DOI 10.1093/jac/dkm161; Ministry of Health Welfare and Sport The Netherlands, 2012, BEN RESP US MED SETT; Mitja O, 2012, LANCET, V379, P342, DOI 10.1016/S0140-6736(11)61624-3; Moyane J. N., 2013, African Journal of Microbiology Research, V7, P2990; Mshana SE, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-28; National Institute for Health and Care Excellence, 2015, ANT STEW SYST PROC E; Nisi R., 2013, ANTIMICROBIAL USE AN; OGAN MT, 1993, J APPL BACTERIOL, V74, P595; Okeke IN, 2005, LANCET INFECT DIS, V5, P568, DOI 10.1016/S1473-3099(05)70217-6; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Okeke IN, 2010, ANTIMICROBIAL RESISTANCE IN DEVELOPING COUNTRIES, P301, DOI 10.1007/978-0-387-89370-9_17; Parry J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3356; Pittet D., CLEAN CARE IS SAFER; Pletz Mathias W, 2011, Med Monatsschr Pharm, V34, P201; Public Health England and the Department of Health and Social Care, 2015, BEH CHANG ANT PRESCR; Radley D. E., 1981, Advances in the control of theileriosis. Proc. Internat. Conf. 9-13 Feb. 1981, Nairobi., P227; Ranji SR, 2008, MED CARE, V46, P847, DOI 10.1097/MLR.0b013e318178eabd; Silverman E, 2015, WALL STREET J; Simonsen GS, 2004, B WORLD HEALTH ORGAN, V82, P928; Song JH, 2012, VACCINE, V30, P2728, DOI 10.1016/j.vaccine.2012.01.091; Speksnijder DC, 2015, ZOONOSES PUBLIC HLTH, V62, P79, DOI 10.1111/zph.12167; Spurling GKP, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004417.pub4; The APUA Global Mission, 2014, PRES POW ANT INCR AC; UNFPA, 2010, EMP WOM PROT THEMS P; Vernet G, 2014, EMERG INFECT DIS, V20, P434, DOI [10.3201/eid2003.121157, 10.3201/EID2003.121157]; Versporten A, 2013, PEDIATR INFECT DIS J, V32, pE242, DOI 10.1097/INF.0b013e318286c612; Versporten A, 2014, LANCET INFECT DIS, V14, P381, DOI 10.1016/S1473-3099(14)70071-4; Viberg N, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-270; Vlieghe E, 2009, INT J ANTIMICROB AG, V34, P295, DOI 10.1016/j.ijantimicag.2009.04.015; Walt G, 2008, HEALTH POLICY PLANN, V23, P308, DOI 10.1093/heapol/czn024; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2005, EV COSTS BEN NAT SUR; WHO, 2012, WHO HIV DRUG RES REP; WHO, 2002, IMP ANT GROWTH PROM; WHO, 2014, INFECT CONTROL; WHO, 2011, CRIT IMP ANT HUM MED; World Bank, 2012, PEOPL PATH OUR PLAN; Xiao YH, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001556; Zingg W, 2015, LANCET INFECT DIS, V15, P212, DOI 10.1016/S1473-3099(14)70854-0	94	95	97	2	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2016	387	10015					285	295		10.1016/S0140-6736(15)00520-6	http://dx.doi.org/10.1016/S0140-6736(15)00520-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA9LQ	26603921	Green Accepted			2022-12-28	WOS:000368130700035
J	Haug, CJ				Haug, Charlotte J.			Report from Paris	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material														Haug, Charlotte Johanne/0000-0001-8217-7376					0	40	41	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2015	373	27					2589	2593		10.1056/NEJMp1515229	http://dx.doi.org/10.1056/NEJMp1515229			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CZ8UH	26629999	Bronze			2022-12-28	WOS:000367374100001
J	Leiser, SF; Miller, H; Rossner, R; Fletcher, M; Leonard, A; Primitivo, M; Rintala, N; Ramos, FJ; Miller, DL; Kaeberlein, M				Leiser, Scott F.; Miller, Hillary; Rossner, Ryan; Fletcher, Marissa; Leonard, Alison; Primitivo, Melissa; Rintala, Nicholas; Ramos, Fresnida J.; Miller, Dana L.; Kaeberlein, Matt			Cell nonautonomous activation of flavin-containing monooxygenase promotes longevity and health span	SCIENCE			English	Article							HYPOXIA-INDUCIBLE FACTOR; CAENORHABDITIS-ELEGANS; C. ELEGANS; LIFE-SPAN; DIETARY RESTRICTION; GENE-EXPRESSION; HIF-1; MOUSE; METABOLISM; PROTEIN	Stabilization of the hypoxia-inducible factor 1 (HIF-1) increases life span and health span in nematodes through an unknown mechanism. We report that neuronal stabilization of HIF-1 mediates these effects in Caenorhabditis elegans through a cell nonautonomous signal to the intestine, which results in activation of the xenobiotic detoxification enzyme flavin-containing monooxygenase-2 (FMO-2). This prolongevity signal requires the serotonin biosynthetic enzyme TPH-1 in neurons and the serotonin receptor SER-7 in the intestine. Intestinal FMO-2 is also activated by dietary restriction (DR) and is necessary for DR-mediated life-span extension, which suggests that this enzyme represents a point of convergence for two distinct longevity pathways. FMOs are conserved in eukaryotes and induced by multiple life span-extending interventions in mice, which suggests that these enzymes may play a critical role in promoting health and longevity across phyla.	[Leiser, Scott F.; Miller, Hillary; Rossner, Ryan; Fletcher, Marissa; Leonard, Alison; Primitivo, Melissa; Rintala, Nicholas; Ramos, Fresnida J.; Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Miller, Dana L.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kaeberlein, M (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	kaeber@uw.edu			NIH [R01AG038518, K99AG045200, T32AG000057]; Samsung Advanced Institute of Technology; Samsung Electronics Co.; American Federation for Aging Research Postdoctoral Fellowship; University of Washington Healthy Aging and Longevity Research Institute; M. J. Murdock Charitable Trust; National Institute on Aging, NIH [R00AGA0033050]; University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging (NIH) [P30AG013280]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057, P30AG013280, R00AG045200, K99AG045200, R01AG038518, R01AG044378] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samsung Advanced Institute of Technology(Samsung); Samsung Electronics Co.(Samsung); American Federation for Aging Research Postdoctoral Fellowship; University of Washington Healthy Aging and Longevity Research Institute; M. J. Murdock Charitable Trust; National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Dolphin for the vector to make the fmo-2p::GFP reporter strains and A. Mendenhall for advice and help with injecting worms. Strains were provided by the Caenorhabditis Genetics Center. This work was supported by NIH grant R01AG038518 and an award from the Samsung Advanced Institute of Technology, Samsung Electronics Co., to M.K. and NIH grant K99AG045200 to S.F.L. S.F.L. and F.J.R. were supported by NIH Training Grant T32AG000057. S.F.L. was also supported by an American Federation for Aging Research Postdoctoral Fellowship. Additional support was provided by the University of Washington Healthy Aging and Longevity Research Institute, the University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging (NIH grant P30AG013280), and an award to M.K. from the M. J. Murdock Charitable Trust. D.L.M. is an Ellison Medical Foundation New Scholar in Aging and receives support from National Institute on Aging, NIH, R00AGA0033050. Additional data are available in the supplementary materials.	Dolphin CT, 1997, NAT GENET, V17, P491, DOI 10.1038/ng1297-491; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Hernandez D, 2004, PHARMACOGENETICS, V14, P117, DOI 10.1097/00008571-200402000-00006; Ivan M, 2001, CURR OPIN GENET DEV, V11, P27, DOI 10.1016/S0959-437X(00)00152-0; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Krueger SK, 2005, PHARMACOL THERAPEUT, V106, P357, DOI 10.1016/j.pharmthera.2005.01.001; Labbadia John, 2014, F1000Prime Rep, V6, P7, DOI 10.12703/P6-7; Lapierre LR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3267; Leiser SF, 2013, J GERONTOL A-BIOL, V68, P1135, DOI 10.1093/gerona/glt016; Mehta R, 2009, SCIENCE, V324, P1196, DOI 10.1126/science.1173507; Miller DL, 2009, CURR BIOL, V19, P1233, DOI 10.1016/j.cub.2009.05.066; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Muller RU, 2009, J AM SOC NEPHROL, V20, P2513, DOI 10.1681/ASN.2009050497; Petalcorin MIR, 2005, GENE, V346, P83, DOI 10.1016/j.gene.2004.09.021; Pocock R, 2008, NAT NEUROSCI, V11, P894, DOI 10.1038/nn.2152; Pocock R, 2010, NAT NEUROSCI, V13, P610, DOI 10.1038/nn.2537; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Shih DM, 2015, J LIPID RES, V56, P22, DOI 10.1194/jlr.M051680; Steinbaugh MJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE488, DOI 10.1152/ajpendo.00110.2012; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585; Veeravalli S, 2014, BIOCHEM PHARMACOL, V90, P88, DOI 10.1016/j.bcp.2014.04.007; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006348	27	70	71	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1375	1378		10.1126/science.aac9257	http://dx.doi.org/10.1126/science.aac9257			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26586189	Green Accepted			2022-12-28	WOS:000366162400042
J	Frieden, TR; Foti, KE; Mermin, J				Frieden, Thomas R.; Foti, Kathryn E.; Mermin, Jonathan			Applying Public Health Principles to the HIV Epidemic - How Are We Doing?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NEW-YORK-CITY; HUMAN-IMMUNODEFICIENCY-VIRUS; UNITED-STATES; SAN-FRANCISCO; INFECTION; NOTIFICATION; BEHAVIORS; THERAPY		[Frieden, Thomas R.; Foti, Kathryn E.; Mermin, Jonathan] Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Frieden, TR (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA USA.			Foti, Kathryn/0000-0002-6380-2735; Frieden, Thomas/0000-0002-4759-2256				[Anonymous], 2004, CAS HIV INF AIDS US; [Anonymous], 2015, NAT HIV AIDS STRAT U; [Anonymous], 2014, HIV EP ANN REP 2014; [Anonymous], 2013, HUM IMM VIR HIV INF; Baggaley RF, 2013, AM J REPROD IMMUNOL, V69, P95, DOI 10.1111/aji.12064; Buchacz K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118923; Centers for Disease Control and Prevention, 2015, HIV SURV REP 2014; Centers for Disease Control and Prevention, 2015, HIV SURV MEN WHO HAV; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Conrad C, 2015, MMWR-MORBID MORTAL W, V64, P443; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Daskalaskis DC, ENDING EPIDEMIC TASK; Dooley Samuel W., 2008, Morbidity and Mortality Weekly Report, V57, P1; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hall HI, 2015, C RETR OPP INF SEATT; Harrison KM, 2010, JAIDS-J ACQ IMM DEF, V53, P124, DOI 10.1097/QAI.0b013e3181b563e7; Johnson AS, 2014, JAMA-J AM MED ASSOC, V312, P432, DOI 10.1001/jama.2014.8534; Landovitz Raphael J, 2015, Top Antivir Med, V23, P85; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Malave MC, 2008, SEX TRANSM DIS, V35, P869, DOI 10.1097/OLQ.0b013e31817d2f82; Marcus JL, 2009, AIDS, V23, P1024, DOI 10.1097/QAD.0b013e32832921a7; McBride KR, 2010, J SEX RES, V47, P123, DOI 10.1080/00224490903402538; McCormack S, 2015, LANCET; Montaner JSG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087872; Munsiff SS, 2006, INT J TUBERC LUNG D, V10, P1133; Niccolai LM, 2002, AIDS EDUC PREV, V14, P183, DOI 10.1521/aeap.14.3.183.23893; Schneider E., 2006, Morbidity and Mortality Weekly Report, V55, P589; Spiller MW, 2015, MMWR-MORBID MORTAL W, V64, P270; Truong HHM, 2009, JAIDS-J ACQ IMM DEF, V51, P502, DOI 10.1097/QAI.0b013e3181a25383; Udeagu CCN, 2013, AIDS, V27, P2271, DOI 10.1097/QAD.0b013e328362fdde; Wiewel EW, 2015, C RETR OPP INF SEATT; Xia Q, 2015, JAIDS-J ACQ IMM DEF, V68, P351, DOI 10.1097/QAI.0000000000000464; Zetola NM, 2007, J CLIN VIROL, V40, P68, DOI 10.1016/j.jcv.2007.06.004; Zetola NM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002591	35	65	65	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2015	373	23					2281	2287		10.1056/NEJMms1513641	http://dx.doi.org/10.1056/NEJMms1513641			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX5LM	26624243	Bronze			2022-12-28	WOS:000365743100015
J	Rowland, L; da Costa, ACL; Galbraith, DR; Oliveira, RS; Binks, OJ; Oliveira, AAR; Pullen, AM; Doughty, CE; Metcalfe, DB; Vasconcelos, SS; Ferreira, LV; Malhi, Y; Grace, J; Mencuccini, M; Meir, P				Rowland, L.; da Costa, A. C. L.; Galbraith, D. R.; Oliveira, R. S.; Binks, O. J.; Oliveira, A. A. R.; Pullen, A. M.; Doughty, C. E.; Metcalfe, D. B.; Vasconcelos, S. S.; Ferreira, L. V.; Malhi, Y.; Grace, J.; Mencuccini, M.; Meir, P.			Death from drought in tropical forests is triggered by hydraulics not carbon starvation	NATURE			English	Article							SOIL-MOISTURE DEFICIT; AMAZONIAN RAIN-FOREST; FOLIAR UPTAKE; CLIMATE; WATER; TREES; VULNERABILITY; MORTALITY; DYNAMICS; XYLEM	Drought threatens tropical rainforests over seasonal to decadal timescales(1-4), but the drivers of tree mortality following drought remain poorly understood(5,6). It has been suggested that reduced availability of non-structural carbohydrates (NSC) critically increases mortality risk through insufficient carbon supply to metabolism ('carbon starvation')(7,8). However, little is known about how NSC stores are affected by drought, especially over the long term, and whether they are more important than hydraulic processes in determining drought-induced mortality. Using data from the world's longest-running experimental drought study in tropical rainforest (in the Brazilian Amazon), we test whether carbon starvation or deterioration of the water-conducting pathways from soil to leaf trigger tree mortality. Biomass loss from mortality in the experimentally droughted forest increased substantially after > 10 years of reduced soil moisture availability. The mortality signal was dominated by the death of large trees, which were at a much greater risk of hydraulic deterioration than smaller trees. However, we find no evidence that the droughted trees suffered carbon starvation, as their NSC concentrations were similar to those of non-droughted trees, and growth rates did not decline in either living or dying trees. Our results indicate that hydraulics, rather than carbon starvation, triggers tree death from drought in tropical rainforest.	[Rowland, L.; Binks, O. J.; Grace, J.; Mencuccini, M.; Meir, P.] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3FF, Midlothian, Scotland; [da Costa, A. C. L.; Oliveira, A. A. R.] Fed Univ Para, Ctr Geosciencias, BR-66075110 Belem, Para, Brazil; [Galbraith, D. R.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Oliveira, R. S.] Univ Estadual Campinas, Inst Biol, BR-13083970 Campinas, SP, Brazil; [Pullen, A. M.] Univ Cambridge, Cambridge CB2 1TN, England; [Doughty, C. E.; Malhi, Y.] Univ Oxford, Environm Change Inst, Oxford OX1 3QY, England; [Metcalfe, D. B.] Lund Univ, Dept Phys Geog & Ecosyst Sci, S-22362 Lund, Sweden; [Vasconcelos, S. S.] EMBRAPA Amazonia Oriental, BR-66095903 Belem, Para, Brazil; [Ferreira, L. V.] Museu Paraense Emilio Goeldi, BR-66077830 Belem, Para, Brazil; [Mencuccini, M.] ICREA CREAF, Cerdanyola Del Valles 08193, Spain; [Meir, P.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia	University of Edinburgh; Universidade Federal do Para; University of Leeds; Universidade de Sao Paulo; Universidade Estadual de Campinas; University of Cambridge; University of Oxford; Lund University; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Museu Paraense Emilio Goeldi; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); ICREA; Australian National University	Rowland, L (corresponding author), Univ Edinburgh, Sch Geosci, Edinburgh EH9 3FF, Midlothian, Scotland.	lucy.rowland@ed.ac.uk	Mencuccini, Maurizio/B-9052-2011; Grace, John/N-9280-2013; Oliveira, Rafael S/B-3422-2013; Vasconcelos, Steel/AAE-9247-2019; Galbraith, David/AAE-8162-2019; Binks, Oliver J/Q-7821-2016; Meir, Patrick/J-8344-2012	Mencuccini, Maurizio/0000-0003-0840-1477; Oliveira, Rafael S/0000-0002-6392-2526; Vasconcelos, Steel/0000-0003-2364-8822; Binks, Oliver J/0000-0002-6291-3644; Rowland, Lucy/0000-0002-0774-3216; Doughty, Christopher/0000-0003-3985-7960; Pullen, Alice/0000-0001-6842-1416; Galbraith, David/0000-0002-5555-4823	UK NERC [NE/J011002/1]; CNPQ [457914/2013-0/MCTI/CNPq/FNDCT/LBA/ESECAFLOR]; ARC [FT110100457]; NERC [NER/A/S/2002/00487, GR3/11706, NE/D01025X/1]; EU FP5-Carbonsink; EU FP7-Amazalert; Gordon and Betty Moore Foundation; NERC [NE/F005040/1, NE/J011002/1, NE/F005776/1] Funding Source: UKRI; Natural Environment Research Council [NE/D01025X/1, NE/J011002/1, NE/F005040/1] Funding Source: researchfish; ICREA Funding Source: Custom	UK NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ARC(Australian Research Council); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EU FP5-Carbonsink; EU FP7-Amazalert; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ICREA(ICREA)	This work was supported by UK NERC grant NE/J011002/1 to P.M. and M.M., CNPQ grant 457914/2013-0/MCTI/CNPq/FNDCT/LBA/ESECAFLOR to A.C.L.D., and ARC grant FT110100457 to P.M. It was previously supported by NERC NER/A/S/2002/00487, NERC GR3/11706, EU FP5-Carbonsink and EU FP7-Amazalert to P.M. and J.G., and by grant support to Y.M. from NERC NE/D01025X/1 and the Gordon and Betty Moore Foundation. L.R., M.M. and P.M. would also like to acknowledge support from S. Sitch, Y. Salmon and B. Christoffersen. The authors would also like to thank three anonymous referees for their useful comments.	Anderegg WRL, 2013, GLOBAL CHANGE BIOL, V19, P1188, DOI 10.1111/gcb.12100; Anderegg WRL, 2012, P NATL ACAD SCI USA, V109, P233, DOI 10.1073/pnas.1107891109; Boisier JP, 2015, NAT CLIM CHANGE, V5, P656, DOI [10.1038/NCLIMATE2658, 10.1038/nclimate2658]; Brando PM, 2008, PHILOS T R SOC B, V363, P1839, DOI 10.1098/rstb.2007.0031; Burkhardt J, 2012, NEW PHYTOL, V196, P774, DOI 10.1111/j.1469-8137.2012.04307.x; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Christensen JH, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1217; da Costa ACL, 2014, PLANT ECOL DIVERS, V7, P7, DOI 10.1080/17550874.2013.798366; Doughty CE, 2015, NATURE, V519, P78, DOI 10.1038/nature14213; Eller CB, 2013, NEW PHYTOL, V199, P151, DOI 10.1111/nph.12248; Ennajeh M, 2011, PHYSIOL PLANTARUM, V142, P205, DOI 10.1111/j.1399-3054.2011.01470.x; Fatichi S, 2014, NEW PHYTOL, V201, P1086, DOI 10.1111/nph.12614; Feldpausch TR, 2012, BIOGEOSCIENCES, V9, P3381, DOI 10.5194/bg-9-3381-2012; Fisher RA, 2007, GLOBAL CHANGE BIOL, V13, P2361, DOI 10.1111/j.1365-2486.2007.01417.x; Fisher RA, 2006, PLANT CELL ENVIRON, V29, P151, DOI 10.1111/j.1365-3040.2005.01407.x; Fisher RA, 2008, AGR FOREST METEOROL, V148, P850, DOI 10.1016/j.agrformet.2007.12.001; Hartmann H, 2015, NEW PHYTOL, V205, P965, DOI 10.1111/nph.13246; Korner C, 2003, J ECOL, V91, P4, DOI 10.1046/j.1365-2745.2003.00742.x; Leuzinger S, 2011, TRENDS ECOL EVOL, V26, P236, DOI 10.1016/j.tree.2011.02.011; da Costa ACL, 2010, NEW PHYTOL, V187, P579, DOI 10.1111/j.1469-8137.2010.03309.x; McDowell NG, 2011, TRENDS ECOL EVOL, V26, P523, DOI 10.1016/j.tree.2011.06.003; Meir P, 2015, BIOSCIENCE, V65, P882, DOI 10.1093/biosci/biv107; Meir P, 2015, NEW PHYTOL, V207, P28, DOI 10.1111/nph.13382; Mencuccini M, 2005, ECOL LETT, V8, P1183, DOI 10.1111/j.1461-0248.2005.00819.x; Metcalfe DB, 2010, NEW PHYTOL, V187, P608, DOI 10.1111/j.1469-8137.2010.03319.x; Metcalfe DB, 2014, ECOL LETT, V17, P324, DOI 10.1111/ele.12233; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; NEUFELD HS, 1992, PLANT PHYSIOL, V100, P1020, DOI 10.1104/pp.100.2.1020; O'Brien MJ, 2014, NAT CLIM CHANGE, V4, P710, DOI [10.1038/NCLIMATE2281, 10.1038/nclimate2281]; Patino S, 2009, BIOGEOSCIENCES, V6, P545, DOI 10.5194/bg-6-545-2009; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Rowland L, 2015, GLOBAL CHANGE BIOL, V21, P4662, DOI 10.1111/gcb.13035; Rowland L, 2014, OECOLOGIA, V174, P295, DOI 10.1007/s00442-013-2766-9; Ruivo MLP, 2003, ADV ECOL SCI, V18-19, P1113; Sala A, 2012, TREE PHYSIOL, V32, P764, DOI 10.1093/treephys/tpr143; Sevanto S, 2014, PLANT CELL ENVIRON, V37, P153, DOI 10.1111/pce.12141; Thomas H, 2013, NEW PHYTOL, V197, P696, DOI 10.1111/nph.12047; YATES DJ, 1995, AUST J BOT, V43, P157, DOI 10.1071/BT9950157; Zanne A.E., DRYAD DIGITAL REPOSI	45	360	380	16	410	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					119	+		10.1038/nature15539	http://dx.doi.org/10.1038/nature15539			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26595275	Green Accepted			2022-12-28	WOS:000365606000060
J	Selby, JV; Forsythe, L; Sox, HC				Selby, Joseph V.; Forsythe, Laura; Sox, Harold C.			Stakeholder-Driven Comparative Effectiveness Research An Update From PCORI	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Selby, Joseph V.; Forsythe, Laura; Sox, Harold C.] Patient Centered Outcomes Res Inst, Washington, DC 20036 USA		Selby, JV (corresponding author), Patient Centered Outcomes Res Inst, 1828 L St NW,Ste 900, Washington, DC 20036 USA.	jvselby@pcori.org						Fleurence RL, 2014, ANN INTERN MED, V161, P122, DOI 10.7326/M13-2412; Forsythe LP, 2016, J GEN INTERN MED, V31, P13, DOI 10.1007/s11606-015-3450-z; Forsythe LP, 2015, EVALUATING ENGAGEMEN; Patient-Centered Outcomes Research Institute, WHAT WE MEAN ENG ENG; Patient-Centered Outcomes Research Institute, WE SEL RES TOP; Web Portal: Patient-Centered Outcomes Research Institute, SUGG PAT CTR RES QUE; Xian Y, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3786	7	55	56	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2015	314	21					2235	2236		10.1001/jama.2015.15139	http://dx.doi.org/10.1001/jama.2015.15139			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX2GT	26595059				2022-12-28	WOS:000365515700013
J	Craven, D				Craven, David			The statistical sins of Jeremy Hunt	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Craven, David] Univ Birmingham, Birmingham, W Midlands, England	University of Birmingham	Craven, D (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.	cravenda@bham.ac.uk		Craven, David/0000-0003-1108-5698				Freemantle N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4596; Palmer William L, 2015, BMJ, V351, ph5774, DOI 10.1136/bmj.h5774; Rimmer A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5624	3	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2015	351								h6358	10.1136/bmj.h6358	http://dx.doi.org/10.1136/bmj.h6358			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX4TL	26612248				2022-12-28	WOS:000365693100007
J	Smith, L; Dunn, B				Smith, Leland; Dunn, Bruce			Opening the window for aqueous electrolytes	SCIENCE			English	Editorial Material									[Smith, Leland; Dunn, Bruce] Univ Calif Los Angeles, Dept Mat Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Smith, L (corresponding author), Univ Calif Los Angeles, Dept Mat Sci, Los Angeles, CA 90095 USA.	bunn@ucla.edu						Goodenough JB, 2010, CHEM MATER, V22, P587, DOI 10.1021/cm901452z; RUETSCHI P, 1973, J ELECTROCHEM SOC, V120, P331, DOI 10.1149/1.2403449; Slater MD, 2013, ADV FUNCT MATER, V23, P947, DOI 10.1002/adfm.201200691; Suntivich J, 2011, SCIENCE, V334, P1383, DOI 10.1126/science.1212858; Suo LM, 2015, SCIENCE, V350, P938, DOI 10.1126/science.aab1595; Verma P, 2010, ELECTROCHIM ACTA, V55, P6332, DOI 10.1016/j.electacta.2010.05.072; Zeng K, 2010, PROG ENERG COMBUST, V36, P307, DOI 10.1016/j.pecs.2009.11.002	7	60	62	5	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					918	918		10.1126/science.aad5575	http://dx.doi.org/10.1126/science.aad5575			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW4IP	26586752				2022-12-28	WOS:000364955200027
J	Isosaka, T; Matsuo, T; Yamaguchi, T; Funabiki, K; Nakanishi, S; Kobayakawa, R; Kobayakawa, K				Isosaka, Tomoko; Matsuo, Tomohiko; Yamaguchi, Takashi; Funabiki, Kazuo; Nakanishi, Shigetada; Kobayakawa, Reiko; Kobayakawa, Ko			Htr2a-Expressing Cells in the Central Amygdala Control the Hierarchy between Innate and Learned Fear	CELL			English	Article							PREDATOR ODOR; CONDITIONED FEAR; C-FOS; SYNAPTIC-TRANSMISSION; PERIAQUEDUCTAL GRAY; RAT; STRESS; BRAIN; TMT; DISORDERS	Fear is induced by innate and learned mechanisms involving separate pathways. Here, we used an olfactory- mediated innate-fear versus learned-fear paradigm to investigate how these pathways are integrated. Notably, prior presentation of innatefear stimuli inhibited learned-freezing response, but not vice versa. Whole-brain mapping and pharmacological screening indicated that serotonin-2A receptor (Htr2a)-expressing cells in the central amygdala (CeA) control both innate and learned freezing, but in opposing directions. In vivo fiber photometry analyses in freely moving mice indicated that innate but not learned-fear stimuli suppressed the activity of Htr2a-expressing CeA cells. Artificial inactivation of these cells upregulated innate-freezing response and downregulated learned-freezing response. Thus, Htr2a-expressing CeA cells serve as a hierarchy generator, prioritizing innate fear over learned fear.	[Isosaka, Tomoko; Matsuo, Tomohiko; Kobayakawa, Reiko; Kobayakawa, Ko] Kansai Med Univ, Inst Biomed Sci, Osaka 5731010, Japan; [Isosaka, Tomoko; Matsuo, Tomohiko; Kobayakawa, Reiko; Kobayakawa, Ko] Osaka Biosci Inst, Dept Funct Neurosci, Osaka 5650874, Japan; [Yamaguchi, Takashi; Funabiki, Kazuo; Nakanishi, Shigetada] Osaka Biosci Inst, Dept Syst Biol, Osaka 5650874, Japan	Kansai Medical University	Kobayakawa, R (corresponding author), Kansai Med Univ, Inst Biomed Sci, Osaka 5731010, Japan.	kobayakr@hirakata.kmu.ac.jp; kobayakk@hirakata.kmu.ac.jp	Core, Vector/CAF-4832-2022	Yamaguchi, Takashi/0000-0001-5153-940X; Kobayakawa, Reiko/0000-0001-6613-5969; Kobayakawa, Ko/0000-0001-6406-5610	PRESTO program of the Japan Science and Technology Agency; Strategic Research Program for Brain Sciences of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry; Takeda Science Foundation	PRESTO program of the Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Strategic Research Program for Brain Sciences of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry; Takeda Science Foundation(Takeda Science Foundation (TSF))	We are grateful to F. Kato for critical comments on the manuscript. We are grateful to H. Tada and A. Kishi for many suggestions regarding the pharmacological analysis. We thank T. Kitsukawa for the c-fos plasmid. We thank H. Takebayashi for jun-b, nr4a1, egr1, egr3, fosb, c-jun, and npas4 plasmids. We thank A. Teratani, N. Hayashi, T. Iida, and S. Kobayashi for technical assistance. This work was supported by the following foundations: the PRESTO program of the Japan Science and Technology Agency; the Strategic Research Program for Brain Sciences of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; the Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry; and the Takeda Science Foundation.	Aguiar DC, 2009, J NEUROSCI RES, V87, P2418, DOI 10.1002/jnr.22082; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Armario A, 2012, CELL MOL NEUROBIOL, V32, P749, DOI 10.1007/s10571-012-9814-6; BEAULIEU S, 1986, NEUROENDOCRINOLOGY, V44, P247, DOI 10.1159/000124652; BLANCHAR.RJ, 1969, J COMP PHYSIOL PSYCH, V68, P129, DOI 10.1037/h0027676; BOLLES RC, 1980, BEHAV BRAIN SCI, V3, P291, DOI 10.1017/S0140525X0000491X; BOUTON ME, 1980, ANIM LEARN BEHAV, V8, P429, DOI 10.3758/BF03199629; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Campeau S, 1997, NEUROSCIENCE, V78, P1087, DOI 10.1016/S0306-4522(96)00632-X; Cousens G, 1998, BEHAV NEUROSCI, V112, P1092, DOI 10.1037/0735-7044.112.5.1092; Davis M., 2000, AMYGDALA, P213; Day HEW, 2004, BRAIN RES, V1025, P139, DOI 10.1016/j.brainres.2004.07.079; De Oca BM, 1998, J NEUROSCI, V18, P3426; Dias BG, 2013, CURR OPIN NEUROBIOL, V23, P346, DOI 10.1016/j.conb.2013.01.013; DUDLEY MW, 1988, DRUG DEVELOP RES, V13, P29, DOI 10.1002/ddr.430130104; Fendt M, 2005, NEUROSCI BIOBEHAV R, V29, P1145, DOI 10.1016/j.neubiorev.2005.04.018; Gore F, 2015, CELL, V162, P134, DOI 10.1016/j.cell.2015.06.027; Goto A, 2015, P NATL ACAD SCI USA, V112, P6718, DOI 10.1073/pnas.1507121112; Gross CT, 2012, NAT REV NEUROSCI, V13, P651, DOI 10.1038/nrn3301; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kobayakawa K., 2011, U.S. Patent, Patent No. [WO 2011096575A1, 2011096575]; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; LeDoux J, 2012, NEURON, V73, P653, DOI 10.1016/j.neuron.2012.02.004; Li CI, 2004, BEHAV NEUROSCI, V118, P324, DOI 10.1037/0735-7044.118.2.324; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Martinez RC, 2011, NEUROSCIENCE, V172, P314, DOI 10.1016/j.neuroscience.2010.10.033; McGregor IS, 2002, BEHAV BRAIN RES, V129, P1, DOI 10.1016/S0166-4328(01)00324-2; Medina JF, 2002, NAT REV NEUROSCI, V3, P122, DOI 10.1038/nrn728; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Morrow BA, 2000, BRAIN RES, V864, P146, DOI 10.1016/S0006-8993(00)02174-0; Ohkura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051286; Parsons RG, 2013, NAT NEUROSCI, V16, P146, DOI 10.1038/nn.3296; Penzo MA, 2014, J NEUROSCI, V34, P2432, DOI 10.1523/JNEUROSCI.4166-13.2014; PEZZONE MA, 1992, BRAIN RES, V597, P41, DOI 10.1016/0006-8993(92)91503-7; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Root CM, 2014, NATURE, V515, P269, DOI 10.1038/nature13897; Rosen JB, 2008, NEUROSCI BIOBEHAV R, V32, P1267, DOI 10.1016/j.neubiorev.2008.05.006; ROTTMAN SJ, 1972, J COMP PHYSIOL PSYCH, V81, P483, DOI 10.1037/h0033703; Silva BA, 2013, NAT NEUROSCI, V16, P1731, DOI 10.1038/nn.3573; Steenland HW, 2009, J NEUROSCI METH, V177, P355, DOI 10.1016/j.jneumeth.2008.10.020; Sukikara MH, 2010, BEHAV BRAIN RES, V209, P226, DOI 10.1016/j.bbr.2010.01.048; Takahashi LK, 2005, NEUROSCI BIOBEHAV R, V29, P1157, DOI 10.1016/j.neubiorev.2005.04.008; VERNETMAURY E, 1984, J CHEM ECOL, V10, P1007, DOI 10.1007/BF00987509; WEISZ DJ, 1992, BEHAV NEUROSCI, V106, P262, DOI 10.1037/0735-7044.106.2.262	50	89	92	3	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1153	1164		10.1016/j.cell.2015.10.047	http://dx.doi.org/10.1016/j.cell.2015.10.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26590419	Bronze			2022-12-28	WOS:000366044700014
J	Zakaria, S; Johnson, EN; Hayashi, JL; Christmas, C				Zakaria, Sammy; Johnson, Erica N.; Hayashi, Jennifer L.; Christmas, Colleen			BECOMING A PHYSICIAN Graduate Medical Education in the Freddie Gray Era	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zakaria, Sammy; Johnson, Erica N.; Hayashi, Jennifer L.; Christmas, Colleen] Johns Hopkins Bayview Med Ctr, Dept Med, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine	Zakaria, S (corresponding author), Johns Hopkins Bayview Med Ctr, Dept Med, Baltimore, MD 21224 USA.			Zakaria, Sammy/0000-0002-1054-4410				Badger E., 2015, WASHINGTON POST; Behforouz HL, 2014, NEW ENGL J MED, V371, P1277, DOI 10.1056/NEJMp1404846; McCoy T., 2015, WASHINGTON POST; SEHAM M, 1964, NEW ENGL J MED, V271, P940, DOI 10.1056/NEJM196410292711806; Wen LS, 2015, JAMA-J AM MED ASSOC, V313, P2425, DOI 10.1001/jama.2015.5561	5	16	16	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2015	373	21					1998	2000		10.1056/NEJMp1509216	http://dx.doi.org/10.1056/NEJMp1509216			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW4JN	26580996				2022-12-28	WOS:000364957700004
J	Low, L; Shah, W; MacEwen, CJ				Low, Liying; Shah, Waqaar; MacEwen, Caroline J.			10-MINUTE CONSULTATION Double vision	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Low, Liying] Univ Birmingham, Academ Unit Ophthalmol, Birmingham B18 7QH, W Midlands, England; [Shah, Waqaar] Royal Coll Gen Practitioners, Clin Innovat & Res Ctr, London, England; [MacEwen, Caroline J.] Univ Dundee, Ophthalmol Dept, Dundee DD1 4HN, Scotland	University of Birmingham; University of Dundee	Low, L (corresponding author), Univ Birmingham, Academ Unit Ophthalmol, Birmingham B18 7QH, W Midlands, England.	LLowl.low@bham.ac.uk		Low, Liying/0000-0002-0631-8891	National Institute for Health Research [ACF-2013-09-005] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Drivers Medical Group DVLA, 2014, MED PRACT GLANC GUID; O'Colmain U, 2014, ACTA OPHTHALMOL, V92, P382, DOI 10.1111/aos.12062; Tamhankar MA, 2013, OPHTHALMOLOGY, V120, P2264, DOI 10.1016/j.ophtha.2013.04.009	3	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2015	351								h5385	10.1136/bmj.h5385	http://dx.doi.org/10.1136/bmj.h5385			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XX	26581615				2022-12-28	WOS:000365352600001
J	Bhargava, A; Chandrasekar, PH				Bhargava, Ashish; Chandrasekar, Pranatharthi H.			Gradually Worsening Tattoo Lesion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MYCOBACTERIUM-CHELONAE; OUTBREAK; INFECTIONS		[Bhargava, Ashish] St Johns Hosp, Div Infect Dis, Detroit, MI USA; [Chandrasekar, Pranatharthi H.] Wayne State Univ, Div Infect Dis, Detroit, MI USA	Wayne State University	Bhargava, A (corresponding author), St Johns Hosp, Div Infect Dis, 19251 Mack Ave,Ste 340, Grosse Pointe Woods, MI 48236 USA.	drashishbhargava@gmail.com	bhargava, ashish/AAZ-5180-2020	bhargava, ashish/0000-0001-6326-0908				Goldman J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5483; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Kennedy BS, 2012, NEW ENGL J MED, V367, P1020, DOI 10.1056/NEJMoa1205114; Khan FA, 2011, CUTIS, V88, P194; Shim TN, 2012, LANCET INFECT DIS, V12, P254, DOI 10.1016/S1473-3099(12)70032-4; Tortoli E, 2009, CLIN MICROBIOL INFEC, V15, P906, DOI 10.1111/j.1469-0691.2009.03014.x; Wentworth AB, 2013, MAYO CLIN PROC, V88, P38, DOI 10.1016/j.mayocp.2012.06.029; Winthrop KL, 2002, NEW ENGL J MED, V346, P1366, DOI 10.1056/NEJMoa012643	8	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2015	314	19					2071	2072		10.1001/jama.2015.10066	http://dx.doi.org/10.1001/jama.2015.10066			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW1PR	26575064				2022-12-28	WOS:000364764200023
J	Schreiber, R				Schreiber, Richard			Adding CT to screening for occult cancer did not increase diagnosis of cancer from screening in unprovoked VTE	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							IDIOPATHIC VENOUS THROMBOEMBOLISM; MALIGNANCY		[Schreiber, Richard] Holy Spirit Hlth Syst A Geisinger Affiliate, Camp Hill, PA USA		Schreiber, R (corresponding author), Holy Spirit Hlth Syst A Geisinger Affiliate, Camp Hill, PA USA.		Schreiber, Richard/AAY-8098-2020	Schreiber, Richard/0000-0002-6138-7048				Alfonso A, 2013, INT J CANCER, V133, P2157, DOI 10.1002/ijc.28229; Bierry G, 2008, AM J ROENTGENOL, V191, P885, DOI 10.2214/AJR.07.3516; Carrier M, 2008, ANN INTERN MED, V149, P323, DOI 10.7326/0003-4819-149-5-200809020-00007; Chauchard M, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000110; Piccioli A, 2004, J THROMB HAEMOST, V2, P884, DOI 10.1111/j.1538-7836.2004.00720.x; Prandoni P, 2010, J THROMB HAEMOST, V8, P1126, DOI 10.1111/j.1538-7836.2010.03797.x; van Doormaal FF, 2011, J THROMB HAEMOST, V9, P79, DOI 10.1111/j.1538-7836.2010.04101.x	7	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					JC9	JC9		10.7326/ACPJC-2015-163-10-009	http://dx.doi.org/10.7326/ACPJC-2015-163-10-009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26571263				2022-12-28	WOS:000365746400010
J	Lister, AM; Sher, AV				Lister, A. M.; Sher, A. V.			Evolution and dispersal of mammoths across the Northern Hemisphere	SCIENCE			English	Article							PROBOSCIDEANS; MEXICO; STATE; USA	Mammoths provide a detailed example of species origins and dispersal, but understanding has been impeded by taxonomic confusion, especially in North America. The Columbian mammoth Mammuthus columbi was thought to have evolved in North America from a more primitive Eurasian immigrant. The earliest American mammoths (1.5 million years ago), however, resemble the advanced Eurasian M. trogontherii that crossed the Bering land bridge around that time, giving rise directly to M. columbi. Woolly mammoth M. primigenius later evolved in Beringia and spread into Europe and North America, leading to a diversity of morphologies as it encountered endemic M. trogontherii and M. columbi, respectively. In North America, this included intermediates ("M. jeffersonii"), suggesting introgression of M. primigenius with M. columbi. The lineage illustrates the dynamic interplay of local adaptation, dispersal, and gene flow in the evolution of a widely distributed species complex.	[Lister, A. M.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Sher, A. V.] Severtsov Inst Ecol & Evolut, Moscow 119071, Russia	Natural History Museum London; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution	Lister, AM (corresponding author), Nat Hist Museum, Dept Earth Sci, Cromwell Rd, London SW7 5BD, England.	a.lister@nhm.ac.uk		Lister, Adrian/0000-0002-7985-138X	Natural Environment Research Council; Royal Society; Natural Environment Research Council [NE/J009490/1] Funding Source: researchfish; NERC [NE/J009490/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	A.L. thanks the Natural Environment Research Council and the Royal Society for funding and colleagues who provided access to collections and helped in various ways (2). Raw data are in the supplementary materials (data sets S1 and S2).	Agenbroad LD, 2005, QUATERN INT, V126, P73, DOI 10.1016/j.quaint.2004.04.016; Arroyo-Cabrales Joaquin, 2003, Deinsea, V9, P17; Bell Christopher J., 2004, P232; Churcher Q. S., 1986, CURRENT RES PLEIST C, V3, P61; Dubrovo I. A., 1953, B COMISSII IZUCH CHE, V17, P76; Enk J., 2014, THESIS; Enk J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r51; Foronova IV, 2007, QUATERN INT, V169, P95, DOI 10.1016/j.quaint.2006.11.001; Gonzalez S, 2003, J HUM EVOL, V44, P379, DOI 10.1016/S0047-2484(03)00004-6; Harington C. R., 1984, QUATERNARY DATING ME, P299, DOI DOI 10.1016/S0920-5446(08)70078-5; Lister A., 2007, MAMMOTHS ICE AGE GIA; Lister A.M., 1992, P185; Lister AM, 2015, GEOL J, V50, P306, DOI 10.1002/gj.2668; Lister Adrian M., 1996, P203; Lister AM, 2005, QUATERN INT, V126, P49, DOI 10.1016/j.quaint.2004.04.014; LISTER AM, 1993, MORPHOLOGICAL CHANGE IN QUATERNARY MAMMALS OF NORTH AMERICA, P178, DOI 10.1017/CBO9780511565052.009; Lister AM, 2001, SCIENCE, V294, P1094, DOI 10.1126/science.1056370; Lucas Spencer G., 2014, New Mexico Geology, V36, P48; Madden C. T., 1981, THESIS; Maglio V.J., 1973, Transactions Am phil Soc, V63, P1, DOI 10.2307/1006229; McDaniel GE, 2006, QUATERN INT, V142, P124, DOI 10.1016/j.quaint.2005.03.011; McDaniel George E. Jr, 2003, Deinsea, V9, P239; Osborn H.F., 1942, PROBOSCIDEA, V2; Saunders JJ, 2010, QUATERN INT, V217, P175, DOI 10.1016/j.quaint.2009.07.031; Sher A.V., 2005, WORLD ELEPHANTS, P153; Sher A. V., 1987, T USSR ACAD SCI EART, V285, P195; Webb S. David, 1995, Bulletin of the Florida Museum of Natural History, V37, P645; Wei G., 2003, EARTH SCI JAPAN, V57, P289, DOI DOI 10.1007/S11430-010-4001-4	28	63	65	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					805	809		10.1126/science.aac5660	http://dx.doi.org/10.1126/science.aac5660			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW3MS	26564853				2022-12-28	WOS:000364897000042
J	Jefferis, JM; Connor, AJ; Clarke, MP				Jefferis, Joanna M.; Connor, Alan J.; Clarke, Michael P.			Amblyopia	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED-TRIAL; ANISOMETROPIC AMBLYOPIA; MODERATE AMBLYOPIA; PRESCHOOL-CHILDREN; VISUAL IMPAIRMENT; OCCLUSION THERAPY; VISION; PREVALENCE; ACUITY; ATROPINE		[Jefferis, Joanna M.] Royal Hallamshire Hosp, Dept Ophthalmol, Sheffield S10 2JF, S Yorkshire, England; [Connor, Alan J.] Hosp Sick Children, Dept Ophthalmol, Toronto, ON M5G 1X8, Canada; [Connor, Alan J.; Clarke, Michael P.] Royal Victoria Infirm, Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Eye Ctr, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	University of Sheffield; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Jefferis, JM (corresponding author), Royal Hallamshire Hosp, Dept Ophthalmol, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.	jojefferis@doctors.org.uk						Adams GGW, 1999, BRIT J OPHTHALMOL, V83, P380; Attebo K, 1998, OPHTHALMOLOGY, V105, P154, DOI 10.1016/S0161-6420(98)91862-0; Awan M, 2010, BRIT J OPHTHALMOL, V94, P1007, DOI 10.1136/bjo.2008.154674; Beck RW, 2003, OPHTHALMOLOGY, V110, P2075, DOI 10.1016/S0161-6420(03)01023-6; BRADLEY A, 1981, INVEST OPHTH VIS SCI, V21, P467; Carlton J, 2008, HEALTH TECHNOL ASSES, V12, P1; Chia A, 2010, INVEST OPHTH VIS SCI, V51, P3411, DOI 10.1167/iovs.09-4461; Clarke MP, 2003, BMJ-BRIT MED J, V327, P1251, DOI 10.1136/bmj.327.7426.1251; Cotter SA, 2007, AM J OPHTHALMOL, V143, P1060, DOI 10.1016/j.ajo.2007.02.029; Cotter SA, 2006, OPHTHALMOLOGY, V113, P895, DOI 10.1016/j.ophtha.2006.01.068; Elliott S, 2014, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD006461.PUB4; Foss AJ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-145; Friedman DS, 2009, OPHTHALMOLOGY, V116, P2128, DOI 10.1016/j.ophtha.2009.04.034; GIASCHI DE, 1993, OPTOMETRY VISION SCI, V70, P192, DOI 10.1097/00006324-199303000-00003; HENDRICKSON AE, 1994, INVEST OPHTH VIS SCI, V35, P3129; Herbison N, 2013, EYE, V27, P1077, DOI 10.1038/eye.2013.113; Hess RF, 2012, OPTOMETRY, V83, P87; Hess RF, 1997, VISION RES, V37, P1303, DOI 10.1016/S0042-6989(96)00277-5; Holmes JM, 2006, LANCET, V367, P1343, DOI 10.1016/S0140-6736(06)68581-4; Holmes JM, 2004, J AAPOS, V8, P420, DOI 10.1016/j.jaapas.2004.07.007; Horwood A, 2003, BRIT J OPHTHALMOL, V87, P1146, DOI 10.1136/bjo.87.9.1146; KAY H, 1983, BRIT J OPHTHALMOL, V67, P131, DOI 10.1136/bjo.67.2.131; Knox PJ, 2012, INVEST OPHTH VIS SCI, V53, P817, DOI 10.1167/iovs.11-8219; Lagreze WA, 2010, DTSCH ARZTEBL INT, V107, P495, DOI 10.3238/arztebl.2010.0495; Leat SJ, 2011, CLIN EXP OPTOM, V94, P514, DOI 10.1111/j.1444-0938.2011.00600.x; Levi DM, 2009, VISION RES, V49, P2535, DOI 10.1016/j.visres.2009.02.010; LEVI DM, 1985, VISION RES, V25, P979, DOI 10.1016/0042-6989(85)90208-1; Li TJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006460.pub2; MCDONALD M, 1985, INVEST OPHTH VIS SCI, V26, P1158; Moseley MJ, 2009, OPTOMETRY VISION SCI, V86, P629, DOI 10.1097/OPX.0b013e3181a7b3e5; Moseley MJ, 2002, OPHTHAL PHYSL OPT, V22, P296, DOI 10.1046/j.1475-1313.2002.00034.x; Murray PI, 2009, OXFORD HDB OPHTHALMO, P680; Pai ASI, 2011, OPHTHALMOLOGY, V118, P1495, DOI 10.1016/j.ophtha.2011.01.027; Pediat Eye Dis Investigator Grp, 2003, ARCH OPHTHALMOL-CHIC, V121, P603; Rahi JS, 2001, BRIT J OPHTHALMOL, V85, P257, DOI 10.1136/bjo.85.3.257; Rein DB, 2012, J PEDIAT OPHTH STRAB, V49, P146, DOI 10.3928/01913913-20110823-02; Rein DB, 2012, J PED OPHTHALMOL STR, V49, P156; Repka MS, 2004, OPHTHALMOLOGY, V111, P2076, DOI 10.1016/j.ophtha.2004.04.032; Repka MX, 2005, ARCH OPHTHALMOL-CHIC, V123, P149; Repka MX, 2002, ARCH OPHTHALMOL-CHIC, V120, P281; Sasaki Y, 2010, NAT REV NEUROSCI, V11, P53, DOI 10.1038/nrn2737; Scheiman MM, 2005, ARCH OPHTHALMOL-CHIC, V123, P437; Sengpiel F, 1996, EYE, V10, P250, DOI 10.1038/eye.1996.54; Stewart CE, 2007, BMJ-BRIT MED J, V335, P707, DOI 10.1136/bmj.39301.460150.55; Stewart CE, 2007, INVEST OPHTH VIS SCI, V48, P2589, DOI 10.1167/iovs.05-1243; Stewart CE, 2013, J AAPOS, V17, P166, DOI 10.1016/j.jaapos.2012.10.021; Stewart CE, 2004, BRIT J OPHTHALMOL, V88, P1552, DOI 10.1136/bjo.2004.044214; Tailor V, 2015, COCHRANE DB SYST REV, V8; Taylor K, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005137.pub3; Teller DY, 1997, INVEST OPHTH VIS SCI, V38, P2183; Tjiam AM, 2013, GRAEF ARCH CLIN EXP, V251, P321, DOI 10.1007/s00417-012-2107-4; Wallace DK, 2006, OPHTHALMOLOGY, V113, P904, DOI 10.1016/j.ophtha.2006.01.069; Wallace MP, 2013, INVEST OPHTH VIS SCI, V54, P6158, DOI 10.1167/iovs.13-11861; Zoete Hd, 2007, REPORT VISION SCREEN	54	16	17	1	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 12	2015	351								h5811	10.1136/bmj.h5811	http://dx.doi.org/10.1136/bmj.h5811			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW4GE	26563241				2022-12-28	WOS:000364948600003
J	Sarri, G; Davies, M; Lumsden, MA				Sarri, Grammati; Davies, Melanie; Lumsden, Mary Ann		Guideline Dev Grp	GUIDELINES Diagnosis and management of menopause: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DURATION		[Sarri, Grammati; Davies, Melanie] Royal Coll Gynaecologists & Obstetricians, Natl Collaborating Ctr Womens & Childrens Hlth, London NW1 4RG, England; [Davies, Melanie] Univ Coll London Hosp, London E1 1BB, England; [Lumsden, Mary Ann] Univ Glasgow, Reprod & Maternal Med, Glasgow, Lanark, Scotland; [Lumsden, Mary Ann] Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Glasgow; University of Glasgow	Sarri, G (corresponding author), Royal Coll Gynaecologists & Obstetricians, Natl Collaborating Ctr Womens & Childrens Hlth, London NW1 4RG, England.	gsarri@rcog.org.uk		Davies, Melanie/0000-0001-6907-5527; Bowring, Claire/0000-0003-4219-4117				Avis NE, 2015, JAMA INTERN MED, V175, P531, DOI 10.1001/jamainternmed.2014.8063; Blumel JE, 2011, MENOPAUSE, V18, P778, DOI 10.1097/gme.0b013e318207851d; Chiechi L. M., 1999, Clinical and Experimental Obstetrics and Gynecology, V26, P88; Health and Social Care Information Centre, 2011, PRESCR COST AN ENGL; Krieger N, 2005, J EPIDEMIOL COMMUN H, V59, P740, DOI 10.1136/jech.2005.033316; Lumsden M, 2005, BJOG-INT J OBSTET GY, V112, P689, DOI 10.1111/j.1471-0528.2005.00613.x; National Institute for Health and Care Excellence, 2015, SUSP CANC REC REF; National Institute for Health and Care Excellence, 2009, EARL LOC ADV BREAST; National Institute for Health and Care Excellence, 2013, FAM BREAST CANC CLAS; National Institute for Health and Care Excellence, 2009, DEPR AD REC MAN; National Institute for Health and Care Excellence, 2015, MEN DIAGN MAN MEN NI	11	54	55	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 12	2015	351								h5746	10.1136/bmj.h5746	http://dx.doi.org/10.1136/bmj.h5746			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW4GE	26563259				2022-12-28	WOS:000364948600002
J	Watts, G				Watts, Geoff			Alan Jon Magill Obituary	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2015	386	10004					1624	1624		10.1016/S0140-6736(15)00546-2	http://dx.doi.org/10.1016/S0140-6736(15)00546-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU0HS	26595626	Bronze			2022-12-28	WOS:000363197500018
J	Abraham, WT; Stevenson, LW; Bourge, RC; Lindenfeld, JA; Bauman, JG; Adamson, PB				Abraham, William T.; Stevenson, Lynne W.; Bourge, Robert C.; Lindenfeld, Jo Ann; Bauman, Jordan G.; Adamson, Philip B.		CHAMPION Trial Study Grp	Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial	LANCET			English	Article							CARDIAC-RESYNCHRONIZATION; MORBIDITY; MORTALITY; DISEASE; DEFIBRILLATOR; HYPERTENSION; SURVIVAL; HOSPITALIZATIONS; CATHETERIZATION; MANAGEMENT	Background In the CHAMPION trial, significant reductions in admissions to hospital for heart failure were seen after 6 months of pulmonary artery pressure guided management compared with usual care. We examine the extended efficacy of this strategy over 18 months of randomised follow-up and the clinical effect of open access to pressure information for an additional 13 months in patients formerly in the control group. Methods The CHAMPION trial was a prospective, parallel, single-blinded, multicentre study that enrolled participants with New York Heart Association (NYHA) Class III heart failure symptoms and a previous admission to hospital. Patients were randomly assigned (1:1) by centre in block sizes of four by a secure validated computerised randomisation system to either the treatment group, in which daily uploaded pulmonary artery pressures were used to guide medical therapy, or to the control group, in which daily uploaded pressures were not made available to investigators. Patients in the control group received all standard medical, device, and disease management strategies available. Patients then remained masked in their randomised study group until the last patient enrolled completed at least 6 months of study follow-up (randomised access period) for an average of 18 months. During the randomised access period, patients in the treatment group were managed with pulmonary artery pressure and patients in the control group had usual care only. At the conclusion of randomised access, investigators had access to pulmonary artery pressure for all patients (open access period) averaging 13 months of follow-up. The primary outcome was the rate of hospital admissions between the treatment group and control group in both the randomised access and open access periods. Analyses were by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00531661. Findings Between Sept 6, 2007, and Oct 7, 2009, 550 patients were randomly assigned to either the treatment group (n=270) or to the control group (n=280). 347 patients (177 in the former treatment group and 170 in the former control group) completed the randomised access period in August, 2010, and transitioned to the open access period which ended April 30, 2012. Over the randomised access period, rates of admissions to hospital for heart failure were reduced in the treatment group by 33% (hazard ratio [HR] 0.67 [95% CI 0.55-0.80]; p<0.0001) compared with the control group. After pulmonary artery pressure information became available to guide therapy during open access (mean 13 months), rates of admissions to hospital for heart failure in the former control group were reduced by 48% (HR 0.52 [95% CI 0.40-0.69]; p<0.0001) compared with rates of admissions in the control group during randomised access. Eight (1%) device-related or system related complications and seven (1%) procedure -related adverse events were reported.	[Abraham, William T.] Ohio State Univ, Div Cardiovasc Med, Columbus, OH 43210 USA; [Stevenson, Lynne W.] Brigham & Womens Hosp, Adv Heart Dis Sect, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA; [Bourge, Robert C.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Lindenfeld, Jo Ann] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Bauman, Jordan G.; Adamson, Philip B.] St Jude Med, Global Res & Dev, Austin, TX USA	University System of Ohio; Ohio State University; Harvard University; Brigham & Women's Hospital; University of Alabama System; University of Alabama Birmingham; Vanderbilt University	Abraham, WT (corresponding author), Ohio State Univ, Div Cardiovasc Med, Columbus, OH 43210 USA.	William.abraham@osumc.edu			St Jude Medical Inc.	St Jude Medical Inc.(St. Jude Medical)	St Jude Medical Inc.	Abraham WT, 2014, NAT REV CARDIOL, V11, P576, DOI 10.1038/nrcardio.2014.114; Abraham WT, 2011, LANCET, V377, P658, DOI 10.1016/S0140-6736(11)60101-3; Abraham WT, 2011, AM HEART J, V161, P558, DOI 10.1016/j.ahj.2010.10.041; Adamson PB, 2014, CIRC-HEART FAIL, V7, P935, DOI 10.1161/CIRCHEARTFAILURE.113.001229; Adamson PB, 2011, J CARD FAIL, V17, P366, DOI 10.1016/j.cardfail.2011.01.011; Adamson PB, 2011, J CARD FAIL, V17, P3, DOI 10.1016/j.cardfail.2010.08.002; Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Benza RL, 2015, J HEART LUNG TRANSPL, V34, P329, DOI 10.1016/j.healun.2014.04.014; Bourge RC, 2008, J AM COLL CARDIOL, V51, P1073, DOI 10.1016/j.jacc.2007.10.061; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Buyze J, 2011, STAT METHODS MED RES, V25, P1; Castaneda J, 2010, REV COLOMB ESTAD, V33, P43; Castro PF, 2007, J HEART LUNG TRANSPL, V26, P85, DOI 10.1016/j.healun.2006.10.006; Centers for Medicare & Medicaid Services, 100 MEDPAR INP HOSP; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Desai AS, 2010, NEW ENGL J MED, V363, P2364, DOI 10.1056/NEJMe1011769; Gardiner JC, 2009, STAT MED, V28, P221, DOI 10.1002/sim.3478; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hardin JW, 2012, GEN ESTIMATING EQUAT; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Hjalmarson A, 1999, LANCET, V353, P2001; Hoeper MM, 2006, J AM COLL CARDIOL, V48, P2546, DOI 10.1016/j.jacc.2006.07.061; Krahnke JS, 2015, J CARD FAIL, V21, P240, DOI 10.1016/j.cardfail.2014.12.008; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Loh JP, 2013, J AM COLL CARDIOL, V61, P1571, DOI 10.1016/j.jacc.2012.08.1035; Maggioni AP, 2002, J AM COLL CARDIOL, V40, P1414, DOI 10.1016/S0735-1097(02)02304-5; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Packer M, 1999, CIRCULATION, V100, P2312, DOI 10.1161/01.CIR.100.23.2312; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Raina A, 2015, J HEART LUNG TRANSPL, V34, P438, DOI 10.1016/j.healun.2015.01.983; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Stevenson LW, 2005, JAMA-J AM MED ASSOC, V294, P1625; Stevenson LW, 2010, CIRC-HEART FAIL, V3, P580, DOI 10.1161/CIRCHEARTFAILURE.109.923300; Verdejo HE, 2007, J AM COLL CARDIOL, V50, P2375, DOI 10.1016/j.jacc.2007.06.061; Wei LJ, 1997, STAT MED, V16, P833, DOI 10.1002/(SICI)1097-0258(19970430)16:8<833::AID-SIM538>3.0.CO;2-2; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Zannad F, 2014, INT J CARDIOL, V175, P30, DOI 10.1016/j.ijcard.2014.05.021; Zile MR, 2008, CIRCULATION, V118, P1433, DOI 10.1161/CIRCULATIONAHA.108.783910; Zile MR, 2011, J CARD FAIL, V17, P282, DOI 10.1016/j.cardfail.2011.01.010	45	330	333	1	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 30	2016	387	10017					453	461		10.1016/S0140-6736(15)00723-0	http://dx.doi.org/10.1016/S0140-6736(15)00723-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC1OX	26560249				2022-12-28	WOS:000368986800034
J	Mendelson, M; Rottingen, JA; Gopinathan, U; Hamer, DH; Wertheim, H; Basnyat, B; Butler, C; Tomson, G; Balasegaram, M				Mendelson, Marc; Rottingen, John-Ame; Gopinathan, Unni; Hamer, Davidson H.; Heiman Wertheim; Basnyat, Buddha; Butler, Christopher; Tomson, Goeran; Balasegaram, Manica			Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries	LANCET			English	Article							COMMUNITY CASE-MANAGEMENT; RESPIRATORY-TRACT INFECTIONS; RESEARCH-AND-DEVELOPMENT; AGED 2-59 MONTHS; ANTIBIOTIC USE; PRIMARY-CARE; NEONATAL-MORTALITY; DIAGNOSTIC-TESTS; ORAL AMOXICILLIN; SEVERE PNEUMONIA	Access to quality-assured antimicrobials is regarded as part of the human right to health, yet universal access is often undermined in low-income and middle-income countries. Lack of access to the instruments necessary to make the correct diagnosis and prescribe antimicrobials appropriately, in addition to weak health systems, heightens the challenge faced by prescribers. Evidence-based interventions in community and health-care settings can increase access to appropriately prescribed antimicrobials. The key global enablers of sustainable financing, governance, and leadership will be necessary to achieve access while preventing excess antimicrobial use.	[Mendelson, Marc] Univ Cape Town, Groote Schuur Hosp, Dept Med, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [Rottingen, John-Ame] Norwegian Inst Publ Hlth, Oslo, Norway; [Rottingen, John-Ame] Univ Oslo, Inst Hlth & Soc, Fac Med, Oslo, Norway; [Rottingen, John-Ame] Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Gopinathan, Unni] Oslo Univ Hosp, Dept Med Biochem, N-0450 Oslo, Norway; [Hamer, Davidson H.] Zambia Ctr Appl Hlth Res & Dev, Lusaka, Zambia; [Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Hamer, Davidson H.] Boston Univ, Sch Med, Dept Med, Infect Dis Sect, Boston, MA 02118 USA; [Heiman Wertheim] Univ Oxford, Natl Hosp Trop Dis, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hanoi, Vietnam; [Heiman Wertheim] Ctr Trop Dis, Nuffield Dept Clin Med, Oxford, England; [Basnyat, Buddha] Univ Oxford, Clin Res Unit Nepal, Kathmandu, Nepal; [Butler, Christopher] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Tomson, Goeran] Karolinska Inst, Dept Learning, Stockholm, Sweden; [Tomson, Goeran] Karolinska Inst, Dept Informat, Stockholm, Sweden; [Tomson, Goeran] Karolinska Inst, Dept Management, Stockholm, Sweden; [Tomson, Goeran] Karolinska Inst, Dept Eth & Publ Hlth, Stockholm, Sweden; [Balasegaram, Manica] Med Sans Frontieres, Access Campaign, Geneva, Switzerland	University of Cape Town; Norwegian Institute of Public Health (NIPH); University of Oslo; Harvard University; Harvard T.H. Chan School of Public Health; University of Oslo; University of Zambia; Boston University; Boston University; National Hospital of Tropical Diseases; University of Oxford; University of Oxford; University of Oxford; University of Oxford; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Doctors Without Borders	Mendelson, M (corresponding author), Univ Cape Town, Groote Schuur Hosp, Dept Med, Div Infect Dis & HIV Med, Observ 7925, ZA-7925 Cape Town, South Africa.	marc.mendelson@uct.ac.za	Hamer, Davidson Howes/J-2020-2019; Wertheim, Heiman FL/F-3338-2016	Hamer, Davidson Howes/0000-0002-4700-1495; Wertheim, Heiman FL/0000-0002-5003-5565; Butler, Christopher/0000-0002-0102-3453; Tomson, Goran/0000-0001-9222-3604; Mendelson, Marc/0000-0001-6668-3893	MRC [G0500956] Funding Source: UKRI; Medical Research Council [G0500956] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10056] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Abbott F, 2013, EMERGING MARKETS WOR; [Anonymous], 2015, 68 WORLD HLTH ASS AN; [Anonymous], 2014, SHARED RESPONSIBILIT; Ardal C, 2015, LANCET, DOI [http://dx.doi.org/10.1016/S0140-6736(15)00470, DOI 10.1016/S0140-6736(15)00470-]; Arnold SR, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003539.PUB2; Ashiru-Oredope D, 2012, J ANTIMICROB CHEMOTH, V67, pI51, DOI 10.1093/jac/dks202; Atun R, 2012, LANCET, V380, P2044, DOI 10.1016/S0140-6736(12)61460-3; Awor P, 2012, AM J TROP MED HYG, V87, P92, DOI 10.4269/ajtmh.2012.11-0791; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Bari A, 2011, LANCET, V378, P1796, DOI 10.1016/S0140-6736(11)61140-9; Bigdeli M, 2013, HEALTH POLICY PLANN, V28, P692, DOI 10.1093/heapol/czs108; Braykov NP, 2014, LANCET INFECT DIS, V14, P1220, DOI 10.1016/S1473-3099(14)70952-1; Butler CC, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2242; Butler CC, 2012, BMJ-BRIT MED J, V344, DOI [10.1136/bmj.d8173, 10.1136/bmj.e682]; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Cals JWL, 2011, J EVAL CLIN PRACT, V17, P1059, DOI 10.1111/j.1365-2753.2010.01472.x; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Cameron A, 2012, VALUE HEALTH, V15, P664, DOI 10.1016/j.jval.2012.04.004; Chanda P, 2011, MALARIA J, V10, DOI [10.1186/1475-2875-10-159, 10.1186/1475-2875-10-158]; Cosby JL, 2007, LANCET INFECT DIS, V7, P749, DOI 10.1016/S1473-3099(07)70263-3; Crisp N, 2014, NEW ENGL J MED, V370, P950, DOI 10.1056/NEJMra1111610; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; d'Acremont V, 2010, CLIN INFECT DIS, V51, P506, DOI 10.1086/655688; Dagan R, 2009, CLIN MICROBIOL INFEC, V15, P16, DOI 10.1111/j.1469-0691.2009.02726.x; Dar OA, 2016, LANCET, V387, P285, DOI 10.1016/S0140-6736(15)00520-6; Denkinger CM, 2013, EXPERT REV MOL DIAGN, V13, P763, DOI 10.1586/14737159.2013.850034; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Drain PK, 2014, LANCET INFECT DIS, V14, P239, DOI 10.1016/S1473-3099(13)70250-0; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Faiz MA, 2005, LANCET, V366, P717; Ghafur A, 2013, INDIAN J CANCER, V50, P71, DOI 10.4103/0019-509X.104065; Ghafur A, 2014, INDIAN J MED MICROBI, V32, P221, DOI 10.4103/0255-0857.129053; Gill CJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d346; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Gough EK, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2267; Gouws E, 2004, B WORLD HEALTH ORGAN, V82, P509; Hamer DH, 2012, PATHOG GLOB HEALTH, V106, P32, DOI 10.1179/1364859411Y.0000000042; Harris G., 2009, NY TIMES; Huang YF, 2013, BRIT J GEN PRACT, V63, pE787, DOI 10.3399/bjgp13X674477; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Kaplan WA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074399; Kaplan WA, 2012, HEALTH POLICY, V106, P211, DOI 10.1016/j.healthpol.2012.04.015; Kift EV, 2014, SAMJ S AFR MED J, V104, P183, DOI [10.7196/samj.7011, 10.7196/SAMJ.7011]; Kift EV, 2011, SAMJ S AFR MED J, V101, P240, DOI 10.7196/SAMJ.4761; Van Nguyen K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1158; Kotwani A, 2012, J CLIN PHARM THER, V37, P308, DOI 10.1111/j.1365-2710.2011.01293.x; Kotwani A, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-285; Kotwani A, 2010, FAM PRACT, V27, P684, DOI 10.1093/fampra/cmq059; Larson B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035444; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Laxminarayan R, 2012, SCIENCE, V338, P615, DOI 10.1126/science.1231010; Lecky DM, 2013, J ANTIMICROB CHEMOTH, V68, P2428, DOI 10.1093/jac/dkt361; Leibovici Leonard, 2012, J Antimicrob Chemother, V67, P12, DOI 10.1093/jac/dkr425; Levin A, 2011, HEALTH POLICY PLANN, V26, pi4, DOI 10.1093/heapol/czr037; Li J, 2006, LANCET INFECT DIS, V6, P589, DOI 10.1016/S1473-3099(06)70580-1; Little P, 2013, LANCET, V382, P1175, DOI 10.1016/S0140-6736(13)60994-0; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Luby SP, 2005, LANCET, V366, P225, DOI 10.1016/S0140-6736(05)66912-7; Mainous AG, 2009, ANN FAM MED, V7, P431, DOI 10.1370/afm.999; Marra CM, 2006, J INFECT DIS, V194, P1771, DOI 10.1086/509512; Meeker D, 2014, JAMA INTERN MED, V174, P425, DOI 10.1001/jamainternmed.2013.14191; Mitja O, 2012, LANCET, V379, P342, DOI 10.1016/S0140-6736(11)61624-3; Moon S, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-39; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Mukanga D, 2012, AM J TROP MED HYG; Narsai Kirti, 2012, South Med Rev, V5, P31; Nguyen DTK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066030; NPS Medicinewise, JOIN FIGHT ANT RES; Otrompke J., 2009, PUBL PRIV PARTN HELP; Parry CM, 2011, EXPERT REV ANTI-INFE, V9, P711, DOI [10.1586/eri.11.47, 10.1586/ERI.11.47]; Patouillard Edith, 2007, Int J Equity Health, V6, P17, DOI 10.1186/1475-9276-6-17; Pincock S, 2003, BRIT MED J, V327, P1245, DOI 10.1136/bmj.327.7426.1245-a; Pletz Mathias W, 2011, Med Monatsschr Pharm, V34, P201; Porco TC, 2009, JAMA-J AM MED ASSOC, V302, P962, DOI 10.1001/jama.2009.1266; Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003; Radyowijati A, 2003, SOC SCI MED, V57, P733, DOI 10.1016/S0277-9536(02)00422-7; Requejo J., 2013, ACCOUNTABILITY MATER; Rottingen JA, 2012, B WORLD HEALTH ORGAN, V90, P398, DOI 10.2471/BLT.12.105460; Rudolf PM, 2004, NEW ENGL J MED, V350, P1384, DOI 10.1056/NEJMp038231; Sertkaya A, 2014, AN FRAM EX VAL ANT P; Shakely D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072912; Skalet AH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000377; So AD, 2011, DRUG RESIST UPDATE, V14, P88, DOI 10.1016/j.drup.2011.01.006; So AD, 2014, UPSALA J MED SCI, V119, P176, DOI 10.3109/03009734.2014.898717; Song JH, 2012, VACCINE, V30, P2728, DOI 10.1016/j.vaccine.2012.01.091; Soofi S, 2012, LANCET, V379, P729, DOI 10.1016/S0140-6736(11)61714-5; Stewart JJ, 2001, NAT BIOTECHNOL, V19, P813, DOI 10.1038/nbt0901-813; Sumpradit N, 2012, B WORLD HEALTH ORGAN, V90, P905, DOI 10.2471/BLT.12.105445; Tougher S, 2012, LANCET, V380, P1916, DOI 10.1016/S0140-6736(12)61732-2; Tzouvelekis LS, 2014, CLIN MICROBIOL INFEC, V20, P862, DOI 10.1111/1469-0691.12697; United Nations, 1966, INT COV EC SOC CULT; United Nations, 2015, TRANSF OUR WORLD 203, DOI DOI 10.1163/157180910X12665776638740; United Nations Children's Fund (UNICEF), 2012, PNEUM DIARRH TACKL D; van Schaik N, 2010, SAMJ S AFR MED J, V100, P671, DOI 10.7196/SAMJ.4162; Walker N, 2013, LANCET, V382, P1029, DOI 10.1016/S0140-6736(13)61748-1; Welschen I, 2004, BRIT MED J, V329, P431, DOI 10.1136/bmj.38182.591238.EB; Wertheim HFL, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001429; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1; WHO, 2010, PREQ PROGR UN PROGR; WHO, 2012, RES DEV MEET HLTH NE; WHO, PUBL HLTH INN INT PR; Whyte S., 2003, SOCIAL LIVES MED; World Health Organization, Q A AFF MED FAC MAL; World Health Organization, INT MAN CHILDH ILLN; WTO, TRAD REL ASP INT PRO; Yadav P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-299; Yeboah-Antwi K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000340; Young M, 2012, AM J TROP MED HYG, V87, P6, DOI 10.4269/ajtmh.2012.12-0221; Zaidi Anita K M, 2013, Pediatr Infect Dis J, V32 Suppl 1, pS7, DOI 10.1097/INF.0b013e31829ff5fc	109	96	98	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2016	387	10014					188	198		10.1016/S0140-6736(15)00547-4	http://dx.doi.org/10.1016/S0140-6736(15)00547-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8LF	26603919				2022-12-28	WOS:000368055500035
J	Stanley, DA; Garratt, MPD; Wickens, JB; Wickens, VJ; Potts, SG; Raine, NE				Stanley, Dara A.; Garratt, Michael P. D.; Wickens, Jennifer B.; Wickens, Victoria J.; Potts, Simon G.; Raine, Nigel E.			Neonicotinoid pesticide exposure impairs crop pollination services provided by bumblebees	NATURE			English	Article							POTENTIAL EXPOSURE; FRUIT-QUALITY; APPLE; POLLEN; BEES; INSECTICIDES; SUCCESS; TRAITS	Recent concern over global pollinator declines has led to considerable research on the effects of pesticides on bees(1-5). Although pesticides are typically not encountered at lethal levels in the field, there is growing evidence indicating that exposure to field-realistic levels can have sublethal effects on bees, affecting their foraging behaviour(1,6,7), homing ability(8,9) and reproductive success(2,5). Bees are essential for the pollination of a wide variety of crops and the majority of wild flowering plants(10-12), but until now research on pesticide effects has been limited to direct effects on bees themselves and not on the pollination services they provide. Here we show the first evidence to our knowledge that pesticide exposure can reduce the pollination services bumblebees deliver to apples, a crop of global economic importance. Bumblebee colonies exposed to a neonicotinoid pesticide provided lower visitation rates to apple trees and collected pollen less often. Most importantly, these pesticide-exposed colonies produced apples containing fewer seeds, demonstrating a reduced delivery of pollination services. Our results also indicate that reduced pollination service delivery is not due to pesticide-induced changes in individual bee behaviour, but most likely due to effects at the colony level. These findings show that pesticide exposure can impair the ability of bees to provide pollination services, with important implications for both the sustained delivery of stable crop yields and the functioning of natural ecosystems.	[Stanley, Dara A.; Raine, Nigel E.] Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England; [Garratt, Michael P. D.; Wickens, Jennifer B.; Wickens, Victoria J.; Potts, Simon G.] Univ Reading, Sch Agr Policy & Dev, Ctr Agri Environm Res, Reading RG6 6AR, Berks, England; [Raine, Nigel E.] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada	University of London; Royal Holloway University London; University of Reading; University of Guelph	Stanley, DA (corresponding author), Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England.	darastanley@gmail.com; nraine@uoguelph.ca	Stanley, Dara/AAR-2947-2020; Stanley, Dara/K-2295-2012; Potts, Simon/ABF-9221-2020; Raine, Nigel/AAK-6425-2020; Garratt, Michael/AAT-2259-2020; Potts, Simon G/C-7250-2008	Stanley, Dara/0000-0001-8948-8409; Stanley, Dara/0000-0001-8948-8409; Potts, Simon/0000-0002-2045-980X; Raine, Nigel/0000-0001-6343-2829; Garratt, Michael/0000-0002-0196-6013; Potts, Simon G/0000-0002-2045-980X; Wickens, Jennifer/0000-0003-0475-6780; Wickens, Victoria/0000-0002-2295-0635	UK Insect Pollinators Initiative [BB/I000178/1, BB/1000348/1]; Living with Environmental Change programme; Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust; Scottish Government; Department for Environment, Food and Rural Affairs (Defra); Natural Environment Research Council (NERC); Rebanks Family Chair in Pollinator Conservation by The W. Garfield Weston Foundation; Biotechnology and Biological Sciences Research Council [BB/I000348/1, BB/I000178/1] Funding Source: researchfish; BBSRC [BB/I000348/1, BB/I000178/1] Funding Source: UKRI	UK Insect Pollinators Initiative; Living with Environmental Change programme; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Scottish Government; Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Rebanks Family Chair in Pollinator Conservation by The W. Garfield Weston Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank technicians at the University of Reading for assistance in apple collection and seed counting, and E. van Leeuwen and colleagues at Royal Holloway University of London for useful discussions. This study was supported by UK Insect Pollinators Initiative grants BB/I000178/1 awarded to N.E.R. and BB/1000348/1 awarded to S.G.P. (funded jointly by the Living with Environmental Change programme, Biotechnology and Biological Sciences Research Council (BBSRC), Wellcome Trust, Scottish Government, Department for Environment, Food and Rural Affairs (Defra) and Natural Environment Research Council (NERC)). N.E.R. is supported as the Rebanks Family Chair in Pollinator Conservation by The W. Garfield Weston Foundation.	Arena M, 2014, ECOTOXICOLOGY, V23, P324, DOI 10.1007/s10646-014-1190-1; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Biddinger DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072587; Botias C, 2015, ENVIRON SCI TECHNOL, V49, P12731, DOI 10.1021/acs.est.5b03459; Brittain C, 2011, BASIC APPL ECOL, V12, P321, DOI 10.1016/j.baae.2010.12.004; Buccheri M, 2004, J PLANT NUTR, V27, P1735, DOI 10.1081/PLN-200026409; BURD M, 1994, BOT REV, V60, P83, DOI 10.1007/BF02856594; Castle SJ, 2005, PEST MANAG SCI, V61, P75, DOI 10.1002/ps.949; Castro S, 2013, PLANT ECOL, V214, P1233, DOI 10.1007/s11258-013-0247-1; Cutler GC, 2015, PEST MANAG SCI, V71, P1368, DOI 10.1002/ps.4042; Decourtye A, 2013, NATURE, V497, P188, DOI 10.1038/497188a; Deglise P, 2002, NEUROSCI LETT, V321, P13, DOI 10.1016/S0304-3940(01)02400-4; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; Eilers EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021363; Feltham H, 2014, ECOTOXICOLOGY, V23, P317, DOI 10.1007/s10646-014-1189-7; Fischer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091364; Garratt M.P.D., 2014, Journal of Pollination Ecology, V12, P9; Garratt MPD, 2014, AGR ECOSYST ENVIRON, V184, P34, DOI 10.1016/j.agee.2013.10.032; Gill RJ, 2014, FUNCT ECOL, V28, P1459, DOI 10.1111/1365-2435.12292; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Godfray HCJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0558; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Kleijn D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8414; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Lautenbach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035954; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Palmer MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2648; Pilling E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077193; Pinheiro J, 2017, PACKAGE NLME LINEAR; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rundlof M, 2015, NATURE, V521, P77, DOI 10.1038/nature14420; Sakamoto RL, 2012, BEHAV ECOL SOCIOBIOL, V66, P669, DOI 10.1007/s00265-011-1314-z; Sheffield Cory S., 2014, Journal of Pollination Ecology, V12, P120; Stewart SD, 2014, ENVIRON SCI TECHNOL, V48, P9762, DOI 10.1021/es501657w; Thompson H., 2013, EFFECTS NEONICOTINOI; Venables WN., 2002, MODERN APPL STAT S; Volz RK, 1996, SCI HORTIC-AMSTERDAM, V66, P169, DOI 10.1016/S0304-4238(96)00934-X; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025	42	180	184	11	436	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					548	+		10.1038/nature16167	http://dx.doi.org/10.1038/nature16167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26580009	Green Accepted			2022-12-28	WOS:000366991900051
J	Oldridge, DA; Wood, AC; Weichert-Leahey, N; Crimmins, I; Sussman, R; Winter, C; McDaniel, LD; Diamond, M; Hart, LS; Zhu, SZ; Durbin, AD; Abraham, BJ; Anders, L; Tian, LF; Zhang, SL; Wei, JS; Khan, J; Bramlett, K; Rahman, N; Capasso, M; Iolascon, A; Gerhard, DS; Auvil, JMG; Young, RA; Hakonarson, H; Diskin, SJ; Look, AT; Maris, JM				Oldridge, Derek A.; Wood, Andrew C.; Weichert-Leahey, Nina; Crimmins, Ian; Sussman, Robyn; Winter, Cynthia; McDaniel, Lee D.; Diamond, Maura; Hart, Lori S.; Zhu, Shizhen; Durbin, Adam D.; Abraham, Brian J.; Anders, Lars; Tian, Lifeng; Zhang, Shile; Wei, Jun S.; Khan, Javed; Bramlett, Kelli; Rahman, Nazneen; Capasso, Mario; Iolascon, Achille; Gerhard, Daniela S.; Auvil, Jaime M. Guidry; Young, Richard A.; Hakonarson, Hakon; Diskin, Sharon J.; Look, A. Thomas; Maris, John M.			Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism	NATURE			English	Article							CELL IDENTITY; HUMAN GENOME; TRANSCRIPTION; INHIBITION; LOCUS; SUSCEPTIBILITY; ASSOCIATION; DISEASE; CANCER; MYCN	Neuroblastoma is a paediatric malignancy that typically arises in early childhood, and is derived from the developing sympathetic nervous system. Clinical phenotypes range from localized tumours with excellent outcomes to widely metastatic disease in which long-term survival is approximately 40% despite intensive therapy. A previous genome-wide association study identified common polymorphisms at the LMO1 gene locus that are highly associated with neuroblastoma susceptibility and oncogenic addiction to LMO1 in the tumour cells(1). Here we investigate the causal DNA variant at this locus and the mechanism by which it leads to neuroblastoma tumorigenesis. We first imputed all possible genotypes across the LMO1 locus and then mapped highly associated single nucleotide polymorphism (SNPs) to areas of chromatin accessibility, evolutionary conservation and transcription factor binding sites. We show that SNP rs2168101 G>T is the most highly associated variant (combined P = 7.47 x 10(-29), odds ratio 0.65, 95% confidence interval 0.60-0.70), and resides in a super-enhancer defined by extensive acetylation of histone H3 lysine 27 within the first intron of LMO1. The ancestral G allele that is associated with tumour formation resides in a conserved GATA transcription factor binding motif. We show that the newly evolved protective TATA allele is associated with decreased total LMO1 expression (P = 0.028) in neuroblastoma primary tumours, and ablates GATA3 binding (P < 0.0001). We demonstrate allelic imbalance favouring the G-containing strand in tumours heterozygous for this SNP, as demonstrated both by RNA sequencing (P < 0.0001) and reporter assays (P = 0.002). These findings indicate that a recently evolved polymorphism within a super-enhancer element in the first intron of LMO1 influences neuroblastoma susceptibility through differential GATA transcription factor binding and direct modulation of LMO1 expression in cis, and this leads to an oncogenic dependency in tumour cells.	[Oldridge, Derek A.; Crimmins, Ian; Sussman, Robyn; Winter, Cynthia; McDaniel, Lee D.; Diamond, Maura; Hart, Lori S.; Diskin, Sharon J.; Maris, John M.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Oldridge, Derek A.; Crimmins, Ian; Sussman, Robyn; Winter, Cynthia; McDaniel, Lee D.; Diamond, Maura; Hart, Lori S.; Diskin, Sharon J.; Maris, John M.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Oldridge, Derek A.] Univ Penn, Perelman Sch Med, Med Scientist Training Program, Philadelphia, PA 19104 USA; [Wood, Andrew C.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, Auckland Region, New Zealand; [Weichert-Leahey, Nina; Durbin, Adam D.; Look, A. Thomas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Weichert-Leahey, Nina; Durbin, Adam D.; Look, A. Thomas] Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Zhu, Shizhen] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Abraham, Brian J.; Anders, Lars; Young, Richard A.] Whitehead Inst Biomed Res, Boston, MA 02142 USA; [Abraham, Brian J.; Anders, Lars; Young, Richard A.] MIT, Boston, MA 02142 USA; [Tian, Lifeng; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Zhang, Shile; Wei, Jun S.; Khan, Javed] NCI, Pediat Oncol Branch, Bethesda, MD 20892 USA; [Bramlett, Kelli] Thermo Fisher Sci, Austin, TX 78744 USA; [Rahman, Nazneen] Inst Canc Res, Sutton SM2 5NG, Surrey, England; [Capasso, Mario; Iolascon, Achille] Univ Naples 2, I-80131 Naples, Italy; [Capasso, Mario; Iolascon, Achille] CEINGE Biotecnol Avanzate, I-80131 Naples, Italy; [Gerhard, Daniela S.; Auvil, Jaime M. Guidry] NCI, Off Canc Genom, Bethesda, MD 20892 USA; [Hakonarson, Hakon; Diskin, Sharon J.; Maris, John M.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Diskin, Sharon J.; Maris, John M.] Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Auckland; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Mayo Clinic; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Thermo Fisher Scientific; University of London; Institute of Cancer Research - UK; Universita della Campania Vanvitelli; CEINGE Biotecnologie Avanzate; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Maris, JM (corresponding author), Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA.	maris@chop.edu	Abraham, Brian/C-2230-2019; Capasso, Mario/D-1617-2014; Young, Richard A/F-6495-2012; Khan, Javed/P-9157-2014; Rahman, Nazneen/D-2802-2013	Abraham, Brian/0000-0001-8085-3027; Young, Richard A/0000-0001-8855-8647; Capasso, Mario/0000-0003-3306-1259; Sussman, Robyn/0000-0002-4057-9622; iolascon, achille/0000-0002-9558-0356; Durbin, Adam/0000-0002-5472-9847; Rahman, Nazneen/0000-0003-4376-0440	NIH [R01-CA124709, R01-CA180692, R00-CA151869, RC1MD004418, 1K99CA178189, T32-HG000046, R01-CA109901]; Giulio D'Angio Endowed Chair; PressOn Foundation; Andrew's Army Foundation; Abramson Family Cancer Research Institute; Brooke Mulford Foundation; University of Pennsylvania Genome Frontiers Institute; Alex's Lemonade Stand Foundation Innovation Award; Alex's Lemonade Stand Foundation; CureSearch for Children's Cancer Foundation; German Cancer Aid 110801; St Baldrick's Foundation Fellow award; George L. Ohrstrom Jr foundation; Wellcome Trust [100210/Z/12/Z]; NHS; Fondazione Italiana per la Lotta al Neuroblastoma; Associazione Oncologia Pediatrica e Neuroblastoma; Associazione Italiana per la Ricerca sul Cancro; NATIONAL CANCER INSTITUTE [R00CA151869, F30CA192831, R01CA124709, K99CA178189, ZIABC011002, R00CA178189, R01CA180692] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [RC1MD004418] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER; Rosetrees Trust [M28-F1-CD2] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giulio D'Angio Endowed Chair; PressOn Foundation; Andrew's Army Foundation; Abramson Family Cancer Research Institute; Brooke Mulford Foundation; University of Pennsylvania Genome Frontiers Institute; Alex's Lemonade Stand Foundation Innovation Award; Alex's Lemonade Stand Foundation; CureSearch for Children's Cancer Foundation; German Cancer Aid 110801; St Baldrick's Foundation Fellow award; George L. Ohrstrom Jr foundation; Wellcome Trust(Wellcome TrustEuropean Commission); NHS; Fondazione Italiana per la Lotta al Neuroblastoma; Associazione Oncologia Pediatrica e Neuroblastoma; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Rosetrees Trust(Rosetrees Trust)	This work was supported in part by NIH grants R01-CA124709 (J.M.M.), R01-CA180692 (J.M.M. and A.T.L.), R00-CA151869 (S.J.D.), RC1MD004418 to the TARGET consortium, 1K99CA178189 (S.Z.), T32-HG000046 (D.A.O.), R01-CA109901 (R.A.Y.), the Giulio D'Angio Endowed Chair (J.M.M.), the PressOn Foundation (J.M.M.), Andrew's Army Foundation (J.M.M.), the Abramson Family Cancer Research Institute (J.M.M.), the Brooke Mulford Foundation (J.M.M.), the University of Pennsylvania Genome Frontiers Institute, an Alex's Lemonade Stand Foundation Innovation Award (A.T.L.), young investigator awards from Alex's Lemonade Stand Foundation (S.Z., A.C.W.) and the CureSearch for Children's Cancer Foundation (S.Z.), grant from the German Cancer Aid 110801 (N.W.-L.), St Baldrick's Foundation Fellow award (A.C.W.), George L. Ohrstrom Jr foundation (A.C.W.), Wellcome Trust Senior Investigator Award Ref: 100210/Z/12/Z (N.R.) and NHS funding to the NIHR Biomedical Research Centre at The Royal Marsden and the ICR (N.R.), Fondazione Italiana per la Lotta al Neuroblastoma (M.C.), Associazione Oncologia Pediatrica e Neuroblastoma (M.C.), and Associazione Italiana per la Ricerca sul Cancro (M.C.). We gratefully acknowledge the Children's Oncology Group (COG) for providing the specimens and clinical data from neuroblastoma patients and thank patients and families for participating in the COG, the UK-based Factors Associated with Childhood Tumors (FACT), and Italian cooperative group studies. We thank A. Renwick who performed the Taqman analyses and A. Zachariou for recruiting participants to the FACT study. We thank G. Blobel for scientific advice and discussion, and generously providing equipment and reagents for ChIP experiments, N. Saeki and H. Sasaki for providing the LMO1 cDNA clone, and Y. Nakatan for providing the lentiviral vector pOZ-FHN.	Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Chipumuro E, 2014, CELL, V159, P1126, DOI 10.1016/j.cell.2014.10.024; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Diskin SJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju047; Diskin SJ, 2012, NAT GENET, V44, P1126, DOI 10.1038/ng.2387; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Durbin AD, 2009, J CLIN INVEST, V119, P1558, DOI 10.1172/JCI37958; Henderson TO, 2011, J CLIN ONCOL, V29, P76, DOI 10.1200/JCO.2010.29.6103; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Latorre V, 2012, CANCER EPIDEM BIOMAR, V21, P658, DOI 10.1158/1055-9965.EPI-11-0830; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Matthews JM, 2013, NAT REV CANCER, V13, P111, DOI 10.1038/nrc3418; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nguyen le B., 2011, PLOS GENET, V7; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Sanda T, 2012, CANCER CELL, V22, P209, DOI 10.1016/j.ccr.2012.06.007; Sur I, 2013, CANCER RES, V73, P4180, DOI 10.1158/0008-5472.CAN-13-0789; Wang K, 2011, NATURE, V469, P216, DOI 10.1038/nature09609; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	30	191	200	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					418	+		10.1038/nature15540	http://dx.doi.org/10.1038/nature15540			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26560027	Green Accepted, Green Published			2022-12-28	WOS:000366678600057
J	Hart, T; Chandrashekhar, M; Aregger, M; Steinhart, Z; Brown, KR; MacLeod, G; Mis, M; Zimmermann, M; Fradet-Turcotte, A; Sun, S; Mero, P; Dirks, P; Sidhu, S; Roth, FP; Rissland, OS; Durocher, D; Angers, S; Moffat, J				Hart, Traver; Chandrashekhar, Megha; Aregger, Michael; Steinhart, Zachary; Brown, Kevin R.; MacLeod, Graham; Mis, Monika; Zimmermann, Michal; Fradet-Turcotte, Amelie; Sun, Song; Mero, Patricia; Dirks, Peter; Sidhu, Sachdev; Roth, Frederick P.; Rissland, Olivia S.; Durocher, Daniel; Angers, Stephane; Moffat, Jason			High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities	CELL			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; MITOCHONDRIAL PROTEIN-SYNTHESIS; HUMAN-CELLS; RNAI SCREENS; INHIBITION; MAP; P53; VULNERABILITIES; OXAZOLIDINONES; ENDONUCLEASE	The ability to perturb genes in human cells is crucial for elucidating gene function and holds great potential for finding therapeutic targets for diseases such as cancer. To extend the catalog of human core and context-dependent fitness genes, we have developed a high-complexity second-generation genome-scale CRISPR-Cas9 gRNA library and applied it to fitness screens in five human cell lines. Using an improved Bayesian analytical approach, we consistently discover 5-fold more fitness genes than were previously observed. We present a list of 1,580 human core fitness genes and describe their general properties. Moreover, we demonstrate that context-dependent fitness genes accurately recapitulate pathway-specific genetic vulnerabilities induced by known oncogenes and reveal cell-type-specific dependencies for specific receptor tyrosine kinases, even in oncogenic KRAS backgrounds. Thus, rigorous identification of human cell line fitness genes using a high-complexity CRISPR-Cas9 library affords a high-resolution view of the genetic vulnerabilities of a cell.	[Hart, Traver; Chandrashekhar, Megha; Aregger, Michael; Brown, Kevin R.; Sun, Song; Mero, Patricia; Sidhu, Sachdev; Roth, Frederick P.; Moffat, Jason] Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Chandrashekhar, Megha; Sun, Song; Dirks, Peter; Sidhu, Sachdev; Roth, Frederick P.; Rissland, Olivia S.; Durocher, Daniel; Moffat, Jason] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Steinhart, Zachary; MacLeod, Graham; Mis, Monika; Angers, Stephane] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON M5S 1A1, Canada; [Steinhart, Zachary; MacLeod, Graham; Mis, Monika; Angers, Stephane] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5S 1A1, Canada; [Angers, Stephane] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A1, Canada; [Zimmermann, Michal; Fradet-Turcotte, Amelie; Roth, Frederick P.; Durocher, Daniel] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Rissland, Olivia S.] Hosp Sick Children, Res Inst, Mol Struct & Funct Program, Toronto, ON M5G 0A4, Canada; [Sun, Song] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Dirks, Peter] Hosp Sick Children, Div Neurosurg, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Sun, Song; Roth, Frederick P.] Univ Toronto, Dept Comp Sci, Toronto, ON M5G 1X8, Canada; [Roth, Frederick P.; Moffat, Jason] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada; [Roth, Frederick P.] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02215 USA	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Uppsala University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Canadian Institute for Advanced Research (CIFAR); Harvard University; Dana-Farber Cancer Institute	Moffat, J (corresponding author), Donnelly Ctr, 160 Coll St, Toronto, ON M5S 3E1, Canada.	j.moffat@utoronto.ca	Moffat, Jason/AAC-1110-2020; Durocher, Daniel/A-7733-2010; Angers, Stephane/E-1432-2014; Roth, Frederick P/H-6308-2011; Fradet-Turcotte, Amelie/G-5790-2017	Moffat, Jason/0000-0002-5663-8586; Durocher, Daniel/0000-0003-3863-8635; Angers, Stephane/0000-0001-7241-9044; Fradet-Turcotte, Amelie/0000-0002-5431-8650; Roth, Frederick/0000-0002-6628-649X; Brown, Kevin/0000-0002-5514-2538; Hart, Traver/0000-0002-1880-3341; Aregger, Michael/0000-0001-6443-9870	Swiss National Science Foundation; CIHR; Swedish Research Council; Ontario Research Fund; Ontario Institute for Cancer Research ITV Program; Canadian Foundation for Innovation; Canada Research Chairs program; Krembil Foundation; Canadian Institutes for Health Research operating grant [CIHR-342551];  [FDN 143343]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CIHR(Canadian Institutes of Health Research (CIHR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Ontario Research Fund; Ontario Institute for Cancer Research ITV Program; Canadian Foundation for Innovation(Canada Foundation for Innovation); Canada Research Chairs program(Canada Research Chairs); Krembil Foundation; Canadian Institutes for Health Research operating grant(Canadian Institutes of Health Research (CIHR)); 	We thank Michael Costanzo, Amy Tong, Charlie Boone, and Brenda Andrews for helpful discussions and comments on the manuscript. We thank Olga Sizova and Amy Tong for technical assistance, Sachin Kumar for providing plasmids, all the members of the Moffat and Angers labs for helpful discussions, Peggy Wang for graphic design, and Aaron Schimmer for chemicals. We thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison (http://exac.broadinstitute.org/about). We also thank Dax Torti at the Donnelly Sequencing Centre for assistance with sequencing. M.A. holds a postdoctoral fellowship from the Swiss National Science Foundation, A.F.-T. holds a CIHR postdoctoral fellowship, M.Z. is an EMBO Long-Term postdoctoral fellow, and S. Sun holds an international post-doc grant from the Swedish Research Council. This work was supported by grants from the Ontario Research Fund (J.M.), Ontario Institute for Cancer Research ITV Program (J.M.), Canadian Foundation for Innovation (J.M.), Canada Research Chairs program (J.M., S.A., and D.D.), Krembil Foundation (D.D.), a Canadian Institutes for Health Research operating grant to J.M. (CIHR-342551), and foundation grant to D.D. (FDN 143343). D.D. is a Tier 1 Canada Research Chair in Molecular Mechanisms of Genome Integrity, S.A. is a Tier 2 Canada Research Chair in Functional Architecture of Signal Transduction, and J.M. is a Tier 2 Canada Research Chair in Functional Genomics of Cancer.	Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Boehm JS, 2015, NAT REV GENET, V16, P373, DOI 10.1038/nrg3967; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; De I, 2015, NAT STRUCT MOL BIOL, V22, P138, DOI 10.1038/nsmb.2951; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Hart T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-778; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Jalving M, 2010, EUR J CANCER, V46, P2369, DOI 10.1016/j.ejca.2010.06.012; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kuraoka I, 2008, J BIOL CHEM, V283, P940, DOI 10.1074/jbc.M706647200; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liu YH, 2015, NATURE, V520, P697, DOI 10.1038/nature14418; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McKee EE, 2006, ANTIMICROB AGENTS CH, V50, P2042, DOI 10.1128/AAC.01411-05; MEUTH M, 1989, EXP CELL RES, V181, P305, DOI 10.1016/0014-4827(89)90090-6; Moffat J, 2007, TRENDS PHARMACOL SCI, V28, P149, DOI 10.1016/j.tips.2007.02.009; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; Nagiec EE, 2005, ANTIMICROB AGENTS CH, V49, P3896, DOI 10.1128/AAC.49.9.3896-3902.2005; Nijhawan D, 2012, CELL, V150, P842, DOI 10.1016/j.cell.2012.07.023; Olson MW, 2006, ANTIMICROB AGENTS CH, V50, P2156, DOI 10.1128/AAC.01499-05; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Ramani AK, 2012, CELL, V148, P792, DOI 10.1016/j.cell.2012.01.019; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Taipale M, 2014, CELL, V158, P434, DOI 10.1016/j.cell.2014.05.039; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Vizeacoumar FJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.54; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	47	813	831	7	155	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6								10.1016/j.cell.2015.11.015	http://dx.doi.org/10.1016/j.cell.2015.11.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26627737	Bronze			2022-12-28	WOS:000366044800004
J	Judson, TJ; Volpp, KG; Detsky, AS				Judson, Timothy J.; Volpp, Kevin G.; Detsky, Allan S.			Harnessing the Right Combination of Extrinsic and Intrinsic Motivation to Change Physician Behavior	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Judson, Timothy J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Volpp, Kevin G.] Univ Penn, LDI Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA; [Volpp, Kevin G.] Cresencz VA Med Ctr, Ctr Hlth Equity & Promot, Philadelphia, PA USA; [Detsky, Allan S.] Univ Toronto, Dept Med, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON M5G 1X5, Canada	University of California System; University of California San Francisco; University of Pennsylvania; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Room 429, Toronto, ON M5G 1X5, Canada.	Adetsky@mtsinai.on.ca		Volpp, Kevin/0000-0003-1423-4599	NATIONAL INSTITUTE ON AGING [P30AG034546] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], MEDSCAPE PHYS COMPEN; Cutler DM, 2015, JAMA-J AM MED ASSOC, V314, P337, DOI 10.1001/jama.2015.7683; Detsky AS, 2007, JAMA-J AM MED ASSOC, V298, P799, DOI 10.1001/jama.298.7.799; DIMATTEO MR, 1993, HEALTH PSYCHOL, V12, P93, DOI 10.1037/0278-6133.12.2.93; Dyrbye LN, 2011, JAMA-J AM MED ASSOC, V305, P2009, DOI 10.1001/jama.2011.652; Khullar D, 2015, NEW ENGL J MED, V372, P2281, DOI 10.1056/NEJMp1502312; Peckham C, MEDSCAPE PHYS COMPEN; Scott A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008451.pub2	8	37	37	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2015	314	21					2233	2234		10.1001/jama.2015.15015	http://dx.doi.org/10.1001/jama.2015.15015			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX2GT	26624821				2022-12-28	WOS:000365515700012
J	Lee, CR; Zeldin, DC				Lee, Craig R.; Zeldin, Darryl C.			Resolvin Infectious Inflammation by Targeting the Host Response	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							SEPSIS		[Lee, Craig R.] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27599 USA; [Zeldin, Darryl C.] Natl Inst Environm Hlth Sci, Div Intramural Res, NIH, Res Triangle Pk, NC USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Lee, CR (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27599 USA.		Zeldin, Darryl C/Y-7091-2018	Zeldin, Darryl C/0000-0002-2087-7307; Lee, Craig/0000-0003-3595-5301	Intramural NIH HHS [Z01 ES025034-14] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES025034] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Dalli J, 2015, NAT MED, V21, P1071, DOI 10.1038/nm.3911; Deshpande A, 2015, AM J MED, V128, P410, DOI 10.1016/j.amjmed.2014.10.057; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479	5	31	32	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2015	373	22					2183	2185		10.1056/NEJMcibr1511280	http://dx.doi.org/10.1056/NEJMcibr1511280			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9YT	26605933	Green Accepted			2022-12-28	WOS:000365354800020
J	Kennedy, AG				Kennedy, Ashley Graham			The title "Doctor" is an anachronism that disrespects patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kennedy, Ashley Graham] Florida Atlantic Univ, Philosophy, Jupiter, FL 33458 USA; [Kennedy, Ashley Graham] Florida Atlantic Univ, Clin Biomed Sci Secondary, Jupiter, FL 33458 USA	State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University	Kennedy, AG (corresponding author), Florida Atlantic Univ, Philosophy, 5353 Parkside Dr, Jupiter, FL 33458 USA.	kennedya@fau.edu						Dancer SJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3211; Granger K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5833; Harris G., 2011, NY TIMES; Palacios-Gonzalez C, 2015, J MED ETHICS, V41, P433, DOI 10.1136/medethics-2013-101900	4	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2015	351								h6240	10.1136/bmj.h6240	http://dx.doi.org/10.1136/bmj.h6240			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX4TG	26608738				2022-12-28	WOS:000365692600006
J	Soares, MP				Soares, Miguel P.			Microbiota's No Wasting Policy	CELL			English	Editorial Material							VIRUS-INFECTION; TOLERANCE; DEFENSE	Schieber et al. demonstrate that a specific gut microbiota bacterial strain induces a host-mediated protection mechanism against inflammation-driven wasting syndrome. This salutary effect confers a net survival advantage against bacterial infection, without interfering with the host's pathogen load, revealing that host-microbiota interactions regulate disease tolerance to infection.	[Soares, Miguel P.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal	Instituto Gulbenkian de Ciencia	Soares, MP (corresponding author), Inst Gulbenkian Ciencias, Rua Quinta Grande 6, P-2780156 Oeiras, Portugal.	mpsoares@igc.gulbenkian.pt		Soares, Miguel/0000-0002-9314-4833				Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Rodrigue-Gervais IG, 2014, CELL HOST MICROBE, V15, P23, DOI 10.1016/j.chom.2013.12.003; Yilmaz B, 2014, CELL, V159, P1277, DOI 10.1016/j.cell.2014.10.053	7	1	1	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1057	1058		10.1016/j.cell.2015.10.077	http://dx.doi.org/10.1016/j.cell.2015.10.077			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26590415	Bronze			2022-12-28	WOS:000366044700006
J	Tataroglu, O; Zhao, XH; Busza, A; Ling, JL; O'Neill, JS; Emery, P				Tataroglu, Ozgur; Zhao, Xiaohu; Busza, Ania; Ling, Jinli; O'Neill, John S.; Emery, Patrick			RETRACTED: Calcium and SOL Protease Mediate Temperature Resetting of Circadian Clocks (Retracted article. See vol. 171, pg. 256, 2017)	CELL			English	Article; Retracted Publication							DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; BODY-TEMPERATURE; LIGHT RESPONSE; ENTRAINMENT; RHYTHMS; NEURONS; SYNCHRONIZATION; CRYPTOCHROME; OSCILLATIONS	Circadian clocks integrate light and temperature input to remain synchronized with the day/night cycle. Although light input to the clock is well studied, the molecularmechanisms by which circadian clocks respond to temperature remain poorly understood. We found that temperature phase shifts Drosophila circadian clocks through degradation of the pacemaker protein TIM. This degradation is mechanistically distinct from photic CRY-dependent TIM degradation. Thermal TIM degradation is triggered by cytosolic calcium increase and CALMODULIN binding to TIM and ismediated by the atypical calpain protease SOL. This thermal input pathway and CRY-dependent light input thus converge on TIM, providing a molecular mechanism for the integration of circadian light and temperature inputs. Mammals use body temperature cycles to keep peripheral clocks synchronized with their brain pacemaker. Interestingly, downregulating the mammalian SOL homolog SOLH blocks thermal mPER2 degradation and phase shifts. Thus, we propose that circadian thermosensation in insects and mammals share common principles.	[Tataroglu, Ozgur; Zhao, Xiaohu; Busza, Ania; Ling, Jinli; Emery, Patrick] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [O'Neill, John S.] MRC Lab Mol Biol, Cambridge CB2 0QH, England	University of Massachusetts System; University of Massachusetts Worcester; MRC Laboratory Molecular Biology	Emery, P (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	patrick.emery@umassmed.edu			NIH [GM079182, GM066777]; Medical Research Council [MC_UP_1201/4]; Wellcome Trust [093734/Z/10/Z]; MRC [MC_UP_1201/4] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066777, T32GM107000, R01GM079182] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We specially thank D. Weaver for discussions and help with mammalian experiments and antibodies and R. Stanewsky for sharing unpublished results. We thank D. Wentworth, D. Szydlik, and C. Yuan for technical assistance, Y. Zhang and S. Antolin for discussions, M. Nitabach for PV and GFP-Aequorin flies, M. Rosbash for LUC control flies, A. Seghal for anti-TIM antibody, R. Stanewsky for anti-PER antibody and BG-LUC flies, the Bloomington and VDRC Drosophila stock centers for fly stocks, and the UMass Medical School shRNA core for viruses expressing Solh shRNAs. This work was supported by NIH grants (GM079182 and GM066777) (to P.E.). J.S.O. is supported by the Medical Research Council (MC_UP_1201/4) and the Wellcome Trust (093734/Z/10/Z).	Allada R, 2003, EMBO J, V22, P3367, DOI 10.1093/emboj/cdg318; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; Boothroyd CE, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030054; Brancaccio M, 2013, NEURON, V78, P714, DOI 10.1016/j.neuron.2013.03.011; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; BRUCE VG, 1956, P NATL ACAD SCI USA, V42, P676, DOI 10.1073/pnas.42.9.676; BRUCE VG, 1960, COLD SPRING HARB SYM, V25, P29, DOI 10.1101/SQB.1960.025.01.005; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Busza A, 2007, J NEUROSCI, V27, P10722, DOI 10.1523/JNEUROSCI.2479-07.2007; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Currie J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-49; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; Ding JM, 1998, NATURE, V394, P381, DOI 10.1038/28639; Ding XZ, 1996, J INVEST MED, V44, P144; Friedrich P, 2004, BIOESSAYS, V26, P1088, DOI 10.1002/bies.20106; Gentile C, 2013, CURR BIOL, V23, P185, DOI 10.1016/j.cub.2012.12.023; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Goda T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1714; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Guo F, 2014, ELIFE, V3, DOI 10.7554/eLife.02780; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Kamei M, 2000, GENOMICS, V64, P82, DOI 10.1006/geno.1999.6098; Kamei M, 1998, GENOMICS, V51, P197, DOI 10.1006/geno.1998.5395; Kaushik R, 2007, PLOS BIOL, V5, P1257, DOI 10.1371/journal.pbio.0050146; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamba P, 2014, CELL REP, V7, P601, DOI 10.1016/j.celrep.2014.03.044; Lee E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004545; Lee Y, 2013, J NEUROSCI, V33, P6716, DOI 10.1523/JNEUROSCI.4237-12.2013; Levine JD, 2002, SCIENCE, V298, P2010, DOI 10.1126/science.1076008; Mazzoni EO, 2005, NEURON, V45, P293, DOI 10.1016/j.neuron.2004.12.038; Melom JE, 2013, J NEUROSCI, V33, P1169, DOI 10.1523/JNEUROSCI.3920-12.2013; Menegazzi P, 2012, J BIOL RHYTHM, V27, P433, DOI 10.1177/0748730412463181; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Noguchi T, 2012, CHRONOBIOL INT, V29, P653, DOI 10.3109/07420528.2012.679330; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; O'Neill JS, 2008, J BIOL RHYTHM, V23, P483, DOI 10.1177/0748730408326682; Ozturk N, 2011, P NATL ACAD SCI USA, V108, P516, DOI 10.1073/pnas.1017093108; Peschel N, 2009, CURR BIOL, V19, P241, DOI 10.1016/j.cub.2008.12.042; Picot M, 2009, J NEUROSCI, V29, P8312, DOI 10.1523/JNEUROSCI.0279-08.2009; PITTENDRIGH CS, 1954, P NATL ACAD SCI USA, V40, P1018, DOI 10.1073/pnas.40.10.1018; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; Reddy AB, 2010, TRENDS CELL BIOL, V20, P36, DOI 10.1016/j.tcb.2009.10.005; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; Sandrelli F, 2007, SCIENCE, V316, P1898, DOI 10.1126/science.1138426; Sehadova H, 2009, NEURON, V64, P251, DOI 10.1016/j.neuron.2009.08.026; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Sidote D, 1998, MOL CELL BIOL, V18, P2004, DOI 10.1128/MCB.18.4.2004; Simoni A, 2014, SCIENCE, V343, P525, DOI 10.1126/science.1245710; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 1997, EMBO J, V16, P5006, DOI 10.1093/emboj/16.16.5006; Sun YS, 2009, P NATL ACAD SCI USA, V106, P13606, DOI 10.1073/pnas.0906377106; Suri VP, 1998, NEURON, V21, P225, DOI 10.1016/S0896-6273(00)80529-2; Tang CHA, 2010, NEURON, V66, P378, DOI 10.1016/j.neuron.2010.04.015; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; Weaver D. R., 2013, FUNDAMENTAL NEUROSCI, P819; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106; Wolfgang W, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0959; Xu XD, 2007, PLANT CELL, V19, P3474, DOI 10.1105/tpc.106.046011; Yang ZH, 1998, NEURON, V21, P215, DOI 10.1016/S0896-6273(00)80528-0; Yao Z, 2014, SCIENCE, V343, P1516, DOI 10.1126/science.1251285; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshii T, 2010, J BIOL RHYTHM, V25, P387, DOI 10.1177/0748730410381962; Yoshii T, 2009, J BIOL RHYTHM, V24, P452, DOI 10.1177/0748730409348551; Zhang Y, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P513, DOI 10.1016/B978-0-12-384747-8.10015-7; Zhao S, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-193	72	13	15	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1214	1224		10.1016/j.cell.2015.10.031	http://dx.doi.org/10.1016/j.cell.2015.10.031			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26590423	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000366044700019
J	Padhi, S; Kemmis-Betty, S; Rajesh, S; Hill, J; Murphy, MF				Padhi, Smita; Kemmis-Betty, Sophia; Rajesh, Sharangini; Hill, Jennifer; Murphy, Michael F.		Guideline Dev Grp	GUIDELINES Blood transfusion: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Padhi, Smita; Kemmis-Betty, Sophia; Rajesh, Sharangini; Hill, Jennifer] Natl Clin Guideline Ctr, London, England; [Murphy, Michael F.] Univ Oxford, NHS Blood & Transplant, Oxford Univ Hosp NHS Fdn Trust, Oxford OX1 2JD, England	Oxford University Hospitals NHS Foundation Trust; University of Oxford	Murphy, MF (corresponding author), Natl Clin Guideline Ctr, London, England.	mike.murphy@nhsbt.nhs.uk		Wonderling, David/0000-0003-0315-6273				Goodnough LT, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6897; Murphy MF, 2014, 2013 NATL PATIENT BL; National Institute for Health and Care Excellence, 2009, MED ADH INV PAT DEC; National Institute for Health and Care Excellence, 2015, BLOOD TRANSF NICE GU; National Institute for Health and Care Excellence, 2011, AN MAN CHRON KIDN DI; National Institute for Health and Care Excellence, 2008, STROK TRANS ISCH ATT; National Institute for Health and Care Excellence, 2012, AC UPP GASTR BLEED 1; National Institute for Health and Care Excellence, 2012, PAT EXP AD NHS SERV; NHS Blood and Transplant, 2013, NAT COMP AUD BLOOD T; NHS Blood and Transplant, 2013, PAT INF LEAFL WILL I	10	79	79	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2015	351								h5832	10.1136/bmj.h5832	http://dx.doi.org/10.1136/bmj.h5832			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XX	26581483				2022-12-28	WOS:000365352600003
J	Hebert, SA; Molony, DA				Hebert, Sean A.; Molony, Donald A.			The CKD-EPI equation for eGFR predicted adverse outcomes after PCI better than other equations	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Hebert, Sean A.; Molony, Donald A.] Univ Texas Houston, Sch Med, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston	Hebert, SA (corresponding author), Univ Texas Houston, Sch Med, Houston, TX USA.							Afsar B, 2014, INT J NEPHROL, V2014, DOI 10.1155/2014/767424; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026	3	4	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					JC12	JC12		10.7326/ACPJC-2015-163-10-012	http://dx.doi.org/10.7326/ACPJC-2015-163-10-012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26571254				2022-12-28	WOS:000365746400013
J	White, RH				White, Richard H.			Review: In older patients with AF or acute VTE, some DOACs reduce thrombotic events and major bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[White, Richard H.] Univ Calif Davis, Davis, CA 95616 USA	University of California System; University of California Davis	White, RH (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.							Cutler TW, 2014, J MANAG CARE SPEC PH, V20, P1028, DOI 10.18553/jmcp.2014.20.10.1028; Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					JC4	JC4		10.7326/ACPJC-2015-163-10-004	http://dx.doi.org/10.7326/ACPJC-2015-163-10-004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26571258	Green Submitted			2022-12-28	WOS:000365746400005
J	Hippisley-Cox, J; Coupland, C				Hippisley-Cox, Julia; Coupland, Carol			Development and validation of risk prediction equations to estimate future risk of blindness and lower limb amputation in patients with diabetes: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOWER-EXTREMITY AMPUTATION; EXTERNAL VALIDATION; MICROVASCULAR COMPLICATIONS; PROSPECTIVE DERIVATION; CARDIOVASCULAR RISK; 10-YEAR RISK; PRIMARY-CARE; MISSING DATA; TYPE-2; MODEL	STUDY QUESTION Is it possible to develop and externally validate risk prediction equations to estimate the 10 year risk of blindness and lower limb amputation in patients with diabetes aged 25-84 years? METHODS This was a prospective cohort study using routinely collected data from general practices in England contributing to the QResearch and Clinical Practice Research Datalink (CPRD) databases during the study period 1998-2014. The equations were developed using 763 QResearch practices (n=454 575 patients with diabetes) and validated in 254 different QResearch practices (n=142 419) and 357 CPRD practices (n=206 050). Cox proportional hazards models were used to derive separate risk equations for blindness and amputation in men and women that could be evaluated at 10 years. Measures of calibration and discrimination were calculated in the two validation cohorts. STUDY ANSWER AND LIMITATIONS Risk prediction equations to quantify absolute risk of blindness and amputation in men and women with diabetes have been developed and externally validated. In the QResearch derivation cohort, 4822 new cases of lower limb amputation and 8063 new cases of blindness occurred during follow-up. The risk equations were well calibrated in both validation cohorts. Discrimination was good in men in the external CPRD cohort for amputation (D statistic 1.69, Harrell's C statistic 0.77) and blindness (D statistic 1.40, Harrell's C statistic 0.73), with similar results in women and in the QResearch validation cohort. The algorithms are based on variables that patients are likely to know or that are routinely recorded in general practice computer systems. They can be used to identify patients at high risk for prevention or further assessment. Limitations include lack of formally adjudicated outcomes, information bias, and missing data. WHAT THIS STUDY ADDS Patients with type 1 or type 2 diabetes are at increased risk of blindness and amputation but generally do not have accurate assessments of the magnitude of their individual risks. The new algorithms calculate the absolute risk of developing these complications over a 10 year period in patients with diabetes, taking account of their individual risk factors. FUNDING, COMPETING INTERESTS, DATA SHARING JH-C is co-director of QResearch, a not for profit organisation which is a joint partnership between the University of Nottingham and Egton Medical Information Systems, and is also a paid director of ClinRisk Ltd. CC is a paid consultant statistician for ClinRisk Ltd.	[Hippisley-Cox, Julia; Coupland, Carol] Univ Nottingham, Div Primary Care, Nottingham NG2 7RD, England	University of Nottingham	Hippisley-Cox, J (corresponding author), Univ Nottingham, Div Primary Care, Nottingham NG2 7RD, England.	Julia.hippisley-cox@nottingham.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Coupland, Carol/0000-0002-2327-3306				Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Aiello LP, 2015, NEW ENGL J MED, V372, P1722, DOI 10.1056/NEJMoa1409463; [Anonymous], OPCS 4 CLASS; [Anonymous], 2010, DRUGS THERAPEUTICS B; Bachmann MO, 1998, J EPIDEMIOL COMMUN H, V52, P45, DOI 10.1136/jech.52.1.45; Barth JH, 2008, DIABETIC MED, V25, P381, DOI 10.1111/j.1464-5491.2008.02436.x; Clarke P, 2002, MED DECIS MAKING, V22, P340, DOI 10.1177/027298902400448902; Collins GS, 2011, DIABETIC MED, V28, P599, DOI 10.1111/j.1464-5491.2011.03237.x; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4181; Foos V, 2012, VALUE HEALTH, V15, pA470, DOI 10.1016/j.jval.2012.08.1521; GAVARD JA, 1993, DIABETES CARE, V16, P1167, DOI 10.2337/diacare.16.8.1167; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Health and Social Care Information Centre, 2015, QUAL OUTC FRAM; Health and Social Care Information Centre, 2014, 2 HSCIC, P37; Hippisley-Cox J, 2004, LANCET, V364, P423, DOI 10.1016/S0140-6736(04)16765-2; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2573; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b880; Hippisley-Cox J, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-49; Hosmer D, 2007, APPL SURVIVAL ANAL R; KLEIN R, 1995, DIABETES CARE, V18, P258, DOI 10.2337/diacare.18.2.258; Leggetter S, 2002, ARCH INTERN MED, V162, P73, DOI 10.1001/archinte.162.1.73; Majeed Azeem, 2004, Health Stat Q, P5; Meltzer D, 2000, Eff Clin Pract, V3, P7; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Moss SE, 1999, DIABETES CARE, V22, P951, DOI 10.2337/diacare.22.6.951; Mueller E, 2006, DIABETES TECHNOL THE, V8, P219, DOI 10.1089/dia.2006.8.219; National Clinical Guideline Centre, 2014, LIP MOD CARD RISK AS, P286; Palmer AJ, 2004, CURR MED RES OPIN, V20, pS5, DOI 10.1185/030079904X1980; Patout CA, 2000, DIABETES CARE, V23, P1339, DOI 10.2337/diacare.23.9.1339; Resnick HE, 1999, ARCH INTERN MED, V159, P2470, DOI 10.1001/archinte.159.20.2470; Rith-Najarian S, 1998, J FAM PRACTICE, V47, P127; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Rubin DB, 1987, MULTIPLE IMPUTATION; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Steyerberg EW, 2007, J CLIN EPIDEMIOL, V60, P979, DOI 10.1016/j.jclinepi.2007.03.003; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Waugh N, 2007, HEALTH TECHNOL ASSES, V11, P1; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Zhao WH, 2013, DIABETES CARE, V36, P3591, DOI 10.2337/dc13-0437	48	35	35	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2015	351								h5441	10.1136/bmj.h5441	http://dx.doi.org/10.1136/bmj.h5441			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW4FX	26560308	hybrid, Green Published			2022-12-28	WOS:000364947900001
J	Costeloe, K; Hardy, P; Juszczak, E; Wilks, M; Millar, MR				Costeloe, Kate; Hardy, Pollyanna; Juszczak, Edmund; Wilks, Mark; Millar, Michael R.		Probiotics Preterm Infants Study	Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial	LANCET			English	Article							PREVENT NECROTIZING ENTEROCOLITIS; BACTERIAL-COLONIZATION; UPDATED METAANALYSIS; PROBIOTICS REDUCE; LONGUM BACTEREMIA; MORTALITY; STRAINS; SEPSIS	Background Probiotics may reduce necrotising enterocolitis and late-onset sepsis after preterm birth. However, there has been concern about the rigour and generalisability of some trials and there is no agreement about whether or not they should be used routinely. We aimed to test the effectiveness of the probiotic Bifidobacterium breve BBG-001 to reduce necrotising enterocolitis, late-onset sepsis, and death in preterm infants. Methods In this multicentre, randomised controlled phase 3 study (the PiPS trial), we recruited infants born between 23 and 30 weeks' gestational age within 48 h of birth from 24 hospitals in southeast England. Infants were randomly assigned (1: 1) to probiotic or placebo via a minimisation algorithm randomisation programme. The probiotic intervention was B breve BBG-001 suspended in dilute elemental infant formula given enterally in a daily dose of 8.2 to 9.2 log(10) CFU; the placebo was dilute infant formula alone. Clinicians and families were masked to allocation. The primary outcomes were necrotising enterocolitis (Bell stage 2 or 3), blood culture positive sepsis more than 72 h after birth; and death before discharge from hospital. All primary analyses were by intention to treat. This trial is registered with ISRCTN, number 05511098 and EudraCT, number 2006-003445-17. Findings Between July 1, 2010, and July 31, 2013, 1315 infants were recruited; of whom 654 were allocated to probiotic and 661 to placebo. Five infants had consent withdrawn after randomisation, thus 650 were analysed in the probiotic group and 660 in the placebo group. Rates of the primary outcomes did not differ significantly between the probiotic and placebo groups. 61 infants (9%) in the probiotic group had necrotising enterocolitis compared with 66 (10%) in the placebo group (adjusted risk ratio 0.93 (95% CI 0.68-1.27); 73 (11%) infants in the probiotics group had sepsis compared with 77 (12%) in the placebo group (0.97 (0.73-1.29); and 54 (8%) deaths occurred before discharge home in the probiotic group compared with 56 (9%) in the placebo group (0.93 [0.67-1.30]). No probiotic-associated adverse events were reported. Interpretation There is no evidence of benefit for this intervention in this population; this result does not support the routine use of B breve BBG-001 for prevention of necrotising enterocolitis and late-onset sepis in very preterm infants.	[Costeloe, Kate] Barts & London Queen Marys Sch Med & Dent, Blizard Inst, Ctr Paediat, London, England; [Hardy, Pollyanna; Juszczak, Edmund] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England; [Wilks, Mark; Millar, Michael R.] Barts Hlth NHS Trust, Royal London Hosp, London E1 1BB, England	University of London; Queen Mary University London; University of Oxford; Barts Health NHS Trust; Royal London Hospital	Costeloe, K (corresponding author), Homerton Univ Hosp, Neonatal Unit, London E9 6SR, England.	k.l.costeloe@qmul.ac.uk		Satta, Giovanni/0000-0002-0120-7885; Fernandez, Ramon/0000-0003-3303-8155	UK National Institute for Health Research Health Technology Assessment programme [05/501/04]	UK National Institute for Health Research Health Technology Assessment programme(National Institute for Health Research (NIHR))	UK National Institute for Health Research Health Technology Assessment programme.; This study was funded by the UK National Institute for Health Research Health Technology Assessment programme, project number 05/501/04. The interventions for this trial were provided without charge by Yakult Honsha Co Ltd (Tokyo, Japan), until the point of entry to the UK. The manufacturer had no role in the design of the trial, the analysis and interpretation of the results, or preparation of this report. We thank all the families who participated in this trial and all the staff in collaborating hospitals.	Adams-Chapman I, 2012, SEMIN PERINATOL, V36, P462, DOI 10.1053/j.semperi.2012.06.009; Alfaleh K, 2014, COCHRANE DB SYST REV, V3; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Berrington JE, 2012, J PEDIATR-US, V160, P49, DOI 10.1016/j.jpeds.2011.06.046; Bertelli C, 2015, CLIN INFECT DIS, V60, P924, DOI 10.1093/cid/ciu946; Bin-Nun A, 2005, J PEDIATR-US, V147, P192, DOI 10.1016/j.jpeds.2005.03.054; Chrzanowska-Liszewska D, 2012, EARLY HUM DEV, V88, P57, DOI 10.1016/j.earlhumdev.2011.07.002; Cilieborg MS, 2012, EARLY HUM DEV, V88, pS41, DOI 10.1016/j.earlhumdev.2011.12.027; Claud EC, 2008, J CLIN GASTROENTEROL, V42, pS46, DOI 10.1097/MCG.0b013e31815a57a8; Deshpande G, 2010, PEDIATRICS, V125, P921, DOI 10.1542/peds.2009-1301; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Fujimoto J, 2011, J APPL MICROBIOL, V110, P209, DOI 10.1111/j.1365-2672.2010.04873.x; Gibson MK, 2014, J MOL BIOL, V426, P3866, DOI 10.1016/j.jmb.2014.05.029; Jacobs SE, 2013, PEDIATRICS, V132, P1055, DOI 10.1542/peds.2013-1339; Jacobsen CN, 1999, APPL ENVIRON MICROB, V65, P4949; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kitajima H, 1997, ARCH DIS CHILD-FETAL, V76, pF101, DOI 10.1136/fn.76.2.F101; Lin HC, 2005, PEDIATRICS, V115, P1, DOI 10.1542/peds.2004-1463; Lin HC, 2008, PEDIATRICS, V122, P693, DOI 10.1542/peds.2007-3007; Medicines and Healthcare products Regulatory Agency, 2012, 8 MHRA; Mihatsch WA, 2012, CLIN NUTR, V31, P6, DOI 10.1016/j.clnu.2011.09.004; Motherway MO, 2011, P NATL ACAD SCI USA, V108, P11217, DOI 10.1073/pnas.1105380108; Ohland CL, 2010, AM J PHYSIOL-GASTR L, V298, pG807, DOI 10.1152/ajpgi.00243.2009; Samanta M, 2009, J TROP PEDIATRICS, V55, P128, DOI 10.1093/tropej/fmn091; Sherman MP, 2010, CLIN PERINATOL, V37, P565, DOI 10.1016/j.clp.2010.05.006; Soll RF, 2010, PEDIATRICS, V125, P1071, DOI 10.1542/peds.2010-0643; StataCorp, 2013, STAT STAT SOFTW REL; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Tarnow-Mordi WO, 2010, PEDIATRICS, V125, P1068, DOI 10.1542/peds.2009-2151; Torrazza RM, 2014, PLOS ONE, V8; Underwood MA, 2013, J PEDIATR-US, V163, P1585, DOI 10.1016/j.jpeds.2013.07.017; US Centers for Disease Control and Prevention, 2014, FAT GASTR MUC INF FO; Ventura M, 2012, TRENDS MICROBIOL, V20, P467, DOI 10.1016/j.tim.2012.07.002; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; Wang QZ, 2012, J PEDIATR SURG, V47, P241, DOI 10.1016/j.jpedsurg.2011.09.064; Zbinden A, 2015, NEONATOLOGY, V107, P56, DOI 10.1159/000367985	36	224	238	3	48	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2016	387	10019					649	660		10.1016/S0140-6736(15)01027-2	http://dx.doi.org/10.1016/S0140-6736(15)01027-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3QH	26628328				2022-12-28	WOS:000369837100024
J	Brunstrom, M; Carlberg, B				Brunstrom, Mattias; Carlberg, Bo			Lower blood pressure targets: to whom do they apply?	LANCET			English	Editorial Material									[Brunstrom, Mattias; Carlberg, Bo] Umea Univ, Dept Publ Hlth & Clin Med, Div Med, SE-90185 Umea, Sweden	Umea University	Carlberg, B (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Div Med, SE-90185 Umea, Sweden.	bo.carlberg@umu.se	Brunström, Mattias/AAB-2512-2021	Brunström, Mattias/0000-0002-7054-0905				[Anonymous], 2015, DIABETES CARE, V38, pS49, DOI 10.2337/dc15-S011; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Thomopoulos C, 2014, J HYPERTENS, V32, P2296, DOI 10.1097/HJH.0000000000000379; US National Heart Lung and Blood Institute, 2015, LANDM NIH STUD SHOWS; Xie X, 2015, LANCET	9	13	13	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 30	2016	387	10017					405	406		10.1016/S0140-6736(15)00816-8	http://dx.doi.org/10.1016/S0140-6736(15)00816-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC1OX	26559745	Green Submitted			2022-12-28	WOS:000368986800004
J	Choudhry, NK; Denberg, TD; Qaseem, A				Choudhry, Niteesh K.; Denberg, Thomas D.; Qaseem, Amir		Amer Coll Phys	Improving Adherence to Therapy and Clinical Outcomes While Containing Costs: Opportunities From the Greater Use of Generic Medications: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							BRAND-NAME DRUGS; CARDIOVASCULAR MEDICATIONS; MEDICARE BENEFICIARIES; ECONOMIC CONSEQUENCES; ANTIEPILEPTIC DRUGS; DECISION-SUPPORT; PILL APPEARANCE; SUBSTITUTION; IMPACT; QUALITY	Description: The discrepancy between health care spending and achieved outcomes in the United States has fueled efforts to identify and address situations where unnecessarily expensive therapies are used when less costly, equally effective options are available. The underuse of generic medications is an important example. Methods: A literature review was conducted to answer 5 questions about generic medications: 1) How commonly are brand-name medications used when a generic version is available? 2) How does the use of generic medications influence adherence? 3) What is the evidence that brand-name and generic medications have similar clinical effects? 4) What are the barriers to increasing the use of generic medications? 5) What strategies can be used to promote cost savings through greater generic medication use? This article was reviewed and approved by the American College of Physicians Clinical Guidelines Committee. Best Practice Advice: Clinicians should prescribe generic medications, if possible, rather than more expensive brand-name medications.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Caril Clin, Roanoke, VA USA; [Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; American College of Physicians	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org			ACP	ACP	Financial support for the development of this paper comes from the ACP operating budget.	Austvoll-Dahlgren A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007017; Banahan BF, 1997, ARCH INTERN MED, V157, P2080, DOI 10.1001/archinte.157.18.2080; Berkowitz SA, 2014, JAMA INTERN MED, V174, P1955, DOI 10.1001/jamainternmed.2014.5294; Bhargava V, 2010, J MANAGE CARE PHARM, V16, P384, DOI 10.18553/jmcp.2010.16.6.384; Brennan TA, 2004, ANN INTERN MED, V141, P126, DOI 10.7326/0003-4819-141-2-200407200-00011; Briesacher BA, 2009, AM J MANAG CARE, V15, P450; Brill A, 2011, OVERSPENDING MULTISO; Campbell EG, 2007, NEW ENGL J MED, V357, P1796, DOI 10.1056/NEJMp078141; Campbell EG, 2013, JAMA INTERN MED, V173, P237, DOI 10.1001/jamainternmed.2013.1539; Centers for Medicare & Medicaid Services, 2015, 5 STAR QU RAT SYST; Choudhry NK, 2008, AM HEART J, V155, P904, DOI 10.1016/j.ahj.2007.11.039; Choudhry NK, 2010, AM J PHARM BENEFIST, V2, P33; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Cox E, 2005, GENERIC DRUG USAGE R; Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867; Dentali F, 2011, PHARMACOTHERAPY, V31, P386, DOI 10.1592/phco.31.4.386; Desai NR, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.07.033; Digiuni M, 2013, J GLAUCOMA, V22, P707, DOI 10.1097/IJG.0b013e318259b47c; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Easthall C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002749; Eban K, 2013, DIRTY MED; Federman AD, 2007, MED CARE, V45, P109, DOI 10.1097/01.mlr.0000250293.24939.2e; Fein AJ, 2014, DRUG CHANNELS   0812; Fischer MA, 2004, JAMA-J AM MED ASSOC, V291, P1850, DOI 10.1001/jama.291.15.1850; Fischer MA, 2003, HEALTH SERV RES, V38, P1051, DOI 10.1111/1475-6773.00162; Fischer MA, 2008, ARCH INTERN MED, V168, P2433, DOI 10.1001/archinte.168.22.2433; Frisk P, 2011, J PHARM HEALTH SERV, V2, P9, DOI 10.1111/j.1759-8893.2011.00036.x; Gagne JJ, 2014, ANN INTERN MED, V161, P400, DOI 10.7326/M13-2942; Gartlehner G, 2006, DRUG CLASS REV 2 GEN; Gellad WF, 2013, ANN INTERN MED, V159, P105, DOI 10.7326/0003-4819-159-2-201307160-00664; Golan S, 2015, CLIN EXP PHARMACOL P, V42, P220, DOI 10.1111/1440-1681.12329; Goldman DP, 2007, JAMA-J AM MED ASSOC, V298, P61, DOI 10.1001/jama.298.1.61; Grant RW, 2011, DIABETES EDUCATOR, V37, P78, DOI 10.1177/0145721710388427; Haas JS, 2005, ANN INTERN MED, V142, P891, DOI 10.7326/0003-4819-142-11-200506070-00006; Hashemi M, 2012, IRAN J OPHTHALMOL, V24, P11; Helfand C, 2013, TOP 10 GENERICS MAKE; Holahan J, 2012, COST COVERAGE IMPLIC; Holmes DR, 2011, CIRCULATION, V124, P1290, DOI 10.1161/CIR.0b013e31822d97d5; Huang ES, 2007, DIABETES CARE, V30, P2478, DOI 10.2337/dc07-0499; Huskamp HA, 2003, NEW ENGL J MED, V349, P2224, DOI 10.1056/NEJMsa030954; IMS Institute for Healthcare Informatics, 2013, DECL MED US COST BET; Ip S, 2005, AHRQ PUBLICATION, V05-E020-2; Kelton CML, 2013, HEALTH AFFAIR, V32, P1204, DOI 10.1377/hlthaff.2013.0161; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Kesselheim AS, 2014, ANN INTERN MED, V161, P96, DOI 10.7326/M13-2381; Kesselheim AS, 2013, JAMA INTERN MED, V173, P202, DOI 10.1001/2013.jamainternmed.997; Kesselheim AS, 2010, DRUGS, V70, P605, DOI 10.2165/10898530-000000000-00000; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Mott DA, 2002, MED CARE, V40, P662, DOI 10.1097/00005650-200208000-00006; Mottram P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003491.pub2; Narayanaswamy Arun, 2007, Indian Journal of Ophthalmology, V55, P127; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; O'Malley AJ, 2006, HEALTH SERV RES, V41, P1876, DOI 10.1111/j.1475-6773.2006.00579.x; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Qaseem A, 2008, ANN INTERN MED, V149, P725, DOI 10.7326/0003-4819-149-10-200811180-00007; Rathe J, 2013, EUR J CLIN PHARMACOL, V69, P1827, DOI 10.1007/s00228-013-1539-z; Rector TS, 2003, MED CARE, V41, P398, DOI 10.1097/00005650-200303000-00008; Roebuck MC, 2011, HEALTH AFFAIR, V30, P91, DOI 10.1377/hlthaff.2009.1087; Rogers T, 2014, JAMA-J AM MED ASSOC, V311, P2065, DOI 10.1001/jama.2014.3485; Rosenthal E, 2014, NY TIMES, pB9; Sanfelix-Gimeno G, 2014, MED CARE, V52, P669, DOI 10.1097/MLR.0000000000000148; Scott AB, 2007, J MANAGE CARE PHARM, V13, P412, DOI 10.18553/jmcp.2007.13.5.412; Sedjo RL, 2008, AM J MANAG CARE, V14, P813; Shrank WH, 2006, ARCH INTERN MED, V166, P332, DOI 10.1001/archinte.166.3.332; Shrank WH, 2011, AM J MED, V124, P309, DOI 10.1016/j.amjmed.2010.11.020; Shrank WH, 2011, ANN PHARMACOTHER, V45, P31, DOI 10.1345/aph.1P389; Shrank WH, 2010, ANN INTERN MED, V153, P633, DOI 10.7326/0003-4819-153-10-201011160-00005; Shrank WH, 2010, HEALTH AFFAIR, V29, P1383, DOI 10.1377/hlthaff.2009.0424; Shrank WH, 2009, HEALTH AFFAIR, V28, P546, DOI 10.1377/hlthaff.28.2.546; Shrank WH, 2009, AM HEART J, V157, P613, DOI 10.1016/j.ahj.2008.12.006; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af; Steinman MA, 2007, J GEN INTERN MED, V22, P645, DOI 10.1007/s11606-006-0074-3; Stenner SP, 2010, J AM MED INFORM ASSN, V17, P681, DOI 10.1136/jamia.2009.002568; Stewart WC, 2002, CURR EYE RES, V24, P387, DOI 10.1076/ceyr.24.5.387.8516; STROM BL, 1987, NEW ENGL J MED, V316, P1456, DOI 10.1056/NEJM198706043162306; Stuart BC, 2009, DIABETES CARE, V32, P647, DOI 10.2337/dc08-1311; Taira DA, 2006, AM J MANAG CARE, V12, P678; Thakurta S, 2009, DRUG CLASS REV PROTO; U.S. Department of Health and Human Services, 2010, EXP US GEN DRUG; U.S. Food and Drug Administration, 2014, UPD BUPR HYDR EXT RE; U.S. Food and Drug Administration, 2015, REV THER EQ GEN BUPR; U.S. Food and Drug Administration, 2008, THYR MED Q A MARY PR; U.S. Food and Drug Administration, 2014, OR BOOK APPR DRUG PR; Waber RL, 2008, JAMA-J AM MED ASSOC, V299, P1016, DOI 10.1001/jama.299.9.1016; Wang B, 2012, ARCH INTERN MED, V172, P1109, DOI 10.1001/archinternmed.2012.2013; Yong PL, 2010, HEALTHCARE IMPERATIV	86	55	56	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 5	2016	164	1					41	+		10.7326/M14-2427	http://dx.doi.org/10.7326/M14-2427			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA4WC	26594818				2022-12-28	WOS:000367801700009
J	Lafont, A; Yang, Y				Lafont, Antoine; Yang, Yi			Magnesium stent scaffolds: DREAMS become reality	LANCET			English	Editorial Material							CORONARY; ANGIOPLASTY; MULTICENTER		[Lafont, Antoine] Univ Paris 05, Paris, France; [Lafont, Antoine] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Dept Cardiol, F-75908 Paris 15, France; [Lafont, Antoine] Ecole Polytech, Hydrodynam Lab LadHyX, CNRS UMR7646, Palaiseau, France; [Yang, Yi] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Shanghai 200030, Peoples R China	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut Polytechnique de Paris; Shanghai Jiao Tong University	Lafont, A (corresponding author), Univ Paris 05, Paris, France.	antoine.lafont@inserm.fr						Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8; Haude M, 2015, LANCET; Haude M, 2013, LANCET, V381, P836, DOI 10.1016/S0140-6736(12)61765-6; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; LAFONT A, 1995, CIRC RES, V76, P996, DOI 10.1161/01.RES.76.6.996; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Ormiston JA, 1997, CIRCULATION, V96, P468; Ormiston JA, 2008, LANCET, V371, P899, DOI 10.1016/S0140-6736(08)60415-8; Serruys PW, 2015, LANCET, V385, P43, DOI 10.1016/S0140-6736(14)61455-0; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Wittchow E, 2013, EUROINTERVENTION, V8, P1441, DOI 10.4244/EIJV8I12A218	11	13	13	2	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2016	387	10013					3	4		10.1016/S0140-6736(15)00804-1	http://dx.doi.org/10.1016/S0140-6736(15)00804-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ9ZU	26560250				2022-12-28	WOS:000367457300004
J	Lu, JM; Zheliuk, O; Leermakers, I; Yuan, NFQ; Zeitler, U; Law, KT; Ye, JT				Lu, J. M.; Zheliuk, O.; Leermakers, I.; Yuan, N. F. Q.; Zeitler, U.; Law, K. T.; Ye, J. T.			Evidence for two-dimensional Ising superconductivity in gated MoS2	SCIENCE			English	Article							UPPER CRITICAL-FIELD; PARAMAGNETIC LIMIT; TRANSITIONS; BEHAVIOR	The Zeeman effect, which is usually detrimental to superconductivity, can be strongly protective when an effective Zeeman field from intrinsic spin-orbit coupling locks the spins of Cooper pairs in a direction orthogonal to an external magnetic field. We performed magnetotransport experiments with ionic-gated molybdenum disulfide transistors, in which gating prepared individual superconducting states with different carrier dopings, and measured an in-plane critical field B-c2 far beyond the Pauli paramagnetic limit, consistent with Zeeman-protected superconductivity. The gating-enhanced B-c2 is more than an order of magnitude larger than it is in the bulk superconducting phases, where the effective Zeeman field is weakened by interlayer coupling. Our study provides experimental evidence of an Ising superconductor, in which spins of the pairing electrons are strongly pinned by an effective Zeeman field.	[Lu, J. M.; Zheliuk, O.; Ye, J. T.] Univ Groningen, Zernike Inst Adv Mat, Device Phys Complex Mat, NL-9747 AG Groningen, Netherlands; [Leermakers, I.; Zeitler, U.] Radboud Univ Nijmegen, HFML, EMFL, NL-6525 ED Nijmegen, Netherlands; [Leermakers, I.; Zeitler, U.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands; [Yuan, N. F. Q.; Law, K. T.] Hong Kong Univ Sci & Technol, Dept Phys, Hong Kong, Hong Kong, Peoples R China	University of Groningen; Radboud University Nijmegen; Radboud University Nijmegen; Hong Kong University of Science & Technology	Ye, JT (corresponding author), Univ Groningen, Zernike Inst Adv Mat, Device Phys Complex Mat, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	j.ye@rug.nl	Institute, Zernike/W-7033-2019; Ye, Jianting/K-8194-2012; Zeitler, Uli/P-5607-2019; Zeitler, Uli/D-4344-2012	Zeitler, Uli/0000-0002-5293-2673; Law, Kam Tuen/0000-0003-0501-6290	High Field Magnet Laboratory Nijmegen (HFML-RU/FOM) of the European Magnetic Field Laboratory; European Research Council [648855 Ig-QPD]; DESCO program (2-Dimensional Electron Systems in Complex Oxides) of the Foundation for Fundamental Research on Matter part of the Netherlands Organization for Scientific Research [149]; Hong Kong Research Grants Council; Croucher Foundation [HKUST3/CRF/13G, 602813, 605512, 16303014]; Innovation Grant	High Field Magnet Laboratory Nijmegen (HFML-RU/FOM) of the European Magnetic Field Laboratory; European Research Council(European Research Council (ERC)European Commission); DESCO program (2-Dimensional Electron Systems in Complex Oxides) of the Foundation for Fundamental Research on Matter part of the Netherlands Organization for Scientific Research; Hong Kong Research Grants Council(Hong Kong Research Grants Council); Croucher Foundation; Innovation Grant	We acknowledge support from the High Field Magnet Laboratory Nijmegen (HFML-RU/FOM), a member of the European Magnetic Field Laboratory. J.T.Y. acknowledges funding from the European Research Council (consolidator grant no. 648855 Ig-QPD). U.Z. was supported by the DESCO program (2-Dimensional Electron Systems in Complex Oxides, program no. 149) of the Foundation for Fundamental Research on Matter, which is part of the Netherlands Organization for Scientific Research. K.T.L. and N.F.Q.Y. were supported by the Hong Kong Research Grants Council and the Croucher Foundation through grants HKUST3/CRF/13G, 602813, 605512, and 16303014 and an Innovation Grant.	ABRIKOSOV AA, 1962, SOV PHYS JETP-USSR, V15, P752; Aoki D, 2001, NATURE, V413, P613, DOI 10.1038/35098048; Aoki D, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.011003; BULAEVSKII LN, 1976, SOV PHYS JETP, V44, P1243; Chaikin PM, 1998, J PHYS-CONDENS MAT, V10, P11301, DOI 10.1088/0953-8984/10/49/019; COLEMAN RV, 1983, PHYS REV B, V27, P125, DOI 10.1103/PhysRevB.27.125; Eknapakul T, 2014, NANO LETT, V14, P1312, DOI 10.1021/nl4042824; FONER S, 1973, PHYS LETT A, VA 45, P429, DOI 10.1016/0375-9601(73)90693-2; Ge YZ, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.241408; Gor'kov LP, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.037004; Huy NT, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.067006; Kacmarcik J, 2008, PHYSICA C, V468, P543, DOI 10.1016/j.physc.2007.11.062; KASHIHARA Y, 1979, J PHYS SOC JPN, V46, P1112, DOI 10.1143/JPSJ.46.1112; Klemm R. A., 2011, INT SERIES MONOGRAPH, V153; KLEMM RA, 1975, PHYS REV B, V12, P877, DOI 10.1103/PhysRevB.12.877; Klemm RA, 2015, PHYSICA C, V514, P86, DOI 10.1016/j.physc.2015.02.023; Kormanyos A, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.045416; Lee IJ, 1997, PHYS REV LETT, V78, P3555, DOI 10.1103/PhysRevLett.78.3555; Lee IJ, 2000, PHYS REV B, V62, P14669, DOI 10.1103/PhysRevB.62.R14669; LYUBOVSKAYA RN, 1990, JETP LETT+, V51, P361; Matsuda Y, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.051005; MORRIS RC, 1973, PHYS REV B, V7, P991, DOI 10.1103/PhysRevB.7.991; Onuki Y., 2012, WEAK VS STRONG SUSTA, P81; PROBER DE, 1980, PHYS REV B, V21, P2717, DOI 10.1103/PhysRevB.21.2717; Reyren N, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3100777; Rosner M, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.245105; Roldan R, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.054515; Samuely P, 2002, PHYSICA C, V369, P61, DOI 10.1016/S0921-4534(01)01221-7; Shi W, 2015, SCI REP-UK, V5, DOI 10.1038/srep12534; STEWART GR, 1984, REV MOD PHYS, V56, P755, DOI 10.1103/RevModPhys.56.755; Taniguchi K, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4740268; TEDROW PM, 1982, PHYS REV B, V25, P171, DOI 10.1103/PhysRevB.25.171; TINKHAM M, 1963, PHYS REV, V129, P2413, DOI 10.1103/PhysRev.129.2413; Tinkham M., 1996, INTRO SUPERCONDUCTIV, V2nd ed.; Ueno K, 2008, NAT MATER, V7, P855, DOI 10.1038/nmat2298; Ueno K, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.020508; Ueno K, 2011, NAT NANOTECHNOL, V6, P408, DOI [10.1038/nnano.2011.78, 10.1038/NNANO.2011.78]; Wang L, 2014, PHYS LETT A, V378, P1336, DOI 10.1016/j.physleta.2014.03.026; WOOLLAM JA, 1976, PHYS REV B, V13, P3843, DOI 10.1103/PhysRevB.13.3843; Wu XS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127002; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Ye JT, 2012, SCIENCE, V338, P1193, DOI 10.1126/science.1228006; Ye JT, 2010, NAT MATER, V9, P125, DOI [10.1038/NMAT2587, 10.1038/nmat2587]; Ye JT, 2011, P NATL ACAD SCI USA, V108, P13002, DOI 10.1073/pnas.1018388108; Yuan HT, 2013, NAT PHYS, V9, P563, DOI [10.1038/NPHYS2691, 10.1038/nphys2691]; Yuan HT, 2009, ADV FUNCT MATER, V19, P1046, DOI 10.1002/adfm.200801633; Yuan NFQ, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.097001; Zhang Y, 2014, NAT NANOTECHNOL, V9, P111, DOI [10.1038/NNANO.2013.277, 10.1038/nnano.2013.277]; Zhu ZY, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.153402	51	498	503	25	522	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1353	1357		10.1126/science.aab2277	http://dx.doi.org/10.1126/science.aab2277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26563134	Green Submitted			2022-12-28	WOS:000366162400037
J	Blake, PR; McAuliffe, K; Corbit, J; Callaghan, TC; Barry, O; Bowie, A; Kleutsch, L; Kramer, KL; Ross, E; Vongsachang, H; Wrangham, R; Warneken, F				Blake, P. R.; McAuliffe, K.; Corbit, J.; Callaghan, T. C.; Barry, O.; Bowie, A.; Kleutsch, L.; Kramer, K. L.; Ross, E.; Vongsachang, H.; Wrangham, R.; Warneken, F.			The ontogeny of fairness in seven societies	NATURE			English	Article							BEHAVIOR; EGALITARIANISM; PUNISHMENT; CULTURE	A sense of fairness plays a critical role in supporting human cooperation(1-3). Adult norms of fair resource sharing vary widely across societies, suggesting that culture shapes the acquisition of fairness behaviour during childhood(4,5). Here we examine how fairness behaviour develops in children from seven diverse societies, testing children from 4 to 15 years of age (n = 866 pairs) in a standardized resource decision task(6,7). We measured two key aspects of fairness decisions: disadvantageous inequity aversion (peer receives more than self) and advantageous inequity aversion (self receives more than a peer). We show that disadvantageous inequity aversion emerged across all populations by middle childhood. By contrast, advantageous inequity aversion was more variable, emerging in three populations and only later in development. We discuss these findings in relation to questions about the universality and cultural specificity of human fairness.	[Blake, P. R.] Boston Univ, Dept Psychol & Brain Sci, Boston, MA 02215 USA; [McAuliffe, K.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [McAuliffe, K.] Boston Coll, Dept Psychol, Chestnut Hill, MA 02467 USA; [McAuliffe, K.; Bowie, A.; Ross, E.; Vongsachang, H.; Wrangham, R.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Corbit, J.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [Callaghan, T. C.] St Francis Xavier Univ, Fac Arts & Sci, Dept Psychol, Antigonish, NS B2G 2W5, Canada; [Barry, O.] Univ Cheikh Anta Diop, Fac Sci & Technol Educ & Training, Dakar, Senegal; [Bowie, A.; Kleutsch, L.; Vongsachang, H.; Warneken, F.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Kramer, K. L.] Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA	Boston University; Yale University; Boston College; Harvard University; Simon Fraser University; Saint Francis Xavier University - Canada; University Cheikh Anta Diop Dakar; Harvard University; Utah System of Higher Education; University of Utah	Blake, PR (corresponding author), Boston Univ, Dept Psychol & Brain Sci, Boston, MA 02215 USA.	pblake@bu.edu; mcaulikg@bc.edu	Blake, Peter/HGD-6519-2022; Kramer, Karen L/AAM-3022-2020; Barry, Oumar/K-6260-2019	Callaghan, Tara/0000-0002-7040-2449	Harvard Academy Junior Faculty Development Grant, Radcliffe Institute for Advanced Study; Herchel Smith Harvard Undergraduate Science Research Program; Harvard College Research Program; John Templeton Foundation; Harvard Department of Human Evolutionary Biology	Harvard Academy Junior Faculty Development Grant, Radcliffe Institute for Advanced Study; Herchel Smith Harvard Undergraduate Science Research Program; Harvard College Research Program; John Templeton Foundation; Harvard Department of Human Evolutionary Biology	We are grateful to the following people for their help with this research: participating children, families, communities and schools; research assistants who collected and coded data; Harvard IQSS; J. Greene; P. Harris and our funding sources (Harvard Academy Junior Faculty Development Grant, Radcliffe Institute for Advanced Study (F.W.); Herchel Smith Harvard Undergraduate Science Research Program (A.B.); Harvard College Research Program (H.V.); John Templeton Foundation (P.R.B.); Harvard Department of Human Evolutionary Biology (K.M.)).	Bahry DL, 2006, J ECON BEHAV ORGAN, V60, P37, DOI 10.1016/j.jebo.2004.07.005; Blake PR, 2014, TRENDS COGN SCI, V18, P559, DOI 10.1016/j.tics.2014.08.003; Blake PR, 2011, COGNITION, V120, P215, DOI 10.1016/j.cognition.2011.04.006; Brosnan SF, 2014, SCIENCE, V346, P314, DOI 10.1126/science.1251776; Chudek M, 2011, TRENDS COGN SCI, V15, P218, DOI 10.1016/j.tics.2011.03.003; Dawes CT, 2007, NATURE, V446, P794, DOI 10.1038/nature05651; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Fehr E, 2013, EUR ECON REV, V64, P369, DOI 10.1016/j.euroecorev.2013.09.006; Guroglu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107996; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; House BR, 2013, P NATL ACAD SCI USA, V110, P14586, DOI 10.1073/pnas.1221217110; Keller H, 2006, J CROSS CULT PSYCHOL, V37, P155, DOI 10.1177/0022022105284494; Leimgruber KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048292; LoBue V, 2011, SOC DEV, V20, P154, DOI 10.1111/j.1467-9507.2009.00560.x; LOEWENSTEIN GF, 1989, J PERS SOC PSYCHOL, V57, P426, DOI 10.1037/0022-3514.57.3.426; McAuliffe K, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0743; McAuliffe K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080966; Paulus M, 2015, J EXP CHILD PSYCHOL, V132, P240, DOI 10.1016/j.jecp.2014.12.007; Robbins E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00353; Rochat P, 2009, J CROSS CULT PSYCHOL, V40, P416, DOI 10.1177/0022022109332844; Schafer M, 2015, PSYCHOL SCI, V26, P1252, DOI 10.1177/0956797615586188; Shaw A, 2012, J EXP PSYCHOL GEN, V141, P382, DOI 10.1037/a0025907; Sheskin M, 2014, COGNITION, V130, P152, DOI 10.1016/j.cognition.2013.10.008; Smith CE, 2013, PLOS ONE, V8, DOI [10.1371/annotation/4b9340db-455b-4e0d-86e5-b6783747111f, 10.1371/journal.pone.0059510]; Sutter M, 2007, J ECON PSYCHOL, V28, P69, DOI 10.1016/j.joep.2006.09.001	31	215	222	21	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					258	+		10.1038/nature15703	http://dx.doi.org/10.1038/nature15703			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX9VH	26580018				2022-12-28	WOS:000366053300040
J	Larson, H				Larson, Heidi			The world must accept that the HPV vaccine is safe	NATURE			English	Editorial Material									[Larson, Heidi] London Sch Hyg & Trop Med, Vaccine Confidence Project, London, England; [Larson, Heidi] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Larson, H (corresponding author), London Sch Hyg & Trop Med, Vaccine Confidence Project, London, England.	heidi.larson@lshtm.ac.uk	Larson, Heidi J./N-1018-2017	Larson, Heidi J./0000-0002-8477-7583					0	17	17	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					9	9		10.1038/528009a	http://dx.doi.org/10.1038/528009a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX3NO	26632553	Bronze			2022-12-28	WOS:000365606000022
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Early cancer diagnosis: how low should we go?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DECISION AID					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Banks J, 2014, LANCET ONCOL, V15, P232, DOI 10.1016/S1470-2045(13)70588-6; Hamilton W, 2013, BRIT J GEN PRACT, V63, DOI 10.3399/bjgp13X660751; McCartney M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h735; Schonberg MA, 2014, JAMA INTERN MED, V174, P417, DOI 10.1001/jamainternmed.2013.13639; Smith SK, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5370	5	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2015	351								h6442	10.1136/bmj.h6442	http://dx.doi.org/10.1136/bmj.h6442			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX9EW	26620544	Bronze			2022-12-28	WOS:000366008800004
J	Dunn, CW				Dunn, Casey W.			GENOMICS Acorn worms in a nutshell	NATURE			English	Editorial Material							HEMICHORDATE		[Dunn, Casey W.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Brown University	Dunn, CW (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	casey_dunn@brown.edu		Dunn, Casey/0000-0003-0628-5150				Cannon JT, 2014, CURR BIOL, V24, P2827, DOI 10.1016/j.cub.2014.10.016; Dunn CW, 2015, CURR OPIN GENET DEV, V35, P25, DOI 10.1016/j.gde.2015.08.006; Kaul-Strehlow S., 2015, EVOLUTIONARY DEV BIO, V6, P59; LESTER SM, 1985, MAR BIOL, V85, P263, DOI 10.1007/BF00393246; Lynch M, 2007, ORIGINS GENOME ARCHI; Mitchell CE, 2013, LETHAIA, V46, P34, DOI 10.1111/j.1502-3931.2012.00319.x; Simakov O, 2015, NATURE, V527, P459, DOI 10.1038/nature16150; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Worsaae K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048529	9	0	0	1	21	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					448	449		10.1038/nature16315	http://dx.doi.org/10.1038/nature16315			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26580019				2022-12-28	WOS:000365352500028
J	Holmes, D				Holmes, David			OVARIAN CANCER: BEYOND RESISTANCE	NATURE			English	Editorial Material																			0	99	102	2	24	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					S217	S217		10.1038/527S217a	http://dx.doi.org/10.1038/527S217a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26605761	Bronze			2022-12-28	WOS:000365352500001
J	Kapur, N				Kapur, Narinder			Unconscious bias harms patients and staff	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											Kapur, N (corresponding author), UCL, Neuropsychol, London WC1E 7HJ, England.	n.kapur@ucl.ac.uk						Banaji MR., 2013, BLIND SPOT HIDDEN BI; Byrne A, 2015, ADV HEALTH SCI EDUC, V20, P1255, DOI 10.1007/s10459-015-9600-6; Croskerry P, 2013, BMJ QUAL SAF, V22, pii65, DOI 10.1136/bmjqs-2012-001713; Croskerry Pat, 2010, J Patient Saf, V6, P199, DOI 10.1097/PTS.0b013e3181f6c01a; Howe ML, 2015, MEMORY, V23, P633, DOI 10.1080/09658211.2015.1010709; Kahneman D., 2011, THINKING FAST SLOW; Kline R., 2014, SNOWY WHITE PEAKS NH; Reilly JB, 2013, BMJ QUAL SAF, V22, P1044, DOI 10.1136/bmjqs-2013-001987; Seshia SS, 2014, J EVAL CLIN PRACT, V20, P734, DOI 10.1111/jep.12280; Stone J, 2011, MED EDUC, V45, P768, DOI 10.1111/j.1365-2923.2011.04026.x; Tse HHM, 2013, J APPL PSYCHOL, V98, P974, DOI 10.1037/a0033862; van Ryn M, 2011, DU BOIS REV, V8, P199, DOI 10.1017/S1742058X11000191	12	4	4	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2015	351								h6347	10.1136/bmj.h6347	http://dx.doi.org/10.1136/bmj.h6347			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX4TL	26612658				2022-12-28	WOS:000365693100006
J	Metcalfe, D; Chowdhury, R; Salim, A				Metcalfe, David; Chowdhury, Ritam; Salim, Ali			What are the consequences when doctors strike?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY; IMPACT; PHYSICIANS; EMERGENCY; SLOWDOWN		[Metcalfe, David; Chowdhury, Ritam; Salim, Ali] Harvard Univ, Sch Med, Ctr Surg & Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Metcalfe, D (corresponding author), Harvard Univ, Sch Med, Ctr Surg & Publ Hlth, Boston, MA 02115 USA.	dmetcalfe@bwh.harvard.edu	Metcalfe, David/D-9699-2012	Metcalfe, David/0000-0003-1008-3105	National Institute for Health Research [ACF-2012-08-003] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Bhuiyan MMZU, 2012, SAMJ S AFR MED J, V102, P755, DOI [10.7196/samj.6045, 10.7196/SAMJ.6045]; Chima SC, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-S1-S5; Cunningham SA, 2008, SOC SCI MED, V67, P1784, DOI 10.1016/j.socscimed.2008.09.044; Erceg M, 2007, COLLEGIUM ANTROPOL, V31, P891; General Medical Council, 2015, GMC ADV DOCT ENGL CO; Grunert J, 2012, STUDENT CAPSTONE J; Harvey M, 2008, NEW ZEAL MED J, V121, P59; Jacobs AT, 2010, COMP LABOUR LAW IND; JAMES JJ, 1979, AM J PUBLIC HEALTH, V69, P437, DOI 10.2105/AJPH.69.5.437; Kaffash J, 2012, PULSE; Lind S., 2012, PULSE; Riley-Smith B, 2015, TELEGRAPH; Rimmer A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6270; Robinson G, 2008, CLIN MED, V8, P272, DOI 10.7861/clinmedicine.8-3-272; ROEMER MI, 1979, SOC SCI MED-MED ECON, V13, P213, DOI 10.1016/0160-7995(79)90002-9; ROEMER MI, 1981, SOC SCI MED-MED ECON, V15, P161, DOI 10.1016/0160-7995(81)90031-9; Ruiz M, 2013, J ROY SOC MED, V106, P362, DOI 10.1177/0141076813490685; Salazar A, 2001, ACAD EMERG MED, V8, P804, DOI 10.1111/j.1553-2712.2001.tb00210.x; Selemogo Mpho, 2014, Indian J Med Ethics, V11, P35; Siegel-Itzkovich J, 2000, BRIT MED J, V320, P1561, DOI 10.1136/bmj.320.7249.1561; SLATER PE, 1983, LANCET, V2, P1306; STEINHERZ R, 1984, LANCET, V1, P107; Thompson SL, 2003, INT J HEALTH SERV, V33, P55, DOI 10.2190/5JBT-FV07-QEM3-5MUT; Thompson SL, 2006, INT J HEALTH SERV, V36, P331, DOI 10.2190/B5CX-UX69-45LY-2D6D; Triggle N, 2012, BBC NEWS        0621; Warneck W, 2007, STRIKES RULES EU27	26	8	8	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2015	351								h6231	10.1136/bmj.h6231	http://dx.doi.org/10.1136/bmj.h6231			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX4TG	26608938				2022-12-28	WOS:000365692600005
J	Callaghan, BC; Price, RS; Feldman, EL				Callaghan, Brian C.; Price, Raymond S.; Feldman, Eva L.			Distal Symmetric Polyneuropathy A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PAINFUL DIABETIC-NEUROPATHY; CARPAL-TUNNEL-SYNDROME; FAMILIAL AMYLOID POLYNEUROPATHY; RANDOMIZED CONTROLLED-TRIAL; LIFE-STYLE INTERVENTION; PERIPHERAL NEUROPATHY; DOUBLE-BLIND; SENSORY NEUROPATHY; BELLS-PALSY; MICROVASCULAR OUTCOMES	IMPORTANCE Peripheral neuropathy is a highly prevalent and morbid condition affecting 2% to 7% of the population. Patients frequently experience pain and are at risk of falls, ulcerations, and amputations. We aimed to review recent diagnostic and therapeutic advances in distal symmetric polyneuropathy, the most common subtype of peripheral neuropathy. OBSERVATIONS Current evidence supports limited routine laboratory testing in patients with distal symmetric polyneuropathy. Patients without a known cause should undergo a complete blood cell count, comprehensive metabolic panel, vitamin B-12 measurement, serum protein electrophoresis with immunofixation, fasting glucose measurement, and glucose tolerance test. The presence of atypical features such as asymmetry, non-length dependence, motor predominance, acute or subacute onset, and prominent autonomic involvement should prompt a consultation with a neurologist or neuromuscular specialist. Electrodiagnostic tests and magnetic resonance imaging of the neuroaxis contribute substantial cost to the diagnostic evaluation, but evidence supporting their use is lacking. Strong evidence supports the use of tricyclic antidepressants, serotonin norepinephrine reuptake inhibitors, and voltage-gated calcium channel ligands in the treatment of neuropathic pain. More intensive glucose control substantially reduces the incidence of distal symmetric polyneuropathy in patients with type 1 diabetes but not in those with type 2 diabetes. CONCLUSIONS AND RELEVANCE The opportunity exists to improve guideline-concordant testing in patients with distal symmetric polyneuropathy. Moreover, the role of electrodiagnostic tests needs to be further defined, and interventions to reduce magnetic resonance imaging use in this population are needed. Even though several efficacious medications exist for neuropathic pain treatment, pain is still underrecognized and undertreated. New disease-modifying medications are needed to prevent and treat peripheral neuropathy, particularly in type 2 diabetes.	[Callaghan, Brian C.; Feldman, Eva L.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Feldman, EL (corresponding author), 109 Zina Pitcher Pl,5017 BSRB, Ann Arbor, MI 48109 USA.	efeldman@umich.edu		Feldman, Eva/0000-0002-9162-2694	National Institutes of Health [K23 NS079417-01, DP3 DK094292, R24 DK082841]; American Diabetes Association; A. Alfred Taubman Medical Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK094292, R24DK082841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS079417] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF14OC0011633] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); A. Alfred Taubman Medical Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Novo Nordisk Fonden(Novo Nordisk Foundation)	Funding support during the preparation of this article was provided by the National Institutes of Health (grant K23 NS079417-01 to B.C.C. and grants DP3 DK094292 and R24 DK082841 to E.L.F.), the American Diabetes Association (to E.L.F.), and the A. Alfred Taubman Medical Research Institute (to E.L.F.).	Abbott CA, 2011, DIABETES CARE, V34, P2220, DOI 10.2337/dc11-1108; Adler AI, 1999, DIABETES CARE, V22, P1029, DOI 10.2337/diacare.22.7.1029; Albers JW, 1995, ANN NEUROL, V38, P869, DOI 10.1002/ana.410380607; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Attal N, 2010, EUR J NEUROL, V17, P1113, DOI 10.1111/j.1468-1331.2010.02999.x; Backonja M, 1998, JAMA-J AM MED ASSOC, V280, P1831, DOI 10.1001/jama.280.21.1831; Beekman R, 2004, MUSCLE NERVE, V30, P202, DOI 10.1002/mus.20093; BEGHI E, 1995, NEUROLOGY, V45, P1832; Berk JL, 2013, JAMA-J AM MED ASSOC, V310, P2658, DOI 10.1001/jama.2013.283815; BHARUCHA NE, 1991, NEUROLOGY, V41, P1315, DOI 10.1212/WNL.41.8.1315; BOULTON AJM, 1985, DIABETES CARE, V8, P125, DOI 10.2337/diacare.8.2.125; Bril V, 2011, NEUROLOGY, V76, P1758, DOI 10.1212/WNL.0b013e3182166ebe; Callaghan BC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007543.pub2; Callaghan B. C., 2013, CLIN PRACTICE, V3, P421; Callaghan BC, 2015, JAMA NEUROL, DOI [10.1001/jamaneurol.2015.2347, DOI 10.1001/JAMARIEUROL.2015.2347]; Callaghan B, 2012, ARCH INTERN MED, V172, P127, DOI 10.1001/archinternmed.2011.1032; Callaghan BC, 2016, J NEUROL NEUROSUR PS, V87, P113, DOI 10.1136/jnnp-2014-307575; Callaghan BC, 2014, ANN INTERN MED, V161, P674, DOI 10.7326/M14-2157; Callaghan BC, 2014, JAMA NEUROL, V71, P1143, DOI 10.1001/jamaneurol.2014.1279; Callaghan BC, 2012, ARCH NEUROL-CHICAGO, V69, P339, DOI 10.1001/archneurol.2011.1735; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; Daousi C, 2004, DIABETIC MED, V21, P976, DOI 10.1111/j.1464-5491.2004.01271.x; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; DYCK PJ, 1993, NEUROLOGY, V43, P817, DOI 10.1212/WNL.43.4.817; DYCK PJ, 1981, ANN NEUROL, V10, P222, DOI 10.1002/ana.410100304; England JD, 2009, NEUROLOGY, V72, P185, DOI 10.1212/01.wnl.0000336370.51010.a1; England JD, 2004, LANCET, V363, P2151, DOI 10.1016/S0140-6736(04)16508-2; FAGIUS J, 1983, ACTA NEUROL SCAND, V67, P173, DOI 10.1111/j.1600-0404.1983.tb04560.x; Falkiner S, 2002, ANZ J SURG, V72, P204, DOI 10.1046/j.1445-2197.2002.02347.x; Finnerup NB, 2015, LANCET NEUROL, V14, P162, DOI 10.1016/S1474-4422(14)70251-0; Forrest KYZ, 1997, DIABETES, V46, P665, DOI 10.2337/diabetes.46.4.665; Franklin GM, 2014, NEUROLOGY, V83, P1277, DOI 10.1212/WNL.0000000000000839; FRANKLIN GM, 1990, AM J EPIDEMIOL, V131, P633, DOI 10.1093/oxfordjournals.aje.a115547; Freynhagen R, 2005, PAIN, V115, P254, DOI 10.1016/j.pain.2005.02.032; Gallagher Gary, 2013, Neurol Clin Pract, V3, P90; Goldstein DJ, 2005, PAIN, V116, P109, DOI 10.1016/j.pain.2005.03.029; Gorson KC, 1999, J NEUROL NEUROSUR PS, V66, P251, DOI 10.1136/jnnp.66.2.251; Griebeler ML, 2014, ANN INTERN MED, V161, P639, DOI 10.7326/M14-0511; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Jenkins PJ, 2013, J HAND SURG-EUR VOL, V38E, P67, DOI 10.1177/1753193412455790; Johannsen L, 2001, J Clin Neuromuscul Dis, V3, P47, DOI 10.1097/00131402-200112000-00001; Kanji JN, 2010, JAMA-J AM MED ASSOC, V303, P1526, DOI 10.1001/jama.2010.428; KATUSIC SK, 1986, ANN NEUROL, V20, P622, DOI 10.1002/ana.410200511; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Latinovic R, 2006, J NEUROL NEUROSUR PS, V77, P263, DOI 10.1136/jnnp.2005.066696; Lesser H, 2004, NEUROLOGY, V63, P2104, DOI 10.1212/01.WNL.0000145767.36287.A1; Lewis RA, 2013, JAMA NEUROL, V70, P981, DOI 10.1001/jamaneurol.2013.3178; Lubec D, 1999, POSTGRAD MED J, V75, P723, DOI 10.1136/pgmj.75.890.723; MASER RE, 1989, DIABETES, V38, P1456, DOI 10.2337/diabetes.38.11.1456; MAX MB, 1987, NEUROLOGY, V37, P589, DOI 10.1212/WNL.37.4.589; Mondelli M, 2005, J NEUROL SCI, V234, P5, DOI 10.1016/j.jns.2005.02.010; Monini S, 2010, ACTA OTORHINOLARYNGO, V30, P198; Pareyson D, 2011, LANCET NEUROL, V10, P320, DOI 10.1016/S1474-4422(11)70025-4; PARTANEN J, 1995, NEW ENGL J MED, V333, P89, DOI 10.1056/NEJM199507133330203; RADHAKRISHNAN K, 1994, BRAIN, V117, P325, DOI 10.1093/brain/117.2.325; Raskin J, 2005, PAIN MED, V6, P346, DOI 10.1111/j.1526-4637.2005.00061.x; Richardson JK, 2002, J AM GERIATR SOC, V50, P1767, DOI 10.1046/j.1532-5415.2002.50503.x; Richter RW, 2005, J PAIN, V6, P253, DOI 10.1016/j.jpain.2004.12.007; Rosenstock J, 2004, PAIN, V110, P628, DOI 10.1016/j.pain.2004.05.001; Rossor AM, 2013, NAT REV NEUROL, V9, P562, DOI 10.1038/nrneurol.2013.179; Rowbotham MC, 2004, PAIN, V110, P697, DOI 10.1016/j.pain.2004.05.010; Rowlands S, 2002, EUR J NEUROL, V9, P63, DOI 10.1046/j.1468-1331.2002.00343.x; Rudolph T, 2007, EUR J NEUROL, V14, P603, DOI 10.1111/j.1468-1331.2007.01758.x; Sandbaek A, 2014, DIABETES CARE, V37, P2015, DOI 10.2337/dc13-1544; Sands ML, 1997, DIABETES CARE, V20, P322, DOI 10.2337/diacare.20.3.322; Saporta ASD, 2011, ANN NEUROL, V69, P22, DOI 10.1002/ana.22166; SAVETTIERI G, 1993, NEUROLOGY, V43, P1115, DOI 10.1212/WNL.43.6.1115; Schoenfeld AJ, 2012, J SPINAL DISORD TECH, V25, P163, DOI 10.1097/BSD.0b013e3182146e55; Schoenfeld AJ, 2012, J SPINAL DISORD TECH, V25, P17, DOI 10.1097/BSD.0b013e31820d77ea; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Simpson D A, 2001, J Clin Neuromuscul Dis, V3, P53; Singleton JR, 2001, DIABETES CARE, V24, P1448, DOI 10.2337/diacare.24.8.1448; Smith AG, 2006, DIABETES CARE, V29, P1294, DOI 10.2337/dc06-0224; Smith AG, 2004, ARCH INTERN MED, V164, P1021, DOI 10.1001/archinte.164.9.1021; STEVENS JC, 1988, NEUROLOGY, V38, P134, DOI 10.1212/WNL.38.1.134; van Slobbe AM, 2004, J NEUROL, V251, P294, DOI 10.1007/s00415-004-0310-x; Visser NA, 2015, NEUROLOGY, V84, P259, DOI 10.1212/WNL.0000000000001160; Vrethem M, 1997, CLIN J PAIN, V13, P313, DOI 10.1097/00002508-199712000-00009; Wernicke JF, 2006, NEUROLOGY, V67, P1411, DOI 10.1212/01.wnl.0000240225.04000.1a	79	114	122	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2015	314	20					2172	2181		10.1001/jama.2015.13611	http://dx.doi.org/10.1001/jama.2015.13611			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XQ	26599185	Green Accepted			2022-12-28	WOS:000365351900021
J	Guo, Z; Ohlstein, B				Guo, Zheng; Ohlstein, Benjamin			Bidirectional Notch signaling regulates Drosophila intestinal stem cell multipotency	SCIENCE			English	Article							ASYMMETRIC SEGREGATION; POSTERIOR MIDGUT; NERVOUS-SYSTEM; DAUGHTER CELL; PROSPERO; DIVISION; MIRANDA; NEUROBLASTS; PROTEIN; FATE	Drosophila intestinal stem cells (ISCs) generate enterocytes (ECs) and enteroendocrine (ee) cells. Previous work suggests that different levels of the Notch ligand Delta (Dl) in ISCs unidirectionally activate Notch in daughters to control multipotency. However, the mechanisms driving different outcomes remain unknown. We found that during ee cell formation, the ee cell marker Prospero localizes to the basal side of dividing ISCs. After asymmetric division, the ee daughter cell acts as a source of Dl that induces low Notch activity in the ISC to maintain identity. Alternatively, ISCs expressing Dl induce high Notch activity in daughter cells to promote EC formation. Our data reveal a conserved role for Notch in Drosophila and mammalian ISC maintenance and suggest that bidirectional Notch signaling may regulate multipotency in other systems.	[Guo, Zheng; Ohlstein, Benjamin] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA	Columbia University	Ohlstein, B (corresponding author), Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA.	bo2160@columbia.edu	Balakrishnan, Christopher/A-3043-2014	Balakrishnan, Christopher/0000-0002-0788-0659; Guo, Zheng/0000-0003-2874-7141	NIH [R01 DK082456-05]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082456, R56DK090078] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Feng, R. Mann, S. Kidd, T. Lieber, M. Zecca, G. Struhl, H. Bellen, G. Veenstra, C. Doe, Y. Jan, T. Nystul, and M. Muskavitch for their generous gifts of fly stocks and reagents; I. Driver for production of the Pdm1 antibody; and E. Lucchetta, N. Rafel, C. Montagne, S. Kidd, and T. Lieber for helpful discussions. Supported by NIH grant R01 DK082456-05 (B.O.).	ARTAVANISTSAKONAS S, 1991, ANNU REV CELL BIOL, V7, P427; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Bardin AJ, 2010, DEVELOPMENT, V137, P705, DOI 10.1242/dev.039404; Biteau B, 2014, CELL REP, V7, P1867, DOI 10.1016/j.celrep.2014.05.024; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fuerstenberg S, 1998, MOL CELL NEUROSCI, V12, P325, DOI 10.1006/mcne.1998.0724; Goulas S, 2012, CELL STEM CELL, V11, P529, DOI 10.1016/j.stem.2012.06.017; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Koch U, 2013, DEVELOPMENT, V140, P689, DOI 10.1242/dev.080614; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee WC, 2009, DEVELOPMENT, V136, P2255, DOI 10.1242/dev.035196; Matsuzaki F, 1998, DEVELOPMENT, V125, P4089; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Micchelli CA, 2011, GENE EXPR PATTERNS, V11, P12, DOI 10.1016/j.gep.2010.08.005; Montagne C, 2014, DEVELOPMENT, V141, P2014, DOI 10.1242/dev.104240; Mori M, 2015, DEVELOPMENT, V142, P258, DOI 10.1242/dev.116855; Nakagoshi H, 2005, DEV GROWTH DIFFER, V47, P383; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Radtke F, 2013, NAT REV IMMUNOL, V13, P427, DOI 10.1038/nri3445; Rajan A, 2009, NAT CELL BIOL, V11, P815, DOI 10.1038/ncb1888; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Shen CP, 1998, GENE DEV, V12, P1837, DOI 10.1101/gad.12.12.1837; SPANA EP, 1995, DEVELOPMENT, V121, P3187; Stanger BZ, 2005, P NATL ACAD SCI USA, V102, P12443, DOI 10.1073/pnas.0505690102; Takashima S, 2011, DEV BIOL, V353, P161, DOI 10.1016/j.ydbio.2011.01.039; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Zecchini V, 1999, CURR BIOL, V9, P460, DOI 10.1016/S0960-9822(99)80211-5; Zeidler MP, 2004, NAT BIOTECHNOL, V22, P871, DOI 10.1038/nbt979; Zeng XK, 2015, CELL REP, V10, P1226, DOI 10.1016/j.celrep.2015.01.051; Zeng XK, 2015, DEVELOPMENT, V142, P644, DOI 10.1242/dev.113357; Zeng XK, 2013, DEVELOPMENT, V140, P3532, DOI 10.1242/dev.096891; Zielke N, 2014, CELL REP, V7, P588, DOI 10.1016/j.celrep.2014.03.020	45	120	120	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263							aab0988	10.1126/science.aab0988	http://dx.doi.org/10.1126/science.aab0988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW4IP	26586765	Green Accepted			2022-12-28	WOS:000364955200037
J	Murre, C				Murre, Cornelis			A Common Mechanism that Underpins Antibody Diversification	CELL			English	Editorial Material							CLASS-SWITCH RECOMBINATION; SOMATIC HYPERMUTATION	Targeting of AID to antibody variable (V) regions results in somatic hypermutation, whereas its recruitment to switch (S) regions leads to class-switch recombination. Yeap et al. find that the mechanism by which variable and switch regions recruit AID essentially is the same but that the two regions differ in the density of double-stranded DNA breaks that are generated. These lead to either point mutations in V exons in somatic hypermutation or deletion of intervening DNA sequences during class switch recombination.	[Murre, Cornelis] Univ Calif San Diego, Div Biol Sci, Dept Mol Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Murre, C (corresponding author), Univ Calif San Diego, Div Biol Sci, Dept Mol Biol, La Jolla, CA 92093 USA.	cmurre@ucsd.edu						Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Chandra V, 2015, TRENDS IMMUNOL, V36, P527, DOI 10.1016/j.it.2015.07.003; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Hackney JA, 2009, ADV IMMUNOL, V101, P163, DOI 10.1016/S0065-2776(08)01005-5; Muramatsu Masamichi, 2007, Adv Immunol, V94, P1, DOI 10.1016/S0065-2776(06)94001-2; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Yeap LS, 2015, CELL, V163, P1124, DOI 10.1016/j.cell.2015.10.042; Zarrin AA, 2004, NAT IMMUNOL, V5, P1275, DOI 10.1038/ni1137	9	2	2	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1055	1056		10.1016/j.cell.2015.10.075	http://dx.doi.org/10.1016/j.cell.2015.10.075			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26590414	Bronze			2022-12-28	WOS:000366044700005
J	Rubiano, AM; Carney, N; Chesnut, R; Puyana, JC				Rubiano, Andres M.; Carney, Nancy; Chesnut, Randall; Puyana, Juan Carlos			Global neurotrauma research challenges and opportunities	NATURE			English	Review							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; MIDDLE-INCOME COUNTRIES; TERM MILD HYPOTHERMIA; COMMON DATA ELEMENTS; INTRACRANIAL-PRESSURE; CLINICAL-TRIALS; INTERNATIONAL WORKSHOP; LATIN-AMERICA; CARE	Traumatic injury to the brain or spinal cord is one of the most serious public health problems worldwide. The devastating impact of 'trauma', a term used to define the global burden of disease related to all injuries, is the leading cause of loss of human potential across the globe, especially in low-and middle-income countries. Enormous challenges must be met to significantly advance neurotrauma research around the world, specifically in underserved and austere environments. Neurotrauma research at the global level needs to be contextualized: different regions have their own needs and obstacles. Interventions that are not considered a priority in some regions could be a priority for others. The introduction of inexpensive and innovative interventions, including mobile technologies and e-health applications, focused on policy management improvement are essential and should be applicable to the needs of the local environment. The simple transfer of a clinical question from resource-rich environments to those of low-and middle-income countries that lack sophisticated interventions may not be the best strategy to address these countries' needs. Emphasis on promoting the design of true 'ecological' studies that include the evaluation of human factors in relation to the process of care, analytical descriptions of health systems, and how leadership is best applied in medical communities and society as a whole will become crucial.	[Rubiano, Andres M.] El Bosque Univ, Inst Neurosci, Neurotrauma Grp, Ave Carrera 9a,131A-02 Edificio Fundadores, Bogota, Colombia; [Carney, Nancy] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97239 USA; [Chesnut, Randall] Harborview Med Ctr, Dept Neurosurg, Neurol Surg Global Hlth, Seattle, WA 98104 USA; [Puyana, Juan Carlos] Univ Pittsburgh, Global Surg, Pittsburgh, PA 15213 USA	Universidad El Bosque; Oregon Health & Science University; Harborview Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Puyana, JC (corresponding author), Univ Pittsburgh, Global Surg, Pittsburgh, PA 15213 USA.	puyanajc@upmc.edu	RUBIANO, ANDRES M/K-6704-2012	RUBIANO, ANDRES M/0000-0001-8931-3254	MEDITECH Foundation Research Group; South Colombian University Public Health Research Group; NIH [R21TW009332-01A1, R25TW009714-01, R01NS080648-01]; FOGARTY INTERNATIONAL CENTER [R25TW009714, R21TW009332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080648] Funding Source: NIH RePORTER	MEDITECH Foundation Research Group; South Colombian University Public Health Research Group; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge support from MEDITECH Foundation Research Group and South Colombian University Public Health Research Group (J. Montenegro, M. N. Suarez and D. Charry) in the preparation of the tables and references. The authors are supported by NIH R21TW009332-01A1, R25TW009714-01 and R01NS080648-01 grants. We are grateful to J. Povlishock for his insightful review and suggestions.	Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; Agrawal A, 2012, INDIAN J NEUROTRAUM, V9, P87, DOI 10.1016/j.ijnt.2012.11.001; Bajracharya A, 2010, J NEUROSCI RURAL PRA, V1, P2, DOI 10.4103/0976-3147.63092; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P268, DOI 10.1097/HTR.0000000000000053; Bickembach J., 2013, INT PERSPECTIVES SPI; Biering-Sorensen F, 2014, SPINAL CORD, V52, P87, DOI 10.1038/sc.2013.169; Borse NN, 2009, INDIAN J MED RES, V129, P321; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, 2014, TRAUM BRAIN INJ US E; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chesnut RM, 2012, NEUROSURGERY, V71, P1055, DOI 10.1227/NEU.0b013e31827276b7; Chiu WT, 2010, ASIA-PAC J PUBLIC HE, V22, P9, DOI 10.1177/1010539509355470; Cripps RA, 2011, SPINAL CORD, V49, P493, DOI 10.1038/sc.2010.146; Furlan JC, 2013, CAN J NEUROL SCI, V40, P456, DOI 10.1017/S0317167100014530; Furlan JC, 2013, CAN J NEUROL SCI, V40, P454, DOI 10.1017/S0317167100014529; Gosselin RA, 2009, TECH ORTHOP, V24, P230, DOI 10.1097/BTO.0b013e3181bfd56c; Green SE, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-74; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; Horton R, 2012, LANCET, V380, P2053, DOI 10.1016/S0140-6736(12)62133-3; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Kahle KT, 2013, NEW ENGL J MED, V368, P1750, DOI 10.1056/NEJMc1301076; Kesinger MR, 2014, INJURY, V45, P1350, DOI 10.1016/j.injury.2014.04.037; Kesinger MR, 2014, WORLD J SURG, V38, P1869, DOI 10.1007/s00268-014-2534-y; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Le Roux P, 2014, CURR OPIN CRIT CARE, V20, P141, DOI 10.1097/MCC.0000000000000078; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Li J, 2011, SPINAL CORD, V49, P777, DOI 10.1038/sc.2011.8; Liu WG, 2006, J INT MED RES, V34, P58, DOI 10.1177/147323000603400107; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Mattei TA, 2013, WORLD NEUROSURG, V79, P602, DOI 10.1016/j.wneu.2013.03.048; Murgio A, 1999, J Neurosurg Sci, V43, P15; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; National Spinal Cord Injury Statistical Center, 2013, 2013 ANN STAT REP SP; Nielsen K, 2012, PREHOSP EMERG CARE, V16, P381, DOI 10.3109/10903127.2012.664245; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Oderud T., 2014, AFRICAN J DISABILITY, V3, P1; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; Puvanachandra P., 2009, PAK J NEUROL SCI, V4, P27; Puvanachandra P, 2008, SALUD PUBLICA MEXICO, V50, pS3; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Rahimi-Movaghar V, 2013, NEUROEPIDEMIOLOGY, V41, P65, DOI 10.1159/000350710; Razmkon Ali, 2013, Bull Emerg Trauma, V1, P5; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rubiano A. M., 2013, J TRAUMA CRIT CARE E, V2, P5; Rubiano AM, 2014, REV PESQUI-CUID FUND, V6, P1, DOI 10.9789/2175-5361.2014.v6i4.1-2; Rubiano AM, 2013, BRAIN INJURY, V27, P262, DOI 10.3109/02699052.2012.750742; Sahuquillo Juan, 2014, Surg Neurol Int, V5, P86, DOI 10.4103/2152-7806.133993; Sarrafzadeh AS, 2014, WORLD NEUROSURG, V82, pE393, DOI 10.1016/j.wneu.2013.07.012; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Sitsapesan HA, 2013, WORLD NEUROSURG, V79, P568, DOI 10.1016/j.wneu.2012.09.018; Thurmond VA, 2010, ARCH PHYS MED REHAB, V91, P1633, DOI 10.1016/j.apmr.2010.06.034; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; Tuszynski MH, 2007, SPINAL CORD, V45, P222, DOI 10.1038/sj.sc.3102009; van den Berg MEL, 2010, NEUROEPIDEMIOLOGY, V34, P184, DOI 10.1159/000279335; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zakrasek EC, 2015, SPINAL CORD, V53, P7, DOI 10.1038/sc.2014.179	63	245	253	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					S193	S197		10.1038/nature16035	http://dx.doi.org/10.1038/nature16035			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW9ZN	26580327	hybrid			2022-12-28	WOS:000365356800016
J	Ackermann, M; Albert, A; Baldini, L; Ballet, J; Barbiellini, G; Barbieri, C; Bastieri, D; Bellazzini, R; Bissaldi, E; Bonino, R; Bottacini, E; Brandt, TJ; Bregeon, J; Bruel, P; Buehler, R; Caliandro, GA; Cameron, RA; Caraveo, PA; Cecchi, C; Charles, E; Chekhtman, A; Cheung, CC; Chiang, J; Chiaro, G; Ciprini, S; Cohen-Tanugi, J; Cuoco, A; Cutini, S; D'Ammando, F; de Palma, F; Desiante, R; Digel, SW; Di Venere, L; Drell, PS; Favuzzi, C; Fegan, SJ; Ferrara, EC; Franckowiak, A; Funk, S; Fusco, P; Gargano, F; Gasparrini, D; Giglietto, N; Giordano, F; Godfrey, G; Grenier, IA; Grondin, MH; Grove, JE; Guillemot, L; Guiriec, S; Hagiwara, K; Harding, AK; Hays, E; Hewitt, JW; Hill, AB; Horan, D; Johnson, TJ; Knodiseder, J; Kuss, M; Larsson, S; Latronico, L; Lemoine-Goumard, M; Li, J; Li, L; Longo, F; Loparco, F; Lovellette, MN; Lubrano, P; Maldera, S; Manfreda, A; Marshall, F; Martin, P; Mayer, M; Mazziotta, MN; Michelson, PF; Mirabal, N; Mizuno, T; Monzani, ME; Morselli, A; Moskalenko, IV; Murgia, S; Naletto, G; Nuss, E; Ohsugi, T; Orienti, M; Orlando, E; Paneque, D; Pesce-Rollins, M; Piron, F; Pivato, G; Porter, TA; Raino, S; Rando, R; Razzano, M; Reimer, A; Reimer, O; Reposeur, T; Romani, RW; Parkinson, PMS; Schulz, A; Sgro, C; Siskind, EJ; Smith, DA; Spada, F; Spandre, G; Spinelli, P; Suson, DJ; Takahashi, H; Thayer, JB; Thompson, DJ; Tibaldo, L; Torres, DF; Uchiyama, Y; Vianello, G; Wood, KS; Wood, M; Zampieri, L				Ackermann, M.; Albert, A.; Baldini, L.; Ballet, J.; Barbiellini, G.; Barbieri, C.; Bastieri, D.; Bellazzini, R.; Bissaldi, E.; Bonino, R.; Bottacini, E.; Brandt, T. J.; Bregeon, J.; Bruel, P.; Buehler, R.; Caliandro, G. A.; Cameron, R. A.; Caraveo, P. A.; Cecchi, C.; Charles, E.; Chekhtman, A.; Cheung, C. C.; Chiang, J.; Chiaro, G.; Ciprini, S.; Cohen-Tanugi, J.; Cuoco, A.; Cutini, S.; D'Ammando, F.; de Palma, F.; Desiante, R.; Digel, S. W.; Di Venere, L.; Drell, P. S.; Favuzzi, C.; Fegan, S. J.; Ferrara, E. C.; Franckowiak, A.; Funk, S.; Fusco, P.; Gargano, F.; Gasparrini, D.; Giglietto, N.; Giordano, F.; Godfrey, G.; Grenier, I. A.; Grondin, M. -H.; Grove, J. E.; Guillemot, L.; Guiriec, S.; Hagiwara, K.; Harding, A. K.; Hays, E.; Hewitt, J. W.; Hill, A. B.; Horan, D.; Johnson, T. J.; Knoediseder, J.; Kuss, M.; Larsson, S.; Latronico, L.; Lemoine-Goumard, M.; Li, J.; Li, L.; Longo, F.; Loparco, F.; Lovellette, M. N.; Lubrano, P.; Maldera, S.; Manfreda, A.; Marshall, F.; Martin, P.; Mayer, M.; Mazziotta, M. N.; Michelson, P. F.; Mirabal, N.; Mizuno, T.; Monzani, M. E.; Morselli, A.; Moskalenko, I. V.; Murgia, S.; Naletto, G.; Nuss, E.; Ohsugi, T.; Orienti, M.; Orlando, E.; Paneque, D.; Pesce-Rollins, M.; Piron, F.; Pivato, G.; Porter, T. A.; Raino, S.; Rando, R.; Razzano, M.; Reimer, A.; Reimer, O.; Reposeur, T.; Romani, R. W.; Parkinson, P. M. Saz; Schulz, A.; Sgro, C.; Siskind, E. J.; Smith, D. A.; Spada, F.; Spandre, G.; Spinelli, P.; Suson, D. J.; Takahashi, H.; Thayer, J. B.; Thompson, D. J.; Tibaldo, L.; Torres, D. F.; Uchiyama, Y.; Vianello, G.; Wood, K. S.; Wood, M.; Zampieri, L.		Fermi LAT Collaboration	An extremely bright gamma-ray pulsar in the Large Magellanic Cloud	SCIENCE			English	Article							LARGE-AREA TELESCOPE; SUPERNOVA REMNANT; LIGHT-CURVE; RADIO; EMISSION; RADIATION; DISCOVERY; B0540-69; MODEL	Pulsars are rapidly spinning, highly magnetized neutron stars, created in the gravitational collapse of massive stars. We report the detection of pulsed giga-electron volt gamma rays from the young pulsar PSR J0540-6919 in the Large Magellanic Cloud, a satellite galaxy of the Milky Way. This is the first gamma-ray pulsar detected in another galaxy. It has the most luminous pulsed gamma-ray emission yet observed, exceeding the Crab pulsar's by a factor of 20. PSR J0540-6919 presents an extreme test case for understanding the structure and evolution of neutron star magnetospheres.	[Ackermann, M.; Buehler, R.; Mayer, M.; Schulz, A.] Deutsch Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany; [Albert, A.; Baldini, L.; Bottacini, E.; Caliandro, G. A.; Cameron, R. A.; Charles, E.; Chiang, J.; Digel, S. W.; Drell, P. S.; Franckowiak, A.; Godfrey, G.; Hill, A. B.; Michelson, P. F.; Monzani, M. E.; Moskalenko, I. V.; Orlando, E.; Paneque, D.; Pesce-Rollins, M.; Porter, T. A.; Reimer, A.; Reimer, O.; Romani, R. W.; Thayer, J. B.; Tibaldo, L.; Vianello, G.; Wood, M.] Stanford Univ, Dept Phys, Kavli Inst Particle Astrophys & Cosmol, WW Hansen Expt Phys Lab, Stanford, CA 94305 USA; [Albert, A.; Baldini, L.; Bottacini, E.; Caliandro, G. A.; Cameron, R. A.; Charles, E.; Chiang, J.; Digel, S. W.; Drell, P. S.; Franckowiak, A.; Godfrey, G.; Hill, A. B.; Michelson, P. F.; Monzani, M. E.; Moskalenko, I. V.; Orlando, E.; Paneque, D.; Pesce-Rollins, M.; Porter, T. A.; Reimer, A.; Reimer, O.; Romani, R. W.; Thayer, J. B.; Tibaldo, L.; Vianello, G.; Wood, M.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Baldini, L.] Univ Pisa, I-56127 Pisa, Italy; [Baldini, L.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Ballet, J.; Grenier, I. A.] Univ Paris Diderot, CEA IRFU CNRS, Lab Astrophys Interact Multiechelles, CEA Saclay,Serv Astrophys, F-91191 Gif Sur Yvette, France; [Barbiellini, G.; Desiante, R.; Longo, F.] Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; [Barbiellini, G.; Longo, F.] Univ Trieste, Dipartimento Fis, I-34127 Trieste, Italy; [Barbieri, C.] Univ Padua, Dept Phys & Astron, I-35122 Padua, Italy; [Bastieri, D.; Rando, R.] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Bastieri, D.; Chiaro, G.; Rando, R.] Univ Padua, Dipartimento Fis & Astron G Galilei, I-35131 Padua, Italy; [Bellazzini, R.; Kuss, M.; Manfreda, A.; Pesce-Rollins, M.; Pivato, G.; Razzano, M.; Sgro, C.; Spada, F.; Spandre, G.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Bissaldi, E.; de Palma, F.; Favuzzi, C.; Fusco, P.; Gargano, F.; Giglietto, N.; Giordano, F.; Loparco, F.; Mazziotta, M. N.; Raino, S.; Spinelli, P.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Bonino, R.; Cuoco, A.; Latronico, L.; Maldera, S.] Ist Nazl Fis Nucl, Sez Torino, I-10125 Turin, Italy; [Bonino, R.; Cuoco, A.] Univ Turin, Dipartimento Fis Gen Amadeo Avogadro, I-10125 Turin, Italy; [Brandt, T. J.; Ferrara, E. C.; Guiriec, S.; Harding, A. K.; Hays, E.; Marshall, F.; Mirabal, N.; Thompson, D. J.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Bregeon, J.; Cohen-Tanugi, J.; Nuss, E.; Piron, F.] Univ Montpellier, CNRS IN2P3, Lab Univers & Particules Montpellier, F-34059 Montpellier, France; [Bruel, P.; Fegan, S. J.; Horan, D.] Ecole Polytech, Lab Leprince Ringuet, CNRS IN2P3, Palaiseau, France; [Caliandro, G. A.] Consorzio Interuniv Fis Spaziale, I-10133 Turin, Italy; [Caraveo, P. A.] INAF Ist Astrofis Spaziale & Fis Cosm, I-20133 Milan, Italy; [Cecchi, C.; Ciprini, S.; Cutini, S.; Gasparrini, D.; Lubrano, P.] Ist Nazl Fis Nucl, Sez Perugia, I-06123 Perugia, Italy; [Cecchi, C.; Lubrano, P.] Univ Perugia, Dipartimento Fis, I-06123 Perugia, Italy; [Chekhtman, A.; Johnson, T. J.] George Mason Univ, Coll Sci, Fairfax, VA 22030 USA; [Chekhtman, A.; Johnson, T. J.] Naval Res Lab, Washington, DC 20375 USA; [Cheung, C. C.; Grove, J. E.; Lovellette, M. N.; Wood, K. S.] Naval Res Lab, Space Sci Div, Washington, DC 20375 USA; [Ciprini, S.; Cutini, S.; Gasparrini, D.] Agenzia Spaziale Italiana ASI Sci Data Ctr, I-00133 Rome, Italy; [Ciprini, S.; Cutini, S.; Gasparrini, D.] INAF Osservatorio Astron Roma, I-00040 Rome, Italy; [D'Ammando, F.; Orienti, M.] INAF Ist Radioastron, I-40129 Bologna, Italy; [D'Ammando, F.] Univ Bologna, Dipartimento Astron, I-40127 Bologna, Italy; [de Palma, F.] Univ Telemat Pegaso Piazza Trieste & Trento, I-80132 Naples, Italy; [Desiante, R.] Univ Udine, I-33100 Udine, Italy; [Di Venere, L.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Raino, S.; Spinelli, P.] Univ & Politecn Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; [Funk, S.] Erlangen Ctr Astroparticle Phys, D-91058 Erlangen, Germany; [Grondin, M. -H.; Lemoine-Goumard, M.; Reposeur, T.; Smith, D. A.] Univ Bordeaux 1, CNRS IN2P3, Ctr Etud Nucl Bordeaux Gradignan, F-33175 Gradignan, France; [Guillemot, L.] Univ Orleans, CNRS, Lab Phys & Chim Environm & Espace, F-45071 Orleans 02, France; [Guillemot, L.] CNRS INSU, Observ Paris, Stn Radioastron Nancay, F-18330 Nancay, France; [Guiriec, S.; Mirabal, N.] NASA Postdoctoral Program, Idaho Falls, ID USA; [Hewitt, J. W.] Univ Maryland Baltimore Cty, Dept Phys, Baltimore, MD 21250 USA; [Hewitt, J. W.] Univ Maryland Baltimore Cty, Ctr Space Sci & Technol, Baltimore, MD 21250 USA; [Hewitt, J. W.] Ctr Res & Explorat Space Sci & Technol, Greenbelt, MD 20771 USA; [Hewitt, J. W.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Hill, A. B.] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Knoediseder, J.; Martin, P.] CNRS, IRAP, F-31028 Toulouse 4, France; [Knoediseder, J.; Martin, P.] Univ Toulouse 3, Observ Midi Pyrenees, IRAP, F-31062 Toulouse, France; [Larsson, S.; Li, L.] KTH Royal Inst Technol, AlbaNova, Dept Phys, SE-10691 Stockholm, Sweden; [Larsson, S.; Li, L.] AlbaNova, Oskar Klein Ctr Cosmoparticle Phys, SE-10691 Stockholm, Sweden; [Li, J.; Torres, D. F.] CSIC, Inst Estudis Espacials Catalunya, Inst Space Sci, E-08193 Barcelona, Spain; [Mizuno, T.; Ohsugi, T.] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima 7398526, Japan; [Morselli, A.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Murgia, S.] Univ Calif Irvine, Ctr Cosmol, Dept Phys & Astron, Irvine, CA 92697 USA; [Naletto, G.] Consiglio Nazl Ric Ist Foton & Nanotecnol UOS Pad, I-35131 Padua, Italy; [Naletto, G.] Univ Padua, Dept Informat Engn, I-35131 Padua, Italy; [Paneque, D.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Astro & Teilchenphys, A-6020 Innsbruck, Austria; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; [Parkinson, P. M. Saz] Univ Calif Santa Cruz, Dept Phys, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Parkinson, P. M. Saz] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Parkinson, P. M. Saz] Univ Hong Kong, Dept Phys, Hong Kong, Hong Kong, Peoples R China; [Siskind, E. J.] NYCB Real Time Comp, Lattingtown, NY 11560 USA; [Suson, D. J.] Purdue Univ Calumet, Dept Chem & Phys, Hammond, IN 46323 USA; [Takahashi, H.] Hiroshima Univ, Dept Phys Sci, Hiroshima 7398526, Japan; [Torres, D. F.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; INAF Astron Observ Padova, I-35122 Padua, Italy	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Pisa; Istituto Nazionale di Fisica Nucleare (INFN); CEA; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; University of Padua; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); University of Turin; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; George Mason University; United States Department of Defense; United States Navy; Naval Research Laboratory; United States Department of Defense; United States Navy; Naval Research Laboratory; Agenzia Spaziale Italiana (ASI); Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); University of Bologna; Pegaso Online University; University of Udine; Politecnico di Bari; University of Erlangen Nuremberg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; National Aeronautics & Space Administration (NASA); University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Southampton; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Royal Institute of Technology; Oskar Klein Centre; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); Hiroshima University; Istituto Nazionale di Fisica Nucleare (INFN); University of California System; University of California Irvine; University of Padua; Max Planck Society; University of Innsbruck; University of Innsbruck; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of Hong Kong; Purdue University System; Purdue University; Hiroshima University; ICREA; Istituto Nazionale Astrofisica (INAF); University of Padua	Martin, P (corresponding author), CNRS, IRAP, F-31028 Toulouse 4, France.	lucas.guillemot@cnrs-orleans.fr; francis.e.marshall@nasa.gov; pierrick.martin@irap.omp.eu	Naletto, Giampiero/S-6329-2016; Giglietto, Nicola/Y-2425-2019; Bonino, Raffaella/AAT-7938-2020; Gasparrini, Dario/X-6699-2019; Bissaldi, Elisabetta/K-7911-2016; cohen-tanugi, Johann/ABB-1481-2021; Torres, Diego F./O-9422-2016; Funk, Stefan/AAI-1568-2021; Bastieri, Denis/AAC-5917-2020; Reimer, Olaf/A-3117-2013; Moskalenko, Igor V/A-1301-2007; Caraveo, Patrizia/AAL-5708-2020; giglietto, nicola/I-8951-2012; Reimer, Anita/K-5822-2015; Rando, Riccardo/O-1302-2019; Morselli, Aldo/G-6769-2011; Bissaldi, Elisabetta/AAB-2443-2021; Takahashi, Hiromitsu H/T-2713-2017; Funk, Stefan/B-7629-2015; Cutini, Sara/ABB-1787-2020; Di Venere, Leonardo/C-7619-2017; Torres, Diego F./AAF-7931-2019; Gargano, Fabio/AAD-5121-2021; Sgrò, Carmelo/K-3395-2016; Torres, Diego F/ABD-7940-2020; Li, Liang/AAB-1075-2020; Bonino, Raffaella/S-2367-2016; Orlando, Elena/R-5594-2016; Mazziotta, Mario Nicola/O-8867-2015	Naletto, Giampiero/0000-0003-2007-3138; Giglietto, Nicola/0000-0002-9021-2888; Gasparrini, Dario/0000-0002-5064-9495; Bissaldi, Elisabetta/0000-0001-9935-8106; cohen-tanugi, Johann/0000-0001-9022-4232; Torres, Diego F./0000-0002-1522-9065; Funk, Stefan/0000-0002-2012-0080; Bastieri, Denis/0000-0002-6954-8862; Reimer, Olaf/0000-0001-6953-1385; Moskalenko, Igor V/0000-0001-6141-458X; Caraveo, Patrizia/0000-0003-2478-8018; giglietto, nicola/0000-0002-9021-2888; Reimer, Anita/0000-0001-8604-7077; Rando, Riccardo/0000-0001-6992-818X; Morselli, Aldo/0000-0002-7704-9553; Bissaldi, Elisabetta/0000-0001-9935-8106; Takahashi, Hiromitsu H/0000-0001-6314-5897; Funk, Stefan/0000-0002-2012-0080; Cutini, Sara/0000-0002-1271-2924; Di Venere, Leonardo/0000-0003-0703-824X; Torres, Diego F./0000-0002-1522-9065; Gargano, Fabio/0000-0002-5055-6395; Li, Liang/0000-0002-1343-3089; Bonino, Raffaella/0000-0002-4264-1215; Orlando, Elena/0000-0001-6406-9910; Ciprini, Stefano/0000-0002-0712-2479; Baldini, Luca/0000-0002-9785-7726; orienti, monica/0000-0003-4470-7094; Ackermann, Markus/0000-0001-8952-588X; Mirabal, Nestor/0000-0002-7021-5838; RAZZANO, MASSIMILIANO/0000-0003-4825-1629; Cecchi, Claudia/0000-0002-2192-8233; Buehler, Rolf/0000-0003-4425-6641; Vianello, Giacomo/0000-0002-2553-0839; Mazziotta, Mario Nicola/0000-0001-9325-4672; Charles, Eric/0000-0002-3925-7802; Raino', Silvia/0000-0002-9181-0345; Fusco, Piergiorgio/0000-0002-9383-2425; Giordano, Francesco/0000-0002-8651-2394; Hill, Adam/0000-0003-3470-4834; Spandre, Gloria/0000-0003-0802-3453; Porter, Troy/0000-0002-2621-4440; Pesce-Rollins, Melissa/0000-0003-1790-8018; Manfreda, Alberto/0000-0002-0998-4953; Murgia, Simona/0000-0003-0516-9422; Zampieri, Luca/0000-0002-6516-1329; Monzani, Maria Elena/0000-0002-8254-5308; D'Ammando, Filippo/0000-0001-7618-7527; Larsson, Stefan/0000-0003-0716-107X; de Palma, Francesco/0000-0001-5898-2834; CUOCO, ALESSANDRO/0000-0003-1504-894X; maldera, simone/0000-0002-0698-4421; Sgro', Carmelo/0000-0001-5676-6214; Grenier, Isabelle/0000-0003-3274-674X; Cameron, Robert/0000-0003-0942-2747; Cheung, Chi (Teddy)/0000-0002-4377-0174; Johnson, Tyrel/0000-0002-2771-472X; Tibaldo, Luigi/0000-0001-7523-570X	Italian Ministry of Education, University and Research (MIUR) [FIRB-2012-RBFR12PM1F]; STFC [ST/K00137X/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/L001209/1 ATLAS Upgrades, ST/K00137X/1, ST/M002071/1 ATLAS Upgrades, ST/M007103/1 ATLAS Upgrades] Funding Source: researchfish; ICREA Funding Source: Custom	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); ICREA(ICREA)	The Fermi-LAT Collaboration acknowledges support for LAT development, operation, and data analysis from NASA and the U.S. Department of Energy (DOE) (United States); Commissariat a l'Energie Atomique (CEA)-Institut de Recherche sur les lois Fondamentales de l'Univers (IRFU) and Institut National de Physique Nucleaire et de Physique des Particules/Centre National de la Recherche Scientifique (France); Agenzia Spaziale Italiana (ASI) and Istituto Nazionale di Fisica Nucleare (Italy); Ministry of Education, Culture, Sports, Science and Technology. KEK, and Japan Aerospace Exploration Agency (Japan); and the K. A. Wallenberg Foundation, the Swedish Research Council, and the National Space Board (Sweden). Science analysis support in the operations phase from the Istituto Nazionale di Astrofisica (INAF) (Italy) and Centre National d'Etudes Spatiales (France) is also gratefully acknowledged. Fermi-LAT data and analysis tools are publicly available from the Fermi Science Support Center at http://fermi.gsfc.nasa.gov/ssc. M.R. was funded by contract FIRB-2012-RBFR12PM1F from the Italian Ministry of Education, University and Research (MIUR).	Abdo AA, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/17; Abdo AA, 2010, ASTRON ASTROPHYS, V512, DOI 10.1051/0004-6361/200913474; Abramowski A, 2015, SCIENCE, V347, P406, DOI 10.1126/science.1261313; Aliu E, 2011, SCIENCE, V334, P69, DOI 10.1126/science.1208192; ATWOOD W, 2013, 2012 FERM S P ECONF; Atwood WB, 2009, ASTROPHYS J, V697, P1071, DOI 10.1088/0004-637X/697/2/1071; Bilous AV, 2015, ASTROPHYS J, V803, DOI 10.1088/0004-637X/803/2/83; BRADT HV, 1993, ASTRON ASTROPHYS SUP, V97, P355; Brambilla G, 2015, ASTROPHYS J, V804, DOI 10.1088/0004-637X/804/2/84; Brantseg T, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/50; Buhler R, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/6/066901; Campana R, 2008, MON NOT R ASTRON SOC, V389, P691, DOI 10.1111/j.1365-2966.2008.13619.x; Chen Y, 2006, ASTROPHYS J, V651, P237, DOI 10.1086/507017; CHENG KS, 1986, ASTROPHYS J, V300, P500, DOI 10.1086/163829; Cordes JM, 2004, ASTROPHYS J, V612, P375, DOI 10.1086/422495; Crawford F, 2005, ADV SPACE RES-SERIES, V35, P1181, DOI 10.1016/j.asr.2005.03.074; Crowther PA, 2010, MON NOT R ASTRON SOC, V408, P731, DOI 10.1111/j.1365-2966.2010.17167.x; DEJAGER OC, 1989, ASTRON ASTROPHYS, V221, P180; Gradari S, 2011, MON NOT R ASTRON SOC, V412, P2689, DOI 10.1111/j.1365-2966.2010.18103.x; Johnston S, 2004, MON NOT R ASTRON SOC, V355, P31, DOI 10.1111/j.1365-2966.2004.08286.x; Kalapotharakos C, 2014, ASTROPHYS J, V793, DOI 10.1088/0004-637X/793/2/97; Kerr M, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/38; Lorimer D.R., 2004, HDB PULSAR ASTRONOMY, V4; Lyutikov M, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/33; MANCHESTER RN, 1993, ASTROPHYS J, V403, pL29, DOI 10.1086/186714; Marshall FE, 1998, ASTROPHYS J, V499, pL179, DOI 10.1086/311381; Mignani RP, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219177; Mignani RP, 2010, ASTRON ASTROPHYS, V515, DOI 10.1051/0004-6361/200913870; Muslimov AG, 2004, ASTROPHYS J, V606, P1143, DOI 10.1086/383079; Ng CY, 2008, ASTROPHYS J, V673, P411, DOI 10.1086/523935; Petri J, 2011, MON NOT R ASTRON SOC, V412, P1870, DOI 10.1111/j.1365-2966.2010.18023.x; Pietrzynski G, 2013, NATURE, V495, P76, DOI 10.1038/nature11878; Romani RW, 2010, ASTROPHYS J, V714, P810, DOI 10.1088/0004-637X/714/1/810; SEWARD FD, 1984, ASTROPHYS J, V287, pL19, DOI 10.1086/184388; Walborn NR, 2014, ASTRON ASTROPHYS, V564, DOI 10.1051/0004-6361/201323082; Williams BJ, 2008, ASTROPHYS J, V687, P1054, DOI 10.1086/592139; Willingale R, 2001, ASTRON ASTROPHYS, V365, pL212, DOI 10.1051/0004-6361:20000114; Zhang L, 2004, ASTROPHYS J, V604, P317, DOI 10.1086/381794	38	34	34	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					801	805		10.1126/science.aac7400	http://dx.doi.org/10.1126/science.aac7400			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW3MS	26564852	Green Published, Green Submitted			2022-12-28	WOS:000364897000041
J	Allison, EH; Bassett, HR				Allison, Edward H.; Bassett, Hannah R.			Climate change in the oceans: Human impacts and responses	SCIENCE			English	Review							VULNERABILITY; ADAPTATION; ENGAGEMENT; FUTURE; POWER	Although it has far-reaching consequences for humanity, attention to climate change impacts on the ocean lags behind concern for impacts on the atmosphere and land. Understanding these impacts, as well as society's diverse perspectives and multiscale responses to the changing oceans, requires a correspondingly diverse body of scholarship in the physical, biological, and social sciences and humanities. This can ensure that a plurality of values and viewpoints is reflected in the research that informs climate policy and may enable the concerns of maritime societies and economic sectors to be heard in key adaptation and mitigation discussions.	[Allison, Edward H.; Bassett, Hannah R.] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Allison, EH (corresponding author), Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98195 USA.	eha1@uw.edu	Allison, Edward Hugh/B-8615-2009	Bassett, Hannah/0000-0001-7348-0293; Allison, Edward/0000-0003-4663-1396				Adger WN, 2013, NAT CLIM CHANGE, V3, P112, DOI [10.1038/NCLIMATE1666, 10.1038/nclimate1666]; Adger WN, 2009, FRONT ECOL ENVIRON, V7, P150, DOI 10.1890/070148; Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; Alongi DM, 2014, ANNU REV MAR SCI, V6, P195, DOI 10.1146/annurev-marine-010213-135020; [Anonymous], 2015, MSNBC; [Anonymous], 2015, EC INT UN WORLD OC S; Arora-Jonsson S, 2011, GLOBAL ENVIRON CHANG, V21, P744, DOI 10.1016/j.gloenvcha.2011.01.005; Barange M, 2014, NAT CLIM CHANGE, V4, P211, DOI [10.1038/NCLIMATE2119, 10.1038/nclimate2119]; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bark RH, 2010, CLIMATIC CHANGE, V102, P467, DOI 10.1007/s10584-009-9708-x; Bennett NJ, 2015, MAR POLICY, V57, P61, DOI 10.1016/j.marpol.2015.03.026; Bliuc AM, 2015, NAT CLIM CHANGE, V5, P226, DOI [10.1038/nclimate2507, 10.1038/NCLIMATE2507]; Bruckner T, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P511; Bulkeley H, 2010, ANNU REV ENV RESOUR, V35, P229, DOI 10.1146/annurev-environ-072809-101747; Bullard R., 2009, RACE PLACE ENV JUSTI, P19; Bunce Matthew, 2010, Environment Development and Sustainability, V12, P407, DOI 10.1007/s10668-009-9203-6; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Caniglia B.S., 2015, CLIMATE CHANGE SOC S, V1, P235, DOI DOI 10.1093/ACPROF:OSO/9780199356102.003.0008; Castree N, 2014, NAT CLIM CHANGE, V4, P763, DOI 10.1038/NCLIMATE2339; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Cinner JE, 2012, GLOBAL ENVIRON CHANG, V22, P12, DOI 10.1016/j.gloenvcha.2011.09.018; Ciplet D, 2013, GLOBAL ENVIRON POLIT, V13, P49, DOI 10.1162/GLEP_a_00153; Clarke L, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P413; Cochran P, 2013, CLIMATIC CHANGE, V120, P557, DOI 10.1007/s10584-013-0735-2; Corneloup ID, 2014, INT ENVIRON AGREEM-P, V14, P281, DOI 10.1007/s10784-013-9227-0; de Sherbinin A., 2011, CHOICE REV ONLINE; Delgado CL, 2003, J NUTR, V133, p3907S, DOI 10.1093/jn/133.11.3907S; Editorial, 2015, NAT CLIM CHANGE, V5, P899; Esteban M, 2012, APPL ENERG, V90, P128, DOI 10.1016/j.apenergy.2011.06.011; Field C.B., 2014, CLIM CHANG 2014 IMP, P1, DOI [DOI 10.1038/446727A, 10.1017/CBO9781107415379]; Galland G, 2012, CLIM POLICY, V12, P764, DOI 10.1080/14693062.2012.692207; Gattuso JP, 2015, SCIENCE, V349, DOI 10.1126/science.aac4722; Gelcich S, 2014, P NATL ACAD SCI USA, V111, P15042, DOI 10.1073/pnas.1417344111; Gossling S, 2005, ECOL ECON, V54, P417, DOI 10.1016/j.ecolecon.2004.10.006; Haalboom B, 2012, ARCTIC, V65, P319; Hall SJ., 2011, BLUE FRONTIERS MANAG; Harsem O, 2015, POLAR REC, V51, P91, DOI 10.1017/S0032247413000624; IPCC, 2013, CLIMATE CHANGE 2022; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Lewis R.R., 2009, COASTAL WETLANDS INT, P787, DOI 10.1016/C2018-0-02302-6; Leyshon C, 2014, CONTEMP SOC SCI, V9, P359, DOI 10.1080/21582041.2014.974890; Lynn K, 2013, CLIMATIC CHANGE, V120, P545, DOI 10.1007/s10584-013-0736-1; Meier WN, 2014, REV GEOPHYS, V52, P185, DOI 10.1002/2013RG000431; Naylor RL, 2007, P NATL ACAD SCI USA, V104, P7752, DOI 10.1073/pnas.0701825104; Nicholls RJ, 2014, WIRES CLIM CHANGE, V5, P129, DOI 10.1002/wcc.253; O'Neill S, 2009, SCI COMMUN, V30, P355, DOI 10.1177/1075547008329201; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Paul BK, 2009, NAT HAZARDS, V50, P289, DOI 10.1007/s11069-008-9340-5; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Stige LC, 2006, P NATL ACAD SCI USA, V103, P3049, DOI 10.1073/pnas.0600057103; Temmerman S, 2013, NATURE, V504, P79, DOI 10.1038/nature12859; Terry G., 2009, Gender and Development, V17, P5, DOI 10.1080/13552070802696839; Trenberth KE, 2015, NAT CLIM CHANGE, V5, P725, DOI 10.1038/NCLIMATE2657; Vadacchino L., 2011, 1064 FAO FISH AQ; Victor DG, 2015, NATURE, V520, P27, DOI 10.1038/520027a; Weber EU, 2013, NAT CLIM CHANGE, V3, P312, DOI 10.1038/nclimate1859; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wolf J, 2011, WIRES CLIM CHANGE, V2, P547, DOI 10.1002/wcc.120	60	72	74	4	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					778	782		10.1126/science.aac8721	http://dx.doi.org/10.1126/science.aac8721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW3MS	26564848				2022-12-28	WOS:000364897000035
J	Vogels, SN; Onvlee, J; Chefdeville, S; van der Avoird, A; Groenenboom, GC; van de Meerakker, SYT				Vogels, Sjoerd N.; Onvlee, Jolijn; Chefdeville, Simon; van der Avoird, Ad; Groenenboom, Gerrit C.; van de Meerakker, Sebastiaan Y. T.			Imaging resonances in low-energy NO-He inelastic collisions	SCIENCE			English	Article							DYNAMICAL RESONANCES; EXCITATION; PLUS	In molecular collisions, resonances occur at specific energies at which the colliding particles temporarily form quasibound complexes, resulting in rapid variations in the energy dependence of scattering cross sections. Experimentally, it has proven challenging to observe such scattering resonances, especially in differential cross sections. We report the observation of resonance fingerprints in the state-to-state differential cross sections for inelastic NO-He collisions in the 13 to 19 centimeter(-1) energy range with 0.3 centimeter(-1) resolution. The observed structures were in excellent agreement with quantum scattering calculations. They were analyzed by separating the resonance contributions to the differential cross sections from the background through a partitioning of the multichannel scattering matrix. This revealed the partial-wave composition of the resonances and their evolution during the collision.	[Vogels, Sjoerd N.; Onvlee, Jolijn; Chefdeville, Simon; van der Avoird, Ad; Groenenboom, Gerrit C.; van de Meerakker, Sebastiaan Y. T.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands	Radboud University Nijmegen	Groenenboom, GC (corresponding author), Radboud Univ Nijmegen, Inst Mol & Mat, Heijendaalseweg 135, NL-6525 AJ Nijmegen, Netherlands.	gerritg@theochem.ru.nl; basvdm@sciencesu.nl	Onvlee, Jolijn/T-1489-2017; van de Meerakker, Sebastiaan Y.T./D-4581-2012; Groenenboom, Gerrit C/F-9692-2015	Onvlee, Jolijn/0000-0001-6080-2548; 	Netherlands Organization for Scientific Research (NWO); NWO via VIDI; NWO via TOP; European Research Council	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO via VIDI; NWO via TOP; European Research Council(European Research Council (ERC)European Commission)	This work is part of the research program of the Foundation for Fundamental Research on Matter (FOM), which is supported financially by the Netherlands Organization for Scientific Research (NWO). S.Y.T.v.d.M. acknowledges further support from NWO via a VIDI and a TOP grant and from the European Research Council via a Starting Grant. We thank A. van Roij, C. Berkhout, N. Janssen, and P. Claus for expert technical support. We thank J. Klos for Providing us with his NO-He PESs. The authors declare no competing financial interests.	Bergeat A, 2015, NAT CHEM, V7, P349, DOI [10.1038/NCHEM.2204, 10.1038/nchem.2204]; Brems V, 2002, J CHEM PHYS, V117, P10635, DOI 10.1063/1.1521127; Chandler DW, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3357286; Chefdeville S, 2013, SCIENCE, V341, P1094, DOI 10.1126/science.1241395; Chefdeville S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.023201; Dong WR, 2010, SCIENCE, V327, P1501, DOI 10.1126/science.1185694; ERLEWEIN W, 1968, Z PHYS, V211, P35, DOI 10.1007/BF01421338; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Henson AB, 2012, SCIENCE, V338, P234, DOI 10.1126/science.1229141; Kim JB, 2015, SCIENCE, V349, P510, DOI 10.1126/science.aac6939; Kirste M, 2012, SCIENCE, V338, P1060, DOI [10.1126/science.1229549, 10.1126/science.1227491]; Lavert-Ofir E, 2014, NAT CHEM, V6, P332, DOI [10.1038/NCHEM.1857, 10.1038/nchem.1857]; Lester W.A., 1976, N COUPLED CHANNEL PR, P1; Qiu MH, 2006, SCIENCE, V311, P1440, DOI 10.1126/science.1123452; Ren ZF, 2008, P NATL ACAD SCI USA, V105, P12662, DOI 10.1073/pnas.0709974105; SHEEN SH, 1975, INT J QUANTUM CHEM, V9, P817, DOI 10.1002/qua.560090506; Shiu W, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.103201; Skodje RT, 2000, PHYS REV LETT, V85, P1206, DOI 10.1103/PhysRevLett.85.1206; Taylor J. R., 1972, SCATTERING THEORY; Wang T, 2013, SCIENCE, V342, P1499, DOI 10.1126/science.1246546; Yang TG, 2015, SCIENCE, V347, P60, DOI 10.1126/science.1260527	21	101	101	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					787	790		10.1126/science.aad2356	http://dx.doi.org/10.1126/science.aad2356			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW3MS	26564849	Green Submitted			2022-12-28	WOS:000364897000037
J	Roffet-Salque, M; Regert, M; Evershed, RR; Outram, AK; Cramp, LJE; Decavallas, O; Dunne, J; Gerbault, P; Mileto, S; Mirabaud, S; Paakkonen, M; Smyth, J; Soberl, L; Whelton, HL; Alday-Ruiz, A; Asplund, H; Bartkowiak, M; Bayer-Niemeier, E; Belhouchet, L; Bernardini, F; Budja, M; Cooney, G; Cubas, M; Danaher, EM; Diniz, M; Domboroczki, L; Fabbri, C; Gonzalez-Urquijo, JE; Guilaine, J; Hachi, S; Hartwell, BN; Hofmann, D; Hohle, I; Ibanez, JJ; Karul, N; Kherbouche, F; Kiely, J; Kotsakis, K; Lueth, F; Mallory, JP; Manen, C; Marciniak, A; Maurice-Chabard, B; McGonigle, MA; Mulazzani, S; Ozdogan, M; Peric, OS; Peric, SR; Petrasch, J; Petrequin, AM; Petrequie, P; Poensgen, U; Pollard, CJ; Poplin, F; Radi, G; Stadler, P; Stauble, H; Tasic, N; Urem-Kotsou, D; Vukovic, JB; Walsh, F; Whittle, A; Wolfram, S; Zapata-Pena, L; Zoughlami, J				Roffet-Salque, Melanie; Regert, Martine; Evershed, Richard R.; Outram, Alan K.; Cramp, Lucy J. E.; Decavallas, Orestes; Dunne, Julie; Gerbault, Pascale; Mileto, Simona; Mirabaud, Sigrid; Paakkonen, Mirva; Smyth, Jessica; Soberl, Lucija; Whelton, Helen L.; Alday-Ruiz, Alfonso; Asplund, Henrik; Bartkowiak, Marta; Bayer-Niemeier, Eva; Belhouchet, Lotfi; Bernardini, Federico; Budja, Mihael; Cooney, Gabriel; Cubas, Miriam; Danaher, Ed M.; Diniz, Mariana; Domboroczki, Laszlo; Fabbri, Cristina; Gonzalez-Urquijo, Jesus E.; Guilaine, Jean; Hachi, Slimane; Hartwell, Barrie N.; Hofmann, Daniela; Hohle, Isabel; Ibanez, Juan J.; Karul, Necmi; Kherbouche, Farid; Kiely, Jacinta; Kotsakis, Kostas; Lueth, Friedrich; Mallory, James P.; Manen, Claire; Marciniak, Arkadiusz; Maurice-Chabard, Brigitte; McGonigle, Martin A.; Mulazzani, Simone; Ozdogan, Mehmet; Peric, Olga S.; Peric, Slavisa R.; Petrasch, Joerg; Petrequin, Anne-Marie; Petrequie, Pierre; Poensgen, Ulrike; Pollard, C. Joshua; Poplin, Francois; Radi, Giovanna; Stadler, Peter; Staeuble, Harald; Tasic, Nenad; Urem-Kotsou, Dushka; Vukovic, Jasna B.; Walsh, Fintan; Whittle, Alasdair; Wolfram, Sabine; Zapata-Pena, Lydia; Zoughlami, Jamel			Widespread exploitation of the honeybee by early Neolithic farmers	NATURE			English	Article							IONIZATION MASS-SPECTROMETRY; APIS-MELLIFERA; BEESWAX; RESIDUES; VESSELS	The pressures on honeybee (Apis mellifera) populations, resulting from threats by modern pesticides, parasites, predators and diseases, have raised awareness of the economic importance and critical role this insect plays in agricultural societies across the globe. However, the association of humans with A. mellifera predates post-industrial-revolution agriculture, as evidenced by the widespread presence of ancient Egyptian bee iconography dating to the Old Kingdom (approximately 2400 BC)(1). There are also indications of Stone Age people harvesting bee products; for example, honey hunting is interpreted from rock art(2) in a prehistoric Holocene context and a beeswax find in a pre-agriculturalist site(3). However, when and where the regular association of A. mellifera with agriculturalists emerged is unknown(4). One of the major products of A. mellifera is beeswax, which is composed of a complex suite of lipids including n-alkanes, n-alkanoic acids and fatty acyl wax esters. The composition is highly constant as it is determined genetically through the insect's biochemistry. Thus, the chemical 'fingerprint' of beeswax provides a reliable basis for detecting this commodity in organic residues preserved at archaeological sites, which we now use to trace the exploitation by humans of A. mellifera temporally and spatially. Here we present secure identifications of beeswax in lipid residues preserved in pottery vessels of Neolithic Old World farmers. The geographical range of bee product exploitation is traced in Neolithic Europe, the Near East and North Africa, providing the palaeoecological range of honeybees during prehistory. Temporally, we demonstrate that bee products were exploited continuously, and probably extensively in some regions, at least from the seventh millennium cal BC, likely fulfilling a variety of technological and cultural functions. The close association of A. mellifera with Neolithic farming communities dates to the early onset of agriculture and may provide evidence for the beginnings of a domestication process.	[Roffet-Salque, Melanie; Evershed, Richard R.; Cramp, Lucy J. E.; Dunne, Julie; Mileto, Simona; Paakkonen, Mirva; Smyth, Jessica; Soberl, Lucija; Whelton, Helen L.] Univ Bristol, Sch Chem, Organ Geochem Unit, Bristol BS8 1TS, Avon, England; [Regert, Martine] Univ Nice Sophia Antipolis, CNRS, UMR 7264, CEPAM Cultures & Environm Prehist Antiqu Moyen Ag, F-06300 Nice, France; [Outram, Alan K.] Univ Exeter, Dept Archaeol, Exeter EX4 4QE, Devon, England; [Cramp, Lucy J. E.; Smyth, Jessica] Univ Bristol, Dept Archaeol & Anthropol, Bristol BS8 1UU, Avon, England; [Decavallas, Orestes] Univ Bordeaux Montaigne, F-33607 Pessac, France; [Decavallas, Orestes; Mirabaud, Sigrid] Lab Ctr Rech & Restaurat Musees France C2RMF, UMR 171, F-75001 Paris, France; [Gerbault, Pascale] UCL, Res Dept Genet Evolut & Environm, London WC1E 6BT, England; [Gerbault, Pascale] UCL, Dept Anthropol, London WC1H 0BW, England; [Mileto, Simona] Free Univ Berlin, Inst Prahist Archaol, D-14195 Berlin, Germany; [Paakkonen, Mirva; Asplund, Henrik] Univ Turku, Dept Archaeol, Turun 20014, Finland; [Soberl, Lucija; Budja, Mihael] Univ Ljubljana, Fac Arts, Dept Archaeol, Ljubljana 1000, Slovenia; [Alday-Ruiz, Alfonso; Zapata-Pena, Lydia] Univ Basque Country EHU UPV, Dept Geog Prehist & Archaeol, Vitoria 01006, Spain; [Bartkowiak, Marta; Marciniak, Arkadiusz] Adam Mickiewicz Univ, Inst Prehist, PL-61614 Poznan, Poland; [Bayer-Niemeier, Eva] Museum Quintana Archaol Kunzing, Partnermuseum Archaol Staatssammlung Munchen, D-94550 Kunzing, Germany; [Belhouchet, Lotfi] Musee Archeol Sousse, Sousse 4000, Tunisia; [Bernardini, Federico] Museo Stor Fis, Ctr Fermi, I-00184 Rome, Italy; [Bernardini, Federico] Ctr Studi & Ric Enrico Fermi, I-00184 Rome, Italy; [Bernardini, Federico] Abdus Salam Int Ctr Theoret Phys, Multidisciplinary Lab, I-34151 Trieste, Italy; [Cooney, Gabriel] Univ Coll Dublin, UCD Sch Archaeol, Dublin 4, Ireland; [Cubas, Miriam; Gonzalez-Urquijo, Jesus E.] Univ Cantabria, Int Inst Prehist Res Cantabria, E-39005 Santander, Spain; [Danaher, Ed M.] Natl Univ Ireland Univ Coll Galway, Dept Archaeol, Galway, Ireland; [Diniz, Mariana] Univ Lisbon, Fac Letras Lisboa, UNIARQ Dept Hist, P-1600214 Lisbon, Portugal; [Domboroczki, Laszlo] Istvan Dobo Castle Museum, H-3300 Eger, Hungary; [Fabbri, Cristina; Radi, Giovanna] Univ Pisa, Dipartimento Civilta & Forme Sapere, I-56126 Pisa, Italy; [Guilaine, Jean; Manen, Claire] Univ Toulouse Jean Jaures, Maison Rech, CNRS UMR TRACES 5608, F-31058 Toulouse 9, France; [Hachi, Slimane; Kherbouche, Farid] CNRPAH, Algiers, Algeria; [Hartwell, Barrie N.; Mallory, James P.] Queens Univ Belfast, Sch Geog Archaeol & Palaeoecol, Belfast BT7 1NN, Antrim, North Ireland; [Hofmann, Daniela] Univ Hamburg, Archaol Inst, D-20146 Hamburg, Germany; [Hohle, Isabel] Artes Grad Sch Humanities Cologne, Graduiertenschule Philosoph Fak, D-50931 Cologne, Germany; [Ibanez, Juan J.] IMF CSIC, Barcelona 08001, Spain; [Karul, Necmi; Ozdogan, Mehmet] Istanbul Univ, Fac Letters, Dept Prehist, TR-34434 Laleli Istanbul, Turkey; [Kiely, Jacinta] Eachtra Archaeol Projects, Clashmore, Waterford, Ireland; [Kotsakis, Kostas] Aristotle Univ Thessaloniki, Fac Philosophy, Sch Hist & Archaeol, Thessaloniki 54124, Greece; [Lueth, Friedrich] German Archaeol Inst, D-14195 Berlin, Germany; [Maurice-Chabard, Brigitte] Musee Rolin, F-71400 Autun, France; [McGonigle, Martin A.] John Cronin & Associates, Buncrana, Donegal, Ireland; [Mulazzani, Simone] Aix Marseille Univ, CNRS, UMR LAMPEA 7269, Ministere Culture & Commun,LabexMed, F-13234 Marseille, France; [Mulazzani, Simone] Univ Roma La Sapienza, Dipartimento Biol Ambientale, I-00185 Rome, Italy; [Peric, Olga S.; Peric, Slavisa R.] Inst Archaeol Belgrade, Belgrade 11000, Serbia; [Petrasch, Joerg] Univ Tubingen, Inst Ur & Fruhgeschichte & Archaol Mittelalters, Abt Jungere Urgeschichte & Fruhgeschichte Schloss, D-72070 Tubingen, Germany; [Petrequin, Anne-Marie; Petrequie, Pierre] CNRS, Maison Sci Homme & Environm CN Ledoux, F-25030 Besancon, France; [Petrequin, Anne-Marie; Petrequie, Pierre] Univ Franche Comte, F-25030 Besancon, France; [Pollard, C. Joshua] Univ Southampton, Fac Humanities, Dept Archaeol, Southampton SO17 1BF, Hants, England; [Poplin, Francois] Museum Natl Hist Nat, F-75005 Paris, France; [Stadler, Peter] Univ Vienna, Dept Pre & Protohist, A-1190 Vienna, Austria; [Staeuble, Harald] Landesamt Archaeol, D-01109 Dresden, Germany; [Tasic, Nenad; Vukovic, Jasna B.] Univ Belgrade, Fac Philosophy, Dept Archaeol, Belgrade 11000, Serbia; [Urem-Kotsou, Dushka] Democritus Univ Thrace, Dept Hist & Ethnol, Komotini, Greece; [Walsh, Fintan] Irish Archaeol Consultancy, Kilcoole, Wicklow, Ireland; [Whittle, Alasdair] Cardiff Univ, Dept Archaeol & Conservat, Cardiff CF10 3EU, S Glam, Wales; [Wolfram, Sabine] State Museum Archaeol Chemnitz, D-09111 Chemnitz, Germany; [Zoughlami, Jamel] Musee Archeol Carthage, Inst Natl Patrimoine Tunis, Carthage, Tunisia	University of Bristol; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Cote d'Azur; University of Exeter; University of Bristol; University of London; University College London; University of London; University College London; Free University of Berlin; University of Turku; University of Ljubljana; University of Basque Country; Adam Mickiewicz University; Abdus Salam International Centre for Theoretical Physics (ICTP); University College Dublin; Universidad de Cantabria; Instituto Internacional de Investigaciones Prehistoricas de Cantabria (IIIPC); Ollscoil na Gaillimhe-University of Galway; Universidade de Lisboa; University of Pisa; Universite de Toulouse; Universite de Toulouse - Jean Jaures; National Centre for Prehistoric, Anthropologic & Historic Research - Algeria; Queens University Belfast; University of Hamburg; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institucion Mila y Fontanals (IMF); Istanbul University; Aristotle University of Thessaloniki; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Sapienza University Rome; Eberhard Karls University of Tubingen; Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; Universite de Franche-Comte; University of Southampton; Museum National d'Histoire Naturelle (MNHN); University of Vienna; University of Belgrade; Democritus University of Thrace; Cardiff University; Universite de Tunis; Institut National du Patrimoine	Roffet-Salque, M (corresponding author), Univ Bristol, Sch Chem, Organ Geochem Unit, Cantocks Close, Bristol BS8 1TS, Avon, England.	melanie.salque@bristol.ac.uk; martine.regert@cepam.cnrs.fr; r.p.evershed@bristol.ac.uk; p.gerbault@ucl.ac.uk	Cubas, Miriam/C-9226-2018; İriz, Erkan/AAF-2026-2019; Karul, Necmi/AAC-5860-2020; Marciniak, Arkadiusz/AAJ-3328-2020; Gonzalez-Urquijo, Jesus/H-7708-2015; Mileto, Simona/AAA-7403-2020; Cramp, Lucy/AAL-6905-2021	Cubas, Miriam/0000-0002-2386-8473; Gonzalez-Urquijo, Jesus/0000-0001-6106-4997; Mileto, Simona/0000-0001-9765-3814; Roffet-Salque, Melanie/0000-0001-9508-788X; Gerbault, Pascale/0000-0003-3824-0870; Smyth, Jessica/0000-0001-8124-1444; Bernardini, Federico/0000-0002-3282-8799; Vukovic, Jasna/0000-0002-7261-6467; Petrasch, Jorg/0000-0002-1297-5994; Alday, Alfonso/0000-0002-0024-3462; Outram, Alan/0000-0003-3360-089X; Whelton, Helen/0000-0002-0844-9916	UK Natural Environment Research Council [R8/H10/63]; English Heritage; European Research Council; Leverhulme Trust; Ministere de la Culture et de la Communication; Ministere de l'Enseignement Superieur et de la Recherche (ACI Jeunes Chercheurs); Natural Environment Research Council; Region PACA; Royal Society; Wellcome Trust; Natural Environment Research Council [1257864, NE/F021054/1] Funding Source: researchfish; NERC [NE/F021054/1] Funding Source: UKRI	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); English Heritage; European Research Council(European Research Council (ERC)European Commission); Leverhulme Trust(Leverhulme Trust); Ministere de la Culture et de la Communication; Ministere de l'Enseignement Superieur et de la Recherche (ACI Jeunes Chercheurs); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Region PACA(Region Provence-Alpes-Cote d'Azur); Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the UK Natural Environment Research Council for partial funding of the mass spectrometry facilities at Bristol (contract no R8/H10/63: http://www.Ismsf.co.uk) and English Heritage, European Research Council, Leverhulme Trust, Ministere de la Culture et de la Communication, Ministere de l'Enseignement Superieur et de la Recherche (ACI Jeunes Chercheurs), Natural Environment Research Council, Region PACA, Royal Society and Wellcome Trust for funding.	Abou-Shaara HF, 2014, VET MED-CZECH, V59, P1, DOI 10.17221/7240-VETMED; Aichholz R, 1999, J CHROMATOGR A, V855, P601, DOI 10.1016/S0021-9673(99)00725-6; Akima H, 1996, ACM T MATH SOFTWARE, V22, P362, DOI 10.1145/232826.232856; Akima H., 1978, ACM Transactions on Mathematical Software, V4, P148, DOI 10.1145/355780.355786; [Anonymous], 1971, INSECT SOC; Bartlein PJ, 2011, CLIM DYNAM, V37, P775, DOI 10.1007/s00382-010-0904-1; Bernardini F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044904; Buckland P. I., 2006, VERSIONS BUGSCEP V7; Carreck NL, 2008, J APICULT RES, V47, P318, DOI 10.3896/IBRA.1.47.4.15; Copley MS, 2005, J ARCHAEOL SCI, V32, P523, DOI 10.1016/j.jas.2004.08.006; Cramp LJE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0819; Cramp LJE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2372; Crane E., 1999, WORLD HIST BEEKEEPIN, DOI DOI 10.4324/9780203819937; d'Errico F, 2012, P NATL ACAD SCI USA, V109, P13214, DOI 10.1073/pnas.1204213109; DAMS M, 1977, NATURE, V268, P228, DOI 10.1038/268228a0; Decavallas O., 2007, COOKING FOOD CULINAR, P148; Evershed RP, 2008, NATURE, V455, P528, DOI 10.1038/nature07180; Evershed RP, 2003, J ARCHAEOL SCI, V30, P1, DOI 10.1006/jasc.2001.0827; Evershed RP, 1997, ANTIQUITY, V71, P979, DOI 10.1017/S0003598X00085860; Garnier N, 2002, ANAL CHEM, V74, P4868, DOI 10.1021/ac025637a; HERON C, 1994, NATURWISSENSCHAFTEN, V81, P266, DOI 10.1007/BF01131579; Heron C., 2007, SHELL MIDDENS ATLANT; Larson G, 2014, ANNU REV ECOL EVOL S, V45, P115, DOI 10.1146/annurev-ecolsys-110512-135813; Limbrey S, 1982, ARCHAEOLOGICAL ASPEC, P279; Mayyas A. S., 2012, ANN FACULTY ARTS AIN, V40, P343; MELLAART J, 1963, ANATOL STUD, V13, P43, DOI DOI 10.2307/3642490; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; R Core Team, 2012, R LANG ENV STAT COMP; Regert M, 2001, BRIT ARCHAEOL REP IN, VS939, P78; Regert M, 2001, ARCHAEOMETRY, V43, P549, DOI 10.1111/1475-4754.00036; Ruttner F., 1987, BIOGEOGRAPHY TAXONOM; Salque M, 2013, NATURE, V493, P522, DOI 10.1038/nature11698; Soberl L., 2014, DOC PRAEHIST, VXLI, P149, DOI 10.4312/dp.41.9; Wallberg A, 2014, NAT GENET, V46, P1081, DOI 10.1038/ng.3077	34	96	100	7	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					226	+		10.1038/nature15757	http://dx.doi.org/10.1038/nature15757			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26560301	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000364396700043
J	Guglani, S				Guglani, Samir			The given world	LANCET			English	Editorial Material									Cheltenham Gen Hosp, Ctr Oncol, Cheltenham GL53 7AN, Glos, England	Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital	Guglani, S (corresponding author), Cheltenham Gen Hosp, Ctr Oncol, Cheltenham GL53 7AN, Glos, England.	sam@medicineunboxed.org							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2015	386	10004					1622	1623		10.1016/S0140-6736(15)00545-0	http://dx.doi.org/10.1016/S0140-6736(15)00545-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU0HS	26595625	Bronze			2022-12-28	WOS:000363197500017
J	Cassese, S; Byrne, RA; Ndrepepa, G; Kufner, S; Wiebe, J; Repp, J; Schunkert, H; Fusaro, M; Kimura, T; Kastrati, A				Cassese, Salvatore; Byrne, Robert A.; Ndrepepa, Gjin; Kufner, Sebastian; Wiebe, Jens; Repp, Janika; Schunkert, Heribert; Fusaro, Massimiliano; Kimura, Takeshi; Kastrati, Adnan			Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials	LANCET			English	Article							SYSTEMATIC REVIEWS; PERFORMANCE; RATIONALE	Background Bioresorbable coronary stents might improve outcomes of patients treated with percutaneous coronary interventions. The everolimus-eluting bioresorbable vascular scaffold is the most studied of these stent platforms; however, its performance versus everolimus-eluting metallic stents remains poorly defined. We aimed to assess the efficacy and safety of everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ischaemic heart disease treated with percutaneous revascularisation. Methods We searched Medline, Embase, the Cochrane Central Register of Controlled Trials (CENTRAL), scientific sessions abstracts, and relevant websites for randomised trials investigating everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents published or posted between Nov 30, 2006, and Oct 12, 2015. The primary efficacy outcome was target lesion revascularisation and the primary safety outcome was definite or probable stent (scaffold) thrombosis. Secondary outcomes were target lesion failure (the composite of cardiac death, target-vessel myocardial infarction, or ischaemia-driven target lesion revascularisation), myocardial infarction, death, and in-device late lumen loss. We derived odds ratios (ORs) and weighted mean differences with 95% CIs, and calculated the risk estimates for the main outcomes according to a random-effects model. This study is registered with PROSPERO, number CRD42015026374. Findings We included six trials, comprising data for 3738 patients randomised to receive percutaneous coronary intervention with either an everolimus-eluting bioresorbable vascular scaffold (n=2337) or an everolimus-eluting metallic stent (n=1401). Median follow-up was 12 months (IQR 9-12). Patients treated with bioresorbable vascular scaffolds had a similar risk of target lesion revascularisation (OR 0.97 [95% CI 0.66-1.43]; p=0.87), target lesion failure (1.20 [0.90-1.60]; p=0.21), myocardial infarction (1.36 [0.98-1.89]; p=0.06), and death (0.95 [0.45-2.00]; p=0.89) as those treated with metallic stents. Patients treated with a bioresorbable vascular scaffold had a higher risk of definite or probable stent thrombosis than those treated with a metallic stent (OR 1.99 [95% CI 1.00-3.98]; p=0.05), with the highest risk between 1 and 30 days after implantation (3.11 [1.24-7.82]; p=0.02). Lesions treated with a bioresorbable vascular scaffold had greater in-device late lumen loss than those treated with a metallic stent (weighted mean difference 0.08 [95% CI 0.05-0.12]; p<0.0001). Interpretation Compared with everolimus-eluting metallic stents, everolimus-eluting bioresorbable vascular scaffolds had similar rates of repeat revascularisation at 1 year of follow-up, despite inferior mid-term angiographic performance. However, patients treated with a bioresorbable vascular scaffold had an increased risk of subacute stent thrombosis. Studies with extended follow-up in a larger number of patients are needed to fully assess the long-term advantages of everolimus-eluting bioresorbable vascular scaffolds.	[Cassese, Salvatore; Byrne, Robert A.; Ndrepepa, Gjin; Kufner, Sebastian; Wiebe, Jens; Repp, Janika; Schunkert, Heribert; Fusaro, Massimiliano; Kastrati, Adnan] Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80636 Munich, Germany; [Schunkert, Heribert; Kastrati, Adnan] Partner Site Munich Heart Alliance, DZHK German Ctr Cardiovascr Res, Munich, Germany; [Kimura, Takeshi] Kyoto Univ Hosp, Dept Cardiovasc Med, Kyoto 606, Japan	German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Kyoto University	Cassese, S (corresponding author), Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80636 Munich, Germany.	cassese@dhm.mhn.de	, Kastrati/Y-2389-2019; Byrne, Robert/C-3902-2016	Byrne, Robert/0000-0001-5224-6393	B Braun Melsungen AG; Biotronik; Boston Scientific; Grants-in-Aid for Scientific Research [25293182] Funding Source: KAKEN	B Braun Melsungen AG; Biotronik; Boston Scientific(Boston Scientific); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	RAB has received fees from B Braun Melsungen AG, Biotronik, and Boston Scientific, outside the submitted work. TK is member of the advisory board of Abbott. AK holds patents in relation to drug-eluting stent technologies, outside the submitted work. All other authors declare no competing interests.	BARNARD GA, 1989, STAT MED, V8, P1469, DOI 10.1002/sim.4780081206; Booth A, 2011, LANCET, V377, P108, DOI 10.1016/S0140-6736(10)60903-8; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Byrne RA, 2015, JACC-CARDIOVASC INTE, V8, P198, DOI 10.1016/j.jcin.2014.11.010; Capodanno D, 2015, EUROINTERVENTION, V10, P1144, DOI 10.4244/EIJY14M07_11; Ellis SG, 2015, NEW ENGL J MED, V373, P1905, DOI 10.1056/NEJMoa1509038; Gao RL, 2015, J AM COLL CARDIOL, V66, P2298, DOI 10.1016/j.jacc.2015.09.054; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Iqbal J, 2014, EUR HEART J, V35, P765, DOI 10.1093/eurheartj/eht542; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kimura T, 2015, EUR HEART J, V36, P3332, DOI 10.1093/eurheartj/ehv435; Mattesini A, 2014, JACC-CARDIOVASC INTE, V7, P741, DOI 10.1016/j.jcin.2014.01.165; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Otsuka F, 2015, EUR HEART J, V36, P2147, DOI 10.1093/eurheartj/ehv205; Otsuka F, 2014, CIRC-CARDIOVASC INTE, V7, P330, DOI 10.1161/CIRCINTERVENTIONS.113.000990; Puricel S, 2015, J AM COLL CARDIOL, V65, P791, DOI 10.1016/j.jacc.2014.12.017; Sabate M, 2015, EUR HEART J; Serruys PW, 2015, LANCET, V385, P43, DOI 10.1016/S0140-6736(14)61455-0; Serruys PW, 2014, EUROINTERVENTION, V9, P1271, DOI 10.4244/EIJV9I11A217; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Wiebe J, 2014, J AM COLL CARDIOL, V64, P2541, DOI 10.1016/j.jacc.2014.09.041; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Woudstra P, 2014, AM HEART J, V167, P133, DOI 10.1016/j.ahj.2013.09.017	23	291	298	3	66	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2016	387	10018					537	544		10.1016/S0140-6736(15)00979-4	http://dx.doi.org/10.1016/S0140-6736(15)00979-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3PV	26597771				2022-12-28	WOS:000369835800032
J	Zhao, LD; Tan, GJ; Hao, SQ; He, JQ; Pei, YL; Chi, H; Wang, H; Gong, SK; Xu, HB; Dravid, VP; Uher, C; Snyder, GJ; Wolverton, C; Kanatzidis, MG				Zhao, Li-Dong; Tan, Gangjian; Hao, Shiqiang; He, Jiaqing; Pei, Yanling; Chi, Hang; Wang, Heng; Gong, Shengkai; Xu, Huibin; Dravid, Vinayak P.; Uher, Ctirad; Snyder, G. Jeffrey; Wolverton, Chris; Kanatzidis, Mercouri G.			Ultrahigh power factor and thermoelectric performance in hole-doped single-crystal SnSe	SCIENCE			English	Article							FIGURE; MERIT; HEAT	Thermoelectric technology, harvesting electric power directly from heat, is a promising environmentally friendly means of energy savings and power generation. The thermoelectric efficiency is determined by the device dimensionless figure of merit ZT(dev), and optimizing this efficiency requires maximizing ZT values over a broad temperature range. Here, we report a record high ZT(dev) similar to 1.34, with ZT ranging from 0.7 to 2.0 at 300 to 773 kelvin, realized in hole-doped tin selenide (SnSe) crystals. The exceptional performance arises from the ultrahigh power factor, which comes from a high electrical conductivity and a strongly enhanced Seebeck coefficient enabled by the contribution of multiple electronic valence bands present in SnSe. SnSe is a robust thermoelectric candidate for energy conversion applications in the low and moderate temperature range.	[Zhao, Li-Dong; Pei, Yanling; Gong, Shengkai; Xu, Huibin] Beihang Univ, Sch Mat Sci & Engn, Beijing 100191, Peoples R China; [Zhao, Li-Dong; Tan, Gangjian; Kanatzidis, Mercouri G.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Hao, Shiqiang; Dravid, Vinayak P.; Snyder, G. Jeffrey; Wolverton, Chris] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [He, Jiaqing] South Univ Sci & Technol China, Dept Phys, Shenzhen 518055, Peoples R China; [Chi, Hang; Uher, Ctirad] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Wang, Heng] CALTECH, Mat Sci, Pasadena, CA 91125 USA	Beihang University; Northwestern University; Northwestern University; Southern University of Science & Technology; University of Michigan System; University of Michigan; California Institute of Technology	Zhao, LD (corresponding author), Beihang Univ, Sch Mat Sci & Engn, Beijing 100191, Peoples R China.	zhaolidong@buaa.edu.cn; m-kanatzidis@northwestern.edu	Dravid, Vinayak/B-6688-2009; He, Jiaqing/A-2245-2010; Zhao, Li-Dong/B-1045-2019; Tan, Gangjian/AAG-5433-2019; Wolverton, Chris/AAZ-3899-2020; Chi, Hang/F-1537-2011; Snyder, G J/I-2263-2015; Wolverton, Christopher/B-7542-2009; Snyder, G. Jeffrey/E-4453-2011	He, Jiaqing/0000-0003-3954-6003; Zhao, Li-Dong/0000-0003-1247-4345; Tan, Gangjian/0000-0002-9087-4048; Chi, Hang/0000-0002-1299-1150; Snyder, G. Jeffrey/0000-0003-1414-8682	U.S. Department of Energy, Office of Science and Office of Basic Energy Sciences [DE-SC0014520]; S3TEC-EFRC [DE-SC0001299]; Beihang University; Recruitment Program for Young Professionals; National Natural Science Foundation of China [51571007]; Science, Technology and Innovation Commission of Shenzhen Municipality [ZDSYS20141118160434515]; Guangdong Science and Technology Fund [2015A030308001]; Energy Frontier Research Centers (EFRC) [DE-SC0001054]	U.S. Department of Energy, Office of Science and Office of Basic Energy Sciences(United States Department of Energy (DOE)); S3TEC-EFRC; Beihang University; Recruitment Program for Young Professionals; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science, Technology and Innovation Commission of Shenzhen Municipality; Guangdong Science and Technology Fund; Energy Frontier Research Centers (EFRC)	This work was supported in part by the U.S. Department of Energy, Office of Science and Office of Basic Energy Sciences, under award DE-SC0014520 (G.T., H.C., V.P.D., S.H., C.W., and M.G.K.); and S3TEC-EFRC grant DE-SC0001299 (G.J.S.). This work was also supported by the "Zhuoyue" Program from Beihang University and the Recruitment Program for Young Professionals and the National Natural Science Foundation of China under grant 51571007 (L.-D.Z., Y.P., S.G., and H.X.). and by the Science, Technology and Innovation Commission of Shenzhen Municipality under grant no. ZDSYS20141118160434515 and Guangdong Science and Technology Fund under grant no. 2015A030308001 (J.H.). The synthesis, characterization, transport measurements, and DFT calculations were supported by DE-SC0014520. The validation measurements were supported by DE-SC0001299. Measurements at University of Michigan (C.U.) were supported by Energy Frontier Research Centers (EFRC) grant DE-SC0001054. All data in the main text and the supplementary materials are available online at www.sciencemag.org.	Bell LE, 2008, SCIENCE, V321, P1457, DOI 10.1126/science.1158899; Biswas K, 2012, NATURE, V489, P414, DOI 10.1038/nature11439; Chen CL, 2014, J MATER CHEM A, V2, P11171, DOI 10.1039/c4ta01643b; Dresselhaus MS, 2007, ADV MATER, V19, P1043, DOI 10.1002/adma.200600527; Heremans JP, 2008, SCIENCE, V321, P554, DOI 10.1126/science.1159725; Heremans JP, 2013, NAT NANOTECHNOL, V8, P471, DOI 10.1038/nnano.2013.129; Hsu KF, 2004, SCIENCE, V303, P818, DOI 10.1126/science.1092963; Kim SI, 2015, SCIENCE, V348, P109, DOI 10.1126/science.aaa4166; Li CW, 2015, NAT PHYS, V11, P1063, DOI [10.1038/nphys3492, 10.1038/NPHYS3492]; Liu W, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.166601; Nassary MM, 2009, TURK J PHYS, V33, P201, DOI 10.3906/fiz-0811-9; Pei YZ, 2012, ADV MATER, V24, P6125, DOI 10.1002/adma.201202919; Pei YZ, 2011, NATURE, V473, P66, DOI 10.1038/nature09996; PLACHKOVA SK, 1984, PHYS STATUS SOLIDI A, V83, P349, DOI 10.1002/pssa.2210830140; Poudel B, 2008, SCIENCE, V320, P634, DOI 10.1126/science.1156446; Poudeu PFR, 2006, ANGEW CHEM INT EDIT, V45, P3835, DOI 10.1002/anie.200600865; Rowe D. M., 1995, CRC HDB THERMOELECTR; Sassi S, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4880817; Serrano-Sanchez F, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4913260; Shi GS, 2015, J APPL PHYS, V117, DOI 10.1063/1.4907805; Shi X, 2011, J AM CHEM SOC, V133, P7837, DOI 10.1021/ja111199y; Smirnov, 1970, SEMICONDUCTING LEAD, V5; Snyder G. J., 2006, THERMOELECTRICS HDB; Tan GJ, 2014, J AM CHEM SOC, V136, P7006, DOI 10.1021/ja500860m; Wang H, 2011, ADV MATER, V23, P1366, DOI 10.1002/adma.201004200; Wu HJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5515; Zhang Q, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201500360; Zhang X, 2015, J MATERIOMICS, V1, P92, DOI 10.1016/j.jmat.2015.01.001; Zhao HZ, 2014, NANO ENERGY, V7, P97, DOI 10.1016/j.nanoen.2014.04.012; Zhao LD, 2014, NATURE, V508, P373, DOI 10.1038/nature13184; Zhao LD, 2014, ENERG ENVIRON SCI, V7, P251, DOI 10.1039/c3ee43099e; Zhao LD, 2013, J AM CHEM SOC, V135, P7364, DOI 10.1021/ja403134b; Zhao LD, 2012, J AM CHEM SOC, V134, P7902, DOI 10.1021/ja301772w; Zhou M, 2008, J AM CHEM SOC, V130, P4527, DOI 10.1021/ja7110652	34	1314	1332	83	1843	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					141	144		10.1126/science.aad3749	http://dx.doi.org/10.1126/science.aad3749			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XQ	26612831				2022-12-28	WOS:000367806500033
J	Paul, F; Arkin, Y; Giladi, A; Jaitin, DA; Kenigsberg, E; Keren-Shaul, H; Winter, D; Lara-Astiaso, D; Gury, M; Weiner, A; David, E; Cohen, N; Lauridsen, FKB; Haas, S; Schlitzer, A; Mildner, A; Ginhoux, F; Jung, S; Trumpp, A; Porse, BT; Tanay, A; Amit, I				Paul, Franziska; Arkin, Ya'ara; Giladi, Amir; Jaitin, Diego Adhemar; Kenigsberg, Ephraim; Keren-Shaul, Hadas; Winter, Deborah; Lara-Astiaso, David; Gury, Meital; Weiner, Assaf; David, Eyal; Cohen, Nadav; Lauridsen, Felicia Kathrine Bratt; Haas, Simon; Schlitzer, Andreas; Mildner, Alexander; Ginhoux, Florent; Jung, Steffen; Trumpp, Andreas; Porse, Bo Torben; Tanay, Amos; Amit, Ido			Transcriptional Heterogeneity and Lineage Commitment in Myeloid Progenitors	CELL			English	Article							HEMATOPOIETIC STEM-CELLS; C/EBP-ALPHA; SELF-RENEWAL; RNA-SEQ; EXPRESSION; GENE; DIFFERENTIATION; IDENTIFICATION; SPECIFICATION; MACROPHAGE	Within the bone marrow, stem cells differentiate and give rise to diverse blood cell types and functions. Currently, hematopoietic progenitors are defined using surface markers combined with functional assays that are not directly linked with in vivo differentiation potential or gene regulatory mechanisms. Here, we comprehensively map myeloid progenitor sub-populations by transcriptional sorting of single cells from the bone marrow. We describe multiple progenitor subgroups, showing unexpected transcriptional priming toward seven differentiation fates but no progenitors with a mixed state. Transcriptional differentiation is correlated with combinations of known and previously undefined transcription factors, suggesting that the process is tightly regulated. Histone maps and knockout assays are consistent with early transcriptional priming, while traditional transplantation experiments suggest that in vivo priming may still allow for plasticity given strong perturbations. These data establish a reference model and general framework for studying hematopoiesis at single-cell resolution.	[Paul, Franziska; Giladi, Amir; Jaitin, Diego Adhemar; Keren-Shaul, Hadas; Winter, Deborah; Lara-Astiaso, David; Gury, Meital; Weiner, Assaf; David, Eyal; Mildner, Alexander; Jung, Steffen; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Arkin, Ya'ara; Kenigsberg, Ephraim; Cohen, Nadav; Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Arkin, Ya'ara; Kenigsberg, Ephraim; Cohen, Nadav; Tanay, Amos] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Lauridsen, Felicia Kathrine Bratt; Porse, Bo Torben] Univ Copenhagen, Rigshosp, Finsen Lab, DK-2200 Copenhagen, Denmark; [Lauridsen, Felicia Kathrine Bratt; Porse, Bo Torben] BRIC, DK-2200 Copenhagen, Denmark; [Lauridsen, Felicia Kathrine Bratt; Porse, Bo Torben] Univ Copenhagen, Fac Hlth Sci, Danish Stem Cell Ctr DanStem, DK-2200 Copenhagen, Denmark; [Haas, Simon] Deutsch Krebsforschungszentrum, Div Stem Cells & Canc, D-69120 Heidelberg, Germany; [Schlitzer, Andreas; Ginhoux, Florent] ASTAR, BIOPOLIS, Singapore Immunol Network SIgN, Singapore 138648, Singapore; [Schlitzer, Andreas] Univ Bonn, Life & Med Sci LIMES Inst, Genom & Immunoregulat, D-53115 Bonn, Germany	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Helmholtz Association; German Cancer Research Center (DKFZ); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of Bonn	Tanay, A (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	amos.tanay@weizmann.ac.il; ido.amit@weizmann.ac.il	mildner, alexander/GQA-3761-2022; Kenigsberg, Ephraim/AAM-5690-2020; mildner, alexander/AAF-9451-2022; Trumpp, Andreas/Z-2141-2019; mildner, alexander/AFK-2161-2022; Mildner, Alexander/ABG-6122-2020; Winter, Deborah R./AAQ-9253-2020; Schlitzer, Andreas/R-2237-2016; Jung, Steffen/K-1409-2012	mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; Trumpp, Andreas/0000-0002-6212-3466; mildner, alexander/0000-0002-2019-8427; Winter, Deborah R./0000-0003-1806-673X; Schlitzer, Andreas/0000-0001-7662-3712; Jung, Steffen/0000-0003-4290-5716; Haas, Simon/0000-0001-9227-2051; Porse, Bo/0000-0001-6043-0844; Paul, Franziska/0000-0003-0344-6764	European Research Council; I-CORE for chromatin and RNA regulation; Israel Science foundation [782/11, 1050/12]; BLUEPRINT FP7 consortium; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Minerva Stiftung research grant; National Human Genome Research Institute Center for Excellence in Genome Science [1P50HG006193]; NovoNordisk Foundation (The Novo Nordisk Foundation section for Stem Cell Biology in Human Disease); Lundbeck Foundation [R108-2012-10312] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); I-CORE for chromatin and RNA regulation; Israel Science foundation(Israel Science Foundation); BLUEPRINT FP7 consortium; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Minerva Stiftung research grant; National Human Genome Research Institute Center for Excellence in Genome Science; NovoNordisk Foundation (The Novo Nordisk Foundation section for Stem Cell Biology in Human Disease); Lundbeck Foundation(Lundbeckfonden)	We thank members of the Tanay and Amit labs for critical discussions and Genia Brodsky for artwork. Research in I.A. and A. Tanay laboratories is supported by the European Research Council, the I-CORE for chromatin and RNA regulation, and personal grants from the Israel Science foundation (782/11, 1050/12) and the BLUEPRINT FP7 consortium. I.A. is supported by the Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine, a Minerva Stiftung research grant, and the National Human Genome Research Institute Center for Excellence in Genome Science (1P50HG006193). A. Tanay is a Kimmel investigator. F.P. is a fellow of the German-Israeli Helmholtz Research School in Cancer Biology. Work in the B.P. laboratory was supported through a center grant from the NovoNordisk Foundation (The Novo Nordisk Foundation section for Stem Cell Biology in Human Disease).	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Becker AM, 2012, BLOOD, V119, P2003, DOI 10.1182/blood-2011-06-364976; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Boulais PE, 2015, BLOOD, V125, P2621, DOI 10.1182/blood-2014-09-570192; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; Etzrodt M, 2014, CELL STEM CELL, V15, P546, DOI 10.1016/j.stem.2014.10.015; Gorgens A, 2013, CELL REP, V3, P1539, DOI 10.1016/j.celrep.2013.04.025; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jeong M, 2014, EXP HEMATOL, V42, P609, DOI 10.1016/j.exphem.2014.04.008; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Kurotaki D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5978; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Liu QQ, 2012, INT J HEMATOL, V95, P640, DOI 10.1007/s12185-012-1078-x; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Miyawaki K, 2015, STEM CELLS, V33, P976, DOI 10.1002/stem.1906; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; Murrel C, 2007, CELL STEM CELL, V1, P357, DOI 10.1016/j.stem.2007.09.008; Orkin S H, 1998, Stem Cells, V16 Suppl 2, P79; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Paul F, 2014, CURR OPIN IMMUNOL, V30, P1, DOI 10.1016/j.coi.2014.04.004; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Schroeder T, 2010, CELL STEM CELL, V6, P203, DOI 10.1016/j.stem.2010.02.006; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Tavor S, 2002, BLOOD, V99, P1794, DOI 10.1182/blood.V99.5.1794; Verbeek W, 2001, LEUKEMIA, V15, P103, DOI 10.1038/sj.leu.2401995; Wang HS, 2014, J IMMUNOL, V193, P1766, DOI 10.4049/jimmunol.1301939; Wilson A, 2009, CURR OPIN GENET DEV, V19, P461, DOI 10.1016/j.gde.2009.08.005; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Winkler IG, 2005, J EXP MED, V201, P1077, DOI 10.1084/jem.20042299; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Ye M, 2013, NAT CELL BIOL, V15, P385, DOI 10.1038/ncb2698; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569	50	553	557	4	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 17	2015	163	7					1663	1677		10.1016/j.cell.2015.11.013	http://dx.doi.org/10.1016/j.cell.2015.11.013			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CZ1GN	26627738	Bronze			2022-12-28	WOS:000366854200014
J	Biller-Andorno, N; Zeltner, T				Biller-Andorno, Nikola; Zeltner, Thomas			INTERNATIONAL HEALTH CARE SYSTEMS Individual Responsibility and Community Solidarity - The Swiss Health Care System	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Biller-Andorno, Nikola] Univ Zurich, Inst Biomed Eth & Hist Med, Zurich, Switzerland; [Zeltner, Thomas] Grad Inst, Global Hlth Program, Geneva, Switzerland; [Zeltner, Thomas] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	University of Zurich; Harvard University; Harvard T.H. Chan School of Public Health	Biller-Andorno, N (corresponding author), Univ Zurich, Inst Biomed Eth & Hist Med, Zurich, Switzerland.			Biller-Andorno, Nikola/0000-0001-7661-1324				De Pietro C, 2015, HEALTH POLICY, V119, P851, DOI 10.1016/j.healthpol.2015.05.004; Fassler M, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14080; OECD/WHO, 2011, OECD REV HLTH SYSTEM, DOI [10.1787/9789264120914-en, DOI 10.1787/9789264120914-EN]; Reinhardt UE, 2004, JAMA-J AM MED ASSOC, V292, P1227, DOI 10.1001/jama.292.10.1227	4	54	54	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2015	373	23					2193	2197		10.1056/NEJMp1508256	http://dx.doi.org/10.1056/NEJMp1508256			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX5LM	26630139	Green Published			2022-12-28	WOS:000365743100001
J	Fauci, AS; Marston, HD				Fauci, Anthony S.; Marston, Hilary D.			Ending the HIV-AIDS Pandemic - Follow the Science	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ANTIRETROVIRAL THERAPY; INFECTION		[Fauci, Anthony S.; Marston, Hilary D.] NIAID, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.							Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816	4	58	59	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2015	373	23					2197	2199		10.1056/NEJMp1502020	http://dx.doi.org/10.1056/NEJMp1502020			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX5LM	26624554	Bronze			2022-12-28	WOS:000365743100002
J	Vicari, P; Sthel, VM				Vicari, Perla; Sthel, Vivia M.			Cystine Crystals in Bone Marrow	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vicari, Perla; Sthel, Vivia M.] Assoc Fundo Incent Pesquisa Med Lab, Sao Paulo, Brazil		Vicari, P (corresponding author), Assoc Fundo Incent Pesquisa Med Lab, Sao Paulo, Brazil.	perla.vicari@afip.com.br							0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2015	373	23					E27	E27		10.1056/NEJMicm1415736	http://dx.doi.org/10.1056/NEJMicm1415736			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5LM	26630152				2022-12-28	WOS:000365743100011
J	Viele, K; Connor, JT				Viele, Kert; Connor, Jason T.			Dose-Finding Trials Optimizing Phase 2 Data in the Drug Development Process	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Viele, Kert; Connor, Jason T.] Berry Consultants LLC, Austin, TX 78746 USA; [Connor, Jason T.] Univ Cent Florida, Coll Med, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Viele, K (corresponding author), Berry Consultants LLC, 4301Westbank Dr,Bldg B,Ste 140, Austin, TX 78746 USA.	kert@berryconsultants.com						Bretz F, 2008, BIOMETRICAL J, V50, P480, DOI 10.1002/bimj.200810438; Dragalin V, 2007, J BIOPHARM STAT, V17, P1051, DOI 10.1080/10543400701643954; Gheorghiade M, 2015, JAMA-J AM MED ASSOC, V314, P2251, DOI 10.1001/jama.2015.15734; Krams M, 2003, STROKE, V34, P2543, DOI 10.1161/01.STR.0000092527.33910.89; Saville BR, 2014, CLIN TRIALS, V11, P485, DOI 10.1177/1740774514531352	5	8	8	2	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2015	314	21					2294	2295		10.1001/jama.2015.16702	http://dx.doi.org/10.1001/jama.2015.16702			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX2GT	26624828				2022-12-28	WOS:000365515700021
J	Huberman, AD; El-Danaf, RN				Huberman, Andrew D.; El-Danaf, Rana N.			BLINDNESS Assassins of eyesight	NATURE			English	Editorial Material							OPEN-ANGLE GLAUCOMA; GANGLION-CELL TYPES		[Huberman, Andrew D.; El-Danaf, Rana N.] Univ Calif San Diego, Sch Med, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Huberman, Andrew D.; El-Danaf, Rana N.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Huberman, Andrew D.; El-Danaf, Rana N.] Univ Calif San Diego, Sch Med, Dept Ophthalmol, La Jolla, CA 92093 USA; [Huberman, Andrew D.] Salk Inst Biol Studies, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute	Huberman, AD (corresponding author), Univ Calif San Diego, Sch Med, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	ahuberman@ucsd.edu; reldanaf@ucsd.edu						Anderson AM, 2012, DEVELOPMENT, V139, P991, DOI 10.1242/dev.077255; Della Santina L, 2013, J NEUROSCI, V33, P17444, DOI 10.1523/JNEUROSCI.5461-12.2013; Dhande OS, 2014, CURR OPIN NEUROBIOL, V24, P133, DOI 10.1016/j.conb.2013.08.006; El-Danaf RN, 2015, J NEUROSCI, V35, P2329, DOI 10.1523/JNEUROSCI.1419-14.2015; Jain Sachin, 2015, J Ophthalmic Vis Res, V10, P178, DOI 10.4103/2008-322X.163766; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Skowronska-Krawczyk D, 2015, MOL CELL, V59, P931, DOI 10.1016/j.molcel.2015.07.027; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; Ward NJ, 2014, J NEUROSCI, V34, P3161, DOI 10.1523/JNEUROSCI.4089-13.2014; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192	10	4	5	2	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					456	457		10.1038/527456a	http://dx.doi.org/10.1038/527456a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26607542				2022-12-28	WOS:000365352500034
J	Marcus, HJ; Wilson, MH				Marcus, Hani J.; Wilson, Mark H.			Insertion of an Intracranial-Pressure Monitor	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Marcus, Hani J.; Wilson, Mark H.] Imperial Coll Healthcare NHS, London, England		Wilson, MH (corresponding author), St Marys Hosp, Dept Neurosurg, Imperial Neurotrauma Ctr, Praed St, London W2 1NY, England.	mark.wilson@imperial.nhs.uk		Wilson, Mark/0000-0002-2346-4911				Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bratton SL., 2007, J NEUROTRAUM, V24, P45, DOI DOI 10.1089/NEU.2007.9989; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Kasotakis G, 2012, J AM COLL SURGEONS, V214, P950, DOI 10.1016/j.jamcollsurg.2012.03.004; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708	5	0	0	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2015	373	22								10.1056/NEJMvcm1406460	http://dx.doi.org/10.1056/NEJMvcm1406460			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9YT	26605942	Green Published			2022-12-28	WOS:000365354800010
J	Victor, DG; Leape, JP				Victor, David G.; Leape, James P.			Global climate agreement: After the talks	NATURE			English	Editorial Material									[Victor, David G.] Univ Calif San Diego, Sch Global Policy & Strategy, Int Relat, San Diego, CA 92103 USA; [Leape, James P.] Stanford Univ, Sch Earth Energy & Environm Sci, Stanford, CA 94305 USA; [Leape, James P.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Victor, David G.; Leape, James P.] World Econ Forums Global Agenda Council Governanc, Washington, DC USA	University of California System; University of California San Diego; Stanford University; Stanford University	Victor, DG (corresponding author), Univ Calif San Diego, Sch Global Policy & Strategy, Int Relat, San Diego, CA 92103 USA.	david.victor@ucsd.edu; jleape@stanford.edu						[Anonymous], 2015, CLIM FIN 2013 14 USD, DOI 10.1787/9789264249424-en; Carlson K. M., 2014, CARBON MGMT, V4, P347; Hsu A, 2015, NAT CLIM CHANGE, V5, P501, DOI 10.1038/nclimate2594; Nepstad D, 2014, SCIENCE, V344, P1118, DOI 10.1126/science.1248525; Overdevest C, 2014, REGUL GOV, V8, P22, DOI 10.1111/j.1748-5991.2012.01133.x; Potoski Matthew, 2009, VOLUNTARY PROGRAMS C; Sabel C. F., 2015, CLIM CHANGE; Victor D, 2011, GLOBAL WARMING GRIDL	8	9	9	1	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					439	441		10.1038/527439a	http://dx.doi.org/10.1038/527439a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26607527	Bronze			2022-12-28	WOS:000365352500014
J	Chiu, HY; Huang, HN				Chiu, Hsien-Yi; Huang, Hsien-Neng			Red-Brown Plaques and Papules in a Patient With Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE MYELOID-LEUKEMIA; MYELODYSPLASTIC SYNDROME; MYELOGENOUS LEUKEMIA; THERAPY; CUTIS		[Chiu, Hsien-Yi] Natl Taiwan Univ, Dept Dermatol, Coll Med, Taipei 10764, Taiwan; [Chiu, Hsien-Yi] Natl Taiwan Univ Hosp Hsin Chu Branch, Dept Dermatol, Hsinchu 300, Taiwan; [Huang, Hsien-Neng] Natl Taiwan Univ Hosp Hsin Chu Branch, Dept Pathol, Hsinchu 300, Taiwan; [Huang, Hsien-Neng] Natl Taiwan Univ, Coll Med, Dept Pathol, Grad Inst Pathol, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Huang, HN (corresponding author), Natl Taiwan Univ Hosp Hsin Chu Branch, Dept Pathol, 25 Ln 442,Sect 1,Jingguo Rd, Hsinchu 300, Taiwan.	ken102huang@gmail.com		Chiu, Hsien-Yi/0000-0002-0493-9707				BAER MR, 1989, CANCER-AM CANCER SOC, V63, P2192, DOI 10.1002/1097-0142(19890601)63:11<2192::AID-CNCR2820631122>3.0.CO;2-R; Kaddu S, 1999, J AM ACAD DERMATOL, V40, P966, DOI 10.1016/S0190-9622(99)70086-1; Lee HY, 2010, ACTA DERM-VENEREOL, V90, P649, DOI 10.2340/00015555-0911; Pedersen-Bjergaard J, 2002, BLOOD, V99, P1909, DOI 10.1182/blood.V99.6.1909; Praga C, 2005, J CLIN ONCOL, V23, P4179, DOI 10.1200/JCO.2005.05.029; Smith RE, 2003, J CLIN ONCOL, V21, P1195, DOI 10.1200/JCO.2003.03.114; SPECTOR JI, 1980, JAMA-J AM MED ASSOC, V244, P1131, DOI 10.1001/jama.244.10.1131; SU WPD, 1984, J AM ACAD DERMATOL, V11, P121; Weinel S, 2008, AUSTRALAS J DERMATOL, V49, P187, DOI 10.1111/j.1440-0960.2008.00466.x; Weinel S, 2009, AUSTRALAS J DERMATOL, V50, P52, DOI 10.1111/j.1440-0960.2008.00504.x	10	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2015	314	20					2182	2183		10.1001/jama.2015.10953	http://dx.doi.org/10.1001/jama.2015.10953			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XQ	26599186				2022-12-28	WOS:000365351900022
J	Woolston, C				Woolston, Chris			4 BIG QUESTIONS	NATURE			English	Editorial Material																			0	11	11	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					S120	S120		10.1038/527S120a	http://dx.doi.org/10.1038/527S120a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO3NJ	26580163	Bronze			2022-12-28	WOS:000416737800001
J	Hallis, LJ; Huss, GR; Nagashima, K; Taylor, GJ; Halldorsson, SA; Hilion, DR; Mottl, MJ; Meech, KJ				Hallis, Lydia J.; Huss, Gary R.; Nagashima, Kazuhide; Taylor, G. Jeffrey; Halldorsson, Saemundur A.; Hilion, David R.; Mottl, Michael J.; Meech, Karen J.			Evidence for primordial water in Earth's deep mantle	SCIENCE			English	Article							OXYGEN-ISOTOPE VARIATIONS; NOBLE-GASES; HE-3/HE-4 RATIOS; DEPLETED MANTLE; MAGMA OCEAN; MELT; ICELAND; SYSTEMATICS; INCLUSIONS; SEAWATER	The hydrogen-isotope [deuterium/hydrogen (D/H)] ratio of Earth can be used to constrain the origin of its water. However, the most accessible reservoir, Earth's oceans, may no longer represent the original (primordial) D/H ratio, owing to changes caused by water cycling between the surface and the interior. Thus, a reservoir completely isolated from surface processes is required to define Earth's original D/H signature. Here we present data for Baffin Island and Icelandic lavas, which suggest that the deep mantle has a low D/H ratio (delta D more negative than -218 per mil). Such strongly negative values indicate the existence of a component within Earth's interior that inherited its D/H ratio directly from the protosolar nebula.	[Hallis, Lydia J.; Huss, Gary R.; Taylor, G. Jeffrey; Meech, Karen J.] Univ Hawaii, NASA Astrobiol Inst, Inst Astron, Honolulu, HI 96822 USA; [Hallis, Lydia J.; Huss, Gary R.; Nagashima, Kazuhide; Taylor, G. Jeffrey] Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; [Halldorsson, Saemundur A.; Hilion, David R.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Mottl, Michael J.] Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; [Meech, Karen J.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA	National Aeronautics & Space Administration (NASA); University of Hawaii System; University of Hawaii System; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Hawaii System; University of Hawaii System	Hallis, LJ (corresponding author), Univ Glasgow, Sch Geog & Earth Sci, Gregory Bldg, Glasgow G12 8QQ, Lanark, Scotland.	lydia.hallis@glasgow.ac.uk	Meech, Karen/CAH-1412-2022; Halldorsson, Saemundur Ari/L-9560-2015	Meech, Karen/0000-0002-2058-5670; Huss, Gary/0000-0003-4281-7839; Nagashima, Kazuhide/0000-0002-9322-3187; Halldorsson, Saemundur Ari/0000-0002-9311-7704; hallis, lydia/0000-0001-6455-8415	National Aeronautics and Space Administration through NASA Astrobiology Institute through the Office of Space Science [NNA09-DA77A]	National Aeronautics and Space Administration through NASA Astrobiology Institute through the Office of Space Science	This material is based on work supported by the National Aeronautics and Space Administration through the NASA Astrobiology Institute under Cooperative Agreement no. NNA09-DA77A, issued through the Office of Space Science. We thank D. Francis for allocation of the Baffin Island picrite samples and K. Gronvold for invaluable help in the field in Iceland. The data reported in this paper are tabulated in the supplementary materials. L.J.H. prepared samples, collected and processed data, and was the primary author of this manuscript. G.R.H. and K.N. managed the ion-microprobe, perfected hydrogen- and oxygen-isotope analytical methods, and assisted with data processing. S.A.H. and D.R.H. collected the Icelandic samples and provided Icelandic geological background. G.J.T. assisted with the development of hydrogen-isotope analytical methods and provided solar system disk model chemistry information. K.J.M. initiated this study and provided solar system disk model chemistry information. All authors discussed the results and commented on the manuscript. Correspondence and requests for materials should be addressed to L. J. Hallis (lydia.hallis@glasgow.ac.uk).	Abramov O, 2009, NATURE, V459, P419, DOI 10.1038/nature08015; Akber-Knutson S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023192; Alexander CMO, 2012, SCIENCE, V337, P721, DOI 10.1126/science.1223474; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Clog M, 2013, EARTH PLANET SC LETT, V381, P156, DOI 10.1016/j.epsl.2013.08.043; Drake MJ, 2005, METEORIT PLANET SCI, V40, P519, DOI 10.1111/j.1945-5100.2005.tb00960.x; Eiler JM, 2001, REV MINERAL GEOCHEM, V43, P319, DOI 10.2138/gsrmg.43.1.319; Elkins-Tanton LT, 2008, EARTH PLANET SC LETT, V271, P181, DOI 10.1016/j.epsl.2008.03.062; Elkins-Tanton LT, 2011, ASTROPHYS SPACE SCI, V332, P359, DOI 10.1007/s10509-010-0535-3; FRANCIS D, 1985, CONTRIB MINERAL PETR, V89, P144, DOI 10.1007/BF00379449; Furi E, 2010, GEOCHIM COSMOCHIM AC, V74, P3307, DOI 10.1016/j.gca.2010.03.023; Gaetani GA, 2012, GEOLOGY, V40, P915, DOI 10.1130/G32992.1; Geiss J, 2004, SPACE SCI REV, V110, P307, DOI 10.1023/B:SPAC.0000023409.54469.40; Genda H, 2008, ICARUS, V194, P42, DOI 10.1016/j.icarus.2007.09.007; Gonnermann HM, 2009, NATURE, V459, P560, DOI 10.1038/nature08018; Gurenko AA, 2002, EARTH PLANET SC LETT, V205, P63, DOI 10.1016/S0012-821X(02)01005-1; Hallis LJ, 2012, EARTH PLANET SC LETT, V359, P84, DOI 10.1016/j.epsl.2012.09.049; Hartley ME, 2013, GEOCHIM COSMOCHIM AC, V123, P55, DOI 10.1016/j.gca.2013.09.008; Hauri E, 2002, CHEM GEOL, V183, P115, DOI 10.1016/S0009-2541(01)00374-6; Helmberger DV, 1998, NATURE, V396, P251, DOI 10.1038/24357; Herzberg C, 2013, NATURE, V493, P393, DOI 10.1038/nature11771; Hilton DR, 1999, EARTH PLANET SC LETT, V173, P53, DOI 10.1016/S0012-821X(99)00215-0; Hoefs J., 2009, STABLE ISOTOPE GEOCH, V6th; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; Holland G, 2006, NATURE, V441, P186, DOI 10.1038/nature04761; Jackson MG, 2010, NATURE, V466, P853, DOI 10.1038/nature09287; Kent AJR, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000743; KURZ MD, 1982, NATURE, V297, P43, DOI 10.1038/297043a0; Labrosse S, 2007, NATURE, V450, P866, DOI 10.1038/nature06356; Macpherson CG, 2005, EARTH PLANET SC LETT, V233, P411, DOI 10.1016/j.epsl.2005.02.037; Marty B, 2012, EARTH PLANET SC LETT, V313, P56, DOI 10.1016/j.epsl.2011.10.040; McKeegan KD, 2001, REV MINERAL GEOCHEM, V43, P279, DOI 10.2138/gsrmg.43.1.279; Panero WR, 2015, J GEOPHYS RES-SOL EA, V120, P894, DOI 10.1002/2014JB011397; ROBILLARD I, 1992, CONTRIB MINERAL PETR, V112, P230, DOI 10.1007/BF00310457; Shaw AM, 2012, NAT GEOSCI, V5, P224, DOI [10.1038/NGEO1406, 10.1038/ngeo1406]; Starkey NA, 2009, EARTH PLANET SC LETT, V277, P91, DOI 10.1016/j.epsl.2008.10.007; Stuart FM, 2003, NATURE, V424, P57, DOI 10.1038/nature01711; Trieloff M, 2000, SCIENCE, V288, P1036, DOI 10.1126/science.288.5468.1036; Xia QK, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013887	40	125	130	3	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					795	797		10.1126/science.aac4834	http://dx.doi.org/10.1126/science.aac4834			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW3MS	26564850				2022-12-28	WOS:000364897000039
J	Abrahamsson, TR				Abrahamsson, Thomas R.			Not all probiotic strains prevent necrotising enterocolitis in premature infants	LANCET			English	Editorial Material							PRETERM INFANTS; SEPSIS		[Abrahamsson, Thomas R.] Linkoping Univ, Div Paediat, Dept Clin & Expt Med, S-58183 Linkoping, Sweden; [Abrahamsson, Thomas R.] Linkoping Univ Hosp, Div Paediat, SE-58185 Linkoping, Sweden	Linkoping University; Linkoping University	Abrahamsson, TR (corresponding author), Linkoping Univ, Div Paediat, Dept Clin & Expt Med, S-58183 Linkoping, Sweden.; Abrahamsson, TR (corresponding author), Linkoping Univ Hosp, Div Paediat, SE-58185 Linkoping, Sweden.	thoab@telia.com						Bin-Nun A, 2005, J PEDIATR-US, V147, P192, DOI 10.1016/j.jpeds.2005.03.054; Costeloe K, 2015, LANCET; Jacobs SE, 2013, PEDIATRICS, V132, P1055, DOI 10.1542/peds.2013-1339; Lin HC, 2005, PEDIATRICS, V115, P1, DOI 10.1542/peds.2004-1463; Lin HC, 2008, PEDIATRICS, V122, P693, DOI 10.1542/peds.2007-3007; Mihatsch WA, 2012, CLIN NUTR, V31, P6, DOI 10.1016/j.clnu.2011.09.004; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Robinson Joan, 2014, Evid Based Child Health, V9, P672, DOI 10.1002/ebch.1977; Samanta M, 2009, J TROP PEDIATRICS, V55, P128, DOI 10.1093/tropej/fmn091; Shlomai NO, 2014, NEONATOLOGY, V105, P64, DOI 10.1159/000354891; Vallabhaneni S, 2015, MMWR-MORBID MORTAL W, V64, P155	11	10	10	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2016	387	10019					624	625		10.1016/S0140-6736(15)01090-9	http://dx.doi.org/10.1016/S0140-6736(15)01090-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3QH	26628329				2022-12-28	WOS:000369837100005
J	Knight, M; Churchill, D				Knight, Marian; Churchill, David			Late preterm rupture of membranes: it pays to wait	LANCET			English	Editorial Material									[Knight, Marian] Univ Oxford, Natl Perinatal Epidemiol Unit, Nuffield Dept Populat Hlth, Oxford OX3 7LF, England; [Churchill, David] Royal Wolverhampton Hosp NHS Trust, New Cross Hosp, Wolverhampton, W Midlands, England	University of Oxford; New Cross Hospital	Knight, M (corresponding author), Univ Oxford, Natl Perinatal Epidemiol Unit, Nuffield Dept Populat Hlth, Oxford OX3 7LF, England.	marian.knight@npeu.ox.ac.uk	Knight, Marian/B-6225-2009	Knight, Marian/0000-0002-1984-4575	Department of Health [NIHR-RP-011-032] Funding Source: Medline; National Institute for Health Research [NIHR-RP-011-032] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Abou El Senoun G, 2014, COCHRANE DB SYST REV, V4; [Anonymous], 2013, Obstet Gynecol, V122, P918, DOI 10.1097/01.AOG.0000435415.21944.8f; Boyle EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e896; Buchanan SL, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004735.pub3; Carroll SGM., 2010, PRETERM PRELABOUR RU; Chan E, 2014, ARCH DIS CHILD-FETAL, V99, pF451, DOI 10.1136/archdischild-2014-306124; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; Kenyon S, 2008, LANCET, V372, P1319, DOI 10.1016/S0140-6736(08)61203-9; Kenyon S, 2013, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD001058.PUB3; Morris JM, 2015, LANCET; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; van der Ham DP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001208	12	2	3	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 30	2016	387	10017					406	408		10.1016/S0140-6736(15)00809-0	http://dx.doi.org/10.1016/S0140-6736(15)00809-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC1OX	26564380				2022-12-28	WOS:000368986800005
J	Feld, JJ; Jacobson, IM; Hezode, C; Asselah, T; Ruane, PJ; Gruener, N; Abergel, A; Mangia, A; Lai, CL; Chan, HLY; Mazzotta, F; Moreno, C; Yoshida, E; Shafran, SD; Towner, WJ; Tran, TT; McNally, J; Osinusi, A; Svarovskaia, E; Zhu, Y; Brainard, DM; McHutchison, JG; Agarwal, K; Zeuzem, S				Feld, J. J.; Jacobson, I. M.; Hezode, C.; Asselah, T.; Ruane, P. J.; Gruener, N.; Abergel, A.; Mangia, A.; Lai, C. -L.; Chan, H. L. Y.; Mazzotta, F.; Moreno, C.; Yoshida, E.; Shafran, S. D.; Towner, W. J.; Tran, T. T.; McNally, J.; Osinusi, A.; Svarovskaia, E.; Zhu, Y.; Brainard, D. M.; McHutchison, J. G.; Agarwal, K.; Zeuzem, S.		ASTRAL-1 Investigators	Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C VIRUS-INFECTION; EPIDEMIOLOGY; PREVALENCE	BACKGROUND A simple treatment regimen that is effective in a broad range of patients who are chronically infected with the hepatitis C virus (HCV) remains an unmet medical need. METHODS We conducted a phase 3, double-blind, placebo-controlled study involving untreated and previously treated patients with chronic HCV genotype 1, 2, 4, 5, or 6 infection, including those with compensated cirrhosis. Patients with HCV genotype 1, 2, 4, or 6 were randomly assigned in a 5: 1 ratio to receive the nucleotide polymerase inhibitor sofosbuvir and the NS5A inhibitor velpatasvir in a once-daily, fixed-dose combination tablet or matching placebo for 12 weeks. Because of the low prevalence of genotype 5 in the study regions, patients with genotype 5 did not undergo randomization but were assigned to the sofosbuvir-velpatasvir group. The primary end point was a sustained virologic response at 12 weeks after the end of therapy. RESULTS Of the 624 patients who received treatment with sofosbuvir-velpatasvir, 34% had HCV genotype 1a, 19% genotype 1b, 17% genotype 2, 19% genotype 4, 6% genotype 5, and 7% genotype 6. A total of 8% of patients were black, 19% had cirrhosis, and 32% had been previously treated for HCV. The rate of sustained virologic response among patients receiving sofosbuvir-velpatasvir was 99% (95% confidence interval, 98 to >99). Two patients receiving sofosbuvir-velpatasvir, both with HCV genotype 1, had a virologic relapse. None of the 116 patients receiving placebo had a sustained virologic response. Serious adverse events were reported in 15 patients (2%) in the sofosbuvir-velpatasvir group and none in the placebo group. CONCLUSIONS Once-daily sofosbuvir-velpatasvir for 12 weeks provided high rates of sustained virologic response among both previously treated and untreated patients infected with HCV genotype 1, 2, 4, 5, or 6, including those with compensated cirrhosis.	[Feld, J. J.] Toronto Ctr Liver Dis, Toronto, ON, Canada; [Yoshida, E.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Shafran, S. D.] Univ Alberta, Edmonton, AB, Canada; [Jacobson, I. M.] Weill Cornell Med Coll, New York, NY USA; [Hezode, C.] Univ Paris Est, Creteil, France; [Asselah, T.] Univ Paris Diderot, INSERM, UMR 1149, Serv Hepatol,Hop Beaujon, Clichy, France; [Abergel, A.] Univ Auvergne, Clermont Ferrand, France; [Ruane, P. J.] Ruane Med & Liver Hlth Inst, Los Angeles, CA USA; [Towner, W. J.] Kaiser Permanente Los Angeles Med Ctr, Los Angeles, CA USA; [Tran, T. T.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [McNally, J.; Osinusi, A.; Svarovskaia, E.; Zhu, Y.; Brainard, D. M.; McHutchison, J. G.] Gilead Sci Inc, Foster City, CA 94404 USA; [Gruener, N.] Univ Munich, Munich, Germany; [Zeuzem, S.] Goethe Univ Frankfurt, Med Ctr, D-60054 Frankfurt, Germany; [Mangia, A.] Casa Sollievo Sofferenza Hosp, San Giovanni Rotondo, Italy; [Mazzotta, F.] Santa Maria Annunziata Hosp, Florence, Italy; [Lai, C. -L.] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Chan, H. L. Y.] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Moreno, C.] Univ Libre Bruxelles, Clin Univ Bruxelles Hop Erasme, Brussels, Belgium; [Agarwal, K.] Kings Coll Hosp Fdn Trust, KinCol, London, England	University of British Columbia; University of Alberta; Cornell University; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Clermont Auvergne (UCA); Kaiser Permanente; Cedars Sinai Medical Center; Gilead Sciences; University of Munich; Goethe University Frankfurt; IRCCS Casa Sollievo Della Sofferenza; University of Hong Kong; Chinese University of Hong Kong; Universite Libre de Bruxelles; King's College Hospital NHS Foundation Trust; King's College Hospital	Feld, JJ (corresponding author), Toronto Western Hosp, Ctr Liver, 399 Bathurst St,6B Fell Pavil, Toronto, ON M5T 2S8, Canada.	jordan.feld@uhn.ca; zeuzem@em.uni-frankfurt.-de	Mathurin, Philippe/A-9121-2018; Hezode, Christophe/U-4659-2018; Zeuzem, Stefan/AAE-7435-2019; Agarwal, Kosh/ABH-8721-2020; Feld, Jordan/AAH-5628-2020; Loustaud-Ratti, Véronique/A-5262-2017; Mangia, A/AAL-5357-2020; Forton, Daniel/AAN-6669-2020; Chan, Henry Lik-Yuen/B-9636-2008	Mathurin, Philippe/0000-0003-3447-2025; Agarwal, Kosh/0000-0002-4754-828X; Feld, Jordan/0000-0003-2640-2211; Mangia, A/0000-0002-2600-3555; Chan, Henry Lik-Yuen/0000-0002-7790-1611; Ustianowski, Andrew/0000-0002-6134-7855; Lai, Ching-Lung/0000-0002-5927-2436; Ryder, Stephen David/0000-0001-9649-4444; Zoulim, Fabien/0000-0002-2245-0083; Aspinall, Richard/0000-0002-5208-8185; Forton, Daniel/0000-0002-0903-9169; Afdhal, Nezam/0000-0002-7342-6593	Gilead Sciences [NCT02201940]; National Institute for Health Research [NF-SI-0512-10124] Funding Source: researchfish	Gilead Sciences(Gilead Sciences); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by Gilead Sciences; ClinicalTrials.gov number, NCT02201940.	American Association for the Study of Liver Diseases and Infectious Diseases Society of America, REC TEST MAN TREAT H; Cheng G, 2013, 48 ANN M EUR ASS STU; Curry MP, 2015, NEW ENGL J MED, V373, P2618, DOI 10.1056/NEJMoa1512614; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Doehle B, 2013, 64 ANN M AM ASS STUD; Everson GT, 2015, ANN INTERN MED, V163, P818, DOI 10.7326/M15-1000; Foster GR, 2015, NEW ENGL J MED, V373, P2608, DOI 10.1056/NEJMoa1512612; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Lawitz E, 2015, J VIRAL HEPATITIS, V22, P1011, DOI 10.1111/jvh.12435; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Muir AJ, 2015, CLIN GASTROENTEROL H, V13, P2166, DOI 10.1016/j.cgh.2015.07.015; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Pianko S, 2015, ANN INTERN MED, V163, P809, DOI 10.7326/M15-1014; Wendt A, 2014, CLIN PHARMACOL-ADV A, V6, P1, DOI 10.2147/CPAA.S30338; Wiens BL, 2014, THER INNOV REGUL SCI, V48, P90, DOI 10.1177/2168479013507272	18	741	764	4	83	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2015	373	27					2599	2607		10.1056/NEJMoa1512610	http://dx.doi.org/10.1056/NEJMoa1512610			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ8UH	26571066	Green Published, Bronze			2022-12-28	WOS:000367374100005
J	Maraia, RJ; Rijal, E				Maraia, Richard J.; Rijal, Eshab			STRUCTURAL BIOLOGY A transcriptional specialist resolved	NATURE			English	Editorial Material							RNA-POLYMERASE-III; TERMINATION; NETWORK		[Maraia, Richard J.; Rijal, Eshab] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Intramural Res Program, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Maraia, RJ (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Intramural Res Program, Bethesda, MD 20892 USA.	maraiar@mail.nih.gov; keshab.rijal@nih.gov	Maraia, Richard/ABC-1442-2020	Maraia, Richard/0000-0002-5209-0066	Intramural NIH HHS [ZIA HD000412-29] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000412] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Arimbasseri AG, 2014, TRANSCR-AUSTIN, V5, DOI 10.4161/trns.27369; Arimbasseri AG, 2015, MOL CELL, V58, P1124, DOI 10.1016/j.molcel.2015.04.002; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; Fernandez-Tornero C, 2010, EMBO J, V29, P3762, DOI 10.1038/emboj.2010.266; Hoffmann NA, 2015, NATURE, V528, P231, DOI 10.1038/nature16143; Iben JR, 2011, NUCLEIC ACIDS RES, V39, P6100, DOI 10.1093/nar/gkr182; Johnson SAS, 2008, J BIOL CHEM, V283, P19184, DOI 10.1074/jbc.M802872200; Khoo SK, 2014, MOL CELL BIOL, V34, P551, DOI 10.1128/MCB.00910-13; Landrieux E, 2006, EMBO J, V25, P118, DOI 10.1038/sj.emboj.7600915; MARTIN FH, 1980, NUCLEIC ACIDS RES, V8, P2295, DOI 10.1093/nar/8.10.2295; Moir RD, 2013, BBA-GENE REGUL MECH, V1829, P361, DOI 10.1016/j.bbagrm.2012.11.001; Rijal K, 2013, NUCLEIC ACIDS RES, V41, P139, DOI 10.1093/nar/gks985; Werner F, 2011, NAT REV MICROBIOL, V9, P85, DOI 10.1038/nrmicro2507; Wu CC, 2011, MOL CELL BIOL, V31, P2715, DOI 10.1128/MCB.05151-11	14	10	10	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					204	205		10.1038/nature16317	http://dx.doi.org/10.1038/nature16317			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26605522	Green Accepted			2022-12-28	WOS:000366053300028
J	Church, G				Church, George			Perspective: Encourage the innovators	NATURE			English	Editorial Material									[Church, George] Harvard Univ, Sch Med, Boston, MA 02138 USA	Harvard University; Harvard Medical School	Church, G (corresponding author), Harvard Univ, Sch Med, Boston, MA 02138 USA.	gmc@harvard.edu		church, george/0000-0001-6232-9969				Center for Genetics and Society, 2007, NAT POL HUM GEN MOD; Hamamy H, 2012, J COMMUN GENET, V3, P185, DOI 10.1007/s12687-011-0072-y; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117	3	14	14	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					S7	S7		10.1038/528S7a	http://dx.doi.org/10.1038/528S7a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26630599	Bronze			2022-12-28	WOS:000365606000003
J	James, J; Kaul, DR; Goldberger, ZD; Saint, S; Skerrett, SJ				James, Jocelyn; Kaul, Daniel R.; Goldberger, Zachary D.; Saint, Sanjay; Skerrett, Shawn J.			Back to Nature	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PNEUMONIC TULAREMIA; MARTHAS-VINEYARD; FRANCISELLA; RECOGNITION; TULARENSIS; INFECTION		[James, Jocelyn; Goldberger, Zachary D.; Skerrett, Shawn J.] Univ Washington, Harborview Med Ctr, Sch Med, Dept Med, Seattle, WA 98104 USA; [James, Jocelyn] Univ Washington, Harborview Med Ctr, Sch Med, Div Gen Internal Med, Seattle, WA 98104 USA; [Goldberger, Zachary D.] Univ Washington, Harborview Med Ctr, Sch Med, Div Cardiol, Seattle, WA 98104 USA; [Skerrett, Shawn J.] Univ Washington, Harborview Med Ctr, Sch Med, Div Pulm & Crit Care Med, Seattle, WA 98104 USA; [Kaul, Daniel R.; Saint, Sanjay] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Kaul, Daniel R.] Univ Michigan, Sch Med, Div Infect Dis, Ann Arbor, MI USA; [Saint, Sanjay] Vet Affairs Ann Arbor Healthcare Syst, Hosp Outcomes Program Excellence, Ann Arbor, MI USA	Harborview Medical Center; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Skerrett, SJ (corresponding author), Harborview Med Ctr, 325 9th Ave,Box 359640, Seattle, WA 98104 USA.	shawn@uw.edu	Saint, Sanjay/AAF-5126-2019					Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; EVANS ME, 1985, MEDICINE, V64, P251, DOI 10.1097/00005792-198507000-00006; Feldman KA, 2001, NEW ENGL J MED, V345, P1601, DOI 10.1056/NEJMoa011374; Francis E, 1925, J AMER MED ASSOC, V84, P1243, DOI 10.1001/jama.1925.02660430001001; Hornick R, 2001, NEW ENGL J MED, V345, P1637, DOI 10.1056/NEJM200111293452211; Jones CL, 2012, MICROBIOL MOL BIOL R, V76, P383, DOI 10.1128/MMBR.05027-11; Kugeler KJ, 2009, CLIN INFECT DIS, V48, P863, DOI 10.1086/597261; Matyas BI, 2007, ANN NY ACAD SCI, V1105, P351, DOI 10.1196/annals.1409.013; MCCRUMB FR, 1961, BACTERIOL REV, V25, P262, DOI 10.1128/MMBR.25.3.262-267.1961; MILLER RP, 1969, AM REV RESPIR DIS, V99, P31; Perez-Castrillon JL, 2001, CLIN INFECT DIS, V33, P573, DOI 10.1086/322601; Targownik LE, 2013, AM J GASTROENTEROL, V108, P1835, DOI 10.1038/ajg.2013.294; Weber IB, 2012, CLIN INFECT DIS, V55, P1283, DOI 10.1093/cid/cis706; Weinberg AN, 2004, J INFECT DIS, V189, P1317, DOI 10.1086/382546	14	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2015	373	23					2271	2276		10.1056/NEJMcps1407030	http://dx.doi.org/10.1056/NEJMcps1407030			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5LM	26630146				2022-12-28	WOS:000365743100012
J	Pfeffer, MA; Claggett, B; Diaz, R; Dickstein, K; Gerstein, HC; Kober, LV; Lawson, FC; Ping, L; Wei, XD; Lewis, EF; Maggioni, AP; McMurray, JJV; Probstfield, JL; Riddle, MC; Solomon, SD; Tardif, JC				Pfeffer, Marc A.; Claggett, Brian; Diaz, Rafael; Dickstein, Kenneth; Gerstein, Hertzel C.; Kober, Lars V.; Lawson, Francesca C.; Ping, Lin; Wei, Xiaodan; Lewis, Eldrin F.; Maggioni, Aldo P.; McMurray, John J. V.; Probstfield, Jeffrey L.; Riddle, Matthew C.; Solomon, Scott D.; Tardif, Jean-Claude		ELIXA Investigators	Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLUCAGON-LIKE PEPTIDE-1; CONGESTIVE-HEART-FAILURE; CARDIOVASCULAR OUTCOMES; MYOCARDIAL-INFARCTION; RECEPTOR AGONISTS; GLYCEMIC CONTROL; DOUBLE-BLIND; FOLLOW-UP; MELLITUS; GLUCOSE	BACKGROUND Cardiovascular morbidity and mortality are higher among patients with type 2 diabetes, particularly those with concomitant cardiovascular diseases, than in most other populations. We assessed the effects of lixisenatide, a glucagon-like peptide 1-receptor agonist, on cardiovascular outcomes in patients with type 2 diabetes who had had a recent acute coronary event. METHODS We randomly assigned patients with type 2 diabetes who had had a myocardial infarction or who had been hospitalized for unstable angina within the previous 180 days to receive lixisenatide or placebo in addition to locally determined standards of care. The trial was designed with adequate statistical power to assess whether lixisenatide was noninferior as well as superior to placebo, as defined by an upper boundary of the 95% confidence interval for the hazard ratio of less than 1.3 and 1.0, respectively, for the primary composite end point of cardiovascular death, myocardial infarction, stroke, or hospitalization for unstable angina. RESULTS The 6068 patients who underwent randomization were followed for a median of 25 months. A primary end-point event occurred in 406 patients (13.4%) in the lixisenatide group and in 399 (13.2%) in the placebo group (hazard ratio, 1.02; 95% confidence interval [CI], 0.89 to 1.17), which showed the noninferiority of lixisenatide to placebo (P < 0.001) but did not show superiority (P = 0.81). There were no significant between-group differences in the rate of hospitalization for heart failure (hazard ratio in the lixisenatide group, 0.96; 95% CI, 0.75 to 1.23) or the rate of death (hazard ratio, 0.94; 95% CI, 0.78 to 1.13). Lixisenatide was not associated with a higher rate of serious adverse events or severe hypoglycemia, pancreatitis, pancreatic neoplasms, or allergic reactions than was placebo. CONCLUSIONS In patients with type 2 diabetes and a recent acute coronary syndrome, the addition of lixisenatide to usual care did not significantly alter the rate of major cardiovascular events or other serious adverse events. (Funded by Sanofi; ELIXA ClinicalTrials.gov number, NCT01147250.)	[Pfeffer, Marc A.; Claggett, Brian; Lewis, Eldrin F.; Solomon, Scott D.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Pfeffer, Marc A.; Claggett, Brian; Lewis, Eldrin F.; Solomon, Scott D.] Harvard Univ, Sch Med, Boston, MA USA; [Diaz, Rafael] Estudios Clin Latinoamer, Rosario, Argentina; [Dickstein, Kenneth] Univ Bergen, Stavanger Univ Hosp, Stavanger, Norway; [Gerstein, Hertzel C.] McMaster Univ, Hamilton, ON, Canada; [Kober, Lars V.] Univ Copenhagen Hosp, Rigshosp, DK-2100 Copenhagen, Denmark; [Lawson, Francesca C.; Ping, Lin; Wei, Xiaodan] Sanofi US, Bridgewater, NJ USA; [Maggioni, Aldo P.] Italian Assoc Hosp Cardiologists, Res Ctr, Florence, Italy; [McMurray, John J. V.] Univ Glasgow, British Heart Fdn Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Probstfield, Jeffrey L.] Univ Washington, Med Ctr, Seattle, WA 98195 USA; [Riddle, Matthew C.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Tardif, Jean-Claude] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Stavanger University Hospital; University of Bergen; McMaster University; Rigshospitalet; University of Copenhagen; Sanofi-Aventis; University of Glasgow; University of Washington; University of Washington Seattle; Oregon Health & Science University; Universite de Montreal	Pfeffer, MA (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	mpfeffer@rics.bwh.harvard.edu	Gerstein, Hertzel/ABB-8781-2020; Zadionchenko, Vladimir/A-7445-2016; Zorkun, Cafer/Q-1247-2019; Podoleanu, Cristian/E-2850-2010; Del Prato, Stefano/K-3405-2016; Gerstein, Hertzel C/B-1235-2013; Bozkuş, Yusuf/AAA-5419-2021; mcmurray, John/B-2467-2013; Lyudmila, Suplotova A/J-3596-2014; Zorkun, Cafer/S-7132-2016; Tütüncü, Neslihan Başçıl/ABG-5027-2020; Rafalskiy, Vladimir V/G-3172-2013; Maggioni, Aldo Pietro/AAL-5334-2020; Greiver, Michelle/N-8764-2015; Saravanan, P/M-6142-2016	Gerstein, Hertzel/0000-0001-8072-2836; Zadionchenko, Vladimir/0000-0003-2377-5266; Zorkun, Cafer/0000-0002-6726-0478; Podoleanu, Cristian/0000-0001-9987-2519; Del Prato, Stefano/0000-0002-5388-0270; Gerstein, Hertzel C/0000-0001-8072-2836; Bozkuş, Yusuf/0000-0002-6976-6659; mcmurray, John/0000-0002-6317-3975; Lyudmila, Suplotova A/0000-0001-9253-8075; Zorkun, Cafer/0000-0002-6726-0478; Tütüncü, Neslihan Başçıl/0000-0002-1816-3903; Rafalskiy, Vladimir V/0000-0002-2503-9580; Maggioni, Aldo Pietro/0000-0003-2764-6779; Greiver, Michelle/0000-0001-8957-0285; Saravanan, P/0000-0002-9566-2626; Sahay, Rakesh/0000-0002-5471-0695; Marin, Francisco/0000-0001-7246-7708; Pieber, Thomas/0000-0003-3554-0405; DUARTE VERA, YAN CARLOS/0000-0003-4685-6907; Sgarbi, Jose/0000-0001-7187-984X; GAZTAMBIDE, SONIA/0000-0003-3569-2265; Manzur, Fernando/0000-0001-6679-5609; S, Paramesh/0000-0002-0693-4483; Jaap, Alan/0000-0001-8289-704X; Cariou, Bertrand/0000-0002-1580-8040; Lubinski, Andrzej/0000-0003-2779-0041; kerlan, veronique/0000-0001-8105-6628; Lanas, Fernando/0000-0003-3595-9759; Kober, Lars/0000-0002-6635-1466; Ciardullo, Anna Vittoria/0000-0001-7265-9064; gibson, martin/0000-0002-1331-1524	Sanofi; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER	Sanofi(Sanofi-Aventis); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funded by Sanofi	Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011, 10.2337/dc12-s004]; [Anonymous], 2012, EUR MED AG GUID CLIN; [Anonymous], 2008, DIAB MELL EV CARD RI; Barkoudah E, 2012, J AM HEART ASSOC, V1, P8, DOI 10.1161/JAHA.111.000059; Bentley-Lewis R, 2015, AM HEART J, V169, P631, DOI 10.1016/j.ahj.2015.02.002; Bolli GB, 2014, DIABETIC MED, V31, P176, DOI 10.1111/dme.12328; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Fonseca VA, 2012, DIABETES CARE, V35, P1225, DOI 10.2337/dc11-1935; Fox CS, 2015, CIRCULATION, V132, P691, DOI 10.1161/CIR.0000000000000230; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2014, LANCET, V384, P1936, DOI 10.1016/S0140-6736(14)60611-5; Goldfine AB, 2008, NEW ENGL J MED, V359, P1092, DOI 10.1056/NEJMp0805758; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Griffin SJ, 2011, LANCET, V378, P156, DOI 10.1016/S0140-6736(11)60698-3; Hayward RA, 2015, NEW ENGL J MED, V372, P2197, DOI 10.1056/NEJMoa1414266; Hiatt WR, 2013, NEW ENGL J MED, V369, P1285, DOI 10.1056/NEJMp1309610; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Jhund PS, 2015, EUR HEART J, V36, P2463, DOI 10.1093/eurheartj/ehv295; Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1; McMurray JJV, 2014, LANCET DIABETES ENDO, V2, P843, DOI 10.1016/S2213-8587(14)70031-2; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Nathanson D, 2012, DIABETOLOGIA, V55, P926, DOI 10.1007/s00125-011-2440-x; Nikolaidis LA, 2004, CIRCULATION, V109, P962, DOI 10.1161/01.CIR.0000120505.91348.58; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; Riddle MC, 2013, DIABETES CARE, V36, P2489, DOI 10.2337/dc12-2454; Saraiva FK, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0142-7; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Smilowitz NR, 2014, CIRCULATION, V129, P2305, DOI 10.1161/CIRCULATIONAHA.113.006985; Timmers L, 2009, J AM COLL CARDIOL, V53, P501, DOI 10.1016/j.jacc.2008.10.033; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Udell JA, 2015, LANCET DIABETES ENDO, V3, P356, DOI 10.1016/S2213-8587(15)00044-3; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Woo JS, 2013, ARTERIOSCL THROM VAS, V33, P2252, DOI 10.1161/ATVBAHA.113.301586; Yang F, 2015, DIABET METAB SYND OB, V8, P315, DOI 10.2147/DMSO.S84005	37	1445	1502	7	122	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2015	373	23					2247	2257		10.1056/NEJMoa1509225	http://dx.doi.org/10.1056/NEJMoa1509225			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5LM	26630143	Bronze, Green Published			2022-12-28	WOS:000365743100008
J	Riggare, S; Unruh, KT				Riggare, Sara; Unruh, Kenton T.			PERSONAL VIEW Patients organise and train doctors to provide better care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Riggare, Sara] Karolinska Inst, Dept Learning Informat Management & Eth, Hlth Informat Ctr, S-17177 Stockholm, Sweden; [Unruh, Kenton T.] Univ Washington, Dept Med, Seattle, WA 98104 USA	Karolinska Institutet; University of Washington; University of Washington Seattle	Riggare, S (corresponding author), Karolinska Inst, Dept Learning Informat Management & Eth, Hlth Informat Ctr, S-17177 Stockholm, Sweden.	sara.riggare@ki.se		Riggare, Sara/0000-0002-2256-7310				Alavi M, 2001, MIS QUART, V25, P107, DOI 10.2307/3250961; Eton DT, 2012, PATIENT-RELAT OUTCOM, V3, P39, DOI 10.2147/PROM.S34681; Post B, 2011, POSTGRAD MED J, V87, P575, DOI 10.1136/pgmj.2011.241604rep; ROSENBERG W, 1995, BMJ-BRIT MED J, V310, P1122, DOI 10.1136/bmj.310.6987.1122; Unruh Kenton T, 2008, Conf Proc Ethnogr Prax Ind Conf, V2008, P40; van der Eijk M, 2011, PARKINSONISM RELAT D, V17, P360, DOI 10.1016/j.parkreldis.2011.02.012	6	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2015	351								h6318	10.1136/bmj.h6318	http://dx.doi.org/10.1136/bmj.h6318			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX9EW	26620969				2022-12-28	WOS:000366008800001
J	Perla, RJ; Finke, B; DeWalt, DA				Perla, Rocco J.; Finke, Bruce; DeWalt, Darren A.			Learning Systems at Scale Where Policy Meets Practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Perla, Rocco J.; Finke, Bruce; DeWalt, Darren A.] Ctr Medicare & Medicaid Innovat, Ctr Medicare & Medicaid Serv, Baltimore, MD USA	Centers for Medicare & Medicaid Services	Perla, RJ (corresponding author), US Dept Hlth & Human Serv, Ctr Medicare & Medicaid Innovat, Ctr Medicare & Medicaid Serv, 2810 Lord Baltimore Dr, Baltimore, MD 21244 USA.	Rocco.Perla@cms.hhs.gov		DeWalt, Darren/0000-0003-2270-751X				Centers for Medicare and Medicaid Services (CMS), COMPR PRIM CAR IN; Howell BL, 2015, JAMA-J AM MED ASSOC, V313, P2317, DOI 10.1001/jama.2015.2902; Langley GL., 2009, IMPROVEMENT GUIDE PR, V2nd; Provost L, 2015, WHATS YOUR THEORY DR; Taylor EF, EVALUATION COMPREHEN	5	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2015	314	20					2131	2132		10.1001/jama.2015.15079	http://dx.doi.org/10.1001/jama.2015.15079			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XQ	26599182				2022-12-28	WOS:000365351900014
J	Robbins, AS; Han, XS; Ward, EM; Simard, EP; Zheng, ZY; Jemal, A				Robbins, Anthony S.; Han, Xuesong; Ward, Elizabeth M.; Simard, Edgar P.; Zheng, Zhiyuan; Jemal, Ahmedin			Association Between the Affordable Care Act Dependent Coverage Expansion and Cervical Cancer Stage and Treatment in Young Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Robbins, Anthony S.; Han, Xuesong; Ward, Elizabeth M.; Zheng, Zhiyuan; Jemal, Ahmedin] Amer Canc Soc, Dept Intramural Res, Atlanta, GA 30303 USA; [Simard, Edgar P.] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA	American Cancer Society; Emory University	Han, XS (corresponding author), Amer Canc Soc, Surveillance & Hlth Serv Res, 250 Williams St NW, Atlanta, GA 30303 USA.	xuesong.han@cancer.org	Policarpio-Nicolas, Maria/F-7331-2015					Greene FL, 2002, AM JOINT COMMITTEE C; Klabunde Carrie N., 2012, Morbidity and Mortality Weekly Report, V61, P41; Lerro CC, 2013, ANN SURG ONCOL, V20, P1759, DOI 10.1245/s10434-013-2901-1; Sommers BD, 2013, HEALTH AFFAIR, V32, P165, DOI 10.1377/hlthaff.2012.0552	4	58	58	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2015	314	20					2189	2191		10.1001/jama.2015.10546	http://dx.doi.org/10.1001/jama.2015.10546			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XQ	26599188	Bronze			2022-12-28	WOS:000365351900024
J	Blackwell, AD; Tamayo, MA; Beheim, B; Trumble, BC; Stieglitz, J; Hooper, PL; Martin, M; Kaplan, H; Gurven, M				Blackwell, Aaron D.; Tamayo, Marilyne A.; Beheim, Bret; Trumble, Benjamin C.; Stieglitz, Jonathan; Hooper, Paul L.; Martin, Melanie; Kaplan, Hillard; Gurven, Michael			Helminth infection, fecundity, and age of first pregnancy in women	SCIENCE			English	Article							REGULATORY T-CELLS; PLASMODIUM-FALCIPARUM; SICKNESS BEHAVIOR; IMMUNE-RESPONSES; POPULATION; IMMUNOLOGY; MECHANISMS; STRATEGY; SIZE	Infection with intestinal helminths results in immunological changes that influence co-infections, and might influence fecundity by inducing immunological states affecting conception and pregnancy. We investigated associations between intestinal helminths and fertility in women, using 9 years of longitudinal data from 986 Bolivian forager-horticulturalists, experiencing natural fertility and 70% helminth prevalence. We found that different species of helminth are associated with contrasting effects on fecundity. Infection with roundworm (Ascaris lumbricoides) is associated with earlier first births and shortened interbirth intervals, whereas infection with hookworm is associated with delayed first pregnancy and extended interbirth intervals. Thus, helminths may have important effects on human fertility that reflect physiological and immunological consequences of infection.	[Blackwell, Aaron D.; Trumble, Benjamin C.; Martin, Melanie; Gurven, Michael] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA; [Blackwell, Aaron D.; Beheim, Bret; Trumble, Benjamin C.; Stieglitz, Jonathan; Hooper, Paul L.; Martin, Melanie; Kaplan, Hillard; Gurven, Michael] Tsimane Hlth & Life Hist Project, San Borja, Bolivia; [Blackwell, Aaron D.; Trumble, Benjamin C.; Martin, Melanie; Gurven, Michael] Univ Calif Santa Barbara, Broom Ctr Demog, Santa Barbara, CA 93106 USA; [Tamayo, Marilyne A.] Univ Missouri, Dept Anthropol, Columbia, MO 65211 USA; [Beheim, Bret; Stieglitz, Jonathan; Kaplan, Hillard] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Trumble, Benjamin C.] Arizona State Univ, Ctr Evolutionary Med, Tempe, AZ 85287 USA; [Trumble, Benjamin C.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Stieglitz, Jonathan] Inst Adv Study Toulouse, Toulouse, France; [Hooper, Paul L.] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Missouri System; University of Missouri Columbia; University of New Mexico; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Emory University	Blackwell, AD (corresponding author), Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA.	blackwell@anth.ucsb.edu	Blackwell, Aaron/B-5258-2008; Martin, Melanie/H-4935-2019	Blackwell, Aaron/0000-0002-5871-9865; Martin, Melanie/0000-0003-0368-2791; Gurven, Michael/0000-0002-5661-527X; Kaplan, Hillard/0000-0002-7398-7358; Trumble, Benjamin/0000-0003-3201-0628	NIH/National Institute on Aging [R01AG024119, R56AG024119, P01AG022500]; NSF [BCS-0422690]; NATIONAL INSTITUTE ON AGING [R01AG024119, R56AG024119, P01AG022500] Funding Source: NIH RePORTER	NIH/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Tsimane for their continued participation; our Bolivian project staff, including D. Eid, I. Maldonado, E. Cortez, N. Zabala, and many others; and four anonymous reviewers for their helpful comments. This work was supported by grants from the NIH/National Institute on Aging (R01AG024119, R56AG024119, P01AG022500) and the NSF (BCS-0422690). Data described in this paper are available as supplementary online materials. The study was reviewed and approved by the Gran Consejo Tsimane, the governing body overseeing Tsimane affairs, and by the institutional review boards of the University of California, Santa Barbara, and the University of New Mexico.	Avitsur R, 1999, PHARMACOL BIOCHEM BE, V64, P787, DOI 10.1016/S0091-3057(99)00165-3; BAUDOIN M, 1975, EVOLUTION, V29, P335, DOI [10.2307/2407221, 10.1111/j.1558-5646.1975.tb00213.x]; Blackwell AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1671; Carp HJA, 2012, J AUTOIMMUN, V38, pJ266, DOI 10.1016/j.jaut.2011.11.016; Clancy KBH, 2013, AM J HUM BIOL, V25, P389, DOI 10.1002/ajhb.22386; Ezenwa VO, 2015, SCIENCE, V347, P175, DOI 10.1126/science.1261714; Fernandez-Nino JA, 2012, T ROY SOC TROP MED H, V106, P701, DOI 10.1016/j.trstmh.2012.07.012; FORBES MRL, 1993, OIKOS, V67, P444, DOI 10.2307/3545356; Geiger SM, 2002, PARASITE IMMUNOL, V24, P499, DOI 10.1046/j.1365-3024.2002.00600.x; Geiger SM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001280; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hurd H, 2001, TRENDS PARASITOL, V17, P363, DOI 10.1016/S1471-4922(01)01927-4; Jiang TT, 2014, J IMMUNOL, V192, P4949, DOI 10.4049/jimmunol.1400498; Kaplan H., 2015, POPULATION HUMAN SCI, P361; Krishnan L, 1996, J IMMUNOL, V156, P653; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Martin M., 2013, PRIMATES PATHOGENS E, P363; Mcallister L, 2012, AM J HUM BIOL, V24, P786, DOI 10.1002/ajhb.22316; McFalls J., 1984, DIS FERTILITY; McSorley HJ, 2010, PARASITE IMMUNOL, V32, P549, DOI 10.1111/j.1365-3024.2010.01224.x; MOLLER AP, 1993, J ANIM ECOL, V62, P309, DOI 10.2307/5362; Neuhaus P, 2003, P ROY SOC B-BIOL SCI, V270, pS213, DOI 10.1098/rsbl.2003.0073; Sen A, 2014, NAT REV ENDOCRINOL, V10, P37, DOI 10.1038/nrendo.2013.212; Shattuck EC, 2015, AM J PHYS ANTHROPOL, V157, P1, DOI 10.1002/ajpa.22698; Stieglitz J, 2015, BRAIN BEHAV IMMUN, V49, P130, DOI 10.1016/j.bbi.2015.05.008; van Nieuwenhoven ALV, 2003, HUM REPROD UPDATE, V9, P347, DOI 10.1093/humupd/dmg026; van Riet E, 2007, IMMUNOBIOLOGY, V212, P475, DOI 10.1016/j.imbio.2007.03.009; Wammes LJ, 2014, LANCET INFECT DIS, V14, P1150, DOI 10.1016/S1473-3099(14)70771-6; Wammes LJ, 2010, EUR J IMMUNOL, V40, P437, DOI 10.1002/eji.200939699	29	65	66	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					970	972		10.1126/science.aac7902	http://dx.doi.org/10.1126/science.aac7902			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW4IP	26586763	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000364955200047
J	Lam, I; Keeney, S				Lam, Isabel; Keeney, Scott			Nonparadoxical evolutionary stability of the recombination initiation landscape in yeast	SCIENCE			English	Article							HOTSPOT CONVERSION PARADOX; MEIOTIC DNA BREAK; SACCHAROMYCES-CEREVISIAE; GENOME; CONSERVATION; COMBINATION; CROSSOVERS; MECHANISMS; MAMMALS; DRIVE	The nonrandom distribution of meiotic recombination shapes heredity and genetic diversification. Theoretically, hotspots-favored sites of recombination initiation-either evolve rapidly toward extinction or are conserved, especially if they are chromosomal features under selective constraint, such as promoters. We tested these theories by comparing genome-wide recombination initiation maps from widely divergent Saccharomyces species. We find that hotspots frequently overlap with promoters in the species tested, and consequently, hotspot positions are well conserved. Remarkably, the relative strength of individual hotspots is also highly conserved, as are larger-scale features of the distribution of recombination initiation. This stability, not predicted by prior models, suggests that the particular shape of the yeast recombination landscape is adaptive and helps in understanding evolutionary dynamics of recombination in other species.	[Lam, Isabel; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA; [Lam, Isabel; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Keeney, Scott] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA.	s-keeney@ski.mskcc.org	Keeney, Scott/GVR-8515-2022	Lam, Isabel/0000-0002-6247-8080	NIH [R01 GM058673, F31 GM097861]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118092, F31GM097861, R01GM058673] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Sequencing data were deposited at the Gene Expression Omnibus (GEO) under accession number GSE71930. We are grateful to D. Greig, C. Hittinger, G. Liti, E. Louis, C. Muller, and J. Roop for providing strains and advice on culturing Saccharomyces species; A. Viale and the Integrated Genomics Operation, Memorial Sloan Kettering Cancer Center (MSKCC), for sequencing; N. Socci (Bioinformatics Core Facility, MSKCC) for mapping Spo11-oligo and MNase-seq reads; S. Shuman for gifts of T4 RNA ligase; and S. Kim, J. Lange, N. Mohibullah, S. Tischfield, and X. Zhu for discussions. We thank M. Przeworski for discussions, communicating data before publication, and comments on the manuscript. This work was supported by NIH grant R01 GM058673. I.L. was supported in part by NIH fellowship F31 GM097861.	Auton A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003984; Baker CL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004916; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Berchowitz LE, 2009, GENOME RES, V19, P2245, DOI 10.1101/gr.096297.109; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; Calabrese P, 2007, P NATL ACAD SCI USA, V104, P4748, DOI 10.1073/pnas.0610195104; Choi K, 2015, PLANT J, V83, P52, DOI 10.1111/tpj.12870; Cole F, 2014, NAT GENET, V46, P1072, DOI 10.1038/ng.3068; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; Coop G, 2007, PLOS GENET, V3, P377, DOI 10.1371/journal.pgen.0030035; de Massy B, 2013, ANNU REV GENET, V47, P563, DOI 10.1146/annurev-genet-110711-155423; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Fowler KR, 2014, GENOME RES, V24, P1650, DOI 10.1101/gr.172122.114; Friberg U, 2008, GENETICS, V179, P2229, DOI 10.1534/genetics.107.085563; Heil CSS, 2015, GENOME BIOL EVOL, V7, P2829, DOI 10.1093/gbe/evv182; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; KABACK DB, 1992, SCIENCE, V256, P228, DOI 10.1126/science.1566070; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Keller PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000533; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Lichten Michael, 2008, V3, P165, DOI 10.1007/7050_2008_040; Liti G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-69; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Louis EJ, 1995, YEAST, V11, P1553, DOI 10.1002/yea.320111604; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Peters AD, 2008, GENETICS, V178, P1579, DOI 10.1534/genetics.107.084061; Pineda-Krch M, 2005, GENETICS, V169, P2319, DOI 10.1534/genetics.104.034363; Pratto F, 2014, SCIENCE, V346, P826, DOI 10.1126/science.1256442; Replansky T, 2008, TRENDS ECOL EVOL, V23, P494, DOI 10.1016/j.tree.2008.05.005; Rockmill B, 2006, GENETICS, V174, P1745, DOI 10.1534/genetics.106.058933; Singhal S, 2015, SCIENCE, V350, P928, DOI 10.1126/science.aad0843; Smukowski CS, 2011, HEREDITY, V107, P496, DOI 10.1038/hdy.2011.44; Thacker D, 2014, NATURE, V510, P241, DOI 10.1038/nature13120; Tsai IJ, 2010, P NATL ACAD SCI USA, V107, P7847, DOI 10.1073/pnas.0908774107; Tsankov AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000414; Ubeda F, 2011, J EVOLUTION BIOL, V24, P541, DOI 10.1111/j.1420-9101.2010.02187.x; WHITE MA, 1993, P NATL ACAD SCI USA, V90, P6621, DOI 10.1073/pnas.90.14.6621; Zanders SE, 2014, ELIFE, V3, DOI 10.7554/eLife.02630	41	66	66	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					932	937		10.1126/science.aad0814	http://dx.doi.org/10.1126/science.aad0814			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW4IP	26586758	Green Submitted, Green Accepted			2022-12-28	WOS:000364955200039
J	Lee, KE; Simon, MC				Lee, Kyoung Eun; Simon, M. Celeste			SnapShot: Hypoxia-Inducible Factors	CELL			English	Editorial Material									[Lee, Kyoung Eun; Simon, M. Celeste] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Lee, KE (corresponding author), Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.		Simon, Celeste/AAG-3941-2021	Lee, Kyoung Eun/0000-0002-3955-7389	NATIONAL CANCER INSTITUTE [P01CA104838] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066310] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA104838] Funding Source: Medline; NHLBI NIH HHS [R01 HL066310] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012; Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557; Mirtschink P, 2015, NATURE, V522, P444, DOI 10.1038/nature14508	4	34	38	8	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1288	1288		10.1016/j.cell.2015.11.011	http://dx.doi.org/10.1016/j.cell.2015.11.011			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26590427	Bronze			2022-12-28	WOS:000366044700025
J	Taguwa, S; Maringer, K; Li, XK; Bernal-Rubio, D; Rauch, JN; Gestwicki, JE; Andino, R; Fernandez-Sesma, A; Frydman, J				Taguwa, Shuhei; Maringer, Kevin; Li, Xiaokai; Bernal-Rubio, Dabeiba; Rauch, Jennifer N.; Gestwicki, Jason E.; Andino, Raul; Fernandez-Sesma, Ana; Frydman, Judith			Defining Hsp70 Subnetworks in Dengue Virus Replication Reveals Key Vulnerability in Flavivirus Infection	CELL			English	Article							3-DIMENSIONAL ARCHITECTURE; MOLECULAR CHAPERONES; DENDRITIC CELLS; PROTEIN; MUTATIONS; TARGETS; BURDEN; HSP90	Viral protein homeostasis depends entirely on the machinery of the infected cell. Accordingly, viruses can illuminate the interplay between cellular proteo-stasis components and their distinct substrates. Here, we define how the Hsp70 chaperone network mediates the dengue virus life cycle. Cytosolic Hsp70 isoforms are required at distinct steps of the viral cycle, including entry, RNA replication, and virion biogenesis. Hsp70 function at each step is specified by nine distinct DNAJ cofactors. Of these, DnaJB11 relocalizes to virus-induced replication complexes to promote RNA synthesis, while DnaJB6 associates with capsid protein and facilitates virion biogenesis. Importantly, an allosteric Hsp70 inhibitor, JG40, potently blocks infection of different dengue serotypes in human primary blood cells without eliciting viral resistance or exerting toxicity to the host cells. JG40 also blocks replication of other medically-important flaviviruses including yellow fever, West Nile and Japanese encephalitis viruses. Thus, targeting host Hsp70 subnetworks provides a path for broad-spectrum antivirals.	[Taguwa, Shuhei; Frydman, Judith] Stanford Univ, Dept Biol & Genet, Stanford, CA 94305 USA; [Maringer, Kevin; Bernal-Rubio, Dabeiba; Fernandez-Sesma, Ana] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Li, Xiaokai; Rauch, Jennifer N.; Gestwicki, Jason E.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Andino, Raul] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Maringer, Kevin] Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England	Stanford University; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Bristol	Frydman, J (corresponding author), Stanford Univ, Dept Biol & Genet, Stanford, CA 94305 USA.	jfrydman@stanford.edu	Rauch, Jennifer/AGI-2683-2022	Rauch, Jennifer/0000-0001-6853-5915; Maringer, Kevin/0000-0003-0977-8807; , judith/0000-0003-2302-6943; Fernandez-Sesma, Ana/0000-0002-3405-6702	DARPA Prophecy; NIH [R01AI073450, R01NS059690]; Wellcome Trust [096062]; Naito Foundation; Uehara Memorial Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073450, P01AI091575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690] Funding Source: NIH RePORTER	DARPA Prophecy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Nguyen for technical assistance and Drs. P. Dolan and A. Gamarnik for helpful discussions. This work was supported by a contract from DARPA Prophecy to R.A., J.F., and A.F.-S.; NIH grants R01AI073450 to A.F.-S. and R01NS059690 to J.E.G.; Wellcome Trust grant 096062 to K.M. and Fellowships from the Naito Foundation and Uehara Memorial Foundation to S.T.	Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934; Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020; Assimon VA, 2013, CURR PHARM DESIGN, V19, P404; Balinsky CA, 2013, J VIROL, V87, P13094, DOI 10.1128/JVI.00704-13; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Butrapet S, 2000, J VIROL, V74, P3011, DOI 10.1128/JVI.74.7.3011-3019.2000; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P941, DOI 10.1038/nrd2485; Dowd KA, 2014, J VIROL, V88, P11726, DOI 10.1128/JVI.01140-14; Geller R, 2007, GENE DEV, V21, P195, DOI 10.1101/gad.1505307; Geller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056762; Geller R, 2012, BBA-MOL CELL RES, V1823, P698, DOI 10.1016/j.bbamcr.2011.11.007; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Lauring AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/nrmicro3003; Li X, 2013, ACM T INTEL SYST TEC, V4, DOI 10.1145/2508037.2508039; Li XK, 2015, MOL CANCER THER, V14, P642, DOI 10.1158/1535-7163.MCT-14-0650; Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013; Limjindaporn T, 2009, BIOCHEM BIOPH RES CO, V379, P196, DOI 10.1016/j.bbrc.2008.12.070; Lindenbach B., 2011, FIELDS VIROLOGY, V5th ed., P1101; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Mayer MP, 2005, REV PHYSIOL BIOCH P, V153, P1, DOI 10.1007/s10254-004-0025-5; Nagy PD, 2012, NAT REV MICROBIOL, V10, P137, DOI 10.1038/nrmicro2692; Neckers L, 2008, CELL HOST MICROBE, V4, P519, DOI 10.1016/j.chom.2008.10.011; OBrien MC, 1996, J BIOL CHEM, V271, P15874, DOI 10.1074/jbc.271.27.15874; Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004; Powers ET, 2013, NAT REV MOL CELL BIO, V14, P237, DOI 10.1038/nrm3542; Rodriguez-Madoz JR, 2010, J VIROL, V84, P9760, DOI 10.1128/JVI.01051-10; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Schmid MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00647; Shepard DS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003306; Stein KC, 2014, J BIOL CHEM, V289, P21120, DOI 10.1074/jbc.M114.572461; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Wang AM, 2013, NAT CHEM BIOL, V9, P112, DOI [10.1038/NCHEMBIO.1140, 10.1038/nchembio.1140]; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Williamson DS, 2009, J MED CHEM, V52, P1510, DOI 10.1021/jm801627a; Ye J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075188; Yi ZG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001255	42	170	176	5	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1108	1123		10.1016/j.cell.2015.10.046	http://dx.doi.org/10.1016/j.cell.2015.10.046			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26582131	Green Accepted, Bronze			2022-12-28	WOS:000366044700011
J	Velasquez-Manoff, M				Velasquez-Manoff, Moises			Genetics: Relative risk	NATURE			English	Editorial Material							BREAST-CANCER; MUTATION CARRIERS; BRCA1											HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; King MC, 2014, JAMA-J AM MED ASSOC, V312, P1091, DOI 10.1001/jama.2014.12483; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Kotsopoulos J, 2014, BREAST CANCER RES TR, V143, P579, DOI 10.1007/s10549-013-2823-4; Pettapiece-Phillips R, 2015, CANCER CAUSE CONTROL, V26, P333, DOI 10.1007/s10552-014-0521-0; Rebbeck TR, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2115	6	4	4	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					S116	S117		10.1038/527S116a	http://dx.doi.org/10.1038/527S116a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26580161	Bronze			2022-12-28	WOS:000365356800006
J	Robinson, JP; Roederer, M				Robinson, J. Paul; Roederer, Mario			Flow cytometry strikes gold	SCIENCE			English	Editorial Material							CELLS; SEPARATION; SYSTEMS; IMMUNE		[Robinson, J. Paul] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Robinson, J. Paul] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Roederer, Mario] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Robinson, JP (corresponding author), Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA.	jpr@flowcyt.cyto.purdue.edu; roederer@nih.gov	Robinson, Joseph/AAA-1001-2020; Roederer, Mario/G-1887-2011	Robinson, Joseph/0000-0001-8383-3240; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005020, ZICAI005101] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Chattopadhyay PK, 2014, NAT IMMUNOL, V15, P128, DOI 10.1038/ni.2796; DITTRICH W, 1969, Z NATURFORSCH PT B, VB 24, P360, DOI 10.1515/znb-1969-0326; Edwards BS, 1999, CYTOMETRY, V37, P156, DOI 10.1002/(SICI)1097-0320(19991001)37:2<156::AID-CYTO9>3.0.CO;2-T; FULWYLER MJ, 1965, SCIENCE, V150, P910, DOI 10.1126/science.150.3698.910; George TC, 2004, CYTOM PART A, V59A, P237, DOI 10.1002/cyto.a.20048; Goddard GR, 2007, ANAL CHEM, V79, P8740, DOI 10.1021/ac071402t; GRAY JW, 1975, P NATL ACAD SCI USA, V72, P1231, DOI 10.1073/pnas.72.4.1231; Gregori G, 2012, CYTOM PART A, V81A, P35, DOI 10.1002/cyto.a.21120; Herzenberg LA, 2014, ANNU REV PHYSIOL, V76, P1, DOI 10.1146/annurev-physiol-021113-170355; HULETT HR, 1969, SCIENCE, V166, P747, DOI 10.1126/science.166.3906.747; Lugli E, 2010, CYTOM PART A, V77A, P705, DOI 10.1002/cyto.a.20901; Robinson JP, 2012, EXPERT OPIN DRUG DIS, V7, P679, DOI 10.1517/17460441.2012.693475; Wang HW, 2008, OPT EXPRESS, V16, P5782, DOI 10.1364/OE.16.005782; Watson A, 2003, BIOTECHNIQUES, V34, P296, DOI 10.2144/03342bi01	15	72	75	5	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					739	740		10.1126/science.aad6770	http://dx.doi.org/10.1126/science.aad6770			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW3MS	26564833				2022-12-28	WOS:000364897000019
J	Grayson, M; Pincock, S				Grayson, Michelle; Pincock, Stephen			nature INDEX 2015 COLLABORATIONS	NATURE			English	Editorial Material														Pincock, Stephen/0000-0003-1655-2902					0	6	6	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					S49	S49		10.1038/527S49a	http://dx.doi.org/10.1038/527S49a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VB5XJ	26560450	Bronze			2022-12-28	WOS:000415917700001
J	Nagot, N; Kankasa, C; Tumwine, JK; Meda, N; Hofmeyr, GJ; Vallo, R; Mwiya, M; Kwagala, M; Traore, H; Sunday, A; Singata, M; Siuluta, C; Some, E; Rutagwera, D; Neboua, D; Ndeezi, G; Jackson, D; Marechal, V; Neveu, D; Engebretsen, IMS; Lombard, C; Blanche, S; Sommerfelt, H; Rekacewicz, C; Tylleskart, T; Van de Perre, P				Nagot, Nicolas; Kankasa, Chipepo; Tumwine, James K.; Meda, Nicolas; Hofmeyr, G. Justus; Vallo, Roselyne; Mwiya, Mwiya; Kwagala, Mary; Traore, Hugues; Sunday, Amwe; Singata, Mandisa; Siuluta, Chafye; Some, Eric; Rutagwera, David; Neboua, Desire; Ndeezi, Grace; Jackson, Debra; Marechal, Valerie; Neveu, Dorine; Engebretsen, Ingunn M. S.; Lombard, Carl; Blanche, Stephane; Sommerfelt, Halvor; Rekacewicz, Claire; Tylleskaert, Thorkild; Van de Perre, Philippe		ANRS 12174 Trial Grp	Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial	LANCET			English	Article							TO-CHILD TRANSMISSION; HUMAN-IMMUNODEFICIENCY-VIRUS; DAR-ES-SALAAM; ANTIRETROVIRAL THERAPY; NEVIRAPINE PROPHYLAXIS; DOSE NEVIRAPINE; PREGNANCY; MOTHERS; LOPINAVIR/RITONAVIR; EFFICACY	Background Strategies to prevent postnatal mother-to-child transmission of HIV-1 in Africa, including infant prophylaxis, have never been assessed past 6 months of breastfeeding, despite breastfeeding being recommended up to 12 months after birth. We aimed to compare the efficacy and safety of infant prophylaxis with the two drug regimens (lamivudine or lopinavir-ritonavir) to prevent postnatal HIV-1 transmission up to 50 weeks of breastfeeding. Methods We did a randomised controlled trial in four sites in Burkina Faso, South Africa, Uganda, and Zambia in children born to HIV-1-infected mothers not eligible for antiretroviral therapy (CD4 count >350 cells per mu L). An independent researcher electronically generated a randomisation schedule; we then used sequentially numbered envelopes to randomly assign (1: 1) HIV-1-uninfected breastfed infants aged 7 days to either lopinavir-ritonavir or lamivudine (paediatric liquid formulations, twice a day) up to 1 week after complete cessation of breastfeeding or at the final visit at week 50. We stratified the randomisation by country and used permuted blocks of four and six. We used a study label on drug bottles to mask participants, study physicians, and assessors to the treatment allocation. The primary outcome was infant HIV-1 infection between age 7 days and 50 weeks, diagnosed every 3 months with HIV-1 DNA PCR, in the modified intention-to-treat population (all who attended at least one follow-up visit). This trial is registered with ClinicalTrials.gov, number NCT00640263. Findings Between Nov 16, 2009, and May 7, 2012, we enrolled and randomised 1273 infants and analysed 1236; 615 assigned to lopinavir-ritonavir or 621 assigned to lamivudine. 17 HIV-1 infections were diagnosed in the study period (eight in the lopinavir-ritonavir group and nine in the lamivudine group), resulting in cumulative HIV-1 infection of 1.4% (95% CI 0.4-2.5) and 1.5% (0.7-2.5), respectively. Infection rates did not differ between the two drug regimens (hazard ratio [HR] of lopinavir-ritonavir versus lamivudine of 0.90, 95% CI 0.35-2.34; p=0.83). Clinical and biological severe adverse events did not differ between groups; 251 (51%) infants had a grade 3-4 event in the lopinavir-ritonavir group compared with 246 (50%) in the lamivudine group. Interpretation Infant HIV-1 prophylaxis with lopinavir-ritonavir was not superior to lamivudine and both drugs led to very low rates of HIV-1 postnatal transmission for up to 50 weeks of breastfeeding. Infant pre-exposure prophylaxis should be extended until the end of HIV-1 exposure and mothers should be informed about the persistent risk of transmission throughout breastfeeding.	[Nagot, Nicolas; Vallo, Roselyne; Marechal, Valerie; Neveu, Dorine; Van de Perre, Philippe] INSERM, U1058, Montpellier, France; [Nagot, Nicolas; Vallo, Roselyne; Marechal, Valerie; Neveu, Dorine; Van de Perre, Philippe] Univ Montpellier, F-34059 Montpellier, France; [Nagot, Nicolas; Van de Perre, Philippe] CHU Montpellier, Montpellier, France; [Kankasa, Chipepo; Mwiya, Mwiya; Siuluta, Chafye; Rutagwera, David] Univ Zambia, Sch Med, Dept Paediat & Child Hlth, Univ Teaching Hosp, Lusaka, Zambia; [Tumwine, James K.; Kwagala, Mary; Ndeezi, Grace] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Paediat & Child Hlth, Kampala, Uganda; [Meda, Nicolas; Traore, Hugues; Some, Eric; Neboua, Desire] Univ Ouagadougou, Fac Hlth Sci, Ctr Int Res Hlth, Ouagadougou, Burkina Faso; [Hofmeyr, G. Justus; Sunday, Amwe; Singata, Mandisa] Cecilia Makiwane Hosp, Effective Care Res Unit, East London Hosp Complex, East London, South Africa; [Hofmeyr, G. Justus; Sunday, Amwe; Singata, Mandisa; Jackson, Debra] Univ Western Cape, Sch Publ Hlth, ZA-7535 Bellville, South Africa; [Engebretsen, Ingunn M. S.; Sommerfelt, Halvor; Tylleskaert, Thorkild] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Lombard, Carl] Med Res Council South Africa, Biostat Unit, Cape Town, South Africa; [Blanche, Stephane] Univ Paris 05, Dept Paediat, URC CIC Necker Cochin, Hop Necker, Paris, France; [Sommerfelt, Halvor] Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth, Ctr Int Hlth, Bergen, Norway; [Sommerfelt, Halvor] Norwegian Inst Publ Hlth, Dept Int Publ Hlth, Oslo, Norway; [Rekacewicz, Claire] Natl Agcy Res AIDS & Viral Hepatitis INSERM ANRS, French Natl Inst Hlth & Med Res, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; University of Zambia; Makerere University; University of the Western Cape; University of Bergen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Bergen; Norwegian Institute of Public Health (NIPH); Institut National de la Sante et de la Recherche Medicale (Inserm)	Van de Perre, P (corresponding author), INSERM, U1058, UFR Pharm, F-34090 Montpellier, France.	p-van_de_perre@chu-montpellier.fr	Van de Perre, Philippe/B-9692-2008; Zongo, Arsene/AAC-3790-2020; Tylleskär, Thorkild/S-5529-2017; Sommerfelt, Halvor/ABD-3552-2020; Engebretsen, Ingunn Marie S/N-5692-2017	Van de Perre, Philippe/0000-0002-3912-0427; Zongo, Arsene/0000-0001-8812-3088; Tylleskär, Thorkild/0000-0003-4801-4324; Sommerfelt, Halvor/0000-0002-5670-9786; Engebretsen, Ingunn Marie S/0000-0001-5852-3611; Jackson, Debra/0000-0003-3307-632X; Vallo, Roselyne/0000-0002-2447-6754; Matoba, Japhet/0000-0001-6021-659X; Nagot, Nicolas/0000-0002-3493-2821; Lombard, Carl/0000-0002-2136-6533	French National Institute of Health and Medical Research-National Agency for Research on AIDS; Viral Hepatitis (Inserm-ANRS); Inserm-ANRS [ANRS 12174]; Total Foundation; European Developing Countries Clinical Trials Partnership (EDCTP) [CT.2006.33020.004]; Research Council of Norway (GlobVac) [183600]	French National Institute of Health and Medical Research-National Agency for Research on AIDS; Viral Hepatitis (Inserm-ANRS); Inserm-ANRS; Total Foundation(Total SA); European Developing Countries Clinical Trials Partnership (EDCTP); Research Council of Norway (GlobVac)(Research Council of Norway)	The French National Institute of Health and Medical Research-National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) sponsored the study. Funding was provided by Inserm-ANRS (ANRS 12174) including funds from the Total Foundation, European Developing Countries Clinical Trials Partnership (EDCTP; grant number CT.2006.33020.004) and the Research Council of Norway (GlobVac grant number 183600). We thank the French Agency for AIDS Research (ANRS) and particularly Brigitte Bazin and Jean-Francois Delfraissy (Director) for their constant encouragement and support. Our gratitude extends to the EDCTP and particularly Charles Mgone (Director) and Montserrat Blazquez as well as to the Global Health and Vaccination Research Program (GLOBVAC) at the Research Council of Norway. We thank the independent data monitoring committee (Simon Cousens [London School of Hygiene & Tropical Medicine, UK], Sithembiso Velaphi [Witwatersrand University, South Africa], Laurent Mandelbrot [Paris 7 University, France], Isabelle de Vincenzi [WHO, Geneva], and Gunnel Biberfeld [Karolinska Institute, Sweden]) and our scientific advisory board (Nigel Rollins [WHO], Rodolphe Thiebaut [University of Bordeaux, France], and Kusum Nathoo [University of Zimbabwe, Harare, Zimbabwe]) for their commitment and their invaluable support for the ANRS 12174 trial. We thank Audrey Jaussent for the elaboration of the randomisation lists. We thank all the women and their infants who agreed to participate in the trial.	Alioum A, 2003, AM J EPIDEMIOL, V158, P596, DOI 10.1093/aje/kwg188; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; Avettand-Fenol V, 2009, J MED VIROL, V81, P217, DOI 10.1002/jmv.21390; Bedri A, 2008, LANCET, V372, P300, DOI 10.1016/S0140-6736(08)61114-9; Chadwick EG, 2008, AIDS, V22, P249, DOI 10.1097/QAD.0b013e3282f2be1d; Chadwick EG, 2009, PEDIATR INFECT DIS J, V28, P215, DOI 10.1097/INF.0b013e31818cc053; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Coovadia HM, 2012, LANCET, V379, P221, DOI 10.1016/S0140-6736(11)61653-X; FDA, 2011, KAL LOP RIT OR SOL L; FRIEDMAN M, 1982, ANN STAT, V10, P101, DOI 10.1214/aos/1176345693; Hudgens MG, 2013, CLIN INFECT DIS, V56, P131, DOI 10.1093/cid/cis808; Jamieson DJ, 2012, LANCET, V379, P2449, DOI 10.1016/S0140-6736(12)60321-3; Kilewo C, 2008, JAIDS-J ACQ IMM DEF, V48, P315, DOI 10.1097/QAI.0b013e31816e395c; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Mofenson LM, 2013, CURR OPIN HIV AIDS, V8, P443, DOI 10.1097/COH.0b013e328363d280; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Nagot N, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-246; Peltier CA, 2009, AIDS, V23, P2415, DOI 10.1097/QAD.0b013e32832ec20d; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Shapiro RL, 2013, ANTIVIR THER, V18, P585, DOI 10.3851/IMP2474; Simon A, 2011, JAMA-J AM MED ASSOC, V306, P70, DOI 10.1001/jama.2011.915; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; Van de Perre P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3763; Van de Perre P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003327; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; World Health Organization, 2021, ANT DRUGS TREAT PREG	30	56	56	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2016	387	10018					566	573		10.1016/S0140-6736(15)00984-8	http://dx.doi.org/10.1016/S0140-6736(15)00984-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3PV	26603917				2022-12-28	WOS:000369835800035
J	Oettle, H; Lehmann, T				Oettle, Helmut; Lehmann, Thorsten			Gemcitabine-resistant pancreatic cancer: a second-line option	LANCET			English	Editorial Material							IRINOTECAN; MONOTHERAPY; SURVIVAL		[Oettle, Helmut] Zentrum Tumormed, D-88045 Friedrichshafen, Germany; [Lehmann, Thorsten] Klinikum Friedrichshafen, Klin Allgemein & Viszeralchirurg, Friedrichshafen, Germany		Oettle, H (corresponding author), Zentrum Tumormed, D-88045 Friedrichshafen, Germany.	helmut.oettle@charite.de						Chen L-T, 2015, 2015 GASTR CANC S SA; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Kalra AV, 2014, CANCER RES, V74, P7003, DOI 10.1158/0008-5472.CAN-14-0572; Lee V, 2012, J PANCREAS, V13, P182; Lima CMR, 2004, J CLIN ONCOL, V22, P3776, DOI 10.1200/JCO.2004.12.082; Oettle H, 2014, CANCER TREAT REV, V40, P1039, DOI 10.1016/j.ctrv.2014.07.003; Oettle H, 2014, J CLIN ONCOL, V32, P2423, DOI 10.1200/JCO.2013.53.6995; Stathopoulos GP, 2006, BRIT J CANCER, V95, P587, DOI 10.1038/sj.bjc.6603301; Sun HH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06747; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wang-Gillam A, 2015, LANCET	11	10	16	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2016	387	10018					507	508		10.1016/S0140-6736(15)01035-1	http://dx.doi.org/10.1016/S0140-6736(15)01035-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3PV	26616909				2022-12-28	WOS:000369835800007
J	Pankow, S; Bamberger, C; Calzolari, D; Martinez-Bartolome, S; Lavallee-Adam, M; Balch, WE; Yates, JR				Pankow, Sandra; Bamberger, Casimir; Calzolari, Diego; Martinez-Bartolome, Salvador; Lavallee-Adam, Mathieu; Balch, William E.; Yates, John R., III			Delta F508 CFTR interactome remodelling promotes rescue of cystic fibrosis	NATURE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOPLASMIC-RETICULUM; PROTEIN; PROTEASOME; IDENTIFICATION; DEGRADATION; TRANSPORT; AUTOPHAGY; MEMBRANE; SURF4	Deletion of phenylalanine 508 of the cystic fibrosis transmembrane conductance regulator (Delta F508 CFTR) is the major cause of cystic fibrosis, one of the most common inherited childhood diseases. The mutated CFTR anion channel is not fully glycosylated and shows minimal activity in bronchial epithelial cells of patients with cystic fibrosis. Low temperature or inhibition of histone deacetylases can partly rescue Delta F508 CFTR cellular processing defects and function. A favourable change of Delta F508 CFTR protein-protein interactions was proposed as a mechanism of rescue; however, CFTR interactome dynamics during temperature shift and inhibition of histone deacetylases are unknown. Here we report the first comprehensive analysis of the CFTR and Delta F508 CFTR interactome and its dynamics during temperature shift and inhibition of histone deacetylases. By using a novel deep proteomic analysis method, we identify 638 individual high-confidence CFTR interactors and discover a Delta F508 deletion-specific interactome, which is extensively remodelled upon rescue. Detailed analysis of the interactome remodelling identifies key novel interactors, whose loss promote Delta F508 CFTR channel function in primary cystic fibrosis epithelia or which are critical for CFTR biogenesis. Our results demonstrate that global remodelling of Delta F508 CFTR interactions is crucial for rescue, and provide comprehensive insight into the molecular disease mechanisms of cystic fibrosis caused by deletion of F508.	[Pankow, Sandra; Bamberger, Casimir; Calzolari, Diego; Martinez-Bartolome, Salvador; Lavallee-Adam, Mathieu; Yates, John R., III] Scripps Res Inst, Dept Chem Physiol, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Yates, JR (corresponding author), Scripps Res Inst, Dept Chem Physiol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	pankows@scripps.edu; jyates@scripps.edu	Martinez-Bartolomé, Salvador/AAA-4391-2020; Bamberger, Tom Casimir/D-1292-2014	Martinez-Bartolomé, Salvador/0000-0001-7592-5612; Bamberger, Tom Casimir/0000-0002-3830-4486; Lavallee-Adam, Mathieu/0000-0003-2124-3872; Pankow, Sandra/0000-0003-3213-9886	National Institutes of Health [5R01HL079442-08, P01AG031097, P41 GM103533, HHSN268201000035C, R01HL095524, R01DK051870]; Cystic Fibrosis Foundation mass spectrometry fellowship [BALCH050X6]; Fonds de recherche du Quebec - Nature et technologies; Tobacco-Related Disease Research Program [23TRU0012]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095524, R01HL079442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation mass spectrometry fellowship; Fonds de recherche du Quebec - Nature et technologies; Tobacco-Related Disease Research Program(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Bamberger for many discussions on statistical analysis, and D. Cociorva and T. Xu for making DTASelect 2.1 available and for suggestions and comments on data analysis strategies. We further thank D. Hutt and D. Roth for discussion. This work was supported by National Institutes of Health grants 5R01HL079442-08 (to J.R.Y. and W.E.B.), P01AG031097 (to J.R.Y.), P41 GM103533 (to J.R.Y.), HHSN268201000035C (to J.R.Y.), and a Cystic Fibrosis Foundation mass spectrometry fellowship BALCH050X6 (to S.P. and J.R.Y.). M.L.-A. holds a postdoctoral fellowship from Fonds de recherche du Quebec - Nature et technologies. W.E.B. is supported by National Institutes of Health grants R01HL095524 and R01DK051870 and Tobacco-Related Disease Research Program grant 23TRU0012.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Bruscia E, 2002, GENE THER, V9, P683, DOI 10.1038/sj.gt.3301741; Callahan MK, 2006, J IMMUNOL, V177, P8393, DOI 10.4049/jimmunol.177.12.8393; Chu BW, 2013, J BIOL CHEM, V288, P34575, DOI 10.1074/jbc.M113.499350; Cociorva Daniel, 2007, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1304s16; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Fujii Y, 2012, BIOCHEM BIOPH RES CO, V422, P615, DOI 10.1016/j.bbrc.2012.05.037; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; LI CH, 1993, NAT GENET, V3, P311, DOI 10.1038/ng0493-311; Li XJ, 2003, ANAL CHEM, V75, P6648, DOI 10.1021/ac034633i; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Mallery DL, 2010, P NATL ACAD SCI USA, V107, P19985, DOI 10.1073/pnas.1014074107; Matsuzaki F, 2011, MOL BIOL CELL, V22, P4602, DOI 10.1091/mbc.E11-01-0068; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Mitrovic S, 2008, MOL BIOL CELL, V19, P1976, DOI 10.1091/mbc.E07-10-0989; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Pankow S., PROTOCOL EXCHA UNPUB; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; Pavlopoulos Georgios A, 2011, BMC Res Notes, V4, P384, DOI 10.1186/1756-0500-4-384; Pearce MMP, 2009, J BIOL CHEM, V284, P10433, DOI 10.1074/jbc.M809801200; Ranish JA, 2004, NAT GENET, V36, P707, DOI 10.1038/ng1385; Santamaria PG, 2003, J BIOL CHEM, V278, P6687, DOI 10.1074/jbc.M209420200; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Taguwa S, 2009, J VIROL, V83, P10427, DOI 10.1128/JVI.01035-09; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Uchida N, 2004, J BIOL CHEM, V279, P1383, DOI 10.1074/jbc.M309125200; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Watson Michael S, 2004, Genet Med, V6, P387, DOI 10.1097/01.GIM.0000139506.11694.7C; Weng MT, 2013, PROTEIN CELL, V4, P807, DOI 10.1007/s13238-013-3056-3; World Health Organization (WHO), 2004, MOL GEN EP CYST FIBR; Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174	55	163	164	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					510	+		10.1038/nature15729	http://dx.doi.org/10.1038/nature15729			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26618866	Green Submitted, Green Accepted			2022-12-28	WOS:000366991900043
J	Bunermann, O; Jiang, HY; Dorenkamp, Y; Kandratsenka, A; Janke, SM; Auerbach, DJ; Wodtke, AM				Buenermann, Oliver; Jiang, Hongyan; Dorenkamp, Yvonne; Kandratsenka, Alexander; Janke, Svenja M.; Auerbach, Daniel J.; Wodtke, Alec M.			Electron-hole pair excitation determines the mechanism of hydrogen atom adsorption	SCIENCE			English	Article							METAL-SURFACES; AB-INITIO; DYNAMICS; SCATTERING; MOLECULES; CREATION; CU(111); BEAMS; LIF; CU	How much translational energy atoms and molecules lose in collisions at surfaces determines whether they adsorb or scatter. The fact that hydrogen (H) atoms stick to metal surfaces poses a basic question. Momentum and energy conservation demands that the light H atom cannot efficiently transfer its energy to the heavier atoms of the solid in a binary collision. How then do H atoms efficiently stick to metal surfaces? We show through experiments that H-atom collisions at an insulating surface (an adsorbed xenon layer on a gold single-crystal surface) are indeed nearly elastic, following the predictions of energy and momentum conservation. In contrast, H-atom collisions with the bare gold surface exhibit a large loss of translational energy that can be reproduced by an atomic-level simulation describing electron-hole pair excitation.	[Buenermann, Oliver; Jiang, Hongyan; Dorenkamp, Yvonne; Kandratsenka, Alexander; Janke, Svenja M.; Auerbach, Daniel J.; Wodtke, Alec M.] Univ Gottingen, Inst Phys Chem, Tammannstr 6, D-37077 Gottingen, Germany; [Buenermann, Oliver; Kandratsenka, Alexander; Janke, Svenja M.; Auerbach, Daniel J.; Wodtke, Alec M.] Max Planck Inst Biophys Chem, Dept Dynam Surfaces, D-37077 Gottingen, Germany; [Buenermann, Oliver; Wodtke, Alec M.] Univ Gottingen, Int Ctr Adv Studies Energy Convers, D-37077 Gottingen, Germany	University of Gottingen; Max Planck Society; University of Gottingen	Bunermann, O (corresponding author), Univ Gottingen, Inst Phys Chem, Tammannstr 6, D-37077 Gottingen, Germany.	oliver.buenermann@chemie.uni-goettingen.de	Wodtke, Alec M/I-4848-2012; Auerbach, Daniel J/J-7109-2014; Kandratsenka, Alexander/A-4561-2008	Auerbach, Daniel J/0000-0001-9494-3066; Kandratsenka, Alexander/0000-0003-2132-1957; Bunermann, Oliver/0000-0001-9837-6548; Wodtke, Alec/0000-0002-6509-2183; Janke, Svenja/0000-0003-3494-2963; Jiang, Hongyan/0000-0003-3559-2774	Humboldt Foundation; Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich 1073]; Agence Nationale de la Recherche (ANR) [WO 1541/1-1]; DFG; Ministerium fur Wissenschaft und Kultur (MWK) Niedersachsen; Volkswagenstiftung [INST 186/902-1]	Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); DFG(German Research Foundation (DFG)); Ministerium fur Wissenschaft und Kultur (MWK) Niedersachsen; Volkswagenstiftung(Volkswagen)	We thank X. Yang and C. Xiao for helping to set up Rydberg Atom Tagging, R. Bursing for helping to design the experimental apparatus, and G.-J. Kroes for assisting in the development of the theory. A.M.W. and D.J.A. gratefully acknowledge support from the Humboldt Foundation. We acknowledge support from the Sonderforschungsbereich 1073 under project A04; from the Deutsche Forschungsgemeinschaft (DFG) and the Agence Nationale de la Recherche (ANR) under grant no. WO 1541/1-1; and from the DFG, the Ministerium fur Wissenschaft und Kultur (MWK) Niedersachsen, and the Volkswagenstiftung under grant no. INST 186/902-1.	AMIRAV A, 1986, PHYS REV LETT, V57, P2299, DOI 10.1103/PhysRevLett.57.2299; Andersson MP, 2008, J CATAL, V255, P6, DOI 10.1016/j.jcat.2007.12.016; Bird DM, 2008, SURF SCI, V602, P1212, DOI 10.1016/j.susc.2008.01.026; Born M, 1927, ANN PHYS-BERLIN, V84, P0457; CARACCIOLO G, 1980, J CHEM PHYS, V72, P4491, DOI 10.1063/1.439690; Cooper R, 2012, ANGEW CHEM INT EDIT, V51, P4954, DOI 10.1002/anie.201201168; FINZEL HU, 1975, SURF SCI, V49, P577, DOI 10.1016/0039-6028(75)90372-6; Gergen B, 2001, SCIENCE, V294, P2521, DOI 10.1126/science.1066134; Golibrzuch K, 2015, ANNU REV PHYS CHEM, V66, P399, DOI 10.1146/annurev-physchem-040214-121958; Haberer D, 2010, NANO LETT, V10, P3360, DOI 10.1021/nl101066m; HABERRECKER K, 1967, NUCL INSTRUM METHODS, V57, P22, DOI 10.1016/0029-554X(67)90492-2; Hellman A, 2006, J PHYS CHEM B, V110, P17719, DOI 10.1021/jp056982h; HIGASHI GS, 1990, APPL PHYS LETT, V56, P656, DOI 10.1063/1.102728; HOLLENBACH D, 1971, ASTROPHYS J, V163, P155, DOI 10.1086/150754; Huang YH, 2000, SCIENCE, V290, P111, DOI 10.1126/science.290.5489.111; Janke SM, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4931669; Johnson TH, 1931, PHYS REV, V37, P847, DOI 10.1103/PhysRev.37.847; KINUGAWA T, 1993, JPN J APPL PHYS 2, V32, pL550, DOI 10.1143/JJAP.32.L550; Kroes GJ, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4891483; LAMONT CLA, 1995, CHEM PHYS LETT, V243, P429, DOI 10.1016/0009-2614(95)00814-K; Langmuir I, 1912, J AM CHEM SOC, V34, P1310, DOI 10.1021/ja02211a004; Lee SM, 2000, SYNTHETIC MET, V113, P209, DOI 10.1016/S0379-6779(99)00275-1; LI YG, 1992, PHYS REV B, V46, P14528, DOI 10.1103/PhysRevB.46.14528; Nienhaus H, 1999, PHYS REV LETT, V82, P446, DOI 10.1103/PhysRevLett.82.446; NORSKOV JK, 1979, SURF SCI, V89, P251, DOI 10.1016/0039-6028(79)90611-3; Pavanello M, 2013, J PHYS CHEM LETT, V4, P3735, DOI 10.1021/jz401955r; SCHNIEDER L, 1991, FARADAY DISCUSS, V91, P259, DOI 10.1039/dc9919100259; SCHNIEDER L, 1990, J CHEM PHYS, V92, P7027, DOI 10.1063/1.458243; Shenvi N, 2009, SCIENCE, V326, P829, DOI 10.1126/science.1179240; Stromquist J, 1998, SURF SCI, V397, P382, DOI 10.1016/S0039-6028(97)00759-0	30	109	109	3	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1346	1349		10.1126/science.aad4972	http://dx.doi.org/10.1126/science.aad4972			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26612832				2022-12-28	WOS:000366162400035
J	Fawcett, AA; Iyer, GC; Clarke, LE; Edmonds, JA; Hultman, NE; McJeon, HC; Rogelj, J; Schuler, R; Alsalam, J; Asrar, GR; Creason, J; Jeong, M; McFarland, J; Mundra, A; Shi, WJ				Fawcett, Allen A.; Iyer, Gokul C.; Clarke, Leon E.; Edmonds, James A.; Hultman, Nathan E.; McJeon, Haewon C.; Rogelj, Joeri; Schuler, Reed; Alsalam, Jameel; Asrar, Ghassem R.; Creason, Jared; Jeong, Minji; McFarland, James; Mundra, Anupriya; Shi, Wenjing			Can Paris pledges avert severe climate change?	SCIENCE			English	Editorial Material									[Fawcett, Allen A.; Alsalam, Jameel; Creason, Jared; McFarland, James] US EPA, Washington, DC 20460 USA; [Iyer, Gokul C.; Clarke, Leon E.; Edmonds, James A.; McJeon, Haewon C.; Asrar, Ghassem R.; Jeong, Minji; Mundra, Anupriya; Shi, Wenjing] Pacific NW Natl Lab, Joint Global Change Res Inst, College Pk, MD 20740 USA; [Iyer, Gokul C.; Clarke, Leon E.; Edmonds, James A.; McJeon, Haewon C.; Asrar, Ghassem R.; Jeong, Minji; Mundra, Anupriya; Shi, Wenjing] Univ Maryland, College Pk, MD 20740 USA; [Hultman, Nathan E.] Univ Maryland, Sch Publ Policy, College Pk, MD 20742 USA; [Rogelj, Joeri] Int Inst Appl Syst Anal, Energy Program, A-2361 Laxenburg, Austria; [Schuler, Reed] US Dept State, Washington, DC 20520 USA	United States Environmental Protection Agency; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; International Institute for Applied Systems Analysis (IIASA)	Iyer, GC (corresponding author), Council Environm Qual, Washington, DC 20506 USA.	gokul.iyer@pnnl.gov	Asrar, Ghassem R./AAK-9517-2020; Fawcett, Allen A/V-9781-2017; Rogelj, Joeri/I-7108-2012	Fawcett, Allen A/0000-0002-2980-0402; Rogelj, Joeri/0000-0003-2056-9061; Shi, Wenjing/0000-0002-9417-7856; McJeon, Haewon/0000-0003-0348-5704	Divn Of Social and Economic Sciences [1056998] Funding Source: National Science Foundation	Divn Of Social and Economic Sciences(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		[Anonymous], 2015, GCAM WIKI DOCUMENTAT; Clarke L, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P413; Climate Action Tracker, 2015, CLOS AR INDCS 2 1 5; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; IPCC, 2015, AR5 SCEN DAT; Iyer G, 2015, TECHNOL FORECAST SOC, V90, P103, DOI 10.1016/j.techfore.2013.08.025; Meinshausen M, 2011, ATMOS CHEM PHYS, V11, P1417, DOI 10.5194/acp-11-1417-2011; Pachauri R.K., 2014, CONTRIBUTION WORKING; Riahi K, 2015, TECHNOL FORECAST SOC, V90, P8, DOI 10.1016/j.techfore.2013.09.016; Rogelj J, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/031003; UNFCCC, 2015, INDCS COMM PART; UNFCCC, 2015, SYNTH REP AGGR EFF I; Waldhoff ST, 2011, CLIMATIC CHANGE, V107, P635, DOI 10.1007/s10584-011-0132-7	13	206	215	3	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1168	1169		10.1126/science.aad5761	http://dx.doi.org/10.1126/science.aad5761			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX4WG	26612835				2022-12-28	WOS:000365700500045
J	Corbyn, Z				Corbyn, Zoe			Research: Biology's big hit	NATURE			English	Editorial Material							ZINC-FINGER NUCLEASES; CLEAVAGE; RNA											Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bibikova M, 2002, GENETICS, V161, P1169; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556	12	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					S4	S5		10.1038/528S4a	http://dx.doi.org/10.1038/528S4a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX3NO	26630597	Bronze			2022-12-28	WOS:000365606000001
J	Molina, JM; Capitant, C; Spire, B; Pialoux, G; Cotte, L; Charreau, I; Tremblay, C; Le Gall, JM; Cua, E; Pasquet, A; Raffi, F; Pintado, C; Chidiac, C; Chas, J; Charbonneau, P; Delaugerre, C; Suzan-Monti, M; Loze, B; Fonsart, J; Peytavin, G; Cheret, A; Timsit, J; Girard, G; Lorente, N; Preau, M; Rooney, JF; Wainberg, MA; Thompson, D; Rozenbaum, W; Dore, V; Marchand, L; Simon, MC; Etien, N; Aboulker, JP; Meyer, L; Delfraissy, JF				Molina, J. -M.; Capitant, C.; Spire, B.; Pialoux, G.; Cotte, L.; Charreau, I.; Tremblay, C.; Le Gall, J. -M.; Cua, E.; Pasquet, A.; Raffi, F.; Pintado, C.; Chidiac, C.; Chas, J.; Charbonneau, P.; Delaugerre, C.; Suzan-Monti, M.; Loze, B.; Fonsart, J.; Peytavin, G.; Cheret, A.; Timsit, J.; Girard, G.; Lorente, N.; Preau, M.; Rooney, J. F.; Wainberg, M. A.; Thompson, D.; Rozenbaum, W.; Dore, V.; Marchand, L.; Simon, M. -C.; Etien, N.; Aboulker, J. -P.; Meyer, L.; Delfraissy, J. -F.		ANRS IPERGAY Study Grp	On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL PROPHYLAXIS; AFRICAN WOMEN; PREVENTION; TRANSMISSION; TENOFOVIR; TRIAL; REDUCTION; EFFICACY; VACCINE	BACKGROUND Antiretroviral preexposure prophylaxis has been shown to reduce the risk of human immunodeficiency virus type 1 (HIV-1) infection in some studies, but conflicting results have been reported among studies, probably due to challenges of adherence to a daily regimen. METHODS We conducted a double-blind, randomized trial of antiretroviral therapy for preexposure HIV-1 prophylaxis among men who have unprotected anal sex with men. Participants were randomly assigned to take a combination of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) or placebo before and after sexual activity. All participants received risk-reduction counseling and condoms and were regularly tested for HIV-1 and HIV-2 and other sexually transmitted infections. RESULTS Of the 414 participants who underwent randomization, 400 who did not have HIV infection were enrolled (199 in the TDF-FTC group and 201 in the placebo group). All participants were followed for a median of 9.3 months (interquartile range, 4.9 to 20.6). A total of 16 HIV-1 infections occurred during follow-up, 2 in the TDF-FTC group (incidence, 0.91 per 100 person-years) and 14 in the placebo group (incidence, 6.60 per 100 person-years), a relative reduction in the TDF-FTC group of 86% (95% confidence interval, 40 to 98; P = 0.002). Participants took a median of 15 pills of TDF-FTC or placebo per month (P = 0.57). The rates of serious adverse events were similar in the two study groups. In the TDF-FTC group, as compared with the placebo group, there were higher rates of gastrointestinal adverse events (14% vs. 5%, P = 0.002) and renal adverse events (18% vs. 10%, P = 0.03). CONCLUSIONS The use of TDF-FTC before and after sexual activity provided protection against HIV-1 infection in men who have sex with men. The treatment was associated with increased rates of gastrointestinal and renal adverse events. (Funded by the National Agency of Research on AIDS and Viral Hepatitis [ANRS] and others; ClinicalTrials.gov number, NCT01473472.)	[Molina, J. -M.; Capitant, C.; Charbonneau, P.; Loze, B.; Rozenbaum, W.] Univ Paris Diderot, Hop St Louis, AP HP, Dept Infect Dis, Paris, France; [Timsit, J.] Univ Paris Diderot, Hop St Louis, AP HP, Dept Sexually Transmitted Dis, Paris, France; [Delaugerre, C.] Univ Paris Diderot, Hop St Louis, AP HP, Virol Lab, Paris, France; [Fonsart, J.] Univ Paris Diderot, Hop St Louis, AP HP, Biochem Lab, Paris, France; [Pialoux, G.; Chas, J.] Hop Tenon, Dept Infect Dis, INSERM UMR 941, Sorbonne Paris Cite, F-75970 Paris, France; [Raffi, F.] Univ Paris 11, Coll Univ Malad Infectieuses & Trop, Paris, France; [Peytavin, G.] Univ Paris 11, Ctr Hosp Bichat Claude Bernard, Lab Toxicol & Pharmacol, Paris, France; [Girard, G.] Univ Paris 11, Coll Etud Mondi, Paris, France; [Dore, V.; Marchand, L.; Simon, M. -C.; Etien, N.; Delfraissy, J. -F.] Univ Paris 11, France Rech Nord & Sud Sida HIV & Hepatites, Paris, France; [Meyer, L.] Kremlin Bictr, Paris, France; [Capitant, C.; Charreau, I.; Aboulker, J. -P.; Meyer, L.] INSERM SC10 US19, Villejuif, France; [Spire, B.; Suzan-Monti, M.; Lorente, N.] INSERM, UMR 912, SESSTIM, Dept Med, F-13258 Marseille, France; [Cotte, L.; Chidiac, C.] Ctr Hosp & Univ Lyon, Hop Croix Rousse, Dept Infect Dis, Lyon, France; [Preau, M.] Univ Lyon 2, Grp Rech Psychol Sociale EA 4163, Lyon, France; [Cua, E.] Ctr Hosp Nice, Dept Infect Dis, Hop Archet, Nice, France; [Pasquet, A.; Cheret, A.] Ctr Hosp Univ Tourcoing, Hop G Dron, Dept Infect Dis, Lille, France; [Le Gall, J. -M.] Assoc AIDES, Pantin, France; [Tremblay, C.] Ctr Hosp Univ Montreal, Montreal, PQ, Canada; [Girard, G.] Univ Montreal, Inst Rech Sante Publ, Montreal, PQ, Canada; [Wainberg, M. A.] McGill Univ, Jewish Gen Hosp, AIDS Ctr, Montreal, PQ H3T 1E2, Canada; [Thompson, D.] Assoc REZO, Montreal, PQ, Canada; [Delfraissy, J. -F.] Gilead Sci, Foster City, CA USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Lyon 2; CHU Nice; Universite de Montreal; Universite de Montreal; McGill University; Gilead Sciences	Molina, JM (corresponding author), Hop St Louis, Dept Infect Dis, 1 Ave Claude Vellefaux, F-75475 Paris, France.	jean-michel.molina@aphp.fr	Lorente, Nicolas/AAB-5279-2019; Spire, Bruno/F-5546-2013; Girard, Gabriel/AAD-4616-2022; Girard, Gabriel/B-4069-2017	Lorente, Nicolas/0000-0002-5320-1493; Spire, Bruno/0000-0002-3546-8020; Girard, Gabriel/0000-0001-9756-0458	National Agency of Research on AIDS and Viral Hepatitis [ANRS]	National Agency of Research on AIDS and Viral Hepatitis [ANRS]	Funded by the National Agency of Research on AIDS and Viral Hepatitis [ANRS] and others	ANRS, 2008, ANRS SCAL GRAD SEV A; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Descamps D, 2006, J MED VIROL, V78, P153, DOI 10.1002/jmv.20522; Fonsart J, 2014, 20 INT AIDS C MELB V; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Garcia-Lerma JG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000391; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Lavoie E, 2008, SEX TRANSM DIS, V35, P25, DOI 10.1097/OLQ.0b013e31814fb113; Le Vu S, 2010, LANCET INFECT DIS, V10, P682, DOI 10.1016/S1473-3099(10)70167-5; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McCormack S, 2015, LANCET; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; UNAIDS, THE GAP REP; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Youle M, 2003, AIDS, V17, P937, DOI 10.1097/00002030-200304110-00027	23	985	1001	1	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2015	373	23					2237	2246		10.1056/NEJMoa1506273	http://dx.doi.org/10.1056/NEJMoa1506273			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5LM	26624850	Bronze			2022-12-28	WOS:000365743100007
J	Ballantyne, JC; Sullivan, MD				Ballantyne, Jane C.; Sullivan, Mark D.			Intensity of Chronic Pain - The Wrong Metric?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH		[Ballantyne, Jane C.] Univ Washington, Sch Med, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Sullivan, Mark D.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ballantyne, JC (corresponding author), Univ Washington, Sch Med, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA.							CASSEL EJ, 1982, NEW ENGL J MED, V306, P639, DOI 10.1056/NEJM198203183061104; Edlund MJ, 2010, CLIN J PAIN, V26, P1, DOI 10.1097/AJP.0b013e3181b99f35; Hashmi JA, 2013, BRAIN, V136, P2751, DOI 10.1093/brain/awt211; Interagency Pain Research Coordinating Committee, 2015, NAT PAIN STRAT COMPR; Kolodny A, 2015, ANNU REV PUBL HEALTH, V36, P559, DOI 10.1146/annurev-publhealth-031914-122957	5	165	166	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2015	373	22					2098	2099		10.1056/NEJMp1507136	http://dx.doi.org/10.1056/NEJMp1507136			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9YT	26605926				2022-12-28	WOS:000365354800003
J	Li, XG; Zhang, DW; Liu, ZY; Li, Z; Du, CW; Dong, CF				Li, Xiaogang; Zhang, Dawei; Liu, Zhiyong; Li, Zhong; Du, Cuiwei; Dong, Chaofang			Materials science: Share corrosion data	NATURE			English	Editorial Material									[Li, Xiaogang; Zhang, Dawei; Liu, Zhiyong; Li, Zhong; Du, Cuiwei; Dong, Chaofang] Univ Sci & Technol Beijing, Inst Adv Mat & Technol, Minist Educ, Key Lab Corros & Protect, Beijing 100083, Peoples R China; [Li, Xiaogang] Chinese Acad Sci, Ningbo Inst Mat Technol & Engn, Ningbo, Zhejiang, Peoples R China	University of Science & Technology Beijing; Chinese Academy of Sciences; Ningbo Institute of Materials Technology and Engineering, CAS	Zhang, DW (corresponding author), Univ Sci & Technol Beijing, Inst Adv Mat & Technol, Minist Educ, Key Lab Corros & Protect, Beijing 100083, Peoples R China.	dzhang@ustb.edu.cn		Li, Xiaogang/0000-0001-9255-7559				Duquette D., 2011, RES OPPORTUNITIES CO; Koch G., 2002, MATER PERFORMANCE; Li X., 2014, INFORM MAT CORROSION; Morcillo M, 2013, CORROS SCI, V77, P6, DOI 10.1016/j.corsci.2013.08.021; Taylor CD, 2015, FARADAY DISCUSS, V180, P459, DOI 10.1039/c4fd00220b	5	385	445	30	328	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					441	442		10.1038/527441a	http://dx.doi.org/10.1038/527441a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26607528	Bronze			2022-12-28	WOS:000365352500015
J	Bouvier, J; Caggiano, V; Leiras, R; Caldeira, V; Bellardita, C; Balueva, K; Fuchs, A; Kiehn, O				Bouvier, Julien; Caggiano, Vittorio; Leiras, Roberto; Caldeira, Vanessa; Bellardita, Carmelo; Balueva, Kira; Fuchs, Andrea; Kiehn, Ole			Descending Command Neurons in the Brainstem that Halt Locomotion	CELL			English	Article							GREEN FLUORESCENT PROTEIN; RETICULOSPINAL NEURONS; V2A INTERNEURONS; FUNCTIONAL-ORGANIZATION; V2-DERIVED INTERNEURONS; SPINAL INTERNEURONS; CIRCUITS; MICE; MOTONEURONS; CATS	The episodic nature of locomotion is thought to be controlled by descending inputs from the brainstem. Most studies have largely attributed this control to initiating excitatory signals, but little is known about putative commands that may specifically determine locomotor offset. To link identifiable brainstem populations to a potential locomotor stop signal, we used developmental genetics and considered a discrete neuronal population in the reticular formation: the V2a neurons. We find that those neurons constitute a major excitatory pathway to locomotor areas of the ventral spinal cord. Selective activation of V2a neurons of the rostral medulla stops ongoing locomotor activity, owing to an inhibition of premotor locomotor networks in the spinal cord. Moreover, inactivation of such neurons decreases spontaneous stopping in vivo. Therefore, the V2a "stop neurons" represent a glutamatergic descending pathway that favors immobility and may thus help control the episodic nature of locomotion.	[Bouvier, Julien; Caggiano, Vittorio; Leiras, Roberto; Caldeira, Vanessa; Bellardita, Carmelo; Fuchs, Andrea; Kiehn, Ole] Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, S-17177 Stockholm, Sweden; [Bouvier, Julien] CNRS, UMR 9197, Paris Saclay Inst Neurosci, F-91190 Gif Sur Yvette, France; [Bouvier, Julien] Univ Paris 11, F-91190 Gif Sur Yvette, France; [Balueva, Kira] Univ Kiel, Inst Physiol, D-24098 Kiel, Germany	Karolinska Institutet; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Kiel	Bouvier, J (corresponding author), Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, S-17177 Stockholm, Sweden.	julien.bouvier@inaf.cnrs-gif.fr; ole.kiehn@ki.se	Bellardita, Carmelo/N-5467-2019; Bouvier, Julien/C-1018-2017; kiehn, ole/AAB-1262-2019; kiehn, ole/AAT-7881-2021	Bellardita, Carmelo/0000-0001-6198-243X; Bouvier, Julien/0000-0002-1307-4426; Caggiano, Vittorio/0000-0002-2186-1550; Leiras, Roberto/0000-0001-7232-2904; Kiehn, Ole/0000-0002-5954-469X	Torsten and Ragnar Soderberg's Foundation; Swedish Research Council; European Research Council; NIH [R01 NS090919]; Hjarnfonden; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS090919] Funding Source: NIH RePORTER	Torsten and Ragnar Soderberg's Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hjarnfonden; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Sharma (University of Chicago), S. Crone (Cincinnati Children's), L. Zagoraiou, (Academy of Athens), and T.M. Jessell (Columbia University) for the Chx10-cre mouse. This work was supported by the Torsten and Ragnar Soderberg's Foundation (O.K.), Swedish Research Council (O.K.), European Research Council (O.K.), NIH R01 NS090919 (O.K.), and Hjarnfonden (O.K.). J.B. was an EMBO fellow. We thank A.C. Westerdahl and P. Low for extensive genotyping and N. Sleiers for animal breeding in Kiehn lab. We also like to thank R. Diaz Heijtz (Karolinska) for advice on the open field test. We declare no conflict of interest regarding this work. The AAV-DIO-hChR2-mCherry virus was a kind gift from K. Deisseroth (Stanford).	Al-Mosawie A, 2007, EUR J NEUROSCI, V26, P3003, DOI 10.1111/j.1460-9568.2007.05907.x; Alvarez FJ, 2007, J PHYSIOL-LONDON, V584, P31, DOI 10.1113/jphysiol.2007.136200; Andersson LS, 2012, NATURE, V488, P642, DOI 10.1038/nature11399; Azim E, 2014, NATURE, V508, P357, DOI 10.1038/nature13021; Bellardita C, 2015, CURR BIOL, V25, P1426, DOI 10.1016/j.cub.2015.04.005; Bouvier J, 2010, NAT NEUROSCI, V13, P1066, DOI 10.1038/nn.2622; Brandao ML, 2008, BEHAV BRAIN RES, V188, P1, DOI 10.1016/j.bbr.2007.10.018; Bretzner F, 2013, J NEUROSCI, V33, P14681, DOI 10.1523/JNEUROSCI.5231-12.2013; Caggiano V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100865; Cepeda-Nieto AC, 2005, MOL CELL NEUROSCI, V28, P30, DOI 10.1016/j.mcn.2004.06.016; Crone SA, 2008, NEURON, V60, P70, DOI 10.1016/j.neuron.2008.08.009; Crone SA, 2009, J NEUROSCI, V29, P7098, DOI 10.1523/JNEUROSCI.1206-09.2009; Deliagina TG, 2000, J NEUROPHYSIOL, V83, P853, DOI 10.1152/jn.2000.83.2.853; Dougherty KJ, 2013, NEURON, V80, P920, DOI 10.1016/j.neuron.2013.08.015; Dougherty KJ, 2010, J NEUROSCI, V30, P24, DOI 10.1523/JNEUROSCI.4821-09.2010; DREW T, 1986, J NEUROPHYSIOL, V55, P375, DOI 10.1152/jn.1986.55.2.375; Dubuc R, 2008, BRAIN RES REV, V57, P172, DOI 10.1016/j.brainresrev.2007.07.016; Esposito MS, 2014, NATURE, V508, P351, DOI 10.1038/nature13023; Feldman J.L., 2014, J PHYSL; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Grillner S, 1996, CURR OPIN NEUROBIOL, V6, P741, DOI 10.1016/S0959-4388(96)80022-5; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; Hagglund M, 2013, P NATL ACAD SCI USA, V110, P11589, DOI 10.1073/pnas.1304365110; Hagglund M, 2010, NAT NEUROSCI, V13, P246, DOI 10.1038/nn.2482; HOLSTEGE JC, 1991, J NEUROSCI, V11, P159; HULTBORN H, 1976, ACTA PHYSIOL SCAND, V96, P193, DOI 10.1111/j.1748-1716.1976.tb10188.x; Jordan LM, 2008, BRAIN RES REV, V57, P183, DOI 10.1016/j.brainresrev.2007.07.019; Juvin L., 2009, Society for Neuroscience Abstract Viewer and Itinerary Planner, V39; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kiehn O, 2011, CURR OPIN NEUROBIOL, V21, P100, DOI 10.1016/j.conb.2010.09.004; Kimura Y, 2013, CURR BIOL, V23, P843, DOI 10.1016/j.cub.2013.03.066; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Liang H., 2015, BRAIN STRUCT FUNCT; Liu J, 2005, J NEUROPHYSIOL, V94, P1392, DOI 10.1152/jn.00136.2005; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Lundfald L, 2007, EUR J NEUROSCI, V26, P2989, DOI 10.1111/j.1460-9568.2007.05906.x; Luppi PH, 2011, SLEEP MED REV, V15, P153, DOI 10.1016/j.smrv.2010.08.002; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; McLean DL, 2015, CURR OPIN NEUROBIOL, V33, P63, DOI 10.1016/j.conb.2015.03.001; MORI S, 1987, PROG NEUROBIOL, V28, P161, DOI 10.1016/0301-0082(87)90010-4; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Perreault MC, 2013, ANN NY ACAD SCI, V1279, P80, DOI 10.1111/nyas.12054; Perrins R, 2002, J NEUROSCI, V22, P4229, DOI 10.1523/JNEUROSCI.22-10-04229.2002; Roberts A, 2008, BRAIN RES REV, V57, P22, DOI 10.1016/j.brainresrev.2007.06.015; Ryczko D, 2013, CURR PHARM DESIGN, V19, P4448, DOI 10.2174/1381612811319240011; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Sivertsen MS, 2014, J NEUROPHYSIOL, V112, P1628, DOI 10.1152/jn.00820.2013; Szokol K, 2011, J NEUROSCI, V31, P4731, DOI 10.1523/JNEUROSCI.5486-10.2011; Takakusaki K, 2003, NEUROSCIENCE, V121, P731, DOI 10.1016/S0306-4522(03)00542-6; Talpalar AE, 2013, NATURE, V500, P85, DOI 10.1038/nature12286; Talpalar AE, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00019; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Vetrivelan R, 2009, J NEUROSCI, V29, P9361, DOI 10.1523/JNEUROSCI.0737-09.2009; Wilson JM, 2005, J NEUROSCI, V25, P5710, DOI 10.1523/JNEUROSCI.0274-05.2005; Yilmaz M, 2013, CURR BIOL, V23, P2011, DOI 10.1016/j.cub.2013.08.015; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349; Zhang JM, 2014, NEURON, V82, P138, DOI 10.1016/j.neuron.2014.02.013; Zhong GS, 2010, J NEUROSCI, V30, P170, DOI 10.1523/JNEUROSCI.4849-09.2010	58	118	118	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1191	1203		10.1016/j.cell.2015.10.074	http://dx.doi.org/10.1016/j.cell.2015.10.074			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26590422	Green Accepted, Bronze			2022-12-28	WOS:000366044700017
J	DeVincenzo, JP; McClure, MW; Symons, JA; Fathi, H; Westland, C; Chanda, S; Lambkin-Williams, R; Smith, P; Zhang, QL; Beigelman, L; Blatt, LM; Fry, J				DeVincenzo, John P.; McClure, Matthew W.; Symons, Julian A.; Fathi, Hosnieh; Westland, Christopher; Chanda, Sushmita; Lambkin-Williams, Rob; Smith, Patrick; Zhang, Qingling; Beigelman, Leo; Blatt, Lawrence M.; Fry, John			Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE SEVERITY; VIRAL LOAD; INFECTION; RESISTANCE; MORTALITY; INFLUENZA; DYNAMICS; ANTIBODY; MEDI-493; FUSION	BACKGROUND Respiratory syncytial virus (RSV) infection is a cause of substantial morbidity and mortality. There is no known effective therapy. METHODS We conducted a randomized, double-blind, clinical trial in healthy adults inoculated with RSV. Participants received the oral nucleoside analogue ALS-008176 or placebo 12 hours after confirmation of RSV infection or 6 days after inoculation. Treatment was administered every 12 hours for 5 days. Viral load, disease severity, resistance, and safety were measured throughout the 28-day study period, with measurement beginning before inoculation. The primary end point was the area under the curve (AUC) for viral load, which was assessed immediately before administration of the first dose through the 12th day after inoculation in participants infected with RSV. RESULTS A total of 62 participants received placebo or one of three ALS-008176 dosing regimens: 1 loading dose of 750 mg followed by 9 maintenance doses of 500 mg (group 1), 1 loading dose of 750 mg followed by 9 maintenance doses of 150 mg (group 2), or 10 doses of 375 mg (group 3). In the 35 infected participants (23 of whom were treated with ALS-008176), the AUCs for viral load for groups 1, 2, and 3 and the placebo group were 59.9, 73.7, 133.4, and 500.9 log 10 plaque-forming-unit equivalents x hours per milliliter, respectively (P=0.001). The time to nondetectability on polymerase-chain-reaction assay (P<0.001), the peak viral load (P=0.001), the AUC for symptom score (P<0.05), and the AUC for mucus weight were lower in all groups receiving ALS-008176 than in the placebo group. Antiviral activity was greatest in the two groups that received a loading dose - viral clearance was accelerated (P=0.05), and the AUC for viral load decreased by 85 to 88% as compared with the placebo group. Within this small trial, no viral rebound or resistance was identified. There were no serious adverse events, and there was no need for premature discontinuation of the study drug. CONCLUSIONS In this RSV challenge study, more rapid RSV clearance and a greater reduction of viral load, with accompanying improvements in the severity of clinical disease, were observed in the groups treated with ALS-008176 than in the placebo group. (Funded by Alios BioPharma; ClinicalTrials.gov number, NCT02094365.)	[DeVincenzo, John P.] Univ Tennessee, Coll Med, Dept Pediat, Memphis, TN USA; [DeVincenzo, John P.] Univ Tennessee, Dept Microbiol, Coll Med, Memphis, TN USA; [DeVincenzo, John P.] Univ Tennessee, Dept Biochem, Coll Med, Memphis, TN USA; [DeVincenzo, John P.] Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN 38103 USA; [McClure, Matthew W.; Symons, Julian A.; Westland, Christopher; Chanda, Sushmita; Zhang, Qingling; Beigelman, Leo; Blatt, Lawrence M.; Fry, John] Alios BioPharma, San Francisco, CA USA; [Fathi, Hosnieh; Lambkin-Williams, Rob] Retroscreen Virol, London, England; [Smith, Patrick] D3 Med, Parsippany, NJ USA; [Smith, Patrick] SUNY Buffalo, Sch Pharm & Pharmaceut Sci, Buffalo, NY 14260 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	DeVincenzo, JP (corresponding author), Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, Rm 400R,50 N Dunlap St, Memphis, TN 38103 USA.		Lambkin-Williams, Robert/P-5963-2016; Lambkin-Williams, Rob/L-2397-2019	Lambkin-Williams, Robert/0000-0003-2107-0174; Lambkin-Williams, Rob/0000-0003-2107-0174; Smith, Patrick/0000-0002-6003-0805	Alios BioPharma	Alios BioPharma	Funded by Alios BioPharma; ClinicalTrials.gov number, NCT02094365.	Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Buckingham SC, 2000, PEDIATR INFECT DIS J, V19, P113, DOI 10.1097/00006454-200002000-00006; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; DeVincenzo JP, 2014, NEW ENGL J MED, V371, P711, DOI 10.1056/NEJMoa1401184; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; DeVincenzo JP, 2005, J INFECT DIS, V191, P1861, DOI 10.1086/430008; Douglas JL, 2005, ANTIMICROB AGENTS CH, V49, P2460, DOI 10.1128/AAC.49.6.2460-2466.2005; El Saleeby CM, 2011, J INFECT DIS, V204, P996, DOI 10.1093/infdis/jir494; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Grad YH, 2014, J VIROL, V88, P7286, DOI 10.1128/JVI.00038-14; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Johnson S, 1999, J INFECT DIS, V180, P35, DOI 10.1086/314846; Kim YI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113100; Leader S, 2003, J PEDIATR-US, V143, pS127, DOI 10.1067/S0022-3476(03)00510-9; Lee N, 2013, CLIN INFECT DIS, V57, P1069, DOI 10.1093/cid/cit471; Lundin A, 2010, ANTIVIR RES, V88, P317, DOI 10.1016/j.antiviral.2010.10.004; McCown MF, 2008, ANTIMICROB AGENTS CH, V52, P1604, DOI 10.1128/AAC.01317-07; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Perkins SM, 2005, J CLIN MICROBIOL, V43, P2356, DOI 10.1128/JCM.43.5.2356-2362.2005; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Ventre K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000181.pub3; Widmer K, 2012, J INFECT DIS, V206, P56, DOI 10.1093/infdis/jis309; Wu H, 2007, J MOL BIOL, V368, P652, DOI 10.1016/j.jmb.2007.02.024; Yan D, 2014, P NATL ACAD SCI USA, V111, pE3441, DOI 10.1073/pnas.1405198111; Zoulim F, 2011, LIVER INT, V31, P111, DOI 10.1111/j.1478-3231.2010.02399.x	26	145	156	1	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2015	373	21					2048	2058		10.1056/NEJMoa1413275	http://dx.doi.org/10.1056/NEJMoa1413275			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW4JN	26580997				2022-12-28	WOS:000364957700010
J	Glass, RI				Glass, Roger I.			Brain disorders across the lifespan FOREWORD	NATURE			English	Editorial Material									[Glass, Roger I.] NIH, Fogarty Int Ctr, 31 Ctr Dr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Glass, RI (corresponding author), NIH, Fogarty Int Ctr, 31 Ctr Dr, Bethesda, MD 20892 USA.							[Anonymous], BRAIN DIS DEV WORLD; United Nations, OP WORK GROUP PROP S; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6	3	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					S150	S150		10.1038/nature16027	http://dx.doi.org/10.1038/nature16027			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26580319	hybrid			2022-12-28	WOS:000365356800008
J	Michor, F; Beal, K				Michor, Franziska; Beal, Kathryn			Improving Cancer Treatment via Mathematical Modeling: Surmounting the Challenges Is Worth the Effort	CELL			English	Review							STAGE BREAST-CANCER; DRUG-RESISTANCE; INTRATUMOR HETEROGENEITY; RADIATION-THERAPY; RANDOMIZED-TRIAL; TUMOR SIZE; CHEMOTHERAPY; EVOLUTION; LEUKEMIA; SURVIVAL	Drug delivery schedules are key factors in the efficacy of cancer therapies, and mathematical modeling of population dynamics and treatment responses can be applied to identify better drug administration regimes as well as provide mechanistic insights. To capitalize on the promise of this approach, the cancer field must meet the challenges of moving this type of work into clinics.	[Michor, Franziska] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Michor, Franziska] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Beal, Kathryn] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Memorial Sloan Kettering Cancer Center	Michor, F (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA.	michor@jimmy.harvard.edu; bealk@mskcc.org			NATIONAL CANCER INSTITUTE [U54CA193461, P30CA008748, U54CA143798] Funding Source: NIH RePORTER; NCI NIH HHS [U54 CA193461, P30 CA008748, U54 CA143798] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Basanta D, 2012, MOL PHARMACEUT, V9, P914, DOI 10.1021/mp200458e; Bellon JR, 2005, J CLIN ONCOL, V23, P1934, DOI 10.1200/JCO.2005.04.032; Bhang HEC, 2015, NAT MED, V21, P440, DOI 10.1038/nm.3841; BONADONNA G, 1995, JAMA-J AM MED ASSOC, V273, P542; Bozic I, 2013, ELIFE, V2, DOI 10.7554/eLife.00747; Brada M, 1999, INT J RADIAT ONCOL, V43, P287, DOI 10.1016/S0360-3016(98)00390-3; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; Coldman AJ, 2000, MATH BIOSCI, V168, P187, DOI 10.1016/S0025-5564(00)00045-6; COSTA MIS, 1995, MATH BIOSCI, V125, P191, DOI 10.1016/0025-5564(94)00027-W; COSTA MIS, 1992, IMA J MATH APPL MED, V9, P215; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Gatenby RA, 2009, CANCER RES, V69, P4894, DOI 10.1158/0008-5472.CAN-08-3658; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Glickman MS, 2012, CELL, V148, P1089, DOI 10.1016/j.cell.2012.02.015; GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727; GOLDIE JH, 1982, CANCER TREAT REP, V66, P439; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Haeno H, 2012, CELL, V148, P362, DOI 10.1016/j.cell.2011.11.060; Hickey BE, 2013, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.CD005212, DOI 10.1002/14651858.CD005212]; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hryniuk W, 2001, Breast Dis, V14, P21; Katouli AA, 2011, B MATH BIOL, V73, P549, DOI 10.1007/s11538-010-9539-y; Lake DE, 2004, DRUGS, V64, P1851, DOI 10.2165/00003495-200464170-00001; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Leder K, 2014, CELL, V156, P603, DOI 10.1016/j.cell.2013.12.029; MARTIN RB, 1992, MATH BIOSCI, V110, P201, DOI 10.1016/0025-5564(92)90038-X; Murray JM, 2003, MATH BIOSCI, V185, P73, DOI 10.1016/S0025-5564(03)00093-2; NORTON L, 1977, CANCER TREAT REP, V61, P1307; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Paridaens R, 2003, ANN ONCOL, V14, P433, DOI 10.1093/annonc/mdg111; Recht A, 1996, NEW ENGL J MED, V334, P1356, DOI 10.1056/NEJM199605233342102; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Shrager J, 2014, NAT REV CLIN ONCOL, V11, P109, DOI 10.1038/nrclinonc.2013.244; Stiehl T, 2015, CANCER RES, V75, P940, DOI 10.1158/0008-5472.CAN-14-2508; Van Loo P, 2014, CURR OPIN GENET DEV, V24, P82, DOI 10.1016/j.gde.2013.12.004; Zhao BY, 2014, P NATL ACAD SCI USA, V111, P10773, DOI 10.1073/pnas.1323934111; [No title captured]	41	77	79	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1059	1063		10.1016/j.cell.2015.11.002	http://dx.doi.org/10.1016/j.cell.2015.11.002			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26590416	Green Accepted, Bronze			2022-12-28	WOS:000366044700007
J	Rabinovich, S; Adler, L; Yizhak, K; Sarver, A; Silberman, A; Agron, S; Stettner, N; Sun, Q; Brandis, A; Helbling, D; Korman, S; Itzkovitz, S; Dimmock, D; Ulitsky, I; Nagamani, SCS; Ruppin, E; Erez, A				Rabinovich, Shiran; Adler, Lital; Yizhak, Keren; Sarver, Alona; Silberman, Alon; Agron, Shani; Stettner, Noa; Sun, Qin; Brandis, Alexander; Helbling, Daniel; Korman, Stanley; Itzkovitz, Shalev; Dimmock, David; Ulitsky, Igor; Nagamani, Sandesh C. S.; Ruppin, Eytan; Erez, Ayelet			Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis	NATURE			English	Article							ARGININOSUCCINATE SYNTHETASE; CANCER; EXPRESSION; CARCINOMA	Cancer cells hijack and remodel existing metabolic pathways for their benefit. Argininosuccinate synthase (ASS1) is a urea cycle enzyme that is essential in the conversion of nitrogen from ammonia and aspartate to urea. A decrease in nitrogen flux through ASS1 in the liver causes the urea cycle disorder citrullinaemia(1). In contrast to the well-studied consequences of loss of ASS1 activity on ureagenesis, the purpose of its somatic silencing in multiple cancers is largely unknown(2). Here we show that decreased activity of ASS1 in cancers supports proliferation by facilitating pyrimidine synthesis via CAD (carbamoyl-phosphate synthase 2, aspartate transcarbamylase, and dihydroorotase complex) activation. Our studies were initiated by delineating the consequences of loss of ASS1 activity in humans with two types of citrullinaemia. We find that in citrullinaemia type I (CTLN I), which is caused by deficiency of ASS1, there is increased pyrimidine synthesis and proliferation compared with citrullinaemia type II (CTLN II), in which there is decreased substrate availability for ASS1 caused by deficiency of the aspartate transporter citrin. Building on these results, we demonstrate that ASS1 deficiency in cancer increases cytosolic aspartate levels, which increases CAD activation by upregulating its substrate availability and by increasing its phosphorylation by S6K1 through the mammalian target of rapamycin (mTOR) pathway. Decreasing CAD activity by blocking citrin, the mTOR signalling, or pyrimidine synthesis decreases proliferation and thus may serve as a therapeutic strategy in multiple cancers where ASS1 is downregulated. Our results demonstrate that ASS1 downregulation is a novel mechanism supporting cancerous proliferation, and they provide a metabolic link between the urea cycle enzymes and pyrimidine synthesis.	[Rabinovich, Shiran; Adler, Lital; Sarver, Alona; Silberman, Alon; Agron, Shani; Stettner, Noa; Ulitsky, Igor; Erez, Ayelet] Weizmann Inst Sci, Dept Regulat Biol, IL-7610001 Rehovot, Israel; [Yizhak, Keren; Ruppin, Eytan] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Sun, Qin; Nagamani, Sandesh C. S.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Brandis, Alexander] Weizmann Inst Sci, Biol Serv, IL-69978 Rehovot, Israel; [Helbling, Daniel; Dimmock, David] Med Coll Wisconsin, Human & Mol Genet & Biochem Ctr, Milwaukee, WI 53226 USA; [Korman, Stanley] Hadassah Med Ctr, Genet & Metab Ctr, IL-91120 Jerusalem, Israel; [Itzkovitz, Shalev] Weizmann Inst Sci, Dept Mol Cell Biol, IL-69978 Tel Aviv, Israel; [Nagamani, Sandesh C. S.] Texas Childrens Hosp, Houston, TX 77030 USA; [Ruppin, Eytan] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Ruppin, Eytan] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Ruppin, Eytan] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA	Weizmann Institute of Science; Tel Aviv University; Baylor College of Medicine; Weizmann Institute of Science; Medical College of Wisconsin; Hebrew University of Jerusalem; Hadassah University Medical Center; Weizmann Institute of Science; Baylor College of Medicine; Tel Aviv University; Sackler Faculty of Medicine; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Erez, A (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-7610001 Rehovot, Israel.	ayelet.erez@weizmann.ac.il	Ulitsky, Igor/HCH-7453-2022; Ruppin, Eytan/R-9698-2017; Dimmock, David/I-7913-2015	Ulitsky, Igor/0000-0003-0555-6561; Ruppin, Eytan/0000-0002-7862-3940; Dimmock, David/0000-0001-6690-2523; Sun, Qin/0000-0002-8270-3943; /0000-0002-2693-5598	Weizmann Institute; European Research Program [CIG618113, ERC614204]; Israel Science Foundation [1343/13, 1952/13]; Minerva grant award [711730]; Adelis Foundation; Henry S. and Anne S. Reich Research Fund; Dukler Fund for Cancer Research; Paul Sparr Foundation; Saul and Theresa Esman Foundation; estate of Fannie Sherr; Teva; Israeli Science Foundation [41/11]; Israeli Cancer Research Fund; Israeli Center of Excellence (I-CORE) Program of the Planning and Budgeting Committee; Israel Cancer Research Foundation; Baylor College of Medicine Intellectual and Developmental Disabilities Research Center Grant from the Eunice Kennedy Shriver National Institute of Child Health & Human Development [1 U54 HD083092]; Doris Duke Charitable Foundation [DDCF 2013095]; Rising Tide Foundation; Abramson Family Center for Young Scientists; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER	Weizmann Institute; European Research Program(European Commission); Israel Science Foundation(Israel Science Foundation); Minerva grant award; Adelis Foundation; Henry S. and Anne S. Reich Research Fund; Dukler Fund for Cancer Research; Paul Sparr Foundation; Saul and Theresa Esman Foundation; estate of Fannie Sherr; Teva(Teva Pharmaceutical Industries); Israeli Science Foundation(Israel Science Foundation); Israeli Cancer Research Fund; Israeli Center of Excellence (I-CORE) Program of the Planning and Budgeting Committee; Israel Cancer Research Foundation; Baylor College of Medicine Intellectual and Developmental Disabilities Research Center Grant from the Eunice Kennedy Shriver National Institute of Child Health & Human Development; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Rising Tide Foundation; Abramson Family Center for Young Scientists; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank A. Gross and B. Lee for discussions. We acknowledge and thank the Weizmann Institute for providing financial and infrastructural support and the Baylor College of Medicine Biochemical Laboratory. We appreciate the statistical analysis by R. Rotkopf and the technical contributions of A. Tishbee, T. Kaufman, D. Laufer and I. Rogachev. A.E. is the incumbent of the Leah Omenn Career Development Chair and is supported by research grants from the European Research Program (CIG618113, ERC614204), the Israel Science Foundation (1343/13; 1952/13) and a Minerva grant award (711730). A.E. received additional support from the Adelis Foundation, the Henry S. and Anne S. Reich Research Fund, the Dukler Fund for Cancer Research, the Paul Sparr Foundation, the Saul and Theresa Esman Foundation, from Joseph Piko Baruch and from the estate of Fannie Sherr. L.A. was supported by a postdoctoral fellowship from Teva. The research of K.Y. and E.R. has been supported by grants from the Israeli Science Foundation (E.R.), the Israeli Cancer Research Fund (E.R.), the Israeli Center of Excellence (I-CORE) Program of the Planning and Budgeting Committee and Israel Science Foundation Grant No. 41/11 (E.R.). A. Sa. is supported by the Israel Cancer Research Foundation and S.N.S.C. is supported by a Baylor College of Medicine Intellectual and Developmental Disabilities Research Center Grant (number 1 U54 HD083092) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development, and by the Doris Duke Charitable Foundation (DDCF 2013095). I.U. was supported by a grant from the Rising Tide Foundation and by a research grant from The Abramson Family Center for Young Scientists.	Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Bjorklund NL, 2012, J NEUROSCI METH, V203, P146, DOI 10.1016/j.jneumeth.2011.09.008; Bordel S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000859; del Arco A, 2002, EUR J BIOCHEM, V269, P3313, DOI 10.1046/j.1432-1033.2002.03018.x; Delage B, 2010, INT J CANCER, V126, P2762, DOI 10.1002/ijc.25202; Dimmock D, 2009, MOL GENET METAB, V96, P44, DOI 10.1016/j.ymgme.2008.10.007; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Folger O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.35; Gu GJ, 2013, NEW BIOTECHNOL, V30, P144, DOI 10.1016/j.nbt.2012.05.005; Hao G, 2004, J BIOL CHEM, V279, P36192, DOI 10.1074/jbc.M404866200; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Kabbarah O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010770; Kobayashi K., 2005, GENEREVIEWS, P1993; Kuijjer ML, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-245; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Long Y, 2013, MOL CANCER THER, V12, P2581, DOI 10.1158/1535-7163.MCT-13-0302; Marion V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067021; Morris SM, 2009, BRIT J PHARMACOL, V157, P922, DOI 10.1111/j.1476-5381.2009.00278.x; Pinthus JH, 2000, CANCER RES, V60, P6563; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Syed N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.197; Tan GS, 2014, J PROTEOME RES, V13, P4833, DOI 10.1021/pr500229n; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; Wheatley DN, 2004, ANTI-CANCER DRUG, V15, P825, DOI 10.1097/00001813-200410000-00002; Yizhak K, 2014, ELIFE, V3, DOI 10.7554/eLife.03641; Zhang YG, 2001, J BIOL CHEM, V276, P20913, DOI 10.1074/jbc.M009047200	26	200	208	4	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					379	+		10.1038/nature15529	http://dx.doi.org/10.1038/nature15529			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26560030	Green Accepted			2022-12-28	WOS:000365356800057
J	Sallum, S; Follette, KB; Eisner, JA; Close, LM; Hinz, P; Kratter, K; Males, J; Skemer, A; Macintosh, B; Tuthill, P; Bailey, V; Defrere, D; Morzinski, K; Rodigas, T; Spalding, E; Vaz, A; Weinberger, AJ				Sallum, S.; Follette, K. B.; Eisner, J. A.; Close, L. M.; Hinz, P.; Kratter, K.; Males, J.; Skemer, A.; Macintosh, B.; Tuthill, P.; Bailey, V.; Defrere, D.; Morzinski, K.; Rodigas, T.; Spalding, E.; Vaz, A.; Weinberger, A. J.			Accreting protoplanets in the LkCa 15 transition disk	NATURE			English	Article							CIRCUMPLANETARY DISKS; PLANETS; CONSTRAINTS; COMPANIONS; ALGORITHM; STARS; PHASE; GAP	Exoplanet detections have revolutionized astronomy, offering new insights into solar system architecture and planet demographics. While nearly 1,900 exoplanets have now been discovered and confirmed(1), none are still in the process of formation. Transition disks, protoplanetary disks with inner clearings(2-4) best explained by the influence of accreting planets(5), are natural laboratories for the study of planet formation. Some transition disks show evidence for the presence of young planets in the form of disk asymmetries(6,7) or infrared sources detected within their clearings, as in the case of LkCa 15 (refs 8, 9). Attempts to observe directly signatures of accretion onto protoplanets have hitherto proven unsuccessful(10). Here we report adaptive optics observations of LkCa 15 that probe within the disk clearing. With accurate source positions over multiple epochs spanning 2009-2015, we infer the presence of multiple companions on Keplerian orbits. We directly detect Ha emission from the innermost companion, LkCa 15 b, evincing hot (about 10,000 kelvin) gas falling deep into the potential well of an accreting protoplanet.	[Sallum, S.; Follette, K. B.; Eisner, J. A.; Close, L. M.; Hinz, P.; Kratter, K.; Males, J.; Skemer, A.; Bailey, V.; Defrere, D.; Morzinski, K.; Spalding, E.; Vaz, A.] Univ Arizona, Dept Astron, 933 North Cherry Ave, Tucson, AZ 85721 USA; [Follette, K. B.; Macintosh, B.] Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA; [Tuthill, P.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Rodigas, T.; Weinberger, A. J.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	University of Arizona; Stanford University; University of Sydney; Carnegie Institution for Science	Sallum, S (corresponding author), Univ Arizona, Dept Astron, 933 North Cherry Ave, Tucson, AZ 85721 USA.	ssallum@email.arizona.edu	Bailey, Vanessa P/H-2247-2018	Bailey, Vanessa P/0000-0002-5407-2806; Hinz, Philip/0000-0002-1954-4564; Morzinski, Katie/0000-0002-1384-0063; Skemer, Andrew/0000-0001-6098-3924; Close, Laird/0000-0002-2167-8246; Macintosh, Bruce/0000-0003-1212-7538; Kratter, Kaitlin/0000-0001-5253-1338; Tuthill, Peter/0000-0001-7026-6291; Spalding, Eckhart/0000-0003-3819-0076; Follette, Katherine/0000-0002-7821-0695; Defrere, Denis/0000-0003-3499-2506; Weinberger, Alycia/0000-0001-6654-7859	NSF AAG grant [1211329]; NASA OSS grant [NNX14AD20G]; National Science Foundation [1228509, DGE-1143953]; NASA through the Sagan Fellowship Program; Direct For Mathematical & Physical Scien [1413744, 1211329] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1410174] Funding Source: National Science Foundation	NSF AAG grant(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NASA OSS grant; National Science Foundation(National Science Foundation (NSF)); NASA through the Sagan Fellowship Program; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by NSF AAG grant no. 1211329 and NASA OSS grant NNX14AD20G. This material is based upon work supported by the National Science Foundation under grant no. 1228509. This work was performed in part under contract with the California Institute of Technology (Caltech) funded by NASA through the Sagan Fellowship Program executed by the NASA Exoplanet Science Institute. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under grant no. DGE-1143953. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors(s) and do not necessarily reflect the views of the National Science Foundation.	Akeson RL, 2013, PUBL ASTRON SOC PAC, V125, P989, DOI 10.1086/672273; Andrews SM, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/42; Ayliffe BA, 2011, MON NOT R ASTRON SOC, V415, P576, DOI 10.1111/j.1365-2966.2011.18730.x; Beauge C, 2003, ASTROPHYS J, V593, P1124, DOI 10.1086/376568; Buscher D. F., 1994, IAU P, V158, P91; Calvet N, 2005, ASTROPHYS J, V630, pL185, DOI 10.1086/491652; Close LM, 2014, ASTROPHYS J LETT, V781, DOI 10.1088/2041-8205/781/2/L30; Close L. M., 2012, SPIE C SERIES, V8447; Duncan MJ, 1998, ASTRON J, V116, P2067, DOI 10.1086/300541; Eisner JA, 2015, ASTROPHYS J LETT, V803, DOI 10.1088/2041-8205/803/1/L4; Faber P, 2007, MON NOT R ASTRON SOC, V382, P1823, DOI 10.1111/j.1365-2966.2007.12490.x; Follette KB, 2013, ASTROPHYS J LETT, V775, DOI 10.1088/2041-8205/775/1/L13; GLADMAN B, 1993, ICARUS, V106, P247, DOI 10.1006/icar.1993.1169; Gullbring E, 1998, ASTROPHYS J, V492, P323, DOI 10.1086/305032; HARTMANN L, 1994, ASTROPHYS J, V426, P669, DOI 10.1086/174104; Hinz P. M., 2008, P SOC PHOTO-OPT INS, V7013, P28; Ireland MJ, 2013, MON NOT R ASTRON SOC, V433, P1718, DOI 10.1093/mnras/stt859; Ireland M. J., 2014, IAU S, V299, P199; Isella A, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/2/129; Isella A, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/30; KENYON SJ, 1995, ASTROPHYS J SUPPL S, V101, P117, DOI 10.1086/192235; Kraus AL, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/5; Lafreniere D, 2007, ASTROPHYS J, V660, P770, DOI 10.1086/513180; Lawson P. R., 2006, SPIE C SERIES, V6268, p1U1; Leisenring JM, 2012, PROC SPIE, V8446, DOI 10.1117/12.924814; Levison H. F., 2013, SWIFT A SOLAR SYSTEM; Maire AL, 2015, ASTRON ASTROPHYS, V576, DOI 10.1051/0004-6361/201425185; Males JR, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/1/32; Markwardt CB, 2009, ASTR SOC P, V411, P251; Marois C, 2006, ASTROPHYS J, V641, P556, DOI 10.1086/500401; Marois C, 2003, IAU SYMP, P275; Martinache F, 2010, ASTROPHYS J, V724, P464, DOI 10.1088/0004-637X/724/1/464; Mawet D, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/2/97; Morzinski KM, 2014, PROC SPIE, V9148, DOI 10.1117/12.2057048; Perez LM, 2014, ASTROPHYS J LETT, V783, DOI 10.1088/2041-8205/783/1/L13; Rebull LM, 2010, ASTROPHYS J SUPPL S, V186, P259, DOI 10.1088/0067-0049/186/2/259; Rigliaco E, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201219832; Sallum S, 2015, ASTROPHYS J, V801, DOI 10.1088/0004-637X/801/2/85; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Soummer R, 2012, ASTROPHYS J LETT, V755, DOI 10.1088/2041-8205/755/2/L28; Spiegel DS, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/174; STROM KM, 1989, ASTRON J, V97, P1451, DOI 10.1086/115085; Thalmann C, 2015, ASTROPHYS J LETT, V808, DOI 10.1088/2041-8205/808/2/L41; Thalmann C, 2014, ASTRON ASTROPHYS, V566, DOI 10.1051/0004-6361/201322915; Thureau N., 2006, SPIE C SERIES, V6268, p1T1; Tuthill PG, 2000, P SOC PHOTO-OPT INS, V4006, P491, DOI 10.1117/12.390244; Whelan ET, 2015, ASTRON ASTROPHYS, V579, DOI 10.1051/0004-6361/201425578; Zhou YF, 2014, ASTROPHYS J LETT, V783, DOI 10.1088/2041-8205/783/1/L17; Zhu ZH, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/16	51	211	212	1	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					342	+		10.1038/nature15761	http://dx.doi.org/10.1038/nature15761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26581290	Green Submitted			2022-12-28	WOS:000365356800048
J	Doshi, P; Stahl-Timmins, W; Merino, JG; Simpkins, C				Doshi, Peter; Stahl-Timmins, Will; Merino, Jose G.; Simpkins, Carolyn			Visualising childhood vaccination schedules across G8 countries	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												pdoshi@bmj.com	Merino, Jose G./J-8474-2019	Merino, Jose G./0000-0002-6676-0008					0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 16	2015	351								h5966	10.1136/bmj.h5966	http://dx.doi.org/10.1136/bmj.h5966			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XU	26568637				2022-12-28	WOS:000365352300003
J	Bouziat, R; Jabri, B				Bouziat, Romain; Jabri, Bana			Breaching the gut-vascular barrier	SCIENCE			English	Editorial Material							CELIAC-DISEASE		[Bouziat, Romain; Jabri, Bana] Univ Chicago, Dept Med, Comm Immunol, Chicago, IL 60637 USA	University of Chicago	Bouziat, R (corresponding author), Univ Chicago, Dept Med, Comm Immunol, Chicago, IL 60637 USA.	bjabri@bsd.uchicago.edu						Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Ciccocioppo R, 2006, AM J CLIN PATHOL, V125, P502, DOI 10.1309/DTYRA91G8R0KTM8M; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Figueira R, 2012, MICROBIOL-SGM, V158, P1147, DOI 10.1099/mic.0.058115-0; Green PHR, 2003, LANCET, V362, P383, DOI 10.1016/S0140-6736(03)14027-5; Gulbransen BD, 2012, NAT REV GASTRO HEPAT, V9, P625, DOI 10.1038/nrgastro.2012.138; Gunn JS, 2014, TRENDS MICROBIOL, V22, P648, DOI 10.1016/j.tim.2014.06.007; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Juuti-Uusitalo K, 2007, CLIN EXP IMMUNOL, V150, P294, DOI 10.1111/j.1365-2249.2007.03500.x; Knolle PA, 2000, IMMUNOL REV, V174, P21, DOI 10.1034/j.1600-0528.2002.017408.x; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Roberts MS, 2002, CLIN PHARMACOKINET, V41, P751, DOI 10.2165/00003088-200241100-00005; Spadoni I, 2015, SCIENCE, V350, P830, DOI 10.1126/science.aad0135; Sun J, 2004, AM J PHYSIOL-GASTR L, V287, pG220, DOI 10.1152/ajpgi.00498.2003; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653	15	14	15	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					742	743		10.1126/science.aad6768	http://dx.doi.org/10.1126/science.aad6768			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW3MS	26564835				2022-12-28	WOS:000364897000021
J	Murthy, R; Kernstine, K				Murthy, Raghav; Kernstine, Kemp			SPOT DIAGNOSIS A man with COPD, fever, and leucocytosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Murthy, Raghav] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Kernstine, Kemp] Univ Texas SW Med Ctr Dallas, Dept Thorac Surg, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Murthy, R (corresponding author), Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA.	raghavamurthy@yahoo.com	murthy, raghav/Y-1500-2019	murthy, raghav/0000-0002-2546-881X					0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 13	2015	351								h6067	10.1136/bmj.h6067	http://dx.doi.org/10.1136/bmj.h6067			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW4HA	26566953				2022-12-28	WOS:000364950900007
J	Spadoni, I; Zagato, E; Bertocchi, A; Paolinelli, R; Hot, E; Di Sabatino, A; Caprioli, F; Bottiglieri, L; Oldani, A; Viale, G; Penna, G; Dejana, E; Rescigno, M				Spadoni, Ilaria; Zagato, Elena; Bertocchi, Alice; Paolinelli, Roberta; Hot, Edina; Di Sabatino, Antonio; Caprioli, Flavio; Bottiglieri, Luca; Oldani, Amanda; Viale, Giuseppe; Penna, Giuseppe; Dejana, Elisabetta; Rescigno, Maria			A gut-vascular barrier controls the systemic dissemination of bacteria	SCIENCE			English	Article							BLOOD-BRAIN-BARRIER	In healthy individuals, the intestinal microbiota cannot access the liver, spleen, or other peripheral tissues. Some pathogenic bacteria can reach these sites, however, and can induce a systemic immune response. How such compartmentalization is achieved is unknown. We identify a gut-vascular barrier (GVB) in mice and humans that controls the translocation of antigens into the bloodstream and prohibits entry of the microbiota. Salmonella typhimurium can penetrate the GVB in a manner dependent on its pathogenicity island (Spi) 2-encoded type III secretion system and on decreased beta-catenin-dependent signaling in gut endothelial cells. The GVB is modified in celiac disease patients with elevated serum transaminases, which indicates that GVB dismantling may be responsible for liver damage in these patients. Understanding the GVB may provide new insights into the regulation of the gut-liver axis.	[Spadoni, Ilaria; Zagato, Elena; Bertocchi, Alice; Hot, Edina; Penna, Giuseppe; Rescigno, Maria] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Paolinelli, Roberta; Oldani, Amanda; Dejana, Elisabetta] Italian Fdn Canc Res FIRC, Inst Mol Oncol IFOM, Milan, Italy; [Di Sabatino, Antonio] Univ Pavia, St Matteo Hosp, Dept Med 1, I-27100 Pavia, Italy; [Caprioli, Flavio] Osped Maggiore Policlin Milano, Fdn IRCCS Ca Granda, Unita Operat Gastroenterol & Endoscopia, Milan, Italy; [Caprioli, Flavio] Univ Milan, Dipartimento Fisiopatol Med Chirurg & Trapianti, Milan, Italy; [Bottiglieri, Luca; Viale, Giuseppe] European Inst Oncol, Dept Pathol & Lab Med, Milan, Italy; [Dejana, Elisabetta; Rescigno, Maria] Univ Milan, Dept Biosci, I-20122 Milan, Italy; [Dejana, Elisabetta] Uppsala Univ, Dept Genet Immunol & Pathol, Uppsala, Sweden	IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; University of Pavia; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS European Institute of Oncology (IEO); University of Milan; Uppsala University	Rescigno, M (corresponding author), European Inst Oncol, Dept Expt Oncol, Milan, Italy.	maria.rescigno@ieo.eu	Viale, Giuseppe/AAE-8921-2019; Bottiglieri, Luca/AAO-3720-2020; Zagato, Elena/N-1285-2017; Dejana, Elisabetta/A-6274-2016; Spadoni, Ilaria/K-1054-2018; Penna, Giuseppe/AAB-8784-2019; Di Sabatino, Antonio/K-8015-2016; Caprioli, Flavio/AAB-5176-2019; Rescigno, Maria/J-9704-2012; Zagato, Elena/AAN-1997-2021	Zagato, Elena/0000-0001-6756-3674; Penna, Giuseppe/0000-0003-3534-7090; Di Sabatino, Antonio/0000-0002-0302-8645; Caprioli, Flavio/0000-0002-8077-8175; Rescigno, Maria/0000-0002-6464-509X; Zagato, Elena/0000-0001-6756-3674; DEJANA, ELISABETTA/0000-0002-0007-0426; Spadoni, Ilaria/0000-0002-1067-0695	European Research Council; Italian Association for Cancer Research (AIRC); Italian Ministry of Health (Ricerca finalizzata); FIRC	European Research Council(European Research Council (ERC)European Commission); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health (Ricerca finalizzata)(Ministry of Health, Italy); FIRC(Fondazione AIRC per la ricerca sul cancro)	This work was funded by the European Research Council (M.R., Dendroworld and HomeoGUT: E.D., Wnt for Brain), the Italian Association for Cancer Research (AIRC) and the Italian Ministry of Health (Ricerca finalizzata). I.S. is the recipient of a FIRC fellowship. The authors declare no competing financial interests.	Balmer ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008618; Daneman R, 2009, IMMUNITY, V31, P722, DOI 10.1016/j.immuni.2009.09.012; Dong Q. G., 1997, ARTERIOSCLER THROMB, V17, P1599; Engelhardt B, 2014, CELL TISSUE RES, V355, P687, DOI 10.1007/s00441-014-1811-2; Fujita H, 2008, MOL BIOL CELL, V19, P1912, DOI 10.1091/mbc.E07-09-0973; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; HALLMANN R, 1995, DEV DYNAM, V202, P325, DOI 10.1002/aja.1002020402; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kannan L, 2013, P NATL ACAD SCI USA, V110, P14348, DOI 10.1073/pnas.1309393110; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lim CH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004270; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2006, J EXP MED, V203, P497, DOI 10.1084/jem.20060227; Mishra PK, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002099; Muller-Redetzky HC, 2014, CELL TISSUE RES, V355, P657, DOI 10.1007/s00441-014-1821-0; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Yuan SY., 2010, REGULATION ENDOTHELI; Zhou YL, 2014, J CLIN INVEST, V124, P3825, DOI 10.1172/JCI76431	20	281	298	12	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					830	834		10.1126/science.aad0135	http://dx.doi.org/10.1126/science.aad0135			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW3MS	26564856				2022-12-28	WOS:000364897000049
J	Walker, Z; Possin, KL; Boeve, BF; Aarsland, D				Walker, Zuzana; Possin, Katherine L.; Boeve, Bradley F.; Aarsland, Dag			Lewy body dementias	LANCET			English	Article							SLEEP BEHAVIOR DISORDER; MILD COGNITIVE IMPAIRMENT; PARKINSONS-DISEASE DEMENTIA; AUTOPSY-CONFIRMED DEMENTIA; EARLY-ONSET DEMENTIA; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; DIAGNOSTIC-CRITERIA; CEREBROSPINAL-FLUID; DOUBLE-BLIND	The broad importance of dementia is undisputed, with Alzheimer's disease justifiably getting the most attention. However, dementia with Lewy bodies and Parkinson's disease dementia, now called Lewy body dementias, are the second most common type of degenerative dementia in patients older than 65 years. Despite this, Lewy body dementias receive little attention and patients are often misdiagnosed, leading to less than ideal management. Over the past 10 years, considerable effort has gone into improving diagnostic accuracy by refining diagnostic criteria and using imaging and other biomarkers. Dementia with Lewy bodies and Parkinson's disease dementia share the same pathophysiology, and effective treatments will depend not only on successful treatment of symptoms but also on targeting the pathological mechanisms of disease, ideally before symptoms and clinical signs develop. We summarise the most pertinent progress from the past 10 years, outlining some of the challenges for the future, which will require refinement of diagnosis and clarification of the pathogenesis, leading to disease-modifying treatments.	[Walker, Zuzana] UCL, Div Psychiat, London, England; [Walker, Zuzana] North Essex Partnership Univ, NHS Fdn Trust, Epping, Essex, England; [Possin, Katherine L.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Boeve, Bradley F.] Coll Med, Mayo Clin, Div Behav Neurol, Dept Neurol, Rochester, MN USA; [Boeve, Bradley F.] Coll Med, Mayo Clin, Div Movement Disorders, Dept Neurol, Rochester, MN USA; [Boeve, Bradley F.] Coll Med, Mayo Clin, Ctr Sleep Med, Rochester, MN USA; [Aarsland, Dag] Stavanger Univ Hosp, Ctr Age Related Dis, Stavanger, Norway; [Aarsland, Dag] Akershus Univ Hosp, Dept Geriatr Psychiat, Oslo, Norway; [Aarsland, Dag] Karolinska Inst, Div Alzheimers Dis Res Ctr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden	University of London; University College London; University of California System; University of California San Francisco; Mayo Clinic; Mayo Clinic; Mayo Clinic; Stavanger University Hospital; University of Oslo; Karolinska Institutet	Walker, Z (corresponding author), St Margarets Hosp, Mental Hlth Unit, Epping CM16 6TN, Essex, England.	z.walker@ucl.ac.uk	Walker, Zuzana/B-8339-2009	Walker, Zuzana/0000-0001-7346-8200; Aarsland, Dag/0000-0001-6314-216X	GE Healthcare; Bayer Healthcare; Novartis; Lundbeck; US National Institute on Ageing; Michael J Fox Foundation; Center for Medicare and Medicaid Innovation; Hellman Family Foundation; Acupera; Cephalon; Allon Pharmaceuticals; FORUM Pharmaceuticals; Cambridge Medicine; American Academy of Neurology; Tau Consortium; H Lundbeck; NATIONAL INSTITUTE ON AGING [K23AG037566] Funding Source: NIH RePORTER	GE Healthcare(General ElectricGE Healthcare); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Novartis(Novartis); Lundbeck(Lundbeck Corporation); US National Institute on Ageing(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Michael J Fox Foundation; Center for Medicare and Medicaid Innovation; Hellman Family Foundation; Acupera; Cephalon; Allon Pharmaceuticals; FORUM Pharmaceuticals; Cambridge Medicine(General Electric); American Academy of Neurology; Tau Consortium; H Lundbeck(Lundbeck Corporation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	ZW has received personal fees from GE Healthcare, Bayer Healthcare, and Novartis; grants from GE Healthcare and Lundbeck; and her National Health Service employer received reimbursement for her time in connection to a phase 4 trial from GE Healthcare, outside the submitted work. KLP has received grants from the US National Institute on Ageing, Michael J Fox Foundation, Center for Medicare and Medicaid Innovation, and the Hellman Family Foundation; contract with Quest Diagnostics; and personal fees from Acupera. BFB has received grants from Cephalon, Allon Pharmaceuticals, FORUM Pharmaceuticals, GE Healthcare; and personal fees from Cambridge Medicine, the American Academy of Neurology, and Tau Consortium, all outside the submitted work. DA has received grants from GE Healthcare, and personal fees from Novartis and H Lundbeck, outside the submitted work.	Aarsland D, 2007, J NEUROL, V254, P38, DOI 10.1007/s00415-006-0234-8; Aarsland D, 2005, J CLIN PSYCHIAT, V66, P633; Aarsland D, 2005, MOVEMENT DISORD, V20, P1255, DOI 10.1002/mds.20527; Aarsland D, 2010, NEUROLOGY, V75, P1062, DOI 10.1212/WNL.0b013e3181f39d0e; Aarsland D, 2009, NEUROLOGY, V72, P1121, DOI 10.1212/01.wnl.0000338632.00552.cb; Aarsland D, 2008, DEMENT GERIATR COGN, V26, P445, DOI 10.1159/000165917; Aarsland D, 2009, LANCET NEUROL, V8, P613, DOI 10.1016/S1474-4422(09)70146-2; Al-Mansoori KM, 2013, CURR ALZHEIMER RES, V10, P559; Alves G, 2014, NEUROLOGY, V82, P1784, DOI 10.1212/WNL.0000000000000425; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Tola-Arribas MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077688; Auning E, 2011, DEMENT GERIATR COGN, V32, P202, DOI 10.1159/000333072; Ballard C, 2013, DRUG AGING, V30, P603, DOI 10.1007/s40266-013-0092-x; Ballard C, 2011, DRUG AGING, V28, P769, DOI 10.2165/11594110-000000000-00000; Belden CM, 2015, AM J ALZHEIMERS DIS, V30, P173, DOI 10.1177/1533317514542642; Benedict R., 1997, BRIEF VISUOSPATIAL M; BENTON AL, 1978, ARCH NEUROL-CHICAGO, V35, P364, DOI 10.1001/archneur.1978.00500300038006; Berge G, 2014, J NEUROL NEUROSUR PS, V85, P1227, DOI 10.1136/jnnp-2013-307228; Boeve BF, 2013, SLEEP MED, V14, P754, DOI 10.1016/j.sleep.2012.10.015; Boeve BF, 2013, LANCET NEUROL, V12, P469, DOI 10.1016/S1474-4422(13)70054-1; Boeve BF, 2011, SLEEP MED, V12, P445, DOI 10.1016/j.sleep.2010.12.009; Boeve BF, 2010, ANN NY ACAD SCI, V1184, P15, DOI 10.1111/j.1749-6632.2009.05115.x; Bonanni L, 2008, BRAIN, V131, P690, DOI 10.1093/brain/awm322; Bonanni L, 2015, NEUROBIOL AGING, V36, P434, DOI 10.1016/j.neurobiolaging.2014.07.009; Boot BP, 2013, CURR TREAT OPTION NE, V15, P738, DOI 10.1007/s11940-013-0261-6; Boot BP, 2013, NEUROLOGY, V81, P833, DOI 10.1212/WNL.0b013e3182a2cbd1; Bott NT, 2014, PARKINSONISM RELAT D, V20, P1430, DOI 10.1016/j.parkreldis.2014.10.007; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Bras J, 2014, HUM MOL GENET, V23, P6139, DOI 10.1093/hmg/ddu334; Bronnick K, 2006, J NEUROL NEUROSUR PS, V77, P1136, DOI 10.1136/jnnp.2006.093146; Brunnstrom H, 2013, INT J GERIATR PSYCH, V28, P738, DOI 10.1002/gps.3881; Burn D, 2006, MOVEMENT DISORD, V21, P1899, DOI 10.1002/mds.21077; Buschke H, 1997, NEUROLOGY, V48, P989, DOI 10.1212/WNL.48.4.989; Cagnin A, 2015, PARKINSONISM RELAT D, V21, P303, DOI 10.1016/j.parkreldis.2014.12.007; Chen-Plotkin AS, 2011, ANN NEUROL, V69, P655, DOI 10.1002/ana.22271; Chiba Y, 2012, DEMENT GERIATR COGN, V33, P273, DOI 10.1159/000339363; Cordery RJ, 2001, ARCH NEUROL-CHICAGO, V58, P505, DOI 10.1001/archneur.58.3.505; Cummings J, 2014, LANCET, V383, P533, DOI 10.1016/S0140-6736(13)62106-6; Delis DC., 2000, CALIFORNIA VERBAL LE; Dobkin RD, 2011, AM J PSYCHIAT, V168, P1066, DOI 10.1176/appi.ajp.2011.10111669; Donaghy P, 2015, AM J GERIAT PSYCHIAT, V23, P23, DOI 10.1016/j.jagp.2013.03.001; Dubbelink KTEO, 2014, NEUROLOGY, V82, P263, DOI 10.1212/WNL.0000000000000034; Dubois B, 2012, MOVEMENT DISORD, V27, P1230, DOI 10.1002/mds.25098; Emre M, 2004, NEW ENGL J MED, V351, P2509, DOI 10.1056/NEJMoa041470; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Emre M, 2010, LANCET NEUROL, V9, P969, DOI 10.1016/S1474-4422(10)70194-0; Fan XL, 2014, NAT NEUROSCI, V17, P471, DOI 10.1038/nn.3637; Ferman TJ, 2011, NEUROLOGY, V77, P875, DOI 10.1212/WNL.0b013e31822c9148; Ferman TJ, 2013, NEUROLOGY, V81, P2032, DOI 10.1212/01.wnl.0000436942.55281.47; Fields JA, 2011, NAT REV NEUROL, V7, P677, DOI 10.1038/nrneurol.2011.173; Filippi M, 2012, EUR J NEUROL, V19, P1487, DOI 10.1111/j.1468-1331.2012.03859.x; Friedman J, 1999, NEW ENGL J MED, V340, P757; Fujishiro H, 2015, GERIATR GERONTOL INT, V15, P817, DOI 10.1111/ggi.12466; George S, 2013, BRAIN PATHOL, V23, P350, DOI 10.1111/bpa.12046; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Graff-Radford J, 2014, NEUROLOGY, V83, P801, DOI 10.1212/WNL.0000000000000734; Hall H, 2014, BRAIN, V137, P2493, DOI 10.1093/brain/awu193; Halliday G, 2011, J NEURAL TRANSM, V118, P713, DOI 10.1007/s00702-011-0641-6; Hamilton JM, 2012, AM J GERIAT PSYCHIAT, V20, P773, DOI 10.1097/JGP.0b013e31823033bc; Heaton R.K., 1993, WISCONSIN CARD SORTI; Horvath J, 2013, PARKINSONISM RELAT D, V19, P864, DOI 10.1016/j.parkreldis.2013.05.010; Howell MJ, 2015, JAMA NEUROL, V72, P707, DOI 10.1001/jamaneurol.2014.4563; Hyun Cheol Hwan, 2013, Exp Neurobiol, V22, P249, DOI 10.5607/en.2013.22.4.249; Ikeda M, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-014-0083-0; Ikeda M, 2013, DEMENT GERIATR COGN, V36, P229, DOI 10.1159/000351672; Iranzo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089741; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Janvin CC, 2006, MOVEMENT DISORD, V21, P1343, DOI 10.1002/mds.20974; Jellinger KA, 2010, NEURODEGENER DIS, V7, P112, DOI 10.1159/000285518; Jokinen P, 2010, PARKINSONISM RELAT D, V16, P666, DOI 10.1016/j.parkreldis.2010.08.021; Jones DR, 2014, THER ADV NEUROL DISO, V7, P33, DOI 10.1177/1756285613493469; Jones SAV, 2014, PSYCHOL MED, V44, P673, DOI 10.1017/S0033291713000494; Kalbe E, 2008, PARKINSONISM RELAT D, V14, P93, DOI 10.1016/j.parkreldis.2007.06.008; Kantarci K, 2012, NEUROBIOL AGING, V33, P2091, DOI 10.1016/j.neurobiolaging.2011.09.024; Kantarci K, 2012, NEUROBIOL AGING, V33, P878, DOI 10.1016/j.neurobiolaging.2010.08.007; Kehagia AA, 2010, LANCET NEUROL, V9, P1200, DOI 10.1016/S1474-4422(10)70212-X; King AE, 2011, MOVEMENT DISORD, V26, P1218, DOI 10.1002/mds.23659; Klassen BT, 2011, NEUROLOGY, V77, P118, DOI 10.1212/WNL.0b013e318224af8d; Kurlan R, 2007, NEUROLOGY, V68, P1356, DOI 10.1212/01.wnl.0000260060.60870.89; Larsson V, 2010, INT J GERIATR PSYCH, V25, P1030, DOI 10.1002/gps.2506; Lee DR, 2014, AM J GERIAT PSYCHIAT, V22, P926, DOI 10.1016/j.jagp.2013.01.072; Lee DR, 2012, INT J GERIATR PSYCH, V27, P989, DOI 10.1002/gps.2823; Lee HJ, 2014, NAT REV NEUROL, V10, P92, DOI 10.1038/nrneurol.2013.275; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th ed.; Lim SM, 2009, J NUCL MED, V50, P1638, DOI 10.2967/jnumed.109.065870; Lim X, 2013, PARKINSONISM RELAT D, V19, P851, DOI 10.1016/j.parkreldis.2013.06.008; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Malek N, 2014, ACTA NEUROL SCAND, V130, P59, DOI 10.1111/ane.12247; Marinus J, 2003, NEUROLOGY, V61, P1222, DOI 10.1212/01.WNL.0000091864.39702.1C; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; Matsunaga S, 2015, AM J GERIAT PSYCHIAT, V23, P373, DOI 10.1016/j.jagp.2013.11.007; McCarter SJ, 2013, SLEEP MED, V14, P237, DOI 10.1016/j.sleep.2012.09.018; McCleery J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010633.pub2; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; McKeith I, 2004, LANCET NEUROL, V3, P19, DOI 10.1016/S1474-4422(03)00619-7; McKeith I, 2007, LANCET NEUROL, V6, P305, DOI 10.1016/S1474-4422(07)70057-1; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Meeus B, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.014; Micanovic C, 2014, J NEURAL TRANSM, V121, P59, DOI 10.1007/s00702-013-1070-5; Minoshima S, 2001, ANN NEUROL, V50, P358, DOI 10.1002/ana.1133; Mok W, 2004, Am J Alzheimers Dis Other Demen, V19, P161, DOI 10.1177/153331750401900309; Mollenhauer B, 2006, DEMENT GERIATR COGN, V22, P200, DOI 10.1159/000094871; Montine TJ, 2014, NEUROLOGY, V83, P851, DOI 10.1212/WNL.0000000000000733; Morgan S, 2012, J NEUROL NEUROSUR PS, V83, P1063, DOI 10.1136/jnnp-2012-302577; Mori E, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-014-0081-2; Mori E, 2012, ANN NEUROL, V72, P41, DOI 10.1002/ana.23557; Nalls MA, 2013, JAMA NEUROL, V70, P727, DOI 10.1001/jamaneurol.2013.1925; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nedelska Z, 2015, NEUROBIOL AGING, V36, P2010, DOI 10.1016/j.neurobiolaging.2015.03.007; Nedelska Z, 2015, NEUROBIOL AGING, V36, P452, DOI 10.1016/j.neurobiolaging.2014.07.005; Nelson PT, 2010, J NEUROL, V257, P359, DOI 10.1007/s00415-009-5324-y; Nervi A, 2011, ARCH NEUROL-CHICAGO, V68, P90, DOI 10.1001/archneurol.2010.319; Nervi A, 2008, ARCH NEUROL-CHICAGO, V65, P1634, DOI 10.1001/archneur.65.12.1634; O'Brien JT, 2009, BRIT J PSYCHIAT, V194, P34, DOI 10.1192/bjp.bp.108.052050; Olson EJ, 2000, BRAIN, V123, P331, DOI 10.1093/brain/123.2.331; Pagonabarraga J, 2008, MOVEMENT DISORD, V23, P998, DOI 10.1002/mds.22007; Papathanasiou ND, 2012, PARKINSONISM RELAT D, V18, P225, DOI 10.1016/j.parkreldis.2011.09.015; Parkkinen L, 2008, ACTA NEUROPATHOL, V115, P399, DOI 10.1007/s00401-008-0346-6; Pedersen KF, 2013, JAMA NEUROL, V70, P580, DOI 10.1001/jamaneurol.2013.2110; Perez F, 2010, J NEUROL NEUROSUR PS, V81, P742, DOI 10.1136/jnnp.2009.189142; Petrou M, 2015, MOVEMENT DISORD, V30, P928, DOI 10.1002/mds.26191; Pollak P, 2004, J NEUROL NEUROSUR PS, V75, P689, DOI 10.1136/jnnp.2003.029868; Pollak P, 1999, LANCET, V353, P2041; Postuma RB, 2015, NEUROLOGY, V84, P1104, DOI 10.1212/WNL.0000000000001364; Postuma RB, 2013, MOVEMENT DISORD, V28, P597, DOI 10.1002/mds.25445; Qiang JK, 2013, ANN NEUROL, V74, P119, DOI 10.1002/ana.23872; Rahkonen T, 2003, J NEUROL NEUROSUR PS, V74, P720, DOI 10.1136/jnnp.74.6.720; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Reitan R, 1985, HALSTEAD REITAN NEUR; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Richard IH, 2012, NEUROLOGY, V78, P1229, DOI 10.1212/WNL.0b013e3182516244; Rolinski M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006504.pub2; Sachdev PS, 2014, NAT REV NEUROL, V10, P634, DOI 10.1038/nrneurol.2014.181; Savica R, 2013, JAMA NEUROL, V70, P1396, DOI 10.1001/jamaneurol.2013.3579; Schenck CH, 2013, SLEEP MED, V14, P744, DOI 10.1016/j.sleep.2012.10.009; Schenck CH, 2002, SLEEP, V25, P120, DOI 10.1093/sleep/25.2.120; Schneider JA, 2012, BRAIN, V135, P3005, DOI 10.1093/brain/aws234; Seppi K, 2011, MOVEMENT DISORD, V26, pS42, DOI 10.1002/mds.23884; Siderowf A, 2010, NEUROLOGY, V75, P1055, DOI 10.1212/WNL.0b013e3181f39a78; Silbert LC, 2010, BRAIN PATHOL, V20, P646, DOI 10.1111/j.1750-3639.2009.00368.x; Smith GE, 2009, NEUROLOGY, V72, pA246; Stevens T, 2002, BRIT J PSYCHIAT, V180, P270, DOI 10.1192/bjp.180.3.270; Stewart T, 2014, AM J PATHOL, V184, P966, DOI 10.1016/j.ajpath.2013.12.007; Stocchi F, 2013, MOVEMENT DISORD, V28, P3, DOI 10.1002/mds.25337; Stubendorff K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005158; Svenningsson P, 2012, LANCET NEUROL, V11, P697, DOI 10.1016/S1474-4422(12)70152-7; Taylor JP, 2012, NEUROIMAG CLIN N AM, V22, P67, DOI 10.1016/j.nic.2011.11.001; Teune LK, 2010, MOVEMENT DISORD, V25, P2395, DOI 10.1002/mds.23291; Tiraboschi P, 2006, BRAIN, V129, P729, DOI 10.1093/brain/awh725; Tiraboschi P, 2015, NEUROLOGY, V84, P496, DOI 10.1212/WNL.0000000000001204; Toledo JB, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-65; Tsuang D, 2013, JAMA NEUROL, V70, P223, DOI 10.1001/jamaneurol.2013.600; Vardy E, 2014, INT J GERIATR PSYCH, V29, P178, DOI 10.1002/gps.3986; Walker RWH, 2009, MOVEMENT DISORD, V24, pS754, DOI 10.1002/mds.22591; Walker Z, 2007, J NEUROL NEUROSUR PS, V78, P1176, DOI 10.1136/jnnp.2006.110122; Walker Z, 2015, BRIT J PSYCHIAT, V206, P145, DOI 10.1192/bjp.bp.114.148643; Wang HF, 2015, J NEUROL NEUROSUR PS, V86, P135, DOI 10.1136/jnnp-2014-307659; Warrington EK., 1991, VISUAL OBJECT SPACE; Williams-Gray CH, 2013, J NEUROL NEUROSUR PS, V84, P1258, DOI 10.1136/jnnp-2013-305277; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245; Yoshita M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120540; Yoshizawa H, 2013, J NEUROL NEUROSUR PS, V84, P1326, DOI 10.1136/jnnp-2012-304381; Youdim Moussa Bh, 2013, Exp Neurobiol, V22, P167, DOI 10.5607/en.2013.22.3.167	165	285	293	5	132	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2015	386	10004					1683	1697		10.1016/S0140-6736(15)00462-6	http://dx.doi.org/10.1016/S0140-6736(15)00462-6			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU0HS	26595642	Green Accepted			2022-12-28	WOS:000363197500035
J	Coovadia, H; Moodley, D				Coovadia, Hoosen; Moodley, Dhayendre			Improving HIV pre-exposure prophylaxis for infants	LANCET			English	Editorial Material							TRANSMISSION; PREVENTION; CHILDREN; WOMEN		[Coovadia, Hoosen] Univ Witwatersrand, Maternal Adolescent & Child Hlth, Sch Publ Hlth, ZA-4091 Durban, South Africa; [Moodley, Dhayendre] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa, Durban, South Africa; [Moodley, Dhayendre] Univ KwaZulu Natal, Womens Hlth & HIV Res Unit, Durban, South Africa	University of Witwatersrand; University of Kwazulu Natal; University of Kwazulu Natal	Coovadia, H (corresponding author), Univ Witwatersrand, Maternal Adolescent & Child Hlth, Sch Publ Hlth, ZA-4091 Durban, South Africa.	hcoovadia@match.org.za	Moodley, Dhayendre/U-6802-2019					Chibwesha CJ, 2011, JAIDS-J ACQ IMM DEF, V58, P224, DOI 10.1097/QAI.0b013e318229147e; Coovadia HM, 2012, LANCET, V379, P221, DOI 10.1016/S0140-6736(11)61653-X; De Schacht C, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18808; Fowler MG, 2015, 22 C RETR OPP INF CR; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Motswere-Chirwa C, 2014, MMWR-MORBID MORTAL W, V63, P158; Nagot N, 2015, LANCET; Paredes R, 2013, J INFECT DIS, V207, pS93, DOI 10.1093/infdis/jit110; Sartorius BKD, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0029-6; Sibiude J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001635; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; World Health Organization, 2012, PROGR UPD US ANT DRU	13	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2016	387	10018					513	514		10.1016/S0140-6736(15)00983-6	http://dx.doi.org/10.1016/S0140-6736(15)00983-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3PV	26603916				2022-12-28	WOS:000369835800010
J	Das, P; Horton, R				Das, Pamela; Horton, Richard			Antibiotics: achieving the balance between access and excess	LANCET			English	Editorial Material									[Das, Pamela; Horton, Richard] The Lancet, London EC2Y 5AS, England		Das, P (corresponding author), The Lancet, London EC2Y 5AS, England.							[Anonymous], 2015, LANCET, DOI [http://dx.doi.org/10.1016/S0140-6736(15)00547-4, DOI 10.1016/S0140-6736(15)00547-4]; Ardal C, 2016, LANCET, V387, P296, DOI 10.1016/S0140-6736(15)00470-5; Dar OA, 2016, LANCET, V387, P285, DOI 10.1016/S0140-6736(15)00520-6; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Laxminarayan R, 2015, LANCET; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1	8	15	16	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2016	387	10014					102	104		10.1016/S0140-6736(15)00729-1	http://dx.doi.org/10.1016/S0140-6736(15)00729-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8LF	26603923				2022-12-28	WOS:000368055500009
J	van Velzen, S; Anderson, GE; Stone, NC; Fraser, M; Wevers, T; Metzger, BD; Jonker, PG; van der Horst, AJ; Staley, TD; Mendez, AJ; Miller-Jones, JCA; Hodgkin, ST; Campbell, HC; Fender, RP				van Velzen, S.; Anderson, G. E.; Stone, N. C.; Fraser, M.; Wevers, T.; Metzger, B. D.; Jonker, P. G.; van der Horst, A. J.; Staley, T. D.; Mendez, A. J.; Miller-Jones, J. C. A.; Hodgkin, S. T.; Campbell, H. C.; Fender, R. P.			A radio jet from the optical and x-ray bright stellar tidal disruption flare ASASSN-14li	SCIENCE			English	Article							MASSIVE BLACK-HOLE; STAR; OUTBURST; TRANSIENTS; NUCLEUS; FLOWS; CORE	The tidal disruption of a star by a supermassive black hole leads to a short-lived thermal flare. Despite extensive searches, radio follow-up observations of known thermal stellar tidal disruption flares (TDFs) have not yet produced a conclusive detection. We present a detection of variable radio emission from a thermal TDF, which we interpret as originating from a newly launched jet. The multiwavelength properties of the source present a natural analogy with accretion-state changes of stellar mass black holes, which suggests that all TDFs could be accompanied by a jet. In the rest frame of the TDF, our radio observations are an order of magnitude more sensitive than nearly all previous upper limits, explaining how these jets, if common, could thus far have escaped detection.	[van Velzen, S.; Mendez, A. J.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Anderson, G. E.; Staley, T. D.; Fender, R. P.] Univ Oxford, Dept Phys, Oxford OX1 3RH, England; [Anderson, G. E.; Miller-Jones, J. C. A.] Curtin Univ, Internat Ctr Radio Astron Res, Perth, WA 6845, Australia; [Stone, N. C.] Columbia Univ, Columbia Astrophys Lab, New York, NY 10027 USA; [Fraser, M.; Hodgkin, S. T.; Campbell, H. C.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Wevers, T.; Jonker, P. G.] Radboud Univ Nijmegen, Dept Astrophys, NL-6525 AJ Nijmegen, Netherlands; [Jonker, P. G.] SRON Netherlands Inst Space Res, SRON, NL-3584 CA Utrecht, Netherlands; [van der Horst, A. J.] George Washington Univ, Dept Phys, Washington, DC 20052 USA	Johns Hopkins University; University of Oxford; Curtin University; Columbia University; University of Cambridge; Radboud University Nijmegen; George Washington University	van Velzen, S (corresponding author), Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA.	sjoert@jhu.edu	Anderson, Gemma/HGE-5759-2022; Miller-Jones, James C. A./B-2411-2013	Miller-Jones, James C. A./0000-0003-3124-2814; van der Horst, Alexander/0000-0001-9149-6707; Fraser, Morgan/0000-0003-2191-1674; Wevers, Thomas/0000-0002-4043-9400; Staley, Tim/0000-0002-4474-5253; Anderson, Gemma/0000-0001-6544-8007; Stone, Nicholas/0000-0002-4337-9458	NASA [HST-HF2-51350.001, NNX14AQ68G]; European Research Council [267697]; International Centre for Radio Astronomy Research (ICRAR), a Joint Venture of Curtin University; University of Western Australia - Western Australian State government; European UnionEuropean Union FP7 program through European Research Council [320360]; NSF [AST-1410950]; Alfred P. Sloan Foundation; NASA through an Einstein Fellowship; Australian Research Council [FT140101082]; STFC [ST/L001381/1, ST/J00541X/1, ST/M003035/1, ST/M007626/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J00541X/1, ST/M007626/1, ST/L001381/1, ST/M003035/1] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); European Research Council(European Research Council (ERC)European Commission); International Centre for Radio Astronomy Research (ICRAR), a Joint Venture of Curtin University; University of Western Australia - Western Australian State government; European UnionEuropean Union FP7 program through European Research Council; NSF(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NASA through an Einstein Fellowship; Australian Research Council(Australian Research Council); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We are grateful to the ASAS-SN team for making their newly identified optical transient public. We thank J. Krolik for useful discussions. We thank the staff of the Mullard Radio Astronomy Observatory for their invaluable assistance in the operation of AMI. We thank the WSRT director for granting the observations in Director's Discretionary Time and the WSRT staff for obtaining these observations. The WSRT is operated by ASTRON (Netherlands Institute for Radio Astronomy) with support from the Netherlands foundation for Scientific Research. S.v.V. is supported by NASA through a Hubble Fellowship (HST-HF2-51350.001). G.E.A., T.D.S., and R.P.F. acknowledge support from the European Research Council via Advanced Investigator Grant 267697. G.E.A. also acknowledges the support of the International Centre for Radio Astronomy Research (ICRAR), a Joint Venture of Curtin University and The University of Western Australia, funded by the Western Australian State government. M.F. and H.C.C. acknowledge support from the European Union FP7 program through European Research Council grant 320360. B.D.M. and N.C.S. acknowledge support from NASA grant NNX14AQ68G, NSF grant AST-1410950, and the Alfred P. Sloan Foundation. N.C.S. is also supported by NASA through an Einstein Fellowship. J.C.A.M.-J. is supported by an Australian Research Council Future Fellowship (FT140101082). The data presented here can be found in the supplementary materials; raw optical/UV/x-ray observations are available in the NASA/Swift archive (http://heasarc.nasa.gov/docs/swift/archive, Target Name: BRUTUS6984_2); raw radio observations (WSRT and AMI) are maintained by the observatories and available upon request.	Bade N, 1996, ASTRON ASTROPHYS, V309, pL35; Berger E, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/36; Bloom JS, 2011, SCIENCE, V333, P203, DOI 10.1126/science.1207150; Bower GC, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/2/84; Brown GC, 2015, MON NOT R ASTRON SOC, V452, P4297, DOI 10.1093/mnras/stv1520; Burrows DN, 2011, NATURE, V476, P421, DOI 10.1038/nature10374; Cenko SB, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/77; Falcke H, 2004, ASTRON ASTROPHYS, V414, P895, DOI 10.1051/0004-6361:20031683; Fender R., 2014, ADV ASTROPHYSICS SQU; Fender RP, 2004, MON NOT R ASTRON SOC, V355, P1105, DOI 10.1111/j.1365-2966.2004.08384.x; Gezari S, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/60; Gezari S, 2012, NATURE, V485, P217, DOI 10.1038/nature10990; Gezari S, 2009, ASTROPHYS J, V698, P1367, DOI 10.1088/0004-637X/698/2/1367; Giannios D, 2011, MON NOT R ASTRON SOC, V416, P2102, DOI 10.1111/j.1365-2966.2011.19188.x; Guillochon J, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/1/23; Holoien T. W.-S., 2015, MON NOT R ASTRON SOC; Kanner J, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/63; Kelley LZ, 2014, MON NOT R ASTRON SOC, V445, P3919, DOI 10.1093/mnras/stu2041; Levan AJ, 2011, SCIENCE, V333, P199, DOI 10.1126/science.1207143; Maccarone TJ, 2003, ASTRON ASTROPHYS, V409, P697, DOI 10.1051/0004-6361:20031146; McKinney JC, 2013, SCIENCE, V339, P49, DOI 10.1126/science.1230811; Miller JM, 2015, NATURE, V526, P542, DOI 10.1038/nature15708; Mimica P, 2015, MON NOT R ASTRON SOC, V450, P2824, DOI 10.1093/mnras/stv825; Shiokawa H, 2015, ASTROPHYS J, V804, DOI 10.1088/0004-637X/804/2/85; Ulmer A, 1999, ASTROPHYS J, V514, P180, DOI 10.1086/306909; van Velzen S, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201220426; van Velzen S, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/53; van Velzen S, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/73; Zauderer BA, 2011, NATURE, V476, P425, DOI 10.1038/nature10366	30	123	123	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268					62	65		10.1126/science.aad1182	http://dx.doi.org/10.1126/science.aad1182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ8QM	26612833	Green Submitted			2022-12-28	WOS:000367364200041
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Grill the politicians live on TV	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Barker K., 2014, NEW SETTLEMENT HLTH; Dunhill L, 2015, HLTH SERV J; Nuffield Trust, 2015, SPOTL GEN EL 2015 MA	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2015	351									10.1136/bmj.h6461	http://dx.doi.org/10.1136/bmj.h6461			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX9EY	26631230	Bronze			2022-12-28	WOS:000366009000006
J	van Leersum, FS; Liu, XM				van Leersum, Frank S.; Liu, Xiaomeng			Acrokeratosis Paraneoplastica	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[van Leersum, Frank S.; Liu, Xiaomeng] Maastricht Univ, Med Ctr, Maastricht, Netherlands	Maastricht University	van Leersum, FS (corresponding author), Maastricht Univ, Med Ctr, Maastricht, Netherlands.	frank.van.leersum@mumc.nl							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2015	373	22					2161	2161		10.1056/NEJMicm1502488	http://dx.doi.org/10.1056/NEJMicm1502488			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9YT	26605930				2022-12-28	WOS:000365354800011
J	Long, JL; Chhetri, DK				Long, Jennifer L.; Chhetri, Dinesh K.			Restoring voice	SCIENCE			English	Editorial Material							SCAR		[Long, Jennifer L.; Chhetri, Dinesh K.] Univ Calif Los Angeles, Dept Head & Neck Surg, Los Angeles, CA 90095 USA; [Long, Jennifer L.] Greater Los Angeles Vet Affairs Med Ctr, Res Serv, Los Angeles, CA 90073 USA	University of California System; University of California Los Angeles	Long, JL (corresponding author), Univ Calif Los Angeles, Dept Head & Neck Surg, Los Angeles, CA 90095 USA.	jlong@mednet.ucla.edu; dchhetri@mednet.ucla.edu	Chhetri, Dinesh Khatri/AAT-4951-2020	Long, Jennifer/0000-0002-4185-2328	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011300] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX001944] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC011300] Funding Source: Medline; BLRD VA [IK2 BX001944] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Veterans Affairs(US Department of Veterans Affairs); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); BLRD VA		Chhetri DK, 2011, LARYNGOSCOPE, V121, P785, DOI 10.1002/lary.21417; Farwell DG, 2013, LARYNGOSCOPE, V123, P2502, DOI 10.1002/lary.24053; Ling CY, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab4014; Long J, 2015, LARYNGOSCOPE, V125, P406, DOI 10.1002/lary.24924; Long JL, 2010, OTOLARYNG HEAD NECK, V142, P438, DOI 10.1016/j.otohns.2009.11.020; Lorenz RR, 2014, OTOLARYNG HEAD NECK, V150, P509, DOI 10.1177/0194599813519748; Svensson B, 2011, LARYNGOSCOPE, V121, P2185, DOI 10.1002/lary.22143; Tse JR, 2015, J ACOUST SOC AM, V138, pEL60, DOI 10.1121/1.4922765; Welham NV, 2011, LARYNGOSCOPE, V121, P1252, DOI 10.1002/lary.21780	9	2	2	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					908	909		10.1126/science.aad7695	http://dx.doi.org/10.1126/science.aad7695			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW4IP	26586745	Green Accepted			2022-12-28	WOS:000364955200020
J	Smaglik, P				Smaglik, Paul			LAB TRANSITIONS The bumpy road to relocation	NATURE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					399	401		10.1038/nj7578-399a	http://dx.doi.org/10.1038/nj7578-399a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26594719				2022-12-28	WOS:000365356800065
J	Libert, T; Grande, D; Asch, DA				Libert, Timothy; Grande, David; Asch, David A.			What web browsing reveals about your health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Advertisers can learn a lot from our digital footprints, including about our health. Timothy Libert and colleagues argue that we need to tighten restrictions on such data for marketing purposes while looking at their potential to improve health	[Libert, Timothy] Univ Penn, Annenberg Sch Commun, Philadelphia, PA 19104 USA; [Grande, David; Asch, David A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Asch, David A.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Asch, David A.] Philadelphia VA Med Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Asch, DA (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.	asch@wharton.upenn.edu	Grande, David/AAJ-8191-2021	Grande, David/0000-0002-6717-6735; Asch, David/0000-0002-7970-286X				Grande D, 2014, ANN INTERN MED, V161, P855, DOI 10.7326/M14-1118; Hoofnagle C, 2012, AMST PRIV C; Libert T, 2015, COMMUN ACM, V58, P68, DOI 10.1145/2658983; Patel MS, 2015, JAMA-J AM MED ASSOC, V313, P459, DOI 10.1001/jama.2014.14781; Roesner F, 2012, P 9 USENIX C NETW SY, P12; Turow J., 2013, THE DAILY YOU	6	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 16	2015	351								h5974	10.1136/bmj.h5974	http://dx.doi.org/10.1136/bmj.h5974			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XU	26572794				2022-12-28	WOS:000365352300004
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Disrespecting confidentiality isn't the answer to FGM	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Bewley S, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5146; Darzi A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3853	2	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 12	2015	351								h5830	10.1136/bmj.h5830	http://dx.doi.org/10.1136/bmj.h5830			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW4GE	26563364	Bronze			2022-12-28	WOS:000364948600004
J	Armstrong, MJ; Gaunt, P; Aithal, GP; Barton, D; Hull, D; Parker, R; Hazlehurst, JM; Guo, K; Abouda, G; Aldersley, MA; Stocken, D; Gough, SC; Tomlinson, JW; Brown, RM; Hubscher, SG; Newsome, PN				Armstrong, Matthew James; Gaunt, Piers; Aithal, Guruprasad P.; Barton, Darren; Hull, Diana; Parker, Richard; Hazlehurst, Jonathan M.; Guo, Kathy; Abouda, George; Aldersley, Mark A.; Stocken, Deborah; Gough, Stephen C.; Tomlinson, Jeremy W.; Brown, Rachel M.; Huebscher, Stefan G.; Newsome, Philip N.		LEAN Trial Team	Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study	LANCET			English	Article							GLUCAGON-LIKE PEPTIDE-1; HEPATIC STEATOSIS; EXENATIDE TREATMENT; RECEPTOR; METAANALYSIS; GLP-1; PIOGLITAZONE; FIBROSIS; OUTCOMES	Background Glucagon-like peptide-1 (GLP-1) analogues reduce hepatic steatosis, concentrations of liver enzymes, and insulin resistance in murine models of fatty liver disease. These analogues are licensed for type 2 diabetes, but their efficacy in patients with non-alcoholic steatohepatitis is unknown. We assessed the safety and efficacy of the longacting GLP-1 analogue, liraglutide, in patients with non-alcoholic steatohepatitis. Methods This multicentre, double-blinded, randomised, placebo-controlled phase 2 trial was conducted in four UK medical centres to assess subcutaneous injections of liraglutide (1.8 mg daily) compared with placebo for patients who are overweight and show clinical evidence of non-alcoholic steatohepatitis. Patients were randomly assigned (1: 1) using a computer-generated, centrally administered procedure, stratified by trial centre and diabetes status. The trial was designed using A'Hern's single-group method, which required eight (38%) of 21 successes in the liraglutide group for the effect of liraglutide to be considered clinically significant. Patients, investigators, clinical trial site staff, and pathologists were masked to treatment assignment throughout the study. The primary outcome measure was resolution of definite non-alcoholic steatohepatitis with no worsening in fibrosis from baseline to end of treatment (48 weeks), as assessed centrally by two independent pathologists. Analysis was done by intention-to-treat analysis, which included all patients who underwent end-of-treatment biopsy. The trial was registered with ClinicalTrials.gov, number NCT01237119. Findings Between Aug 1, 2010, and May 31, 2013, 26 patients were randomly assigned to receive liraglutide and 26 to placebo. Nine (39%) of 23 patients who received liraglutide and underwent end-of-treatment liver biopsy had resolution of definite non-alcoholic steatohepatitis compared with two (9%) of 22 such patients in the placebo group (relative risk 4.3 [95% CI 1.0-17.7]; p= 0.019). Two (9%) of 23 patients in the liraglutide group versus eight (36%) of 22 patients in the placebo group had progression of fibrosis (0.2 [0.1-1.0]; p= 0.04). Most adverse events were grade 1 (mild) to grade 2 (moderate) in severity, transient, and similar in the two treatment groups for all organ classes and symptoms, with the exception of gastrointestinal disorders in 21 (81%) of 23 patients in the liraglutide group and 17 (65%) of 22 patients in the placebo group, which included diarrhoea (ten [38%] patients in the liraglutide group vs five [19%] in the placebo group), constipation (seven [27%] vs none), and loss of appetite (eight [31%] vs two [8%]). Interpretation Liraglutide was safe, well tolerated, and led to histological resolution of non-alcoholic steatohepatitis, warranting extensive, longer-term studies.	[Armstrong, Matthew James; Barton, Darren; Hull, Diana; Parker, Richard; Guo, Kathy; Newsome, Philip N.] Univ Birmingham, NIHR, Birmingham Liver Biomed Res Unit, Birmingham, W Midlands, England; [Armstrong, Matthew James; Barton, Darren; Hull, Diana; Parker, Richard; Guo, Kathy; Newsome, Philip N.] Univ Birmingham, Liver Res Ctr, Birmingham B15 2TH, W Midlands, England; [Armstrong, Matthew James; Parker, Richard; Newsome, Philip N.] Queen Elizabeth Hosp, Liver & Hepatobiliary Unit, Birmingham, W Midlands, England; [Gaunt, Piers; Barton, Darren; Hull, Diana; Guo, Kathy] Univ Birmingham, NIHR Birmingham Liver Biomed Res Unit, Clin Trial Grp EDD, CRUK Clin Trials Unit, Birmingham B15 2TH, W Midlands, England; [Aithal, Guruprasad P.] Nottingham Univ Hosp NHS Trust, NIHR Nottingham Digest Dis Biomed Res Unit, Nottingham, England; [Aithal, Guruprasad P.] Univ Nottingham, Nottingham NG7 2RD, England; [Hazlehurst, Jonathan M.; Gough, Stephen C.; Tomlinson, Jeremy W.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Hazlehurst, Jonathan M.; Gough, Stephen C.; Tomlinson, Jeremy W.] Univ Oxford, Churchill Hosp, NIHR Oxford Biomed Res Ctr, Oxford, England; [Abouda, George] Hull Royal Infirm, Dept Gastroenterol & Hepatol, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Aldersley, Mark A.] St James Univ Hosp, Liver Unit, Leeds, W Yorkshire, England; [Stocken, Deborah] Newcastle Univ, Newcastle Clin Trial Unit, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Barton, Darren; Huebscher, Stefan G.] Queen Elizabeth Hosp, Dept Cellular Pathol, Birmingham B15 2TH, W Midlands, England; [Huebscher, Stefan G.] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TH, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; Nottingham University Hospital NHS Trust; University of Nottingham; University of Oxford; University of Oxford; University of Hull; Saint James's University Hospital; Newcastle University - UK; University of Birmingham; University of Birmingham	Newsome, PN (corresponding author), Univ Birmingham, NIHR, Birmingham Liver Biomed Res Unit, Birmingham, W Midlands, England.; Newsome, PN (corresponding author), Univ Birmingham, Liver Res Ctr, Birmingham B15 2TH, W Midlands, England.	p.n.newsome@bham.ac.uk	Newsome, Philip N/D-4495-2018; Parker, Richard/AFK-1737-2022; Aldersley, Mark/AGG-5271-2022	Newsome, Philip N/0000-0001-6085-3652; Parker, Richard/0000-0003-4888-8670; Aithal, Guruprasad/0000-0003-3924-4830; Armstrong, Matthew/0000-0002-3425-1161; Tomlinson, Jeremy/0000-0002-3170-8533; Stocken, Deborah/0000-0001-8031-1738; Barton, Darren/0000-0003-0106-5861	Wellcome Trust [089780/Z/09/Z]; National Institute of Health Research; Novo Nordisk; National Institute of Health Research (NIHR) Birmingham Liver Biomedical Research Unit (BRU); MRC [MR/L022699/1] Funding Source: UKRI; Medical Research Council [G0802765, MR/L022699/1] Funding Source: researchfish; National Institute for Health Research [ACF-2011-09-006] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Health Research(National Institute for Health Research (NIHR)); Novo Nordisk(Novo Nordisk); National Institute of Health Research (NIHR) Birmingham Liver Biomedical Research Unit (BRU); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Wellcome Trust, National Institute of Health Research, and Novo Nordisk.r The LEAN trial represents independent academic research funded by the Wellcome Trust (clinical research training fellowship ref. 089780/Z/09/Z, awarded to MJA), Novo Nordisk (educational grant awarded to PNN, free supply of trial drugs), and the National Institute of Health Research (NIHR) Birmingham Liver Biomedical Research Unit (BRU). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. The clinical study was carried out at the NIHR/Wellcome Trust Birmingham Clinical Research Facility. We thank the patients enrolled in the trial and the Data Management Committee (DMC), consisting of Peter Hayes (DMC Chair; Independent Liver Expert), Sarah Brown (Independent Senior Statistician), and Jude Oben (Independent Liver Expert), for their time and input.	Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Armstrong MJ, 2013, ALIMENT PHARM THER, V37, P234, DOI 10.1111/apt.12149; Armstrong MJ, 2014, HEPATOLOGY, V59, P1174, DOI 10.1002/hep.26717; Armstrong MJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003995; Astrup A, 2009, LANCET, V374, P1606, DOI 10.1016/S0140-6736(09)61375-1; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Ben-Shlomo S, 2011, J HEPATOL, V54, P1214, DOI 10.1016/j.jhep.2010.09.032; Buse JB, 2007, CLIN THER, V29, P139, DOI 10.1016/j.clinthera.2007.01.015; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Ellrichmann M, 2009, AM J GASTROENTEROL, V104, P3112, DOI 10.1038/ajg.2009.444; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; Henry RR, 2011, ENDOCR PRACT, V17, P906, DOI 10.4158/EP.17.6.906; Kenny PR, 2010, AM J GASTROENTEROL, V105, P2707, DOI 10.1038/ajg.2010.363; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Knudsen LB, 2000, J MED CHEM, V43, P1664, DOI 10.1021/jm9909645; Lee JW, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-7; Mells JE, 2012, AM J PHYSIOL-GASTR L, V302, pG225, DOI 10.1152/ajpgi.00274.2011; Musso G, 2010, HEPATOLOGY, V52, P79, DOI 10.1002/hep.23623; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Ratziu V, 2013, NAT REV GASTRO HEPAT, V10, P676, DOI 10.1038/nrgastro.2013.193; Sanyal Arun J, 2011, Hepatology, V54, P344, DOI 10.1002/hep.24376; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Sharma S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025269; Svegliati-Baroni G, 2011, LIVER INT, V31, P1285, DOI 10.1111/j.1478-3231.2011.02462.x; Trevaskis JL, 2012, AM J PHYSIOL-GASTR L, V302, pG762, DOI 10.1152/ajpgi.00476.2011; Tushuizen ME, 2006, LIVER INT, V26, P1015, DOI 10.1111/j.1478-3231.2006.01315.x; Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268	31	972	1018	9	99	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2016	387	10019					679	690		10.1016/S0140-6736(15)00803-X	http://dx.doi.org/10.1016/S0140-6736(15)00803-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3QH	26608256	Green Submitted			2022-12-28	WOS:000369837100027
J	Kohli, A; Kattakuzhy, S; Sidharthan, S; Nelson, A; McLaughlin, M; Seamon, C; Wilson, E; Meissner, EG; Sims, Z; Silk, R; Gross, C; Akoth, E; Tang, L; Price, A; Jolley, TA; Emmanuel, B; Proschan, M; Teferi, G; Chavez, J; Abbott, S; Osinusi, A; Mo, HM; Polis, MA; Masur, H; Kottilil, S				Kohli, Anita; Kattakuzhy, Sarah; Sidharthan, Sreetha; Nelson, Amy; McLaughlin, Mary; Seamon, Cassie; Wilson, Eleanor; Meissner, Eric G.; Sims, Zayani; Silk, Rachel; Gross, Chloe; Akoth, Elizabeth; Tang, Lydia; Price, Angie; Jolley, Tim A.; Emmanuel, Benjamin; Proschan, Michael; Teferi, Gebeyehu; Chavez, Jose; Abbott, Stephen; Osinusi, Anuoluwapo; Mo, Hongmei; Polis, Michael A.; Masur, Henry; Kottilil, Shyam			Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; VIROLOGICAL RESPONSE; SOFOSBUVIR; HCV; LEDIPASVIR; RIBAVIRIN	Background: Treatment of chronic hepatitis C virus (HCV) infection with direct-acting antivirals (DAAs) for 6 weeks achieves sustained virologic response (SVR) rates of 95% in some patients. If effective, shorter therapeutic courses could improve adherence and treatment costs. Objective: To determine factors predictive of SVR to 4 weeks of DAA treatment in patients with stage F0 to F2 liver fibrosis. Design: Open-label, nonrandomized, phase 2a trial. (Clinical Trials. gov: NCT01805882) Setting: Single-center. Patients: 50 treatment-naive and predominantly African American patients with HCV genotype 1 infection and early-stage liver fibrosis were sequentially enrolled into 2 treatment groups. Intervention: 25 participants received a 3-drug regimen consisting of ledipasvir and sofosbuvir plus GS-9451 for 4 weeks, and 25 received a 4-drug regimen consisting of ledipasvir, sofosbuvir, GS-9451, and GS-9669 for 4 weeks. Measurements: The primary efficacy end point was SVR12 (HCV RNA level below the lower limit of quantification at post-treatment week 12). Results: Forty percent (10 of 25) (95% CI, 21% to 61%) of patients in the 3-drug group and 20% (5 of 25) (CI, 7% to 41%) of those in the 4-drug group achieved SVR12. Exploratory analysis suggested that lower baseline HCV viral load, younger age, and HCV genotype 1b were associated with SVR12. Ten patients had baseline HCV variants conferring greater than 20-fold resistance in vitro to at least 1 study DAA; all had viral relapse. Forty-eight percent (12 of 25) of patients receiving the 3-drug regimen and 72% (18 of 25) of those receiving the 4-drug regimen had adverse events, most of which were mild. One participant was lost to follow-up. Limitation: Nonrandomized study design and small sample of patients with early-stage fibrosis. Conclusion: Combination DAA therapy with 3 or 4 drugs for 4 weeks was well-tolerated but resulted in limited cure rates.	[Kohli, Anita; Sims, Zayani; Masur, Henry] Natl Inst Hlth Clin Ctr, Dept Crit Care Med, Bldg 10,Room 2c145,10 Ctr Dr, Bethesda, MD 20814 USA; [Kattakuzhy, Sarah; Silk, Rachel; Gross, Chloe; Akoth, Elizabeth] Univ Maryland, Inst Human Virol, 5415 Cedar Lane, Baltimore, MD 21201 USA; [Sidharthan, Sreetha; Nelson, Amy; Tang, Lydia; Price, Angie; Emmanuel, Benjamin; Kottilil, Shyam] Univ Maryland, Inst Human Virol, Div Clin Care & Res, 725 West Lombard St, Baltimore, MD 21201 USA; [McLaughlin, Mary; Seamon, Cassie; Wilson, Eleanor] NIAID, NIH, Immunoregulat Lab, Bldg 10,Room 8c434,10 Ctr Dr, Bethesda, MD 20814 USA; [Meissner, Eric G.] Med Univ South Carolina, Dept Infect Dis, 135 Rutledge Ave,MSC752, Charleston, SC 29425 USA; [Jolley, Tim A.] NIAID, Natl Inst Hlth, Immunoregulat Lab, Bldg 10,Room 8c311,10 Ctr Dr, Bethesda, MD 20814 USA; [Proschan, Michael] NIAID, Natl Inst Hlth, Biostat Res Branch, 6700A Rockledge Dr,Room 5140, Bethesda, MD 20892 USA; [Teferi, Gebeyehu; Abbott, Stephen] Unity Hlth Care, 40 Patterson St NE, Washington, DC 20002 USA; [Chavez, Jose] Unity Hlth Care, 3020 14th St NW, Washington, DC 20009 USA; [Osinusi, Anuoluwapo; Mo, Hongmei] Gilead Sci Inc, 333 Lakeside Blvd, Foster City, CA 94404 USA; [Polis, Michael A.] NIAID, Collaborat Clin Res Branch, Div Clin Res, NIH, Bldg 5601fl,Room 4d40,5601 Fishers Lane, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Gilead Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kottilil, S (corresponding author), Univ Maryland, Div Clin Care & Res, Inst Human Virol, Room S222,725 West Lombard St, Baltimore, MD 21201 USA.	SKottilil@ihv.umaryland.edu	Kottilil, Shyam/ABF-7605-2021	Wilson, Eleanor/0000-0002-4855-514X; Nelson, Amy/0000-0001-9028-1894	National Institute of Allergy and Infectious Diseases; National Cancer Institute; Clinical Center Intramural Program; National Institutes of Health; Gilead Sciences; CLINICAL CENTER [ZIACL009010] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Clinical Center Intramural Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gilead Sciences(Gilead Sciences); CLINICAL CENTER	National Institute of Allergy and Infectious Diseases, National Cancer Institute, and Clinical Center Intramural Program; supported in part by a cooperative research and development agreement between the National Institutes of Health and Gilead Sciences.	Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Fried MW, 2011, J HEPATOL, V55, P69, DOI 10.1016/j.jhep.2010.10.032; Gane EJ, 2014, GASTROENTEROLOGY, V146, P736, DOI 10.1053/j.gastro.2013.11.007; Gilead Sciences, 2014, HARV US PRESCR INF; Kohli A, 2015, LANCET, V385, P1107, DOI 10.1016/S0140-6736(14)61228-9; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lawitz E, 2014, 65 ANN M AM ASS STUD; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; National Institute of Allergy and Infectious Diseases, 2004, DIV AIDS TABL GRAD S; Osinusi A, 2013, JAMA-J AM MED ASSOC, V310, P804, DOI 10.1001/jama.2013.109309; Petersen T, 2014, 21 C RETR OPP INF BO; Pollack A, 2014, NY TIMES, pB2; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Sims Z, 2014, HIV LIV DIS 2014 MOR; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145	18	48	48	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2015	163	12					899	+		10.7326/M15-0642	http://dx.doi.org/10.7326/M15-0642			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY4BS	26595450				2022-12-28	WOS:000366354200015
J	Feng, YQ; van der Veeken, J; Shugay, M; Putintseva, EV; Osmanbeyoglu, HU; Dikiy, S; Hoyos, BE; Moltedo, B; Hemmers, S; Treuting, P; Leslie, CS; Chudakov, DM; Rudensky, AY				Feng, Yongqiang; van der Veeken, Joris; Shugay, Mikhail; Putintseva, Ekaterina V.; Osmanbeyoglu, Hatice U.; Dikiy, Stanislav; Hoyos, Beatrice E.; Moltedo, Bruno; Hemmers, Saskia; Treuting, Piper; Leslie, Christina S.; Chudakov, Dmitriy M.; Rudensky, Alexander Y.			A mechanism for expansion of regulatory T-cell repertoire and its role in self-tolerance	NATURE			English	Article							NEGATIVE SELECTION; IMMUNE REPERTOIRES; THYMIC SELECTION; ANTIGEN; INDUCTION; RESPONSES; FOXP3; ENCEPHALOMYELITIS; DIFFERENTIATION; RECOGNITION	T-cell receptor (TCR) signalling has a key role in determining T-cell fate. Precursor cells expressing TCRs within a certain low-affinity range for complexes of self-peptide and major histocompatibility complex (MHC) undergo positive selection and differentiate into naive T cells expressing a highly diverse self-MHC-restricted TCR repertoire. In contrast, precursors displaying TCRs with a high affinity for 'self' are either eliminated through TCR-agonist-induced apoptosis (negative selection)(1) or restrained by regulatory T (T-reg) cells, whose differentiation and function are controlled by the X-chromosome-encoded transcription factor Foxp3 (reviewed in ref. 2). Foxp3 is expressed in a fraction of self-reactive T cells that escape negative selection in response to agonist-driven TCR signals combined with interleukin 2 (IL-2) receptor signalling. In addition to Treg cells, TCR-agonist-driven selection results in the generation of several other specialized T-cell lineages such as natural killer T cells and innate mucosal-associated invariant T cells(3). Although the latter exhibit a restricted TCR repertoire, Treg cells display a highly diverse collection of TCRs(4-6). Here we explore in mice whether a specialized mechanism enables agonist-driven selection of T-reg cells with a diverse TCR repertoire, and the importance this holds for self-tolerance. We show that the intronic Foxp3 enhancer conserved noncoding sequence 3 (CNS3) acts as an epigenetic switch that confers a poised state to the Foxp3 promoter in precursor cells to make T-reg cell lineage commitment responsive to a broad range of TCR stimuli, particularly to suboptimal ones. CNS3-dependent expansion of the TCR repertoire enables T-reg cells to control self-reactive T cells effectively, especially when thymic negative selection is genetically impaired. Our findings highlight the complementary roles of these two main mechanisms of self-tolerance.	[Feng, Yongqiang; van der Veeken, Joris; Dikiy, Stanislav; Hoyos, Beatrice E.; Moltedo, Bruno; Hemmers, Saskia; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Feng, Yongqiang; van der Veeken, Joris; Dikiy, Stanislav; Hoyos, Beatrice E.; Moltedo, Bruno; Hemmers, Saskia; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, Ludwig Ctr, New York, NY 10065 USA; [Shugay, Mikhail; Putintseva, Ekaterina V.; Chudakov, Dmitriy M.] Shemyakin Ovchinnikov Inst Bioorgan Chem RAS, Moscow 117997, Russia; [Shugay, Mikhail; Chudakov, Dmitriy M.] Pirogov Russian Natl Res Med Univ, Moscow 117997, Russia; [Shugay, Mikhail; Putintseva, Ekaterina V.; Chudakov, Dmitriy M.] Masaryk Univ, Cent European Inst Technol, Brno 62500, Czech Republic; [Osmanbeyoglu, Hatice U.; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA; [Treuting, Piper] Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Pirogov Russian National Research Medical University; Masaryk University Brno; Memorial Sloan Kettering Cancer Center; University of Washington; University of Washington Seattle	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA.	rudenska@mskcc.org	Treuting, Piper M./AAB-2721-2019; Dikiy, Stanislav/GWR-2104-2022; Chudakov, Dmitriy M/G-7741-2014; Feng, Yongqiang/N-2731-2018; Shugay, Mikhail/O-1073-2016; Dikiy, Stanislav/HIR-5027-2022; Osmanbeyoglu, Hatice Ulku/Q-1822-2019; Feng, Yongqiang/AAR-7719-2021; Putintseva, Ekaterina/M-6818-2015	Treuting, Piper M./0000-0002-1812-1519; Chudakov, Dmitriy M/0000-0003-0430-790X; Feng, Yongqiang/0000-0002-2320-5063; Shugay, Mikhail/0000-0001-7826-7942; Feng, Yongqiang/0000-0002-2320-5063; Dikiy, Stanislav/0000-0002-8287-6561; Putintseva, Ekaterina/0000-0003-4421-3844; van der Veeken, Joris/0000-0001-7299-2174; Osmanbeyoglu, Hatice/0000-0002-3175-1777	Cancer Research Institute; NIH [R37 AI034206, U01 HG007893]; Cancer Center Support Grant [P30 CA008748]; Howard Hughes Medical Institute; MCB program RAS; RFBR [14-04-01247, 15-34-21052]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206, R01AI034206] Funding Source: NIH RePORTER	Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; Howard Hughes Medical Institute(Howard Hughes Medical Institute); MCB program RAS; RFBR(Russian Foundation for Basic Research (RFBR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Bos, A. Arvey, C. Konopacki, G. Gasteiger, S. Lee, T. Chinen and K. Wu for technical assistance, CKP IBCH for equipment, and R. Prinjha for providing iBET. Y.F. was supported by a Postdoctoral Fellowship of the Cancer Research Institute. This study was supported by NIH grants R37 AI034206 and U01 HG007893, Cancer Center Support Grant P30 CA008748, and the Howard Hughes Medical Institute (A.Y.R.). M.S., E.V.P. and D.M.C. were supported by MCB program RAS and RFBR grants 14-04-01247 and 15-34-21052.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Britanova OV, 2014, J IMMUNOL, V192, P2689, DOI 10.4049/jimmunol.1302064; Chandra S, 2015, ADV IMMUNOL, V127, P145, DOI 10.1016/bs.ai.2015.03.003; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Davie J. R., 2003, J NUTR, V133, p2485S; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Egorov ES, 2015, J IMMUNOL, V194, P6155, DOI 10.4049/jimmunol.1500215; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Giraud M, 2012, P NATL ACAD SCI USA, V109, P535, DOI 10.1073/pnas.1119351109; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; JANEWAY CA, 1984, J IMMUNOL, V132, P662; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Kosmrlj A, 2008, P NATL ACAD SCI USA, V105, P16671, DOI 10.1073/pnas.0808081105; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Lee HM, 2012, IMMUNITY, V37, P475, DOI 10.1016/j.immuni.2012.07.009; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Seddon B, 2000, SCIENCE, V290, P127, DOI 10.1126/science.290.5489.127; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shugay M., PLOS COMPUT BIOL; Shugay M, 2014, NAT METHODS, V11, P653, DOI [10.1038/NMETH.2960, 10.1038/nmeth.2960]; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017; Yates AJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00013; Zhen QL, 2005, J CLIN INVEST, V115, P3428, DOI 10.1172/JCI23587; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	42	104	110	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					132	+		10.1038/nature16141	http://dx.doi.org/10.1038/nature16141			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26605529	Green Accepted			2022-12-28	WOS:000365606000063
J	Cejas, DM				Cejas, Diana M.			Every Little Anniversary	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Cejas, Diana M.] Univ Chicago, Dept Pediat, Sect Pediat Neurol, Chicago, IL 60637 USA	University of Chicago	Cejas, DM (corresponding author), Univ Chicago, Dept Pediat, Sect Pediat Neurol, Chicago, IL 60637 USA.	diana.cejas@uchospitals.edu	Cejas, Diana/GQZ-5527-2022; Cejas, Diana/GQZ-5486-2022	Cejas, Diana/0000-0003-0936-5148					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2015	314	21					2237	2237		10.1001/jama.2015.12385	http://dx.doi.org/10.1001/jama.2015.12385			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX2GT	26624822				2022-12-28	WOS:000365515700014
J	Cole, TB				Cole, Thomas B.			Boy and the Candle	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2015	314	21					2218	2219		10.1001/jama.2014.12119	http://dx.doi.org/10.1001/jama.2014.12119			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX2GT	26624812				2022-12-28	WOS:000365515700001
J	Tran, C; Wilder, E; Griffin, JR				Tran, Connie; Wilder, Elizabeth; Griffin, John R.			Stomatitis, Cutaneous Bullae, and Renal Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PEMPHIGUS-VULGARIS; PREDNISONE		[Tran, Connie] Baylor Scott & White Hlth, Dallas, TX 75246 USA; [Tran, Connie] Texas A&M Coll Med, College Stn, TX USA; [Wilder, Elizabeth; Griffin, John R.] Baylor Scott & White Hlth, Dept Dermatol, Dallas, TX 75246 USA	Baylor Health Care System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor Health Care System	Griffin, JR (corresponding author), Baylor Scott & White Hlth, Dept Dermatol, 3900 Junius St,Ste 145, Dallas, TX 75246 USA.	johnrgriffin@gmail.com						AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Atzmony L, 2014, AM J CLIN DERMATOL, V15, P503, DOI 10.1007/s40257-014-0101-9; Beissert S, 2010, J INVEST DERMATOL, V130, P2041, DOI 10.1038/jid.2010.91; Bystryn JC, 2005, LANCET, V366, P61, DOI 10.1016/S0140-6736(05)66829-8; Chaidemenos G, 2011, J EUR ACAD DERMATOL, V25, P206, DOI 10.1111/j.1468-3083.2010.03753.x; Colliou N, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005166; Harman KE, 2003, BRIT J DERMATOL, V149, P926, DOI 10.1111/j.1365-2133.2003.05665.x; Yepes JF, 2012, JAMA-J AM MED ASSOC, V307, P2430, DOI 10.1001/jama.2012.4307; Zhao CY, 2015, DRUGS, V75, P271, DOI 10.1007/s40265-015-0353-6	9	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2015	314	21					2296	2297		10.1001/jama.2015.10735	http://dx.doi.org/10.1001/jama.2015.10735			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX2GT	26624829				2022-12-28	WOS:000365515700022
J	Zheng, XF; Carstens, JL; Kim, J; Scheible, M; Kaye, J; Sugimoto, H; Wu, CC; LeBleu, VS; Kalluri, R				Zheng, Xiaofeng; Carstens, Julienne L.; Kim, Jiha; Scheible, Matthew; Kaye, Judith; Sugimoto, Hikaru; Wu, Chia-Chin; LeBleu, Valerie S.; Kalluri, Raghu			Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer	NATURE			English	Article							DUCTAL ADENOCARCINOMA; GENE-EXPRESSION; CELLS; SNAIL; EMT; TUMORS; BETA; PROLIFERATION; REPRESSION; RESISTANCE	Diagnosis of pancreatic ductal adenocarcinoma (PDAC) is associated with a dismal prognosis despite current best therapies; therefore new treatment strategies are urgently required. Numerous studies have suggested that epithelial-to-mesenchymal transition (EMT) contributes to early-stage dissemination of cancer cells and is pivotal for invasion and metastasis of PDAC(1-4). EMT is associated with phenotypic conversion of epithelial cells into mesenchymal-like cells in cell culture conditions, although such defined mesenchymal conversion (with spindle-shaped morphology) of epithelial cells in vivo is rare, with quasi-mesenchymal phenotypes occasionally observed in the tumour (partial EMT)(5,6). Most studies exploring the functional role of EMT in tumours have depended on cell-culture-induced loss-of-function and gain-of-function experiments involving EMT-inducing transcription factors such as Twist, Snail and Zeb1 (refs 2,3,7-10). Therefore, the functional contribution of EMT to invasion and metastasis remains unclear(4,6), and genetically engineered mouse models to address a causal connection are lacking. Here we functionally probe the role of EMT in PDAC by generating mouse models of PDAC with deletion of Snail or Twist, two key transcription factors responsible for EMT. EMT suppression in the primary tumour does not alter the emergence of invasive PDAC, systemic dissemination or metastasis. Suppression of EMT leads to an increase in cancer cell proliferation with enhanced expression of nucleoside transporters in tumours, contributing to enhanced sensitivity to gemcitabine treatment and increased overall survival of mice. Collectively, our study suggests that Snail- or Twist-induced EMT is not rate-limiting for invasion and metastasis, but highlights the importance of combining EMT inhibition with chemotherapy for the treatment of pancreatic cancer.	[Zheng, Xiaofeng; Carstens, Julienne L.; Kim, Jiha; Scheible, Matthew; Kaye, Judith; Sugimoto, Hikaru; LeBleu, Valerie S.; Kalluri, Raghu] Univ Texas MD Anderson Canc Ctr, Metastasis Res Ctr, Dept Canc Biol, Houston, TX 77054 USA; [Wu, Chia-Chin] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77054 USA; [Kalluri, Raghu] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Kalluri, Raghu] Rice Univ, Dept Bioengn, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Rice University	Kalluri, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Metastasis Res Ctr, Dept Canc Biol, Houston, TX 77054 USA.	rkalluri@mdanderson.org	Wu, Chia-Chin/ABD-5516-2021; Kalluri, Raghu/E-2677-2015	Wu, Chia-Chin/0000-0002-5208-6016; Scheible, Matthew/0000-0001-5783-3968; Kalluri, Raghu/0000-0002-2190-547X; Carstens, Julienne/0000-0001-9914-0430	NCI [P30CA16672]; Cancer Prevention and Research Institute of Texas; UT MDACC Khalifa Bin Zayed Al Nahya Foundation; NATIONAL CANCER INSTITUTE [U54CA163191, U01CA151925, R01CA155370, P30CA016672, R01CA125550] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention and Research Institute of Texas; UT MDACC Khalifa Bin Zayed Al Nahya Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We wish to thank D. Lundy, S. Yang, Z. Xiao, R. Deliz-Aguirre, T. Miyake and S. Lovisa for technical support and K. M. Ramirez and R. Jewell in the South Campus Flow Cytometry Core Laboratory of MD Anderson Cancer Center for flow cytometry cell sorting and analyses (partly supported by NCI grant no. P30CA16672). We also wish to thank E. Chang for scanning slides of histopathological specimens. This study was primarily supported by the Cancer Prevention and Research Institute of Texas. The research in the LeBleu laboratory is supported by UT MDACC Khalifa Bin Zayed Al Nahya Foundation.	Alagesan B, 2015, CLIN CANCER RES, V21, P396, DOI 10.1158/1078-0432.CCR-14-1591; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Cursons J, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0106-x; Gore AJ, 2014, J CLIN INVEST, V124, P338, DOI 10.1172/JCI71526; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Hugo HJ, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3580; Ijichi H, 2006, GENE DEV, V20, P3147, DOI 10.1101/gad.1475506; Javle MM, 2007, ANN SURG ONCOL, V14, P3527, DOI 10.1245/s10434-007-9540-3; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Keskin D, 2015, CELL REP, V10, P1066, DOI 10.1016/j.celrep.2015.01.035; Kleger A, 2014, ANN ONCOL, V25, P1260, DOI 10.1093/annonc/mdu013; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Masugi Y, 2010, HUM PATHOL, V41, P1061, DOI 10.1016/j.humpath.2010.01.016; McDonald OG, 2012, ADV ANAT PATHOL, V19, P351, DOI 10.1097/PAP.0b013e318273f998; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Muraoka-Cook RS, 2005, CLIN CANCER RES, V11, p937S; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Offield MF, 1996, DEVELOPMENT, V122, P983; Park JY, 2011, APPL IMMUNOHISTO M M, V19, P444, DOI 10.1097/PAI.0b013e318206d958; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stockinger A, 2001, J CELL BIOL, V154, P1185, DOI 10.1083/jcb.200104036; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Wang ZW, 2013, J CELL PHYSIOL, V228, P556, DOI 10.1002/jcp.24162; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yin T, 2007, J SURG RES, V141, P196, DOI 10.1016/j.jss.2006.09.027; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhang KJ, 2010, INT J MOL SCI, V11, P4891, DOI 10.3390/ijms11124891	37	1378	1417	6	395	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					525	+		10.1038/nature16064	http://dx.doi.org/10.1038/nature16064			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26560028	Green Accepted			2022-12-28	WOS:000365352500050
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Why less confidence may be a good thing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Gregory A, 2015, MIRROR          1019; Knapton S, 2015, TELEGRAPH; National Institute for Health and Care Excellence, 2015, MEN DIAGN MAN NICE G	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2015	351								h6321	10.1136/bmj.h6321	http://dx.doi.org/10.1136/bmj.h6321			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX4TG	26607839	Bronze			2022-12-28	WOS:000365692600013
J	Cates, C; Karner, C				Cates, Christopher; Karner, Charlotta			Clinical importance cannot be ruled out using mean difference alone	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED-TRIALS; OUTCOMES		[Cates, Christopher] St Georges Univ London, Populat Hlth Res Inst, London SW17 0RE, England; [Karner, Charlotta] BMJ Technol Assessment Grp, London, England	St Georges University London	Cates, C (corresponding author), St Georges Univ London, Populat Hlth Res Inst, London SW17 0RE, England.	ccates@sgul.ac.uk		Cates, Christopher/0000-0002-7056-9433	National Institute for Health Research [10/4001/01] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		GUYATT G, 1986, NEW ENGL J MED, V314, P889, DOI 10.1056/NEJM198604033141406; Guyatt GH, 1998, BRIT MED J, V316, P690, DOI 10.1136/bmj.316.7132.690; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Jones PW, 2014, AM J RESP CRIT CARE, V189, P250, DOI 10.1164/rccm.201310-1863PP; Jones PW, 2002, EUR RESPIR J, V19, P398, DOI 10.1183/09031936.02.00063702; Karner C, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009285.pub2, 10.1002/14651858.CD009285.pub3]; McGlothlin AE, 2014, JAMA-J AM MED ASSOC, V312, P1342, DOI 10.1001/jama.2014.13128; Schriger DL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8486; Senn S, 2004, BMJ-BRIT MED J, V329, P966, DOI 10.1136/bmj.329.7472.966; Senn S, 1998, BRIT MED J, V317, P537; Snapinn SM, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-31; Zivanovic S, 2014, NEW ENGL J MED, V370, P1121, DOI 10.1056/NEJMoa1309220	12	10	10	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2015	351								h5496	10.1136/bmj.h5496	http://dx.doi.org/10.1136/bmj.h5496			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9YB	26588935				2022-12-28	WOS:000365353000001
J	Narasimhan, S				Narasimhan, Sri			Matters of Size	CELL			English	Editorial Material							BODY-SIZE; EVOLUTION											Alba DM, 2015, SCIENCE, V350, DOI 10.1126/science.aab2625; Berger LR, 2015, ELIFE, V4, DOI 10.7554/eLife.09560; Dirks PHGM, 2015, ELIFE, V4, DOI 10.7554/eLife.09561; Galis F, 2007, J EXP ZOOL PART B, V308B, P119, DOI 10.1002/jez.b.21116; Guevara-Aguirre J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001845; Lloyd AC, 2013, CELL, V154, P1194, DOI 10.1016/j.cell.2013.08.053; Narasimhan SD, 2009, CURR BIOL, V19, pR657, DOI 10.1016/j.cub.2009.06.013; Roy K, 2008, SCIENCE, V321, P1451, DOI 10.1126/science.1163097; Smith FA, 2010, SCIENCE, V330, P1216, DOI 10.1126/science.1194830; Stringer C, 2014, NATURE, V514, P427, DOI 10.1038/514427a; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Van Voorhies WA, 2005, BIOL LETTERS, V1, P247, DOI 10.1098/rsbl.2004.0278	12	2	2	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1043	1045						2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26590410	Bronze			2022-12-28	WOS:000366044700001
J	Knight, SC; Xie, LQ; Deng, WL; Guglielmi, B; Witkowsky, LB; Bosanac, L; Zhang, ET; El Beheiry, M; Masson, JB; Dahan, M; Liu, Z; Doudna, JA; Tjian, R				Knight, Spencer C.; Xie, Liangqi; Deng, Wulan; Guglielmi, Benjamin; Witkowsky, Lea B.; Bosanac, Lana; Zhang, Elisa T.; El Beheiry, Mohamed; Masson, Jean-Baptiste; Dahan, Maxime; Liu, Zhe; Doudna, Jennifer A.; Tjian, Robert			Dynamics of CRISPR-Cas9 genome interrogation in living cells	SCIENCE			English	Article							RNA-GUIDED CAS9; MAMMALIAN-CELLS; TARGET DNA; ENDONUCLEASE CAS9; BINDING; MICROSCOPY; TRANSCRIPTION; SPECIFICITY; CLEAVAGE; IMMUNITY	The RNA-guided CRISPR-associated protein Cas9 is used for genome editing, transcriptional modulation, and live-cell imaging. Cas9-guide RNA complexes recognize and cleave double-stranded DNA sequences on the basis of 20-nucleotide RNA-DNA complementarity, but the mechanism of target searching in mammalian cells is unknown. Here, we use single-particle tracking to visualize diffusion and chromatin binding of Cas9 in living cells. We show that three-dimensional diffusion dominates Cas9 searching in vivo, and off-target binding events are, on average, short-lived (<1 second). Searching is dependent on the local chromatin environment, with less sampling and slower movement within heterochromatin. These results reveal how the bacterial Cas9 protein interrogates mammalian genomes and navigates eukaryotic chromatin structure.	[Knight, Spencer C.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Xie, Liangqi; Guglielmi, Benjamin; Witkowsky, Lea B.; Bosanac, Lana; Zhang, Elisa T.; Doudna, Jennifer A.; Tjian, Robert] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Deng, Wulan; Masson, Jean-Baptiste; Liu, Zhe; Tjian, Robert] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Deng, Wulan; Dahan, Maxime; Liu, Zhe; Tjian, Robert] Howard Hughes Med Inst, Janelia Res Campus, Transcript Imaging Consortium, Ashburn, VA USA; [El Beheiry, Mohamed; Dahan, Maxime] Inst Curie, CNRS, UMR 168, Lab Physicochim Curie, F-75231 Paris, France; [Doudna, Jennifer A.; Tjian, Robert] Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA; [Tjian, Robert] Univ Calif Berkeley, Li Ka Shing Biomed & Hlth Sci Ctr, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Stanford University; Li Ka Shing Center; University of California System; University of California Berkeley	Liu, Z (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	liuz11@janelia.hhmi.org; doudna@berkeley.edu; jmlim@berkeley.edu	Deng, Wulan/ABX-6870-2022	Xie, Liangqi/0000-0002-6546-9622; Dahan, Maxime/0000-0002-4943-2491; masson, jean-baptiste/0000-0002-5484-9056	Janelia Visitor Program; National Science Foundation Graduate Research Fellowship; Helen Hay Whitney Foundation; Janelia Fellow Program; National Science Foundation [MCB-1244557]; California Institute for Regenerative Medicine (CIRM) [RB4-06016]; Gordon and Betty Moore Foundation	Janelia Visitor Program; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Helen Hay Whitney Foundation; Janelia Fellow Program; National Science Foundation(National Science Foundation (NSF)); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	We thank L. Lavis for generously providing HaloTag ligands for imaging experiments: J. Macklin for expert assistance with FCS experiments; and X. Darzacq, R. Singer, J. Cate, and members of the Doudna and Tjian labs for helpful discussions and critical reading of the manuscript. S.C.K. acknowledges support from the Janelia Visitor Program, S.C.K. and E.T.Z. acknowledge support from the National Science Foundation Graduate Research Fellowship Program, W.D. acknowledges support from the Helen Hay Whitney Foundation, and Z.L. acknowledges support from the Janelia Fellow Program. Funding was provided by the National Science Foundation (MCB-1244557 to J.A.D.) and the California Institute for Regenerative Medicine (CIRM, RB4-06016 to R.T.). J.A.D. and R.T. are Investigators of the Howard Hughes Medical Institute. This work was performed in part at the University of California Berkeley Cancer Research Laboratory Molecular Imaging Center, supported by the Gordon and Betty Moore Foundation. J.A.D. is a co-founder of Caribou Biosciences, Inc., Editas Medicine and Intellia Therapeutics.	Abrahamsson S, 2013, NAT METHODS, V10, P60, DOI [10.1038/NMETH.2277, 10.1038/nmeth.2277]; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; El Beheiry M, 2015, NAT METHODS, V12, P594, DOI 10.1038/nmeth.3441; Espinoza CA, 2007, RNA, V13, P583, DOI 10.1261/rna.310307; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gebhardt JCM, 2013, NAT METHODS, V10, P421, DOI [10.1038/nmeth.2411, 10.1038/NMETH.2411]; Grimm JB, 2015, NAT METHODS, V12, P244, DOI [10.1038/NMETH.3256, 10.1038/nmeth.3256]; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jurka J, 2005, CYTOGENET GENOME RES, V110, P117, DOI 10.1159/000084943; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Liu Z, 2014, ELIFE, V3, DOI 10.7554/eLife.04236; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Mueller F, 2010, CURR OPIN CELL BIOL, V22, P403, DOI 10.1016/j.ceb.2010.03.002; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Normanno D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8357; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Terns RM, 2014, TRENDS GENET, V30, P111, DOI 10.1016/j.tig.2014.01.003; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889	28	228	233	7	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					823	826		10.1126/science.aac6572	http://dx.doi.org/10.1126/science.aac6572			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW3MS	26564855				2022-12-28	WOS:000364897000047
J	Brown, R; Vyas, S				Brown, Rachel; Vyas, Sanjay			10 MINUTE CONSULTATION Pelvic pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT		[Brown, Rachel] Montpelier Hlth Ctr, Bristol BS6 5PT, Avon, England; [Vyas, Sanjay] Southmead Hosp, Bristol BS10 5NB, Avon, England	Southmead Hospital	Brown, R (corresponding author), Montpelier Hlth Ctr, Bristol BS6 5PT, Avon, England.	Rachel.Brown@gp-l81012.nhs.uk						Dunselman GAJ, 2014, HUM REPROD, V29, P400, DOI 10.1093/humrep/det457; NICE, 2015, SUSP CANC REC REF NI; NICE Clinical Knowledge Summaries, 2014, ENDOMETRIOSIS; Proctor M, 2006, BMJ-BRIT MED J, V332, P1134, DOI 10.1136/bmj.332.7550.1134; Vyas S, 2015, OBSTET GYNAECOL REPR, V25, P133, DOI DOI 10.1016/J.OGRM.2015.02.001; Washington Coalition of Sexual Assault Programs, SCREEN QUEST	6	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 12	2015	351								h5637	10.1136/bmj.h5637	http://dx.doi.org/10.1136/bmj.h5637			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW4GE	26563352				2022-12-28	WOS:000364948600001
J	Okubo, TS; Mackevicius, EL; Payne, HL; Lynch, GF; Fee, MS				Okubo, Tatsuo S.; Mackevicius, Emily L.; Payne, Hannah L.; Lynch, Galen F.; Fee, Michale S.			Growth and splitting of neural sequences in songbird vocal development	NATURE			English	Article							ZEBRA FINCH; BASAL-GANGLIA; DEPENDENT PLASTICITY; FOREBRAIN CIRCUIT; YOUNG SONGBIRDS; NETWORK MODEL; BIRDSONG; DYNAMICS; GENERATION; NEURONS	Neural sequences are a fundamental feature of brain dynamics underlying diverse behaviours, but the mechanisms by which they develop during learning remain unknown. Songbirds learn vocalizations composed of syllables; in adult birds, each syllable is produced by a different sequence of action potential bursts in the premotor cortical area HVC. Here we carried out recordings of large populations of HVC neurons in singing juvenile birds throughout learning to examine the emergence of neural sequences. Early in vocal development, HVC neurons begin producing rhythmic bursts, temporally locked to a 'prototype' syllable. Different neurons are active at different latencies relative to syllable onset to form a continuous sequence. Through development, as new syllables emerge from the prototype syllable, initially highly overlapping burst sequences become increasingly distinct. We propose a mechanistic model in which multiple neural sequences can emerge from the growth and splitting of a common precursor sequence.	[Okubo, Tatsuo S.; Mackevicius, Emily L.; Lynch, Galen F.; Fee, Michale S.] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Payne, Hannah L.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Massachusetts Institute of Technology (MIT); Stanford University	Fee, MS (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, E25-618, Cambridge, MA 02139 USA.	fee@mit.edu		/0000-0003-4307-0247; Mackevicius, Emily/0000-0001-6593-4398; Fee, Michale/0000-0001-7539-1745	NIH [R01DC009183, R25MH062204]; Mathers Foundation; Nakajima Foundation; Schoemaker Fellowship; Department of Defense (DoD) through the National Defense Science & Engineering Graduate Fellowship (NDSEG) Program; National Science Foundation (NSF) Graduate Research Fellowship Program [DGE-114747]; NSF Integrative Graduate Education and Research Traineeship [0801700]; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH062204] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009183] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; Nakajima Foundation; Schoemaker Fellowship; Department of Defense (DoD) through the National Defense Science & Engineering Graduate Fellowship (NDSEG) Program; National Science Foundation (NSF) Graduate Research Fellowship Program(National Science Foundation (NSF)); NSF Integrative Graduate Education and Research Traineeship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Wilson, J. Kornfeld, M. Jazayeri, S. Seung, N. Ji, and M. Stetner for comments on the manuscript. Funding to M.S.F. was provided by the NIH (grant no. R01DC009183) and by the Mathers Foundation, to T.S.O. by the Nakajima Foundation and Schoemaker Fellowship, to E.L.M. by the Department of Defense (DoD) through the National Defense Science & Engineering Graduate Fellowship (NDSEG) Program, and to H.L.P. by the National Science Foundation (NSF) Graduate Research Fellowship Program (no. DGE-114747) and the NSF Integrative Graduate Education and Research Traineeship (no. 0801700). The modelling work was begun in the Methods in Computational Neuroscience course at the Marine Biological Laboratory (NIH grant number R25MH062204).	Abbott LF, 1996, CEREB CORTEX, V6, P406, DOI 10.1093/cercor/6.3.406; Ali F, 2013, NEURON, V80, P494, DOI 10.1016/j.neuron.2013.07.049; Amador A, 2013, NATURE, V495, P59, DOI 10.1038/nature11967; Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; Aronov D, 2011, J NEUROSCI, V31, P16353, DOI 10.1523/JNEUROSCI.3009-11.2011; Ashmore RC, 2005, J NEUROSCI, V25, P8543, DOI 10.1523/JNEUROSCI.1668-05.2005; Bertram R, 2014, NEUROSCIENCE, V277, P806, DOI 10.1016/j.neuroscience.2014.07.061; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Brainard MS, 2013, ANNU REV NEUROSCI, V36, P489, DOI 10.1146/annurev-neuro-060909-152826; Buonomano DV, 2005, J NEUROPHYSIOL, V94, P2275, DOI 10.1152/jn.01250.2004; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Charlesworth JD, 2011, NAT NEUROSCI, V14, P373, DOI 10.1038/nn.2748; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Dragoi G, 2011, NATURE, V469, P397, DOI 10.1038/nature09633; Duda R. O., 2001, PATTERN CLASSIFICATI; Eichenbaum H, 2014, NAT REV NEUROSCI, V15, P732, DOI 10.1038/nrn3827; Fee MS, 2011, NEUROSCIENCE, V198, P152, DOI 10.1016/j.neuroscience.2011.09.069; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Fee MS, 2001, J NEUROSCI METH, V112, P83, DOI 10.1016/S0165-0270(01)00426-5; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Fiete IR, 2004, J NEUROPHYSIOL, V92, P2274, DOI 10.1152/jn.01133.2003; Fujimoto H, 2011, J NEUROSCI, V31, P10023, DOI 10.1523/JNEUROSCI.1606-11.2011; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Garst-Orozco J, 2014, ELIFE, V3, DOI 10.7554/eLife.03697; Gibb L, 2009, J NEUROPHYSIOL, V102, P1748, DOI 10.1152/jn.00670.2007; Glaze CM, 2013, J NEUROPHYSIOL, V109, P1025, DOI 10.1152/jn.00578.2012; Goldberg JH, 2012, NAT NEUROSCI, V15, P620, DOI 10.1038/nn.3047; Goller F, 2004, ANN NY ACAD SCI, V1016, P130, DOI 10.1196/annals.1298.009; Goller F, 2001, P ROY SOC B-BIOL SCI, V268, P2301, DOI 10.1098/rspb.2001.1805; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hahnloser RHR, 2006, J NEUROPHYSIOL, V96, P794, DOI 10.1152/jn.01064.2005; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Immelmann K., 1969, P61; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Jin DZ, 2007, J COMPUT NEUROSCI, V23, P283, DOI 10.1007/s10827-007-0032-z; Jun JK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000723; Kanji, 2006, 100 STAT TESTS, P242; KONISHI M, 1985, ANNU REV NEUROSCI, V8, P125, DOI 10.1146/annurev.ne.08.030185.001013; Kosche G, 2015, J NEUROSCI, V35, P1217, DOI 10.1523/JNEUROSCI.4346-14.2015; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Leonardo A, 2005, J NEUROSCI, V25, P652, DOI 10.1523/JNEUROSCI.3036-04.2005; Li MR, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011918; Lim Y, 2012, IEEE SIGNAL PROC LET, V19, P684, DOI 10.1109/LSP.2012.2211012; Lipkind D, 2013, NATURE, V498, P104, DOI 10.1038/nature12173; Lipkind D, 2011, P NATL ACAD SCI USA, V108, P15572, DOI 10.1073/pnas.1012941108; Liu WC, 2004, P NATL ACAD SCI USA, V101, P18177, DOI 10.1073/pnas.0408065101; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Mandelblat-Cerf Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096484; Markowitz JE, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003052; McDonald J.H., 2014, HDB BIOL STAT; Mitra P., 2007, OBSERVED BRAIN DYNAM; Mooney R, 2009, LEARN MEMORY, V16, P655, DOI 10.1101/lm.1065209; Murakami M, 2014, NAT NEUROSCI, V17, P1574, DOI 10.1038/nn.3826; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Ohno S., 1970, EVOLUTION GENE DUPLI; Okubo Tatsuo S, 2014, Cold Spring Harb Protoc, V2014, P1273, DOI 10.1101/pdb.prot084624; Oppenheim AV, 2004, IEEE SIGNAL PROC MAG, V21, P95, DOI 10.1109/MSP.2004.1328092; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Peters AJ, 2014, NATURE, V510, P263, DOI 10.1038/nature13235; Pfeiffer BE, 2013, NATURE, V497, P74, DOI 10.1038/nature12112; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Rajan R, 2013, CURR BIOL, V23, P87, DOI 10.1016/j.cub.2012.11.040; Ravbar P, 2012, J NEUROSCI, V32, P3422, DOI 10.1523/JNEUROSCI.3740-11.2012; Rieke F., 1997, SPIKES EXPLORING NEU; Saar S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001461; SIMPSON HB, 1990, J NEUROSCI, V10, P1541; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Tchernichovski O, 2004, ANN NY ACAD SCI, V1016, P348, DOI 10.1196/annals.1298.031; Tchernichovski O, 2002, J COMP PHYSIOL A, V188, P867, DOI 10.1007/s00359-002-0352-4; Vallentin D, 2015, J NEUROSCI, V35, P299, DOI 10.1523/JNEUROSCI.3698-14.2015; Veit L, 2011, J NEUROPHYSIOL, V106, P1747, DOI 10.1152/jn.00247.2011; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Walton C, 2012, J NEUROSCI, V32, P761, DOI 10.1523/JNEUROSCI.3434-11.2012; Wikenheiser AM, 2015, NAT NEUROSCI, V18, P289, DOI 10.1038/nn.3909; Zann RA., 1996, ZEBRA FINCH SYNTHESI	80	70	70	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					352	+		10.1038/nature15741	http://dx.doi.org/10.1038/nature15741			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26618871	Green Accepted, Green Published			2022-12-28	WOS:000366678600043
J	Gong, YY; Huang, C; Li, JZ; Grewe, BF; Zhang, YP; Eismann, S; Schnitzer, MJ				Gong, Yiyang; Huang, Cheng; Li, Jin Zhong; Grewe, Benjamin F.; Zhang, Yanping; Eismann, Stephan; Schnitzer, Mark J.			High-speed recording of neural spikes in awake mice and flies with a fluorescent voltage sensor	SCIENCE			English	Article							DROSOPHILA ANTENNAL LOBE; MOUSE VISUAL-CORTEX; NEURONAL-ACTIVITY; FRET; CIRCUITS; PROTEINS; BURSTS; BRIGHT	Genetically encoded voltage indicators (GEVIs) are a promising technology for fluorescence readout of millisecond-scale neuronal dynamics. Previous GEVIs had insufficient signaling speed and dynamic range to resolve action potentials in live animals. We coupled fast voltage-sensing domains from a rhodopsin protein to bright fluorophores through resonance energy transfer. The resulting GEVIs are sufficiently bright and fast to report neuronal action potentials and membrane voltage dynamics in awake mice and flies, resolving fast spike trains with 0.2-millisecond timing precision at spike detection error rates orders of magnitude better than previous GEVIs. In vivo imaging revealed sensory-evoked responses, including somatic spiking, dendritic dynamics, and intracellular voltage propagation. These results empower in vivo optical studies of neuronal electrophysiology and coding and motivate further advancements in high-speed microscopy.	[Gong, Yiyang; Huang, Cheng; Li, Jin Zhong; Grewe, Benjamin F.; Zhang, Yanping; Eismann, Stephan; Schnitzer, Mark J.] Stanford Univ, James H Clark Ctr, Stanford, CA 94305 USA; [Gong, Yiyang; Li, Jin Zhong; Grewe, Benjamin F.; Zhang, Yanping; Eismann, Stephan; Schnitzer, Mark J.] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Gong, Yiyang] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [Zhang, Yanping; Schnitzer, Mark J.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Duke University; Howard Hughes Medical Institute; Stanford University	Gong, YY (corresponding author), Stanford Univ, James H Clark Ctr, Stanford, CA 94305 USA.	yiyang.gong@duke.edu; mschnitz@stanford.edu	Grewe, Benjamin/E-7044-2017	Grewe, Benjamin/0000-0001-8560-2120; Gong, Yiyang/0000-0002-1855-930X; Huang, Cheng/0000-0001-9936-4813	Defense Advanced Research Projects Agency; NIH Pioneer award; NIH BRAIN Initiative U01 grant; Stanford CNC Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090600] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003560] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH Pioneer award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH BRAIN Initiative U01 grant; Stanford CNC Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We gratefully acknowledge research funding from the Defense Advanced Research Projects Agency, an NIH Pioneer award, an NIH BRAIN Initiative U01 grant, and the Stanford CNC Program. We thank J. Li for animal husbandry. Genetic sequence data are in the supplementary materials. We licensed mNeonGreen from Allele Biotechnology & Pharmaceuticals (San Diego), which charges $100 to $300 per laboratory for a materials transfer agreement.	Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; Diba K, 2014, J NEUROSCI, V34, P14984, DOI 10.1523/JNEUROSCI.1091-14.2014; Gong YY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4674; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hamel EJO, 2015, NEURON, V86, P140, DOI 10.1016/j.neuron.2015.03.055; Hochbaum DR, 2014, NAT METHODS, V11, P825, DOI [10.1038/NMETH.3000, 10.1038/nmeth.3000]; Inoue M, 2015, NAT METHODS, V12, P64, DOI [10.1038/NMETH.3185, 10.1038/nmeth.3185]; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Knopfel T, 2012, NAT REV NEUROSCI, V13, P687, DOI 10.1038/nrn3293; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Lundby A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002514; Mathy A, 2009, NEURON, V62, P388, DOI 10.1016/j.neuron.2009.03.023; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Peterka DS, 2011, NEURON, V69, P9, DOI 10.1016/j.neuron.2010.12.010; Prevedel R, 2014, NAT METHODS, V11, P727, DOI [10.1038/NMETH.2964, 10.1038/nmeth.2964]; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/nmeth.2413, 10.1038/NMETH.2413]; Sheffield MEJ, 2015, NATURE, V517, P200, DOI 10.1038/nature13871; Smith SL, 2013, NATURE, V503, P115, DOI 10.1038/nature12600; St-Pierre F, 2014, NAT NEUROSCI, V17, P884, DOI 10.1038/nn.3709; Tsunoda SP, 2006, BIOPHYS J, V91, P1471, DOI 10.1529/biophysj.106.086421; Tsutsui H, 2008, NAT METHODS, V5, P683, DOI 10.1038/nmeth.1235; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; Watson BO, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00029; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wilt BA, 2013, BIOPHYS J, V104, P51, DOI 10.1016/j.bpj.2012.07.058; Zou P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5625; Zuo YF, 2015, CURR BIOL, V25, P357, DOI 10.1016/j.cub.2014.11.065	32	273	278	5	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2015	350	6266					1361	1366		10.1126/science.aab0810	http://dx.doi.org/10.1126/science.aab0810			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1JL	26586188	Green Accepted			2022-12-28	WOS:000366162400039
J	Marteau, TM; Hollands, GJ; Shemilt, I; Jebb, SA				Marteau, Theresa M.; Hollands, Gareth J.; Shemilt, Ian; Jebb, Susan A.			Downsizing: policy options to reduce portion sizes to help tackle obesity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PUBLIC ACCEPTABILITY; ENERGY-INTAKE; FAST-FOOD; GOVERNMENT; CONSUMPTION		[Marteau, Theresa M.] Univ Cambridge, Behav & Hlth Res Unit, Behav & Hlth, Cambridge, England; [Hollands, Gareth J.; Shemilt, Ian] Univ Cambridge, Behav & Hlth Res Unit, Cambridge, England; [Jebb, Susan A.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Diet & Populat Hlth, Oxford OX1 2JD, England	University of Cambridge; University of Cambridge; University of Oxford	Marteau, TM (corresponding author), Univ Cambridge, Behav & Hlth Res Unit, Behav & Hlth, Cambridge, England.	tm388@cam.ac.uk		Jebb, Susan/0000-0001-9190-2920; Hollands, Gareth/0000-0002-0492-3924; Shemilt, Ian/0000-0003-4862-2135; Marteau, Theresa/0000-0003-3025-1129	MRC [MC_U105960389] Funding Source: UKRI; Medical Research Council [MC_U105960389] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		[Anonymous], 2015, 8 EVERYDAY PRODUCTS; [Anonymous], 2012, NY TIMES; Benton D, 2015, CRIT REV FOOD SCI, V55, P988, DOI 10.1080/10408398.2012.679980; Bonfield P., 2014, PLAN PUBLIC PROCUREM; Brown N, 2015, GROCER          0130; Bryden A, 2013, HEALTH POLICY, V110, P186, DOI 10.1016/j.healthpol.2013.02.009; Cavanagh K, 2014, J HEALTH PSYCHOL, V19, P730, DOI 10.1177/1359105313478645; Clift J., 2013, PORTION DISTORTION M, P22; Department for Environment Food and Rural Affairs, 2014, FOOD STAT POCK; Diepeveen S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-756; Diliberti N, 2004, OBES RES, V12, P562, DOI 10.1038/oby.2004.64; Dobbs R., 2014, OVERCOMING OBESITY I; Freudenberg N., 2014, LETHAL LEGAL CORPORA; Hawkes C, 2015, LANCET, V385, P2410, DOI 10.1016/S0140-6736(14)61745-1; Hollands GJ, 2015, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009164.pub2, 10.1002/14651858.CD011045.pub2]; Hollands GJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1218; Huang TTK, 2015, LANCET, V385, P2422, DOI 10.1016/S0140-6736(14)61743-8; Knai C, 2015, FOOD POLICY, V54, P1, DOI 10.1016/j.foodpol.2015.04.002; Lewis HB, 2015, OBESITY, V23, P1362, DOI 10.1002/oby.21105; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; NICE, 2015, MAINT HLTH WEIGHT PR, V7; Pechey R, 2014, SOC SCI MED, V113, P104, DOI 10.1016/j.socscimed.2014.05.010; Pomeranz JL, 2014, NEW ENGL J MED, V371, P1956, DOI 10.1056/NEJMp1410076; Promberger M, 2012, SOC SCI MED, V75, P2509, DOI 10.1016/j.socscimed.2012.09.033; Rutter H, 2012, INT J PUBLIC HEALTH, V57, P657, DOI 10.1007/s00038-012-0385-6; Sahud HB, 2006, PEDIATRICS, V118, P2290, DOI 10.1542/peds.2006-1228; Schwartz J, 2012, HEALTH AFFAIR, V31, P399, DOI 10.1377/hlthaff.2011.0224; Spanos S, 2015, EAT BEHAV, V16, P40, DOI 10.1016/j.eatbeh.2014.10.007; Steenhuis IHM, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-58; Surgeon General, 2014, HLTH CONS SMOK 50 YE; Swinburn B, 2015, LANCET, V385, P2534, DOI 10.1016/S0140-6736(14)61747-5; Versluis I, 2015, APPETITE, V87, P116, DOI 10.1016/j.appet.2014.12.097; WHO, 2015, INT PHARM, P1; World Health Organization, 2014, EUR FOOD NUTR ACT PL; World Health Organization, 2009, EV EFF COST EFF INT; World Health Organization, 2013, GEND DYSPH, P1; Zlatevska N, 2014, J MARKETING, V78, P140, DOI 10.1509/jm.12.0303	37	77	77	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2015	351								h5863	10.1136/bmj.h5863	http://dx.doi.org/10.1136/bmj.h5863			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX9EY	26630968	Green Published, hybrid			2022-12-28	WOS:000366009000001
J	Bratton, DJ; Gaisl, T; Wons, AM; Kohler, M				Bratton, Daniel J.; Gaisl, Thomas; Wons, Annette M.; Kohler, Malcolm			CPAP vs Mandibular Advancement Devices and Blood Pressure in Patients With Obstructive Sleep Apnea A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							POSITIVE AIRWAY PRESSURE; RANDOMIZED CONTROLLED-TRIAL; EFFECTS META-REGRESSION; RESISTANT HYPERTENSION; ORAL APPLIANCE; HEART-FAILURE; BAROREFLEX SENSITIVITY; ENDOTHELIAL FUNCTION; THERAPY WITHDRAWAL; VASCULAR RISK	IMPORTANCE Obstructive sleep apnea is associated with higher levels of blood pressure (BP), which can lead to increased cardiovascular risk. OBJECTIVE To compare the association of continuous positive airway pressure (CPAP), mandibular advancement devices (MADs), and inactive control groups (placebo or no treatment) with changes in systolic BP (SBP) and diastolic BP (DBP) in patients with obstructive sleep apnea. DATA SOURCES The databases of MEDLINE, EMBASE, and the Cochrane Library were searched up to the end of August 2015 and study bibliographies were reviewed. STUDY SELECTION Randomized clinical trials comparing the effect of CPAP or MADs (vs each other or an inactive control) on BP in patients with obstructive sleep apnea were selected by consensus. Of 872 studies initially identified, 51 were selected for analysis. DATA EXTRACTION AND SYNTHESIS Datawere extracted by one reviewer and checked by another reviewer. A network meta-analysis using multivariate random-effects meta-regression was used to estimate pooled differences between each intervention. Meta-regression was used to assess the association between trial characteristics and the reported effects of CPAP vs inactive control. MAIN OUTCOMES AND MEASURES Absolute change in SBP and DBP from baseline to follow-up. RESULTS Of the 51 studies included in the analysis (4888 patients), 44 compared CPAP with an inactive control, 3 compared MADs with an inactive control, 1 compared CPAP with an MAD, and 3 compared CPAP, MADs, and an inactive control. Compared with an inactive control, CPAP was associated with a reduction in SBP of 2.5mmHg (95% CI, 1.5 to 3.5mmHg; P < .001) and in DBP of 2.0mmHg (95% CI, 1.3 to 2.7mmHg; P < .001). A 1-hour-per-night increase in mean CPAP use was associated with an additional reduction in SBP of 1.5mmHg (95% CI, 0.8 to 2.3mmHg; P < .001) and an additional reduction in DBP of 0.9mmHg (95% CI, 0.3 to 1.4mm Hg; P = .001). Compared with an inactive control, MADs were associated with a reduction in SBP of 2.1mmHg (95% CI, 0.8 to 3.4mmHg; P = .002) and in DBP of 1.9mmHg (95% CI, 0.5 to 3.2mmHg; P = .008). There was no significant difference between CPAP and MADs in their association with change in SBP (-0.5mmHg [95% CI, -2.0 to 1.0mmHg]; P = .55) or in DBP (-0.2mmHg [95% CI, -1.6 to 1.3mmHg]; P = .82). CONCLUSIONS AND RELEVANCE Among patients with obstructive sleep apnea, both CPAP and MADs were associated with reductions in BP. Network meta-analysis did not identify a statistically significant difference between the BP outcomes associated with these therapies.	[Bratton, Daniel J.; Gaisl, Thomas; Wons, Annette M.; Kohler, Malcolm] Univ Zurich Hosp, Dept Pulmonol, CH-8091 Zurich, Switzerland; [Kohler, Malcolm] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Kohler, Malcolm] Univ Zurich, Ctr Interdisciplinary Sleep Res, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich	Kohler, M (corresponding author), Univ Zurich Hosp, Ramistr 100, CH-8091 Zurich, Switzerland.	malcolm.kohler@usz.ch	Gaisl, Thomas/I-7762-2019	Gaisl, Thomas/0000-0002-9017-6143; Bratton, Daniel/0000-0002-6135-0894	Swiss National Science Foundation [32003B_143365/1]; University of Zurich Clinical Research Priority Program Sleep and Health	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich Clinical Research Priority Program Sleep and Health	This research was supported by grant 32003B_143365/1 from the Swiss National Science Foundation and by funding from the University of Zurich Clinical Research Priority Program Sleep and Health.	Andren A, 2013, SLEEP BREATH, V17, P705, DOI 10.1007/s11325-012-0746-7; [Anonymous], 2005, CIRCULATION, V2005, P112; Barbe F, 2001, ANN INTERN MED, V134, P1015, DOI 10.7326/0003-4819-134-11-200106050-00007; Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; Barnes M, 2004, AM J RESP CRIT CARE, V170, P656, DOI 10.1164/rccm.200311-1571OC; Barnes M, 2002, AM J RESP CRIT CARE, V165, P773, DOI 10.1164/ajrccm.165.6.2003166; Bazzano LA, 2007, HYPERTENSION, V50, P417, DOI 10.1161/HYPERTENSIONAHA.106.085175; Becker HF, 2003, CIRCULATION, V107, P68, DOI 10.1161/01.CIR.0000042706.47107.7A; Bennett LS, 1998, THORAX, V53, pS58, DOI 10.1136/thx.53.2008.S58; Bratton DJ, 2014, THORAX, V69, P1128, DOI 10.1136/thoraxjnl-2013-204993; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Campos-Rodriguez F, 2006, CHEST, V129, P1459, DOI 10.1378/chest.129.6.1459; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Chirinos JA, 2014, NEW ENGL J MED, V370, P2265, DOI 10.1056/NEJMoa1306187; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Comondore VR, 2009, LUNG, V187, P17, DOI 10.1007/s00408-008-9115-5; Coughlin SR, 2007, EUR RESPIR J, V29, P720, DOI 10.1183/09031936.00043306; Craig SE, 2012, THORAX, V67, P1090, DOI 10.1136/thoraxjnl-2012-202178; Cross MD, 2008, THORAX, V63, P578, DOI 10.1136/thx.2007.081877; Dal-Fabbro C, 2014, SLEEP BREATH, V18, P749, DOI 10.1007/s11325-014-0937-5; de Oliveira AC, 2014, AM J RESP CRIT CARE, V190, P345, DOI 10.1164/rccm.201403-0479LE; Drager LF, 2007, AM J RESP CRIT CARE, V176, P706, DOI 10.1164/rccm.200703-500OC; Drager LF, 2011, HYPERTENSION, V57, P549, DOI 10.1161/HYPERTENSIONAHA.110.165969; Duran-Cantolla J, 2010, BMJ-BRIT MED J, V341, pc5991; Egea CJ, 2008, SLEEP MED, V9, P660, DOI 10.1016/j.sleep.2007.06.018; Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140; Engleman HM, 1996, SLEEP, V19, P378, DOI 10.1093/sleep/19.5.378; Faccenda JF, 2001, AM J RESP CRIT CARE, V163, P344, DOI 10.1164/ajrccm.163.2.2005037; Fava C, 2014, CHEST, V145, P762, DOI 10.1378/chest.13-1115; Giles TL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001106.pub3; Gotsopoulos H, 2004, SLEEP, V27, P934, DOI 10.1093/sleep/27.5.934; Gottlieb DJ, 2014, NEW ENGL J MED, V370, P2276, DOI 10.1056/NEJMoa1306766; Haentjens P, 2007, ARCH INTERN MED, V167, P757, DOI 10.1001/archinte.167.8.757; Hall AB, 2014, CIRCULATION, V130, P892, DOI 10.1161/CIRCULATIONAHA.113.005893; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hoyos CM, 2015, AM J HYPERTENS, V28, P1222, DOI 10.1093/ajh/hpv023; Hoyos CM, 2012, THORAX, V67, P1081, DOI 10.1136/thoraxjnl-2011-201420; Huang ZW, 2015, AM J HYPERTENS, V28, P300, DOI 10.1093/ajh/hpu147; Hui DS, 2006, THORAX, V61, P1083, DOI 10.1136/thx.2006.064063; Iftikhar IH, 2013, J CLIN SLEEP MED, V9, P165, DOI 10.5664/jcsm.2420; Ip MSM, 2004, AM J RESP CRIT CARE, V169, P348, DOI 10.1164/rccm.200306-767OC; Jones A, 2013, SLEEP MED, V14, P1260, DOI 10.1016/j.sleep.2013.08.786; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Kohler M, 2011, AM J RESP CRIT CARE, V184, P1192, DOI 10.1164/rccm.201106-0964OC; Kohler M, 2010, NAT REV CARDIOL, V7, P677, DOI 10.1038/nrcardio.2010.145; Lam B, 2007, THORAX, V62, P354, DOI 10.1136/thx.2006.063644; Lam JCM, 2010, EUR RESPIR J, V35, P138, DOI 10.1183/09031936.00047709; Lefebvre C, 2011, COCHRANE HDB SYSTEMA; Litvin AY, 2013, VASC HEALTH RISK MAN, V9, P229, DOI 10.2147/VHRM.S40231; Lozano L, 2010, J HYPERTENS, V28, P2161, DOI 10.1097/HJH.0b013e32833b9c63; Martinez-Garcia MA, 2013, JAMA-J AM MED ASSOC, V310, P2407, DOI 10.1001/jama.2013.281250; McMillan A, 2014, LANCET RESP MED, V2, P804, DOI 10.1016/S2213-2600(14)70172-9; Monasterio C, 2001, AM J RESP CRIT CARE, V164, P939, DOI 10.1164/ajrccm.164.6.2008010; Montesi SB, 2012, J CLIN SLEEP MED, V8, P587, DOI 10.5664/jcsm.2170; Muxfeldt ES, 2015, HYPERTENSION, V65, P736, DOI 10.1161/HYPERTENSIONAHA.114.04852; Nguyen PK, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-50; Noda A, 2007, HYPERTENS RES, V30, P669, DOI 10.1291/hypres.30.669; Norman D, 2006, HYPERTENSION, V47, P840, DOI 10.1161/01.HYP.0000217128.41284.78; Pamidi S, 2015, AM J RESP CRIT CARE, V192, P96, DOI 10.1164/rccm.201408-1564OC; Pedrosa RP, 2013, CHEST, V144, P1487, DOI 10.1378/chest.13-0085; Pepperell JCT, 2002, LANCET, V359, P204, DOI 10.1016/S0140-6736(02)07445-7; Phillips CL, 2013, AM J RESP CRIT CARE, V187, P879, DOI 10.1164/rccm.201212-2223OC; Quinnell TG, 2014, THORAX, V69, P938, DOI 10.1136/thoraxjnl-2014-205464; Robinson GV, 2006, EUR RESPIR J, V27, P1229, DOI 10.1183/09031936.06.00062805; Rossi VA, 2013, THORAX, V68, P854, DOI 10.1136/thoraxjnl-2013-203508; Ruttanaumpawan P, 2008, J HYPERTENS, V26, P1163, DOI 10.1097/HJH.0b013e3282fb81ed; Schein ASO, 2014, J HYPERTENS, V32, P1762, DOI 10.1097/HJH.0000000000000250; Takaesu Y, 2012, SLEEP MED, V13, P156, DOI 10.1016/j.sleep.2011.10.016; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Weaver TE, 2012, AM J RESP CRIT CARE, V186, P677, DOI 10.1164/rccm.201202-0200OC; White IR, 2012, RES SYNTH METHODS, V3, P111, DOI 10.1002/jrsm.1045; White IR, 2011, STATA J, V11, P255, DOI 10.1177/1536867X1101100206; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080	76	203	206	2	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2015	314	21					2280	2293		10.1001/jama.2015.16303	http://dx.doi.org/10.1001/jama.2015.16303			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX2GT	26624827	Bronze			2022-12-28	WOS:000365515700020
J	Julien, MH				Julien, Marc-Henri			Magnetic fields make waves in cuprates	SCIENCE			English	Editorial Material							CHARGE ORDER		Univ Grenoble Alpes, CNRS, EMFL, Lab Natl Champs Magnet Intenses, F-38042 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Julien, MH (corresponding author), Univ Grenoble Alpes, CNRS, EMFL, Lab Natl Champs Magnet Intenses, F-38042 Grenoble, France.	marc-henri.julien@lncmi.cnrs.fr	Julien, Marc-Henri/A-2352-2010	Julien, Marc-Henri/0000-0003-2378-3258				Doiron-Leyraud N, 2007, NATURE, V447, P565, DOI 10.1038/nature05872; Gerber S, 2015, SCIENCE, V350, P949, DOI 10.1126/science.aac6257; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; Hoffman JE, 2002, SCIENCE, V295, P466, DOI 10.1126/science.1066974; Howald C, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.014533; LeBoeuf D, 2013, NAT PHYS, V9, P79, DOI 10.1038/nphys2502; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Wu T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7438; Wu T, 2011, NATURE, V477, P191, DOI 10.1038/nature10345	11	21	21	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					914	915		10.1126/science.aad3279	http://dx.doi.org/10.1126/science.aad3279			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW4IP	26586749				2022-12-28	WOS:000364955200024
J	Kern, A; Mavrikaki, M; Ullrich, C; Albarran-Zeckler, R; Brantley, AF; Smith, RG				Kern, Andras; Mavrikaki, Maria; Ullrich, Celine; Albarran-Zeckler, Rosie; Brantley, Alicia Faruzzi; Smith, Roy G.			Hippocampal Dopamine/DRD1 Signaling Dependent on the Ghrelin Receptor	CELL			English	Article							LONG-TERM-MEMORY; HORMONE SECRETAGOGUE RECEPTOR; PREPULSE INHIBITION; BRAIN-AREAS; FOOD-INTAKE; GROWTH; RAT; NEURONS; POTENTIATION; HETEROMERS	The ghrelin receptor (GHSR1a) and dopamine receptor- 1 (DRD1) are coexpressed in hippocampal neurons, yet ghrelin is undetectable in the hippocampus; therefore, we sought a function for apo-GHSR1a. Real-time single-molecule analysis on hippocampal neurons revealed dimerization between apoGHSR1a and DRD1 that is enhanced by DRD1 agonism. In addition, proximity measurements support formation of preassembled apo-GHSR1a:DRD1:G alpha(q) heteromeric complexes in hippocampal neurons. Activation by a DRD1 agonist produced non-canonical signal transduction via G alpha(q)-PLC-IP3-Ca2+ at the expense of canonical DRD1 G alpha(s) cAMP signaling to result in CaMKII activation, glutamate receptor exocytosis, synaptic reorganization, and expression of early markers of hippocampal synaptic plasticity. Remarkably, this pathway is blocked by genetic or pharmacological inactivation of GHSR1a. In mice, GHSR1a inactivation inhibits DRD1-mediated hippocampal behavior and memory. Our findings identify a previously unrecognized mechanism essential for DRD1 initiation of hippocampal synaptic plasticity that is dependent on GHSR1a, and independent of cAMP signaling.	[Kern, Andras; Mavrikaki, Maria; Ullrich, Celine; Albarran-Zeckler, Rosie; Smith, Roy G.] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL 33458 USA; [Brantley, Alicia Faruzzi] Scripps Res Inst, Dept Neurosci & Behav Core, Jupiter, FL 33458 USA	Scripps Research Institute; Scripps Research Institute	Kern, A (corresponding author), Scripps Res Inst, Dept Metab & Aging, Jupiter, FL 33458 USA.	akern@scripps.edu; rgsmith@scripps.edu	Brantley, Alicia Faruzzi/AHB-9354-2022	Brantley, Alicia Faruzzi/0000-0002-4330-451X; Mavrikaki, Maria/0000-0002-8646-5022	NIH [R01AG019230]; NATIONAL INSTITUTE ON AGING [R01AG019230] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Bryan Wharram and Dr. Sukhvir Mahal (TSRI) for assistance in managing the mouse colonies, and Dr. Cristina Grande (TSRI) for help with intracranial drug delivery. We thank AEterna Zentaris, Inc. (Germany) for providing JMV2959; IPSEN (Milford, MA, USA) for BIM-28163; and Dr. Jeffry M. Friedman (Rockefeller University, NY) for 3P peptide used in pS6 experiments. We thank Dr. Courtney Miller and Dr. Sukhvir Mahal (TSRI) for helpful comments on the manuscript. This work was supported by NIH grant R01AG019230 to R.G.S.	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Cepeda Carlos, 2006, Sci STKE, V2006, ppe20, DOI 10.1126/stke.3332006pe20; Cone JJ, 2014, J NEUROSCI, V34, P4905, DOI 10.1523/JNEUROSCI.4404-13.2014; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Ellenbroek BA, 2002, EUR J NEUROSCI, V15, P1237, DOI 10.1046/j.1460-9568.2002.01948.x; Engel JA, 2015, PSYCHOPHARMACOLOGY, V232, P4285, DOI 10.1007/s00213-015-4054-3; Fiorenza NG, 2012, BEHAV BRAIN RES, V232, P210, DOI 10.1016/j.bbr.2012.04.015; Furness JB, 2011, NEUROSCIENCE, V193, P1, DOI 10.1016/j.neuroscience.2011.07.063; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; GASBARRI A, 1994, BRAIN RES, V668, P71, DOI 10.1016/0006-8993(94)90512-6; Geyer Mark A, 2003, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0817s24; Grouselle D, 2008, J NEUROENDOCRINOL, V20, P1138, DOI 10.1111/j.1365-2826.2008.01770.x; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Hamdan FF, 2006, CURR PROTOC NEUROSCI, V5, P523, DOI DOI 10.1002/0471142301.NS0523S34; Hamilton TJ, 2010, P NATL ACAD SCI USA, V107, P18185, DOI 10.1073/pnas.1011558107; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Jiang H, 2006, MOL ENDOCRINOL, V20, P1772, DOI 10.1210/me.2005-0084; Jin LQ, 2003, J NEUROCHEM, V85, P378, DOI 10.1046/j.1471-4159.2003.01698.x; Kasai RS, 2014, CURR OPIN CELL BIOL, V27, P78, DOI 10.1016/j.ceb.2013.11.008; Kern A, 2012, NEURON, V73, P317, DOI 10.1016/j.neuron.2011.10.038; Knight ZA, 2012, CELL, V151, P1126, DOI 10.1016/j.cell.2012.10.039; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Ladepeche L, 2013, P NATL ACAD SCI USA, V110, P18005, DOI 10.1073/pnas.1310145110; Lezcano N, 2002, J NEUROPHYSIOL, V87, P2167, DOI 10.1152/jn.00541.2001; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; MANSBACH RS, 1988, PSYCHOPHARMACOLOGY, V94, P507, DOI 10.1007/BF00212846; Mary S, 2013, J BIOL CHEM, V288, P24656, DOI 10.1074/jbc.M113.453423; Nai Q, 2010, BIOL PSYCHIAT, V67, P246, DOI 10.1016/j.biopsych.2009.08.011; Pirnik Z, 2011, NEUROCHEM INT, V59, P889, DOI 10.1016/j.neuint.2011.08.001; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545; Sakata I, 2009, REGUL PEPTIDES, V155, P91, DOI 10.1016/j.regpep.2009.04.001; Sarinana J, 2014, P NATL ACAD SCI USA, V111, P8245, DOI 10.1073/pnas.1407395111; Schaeffer M, 2013, P NATL ACAD SCI USA, V110, P1512, DOI 10.1073/pnas.1212137110; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Smith RG, 1997, ENDOCR REV, V18, P621, DOI 10.1210/er.18.5.621; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9	43	72	76	3	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1176	1190		10.1016/j.cell.2015.10.062	http://dx.doi.org/10.1016/j.cell.2015.10.062			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26590421	Green Accepted, Bronze			2022-12-28	WOS:000366044700016
J	Stankovic, KM; Tan, OT; Sadow, PM				Stankovic, Konstantina M.; Tan, Oon T.; Sadow, Peter M.			Case 36-2015: A 27-Year-Old Woman with a Lesion of the Ear Canal	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							T-CELL LYMPHOMA; ANGIOLYMPHOID HYPERPLASIA; EOSINOPHILIA; LASER		[Stankovic, Konstantina M.] Massachusetts Gen Hosp, Dept Otolaryngol, Boston, MA 02114 USA; [Sadow, Peter M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Stankovic, Konstantina M.; Sadow, Peter M.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA; [Tan, Oon T.] Massachusetts Eye & Ear Infirm, Dept Laser & Reconstruct Surg, Boston, MA 02114 USA; [Stankovic, Konstantina M.; Tan, Oon T.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA; [Sadow, Peter M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Stankovic, KM (corresponding author), Massachusetts Gen Hosp, Dept Otolaryngol, Boston, MA 02114 USA.		Sadow, Peter/AAO-9878-2020; Sadow, Peter/E-7691-2015	Sadow, Peter/0000-0003-1036-6367; Sadow, Peter/0000-0003-1036-6367				Ackermann G, 2002, LASER MED SCI, V17, P70, DOI 10.1007/s101030200013; ANDERSON RR, 1983, SCIENCE, V220, P524, DOI 10.1126/science.6836297; [Anonymous], 2010, N ENGL J MED, V363, P2146; Bouchier-Hayes DM, 2006, J ENDOUROL, V20, P580, DOI 10.1089/end.2006.20.580; Effat KG, 2006, J LARYNGOL OTOL, V120, P411, DOI 10.1017/S0022215106001009; Geraud C, 2011, BRIT J DERMATOL, V164, P457, DOI 10.1111/j.1365-2133.2010.10105.x; Mariatos G, 1999, ORAL ONCOL, V35, P435, DOI 10.1016/S1368-8375(99)00006-8; Medscape, ANG HYP EOS; NEIMAN RS, 1981, CANCER-AM CANCER SOC, V48, P1426, DOI 10.1002/1097-0142(19810915)48:6<1426::AID-CNCR2820480626>3.0.CO;2-G; Newman LS, 1997, NEW ENGL J MED, V336, P1224, DOI 10.1056/NEJM199704243361706; Petrella T, 2007, AM J SURG PATHOL, V31, P1887, DOI 10.1097/PAS.0b013e318068b527; Saiji EGL, 2013, PRACTICAL SOFT TISSU, P160; Saleh N, 2005, EGYPTIAN DERMATOL, V1, P5; TAN OT, 1989, J INVEST DERMATOL, V92, P868, DOI 10.1111/1523-1747.ep12696885	14	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2015	373	21					2070	2077		10.1056/NEJMcpc1410941	http://dx.doi.org/10.1056/NEJMcpc1410941			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW4JN	26581000				2022-12-28	WOS:000364957700013
J	Bacharier, LB; Guilbert, TW; Mauger, DT; Boehmer, S; Beigelman, A; Fitzpatrick, AM; Jackson, DJ; Baxi, SN; Benson, M; Burnham, CAD; Cabana, M; Castro, M; Chmiel, JF; Covar, R; Daines, M; Gaffin, JM; Gentile, DA; Holguin, F; Israel, E; Kelly, HW; Lazarus, SC; Lemanske, RF; Ly, N; Meade, K; Morgan, W; Moy, J; Olin, T; Peters, SP; Phipatanakul, W; Pongracic, JA; Raissy, HH; Ross, K; Sheehan, WJ; Sorkness, C; Szefler, SJ; Teague, WG; Thyne, S; Martinez, FD				Bacharier, Leonard B.; Guilbert, Theresa W.; Mauger, David T.; Boehmer, Susan; Beigelman, Avraham; Fitzpatrick, Anne M.; Jackson, Daniel J.; Baxi, Sachin N.; Benson, Mindy; Burnham, Carey-Ann D.; Cabana, Michael; Castro, Mario; Chmiel, James F.; Covar, Ronina; Daines, Michael; Gaffin, Jonathan M.; Gentile, Deborah Ann; Holguin, Fernando; Israel, Elliot; Kelly, H. William; Lazarus, Stephen C.; Lemanske, Robert F., Jr.; Ly, Ngoc; Meade, Kelley; Morgan, Wayne; Moy, James; Olin, Tod; Peters, Stephen P.; Phipatanakul, Wanda; Pongracic, Jacqueline A.; Raissy, Hengameh H.; Ross, Kristie; Sheehan, William J.; Sorkness, Christine; Szefler, Stanley J.; Teague, W. Gerald; Thyne, Shannon; Martinez, Fernando D.		Natl Heart Lung & Blood Inst	Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIGH-RISK; RHINOVIRUS ILLNESSES; ASTHMA; CHILDHOOD; CORTICOSTEROIDS; INTERLEUKIN-8; ASSOCIATION; INFECTIONS; SYMPTOMS; BACTERIA	IMPORTANCE Many preschool children develop recurrent, severe episodes of lower respiratory tract illness (LRTI). Although viral infections are often present, bacteria may also contribute to illness pathogenesis. Strategies that effectively attenuate such episodes are needed. OBJECTIVE To evaluate if early administration of azithromycin, started prior to the onset of severe LRTI symptoms, in preschool children with recurrent severe LRTIs can prevent the progression of these episodes. DESIGN, SETTING, AND PARTICIPANTS A randomized, double-blind, placebo-controlled, parallel-group trial conducted across 9 academic US medical centers in the National Heart, Lung, and Blood Institute's AsthmaNet network, with enrollment starting in April 2011 and follow-up complete by December 2014. Participants were 607 children aged 12 through 71 months with histories of recurrent, severe LRTIs and minimal day-to-day impairment. INTERVENTION Participants were randomly assigned to receive azithromycin (12mg/kg/d for 5 days; n = 307) or matching placebo (n = 300), started early during each predefined RTI (child's signs or symptoms prior to development of LRTI), based on individualized action plans, over a 12-through 18-month period. MAIN OUTCOMES AND MEASURES The primary outcome measure was the number of RTIs not progressing to a severe LRTI, measured at the level of the RTI, that would in clinical practice trigger the prescription of oral corticosteroids. Presence of azithromycin-resistant organisms in oropharyngeal samples, along with adverse events, were among the secondary outcome measures. RESULTS A total of 937 treated RTIs (azithromycin group, 473; placebo group, 464) were experienced by 443 children (azithromycin group, 223; placebo group, 220), including 92 severe LRTIs (azithromycin group, 35; placebo group, 57). Azithromycin significantly reduced the risk of progressing to severe LRTI relative to placebo (hazard ratio, 0.64 [95% CI, 0.41-0.98], P =.04; absolute risk for first RTI: 0.05 for azithromycin, 0.08 for placebo; risk difference, 0.03 [95% CI, 0.00-0.06]). Induction of azithromycin-resistant organisms and adverse events were infrequently observed. CONCLUSIONS AND RELEVANCE Among young children with histories of recurrent severe LRTIs, the use of azithromycin early during an apparent RTI compared with placebo reduced the likelihood of severe LRTI. More information is needed on the development of antibiotic-resistant pathogens with this strategy.	[Bacharier, Leonard B.; Beigelman, Avraham; Castro, Mario] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Guilbert, Theresa W.] Cincinnati Childrens Hosp & Med Ctr, Cincinnati, OH USA; [Mauger, David T.; Boehmer, Susan] Penn State Univ, Dept Publ Hlth Sci, Hershey, PA USA; [Fitzpatrick, Anne M.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Jackson, Daniel J.] Univ Wisconsin, Sch Med & Publ Hlth, Pediat Sect Allergy Immunol & Rheumatol, Madison, WI 53706 USA; [Baxi, Sachin N.; Phipatanakul, Wanda; Sheehan, William J.] Boston Childrens Hosp, Div Allergy Immunol, Boston, MA USA; [Benson, Mindy; Meade, Kelley] Benioff Childrens Hosp, Oakland, CA USA; [Burnham, Carey-Ann D.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Cabana, Michael; Lazarus, Stephen C.] Univ Calif San Francisco, Med, San Francisco, CA 94143 USA; [Chmiel, James F.; Ross, Kristie] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Covar, Ronina; Olin, Tod] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Daines, Michael; Morgan, Wayne] Univ Arizona, Arizona Resp Ctr, Tucson, AZ USA; [Gaffin, Jonathan M.] Boston Childrens Hosp, Div Resp Dis, Boston, MA USA; [Gentile, Deborah Ann] Allegheny Gen Hosp, Dept Pediat, Pittsburgh, PA 15212 USA; [Holguin, Fernando] Univ Pittsburgh, Asthma Inst, Pittsburgh, PA USA; [Israel, Elliot] Brigham & Womens Hosp, Boston, MA 02115 USA; [Kelly, H. William] Univ New Mexico, Sch Med, Dept Pediat, Albuquerque, NM 87131 USA; [Lemanske, Robert F., Jr.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53706 USA; [Ly, Ngoc] Univ Calif San Francisco, Airway Clin Res Ctr, San Francisco, CA 94143 USA; [Moy, James] Stroger Hosp Cook Cty Pediat Serv, Chicago, IL USA; [Peters, Stephen P.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Pongracic, Jacqueline A.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Raissy, Hengameh H.] Univ New Mexico, Dept Pediat Pulm, Albuquerque, NM 87131 USA; [Sorkness, Christine] Univ Wisconsin, Madison, WI 53706 USA; [Szefler, Stanley J.] Childrens Hosp Colorado, Breathing Inst, Denver, CO USA; [Teague, W. Gerald] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Thyne, Shannon] San Francisco Gen Hosp, Dept Pediat, San Francisco, CA 94110 USA; [Martinez, Fernando D.] Univ Arizona, Arizona Resp Ctr, Tucson, AZ USA	Washington University (WUSTL); Cincinnati Children's Hospital Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Emory University; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Boston Children's Hospital; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Washington University (WUSTL); University of California System; University of California San Francisco; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; National Jewish Health; University of Arizona; Harvard University; Boston Children's Hospital; Allegheny General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; University of New Mexico; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Francisco; John H Stroger Junior Hospital Cook County; Wake Forest University; Wake Forest Baptist Medical Center; Ann & Robert H. Lurie Children's Hospital of Chicago; University of New Mexico; University of Wisconsin System; University of Wisconsin Madison; Children's Hospital Colorado; University of Virginia; San Francisco General Hospital Medical Center; University of Arizona	Bacharier, LB (corresponding author), Washington Univ, Sch Med, Dept Pediat, Campus Box 8116,660 S Euclid Ave, St Louis, MO 63110 USA.	bacharier_l@kidswustl.edu		Fitzpatrick, Anne/0000-0002-2933-5926; GAFFIN, JONATHAN/0000-0003-2213-4504; Bacharier, Leonard/0000-0003-0432-2704; Szefler, Stanley/0000-0002-6911-3199	National Heart, Lung, and Blood Institute (NHLBI) as part of AsthmaNet [HL098102, HL098096, HL098075, HL098090, HL098177, HL098098, HL098107, HL098112, HL098103, HL098115, TR001082, TR000439, TR000448, TR000454]; NHLBI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439, UL1TR001082, UL1TR001449, UL1TR000041, UL1TR000448, UL1TR000454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL098096, U10HL098098, U10HL098102, U10HL098115, U10HL098177, U10HL098103, U10HL098107, U10HL098090, U10HL098075, U10HL098112] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI106945, K23AI104780] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI) as part of AsthmaNet; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by grants HL098102, HL098096, HL098075, HL098090, HL098177, HL098098, HL098107, HL098112, HL098103, HL098115, TR001082, TR000439, TR000448, and TR000454 from the National Heart, Lung, and Blood Institute (NHLBI) as part of AsthmaNet, a clinical trials network supported by a cooperative agreement with NHLBI. GlaxoSmithKline, Merck, Teva, Boehringer Ingelheim, and Sunovion provided products for NHLBI AsthmaNet studies.	Bacharier LB, 2008, J ALLERGY CLIN IMMUN, V122, P1127, DOI 10.1016/j.jaci.2008.09.029; Beigelman A, 2015, J ALLERGY CLIN IMMUN, V135, P1171, DOI 10.1016/j.jaci.2014.10.001; Beigelman A, 2013, J ALLERGY CLIN IMMUN, V131, P1518, DOI 10.1016/j.jaci.2013.01.034; Bisgaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4978; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; De Boeck K, 2011, PEDIATRICS, V127, P1022, DOI 10.1542/peds.2009-3068; Ducharme FM, 2009, NEW ENGL J MED, V360, P339, DOI 10.1056/NEJMoa0808907; Gern JE, 2002, PEDIAT ALLERG IMM-UK, V13, P386, DOI 10.1034/j.1399-3038.2002.01093.x; Gielen V, 2010, EUR RESPIR J, V36, P646, DOI 10.1183/09031936.00095809; Guilbert TW, 2004, CONTROL CLIN TRIALS, V25, P286, DOI 10.1016/j.cct.2004.03.002; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Guilbert TW, 2004, J ALLERGY CLIN IMMUN, V114, P1282, DOI 10.1016/j.jaci.2004.09.020; Hersh AL, 2013, PEDIATRICS, V132, P1146, DOI 10.1542/peds.2013-3260; Hull J, 2000, THORAX, V55, P1023, DOI 10.1136/thorax.55.12.1023; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Johnston SL, 2006, NEW ENGL J MED, V354, P1589, DOI 10.1056/NEJMoa044080; Khetsuriani N, 2007, J ALLERGY CLIN IMMUN, V119, P314, DOI 10.1016/j.jaci.2006.08.041; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Kloepfer KM, 2014, J ALLERGY CLIN IMMUN, V133, P1301, DOI 10.1016/j.jaci.2014.02.030; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Kozyrskyj AL, 2006, PEDIATRICS, V117, pE1104, DOI 10.1542/peds.2005-2443; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Ly NP, 2006, PEDIATRICS, V117, pE1132, DOI 10.1542/peds.2005-2271; Marguet C, 1999, AM J RESP CRIT CARE, V159, P1533, DOI 10.1164/ajrccm.159.5.9805028; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Moorman Jeanne E, 2012, Vital Health Stat 3, P1; Panickar J, 2009, NEW ENGL J MED, V360, P329, DOI 10.1056/NEJMoa0804897; Paul IM, 2011, PEDIATRICS, V127, P1014, DOI 10.1542/peds.2011-0218; Program NAEaP, 2007, PROGR NAEAP PUBL, V08-4051; Rivera-Spoljaric K, 2009, J PEDIATR-US, V154, P877, DOI 10.1016/j.jpeds.2008.12.029; Sarpong EM, 2015, HEALTH SERV RES, V50, P830, DOI 10.1111/1475-6773.12260; Simpson JL, 2008, AM J RESP CRIT CARE, V177, P148, DOI 10.1164/rccm.200707-1134OC; Zeiger RS, 2011, NEW ENGL J MED, V365, P1990, DOI 10.1056/NEJMoa1104647	33	178	183	1	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2015	314	19					2034	2044		10.1001/jama.2015.13896	http://dx.doi.org/10.1001/jama.2015.13896			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW1PR	26575060	Green Accepted, Bronze			2022-12-28	WOS:000364764200018
J	Jemal, A; Fedewa, SA; Ma, JM; Siegel, R; Lin, CC; Brawley, O; Ward, EM				Jemal, Ahmedin; Fedewa, Stacey A.; Ma, Jiemin; Siegel, Rebecca; Lin, Chun Chieh; Brawley, Otis; Ward, Elizabeth M.			Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TASK-FORCE RECOMMENDATION; US; IMPACT; FINASTERIDE; MORTALITY; ACCURACY; RATES; TIME; RISK	IMPORTANCE Prostate cancer incidence in men 75 years and older substantially decreased following the 2008 US Preventive Services Task Force (USPSTF) recommendation against prostate-specific antigen (PSA)-based screening for this age group. It is unknown whether incidence has changed since the USPSTF recommendation against screening for all men in May 2012. OBJECTIVE To examine recent changes in stage-specific prostate cancer incidence and PSA screening rates following the 2008 and 2012 USPSTF recommendations. DESIGN AND SETTINGS Ecologic study of age-standardized prostate cancer incidence (newly diagnosed cases/100 000 men aged >= 50 years) by stage from 2005 through 2012 using data from 18 population-based Surveillance, Epidemiology, and End Results (SEER) registries and PSA screening rate in the past year among men 50 years and older without a history of prostate cancer who responded to the 2005 (n = 4580), 2008 (n = 3476), 2010 (n = 4157), and 2013 (n = 6172) National Health Interview Survey (NHIS). EXPOSURES The USPSTF recommendations to omit PSA-based screening for average-risk men. MAIN OUTCOMES AND MEASURES Prostate cancer incidence and incidence ratios (IRs) comparing consecutive years from 2005 through 2012 by age (>= 50, 50-74, and >= 75 years) and SEER summary stage categorized as local/regional or distant and PSA screening rate and rate ratios (SRRs) comparing successive survey years by age. RESULTS Prostate cancer incidence per 100 000 in men 50 years and older (N = 446 009 in SEER areas) was 534.9 in 2005, 540.8 in 2008, 505.0 in 2010, and 416.2 in 2012; rates began decreasing in 2008 and the largest decrease occurred between 2011 and 2012, from 498.3 (99% CI, 492.8-503.9) to 416.2 (99% CI, 411.2-421.2). The number of men 50 years and older diagnosed with prostate cancer nationwide declined by 33 519, from 213 562 men in 2011 to 180 043 men in 2012. Declines in incidence since 2008 were confined to local/regional-stage disease and were similar across age and race/ethnicity groups. The percentage of men 50 years and older reporting PSA screening in the past 12 months was 36.9% in 2005, 40.6% in 2008, 37.8% in 2010, and 30.8% in 2013. In relative terms, screening rates increased by 10% (SRR, 1.10; 99% CI, 1.01-1.21) between 2005 and 2008 and then decreased by 18%(SRR, 0.82; 99% CI, 0.75-0.89) between 2010 and 2013. Similar screening patterns were found in age subgroups 50 to 74 years and 75 years and older. CONCLUSIONS AND RELEVANCE Both the incidence of early-stage prostate cancer and rates of PSA screening have declined and coincide with 2012 USPSTF recommendation to omit PSA screening from routine primary care for men. Longer follow-up is needed to see whether these decreases are associated with trends in mortality.	[Jemal, Ahmedin; Fedewa, Stacey A.; Ma, Jiemin; Siegel, Rebecca; Lin, Chun Chieh] Amer Canc Soc, Surveillance & Hlth Serv Res, Atlanta, GA 30303 USA; [Brawley, Otis] Amer Canc Soc, Off Chief Med Officer Res, Atlanta, GA 30303 USA; [Ward, Elizabeth M.] Amer Canc Soc, Intramural Res, Atlanta, GA 30303 USA	American Cancer Society; American Cancer Society; American Cancer Society	Jemal, A (corresponding author), Amer Canc Soc, Surveillance & Hlth Serv Res, 250 Williams St NW, Atlanta, GA 30303 USA.	ahmedin.jemal@cancer.org		Fedewa, Stacey/0000-0002-3624-6382	Intramural Research Department of the American Cancer Society	Intramural Research Department of the American Cancer Society	This project was supported by the Intramural Research Department of the American Cancer Society.	Ablin RJ, 2012, CANCER EPIDEM BIOMAR, V21, P391, DOI 10.1158/1055-9965.EPI-12-0058; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; [Anonymous], SURV RES PROGR CANC; [Anonymous], PUBL COMM DRAFT REC; Barry MJ, 2015, AM J PREV MED, V49, P520, DOI 10.1016/j.amepre.2015.03.002; Bhindi B, 2015, J UROLOGY, V193, P1519, DOI 10.1016/j.juro.2014.11.096; Bieler GS, 2010, AM J EPIDEMIOL, V171, P618, DOI 10.1093/aje/kwp440; Brett AS, 2011, NEW ENGL J MED, V365, P1949, DOI 10.1056/NEJMp1112191; Carter HB, 2013, J UROLOGY, V190, P419, DOI 10.1016/j.juro.2013.04.119; Centers of Medicare & Medicaid Services, YOUR MED COV; Chan ECY, 2004, AM J PUBLIC HEALTH, V94, P1336, DOI 10.2105/AJPH.94.8.1336; Clegg LX, 2002, J NATL CANCER I, V94, P1537; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Drazer MW, 2015, J CLIN ONCOL, V33, P2416, DOI 10.1200/JCO.2015.61.6532; Gross CP, 2006, JAMA-J AM MED ASSOC, V296, P2815, DOI 10.1001/jama.296.23.2815; Gulati R, 2013, ANN INTERN MED, V158, P145, DOI 10.7326/0003-4819-158-3-201302050-00003; Hamilton RJ, 2010, CANCER EPIDEM BIOMAR, V19, P2164, DOI 10.1158/1055-9965.EPI-10-0082; Howard DH, 2013, HEALTH AFFAIR, V32, P596, DOI 10.1377/hlthaff.2012.0555; Howard DH, 2012, ARCH INTERN MED, V172, P1267, DOI 10.1001/archinternmed.2012.2768; [Internet] Centers for Disease Control and Prevention, NAT HLTH INT SURV; Martinez ME, 2016, HLTH INSURANCE COVER; McNaughton-Collins MF, 2011, NEW ENGL J MED, V365, P1951, DOI 10.1056/NEJMp1111894; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; POTOSKY AL, 1995, JAMA-J AM MED ASSOC, V273, P548, DOI 10.1001/jama.273.7.548; Prabhu V, 2015, BJU INT, V116, P65, DOI 10.1111/bju.12748; Ramon J., 2007, PROSTATE CANC; Rauscher GH, 2008, CANCER EPIDEM BIOMAR, V17, P748, DOI 10.1158/1055-9965.EPI-07-2629; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Ross JS, 2012, ARCH INTERN MED, V172, P1601, DOI 10.1001/archinternmed.2012.3726; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Surveillance Epidemiology and End Results (SEER) Program, 2014, SEER STAT DAT INC SE; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Tiwari RC, 2006, STAT METHODS MED RES, V15, P547, DOI 10.1177/0962280206070621; U. S. Department of Health and Human Services Centers for Disease Control and Prevention and National Cancer Institute, US CANC STAT 1999 20; US Preventive Serv Task Force, 2008, ANN INTERN MED, V149, P185, DOI 10.7326/0003-4819-149-3-200808050-00008; Wolf AMD, 1996, ARCH INTERN MED, V156, P1333, DOI 10.1001/archinte.156.12.1333; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066; Young JL, 2001, NIH PUB; Zeliadt SB, 2011, J NATL CANCER I, V103, P520, DOI 10.1093/jnci/djr007	40	314	316	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2015	314	19					2054	2061		10.1001/jama.2015.14905	http://dx.doi.org/10.1001/jama.2015.14905			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW1PR	26575061	Bronze			2022-12-28	WOS:000364764200020
J	Giri, N; Del Popolo, MG; Melaugh, G; Greenaway, RL; Ratzke, K; Koschine, T; Pison, L; Gomes, MFC; Cooper, AI; James, SL				Giri, Nicola; Del Popolo, Mario G.; Melaugh, Gavin; Greenaway, Rebecca L.; Raetzke, Klaus; Koschine, Toenjes; Pison, Laure; Gomes, Margarida F. Costa; Cooper, Andrew I.; James, Stuart L.			Liquids with permanent porosity	NATURE			English	Article							POROUS ORGANIC CAGES; METHANE; SOLUBILITY; BINDING; SEPARATION; FRAMEWORKS; CRYSTALS; SOLVENTS; GASES	Porous solids such as zeolites(1) and metal-organic frameworks(2,3) are useful in molecular separation and in catalysis, but their solid nature can impose limitations. For example, liquid solvents, rather than porous solids, are the most mature technology for post-combustion capture of carbon dioxide because liquid circulation systems are more easily retrofitted to existing plants. Solid porous adsorbents offer major benefits, such as lower energy penalties in adsorption-desorption cycles(4), but they are difficult to implement in conventional flow processes. Materials that combine the properties of fluidity and permanent porosity could therefore offer technological advantages, but permanent porosity is not associated with conventional liquids(5). Here we report free-flowing liquids whose bulk properties are determined by their permanent porosity. To achieve this, we designed cage molecules(6,7) that provide a well-defined pore space and that are highly soluble in solvents whose molecules are too large to enter the pores. The concentration of unoccupied cages can thus be around 500 times greater than in other molecular solutions that contain cavities(8-10), resulting in a marked change in bulk properties, such as an eightfold increase in the solubility of methane gas. Our results provide the basis for development of a new class of functional porous materials for chemical processes, and we present a one-step, multigram scale-up route for highly soluble 'scrambled' porous cages prepared from a mixture of commercially available reagents. The unifying design principle for these materials is the avoidance of functional groups that can penetrate into the molecular cage cavities.	[Giri, Nicola; James, Stuart L.] Queens Univ Belfast, Sch Chem & Chem Engn, Belfast BT9 5AG, Antrim, North Ireland; [Del Popolo, Mario G.; Melaugh, Gavin] Queens Univ Belfast, Sch Math & Phys, Belfast BT7 1NN, Antrim, North Ireland; [Del Popolo, Mario G.] Univ Nacl Cuyo, CONICET, RA-5500 Mendoza, Argentina; [Del Popolo, Mario G.] Univ Nacl Cuyo, Fac Ciencias Exactas & Nat, RA-5500 Mendoza, Argentina; [Greenaway, Rebecca L.; Cooper, Andrew I.] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England; [Greenaway, Rebecca L.; Cooper, Andrew I.] Univ Liverpool, Ctr Mat Discovery, Liverpool L69 7ZD, Merseyside, England; [Raetzke, Klaus; Koschine, Toenjes] Univ Kiel, Tech Fak, D-24143 Kiel, Germany; [Pison, Laure; Gomes, Margarida F. Costa] Univ Clermont Ferrand, Inst Chim Clermont Ferrand, CNRS, UMR 6296, F-63178 Aubiere, France	Queens University Belfast; Queens University Belfast; University Nacional Cuyo Mendoza; University Nacional Cuyo Mendoza; University of Liverpool; University of Liverpool; University of Kiel; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	James, SL (corresponding author), Queens Univ Belfast, Sch Chem & Chem Engn, David Keir Bldg,Stranmillis Rd, Belfast BT9 5AG, Antrim, North Ireland.	S.James@qub.ac.uk	Del Pópolo, Mario G./AAF-1920-2019; Del Popolo, Mario G./C-9253-2012; Greenaway, Rebecca/AAL-2703-2021; Greenaway, Rebecca/A-3923-2015; Cooper, Andrew/ABE-7766-2020	Del Pópolo, Mario G./0000-0002-1435-2424; Del Popolo, Mario G./0000-0002-1435-2424; Greenaway, Rebecca/0000-0003-1541-4399; Costa Gomes, Margarida/0000-0001-8637-6057	Leverhulme Trust [F/00 203/T]; EPSRC [EP/C511794/1]; ANPCyT [PICT-2011-2128]; EC-H2020. MSCRISE programme [643998 ENACT]; CNRS; Blaise Pascal University; Auvergne Regional Government, France; European Research Council under the European Union's Seventh Framework Programme/ERC [321156]; Engineering and Physical Sciences Research Council [EP/C511794/1, EP/K039687/1] Funding Source: researchfish; EPSRC [EP/K039687/1] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ANPCyT(ANPCyT); EC-H2020. MSCRISE programme; CNRS(Centre National de la Recherche Scientifique (CNRS)); Blaise Pascal University; Auvergne Regional Government, France; European Research Council under the European Union's Seventh Framework Programme/ERC(European Research Council (ERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the Leverhulme Trust (F/00 203/T) and by EPSRC (EP/C511794/1) M.G.D.P acknowledges financial support from ANPCyT (PICT-2011-2128) and from the EC-H2020. MSCRISE-2014 programme, through project 643998 ENACT. L.P. and M.C.G. acknowledge support from the Contrat d'Objectifs Portages (CNRS, Blaise Pascal University, and the Auvergne Regional Government, France). A.I.C. acknowledges the European Research Council under the European Union's Seventh Framework Programme/ERC Grant Agreement no 321156 for financial support. We thank M. E. Briggs for assistance with the cage syntheses.	Chaffee KE, 2009, J PHYS CHEM A, V113, P13675, DOI 10.1021/jp903452k; Cheetham AK, 1999, ANGEW CHEM INT EDIT, V38, P3268, DOI 10.1002/(SICI)1521-3773(19991115)38:22<3268::AID-ANIE3268>3.0.CO;2-U; Chen L, 2014, NAT MATER, V13, P954, DOI [10.1038/NMAT4035, 10.1038/nmat4035]; D'Alessandro DM, 2010, ANGEW CHEM INT EDIT, V49, P6058, DOI 10.1002/anie.201000431; DARWISH NA, 1994, J CHEM ENG DATA, V39, P781, DOI 10.1021/je00016a032; Giri N, 2012, CHEM SCI, V3, P2153, DOI 10.1039/c2sc01007k; Hasell T, 2014, J AM CHEM SOC, V136, P1438, DOI 10.1021/ja409594s; Houndonougbo Y, 2013, J PHYS CHEM C, V117, P10326, DOI 10.1021/jp3096192; Jiang S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1207; Jones JTA, 2011, NATURE, V474, P367, DOI 10.1038/nature10125; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; LANNUNG A, 1960, ACTA CHEM SCAND, V14, P1124, DOI 10.3891/acta.chem.scand.14-1124; Little MA, 2012, ANGEW CHEM INT EDIT, V51, P764, DOI 10.1002/anie.201106512; MAHMOOD T, 1990, THIRD INTERNATIONAL WORKSHOP ON POSITRON AND POSITRONIUM CHEMISTRY, P640; Melaugh G, 2014, PHYS CHEM CHEM PHYS, V16, P9422, DOI 10.1039/c4cp00582a; Mogensen O. E., 1995, SPRINGER SERIES CHEM, V58; O'Reilly N, 2007, CHEM-EUR J, V13, P3020, DOI 10.1002/chem.200700090; PIEROTTI RA, 1963, J PHYS CHEM-US, V67, P1840, DOI 10.1021/j100803a024; PIEROTTI RA, 1976, CHEM REV, V76, P717, DOI 10.1021/cr60304a002; POHORILLE A, 1990, J AM CHEM SOC, V112, P5066, DOI 10.1021/ja00169a011; ROBBINS TA, 1994, J AM CHEM SOC, V116, P111, DOI 10.1021/ja00080a014; Tozawa T, 2009, NAT MATER, V8, P973, DOI [10.1038/nmat2545, 10.1038/NMAT2545]; Wright PA, 2008, RSC MATER MONOGR, P1; Zhang JS, 2015, ANGEW CHEM INT EDIT, V54, P932, DOI 10.1002/anie.201409420	24	283	293	30	577	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					216	+		10.1038/nature16072	http://dx.doi.org/10.1038/nature16072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26560299	Green Accepted			2022-12-28	WOS:000364396700041
J	Mathieson, I; Lazaridis, I; Rohland, N; Mallick, S; Patterson, N; Roodenberg, SA; Harney, E; Stewardson, K; Fernandes, D; Novak, M; Sirak, K; Gamba, C; Jones, ER; Llamas, B; Dryomov, S; Pickrell, J; Arsuaga, JL; de Castro, JMB; Carbonell, E; Gerritsen, F; Khokhlov, A; Kuznetsov, P; Lozano, M; Meller, H; Mochalov, O; Moiseyev, V; Guerra, MAR; Roodenberg, J; Verges, JM; Krause, J; Cooper, A; Alt, KW; Brown, D; Anthony, D; Lalueza-Fox, C; Haak, W; Pinhasi, R; Reich, D				Mathieson, Iain; Lazaridis, Iosif; Rohland, Nadin; Mallick, Swapan; Patterson, Nick; Roodenberg, Songul Alpaslan; Harney, Eadaoin; Stewardson, Kristin; Fernandes, Daniel; Novak, Mario; Sirak, Kendra; Gamba, Cristina; Jones, Eppie R.; Llamas, Bastien; Dryomov, Stanislav; Pickrell, Joseph; Luis Arsuaga, Juan; Bermudez de Castro, Jose Maria; Carbonell, Eudald; Gerritsen, Fokke; Khokhlov, Aleksandr; Kuznetsov, Pavel; Lozano, Marina; Meller, Harald; Mochalov, Oleg; Moiseyev, Vyacheslav; Rojo Guerra, Manuel A.; Roodenberg, Jacob; Maria Verges, Josep; Krause, Johannes; Cooper, Alan; Alt, Kurt W.; Brown, Dorcas; Anthony, David; Lalueza-Fox, Carles; Haak, Wolfgang; Pinhasi, Ron; Reich, David			Genome-wide patterns of selection in 230 ancient Eurasians	NATURE			English	Article							GENETIC-DETERMINANTS; POSITIVE SELECTION; EYE COLOR; ASSOCIATION; EUROPEANS; LOCI; EXPRESSION; DISEASE; EDAR; DNA	Ancient DNA makes it possible to observe natural selection directly by analysing samples from populations before, during and after adaptation events. Here we report a genome-wide scan for selection using ancient DNA, capitalizing on the largest ancient DNA data set yet assembled: 230 West Eurasians who lived between 6500 and 300 BC, including 163 with newly reported data. The new samples include, to our knowledge, the first genome-wide ancient DNA from Anatolian Neolithic farmers, whose genetic material we obtained by extracting from petrous bones, and who we show were members of the population that was the source of Europe's first farmers. We also report a transect of the steppe region in Samara between 5600 and 300 BC, which allows us to identify admixture into the steppe from at least two external sources. We detect selection at loci associated with diet, pigmentation and immunity, and two independent episodes of selection on height.	[Mathieson, Iain; Lazaridis, Iosif; Rohland, Nadin; Mallick, Swapan; Harney, Eadaoin; Stewardson, Kristin; Pickrell, Joseph; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Lazaridis, Iosif; Rohland, Nadin; Mallick, Swapan; Patterson, Nick; Reich, David] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Mallick, Swapan; Harney, Eadaoin; Stewardson, Kristin; Reich, David] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Fernandes, Daniel; Novak, Mario; Sirak, Kendra; Gamba, Cristina; Pinhasi, Ron] Univ Coll Dublin, Sch Archaeol, Dublin 4, Ireland; [Fernandes, Daniel; Novak, Mario; Sirak, Kendra; Gamba, Cristina; Pinhasi, Ron] Univ Coll Dublin, Earth Inst, Dublin 4, Ireland; [Novak, Mario] Inst Anthropol Res, Zagreb 10000, Croatia; [Sirak, Kendra] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Gamba, Cristina; Jones, Eppie R.] Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland; [Llamas, Bastien; Cooper, Alan; Haak, Wolfgang] Univ Adelaide, Sch Biol Sci, Australian Ctr Ancient DNA, Adelaide, SA 5005, Australia; [Llamas, Bastien; Haak, Wolfgang] Univ Adelaide, Sch Environm Inst, Australian Ctr Ancient DNA, Adelaide, SA 5005, Australia; [Dryomov, Stanislav] Russian Acad Sci, Inst Mol & Cellular Biol, Siberian Branch, Lab Human Mol Genet, Novosibirsk 630090, Russia; [Dryomov, Stanislav] Russian Acad Sci, Inst Archaeol & Ethnog, Siberian Branch, Dept Paleolith Archaeol, Novosibirsk 630090, Russia; [Luis Arsuaga, Juan] Ctr Mixto UCM ISCIII Evoluc & Comportamiento Huma, Madrid 28040, Spain; [Luis Arsuaga, Juan] Univ Complutense Madrid, Fac Ciencias Geol, Dept Paleontol, E-28040 Madrid, Spain; [Bermudez de Castro, Jose Maria] Ctr Nacl Invest Evoluc Humana CENIEH, Burgos 09002, Spain; [Carbonell, Eudald; Lozano, Marina; Maria Verges, Josep] IPHES Inst Catala Paleoecol Humana & Evolucio Soc, Tarragona 43007, Spain; [Carbonell, Eudald; Lozano, Marina; Maria Verges, Josep] Univ Rovira & Virgili, Area Prehist, Tarragona 43002, Spain; [Gerritsen, Fokke] Netherlands Inst Turkey, TR-34433 Istanbul, Turkey; [Khokhlov, Aleksandr; Kuznetsov, Pavel; Mochalov, Oleg] Volga State Acad Social Sci & Humanities, Samara 443099, Russia; [Meller, Harald; Alt, Kurt W.] State Off Heritage Management & Archaeol, D-06114 Halle, Germany; [Meller, Harald; Alt, Kurt W.] Archaeol Saxony Anhalt & State Museum Prehist, D-06114 Halle, Germany; [Moiseyev, Vyacheslav] RAS, Peter Great Museum Anthropol & Ethnog Kunstkamera, St Petersburg 199034, Russia; [Rojo Guerra, Manuel A.] Univ Valladolid, Dept Prehist & Archaeol, E-47002 Valladolid, Spain; [Roodenberg, Jacob] Netherlands Inst Near East, NL-2300 RA Leiden, Netherlands; [Krause, Johannes; Haak, Wolfgang] Max Planck Inst Sci Human Hist, D-07745 Jena, Germany; [Krause, Johannes] Univ Tubingen, Inst Archaeol Sci, D-72070 Tubingen, Germany; [Alt, Kurt W.] Danube Private Univ, A-3500 Krems, Austria; [Alt, Kurt W.] Univ Basel, Inst Prehist & Archaeol Sci, CH-4003 Basel, Switzerland; [Brown, Dorcas; Anthony, David] Hartwick Coll, Dept Anthropol, Oneonta, NY 13820 USA; [Lalueza-Fox, Carles] CSIC Univ Pompeu Fabra, Inst Evolutionary Biol, Barcelona 08003, Spain	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University College Dublin; University College Dublin; Institute for Anthropological Research Zagreb; Emory University; Trinity College Dublin; University of Adelaide; University of Adelaide; Russian Academy of Sciences; Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences; Complutense University of Madrid; UCM-ISCIII Center for Human Evolution & Behavior; Complutense University of Madrid; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili; Netherlands Institute in Turkey; Samara State University of Social Sciences & Education; Russian Academy of Sciences; The Kunstkamera; Universidad de Valladolid; Eberhard Karls University of Tubingen; University of Basel; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University	Mathieson, I (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	iain_mathieson@hms.harvard.edu; haak@shh.mpg.de; ron.pinhasi@ucd.ie; reich@genetics.med.harvard.edu	Rojo-Guerra, Manuel Ángel/AAB-6968-2019; Lozano, Marina/G-7293-2015; Dryomov, Stanislav/N-5476-2015; Haak, Wolfgang/Z-4947-2019; Krause, Johannes/AFP-2642-2022; Moiseyev, Vyacheslav/AAD-2659-2019; Gamba, Cristina/B-9427-2015; Llamas, Bastien/AAK-1693-2021; Novak, Mario/AAW-6417-2021; Khokhlov, Aleksander/F-4737-2017; Novak, Mario/AAX-1795-2021; LALUEZA-FOX, CARLES/AAG-5341-2020; Pinhasi, Ron/AAT-1531-2020; Llamas, Bastien/Y-2781-2018	Rojo-Guerra, Manuel Ángel/0000-0002-9317-8654; Lozano, Marina/0000-0002-6304-7848; Haak, Wolfgang/0000-0003-2475-2007; Krause, Johannes/0000-0001-9144-3920; Gamba, Cristina/0000-0003-1187-0258; Llamas, Bastien/0000-0002-5550-9176; Khokhlov, Aleksander/0000-0003-0442-9616; LALUEZA-FOX, CARLES/0000-0002-1730-5914; Pinhasi, Ron/0000-0003-1629-8131; Llamas, Bastien/0000-0002-5550-9176; Gerritsen, F.A./0000-0002-6665-1928; Kuznetsov, Pavel/0000-0002-4898-5350; Novak, Mario/0000-0002-4567-8742; Harney, Eadaoin/0000-0001-9385-7297; Sirak, Kendra/0000-0003-2347-3479; Bermudez de Castro, Jose Maria/0000-0003-1314-3273; Cooper, Alan/0000-0002-7738-7851; Arsuaga, Juan Luis/0000-0001-5361-2295; M Fernandes, Daniel/0000-0002-7434-6552	Human Frontier Science Program [LT001095/2014-L]; Irish Research Council for Humanities and Social Sciences (IRCHSS); Netherlands Organization for Scientific Research [380-62-005]; RFBR [15-06-01916]; RFH [15-11-63008]; Ministry of Education and Science of the Russia Federation [33.1195.2014/k]; ERC starting grant APGREID; DFG [KR 4015/1-1, AL 287/14-1]; Spanish government [BFU2015-64699-P]; Australian Research Council [DP130102158]; ERC starting grant ADNABIOARC [263441]; Irish Research Council ERC support grant; US National Science Foundation HOMINID grant [BCS-1032255]; US National Institutes of Health [GM100233]; Howard Hughes Medical Institute; Direct For Social, Behav & Economic Scie [1032255] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100233] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Irish Research Council for Humanities and Social Sciences (IRCHSS)(Irish Research Council for Science, Engineering and Technology); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); RFBR(Russian Foundation for Basic Research (RFBR)); RFH; Ministry of Education and Science of the Russia Federation; ERC starting grant APGREID(European Research Council (ERC)); DFG(German Research Foundation (DFG)); Spanish government(Spanish GovernmentEuropean Commission); Australian Research Council(Australian Research Council); ERC starting grant ADNABIOARC; Irish Research Council ERC support grant(Irish Research Council for Science, Engineering and Technology); US National Science Foundation HOMINID grant(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. de Bakker, J. Burger, C. Economou, E. Fornander, Q. Fu, F. Hallgren, K. Kirsanow, A. Mittnik, I. Olalde, A. Powell, P. Skoglund, S. Tabrizi and A. Tandon for discussions, suggestions about SNPs to include, or contribution to sample preparation or data curation. We thank S. Paabo, M. Meyer, Q. Fu and B. Nickel for collaboration in developing the 1240k capture reagent. We thank J. M. V. Encinas and M. E. Prada for allowing us to resample La Brana 1. I. M. was supported by the Human Frontier Science Program LT001095/2014-L. C.G. was supported by the Irish Research Council for Humanities and Social Sciences (IRCHSS). F.G. was supported by a grant of the Netherlands Organization for Scientific Research, no. 380-62-005. A. K., P. K. and O.M. were supported by RFBR no. 15-06-01916 and RFH no. 15-11-63008 and O.M. by a state grant of the Ministry of Education and Science of the Russia Federation no. 33.1195.2014/k. J. K. was supported by ERC starting grant APGREID and DFG grant KR 4015/1-1. K.W.A. was supported by DFG grant AL 287/14-1. C.L.-F. was supported by a BFU2015-64699-P grant from the Spanish government. W.H. and B.L. were supported by Australian Research Council DP130102158. R.P. was supported by ERC starting grant ADNABIOARC (263441), and an Irish Research Council ERC support grant. D.R. was supported by US National Science Foundation HOMINID grant BCS-1032255, US National Institutes of Health grant GM100233, and the Howard Hughes Medical Institute.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Beleza S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003372; Berg JJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004412; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bokor S, 2010, J LIPID RES, V51, P2325, DOI 10.1194/jlr.M006205; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Burger J, 2007, P NATL ACAD SCI USA, V104, P3736, DOI 10.1073/pnas.0607187104; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chauhan S, 2013, MOL CELL, V50, P16, DOI 10.1016/j.molcel.2013.01.024; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Eiberg H, 2008, HUM GENET, V123, P177, DOI 10.1007/s00439-007-0460-x; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Fujimoto A, 2008, HUM MOL GENET, V17, P835, DOI 10.1093/hmg/ddm355; Fumagalli M, 2015, SCIENCE, V349, P1343, DOI 10.1126/science.aab2319; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Grundemann D, 2005, P NATL ACAD SCI USA, V102, P5256, DOI 10.1073/pnas.0408624102; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Huff CD, 2012, MOL BIOL EVOL, V29, P101, DOI 10.1093/molbev/msr151; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kamberov YG, 2013, CELL, V152, P691, DOI 10.1016/j.cell.2013.01.016; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Kimura R, 2009, AM J HUM GENET, V85, P528, DOI 10.1016/j.ajhg.2009.09.006; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Loh PR, 2013, GENETICS, V193, P1233, DOI 10.1534/genetics.112.147330; Mathias RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044926; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pinhasi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129102; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000505; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Skoglund P, 2013, J ARCHAEOL SCI, V40, P4477, DOI 10.1016/j.jas.2013.07.004; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Turchin MC, 2012, NAT GENET, V44, P1015, DOI 10.1038/ng.2368; Uciechowski P, 2011, J LEUKOCYTE BIOL, V90, P377, DOI 10.1189/jlb.0409233; Underhill PA, 2015, EUR J HUM GENET, V23, P124, DOI 10.1038/ejhg.2014.50; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wilde S, 2014, P NATL ACAD SCI USA, V111, P4832, DOI 10.1073/pnas.1316513111; Wong SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000979	60	652	666	9	281	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					499	+		10.1038/nature16152	http://dx.doi.org/10.1038/nature16152			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CZ3GH	26595274	Green Submitted, Green Accepted			2022-12-28	WOS:000366991900041
J	Wang, HC; Lin, CC; Cheung, R; Zhang-Hooks, Y; Agarwal, A; Ellis-Davies, G; Rock, J; Bergles, DE				Wang, Han Chin; Lin, Chun-Chieh; Cheung, Rocky; Zhang-Hooks, YingXin; Agarwal, Amit; Ellis-Davies, Graham; Rock, Jason; Bergles, Dwight E.			Spontaneous Activity of Cochlear Hair Cells Triggered by Fluid Secretion Mechanism in Adjacent Support Cells	CELL			English	Article							SENSORY EPITHELIA; ACTION-POTENTIALS; INNER; EXPRESSION; HEARING; INHIBITION; SYNAPSES; PATTERN; TMEM16A; ORIGIN	Spontaneous electrical activity of neurons in developing sensory systems promotes their maturation and proper connectivity. In the auditory system, spontaneous activity of cochlear inner hair cells (IHCs) is initiated by the release of ATP from glia-like inner supporting cells (ISCs), facilitating maturation of central pathways before hearing onset. Here, we find that ATP stimulates purinergic autoreceptors in ISCs, triggering Cl- efflux and osmotic cell shrinkage by opening TMEM16A Ca2+-activated Cl- channels. Release of Cl- from ISCs also forces K+ efflux, causing transient depolarization of IHCs near ATP release sites. Genetic deletion of TMEM16A markedly reduces the spontaneous activity of IHCs and spiral ganglion neurons in the developing cochlea and prevents ATP-dependent shrinkage of supporting cells. These results indicate that supporting cells in the developing cochlea have adapted a pathway used for fluid secretion in other organs to induce periodic excitation of hair cells.	[Wang, Han Chin; Lin, Chun-Chieh; Cheung, Rocky; Zhang-Hooks, YingXin; Agarwal, Amit; Bergles, Dwight E.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Ellis-Davies, Graham] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Rock, Jason] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Bergles, Dwight E.] Johns Hopkins Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA	Johns Hopkins University; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Medicine	Bergles, DE (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, 725 North Wolfe St,WBSB 1001, Baltimore, MD 21205 USA.	dbergles@jhmi.edu	Bergles, Dwight/U-8343-2019; Agarwal, Amit/B-7735-2008	Bergles, Dwight/0000-0002-7133-7378; Agarwal, Amit/0000-0001-7948-4498; Cheung, Rocky/0000-0001-6736-9687; Wang, Han Chin/0000-0001-8270-6645	NIH [NS050274, MH084020, DC008860, GM053395, NS06972]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH084020, P50MH100024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069720, P30NS050274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008860] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank Dr. Angelika Doetzlhofer for assistance with in situ hybridization and members of the Bergles laboratory for helpful discussions. Supported by grants from the NIH (NS050274, MH084020, DC008860 for D.E.B. and GM053395, NS06972 for G.E.-D.).	Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Burnstock G, 2000, J PHARMACOL EXP THER, V295, P862; Eskandari S, 2002, J MEMBRANE BIOL, V185, P93, DOI 10.1007/s00232-001-0115-0; Freyer L, 2011, DEVELOPMENT, V138, P5403, DOI 10.1242/dev.069849; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Glowatzki E, 2006, J NEUROSCI, V26, P7659, DOI 10.1523/JNEUROSCI.1545-06.2006; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; GULLEY RL, 1976, J NEUROCYTOL, V5, P479, DOI 10.1007/BF01181652; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Housley GD, 2009, TRENDS NEUROSCI, V32, P128, DOI 10.1016/j.tins.2009.01.001; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; Huang LC, 2010, PURINERG SIGNAL, V6, P231, DOI 10.1007/s11302-010-9191-x; Ito K, 2010, PURINERG SIGNAL, V6, P201, DOI 10.1007/s11302-010-9183-x; Jagger DJ, 2006, J NEUROSCI, V26, P1260, DOI 10.1523/JNEUROSCI.4278-05.2006; Johnson SL, 2011, NAT NEUROSCI, V14, P711, DOI 10.1038/nn.2803; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kirkby LA, 2013, NEURON, V80, P1129, DOI 10.1016/j.neuron.2013.10.030; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Kros CJ, 2007, HEARING RES, V227, P3, DOI 10.1016/j.heares.2006.12.005; LIPPE WR, 1994, J NEUROSCI, V14, P1486, DOI 10.1523/JNEUROSCI.14-03-01486.1994; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Moody WJ, 2005, PHYSIOL REV, V85, P883, DOI 10.1152/physrev.00017.2004; Novak I, 2011, ACTA PHYSIOL, V202, P501, DOI 10.1111/j.1748-1716.2010.02225.x; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Paukert M, 2014, NEURON, V82, P1263, DOI 10.1016/j.neuron.2014.04.038; Rau A, 1999, J COMP NEUROL, V405, P271; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Scheffer DI, 2015, J NEUROSCI, V35, P6366, DOI 10.1523/JNEUROSCI.5126-14.2015; Schreiber R, 2015, PFLUG ARCH EUR J PHY, V467, P1203, DOI 10.1007/s00424-014-1559-2; Sendin G, 2014, P NATL ACAD SCI USA, V111, P1999, DOI 10.1073/pnas.1319615111; SOBKOWICZ HM, 1982, J NEUROSCI, V2, P942; Sugasawa M, 1996, AM J PHYSIOL-CELL PH, V271, pC1817, DOI 10.1152/ajpcell.1996.271.6.C1817; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; Tritsch NX, 2010, NAT NEUROSCI, V13, P1050, DOI 10.1038/nn.2604; Tritsch NX, 2010, PURINERG SIGNAL, V6, P155, DOI 10.1007/s11302-010-9189-4; Tritsch NX, 2010, J NEUROSCI, V30, P1539, DOI 10.1523/JNEUROSCI.3875-09.2010; Wang HC, 2015, CELL TISSUE RES, V361, P65, DOI 10.1007/s00441-014-2007-5; Yi Eunyoung, 2013, Exp Neurobiol, V22, P322, DOI 10.5607/en.2013.22.4.322	41	81	86	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6								10.1016/j.cell.2015.10.070	http://dx.doi.org/10.1016/j.cell.2015.10.070			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26627734	Green Accepted, Bronze			2022-12-28	WOS:000366044800002
J	Gewin, V				Gewin, Virginia			MEDICINE Expanding possibilities	NATURE			English	Editorial Material																		Cancer M. C., 2015, NATURE; Courtney D. G, 2015, GENE THERAPY; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884	5	1	3	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					S10	S11		10.1038/528S10a	http://dx.doi.org/10.1038/528S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26630591	Bronze			2022-12-28	WOS:000365606000005
J	[Anonymous]				[Anonymous]			The Writer as Critic (Reprinted from JAMA, vol 194, pg 1130, 1965)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1965, JAMA, V194, P1130	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2015	314	21					2310	2310		10.1001/jama.2014.12126	http://dx.doi.org/10.1001/jama.2014.12126			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX2GT	26624841				2022-12-28	WOS:000365515700033
J	Nobes, C; Lloyd, A; Marsh, M				Nobes, Catherine; Lloyd, Alison; Marsh, Mark			Alan Hall (1952-2015)	SCIENCE			English	Biographical-Item									[Nobes, Catherine] Univ Bristol, Sch Chem, Bristol BS8 1TD, Avon, England; [Lloyd, Alison; Marsh, Mark] UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England	University of Bristol; MRC Laboratory Molecular Biology; University of London; University College London	Nobes, C (corresponding author), Univ Bristol, Sch Chem, Univ Walk, Bristol BS8 1TD, Avon, England.	m.marsh@ucl.ac.uk	Marsh, Mark/B-4105-2009	Marsh, Mark/0000-0002-0213-3259	Medical Research Council [MC_U122663296, MC_UU_12018/1] Funding Source: Medline; MRC [MC_UU_12018/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		HALL A, PUBLICATION LIST	1	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1039	1039		10.1126/science.aad8407	http://dx.doi.org/10.1126/science.aad8407			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY5BJ	26612941				2022-12-28	WOS:000366422600027
J	Horsburgh, CR; Barry, CE; Lange, C				Horsburgh, C. Robert, Jr.; Barry, Clifton E., III; Lange, Christoph			Treatment of Tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MULTIDRUG-RESISTANT TUBERCULOSIS; RESOURCE-LIMITED SETTINGS; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; HIV; PYRAZINAMIDE; CHEMOTHERAPY; REGIMEN; ADULTS		[Horsburgh, C. Robert, Jr.] Boston Univ, Dept Epidemiol, Boston, MA 02118 USA; [Horsburgh, C. Robert, Jr.] Boston Univ, Dept Biostat, Boston, MA 02118 USA; [Horsburgh, C. Robert, Jr.] Boston Univ, Dept Med, Boston, MA 02118 USA; [Horsburgh, C. Robert, Jr.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02118 USA; [Barry, Clifton E., III] NIAID, TB Res Sect, NIH, Bethesda, MD 20892 USA; [Barry, Clifton E., III] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Lange, Christoph] Res Ctr Borstel, German Ctr Infect Res DZIF TB Unit, Div Clin Infect Dis, Borstel, Germany; [Lange, Christoph] Univ Lubeck, Int Health Infect Dis, Lubeck, Germany	Boston University; Boston University; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cape Town; Forschungszentrum Borstel; German Center for Infection Research; University of Lubeck	Horsburgh, CR (corresponding author), Boston Univ, Sch Publ Hlth, Dept Epidemiol, 715 Albany St,T3E, Boston, MA 02118 USA.	rhorsbu@bu.edu	Barry, III, Clifton/H-3839-2012; Barry, Clifton E/ABE-7992-2020; Lange, Christoph/J-6289-2012	Barry, III, Clifton/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X; Lange, Christoph/0000-0002-9691-4741; Horsburgh, C./0000-0001-6838-7895	Janssen; Chiesi; Gilead; AbbVie; Merck Sharp Dohme	Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Chiesi(Chiesi Pharmaceuticals Inc); Gilead(Gilead Sciences); AbbVie(AbbVie); Merck Sharp Dohme(Merck & Company)	Dr. Horsburgh reports receiving fees from Janssen for serving on a data and safety monitoring board; and Dr. Lange, lecture fees from Chiesi, Gilead, AbbVie, and Merck Sharp & Dohme. No other potential conflict of interest relevant to this article was reported.	Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Ait-Khaled N, 2010, MANAGEMENT TUBERCULO, P1; Albanna AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025075; ALLAN WGL, 1977, AM REV RESPIR DIS, V115, P727; [Anonymous], 2013, GUID MAN TUB CHILDR; [Anonymous], 2014, CANADIAN TUBERCULOSI; Aung KJM, 2014, INT J TUBERC LUNG D, V18, P1180, DOI 10.5588/ijtld.14.0100; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; BioMed Central, EV STAND TREATM REG; Boeree MJ, 2015, AM J RESP CRIT CARE, V191, P1058, DOI 10.1164/rccm.201407-1264OC; Brown AC, 2015, J CLIN MICROBIOL, V53, P2230, DOI 10.1128/JCM.00486-15; Burman WJ, 2009, EMERG INFECT DIS, V15, P1061, DOI 10.3201/eid1507.081253; Chideya S, 2009, CLIN INFECT DIS, V48, P1685, DOI 10.1086/599040; Dartois V, 2014, NAT REV MICROBIOL, V12, P159, DOI 10.1038/nrmicro3200; Department of Health, 2013, MAN DRUG RES TUB POL; Department of Health Republic of South Africa, 2014, NAT TUB MAN GUID; Drusano GL, 2007, CLIN INFECT DIS, V45, pS89, DOI 10.1086/518137; Egelund EF, 2015, CLIN PHARMACOL THER, V98, P387, DOI 10.1002/cpt.180; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; Franke MF, 2015, ANN AM THORAC SOC, V12, P674, DOI 10.1513/AnnalsATS.201411-538OC; Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426; Government of India, 2018, GUIDELINES CLIN OPER; Gunther G, 2015, EMERG INFECT DIS, V21, P409, DOI 10.3201/eid2103.141343; Hayashi Y, 2011, CLIN INFECT DIS, V52, P1232, DOI 10.1093/cid/cir063; Huyen MNT, 2013, J INFECT DIS, V207, P1516, DOI 10.1093/infdis/jit048; Jawahar MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067030; Jindani A, 2014, NEW ENGL J MED, V371, P1599, DOI 10.1056/NEJMoa1314210; Johnson JL, 2009, AM J RESP CRIT CARE, V180, P558, DOI 10.1164/rccm.200904-0536OC; Karumbi J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003343.pub4; Kempker RR, 2015, ANTIMICROB AGENTS CH, V59, P3149, DOI 10.1128/AAC.00379-15; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Kuaban C, 2015, INT J TUBERC LUNG D, V19, P517, DOI 10.5588/ijtld.14.0535; Kumar A, 2013, INDIAN PEDIATR, V50, P301, DOI 10.1007/s13312-013-0085-1; Lange C, 2014, EUR RESPIR J, V44, P23, DOI 10.1183/09031936.00188313; Lawn SD, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-253; Lenaerts A, 2015, IMMUNOL REV, V264, P288, DOI 10.1111/imr.12252; Lv XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065037; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Matsumoto T, 2014, PHARMACOGENOMICS, V15, P601, DOI 10.2217/pgs.14.38; Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817; Miotto P, 2015, CHEST, V147, P1135, DOI 10.1378/chest.14-1286; Mitchison D, 2012, INT J TUBERC LUNG D, V16, P724, DOI 10.5588/ijtld.12.0083; MITCHISON DA, 1979, CHEST, V76, P771, DOI 10.1378/chest.76.6_Supplement.771; Mitchison DA, 2000, INT J TUBERC LUNG D, V4, P796; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; National Institute for Health and Care Excellence, 2011, CLIN DIAGN MAN TUB M; Nunn AJ, 2010, INT J TUBERC LUNG D, V14, P241; Olaru ID, 2015, EUR RESPIR J, V45, P1119, DOI 10.1183/09031936.00162314; Pasipanodya JG, 2013, J INFECT DIS, V208, P1464, DOI 10.1093/infdis/jit352; Pethe K, 2013, NAT MED, V19, P1157, DOI 10.1038/nm.3262; Prideaux B, 2015, NAT MED, V21, P1223, DOI 10.1038/nm.3937; Prideaux B, 2011, ANAL CHEM, V83, P2112, DOI 10.1021/ac1029049; Rock JM, 2015, NAT GENET, V47, P677, DOI 10.1038/ng.3269; Ruslami R, 2013, LANCET INFECT DIS, V13, P27, DOI 10.1016/S1473-3099(12)70264-5; Saukkonen JJ, 2012, AM J RESP CRIT CARE, V185, P598, DOI 10.1164/rccm.201112-2174ED; Schaberg T, 2012, Pneumologie, V66, P133, DOI 10.1055/s-0031-1291619; Semvua HH, 2015, THER DRUG MONIT, V37, P22, DOI 10.1097/FTD.0000000000000108; Sreenivas AR, 2014, STANDARDS TB CARE IN; Treatment of tuberculosis: American Thoracic Society CDC and Infectious Diseases Society of America, 2003, MMWR RECOMM REP, V52, P1; Uthman OA, 2015, ANN INTERN MED, V163, P32, DOI 10.7326/M14-2979; Walker TM, 2015, LANCET INFECT DIS, V15, P1193, DOI 10.1016/S1473-3099(15)00062-6; Weiner M, 2005, CLIN INFECT DIS, V40, P1481, DOI 10.1086/429321; Weiner M, 2010, ANTIMICROB AGENTS CH, V54, P4192, DOI 10.1128/AAC.00353-10; Weis S, 2001, PUBLIC HEALTH REP, V116, P41; WHO, 2009, TREATM TUB GUID NAT; World Health Organization, 2014, COMP HDB WHO GUID PR; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization(WHO), 2014, GUID NAT TUB PROGR M, V2nd	69	193	198	3	68	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2015	373	22					2149	2160		10.1056/NEJMra1413919	http://dx.doi.org/10.1056/NEJMra1413919			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9YT	26605929				2022-12-28	WOS:000365354800009
J	Vidal, J				Vidal, John			Paris climate change talks: what doctors need to know	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Vidal, John] Guardian, London, England		Vidal, J (corresponding author), Guardian, London, England.	john.vidal@theguardian.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2015	351								h6316	10.1136/bmj.h6316	http://dx.doi.org/10.1136/bmj.h6316			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX4SX	26602430				2022-12-28	WOS:000365691700009
J	Sarri, G; Davies, M; Gholitabar, M; Norman, JE				Sarri, Grammati; Davies, Melanie; Gholitabar, Maryam; Norman, Jane E.		Guideline Dev Grp	GUIDELINES Preterm labour: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sarri, Grammati; Davies, Melanie; Gholitabar, Maryam] Royal Coll Obstetricians & Gynaecologists, Natl Collaborating Ctr Womens & Childrens Hlth, London, England; [Davies, Melanie] Univ Coll London Hosp, London, England; [Norman, Jane E.] Univ Edinburgh, MRC Ctr Reprod Hlth, Tommys Ctr Maternal & Fetal Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Edinburgh	Sarri, G (corresponding author), Royal Coll Obstetricians & Gynaecologists, Natl Collaborating Ctr Womens & Childrens Hlth, London, England.	gsarri@rcog.org.uk		Davies, Melanie/0000-0001-6907-5527; Norman, Jane/0000-0001-6031-6953	MRC [G0700452, G1002033] Funding Source: UKRI; Medical Research Council [G0700452, G1002033] Funding Source: researchfish; Chief Scientist Office [CZG/2/575] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office		Costeloe KL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7976; National Institute for Health and Care Excellence, 2015, PRET LAB NEW GUID 25; National Institute for Health and Care Excellence, 2014, INTR CAR HLTH WOM BA; National Institute for Health and Care Excellence, 2011, CAES SECT CLIN GUID; Norman JE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000153; Office for National Statistics, 2012, GEST SPEC INF MORT 2	6	21	21	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2015	351								h6283	10.1136/bmj.h6283	http://dx.doi.org/10.1136/bmj.h6283			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX4SR	26596828	Green Published			2022-12-28	WOS:000365691100003
J	Singhal, S; Leffler, EM; Sannareddy, K; Turner, I; Venn, O; Hooper, DM; Strand, AI; Li, QY; Raney, B; Balakrishnan, CN; Griffith, SC; McVean, G; Przeworski, M				Singhal, Sonal; Leffler, Ellen M.; Sannareddy, Keerthi; Turner, Isaac; Venn, Oliver; Hooper, Daniel M.; Strand, Alva I.; Li, Qiye; Raney, Brian; Balakrishnan, Christopher N.; Griffith, Simon C.; McVean, Gil; Przeworski, Molly			Stable recombination hotspots in birds	SCIENCE			English	Article							BIASED GENE CONVERSION; MEIOTIC RECOMBINATION; LANDSCAPE; GENOME; PRDM9; INITIATION; EVOLUTION; REVEALS; ISLANDS; RATES	The DNA-binding protein PRDM9 has a critical role in specifying meiotic recombination hotspots in mice and apes, but it appears to be absent from other vertebrate species, including birds. To study the evolution and determinants of recombination in species lacking the gene that encodes PRDM9, we inferred fine-scale genetic maps from population resequencing data for two bird species: the zebra finch, Taeniopygia guttata, and the long-tailed finch, Poephila acuticauda. We found that both species have recombination hotspots, which are enriched near functional genomic elements. Unlike in mice and apes, most hotspots are shared between the two species, and their conservation seems to extend over tens of millions of years. These observations suggest that in the absence of PRDM9, recombination targets functional features that both enable access to the genome and constrain its evolution.	[Singhal, Sonal; Strand, Alva I.; Przeworski, Molly] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Singhal, Sonal; Przeworski, Molly] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Leffler, Ellen M.; Sannareddy, Keerthi] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Leffler, Ellen M.; Turner, Isaac; Venn, Oliver; McVean, Gil] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Hooper, Daniel M.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Li, Qiye] BGI Shenzhen, China Natl Genebank, Shenzhen 518083, Peoples R China; [Raney, Brian] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Balakrishnan, Christopher N.] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Griffith, Simon C.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	Columbia University; Columbia University; University of Chicago; University of Oxford; Wellcome Centre for Human Genetics; University of Chicago; Beijing Genomics Institute (BGI); University of California System; University of California Santa Cruz; University of North Carolina; East Carolina University; Macquarie University	Singhal, S (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	sonal.singhal1@gmail.com; molly.przew@gmail.com	Griffith, Simon/AAH-3706-2021; Li, Qiye/C-1348-2015; Griffith, Simon/A-1996-2010; Leffler, Ellen/I-3010-2019; Raney, Brian/ABE-6267-2020; Balakrishnan, Christopher/A-3043-2014	Griffith, Simon/0000-0001-7612-4999; Li, Qiye/0000-0002-5993-0312; Griffith, Simon/0000-0001-7612-4999; Leffler, Ellen/0000-0002-1614-9366; Turner, Isaac/0000-0002-2378-4886; Strand, Alva/0000-0001-6929-5968; Sannareddy, Keerthi Sindhura/0000-0003-0684-7045; Balakrishnan, Christopher/0000-0002-0788-0659	Wellcome Trust [086786/Z/08/Z, 090532/Z/09/Z]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083098, T32GM008798] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was started when M.P. was a Howard Hughes Medical Institute Early Career Scientist and was funded, in part, by Wellcome Trust grants 086786/Z/08/Z to O.V. and 090532/Z/09/Z to the Wellcome Trust Centre for Human Genetics. We thank B. de Massy, C. Grey, S. Myers, T. Price, M. Schumer, J. Wall, A. Williams, and J. Willis for helpful discussions and/or comments on the manuscript; K. Argoud and P. Piazza at the Genomics Core at the Wellcome Trust Centre for Human Genetics for assistance with laboratory work; and M. T. Gilbert for sharing the zebra finch gene annotations in advance of publication. We thank I. Lam and S. Keeney for sharing their unpublished manuscript with us, S. Keeney for many helpful discussions, and A. Johnson for the illustrations used in Fig. 1. Binary Alignment Map files for genomic data and filtered variant call files for the zebra finch, long-tailed finch, and double-barred finch are available at www.ebi.ac.uk/ena/data/view/PRJEB10586. Sequence reads for zebra finch RNA sequencing experiments are available at www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA295077. Masked genome files, the reconstructed ancestral genome, and recombination maps for both species are available at DataDryad (doi: 10.5061/dryad.fd24j). All scripts and an electronic laboratory notebook for this work are available at https://github.com/singhal/postdoc and https://github.com/singhal/labnotebook, respectively.	Auton A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003984; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Axelsson E, 2012, GENOME RES, V22, P51, DOI 10.1101/gr.124123.111; Backstrom N, 2010, GENOME RES, V20, P485, DOI 10.1101/gr.101410.109; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; Chan AH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003090; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Choi KH, 2013, NAT GENET, V45, P1327, DOI 10.1038/ng.2766; CHRISTIDIS L, 1986, GENETICA, V71, P81, DOI 10.1007/BF00058691; de Massy B, 2013, ANNU REV GENET, V47, P563, DOI 10.1146/annurev-genet-110711-155423; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dumont BL, 2008, EVOLUTION, V62, P276, DOI 10.1111/j.1558-5646.2007.00278.x; Hellsten U, 2013, P NATL ACAD SCI USA, V110, P19478, DOI 10.1073/pnas.1319032110; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Itoh Y, 2011, CHROMOSOMA, V120, P255, DOI 10.1007/s00412-010-0308-3; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kaur T, 2014, GENETICS, V196, P137, DOI 10.1534/genetics.113.158857; Kawakami T, 2014, MOL ECOL, V23, P4035, DOI 10.1111/mec.12810; Lam I, 2015, SCIENCE, V350, P932, DOI 10.1126/science.aad0814; Leffler EM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001388; Mugal CF, 2013, MOL BIOL EVOL, V30, P1700, DOI 10.1093/molbev/mst067; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Nachman MW, 2001, TRENDS GENET, V17, P481, DOI 10.1016/S0168-9525(01)02409-X; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; Otto SP, 2011, TRENDS GENET, V27, P358, DOI 10.1016/j.tig.2011.05.001; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Wallberg A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005189; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Weber CC, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0549-1; Wijnker E, 2013, ELIFE, V2, DOI 10.7554/eLife.01426; Williams AL, 2015, ELIFE, V4, DOI 10.7554/eLife.04637; Zhang G., 2012, **DATA OBJECT**, DOI [10.5524/100040, DOI 10.5524/100040]; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385	39	156	157	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					928	932		10.1126/science.aad0843	http://dx.doi.org/10.1126/science.aad0843			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW4IP	26586757	Green Submitted, Green Accepted			2022-12-28	WOS:000364955200038
J	Janssen, M; Renn, J				Janssen, Michel; Renn, Juergen			Einstein was no lone genius	NATURE			English	Editorial Material									[Janssen, Michel] Univ Minnesota, Program Hist Sci Technol & Med, Minneapolis, MN USA; [Renn, Juergen] Max Planck Inst Hist Sci, Berlin, Germany	University of Minnesota System; University of Minnesota Twin Cities; Max Planck Society	Janssen, M (corresponding author), Univ Minnesota, Program Hist Sci Technol & Med, Minneapolis, MN USA.	janss011@umn.edu; renn@mpiwg-berlin.mpg.de						Clark R. W, 1971, EINSTEIN LIFE TIMES, P156; Crelinsten Jeffrey, 2013, E JURY RACE TEST REL; Gutfreund H, 2015, ROAD RELATIVITY; Janssen Michel, 2014, CAMBRIDGE COMPANION; Norton J.D., 2015, STANFORD ENCY PHILOS; Pais A, 1982, SUBTLE IS LORD SCI L, P212; Renn J, 2007, GENESIS GEN RELATIVI, V2, P819; Sauer T, 2015, P 13 M GROSSM M, P456, DOI [10.1142/9789814623995_0023, DOI 10.1142/9789814623995_0023]; STACHEL J, 1987, COLLECTED PAPERS A E; [No title captured]	10	6	6	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					298	300		10.1038/527298a	http://dx.doi.org/10.1038/527298a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW9ZN	26581276	Bronze			2022-12-28	WOS:000365356800028
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING An unexpected headline: more US white people are dying	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kamerow, Douglas] Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20052 USA; [Kamerow, Douglas] Georgetown Univ, Family Med, Washington, DC 20057 USA	Georgetown University	Kamerow, D (corresponding author), Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20052 USA.	dkamerow@aafp.org		Kamerow, Douglas/0000-0001-7000-9957				[Anonymous], 2015, NY TIMES; Ashenbach J, 2015, WASHINGTON POST; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Kolata G, 2015, NY TIMES, pA1; Ma JM, 2015, JAMA-J AM MED ASSOC, V314, P1731, DOI 10.1001/jama.2015.12319; McKay B, 2015, WALL STREET J, pA1	6	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 17	2015	351								h6180	10.1136/bmj.h6180	http://dx.doi.org/10.1136/bmj.h6180			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XV	26578225				2022-12-28	WOS:000365352400006
J	Macdonald-Wallis, C; Silverwood, RJ; de Stavola, BL; Inskip, H; Cooper, C; Godfrey, KM; Crozier, S; Fraser, A; Nelson, SM; Lawlor, DA; Tilling, K				Macdonald-Wallis, Corrie; Silverwood, Richard J.; de Stavola, Bianca L.; Inskip, Hazel; Cooper, Cyrus; Godfrey, Keith M.; Crozier, Sarah; Fraser, Abigail; Nelson, Scott M.; Lawlor, Debbie A.; Tilling, Kate			Antenatal blood pressure for prediction of pre-eclampsia, preterm birth, and small for gestational age babies: development and validation in two general population cohorts	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UTERINE ARTERY DOPPLER; PLASMA-PROTEIN-A; NULLIPAROUS WOMEN; HYPERTENSIVE DISORDERS; 1ST-TRIMESTER PREDICTION; CLINICAL RISK; FETAL-GROWTH; PREGNANCY; WEIGHT; MODEL	STUDY QUESTION Can routine antenatal blood pressure measurements between 20 and 36 weeks' gestation contribute to the prediction of pre-eclampsia and its associated adverse outcomes? METHODS This study used repeated antenatal measurements of blood pressure from 12 996 women in the Avon Longitudinal Study of Parents and Children (ALSPAC) to develop prediction models and validated these in 3005 women from the Southampton Women's Survey (SWS). A model based on maternal early pregnancy characteristics only (BMI, height, age, parity, smoking, existing and previous gestational hypertension and diabetes, and ethnicity) plus initial mean arterial pressure was compared with a model additionally including current mean arterial pressure, a model including the deviation of current mean arterial pressure from a stratified normogram, and a model including both at different gestational ages from 20-36 weeks. STUDY ANSWER AND LIMITATIONS The addition of blood pressure measurements from 28 weeks onwards improved prediction models compared with use of early pregnancy risk factors alone, but they contributed little to the prediction of preterm birth or small for gestational age. Though multiple imputation of missing data was used to increase the sample size and minimise selection bias, the validation sample might have been slightly underpowered as the number of cases of pre-eclampsia was just below the recommended 100. Several risk factors were self reported, potentially introducing measurement error, but this reflects how information would be obtained in clinical practice. WHAT THIS STUDY ADDS The addition of routinely collected blood pressure measurements from 28 weeks onwards improves predictive models for pre-eclampsia based on blood pressure in early pregnancy and other characteristics, facilitating a reduction in scheduled antenatal care.	[Macdonald-Wallis, Corrie; Fraser, Abigail; Lawlor, Debbie A.; Tilling, Kate] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England; [Macdonald-Wallis, Corrie; Fraser, Abigail; Lawlor, Debbie A.; Tilling, Kate] Univ Bristol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Silverwood, Richard J.; de Stavola, Bianca L.] London Sch Hyg & Trop Med, Dept Med Stat, London WC1E 7HT, England; [Silverwood, Richard J.; de Stavola, Bianca L.] London Sch Hyg & Trop Med, Ctr Stat Methodol, London WC1E 7HT, England; [Inskip, Hazel; Cooper, Cyrus; Godfrey, Keith M.; Crozier, Sarah] Univ Southampton, Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton SO16 6YD, Hants, England; [Inskip, Hazel; Cooper, Cyrus; Godfrey, Keith M.] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton SO16 6YD, Hants, England; [Inskip, Hazel; Cooper, Cyrus; Godfrey, Keith M.] Southampton Gen Hosp, Univ Hosp Southampton NHS Fdn Trust, Southampton SO16 6YD, Hants, England; [Cooper, Cyrus] Univ Oxford, Natl Inst Hlth Res, Musculoskeletal Biomed Res Unit, Oxford OX3 7LE, England; [Nelson, Scott M.] Univ Glasgow, Sch Med, Glasgow G12 8QQ, Lanark, Scotland	University of Bristol; University of Bristol; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Oxford; University of Glasgow	Macdonald-Wallis, C (corresponding author), Univ Bristol, MRC Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England.	C.Macdonald-Wallis@bristol.ac.uk	Tilling, Kate/AAY-1578-2021; Silverwood, Richard/A-1249-2014; Inskip, Hazel/L-5467-2018	Silverwood, Richard/0000-0002-2744-1194; Inskip, Hazel/0000-0001-8897-1749; Tilling, Kate/0000-0002-1010-8926; Lawlor, Debbie A/0000-0002-6793-2262; Godfrey, Keith/0000-0002-4643-0618; Crozier, Sarah/0000-0002-9524-1127; De Stavola, Bianca Lucia/0000-0001-7853-0528; Fraser, Abigail/0000-0002-7741-9470; Cooper, Cyrus/0000-0003-3510-0709; Macdonald-Wallis, Corrie/0000-0002-4447-3817	UK Wellcome Trust [WT087997MA]; US National Institutes of Health [R01 DK077659]; UK Medical Research Council (MRC) [MR/J011932/1, 0701594]; UK MRC [MC_UU_12013/5, MC_UU_12013/9]; Wellcome Trust; University of Bristol; National Institute of Health Research Senior Investigator Award [NF-SI-0611-10196]; European Union's Seventh Framework Programme [289346]; National Institute for Health Research through NIHR Southampton Biomedical Research Centre; MRC [MC_U147585827, MC_UU_12013/9, MC_UU_12011/4, G0701594, MC_UU_12013/5, MC_UP_A620_1017, MC_U147585819, MR/M009351/1, MR/J011932/1] Funding Source: UKRI; British Heart Foundation [RG/07/009/23120] Funding Source: researchfish; Medical Research Council [MC_U147585819, G0701594, MC_PC_15018, MC_UU_12013/9, MR/J011932/1, U1475000001, MR/M009351/1, MC_UP_A620_1017, MC_UU_12011/1, MC_UU_12013/5, MC_UP_A620_1014, MC_UU_12011/4, MC_U147585827] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082, NF-SI-0513-10085] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077659] Funding Source: NIH RePORTER	UK Wellcome Trust(Wellcome Trust); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); University of Bristol; National Institute of Health Research Senior Investigator Award; European Union's Seventh Framework Programme(European Commission); National Institute for Health Research through NIHR Southampton Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the UK Wellcome Trust (grant No WT087997MA) and US National Institutes of Health (grant No R01 DK077659). CM-W and AF are funded by UK Medical Research Council (MRC) research fellowships (grant No MR/J011932/1 and 0701594, respectively). Core support for ALSPAC is provided by the UK MRC, the Wellcome Trust, and the University of Bristol. CMW, DAL, AF, and KT work in a unit that receives funds from the UK MRC (MC_UU_12013/5 and MC_UU_12013/9). DAL has a National Institute of Health Research Senior Investigator Award (NF-SI-0611-10196). Core support for SWS is provided by the UK MRC, with adjunctive support from the European Union's Seventh Framework Programme (FP7/2007-2013), project EarlyNutrition under grant agreement n 289346. KMG and CC are supported by the National Institute for Health Research through the NIHR Southampton Biomedical Research Centre. The funders had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Akolekar R, 2011, PRENATAL DIAG, V31, P66, DOI 10.1002/pd.2660; ANANTH CV, 1995, EPIDEMIOLOGY, V6, P391, DOI 10.1097/00001648-199507000-00011; Bakker R, 2011, AM J EPIDEMIOL, V174, P797, DOI 10.1093/aje/kwr151; Bastawrous A, 2012, EYE, V26, P343, DOI 10.1038/eye.2012.6; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; Centre for Maternal and Child Enquiries (CMACE), 2011, PER MORT 2009; Chappell LC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6398; Cnossen JS, 2008, BMJ-BRIT MED J, V336, P1117, DOI 10.1136/bmj.39540.522049.BE; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Dugoff L, 2004, AM J OBSTET GYNECOL, V191, P1446, DOI 10.1016/j.ajog.2004.06.052; Fraser A, 2012, INT J EPIDEMIOL, V42, P14; Gaillard R, 2011, EUR HEART J, V32, P3088, DOI 10.1093/eurheartj/ehr275; Giardini ME, 2014, IEEE ENG MED BIO, P2177, DOI 10.1109/EMBC.2014.6944049; Greer IA, 2005, BMJ-BRIT MED J, V330, P549, DOI 10.1136/bmj.330.7491.549; Heath VCF, 1998, ULTRASOUND OBST GYN, V12, P312, DOI 10.1046/j.1469-0705.1998.12050312.x; Huusom LD, 2011, BJOG-INT J OBSTET GY, V118, P1, DOI 10.1111/j.1471-0528.2010.02782.x; Inskip HM, 2006, INT J EPIDEMIOL, V35, P42, DOI 10.1093/ije/dyi202; Kenny LC, 2014, HYPERTENSION, V64, P644, DOI 10.1161/HYPERTENSIONAHA.114.03578; Kleinrouweler CE, 2016, AM J OBSTET GYNECOL, V214, P79, DOI 10.1016/j.ajog.2015.06.013; Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4; Leckie G., 2011, RUNMLWIN STATA MODUL; Macdonald-Wallis C, 2014, J HYPERTENS, V33, P10; Macdonald-Wallis C, 2014, HYPERTENSION, V64, P36, DOI 10.1161/HYPERTENSIONAHA.113.02766; Macdonald-Wallis C, 2012, HYPERTENSION, V59, P1241, DOI 10.1161/HYPERTENSIONAHA.111.187039; Milne F, 2005, BRIT MED J, V330, P576, DOI 10.1136/bmj.330.7491.576; Myatt L, 2012, OBSTET GYNECOL, V119, P1234, DOI 10.1097/AOG.0b013e3182571669; National Institute for Health and Clinical Excellence, 2008, ANT CAR NICE CLIN GU; Nijdam ME, 2010, J HYPERTENS, V28, P119, DOI 10.1097/HJH.0b013e32833191b0; North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875; Onwudiwe N, 2008, ULTRASOUND OBST GYN, V32, P877, DOI 10.1002/uog.6124; Pell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053747; Pipkin FB, 1998, J HYPERTENS, V16, P221, DOI 10.1097/00004872-199816020-00013; Plasencia W, 2008, ULTRASOUND OBST GYN, V32, P138, DOI 10.1002/uog.5402; Plasencia W, 2007, ULTRASOUND OBST GYN, V30, P742, DOI 10.1002/uog.5157; Poon LCY, 2009, ULTRASOUND OBST GYN, V33, P23, DOI 10.1002/uog.6280; Poon LCY, 2008, HYPERTENSION, V51, P1027, DOI 10.1161/HYPERTENSIONAHA.107.104646; Poon LCY, 2009, HYPERTENSION, V53, P812, DOI 10.1161/HYPERTENSIONAHA.108.127977; Smith GCS, 2002, J CLIN ENDOCR METAB, V87, P1762, DOI 10.1210/jc.87.4.1762; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Steer PJ, 2004, BRIT MED J, V329, P1312, DOI 10.1136/bmj.38258.566262.7C; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017; Vergouwe Y, 2010, J CLIN EPIDEMIOL, V63, P205, DOI 10.1016/j.jclinepi.2009.03.017; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Xiong X, 2002, AM J EPIDEMIOL, V155, P203, DOI 10.1093/aje/155.3.203	49	34	35	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 17	2015	351								h5948	10.1136/bmj.h5948	http://dx.doi.org/10.1136/bmj.h5948			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XV	26578347	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000365352400001
J	Carrizosa, E; Mempel, TR				Carrizosa, Esteban; Mempel, Thorsten R.			IMMUNOLOGY In the right place at the right time	NATURE			English	Editorial Material							T-CELLS; TCR		[Carrizosa, Esteban] Harvard Univ, Sch Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Carrizosa, E (corresponding author), Harvard Univ, Sch Med, Boston, MA 02114 USA.	tmempel@mgh.harvard.edu						Bauer CA, 2014, J CLIN INVEST, V124, P2425, DOI 10.1172/JCI66375; Benoist C, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007021; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Hogquist KA, 2014, NAT IMMUNOL, V15, P815, DOI 10.1038/ni.2938; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Liu ZD, 2015, NATURE, V528, P225, DOI 10.1038/nature16169; O'Gorman WE, 2009, J IMMUNOL, V183, P332, DOI 10.4049/jimmunol.0900691; Vahl JC, 2014, IMMUNITY, V41, P722, DOI 10.1016/j.immuni.2014.10.012	9	2	2	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					205	206		10.1038/nature16312	http://dx.doi.org/10.1038/nature16312			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26605531				2022-12-28	WOS:000366053300029
J	Lewis, JI; Fridley, DG; Price, LK; Lu, HY; Romankiewicz, JP				Lewis, Joanna I.; Fridley, David G.; Price, Lynn K.; Lu, Hongyou; Romankiewicz, John P.			Understanding China's non-fossil energy targets	SCIENCE			English	Editorial Material									[Lewis, Joanna I.] Georgetown Univ, Edmund A Walsh Sch Foreign Serv, Sci Technol & Int Affairs Program, Washington, DC 20057 USA; [Lewis, Joanna I.; Fridley, David G.; Price, Lynn K.; Lu, Hongyou] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, China Energy Grp, Berkeley, CA 94720 USA; [Lu, Hongyou; Romankiewicz, John P.] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA	Georgetown University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Lewis, JI (corresponding author), Georgetown Univ, Edmund A Walsh Sch Foreign Serv, Sci Technol & Int Affairs Program, Washington, DC 20057 USA.	Joanna.Lewis@georgetown.edu	Lu, Hongyou/HGT-8518-2022	Lu, Hongyou/0000-0003-1399-1977; Lewis, Joanna I./0000-0002-5362-1308	Direct For Social, Behav & Economic Scie [1262452] Funding Source: National Science Foundation	Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Department of Climate Change National Development and Reform Commission of China, 2015, ENH ACT CLIM CHANG C; Editorial Board of the China Electric Power Yearbook, 2011, CHIN EL POW YB 2011; EIA, 2019, ANN EN OUTL; EIA DOE, 2012, ANN EN OUTL 2011; Fu S., 2015, COMMENTS CHINAS INDC; Lightfoot HD, 2007, ENERGY, V32, P1478, DOI 10.1016/j.energy.2006.10.009; Martinot E, 2007, ANNU REV ENV RESOUR, V32, P205, DOI 10.1146/annurev.energy.32.080106.133554; Moomaw W., 2011, IPCC SPECIAL REPORT; National Bureau of Statistics, 2011, CHIN EN STAT YB 2011; OECD IEA Eurostat, 2004, EN STAT MAN; REN21, 2015, REN GLOB STAT REP 20; Stratistical BP, 2014, STAT REV WORLD ENERG, V67, P1; Su W., 2010, COPENHAGEN ACCORD; World Energy Council, 2013, WORLD EN SCEN COMP E; [No title captured]	15	21	21	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1034	1036		10.1126/science.aad1084	http://dx.doi.org/10.1126/science.aad1084			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY5BJ	26612938				2022-12-28	WOS:000366422600024
J	Cho, JL; McDermott, S; Tsibris, AM; Mark, EJ				Cho, Josalyn L.; McDermott, Shaunagh; Tsibris, Athe M.; Mark, Eugene J.			Case 37-2015: A 76-Year-Old Man with Fevers, Leukopenia, and Pulmonary Infiltrates Disseminated Mycobacterium bovis infection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GRANULOMATOUS LUNG-DISEASE; HOT-TUB LUNG; HYPERSENSITIVITY PNEUMONITIS; NONTUBERCULOUS MYCOBACTERIA; MILIARY TUBERCULOSIS; RADIOLOGIC FEATURES; CLINICAL-FEATURES; AVIUM COMPLEX; DIAGNOSIS; HISTOPATHOLOGY		[Cho, Josalyn L.; Tsibris, Athe M.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [McDermott, Shaunagh] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Mark, Eugene J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Cho, Josalyn L.; Tsibris, Athe M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [McDermott, Shaunagh] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Mark, Eugene J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Cho, JL (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Cho, Josalyn/ABF-8931-2021	Cho, Josalyn/0000-0002-0367-4495				Barrios RJ, 2008, ARCH PATHOL LAB MED, V132, P199, DOI 10.1043/1543-2165(2008)132[199:HPH]2.0.CO;2; Cadranel J, 2002, EUR RESPIR J, V20, P750, DOI 10.1183/09031936.02.00404102; Cha SI, 2006, EUR RESPIR J, V28, P364, DOI 10.1183/09031936.06.00076705; GAUDIN PB, 1995, AM J CLIN PATHOL, V104, P7, DOI 10.1093/ajcp/104.1.7; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Grunes D, 2013, J CLIN PATHOL, V66, P888, DOI 10.1136/jclinpath-2012-201337; GUPTA RC, 1988, CHEST, V94, P1296, DOI 10.1378/chest.94.6.1296; Hanak V, 2006, RESP MED, V100, P610, DOI 10.1016/j.rmed.2005.08.005; Hariri LP, 2012, HUM PATHOL, V43, P660, DOI 10.1016/j.humpath.2011.06.001; Judson MA, 2015, CLIN REV ALLERG IMMU, V49, P63, DOI 10.1007/s12016-014-8450-y; Kahana LM, 1997, CHEST, V111, P242, DOI 10.1378/chest.111.1.242; KESTEN S, 1990, THORAX, V45, P709, DOI 10.1136/thx.45.9.709; Khoor A, 2001, AM J CLIN PATHOL, V115, P755, DOI 10.1309/JRDC-0MJV-ACA3-2U9L; KRYSL J, 1994, CAN ASSOC RADIOL J, V45, P101; LAMM DL, 1986, J UROLOGY, V135, P272, DOI 10.1016/S0022-5347(17)45606-0; Lee JS, 2000, AM J ROENTGENOL, V175, P1335, DOI 10.2214/ajr.175.5.1751335; Low SU, 2006, J CLIN PATHOL, V59, P223; MAARTENS G, 1990, AM J MED, V89, P291, DOI 10.1016/0002-9343(90)90340-J; Mukhopadhyay S, 2010, ARCH PATHOL LAB MED, V134, P667, DOI 10.1043/1543-2165-134.5.667; PALAYEW M, 1993, CHEST, V104, P307, DOI 10.1378/chest.104.1.307; Rickman OB, 2002, MAYO CLIN PROC, V77, P1233, DOI 10.4065/77.11.1233; Saccente M, 2010, CLIN MICROBIOL REV, V23, P367, DOI 10.1128/CMR.00056-09; Selman M, 2012, AM J RESP CRIT CARE, V186, P314, DOI 10.1164/rccm.201203-0513CI; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Smith JA, 2012, RESPIROLOGY, V17, P913, DOI 10.1111/j.1440-1843.2012.02150.x; Sood A, 2007, ENVIRON HEALTH PERSP, V115, P262, DOI 10.1289/ehp.9542	26	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2015	373	22					2162	2172		10.1056/NEJMcpc1504839	http://dx.doi.org/10.1056/NEJMcpc1504839			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9YT	26605931				2022-12-28	WOS:000365354800013
J	Gross, JG; Glassman, AR; Jampol, LM; Inusah, S; Aiello, LP; Antoszyk, AN; Baker, CW; Berger, BB; Bressler, NM; Browning, D; Elman, MJ; Ferris, FL; Friedman, SM; Marcus, DM; Melia, M; Stockdale, CR; Sun, JK; Beck, RW				Gross, Jeffrey G.; Glassman, Adam R.; Jampol, Lee M.; Inusah, Seidu; Aiello, Lloyd Paul; Antoszyk, Andrew N.; Baker, Carl W.; Berger, Brian B.; Bressler, Neil M.; Browning, David; Elman, Michael J.; Ferris, Frederick L., III; Friedman, Scott M.; Marcus, Dennis M.; Melia, Michele; Stockdale, Cynthia R.; Sun, Jennifer K.; Beck, Roy W.		Diabet Retinopathy Clin Res Networ	Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VISUAL-ACUITY; BEVACIZUMAB; AFLIBERCEPT	IMPORTANCE Panretinal photocoagulation (PRP) is the standard treatment for reducing severe visual loss from proliferative diabetic retinopathy. However, PRP can damage the retina, resulting in peripheral vision loss or worsening diabetic macular edema (DME). OBJECTIVE To evaluate the noninferiority of intravitreous ranibizumab compared with PRP for visual acuity outcomes in patients with proliferative diabetic retinopathy. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial conducted at 55 US sites among 305 adults with proliferative diabetic retinopathy enrolled between February and December 2012 (mean age, 52 years; 44% female; 52% white). Both eyes were enrolled for 89 participants (1 eye to each study group), with a total of 394 study eyes. The final 2-year visit was completed in January 2015. INTERVENTIONS Individual eyes were randomly assigned to receive PRP treatment, completed in 1 to 3 visits (n = 203 eyes), or ranibizumab, 0.5mg, by intravitreous injection at baseline and as frequently as every 4 weeks based on a structured re-treatment protocol (n = 191 eyes). Eyes in both treatment groups could receive ranibizumab for DME. MAIN OUTCOMES AND MEASURES The primary outcome was mean visual acuity change at 2 years (5-letter noninferiority margin; intention-to-treat analysis). Secondary outcomes included visual acuity area under the curve, peripheral visual field loss, vitrectomy, DME development, and retinal neovascularization. RESULTS Mean visual acuity letter improvement at 2 years was +2.8 in the ranibizumab group vs +0.2 in the PRP group (difference, +2.2; 95% CI, -0.5 to +5.0; P < .001 for noninferiority). The mean treatment group difference in visual acuity area under the curve over 2 years was +4.2 (95% CI, +3.0 to +5.4; P < .001). Mean peripheral visual field sensitivity loss was worse (-23 dB vs -422 dB; difference, 372 dB; 95% CI, 213-531 dB; P < .001), vitrectomy was more frequent (15% vs 4%; difference, 9%; 95% CI, 4%-15%; P < .001), and DME development was more frequent (28% vs 9%; difference, 19%; 95% CI, 10%-28%; P < .001) in the PRP group vs the ranibizumab group, respectively. Eyes without active or regressed neovascularization at 2 years were not significantly different (35% in the ranibizumab group vs 30% in the PRP group; difference, 3%; 95% CI, -7% to 12%; P = .58). One eye in the ranibizumab group developed endophthalmitis. No significant differences between groups in rates of major cardiovascular events were identified. CONCLUSIONS AND RELEVANCE Among eyes with proliferative diabetic retinopathy, treatment with ranibizumab resulted in visual acuity that was noninferior to (not worse than) PRP treatment at 2 years. Although longer-term follow-up is needed, ranibizumab may be a reasonable treatment alternative, at least through 2 years, for patients with proliferative diabetic retinopathy.	[Gross, Jeffrey G.] Carolina Retina Ctr PA, Columbia, SC USA; [Glassman, Adam R.; Inusah, Seidu; Melia, Michele; Beck, Roy W.] Jaeb Ctr Hlth Res, Tampa, FL 33647 USA; [Jampol, Lee M.; Stockdale, Cynthia R.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Aiello, Lloyd Paul; Sun, Jennifer K.] Harvard Univ, Joslin Diabet Ctr, Beetham Eye Inst, Dept Ophthalmol, Boston, MA 02115 USA; [Antoszyk, Andrew N.; Browning, David] Charlotte Eye Ear Nose & Throat Associates PA, Charlotte, NC USA; [Baker, Carl W.] Paducah Retinal Ctr, Paducah, KY USA; [Berger, Brian B.] Retina Res Ctr, Austin, TX USA; [Bressler, Neil M.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Elman, Michael J.] Elman Retina Grp PA, Baltimore, MD USA; [Ferris, Frederick L., III] NEI, NIH, Bethesda, MD 20892 USA; [Friedman, Scott M.] Florida Retina Consultants, Lakeland, FL USA; [Marcus, Dennis M.] Southeast Retina Ctr PC, Augusta, GA USA	JAEB Center For Health Research; Northwestern University; Feinberg School of Medicine; Harvard University; Joslin Diabetes Center, Inc.; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Glassman, AR (corresponding author), Jaeb Ctr Hlth Res, 15310 Amberly Dr,Ste 350, Tampa, FL 33647 USA.	drcrstat2@jaeb.org	Sun, Jennifer K/AAP-2734-2020	Sun, Jennifer K/0000-0003-0915-6303; Ferris, Frederick/0000-0002-4933-0639; Elman, Michael/0000-0001-7726-9508; Glassman, Adam/0000-0003-0173-1684	National Eye Institute; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, US Department of Health and Human Services [EY14231, EY23207, EY18817]; Genentech; NATIONAL EYE INSTITUTE [U10EY018817, U10EY023207, U10EY014231] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, US Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Genentech(Roche HoldingGenentech); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported through a cooperative agreement from the National Eye Institute and the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, US Department of Health and Human Services (grants EY14231, EY23207, and EY18817). Genentech provided ranibizumab for the study and funds to the DRCR.net to defray the study's clinical site costs.	Aiello LP, 2011, OPHTHALMOLOGY, V118, pE5, DOI 10.1016/j.ophtha.2011.09.058; Aiello LP, 2005, NEW ENGL J MED, V353, P839, DOI 10.1056/NEJMe058142; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; [Anonymous], 1981, OPHTHALMOLOGY, V88, P583; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Beck RW, 2007, OPHTHALMOLOGY, V114, P1804, DOI 10.1016/j.ophtha.2007.06.047; Beck RW, 2003, AM J OPHTHALMOL, V135, P194, DOI 10.1016/S0002-9394(02)01825-1; Bressler SB, 2014, JAMA OPHTHALMOL, V132, P1113, DOI 10.1001/jamaophthalmol.2014.1698; Brucker AJ, 2009, ARCH OPHTHALMOL-CHIC, V127, P132, DOI 10.1001/archophthalmol.2008.565; Centers for Disease Control and Prevention, 2004, ANTIBIOTIC RESISTANC; Diabetic Retinopathy Clinical Research Network*, 2013, JAMA Ophthalmol, V131, P283, DOI 10.1001/jamaophthalmol.2013.2015; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Googe J, 2011, RETINA-J RET VIT DIS, V31, P1009, DOI 10.1097/IAE.0b013e318217d739; Ip MS, 2012, ARCH OPHTHALMOL-CHIC, V130, P1145, DOI 10.1001/archophthalmol.2012.1043; Korobelnik JF, 2014, OPHTHALMOLOGY, V121, P2247, DOI 10.1016/j.ophtha.2014.05.006; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Rezaei K, 2014, GLOBAL TRENDS RETINA; SAS Institute Inc, 2011, SAS STAT 9 3 US GUID; Silva PS, 2013, RETINA; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Wells JA, 2015, NEW ENGL J MED, V372, P1193, DOI 10.1056/NEJMoa1414264	23	427	438	3	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2015	314	20					2137	2146		10.1001/jama.2015.15217	http://dx.doi.org/10.1001/jama.2015.15217			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XQ	26565927	Green Accepted, Bronze			2022-12-28	WOS:000365351900017
J	Rao, N				Rao, Nyapati			A Hobson's Choice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rao, Nyapati] Nassau Univ Med Ctr, Dept Psychiat, E Meadow, NY 11554 USA		Rao, N (corresponding author), Nassau Univ Med Ctr, Dept Psychiat, E Meadow, NY 11554 USA.	nrao@numc.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2015	314	20					2133	2134		10.1001/jama.2015.10252	http://dx.doi.org/10.1001/jama.2015.10252			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XQ	26599183				2022-12-28	WOS:000365351900015
J	Li, L; Connors, MJ; Kolle, M; England, GT; Speiser, DI; Xiao, XH; Aizenberg, J; Ortiz, C				Li, Ling; Connors, Matthew J.; Kolle, Mathias; England, Grant T.; Speiser, Daniel I.; Xiao, Xianghui; Aizenberg, Joanna; Ortiz, Christine			Multifunctionality of chiton biomineralized armor with an integrated visual system	SCIENCE			English	Article							SHELL; EYES; MOLLUSCA; DESIGN; LENSES	Nature provides a multitude of examples of multifunctional structural materials in which trade-offs are imposed by conflicting functional requirements. One such example is the biomineralized armor of the chiton Acanthopleura granulata, which incorporates an integrated sensory system that includes hundreds of eyes with aragonite-based lenses. We use optical experiments to demonstrate that these microscopic lenses are able to form images. Light scattering by the polycrystalline lenses is minimized by the use of relatively large, crystallographically aligned grains. Multiscale mechanical testing reveals that as the size, complexity, and functionality of the integrated sensory elements increase, the local mechanical performance of the armor decreases. However, A. granulata has evolved several strategies to compensate for its mechanical vulnerabilities to form a multipurpose system with co-optimized optical and structural functions.	[Li, Ling; Connors, Matthew J.; Ortiz, Christine] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Li, Ling; England, Grant T.; Aizenberg, Joanna] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Kolle, Mathias] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Speiser, Daniel I.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Xiao, Xianghui] Argonne Natl Lab, Adv Photon Source, Expt Facil Div, Argonne, IL 60439 USA; [Aizenberg, Joanna] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Aizenberg, Joanna] Harvard Univ, Kavli Inst Bionano Sci & Technol, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); University of South Carolina; University of South Carolina System; University of South Carolina Columbia; United States Department of Energy (DOE); Argonne National Laboratory; Harvard University; Harvard University	Ortiz, C (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	cortiz@mit.edu	Li, Ling/F-3671-2014; Kolle, Mathias/E-3313-2013; Speiser, Daniel Isaac/AGL-4870-2022	Li, Ling/0000-0002-6741-9741; Kolle, Mathias/0000-0001-7395-8824; Speiser, Daniel Isaac/0000-0001-6662-3583; Connors, Matthew/0000-0001-9314-8271	U.S. Army Research Office through the Massachusetts Institute of Technology (MIT) Institute for Soldier Nanotechnologies [W911NF-07-D-0004]; National Security Science and Engineering Faculty Fellowship Program [N00244-09-1-0064]; National Science Foundation [DMR-08-19762]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NSF Designing Materials to Revolutionize and Engineer our Future program [DMR 1533985]; Alexander von Humboldt Foundation; MIT Department of Mechanical Engineering; NSF [DEB-1354831]	U.S. Army Research Office through the Massachusetts Institute of Technology (MIT) Institute for Soldier Nanotechnologies; National Security Science and Engineering Faculty Fellowship Program; National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF Designing Materials to Revolutionize and Engineer our Future program(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); MIT Department of Mechanical Engineering; NSF(National Science Foundation (NSF))	We gratefully acknowledge support from the U.S. Army Research Office through the Massachusetts Institute of Technology (MIT) Institute for Soldier Nanotechnologies (contract W911NF-07-D-0004) and the National Security Science and Engineering Faculty Fellowship Program (N00244-09-1-0064). This work made use of the Materials Research Science and Engineering Center Shared Experimental Facilities at MIT, supported by the National Science Foundation under award number DMR-08-19762. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. M.K. and J.A. gratefully acknowledge support by the NSF Designing Materials to Revolutionize and Engineer our Future program (DMR 1533985). M.K. thanks the Alexander von Humboldt Foundation for a Feodor Lynen Research Fellowship and gratefully acknowledges financial support from the MIT Department of Mechanical Engineering. D.I.S. gratefully acknowledges support by the NSF (DEB-1354831). We thank A. Schwartzman, Y. Zhang, and S. Chen for their technical assistance and E. Belmonte and B. Anseeuw for providing photographs of A. granulata. D.I.S. collected and identified chiton specimens. M.J.C. and X.X. performed synchrotron experiments. M.J.C. and L.L. processed and analyzed data from synchrotron experiments. L.L. performed electron microscopy studies and mechanical tests with data analysis. M.J.C., G.T.E., M.K., and L.L. performed optical measurements and data analysis. M.K. wrote the ray-tracing program. M.J.C and M.K. performed ray-trace simulations. All authors interpreted results. L.L. and M.J.C. prepared figures, tables, and movies and wrote the draft manuscript. C.O. and J.A. supervised the project. All authors revised the manuscript for submission.	Aizenberg J, 2004, P NATL ACAD SCI USA, V101, P3358, DOI 10.1073/pnas.0307843101; Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; Arey LB, 1919, J EXP ZOOL, V29, P157, DOI 10.1002/jez.1400290203; BOYLE P R, 1972, Marine Behaviour and Physiology, V1, P171; BOYLE PR, 1969, Z ZELLFORSCH MIK ANA, V102, P313, DOI 10.1007/BF00335443; Connors MJ, 2012, J STRUCT BIOL, V177, P314, DOI 10.1016/j.jsb.2011.12.019; Dunlop JWC, 2010, ANNU REV MATER RES, V40, P1, DOI 10.1146/annurev-matsci-070909-104421; Fratzl P, 2013, RSC SMART MATER, pV, DOI 10.1039/9781849737555-FP005; Hager MD, 2010, ADV MATER, V22, P5424, DOI 10.1002/adma.201003036; Kirschner CM, 2012, ANNU REV MATER RES, V42, P211, DOI 10.1146/annurev-matsci-070511-155012; Land MF, 2012, OXF ANIMAL BIOL SER, P1; Lee MR, 2007, PALAEONTOLOGY, V50, P1031, DOI 10.1111/j.1475-4983.2007.00710.x; Li L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7322; Li L, 2014, NAT MATER, V13, P501, DOI [10.1038/NMAT3920, 10.1038/nmat3920]; Li L, 2013, ADV MATER, V25, P2344, DOI 10.1002/adma.201204589; Liu J, 2013, P NATL ACAD SCI USA, V110, P6694, DOI 10.1073/pnas.1305209110; Moseley H.N., 1885, Q J MICROSC SCI, V25, P37; NILSSON DE, 1994, PHILOS T ROY SOC B, V346, P195, DOI 10.1098/rstb.1994.0141; Nowikoff M, 1907, Z WISS ZOOL ABT A, V88, P153; OMELICH PAUL, 1967, VELIGER, V10, P77; Reindl S, 1997, J SUBMICR CYTOL PATH, V29, P135; Serb Jeanne M., 2008, Evolution Education and Outreach, V1, P439, DOI 10.1007/s12052-008-0084-1; Speiser DI, 2014, J NAT HIST, V48, P2899, DOI 10.1080/00222933.2014.959572; Speiser DI, 2011, CURR BIOL, V21, P665, DOI 10.1016/j.cub.2011.03.033; Sundar VC, 2003, NATURE, V424, P899, DOI 10.1038/424899a; Thomas JP, 2005, JOM-US, V57, P18, DOI 10.1007/s11837-005-0228-5; TOWE KM, 1973, SCIENCE, V179, P1007, DOI 10.1126/science.179.4077.1007	27	50	51	6	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					952	956		10.1126/science.aad1246	http://dx.doi.org/10.1126/science.aad1246			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW4IP	26586760	Green Submitted			2022-12-28	WOS:000364955200043
J	Suo, LM; Borodin, O; Gao, T; Olguin, M; Ho, J; Fan, XL; Luo, C; Wang, CS; Xu, K				Suo, Liumin; Borodin, Oleg; Gao, Tao; Olguin, Marco; Ho, Janet; Fan, Xiulin; Luo, Chao; Wang, Chunsheng; Xu, Kang			"Water-in-salt" electrolyte enables high-voltage aqueous lithium-ion chemistries	SCIENCE			English	Article							PROPYLENE CARBONATE; CYCLING STABILITY; RECHARGEABLE LI; ENERGY-STORAGE; BATTERIES; TRANSPORT; ANODE; INTERCALATION; CHALLENGES; SOLVATION	Lithium-ion batteries raise safety, environmental, and cost concerns, which mostly arise from their nonaqueous electrolytes. The use of aqueous alternatives is limited by their narrow electrochemical stability window (1.23 volts), which sets an intrinsic limit on the practical voltage and energy output. We report a highly concentrated aqueous electrolyte whose window was expanded to similar to 3.0 volts with the formation of an electrode-electrolyte interphase. A full lithium-ion battery of 2.3 volts using such an aqueous electrolyte was demonstrated to cycle up to 1000 times, with nearly 100% coulombic efficiency at both low (0.15 coulomb) and high (4.5 coulombs) discharge and charge rates.	[Suo, Liumin; Gao, Tao; Fan, Xiulin; Luo, Chao; Wang, Chunsheng] Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20740 USA; [Borodin, Oleg; Olguin, Marco; Ho, Janet; Xu, Kang] US Army Res Lab, Electrochem Branch, Sensor & Electron Devices Directorate, Power & Energy Div, Adelphi, MD 20783 USA	University System of Maryland; University of Maryland College Park; United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL)	Wang, CS (corresponding author), Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20740 USA.	cswang@umd.edu; conrad.k.xu.civ@mail.mil	Borodin, Oleg/AAY-1655-2021; Borodin, Oleg/B-6855-2012; Fan, Xiulin/AAY-9245-2020; Gao, Tao/ABD-1559-2021; Fan, Xiulin/AAJ-9893-2020; Suo, Liumin/AAL-4306-2020; Wang, Chunsheng/H-5767-2011; Xu, Kang/ABG-3307-2020	Borodin, Oleg/0000-0002-9428-5291; Borodin, Oleg/0000-0002-9428-5291; Fan, Xiulin/0000-0001-7294-480X; Gao, Tao/0000-0003-0204-3269; Suo, Liumin/0000-0002-6772-8421; Wang, Chunsheng/0000-0002-8626-6381; Xu, Kang/0000-0002-6946-8635; Luo, Chao/0000-0001-8497-8548	DOE ARPA-E [DEAR0000389]; Maryland Nano Center; NispLab; NSF as a MRSEC Shared Experimental Facility; Oak Ridge Associated Universities postdoctoral fellowship	DOE ARPA-E(United States Department of Energy (DOE)); Maryland Nano Center; NispLab; NSF as a MRSEC Shared Experimental Facility(National Science Foundation (NSF)); Oak Ridge Associated Universities postdoctoral fellowship	C.W. and K.X. gratefully acknowledge both funding and inspiration from P. Liu of DOE ARPA-E (DEAR0000389). We also acknowledge the support of the Maryland Nano Center and its NispLab. The NispLab is supported in part by the NSF as a MRSEC Shared Experimental Facility. We thank K. Gaskell, Y.-F. Lam, S.-C. Liou, A. Goyal, and S. R. Raghavan for technical support and helpful discussions. Modeling efforts were supported by ARL Enterprise for Multiscale Research of Materials. M.O. was supported by an Oak Ridge Associated Universities postdoctoral fellowship.	ANGELL CA, 1993, NATURE, V362, P137, DOI 10.1038/362137a0; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Bockris J. O. M., 2000, MODERN ELECTROCHEMIS; Bogle X, 2013, J PHYS CHEM LETT, V4, P1664, DOI 10.1021/jz400661k; Burns JC, 2011, J ELECTROCHEM SOC, V158, pA255, DOI 10.1149/1.3531997; Cresce A. v., 2014, NANO LETT, V14, P1405, DOI DOI 10.1021/N1404471V; Dunn B, 2011, SCIENCE, V334, P928, DOI 10.1126/science.1212741; Goodenough JB, 2010, CHEM MATER, V22, P587, DOI 10.1021/cm901452z; Hammami A, 2003, NATURE, V424, P635, DOI 10.1038/424635b; Hu LB, 2014, P NATL ACAD SCI USA, V111, P3205, DOI 10.1073/pnas.1401033111; Jeong SK, 2013, ELECTROCHEM COMMUN, V31, P24, DOI 10.1016/j.elecom.2013.02.019; Kim H, 2014, CHEM REV, V114, P11788, DOI 10.1021/cr500232y; Kramer E, 2013, J ELECTROCHEM SOC, V160, pA356, DOI 10.1149/2.081302jes; LI W, 1994, J ELECTROCHEM SOC, V141, P2310, DOI 10.1149/1.2055118; LI W, 1994, SCIENCE, V264, P1115, DOI 10.1126/science.264.5162.1115; Luo JY, 2007, ADV FUNCT MATER, V17, P3877, DOI 10.1002/adfm.200700638; Luo JY, 2010, NAT CHEM, V2, P760, DOI [10.1038/nchem.763, 10.1038/NCHEM.763]; Lux SF, 2013, J ELECTROCHEM SOC, V160, pA1694, DOI 10.1149/2.039310jes; Marcus Y, 2009, CHEM REV, V109, P1346, DOI 10.1021/cr8003828; McOwen DW, 2014, ENERG ENVIRON SCI, V7, P416, DOI 10.1039/c3ee42351d; Nie MY, 2013, J PHYS CHEM C, V117, P25381, DOI 10.1021/jp409765w; OHTAKI H, 1993, CHEM REV, V93, P1157, DOI 10.1021/cr00019a014; Park JW, 2013, J PHYS CHEM C, V117, P4431, DOI 10.1021/jp400153m; Perron G, 1997, CAN J CHEM, V75, P1608, DOI 10.1139/v97-191; Qin H, 2014, J POWER SOURCES, V249, P367, DOI 10.1016/j.jpowsour.2013.10.091; Seo DM, 2012, J ELECTROCHEM SOC, V159, pA1489, DOI 10.1149/2.035209jes; Suo LM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2513; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Ueno K, 2012, J PHYS CHEM B, V116, P11323, DOI 10.1021/jp307378j; Wang HB, 2007, ELECTROCHIM ACTA, V52, P5102, DOI 10.1016/j.electacta.2007.02.004; Wang HB, 2007, ELECTROCHIM ACTA, V52, P3280, DOI 10.1016/j.electacta.2006.10.010; Wang YG, 2006, J ELECTROCHEM SOC, V153, pA450, DOI 10.1149/1.2140678; Wang YG, 2012, ADV ENERGY MATER, V2, P830, DOI 10.1002/aenm.201200065; Whittingham MS, 2004, CHEM REV, V104, P4271, DOI 10.1021/cr020731c; Xu K, 2004, CHEM REV, V104, P4303, DOI 10.1021/cr030203g; Xu K, 2007, J PHYS CHEM C, V111, P7411, DOI 10.1021/jp068691u; Xu K, 2014, CHEM REV, V114, P11503, DOI 10.1021/cr500003w; Xu K, 2011, J MATER CHEM, V21, P9849, DOI 10.1039/c0jm04309e; Yamada Y, 2014, J AM CHEM SOC, V136, P5039, DOI 10.1021/ja412807w; Yoshida K, 2011, J PHYS CHEM C, V115, P18384, DOI 10.1021/jp206881t; Yoshida K, 2011, J AM CHEM SOC, V133, P13121, DOI 10.1021/ja203983r	41	1844	1881	187	2504	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					938	943		10.1126/science.aab1595	http://dx.doi.org/10.1126/science.aab1595			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW4IP	26586759				2022-12-28	WOS:000364955200040
J	Kielian, M; Saphire, EO				Kielian, Margaret; Saphire, Erica Ollmann			Potent Antibody Protection against an Emerging Alphavirus Threat	CELL			English	Editorial Material							CHIKUNGUNYA VIRUS; PROTEINS; VACCINE; FUSION	Chikungunya virus recently caused large outbreaks world-wide. In this issue of Cell, Fox et al. describe several potently neutralizing antibodies against multiple alphaviruses. The structure of the virus in complex with one of the antibodies reveals the antibody-induced rearrangement and crosslinking of the viral surface proteins that result in neutralization.	[Kielian, Margaret] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Saphire, Erica Ollmann] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Saphire, Erica Ollmann] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Yeshiva University; Albert Einstein College of Medicine; Scripps Research Institute; Scripps Research Institute	Kielian, M (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA.	margaret.kielian@einstein.yu.edu; erica@scripps.edu		Kielian, Margaret/0000-0002-7395-4791; Saphire, Erica Ollmann/0000-0002-1206-7451	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075647] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI075647] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cassone A, 2015, PATHOG GLOB HEALTH, V109, P43, DOI 10.1179/2047772415Z.000000000253; Fox JM, 2015, CELL, V163, P1095, DOI 10.1016/j.cell.2015.10.050; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; Johansson MA, 2015, TRENDS PARASITOL, V31, P43, DOI 10.1016/j.pt.2014.12.008; Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107; Kuhn R. J., 2013, FIELDS VIROLOGY, P629; Li L, 2010, NATURE, V468, P705, DOI 10.1038/nature09546; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; Weaver SC, 2012, EXPERT REV VACCINES, V11, P1087, DOI [10.1586/ERV.12.84, 10.1586/erv.12.84]	10	5	5	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1053	1054		10.1016/j.cell.2015.11.006	http://dx.doi.org/10.1016/j.cell.2015.11.006			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26590413	Bronze			2022-12-28	WOS:000366044700004
J	Federico, SM				Federico, Sara M.			Ditch the Scale	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Federico, Sara M.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Federico, Sara M.] Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Pediat, Memphis, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Federico, SM (corresponding author), St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	sara.federico@stjude.org	Federico, Sara/N-8159-2018						0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2015	314	19					2025	2026		10.1001/jama.2015.5916	http://dx.doi.org/10.1001/jama.2015.5916			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW1PR	26575057				2022-12-28	WOS:000364764200014
J	Losby, JE; Sani, FF; Grandmont, DT; Diao, Z; Belov, M; Burgess, JAJ; Compton, SR; Hiebert, WK; Vick, D; Mohammad, K; Salimi, E; Bridges, GE; Thomson, DJ; Freeman, MR				Losby, J. E.; Sani, F. Fani; Grandmont, D. T.; Diao, Z.; Belov, M.; Burgess, J. A. J.; Compton, S. R.; Hiebert, W. K.; Vick, D.; Mohammad, K.; Salimi, E.; Bridges, G. E.; Thomson, D. J.; Freeman, M. R.			Torque-mixing magnetic resonance spectroscopy	SCIENCE			English	Article							FORCE MICROSCOPY	A universal, torque-mixing method for magnetic resonance spectroscopy is presented. In analogy to resonance detection by magnetic induction, the transverse component of a precessing dipole moment can be measured in sensitive broadband spectroscopy, here using a resonant mechanical torque sensor. Unlike induction, the torque amplitude allows equilibrium magnetic properties to be monitored simultaneously with the spin dynamics. Comprehensive electron spin resonance spectra of a single-crystal, mesoscopic yttrium iron garnet disk at room temperature reveal assisted switching between magnetization states and mode-dependent spin resonance interactions with nanoscale surface imperfections. The rich detail allows analysis of even complex three-dimensional spin textures. The flexibility of microelectromechanical and optomechanical devices combined with broad generality and capabilities of torque-mixing magnetic resonance spectroscopy offers great opportunities for development of integrated devices.	[Losby, J. E.; Sani, F. Fani; Grandmont, D. T.; Diao, Z.; Burgess, J. A. J.; Compton, S. R.; Hiebert, W. K.; Freeman, M. R.] Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada; [Losby, J. E.; Sani, F. Fani; Diao, Z.; Belov, M.; Burgess, J. A. J.; Compton, S. R.; Hiebert, W. K.; Vick, D.; Freeman, M. R.] Natl Inst Nanotechnol, Edmonton, AB TEG 2M9, Canada; [Mohammad, K.; Salimi, E.; Bridges, G. E.; Thomson, D. J.] Univ Manitoba, Elect & Comp Engn, Winnipeg, MB R3T 5V6, Canada	University of Alberta; National Research Council Canada; University of Manitoba	Freeman, MR (corresponding author), Univ Alberta, Dept Phys, 4-181 Centennial Ctr Interdisciplinary Sci Edmont, Edmonton, AB T6G 2E1, Canada.	mark.freeman@ualberta.ca	Freeman, Mark R/E-4609-2013; Salimi, Elham/AGZ-7155-2022; Thomson, Douglas/I-7546-2013	Freeman, Mark R/0000-0002-6607-6521; Hiebert, Wayne/0000-0002-2064-7907; thomson, douglas/0000-0002-3059-3455; Diao, Zhu/0000-0002-4049-5672	Natural Sciences and Engineering Research Council Canada [RGPIN 170827-2010, RGPIN 04239, RGPIN 2014-04796]; Canada Research Chairs [950206567]; Alberta Innovates Technology Futures (iCiNano); National Institute for Nanotechnology (NINT) [A1-004906]; Canada Foundation for Innovation [20314]; Manitoba Research and Innovation Fund; Canadian Microelectronics Corp.	Natural Sciences and Engineering Research Council Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs(Canada Research ChairsCGIAR); Alberta Innovates Technology Futures (iCiNano); National Institute for Nanotechnology (NINT); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Manitoba Research and Innovation Fund; Canadian Microelectronics Corp.	The authors very gratefully acknowledge support from Natural Sciences and Engineering Research Council Canada (RGPIN 170827-2010, RGPIN 04239, and RGPIN 2014-04796), Canada Research Chairs (950206567), Alberta Innovates Technology Futures (iCiNano), National Institute for Nanotechnology (NINT A1-004906), Canada Foundation for Innovation (20314), Manitoba Research and Innovation Fund, and Canadian Microelectronics Corp. The nanomechanical torque sensors were fabricated at the University of Alberta NanoFab and NINT. Electron diffraction was performed by P. Li at the NINT microscopy center. D. Fortin assisted in the design and rendering of Fig. 1A. We thank J. P. Davis and R. Lockwood for critical reading of the manuscript, R. E. Wasilyshen for useful conversations, and anonymous referees for constructive suggestions. The data described in the paper are available upon request.	ALZETTA G, 1967, NUOVO CIMENT B, V52, P392, DOI 10.1007/BF02711084; Ascoli C, 1996, APPL PHYS LETT, V69, P3920, DOI 10.1063/1.117570; BLOCH F, 1946, PHYS REV, V70, P474, DOI 10.1103/PhysRev.70.474; Burgess JAJ, 2013, SCIENCE, V339, P1051, DOI 10.1126/science.1231390; Chen T., 2012, THESIS; Cowburn RP, 1999, PHYS REV LETT, V83, P1042, DOI 10.1103/PhysRevLett.83.1042; Diao Z, 2013, J VAC SCI TECHNOL B, V31, DOI 10.1116/1.4821194; Flipse J, 2012, NAT NANOTECHNOL, V7, P166, DOI [10.1038/nnano.2012.2, 10.1038/NNANO.2012.2]; Goennenwein S. T. B., 2014, SOLID STATE COMMUN, V198; GRIFFITHS JHE, 1946, NATURE, V158, P670, DOI 10.1038/158670a0; Guo F, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.017601; Hahn C, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.217204; Heinrich B, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.066604; Kikkawa T, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.067207; KITTEL C, 1947, PHYS REV, V71, P270, DOI 10.1103/PhysRev.71.270.2; Landau LD., 1935, PHYS SOVIETUNION, V8, P153, DOI DOI 10.1016/B978-0-08-036364-6.50008-9; Lim SH, 2014, EPL-EUROPHYS LETT, V105, DOI 10.1209/0295-5075/105/37009; Losby J, 2012, J APPL PHYS, V111, DOI 10.1063/1.3676231; Mamin HJ, 2009, NANO LETT, V9, P3020, DOI 10.1021/nl901466p; Nozaki Y, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2775047; Park JP, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.020403; Rahm M, 2003, APPL PHYS LETT, V82, P4110, DOI 10.1063/1.1581363; Rugar D, 2015, NAT NANOTECHNOL, V10, P120, DOI [10.1038/nnano.2014.288, 10.1038/NNANO.2014.288]; RUGAR D, 1994, SCIENCE, V264, P1560, DOI 10.1126/science.264.5165.1560; Serga AA, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/26/264002; SIDLES JA, 1995, REV MOD PHYS, V67, P249, DOI 10.1103/RevModPhys.67.249; Sukhostavets OV, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.247601; Uhlig T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.237205; Wintz S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.177201; Woltersdorf G, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.227207; Zhang Z, 1998, APPL PHYS LETT, V73, P2036, DOI 10.1063/1.122359	31	29	29	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					798	801		10.1126/science.aad2449	http://dx.doi.org/10.1126/science.aad2449			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW3MS	26564851				2022-12-28	WOS:000364897000040
J	Guglani, S				Guglani, Samir			Medicine Unboxed: frontiers and mortality	LANCET			English	Editorial Material									Cheltenham Gen Hosp, Ctr Oncol, Cheltenham GL53 7AN, Glos, England	Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital	Guglani, S (corresponding author), Cheltenham Gen Hosp, Ctr Oncol, Cheltenham GL53 7AN, Glos, England.	sam@medicineunboxed.org						Guglani S, 2015, LANCET, V386, P1622, DOI 10.1016/S0140-6736(15)00545-0	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2015	386	10004					1611	1611		10.1016/S0140-6736(15)00550-4	http://dx.doi.org/10.1016/S0140-6736(15)00550-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU0HS	26595617				2022-12-28	WOS:000363197500010
J	van Kessel, MAHJ; Speth, DR; Albertsen, M; Nielsen, PH; Op den Camp, HJM; Kartal, B; Jetten, MSM; Lucker, S				van Kessel, Maartje A. H. J.; Speth, Daan R.; Albertsen, Mads; Nielsen, Per H.; Op den Camp, Huub J. M.; Kartal, Boran; Jetten, Mike S. M.; Lucker, Sebastian			Complete nitrification by a single microorganism	NATURE			English	Article							NITRITE-OXIDIZING BACTERIA; IN-SITU HYBRIDIZATION; AMMONIA MONOOXYGENASE; NITROSOMONAS-EUROPAEA; PHYSIOLOGY; UREA; TOOL; MICROAUTORADIOGRAPHY; COMBINATION; DIVERSITY	Nitrification is a two-step process where ammonia is first oxidized to nitrite by ammonia-oxidizing bacteria and/or archaea, and subsequently to nitrate by nitrite-oxidizing bacteria. Already described by Winogradsky in 18901, this division of labour between the two functional groups is a generally accepted characteristic of the biogeochemical nitrogen cycle(2). Complete oxidation of ammonia to nitrate in one organism (complete ammonia oxidation; comammox) is energetically feasible, and it was postulated that this process could occur under conditions selecting for species with lower growth rates but higher growth yields than canonical ammonia-oxidizing microorganisms(3). Still, organisms catalysing this process have not yet been discovered. Here we report the enrichment and initial characterization of two Nitrospira species that encode all the enzymes necessary for ammonia oxidation via nitrite to nitrate in their genomes, and indeed completely oxidize ammonium to nitrate to conserve energy. Their ammonia monooxygenase (AMO) enzymes are phylogenetically distinct from currently identified AMOs, rendering recent acquisition by horizontal gene transfer from known ammonia-oxidizing microorganisms unlikely. We also found highly similar amoA sequences (encoding the AMO subunit A) in public sequence databases, which were apparently misclassified as methane monooxygenases. This recognition of a novel amoA sequence group will lead to an improved understanding of the environmental abundance and distribution of ammonia-oxidizing microorganisms. Furthermore, the discovery of the long-sought-after comammox process will change our perception of the nitrogen cycle.	[van Kessel, Maartje A. H. J.; Speth, Daan R.; Op den Camp, Huub J. M.; Kartal, Boran; Jetten, Mike S. M.; Lucker, Sebastian] Radboud Univ Nijmegen, IWWR, Dept Microbiol, NL-6525 AJ Nijmegen, Netherlands; [Albertsen, Mads; Nielsen, Per H.] Aalborg Univ, Dept Chem & Biosci, Ctr Microbial Communities, DK-9220 Aalborg, Denmark; [Kartal, Boran] Univ Ghent, Microbiol Lab, B-9000 Ghent, Belgium; [Jetten, Mike S. M.] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands	Radboud University Nijmegen; Aalborg University; Ghent University; Delft University of Technology	Lucker, S (corresponding author), Radboud Univ Nijmegen, IWWR, Dept Microbiol, Heyendaalseweg 135, NL-6525 AJ Nijmegen, Netherlands.	s.luecker@science.ru.nl	Nielsen, Per Halkjær/T-6796-2018; Camp, Huub J.M. Op den/F-5114-2011; Kartal, Boran/ABD-5400-2021; Jetten, Mike/B-8834-2011; Lücker, Sebastian/E-6186-2013; Albertsen, Mads/T-7358-2018	Nielsen, Per Halkjær/0000-0002-6402-1877; Camp, Huub J.M. Op den/0000-0003-1990-9030; Jetten, Mike/0000-0002-4691-7039; Lücker, Sebastian/0000-0003-2935-4454; Albertsen, Mads/0000-0002-6151-190X; Kartal, Boran/0000-0003-4199-952X; van Kessel, Maartje/0000-0003-0271-6478	Technology Foundation STW [13146]; BE-Basic Foundation [fs7-002]; Danish Council for Independent Research [DFF 4005-00369]; European Research Council (ERC) [anammox 232937, Eco_MoM 339880]; Dutch Ministry of Education, Culture and Science [SIAM 024002002]; Netherlands Organization for Scientific Research (NWO VENI) [863.11.003, 863.14.019]; Radboud Excellence Initiative	Technology Foundation STW(Technologiestichting STW); BE-Basic Foundation; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); European Research Council (ERC)(European Research Council (ERC)); Dutch Ministry of Education, Culture and Science; Netherlands Organization for Scientific Research (NWO VENI)(Netherlands Organization for Scientific Research (NWO)); Radboud Excellence Initiative	We would like to thank K. Stultiens, T. van Alen, J. Frank, P. Klaren, L. Pierson and L. Claessens-Joosten for technical assistance, T. Spanings for biofilter maintenance and C. Herbold for the ANI analysis. We are grateful for the use of the confocal microscope from the Microscopic Imaging Centre (MIC, Radboud UMC, Nijmegen) and would like to thank H. Croes and M. Willemse for technical assistance. The LABGeM team and the National Infrastructure "France Genomique" are acknowledged for support within the MicroScope annotation platform. We are thankful to C. Dupont, A. Santoro and M. Saito for consenting to our use of the Nitrospira marina nxrA sequences, which were produced by the US Department of Energy Joint Genome Institute. M.A.H.J.v.K was supported by the Technology Foundation STW (grant 13146), D.R.S. by the BE-Basic Foundation (grant fs7-002), M. A. and P.H.N. by the Danish Council for Independent Research (DFF 4005-00369), M.S.M.J. by the European Research Council (ERC Advanced Grant projects anammox 232937 and Eco_MoM 339880) and the Dutch Ministry of Education, Culture and Science (Gravitation grant SIAM 024002002), B.K. and S.L. by the Netherlands Organization for Scientific Research (NWO VENI grants 863.11.003 and 863.14.019, respectively). The Radboud Excellence Initiative is acknowledged for support to S.L.	Albertsen M., 2015, MMGENOME TOOLS EXTRA; Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Alm EW, 1996, APPL ENVIRON MICROB, V62, P3557, DOI 10.1128/AEM.62.10.3557-3559.1996; Alonso-Saez L, 2012, P NATL ACAD SCI USA, V109, P17989, DOI 10.1073/pnas.1201914109; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Berube PM, 2012, J BACTERIOL, V194, P3448, DOI 10.1128/JB.00133-12; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Burton SAQ, 2001, APPL ENVIRON MICROB, V67, P2952, DOI 10.1128/AEM.67.7.2952-2957.2001; Costa E, 2006, TRENDS MICROBIOL, V14, P213, DOI 10.1016/j.tim.2006.03.006; Crab R, 2007, AQUACULTURE, V270, P1, DOI 10.1016/j.aquaculture.2007.05.006; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Daims H, 2001, APPL ENVIRON MICROB, V67, P5273, DOI 10.1128/AEM.67.11.5273-5284.2001; Daims H, 2005, MOL MICROBIAL ECOLOG, P213; Daims H, 2015, NATURE; Daims H, 2007, APPL MICROBIOL BIOT, V75, P237, DOI 10.1007/s00253-007-0886-z; Dupont CL, 2012, ISME J, V6, P1186, DOI 10.1038/ismej.2011.189; Eddy S.R., 2015, HMMER BIOSEQUENCE AN; El Sheikh AF, 2008, APPL ENVIRON MICROB, V74, P312, DOI 10.1128/AEM.01654-07; Ginestet P, 1998, APPL ENVIRON MICROB, V64, P2266; Glass E. M., 2010, COLD SPRING HARB PRO, V2010; Griess P., 1879, BER DTSCH CHEM GES, V12, P426, DOI [DOI 10.2147/DDDT.S165440, 10.1002/cber.187901201117., DOI 10.1002/CBER.187901201117]; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; HYMAN MR, 1992, J BIOL CHEM, V267, P1534; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Juretschko S, 1998, APPL ENVIRON MICROB, V64, P3042; Klotz MG, 2008, FEMS MICROBIOL LETT, V278, P146, DOI 10.1111/j.1574-6968.2007.00970.x; Koch H, 2015, P NATL ACAD SCI USA, V112, P11371, DOI 10.1073/pnas.1506533112; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lee N, 1999, APPL ENVIRON MICROB, V65, P1289; Leggett RM, 2014, BIOINFORMATICS, V30, P566, DOI 10.1093/bioinformatics/btt702; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; Luesken FA, 2011, APPL MICROBIOL BIOT, V92, P845, DOI 10.1007/s00253-011-3361-9; Lupo D, 2007, P NATL ACAD SCI USA, V104, P19303, DOI 10.1073/pnas.0706563104; MCTAVISH H, 1993, J BACTERIOL, V175, P2436, DOI 10.1128/JB.175.8.2436-2444.1993; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mobarry BK, 1996, APPL ENVIRON MICROB, V62, P2156, DOI 10.1128/AEM.62.6.2156-2162.1996; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Prjibelski AD, 2014, BIOINFORMATICS, V30, P293, DOI 10.1093/bioinformatics/btu266; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rasko DA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-2; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Schmid M, 2000, SYST APPL MICROBIOL, V23, P93, DOI 10.1016/S0723-2020(00)80050-8; Solomon CM, 2010, AQUAT MICROB ECOL, V59, P67, DOI 10.3354/ame01390; Spieck E, 2011, METHOD ENZYMOL, V486, P109, DOI [10.1016/S0076-6879(11)86005-2, 10.1016/B978-0-12-381294-0.00005-5]; Stahl D. A., 1991, NUCL ACID TECHNIQUES; Stoecker K, 2006, P NATL ACAD SCI USA, V103, P2363, DOI 10.1073/pnas.0506361103; Strous M, 1999, APPL ENVIRON MICROB, V65, P3248; Taylor AE, 2013, APPL ENVIRON MICROB, V79, P6544, DOI 10.1128/AEM.01928-13; TAYLOR S, 1974, ANAL BIOCHEM, V60, P153, DOI 10.1016/0003-2697(74)90140-7; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Vallenet D, 2013, NUCLEIC ACIDS RES, V41, pE636, DOI 10.1093/nar/gks1194; Vlaeminck SE, 2011, ENVIRON MICROBIOL, V13, P283, DOI 10.1111/j.1462-2920.2010.02345.x; Wagner M, 2006, CURR OPIN BIOTECH, V17, P83, DOI 10.1016/j.copbio.2005.12.006; WAGNER M, 1995, SYST APPL MICROBIOL, V18, P251, DOI 10.1016/S0723-2020(11)80396-6; Winogradsky S., 1890, ANN I PASTEUR, V4, P213; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	64	873	895	112	1456	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2015	528	7583					555	+		10.1038/nature16459	http://dx.doi.org/10.1038/nature16459			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ3GH	26610025	Green Accepted			2022-12-28	WOS:000366991900053
J	Mosta, P; Ott, CD; Radice, D; Roberts, LF; Schnetter, E; Haas, R				Moesta, Philipp; Ott, Christian D.; Radice, David; Roberts, Luke F.; Schnetter, Erik; Haas, Roland			A large-scale dynamo and magnetoturbulence in rapidly rotating core-collapse supernovae	NATURE			English	Article							GAMMA-RAY BURSTS; MAGNETOROTATIONAL INSTABILITY; MAGNETIC-FIELDS; INVERSE CASCADE; MASSIVE STARS; NEUTRON-STARS; SIMULATIONS; EXPLOSIONS; TURBULENCE; DISKS	Magnetohydrodynamic turbulence is important in many high-energy astrophysical systems, where instabilities can amplify the local magnetic field over very short timescales(1,2). Specifically, the magnetorotational instability and dynamo action(3-6) have been suggested as a mechanism for the growth of magnetar-strength magnetic fields (of 10(15) gauss and above) and for powering the explosion(7-10) of a rotating massive star(11,12). Such stars are candidate progenitors of type Ic-bl hypernovae(13,14), which make up all supernovae that are connected to long gamma-ray bursts(15,16). The magnetorotational instability has been studied with local high-resolution shearing-box simulations in three dimensions(17-19), and with global two-dimensional simulations(20), but it is not known whether turbulence driven by this instability can result in the creation of a large-scale, ordered and dynamically relevant field. Here we report results from global, three-dimensional, general-relativistic magnetohydrodynamic turbulence simulations. We show that hydromagnetic turbulence in rapidly rotating protoneutron stars produces an inverse cascade of energy. We find a large-scale, ordered toroidal field that is consistent with the formation of bipolar magnetorotationally driven outflows. Our results demonstrate that rapidly rotating massive stars are plausible progenitors for both type Ic-bl supernovae(13,21,22) and long gamma-ray bursts, and provide a viable mechanism for the formation of magnetars(23,24). Moreover, our findings suggest that rapidly rotating massive stars might lie behind potentially magnetar-powered superluminous supernovae(25,26).	[Moesta, Philipp; Ott, Christian D.; Radice, David; Roberts, Luke F.] CALTECH, Walter Burke Inst Theoret Phys, TAPIR, Pasadena, CA 91125 USA; [Moesta, Philipp] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Schnetter, Erik] Perimeter Inst Theoret Phys, Waterloo, ON N2L 2Y5, Canada; [Schnetter, Erik] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; [Schnetter, Erik] Louisiana State Univ, Ctr Computat & Technol, Baton Rouge, LA 70803 USA; [Haas, Roland] Max Planck Inst Gravitat Phys, D-14476 Potsdam, Germany	California Institute of Technology; University of California System; University of California Berkeley; Perimeter Institute for Theoretical Physics; University of Guelph; Louisiana State University System; Louisiana State University; Max Planck Society	Mosta, P (corresponding author), CALTECH, Walter Burke Inst Theoret Phys, TAPIR, Mailcode 350-17, Pasadena, CA 91125 USA.	pmoesta@berkeley.edu	Ott, Christian/G-2651-2011; Schnetter, Erik/G-4838-2016	Ott, Christian/0000-0003-4993-2055; Roberts, Luke/0000-0001-7364-7946; Schnetter, Erik/0000-0002-4518-9017; Haas, Roland/0000-0003-1424-6178	National Science Foundation (NSF) [AST-1212170, PHY-1151197, OCI-0905046]; NASA [PF5-160140, PF3-140114]; National Science and Engineering Research Council of Canada (NSERC); Sherman Fairchild Foundation; Direct For Computer & Info Scie & Enginr [1440083, 0905046] Funding Source: National Science Foundation; Direct For Mathematical & Physical Scien [1212170] Funding Source: National Science Foundation; Division Of Physics [1212460, 1151197] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Sherman Fairchild Foundation; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank S. Couch, J. Zrake, D. Tsang, C. Wheeler, E. Bentivegna and I. Hinder for discussions. This research was supported by National Science Foundation (NSF) grants AST-1212170, PHY-1151197 and OCI-0905046; by NASA through the Einstein Fellowship Program, grants PF5-160140 (to P.M.) and PF3-140114 (to L.F.R.); by a National Science and Engineering Research Council of Canada (NSERC) award to E. S.; and by the Sherman Fairchild Foundation. The simulations were carried out on the NSF/National Center for Supercomputing Applications (NCSA) BlueWaters supercomputer (PRAC ACI-1440083).	Akiyama S, 2003, ASTROPHYS J, V584, P954, DOI 10.1086/344135; Balbus SA, 1998, REV MOD PHYS, V70, P1, DOI 10.1103/RevModPhys.70.1; BALBUS SA, 1991, ASTROPHYS J, V376, P214, DOI 10.1086/170270; Bogovalov SV, 1997, ASTRON ASTROPHYS, V323, P634; Brandenburg A, 2005, PHYS REP, V417, P1, DOI 10.1016/j.physrep.2005.06.005; Brandenburg A, 2001, ASTROPHYS J, V550, P824, DOI 10.1086/319783; Burrows A, 2007, ASTROPHYS J, V664, P416, DOI 10.1086/519161; Drout MR, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/97; DUNCAN RC, 1992, ASTROPHYS J, V392, pL9, DOI 10.1086/186413; Einfeldt B., 1988, SHOCK TUBES WAVES, P671; ESWARAN V, 1988, COMPUT FLUIDS, V16, P257, DOI 10.1016/0045-7930(88)90013-8; FRICKE K, 1969, ASTRON ASTROPHYS, V1, P388; FRISCH U, 1975, J FLUID MECH, V68, P769, DOI 10.1017/S002211207500122X; FRISCH U., 1995, TURBULENCE LEGACY AN; Galama TJ, 1998, NATURE, V395, P670, DOI 10.1038/27150; GOODMAN J, 1994, ASTROPHYS J, V432, P213, DOI 10.1086/174562; Greiner J, 2015, NATURE, V523, P189, DOI 10.1038/nature14579; Guilet J, 2015, MON NOT R ASTRON SOC, V447, P3992, DOI 10.1093/mnras/stu2550; Heger A, 2000, ASTROPHYS J, V544, P1016, DOI 10.1086/317239; Hjorth J., 2012, GAMMA RAY BURSTS; LATTIMER JM, 1991, NUCL PHYS A, V535, P331, DOI 10.1016/0375-9474(91)90452-C; LEBLANC JM, 1970, ASTROPHYS J, V161, P541, DOI 10.1086/150558; Loffler F, 2012, CLASSICAL QUANT GRAV, V29, DOI 10.1088/0264-9381/29/11/115001; Masada Y, 2015, ASTROPHYS J LETT, V798, DOI 10.1088/2041-8205/798/1/L22; Modjaz M, 2011, ASTRON NACHR, V332, P434, DOI 10.1002/asna.201111562; Mosta P, 2014, ASTROPHYS J LETT, V785, DOI 10.1088/2041-8205/785/2/L29; Mosta P, 2014, CLASSICAL QUANT GRAV, V31, DOI 10.1088/0264-9381/31/1/015005; Moffatt H. K., 1978, MAGNETIC FIELD GENER; Nicholl M, 2013, NATURE, V502, P346, DOI 10.1038/nature12569; Nishimura N, 2015, ASTROPHYS J, V810, DOI 10.1088/0004-637X/810/2/109; O'Connor E, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/11/114103; Obergaulinger M, 2006, ASTRON ASTROPHYS, V450, P1107, DOI 10.1051/0004-6361:20054306; Obergaulinger M, 2009, ASTRON ASTROPHYS, V498, P241, DOI 10.1051/0004-6361/200811323; Ott CD, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.024026; Ott CD, 2006, ASTROPHYS J SUPPL S, V164, P130, DOI 10.1086/500832; Pessah ME, 2009, ASTROPHYS J LETT, V698, pL72, DOI 10.1088/0004-637X/698/1/L72; Reisswig C, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.064023; Sawai H, 2013, ASTROPHYS J LETT, V770, DOI 10.1088/2041-8205/770/2/L19; Soderberg AM, 2006, NATURE, V442, P1014, DOI 10.1038/nature05087; Takiwaki T, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/30; Tchekhovskoy A, 2007, MON NOT R ASTRON SOC, V379, P469, DOI 10.1111/j.1365-2966.2007.11876.x; THOMPSON C, 1993, ASTROPHYS J, V408, P194, DOI 10.1086/172580; Thompson TA, 2005, ASTROPHYS J, V620, P861, DOI 10.1086/427177; Toth G, 2000, J COMPUT PHYS, V161, P605, DOI 10.1006/jcph.2000.6519; Wheeler JC, 2002, ASTROPHYS J, V568, P807, DOI 10.1086/338953; Winteler C, 2012, ASTROPHYS J LETT, V750, DOI 10.1088/2041-8205/750/1/L22; Woosley SE, 2006, ASTROPHYS J, V637, P914, DOI 10.1086/498500; Zrake J, 2013, ASTROPHYS J LETT, V769, DOI 10.1088/2041-8205/769/2/L29	49	178	181	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2015	528	7582					376	+		10.1038/nature15755	http://dx.doi.org/10.1038/nature15755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY8SM	26618868	Green Submitted, Green Accepted			2022-12-28	WOS:000366678600047
J	Gonzalez-Sandoval, A; Towbin, BD; Kalck, V; Cabianca, DS; Gaidatzis, D; Hauer, MH; Geng, LQ; Wang, L; Yang, T; Wang, XH; Zhao, KH; Gasser, SM				Gonzalez-Sandoval, Adriana; Towbin, Benjamin D.; Kalck, Veronique; Cabianca, Daphne S.; Gaidatzis, Dimos; Hauer, Michael H.; Geng, Liqing; Wang, Li; Yang, Teddy; Wang, Xinghao; Zhao, Kehao; Gasser, Susan M.			Perinuclear Anchoring of H3K9-Methylated Chromatin Stabilizes Induced Cell Fate in C. elegans Embryos	CELL			English	Article							NUCLEAR LAMINA; GENOME INTERACTIONS; HETEROCHROMATIN; HISTONE; PROTEIN; HP1; METHYLATION; EPIGENETICS; MEMBRANE; DYNAMICS	Interphase chromatin is organized in distinct nuclear sub-compartments, reflecting its degree of compaction and transcriptional status. In Caenorhabditis elegans embryos, H3K9 methylation is necessary to silence and to anchor repeat-rich heterochromatin at the nuclear periphery. In a screen for perinuclear anchors of heterochromatin, we identified a previously uncharacterized C. elegans chromodomain protein, CEC-4. CEC-4 binds preferentially mono-, di-, or tri-methylated H3K9 and localizes at the nuclear envelope independently of H3K9 methylation and nuclear lamin. CEC-4 is necessary for endogenous heterochromatin anchoring, but not for transcriptional repression, in contrast to other known H3K9 methyl-binders in worms, which mediate gene repression but not perinuclear anchoring. When we ectopically induce a muscle differentiation program in embryos, cec-4 mutants fail to commit fully to muscle cell fate. This suggests that perinuclear sequestration of chromatin during development helps restrict cell differentiation programs by stabilizing commitment to a specific cell fate.	[Gonzalez-Sandoval, Adriana; Towbin, Benjamin D.; Kalck, Veronique; Cabianca, Daphne S.; Gaidatzis, Dimos; Hauer, Michael H.; Gasser, Susan M.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Gonzalez-Sandoval, Adriana; Hauer, Michael H.; Gasser, Susan M.] Univ Basel, Fac Nat Sci, CH-4056 Basel, Switzerland; [Gaidatzis, Dimos] Swiss Inst Bioinformat, CH-4058 Basel, Switzerland; [Geng, Liqing; Wang, Li; Yang, Teddy; Wang, Xinghao; Zhao, Kehao] China Novartis Inst Biomed Res Co Ltd, Shanghai 201203, Peoples R China	Friedrich Miescher Institute for Biomedical Research; University of Basel; Swiss Institute of Bioinformatics; Novartis	Gasser, SM (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	susan.gasser@fmi.ch	Towbin, Benjamin D/C-8545-2018; Towbin, Benjamin D/AAO-8064-2021; Hauer, Michael/U-4800-2019	Towbin, Benjamin D/0000-0001-7046-1257; Cabianca, Daphne Selvaggia/0000-0002-1834-7868; Gonzalez Sandoval, Adriana Verenisse/0000-0002-0930-1374; Zhao, Kehao/0000-0003-2485-058X; Hauer, Michael/0000-0001-7463-3191; Gasser, Susan/0000-0003-3610-9123	Caenorhabditis Genetics Center (CGC) of the NIH Office of Research Infrastructure Programs [P40 OD010440]; FP7 Marie Curie Network Nucleosome 4D; SNSF NCCR "Frontiers in Genetics"; FMI; SNSF	Caenorhabditis Genetics Center (CGC) of the NIH Office of Research Infrastructure Programs; FP7 Marie Curie Network Nucleosome 4D; SNSF NCCR "Frontiers in Genetics"; FMI; SNSF(Swiss National Science Foundation (SNSF))	Some strains were provided by the Caenorhabditis Genetics Center (CGC) of the NIH Office of Research Infrastructure Programs (P40 OD010440). We thank G-J. Hendriks, H. Grosshans, R. Thierry, P. Zeller, A. Peters, P. Hein, Y. Gruenbaum, and P. Askjaer for reagents and materials. We thank J. Lieb and K. Ikegami for training A.G.-S. in LEM-2 ChIP. We thank the FMI Worm, Genomics, Protein Structure, Protein Analysis, and Microscopy facilities for valuable advice and support. A.G.-S. was supported by FP7 Marie Curie Network Nucleosome 4D and the SNSF NCCR "Frontiers in Genetics." S.M.G. thanks the FMI and SNSF for support.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Brachner A, 2011, BIOCHEM SOC T, V39, P1735, DOI 10.1042/BST20110724; Couteau F, 2002, EMBO REP, V3, P235, DOI 10.1093/embo-reports/kvf051; Eberhart A, 2013, CHROMOSOME RES, V21, P535, DOI 10.1007/s10577-013-9375-7; Etchberger JF, 2007, GENE DEV, V21, P1653, DOI 10.1101/gad.1560107; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fukushige T, 2005, DEVELOPMENT, V132, P1795, DOI 10.1242/dev.01774; Fussner E, 2010, COLD SH Q B, V75, P245, DOI 10.1101/sqb.2010.75.012; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gonzalez-Aguilera C, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r21; Greer EL, 2014, CELL REP, V7, P113, DOI 10.1016/j.celrep.2014.02.044; Gudise S, 2011, J CELL SCI, V124, P2077, DOI 10.1242/jcs.078923; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Harr JC, 2015, J CELL BIOL, V208, P33, DOI 10.1083/jcb.201405110; Hirano Y, 2012, J BIOL CHEM, V287, P42654, DOI 10.1074/jbc.M112.397950; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Hiratani L, 2009, CURR OPIN GENET DEV, V19, P142, DOI 10.1016/j.gde.2009.02.002; Holmer L, 1998, GENOMICS, V54, P469, DOI 10.1006/geno.1998.5615; Ikegami K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r120; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Kubben N, 2012, CHROMOSOMA, V121, P447, DOI 10.1007/s00412-012-0376-7; Mattout A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0760-8; Meister P, 2011, CURR OPIN GENET DEV, V21, P167, DOI 10.1016/j.gde.2011.01.023; Meister P, 2010, GENE DEV, V24, P766, DOI 10.1101/gad.559610; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Nestorov P, 2013, CURR TOP DEV BIOL, V104, P243, DOI 10.1016/B978-0-12-416027-9.00008-5; Nigg E A, 1992, Semin Cell Biol, V3, P245, DOI 10.1016/1043-4682(92)90026-R; Padeken J, 2014, CURR OPIN CELL BIOL, V28, P54, DOI 10.1016/j.ceb.2014.03.001; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Poleshko A, 2013, CELL REP, V5, P292, DOI 10.1016/j.celrep.2013.09.024; Solovei I, 2013, CELL, V152, P584, DOI 10.1016/j.cell.2013.01.009; Steffen PA, 2012, BIOESSAYS, V34, P901, DOI 10.1002/bies.201200076; Studencka M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002940; Studencka M, 2012, MOL CELL BIOL, V32, P251, DOI 10.1128/MCB.05229-11; Taddei A, 2012, GENETICS, V192, P107, DOI 10.1534/genetics.112.140608; Talamas JA, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00095; Taouji S, 2009, CURR GENOMICS, V10, P93, DOI 10.2174/138920209787847041; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Towbin BD, 2010, COLD SH Q B, V75, P555, DOI 10.1101/sqb.2010.75.041; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Wilson KL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000554; Ye Q, 1996, J BIOL CHEM, V271, P14653, DOI 10.1074/jbc.271.25.14653; Zheng CG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004017; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	49	115	119	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6					1333	1347		10.1016/j.cell.2015.10.066	http://dx.doi.org/10.1016/j.cell.2015.10.066			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26607792	Bronze			2022-12-28	WOS:000366044800015
J	Suriben, R; Kaihara, KA; Paolino, M; Reichelt, M; Kummerfeld, SK; Modrusan, Z; Dugger, DL; Newton, K; Sagolla, M; Webster, JD; Liu, JF; Hebrok, M; Dixit, VM				Suriben, Rowena; Kaihara, Kelly A.; Paolino, Magdalena; Reichelt, Mike; Kummerfeld, Sarah K.; Modrusan, Zora; Dugger, Debra L.; Newton, Kim; Sagolla, Meredith; Webster, Joshua D.; Liu, Jinfeng; Hebrok, Matthias; Dixit, Vishva M.			beta-Cell Insulin Secretion Requires the Ubiquitin Ligase COP1	CELL			English	Article							TUMOR-SUPPRESSOR; GRANULES; EXPRESSION; FAILURE; PROGRESSION; EXOCYTOSIS; DYNAMICS; DOCKING; FUSION; ETV5	A variety of signals finely tune insulin secretion by pancreatic beta cells to prevent both hyper- and hypoglycemic states. Here, we show that post-translational regulation of the transcription factors ETV1, ETV4, and ETV5 by the ubiquitin ligase COP1 (also called RFWD2) in beta cells is critical for insulin secretion. Mice lacking COP1 in beta cells developed diabetes due to insulin granule docking defects that were fully rescued by genetic deletion of Etv1, Etv4, and Etv5. Genes regulated by ETV1, ETV4, or ETV5 in the absence of mouse COP1 were enriched in human diabetes-associated genes, suggesting that they also influence human beta-cell pathophysiology. In normal b cells, ETV4 was stabilized upon membrane depolarization and limited insulin secretion under hyperglycemic conditions. Collectively, our data reveal that ETVs negatively regulate insulin secretion for the maintenance of normoglycemia.	[Suriben, Rowena; Paolino, Magdalena; Dugger, Debra L.; Newton, Kim; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Kaihara, Kelly A.; Hebrok, Matthias] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Reichelt, Mike; Sagolla, Meredith; Webster, Joshua D.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Kummerfeld, Sarah K.; Liu, Jinfeng] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Modrusan, Zora] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech; University of California System; University of California San Francisco; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	Paolino, Magdalena/AAN-9417-2020; dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326; Liu, Jinfeng/0000-0002-0343-8222; Kaihara, Kelly/0000-0002-1277-6418; Kummerfeld, Sarah/0000-0002-0089-2358; Paolino, Magdalena/0000-0001-9724-9029	American Diabetes Mentor Award; Juvenile Diabetes Foundation [JDRF 17-2013-380]; Leona M. and Harry B. Helmsley Charitable Trust	American Diabetes Mentor Award; Juvenile Diabetes Foundation(Juvenile Diabetes Research Foundation); Leona M. and Harry B. Helmsley Charitable Trust	We thank the laboratories of Andy Peterson and Bernard Allan for discussions; Barton Wicksteed, Laszlo Komuves, Zhen Zhang, and Mira Chaurushiya for technical advice; and Ole Madsen and the DSHB for the proinsulin antibody. K.A.K. was supported by an American Diabetes Mentor Award to M.H. Work in M.H.'s laboratory was supported by grants from the Juvenile Diabetes Foundation (JDRF 17-2013-380) and the Leona M. and Harry B. Helmsley Charitable Trust.	Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Berglund ED, 2008, DIABETES, V57, P1790, DOI 10.2337/db07-1615; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; EIZIRIK DL, 1992, J CLIN INVEST, V90, P1263, DOI 10.1172/JCI115989; Fukuda M, 2002, BIOCHEM J, V366, P681, DOI 10.1042/BJ20020484; Fukuda M, 2002, J BIOL CHEM, V277, P4601, DOI 10.1074/jbc.C100588200; Fukuda M, 2013, TRAFFIC, V14, P949, DOI 10.1111/tra.12083; Gaisano HY, 2014, TRENDS ENDOCRIN MET, V25, P381, DOI 10.1016/j.tem.2014.03.005; Gomi H, 2005, J CELL BIOL, V171, P99, DOI 10.1083/jcb.200505179; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Gutierrez-Aguilar R, 2014, DIABETOLOGIA, V57, P383, DOI 10.1007/s00125-013-3096-5; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kaihara KA, 2013, DIABETES, V62, P1527, DOI 10.2337/db12-1013; Kasai K, 2005, J CLIN INVEST, V115, P388, DOI 10.1172/JCI200522955; Kitamura T, 2013, NAT REV ENDOCRINOL, V9, P615, DOI 10.1038/nrendo.2013.157; Kurowska M, 2012, BLOOD, V119, P3879, DOI 10.1182/blood-2011-09-382556; Lau OS, 2012, TRENDS PLANT SCI, V17, P584, DOI 10.1016/j.tplants.2012.05.004; Lu BC, 2009, NAT GENET, V41, P1295, DOI 10.1038/ng.476; Ma LG, 2002, PLANT CELL, V14, P2383, DOI 10.1105/tpc.004416; Magnuson MA, 2013, CELL METAB, V18, P9, DOI 10.1016/j.cmet.2013.06.011; Mao JH, 2009, DEV CELL, V16, P600, DOI 10.1016/j.devcel.2009.02.005; Migliorini D, 2011, J CLIN INVEST, V121, P1329, DOI 10.1172/JCI45784; ORCI L, 1985, CELL, V42, P671, DOI 10.1016/0092-8674(85)90124-2; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Rustenbeck I, 2004, DIABETES, V53, pS140, DOI 10.2337/diabetes.53.suppl_3.S140; Saito T, 2008, BIOMED RES-TOKYO, V29, P85, DOI 10.2220/biomedres.29.85; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Song WJ, 2011, CELL METAB, V13, P308, DOI 10.1016/j.cmet.2011.02.002; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tsuboi T, 2005, J BIOL CHEM, V280, P25565, DOI 10.1074/jbc.M501674200; Vitari AC, 2011, NATURE, V474, P403, DOI 10.1038/nature10005; Wang H, 2013, MOL BIOL CELL, V24, P319, DOI 10.1091/mbc.E12-04-0265; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Xie L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067561; Yamazaki H, 2006, AM J PHYSIOL-ENDOC M, V291, pE1381, DOI 10.1152/ajpendo.00137.2006; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Zhang Z, 2009, DEV CELL, V16, P607, DOI 10.1016/j.devcel.2009.02.008	45	29	29	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 6	2015	163	6								10.1016/j.cell.2015.10.076	http://dx.doi.org/10.1016/j.cell.2015.10.076			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SE	26627735	Bronze			2022-12-28	WOS:000366044800001
J	Maxmen, A				Maxmen, Amy			THREE TECHNOLOGIES THAT CHANGED GENETICS	NATURE			English	Editorial Material																			0	3	3	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					S2	S3		10.1038/528S2a	http://dx.doi.org/10.1038/528S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8AY	26630596	Bronze			2022-12-28	WOS:000371580500002
J	Gulland, A				Gulland, Anne			"It's the duty of every doctor to get involved with research"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												agulland@bmj.com						Medical Schools Council, 2015, SURV STAFF LEV MED C; Ozdemir BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118253; Rahman NM, 2015, DONT LET ME ADV THOR, pA6388	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2015	351								h6329	10.1136/bmj.h6329	http://dx.doi.org/10.1136/bmj.h6329			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX4TP	26614297				2022-12-28	WOS:000365693500001
J	Gibbons, A				Gibbons, Ann			Humans may have reached Chile by 18,500 years ago	SCIENCE			English	News Item																			0	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					898	898		10.1126/science.350.6263.898	http://dx.doi.org/10.1126/science.350.6263.898			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW4IP	26586741				2022-12-28	WOS:000364955200014
J	Barnett, J; Rogers, S; Webber, M; Finlayson, B; Wang, M				Barnett, Jon; Rogers, Sarah; Webber, Michael; Finlayson, Brian; Wang, Mark			Sustainability: Transfer project cannot meet China's water needs	NATURE			English	Editorial Material							SECURITY		[Barnett, Jon; Rogers, Sarah; Webber, Michael; Finlayson, Brian; Wang, Mark] Univ Melbourne, Sch Geog, Melbourne, Vic 3010, Australia	University of Melbourne	Barnett, J (corresponding author), Univ Melbourne, Sch Geog, Melbourne, Vic 3010, Australia.	jbarn@unimelb.edu.au	Wang, Mark/AGI-2421-2022; Finlayson, Brian L/H-9638-2014; Barnett, Jon/AAQ-9002-2021	Finlayson, Brian L/0000-0001-8708-3475; Barnett, Jon/0000-0002-0862-0808; WANG, MARK/0000-0002-1813-3632				Chen D, 2013, APPL GEOGR, V45, P303, DOI 10.1016/j.apgeog.2013.09.025; Crow-Miller B, 2015, WATER ALTERN, V8, P173; Heberer T, 2009, ROUTL CONTEMP CHINA, V31, P1; Jiang Y, 2015, ENVIRON SCI POLICY, V54, P106, DOI 10.1016/j.envsci.2015.06.006; Wang AL, 2013, HARVARD ENVIRON LAW, V37, P365; Wang H, 2004, J ENVIRON MANAGE, V71, P123, DOI 10.1016/j.jenvman.2004.01.007; Webber M, 2012, MAK CAP RUR CHIN; Webber M, 2008, GLOBAL ENVIRON CHANG, V18, P617, DOI 10.1016/j.gloenvcha.2008.07.014; Yang XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115269; Yee WH, 2013, CHINA QUART, P101, DOI 10.1017/S0305741012001543	10	83	84	17	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					295	297		10.1038/527295a	http://dx.doi.org/10.1038/527295a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26581275	Bronze			2022-12-28	WOS:000365356800027
J	Barratt, A				Barratt, Alexandra			Perspective: The risks of overdiagnosis	NATURE			English	Editorial Material							BREAST-CANCER; BENEFITS; HARMS		[Barratt, Alexandra] Univ Sydney, Sydney, NSW 2006, Australia	University of Sydney	Barratt, A (corresponding author), Univ Sydney, Sydney, NSW 2006, Australia.	Alexandra.Barratt@sydney.edu.au	Barratt, Alexandra/A-7349-2011	Barratt, Alexandra/0000-0002-2561-3319				Carter JL, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7773; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Gotzsche P., 2013, COCHRANE DB SYST REV, V2013; Hersch J, 2015, LANCET, V385, P1642, DOI 10.1016/S0140-6736(15)60123-4; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Welch HG, 2014, JAMA INTERN MED, V174, P448, DOI 10.1001/jamainternmed.2013.13635; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099	7	4	4	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					S104	S104		10.1038/527S104a	http://dx.doi.org/10.1038/527S104a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW9ZN	26580156	Bronze			2022-12-28	WOS:000365356800001
J	Tshala-Katumbay, D; Mwanza, JC; Rohlman, DS; Maestre, G; Oria, RB				Tshala-Katumbay, Desire; Mwanza, Jean-Claude; Rohlman, Diane S.; Maestre, Gladys; Oria, Reinaldo B.			A global perspective on the influence of environmental exposures on the nervous system	NATURE			English	Review							RECEPTOR-TYROSINE-KINASE; MOTOR-NEURON DISEASES; SPASTIC PARAPARESIS; GUT MICROBIOTA; DIESEL EXHAUST; BISPHENOL-A; FOOD TOXINS; OIL-SPILLS; HTLV-I; KONZO	Economic transitions in the era of globalization warrant a fresh look at the neurological risks associated with environmental change. These are driven by industrial expansion, transfer and mobility of goods, climate change and population growth. In these contexts, risk of infectious and non-infectious diseases are shared across geographical boundaries. In low-and middle-income countries, the risk of environmentally mediated brain disease is augmented several fold by lack of infrastructure, poor health and safety regulations, and limited measures for environmental protection. Neurological disorders may occur as a result of direct exposure to chemical and/or non-chemical stressors, including but not limited to, ultrafine particulate matters. Individual susceptibilities to exposure-related diseases are modified by genetic, epigenetic and metagenomic factors. The existence of several uniquely exposed populations, including those in the areas surrounding the Niger Delta or north western Amazon oil operations; those working in poorly regulated environments, such as artisanal mining industries; or those, mostly in sub-Saharan Africa, relying on cassava as a staple food, offers invaluable opportunities to advance the current understanding of brain responses to environmental challenges. Increased awareness of the brain disorders that are prevalent in low-and middle-income countries and investments in capacity for further environmental health-related research are positive steps towards improving human health.	[Tshala-Katumbay, Desire] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA; [Tshala-Katumbay, Desire] Natl Inst Biomed Res, Kinshasa 1197 I, DEM REP CONGO; [Tshala-Katumbay, Desire] Univ Kinshasa, Dept Neurol, Kinshasa 825 XI, DEM REP CONGO; [Mwanza, Jean-Claude] Univ N Carolina, Dept Ophthalmol, Chapel Hill, NC 27599 USA; [Rohlman, Diane S.] Univ Iowa, Occupat & Environm Hlth, Iowa City, IA 52242 USA; [Rohlman, Diane S.] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97239 USA; [Maestre, Gladys] Columbia Univ, Med Ctr, GH Sergievsky Ctr, New York, NY 10032 USA; [Oria, Reinaldo B.] Univ Fed Ceara, Dept Morphol, BR-60020 Fortaleza, Ceara, Brazil; [Oria, Reinaldo B.] Univ Fed Ceara, Inst Biomed, BR-60020 Fortaleza, Ceara, Brazil	Oregon Health & Science University; Institute Nacional de Recherche Biomedical; Universite de Kinshasa; University of North Carolina; University of North Carolina Chapel Hill; University of Iowa; Oregon Health & Science University; Columbia University; Universidade Federal do Ceara; Universidade Federal do Ceara	Tshala-Katumbay, D (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA.	tshalad@ohsu.edu	Oria, Reinaldo B/D-6440-2014; Mwanza, Jean-Claude/L-4235-2017; , Gladys/L-5092-2015; Rohlman, Diane/E-5556-2015	, Gladys/0000-0001-5690-8833; Rohlman, Diane/0000-0002-6697-1577; Oria, Reinaldo/0000-0002-6914-5481	NIEHS; Fogarty International Centre; FOGARTY INTERNATIONAL CENTER [R21TW010004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022163, R01ES019841, P30ES005605] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Fogarty International Centre(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	All the authors are thankful to NIEHS and Fogarty International Centre for research grant support and the scientific expertise of their respective programme officers A. Kirshner and K. Michels and staff members. The intellectual contribution of R. Kalaria of Newcastle University, UK, is very much appreciated.	Ali SF, 2011, INT J ENV RES PUB HE, V8, P4702, DOI 10.3390/ijerph8124702; Alonso C, 2014, ADV EXP MED BIOL, V817, P73, DOI 10.1007/978-1-4939-0897-4_4; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Bale TL, 2014, DIALOGUES CLIN NEURO, V16, P297; Banea JP, 2014, FOOD NUTR BULL, V35, P28, DOI 10.1177/156482651403500104; Banea M, 1997, LANCET, V349, P621, DOI 10.1016/S0140-6736(05)61569-3; Bihaqi SW, 2014, NEUROTOXICOLOGY, V44, P114, DOI 10.1016/j.neuro.2014.06.008; Blanc-Lapierre A, 2013, AM J EPIDEMIOL, V177, P1086, DOI 10.1093/aje/kws346; Block ML, 2004, FASEB J, V18, P1618, DOI 10.1096/fj.04-1945fje; Boivin MJ, 2013, PEDIATRICS, V131, pE1231, DOI 10.1542/peds.2012-3011; Breton J, 2013, TOXICOL LETT, V222, P132, DOI 10.1016/j.toxlet.2013.07.021; Catalani S, 2012, HUM EXP TOXICOL, V31, P421, DOI 10.1177/0960327111414280; Charlet L, 2012, COORDIN CHEM REV, V256, P2147, DOI 10.1016/j.ccr.2012.05.012; Ciglenecki I, 2011, FOOD CHEM TOXICOL, V49, P579, DOI 10.1016/j.fct.2010.05.081; Cliff J, 1997, TROP MED INT HEALTH, V2, P1068, DOI 10.1046/j.1365-3156.1997.d01-178.x; Collotta M, 2013, TOXICOLOGY, V307, P35, DOI 10.1016/j.tox.2013.01.017; Costa LG, 2014, TOXICOL LETT, V230, P282, DOI 10.1016/j.toxlet.2013.11.011; Costa LG, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/736385; Crane AL, 2013, J EXPO SCI ENV EPID, V23, P356, DOI 10.1038/jes.2012.113; Currie J, 2013, ANNU REV ECON, V5, P1, DOI 10.1146/annurev-economics-081412-103704; Dosunmu R, 2012, MECH AGEING DEV, V133, P435, DOI 10.1016/j.mad.2012.05.003; Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Erisman JW, 2015, NATURE, V519, P151, DOI 10.1038/519151a; Farina M, 2011, LIFE SCI, V89, P555, DOI 10.1016/j.lfs.2011.05.019; Ferguson KT, 2013, INT J PSYCHOL, V48, P437, DOI 10.1080/00207594.2013.804190; Florea AM, 2006, BIOMETALS, V19, P419, DOI 10.1007/s10534-005-4451-x; Fonnum F, 2009, J NEUROCHEM, V111, P1327, DOI 10.1111/j.1471-4159.2009.06427.x; Gleadow RM, 2009, PLANT BIOLOGY, V11, P76, DOI 10.1111/j.1438-8677.2009.00238.x; Goodrich JM, 2012, TOXICOL IN VITRO, V26, P630, DOI 10.1016/j.tiv.2012.02.005; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; Guerrant RL, 2013, NAT REV GASTRO HEPAT, V10, P220, DOI 10.1038/nrgastro.2012.239; Guerrant RL, 2002, ARCH MED RES, V33, P351, DOI 10.1016/S0188-4409(02)00379-X; Haile M, 2005, PHILOS T R SOC B, V360, P2169, DOI 10.1098/rstb.2005.1746; Harley KG, 2013, ENVIRON RES, V126, P43, DOI 10.1016/j.envres.2013.06.004; Jackson PB, 2009, AUTISM RES, V2, P232, DOI 10.1002/aur.87; Jamal GA, 2002, OCCUP ENVIRON MED, V59, P434, DOI 10.1136/oem.59.7.434; JEANNEL D, 1993, J ACQ IMMUN DEF SYND, V6, P840; Jernelov A, 2010, AMBIO, V39, P353, DOI 10.1007/s13280-010-0085-5; Kaji Ryuji, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS190, DOI 10.1016/S1353-8020(11)70059-1; Kang Y, 2011, SCI TOTAL ENVIRON, V412, P1, DOI 10.1016/j.scitotenv.2011.10.026; Kassa RM, 2011, FOOD CHEM TOXICOL, V49, P571, DOI 10.1016/j.fct.2010.05.080; Kilburn KH, 2000, ARCH ENVIRON HEALTH, V55, P11, DOI 10.1080/00039890009603379; Kim KH, 2014, J ENVIRON SCI HEAL C, V32, P299, DOI 10.1080/10590501.2014.941279; Kisby GE, 2011, INT J ENV RES PUB HE, V8, P3889, DOI 10.3390/ijerph8103889; Korpe PS, 2012, TRENDS MOL MED, V18, P328, DOI 10.1016/j.molmed.2012.04.007; Kumar V, 2009, ARCH TOXICOL, V83, P965, DOI 10.1007/s00204-009-0455-6; Lang VF, 2015, J INT DEV, V27, P399, DOI 10.1002/jid.3084; Lee SE, 2011, CURR OPIN NEUROL, V24, P517, DOI 10.1097/WCO.0b013e32834cd50a; Levy BS, 2011, INT J OCCUP ENV HEAL, V17, P161; Linares V, 2015, ARCH TOXICOL, V89, P335, DOI 10.1007/s00204-015-1457-1; Liu J, 2002, ENVIRON HEALTH PERSP, V110, P119, DOI 10.1289/ehp.02110119; LUDOLPH AC, 1987, BRAIN, V110, P149, DOI 10.1093/brain/110.1.149; MAESTRE G, 1995, ANN NEUROL, V37, P254, DOI 10.1002/ana.410370217; Makila-Mabe BG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107191; Marler TE, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00526; Mason LH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/840547; Miodovnik A, 2011, NEUROTOXICOLOGY, V32, P261, DOI 10.1016/j.neuro.2010.12.009; Mlingi NLV, 2011, FOOD CHEM TOXICOL, V49, P673, DOI 10.1016/j.fct.2010.09.017; Morahan JM, 2007, AM J MED GENET B, V144B, P885, DOI 10.1002/ajmg.b.30543; Nean A, 2013, TOXICOL RES, V2, P99; Ngudi DD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001759; Nzwalo H, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001051; Okitundu Luwa E-Andjafono Daniel, 2014, Pan Afr Med J, V18, P213, DOI 10.11604/pamj.2014.18.213.4572; Oluwole OSA, 2000, J NEUROL NEUROSUR PS, V69, P96, DOI 10.1136/jnnp.69.1.96; Oria RB, 2010, BRAZ J MED BIOL RES, V43, P249, DOI 10.1590/S0100-879X2010007500003; Oria RB, 2005, PEDIATR RES, V57, P310, DOI 10.1203/01.PDR.0000148719.82468.CA; Oteiza Patricia I., 2004, Molecular Aspects of Medicine, V25, P103, DOI 10.1016/j.mam.2004.02.012; Patrick PD, 2005, CHILD NEUROPSYCHOL, V11, P233, DOI 10.1080/092970490911252; Peng Y, 2013, INT REV NEUROBIOL, V113, P135, DOI 10.1016/B978-0-12-418700-9.00005-8; Petri WA, 2008, J CLIN INVEST, V118, P1277, DOI 10.1172/JCI34005; Petri WA, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0187-1; Prendergast AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086928; Rahman A, 2004, WATER SCI TECHNOL, V49, P147, DOI 10.2166/wst.2004.0440; Rieder M, 2012, ARCH DIS CHILD, V97, P59, DOI 10.1136/adc.2009.178186; Rohlman DS, 2014, METAB BRAIN DIS, V29, P845, DOI 10.1007/s11011-014-9565-9; Sanders Talia, 2009, Reviews on Environmental Health, V24, P15; Sarmento A, 2015, J SCI FOOD AGR, V95, P179, DOI 10.1002/jsfa.6702; Seccatore J, 2014, SCI TOTAL ENVIRON, V496, P662, DOI 10.1016/j.scitotenv.2014.05.003; Singh S, 2012, MUTAT RES-GEN TOX EN, V741, P101, DOI 10.1016/j.mrgentox.2011.11.001; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Sousa I, 2009, EUR J HUM GENET, V17, P749, DOI 10.1038/ejhg.2008.215; Spencer PS, 1999, DRUG METAB REV, V31, P561, DOI 10.1081/DMR-100101936; SPENCER PS, 1980, CRC CR REV TOXICOL, V7, P279, DOI 10.3109/10408448009037489; SPENCER PS, 1983, NEUROBEH TOXICOL TER, V5, P625; Sumner A., 2010, GLOBAL POVERTY NEW B, P1; TEKLEHAIMANOT R, 1990, EPILEPSY RES, V7, P230, DOI 10.1016/0920-1211(90)90020-V; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Tshala-Katumbay D, 2013, NEUROLOGY, V80, P949, DOI 10.1212/WNL.0b013e3182840b81; Tshala-Katumbay D, 2002, MUSCLE NERVE, V25, P230, DOI 10.1002/mus.10029; Tshala-Katumbay D, 2009, NEUROCHEM RES, V34, P1919, DOI 10.1007/s11064-009-9977-9; Tylleskar T, 1996, J ACQ IMMUN DEF SYND, V12, P317, DOI 10.1097/00042560-199607000-00014; TYLLESKAR T, 1995, INT J EPIDEMIOL, V24, P949, DOI 10.1093/ije/24.5.949; TYLLESKAR T, 1994, NEUROLOGY, V44, P959, DOI 10.1212/WNL.44.5.959; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Viaene MK., 2002, ARCH PUBLIC HLTH, V60, P217; Vidal AC, 2014, GENET EPIGENETICS, V6, P37, DOI 10.4137/GEG.S18067; Volk HE, 2014, EPIDEMIOLOGY, V25, P44, DOI 10.1097/EDE.0000000000000030; Wang Guoying, 2014, Curr Environ Health Rep, V1, P78; World Bank, 2015, LOW MIDDL INC COUNTR; World Bank, 2015, GLOB MON REP 2014 20; Yang YM, 2014, NAT COMMUN, V5, DOI [10.1038/ncomms5564, 10.1038/ncomms6110]; Yolton K, 2011, NEUROTOXICOL TERATOL, V33, P558, DOI 10.1016/j.ntt.2011.08.003	103	40	40	5	94	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					S187	S192		10.1038/nature16034	http://dx.doi.org/10.1038/nature16034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26580326	hybrid, Green Submitted, Green Accepted			2022-12-28	WOS:000365356800015
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Stop blaming patients for emergency visits	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						[Anonymous], 2015, BBC NEWS; [Anonymous], CHOOS WELL; Barnsley Hospital NHS Foundation Trust, 2014, REP SHOWS ONL 22 PEO; Blunt I, 2014, FOCUS A E ATTENDANCE; Boseley S, 2013, GUARDIAN; Hunt J, 2015, HLTH SERV J; NHS England, 2015, SAF FAST BETT GOOD P; NHS England, 2013, URG EM CAR REV END P; Roberts N., 2014, GP ONLINE       1125; Royal College of Emergency Medicine Patients Association, 2015, TIM ACT URG CAR A E	10	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 13	2015	351								h6119	10.1136/bmj.h6119	http://dx.doi.org/10.1136/bmj.h6119			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW4HA	26566636	Bronze			2022-12-28	WOS:000364950900010
J	Duncan, R				Duncan, Robert			EARTH SCIENCE Deadly combination	NATURE			English	Editorial Material							CRETACEOUS-PALEOGENE BOUNDARY; EVENTS; IMPACT		Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Oregon State University	Duncan, R (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	rduncan@coas.oregonstate.edu						Chenet AL, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005644; Courtillot VE, 2003, CR GEOSCI, V335, P113, DOI 10.1016/S1631-0713(03)00006-3; FRAM MS, 1993, NATURE, V363, P712, DOI 10.1038/363712a0; Manga M, 2006, ANNU REV EARTH PL SC, V34, P263, DOI 10.1146/annurev.earth.34.031405.125125; Renne PR, 2015, SCIENCE, V350, P76, DOI 10.1126/science.aac7549; Renne PR, 2013, SCIENCE, V339, P684, DOI 10.1126/science.1230492; Richards MA, 2015, GEOL SOC AM BULL, V127, P1507, DOI 10.1130/B31167.1; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265	8	0	0	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					172	173		10.1038/527172a	http://dx.doi.org/10.1038/527172a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26560294				2022-12-28	WOS:000364396700029
J	Bell, S; Dekker, FW; Vadiveloo, T; Marwick, C; Deshmukh, H; Donnan, PT; Van Diepen, M				Bell, Samira; Dekker, Friedo W.; Vadiveloo, Thenmalar; Marwick, Charis; Deshmukh, Harshal; Donnan, Peter T.; Van Diepen, Merel			Risk of postoperative acute kidney injury in patients undergoing orthopaedic surgery-development and validation of a risk score and effect of acute kidney injury on survival: observational cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MULTIVARIABLE PREDICTION MODEL; ACUTE-RENAL-FAILURE; INDIVIDUAL PROGNOSIS; MULTIPLE IMPUTATION; DIAGNOSIS TRIPOD; EXTERNAL VALIDATION; MORTALITY; IMPACT; PERFORMANCE; DISEASE	STUDY QUESTION What is the predicted risk of acute kidney injury after orthopaedic surgery and does it affect short term and long term survival? METHODS The cohort comprised adults resident in the National Health Service Tayside region of Scotland who underwent orthopaedic surgery from 1 January 2005 to 31 December 2011. The model was developed in 6220 patients (two hospitals) and externally validated in 4395 patients from a third hospital. Several preoperative variables were selected for candidate predictors, based on literature, clinical expertise, and availability in the orthopaedic surgery setting. The main outcomes were the development of any severity of acute kidney injury (stages 1-3) within the first postoperative week, and 90 day, one year, and longer term survival. STUDY ANSWER AND LIMITATIONS Using logistic regression analysis, independent predictors of acute kidney injury were older age, male sex, diabetes, number of prescribed drugs, lower estimated glomerular filtration rate, use of angiotensin converting enzyme inhibitors or angiotensin receptor blockers, and American Society of Anesthesiologists grade. The model's predictive performance for discrimination was good (C statistic 0.74 in development cohort, 0.70 in validation cohort). Calibration was good in the development cohort and after recalibration in the validation cohort. Only the highest risks were over-predicted. Survival was worse in patients with acute kidney injury compared with those without (adjusted hazard ratio 1.53, 95% confidence interval 1.38 to 1.70). This was most noticeable in the short term (adjusted hazard ratio: 90 day 2.36, 1.94 to 2.87) and diminished over time (90 day-one year 1.40, 1.10 to 1.79; >1 year 1.28, 1.10 to 1.48). The model used routinely collected data in the orthopaedic surgery setting therefore some variables that could potentially improve predictive performance were not available. However, the readily available predictors make the model easily applicable. WHAT THIS STUDY ADDS A preoperative risk prediction model consisting of seven predictors for acute kidney injury was developed, with good predictive performance in patients undergoing orthopaedic surgery. Survival was significantly poorer in patients even with mild (stage 1) postoperative acute kidney injury. FUNDING, COMPETING INTERESTS, DATA SHARING SB received grants from Tenovus Tayside, Chief Scientist Office, and the Royal College of Physicians and Surgeons of Glasgow; PT receives grants from Novo Nordisk, GlaxoSmithKline, and the New Drugs Committee of the Scottish Medicines Consortium. No additional data are available.	[Bell, Samira] Ninewells Hosp, NHS Tayside, Renal Unit, Dundee DD1 9SY, Scotland; [Dekker, Friedo W.; Van Diepen, Merel] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Vadiveloo, Thenmalar; Marwick, Charis; Deshmukh, Harshal; Donnan, Peter T.] Univ Dundee, Sch Med, Div Populat Hlth Sci, Dundee, Scotland	University of Dundee; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Dundee	Bell, S (corresponding author), Ninewells Hosp, NHS Tayside, Renal Unit, Dundee DD1 9SY, Scotland.	samira.bell@nhs.net	Deshmukh, Harshal/AAS-4090-2021; Dekker, Friedo/B-6452-2011	Deshmukh, Harshal/0000-0002-3859-3118; Bell, Samira/0000-0001-9100-1575; Dekker, Friedo/0000-0002-2433-2494; Mansoorian, Bahareh/0000-0001-7855-6824; Donnan, Peter/0000-0001-7828-0610; Vadiveloo, Thenmalar/0000-0001-5531-6289; Marwick, Charis/0000-0003-2488-2362	Tenovus Tayside, Chief Scientist Office, Scotland; Royal College of Physicians and Surgeons of Glasgow	Tenovus Tayside, Chief Scientist Office, Scotland; Royal College of Physicians and Surgeons of Glasgow	This study was funded by Tenovus Tayside, Chief Scientist Office, Scotland and a travelling fellowship from the Royal College of Physicians and Surgeons of Glasgow. The funders had no role in the study design; collection, analysis, and interpretation of the data; writing of the report; or the decision to submit the article for publication. The researchers are independent of the funders.	[Anonymous], 2015, PACKAGE RMS PROGRAM; Austin PC, 2014, STAT MED, V33, P517, DOI 10.1002/sim.5941; Bell S, 2014, J AM SOC NEPHROL, V25, P2625, DOI 10.1681/ASN.2014010035; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; Bucaloiu ID, 2012, KIDNEY INT, V81, P477, DOI 10.1038/ki.2011.405; Calvert S, 2012, PERIOPER MED-LONDON, V1, DOI 10.1186/2047-0525-1-6; Candela-Toha A, 2008, CLIN J AM SOC NEPHRO, V3, P1260, DOI 10.2215/CJN.00560208; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; de Goeij MCM, 2013, NEPHROL DIAL TRANSPL, V28, P2415, DOI 10.1093/ndt/gft221; Dekker FW, 2008, KIDNEY INT, V74, P994, DOI 10.1038/ki.2008.328; Efron B., 1994, INTRO BOOTSTRAP; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hobson C, 2015, ANN SURG, V261, P1207, DOI 10.1097/SLA.0000000000000732; Ivanov J, 1999, CIRCULATION, V99, P2098, DOI 10.1161/01.CIR.99.16.2098; Janssen KJM, 2009, CAN J ANAESTH, V56, P194, DOI 10.1007/s12630-009-9041-x; Joannidis M, 2009, INTENS CARE MED, V35, P1692, DOI 10.1007/s00134-009-1530-4; Kerr M, 2014, NEPHROL DIAL TRANSPL, V29, P1362, DOI 10.1093/ndt/gfu016; Kheterpal S, 2007, ANESTHESIOLOGY, V107, P892, DOI 10.1097/01.anes.0000290588.29668.38; Kheterpal S, 2009, ANESTHESIOLOGY, V110, P505, DOI 10.1097/ALN.0b013e3181979440; Kidney Disease: Improving Global Outcomes (KDIGO), 2012, KIDNEY INT SUPPL, V2, P1, DOI [10.1038/kisup.2012.1, DOI 10.1038/KISUP.2012.1]; Krumholz HM, 1999, CIRCULATION, V99, P2067, DOI 10.1161/01.CIR.99.16.2067; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Murugan R, 2011, NAT REV NEPHROL, V7, P209, DOI 10.1038/nrneph.2011.13; National Institute for Health and Care Excellence, 2013, AC KIDN INJ PREV DET; Perkins AJ, 2004, J CLIN EPIDEMIOL, V57, P1040, DOI 10.1016/j.jclinepi.2004.03.002; Quan HD, 2002, MED CARE, V40, P675, DOI 10.1097/00005650-200208000-00007; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; SECHZER PH, 1963, ANESTHESIOLOGY, V24, P779, DOI 10.1097/00000542-196311000-00005; Siew ED, 2010, KIDNEY INT, V77, P536, DOI 10.1038/ki.2009.479; Slankamenac K, 2013, WORLD J SURG, V37, P2618, DOI 10.1007/s00268-013-2159-6; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2009, CLIN PREDICTION MODE, DOI 10.1007/978-0-387-77244-8; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Thakar CV, 2007, CLIN J AM SOC NEPHRO, V2, P426, DOI 10.2215/CJN.03961106; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; Thakar CV, 2003, AM J KIDNEY DIS, V41, P742, DOI 10.1016/S0272-6386(03)00021-0; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Uchino S, 2010, NEPHROL DIAL TRANSPL, V25, P1833, DOI 10.1093/ndt/gfp624; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Wijeysundera DN, 2007, JAMA-J AM MED ASSOC, V297, P1801, DOI 10.1001/jama.297.16.1801	43	87	91	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2015	351								h5639	10.1136/bmj.h5639	http://dx.doi.org/10.1136/bmj.h5639			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW4FX	26561522	Green Published, hybrid			2022-12-28	WOS:000364947900003
J	Cheng, JX; Xie, XS				Cheng, Ji-Xin; Xie, X. Sunney			Vibrational spectroscopic imaging of living systems: An emerging platform for biology and medicine	SCIENCE			English	Review							STIMULATED RAMAN-SCATTERING; IN-VIVO; CARS MICROSCOPY; LABEL-FREE; LIVE CELLS; PHOTOACOUSTIC TOMOGRAPHY; DEEP-TISSUE; SPECTRAL-ANALYSIS; PHOTON MIGRATION; FIBEROPTIC ARRAY	Vibrational spectroscopy has been extensively applied to the study of molecules in gas phase, in condensed phase, and at interfaces. The transition from spectroscopy to spectroscopic imaging of living systems, which allows the spectrum of biomolecules to act as natural contrast, is opening new opportunities to reveal cellular machinery and to enable molecule-based diagnosis. Such a transition, however, involves more than a simple combination of spectrometry and microscopy. We review recent efforts that have pushed the boundary of the vibrational spectroscopic imaging field in terms of spectral acquisition speed, detection sensitivity, spatial resolution, and imaging depth. We further highlight recent applications in functional analysis of single cells and in label-free detection of diseases.	[Cheng, Ji-Xin] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Cheng, Ji-Xin] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Harvard University	Cheng, JX (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.; Cheng, JX (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.; Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	jcheng@purdue.edu; xie@chemistry.harvard.edu						Allen TJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.061209; Andresen ER, 2011, OPT LETT, V36, P2387, DOI 10.1364/OL.36.002387; BEGLEY RF, 1974, APPL PHYS LETT, V25, P387, DOI 10.1063/1.1655519; Beier HT, 2011, OPT EXPRESS, V19, P18885, DOI 10.1364/OE.19.018885; Belanger E, 2011, BIOMED OPT EXPRESS, V2, P2698, DOI 10.1364/BOE.2.002698; Bell AG, 1880, AM J SCI, V20, P305, DOI DOI 10.2475/AJS.S3-20.118.305; Bergner G, 2011, ANALYST, V136, P3686, DOI 10.1039/c0an00956c; Bhargava R, 2012, APPL SPECTROSC, V66, P1091, DOI 10.1366/12-06801; Buckley K, 2014, J RAMAN SPECTROSC, V45, P188, DOI 10.1002/jrs.4434; Camp CH, 2014, NAT PHOTONICS, V8, P627, DOI [10.1038/nphoton.2014.145, 10.1038/NPHOTON.2014.145]; Cerussi A, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2337546; Cerussi AE, 2011, PHILOS T R SOC A, V369, P4512, DOI 10.1098/rsta.2011.0279; Cheng J. X., 2013, COHERENT RAMAN SCATT; Cheng JX, 2007, APPL SPECTROSC, V61, p197A, DOI 10.1366/000370207781746044; Cheng JX, 2002, J PHYS CHEM B, V106, P8493, DOI 10.1021/jp025771z; Cheng JX, 2002, BIOPHYS J, V83, P502, DOI 10.1016/S0006-3495(02)75186-2; Cheng JX, 2002, J OPT SOC AM B, V19, P1363, DOI 10.1364/JOSAB.19.001363; Cheng JX, 2001, OPT LETT, V26, P1341, DOI 10.1364/OL.26.001341; Chiu WS, 2015, P NATL ACAD SCI USA, V112, P7725, DOI 10.1073/pnas.1503791112; Cicerone MT, 2012, J RAMAN SPECTROSC, V43, P637, DOI 10.1002/jrs.3169; Demers JLH, 2015, BIOMED OPT EXPRESS, V6, P793, DOI 10.1364/BOE.6.000793; Dou W, 2012, BIOPHYS J, V102, P1666, DOI 10.1016/j.bpj.2012.01.057; DUNCAN MD, 1982, OPT LETT, V7, P350, DOI 10.1364/OL.7.000350; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Esmonde-White KA, 2011, ANALYST, V136, P1675, DOI 10.1039/c0an00824a; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; Everall N, 2004, APPL SPECTROSC, V58, P591, DOI 10.1366/000370204774103426; Everall N, 2001, APPL SPECTROSC, V55, P1701, DOI 10.1366/0003702011954053; Freudiger CW, 2014, NAT PHOTONICS, V8, P153, DOI [10.1038/nphoton.2013.360, 10.1038/NPHOTON.2013.360]; Freudiger CW, 2012, LAB INVEST, V92, P1492, DOI 10.1038/labinvest.2012.109; Freudiger CW, 2008, SCIENCE, V322, P1857, DOI 10.1126/science.1165758; Fu D, 2014, NAT CHEM, V6, P615, DOI [10.1038/nchem.1961, 10.1038/NCHEM.1961]; Fu D, 2014, ANAL CHEM, V86, P4115, DOI 10.1021/ac500014b; Fu D, 2013, J PHYS CHEM B, V117, P4634, DOI 10.1021/jp308938t; Fu D, 2012, J AM CHEM SOC, V134, P3623, DOI 10.1021/ja210081h; Fu Y, 2007, J NEUROSCI RES, V85, P2870, DOI 10.1002/jnr.21403; Fussell AL, 2014, J RAMAN SPECTROSC, V45, P495, DOI 10.1002/jrs.4515; Gong L, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.013818; Hartshorn CM, 2013, ANAL CHEM, V85, P8102, DOI 10.1021/ac400671p; Hellerer T, 2007, P NATL ACAD SCI USA, V104, P14658, DOI 10.1073/pnas.0703594104; Heuke S, 2013, BRIT J DERMATOL, V169, P794, DOI 10.1111/bjd.12427; Hielscher AH, 2002, DIS MARKERS, V18, P313, DOI 10.1155/2002/164252; Hong SL, 2014, ANGEW CHEM INT EDIT, V53, P5827, DOI 10.1002/anie.201400328; Hu CR, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.086005; Hu FH, 2014, ANALYST, V139, P2312, DOI 10.1039/c3an02281a; Jansen K, 2014, PHOTOACOUSTICS, V2, P12, DOI 10.1016/j.pacs.2013.11.003; Jansen K, 2011, OPT LETT, V36, P597, DOI 10.1364/OL.36.000597; Jermyn M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2384; Ji MB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005954; Kang EN, 2006, ANAL CHEM, V78, P8036, DOI 10.1021/ac061218s; Keller MD, 2009, OPT LETT, V34, P926, DOI 10.1364/OL.34.000926; Kim H, 2012, OPT EXPRESS, V20, P6042, DOI 10.1364/OE.20.006042; Knoll B, 1999, NATURE, V399, P134, DOI 10.1038/20154; Konig K, 2011, LASER PHYS LETT, V8, P465, DOI 10.1002/lapl.201110014; Krafft C, 2009, J BIOPHOTONICS, V2, P303, DOI 10.1002/jbio.200810063; Kukretia S, 2008, DIS MARKERS, V25, P281, DOI 10.1155/2008/651308; Le TT, 2010, J LIPID RES, V51, P3091, DOI 10.1194/jlr.R008730; Lee HJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep07930; Lee YJ, 2011, ANAL CHEM, V83, P2733, DOI 10.1021/ac103351q; Legare F, 2006, OPT EXPRESS, V14, P4427, DOI 10.1364/OE.14.004427; Li JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06807; Li L, 2005, BIOPHYS J, V89, P3480, DOI 10.1529/biophysj.105.065607; Li R, 2015, BIOMED OPT EXPRESS, V6, P1273, DOI 10.1364/BOE.6.001273; Li R, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.040502; Liao CS, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500738; Liao CS, 2015, J PHYS CHEM C, V119, P19397, DOI 10.1021/acs.jpcc.5b06980; Liao CS, 2015, LIGHT-SCI APPL, V4, DOI 10.1038/lsa.2015.38; Lin CY, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3533716; Liu B, 2015, ANAL CHEM, V87, P9436, DOI 10.1021/acs.analchem.5b02434; Liu ZF, 2013, ELECTRON LETT, V49, DOI 10.1049/el.2013.0220; Lu FK, 2015, P NATL ACAD SCI USA, V112, P11624, DOI 10.1073/pnas.1515121112; Lyn RK, 2010, BIOCHEM BIOPH RES CO, V399, P518, DOI 10.1016/j.bbrc.2010.07.101; Mansfield JC, 2013, ANAL CHEM, V85, P5055, DOI 10.1021/ac400266a; Marks DL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.123905; Marx B, 2014, J RAMAN SPECTROSC, V45, P521, DOI 10.1002/jrs.4528; Masia F, 2013, ANAL CHEM, V85, P10820, DOI 10.1021/ac402303g; Matousek P, 2005, APPL SPECTROSC, V59, P393, DOI 10.1366/0003702053641450; Matousek P, 2013, J BIOPHOTONICS, V6, P7, DOI 10.1002/jbio.201200141; Min W, 2011, ANNU REV PHYS CHEM, V62, P507, DOI 10.1146/annurev.physchem.012809.103512; Mittal R, 2013, LASER SURG MED, V45, P496, DOI 10.1002/lsm.22168; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; Muller M, 2002, J PHYS CHEM B, V106, P3715, DOI 10.1021/jp014012y; Muller M, 2007, CHEMPHYSCHEM, V8, P2156, DOI 10.1002/cphc.200700202; Nan XL, 2003, J LIPID RES, V44, P2202, DOI 10.1194/jlr.D300022-JLR200; Nandakumar P, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033026; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/nmeth.1483, 10.1038/NMETH.1483]; Owyoung A, 1977, OPT LETT, V1, P152, DOI 10.1364/OL.1.000152; Ozeki Y, 2012, NAT PHOTONICS, V6, P844, DOI [10.1038/nphoton.2012.263, 10.1038/NPHOTON.2012.263]; Ozeki Y, 2009, OPT EXPRESS, V17, P3651, DOI 10.1364/OE.17.003651; Paar M, 2012, J BIOL CHEM, V287, P11164, DOI 10.1074/jbc.M111.316794; Palonpon AF, 2013, NAT PROTOC, V8, P677, DOI 10.1038/nprot.2013.030; Petterson IEI, 2010, ANALYST, V135, P3255, DOI 10.1039/c0an00611d; Pliss A, 2010, P NATL ACAD SCI USA, V107, P12771, DOI 10.1073/pnas.1006374107; Ploetz E, 2007, APPL PHYS B-LASERS O, V87, P389, DOI 10.1007/s00340-007-2630-x; Potma EO, 2003, J RAMAN SPECTROSC, V34, P642, DOI 10.1002/jrs.1045; Rajapaksa I, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3652760; Rajian JR, 2013, J PHYS CHEM LETT, V4, P3211, DOI 10.1021/jz401638e; Rock W, 2013, OPT EXPRESS, V21, P15113, DOI 10.1364/OE.21.015113; Saar BG, 2011, OPT LETT, V36, P2396, DOI 10.1364/OL.36.002396; Saar BG, 2010, SCIENCE, V330, P1368, DOI 10.1126/science.1197236; Saar BG, 2010, ANGEW CHEM INT EDIT, V49, P5476, DOI 10.1002/anie.201000900; Schulmerich MV, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2904940; Schulmerich MV, 2007, APPL SPECTROSC, V61, P671, DOI 10.1366/000370207781393307; Schulmerich MV, 2006, APPL SPECTROSC, V60, P109, DOI 10.1366/000370206776023340; Seto K, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4818670; Shen YH, 2014, ANGEW CHEM INT EDIT, V53, P5596, DOI 10.1002/anie.201310725; Shi YZ, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3641988; Siesler HW., 2001, NEAR INFRARED SPECTR, V1, DOI [10.1002/9783527612666, DOI 10.1002/9783527612666]; Sil S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05308; Slipchenko MN, 2012, J BIOPHOTONICS, V5, P801, DOI 10.1002/jbio.201200005; Slipchenko MN, 2010, ANALYST, V135, P2613, DOI 10.1039/c0an00252f; Slipchenko MN, 2009, J PHYS CHEM B, V113, P7681, DOI 10.1021/jp902231y; Srinivasan S, 2008, OPT EXPRESS, V16, P12190, DOI 10.1364/OE.16.012190; Stone N, 2007, ANALYST, V132, P899, DOI 10.1039/b705029a; TERHUNE RW, 1965, PHYS REV LETT, V14, P681, DOI 10.1103/PhysRevLett.14.681; Vartiainen EM, 2006, OPT EXPRESS, V14, P3622, DOI 10.1364/OE.14.003622; Volkmer A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.023901; Wang B, 2012, OPT LETT, V37, P1244, DOI 10.1364/OL.37.001244; Wang HF, 2007, J OPT SOC AM B, V24, P544, DOI 10.1364/JOSAB.24.000544; Wang HW, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.238106; Wang HF, 2005, BIOPHYS J, V89, P581, DOI 10.1529/biophysj.105.061911; Wang K, 2013, J BIOPHOTONICS, V6, P815, DOI 10.1002/jbio.201300005; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Wang MC, 2011, NAT METHODS, V8, P135, DOI 10.1038/NMETH.1556; Wang P, 2014, ANGEW CHEM INT EDIT, V53, P11787, DOI 10.1002/anie.201406029; Wang P, 2014, SCI REP-UK, V4, DOI 10.1038/srep06889; Wang P, 2013, J PHYS CHEM LETT, V4, P2177, DOI 10.1021/jz400559a; Wang P, 2013, NAT PHOTONICS, V7, P450, DOI [10.1038/NPHOTON.2013.97, 10.1038/nphoton.2013.97]; Wang P, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.9.096010; Wang P, 2012, J BIOPHOTONICS, V5, P25, DOI 10.1002/jbio.201100102; Wang YM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1925; Wei L, 2014, NAT METHODS, V11, P410, DOI [10.1038/NMETH.2878, 10.1038/nmeth.2878]; Wei L, 2013, P NATL ACAD SCI USA, V110, P11226, DOI 10.1073/pnas.1303768110; Weinigel M, 2014, LASER PHYS LETT, V11, DOI 10.1088/1612-2011/11/5/055601; WOODBURY EJ, 1962, P IRE, V50, P2367; Xie XS, 2006, SCIENCE, V312, P228, DOI 10.1126/science.1127566; Xu XA, 2011, NAT PHOTONICS, V5, P154, DOI 10.1038/NPHOTON.2010.306; Yakovlev VV, 2011, OPT LETT, V36, P1233, DOI 10.1364/OL.36.001233; Yakovlev VV, 2010, P NATL ACAD SCI USA, V107, P20335, DOI 10.1073/pnas.1012432107; Yamakoshi H, 2012, J AM CHEM SOC, V134, P20681, DOI 10.1021/ja308529n; Yamakoshi H, 2011, J AM CHEM SOC, V133, P6102, DOI 10.1021/ja108404p; Yampolsky S, 2014, NAT PHOTONICS, V8, P650, DOI [10.1038/nphoton.2014.143, 10.1038/NPHOTON.2014.143]; Yue SH, 2014, CELL METAB, V19, P393, DOI 10.1016/j.cmet.2014.01.019; Yue SH, 2011, LASER PHOTONICS REV, V5, P496, DOI 10.1002/lpor.201000027; Zhang DL, 2014, ACCOUNTS CHEM RES, V47, P2282, DOI 10.1021/ar400331q; Zhang DL, 2013, ANAL CHEM, V85, P98, DOI 10.1021/ac3019119; Zhang D, 2011, J PHYS CHEM LETT, V2, P1248, DOI 10.1021/jz200516n; Zumbusch A, 1999, PHYS REV LETT, V82, P4142, DOI 10.1103/PhysRevLett.82.4142	148	440	453	27	435	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264							aaa8870	10.1126/science.aaa8870	http://dx.doi.org/10.1126/science.aaa8870			84	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY5BJ	26612955				2022-12-28	WOS:000366422600033
J	Hempson, GP; Archibald, S; Bond, WJ				Hempson, Gareth P.; Archibald, Sally; Bond, William J.			A continent-wide assessment of the form and intensity of large mammal herbivory in Africa	SCIENCE			English	Article							VEGETATION-FIRE; CLIMATE-CHANGE; WOODY COVER; BODY-SIZE; IMPACTS; EXTINCTION; DIVERSITY; EVOLUTION; RAINFALL; ECOLOGY	Megafaunal extinctions and a lack of suitable remote sensing technology impede our understanding of both the ecological legacy and current impacts of large mammal herbivores in the Earth system. To address this, we reconstructed the form and intensity of herbivory pressure across sub-Saharan Africa similar to 1000 years ago. Specifically, we modeled and mapped species-level biomass for 92 large mammal herbivores using census data, species distributions, and environmental covariates. Trait-based classifications of these species into herbivore functional types, and analyses of their biomass surfaces, reveal four ecologically distinct continental-scale herbivory regimes, characterized by internally similar forms and intensities of herbivory pressure. Associations between herbivory regimes, fire prevalence, soil nutrient status, and rainfall provide important insights into African ecology and pave the way for integrating herbivores into global-scale studies.	[Hempson, Gareth P.; Bond, William J.] Univ Cape Town, Dept Biol Sci, Private Bag X1, ZA-7701 Rondebosch, South Africa; [Hempson, Gareth P.; Archibald, Sally] Univ Witwatersrand, Sch Anim Plant & Environm Sci, ZA-2050 Johannesburg, South Africa; [Bond, William J.] Univ Cape Town, Dept Biol Sci, South African Environm Observat Network, ZA-7701 Rondebosch, South Africa	University of Cape Town; University of Witwatersrand; National Research Foundation - South Africa; South African Environmental Observation Network (SAEON); University of Cape Town	Hempson, GP (corresponding author), Univ Cape Town, Dept Biol Sci, Private Bag X1, ZA-7701 Rondebosch, South Africa.	ghempson@gmail.com	Bond, William/AAY-7631-2020; Hempson, Gareth P./I-3877-2019; Archibald, Sally/O-1659-2015	Hempson, Gareth P./0000-0001-8055-4895; Archibald, Sally/0000-0003-2786-3976; Bond, William/0000-0002-3441-2084	Claude Leon Foundation	Claude Leon Foundation	G.P.H. and W.J.B. conceived the project, G.P.H. and S.A. provided the data, and G.P.H. analyzed the data and led the writing. All authors contributed to the writing and intellectual development of the manuscript. N. Owen-Smith provided census data and insightful feedback. G.P.H. was supported by a fellowship from the Claude Leon Foundation. The authors declare that they have no competing interests. Data used in this study are available in the supplementary materials and at www.iucnredlist.org/, http://worldclim.org/, http://climate.geog.udel.edu/similar to climate/, www.fao.org/, www.globalfiredata.org/, and http://modis.gsfc.nasa.gov/.	Archibald S, 2013, P NATL ACAD SCI USA, V110, P6442, DOI 10.1073/pnas.1211466110; Asner GP, 2009, P NATL ACAD SCI USA, V106, P4947, DOI 10.1073/pnas.0810637106; Beerling DJ, 2006, GLOBAL CHANGE BIOL, V12, P2023, DOI 10.1111/j.1365-2486.2006.01239.x; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Bond WJ, 2010, NEW PHYTOL, V188, P1137, DOI 10.1111/j.1469-8137.2010.03418.x; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bond WJ, 2005, J VEG SCI, V16, P261, DOI 10.1658/1100-9233(2005)016[0261:LPOTWA]2.0.CO;2; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bond WJ, 2003, S AFR J BOT, V69, P79, DOI 10.1016/S0254-6299(15)30362-8; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Bucini G, 2007, GLOBAL ECOL BIOGEOGR, V16, P593, DOI 10.1111/j.1466-8238.2007.00325.x; Burney DA, 2005, TRENDS ECOL EVOL, V20, P395, DOI 10.1016/j.tree.2005.04.022; Calvo MM, 2015, NEW PHYTOL, V208, P987, DOI 10.1111/nph.13485; Chamaille-Jammes S, 2007, J APPL ECOL, V44, P625, DOI 10.1111/j.1365-2664.2007.01300.x; Charles-Dominique T., 2015, S AFR J BOT; COE MJ, 1976, OECOLOGIA, V22, P341, DOI 10.1007/BF00345312; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Donlan J, 2005, NATURE, V436, P913, DOI 10.1038/436913a; Dwyer E, 2000, INT J REMOTE SENS, V21, P1289, DOI 10.1080/014311600210182; EAST R, 1984, AFR J ECOL, V22, P245, DOI 10.1111/j.1365-2028.1984.tb00700.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; FRITZ H, 1994, P ROY SOC B-BIOL SCI, V256, P77, DOI 10.1098/rspb.1994.0052; Fritz H, 2002, OECOLOGIA, V131, P620, DOI 10.1007/s00442-002-0919-3; Gagnon M, 2000, J MAMMAL, V81, P490, DOI 10.1644/1545-1542(2000)081&lt;0490:DPIEAB&gt;2.0.CO;2; Gill JL, 2014, NEW PHYTOL, V201, P1163, DOI 10.1111/nph.12576; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; Hansen MC, 2003, EARTH INTERACT, V7; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Hoppe-Dominik B, 2011, AFR J ECOL, V49, P450, DOI 10.1111/j.1365-2028.2011.01277.x; ILLIUS AW, 1992, OECOLOGIA, V89, P428, DOI 10.1007/BF00317422; Keesing F, 2014, BIOSCIENCE, V64, P487, DOI 10.1093/biosci/biu059; Lavorel S, 1997, TRENDS ECOL EVOL, V12, P474, DOI 10.1016/S0169-5347(97)01219-6; Legge S, 2011, AUSTRAL ECOL, V36, P791, DOI 10.1111/j.1442-9993.2010.02218.x; Lehmann CER, 2014, SCIENCE, V343, P548, DOI 10.1126/science.1247355; Murphy BP, 2013, J BIOGEOGR, V40, P1048, DOI 10.1111/jbi.12065; OESTERHELD M, 1992, NATURE, V356, P234, DOI 10.1038/356234a0; Olff H, 2002, NATURE, V415, P901, DOI 10.1038/415901a; Owen-Smith NR, 1988, MEGAHERBIVORES; Pachzelt A, 2013, ECOL MODEL, V263, P92, DOI 10.1016/j.ecolmodel.2013.04.025; Rule S, 2012, SCIENCE, V335, P1483, DOI 10.1126/science.1214261; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Sankaran M, 2008, GLOBAL ECOL BIOGEOGR, V17, P236, DOI 10.1111/j.1466-8238.2007.00360.x; Sankaran M, 2013, J ECOL, V101, P1389, DOI 10.1111/1365-2745.12147; Scheiter S, 2012, NEW PHYTOL, V195, P653, DOI 10.1111/j.1469-8137.2012.04202.x; Scheiter S, 2009, GLOBAL CHANGE BIOL, V15, P2224, DOI 10.1111/j.1365-2486.2008.01838.x; Scholes R.J., 1993, AFRICAN SAVANNA SYNT; Van der Werf G. R., 2010, ATMOS CHEM PHYS DISC, V10, P16153, DOI DOI 10.5194/ACPD-10-16153-2010; WHITTAKER R H, 1975, P385; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Woinarski JCZ, 2015, P NATL ACAD SCI USA, V112, P4531, DOI 10.1073/pnas.1417301112; Woodward FI, 2004, PHILOS T ROY SOC B, V359, P1465, DOI 10.1098/rstb.2004.1525; Zarnetske PL, 2012, SCIENCE, V336, P1516, DOI 10.1126/science.1222732; Zimov SA, 2005, SCIENCE, V308, P796, DOI 10.1126/science.1113442; ZIMOV SA, 1995, AM NAT, V146, P765, DOI 10.1086/285824	55	141	141	5	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1056	1061		10.1126/science.aac7978	http://dx.doi.org/10.1126/science.aac7978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY5BJ	26612946				2022-12-28	WOS:000366422600035
J	Snyder, A; Pamer, E; Wolchok, J				Snyder, Alexandra; Pamer, Eric; Wolchok, Jedd			Could microbial therapy boost cancer immunotherapy?	SCIENCE			English	Editorial Material							CTLA-4 BLOCKADE; IPILIMUMAB		[Snyder, Alexandra] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Snyder, Alexandra] Weill Cornell Med Coll, New York, NY USA; [Pamer, Eric] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10021 USA; [Pamer, Eric] Lucille Castori Ctr Microbes Inflammat & Canc, New York, NY USA; [Wolchok, Jedd] Mem Sloan Kettering Canc Ctr, Dept Med, Swim Amer Ludwig Collaborat Res Lab, New York, NY 10021 USA; [Wolchok, Jedd] Weill Cornell Med Coll, Program Immunol, Ludwig Ctr Canc Immunotherapy, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Snyder, A (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	wolchokj@mskcc.org		Snyder Charen, Alexandra/0000-0002-2606-3523				Berman David, 2010, Cancer Immun, V10, P11; Horai R, 2015, IMMUNITY, V43, P343, DOI 10.1016/j.immuni.2015.07.014; Ku GY, 2010, CANCER-AM CANCER SOC, V116, P1767, DOI 10.1002/cncr.24951; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Taur Y, 2014, BLOOD, V124, P1174, DOI 10.1182/blood-2014-02-554725; Taur Y, 2013, CURR OPIN INFECT DIS, V26, P332, DOI 10.1097/QCO.0b013e3283630dd3; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	14	30	37	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1031	1032		10.1126/science.aad7706	http://dx.doi.org/10.1126/science.aad7706			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY5BJ	26612936				2022-12-28	WOS:000366422600022
J	Errico, C; Pierre, J; Pezet, S; Desailly, Y; Lenkei, Z; Couture, O; Tanter, M				Errico, Claudia; Pierre, Juliette; Pezet, Sophie; Desailly, Yann; Lenkei, Zsolt; Couture, Olivier; Tanter, Mickael			Ultrafast ultrasound localization microscopy for deep super-resolution vascular imaging	NATURE			English	Article							ACOUSTIC SUPERRESOLUTION; MOUSE-BRAIN; BREAKING; VELOCITY; LIMIT	Non-invasive imaging deep into organs at microscopic scales remains an open quest in biomedical imaging. Although optical microscopy is still limited to surface imaging owing to optical wave diffusion and fast decorrelation in tissue, revolutionary approaches such as fluorescence photo-activated localization microscopy led to a striking increase in resolution by more than an order of magnitude in the last decade(1). In contrast with optics, ultrasonic waves propagate deep into organs without losing their coherence and are much less affected by in vivo decorrelation processes. However, their resolution is impeded by the fundamental limits of diffraction, which impose a long-standing trade-off between resolution and penetration. This limits clinical and preclinical ultrasound imaging to a sub-millimetre scale. Here we demonstrate in vivo that ultrasound imaging at ultrafast frame rates (more than 500 frames per second) provides an analogue to optical localization microscopy by capturing the transient signal decorrelation of contrast agents-inert gas microbubbles. Ultrafast ultrasound localization microscopy allowed both non-invasive sub-wavelength structural imaging and haemodynamic quantification of rodent cerebral microvessels (less than ten micrometres in diameter) more than ten millimetres below the tissue surface, leading to transcranial whole-brain imaging within short acquisition times (tens of seconds). After intravenous injection, single echoes from individual microbubbles were detected through ultrafast imaging. Their localization, not limited by diffraction, was accumulated over 75,000 images, yielding 1,000,000 events per coronal plane and statistically independent pixels of ten micrometres in size. Precise temporal tracking of microbubble positions allowed us to extract accurately in-plane velocities of the blood flow with a large dynamic range (from one millimetre per second to several centimetres per second). These results pave the way for deep non-invasive microscopy in animals and humans using ultrasound. We anticipate that ultrafast ultrasound localization microscopy may become an invaluable tool for the fundamental understanding and diagnostics of various disease processes that modify the microvascular blood flow, such as cancer, stroke and arteriosclerosis.	[Errico, Claudia; Pierre, Juliette; Desailly, Yann; Couture, Olivier; Tanter, Mickael] INSERM, Inst Langevin, 1 Rue Jussieu, F-75005 Paris, France; [Errico, Claudia; Pierre, Juliette; Desailly, Yann; Couture, Olivier; Tanter, Mickael] PSL Res Univ, ESPCI ParisTech, Inst Langevin, F-75005 Paris, France; [Errico, Claudia; Pierre, Juliette; Desailly, Yann; Couture, Olivier; Tanter, Mickael] CNRS, UMR 7587, F-75005 Paris, France; [Pezet, Sophie; Lenkei, Zsolt] CNRS, UMR 8249, F-75005 Paris, France; [Pezet, Sophie; Lenkei, Zsolt] PSL Res Univ, ESPCI ParisTech, Brain Plast Unit, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Tanter, M (corresponding author), INSERM, Inst Langevin, 1 Rue Jussieu, F-75005 Paris, France.	mickael.tanter@espci.fr	PEZET, sophie/AAR-1239-2021; Lenkei, Zsolt/G-4369-2013; Mickael, Tanter/H-4657-2012	PEZET, sophie/0000-0002-3305-3315; Lenkei, Zsolt/0000-0002-1142-5931; Mickael, Tanter/0000-0001-7739-8051; Couture, Olivier/0000-0002-8683-1424; Pierre, Juliette/0000-0002-3361-643X	Agence Nationale de la Recherche (ANR), within the project ANR MUSLI; Fondation Pierre-Gilles de Gennes; LABEX WIFI (Laboratory of Excellence) within the French Program "Investments for the Future" [ANR-10-LABX-24, ANR-10-IDEX-0001-02 PSL*]	Agence Nationale de la Recherche (ANR), within the project ANR MUSLI(French National Research Agency (ANR)); Fondation Pierre-Gilles de Gennes; LABEX WIFI (Laboratory of Excellence) within the French Program "Investments for the Future"	This work was supported principally by the Agence Nationale de la Recherche (ANR), within the project ANR MUSLI. We thank the Fondation Pierre-Gilles de Gennes for funding C.E. The laboratory was also supported by LABEX WIFI (Laboratory of Excellence ANR-10-LABX-24) within the French Program "Investments for the Future" under reference ANR-10-IDEX-0001-02 PSL*.	Bercoff J, 2011, IEEE T ULTRASON FERR, V58, P134, DOI 10.1109/TUFFC.2011.1780; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Christensen-Jeffries K, 2015, IEEE T MED IMAGING, V34, P433, DOI 10.1109/TMI.2014.2359650; Chugh BP, 2009, NEUROIMAGE, V47, P1312, DOI 10.1016/j.neuroimage.2009.03.083; Couture O., 2010, Patent No. [(PCT)/FR2011/052810, 2011052810]; Couture O, 2009, ULTRASOUND MED BIOL, V35, P1908, DOI 10.1016/j.ultrasmedbio.2009.05.020; Demene C, 2015, IEEE T MED IMAGING, V34, P2271, DOI 10.1109/TMI.2015.2428634; Denarie B, 2013, IEEE T MED IMAGING, V32, P1265, DOI 10.1109/TMI.2013.2255310; Desailly Y, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826597; Dietrich CF, 2012, ULTRASCHALL MED, V33, P344, DOI 10.1055/s-0032-1313026; Duck FA, 2013, PHYS PROPERTIES TISS; Errico C, 2016, NEUROIMAGE, V124, P752, DOI 10.1016/j.neuroimage.2015.09.037; Gessner RC, 2013, INT J BIOMED IMAGING, V2013, DOI 10.1155/2013/936593; GOSS S A, 1979, Ultrasound in Medicine and Biology, V5, P181, DOI 10.1016/0301-5629(79)90086-3; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hong GS, 2012, NAT MED, V18, P1841, DOI 10.1038/nm.2995; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Huang CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078186; Itoh Y, 2012, J CEREBR BLOOD F MET, V32, P1167, DOI 10.1038/jcbfm.2012.5; Kamoun WS, 2010, NAT METHODS, V7, P655, DOI [10.1038/NMETH.1475, 10.1038/nmeth.1475]; Mace E, 2011, NAT METHODS, V8, P662, DOI [10.1038/nmeth.1641, 10.1038/NMETH.1641]; Mishra A, 2014, NAT PROTOC, V9, P323, DOI 10.1038/nprot.2014.019; O'Reilly MA, 2013, MED PHYS, V40, DOI 10.1118/1.4823762; Osmanski BF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6023; Pernot M, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2162700; Szabo T. L., 2004, DIAGNOSTIC ULTRASOUN, P337; Tanter M, 2002, IEEE T ULTRASON FERR, V49, P1363, DOI 10.1109/TUFFC.2002.1041078; Tanter M, 2014, IEEE T ULTRASON FERR, V61, P102, DOI [10.1109/TUFFC.2014.2882, 10.1109/TUFFC.2014.6689779]; Viessmann OM, 2013, PHYS MED BIOL, V58, P6447, DOI 10.1088/0031-9155/58/18/6447; WALKER WF, 1995, IEEE T ULTRASON FERR, V42, P301, DOI 10.1109/58.365243; Watson C, 2006, RAT BRAIN STEREOTAXI; Yao JJ, 2015, NAT METHODS, V12, P407, DOI 10.1038/nmeth.3336	32	598	625	41	456	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					499	+		10.1038/nature16066	http://dx.doi.org/10.1038/nature16066			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26607546				2022-12-28	WOS:000365352500044
J	Mohan, C; Assassi, S				Mohan, Chandra; Assassi, Shervin			Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; C-REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE; ERYTHROCYTE SEDIMENTATION-RATE; INTERSTITIAL LUNG-DISEASE; RNA-POLYMERASE-III; AXIAL SPONDYLOARTHRITIS PART; PERIPHERAL-BLOOD CELLS; PHASE REACTANT LEVELS; ANTI-KU ANTIBODIES	Serological and proteomic biomarkers can help clinicians diagnose rheumatic diseases earlier and assess disease activity more accurately. These markers have been incorporated into the recently revised classification criteria of several diseases to enable early diagnosis and timely initiation of treatment. Furthermore, they also facilitate more accurate subclassification and more focused monitoring for the detection of certain disease manifestations, such as lung and renal involvement. These biomarkers can also make the assessment of disease activity and treatment response more reliable. Simultaneously, several new serological and proteomic biomarkers have become available in the routine clinical setting-for example, a protein biomarker panel for rheumatoid arthritis and a myositis antibody panel for dermatomyositis and polymyositis. This review will focus on commercially available antibody and proteomic biomarkers in rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis (scleroderma), dermatomyositis and polymyositis, and axial spondyloarthritis (including ankylosing spondylitis). It will discuss how these markers can facilitate early diagnosis as well as more accurate subclassification and assessment of disease activity in the clinical setting. The ultimate goal of current and future biomarkers in rheumatic diseases is to enable early detection of these diseases and their clinical manifestations, and to provide effective monitoring and treatment regimens that are tailored to each patient's needs and prognosis.	[Mohan, Chandra] Univ Houston, Dept Biomed Engn, Houston, TX 77204 USA; [Assassi, Shervin] Univ Texas Hlth Sci Ctr Houston, Div Rheumatol, Houston, TX 77030 USA	University of Houston System; University of Houston; University of Texas System; University of Texas Health Science Center Houston	Assassi, S (corresponding author), Univ Texas Hlth Sci Ctr Houston, Div Rheumatol, Houston, TX 77030 USA.	shervin.assassi@uth.tmc.edu	Mohan, Chandra/GPX-8233-2022		National Institutes of Health [K23-AR-061436]; Scleroderma Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR061436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This review is supported by funds from the National Institutes of Health K23-AR-061436 (SA) and the Scleroderma Foundation Collaborative Research Grant.	Aggarwal R, 2009, ARTHRITIS RHEUM-US, V60, P1112, DOI 10.1002/art.24409; Airo' P, 2011, J RHEUMATOL, V38, P1329, DOI 10.3899/jrheum.101144; Al Daabil M, 2014, INT J CLIN PRACT, V68, P1508, DOI 10.1111/ijcp.12466; Al-Awadhi A, 1999, J RHEUMATOL, V26, P1250; Alba P, 2003, ANN RHEUM DIS, V62, P556, DOI 10.1136/ard.62.6.556; Aman S, 2000, RHEUMATOLOGY, V39, P1009, DOI 10.1093/rheumatology/39.9.1009; Andersson MLE, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-229; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; ARNETT FC, 1981, J RHEUMATOL, V8, P925; Arriens Cristina, 2013, Int J Clin Rheumtol, V8, P671; Assassi S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3125; Assassi S, 2010, ARTHRITIS RHEUM-US, V62, P589, DOI 10.1002/art.27224; Assassi S, 2009, ARTHRIT CARE RES, V61, P1403, DOI 10.1002/art.24734; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Baechler EC, 2007, MOL MED, V13, P59, DOI 10.2119/2006-00085.Baechler; Bakker MF, 2012, ANN RHEUM DIS, V71, P1692, DOI 10.1136/annrheumdis-2011-200963; Barnes EV, 2005, LUPUS, V14, P576, DOI 10.1191/0961203305lu2157oa; Bauer JW, 2006, PLOS MED, V3, P2274, DOI 10.1371/journal.pmed.0030491; Bauer JW, 2009, ARTHRITIS RHEUM-US, V60, P3098, DOI 10.1002/art.24803; Bennett AN, 2008, ARTHRITIS RHEUM-US, V58, P3413, DOI 10.1002/art.24024; Bertoli AM, 2008, J RHEUMATOL, V35, P2355, DOI 10.3899/jrheum.080175; BERTOUCH JV, 1983, ANN RHEUM DIS, V42, P655, DOI 10.1136/ard.42.6.655; Birmingham DJ, 2010, LUPUS, V19, P1272, DOI 10.1177/0961203310371154; Bobbio-Pallavicini F, 2007, ANN NY ACAD SCI, V1109, P287, DOI 10.1196/annals.1398.034; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; BOOTSMA H, 1995, LANCET, V345, P1595, DOI 10.1016/S0140-6736(95)90114-0; Braun J, 1998, ARTHRITIS RHEUM-US, V41, P58, DOI 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G; Bredella MA, 2006, AM J ROENTGENOL, V187, P1420, DOI 10.2214/AJR.05.1423; Brouwer R, 2001, ANN RHEUM DIS, V60, P116, DOI 10.1136/ard.60.2.116; Bunn CC, 1998, BRIT J RHEUMATOL, V37, P15; Burska A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/545493; Cavazzana I, 2008, LUPUS, V17, P727, DOI 10.1177/0961203308089442; Chiche L, 2014, ARTHRITIS RHEUMATOL, V66, P1583, DOI 10.1002/art.38628; CHU P, 1988, BRIT MED J, V297, P1449, DOI 10.1136/bmj.297.6661.1449; Coghlan JG, 2014, ANN RHEUM DIS, V73, P1340, DOI 10.1136/annrheumdis-2013-203301; Coiffier G, 2013, JOINT BONE SPINE, V80, P250, DOI 10.1016/j.jbspin.2012.08.004; Cortes-Hernandez J, 2004, AM J MED, V116, P165, DOI 10.1016/j.amjmed.2003.08.034; Cozzani E, 2014, AUTOIMMUNE DIS, V2014, P321; Curtis JR, 2012, ARTHRIT CARE RES, V64, P1794, DOI 10.1002/acr.21767; D'Aoust J, 2014, ARTHRITIS RHEUMATOL, V66, P1608, DOI 10.1002/art.38428; DAVIS P, 1977, ANN RHEUM DIS, V36, P157, DOI 10.1136/ard.36.2.157; DeMarco PJ, 2002, ARTHRITIS RHEUM-US, V46, P2983, DOI 10.1002/art.10589; Denarie D, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/537324; Devlin J, 1997, J RHEUMATOL, V24, P9; Eastman PS, 2012, J PHARMACEUT BIOMED, V70, P415, DOI 10.1016/j.jpba.2012.06.003; Elhai M, 2012, RHEUMATOLOGY, V51, P1017, DOI 10.1093/rheumatology/ker269; Eriksson C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3258; Feldtkeller E, 2003, RHEUMATOL INT, V23, P61, DOI 10.1007/s00296-002-0237-4; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Fiorentino D, 2011, J AM ACAD DERMATOL, V65, P25, DOI 10.1016/j.jaad.2010.09.016; Firooz N, 2011, LUPUS, V20, P588, DOI 10.1177/0961203310393378; Geusens PP, 2006, ARTHRITIS RHEUM-US, V54, P1772, DOI 10.1002/art.21896; Geusens P, 2012, THER ADV MUSCULOSKEL, V4, P225, DOI 10.1177/1759720X12438080; Ghrenassia E, 2014, J RHEUMATOL, V41, P99, DOI 10.3899/jrheum.130386; Graf J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006242; GREER JM, 1989, ARCH INTERN MED, V149, P2473, DOI 10.1001/archinte.149.11.2473; Gregersen PK, 2014, ARTHRITIS RHEUMATOL, V66, P1418, DOI 10.1002/art.38629; Hamaguchi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060442; Hamaguchi Y, 2011, ARCH DERMATOL, V147, P391, DOI 10.1001/archdermatol.2011.52; Haroon N, 2013, ARTHRITIS RHEUM-US, V65, P2645, DOI 10.1002/art.38070; Haugbro K, 2004, ANN RHEUM DIS, V63, P386, DOI 10.1136/ard.2003.016303; Heiland GR, 2012, ANN RHEUM DIS, V71, P572, DOI 10.1136/annrheumdis-2011-200216; Hinchcliff M, 2013, J INVEST DERMATOL, V133, P1979, DOI 10.1038/jid.2013.130; Ho A, 2001, ARTHRITIS RHEUM-US, V44, P2350, DOI 10.1002/1529-0131(200110)44:10<2350::AID-ART398>3.0.CO;2-A; HOCHBERG MC, 1986, SEMIN ARTHRITIS RHEU, V15, P168, DOI 10.1016/0049-0172(86)90014-4; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Houseman M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3734; Hueber W, 2006, PROTEOMICS, V6, P4100, DOI 10.1002/pmic.200600017; Hui L, 2010, CLIN RHEUMATOL, V29, P413, DOI 10.1007/s10067-009-1337-2; Iaccarino L, 2014, J AUTOIMMUN, V48-49, P122, DOI 10.1016/j.jaut.2013.11.005; Ioannidis JPA, 2005, AM J MED, V118, P2, DOI 10.1016/j.amjmed.2004.04.031; Iwamoto J, 2003, CALCIFIED TISSUE INT, V72, P491, DOI 10.1007/s00223-002-1024-7; Jacobsen S, 1997, CLIN RHEUMATOL, V16, P384, DOI 10.1007/BF02242456; Lopez-Longo FJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P419, DOI 10.1002/art.24390; Johnson C, 2014, RESP MED, V108, P1542, DOI 10.1016/j.rmed.2014.09.003; Joseph CG, 2014, SCIENCE, V343, P152, DOI 10.1126/science.1246886; Joshi R, 2012, ARTHRIT CARE RES, V64, P780, DOI 10.1002/acr.21601; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Kay J, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4469; KHAN MA, 1977, J RHEUMATOL, V4, P39; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Koschik RW, 2012, CLIN EXP RHEUMATOL, V30, pS12; Lazarou IN, 2013, J RHEUMATOL, V40, P550, DOI 10.3899/jrheum.120682; Lega JC, 2014, AUTOIMMUN REV, V13, P883, DOI 10.1016/j.autrev.2014.03.004; Lemm G, 1988, Scand J Rheumatol Suppl, V75, P256; LEROY EC, 1988, J RHEUMATOL, V15, P202; Liu XC, 2013, ARTHRIT CARE RES, V65, P1375, DOI 10.1002/acr.21968; Liu XC, 2013, ARTHRITIS RHEUM-US, V65, P226, DOI 10.1002/art.37742; LOVE LA, 1991, MEDICINE, V70, P360, DOI 10.1097/00005792-199111000-00002; Mahler M, 2014, AUTOIMMUN REV, V13, P367, DOI 10.1016/j.autrev.2014.01.022; Malik S, 2007, LUPUS, V16, P863, DOI 10.1177/0961203307083365; Mc Ardle A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0652-z; McClain MT, 2004, ARTHRITIS RHEUM-US, V50, P1226, DOI 10.1002/art.20120; McGeough CM, 2012, RHEUMATOL INT, V32, P1647, DOI 10.1007/s00296-011-1838-6; Meyer PWA, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/158514; Milano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002696; Moinzadeh P, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4486; Moroni G, 2009, ANN RHEUM DIS, V68, P234, DOI 10.1136/ard.2008.094508; MORROW WJW, 1981, J RHEUMATOL, V8, P599; Muangchan C, 2012, ARTHRIT CARE RES, V64, P1405, DOI 10.1002/acr.21716; Munroe ME, 2014, ARTHRITIS RHEUMATOL, V66, P1888, DOI 10.1002/art.38573; Nguyen B, 2011, ARTHRITIS RHEUM-US, V63, P530, DOI 10.1002/art.30111; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Nielsen CT, 2014, LUPUS SCI MED, V1, DOI 10.1136/lupus-2014-000026; Nihtyanova SI, 2014, ARTHRITIS RHEUMATOL, V66, P1625, DOI 10.1002/art.38390; Nikpour M, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3544; Nishimura K, 2007, ANN INTERN MED, V146, P797, DOI 10.7326/0003-4819-146-11-200706050-00008; Olsen NJ, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3927; Olson SW, 2013, CLIN J AM SOC NEPHRO, V8, P1702, DOI 10.2215/CJN.01910213; Ortega-Hernandez OD, 2012, BEST PRACT RES CL RH, V26, P61, DOI 10.1016/j.berh.2012.01.009; Ozbek S, 2003, ACTA MED OKAYAMA, V57, P187; Pedersen SJ, 2011, ARTHRITIS RHEUM-US, V63, P3789, DOI 10.1002/art.30627; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Petri M, 2009, J RHEUMATOL, V36, P2476, DOI 10.3899/jrheum.090019; Petri MA, 2013, ARTHRITIS RHEUM-US, V65, P2143, DOI 10.1002/art.37995; Plant MJ, 2000, ARTHRITIS RHEUM, V43, P1473, DOI 10.1002/1529-0131(200007)43:7<1473::AID-ANR9>3.0.CO;2-N; Poddubnyy D, 2014, ANN RHEUM DIS, V73, P2137, DOI 10.1136/annrheumdis-2013-203824; Poddubnyy D, 2012, ARTHRITIS RHEUM-US, V64, P1388, DOI 10.1002/art.33465; Poddubnyy D, 2011, ANN RHEUM DIS, V70, P1369, DOI 10.1136/ard.2010.145995; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Raza K, 2005, J RHEUMATOL, V32, P231; Reveille JD, 2012, ARTHRITIS RHEUM-US, V64, P1407, DOI 10.1002/art.33503; RICKER DM, 1991, AM J KIDNEY DIS, V18, P678, DOI 10.1016/S0272-6386(12)80609-3; Rose T, 2013, ANN RHEUM DIS, V72, P1639, DOI 10.1136/annrheumdis-2012-201586; Rovin BH, 2012, ARTHRITIS RHEUM-US, V64, P1215, DOI 10.1002/art.34359; Rozman B, 2008, ANN RHEUM DIS, V67, P1282, DOI 10.1136/ard.2007.073981; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Rudwaleit M, 2009, ARTHRITIS RHEUM-US, V60, P717, DOI 10.1002/art.24483; Salazar GA, 2015, SEMIN ARTHRITIS RHEU, V44, P680, DOI 10.1016/j.semarthrit.2014.11.006; Shah AA, 2010, ARTHRITIS RHEUM-US, V62, P2787, DOI 10.1002/art.27549; Sharif R, 2011, J RHEUMATOL, V38, P1622, DOI 10.3899/jrheum.110071; Sieper J, 2013, ANN RHEUM DIS, V72, P1621, DOI 10.1136/annrheumdis-2012-201777; Slater CA, 1996, ARCH INTERN MED, V156, P1421, DOI 10.1001/archinte.156.13.1421; Smith SL, 2013, ANN RHEUM DIS, V72, P1118, DOI 10.1136/annrheumdis-2012-202743; Steen VD, 2005, SEMIN ARTHRITIS RHEU, V35, P35, DOI 10.1016/j.semarthrit.2005.03.005; Steen VD, 1998, ARTHRITIS RHEUM, V41, P1613, DOI 10.1002/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O; Steen VD, 2007, ANN RHEUM DIS, V66, P940, DOI 10.1136/ard.2006.066068; Stohl W, 2012, ARTHRITIS RHEUM-US, V64, P2328, DOI 10.1002/art.34400; Stojan G, 2013, LUPUS, V22, P827, DOI 10.1177/0961203313492578; Streicher K, 2014, ARTHRITIS RHEUMATOL, V66, P173, DOI 10.1002/art.38194; Sundaragiri Pranathi Rao, 2014, BMJ Case Rep, V2014, DOI 10.1136/bcr-2014-204296; Suresh E, 2004, J ROY SOC MED, V97, P421, DOI 10.1258/jrsm.97.9.421; Syversen SW, 2009, J RHEUMATOL, V36, P266, DOI 10.3899/jrheum.080180; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tan FK, 2006, RHEUMATOLOGY, V45, P694, DOI 10.1093/rheumatology/kei244; TARGOFF IN, 1990, ARTHRITIS RHEUM, V33, P1361, DOI 10.1002/art.1780330908; Taylor P, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/815038; TERBORG EJ, 1990, ARTHRITIS RHEUM-US, V33, P634, DOI 10.1002/art.1780330505; TERBORG EJ, 1990, J RHEUMATOL, V17, P1642; Torikai Eiji, 2006, Mod Rheumatol, V16, P350, DOI 10.1007/s10165-006-0517-z; Tseng CE, 2006, ARTHRITIS RHEUM-US, V54, P3623, DOI 10.1002/art.22198; Turina MC, 2014, ANN RHEUM DIS, V73, P1746, DOI 10.1136/annrheumdis-2014-205506; Tyndall AJ, 2010, ANN RHEUM DIS, V69, P1809, DOI 10.1136/ard.2009.114264; van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI [10.1136/annrheumdis-2013-204424, 10.1002/art.38098]; van der Heijde D, 2009, ANN RHEUM DIS, V68, P1811, DOI 10.1136/ard.2008.100826; van Tuyl LHD, 2010, ANN RHEUM DIS, V69, P1623, DOI 10.1136/ard.2009.121764; van Venrooij WJ, 2008, ANN NY ACAD SCI, V1143, P268, DOI 10.1196/annals.1443.013; van Vollenhoven RF, 2012, ANN RHEUM DIS, V71, P1343, DOI 10.1136/annrheumdis-2011-200937; VANDERHEIJDE DMFM, 1990, ANN RHEUM DIS, V49, P916, DOI 10.1136/ard.49.11.916; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; VANLEEUWEN MA, 1993, BRIT J RHEUMATOL, V32, P9; Vila LM, 2005, J RHEUMATOL, V32, P2150; Vis M, 2006, ANN RHEUM DIS, V65, P1495, DOI 10.1136/ard.2005.044198; Wallis D, 2013, J RHEUMATOL, V40, P2038, DOI 10.3899/jrheum.130588; Wang B, 2013, CLIN PHARMACOL THER, V93, P483, DOI 10.1038/clpt.2013.35; Whitfield ML, 2003, P NATL ACAD SCI USA, V100, P12319, DOI 10.1073/pnas.1635114100; Wu Tianfu, 2010, Expert Opin Med Diagn, V4, P293, DOI 10.1517/17530059.2010.492828	169	44	49	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2015	351								h5079	10.1136/bmj.h5079	http://dx.doi.org/10.1136/bmj.h5079			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX4TL	26612523	Green Published			2022-12-28	WOS:000365693100001
J	Conway, F; Majeed, A; Easton, G				Conway, Francesca; Majeed, Azeem; Easton, Graham			Diagnosing chronic obstructive pulmonary disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Conway, Francesca; Majeed, Azeem; Easton, Graham] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London W6 8RP, England	Imperial College London	Conway, F (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London W6 8RP, England.	francesca.conway07@imperial.ac.uk	Easton, Graham/K-8359-2019	Majeed, Azeem/0000-0002-2357-9858; Conway, Francesca M/0000-0003-3429-4759				Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2015, GLOBAL STRATEGY DIAG; National Institute for Health and Care Excellence, 2010, CHRON OBSTR PULM DIS; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008	3	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2015	351								h6171	10.1136/bmj.h6171	http://dx.doi.org/10.1136/bmj.h6171			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX4SX	26602938	Green Published			2022-12-28	WOS:000365691700003
J	Sohn, E				Sohn, Emily			Screening: Don't look now	NATURE			English	Editorial Material							CANCER; MORTALITY											Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Friedewald SM, 2014, JAMA-J AM MED ASSOC, V311, P2499, DOI 10.1001/jama.2014.6095; Gotzsche PC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub4; Harding C, 2015, JAMA INTERN MED, V175, P1483, DOI 10.1001/jamainternmed.2015.3043; Harris R, 2011, PREV MED, V53, P108, DOI 10.1016/j.ypmed.2011.07.004; Jorgensen Karsten J, 2009, BMC Womens Health, V9, P36, DOI 10.1186/1472-6874-9-36; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Miller AB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g366; Ong MS, 2015, HEALTH AFFAIR, V34, P576, DOI 10.1377/hlthaff.2014.1087	9	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					S118	S119		10.1038/527S118a	http://dx.doi.org/10.1038/527S118a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26580162	Bronze			2022-12-28	WOS:000365356800007
J	Wang, MT; Holderfield, M; Galeas, J; Delrosario, R; To, MD; Balmain, A; McCormick, F				Wang, Man-Tzu; Holderfield, Matthew; Galeas, Jacqueline; Delrosario, Reyno; To, Minh D.; Balmain, Allan; McCormick, Frank			K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt Signaling	CELL			English	Article							DEPENDENT PROTEIN-KINASE; STEM-CELL PROPERTIES; CANCER-CELLS; PANCREATIC-CANCER; TUMOR-SUPPRESSOR; HUMAN-TISSUES; LUNG-CANCER; FREE DNA; H-RAS; N-RAS	K-Ras and H-Ras share identical effectors and have similar properties; however, the high degree of tumor-type specificity associated with K-Ras and H-Ras mutations suggests that they have unique roles in oncogenesis. Here, we report that oncogenic K-Ras, but not H-Ras, suppresses non-canonical Wnt/Ca2+ signaling, an effect that contributes strongly to its tumorigenic properties. K-Ras does this by binding to calmodulin and so reducing CaMKii activity and expression of Fzd8. Restoring Fzd8 in K-Ras mutant pancreatic cells suppresses malignancy, whereas depletion of Fzd8 in H-Ras V-12-transformed cells enhances their tumor initiating capacity. Interrupting K-Ras-calmodulin binding using genetic means or by treatment with an orally active protein kinase C (PKC)-activator, prostratin, represses tumorigenesis in K-Ras mutant pancreatic cancer cells. These findings provide an alternative way to selectively target this " undruggable" protein.	[Wang, Man-Tzu; Holderfield, Matthew; Galeas, Jacqueline; Delrosario, Reyno; To, Minh D.; Balmain, Allan; McCormick, Frank] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	McCormick, F (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, 1450 3rd St, San Francisco, CA 94158 USA.	mccormic@cc.ucsf.edu		Holderfield, Matthew/0000-0001-8474-3220	Daiichi Sankyo, Tokyo; Lustgarten Foundation	Daiichi Sankyo, Tokyo; Lustgarten Foundation	Parts of this work were supported by grants from Daiichi Sankyo, Tokyo and the Lustgarten Foundation. We acknowledge Drs. Yu-Jen Lu and Chen-Yen Yang for helping with parts of the animal experiments, including oral gavage treatment and blood collection. We thank Dr. Bob Coffey for providing Lrig1 mice and Drs. Kevin Haigis and Tyler Jacks for the HrasLSLG12V mice. F.M. and M.-T.W. are the co-founders of K-Gen, Limited.	Anker P, 1999, CANCER METAST REV, V18, P65, DOI 10.1023/A:1006260319913; Antal CE, 2015, CELL, V160, P489, DOI 10.1016/j.cell.2015.01.001; BACHS O, 1994, CELL CALCIUM, V16, P289, DOI 10.1016/0143-4160(94)90092-2; BALMAIN A, 1983, NATURE, V303, P72, DOI 10.1038/303072a0; Basu A, 2010, THESCIENTIFICWORLDJO, V10, P2272, DOI 10.1100/tsw.2010.214; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; BOS JL, 1989, CANCER RES, V49, P4682; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Cheng C, 2009, CANCER SCI, V100, P303, DOI 10.1111/j.1349-7006.2008.01021.x; CHESA PG, 1987, P NATL ACAD SCI USA, V84, P3234, DOI 10.1073/pnas.84.10.3234; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Fujii H, 2009, INT J ONCOL, V34, P1381, DOI 10.3892/ijo_00000265; FURTH ME, 1987, ONCOGENE, V1, P47; Gou SM, 2007, PANCREAS, V34, P429, DOI 10.1097/MPA.0b013e318033f9f4; Herbst A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-74; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jaks V, 2010, EXP CELL RES, V316, P1422, DOI 10.1016/j.yexcr.2010.03.014; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; Krebs J, 1998, BBA-MOL CELL RES, V1448, P183, DOI 10.1016/S0167-4889(98)00142-6; LEON J, 1987, MOL CELL BIOL, V7, P1535, DOI 10.1128/MCB.7.4.1535; Lopez-Alcala C, 2008, J BIOL CHEM, V283, P10621, DOI 10.1074/jbc.M706238200; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Marquez N, 2008, BIOCHEM PHARMACOL, V75, P1370, DOI 10.1016/j.bcp.2007.12.004; Page ME, 2013, CELL STEM CELL, V13, P471, DOI 10.1016/j.stem.2013.07.010; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Potenza N, 2005, EMBO REP, V6, P432, DOI 10.1038/sj.embor.7400397; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Quinlan MP, 2008, MOL CELL BIOL, V28, P2659, DOI 10.1128/MCB.01661-07; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Saitoh T, 2001, INT J ONCOL, V18, P991; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Schulman H, 1993, CURR OPIN CELL BIOL, V5, P247, DOI 10.1016/0955-0674(93)90111-3; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Sikora K, 2015, INT J BIOL MARKER, V30, pE136, DOI 10.5301/jbm.5000088; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Singh SK, 2003, CANCER RES, V63, P5821; Sozzi G, 2003, J CLIN ONCOL, V21, P3902, DOI 10.1200/JCO.2003.02.006; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; STEWART AA, 1982, FEBS LETT, V137, P80, DOI 10.1016/0014-5793(82)80319-0; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Sugimura R, 2010, BIRTH DEFECTS RES C, V90, P243, DOI 10.1002/bdrc.20195; To MD, 2008, NAT GENET, V40, P1240, DOI 10.1038/ng.211; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Weekes Colin D, 2011, Cancers (Basel), V3, P3676, DOI 10.3390/cancers3033676; Wei F, 2012, CANCER LETT, V322, P58, DOI 10.1016/j.canlet.2012.02.005; Wong CE, 2013, GENE DEV, V27, P670, DOI 10.1101/gad.210427.112; ZAYED S, 1984, PLANTA MED, V50, P65, DOI 10.1055/s-2007-969623	59	135	137	4	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1237	1251		10.1016/j.cell.2015.10.041	http://dx.doi.org/10.1016/j.cell.2015.10.041			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26590425	Bronze			2022-12-28	WOS:000366044700021
J	Carroll, AE				Carroll, Aaron E.			Doing Less Is Sometimes Enough	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMPUTED-TOMOGRAPHY; ACUTE APPENDICITIS; APPENDECTOMY; METAANALYSIS; OUTCOMES; SURGERY; CANCER; CT		[Carroll, Aaron E.] Indiana Univ Sch Med, Ctr Pediat & Adolescent Comparat Effectiveness Re, Indianapolis, IN 46202 USA; [Carroll, Aaron E.] Indiana Univ Sch Med, Ctr Hlth Policy & Professionalism Res, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Carroll, AE (corresponding author), Indiana Univ Sch Med, Ctr Pediat & Adolescent Comparat Effectiveness Re, 410 W Tenth St,HITS 4099C, Indianapolis, IN 46202 USA.	aaecarro@iupui.edu						Ansaloni L, 2011, DIGEST SURG, V28, P210, DOI 10.1159/000324595; Bachur RG, 2015, JAMA PEDIATR, V169, P755, DOI 10.1001/jamapediatrics.2015.0479; Bachur RG, 2012, J PEDIATR-US, V160, P1034, DOI 10.1016/j.jpeds.2011.11.037; Davidoff F, 2015, JAMA INTERN MED, V175, P809, DOI 10.1001/jamainternmed.2015.0167; Doria AS, 2006, RADIOLOGY, V241, P83, DOI 10.1148/radiol.2411050913; Kurian AW, 2014, JAMA-J AM MED ASSOC, V312, P902, DOI 10.1001/jama.2014.10707; Livingston E, 2015, JAMA-J AM MED ASSOC, V313, P2327, DOI 10.1001/jama.2015.6266; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Raja AS, 2010, RADIOLOGY, V256, P460, DOI 10.1148/radiol.10091570; Salminen P, 2015, JAMA-J AM MED ASSOC, V313, P2340, DOI 10.1001/jama.2015.6154	10	2	2	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2015	314	19					2069	2070		10.1001/jama.2015.12946	http://dx.doi.org/10.1001/jama.2015.12946			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW1PR	26575063				2022-12-28	WOS:000364764200022
J	Mastalerz, M				Mastalerz, Michael			MATERIALS CHEMISTRY liquefied molecular holes	NATURE			English	Editorial Material							ORGANIC CAGES		Heidelberg Univ, Inst Organ Chem, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Mastalerz, M (corresponding author), Heidelberg Univ, Inst Organ Chem, D-69120 Heidelberg, Germany.	michael.mastalerz@oci.uni-heidelberg.de	Mastalerz, Michael/M-3176-2013					Barrer R.M., 1978, ZEOLITE CLAY MINERAL; Brutschy M, 2012, ADV MATER, V24, P6049, DOI 10.1002/adma.201202786; Giri N, 2015, NATURE, V527, P216, DOI 10.1038/nature16072; Giri N, 2012, CHEM SCI, V3, P2153, DOI 10.1039/c2sc01007k; Hasell T, 2012, ADV MATER, V24, P5732, DOI 10.1002/adma.201202000; Kewley A, 2015, CHEM MATER, V27, P3207, DOI 10.1021/acs.chemmater.5b01112; O'Reilly N, 2007, CHEM-EUR J, V13, P3020, DOI 10.1002/chem.200700090; Slater AG, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8075; Tozawa T, 2009, NAT MATER, V8, P973, DOI [10.1038/nmat2545, 10.1038/NMAT2545]; YAGHI OM, 1995, NATURE, V378, P703, DOI 10.1038/378703a0	10	27	27	4	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					174	176		10.1038/527174a	http://dx.doi.org/10.1038/527174a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26560295				2022-12-28	WOS:000364396700031
J	Mathews, DJH; Lovell-Badge, R; Chan, S; Donovan, PJ; Douglas, T; Gyngell, C; Harris, J; Regenberg, A				Mathews, Debra J. H.; Lovell-Badge, Robin; Chan, Sarah; Donovan, Peter J.; Douglas, Thomas; Gyngell, Christopher; Harris, John; Regenberg, Alan			CRISPR: A path through the thicket	NATURE			English	Editorial Material									[Mathews, Debra J. H.] Johns Hopkins Berman Inst Bioeth, Sci Programmes, Baltimore, MD 21205 USA; [Mathews, Debra J. H.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21218 USA; [Lovell-Badge, Robin] Francis Crick Inst, Lab Stem Cell Biol & Dev Genet, London, England	Johns Hopkins University; Johns Hopkins University; Francis Crick Institute	Mathews, DJH (corresponding author), Johns Hopkins Berman Inst Bioeth, Sci Programmes, Baltimore, MD 21205 USA.	dmathews@jhu.edu	Regenberg, Alan/Q-6809-2019	Lovell-Badge, Robin/0000-0001-9364-4179; Regenberg, Alan/0000-0003-0604-9596; Gyngell, Christopher/0000-0002-1340-3947; Douglas, Thomas/0000-0002-6788-3608; Mathews, Debra/0000-0002-4897-7617	Medical Research Council [MC_U117562207] Funding Source: Medline; MRC [MC_U117562207] Funding Source: UKRI; The Francis Crick Institute [10107] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Francis Crick Institute		Einsiedel EF, 2012, DEV WORLD BIOETH, V12, P35, DOI 10.1111/j.1471-8847.2012.00319.x; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Regenberg AC, 2009, STEM CELLS, V27, P2312, DOI 10.1002/stem.132; Sancho M, 2014, CELL CYCLE, V13, P9, DOI 10.4161/cc.27026; Shendure J, 2015, SCIENCE, V349, P1478, DOI 10.1126/science.aaa9119; Suzuki T, 2014, SCI REP-UK, V4, DOI 10.1038/srep07621; Tan EP, 2015, GENESIS, V53, P225, DOI 10.1002/dvg.22835; *US PRES COMM STUD, 1982, SPLIC LIF SOC ETH IS; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	9	17	17	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					159	161		10.1038/527159a	http://dx.doi.org/10.1038/527159a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26560284	Bronze			2022-12-28	WOS:000364396700018
J	Hu, JZ; Zhang, Y; Zhao, LJ; Frock, RL; Du, Z; Meyers, RM; Meng, FL; Schatz, DG; Alt, FW				Hu, Jiazhi; Zhang, Yu; Zhao, Lijuan; Frock, Richard L.; Du, Zhou; Meyers, Robin M.; Meng, Fei-long; Schatz, David G.; Alt, Frederick W.			Chromosomal Loop Domains Direct the Recombination of Antigen Receptor Genes	CELL			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CELL IDENTITY GENES; V(D)J RECOMBINATION; TRANSCRIPTION FACTORS; DNA BREAKS; GENOME; CTCF; MECHANISMS; COMPLEXES; REVEALS	RAG initiates antibody V(D)J recombination in developing lymphocytes by generating "on-target'' DNA breaks at matched pairs of bona fide recombination signal sequences (RSSs). We employ bait RAG-generated breaks in endogenous or ectopically inserted RSS pairs to identify huge numbers of RAG "off-target'' breaks. Such breaks occur at the simple CAC motif that defines the RSS cleavage site and are largely confined within convergent CTCF-binding element (CBE)-flanked loop domains containing bait RSS pairs. Marked orientation dependence of RAG off-target activity within loops spanning up to 2 megabases implies involvement of linear tracking. In this regard, major RAG off-targets in chromosomal translocations occur as convergent RSS pairs at enhancers within a loop. Finally, deletion of a CBE-based IgH locus element disrupts V(D) J recombination domains and, correspondingly, alters RAG on-and off-target distributions within IgH. Our findings reveal how RAG activity is developmentally focused and implicate mechanisms by which chromatin domains harness biological processes within them.	[Hu, Jiazhi; Zhang, Yu; Zhao, Lijuan; Frock, Richard L.; Du, Zhou; Meyers, Robin M.; Meng, Fei-long; Schatz, David G.; Alt, Frederick W.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Hu, Jiazhi; Zhang, Yu; Zhao, Lijuan; Frock, Richard L.; Du, Zhou; Meyers, Robin M.; Meng, Fei-long; Alt, Frederick W.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Hu, Jiazhi; Zhang, Yu; Zhao, Lijuan; Frock, Richard L.; Du, Zhou; Meyers, Robin M.; Meng, Fei-long; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Schatz, David G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Yale University	Alt, FW (corresponding author), Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu	Frock, Richard/I-6934-2019	Frock, Richard/0000-0001-6963-4931; Hu, Jiazhi/0000-0002-6345-0039; Meng, Feilong/0000-0003-0333-6872; Meyers, Robin/0000-0002-1802-7231; Zhang, Yu/0000-0002-1126-770X	NIH [AI020047, AI032524]; LLS SCOR [7009-12]; Robertson Foundation/Cancer Research Institute Irvington Fellowship; Leukemia and Lymphoma Society; NIH NRSA [AI007512]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007512, R01AI032524, R01AI020047, R37AI032524, R37AI020047] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LLS SCOR; Robertson Foundation/Cancer Research Institute Irvington Fellowship; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the Alt lab members and Richard Young (MIT) and Jay Bradner (DFCI) for stimulating discussions. This work was supported by NIH grant AI020047 and LLS SCOR 7009-12 to F.W.A. and NIH grant AI032524 to D.G.S. F.W.A. and D.G.S. are Howard Hughes Medical Institute Investigators. J.H. is supported by a Robertson Foundation/Cancer Research Institute Irvington Fellowship. Y.Z. is supported by a career development fellowship from the Leukemia and Lymphoma Society. R.L.F. was supported by the NIH NRSA AI007512. F.-L.M. is a Lymphoma Research Foundation postdoctoral fellow.	Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; BOEHM T, 1989, EMBO J, V8, P2621, DOI 10.1002/j.1460-2075.1989.tb08402.x; Bossen C, 2012, ANNU REV IMMUNOL, V30, P337, DOI 10.1146/annurev-immunol-020711-075003; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dong JC, 2015, NATURE, V525, P134, DOI 10.1038/nature14970; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Kim MS, 2015, NATURE, V518, P507, DOI 10.1038/nature14174; Kroenlein H, 2012, GENE CHROMOSOME CANC, V51, P290, DOI 10.1002/gcc.21915; Lane AA, 2014, NAT GENET, V46, P618, DOI 10.1038/ng.2949; Lapkouski M, 2015, J BIOL CHEM, V290, P14618, DOI 10.1074/jbc.M115.641787; Larmonie NSD, 2013, HAEMATOLOGICA, V98, P1173, DOI 10.3324/haematol.2012.082156; Lin SG, 2015, P NATL ACAD SCI USA, V112, P1815, DOI 10.1073/pnas.1424936112; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; MEIER JT, 1993, MOL CELL BIOL, V13, P1078, DOI 10.1128/MCB.13.2.1078; Merelli I, 2010, NUCLEIC ACIDS RES, V38, pW262, DOI 10.1093/nar/gkq391; Messier TL, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9440; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Nakahashi H, 2013, CELL REP, V3, P1678, DOI 10.1016/j.celrep.2013.04.024; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Onozawa M, 2012, GENE CHROMOSOME CANC, V51, P525, DOI 10.1002/gcc.21942; Papaemmanuil E, 2014, NAT GENET, V46, P116, DOI 10.1038/ng.2874; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Ranganath S, 2008, J IMMUNOL, V180, P2339, DOI 10.4049/jimmunol.180.4.2339; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Teng G, 2015, CELL, V162, P751, DOI 10.1016/j.cell.2015.07.009; Tepsuporn S, 2014, CANCER IMMUNOL RES, V2, P857, DOI 10.1158/2326-6066.CIR-14-0090; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; YANCOPOULOS GD, 1986, ANNU REV IMMUNOL, V4, P339, DOI 10.1146/annurev.iy.04.040186.002011; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386; Zha S, 2011, NATURE, V469, P250, DOI 10.1038/nature09604; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	46	105	105	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					947	959		10.1016/j.cell.2015.10.016	http://dx.doi.org/10.1016/j.cell.2015.10.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26593423	Bronze, Green Accepted			2022-12-28	WOS:000364829700019
J	Xie, XF; Atkins, E; Lv, JC; Bennett, A; Neal, B; Ninomiya, T; Woodward, M; MacMahon, S; Turnbull, F; Hillis, GS; Chalmers, J; Mant, J; Salam, A; Rahimi, K; Perkovic, V; Rodgers, A				Xie, Xinfang; Atkins, Emily; Lv, Jicheng; Bennett, Alexander; Neal, Bruce; Ninomiya, Toshiharu; Woodward, Mark; MacMahon, Stephen; Turnbull, Fiona; Hillis, Graham S.; Chalmers, John; Mant, Jonathan; Salam, Abdul; Rahimi, Kazem; Perkovic, Vlado; Rodgers, Anthony			Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis	LANCET			English	Article							ANTIHYPERTENSIVE TREATMENT; KIDNEY-DISEASE; HYPERTENSION; PROGRESSION; TARGET; TRIAL; MANAGEMENT; VALSARTAN; MORTALITY; THERAPY	Background Recent hypertension guidelines have reversed previous recommendations for lower blood pressure targets in high-risk patients, such as those with cardiovascular disease, renal disease, or diabetes. This change represents uncertainty about whether more intensive blood pressure-lowering strategies are associated with greater reductions in risk of major cardiovascular and renal events. We aimed to assess the efficacy and safety of intensive blood pressure-lowering strategies. Methods For this updated systematic review and meta-analysis, we systematically searched MEDLINE, Embase, and the Cochrane Library for trials published between Jan 1, 1950, and Nov 3, 2015. We included randomised controlled trials with at least 6 months' follow-up that randomly assigned participants to more intensive versus less intensive blood pressure-lowering treatment, with different blood pressure targets or different blood pressure changes from baseline. We did not use any age or language restrictions. We did a meta-analysis of blood pressure reductions on relative risk (RR) of major cardiovascular events (myocardial infarction, stroke, heart failure, or cardiovascular death, separately and combined), and non-vascular and all-cause mortality, end-stage kidney disease, and adverse events, as well as albuminuria and progression of retinopathy in trials done in patients with diabetes. Findings We identified 19 trials including 44 989 participants, in whom 2496 major cardiovascular events were recorded during a mean 3.8 years of follow-up (range 1.0-8.4 years). Our meta-analysis showed that after randomisation, patients in the more intensive blood pressure-lowering treatment group had mean blood pressure levels of 133/76 mm Hg, compared with 140/81 mm Hg in the less intensive treatment group. Intensive blood pressure-lowering treatment achieved RR reductions for major cardiovascular events (14% [95% CI 4-22]), myocardial infarction (13% [0-24]), stroke (22% [10-32]), albuminuria (10% [3-16]), and retinopathy progression (19% [0-34]). However, more intensive treatment had no clear effects on heart failure (15% [95% CI -11 to 34]), cardiovascular death (9% [-11 to 26]), total mortality (9% [-3 to 19]), or end-stage kidney disease (10% [-6 to 23]). The reduction in major cardiovascular events was consistent across patient groups, and additional blood pressure lowering had a clear benefit even in patients with systolic blood pressure lower than 140 mm Hg. The absolute benefits were greatest in trials in which all enrolled patients had vascular disease, renal disease, or diabetes. Serious adverse events associated with blood pressure lowering were only reported by six trials and had an event rate of 1.2% per year in intensive blood pressure-lowering group participants, compared with 0.9% in the less intensive treatment group (RR 1.35 [95% CI 0.93-1 . 97]). Severe hypotension was more frequent in the more intensive treatment regimen (RR 2.68 [1.21-5 . 89], p= 0 . 015), but the absolute excess was small (0 . 3% vs 0 . 1% per person-year for the duration of follow-up). Interpretation Intensive blood pressure lowering provided greater vascular protection than standard regimens. In high-risk patients, there are additional benefits from more intensive blood pressure lowering, including for those with systolic blood pressure below 140 mmHg. The net absolute benefits of intensive blood pressure lowering in high-risk individuals are large.	[Xie, Xinfang; Lv, Jicheng] Peking Univ, Hosp 1, Dept Med, Div Renal, Beijing 100871, Peoples R China; [Atkins, Emily; Lv, Jicheng; Bennett, Alexander; Neal, Bruce; Woodward, Mark; MacMahon, Stephen; Turnbull, Fiona; Chalmers, John; Salam, Abdul; Perkovic, Vlado; Rodgers, Anthony] Univ Sydney, George Inst Global Hlth, POB M201,Missenden Rd, Sydney, NSW 2050, Australia; [Woodward, Mark; MacMahon, Stephen; Rahimi, Kazem] Univ Oxford, Nuffield Dept Populat Hlth, George Inst Global Hlth, Oxford, England; [Ninomiya, Toshiharu] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Hillis, Graham S.] Royal Perth Hosp, Dept Cardiol, Wellington St, Perth, WA 6001, Australia; [Mant, Jonathan] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England	Peking University; George Institute for Global Health; University of Sydney; University of Oxford; Kyushu University; Royal Perth Hospital; University of Western Australia; University of Cambridge	Lv, JC (corresponding author), Peking Univ, Hosp 1, Dept Med, Div Renal, Beijing 100871, Peoples R China.; Lv, JC; Rodgers, A (corresponding author), Univ Sydney, George Inst Global Hlth, POB M201,Missenden Rd, Sydney, NSW 2050, Australia.	jichenglv75@gmail.com; arodgers@georgeinstitute.org	Rahimi, Kazem/AAA-4250-2022; Salam, Abdul/GWC-1029-2022; Woodward, Mark/D-8492-2015; Perkovic, Vlado/AAY-1933-2021; Atkins, Emily R/J-5504-2013; Woodward, Mark/L-6817-2017; Rahimi, Kazem/Q-1279-2015	Atkins, Emily R/0000-0003-2522-3510; Neal, Bruce/0000-0002-0490-7465; Rahimi, Kazem/0000-0002-4807-4610; Woodward, Mark/0000-0001-9800-5296; Chalmers, John/0000-0002-9931-0580; MacMahon, Stephen/0000-0003-2064-7699; Abdul Salam, Mohammad/0000-0002-5870-7936; Rodgers, Anthony/0000-0003-1282-1896	National Health and Medical Research Council of Australia [APP1052555, APP1066280]; National Natural Science Foundation of China [81270795]; Program for New Century Excellent Talents in University from the Ministry of Education of China [NCET-12-0011]; Excellent Young Scientists Fund of the National Natural Science Foundation of China [813220065]; National Health and Medical Research Council of Australia; National Institute for Health Research [CDF-2013-06-012] Funding Source: researchfish	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University from the Ministry of Education of China; Excellent Young Scientists Fund of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institute for Health Research(National Institute for Health Research (NIHR))	National Health and Medical Research Council of Australia.; This work was funded by National Health and Medical Research Council of Australia Program Grant APP1052555. JL was supported by the grant from the National Natural Science Foundation of China (no. 81270795), Program for New Century Excellent Talents in University from the Ministry of Education of China grant NCET-12-0011, and Excellent Young Scientists Fund of the National Natural Science Foundation of China (no. 813220065). AR was supported by a National Health and Medical Research Council of Australia Principal Research Fellowship APP1066280. We are very grateful to Giuseppe Remuzzi and the REIN study group for providing useful additional information for this meta-analysis.	[Anonymous], 2011, CLIN MAN PRIM HYP AD; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Arguedas JA, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004349.PUB2; Asayama K, 2012, HYPERTENS RES, V35, P1102, DOI 10.1038/hr.2012.125; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Chalmers J, 2011, CIRCULATION, V124, P1700, DOI 10.1161/CIRCULATIONAHA.111.057091; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Estacio RO, 2006, AM J HYPERTENS, V19, P1241, DOI 10.1016/j.amjhyper.2006.05.011; Estacio RO, 2000, DIABETES CARE, V23, pB54; Feldman RD, 2009, HYPERTENSION, V53, P646, DOI 10.1161/HYPERTENSIONAHA.108.123455; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; JACOBS D, 1992, CIRCULATION, V86, P1046, DOI 10.1161/01.CIR.86.3.1046; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Jatos Study Grp, 2008, HYPERTENS RES, V31, P2115, DOI 10.1291/hypres.31.2115; Kerr AJ, 2009, HEART, V95, P125, DOI 10.1136/hrt.2007.140905; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lv JC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001293; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Ogihara T, 2010, HYPERTENSION, V56, P196, DOI 10.1161/HYPERTENSIONAHA.109.146035; Peters R, 2010, AGE AGEING, V39, P609, DOI 10.1093/ageing/afq071; Rodgers A, 2004, PLOS MED, V1, P44, DOI 10.1371/journal.pmed.0010027; Ruggenenti P, 2005, LANCET, V365, P939, DOI 10.1016/S0140-6736(05)71082-5; Sarnak MJ, 2005, ANN INTERN MED, V142, P342, DOI 10.7326/0003-4819-142-5-200503010-00009; Schrier R, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000018407.60002.B9; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Thompson AM, 2011, JAMA-J AM MED ASSOC, V305, P913, DOI 10.1001/jama.2011.250; TOTO RD, 1995, KIDNEY INT, V48, P851, DOI 10.1038/ki.1995.361; Verdecchia P, 2009, LANCET, V374, P525, DOI 10.1016/S0140-6736(09)61340-4; Wald DS, 2009, AM J MED, V122, P290, DOI 10.1016/j.amjmed.2008.09.038; Warwick J, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0328-1; Wei Y, 2013, J CLIN HYPERTENS, V15, P420, DOI 10.1111/jch.12094; Woodward M., 2005, EPIDEMIOLOGY DESIGN; Wuhl E, 2009, NEW ENGL J MED, V361, P1639, DOI 10.1056/NEJMoa0902066	40	628	671	7	195	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 30	2016	387	10017					435	443		10.1016/S0140-6736(15)00805-3	http://dx.doi.org/10.1016/S0140-6736(15)00805-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC1OX	26559744	Green Published			2022-12-28	WOS:000368986800032
J	Emanuel, EJ; Ubel, PA; Kessler, JB; Meyer, G; Muller, RW; Navathe, AS; Patel, P; Pearl, R; Rosenthal, MB; Sacks, L; Sen, AP; Sherman, P; Volpp, KG				Emanuel, Ezekiel J.; Ubel, Peter A.; Kessler, Judd B.; Meyer, Gregg; Muller, Ralph W.; Navathe, Amol S.; Patel, Pankaj; Pearl, Robert; Rosenthal, Meredith B.; Sacks, Lee; Sen, Aditi P.; Sherman, Paul; Volpp, Kevin G.			Using Behavioral Economics to Design Physician Incentives That Deliver High-Value Care	ANNALS OF INTERNAL MEDICINE			English	Article							PAY-FOR-PERFORMANCE; METAANALYSIS; DEFAULTS; QUALITY	Behavioral economics provides insights about the development of effective incentives for physicians to deliver high-value care. It suggests that the structure and delivery of incentives can shape behavior, as can thoughtful design of the decision-making environment. This article discusses several principles of behavioral economics, including inertia, loss aversion, choice overload, and relative social ranking. Whereas these principles have been applied to motivate personal health decisions, retirement planning, and savings behavior, they have been largely ignored in the design of physician incentive programs. Applying these principles to physician incentives can improve their effectiveness through better alignment with performance goals. Anecdotal examples of successful incentive programs that apply behavioral economics principles are provided, even as the authors recognize that its application to the design of physician incentives is largely untested, and many outstanding questions exist. Application and rigorous evaluation of infrastructure changes and incentives are needed to design payment systems that incentivize high-quality, cost-conscious care.	[Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; Univ Penn, Wharton Sch, Leonard Davis Inst, CHIBE,Univ Penn Hlth Syst, Philadelphia, PA 19104 USA; Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equity Res & Promot, Philadelphia, PA USA; Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA; [Ubel, Peter A.] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA; [Meyer, Gregg] Partners Healthcare Syst, Boston, MA 02199 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Sacks, Lee] Advocate Phys Partners, Chicago, IL USA; [Pearl, Robert] Permanente Med Grp Inc, Oakland, CA 94612 USA; Grp Hlth, Seattle, WA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; Duke University; Duke University; Partners Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health; Permanente Medical Groups	Emanuel, EJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 122 Coll Hall, Philadelphia, PA 19104 USA.	vp-global@upenn.edu		Volpp, Kevin/0000-0003-1423-4599; Navathe, Amol/0000-0001-7182-4988	Commonwealth Fund; NATIONAL INSTITUTE ON AGING [P30AG034546] Funding Source: NIH RePORTER	Commonwealth Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	In part by The Commonwealth Fund. The funding source reviewed the manuscript but did not make any fundamental alterations.	Allcott H, 2014, AM ECON REV, V104, P3003, DOI 10.1257/aer.104.10.3003; Ariely D., 2008, PREDICTABLY IRRATION; Ayres I, 2013, J LAW ECON ORGAN, V29, P992, DOI 10.1093/jleo/ews020; Baicker K, 2012, MILBANK Q, V90, P107, DOI 10.1111/j.1468-0009.2011.00656.x; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Bentzen SM, 2008, LANCET ONCOL, V9, P331, DOI [10.1016/S1470-2045(08)70077-9, 10.1016/S1470-2045(08)60348-7]; Centers for Medicare & Medicaid Services, 2008, FREQ ASK QUEST AC EP; Choi JJ, 2003, AM ECON REV, V93, P180, DOI 10.1257/000282803321947010; Elbel B, 2009, HEALTH AFFAIR, V28, pW1110, DOI 10.1377/hlthaff.28.6.w1110; Frank R.G., 2004, NATL BUREAU EC RES; Fryer RG., 2012, ENHANCING EFFICACY T, V252, P18237; Gagne JJ, 2014, ANN INTERN MED, V161, P400, DOI 10.7326/M13-2942; Hull CL, 1932, PSYCHOL REV, V39, P25, DOI 10.1037/h0072640; Jeffery RW, 2012, PREV MED, V55, pS61, DOI 10.1016/j.ypmed.2011.12.024; Johnson EJ, 2003, SCIENCE, V302, P1338, DOI 10.1126/science.1091721; Kahneman D., 2011, THINKING FAST SLOW; Kolstad JT, 2013, AM ECON REV, V103, P2875, DOI 10.1257/aer.103.7.2875; Lacetera N, 2010, J ECON BEHAV ORGAN, V76, P225, DOI 10.1016/j.jebo.2010.08.007; Loewenstein G, 2013, HEALTH AFFAIR, V32, P1244, DOI 10.1377/hlthaff.2012.1163; Lussier JP, 2006, ADDICTION, V101, P192, DOI 10.1111/j.1360-0443.2006.01311.x; Madrian BC, 2001, Q J ECON, V116, P1149, DOI 10.1162/003355301753265543; Meyer GS, 2008, ADV PATIENT SAFETY N, V3; O'Donoghue T, 1999, AM ECON REV, V89, P103, DOI 10.1257/aer.89.1.103; Patel MS, 2014, ANN INTERN MED, V161, pS44, DOI 10.7326/M13-3001; Petry NM, 2012, AM J MED, V125, P888, DOI 10.1016/j.amjmed.2012.01.003; REDELMEIER DA, 1995, JAMA-J AM MED ASSOC, V273, P302, DOI 10.1001/jama.273.4.302; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Rosenthal MB, 2008, NEW ENGL J MED, V359, P1197, DOI 10.1056/NEJMp0804658; Samuelson William, 1988, J RISK UNCERTAINTY, V1, P759, DOI DOI 10.1007/BF00055564; Shah AM, 2014, J MARKETING RES, V51, P773, DOI 10.1509/jmr.13.0434; Thaler RH, 1999, J BEHAV DECIS MAKING, V12, P183, DOI 10.1002/(SICI)1099-0771(199909)12:3<183::AID-BDM318>3.0.CO;2-F; Thaler RH., 2021, NUDGE FINAL EDITION; Thaler RH, 2008, MARKET SCI, V27, P15, DOI 10.1287/mksc.1070.0330; Torchiana DF, 2013, HEALTH AFFAIR, V32, P1748, DOI 10.1377/hlthaff.2013.0377; Van der Sijs H, 2006, J AM MED INFORM ASSN, V13, P138, DOI 10.1197/jamia.M1809; VISCUSI WK, 1990, J POLIT ECON, V98, P1253, DOI 10.1086/261733; Volpp KG, 2009, HEALTH AFFAIR, V28, P206, DOI 10.1377/hlthaff.28.1.206	38	119	120	5	54	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2016	164	2					114	+		10.7326/M15-1330	http://dx.doi.org/10.7326/M15-1330			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB0CI	26595370				2022-12-28	WOS:000368175800015
J	He, TH; Li, K; Roberts, MS; Spaulding, AC; Ayer, T; Grefenstette, JJ; Chhatwal, J				He, Tianhua; Li, Kan; Roberts, Mark S.; Spaulding, Anne C.; Ayer, Turgay; Grefenstette, John J.; Chhatwal, Jagpreet			Prevention of Hepatitis C by Screening and Treatment in US Prisons	ANNALS OF INTERNAL MEDICINE			English	Article							VIRUS-INFECTION; COST-EFFECTIVENESS; UNITED-STATES; COHORT; HEALTH; SOFOSBUVIR; RECOMMENDATIONS; POPULATIONS; TELAPREVIR; LEDIPASVIR	Background: The prevalence of hepatitis C virus (HCV) in U.S. prisoners is high; however, HCV testing and treatment are rare. Infected inmates released back into society contribute to the spread of HCV in the general population. Routine hepatitis screening of inmates followed by new therapies may reduce ongoing HCV transmission. Objective: To evaluate the health and economic effect of HCV screening and treatment in prisons on the HCV epidemic in society. Design: Agent-based microsimulation model of HCV transmission and progression of HCV disease. Data Sources: Published literature. Target Population: Population in U.S. prisons and general community. Time Horizon: 30 years. Perspective: Societal. Interventions: Risk-based and universal opt-out hepatitis C screening in prisons, followed by treatment in a portion of patients. Outcome Measures: Prevention of HCV transmission and associated disease in prisons and society, costs, quality-adjusted life-years (QALYs), incremental cost-effectiveness ratio (ICER), and total prison budget. Results of Base-Case Analysis: Implementing risk-based and opt-out screening could diagnose 41 900 to 122 700 new HCV cases in prisons in the next 30 years. Compared with no screening, these scenarios could prevent 5500 to 12 700 new HCV infections caused by released inmates, wherein about 90% of averted infections would have occurred outside of prisons. Screening could also prevent 4200 to 11 700 liver-related deaths. The ICERs of screening scenarios were $19 600 to $29 200 per QALY, and the respective first-year prison budget was $900 to $1150 million. Prisons would require an additional 12.4% of their current health care budget to implement such interventions. Results of Sensitivity Analysis: Results were sensitive to the time horizon, and ICERs otherwise remained less than $50 000 per QALY. Limitation: Data on transmission network, reinfection rate, and opt-out HCV screening rate are lacking. Conclusion: Universal opt-out HCV screening in prisons is highly cost-effective and would reduce HCV transmission and HCV-associated diseases primarily in the outside community. Investing in U.S. prisons to manage hepatitis C is a strategic approach to address the current epidemic.	Univ Pittsburgh, Pittsburgh, PA USA; Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; Georgia Inst Technol, H Milton Stewart Sch Ind & Syst Engn, Atlanta, GA 30332 USA; [Chhatwal, Jagpreet] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tsinghua University; University of Texas System; University of Texas Health Science Center Houston; Emory University; Rollins School Public Health; University System of Georgia; Georgia Institute of Technology; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Chhatwal, J (corresponding author), Massachusetts Gen Hosp, Inst Technol Assessment, 101 Merrimac St,10th Floor, Boston, MA 02114 USA.	jagchhatwal@mgh.harvard.edu			National Center for Advancing Translational Sciences of the National Institutes of Health [KL2TR000146]; China Scholarship Council; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); China Scholarship Council(China Scholarship Council); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	In part by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number KL2TR000146. Dr. He's effort was supported by the China Scholarship Council.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Association for the Study of Liver Diseases and Infectious Diseases Society of America, 2015, HCV GUID REC TEST MA; Beck AJ, 2004, HEPATITIS TESTING TR; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Chhatwal J, 2015, PHARMACOECONOMICS, V33, P423, DOI 10.1007/s40273-015-0254-2; Chhatwal J, 2015, ANN INTERN MED, V162, P397, DOI 10.7326/M14-1336; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Eckman MH, 2013, CLIN INFECT DIS, V56, P1382, DOI 10.1093/cid/cit069; Ginder S, 2013, 242186 NCJ BUR JUST; Graham CS, 2015, JAMA-J AM MED ASSOC, V313, P1217, DOI 10.1001/jama.2015.1111; Harrison P. M., 2002, PRISONERS IN 2002; Hill A, 2014, CLIN INFECT DIS, V58, P928, DOI 10.1093/cid/ciu012; Hughes T., 2003, REENTRY TRENDS US; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; James N., 2014, BUREAU PRISONS BOP O; Kabiri M, 2014, ANN INTERN MED, V161, P170, DOI 10.7326/M14-0095; Krahn M, 2004, MED DECIS MAKING, V24, P20, DOI 10.1177/0272989X03261568; Krajden M, 2010, CAN J GASTROENTEROL, V24, P717, DOI 10.1155/2010/569692; Kyckelhahn T., 2012, 239672 NCJ BUR JUST; Larney S, 2014, AM J PUBLIC HEALTH, V104, pE69, DOI 10.2105/AJPH.2014.301943; Liu S, 2014, ANN INTERN MED, V161, P546, DOI 10.7326/M14-0602; Liu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058975; Macal CM, 2010, J SIMUL, V4, P151, DOI 10.1057/jos.2010.3; Martin NK, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003153; Maru DSR, 2008, CLIN INFECT DIS, V47, P952, DOI 10.1086/591707; McGarry LJ, 2012, HEPATOLOGY, V55, P1344, DOI 10.1002/hep.25510; Moorjani H, 2015, EMERG INFECT DIS, V21, P186, DOI 10.3201/eid2101.141025; Moyer VA, 2013, ANN INTERN MED, V159, P349, DOI 10.7326/0003-4819-159-5-201309030-00672; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Rich JD, 2014, NEW ENGL J MED, V370, P1871, DOI 10.1056/NEJMp1311941; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Silverman E, 2015, WALL STREET J; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Spaulding AC, 2006, ANN INTERN MED, V144, P762, DOI 10.7326/0003-4819-144-10-200605160-00010; Spaulding AC, 2015, AM J PUBLIC HEALTH, V105, pE51, DOI 10.2105/AJPH.2014.302546; Spaulding AC, 2011, AM J EPIDEMIOL, V173, P479, DOI 10.1093/aje/kwq422; Spaulding Anne S, 2013, Top Antivir Med, V21, P27; Suryaprasad AG, 2014, CLIN INFECT DIS, V59, P1411, DOI 10.1093/cid/ciu643; Sweeting MJ, 2006, J CLIN EPIDEMIOL, V59, P144, DOI 10.1016/j.jclinepi.2005.06.008; Varan AK, 2014, PUBLIC HEALTH REP, V129, P187, DOI 10.1177/003335491412900213; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; West HC, 2010, 230113 NCJ BUR JUST; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	43	107	109	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2016	164	2					84	92		10.7326/M15-0617	http://dx.doi.org/10.7326/M15-0617			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB0CI	26595252	Green Accepted			2022-12-28	WOS:000368175800012
J	Paul, S; Saxena, A; Terrin, N; Viveiros, K; Balk, EM; Wong, JB				Paul, Sonali; Saxena, Akriti; Terrin, Norma; Viveiros, Kathleen; Balk, Ethan M.; Wong, John B.			Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							BREAST-CANCER PATIENTS; RECEIVING CYTOTOXIC CHEMOTHERAPY; LAMIVUDINE PROPHYLAXIS; HBV REACTIVATION; PREEMPTIVE LAMIVUDINE; COST-EFFECTIVENESS; POSITIVE PATIENTS; RISK; LYMPHOMA; IDENTIFICATION	Background: Solid tumor chemotherapy regimens pose a risk for hepatitis B virus (HBV) reactivation, but screening and antiviral prophylaxis remains controversial because of insufficient evidence. Purpose: To determine the risk for HBV reactivation with and without antiviral prophylaxis and the effectiveness of prophylaxis in adults with solid tumors and chronic or resolved HBV infection. Data Sources: MEDLINE through 1 July 2015 and Web of Science, Cochrane Central Register of Controlled Trials, TOXNET, and Scopus through 1 March 2015. Study Selection: 26 English-language observational studies and randomized, controlled trials in patients with chronic or resolved HBV receiving chemotherapy for solid tumors. Data Extraction: Study characteristics, quality, and risk of bias were assessed by 1 researcher and verified by another independent researcher. Data Synthesis: Random-effects model meta-analyses were used to estimate the risk and odds ratio (OR) of reactivation with versus without antiviral prophylaxis. Reactivation in chronic HBV without prophylaxis ranged from 4% to 68% (median, 25%) with substantial heterogeneity. Prophylaxis reduced the risk for HBV reactivation (OR, 0.12 [95% CI, 0.06 to 0.22]), HBV-related hepatitis (OR, 0.18 [CI, 0.10 to 0.32]), and chemotherapy interruption (OR, 0.10 [CI, 0.04 to 0.27]). In 3 studies of patients with resolved HBV infection, none received HBV prophylaxis and reactivation risk ranged from 0.3% to 9.0%. Limitations: Significant heterogeneity in underlying study populations and treatment regimens, incomplete baseline data, possibility of publication bias, and limited study quality. Most studies were observational and from Asia. Conclusion: In patients with chronic HBV receiving solid tumor chemotherapy, the risk for HBV reactivation is similar to the risk with other types of immunosuppressive therapy. Results support HBV screening and antiviral prophylaxis before initiation of chemotherapy for solid tumors.	Massachusetts Gen Hosp, Tufts Med Ctr, Boston, MA 02114 USA; Boston Med Ctr, Boston, MA USA; Brown Univ, Sch Publ Hlth, Providence, RI 02912 USA	Harvard University; Massachusetts General Hospital; Tufts Medical Center; Boston Medical Center; Brown University	Paul, S (corresponding author), Massachusetts Gen Hosp, Gastroenterol Associates, 55 Fruit St,Blake 4, Boston, MA 02114 USA.	sonali.paul2@gmail.com	Balk, Ethan/AAJ-2547-2020	Wong, John/0000-0003-4203-9010	National Center for Advancing Translational Sciences; National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000073, UL1TR001064] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	National Center for Advancing Translational Sciences and National Institutes of Health.	Alexopoulos CG, 1999, BRIT J CANCER, V81, P69, DOI 10.1038/sj.bjc.6690652; Alter MJ, 2003, J HEPATOL, V39, pS64, DOI 10.1016/S0168-8278(03)00141-7; Artz AS, 2010, J CLIN ONCOL, V28, P3199, DOI 10.1200/JCO.2010.30.0673; Borentain P, 2010, J VIRAL HEPATITIS, V17, P807, DOI 10.1111/j.1365-2893.2009.01239.x; Centers for Disease Control and Prevention, 1988, MMWR-MORBID MORTAL W, V37, P351; Centers for Disease Control (CDC), 1988, MMWR Morb Mortal Wkly Rep, V37, P341; Chen KL, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0015-9; Chen WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131545; Cheng JCH, 2004, CANCER-AM CANCER SOC, V101, P2126, DOI 10.1002/cncr.20591; Dai MS, 2004, LIVER INT, V24, P540, DOI 10.1111/j.1478-3231.2004.0964.x; Dai MS, 2004, SUPPORT CARE CANCER, V12, P191, DOI 10.1007/s00520-003-0549-2; Day FL, 2011, J ONCOL PRACT, V7, P141, DOI 10.1200/JOP.2010.000133; Day FL, 2011, J CLIN ONCOL, V29, P3270, DOI 10.1200/JCO.2011.35.1635; Dong HJ, 2013, J CLIN VIROL, V57, P209, DOI 10.1016/j.jcv.2013.03.010; Eren OO, 2009, MED ONCOL, V26, P386, DOI 10.1007/s12032-008-9133-4; Evens AM, 2011, ANN ONCOL, V22, P1170, DOI 10.1093/annonc/mdq583; Hagiwara S, 2012, DIGEST DIS, V30, P541, DOI 10.1159/000343056; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Ho EY, 2015, HEPATOL INT, V9, P224, DOI 10.1007/s12072-015-9612-6; Hwang JP, 2012, SUPPORT CARE CANCER, V20, P2999, DOI 10.1007/s00520-012-1576-7; Hwang JP, 2010, AM J PUBLIC HEALTH, V100, pS118, DOI 10.2105/AJPH.2009.162776; Katz LH, 2008, J VIRAL HEPATITIS, V15, P89, DOI 10.1111/j.1365-2893.2007.00902.x; Kim E, 2014, HEPATO-GASTROENTEROL, V61, P1704; Kim IK, 2012, ANTIMICROB AGENTS CH, V56, P5511, DOI 10.1128/AAC.00821-12; Kohrt HE, 2006, ALIMENT PHARM THERAP, V24, P1003, DOI 10.1111/j.1365-2036.2006.03081.x; Kusumoto S, 2015, CLIN INFECT DIS, V61, P719, DOI 10.1093/cid/civ344; Lee HJ, 2014, BREAST CANCER-TOKYO, V21, P387, DOI 10.1007/s12282-012-0417-3; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Lim LL, 2002, ALIMENT PHARM THER, V16, P1939, DOI 10.1046/j.1365-2036.2002.01364.x; Lin GN, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0119-0; Lin SY, 2007, HEPATOLOGY, V46, P1034, DOI 10.1002/hep.21784; Ling WHY, 2013, BRIT J CANCER, V108, P1931, DOI 10.1038/bjc.2013.225; Liu JY, 2015, J FORMOS MED ASSOC, V114, P164, DOI 10.1016/j.jfma.2012.10.007; Lok ASF, 2012, ANN INTERN MED, V156, P743, DOI 10.7326/0003-4819-156-10-201205150-00013; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; LOK ASF, 1991, GASTROENTEROLOGY, V100, P182, DOI 10.1016/0016-5085(91)90599-G; Long MJ, 2011, BREAST CANCER RES TR, V127, P705, DOI 10.1007/s10549-011-1455-9; Loomba R, 2008, ANN INTERN MED, V148, P519, DOI 10.7326/0003-4819-148-7-200804010-00008; Martyak LA, 2008, LIVER INT, V28, P28, DOI 10.1111/j.1478-3231.2007.01618.x; Nishida T, 2013, HEPATOL RES, V43, P339, DOI 10.1111/j.1872-034X.2012.01073.x; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Perrillo RP, 2015, JAMA-J AM MED ASSOC, V313, P1617, DOI 10.1001/jama.2015.2571; Reddy KR, 2015, GASTROENTEROLOGY, V148, P215, DOI 10.1053/j.gastro.2014.10.039; Rucker G, 2008, STAT MED, V27, P746, DOI 10.1002/sim.2971; Rucker G, 2009, STAT MED, V28, P721, DOI 10.1002/sim.3511; Seto WK, 2014, J CLIN ONCOL, V32, P3736, DOI 10.1200/JCO.2014.56.7081; Shouval D, 2013, SEMIN LIVER DIS, V33, P167, DOI 10.1055/s-0033-1345722; Sohn BS, 2011, JPN J CLIN ONCOL, V41, P1059, DOI 10.1093/jjco/hyr106; Sterne JAC, 2011, COCHRANE HDB SYSTEMA; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Tsai SH, 2011, SUPPORT CARE CANCER, V19, P1779, DOI 10.1007/s00520-010-1019-2; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wallace BC, 2012, J STAT SOFTW, V49, P1, DOI 10.18637/jss.v049.i05; Wasley A, 2010, J INFECT DIS, V202, P192, DOI 10.1086/653622; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Wells G., NEWCASTLE OTTAWA SCA; Xu J, 2012, ONCOL LETT, V4, P471, DOI 10.3892/ol.2012.745; Yang Y, 2015, CANCER CHEMOTH PHARM, V75, P783, DOI 10.1007/s00280-015-2700-4; Yeo W, 2005, AM J CLIN ONCOL-CANC, V28, P379, DOI 10.1097/01.coc.0000159554.97885.88; Yeo W, 2004, BREAST CANCER RES TR, V88, P209, DOI 10.1007/s10549-004-0725-1; Yeo W, 2004, BRIT J CANCER, V90, P1306, DOI 10.1038/sj.bjc.6601699; Yeo W, 2003, J MED VIROL, V70, P553, DOI 10.1002/jmv.10430; Yeo W, 2000, J MED VIROL, V62, P299, DOI 10.1002/1096-9071(200011)62:3&lt;299::AID-JMV1&gt;3.0.CO;2-0; Yun J, 2011, BRIT J CANCER, V104, P559, DOI 10.1038/bjc.2011.4; Zheng YH, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.6496; Zurawska U, 2012, J CLIN ONCOL, V30, P3167, DOI 10.1200/JCO.2011.40.7510	68	113	116	3	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 5	2016	164	1					30	+		10.7326/M15-1121	http://dx.doi.org/10.7326/M15-1121			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA4WC	26595058	Green Accepted			2022-12-28	WOS:000367801700008
J	Foster, GR; Afdhal, N; Roberts, SK; Brau, N; Gane, EJ; Pianko, S; Lawitz, E; Thompson, A; Shiffman, ML; Cooper, C; Towner, WJ; Conway, B; Ruane, P; Bourliere, M; Asselah, T; Berg, T; Zeuzem, S; Rosenberg, W; Agarwal, K; Stedman, CAM; Mo, H; Dvory-Sobol, H; Han, L; Wang, J; McNally, J; Osinusi, A; Brainard, DM; McHutchison, JG; Mazzotta, F; Tran, TT; Gordon, SC; Patel, K; Reau, N; Mangia, A; Sulkowski, M				Foster, G. R.; Afdhal, N.; Roberts, S. K.; Braeu, N.; Gane, E. J.; Pianko, S.; Lawitz, E.; Thompson, A.; Shiffman, M. L.; Cooper, C.; Towner, W. J.; Conway, B.; Ruane, P.; Bourliere, M.; Asselah, T.; Berg, T.; Zeuzem, S.; Rosenberg, W.; Agarwal, K.; Stedman, C. A. M.; Mo, H.; Dvory-Sobol, H.; Han, L.; Wang, J.; McNally, J.; Osinusi, A.; Brainard, D. M.; McHutchison, J. G.; Mazzotta, F.; Tran, T. T.; Gordon, S. C.; Patel, K.; Reau, N.; Mangia, A.; Sulkowski, M.		ASTRAL-2 & ASTRAL-3 Investigators	Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C VIRUS-INFECTION	BACKGROUND In phase 2 trials, treatment with the combination of the nucleotide polymerase inhibitor sofosbuvir and the NS5A inhibitor velpatasvir resulted in high rates of sustained virologic response in patients chronically infected with hepatitis C virus (HCV) genotype 2 or 3. METHODS We conducted two randomized, phase 3, open-label studies involving patients who had received previous treatment for HCV genotype 2 or 3 and those who had not received such treatment, including patients with compensated cirrhosis. In one trial, patients with HCV genotype 2 were randomly assigned in a 1: 1 ratio to receive sofosbuvir-velpatasvir,in a once-daily, fixed-dose combination tablet (134 patients), or sofosbuvir plus weight-based ribavirin (132 patients) for 12 weeks. In a second trial, patients with HCV genotype 3 were randomly assigned in a 1: 1 ratio to receive sofosbuvir-velpatasvir for 12 weeks (277 patients) or sofosbuvir-ribavirin for 24 weeks (275 patients). The primary end point for the two trials was a sustained virologic response at 12 weeks after the end of therapy. RESULTS Among patients with HCV genotype 2, the rate of sustained virologic response in the sofosbuvir-velpatasvir group was 99% (95% confidence interval [CI], 96 to 100), which was superior to the rate of 94% (95% CI, 88 to 97) in the sofosbuvir-ribavirin group (P = 0.02). Among patients with HCV genotype 3, the rate of sustained virologic response in the sofosbuvir-velpatasvir group was 95% (95% CI, 92 to 98), which was superior to the rate of 80% (95% CI, 75 to 85) in the sofosbuvir-ribavirin group (P<0.001). The most common adverse events in the two studies were fatigue, headache, nausea, and insomnia. CONCLUSIONS Among patients with HCV genotype 2 or 3 with or without previous treatment, including those with compensated cirrhosis, 12 weeks of treatment with sofosbuvir-velpatasvir resulted in rates of sustained virologic response that were superior to those with standard treatment with sofosbuvir-ribavirin.	[Foster, G. R.] Queen Mary Univ London, London E1 4AT, England; [Rosenberg, W.] UCL, London WC1E 6BT, England; [Rosenberg, W.] Kings Coll Hosp London, London SE5 8RX, England; [Agarwal, K.] Inst Liver Studies, London, England; [Afdhal, N.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Roberts, S. K.] Alfred Hlth, Melbourne, Vic, Australia; [Roberts, S. K.] Monash Univ, Melbourne, Vic 3004, Australia; [Thompson, A.] St Vincents Hosp, Melbourne, Vic, Australia; [Pianko, S.] Monash Hlth, Clayton, Vic, Australia; [Pianko, S.] Monash Univ, Clayton, Vic, Australia; [Braeu, N.] James J Peters Vet Affairs Med Ctr, Bronx, NY USA; [Braeu, N.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Gane, E. J.] Auckland Clin Studies, Auckland, New Zealand; [Stedman, C. A. M.] Christchurch Clin Studies Trust & Univ Otago, Christchurch, New Zealand; [Lawitz, E.] Univ Texas Hlth Sci Ctr San Antonio, Texas Liver Inst, San Antonio, TX 78229 USA; [Shiffman, M. L.] Liver Inst Virginia, Richmond, VA USA; [Cooper, C.] Univ Ottawa, Ottawa, ON, Canada; [Conway, B.] Vancouver Infect Dis Ctr, Vancouver, BC, Canada; [Towner, W. J.] Kaiser Permanente, Los Angeles, CA USA; [Ruane, P.] Ruane Med, Los Angeles, CA USA; [Tran, T. T.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Berg, T.; Mo, H.; Dvory-Sobol, H.; Han, L.; Wang, J.; McNally, J.; Osinusi, A.; Brainard, D. M.; McHutchison, J. G.] Gilead Sci Inc, Foster City, CA 94404 USA; [Bourliere, M.] Hop St Joseph, Marseille, France; [Asselah, T.] Univ Paris Diderot, INSERM, UMR 1149, Hop Beaujon,Serv Hepatol, Clichy, France; [Berg, T.] Univ Hosp Leipzig, Leipzig, Germany; [Zeuzem, S.] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany; [Mazzotta, F.] Santa Maria Annunziata Hosp, Florence, Italy; [Mangia, A.] Casa Sollievo Sofferenza Hosp, San Giovanni Rotondo, Italy; [Gordon, S. C.] Henry Ford Hlth Syst, Detroit, MI USA; [Patel, K.] Duke Univ, Sch Med, Durham, NC USA; [Reau, N.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Sulkowski, M.] Johns Hopkins Univ, Baltimore, MD USA	University of London; Queen Mary University London; University of London; University College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Harvard University; Beth Israel Deaconess Medical Center; Monash University; St Vincent's Hospital Melbourne; Monash University; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Health San Antonio; University of Ottawa; Kaiser Permanente; Cedars Sinai Medical Center; Gilead Sciences; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Leipzig University; Goethe University Frankfurt; IRCCS Casa Sollievo Della Sofferenza; Henry Ford Health System; Henry Ford Hospital; Duke University; Rush University; Johns Hopkins University	Foster, GR (corresponding author), Queen Mary Univ London, Liver Unit, 4 Newark St, London E1 4AT, England.	g.r.foster@qmul.ac.uk	Agarwal, Kosh/ABH-8721-2020; Leggett, Barbara A/D-3579-2011; Rosenberg, William/ABA-1071-2021; Hezode, Christophe/U-4659-2018; Mangia, A/AAL-5357-2020; Loustaud-Ratti, Véronique/A-5262-2017; Mathurin, Philippe/A-9121-2018; Forton, Daniel/AAN-6669-2020; Cooper, Curtis/M-9320-2019; Zeuzem, Stefan/AAE-7435-2019	Agarwal, Kosh/0000-0002-4754-828X; Rosenberg, William/0000-0002-2732-2304; Mangia, A/0000-0002-2600-3555; Mathurin, Philippe/0000-0003-3447-2025; Afdhal, Nezam/0000-0002-7342-6593; Aspinall, Richard/0000-0002-5208-8185; Forton, Daniel/0000-0002-0903-9169; Ryder, Stephen David/0000-0001-9649-4444; Zoulim, Fabien/0000-0002-2245-0083; Leggett, Barbara/0000-0003-2062-7380; Ustianowski, Andrew/0000-0002-6134-7855; Foster, Graham/0000-0002-3704-386X	Gilead Sciences; National Institute for Health Research [NF-SI-0512-10124] Funding Source: researchfish	Gilead Sciences(Gilead Sciences); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by Gilead Sciences; ASTRAL-2 ClinicalTrials.gov number, NCT02220998; and ASTRAL-3, NCT02201953.	American Association for the Study of Liver Diseases and Infectious Diseases Society of America, REC TEST MAN TREAT H; Ampuero J, 2014, ALIMENT PHARM THER, V39, P686, DOI 10.1111/apt.12646; [Anonymous], 2014, SOV SOF PRESCR INF; [Anonymous], 2013, REB RIB PRESCR INF; Cheng G, 2013, 48 ANN M EUR ASS STU; Curry MP, 2015, NEW ENGL J MED, V373, P2618, DOI 10.1056/NEJMoa1512614; Doehle B, 2013, 64 ANN M AM ASS STUD; Everson GT, 2015, ANN INTERN MED, V163, P818, DOI 10.7326/M15-1000; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Foster GR, 2015, GASTROENTEROLOGY; Goossens N, 2014, HEPATOLOGY, V59, P2403, DOI 10.1002/hep.26905; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Lawitz E, 2015, J VIRAL HEPAT; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Pianko S, 2015, ANN INTERN MED, V163, P809, DOI 10.7326/M15-1014; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145	17	593	611	0	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2015	373	27					2608	2617		10.1056/NEJMoa1512612	http://dx.doi.org/10.1056/NEJMoa1512612			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ8UH	26575258	Green Published			2022-12-28	WOS:000367374100006
J	Liu, ZD; Gerner, MY; Van Panhuys, N; Levine, AG; Rudensky, AY; Germain, RN				Liu, Zhiduo; Gerner, Michael Y.; Van Panhuys, Nicholas; Levine, Andrew G.; Rudensky, Alexander Y.; Germain, Ronald N.			Immune homeostasis enforced by co-localized effector and regulatory T cells	NATURE			English	Article							DENDRITIC CELLS; INTERLEUKIN-2; IL-2; RESPONSES; MECHANISMS; GENERATION; TOLERANCE; ABSENCE; CTLA-4; CD73	FOXP3(+) regulatory T cells (T-reg cells) prevent autoimmunity by limiting the effector activity of T cells that have escaped thymic negative selection or peripheral inactivation. Despite the information available about molecular factors mediating the suppressive function of T-reg cells, the relevant cellular events in intact tissues remain largely unexplored, and whether Treg cells prevent activation of self-specific T cells or primarily limit damage from such cells has not been determined. Here we use multiplex, quantitative imaging in mice to show that, within secondary lymphoid tissues, highly suppressive Treg cells expressing phosphorylated STAT5 exist in discrete clusters with rare IL-2-positive T cells that are activated by self-antigens. This local IL-2 induction of STAT5 phosphorylation in T-reg cells is part of a feedback circuit that limits further autoimmune responses. Inducible ablation of T cell receptor expression by T-reg cells reduces their regulatory capacity and disrupts their localization in clusters, resulting in uncontrolled effector T cell responses. Our data thus reveal that autoreactive T cells are activated to cytokine production on a regular basis, with physically co-clustering T cell receptor-stimulated T-reg cells responding in a negative feedback manner to suppress incipient autoimmunity and maintain immune homeostasis.	[Liu, Zhiduo; Gerner, Michael Y.; Van Panhuys, Nicholas; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Levine, Andrew G.; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Levine, Andrew G.; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rgermain@nih.gov	Germain, Ronald/ABE-7090-2020; van Panhuys, Nicholas/E-1812-2011; van Panhuys, Nick/F-7034-2016; Germain, Ronald N./Z-1945-2019	van Panhuys, Nick/0000-0003-2199-852X; Gerner, Michael/0000-0001-5406-8308	NIAID, NIH; US National Institutes of Health [R37AI034206, T32GM007739]; Ludwig Cancer Center at Memorial Sloan-Kettering Cancer Center; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206, ZIAAI000403, ZIAAI000545, ZIAAI000758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Cancer Center at Memorial Sloan-Kettering Cancer Center; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Belkaid for providing germ-free mice. We also would like to thank members of the Lymphocyte Biology Section, Laboratory of Systems Biology for their helpful comments during the course of these studies and critical input during preparation of this manuscript. This work was supported by the Intramural Research Program of NIAID, NIH and by the US National Institutes of Health (R37AI034206 to A.Y.R.; T32GM007739 to A.G.L.), the Ludwig Cancer Center at Memorial Sloan-Kettering Cancer Center (A.Y.R.), and the Howard Hughes Medical Institute (A.Y.R.).	Almeida ARM, 2006, J IMMUNOL, V177, P192, DOI 10.4049/jimmunol.177.1.192; Amado IF, 2013, J EXP MED, V210, P2707, DOI 10.1084/jem.20122759; Benoist C, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007021; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cheng GY, 2011, IMMUNOL REV, V241, P63, DOI 10.1111/j.1600-065X.2011.01004.x; Chinen T, 2010, J EXP MED, V207, P2323, DOI 10.1084/jem.20101235; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Germain RN, 2012, NAT IMMUNOL, V13, P902, DOI 10.1038/ni.2404; Gerner MY, 2015, IMMUNITY, V42, P172, DOI 10.1016/j.immuni.2014.12.024; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Hofer T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00268; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Naramura M, 1998, IMMUNITY, V9, P209, DOI 10.1016/S1074-7613(00)80603-2; O'Gorman WE, 2009, J IMMUNOL, V183, P332, DOI 10.4049/jimmunol.0900691; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Powell JD, 1998, IMMUNOL REV, V165, P287, DOI 10.1111/j.1600-065X.1998.tb01246.x; Radtke AJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004637; Read S, 2006, J IMMUNOL, V177, P4376, DOI 10.4049/jimmunol.177.7.4376; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Vahl JC, 2014, IMMUNITY, V41, P722, DOI 10.1016/j.immuni.2014.10.012; van Panhuys N, 2014, IMMUNITY, V41, P63, DOI 10.1016/j.immuni.2014.06.003; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang HY, 2010, SEMIN IMMUNOPATHOL, V32, P173, DOI 10.1007/s00281-010-0202-3; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Xing Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006957	36	188	194	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					225	+		10.1038/nature16169	http://dx.doi.org/10.1038/nature16169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26605524	Green Accepted			2022-12-28	WOS:000366053300033
J	Mokranjac, D; Neupert, W				Mokranjac, Dejana; Neupert, Walter			CELL BIOLOGY Architecture of a protein entry gate	NATURE			English	Editorial Material							TRANSLOCATION; MITOCHONDRIA; TOM		[Mokranjac, Dejana] Univ Munich, Dept Physiol Chem, Biomed Ctr Munich, D-82152 Martinsried, Germany; [Neupert, Walter] Max Planck Inst Biochem, D-82152 Martinsried, Germany	University of Munich; Max Planck Society	Mokranjac, D (corresponding author), Univ Munich, Dept Physiol Chem, Biomed Ctr Munich, D-82152 Martinsried, Germany.	dejana.mokranjac@med.lmu.de; neupert@biochem.mpg.de		Mokranjac, Dejana/0000-0002-4005-6979				Baud C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6271; Bragoszewski P, 2015, P NATL ACAD SCI USA, V112, P7713, DOI 10.1073/pnas.1504615112; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Lackey SWK, 2014, J BIOL CHEM, V289, P21640, DOI 10.1074/jbc.M114.578765; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Model K, 2008, J MOL BIOL, V383, P1049, DOI 10.1016/j.jmb.2008.07.087; Neupert W, 2015, J MOL BIOL, V427, P1135, DOI 10.1016/j.jmb.2015.02.001; Noinaj N, 2014, STRUCTURE, V22, P1055, DOI 10.1016/j.str.2014.05.008; Qiu J, 2013, CELL, V154, P596, DOI 10.1016/j.cell.2013.06.033; Rapaport D, 1998, MOL CELL BIOL, V18, P5256, DOI 10.1128/MCB.18.9.5256; Schmidt O, 2011, CELL, V144, P227, DOI 10.1016/j.cell.2010.12.015; Shiota T, 2015, SCIENCE, V349, P1544, DOI 10.1126/science.aac6428; Shiota T, 2011, P NATL ACAD SCI USA, V108, P15179, DOI 10.1073/pnas.1105921108; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Waegemann K, 2015, J MOL BIOL, V427, P1075, DOI 10.1016/j.jmb.2014.07.015	15	12	12	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2015	528	7581					201	202		10.1038/nature16318	http://dx.doi.org/10.1038/nature16318			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9VH	26605527				2022-12-28	WOS:000366053300026
J	Zhang, JH; Walsh, MF; Wu, G; Edmonson, MN; Gruber, TA; Easton, J; Hedges, D; Ma, XT; Zhou, X; Yergeau, DA; Wilkinson, MR; Vadodaria, B; Chen, X; McGee, RB; Hines-Dowell, S; Nuccio, R; Quinn, E; Shurtleff, SA; Rusch, M; Patel, A; Becksfort, JB; Wang, SG; Weaver, MS; Ding, L; Mardis, ER; Wilson, RK; Gajjar, A; Ellison, DW; Pappo, AS; Pui, CH; Nichols, KE; Downing, JR				Zhang, Jinghui; Walsh, Michael F.; Wu, Gang; Edmonson, Michael N.; Gruber, Tanja A.; Easton, John; Hedges, Dale; Ma, Xiaotu; Zhou, Xin; Yergeau, Donald A.; Wilkinson, Mark R.; Vadodaria, Bhavin; Chen, Xiang; McGee, Rose B.; Hines-Dowell, Stacy; Nuccio, Regina; Quinn, Emily; Shurtleff, Sheila A.; Rusch, Michael; Patel, Aman; Becksfort, Jared B.; Wang, Shuoguo; Weaver, Meaghann S.; Ding, Li; Mardis, Elaine R.; Wilson, Richard K.; Gajjar, Amar; Ellison, David W.; Pappo, Alberto S.; Pui, Ching-Hon; Nichols, Kim E.; Downing, James R.			Germline Mutations in Predisposition Genes in Pediatric Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STRUCTURAL-VARIATION; BIALLELIC MUTATIONS; GENOMIC LANDSCAPE; CHILDHOOD-CANCER; EWINGS-SARCOMA; BREAST; BRCA2; HETEROZYGOSITY; CARRIERS; TUMORS	BACKGROUND The prevalence and spectrum of predisposing mutations among children and adolescents with cancer are largely unknown. Knowledge of such mutations may improve the understanding of tumorigenesis, direct patient care, and enable genetic counseling of patients and families. METHODS In 1120 patients younger than 20 years of age, we sequenced the whole genomes (in 595 patients), whole exomes (in 456), or both (in 69). We analyzed the DNA sequences of 565 genes, including 60 that have been associated with autosomal dominant cancerpredisposition syndromes, for the presence of germline mutations. The pathogenicity of the mutations was determined by a panel of medical experts with the use of cancer-specific and locus-specific genetic databases, the medical literature, computational predictions, and second hits identified in the tumor genome. The same approach was used to analyze data from 966 persons who did not have known cancer in the 1000 Genomes Project, and a similar approach was used to analyze data from an autism study (from 515 persons with autism and 208 persons without autism). RESULTS Mutations that were deemed to be pathogenic or probably pathogenic were identified in 95 patients with cancer (8.5%), as compared with 1.1% of the persons in the 1000 Genomes Project and 0.6% of the participants in the autism study. The most commonly mutated genes in the affected patients were TP53 (in 50 patients), APC (in 6), BRCA2 (in 6), NF1 (in 4), PMS2 (in 4), RB1 (in 3), and RUNX1 (in 3). A total of 18 additional patients had protein-truncating mutations in tumor-suppressor genes. Of the 58 patients with a predisposing mutation and available information on family history, 23 (40%) had a family history of cancer. CONCLUSIONS Germline mutations in cancer-predisposing genes were identified in 8.5% of the children and adolescents with cancer. Family history did not predict the presence of an underlying predisposition syndrome in most patients.	[Zhang, Jinghui; Wu, Gang; Edmonson, Michael N.; Hedges, Dale; Ma, Xiaotu; Zhou, Xin; Wilkinson, Mark R.; Chen, Xiang; Rusch, Michael; Patel, Aman; Becksfort, Jared B.; Wang, Shuoguo] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Walsh, Michael F.; Gruber, Tanja A.; McGee, Rose B.; Hines-Dowell, Stacy; Nuccio, Regina; Quinn, Emily; Pappo, Alberto S.; Pui, Ching-Hon; Nichols, Kim E.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Gruber, Tanja A.; Wilkinson, Mark R.; Shurtleff, Sheila A.; Ellison, David W.; Pui, Ching-Hon; Downing, James R.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Zhang, Jinghui; Walsh, Michael F.; Wu, Gang; Edmonson, Michael N.; Gruber, Tanja A.; Easton, John; Ma, Xiaotu; Yergeau, Donald A.; Vadodaria, Bhavin; Chen, Xiang; McGee, Rose B.; Hines-Dowell, Stacy; Nuccio, Regina; Quinn, Emily; Shurtleff, Sheila A.; Rusch, Michael; Patel, Aman; Becksfort, Jared B.; Wang, Shuoguo; Weaver, Meaghann S.; Gajjar, Amar; Ellison, David W.; Pappo, Alberto S.; Pui, Ching-Hon; Nichols, Kim E.; Downing, James R.] St Jude Childrens Res Hosp, Pediat Canc Genome Project, Memphis, TN 38105 USA; [Ding, Li; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63130 USA; [Ding, Li; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO 63130 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Washington University (WUSTL); Washington University (WUSTL)	Downing, JR (corresponding author), St Jude Childrens Res Hosp, Dept Pathol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	james.downing@stjude.org	Gruber, Tanja/AAH-1248-2021; Wilson, Richard K./AAF-4139-2019; Pui, Ching-Hon/N-8076-2018; Nichols, Kim/E-9353-2016; Chen, Xiang/N-2524-2018; Rusch, Michael/AAG-1998-2019; Ellison, David/N-4806-2018; Downing, James R./N-8102-2018; Wu, Gang/M-8012-2014; Mardis, Elaine/W-2202-2019; Gajjar, Amar/N-8059-2018; Zhang, Jing/GWZ-7332-2022; Nichols, Kim/AAP-8592-2020	Wilson, Richard K./0000-0002-1992-1358; Pui, Ching-Hon/0000-0003-0303-5658; Nichols, Kim/0000-0002-5581-6555; Chen, Xiang/0000-0002-2499-8261; Rusch, Michael/0000-0002-5363-1848; Wu, Gang/0000-0002-1678-5864; Nichols, Kim/0000-0002-5581-6555; Easton, John/0000-0003-4503-6608	American Lebanese Syrian Associated Charities; Cancer Center Support (Core) from National Cancer Institute [CA21765]; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA180006] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Cancer Center Support (Core) from National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by funding from the American Lebanese Syrian Associated Charities to St. Jude Children's Research Hospital and by a Cancer Center Support (Core) grant (CA21765) from the National Cancer Institute to St. Jude Children's Research Hospital.	Alter BP, 2002, FANCONI ANEMIA; Armes JE, 1999, CANCER RES, V59, P2011; Bombard Y, 2012, AM J BIOETHICS, V12, P12, DOI 10.1080/15265161.2012.699157; Bougeard G, 2008, J MED GENET, V45, P535, DOI 10.1136/jmg.2008.057570; Brooks GA, 2006, CANCER BIOL THER, V5, P1098, DOI 10.4161/cbt.5.9.3167; Cavalli LR, 2004, CANCER GENET CYTOGEN, V149, P38, DOI 10.1016/S0165-4608(03)00282-6; Chen X, 2015, NAT METHODS, V12, P527, DOI 10.1038/nmeth.3394; Cope JU, 2001, MED PEDIATR ONCOL, V36, P290, DOI 10.1002/1096-911X(20010201)36:2<290::AID-MPO1067>3.0.CO;2-5; Dworkin AM, 2009, FAM CANCER, V8, P339, DOI 10.1007/s10689-009-9240-1; Edmonson MN, 2011, BIOINFORMATICS, V27, P865, DOI 10.1093/bioinformatics/btr032; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Holmfeldt L, 2013, NAT GENET, V45, P242, DOI 10.1038/ng.2532; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Johnston JJ, 2012, AM J HUM GENET, V91, P97, DOI 10.1016/j.ajhg.2012.05.021; Knapke S, 2012, PEDIATR BLOOD CANCER, V58, P85, DOI 10.1002/pbc.23283; Lindor NM, 2008, J NATL CANC I MONOGR, V38, P1, DOI DOI 10.1093/JNCIMONOGRAPHS/LGN001; Lucas AL, 2013, CLIN CANCER RES, V19, P3396, DOI 10.1158/1078-0432.CCR-12-3020; Magnusson S, 2008, FAM CANCER, V7, P331, DOI 10.1007/s10689-008-9195-7; Meldrum Cliff, 2011, Clin Biochem Rev, V32, P177; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Mittal R, 2008, MED PRIN PRACT, V17, P84, DOI 10.1159/000109597; Offit K, 2004, JAMA-J AM MED ASSOC, V292, P1469, DOI 10.1001/jama.292.12.1469; Osorio A, 2002, INT J CANCER, V99, P305, DOI 10.1002/ijc.10337; Pizzo PA, 2011, PRINCIPLES PRACTICE; Pui CH, 2012, CHILDHOOD LEUKEMIAS, 3RD EDITION, P1, DOI 10.1017/CBO9780511977633; Randall RL, 2010, J ONCOL, V2010, DOI 10.1155/2010/397632; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sawyer SL, 2015, CANCER DISCOV, V5, P135, DOI 10.1158/2159-8290.CD-14-1156; Spunt SL, 2006, CANCER-AM CANCER SOC, V107, P201, DOI 10.1002/cncr.21962; Staff S, 2001, BRIT J CANCER, V85, P1201, DOI 10.1054/bjoc.2001.2062; Storm C, 2008, J ONCOL PRACT, V4, P229, DOI 10.1200/JOP.0858504; Tahasildar N, 2011, J ORTHOP TRAUMATOL, V12, P167, DOI 10.1007/s10195-011-0152-0; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Willems AJ, 2008, CLIN CANCER RES, V14, P2953, DOI 10.1158/1078-0432.CCR-07-5237; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937	39	639	643	7	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2015	373	24					2336	2346		10.1056/NEJMoa1508054	http://dx.doi.org/10.1056/NEJMoa1508054			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY0QW	26580448	Green Accepted			2022-12-28	WOS:000366111600008
J	Bazan, F; Busto, M				Bazan, Fernando; Busto, Marcos			Pylephlebitis as a Complication of Diverticulitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bazan, Fernando; Busto, Marcos] Hosp Mar, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Bazan, F (corresponding author), Hosp Mar, Barcelona, Spain.	ferx.bazan@gmail.com							0	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 3	2015	373	23					2270	2270		10.1056/NEJMicm1501584	http://dx.doi.org/10.1056/NEJMicm1501584			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5LM	26630145				2022-12-28	WOS:000365743100010
J	Libman, IM; Miller, KM; DiMeglio, LA; Bethin, KE; Katz, ML; Shah, A; Simmons, JH; Haller, MJ; Raman, S; Tamborlane, WV; Coffey, JK; Saenz, AM; Beck, RW; Nadeau, KJ				Libman, Ingrid M.; Miller, Kellee M.; DiMeglio, Linda A.; Bethin, Kathleen E.; Katz, Michelle L.; Shah, Avni; Simmons, Jill H.; Haller, Michael J.; Raman, Sripriya; Tamborlane, William V.; Coffey, Julie K.; Saenz, Ashleigh M.; Beck, Roy W.; Nadeau, Kristen J.		T1D Exchange Clinic Network Metfor	Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESISTANCE; SENSITIVITY; COMPLICATIONS; MELLITUS	IMPORTANCE Previous studies assessing the effect of metformin on glycemic control in adolescents with type 1 diabetes have produced inconclusive results. OBJECTIVE To assess the efficacy and safety of metformin as an adjunct to insulin in treating overweight adolescents with type 1 diabetes. DESIGN, SETTING, AND PARTICIPANTS Multicenter (26 pediatric endocrinology clinics), double-blind, placebo-controlled randomized clinical trial involving 140 adolescents aged 12.1 to 19.6 years (mean [SD] 15.3 [1.7] years) with mean type 1 diabetes duration 7.0 (3.3) years, mean body mass index (BMI) 94th (4) percentile, mean total daily insulin 1.1 (0.2) U/kg, and mean HbA(1c) 8.8% (0.7%). INTERVENTIONS Randomization to receive metformin (n = 71) (<= 2000mg/d) or placebo (n = 69). MAIN OUTCOMES AND MEASURES Primary outcome was change in HbA(1c) from baseline to 26 weeks adjusted for baseline HbA(1c). Secondary outcomes included change in blinded continuous glucose monitor indices, total daily insulin, BMI, waist circumference, body composition, blood pressure, and lipids. RESULTS Between October 2013 and February 2014, 140 participants were enrolled. Baseline HbA(1c) was 8.8% in each group. At 13-week follow-up, reduction in HbA(1c) was greater with metformin (-0.2%) than placebo (0.1%; mean difference, -0.3%[95% CI, -0.6% to 0.0%]; P = .02). However, this differential effect was not sustained at 26-week follow up when mean change in HbA(1c) from baseline was 0.2% in each group (mean difference, 0%[95% CI, -0.3% to 0.3%]; P = .92). At 26-week follow-up, total daily insulin per kg of body weight was reduced by at least 25% from baseline among 23%(16) of participants in the metformin group vs 1% (1) of participants in the placebo group (mean difference, 21% [95% CI, 11% to 32%]; P = .003), and 24%(17) of participants in the metformin group and 7%(5) of participants in the placebo group had a reduction in BMI z score of 10% or greater from baseline to 26 weeks (mean difference, 17%[95% CI, 5% to 29%]; P = .01). Gastrointestinal adverse events were reported by more participants in the metformin group than in the placebo group (mean difference, 36%[95% CI, 19% to 51%]; P < .001). CONCLUSIONS AND RELEVANCE Among overweight adolescents with type 1 diabetes, the addition of metformin to insulin did not improve glycemic control after 6 months. Of multiple secondary end points, findings favored metformin only for insulin dose and measures of adiposity; conversely, use of metformin resulted in an increased risk for gastrointestinal adverse events. These results do not support prescribing metformin to overweight adolescents with type 1 diabetes to improve glycemic control.	[Libman, Ingrid M.] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Miller, Kellee M.; Saenz, Ashleigh M.; Beck, Roy W.] Jaeb Ctr Hlth Res, Tampa, FL 33647 USA; [DiMeglio, Linda A.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Bethin, Kathleen E.] SUNY Buffalo, Sch Med & Biomed Sci, Buffalo, NY 14260 USA; [Katz, Michelle L.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Shah, Avni] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Simmons, Jill H.] Vanderbilt Univ, Nashville, TN 37235 USA; [Haller, Michael J.] Univ Florida, Gainesville, FL USA; [Raman, Sripriya] Childrens Mercy Hosp, Kansas City, MO 64108 USA; [Tamborlane, William V.] Yale Univ, New Haven, CT USA; [Coffey, Julie K.] Univ Iowa, Iowa City, IA USA; [Nadeau, Kristen J.] Univ Colorado, Aurora, CO USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; JAEB Center For Health Research; Indiana University System; Indiana University Bloomington; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Harvard University; Joslin Diabetes Center, Inc.; Stanford University; Vanderbilt University; State University System of Florida; University of Florida; Children's Mercy Hospital; Yale University; University of Iowa; University of Colorado System; University of Colorado Anschutz Medical Campus	Nadeau, KJ (corresponding author), Jaeb Ctr Hlth Res, 15310 Amberly Dr,Ste 350, Tampa, FL 33647 USA.	T1DStats@jaeb.org	Bethin, Kathleen/L-8904-2019; DiMeglio, Linda A./F-9277-2019	Bethin, Kathleen/0000-0002-6100-4983; DiMeglio, Linda A./0000-0002-8033-6078; Simmons, Jill/0000-0002-4189-6718	Juvenile Diabetes Research Foundation; National Institute of Diabetes and Digestive and Kidney Diseases [K12DK094721]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K12DK094721] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by the Juvenile Diabetes Research Foundation. Part of Dr Katz's time was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (K12DK094721).	AMIEL SA, 1986, NEW ENGL J MED, V315, P215, DOI 10.1056/NEJM198607243150402; Bjornstad P, 2015, WORLD J DIABETES, V6, P8, DOI 10.4239/wjd.v6.i1.8; Centers for Disease Control and Prevention, 2000, CDC GROWTH CHARTS US; Cleland SJ, 2013, DIABETOLOGIA, V56, P1462, DOI 10.1007/s00125-013-2904-2; DuBose SN, 2015, J PEDIATR-US, V167, P627, DOI 10.1016/j.jpeds.2015.05.046; Hamilton J, 2003, DIABETES CARE, V26, P138, DOI 10.2337/diacare.26.1.138; Libman IM, 2003, DIABETES CARE, V26, P2871, DOI 10.2337/diacare.26.10.2871; Little R. J. A., 1987, STAT ANAL MISSING DA; Lund SS, 2009, DIABETES OBES METAB, V11, P966, DOI 10.1111/j.1463-1326.2009.01079.x; Lund SS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003363; Nadeau KJ, 2015, PEDIATR DIABETES, V16, P196, DOI 10.1111/pedi.12140; Nadeau KJ, 2010, J CLIN ENDOCR METAB, V95, P513, DOI 10.1210/jc.2009-1756; Nwosu BU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137525; Sarnblad S, 2003, EUR J ENDOCRINOL, V149, P323, DOI 10.1530/eje.0.1490323; Schauer IE, 2011, DIABETES, V60, P306, DOI 10.2337/db10-0328; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Specht BJ, 2013, J PEDIATR-US, V162, P297, DOI 10.1016/j.jpeds.2012.07.036; Vella S, 2010, DIABETOLOGIA, V53, P809, DOI 10.1007/s00125-009-1636-9; Wiernsperger NF, 1999, DRUGS, V58, P31, DOI 10.2165/00003495-199958001-00009	19	100	106	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2015	314	21					2241	2250		10.1001/jama.2015.16174	http://dx.doi.org/10.1001/jama.2015.16174			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX2GT	26624824	Green Published, Bronze			2022-12-28	WOS:000365515700016
J	Gill, JL				Gill, Jacquelyn L.			Learning from Africa's herbivores	SCIENCE			English	Editorial Material									[Gill, Jacquelyn L.] Univ Maine, Sch Biol & Ecol, Climate Change Inst, Orono, ME 04469 USA	University of Maine System; University of Maine Orono	Gill, JL (corresponding author), Univ Maine, Sch Biol & Ecol, Climate Change Inst, Orono, ME 04469 USA.	jacquelyn.gill@maine.edu	Gill, Jacquelyn/HCH-8486-2022					Archibald S, 2013, P NATL ACAD SCI USA, V110, P6442, DOI 10.1073/pnas.1211466110; Bakker ES, 2016, P NATL ACAD SCI USA, V113, P847, DOI 10.1073/pnas.1502545112; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Faurby S, 2015, DIVERS DISTRIB, V21, P1155, DOI 10.1111/ddi.12369; Hempson GP, 2015, SCIENCE, V350, P1056, DOI 10.1126/science.aac7978; Knapp AK, 1999, BIOSCIENCE, V49, P39, DOI 10.2307/1313492; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Svenning JC, 2016, P NATL ACAD SCI USA, V113, P898, DOI 10.1073/pnas.1502556112; Wittemyer G, 2014, P NATL ACAD SCI USA, V111, P13117, DOI 10.1073/pnas.1403984111	11	6	6	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1036	1037		10.1126/science.aad6760	http://dx.doi.org/10.1126/science.aad6760			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY5BJ	26612939				2022-12-28	WOS:000366422600025
J	Courtwright, DT				Courtwright, David T.			HISTORY OF MEDICINE Preventing and Treating Narcotic Addiction - A Century of Federal Drug Control	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Courtwright, David T.] Univ N Florida, Dept Hist, Jacksonville, FL 32224 USA	State University System of Florida; University of North Florida	Courtwright, DT (corresponding author), Univ N Florida, Dept Hist, Jacksonville, FL 32224 USA.							ADAMS JFA, 1889, BOSTON MED SURG J, V121, P351, DOI 10.1056/NEJM188910101211502; [Anonymous], 1903, PHARM ERA, V29, P445; Cherkis J., 2015, HUFFINGTON POST; Courtwright DT., 2001, DARK PARADISE HIST O, VEnl. ed., pxiii, 326; Spillane J. F., 2000, COCAINE MED MARVEL M	5	20	20	2	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2015	373	22					2095	2097		10.1056/NEJMp1508818	http://dx.doi.org/10.1056/NEJMp1508818			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW9YT	26605925				2022-12-28	WOS:000365354800002
J	VanBuren, R; Bryant, D; Edger, PP; Tang, HB; Burgess, D; Challabathula, D; Spittle, K; Hall, R; Gu, J; Lyons, E; Freeling, M; Bartels, D; Ten Hallers, B; Hastie, A; Michael, TP; Mockler, TC				VanBuren, Robert; Bryant, Doug; Edger, Patrick P.; Tang, Haibao; Burgess, Diane; Challabathula, Dinakar; Spittle, Kristi; Hall, Richard; Gu, Jenny; Lyons, Eric; Freeling, Michael; Bartels, Dorothea; Ten Hallers, Boudewijn; Hastie, Alex; Michael, Todd P.; Mockler, Todd C.			Single-molecule sequencing of the desiccation-tolerant grass Oropetium thomaeum	NATURE			English	Article							STRUCTURAL VARIATION; GENOME COMPARISONS; TANDEM REPEATS; DNA; REVEALS; GENE; SIZE; IDENTIFICATION; TRANSCRIPTOME; ANNOTATION	Plant genomes, and eukaryotic genomes in general, are typically repetitive, polyploid and heterozygous, which complicates genome assembly(1). The short read lengths of early Sanger and current next-generation sequencing platforms hinder assembly through complex repeat regions, and many draft and reference genomes are fragmented, lacking skewed GC and repetitive intergenic sequences, which are gaining importance due to projects like the Encyclopedia of DNA Elements (ENCODE)(2). Here we report the whole-genome sequencing and assembly of the desiccation-tolerant grass Oropetium thomaeum. Using only single-molecule real-time sequencing, which generates long (>16 kilobases) reads with random errors, we assembled 99% (244 megabases) of the Oropetium genome into 625 contigs with an N50 length of 2.4 megabases. Oropetium is an example of a 'near-complete' draft genome which includes gapless coverage over gene space as well as intergenic sequences such as centromeres, telomeres, transposable elements and rRNA clusters that are typically unassembled in draft genomes. Oropetium has 28,466 protein-coding genes and 43% repeat sequences, yet with 30% more compact euchromatic regions it is the smallest known grass genome. The Oropetium genome demonstrates the utility of single-molecule real-time sequencing for assembling high-quality plant and other eukaryotic genomes, and serves as a valuable resource for the plant comparative genomics community.	[VanBuren, Robert; Bryant, Doug; Mockler, Todd C.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Edger, Patrick P.; Burgess, Diane; Freeling, Michael] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Edger, Patrick P.] Michigan State Univ, Dept Hort, E Lansing, MI 48323 USA; [Tang, Haibao; Lyons, Eric] Univ Arizona, Sch Plant Sci, IPlant Collaborat, Tucson, AZ 85721 USA; [Tang, Haibao] Fujian Agr & Forestry Univ, HIST, Ctr Genom & Biotechnol, Fuzhou 350002, Peoples R China; [Challabathula, Dinakar; Bartels, Dorothea] Univ Bonn, IMBIO, D-53115 Bonn, Germany; [Spittle, Kristi; Hall, Richard; Gu, Jenny] Pacific Biosci, Menlo Pk, CA 94025 USA; [Ten Hallers, Boudewijn; Hastie, Alex] BioNano Genom, San Diego, CA 92121 USA; [Michael, Todd P.] Ibis Biosci, Carlsbad, CA 92008 USA	Donald Danforth Plant Science Center; University of California System; University of California Berkeley; Michigan State University; University of Arizona; Fujian Agriculture & Forestry University; University of Bonn	VanBuren, R (corresponding author), Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA.	toddpmichael@gmail.com; tmockler@danforthcenter.org	Edger, Patrick/AAP-3846-2021; Mockler, Todd C/L-2609-2013; Edger, Patrick/ABE-6442-2020; Tang, Haibao/A-6715-2011; Challabathula, Dinakar/H-3491-2017	Mockler, Todd C/0000-0002-0462-5775; Tang, Haibao/0000-0002-3460-8570; Lyons, Eric/0000-0002-3348-8845; Challabathula, Dinakar/0000-0002-7158-5902	National Science foundation [DBI-1401572, DBI-120793]; USDA NIFA [CO471A-B]; Department of Energy [DE-SC0012639, DE-SC-0008769]; Donald Danforth Plant Science Center; Enterprise Rent-A-Car Institute for Renewable Fuels; Division Of Integrative Organismal Systems [1401572] Funding Source: National Science Foundation	National Science foundation(National Science Foundation (NSF)); USDA NIFA(United States Department of Agriculture (USDA)); Department of Energy(United States Department of Energy (DOE)); Donald Danforth Plant Science Center; Enterprise Rent-A-Car Institute for Renewable Fuels; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is supported in part by funding from the National Science foundation (DBI-1401572 to R.V.; DBI-120793 to P.P.E.), USDA NIFA (CO471A-B to M.F.), the Department of Energy (DE-SC0012639 to T.C.M. and T.P.M.; DE-SC-0008769 to T.C.M.), the Donald Danforth Plant Science Center to T.C.M. and the Enterprise Rent-A-Car Institute for Renewable Fuels to T.C.M. Sequencing was provided by Pacific Biosciences under the 'Most Interesting Genome in the World' 2014 SMRT grant program.	Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Au KF, 2013, P NATL ACAD SCI USA, V110, pE4821, DOI 10.1073/pnas.1320101110; Bartels D, 2002, MAYDICA, V47, P185; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beaulieu JM, 2008, NEW PHYTOL, V179, P975, DOI 10.1111/j.1469-8137.2008.02528.x; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bennetzen JL, 1997, PLANT CELL, V9, P1509, DOI 10.1105/tpc.9.9.1509; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Cao HZ, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-34; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; El Baidouri M, 2013, GENOME BIOL EVOL, V5, P954, DOI 10.1093/gbe/evt025; Elert E, 2014, NATURE, V514, pS50, DOI 10.1038/514S50a; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; Flutre T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016526; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Freeling M, 2015, MOL PLANT, V8, P899, DOI 10.1016/j.molp.2015.02.009; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Ibarra-Laclette E, 2013, NATURE, V498, P94, DOI 10.1038/nature12132; International Barley Genome Sequencing Consortium, 2012, Nature, V491, P711, DOI 10.1038/nature11543; Jones N, 2005, NEW PHYTOL, V165, P391, DOI 10.1111/j.1469-8137.2004.01225.x; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Lam ET, 2012, NAT BIOTECHNOL, V30, P771, DOI 10.1038/nbt.2303; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Leushkin EV, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-476; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lyons E, 2008, PLANT J, V53, P661, DOI 10.1111/j.1365-313X.2007.03326.x; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Melters DP, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r10; Michael TP, 2015, CURR OPIN PLANT BIOL, V24, P71, DOI 10.1016/j.pbi.2015.02.002; Michael TP, 2014, BRIEF FUNCT GENOMICS, V13, P308, DOI 10.1093/bfgp/elu005; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/NMETH.2212, 10.1038/nmeth.2212]; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Tang HB, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-102; Tang HB, 2010, P NATL ACAD SCI USA, V107, P472, DOI 10.1073/pnas.0908007107; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4311; Wicker T, 2010, GENOME RES, V20, P1229, DOI 10.1101/gr.107284.110; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; ZHANG HB, 1995, PLANT J, V7, P175, DOI 10.1046/j.1365-313X.1995.07010175.x	55	196	204	5	90	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					508	U209		10.1038/nature15714	http://dx.doi.org/10.1038/nature15714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26560029	hybrid, Green Submitted			2022-12-28	WOS:000365352500046
J	van der Aa, HPA; van Rens, GHMB; Comijs, HC; Margrain, TH; Gallindo-Garre, F; Twisk, JWR; van Nispen, RMA				van der Aa, Hilde P. A.; van Rens, Ger H. M. B.; Comijs, Hannie C.; Margrain, Tom H.; Gallindo-Garre, Francisca; Twisk, Jos W. R.; van Nispen, Ruth M. A.			Stepped care for depression and anxiety in visually impaired older adults: multicentre randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; HOSPITAL ANXIETY; SELF-REPORTS; CES-D; SCALE; PREVALENCE; QUESTIONNAIRE; VALIDATION; SYMPTOMS; VALIDITY	STUDY QUESTION Is stepped care compared with usual care effective in preventing the onset of major depressive, dysthymic, and anxiety disorders in older people with visual impairment (caused mainly by age related eye disease) and subthreshold depression and/or anxiety? METHODS 265 people aged >= 50 were randomly assigned to a stepped care programme plus usual care (n=131) or usual care only (n=134). Supervised occupational therapists, social workers, and psychologists from low vision rehabilitation organisations delivered the stepped care programme, which comprised watchful waiting, guided self help based on cognitive behavioural therapy, problem solving treatment, and referral to a general practitioner. The primary outcome was the 24 month cumulative incidence (seven measurements) of major depressive dysthymic and/or anxiety disorders (panic disorder, agoraphobia, social phobia, and generalised anxiety disorder). Secondary outcomes were change in symptoms of depression and anxiety, vision related quality of life, health related quality of life, and adaptation to vision loss over time up to 24 months' follow-up. STUDY ANSWER AND LIMITATIONS 62 participants (46%) in the usual care group and 38 participants (29%) from the stepped care group developed a disorder. The intervention was associated with a significantly reduced incidence (relative risk 0.63, 95% confidence interval 0.45 to 0.87; P=0.01), even if time to the event was taken into account (adjusted hazard ratio 0.57, 0.35 to 0.93; P=0.02). The number needed to treat was 5.8 (3.5 to 17.3). The dropout rate was fairly high (34.3%), but rates were not significantly different for the two groups, indicating that the intervention was as acceptable as usual care. Participants who volunteered and were selected for this study might not be representative of visually impaired older adults in general (responders were significantly younger than non-responders), thereby reducing the generalisability of the outcomes. WHAT THIS STUDY ADDS Stepped care seems to be a promising way to deal with depression and anxiety in visually impaired older adults. This approach could lead to standardised strategies for the screening, monitoring, treatment, and referral of visually impaired older adults with depression and anxiety.	[van der Aa, Hilde P. A.; van Rens, Ger H. M. B.; van Nispen, Ruth M. A.] Vrije Univ Amsterdam, Med Ctr, Dept Ophthalmol, NL-1081 HV Amsterdam, Netherlands; [van der Aa, Hilde P. A.; van Rens, Ger H. M. B.; van Nispen, Ruth M. A.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res EMGO, NL-1081 HV Amsterdam, Netherlands; [Comijs, Hannie C.] VUmc GGZinGeest, Dept Psychiat, NL-1081 HL Amsterdam, Netherlands; [Margrain, Tom H.] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff CF24 4HQ, S Glam, Wales; [Gallindo-Garre, Francisca; Twisk, Jos W. R.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Cardiff University; Vrije Universiteit Amsterdam	van der Aa, HPA (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Ophthalmol, NL-1081 HV Amsterdam, Netherlands.	h.vanderaa@vumc.nl	van Rens, Ger/I-6247-2018	van Nispen, Ruth M.A./0000-0003-1227-1177; Margrain, Tom/0000-0003-1280-0809	ZonMw InZicht, Dutch Organisation for Health Research and Development-InSight Society [60-0063598108]	ZonMw InZicht, Dutch Organisation for Health Research and Development-InSight Society	The study was supported by ZonMw InZicht, the Dutch Organisation for Health Research and Development-InSight Society (grant No 60-0063598108). The sponsor had no role in the design and conduct of the present study or in the writing of the manuscript.	Adamson JA, 2005, J AM GERIATR SOC, V53, P1128, DOI 10.1111/j.1532-5415.2005.53355.x; Augustin A, 2007, INVEST OPHTH VIS SCI, V48, P1498, DOI 10.1167/iovs.06-0761; Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510; Beekman ATF, 1999, BRIT J PSYCHIAT, V174, P307, DOI 10.1192/bjp.174.4.307; Binns AM, 2012, SURV OPHTHALMOL, V57, P34, DOI 10.1016/j.survophthal.2011.06.006; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; BRESLAU N, 1985, PSYCHIAT RES, V15, P219, DOI 10.1016/0165-1781(85)90079-4; Brody BL, 2001, OPHTHALMOLOGY, V108, P1893, DOI 10.1016/S0161-6420(01)00754-0; Bryant C, 2008, J AFFECT DISORDERS, V109, P233, DOI 10.1016/j.jad.2007.11.008; Callahan CM, 2002, MED CARE, V40, P771, DOI 10.1097/00005650-200209000-00007; Casten RJ, 2013, CURR OPIN OPHTHALMOL, V24, P239, DOI 10.1097/ICU.0b013e32835f8e55; Evans JR, 2007, OPHTHALMOLOGY, V114, P283, DOI 10.1016/j.ophtha.2006.10.006; Hakkaart-van Roijen L, 2002, MANUAL TRIMBOS IMTA; Horowitz A, 2005, AM J GERIAT PSYCHIAT, V13, P180, DOI 10.1176/appi.ajgp.13.3.180; Horowitz A, 2007, J VISUAL IMPAIR BLIN, V101, P146, DOI 10.1177/0145482X0710100303; Hutschemaekers Giel J M, 2003, Int J Integr Care, V3, pe10; Jones GC, 2009, REHABIL PSYCHOL, V54, P164, DOI 10.1037/a0015910; Kok I, 2003, CLIENT APPRECIATION; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574; Lotery A, 2007, BRIT J OPHTHALMOL, V91, P1303, DOI 10.1136/bjo.2007.116939; Meadows G, 2000, SOC PSYCH PSYCH EPID, V35, P427, DOI 10.1007/s001270050260; Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540; National Institute for Health and Care Excellence (NICE), DEPR AD CHRON PHYS H; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; van der Aa HPA, 2015, QUAL LIFE RES, V24, P969, DOI 10.1007/s11136-014-0835-0; van der Aa HPA, 2015, INVEST OPHTH VIS SCI, V56, P849, DOI 10.1167/iovs.14-15848; van der Aa HPA, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-209; van Nispen RMA, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-125; van Nispen RMA, 2010, J CLIN EPIDEMIOL, V63, P321, DOI 10.1016/j.jclinepi.2009.06.012; van Straten A, 2015, PSYCHOL MED, V45, P231, DOI 10.1017/S0033291714000701; van Vliet I M, 2007, Tijdschr Psychiatr, V49, P393; van't Veer-Tazelaar PJ, 2011, AM J GERIAT PSYCHIAT, V19, P230, DOI 10.1097/JGP.0b013e3181faee4d; van't Veer-Tazelaar PJ, 2009, ARCH GEN PSYCHIAT, V66, P297, DOI 10.1001/archgenpsychiatry.2008.555; Vreeken H, 2011, GUIDELINE VISION DIS, P15; World Health Organization, GLOB DAT VIS IMP 201	36	54	54	2	42	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2015	351								h6127	10.1136/bmj.h6127	http://dx.doi.org/10.1136/bmj.h6127			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX4SR	26597263	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000365691100002
J	Clery, D				Clery, Daniel			SPACE PHYSICS LISA Pathfinder tests spacetime sensor	SCIENCE			English	News Item														Clery, Daniel/0000-0002-8742-3596					0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					894	895		10.1126/science.350.6263.894	http://dx.doi.org/10.1126/science.350.6263.894			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW4IP	26586737				2022-12-28	WOS:000364955200010
J	Davidson, LL; Grigorenko, EL; Boivin, MJ; Rapa, E; Stein, A				Davidson, Leslie L.; Grigorenko, Elena L.; Boivin, Michael J.; Rapa, Elizabeth; Stein, Alan			A focus on adolescence to reduce neurological, mental health and substance-use disability	NATURE			English	Review							MIDDLE-INCOME COUNTRIES; GLOBAL BURDEN; YOUNG-PEOPLE; DISORDERS; CHILDREN; SUPPORT; RISK; INTERVENTION; PSYCHOSIS; EXPOSURE	Globally, there is a crucial need to prioritize research directed at reducing neurological, mental health and substance-use disorders in adolescence, which is a pivotal age for the development of self-control and regulation. In adolescence, behaviour optimally advances towards adaptive long-term goals and suppresses conflicting maladaptive short-lived urges to balance impulsivity, exploration and defiance, while establishing effective societal participation. When self-control fails to develop, violence, injury and neurological, mental health and substance-use disorders can result, further challenging the development of self-regulation and impeding the transition to a productive adulthood. Adolescent outcomes, positive and negative, arise from both a life-course perspective and within a socioecological framework. Little is known about the emergence of self-control and regulation in adolescents in low-and middle-income countries where enormous environmental threats are more common (for example, poverty, war, local conflicts, sex trafficking and slavery, early marriage and/or pregnancy, and the absence of adequate access to education) than in high-income countries and can threaten optimal neurodevelopment. Research must develop or adapt appropriate assessments of adolescent ability and disability, social inclusion and exclusion, normative development, and neurological, mental health and substance-use disorders. Socioecological challenges in low-and middle-income countries require innovative strategies to prevent mental health, neurological and substance-use disorders and develop effective interventions for adolescents at risk, especially those already living with these disorders and the consequent disability.	[Davidson, Leslie L.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol & Pediat, 722 West 168 St Room 1613, New York, NY 10032 USA; [Davidson, Leslie L.] Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA; [Grigorenko, Elena L.] Yale Univ, Dept Psychol, Dept Epidemiol & Publ Hlth, Child Study Ctr, New Haven, CT 06519 USA; [Boivin, Michael J.] Michigan State Univ, Coll Osteopath Med, Dept Psychiat, E Lansing, MI 48824 USA; [Boivin, Michael J.] Michigan State Univ, Coll Osteopath Med, Dept Neurol & Ophthalmol, E Lansing, MI 48824 USA; [Rapa, Elizabeth; Stein, Alan] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England; [Stein, Alan] Univ Witwatersrand, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa	Columbia University; Columbia University; Yale University; Michigan State University; Michigan State University College of Osteopathic Medicine; Michigan State University; Michigan State University College of Osteopathic Medicine; University of Oxford; University of Witwatersrand	Davidson, LL (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol & Pediat, 722 West 168 St Room 1613, New York, NY 10032 USA.	LLD1@columbia.edu	Grigorenko, Elena/V-2418-2019	Stein, Alan/0000-0001-8207-2822; Rapa, Elizabeth/0000-0001-8818-8148	Fogarty International Center	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The authors declare no competing financial interests. Financial support for publication has been provided by the Fogarty International Center.	Belfer ML, 2008, J CHILD PSYCHOL PSYC, V49, P226, DOI 10.1111/j.1469-7610.2007.01855.x; Betancourt TS, 2013, HARVARD REV PSYCHIAT, V21, P70, DOI 10.1097/HRP.0b013e318283bf8f; Bhana A, 2014, AIDS CARE, V26, P1, DOI 10.1080/09540121.2013.806770; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blum RW, 2014, J ADOLESCENT HEALTH, V55, pS4, DOI 10.1016/j.jadohealth.2014.09.009; Casale M, 2015, AM J COMMUN PSYCHOL, V55, P336, DOI 10.1007/s10464-015-9705-3; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Colver AF, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-675; Coren Esther, 2013, Evid Based Child Health, V8, P1140, DOI 10.1002/ebch.1923; DIMDI, 2005, INT CLASS FUNCT DIS; Ehlers CL, 2010, ALCOHOL, V44, P27, DOI 10.1016/j.alcohol.2009.09.033; Elafros MA, 2013, EPILEPSY BEHAV, V27, P188, DOI 10.1016/j.yebeh.2013.01.005; Fazel M, 2014, LANCET PSYCHIAT, V1, P388, DOI 10.1016/S2215-0366(14)70357-8; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Grigorenko E. L., 2004, CULTURE COMPETENCE, P22; Hazra R, 2010, ANNU REV MED, V61, P169, DOI 10.1146/annurev.med.050108.151127; Hodgkinson S, 2014, PEDIATRICS, V133, P114, DOI 10.1542/peds.2013-0927; Layne CM, 2010, CHILD DEV, V81, P1053, DOI 10.1111/j.1467-8624.2010.01454.x; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Maticka-Tyndale E, 2010, EVAL PROGRAM PLANN, V33, P98, DOI 10.1016/j.evalprogplan.2009.07.001; Matthews DB, 2010, ALCOHOL, V44, P1, DOI 10.1016/j.alcohol.2009.10.018; Maulik PK, 2011, RES DEV DISABIL, V32, P419, DOI 10.1016/j.ridd.2010.12.018; McFarlane WR, 2014, PSYCHIAT SERV, V65, P1194, DOI 10.1176/appi.ps.201300336; Miklowitz DJ, 2014, J AM ACAD CHILD PSY, V53, P848, DOI 10.1016/j.jaac.2014.04.020; Morgan C, 2015, SOC PSYCH PSYCH EPID, V50, P879, DOI 10.1007/s00127-015-1013-6; Offord DR, 2000, ADDICT BEHAV, V25, P833, DOI 10.1016/S0306-4603(00)00132-5; Olumide AO, 2014, J ADOLESCENT HEALTH, V55, pS39, DOI 10.1016/j.jadohealth.2014.08.024; Patel V, 2008, J CHILD PSYCHOL PSYC, V49, P313, DOI 10.1111/j.1469-7610.2007.01824.x; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Patton GC, 2014, LANCET, V383, P1404, DOI [10.1016/s0140-6736(13)62116-9, 10.1016/S0140-6736(13)62116-9]; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Reed RV, 2012, LANCET, V379, P250, DOI 10.1016/S0140-6736(11)60050-0; Richter LM, 2012, INT J EPIDEMIOL, V41, P621, DOI 10.1093/ije/dyq251; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Stockl H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-751; Toumbourou JW, 2007, LANCET, V369, P1391, DOI 10.1016/S0140-6736(07)60369-9; Tyrer RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089359; UNICEF, 2012, PROGR CHILDR REP CAR; UNICEF, 2013, STATE WORLDS CHILDRE; UNICEF, 2012, END CHILD MARR PROGR; Verho A., 2012, J ENV PUBLIC HLTH, V2012; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; World Bank, 2021, STATE PEACEBUILDING; World Health Organization, WHO DIS ASS SCHED 2; World Health Organization, 2015, MEN VACC NOW REC ROU; Wuermli AJ, 2015, CHILD DEV PERSPECT, V9, P61, DOI 10.1111/cdep.12108; Zaridze D, 2014, LANCET, V383, P1465, DOI 10.1016/S0140-6736(13)62247-3	48	51	52	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					S161	S166		10.1038/nature16030	http://dx.doi.org/10.1038/nature16030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW9ZN	26580322	hybrid			2022-12-28	WOS:000365356800011
J	Fratzl, P				Fratzl, Peter			Extra dimension for bone analysis	NATURE			English	Editorial Material							X-RAY-SCATTERING; ORIENTATION; SAXS		[Fratzl, Peter] Max Planck Inst Colloids & Interfaces, Dept Biomat, D-14424 Potsdam, Germany	Max Planck Society	Fratzl, P (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomat, D-14424 Potsdam, Germany.	fratzl@mpikg.mpg.de	Fratzl, Peter/H-9095-2012	Fratzl, Peter/0000-0003-4437-7830				Fratzl P, 1997, J APPL CRYSTALLOGR, V30, P765, DOI 10.1107/S0021889897001775; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Georgiadis M, 2015, BONE, V71, P42, DOI 10.1016/j.bone.2014.10.002; Jaschouz D, 2003, J APPL CRYSTALLOGR, V36, P494, DOI 10.1107/S0021889803000566; Liebi M, 2015, NATURE, V527, P349, DOI 10.1038/nature16056; Pabisch S, 2013, METHOD ENZYMOL, V532, P391, DOI 10.1016/B978-0-12-416617-2.00018-7; Rinnerthaler S, 1999, CALCIFIED TISSUE INT, V64, P422, DOI 10.1007/PL00005824; Schaff F, 2015, NATURE, V527, P353, DOI 10.1038/nature16060; Stribeck N, 2008, MACROMOLECULES, V41, P7637, DOI 10.1021/ma8015322; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271	10	8	8	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					308	309		10.1038/527308a	http://dx.doi.org/10.1038/527308a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26581285				2022-12-28	WOS:000365356800037
J	Tauxe, W				Tauxe, Will			A tumour through time	NATURE			English	Editorial Material																			0	8	8	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					S102	S103		10.1038/527S102a	http://dx.doi.org/10.1038/527S102a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VB7HZ	26580155	Bronze			2022-12-28	WOS:000416842500001
J	Vieira, NM; Elvers, I; Alexander, MS; Moreira, YB; Eran, A; Gomes, JP; Marshall, JL; Karlsson, EK; Verjovski-Almeida, S; Lindblad-Toh, K; Kunkel, LM; Zatz, M				Vieira, Natassia M.; Elvers, Ingegerd; Alexander, Matthew S.; Moreira, Yuri B.; Eran, Alal; Gomes, Juliana P.; Marshall, Jamie L.; Karlsson, Elinor K.; Verjovski-Almeida, Sergio; Lindblad-Toh, Kerstin; Kunkel, Louis M.; Zatz, Mayana			Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype	CELL			English	Article							NONSENSE MUTATIONS; MOLECULAR-BASIS; MILDER COURSE; MDX MOUSE; MUSCLES; MODEL; GENE; RESTORATION; EXPRESSION; DEPLETION	Duchenne muscular dystrophy (DMD), caused by mutations at the dystrophin gene, is the most common form of muscular dystrophy. There is no cure for DMD and current therapeutic approaches to restore dystrophin expression are only partially effective. The absence of dystrophin in muscle results in dysregulation of signaling pathways, which could be targets for disease therapy and drug discovery. Previously, we identified two exceptional Golden Retriever muscular dystrophy (GRMD) dogs that are mildly affected, have functional muscle, and normal lifespan despite the complete absence of dystrophin. Now, our data on linkage, whole-genome sequencing, and transcriptome analyses of these dogs compared to severely affected GRMD and control animals reveals that increased expression of Jagged1 gene, a known regulator of the Notch signaling pathway, is a hallmark of the mild phenotype. Functional analyses demonstrate that Jagged1 overexpression ameliorates the dystrophic phenotype, suggesting that Jagged1 may represent a target for DMD therapy in a dystrophin-independent manner.	[Vieira, Natassia M.; Alexander, Matthew S.; Marshall, Jamie L.; Kunkel, Louis M.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA; [Vieira, Natassia M.; Alexander, Matthew S.; Eran, Alal; Marshall, Jamie L.; Kunkel, Louis M.] Harvard Univ, Sch Med, Dept Pediat & Genet, Boston, MA 02115 USA; [Vieira, Natassia M.; Gomes, Juliana P.; Zatz, Mayana] Univ Sao Paulo, Biosci Inst, Human Genome & Stem Cell Ctr, BR-05508090 Sao Paulo, Brazil; [Elvers, Ingegerd; Karlsson, Elinor K.; Lindblad-Toh, Kerstin] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Elvers, Ingegerd; Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, S-75124 Uppsala, Sweden; [Alexander, Matthew S.] Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Moreira, Yuri B.; Verjovski-Almeida, Sergio] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508000 Sao Paulo, Brazil; [Verjovski-Almeida, Sergio] Inst Butantan, BR-05508050 Sao Paulo, Brazil; [Kunkel, Louis M.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Karlsson, Elinor K.] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Universidade de Sao Paulo; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Uppsala University; Harvard University; Boston Children's Hospital; Universidade de Sao Paulo; Instituto Butantan; Harvard University; Boston Children's Hospital; University of Massachusetts System; University of Massachusetts Worcester	Kunkel, LM (corresponding author), Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA.	kunkel@enders.tch.harvard.edu; mayazatz@usp.br	Verjovski-Almeida, Sergio/E-4082-2012; Eran, Alal/AAA-8776-2021; Gomes, Juliana/K-6153-2016; Zatz, Mayana/M-5338-2015	Verjovski-Almeida, Sergio/0000-0002-6356-2401; Gomes, Juliana/0000-0002-2000-4848; Zatz, Mayana/0000-0003-3970-8025; Karlsson, Elinor/0000-0002-4343-3776; Eran, Alal/0000-0001-6784-7597	Duchenne Foundation; FAPESP-CEPID [2013/08028-1]; CNPq [705019/2009]; INCT [2008/578997]; FID [000663/2014]; Bernard F. and Alva B. Gimbel Foundation; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the NIH [R01AR064300]; Swedish Research Council; ERC; Muscular Dystrophy Association (MDA) Development Grant [MDA352465, MDA255059]; NIH [5P30 -HD18655-34]; Pfizer; AACD; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064300] Funding Source: NIH RePORTER	Duchenne Foundation; FAPESP-CEPID(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT; FID; Bernard F. and Alva B. Gimbel Foundation; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Swedish Research Council(Swedish Research CouncilEuropean Commission); ERC(European Research Council (ERC)European Commission); Muscular Dystrophy Association (MDA) Development Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); AACD; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding for this work was generously provided by the Duchenne Foundation (M.Z.), FAPESP-CEPID under award number 2013/08028-1 (M.Z., N.M.V.), CNPq under award number 705019/2009 (M.Z.), INCT under award number 2008/578997 (M.Z.), AACD (M.Z.), FID under award number 000663/2014 (M.Z.) the Bernard F. and Alva B. Gimbel Foundation (L.M.K.). Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the NIH under award number R01AR064300 (to L.M.K.). Additional funding for this project came from the, Swedish Research Council (I.E.) and ERC (K.L.-T.). N.M.V. is supported by a Muscular Dystrophy Association (MDA) Development Grant MDA352465. M.S.A. is supported by a Muscular Dystrophy Association (MDA) Development Grant MDA255059. Some of the sequencing was performed in the Molecular Genetics Core laboratory of the Boston Children's Hospital Intellectual and Developmental Disabilities Research Center (IDDRC) supported by NIH grant (5P30 -HD18655-34). We would like to thank Munira Guilhon, Jessica Alfoldi, Peter Serafini, Marcos Valadares, Eder Zucconi, Mariane Secco, Emanuela Gussoni, Fedik Rahimov, Jose Visintin, and Jeremy Johnson for support and helpful suggestions, and Leslie Gaffney for help with figures. We thank the Broad Institute Genomics Platform for sequencing, and Chris Lawrence and Jason Best, who managed the fish facility at Boston Children's Hospital. We are extremely grateful for the extraordinary care and dedication of the veterinarians Vivian Landini, Thais Andrade, and Erica Cangussu from the Institute of Biosciences GRMD dogs kennel at the University of Sao Paulo. L.M.K. has research funding from Pfizer to develop small molecules which would increase Jagged1 expression in mice.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Bassett D, 2004, CLIN EXP PHARMACOL P, V31, P537, DOI 10.1111/j.1440-1681.2004.04030.x; Bassett DI, 2003, DEVELOPMENT, V130, P5851, DOI 10.1242/dev.00799; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Castro-Gago M, 2015, NEUROMUSCULAR DISORD, V25, P443, DOI 10.1016/j.nmd.2015.02.009; CHAPMAN VM, 1989, P NATL ACAD SCI USA, V86, P1292, DOI 10.1073/pnas.86.4.1292; Church JE, 2014, EXP PHYSIOL, V99, P675, DOI 10.1113/expphysiol.2013.077255; Collesi C, 2008, J CELL BIOL, V183, P117, DOI 10.1083/jcb.200806091; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; COOPER BJ, 1988, NATURE, V334, P154, DOI 10.1038/334154a0; COUTEAUX R, 1988, BIOL CELL, V62, P171, DOI 10.1016/0248-4900(88)90034-2; Dong YF, 2014, STEM CELL TRANSL MED, V3, P1456, DOI 10.5966/sctm.2014-0034; Fairclough RJ, 2013, NAT REV GENET, V14, P373, DOI 10.1038/nrg3460; Flanigan KM, 2013, ANN NEUROL, V73, P481, DOI 10.1002/ana.23819; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Guiraud S, 2015, ANNU REV GENOM HUM G, V16, P281, DOI 10.1146/annurev-genom-090314-025003; Heydemann A, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-26; Hoeppner MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091172; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Im WB, 1996, HUM MOL GENET, V5, P1149, DOI 10.1093/hmg/5.8.1149; Jiang CH, 2014, DIS MODEL MECH, V7, P997, DOI 10.1242/dmm.015917; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kayali R, 2012, HUM MOL GENET, V21, P4007, DOI 10.1093/hmg/dds223; KOENIG M, 1989, AM J HUM GENET, V45, P498; KORNEGAY JN, 1988, MUSCLE NERVE, V11, P1056, DOI 10.1002/mus.880111008; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Manke T, 2010, HUM MUTAT, V31, P477, DOI 10.1002/humu.21209; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; Mendell JR, 2010, NEW ENGL J MED, V363, P1429, DOI 10.1056/NEJMoa1000228; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Mu XD, 2015, HUM MOL GENET, V24, P2923, DOI 10.1093/hmg/ddv055; Ottone C, 2014, NAT CELL BIOL, V16, P1045, DOI 10.1038/ncb3045; PASSOSBUENO MR, 1994, HUM MOL GENET, V3, P919, DOI 10.1093/hmg/3.6.919; Pedrosa AR, 2015, ARTERIOSCL THROM VAS, V35, P1134, DOI 10.1161/ATVBAHA.114.304741; Pegoraro E, 2011, NEUROLOGY, V76, P219, DOI 10.1212/WNL.0b013e318207afeb; SHARP NJH, 1992, GENOMICS, V13, P115, DOI 10.1016/0888-7543(92)90210-J; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; VAINZOF M, 1990, J NEUROL SCI, V98, P221, DOI 10.1016/0022-510X(90)90263-M; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Wen YF, 2012, MOL CELL BIOL, V32, P2300, DOI 10.1128/MCB.06753-11; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Xiao YG, 2013, ARTERIOSCL THROM VAS, V33, P2733, DOI 10.1161/ATVBAHA.113.302062; Zatz M, 2015, NEUROMUSCULAR DISORD, V25, P371, DOI 10.1016/j.nmd.2015.02.007; Zatz M, 2014, NEUROMUSCULAR DISORD, V24, P986, DOI 10.1016/j.nmd.2014.06.003; Zucconi E, 2010, NEUROMUSCULAR DISORD, V20, P64, DOI 10.1016/j.nmd.2009.10.011	51	93	100	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1204	1213		10.1016/j.cell.2015.10.049	http://dx.doi.org/10.1016/j.cell.2015.10.049			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26582133	Green Accepted, Bronze			2022-12-28	WOS:000366044700018
J	Zhu, ZH				Zhu, Zhaohuan			Growing planet brought to light	NATURE			English	Editorial Material							T-TAURI STARS; MAGNETOSPHERIC ACCRETION; CANDIDATE; DISK		[Zhu, Zhaohuan] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA	Princeton University	Zhu, ZH (corresponding author), Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA.	zhzhu@astro.princeton.edu						Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Calvet N, 1998, ASTROPHYS J, V509, P802, DOI 10.1086/306527; Close LM, 2014, PROC SPIE, V9148, DOI 10.1117/12.2057297; Espaillat C., 2014, PROTOSTARS PLANETS, P497, DOI [10.2458/azuuapress9780816531240-ch022, DOI 10.2458/AZUUAPRESS9780816531240-CH022, DOI 10.2458/AZU_UAPRESS_9780816531240-CH022]; HARTMANN L, 1994, ASTROPHYS J, V426, P669, DOI 10.1086/174104; Kraus AL, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/5; Lovelace RVE, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/2/51; Quanz SP, 2013, ASTROPHYS J LETT, V766, DOI 10.1088/2041-8205/766/1/L1; Reggiani M, 2014, ASTROPHYS J LETT, V792, DOI 10.1088/2041-8205/792/1/L23; Sallum S, 2015, NATURE, V527, P342, DOI 10.1038/nature15761; Zhu Z., 2015, Z ASTROPHYS, V799, P16	11	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					310	311		10.1038/527310a	http://dx.doi.org/10.1038/527310a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26581286				2022-12-28	WOS:000365356800039
J	Wong, VWS; Wong, GLH				Wong, Vincent Wai-Sun; Wong, Grace Lai-Hung			A LEAN treatment for non-alcoholic steatohepatitis	LANCET			English	Editorial Material							FATTY LIVER-DISEASE; FIBROSIS; TRIAL; FEATURES; PLACEBO		[Wong, Vincent Wai-Sun] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Wong, VWS (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	wongv@cuhk.edu.hk	Wong, Grace LH/L-8586-2014; Wong, Vincent WS/K-3864-2014	Wong, Grace LH/0000-0002-2863-9389; Wong, Vincent WS/0000-0003-2215-9410				Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Armstrong MJ, 2015, LANCET; Bhala N, 2011, HEPATOLOGY, V54, P1208, DOI 10.1002/hep.24491; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Harrison SA, 2009, HEPATOLOGY, V49, P80, DOI 10.1002/hep.22575; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014; Vilar-Gomez E, 2015, GASTROENTEROLOGY, V149, P367, DOI 10.1053/j.gastro.2015.04.005; Wong VWS, 2015, J HEPATOL, V62, P182, DOI 10.1016/j.jhep.2014.08.041; Wong VWS, 2010, GUT, V59, P969, DOI 10.1136/gut.2009.205088; Wong VWS, 2009, CLIN GASTROENTEROL H, V7, P1113, DOI 10.1016/j.cgh.2009.05.025	15	4	5	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2016	387	10019					628	630		10.1016/S0140-6736(15)00982-4	http://dx.doi.org/10.1016/S0140-6736(15)00982-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3QH	26608257				2022-12-28	WOS:000369837100008
J	Bapat, SP; Suh, JM; Fang, S; Liu, SH; Zhang, Y; Cheng, A; Zhou, C; Liang, YQ; LeBlanc, M; Liddle, C; Atkins, AR; Yu, RT; Downes, M; Evans, RM; Zheng, Y				Bapat, Sagar P.; Suh, Jae Myoung; Fang, Sungsoon; Liu, Sihao; Zhang, Yang; Cheng, Albert; Zhou, Carmen; Liang, Yuqiong; LeBlanc, Mathias; Liddle, Christopher; Atkins, Annette R.; Yu, Ruth T.; Downes, Michael; Evans, Ronald M.; Zheng, Ye			Depletion of fat-resident T-reg cells prevents age-associated insulin resistance	NATURE			English	Article							VISCERAL ADIPOSE-TISSUE; RNA-SEQ; ORCHESTRATE DEVELOPMENT; PPAR-GAMMA; BEIGE FAT; MACROPHAGES; OBESITY; INFLAMMATION; DIFFERENTIATION; ACCUMULATION	Age-associated insulin resistance (IR) and obesity-associated IR are two physiologically distinct forms of adult-onset diabetes. While macrophage-driven inflammation is a core driver of obesity-associated IR1-6, the underlying mechanisms of the obesity-independent yet highly prevalent age-associated IR7 are largely unexplored. Here we show, using comparative adipo-immune profiling in mice, that fat-resident regulatory T cells, termed fT(reg) cells, accumulate in adipose tissue as a function of age, but not obesity. Supporting the existence of two distinct mechanisms underlying IR, mice deficient in fT(reg) cells are protected against age-associated IR, yet remain susceptible to obesity-associated IR and metabolic disease. By contrast, selective depletion of fT(reg) cells via anti-ST2 antibody treatment increases adipose tissue insulin sensitivity. These findings establish that distinct immune cell populations within adipose tissue underlie ageing- and obesity-associated IR, and implicate fT(reg) cells as adipo-immune drivers and potential therapeutic targets in the treatment of age-associated IR.	[Bapat, Sagar P.; Zhang, Yang; Cheng, Albert; Zhou, Carmen; Liang, Yuqiong; Zheng, Ye] Salk Inst Biol Studies, Immunobiol & Microbial Pathogenesis Lab, La Jolla, CA 92037 USA; [Bapat, Sagar P.; Suh, Jae Myoung; Fang, Sungsoon; Liu, Sihao; LeBlanc, Mathias; Atkins, Annette R.; Yu, Ruth T.; Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Suh, Jae Myoung] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon 34141, South Korea; [Fang, Sungsoon] Sejong Univ, Dept Biotechnol, Coll Life Sci, Seoul 143747, South Korea; [Liddle, Christopher] Univ Sydney, Sydney Med Sch, Westmead Millennium Inst, Storr Liver Ctr, Sydney, NSW 2145, Australia; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Salk Institute; Korea Advanced Institute of Science & Technology (KAIST); Sejong University; University of Sydney; Westmead Institute for Medical Research; Howard Hughes Medical Institute; Salk Institute	Evans, RM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	evans@salk.edu; yzheng@salk.edu	Evans, Ronald/AAF-4001-2019; Suh, Jae Myoung/B-3268-2015	Evans, Ronald/0000-0002-9986-5965; Suh, Jae Myoung/0000-0001-8097-4662; Atkins, Annette/0000-0003-2558-7058; Yu, Ruth/0000-0002-9527-9627; Zhang, Kevin/0000-0002-2074-6876	National Institutes of Health (NIH) [F30 DK096828, T32 GM007198]; National Health and Medical Research Council of Australia [512354, 632886, 1043199]; NIH [DK057978, DK090962, HL088093, HL105278, ES010337]; Glenn Foundation for Medical Research; Leona M. and Harry B. Helmsley Charitable Trust; Ipsen/Biomeasure; California Institute for Regenerative Medicine; Ellison Medical Foundation; Nomis Foundation; Rita Allen Foundation; Emerald Foundation; Hearst Foundation; National Multiple Sclerosis Society; National Institutes of Health [AI099295, AI107027]; National Cancer Institute [CA014195]; James B. Pendleton Charitable Trust; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105278, P01HL088093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107027, R56AI099295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057978, F30DK096828, R24DK090962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; Leona M. and Harry B. Helmsley Charitable Trust; Ipsen/Biomeasure(Ipsen); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Ellison Medical Foundation(Lawrence Ellison Foundation); Nomis Foundation; Rita Allen Foundation; Emerald Foundation; Hearst Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); James B. Pendleton Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank L. Chong, J. Alvarez, Y. Dai, S. Kaufman and B. Collins for technical assistance, L. Ong and C. Brondos for administrative assistance, and J. Simon for assistance with graphics. S.P.B. is supported by National Institutes of Health (NIH) grants F30 DK096828 and T32 GM007198. C. L. and M.D. are funded by grants from the National Health and Medical Research Council of Australia Project grants 512354, 632886 and 1043199. R.M.E. is an Investigator of the Howard Hughes Medical Institute (HHMI) at the Salk Institute and March of Dimes Chair in Molecular and Developmental Biology, and is supported by NIH grants DK057978, DK090962, HL088093, HL105278 and ES010337, the Glenn Foundation for Medical Research, the Leona M. and Harry B. Helmsley Charitable Trust, Ipsen/Biomeasure, California Institute for Regenerative Medicine and The Ellison Medical Foundation. Y. Zheng is supported by the Nomis Foundation, the Rita Allen Foundation, the Emerald Foundation, the Hearst Foundation, the National Multiple Sclerosis Society, and National Institutes of Health (AI099295 and AI107027). This work was also supported by National Cancer Institute funded Salk Institute Cancer Center core facilities (CA014195) and the James B. Pendleton Charitable Trust.	Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; CDC, 2014, NAT DIAB STAT REP; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ferrante AW, 2013, J CLIN INVEST, V123, P4992, DOI 10.1172/JCI73658; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Lumeng CN, 2011, J IMMUNOL, V187, P6208, DOI 10.4049/jimmunol.1102188; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schwartz DR, 2011, TRENDS ENDOCRIN MET, V22, P259, DOI 10.1016/j.tem.2011.03.005; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Sun K, 2012, P NATL ACAD SCI USA, V109, P5874, DOI 10.1073/pnas.1200447109; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	36	202	210	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					137	+		10.1038/nature16151	http://dx.doi.org/10.1038/nature16151			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26580014	Green Accepted			2022-12-28	WOS:000365606000064
J	Ritz, C; Edwards, TL; Durand, G; Payne, AJ; Peyaud, V; Hindmarsh, RCA				Ritz, Catherine; Edwards, Tamsin L.; Durand, Gael; Payne, Antony J.; Peyaud, Vincent; Hindmarsh, Richard C. A.			Potential sea-level rise from Antarctic ice-sheet instability constrained by observations	NATURE			English	Article							PINE ISLAND; WEST ANTARCTICA; GROUNDING LINE; THWAITES; RETREAT; DISCHARGE; GLACIERS	Large parts of the Antarctic ice sheet lying on bedrock below sea level may be vulnerable to marine-ice-sheet instability (MISI)(1), a self-sustaining retreat of the grounding line triggered by oceanic or atmospheric changes. There is growing evidence(2-4) that MISI may be underway throughout the Amundsen Sea embayment (ASE), which contains ice equivalent to more than a metre of global sea-level rise. If triggered in other regions(5-8), the centennial to millennial contribution could be several metres. Physically plausible projections are challenging(9): numerical models with sufficient spatial resolution to simulate grounding-line processes have been too computationally expensive(2,3,10) to generate large ensembles for uncertainty assessment, and lower-resolution model projections(11) rely on parameterizations that are only loosely constrained by present day changes. Here we project that the Antarctic ice sheet will contribute up to 30 cm sea-level equivalent by 2100 and 72 cm by 2200 (95% quantiles) where the ASE dominates. Our process-based, statistical approach gives skewed and complex probability distributions (single mode, 10 cm, at 2100; two modes, 49 cm and 6 cm, at 2200). The dependence of sliding on basal friction is a key unknown: nonlinear relationships favour higher contributions. Results are conditional on assessments of MISI risk on the basis of projected triggers under the climate scenario A1B (ref. 9), although sensitivity to these is limited by theoretical and topographical constraints on the rate and extent of ice loss. We find that contributions are restricted by a combination of these constraints, calibration with success in simulating observed ASE losses, and low assessed risk in some basins. Our assessment suggests that upper-bound estimates from low-resolution models and physical arguments9 (up to a metre by 2100 and around one and a half by 2200) are implausible under current understanding of physical mechanisms and potential triggers.	[Ritz, Catherine; Durand, Gael; Peyaud, Vincent] CNRS, LGGE, F-38041 Grenoble, France; [Ritz, Catherine; Durand, Gael; Peyaud, Vincent] Univ Grenoble Alpes, LGGE, F-38041 Grenoble, France; [Edwards, Tamsin L.] Open Univ, Fac Sci, Dept Environm Earth & Ecosyst, Milton Keynes MK7 6AA, Bucks, England; [Edwards, Tamsin L.; Payne, Antony J.] Univ Bristol, Dept Geog Sci, Bristol BS8 1SS, Avon, England; [Hindmarsh, Richard C. A.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England	Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Open University - UK; University of Bristol; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Edwards, TL (corresponding author), Open Univ, Fac Sci, Dept Environm Earth & Ecosyst, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.	tamsin.edwards@open.ac.uk	Hindmarsh, Richard C A/C-1405-2012; Hindmarsh, Richard/N-1195-2019; payne, antony/A-8916-2008; Edwards, Tamsin/H-6462-2019	Hindmarsh, Richard C A/0000-0003-1633-2416; Hindmarsh, Richard/0000-0003-1633-2416; payne, antony/0000-0001-8825-8425; Edwards, Tamsin/0000-0002-4760-4704; Durand, Gael/0000-0001-8979-2355; Peyaud, Vincent/0000-0001-5583-4086; Ritz, Catherine/0000-0003-0785-8571	ice2sea project - European Commission's 7th Framework Programme [226375, ice2sea119]; UK National Centre for Earth Observation; NERC iGlass project; NERC; UK Met Office Joint Weather and Climate Research Programme; French National Research Agency (ANR) under the SUMER [Blanc SIMI 6, ANR-12-BS06-0018]; Rhone-Alpes region [CPER07 13 CIRA]; NERC [bas0100034, NE/F01550X/1, NE/J008087/1, NE/F015526/1, NE/I010874/1] Funding Source: UKRI; Natural Environment Research Council [NE/F015526/1, bas0100034, NE/J008087/1, NE/F01550X/1, NE/I010874/1] Funding Source: researchfish	ice2sea project - European Commission's 7th Framework Programme; UK National Centre for Earth Observation; NERC iGlass project; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK Met Office Joint Weather and Climate Research Programme; French National Research Agency (ANR) under the SUMER(French National Research Agency (ANR)); Rhone-Alpes region(Region Auvergne-Rhone-Alpes); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the ice2sea project funded by the European Commission's 7th Framework Programme through grant number 226375 (ice2sea contribution number ice2sea119), the UK National Centre for Earth Observation, NERC iGlass project, NERC and UK Met Office Joint Weather and Climate Research Programme, and the French National Research Agency (ANR) under the SUMER (Blanc SIMI 6) 2012 project ANR-12-BS06-0018. Most of the computations were performed using the CIMENT infrastructure (https://ciment.ujf-grenoble.fr), which is supported by the Rhone-Alpes region (grant CPER07 13 CIRA; http://www.ci-ra.org). We thank A. Shepherd and M. McMillan for observational data, H. Hellmer and R. Timmerman for model projection data, D. Vaughan and H. Hellmer for discussions about retreat onset, and J. C. Rougier for discussions about experimental design and calibration.	Bamber JL, 2013, NAT CLIM CHANGE, V3, P424, DOI [10.1038/nclimate1778, 10.1038/NCLIMATE1778]; Cornford SL, 2015, CRYOSPHERE, V9, P1579, DOI 10.5194/tc-9-1579-2015; Favier L, 2014, NAT CLIM CHANGE, V4, P117, DOI [10.1038/nclimate2094, 10.1038/NCLIMATE2094]; Gudmundsson GH, 2012, CRYOSPHERE, V6, P1497, DOI 10.5194/tc-6-1497-2012; Hellmer HH, 2012, NATURE, V485, P225, DOI 10.1038/nature11064; Intergovernmental Panel on Climate Change, 2013, WORK GROUP 1 CONTR I; Joughin I, 2014, SCIENCE, V344, P735, DOI 10.1126/science.1249055; Joughin I, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044819; Joughin I, 2009, J GLACIOL, V55, P245, DOI 10.3189/002214309788608705; Katsman CA, 2011, CLIMATIC CHANGE, V109, P617, DOI 10.1007/s10584-011-0037-5; Khazendar A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3857; Munneke PK, 2014, J GLACIOL, V60, P205, DOI 10.3189/2014JoG13J183; Le Brocq A. M., 2010, EARTH SYST SCI DATA, V2, P247, DOI [10.5194/essd-2-247-2010, DOI 10.5194/essd-2-247-2010, DOI 10.5194/ESSD-2-247-2010]; Levermann A, 2014, EARTH SYST DYNAM, V5, P271, DOI 10.5194/esd-5-271-2014; Little CM, 2013, NAT CLIM CHANGE, V3, P654, DOI [10.1038/NCLIMATE1845, 10.1038/nclimate1845]; Mengel M, 2014, NAT CLIM CHANGE, V4, P451, DOI [10.1038/NCLIMATE2226, 10.1038/nclimate2226]; Park JW, 2013, GEOPHYS RES LETT, V40, P2137, DOI 10.1002/grl.50379; Pollard D, 2015, EARTH PLANET SC LETT, V412, P112, DOI 10.1016/j.epsl.2014.12.035; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Rignot E, 2014, GEOPHYS RES LETT, V41, P3502, DOI 10.1002/2014GL060140; Ritz C, 2001, J GEOPHYS RES-ATMOS, V106, P31943, DOI 10.1029/2001JD900232; Ross N, 2012, NAT GEOSCI, V5, P393, DOI [10.1038/NGEO1468, 10.1038/ngeo1468]; Schoof C, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000664; Timmermann R, 2013, OCEAN DYNAM, V63, P1011, DOI 10.1007/s10236-013-0642-0	24	233	234	2	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					115	+		10.1038/nature16147	http://dx.doi.org/10.1038/nature16147			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26580020	Green Submitted, Green Accepted			2022-12-28	WOS:000365606000059
J	Peterson, MD; Ryan, JM; Hurvitz, EA; Mahmoudi, E				Peterson, Mark D.; Ryan, Jennifer M.; Hurvitz, Edward A.; Mahmoudi, Elham			Chronic Conditions in Adults With Cerebral Palsy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Peterson, Mark D.; Hurvitz, Edward A.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Ryan, Jennifer M.] Brunel Univ, Inst Environm Hlth & Soc, London, England; [Mahmoudi, Elham] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Brunel University; University of Michigan System; University of Michigan	Peterson, MD (corresponding author), Univ Michigan Hosp & Hlth Syst, 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 USA.	mdpeterz@med.umich.edu	Peterson, Mark/ABD-3853-2020	Peterson, Mark/0000-0002-9861-4275; Mahmoudi, Elham/0000-0002-9746-8165; Ryan, Jennifer/0000-0003-3768-2132; Meade, Michelle/0000-0002-7840-6364	NICHD NIH HHS [K01 HD074706, 1KO1 HD074706] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K01HD074706] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Cohen JW, 1996, INQUIRY-J HEALTH CAR, V33, P373; Murphy KP, 2000, ARCH PHYS MED REHAB, V81, P807, DOI 10.1016/S0003-9993(00)90115-1; Peterson MD, 2013, OBES REV, V14, P171, DOI 10.1111/j.1467-789X.2012.01052.x; Strauss D, 1999, DEV MED CHILD NEUROL, V41, P580, DOI 10.1017/S001216229900122X	4	103	103	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 1	2015	314	21					2303	2305		10.1001/jama.2015.11025	http://dx.doi.org/10.1001/jama.2015.11025			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX2GT	26624831	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000365515700024
J	Litchinitser, NM; Sun, JB				Litchinitser, Natalia M.; Sun, Jingbo			Optical meta-atoms: Going nonlinear	SCIENCE			English	Editorial Material							METAMATERIALS		[Litchinitser, Natalia M.; Sun, Jingbo] SUNY Buffalo, Dept Elect Engn, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Litchinitser, NM (corresponding author), SUNY Buffalo, Dept Elect Engn, Buffalo, NY 14260 USA.	natashal@buffalo.edu						Alloatti L, 2015, APPL PHYS LETT, V107, DOI 10.1063/1.4931492; Cai W, 2010, OPTICAL METAMATERIALS: FUNDAMENTALS AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-1151-3; Kauranen M, 2012, NAT PHOTONICS, V6, P737, DOI [10.1038/NPHOTON.2012.244, 10.1038/nphoton.2012.244]; Khurgin JB, 2013, OPT EXPRESS, V21, P27460, DOI 10.1364/OE.21.027460; Kuzyk MG, 2000, PHYS REV LETT, V85, P1218, DOI 10.1103/PhysRevLett.85.1218; Lapine M, 2014, REV MOD PHYS, V86, P1093, DOI 10.1103/RevModPhys.86.1093; Lee J, 2014, NATURE, V511, P65, DOI 10.1038/nature13455; Lytel R, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.043824; MILLER RC, 1964, APPL PHYS LETT, V5, P17, DOI 10.1063/1.1754022; O'Brien K, 2015, NAT MATER, V14, P379, DOI [10.1038/NMAT4214, 10.1038/nmat4214]; Shadrivov IV, 2015, SPRINGER SER MATER S, V200, pVII	11	22	22	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1033	1034		10.1126/science.aad7212	http://dx.doi.org/10.1126/science.aad7212			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY5BJ	26612937				2022-12-28	WOS:000366422600023
J	Georgalas, I; Koutsandrea, C				Georgalas, Ilias; Koutsandrea, Chryssanthi			Amaurosis Fugax Caused by a Branch Retinal Artery Embolus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Georgalas, Ilias; Koutsandrea, Chryssanthi] Univ Athens, Athens 11528, Greece	National & Kapodistrian University of Athens	Georgalas, I (corresponding author), Univ Athens, Athens 11528, Greece.	igeorgalas@yahoo.com	Georgalas, Ilias/AAD-5946-2019	Georgalas, Ilias/0000-0002-6171-5865					0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2015	373	22					E26	E26		10.1056/NEJMicm1500779	http://dx.doi.org/10.1056/NEJMicm1500779			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9YT	26605943				2022-12-28	WOS:000365354800012
J	Reading-Ikkanda, L				Reading-Ikkanda, Lucy			THE PROBLEM WITH PLATINUM	NATURE			English	Editorial Material																			0	99	102	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					S218	S219						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VB6BH	26605761	Bronze			2022-12-28	WOS:000416338700001
J	Jaworski, A; Tom, I; Tong, RK; Gildea, HK; Koch, AW; Gonzalez, LC; Tessier-Lavigne, M				Jaworski, Alexander; Tom, Irene; Tong, Raymond K.; Gildea, Holly K.; Koch, Alexander W.; Gonzalez, Lino C.; Tessier-Lavigne, Marc			Operational redundancy in axon guidance through the multifunctional receptor Robo3 and its ligand NELL2	SCIENCE			English	Article							EGF-LIKE REPEATS; COMMISSURAL AXONS; SPINAL-CORD; PROTEINS; SLIT; FAMILY; RESPONSIVENESS; NETRINS; SWITCH	Axon pathfinding is orchestrated by numerous guidance cues, including Slits and their Robo receptors, but it remains unclear how information from multiple cues is integrated or filtered. Robo3, a Robo family member, allows commissural axons to reach and cross the spinal cord midline by antagonizing Robo1/2-mediated repulsion from midline-expressed Slits and potentiating deleted in colorectal cancer (DCC)-mediated midline attraction to Netrin-1, but without binding either Slits or Netrins. We identified a secreted Robo3 ligand, neural epidermal growth factor-like-like 2 (NELL2), which repels mouse commissural axons through Robo3 and helps steer them to the midline. These findings identify NELL2 as an axon guidance cue and establish Robo3 as a multifunctional regulator of pathfinding that simultaneously mediates NELL2 repulsion, inhibits Slit repulsion, and facilitates Netrin attraction to achieve a common guidance purpose.	[Jaworski, Alexander; Tessier-Lavigne, Marc] Genentech Inc, Div Res, San Francisco, CA 94080 USA; [Jaworski, Alexander; Tessier-Lavigne, Marc] Rockefeller Univ, Lab Brain Dev & Repair, New York, NY 10065 USA; [Jaworski, Alexander; Gildea, Holly K.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Tom, Irene; Tong, Raymond K.; Koch, Alexander W.; Gonzalez, Lino C.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Rockefeller University; Brown University; Roche Holding; Genentech	Jaworski, A (corresponding author), Genentech Inc, Div Res, San Francisco, CA 94080 USA.	alexander_jaworski@brown.edu; marctl@rockefeller.edu		Jaworski, Alexander/0000-0002-4596-5450; Gildea, Holly/0000-0002-9549-890X	Genentech; Rockefeller University; Brown University; Roche	Genentech(Roche HoldingGenentech); Rockefeller University; Brown University; Roche(Roche Holding)	We thank the members of the Tessier-Lavigne laboratory for discussion and suggestions. We are grateful to C. Culiat for sharing NELL1 mutant mice, J. Ernst for help with purification of recombinant proteins, S. Warming for advice on the assembly of the NELL2 targeting vector by recombineering, M. Roose-Girma for help with generation of NELL2 mutant mice, and M. Yaylaoglu for providing probe templates for in situ hybridization. The NELL2 conditional and full knockout mice as well as cDNA constructs described here are available from A.J. under a material transfer agreement with Genentech. We also thank N. Velarde, D. Collado, K. Sono, and Y. Zhou for technical assistance. This work was supported by Genentech, The Rockefeller University, and Brown University. The supplementary materials contain additional data. Roche provided part of the support for the study but does not stand to benefit from it because no patents were filed.	Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Camurri L, 2005, MOL CELL NEUROSCI, V30, P485, DOI 10.1016/j.mcn.2005.07.014; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Dickson BJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002055; Haddick PCG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084823; Jaworski A, 2010, J NEUROSCI, V30, P9445, DOI 10.1523/JNEUROSCI.6290-09.2010; Jiang YL, 2009, MOL CELL NEUROSCI, V41, P113, DOI 10.1016/j.mcn.2009.02.006; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kolodkin Alex L, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a001727; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Mambetisaeva ET, 2005, DEV DYNAM, V233, P41, DOI 10.1002/dvdy.20324; MATSUHASHI S, 1995, DEV DYNAM, V203, P212, DOI 10.1002/aja.1002030209; Ramani SR, 2012, ANAL BIOCHEM, V420, P127, DOI 10.1016/j.ab.2011.09.017; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Watanabe TK, 1996, GENOMICS, V38, P273, DOI 10.1006/geno.1996.0628; Zelina P, 2014, NEURON, V84, P1258, DOI 10.1016/j.neuron.2014.11.004; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	20	68	68	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					961	965		10.1126/science.aad2615	http://dx.doi.org/10.1126/science.aad2615			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW4IP	26586761				2022-12-28	WOS:000364955200045
J	Abeles, FF				Abeles, Francine F.			Mathematics: Logic and Lewis Carroll	NATURE			English	Editorial Material									[Abeles, Francine F.] Kean Univ, Math & Comp Sci, Union, NJ USA		Abeles, FF (corresponding author), Kean Univ, Math & Comp Sci, Union, NJ USA.	fabeles@kean.edu							0	2	2	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					302	304		10.1038/527302a	http://dx.doi.org/10.1038/527302a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW9ZN	26581277	Bronze			2022-12-28	WOS:000365356800030
J	Chen, J; Coakley, A; O'Connor, M; Petrov, A; O'Leary, SE; Atkins, JF; Puglisi, JD				Chen, Jin; Coakley, Arthur; O'Connor, Michelle; Petrov, Alexey; O'Leary, Sean E.; Atkins, John F.; Puglisi, Joseph D.			Coupling of mRNA Structure Rearrangement to Ribosome Movement during Bypassing of Non-coding Regions	CELL			English	Article							SINGLE-MOLECULE FLUORESCENCE; OPEN READING FRAMES; EXIT TUNNEL; COMPOSITIONAL DYNAMICS; NASCENT PEPTIDE; CODING GAP; REAL-TIME; TRANSLATION; TRANSLOCATION; MAINTENANCE	Nearly half of the ribosomes translating a particular bacteriophage T4 mRNA bypass a region of 50 nt, resuming translation 30 of this gap. How this large-scale, specific hop occurs and what determines whether a ribosome bypasses remain unclear. We apply single-molecule fluorescence with zeromode waveguides to track individual Escherichia coli ribosomes during translation of T4's gene 60 mRNA. Ribosomes that bypass are characterized by a 10- to 20-fold longer pause in a non-canonical rotated state at the take-off codon. During the pause, mRNA secondary structure rearrangements are coupled to ribosome forward movement, facilitated by nascent peptide interactions that disengage the ribosome anticodon-codon interactions for slippage. Close to the landing site, the ribosome then scans mRNA in search of optimal base-pairing interactions. Our results provide a mechanistic and conformational framework for bypassing, highlighting a non-canonical ribosomal state to allow for mRNA structure refolding to drive large-scale ribosome movements.	[Chen, Jin; Petrov, Alexey; O'Leary, Sean E.; Puglisi, Joseph D.] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA; [Chen, Jin] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Coakley, Arthur; O'Connor, Michelle; Atkins, John F.] Natl Univ Ireland Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland; [Atkins, John F.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA	Stanford University; Stanford University; University College Cork; Utah System of Higher Education; University of Utah	Atkins, JF (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Biochem & Cell Biol, Western Gateway Bldg,Western Rd, Cork, Ireland.	j.atkins@ucc.ie; puglisi@stanford.edu		Atkins, John/0000-0001-7933-0165	U.S. NIH [GM51266, GM099687, GM111858]; Stanford Interdisciplinary Graduate Fellowship; Science Foundation Ireland grants (SFI grant) [12/IP1492, 13/1A/1853]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM111858, R01GM051266, R00GM111858, R01GM099687] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Interdisciplinary Graduate Fellowship; Science Foundation Ireland grants (SFI grant)(Science Foundation Ireland); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Gary Loughran for his support. This work was supported by U.S. NIH grants (GM51266 to J.D.P., GM099687 to J.D.P., and GM111858 to S.E.O'L.), a Stanford Interdisciplinary Graduate Fellowship (to J.C.), and Science Foundation Ireland grants (SFI grant codes 12/IP1492 and 13/1A/1853) (to J.F.A.).	Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Aitken CE, 2010, NAT STRUCT MOL BIOL, V17, P793, DOI 10.1038/nsmb.1828; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Bucklin DJ, 2005, J MOL BIOL, V345, P39, DOI 10.1016/j.jmb.2004.10.037; Caliskan N, 2014, CELL, V157, P1619, DOI 10.1016/j.cell.2014.04.041; Chen J, 2014, NATURE, V512, P328, DOI 10.1038/nature13428; Chen J, 2014, P NATL ACAD SCI USA, V111, P664, DOI 10.1073/pnas.1315735111; Chen J, 2013, NAT STRUCT MOL BIOL, V20, P718, DOI 10.1038/nsmb.2567; Chen J, 2012, CURR OPIN STRUC BIOL, V22, P804, DOI 10.1016/j.sbi.2012.09.004; Chen J, 2012, J AM CHEM SOC, V134, P5734, DOI 10.1021/ja2119964; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Dunkle JA, 2015, BIOCHIMIE, V114, P90, DOI 10.1016/j.biochi.2015.02.007; Ennifar E, 2000, J MOL BIOL, V304, P35, DOI 10.1006/jmbi.2000.4204; Goldman DH, 2015, SCIENCE, V348, P457, DOI 10.1126/science.1261909; Hansen TM, 2003, EMBO REP, V4, P499, DOI 10.1038/sj.embor.embor825; Herr AJ, 2000, ANNU REV BIOCHEM, V69, P343, DOI 10.1146/annurev.biochem.69.1.343; Herr AJ, 1999, EMBO J, V18, P2886, DOI 10.1093/emboj/18.10.2886; Herr AJ, 2000, EMBO J, V19, P2671, DOI 10.1093/emboj/19.11.2671; Herr AJ, 2004, J BIOL CHEM, V279, P11081, DOI 10.1074/jbc.M311491200; Herr AJ, 2001, J MOL BIOL, V311, P445, DOI 10.1006/jmbi.2001.4899; HUANG WM, 1988, SCIENCE, V239, P1005, DOI 10.1126/science.2830666; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Johansson M, 2014, CELL REP, V7, P1534, DOI 10.1016/j.celrep.2014.04.034; Koutmou KS, 2015, ELIFE, V4, DOI 10.7554/eLife.05534; Lang BF, 2014, P NATL ACAD SCI USA, V111, P5926, DOI 10.1073/pnas.1322190111; Lindsley D, 2005, J MOL BIOL, V349, P261, DOI 10.1016/j.jmb.2005.03.031; Lindsley D, 2005, EMBO REP, V6, P147, DOI 10.1038/sj.embor.7400332; Liu CY, 2011, BIOPHYS J, V100, P2201, DOI 10.1016/j.bpj.2011.03.023; Maldonado R, 1998, J BACTERIOL, V180, P1822, DOI 10.1128/JB.180.7.1822-1830.1998; Marquez V, 2004, CELL, V118, P45, DOI 10.1016/j.cell.2004.06.012; Marshall RA, 2008, P NATL ACAD SCI USA, V105, P15364, DOI 10.1073/pnas.0805299105; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nilsson OB, 2015, CELL REP, V12, P1533, DOI 10.1016/j.celrep.2015.07.065; Nosek J, 2015, TRENDS GENET, V31, P187, DOI 10.1016/j.tig.2015.02.010; Qin PW, 2014, EMBO REP, V15, P185, DOI 10.1002/embr.201337762; Qu XH, 2011, NATURE, V475, P118, DOI 10.1038/nature10126; Samatova E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5459; Tinoco I, 2013, BIOPOLYMERS, V99, P1147, DOI 10.1002/bip.22293; Todd GC, 2013, RNA, V19, P685, DOI 10.1261/rna.037291.112; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Tsai A, 2014, CELL REP, V7, P1521, DOI 10.1016/j.celrep.2014.04.033; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; WEISS RB, 1990, CELL, V62, P117, DOI 10.1016/0092-8674(90)90245-A; Wills NM, 2008, EMBO J, V27, P2533, DOI 10.1038/emboj.2008.170; Wills NM, 2010, NUCLEIC ACIDS MOL BI, V24, P365, DOI 10.1007/978-0-387-89382-2_17; Yan SN, 2015, CELL, V160, P870, DOI 10.1016/j.cell.2015.02.003; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	49	28	28	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1267	1280		10.1016/j.cell.2015.10.064	http://dx.doi.org/10.1016/j.cell.2015.10.064			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26590426	Green Accepted, Bronze			2022-12-28	WOS:000366044700023
J	Silberberg, D; Anand, NP; Michels, K; Kalaria, RN				Silberberg, Donald; Anand, Nalini P.; Michels, Kathleen; Kalaria, Raj N.			Brain and other nervous system disorders across the lifespan - global challenges and opportunitiesINTRODUCTION	NATURE			English	Editorial Material							BURDEN; DISEASE; DISABILITY; COUNTRIES; INJURIES	This is an exciting time for scientific discovery that aims to reduce the frequency and impact of neurological, mental health and substance-use disorders. As it became increasingly clear that low-and middle-income countries have a disproportionate share of these disorders, and that many of the problems are best addressed by indigenous researchers who can seek context-sensitive solutions, the US National Institutes of Health and other research funders began to invest more in low-and middle-income country-focused research and research capacity-building to confront this significant public health challenge. In an effort to identify existing information, knowledge gaps, and emerging research and research capacity-building opportunities that are particularly relevant to low-and middle-income countries, in February 2014 the Center for Global Health Studies at the National Institutes of Health Fogarty International Center held a workshop to explore these issues with scientific experts from low-and middle-income countries and the United States. This evolved into the preparation of the Reviews in this supplement, which is designed to highlight opportunities and challenges associated with topical areas in brain-disorders research over the coming decade. This Introduction highlights some of the over-arching and intersecting priorities for addressing causes, prevention, treatment and rehabilitation as well as best practices to promote overall nervous system health. We review some brain disorders in low-and middle-income countries, while the Reviews describe relevant issues and the epidemiology of particular conditions in greater depth.	[Silberberg, Donald] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Anand, Nalini P.] NIH, Div Int Sci Policy Planning & Evaluat, Bethesda, MD 20892 USA; [Anand, Nalini P.] NIH, Ctr Global Hlth Studies, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Michels, Kathleen] NIH, Div Int Res & Training, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Kalaria, Raj N.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England	University of Pennsylvania; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Newcastle University - UK	Silberberg, D (corresponding author), Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA.	silberbe@mail.med.upenn.edu; r.n.kalaria@ncl.ac.uk	Kalaria, Raj/AAX-2630-2020		Medical Research Council [G0502157, G0400074, G0900652, G1100540, MR/L016451/1] Funding Source: Medline; MRC [G0502157, G0900652, MR/L016451/1, G0400074, G1100540] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Chin JH, 2014, NEUROLOGY, V83, P349, DOI 10.1212/WNL.0000000000000610; Fogarty International Center, 2015, GLOB BRAIN PROGR; Grand Challenges Canada, 2015, GRAND CHALL CAN SAV; Institute of Medicine, 2001, NEUR PSYCH DEV DIS D; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P495; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Spencer Stuart, 2013, Glob Cardiol Sci Pract, V2013, P115, DOI 10.5339/gcsp.2013.15; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; World Health Organization (WHO), 17 NEGL TROP DIS; World Health Organization World Economic Forum, 2011, BURD BEST BUYS RED E	13	50	52	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					S151	S154		10.1038/nature16028	http://dx.doi.org/10.1038/nature16028			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW9ZN	26580320	hybrid			2022-12-28	WOS:000365356800009
J	von Schwartzenberg, RJ; Turnbaugh, PJ				von Schwartzenberg, Reiner Jumpertz; Turnbaugh, Peter J.			Siri, What Should I Eat?	CELL			English	Editorial Material								Zeevi et al. report that extensive monitoring of a human cohort for variations in dietary intake, lifestyle, host phenotype, and the gut microbiome has enabled the development of a machine-learning algorithm that accurately predicts the individual glycemic response to meals, providing an important first step toward personalized nutrition.	[von Schwartzenberg, Reiner Jumpertz; Turnbaugh, Peter J.] Univ Calif San Francisco, Dept Microbiol & Immunol, GW Hooper Res Fdn, San Francisco, CA 94143 USA; [von Schwartzenberg, Reiner Jumpertz] Charite, Dept Endocrinol & Metab Dis, D-10117 Berlin, Germany	University of California System; University of California San Francisco; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Turnbaugh, PJ (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, GW Hooper Res Fdn, 513 Parnassus Ave,HSE 1001F, San Francisco, CA 94143 USA.	peter.turnbaugh@ucsf.edu		Turnbaugh, Peter/0000-0002-0888-2875; Jumpertz von Schwartzenberg, Reiner/0000-0002-5544-099X				[Anonymous], 2014, NAT DIAB STAT REP; Cavalot F, 2011, DIABETES CARE, V34, P2237, DOI 10.2337/dc10-2414; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dodd H, 2011, AM J CLIN NUTR, V94, P992, DOI 10.3945/ajcn.111.012138; Haiser HJ, 2013, SCIENCE, V341, P295, DOI 10.1126/science.1235872; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001	10	10	10	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 19	2015	163	5					1051	1052		10.1016/j.cell.2015.11.012	http://dx.doi.org/10.1016/j.cell.2015.11.012			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CX9SD	26590412	Bronze			2022-12-28	WOS:000366044700003
J	Deming, D				Deming, Drake			ASTRONOMY A small star with an Earth-like planet	NATURE			English	Editorial Material							LOW-MASS		Univ Maryland, Dept Astron, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Deming, D (corresponding author), Univ Maryland, Dept Astron, College Pk, MD 20742 USA.	ddeming@astro.umd.edu						Beichman C, 2014, PUBL ASTRON SOC PAC, V126, P1134, DOI 10.1086/679566; Berta-Thompson ZK, 2015, NATURE, V527, P204, DOI 10.1038/nature15762; Jenkins JM, 2015, ASTRON J, V150, DOI 10.1088/0004-6256/150/2/56; Lissauer JJ, 2011, NATURE, V470, P53, DOI 10.1038/nature09760; Mann AW, 2015, ASTROPHYS J, V804, DOI 10.1088/0004-637X/804/1/64; Ricker GR, 2015, J ASTRON TELESC INST, V1, DOI 10.1117/1.JATIS.1.1.014003	7	1	1	0	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					169	170		10.1038/527169a	http://dx.doi.org/10.1038/527169a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RC	26560293				2022-12-28	WOS:000364396700027
J	Meyer, KD; Patil, DP; Zhou, J; Zinoviev, A; Skabkin, MA; Elemento, O; Pestova, TV; Qian, SB; Jaffrey, SR				Meyer, Kate D.; Patil, Deepak P.; Zhou, Jun; Zinoviev, Alexandra; Skabkin, Maxim A.; Elemento, Olivier; Pestova, Tatyana V.; Qian, Shu-Bing; Jaffrey, Samie R.			5 ' UTR m(6)A Promotes Cap-Independent Translation	CELL			English	Article							INTERNAL RIBOSOME ENTRY; MESSENGER-RNA METHYLATION; INITIATION-FACTORS; NUCLEOTIDE-RESOLUTION; SITES; ACTIVATION; REGULATORS; MECHANISM; STRESS; EIF3	Protein translation typically begins with the recruitment of the 43S ribosomal complex to the 5' cap of mRNAs by a cap-binding complex. However, some transcripts are translated in a cap-independent manner through poorly understood mechanisms. Here, we show that mRNAs containing N-6-methyladenosine (m(6)A) in their 5' UTR can be translated in a cap-independent manner. A single 5' UTR m(6)A directly binds eukaryotic initiation factor 3 (eIF3), which is sufficient to recruit the 43S complex to initiate translation in the absence of the cap-binding factor eIF4E. Inhibition of adenosine methylation selectively reduces translation of mRNAs containing 5'UTR m(6)A. Additionally, increased m(6)A levels in the Hsp70 mRNA regulate its cap-independent translation following heat shock. Notably, we find that diverse cellular stresses induce a transcriptomewide redistribution of m(6)A, resulting in increased numbers of mRNAs with 5' UTR m(6)A. These data show that 5' UTR m(6)A bypasses 5' cap-binding proteins to promote translation under stresses.	[Meyer, Kate D.; Patil, Deepak P.; Jaffrey, Samie R.] Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10065 USA; [Zhou, Jun; Qian, Shu-Bing] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Zinoviev, Alexandra; Skabkin, Maxim A.; Pestova, Tatyana V.] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Elemento, Olivier] Cornell Univ, Dept Physiol & Biophys, Weill Med Coll, New York, NY 10065 USA; [Elemento, Olivier] Cornell Univ, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, Weill Med Coll, New York, NY 10065 USA	Cornell University; Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Cornell University; Cornell University	Jaffrey, SR (corresponding author), Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10065 USA.	srj2003@med.cornell.edu	Jun, Zhou/CAG-4742-2022	Jun, Zhou/0000-0001-7261-2207; Meyer, Kate/0000-0001-7197-4054; Patil, Deepak/0000-0001-8825-0327; Jaffrey, Samie/0000-0003-3615-6958	NIH [K99MH104712, R01DA037755, AG042400, GM59660]; Revson Senior Fellowship in Biomedical Sciences; NSF CAREER grant [1054964]; NATIONAL CANCER INSTITUTE [R01CA186702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH104712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG042400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037755] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Revson Senior Fellowship in Biomedical Sciences; NSF CAREER grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the S.R.J. laboratory for helpful comments and suggestions. This work was supported by NIH grant K99MH104712 and the Revson Senior Fellowship in Biomedical Sciences (K.D.M.), NIH grants R01DA037755 (S.R.J.), AG042400 (S.-B.Q), and GM59660 (T.V.P.), and NSF CAREER grant 1054964 (O.E.).	De Gregorio E, 1998, RNA, V4, P828, DOI 10.1017/S1355838298980372; des Georges A, 2015, NATURE, V525, P491, DOI 10.1038/nature14891; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Gilbert WV, 2010, J BIOL CHEM, V285, P29033, DOI 10.1074/jbc.R110.150532; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; Kozak M, 2005, NUCLEIC ACIDS RES, V33, P6593, DOI 10.1093/nar/gki958; Kruse S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00126; Lee ASY, 2015, NATURE, V522, P111, DOI 10.1038/nature14267; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/nmeth.3453, 10.1038/NMETH.3453]; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Mikami S, 2006, PROTEIN EXPRES PURIF, V46, P348, DOI 10.1016/j.pep.2005.09.021; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Roost C, 2015, J AM CHEM SOC, V137, P8308, DOI 10.1021/jacs.5b05858; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Sun J, 2011, J BIOL CHEM, V286, P6791, DOI 10.1074/jbc.M110.172882; Terenin IM, 2013, NUCLEIC ACIDS RES, V41, P1807, DOI 10.1093/nar/gks1282; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Xue SF, 2015, NATURE, V517, P33, DOI 10.1038/nature14010	32	971	1012	13	149	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	2015	163	4					999	1010		10.1016/j.cell.2015.10.012	http://dx.doi.org/10.1016/j.cell.2015.10.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NS	26593424	Bronze, Green Accepted			2022-12-28	WOS:000364829700023
J	Laxminarayan, R; Matsoso, P; Pant, S; Brower, C; Rottingen, JA; Klugman, K; Davies, S				Laxminarayan, Ramanan; Matsoso, Precious; Pant, Suraj; Brower, Charles; Rottingen, John-Ame; Klugman, Keith; Davies, Sally			Access to effective antimicrobials: a worldwide challenge	LANCET			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; RESISTANT STAPHYLOCOCCUS-AUREUS; UNITED-STATES; STREPTOCOCCUS-PNEUMONIAE; ANTIBIOTIC-RESISTANCE; RISK-FACTORS; MORTALITY; CARE; CHILDREN; EPIDEMIOLOGY	Recent years have seen substantial improvements in life expectancy and access to antimicrobials, especially in low-income and lower-middle-income countries, but increasing pathogen resistance to antimicrobials threatens to roll back this progress. Resistant organisms in health-care and community settings pose a threat to survival rates from serious infections, including neonatal sepsis and health-care-associated infections, and limit the potential health benefits from surgeries, transplants, and cancer treatment. The challenge of simultaneously expanding appropriate access to antimicrobials, while restricting inappropriate access, particularly to expensive, newer generation antimicrobials, is unique in global health and requires new approaches to financing and delivering health care and a one-health perspective on the connections between pathogen transmission in animals and humans. Here, we describe the importance of effective antimicrobials. We assess the disease burden caused by limited access to antimicrobials, attributable to resistance to antimicrobials, and the potential effect of vaccines in restricting the need for antibiotics.	[Laxminarayan, Ramanan] Princeton Environm Inst, Princeton, NJ USA; [Laxminarayan, Ramanan] Publ Hlth Fdn India, New Delhi, India; [Laxminarayan, Ramanan; Pant, Suraj; Brower, Charles] Ctr Dis Dynam Econ & Policy, Washington, DC 20005 USA; [Matsoso, Precious] Directorate Hlth, Pretoria, South Africa; [Rottingen, John-Ame] Univ Oslo, Norwegian Inst Publ Hlth, Oslo, Norway; [Rottingen, John-Ame] Univ Oslo, Fac Med, Inst Hlth & Soc, Oslo, Norway; [Rottingen, John-Ame] Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Klugman, Keith] Bill & Melinda Gates Fdn, Seattle, WA USA; [Davies, Sally] Dept Hlth, New York, NY USA	Princeton University; Public Health Foundation of India; Norwegian Institute of Public Health (NIPH); University of Oslo; University of Oslo; Harvard University; Harvard T.H. Chan School of Public Health; Bill & Melinda Gates Foundation	Laxminarayan, R (corresponding author), Ctr Dis Dynam Econ & Policy, Washington, DC 20005 USA.	ramanan@cddep.org	Laxminarayan, Ramanan/ABD-5050-2021	Brower, Charles/0000-0002-9980-9031				Aarestrup FM, 2001, ANTIMICROB AGENTS CH, V45, P2054, DOI 10.1128/AAC.45.7.2054-2059.2001; Aarestrup FM, 2010, AM J VET RES, V71, P726, DOI 10.2460/ajvr.71.7.726; Andrews NJ, 2014, LANCET INFECT DIS, V14, P839, DOI 10.1016/S1473-3099(14)70822-9; [Anonymous], 2012, NATURE, V491, P495, DOI 10.1038/491495a; Ardal C, 2016, LANCET, V387, P296, DOI 10.1016/S0140-6736(15)00470-5; Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; Arnold F, 2012, INDEPENDENT EVALUATI; Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Birbeck GL, 2004, TROP DOCT, V34, P84, DOI 10.1177/004947550403400208; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Boni MF, 2008, P NATL ACAD SCI USA, V105, P14216, DOI 10.1073/pnas.0804628105; BREIMAN RF, 1990, ARCH INTERN MED, V150, P1401, DOI 10.1001/archinte.150.7.1401; Chantziaras I, 2014, J ANTIMICROB CHEMOTH, V69, P827, DOI 10.1093/jac/dkt443; Cogliani C, 2011, MICROBE, V6, P274, DOI DOI 10.1128/MICROBE.6.274.1; Collignon P, 2009, CLIN INFECT DIS, V49, P132, DOI 10.1086/599374; Dar OA, 2016, LANCET, V387, P285, DOI 10.1016/S0140-6736(15)00520-6; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Dong HJ, 1999, HEALTH POLICY, V48, P29, DOI 10.1016/S0168-8510(99)00026-3; DOWLING HF, 1951, AM J MED SCI, V222, P396, DOI 10.1097/00000441-195110000-00005; Downie L, 2013, ARCH DIS CHILD, V98, P146, DOI 10.1136/archdischild-2012-302033; Dritz SS, 2002, J AM VET MED ASSOC, V220, P1690, DOI 10.2460/javma.2002.220.1690; FAO, 2012, FOOD OUTL GLOB MARK; FAO (Food and Agriculture Organization of the United Nations), LIV FOOD SEC; Ferech M, 2006, J ANTIMICROB CHEMOTH, V58, P401, DOI 10.1093/jac/dkl188; Fowler VG, 2013, JAMA-J AM MED ASSOC, V309, P1368, DOI 10.1001/jama.2013.3010; FOXMAN B, 1987, J CHRON DIS, V40, P429, DOI 10.1016/0021-9681(87)90176-7; Hadi U, 2008, INT J INFECT DIS, V12, P622, DOI 10.1016/j.ijid.2008.01.002; Harboe ZB, 2014, CLIN INFECT DIS, V59, P1066, DOI 10.1093/cid/ciu524; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Hook EW, 2013, MMWR-MORBID MORTAL W, V62, P103; Jacob JT, 2013, MMWR-MORBID MORTAL W, V62, P165; Klein EY, 2013, AM J EPIDEMIOL, V177, P666, DOI 10.1093/aje/kws273; Klugman KP, 2009, VACCINE, V27, pC9, DOI 10.1016/j.vaccine.2009.06.007; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Laxminarayan R, 2002, J HEALTH ECON, V21, P709, DOI 10.1016/S0167-6296(02)00034-6; Laxminarayan R, 2015, COSTS WITHDRAWAL ANT; Laxminarayan R, 2014, SCIENCE, V345, P1299, DOI 10.1126/science.1254163; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Laxminarayan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1567; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Maron DF, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-48; Mendelson M, 2016, LANCET, V387, P188, DOI 10.1016/S0140-6736(15)00547-4; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Nations U., 2012, COMMISSION LIFE SAVI; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Ortqvist A, 2005, SEMIN RESP CRIT CARE, V26, P563, DOI 10.1055/s-2005-925523; Podolsky E, 2006, PNEUMONIA ANTIBIOTIC; Reyes H, 1997, HEALTH POLICY PLANN, V12, P214, DOI 10.1093/heapol/12.3.214; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Saleem AF, 2010, J INFECT DEV COUNTR, V4, P30, DOI 10.3855/jidc.533; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Sethi S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-35; Smith R, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1493; Song JH, 2011, J ANTIMICROB CHEMOTH, V66, P1061, DOI 10.1093/jac/dkr024; Tilghman RC, 1937, ARCH INTERN MED, V59, P602, DOI 10.1001/archinte.1937.00170200044004; Tomasz A, 1997, CLIN INFECT DIS, V24, pS85, DOI 10.1093/clinids/24.Supplement_1.S85; U.S.FDA, NEW AN DRUGS NEW AN; UNICEF, 2013, PROP CHILDR AG 0 59; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; VanderStichele RH, 2006, J ANTIMICROB CHEMOTH, V58, P159, DOI 10.1093/jac/dkl147; Viswanathan R, 2012, J HEALTH POPUL NUTR, V30, P41; von Gottberg A, 2006, B WORLD HEALTH ORGAN, V84, P811, DOI 10.2471/BLT.06.030361; Waters Donald, 2011, J Glob Health, V1, P154; World Health Organization, BAS REP GLOB SEX TRA; World Health Organization (WHO), 2014, WHO VACC PREV DIS MO; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X	70	610	622	6	266	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2016	387	10014					168	175		10.1016/S0140-6736(15)00474-2	http://dx.doi.org/10.1016/S0140-6736(15)00474-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8LF	26603918				2022-12-28	WOS:000368055500033
J	Sztainberg, Y; Chen, HM; Swann, JW; Hao, S; Tang, B; Wu, ZY; Tang, JR; Wan, YW; Liu, ZD; Rigo, F; Zoghbi, HY				Sztainberg, Yehezkel; Chen, Hong-mei; Swann, John W.; Hao, Shuang; Tang, Bin; Wu, Zhenyu; Tang, Jianrong; Wan, Ying-Wooi; Liu, Zhandong; Rigo, Frank; Zoghbi, Huda Y.			Reversal of phenotypes in MECP2 duplication mice using genetic rescue or antisense oligonucleotides	NATURE			English	Article							MOUSE MODEL; LEARNING-DEFICITS; OVEREXPRESSION; THERAPEUTICS; BEHAVIOR; THERAPY; DOSAGE; XLMR; RNA	Copy number variations have been frequently associated with developmental delay, intellectual disability and autism spectrum disorders(1). MECP2 duplication syndrome is one of the most common genomic rearrangements in males(2) and is characterized by autism, intellectual disability, motor dysfunction, anxiety, epilepsy, recurrent respiratory tract infections and early death(3-5). The broad range of deficits caused by methyl-CpG-binding protein 2 (MeCP2) overexpression poses a daunting challenge to traditional biochemical-pathway-based therapeutic approaches. Accordingly, we sought strategies that directly target MeCP2 and are amenable to translation into clinical therapy. The first question that we addressed was whether the neurological dysfunction is reversible after symptoms set in. Reversal of phenotypes in adult symptomatic mice has been demonstrated in some models of monogenic loss-of-function neurological disorders(6-8), including loss of MeCP2 in Rett syndrome(9), indicating that, at least in some cases, the neuroanatomy may remain sufficiently intact so that correction of the molecular dysfunction underlying these disorders can restore healthy physiology. Given the absence of neurodegeneration in MECP2 duplication syndrome, we propose that restoration of normal MeCP2 levels in MECP2 duplication adult mice would rescue their phenotype. By generating and characterizing a conditional Mecp2-overexpressing mouse model, here we show that correction of MeCP2 levels largely reverses the behavioural, molecular and electrophysiological deficits. We also reduced MeCP2 using an antisense oligonucleotide strategy, which has greater translational potential. Antisense oligonucleotides are small, modified nucleic acids that can selectively hybridize with messenger RNA transcribed from a target gene and silence it(10,11), and have been successfully used to correct deficits in different mouse models(12-18). We find that antisense oligonucleotide treatment induces a broad phenotypic rescue in adult symptomatic transgenic MECP2 duplication mice (MECP2-TG)(19,20), and corrected MECP2 levels in lymphoblastoid cells from MECP2 duplication patients in a dose-dependent manner.	[Sztainberg, Yehezkel; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Sztainberg, Yehezkel; Hao, Shuang; Tang, Bin; Wu, Zhenyu; Tang, Jianrong; Wan, Ying-Wooi; Liu, Zhandong; Zoghbi, Huda Y.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Chen, Hong-mei; Swann, John W.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Cain Fdn Labs, Houston, TX 77030 USA; [Chen, Hong-mei; Swann, John W.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Chen, Hong-mei; Swann, John W.; Hao, Shuang; Tang, Bin; Wu, Zhenyu; Tang, Jianrong; Liu, Zhandong; Zoghbi, Huda Y.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Wan, Ying-Wooi] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Rigo, Frank] ISIS Pharmaceut, Carlsbad, CA 92010 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Isis Pharmaceuticals Inc; Baylor College of Medicine; Howard Hughes Medical Institute	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	hzoghbi@bcm.edu		Zoghbi, Huda/0000-0002-0700-3349; Liu, Zhandong/0000-0002-7608-0831	National Institutes of Health [5R01NS057819, 5P30HD024064]; Rett Syndrome Research Trust (401 Project); Carl. C. Anderson, Sr and Marie Jo Anderson Charitable Foundation; Howard Hughes Medical Institute; NSF [DMS-1263932]; Baylor Intellectual Disabilities Research Center [1U54HD083092]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064, U54HD083092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rett Syndrome Research Trust (401 Project); Carl. C. Anderson, Sr and Marie Jo Anderson Charitable Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF(National Science Foundation (NSF)); Baylor Intellectual Disabilities Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Jaenisch for the Mecp2<SUP>tm1Jae</SUP> mice, S. Chun for ASOs tolerability studies in wild-type mice, L. Lombardi, M. Rousseaux, C. Alcott and V. Brandt for critical input, and C. Spencer for behavioural assays training. We are indebted to the patients and families who participated in this study. This project was funded by the National Institutes of Health (5R01NS057819 and 5P30HD024064 to H.Y.Z.), the Rett Syndrome Research Trust (401 Project), the Carl. C. Anderson, Sr and Marie Jo Anderson Charitable Foundation, the Howard Hughes Medical Institute (H.Y.Z.), NSF DMS-1263932 (Z.L.), and the Baylor Intellectual Disabilities Research Center (1U54HD083092) neurovisualization, neuroconnectivity and neurobehavioral cores.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chao HT, 2012, NAT NEUROSCI, V15, P176, DOI 10.1038/nn.3027; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Cook MN, 2001, BEHAV NEUROSCI, V115, P468, DOI 10.1037/0735-7044.115.2.468; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Han K, 2013, NATURE, V503, P72, DOI 10.1038/nature12630; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Lentz JJ, 2013, NAT MED, V19, P345, DOI 10.1038/nm.3106; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Lubs H, 1999, AM J MED GENET, V85, P243, DOI 10.1002/(SICI)1096-8628(19990730)85:3<243::AID-AJMG11>3.0.CO;2-E; Lugtenberg D, 2009, EUR J HUM GENET, V17, P444, DOI 10.1038/ejhg.2008.208; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Meng LY, 2015, NATURE, V518, P409, DOI 10.1038/nature13975; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Patel P. I., 1992, NAT NEUROSCI, V1, P159; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Ramocki MB, 2010, AM J MED GENET A, V152A, P1079, DOI 10.1002/ajmg.a.33184; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Samaco RC, 2012, NAT GENET, V44, P206, DOI 10.1038/ng.1066; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Southwell AL, 2012, TRENDS MOL MED, V18, P634, DOI 10.1016/j.molmed.2012.09.001; Van Esch H, 2011, MOL SYNDROMOL, V2, P128, DOI 10.1159/000329580; Wheeler TM, 2012, NATURE, V488, P111, DOI 10.1038/nature11362	37	113	119	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					123	+		10.1038/nature16159	http://dx.doi.org/10.1038/nature16159			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26605526	Green Accepted			2022-12-28	WOS:000365606000061
J	Tripathy, K; Ramesh, P; Sharma, YR				Tripathy, Koushik; Ramesh, Priyanka; Sharma, Yog Raj			9 SPOT DIAGNOSIS Headache and amaurosis fugax in an obese woman	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Tripathy, Koushik; Ramesh, Priyanka; Sharma, Yog Raj] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences	Tripathy, K (corresponding author), All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, India.		Ramesh, Priyanka/HHZ-0349-2022; Tripathy, Koushik/O-1801-2019	Tripathy, Koushik/0000-0002-9756-128X					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2015	351								h6365	10.1136/bmj.h6365	http://dx.doi.org/10.1136/bmj.h6365			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX9EX	26627820				2022-12-28	WOS:000366008900001
J	Claxton, K; Griffin, S; Koffijberg, H; McKenna, C				Claxton, Karl; Griffin, Susan; Koffijberg, Hendrik; McKenna, Claire			How to estimate the health benefits of additional research and changing clinical practice	BMJ-BRITISH MEDICAL JOURNAL			English	Article							METAANALYSIS; INFORMATION; TRIALS	A simple extension of standard meta-analysis can provide quantitative estimates of the potential health benefits of further research and of implementing the findings of existing research, which can help inform research prioritisation and efforts to change clinical practice	[Claxton, Karl; Griffin, Susan; McKenna, Claire] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Claxton, Karl] Univ York, Dept Econ & Related Studies, York YO10 5DD, N Yorkshire, England; [Koffijberg, Hendrik] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Koffijberg, Hendrik] Univ Twente, Dept Hlth Technol, NL-7500 AE Enschede, Netherlands; [Koffijberg, Hendrik] Univ Twente, Res Serv, NL-7500 AE Enschede, Netherlands	University of York - UK; University of York - UK; Utrecht University; Utrecht University Medical Center; University of Twente; University of Twente	Griffin, S (corresponding author), Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England.	susan.griffin@york.ac.uk	Griffin, Susan/AAE-8970-2020	Griffin, Susan/0000-0003-2188-8400; Koffijberg, Hendrik/0000-0002-1753-0652	Patient Centered Outcomes Research Institute (PCORI) in the USA; Netherlands Organization for Scientific Research (NWO) [916.11.126]; MRC [G0802659, MC_U145079308] Funding Source: UKRI; Medical Research Council [MC_U145079308, G0802659] Funding Source: researchfish	Patient Centered Outcomes Research Institute (PCORI) in the USA(Patient-Centered Outcomes Research Institute - PCORI); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the Patient Centered Outcomes Research Institute (PCORI) in the USA. Initial findings were presented at the PCORI methodology workshop for prioritising specific research topics in Washington, DC, December 2012. HK was also supported by the Netherlands Organization for Scientific Research (NWO, grant 916.11.126). Neither organisation was involved in the study.	ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; Claxton K, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16460; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Claxton K, 2013, 83 U YORK CTR HLTH E; Claxton KP, 2015, HEALTH TECHNOL ASSES, P19; Colbourn TE, 2007, BMJ-BRIT MED J, V335, P655, DOI 10.1136/bmj.39325.681806.AD; Dundar Y, 2004, HEALTH TECHNOL ASSES, V8, P1; Fleurence RL, 2013, MED DECIS MAKING, V33, P460, DOI 10.1177/0272989X13486979; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; Sutton AJ, 2001, STAT METHODS MED RES, V10, P277, DOI 10.1191/096228001678227794; Whitehead A., 2002, METAANALYSIS CONTROL; YUSUF S, 1985, EUR HEART J, V6, P556, DOI 10.1093/oxfordjournals.eurheartj.a061905	12	19	19	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2015	351								h5987	10.1136/bmj.h5987	http://dx.doi.org/10.1136/bmj.h5987			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX4TG	26608737	Bronze, Green Published			2022-12-28	WOS:000365692600003
J	Birbeck, GL; Meyer, AC; Ogunniyi, A				Birbeck, Gretchen L.; Meyer, Ana-Claire; Ogunniyi, Adesola			Nervous system disorders across the life course in resource-limited settings	NATURE			English	Review							INTIMA-MEDIA THICKNESS; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; RISK-FACTORS; CARDIOVASCULAR RISK; STROKE; DEMENTIA; CHILDHOOD; EPILEPSY; PREVALENCE	The resiliency of the adult nervous system is markedly affected by the environment and the circumstances during infant and child development. As such, adults in resource-limited settings who may have experienced early deprivation are particularly vulnerable to subsequent neurological disorders. Adult populations in countries with relatively recent advances in economic development may still have a higher susceptibility to neurological illness or injury that is reflective of the socioeconomic environment that was present during that population's infancy and childhood. Brain and peripheral nervous system research conducted over the past decade in resource-limited settings has led to an impressive and growing body of knowledge that informs our understanding of neurological function and dysfunction, independent of geography. Neurological conditions feature prominently in the burgeoning epidemic of non-communicable diseases facing low-and middle-income countries. Neurological research in these countries is needed to address this burden of disease. Although the burden of more prevalent and severe neurological disease poses public health and clinical challenges in settings with limited neurological expertise, the same factors, along with genetic heterogeneity and the relative absence of ingrained clinical care practices, offer circumstances well-suited for the conduct of crucial future research that is globally relevant.	[Birbeck, Gretchen L.] Univ Rochester, Dept Neurol, Epilepsy Div, 265 Crittenden Blvd,CU420694, Rochester, NY 14642 USA; [Birbeck, Gretchen L.] Chikankata Hosp, Chikankata Epilepsy Care Team, Mazabuka, Zambia; [Meyer, Ana-Claire] Yale Univ, Dept Neurol, New Haven, CT 06520 USA; [Meyer, Ana-Claire] Kenya Govt Med Res Ctr, Kisumu, Kenya; [Ogunniyi, Adesola] Univ Ibadan, Dept Med, Ibadan 200001, Nigeria	University of Rochester; Yale University; Kenya Medical Research Institute; University of Ibadan	Birbeck, GL (corresponding author), Univ Rochester, Dept Neurol, Epilepsy Div, 265 Crittenden Blvd,CU420694, Rochester, NY 14642 USA.	gretchen_birbeck@urmc.rochester.edu			National Institutes of Health; Fogarty International Center; FOGARTY INTERNATIONAL CENTER [K01TW008764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work emanated from the Tenth Anniversary BRAIN Disorders in the Developing World Symposium. We are grateful to all participants and to National Institutes of Health and the Fogarty International Center for sponsoring the meeting.	Aiwansoba IF, 2014, ANN AFR MED, V13, P11, DOI 10.4103/1596-3519.126936; Akinyemi RO, 2014, J NEUROL SCI, V346, P241, DOI 10.1016/j.jns.2014.08.042; Alzihemer's Disease International, 2010, GLOB EC IMP DEM; Asato MR, 2014, EPILEPSY BEHAV, V31, P127, DOI 10.1016/j.yebeh.2013.11.027; Atadzhanov M, 2013, NEUROL INT, V5, P69, DOI 10.4081/ni.2013.e20; Baiyewu O, 2002, EUR J NEUROL, V9, P573, DOI 10.1046/j.1468-1331.2002.00434.x; Banea JP, 2014, FOOD NUTR BULL, V35, P28, DOI 10.1177/156482651403500104; Bergen DC, 2002, ARCH NEUROL-CHICAGO, V59, P1194, DOI 10.1001/archneur.59.7.1194; Bergen DC, 2008, NEUROLOGY, V71, P447, DOI 10.1212/01.wnl.0000324420.03960.36; Birbeck GL, 2011, AM J TROP MED HYG, V85, P782, DOI 10.4269/ajtmh.2011.11-0187; Boutajangout A, 2009, J ALZHEIMERS DIS, V18, P961, DOI 10.3233/JAD-2009-1204; Bower JH, 2012, J NEUROL SCI, V320, P52, DOI 10.1016/j.jns.2012.06.007; Braun Kim Van Naarden, 2007, Morbidity and Mortality Weekly Report, V56, P29; Castro-Alvarez JF, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00243; Chandra V, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P627; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Coume M, 2012, GERIATR PSYCHOL NEUR, V10, P39, DOI 10.1684/pnv.2012.0334; Ding D, 2006, LANCET NEUROL, V5, P823, DOI 10.1016/S1474-4422(06)70528-2; Elafros MA, 2013, EPILEPSY BEHAV, V27, P188, DOI 10.1016/j.yebeh.2013.01.005; Falkner B, 2010, PEDIATR NEPHROL, V25, P1219, DOI 10.1007/s00467-009-1200-3; Ferreiro KN, 2010, BRAZ J PHYS THER, V14, P377, DOI 10.1590/S1413-35552010005000018; Fiest KM, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0444-x; Galadanci NA, 2015, PEDIATR BLOOD CANCER, V62, P395, DOI 10.1002/pbc.25289; Getahun H, 1999, LANCET, V354, P306, DOI 10.1016/S0140-6736(99)02532-5; Guerchet M, 2009, DEMENT GERIATR COGN, V27, P34, DOI 10.1159/000188661; Gureje O, 2006, ANN NEUROL, V59, P182, DOI 10.1002/ana.20694; Gureje O, 2006, J AM GERIATR SOC, V54, P1784, DOI 10.1111/j.1532-5415.2006.00944.x; Hair NL, 2015, JAMA PEDIATR, V169, P822, DOI 10.1001/jamapediatrics.2015.1475; Hamadani JD, 2014, PEDIATRICS, V134, pE1001, DOI 10.1542/peds.2014-0694; Hashmi M, 2013, INT J STROKE, V8, P575, DOI 10.1111/j.1747-4949.2012.00827.x; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heckmann JM, 2004, BRAIN, V127, P133, DOI 10.1093/brain/awh009; HENDRIE HC, 1995, AM J PSYCHIAT, V152, P1485; Herenu CB, 2007, GENE THER, V14, P237, DOI 10.1038/sj.gt.3302870; Ineichen B, 2000, SOC SCI MED, V50, P1673, DOI 10.1016/S0277-9536(99)00392-5; Joray ML, 2015, NUTR RES, V35, P49, DOI 10.1016/j.nutres.2014.10.006; Juonala M, 2010, CIRCULATION, V122, P2514, DOI 10.1161/CIRCULATIONAHA.110.966465; Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8; Kvalsund M., 2015, NEUROLOGY, V84, pP5049; Kwasa J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032898; Lalli MA, 2012, HUM MUTAT, V33, P1630, DOI 10.1002/humu.22167; LaRosa Christopher, 2010, J Med Liban, V58, P132; Llibre R., 2008, LANCET, V372, P464, DOI DOI 10.1016/S0140-6736(08)61002-8; London L, 2012, NEUROTOXICOLOGY, V33, P887, DOI 10.1016/j.neuro.2012.01.004; Makeyev O, 2013, IEEE T NEUR SYS REH, V21, P383, DOI 10.1109/TNSRE.2012.2198244; Mansour H, 2009, AM J MED GENET B, V150B, P879, DOI 10.1002/ajmg.b.30913; Mbewe EK, 2013, AM J TROP MED HYG, V89, P873, DOI 10.4269/ajtmh.13-0062; Nair G, 2012, INT J ALZHEIMERS DIS, V2012; Napoli C, 1999, LANCET, V354, P1234, DOI 10.1016/S0140-6736(99)02131-5; Nishida F, 2011, NEUROSCIENCE, V177, P195, DOI 10.1016/j.neuroscience.2011.01.013; Nishioka K, 2010, NEUROSCI LETT, V477, P57, DOI 10.1016/j.neulet.2009.11.066; Ntsekhe M, 2013, HEART, V99, P1230, DOI 10.1136/heartjnl-2012-303585; Ochayi B, 2006, AGING MENT HEALTH, V10, P616, DOI 10.1080/13607860600736182; Ogunniyi A, 2005, West Afr J Med, V24, P259; Ogunniyi A, 2011, ACTA NEUROL SCAND, V124, P396, DOI 10.1111/j.1600-0404.2011.01491.x; Ogunniyi A, 2011, INT PSYCHOGERIATR, V23, P387, DOI 10.1017/S1041610210001390; Organization WH, 2006, NEUR DIS PUBL HLTH C, DOI 10.1001/archneurol.2007.19; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Piedrahita D, 2010, J NEUROSCI, V30, P13966, DOI 10.1523/JNEUROSCI.3637-10.2010; Potchen MJ, 2013, NEUROLOGY, V81, P585, DOI 10.1212/WNL.0b013e31829e6ed5; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Ringman JM, 2005, J GERIATR PSYCH NEUR, V18, P228, DOI 10.1177/0891988705281878; Rubiano AM, 2013, BRAIN INJURY, V27, P262, DOI 10.3109/02699052.2012.750742; Rumbaugh Jeffrey A, 2008, Futur HIV Ther, V2, P271, DOI 10.2217/17469600.2.3.271; Spencer PS, 1999, DRUG METAB REV, V31, P561, DOI 10.1081/DMR-100101936; Sposato LA, 2013, INT J STROKE, V8, P591, DOI 10.1111/ijs.12171; Tirschwell DL, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-150; Tshala-Katumbay D Desire, 2007, Handb Clin Neurol, V82, P353, DOI 10.1016/S0072-9752(07)80021-2; Wagner RG, 2014, EPILEPSY RES, V108, P782, DOI 10.1016/j.eplepsyres.2014.01.004; Walker RW, 2003, STROKE, V34, P1604, DOI 10.1161/01.STR.0000077943.63718.67; Whalley LJ, 2011, MATURITAS, V69, P365, DOI 10.1016/j.maturitas.2011.05.010; Whalley LJ, 2006, LANCET NEUROL, V5, P87, DOI 10.1016/S1474-4422(05)70286-6	72	18	18	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					S167	S171		10.1038/nature16031	http://dx.doi.org/10.1038/nature16031			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26580323	Green Accepted, hybrid			2022-12-28	WOS:000365356800012
J	Stein, MB; Sareen, J				Stein, Murray B.; Sareen, Jitender			Generalized Anxiety Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; MAJOR DEPRESSIVE DISORDER; QUALITY-OF-LIFE; PHARMACOLOGICAL-TREATMENT; PRIMARY-CARE; MENTAL-DISORDERS; COMORBID ANXIETY; DOUBLE-BLIND; MEDICATION; EFFICACY	A 46-year-old married woman presents with insomnia, headaches, muscle tension, and back pain. She describes a long-term pattern of worrying about several life situations, including health, finances, and her job, and she notes increased anxiety associated with her teenager's leaving home to attend college. She drinks alcohol daily to reduce the tension and help her sleep. In reviewing her history, you note that she has visited your office many times over the past year because of physical symptoms. What do you advise?	[Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Stein, Murray B.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Sareen, Jitender] Univ Manitoba, Dept Psychiat, Winnipeg, MB R3T 2N2, Canada; [Sareen, Jitender] Univ Manitoba, Dept Psychol, Winnipeg, MB R3T 2N2, Canada; [Sareen, Jitender] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of Manitoba; University of Manitoba; University of Manitoba	Stein, MB (corresponding author), Univ Calif San Diego, 9500 Gilman Dr,Mail Code 0855, La Jolla, CA 92093 USA.	mstein@ucsd.edu		Sareen, Jitender/0000-0001-8573-6495	Janssen; Pfizer; Tonix Pharmaceuticals; Care Management Technologies	Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer(Pfizer); Tonix Pharmaceuticals; Care Management Technologies	Dr. Stein reports receiving consulting fees from Janssen, Pfizer, and Tonix Pharmaceuticals, and from Care Management Technologies for providing a review of health service protocols. No other potential conflict of interest relevant to this article was reported.	Afifi TO, 2012, PEDIATRICS, V130, P184, DOI 10.1542/peds.2011-2947; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Andrews G, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0533-1; Asmundson GJG, 2013, DEPRESS ANXIETY, V30, P362, DOI 10.1002/da.22043; Baldwin DS, 2015, J PSYCHOPHARMACOL, V29, P1047, DOI 10.1177/0269881115598411; Ball TM, 2013, PSYCHOL MED, V43, P1475, DOI 10.1017/S0033291712002383; Bandelow B, 2012, INT J PSYCHIAT CLIN, V16, P77, DOI 10.3109/13651501.2012.667114; Bereza BG, 2012, CAN J PSYCHIAT, V57, P470, DOI 10.1177/070674371205700805; Bomyea J, 2015, J ANXIETY DISORD, V33, P90, DOI 10.1016/j.janxdis.2015.05.004; Brenes GA, 2015, JAMA PSYCHIAT, V72, P1012, DOI 10.1001/jamapsychiatry.2015.1154; Chartrand H, 2012, DEPRESS ANXIETY, V29, P172, DOI 10.1002/da.20882; Chessick CA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006115; Craske MG, 2011, ARCH GEN PSYCHIAT, V68, P378, DOI 10.1001/archgenpsychiatry.2011.25; Cuijpers P, 2014, CLIN PSYCHOL REV, V34, P130, DOI 10.1016/j.cpr.2014.01.002; de Gage SB, 2015, EXPERT OPIN DRUG SAF, V14, P733, DOI 10.1517/14740338.2015.1014796; Fonzo GA, 2014, J AFFECT DISORDERS, V169, P76, DOI 10.1016/j.jad.2014.07.031; Gentes EL, 2011, CLIN PSYCHOL REV, V31, P923, DOI 10.1016/j.cpr.2011.05.001; Gommoll C, 2015, DEPRESS ANXIETY, V32, P451, DOI 10.1002/da.22365; Guaiana G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006815.pub2; Hettema JM, 2005, ARCH GEN PSYCHIAT, V62, P182, DOI 10.1001/archpsyc.62.2.182; Hettema JM, 2015, PSYCHOL MED; Hilbert K, 2014, J AFFECT DISORDERS, V158, P114, DOI 10.1016/j.jad.2014.01.022; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Kapczinski F., 2003, COCHRANE DB SYST REV, V2003, DOI [DOI 10.1002/14651858.CD003592, 10.1002/14651858.CD003592]; Katzman MA, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-S1-S1; Kessler RC, 2008, ANNU REV PUBL HEALTH, V29, P115, DOI 10.1146/annurev.publhealth.29.020907.090847; Kreys TJM, 2015, PHARMACOTHERAPY, V35, P175, DOI 10.1002/phar.1529; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Krystal JH, 2015, JAMA PSYCHIAT, V72, P734, DOI 10.1001/jamapsychiatry.2015.0351; Mackenzie CS, 2011, AM J GERIAT PSYCHIAT, V19, P305, DOI 10.1097/JGP.0b013e318202bc62; Mahableshwarkar AR, 2014, HUM PSYCHOPHARM CLIN, V29, P64, DOI 10.1002/hup.2371; McHugh RK, 2013, J CLIN PSYCHIAT, V74, P595, DOI 10.4088/JCP.12r07757; Mohatt J, 2014, AM J PSYCHIAT, V171, P741, DOI 10.1176/appi.ajp.2014.13101337; Moreno-Peral P, 2014, J AFFECT DISORDERS, V168, P337, DOI 10.1016/j.jad.2014.06.021; Ramsawh HJ, 2010, ARCH PEDIAT ADOL MED, V164, P965, DOI 10.1001/archpediatrics.2010.170; Ravindran LN, 2009, KAPLAN SADOCK COMPRE, P1906; Reinhold JA, 2015, EXPERT OPIN PHARMACO, V16, P1669, DOI 10.1517/14656566.2015.1059424; Robinson J, 2011, ARCH GEN PSYCHIAT, V68, P800, DOI 10.1001/archgenpsychiatry.2011.75; Robinson OJ, 2014, LANCET PSYCHIAT, V1, P294, DOI 10.1016/S2215-0366(14)70305-0; Roest AM, 2015, JAMA PSYCHIAT, V72, P500, DOI 10.1001/jamapsychiatry.2015.15; Roy-Byrne P, 2010, JAMA-J AM MED ASSOC, V303, P1921, DOI 10.1001/jama.2010.608; Sareen J, 2006, ARCH INTERN MED, V166, P2109, DOI 10.1001/archinte.166.19.2109; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stein MB, 2005, MED CARE, V43, P1164, DOI 10.1097/01.mlr.0000185750.18119.fd; Strawn JR, 2015, DEPRESS ANXIETY, V32, P149, DOI 10.1002/da.22329; Taylor WD, 2014, NEW ENGL J MED, V371, P1228, DOI 10.1056/NEJMcp1402180; Wetherell JL, 2013, AM J PSYCHIAT, V170, P782, DOI 10.1176/appi.ajp.2013.12081104; Wilson H, 2015, CNS DRUGS, V29, P29, DOI 10.1007/s40263-014-0217-8; Zbozinek TD, 2012, DEPRESS ANXIETY, V29, P1065, DOI 10.1002/da.22026	50	117	122	3	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2015	373	21					2059	2068		10.1056/NEJMcp1502514	http://dx.doi.org/10.1056/NEJMcp1502514			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW4JN	26580998				2022-12-28	WOS:000364957700011
J	Donato, A				Donato, Anthony			In AF requiring warfarin interruption, no anticoagulation bridging was noninferior to bridging for thromboembolism	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Donato, Anthony] Reading Hlth Syst, Reading, PA USA		Donato, A (corresponding author), Reading Hlth Syst, Reading, PA USA.							Douketis JD, 2012, CHEST, V141, pE326S, DOI 10.1378/chest.11-2298	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					JC5	JC5		10.7326/ACPJC-2015-163-10-005	http://dx.doi.org/10.7326/ACPJC-2015-163-10-005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26571259				2022-12-28	WOS:000365746400006
J	Sammon, JD; Abdollah, F; Choueiri, TK; Kantoff, P; Nguyen, PL; Menon, M; Trinh, QD				Sammon, Jesse D.; Abdollah, Firas; Choueiri, Toni K.; Kantoff, PhilipW.; Nguyen, Paul L.; Menon, Mani; Quoc-Dien Trinh			Prostate-Specific Antigen Screening After 2012 US Preventive Services Task Force Recommendations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Sammon, Jesse D.; Quoc-Dien Trinh] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA 02115 USA; [Abdollah, Firas; Menon, Mani] Henry Ford Hlth Syst, VUI Ctr Outcomes Res,Analyt & Evaluat, Detroit, MI USA; [Choueiri, Toni K.; Kantoff, PhilipW.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Nguyen, Paul L.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Henry Ford Health System; Henry Ford Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Sammon, JD (corresponding author), Brigham & Womens Hosp, 45 Francis St, Boston, MA 02115 USA.	jsammon@partners.org	Abdollah, Firas/AAM-9162-2020; Choueiri, Toni/K-5238-2019	Abdollah, Firas/0000-0003-1298-8231; Choueiri, Toni/0000-0002-9201-3217; Kantoff, Philip/0000-0001-7275-0597	NCI NIH HHS [P30 CA008748] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Loeb S, 2014, EUR UROL, V65, P1046, DOI 10.1016/j.eururo.2013.12.062; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Prasad SM, 2012, JAMA-J AM MED ASSOC, V307, P1692, DOI 10.1001/jama.2012.534; Scosyrev E, 2012, BJU INT, V110, P1485, DOI 10.1111/j.1464-410X.2012.11013.x	5	95	95	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	2015	314	19					2075	2077		10.1001/jama.2015.7273	http://dx.doi.org/10.1001/jama.2015.7273			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW1PR	26575066	Bronze			2022-12-28	WOS:000364764200025
J	Shaw, D; Melton, P				Shaw, David; Melton, Peter			Should GPs be paid to reduce unnecessary referrals?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Shaw, David] Univ Basel, Inst Biomed Eth, CH-4003 Basel, Switzerland; [Melton, Peter] North East Lincolnshire Clin Commissioning Grp, London, England	University of Basel	Shaw, D (corresponding author), Univ Basel, Inst Biomed Eth, CH-4003 Basel, Switzerland.	david.shaw@unibas.ch; peter.melton@nhs.net						Clews Graham, 2006, Health Serv J, V116, P14; Cusick J, 2015, INDEPENDENT; Foot C., 2010, QUALITY GP DIAGNOSIS; General Medical Council, 2012, RAIS ACT PAT SAF; General Medical Council, 2013, GOOD MED PRACT FIN C; General Medical Council, 2013, GOOD MED PRACT HON F; King's Fund, MAN EL ACT REF QUAL; Matthews-King A, 2014, PULSE; NHS England, COMM QUAL INN CQUIN; North East Lincolnshire CCG, 2015, COMB CANC TOG; Wright J, 1996, FAM PRACT, V13, P259, DOI 10.1093/fampra/13.3.259	11	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 17	2015	351								h6148	10.1136/bmj.h6148	http://dx.doi.org/10.1136/bmj.h6148			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XV	26578085				2022-12-28	WOS:000365352400004
J	Wagner, PJ				Wagner, Peter J.			One era you are in-the next you are out	SCIENCE			English	Editorial Material							FOSSIL RECORD; BODY-SIZE; EVOLUTION; TRENDS; EXTINCTIONS; CARNIVORA; MAMMALIA		Smithsonian Inst, Dept Paleobiol, Natl Museum Nat Hist, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Wagner, PJ (corresponding author), Smithsonian Inst, Dept Paleobiol, Natl Museum Nat Hist, Washington, DC 20560 USA.	wagnerpj@si.edu						BOTTJER D J, 1988, Palaios, V3, P540, DOI 10.2307/3514444; Finarelli JA, 2006, SYST BIOL, V55, P301, DOI 10.1080/10635150500541698; Finarelli JA, 2013, EVOLUTION, V67, P3678, DOI 10.1111/evo.12222; GOULD SJ, 1988, J PALEONTOL, V62, P319, DOI 10.1017/S0022336000059126; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; Liow LH, 2010, SYST BIOL, V59, P646, DOI 10.1093/sysbio/syq052; Lyons SK, 2004, EVOL ECOL RES, V6, P339; MCSHEA DW, 1994, EVOLUTION, V48, P1747, DOI 10.1111/j.1558-5646.1994.tb02211.x; Sallan L, 2015, SCIENCE, V350, P812, DOI 10.1126/science.aac7373; Slater GJ, 2013, METHODS ECOL EVOL, V4, P734, DOI 10.1111/2041-210X.12084; STANLEY S.M, 1975, P NATL ACAD SCI USA, V276, P56; VRBA ES, 1986, PALEOBIOLOGY, V12, P217, DOI 10.1017/S0094837300013671; Wagner PJ, 1996, EVOLUTION, V50, P990, DOI 10.1111/j.1558-5646.1996.tb02341.x	13	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					736	737		10.1126/science.aad6283	http://dx.doi.org/10.1126/science.aad6283			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW3MS	26564831				2022-12-28	WOS:000364897000017
J	Wang-Gillam, A; Li, CP; Bodoky, G; Dean, A; Shan, YS; Jameson, G; Macarulla, T; Lee, KH; Cunningham, D; Blanc, JF; Hubner, RA; Chiu, CF; Schwartsmann, G; Siveke, JT; Braiteh, F; Moyo, V; Belanger, B; Dhindsa, N; Bayever, E; Von Hoff, DD; Chen, LT				Wang-Gillam, Andrea; Li, Chung-Pin; Bodoky, Gyoergy; Dean, Andrew; Shan, Yan-Shen; Jameson, Gayle; Macarulla, Teresa; Lee, Kyung-Hun; Cunningham, David; Blanc, Jean F.; Hubner, Richard A.; Chiu, Chang-Fang; Schwartsmann, Gilberto; Siveke, Jens T.; Braiteh, Fadi; Moyo, Victor; Belanger, Bruce; Dhindsa, Navreet; Bayever, Eliel; Von Hoff, Daniel D.; Chen, Li-Tzong		NAPOLI-1 Study Grp	Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial	LANCET			English	Article							2ND-LINE CHEMOTHERAPY; PLUS GEMCITABINE; ADENOCARCINOMA; OXALIPLATIN; DOCETAXEL; FOLFIRI; PEP02; 5-FLUOROURACIL; CARCINOMA; SURVIVAL	Background Nanoliposomal irinotecan showed activity in a phase 2 study in patients with metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based therapies. We assessed the effect of nanoliposomal irinotecan alone or combined with fluorouracil and folinic acid in a phase 3 trial in this population. Methods We did a global, phase 3, randomised, open-label trial at 76 sites in 14 countries. Eligible patients with metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based therapy were randomly assigned (1: 1) using an interactive web response system at a central location to receive either nanoliposomal irinotecan monotherapy (120 mg/m(2) every 3 weeks, equivalent to 100 mg/m(2) of irinotecan base) or fluorouracil and folinic acid. A third arm consisting of nanoliposomal irinotecan (80 mg/m(2), equivalent to 70 mg/m(2) of irinotecan base) with fluorouracil and folinic acid every 2 weeks was added later (1: 1: 1), in a protocol amendment. Randomisation was stratified by baseline albumin, Karnofsky performance status, and ethnic origin. Treatment was continued until disease progression or intolerable toxic effects. The primary endpoint was overall survival, assessed in the intention-to-treat population. The primary analysis was planned after 305 events. Safety was assessed in all patients who had received study drug. This trial is registered at ClinicalTrials.gov, number NCT01494506. Findings Between Jan 11, 2012, and Sept 11, 2013, 417 patients were randomly assigned either nanoliposomal irinotecan plus fluorouracil and folinic acid (n=117), nanoliposomal irinotecan monotherapy (n=151), or fluorouracil and folinic acid (n=149). After 313 events, median overall survival in patients assigned nanoliposomal irinotecan plus fluorouracil and folinic acid was 6.1 months (95% CI 4.8-8.9) vs 4.2 months (3.3-5.3) with fluorouracil and folinic acid (hazard ratio 0.67, 95% CI 0.49-0.92; p=0.012). Median overall survival did not differ between patients assigned nanoliposomal irinotecan monotherapy and those allocated fluorouracil and folinic acid (4.9 months [4.2-5.6] vs 4.2 months [3.6-4.9]; 0.99, 0.77-1.28; p=0.94). The grade 3 or 4 adverse events that occurred most frequently in the 117 patients assigned nanoliposomal irinotecan plus fluorouracil and folinic acid were neutropenia (32 [27%]), diarrhoea (15 [13%]), vomiting (13 [11%]), and fatigue (16 [14%]). Interpretation Nanoliposomal irinotecan in combination with fluorouracil and folinic acid extends survival with a manageable safety profile in patients with metastatic pancreatic ductal adenocarcinoma who previously received gemcitabine-based therapy. This agent represents a new treatment option for this population.	[Wang-Gillam, Andrea] Washington Univ, Sch Med, St Louis, MO USA; [Li, Chung-Pin] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Taipei, Taiwan; [Li, Chung-Pin] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Bodoky, Gyoergy] St Laszlo Teaching Hosp, Budapest, Hungary; [Dean, Andrew] St John God Hosp, Subiaco, WA, Australia; [Chen, Li-Tzong] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan 704, Taiwan; [Chen, Li-Tzong] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Shan, Yan-Shen; Chen, Li-Tzong] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Tainan 701, Taiwan; [Jameson, Gayle; Von Hoff, Daniel D.] TGen, Phoenix, AZ USA; [Jameson, Gayle; Von Hoff, Daniel D.] HonorHlth, Scottsdale, AZ USA; [Macarulla, Teresa] HUVH, Barcelona, Spain; [Macarulla, Teresa] VHIO, Barcelona, Spain; [Lee, Kyung-Hun] Seoul Natl Univ Hosp, Seoul 110744, South Korea; [Cunningham, David] Royal Marsden Hosp, London SW3 6JJ, England; [Blanc, Jean F.] Hop St Andre, Bordeaux, France; [Hubner, Richard A.] Christie NHS Fdn Trust, Manchester, Lancs, England; [Chiu, Chang-Fang] China Med Univ Hosp, Taichung, Taiwan; [Schwartsmann, Gilberto] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Siveke, Jens T.] Tech Univ Munich, Klinikum Rechts Isar, Munich, Germany; [Braiteh, Fadi] Comprehens Canc Ctr Nevada, Las Vegas, NV USA; [Moyo, Victor; Belanger, Bruce; Dhindsa, Navreet; Bayever, Eliel] Merrimack Pharmaceut, Cambridge, MA USA	Washington University (WUSTL); Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; St John of God Health Care; National Health Research Institutes - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Translational Genomics Research Institute; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Seoul National University (SNU); Seoul National University Hospital; Royal Marsden NHS Foundation Trust; CHU Bordeaux; Christie NHS Foundation Trust; China Medical University Taiwan; China Medical University Hospital - Taiwan; Technical University of Munich; Comprehensive Cancer Centers of Nevada	Chen, LT (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Tainan 704, Taiwan.	leochen@nhri.org.tw	Miquel, Josep Maria/AAG-3508-2019; Macarulla, Teresa/AAG-9230-2019; Schwartsmann, Gilberto/G-4256-2016; Siveke, Jens/AAQ-6170-2021	Schwartsmann, Gilberto/0000-0002-7850-1644; Cunningham, David/0000-0001-5158-1069; Macarulla, Teresa/0000-0002-5856-4082; Moyo, Victor/0000-0001-8470-5347; Raoul, Jean-Luc/0000-0001-6305-8953	Merrimack Pharmaceuticals	Merrimack Pharmaceuticals	This study was funded by Merrimack Pharmaceuticals. We thank the patients and their families who participated in this study; C Grace Yeh (PharmaEngine) and John Fitzgerald (Merrimack Pharmaceuticals) for input on the design and analysis of the study and review of the manuscript; Deyaa Adib (Baxalta) for review of the data and contributions to the manuscript; Istvan Molnar for analysis and review of the data and review of the report; and Khalid Mamlouk (Merrimack Pharmaceuticals) for help with the content and coordination of revisions of this manuscript. Medical writing support (funded by Merrimack Pharmaceuticals) was provided by Beth Kamp.	American Cancer Society, 2015, CANC FACTS FIG 2015; Assaf E, 2011, ONCOLOGY-BASEL, V80, P301, DOI 10.1159/000329803; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cantore M, 2004, ONCOLOGY-BASEL, V67, P93, DOI 10.1159/000080993; Cereda S, 2010, ANTICANCER RES, V30, P4785; Chang TC, 2015, CANCER CHEMOTH PHARM, V75, P579, DOI 10.1007/s00280-014-2671-x; Chibaudel B, 2015, P AM SOC CLIN ONC S3, V33; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Gebbia V, 2010, AM J CLIN ONCOL-CANC, V33, P461, DOI 10.1097/COC.0b013e3181b4e3b0; Gill S, 2014, P AM SOC CLIN ONC S5, V32; Kalra AV, 2014, CANCER RES, V74, P7003, DOI 10.1158/0008-5472.CAN-14-0572; Ko AH, 2013, BRIT J CANCER, V109, P920, DOI 10.1038/bjc.2013.408; Ko AH, 2008, CANCER INVEST, V26, P47, DOI 10.1080/07357900701681483; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; National Comprehensive Cancer Network, 2015, NCCN GUID TREATM CAN; Neuzillet C, 2012, WORLD J GASTROENTERO, V18, P4533, DOI 10.3748/wjg.v18.i33.4533; Oettle H, 2014, J CLIN ONCOL, V32, P2423, DOI 10.1200/JCO.2013.53.6995; Oh SY, 2010, INVEST NEW DRUG, V28, P343, DOI 10.1007/s10637-009-9265-1; Ramanathan RK, 26 EORTC NCI AACR S; Reni M, 2004, CANCER INVEST, V22, P688, DOI 10.1081/CNV-200032929; Roy AC, 2013, ANN ONCOL, V24, P1567, DOI 10.1093/annonc/mdt002; Smith NF, 2006, TOXICOL IN VITRO, V20, P163, DOI 10.1016/j.tiv.2005.06.045; Storniolo AM, 1999, CANCER, V85, P1261, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1261::AID-CNCR7>3.0.CO;2-T; Ulrich-Pur H, 2003, BRIT J CANCER, V88, P1180, DOI 10.1038/sj.bjc.6600883; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Walker EJ, 2014, WORLD J GASTROENTERO, V20, P2224, DOI 10.3748/wjg.v20.i9.2224; Yi SY, 2009, CANCER CHEMOTH PHARM, V63, P1141, DOI 10.1007/s00280-008-0839-y; Yoo C, 2009, BRIT J CANCER, V101, P1658, DOI 10.1038/sj.bjc.6605374; Zaniboni A, 2012, CANCER CHEMOTH PHARM, V69, P1641, DOI 10.1007/s00280-012-1875-1	29	648	677	2	75	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2016	387	10018					545	557		10.1016/S0140-6736(15)00986-1	http://dx.doi.org/10.1016/S0140-6736(15)00986-1			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3PV	26615328				2022-12-28	WOS:000369835800033
J	Robinson, TP; Wertheim, HFL; Kakkar, M; Kariuki, S; Bu, DP; Price, LB				Robinson, Timothy P.; Wertheim, Heiman F. L.; Kakkar, Manish; Kariuki, Samuel; Bu, Dengpan; Price, Lance B.			Animal production and antimicrobial resistance in the clinic	LANCET			English	Editorial Material							FOOD ANIMALS		[Robinson, Timothy P.] Int Livestock Res Inst, Livestock Syst & Environm, Nairobi 00100, Kenya; [Wertheim, Heiman F. L.] Univ Oxford, Clin Res Unit, Wellcome Trust MajorOverseas Programme, Hanoi, Vietnam; [Wertheim, Heiman F. L.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Wertheim, Heiman F. L.] Radboudumc, Dept Med Microbiol, Nijmegen, Netherlands; [Kakkar, Manish] Publ Hlth Fdn India, Gurgaon, India; [Kariuki, Samuel] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Bu, Dengpan] Chinese Acad Agr Sci, State Key Lab Anim Nutr, Inst Anim Sci, Beijing 100193, Peoples R China; [Price, Lance B.] George Washington Univ, Milken Inst Sch Publ Hlth, Washington, DC USA; [Price, Lance B.] Translat Genom Res Inst, Div Pathogen Gen, Flagstaff, AZ USA	CGIAR; International Livestock Research Institute (ILRI); University of Oxford; University of Oxford; Radboud University Nijmegen; Public Health Foundation of India; Kenya Medical Research Institute; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; George Washington University; Translational Genomics Research Institute	Robinson, TP (corresponding author), Int Livestock Res Inst, Livestock Syst & Environm, Nairobi 00100, Kenya.	t.robinson@cgiar.org	Wertheim, Heiman FL/F-3338-2016	Wertheim, Heiman FL/0000-0002-5003-5565	Medical Research Council [G1100783] Funding Source: Medline; MRC [G1100783] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aarestrup FM, 2001, ANTIMICROB AGENTS CH, V45, P2054, DOI 10.1128/AAC.45.7.2054-2059.2001; Ardal C, 2016, LANCET, V387, P296, DOI 10.1016/S0140-6736(15)00470-5; Chick-fil-A, 2014, ANT FREE CHICK; Dar OA, 2016, LANCET, V387, P285, DOI 10.1016/S0140-6736(15)00520-6; Dutil L, 2010, EMERG INFECT DIS, V16, P48, DOI 10.3201/eid1601.090729; Food and Drug Administration, 2012, GUID IND JUD US MED; Forslund K, 2013, GENOME RES, V23, P1163, DOI 10.1101/gr.155465.113; Grace D., 2015, REV EVIDENCE ANTIMIC, DOI [10.12774/eod_cr.june2015.graced, DOI 10.12774/EOD_CR.JUNE2015.GRACED]; Gupta A, 2004, EMERG INFECT DIS, V10, P1102, DOI 10.3201/eid1006.030635; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Larsen J, 2015, EURO SURVEILL, V20; Laxminarayan R., 2015, OECD FOOD AGR FISH P, V78, P78, DOI [10.1787/5js64kst5wvl-en, DOI 10.1787/5JS64KST5WVL-EN]; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Layne N, 2015, COSTCO WORKING END U; MATHER AE, 2011, P BIOL SCI, V279, P1630, DOI DOI 10.1098/rspb.2011.1975; Mendelson M, 2016, LANCET, V387, P188, DOI 10.1016/S0140-6736(15)00547-4; Nordstrom L, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00029; O'Neill J., 2014, REV ANTIMICROBIAL RE; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; WHO, 2011, CRIT IMP ANT HUM MED; Woolhouse M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0083; Zhang QQ, 2015, ENVIRON SCI TECHNOL, V49, P6772, DOI 10.1021/acs.est.5b00729	23	43	45	0	30	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2016	387	10014					E1	E3		10.1016/S0140-6736(15)00730-8	http://dx.doi.org/10.1016/S0140-6736(15)00730-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8LF	26603925				2022-12-28	WOS:000368055500001
J	Lehmann, J; Kleber, M				Lehmann, Johannes; Kleber, Markus			The contentious nature of soil organic matter	NATURE			English	Article							EARTH SYSTEM MODELS; HUMIC SUBSTANCES; BLACK CARBON; LITTER DECOMPOSITION; MOLECULAR-STRUCTURE; TEMPERATURE SENSITIVITY; ELECTRON-ACCEPTORS; GLASS-TRANSITION; CONCEPTUAL-MODEL; PLANT	The exchange of nutrients, energy and carbon between soil organic matter, the soil environment, aquatic systems and the atmosphere is important for agricultural productivity, water quality and climate. Long-standing theory suggests that soil organic matter is composed of inherently stable and chemically unique compounds. Here we argue that the available evidence does not support the formation of large-molecular-size and persistent 'humic substances' in soils. Instead, soil organic matter is a continuum of progressively decomposing organic compounds. We discuss implications of this view of the nature of soil organic matter for aquatic health, soil carbon-climate interactions and land management.	[Lehmann, Johannes] Cornell Univ, Coll Agr & Life Sci, Soil & Crop Sci, Sch Integrated Plant Sci, Ithaca, NY 14853 USA; [Lehmann, Johannes] Cornell Univ, Atkinson Ctr Sustainable Future, Ithaca, NY USA; [Kleber, Markus] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA; [Kleber, Markus] Leibniz Zentrum Agrarlandschaftsforsch ZALF, Inst Bodenlandschaftsforsch, Muncheberg, Germany	Cornell University; Cornell University; Oregon State University; Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF)	Lehmann, J (corresponding author), Cornell Univ, Coll Agr & Life Sci, Soil & Crop Sci, Sch Integrated Plant Sci, Ithaca, NY 14853 USA.	CL273@cornell.edu	Kleber, Markus/M-1381-2019; Lehmann, Johannes/H-2682-2014	Kleber, Markus/0000-0002-5681-2361; Lehmann, Johannes/0000-0002-4701-2936				ABER JD, 1990, CAN J BOT, V68, P2201, DOI 10.1139/b90-287; Achard F.K., 1786, CRELLS CHEM ANN, V2, P391; Aristilde L, 2013, ENVIRON TOXICOL CHEM, V32, P1467, DOI 10.1002/etc.2214; Arrhenius S., 1889, Z PHYS CHEM, V4U, P226, DOI [10.1515/zpch-1889-0416, DOI 10.1515/ZPCH-1889-0416]; Baldock J., 2000, HDB SOIL SCI, pB25, DOI DOI 10.1038/194324B0; Baldock J. A., 2011, HDB SOIL SCI RESOURC; BALDOCK JA, 1992, BIOGEOCHEMISTRY, V16, P1, DOI 10.1007/BF02402261; Berbara RLL, 2014, PHYSIOLOGICAL MECH A, V1, P297; Berg B., 1980, Ecological Bulletins, V32, P373; Bocanegra MP, 2006, COMMUN SOIL SCI PLAN, V37, P239, DOI 10.1080/00103620500408779; Bonan GB, 2013, GLOBAL CHANGE BIOL, V19, P957, DOI 10.1111/gcb.12031; Bosatta E, 1999, SOIL BIOL BIOCHEM, V31, P1889, DOI 10.1016/S0038-0717(99)00105-4; BOSATTA E, 1991, AM NAT, V138, P227, DOI 10.1086/285213; Brady N. C., 2008, NATURE PROPERTIES SO; Burdon J, 2001, SOIL SCI, V166, P752, DOI 10.1097/00010694-200111000-00004; Calvo P, 2014, PLANT SOIL, V383, P3, DOI [10.1007/s11104-014-2131-8, 10.1109/BigData.2014.7004461]; CAMPBELL CA, 1967, SOIL SCI, V104, P217, DOI 10.1097/00010694-196709000-00010; Chen CM, 2014, ENVIRON SCI TECHNOL, V48, P6678, DOI 10.1021/es405485a; Chen J, 1998, NATURE, V392, P558, DOI 10.1038/33305; Chilom G, 2005, ORG GEOCHEM, V36, P1339, DOI 10.1016/j.orggeochem.2005.06.007; Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Conant RT, 2008, GLOBAL CHANGE BIOL, V14, P868, DOI 10.1111/j.1365-2486.2008.01541.x; Cotrufo MF, 2013, GLOBAL CHANGE BIOL, V19, P988, DOI 10.1111/gcb.12113; Craine JM, 2010, NAT GEOSCI, V3, P854, DOI [10.1038/ngeo1009, 10.1038/NGEO1009]; Dal Ferro N, 2015, SOIL SCI SOC AM J, V79, P1008, DOI 10.2136/sssaj2015.03.0097; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Erhagen B, 2013, GLOBAL CHANGE BIOL, V19, P3858, DOI 10.1111/gcb.12342; Essington, 2004, SOIL WATER CHEM INTE; Fakour H, 2014, J HAZARD MATER, V279, P569, DOI 10.1016/j.jhazmat.2014.07.039; Forbes MS, 2006, SCI TOTAL ENVIRON, V370, P190, DOI 10.1016/j.scitotenv.2006.06.007; Gillespie AW, 2011, SOIL BIOL BIOCHEM, V43, P766, DOI 10.1016/j.soilbio.2010.12.010; Gleich GJ, 2013, EOSINOPHILS IN HEALTH AND DISEASE, P1, DOI 10.1016/B978-0-12-394385-9.00001-8; Gramss G, 1999, BIODEGRADATION, V10, P51, DOI 10.1023/A:1008368923383; Gramss G, 1999, MICROB ECOL, V37, P140, DOI 10.1007/s002489900138; Guggenberger G, 2005, SOIL BIOL, V3, P85; Hamer U, 2004, ORG GEOCHEM, V35, P823, DOI 10.1016/j.orggeochem.2004.03.003; Hatcher PG, 2004, MAR CHEM, V92, P5, DOI 10.1016/j.marchem.2004.06.014; Hayes M. H. B., 1990, Soil colloids and their associations in aggregates., P245; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Hedges J. I., 1988, Humic substances and their role in the environment., P45; Hedges JI, 2000, ORG GEOCHEM, V31, P945, DOI 10.1016/S0146-6380(00)00096-6; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; Hedges JI, 1997, ORG GEOCHEM, V27, P319, DOI 10.1016/S0146-6380(97)00056-9; Hedges JI, 1999, MAR CHEM, V65, P55, DOI 10.1016/S0304-4203(99)00010-9; Heymann K, 2014, GEODERMA, V235, P163, DOI 10.1016/j.geoderma.2014.07.011; Horwath W., 2015, SOIL MICROBIOLOGY EC, Vthird, P339, DOI [10.1016/B978-0-12-415955-6.00012-8, DOI 10.1016/B978-0-12-415955-6.00012-8]; Huang P.M., 2009, BIOPHYSICO CHEM PROC, P41, DOI DOI 10.1002/9780470494950.CH2; International Humic Substances Society (IHSS), 2015, WHAT AR HUM SUBST; Janzen HH, 2015, EUR J SOIL SCI, V66, P19, DOI 10.1111/ejss.12194; Jenkinson DS, 2008, EUR J SOIL SCI, V59, P400, DOI 10.1111/j.1365-2389.2008.01026.x; JENKINSON DS, 1977, SOIL SCI, V123, P298, DOI 10.1097/00010694-197705000-00005; Kappler A, 2014, ENVIRON SCI TECH LET, V1, P339, DOI 10.1021/ez5002209; Keiluweit M, 2015, NAT CLIM CHANGE, V5, P588, DOI 10.1038/nclimate2580; Keiluweit M, 2010, ENVIRON SCI TECHNOL, V44, P1247, DOI 10.1021/es9031419; Kelleher BP, 2006, ENVIRON SCI TECHNOL, V40, P4605, DOI 10.1021/es0608085; Keller JK, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00382.1; Kleber M, 2015, ADV AGRON, V130, P1, DOI 10.1016/bs.agron.2014.10.005; Klotzbucher T, 2011, ECOLOGY, V92, P1052, DOI 10.1890/i0012-9658-92-5-1052; Kluepfel L, 2014, ENVIRON SCI TECHNOL, V48, P5601, DOI 10.1021/es500906d; Klupfel L, 2014, NAT GEOSCI, V7, P195, DOI 10.1038/NGEO2084; Knicker H, 2008, ORG GEOCHEM, V39, P935, DOI 10.1016/j.orggeochem.2008.03.021; Knicker H, 2007, BIOGEOCHEMISTRY, V85, P91, DOI 10.1007/s10533-007-9104-4; Kogel-Knabner I, 2002, SOIL BIOL BIOCHEM, V34, P139, DOI 10.1016/S0038-0717(01)00158-4; Kononova M. M., 1961, SOIL ORGANIC MATTER; Koven CD, 2013, BIOGEOSCIENCES, V10, P7109, DOI 10.5194/bg-10-7109-2013; Kuhn Thomas S., 1962, STRUCTURE SCI REVOLU; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Leboeuf EJ, 2000, ENVIRON SCI TECHNOL, V34, P3623, DOI 10.1021/es991103o; Lehmann J, 2008, NAT GEOSCI, V1, P238, DOI 10.1038/ngeo155; Lehmann J, 2007, BIOGEOCHEMISTRY, V85, P45, DOI 10.1007/s10533-007-9105-3; Lehmann J, 2008, NAT GEOSCI, V1, P832, DOI 10.1038/ngeo358; Lorenz K, 2007, GEODERMA, V142, P1, DOI 10.1016/j.geoderma.2007.07.013; Lovley DR, 1996, NATURE, V382, P445, DOI 10.1038/382445a0; Maillard LC, 1916, ANN CHIM FRANCE, V5, P258; Marin-Spiotta E, 2014, BIOGEOCHEMISTRY, V117, P279, DOI 10.1007/s10533-013-9949-7; Martinez CM, 2013, APPL MICROBIOL BIOT, V97, P9897, DOI 10.1007/s00253-013-5190-5; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Melton ED, 2014, NAT REV MICROBIOL, V12, P797, DOI 10.1038/nrmicro3347; Miltner A, 2012, BIOGEOCHEMISTRY, V111, P41, DOI 10.1007/s10533-011-9658-z; Mylotte R, 2015, J SOIL SEDIMENT, V15, P211, DOI 10.1007/s11368-014-0970-9; Myneni SCB, 1999, SCIENCE, V286, P1335, DOI 10.1126/science.286.5443.1335; Nebbioso A, 2012, ANAL CHIM ACTA, V720, P77, DOI 10.1016/j.aca.2012.01.027; Newman DK, 2000, NATURE, V405, P94, DOI 10.1038/35011098; Nunan N, 2015, SOIL BIOL BIOCHEM, V88, P128, DOI 10.1016/j.soilbio.2015.05.018; Parton WJ, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001193; Piccolo A, 2001, SOIL SCI, V166, P810, DOI 10.1097/00010694-200111000-00007; Rice JA, 2001, SOIL SCI, V166, P848, DOI 10.1097/00010694-200111000-00009; Richardson S. D., 2012, HDB ENV CHEM EMERGIN, V20, P93, DOI DOI 10.1007/698_2011_125; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; Riley WJ, 2014, GEOSCI MODEL DEV, V7, P1335, DOI 10.5194/gmd-7-1335-2014; Rodionov A, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003669; Rose MT, 2014, ADV AGRON, V124, P37, DOI 10.1016/B978-0-12-800138-7.00002-4; Schaumann GE, 2006, J PLANT NUTR SOIL SC, V169, P145, DOI 10.1002/jpln.200521785; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Schnitzer M., 2011, ADV AGRON, P143, DOI DOI 10.1016/13978-0-12-386473-4.00003-8; Schumacher M, 2005, ENVIRON SCI TECHNOL, V39, P9094, DOI 10.1021/es050099f; Schurig C, 2013, BIOGEOCHEMISTRY, V113, P595, DOI 10.1007/s10533-012-9791-3; Sierra CA, 2015, J ADV MODEL EARTH SY, V7, P335, DOI 10.1002/2014MS000358; Skjemstad JO, 1996, AUST J SOIL RES, V34, P251, DOI 10.1071/SR9960251; Sollins P, 1996, GEODERMA, V74, P65, DOI 10.1016/S0016-7061(96)00036-5; Solomon D, 2007, GEOCHIM COSMOCHIM AC, V71, P2285, DOI 10.1016/j.gca.2007.02.014; Spaccini R, 2002, SOIL BIOL BIOCHEM, V34, P1839, DOI 10.1016/S0038-0717(02)00197-9; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Stevenson F. J., 1982, Humus chemistry, genesis, composition, reactions.; Stockmann U, 2013, AGR ECOSYST ENVIRON, V164, P80, DOI 10.1016/j.agee.2012.10.001; Stumm W., 1981, AQUATIC CHEM INTRO E; Sutton R, 2005, ENVIRON SCI TECHNOL, V39, P9009, DOI 10.1021/es050778q; Tan KH, 2014, BOOKS SOIL PLANT ENV, P1, DOI 10.1201/b17037; Tang WW, 2014, SCI TOTAL ENVIRON, V468, P1014, DOI 10.1016/j.scitotenv.2013.09.044; Tatzber M, 2009, SOIL SCI SOC AM J, V73, P744, DOI 10.2136/sssaj2008.0235; Todd-Brown KEO, 2013, BIOGEOSCIENCES, V10, P1717, DOI 10.5194/bg-10-1717-2013; Todd-Brown KEO, 2012, BIOGEOCHEMISTRY, V109, P19, DOI 10.1007/s10533-011-9635-6; Treseder KK, 2012, BIOGEOCHEMISTRY, V109, P7, DOI 10.1007/s10533-011-9636-5; Trevisan S, 2011, ENVIRON EXP BOT, V74, P45, DOI 10.1016/j.envexpbot.2011.04.017; Trumbore SE, 1997, P NATL ACAD SCI USA, V94, P8284, DOI 10.1073/pnas.94.16.8284; Uchimiya M, 2010, AQUAT GEOCHEM, V16, P173, DOI 10.1007/s10498-009-9077-0; van Bemmelen J. M., 1888, LANDW VERS STAT, V35, P69; von Lutzow M, 2006, EUR J SOIL SCI, V57, P426, DOI 10.1111/j.1365-2389.2006.00809.x; Waksman S. A., 1936, HUMUS ORIGIN CHEM CO; Wang WD, 2014, CHEM ENG J, V256, P137, DOI 10.1016/j.cej.2014.06.113; WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242; Wershaw R. L., 2004, 20045121 US GEOL SUR; Wiesenberg GLB, 2004, ORG GEOCHEM, V35, P1371, DOI [10.1016/j.orggeochem.2004.03.009, 10.1016/S0146-6380(04)00122-6]; Yang J, 2014, ENVIRON SCI TECHNOL, V48, P13776, DOI 10.1021/es504038a	125	1656	1745	317	2515	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					60	68		10.1038/nature16069	http://dx.doi.org/10.1038/nature16069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26595271				2022-12-28	WOS:000365606000049
J	Wall, DH; Nielsen, UN; Six, J				Wall, Diana H.; Nielsen, Uffe N.; Six, Johan			Soil biodiversity and human health	NATURE			English	Article							PARTICULATE MATTER; ECOSYSTEM SERVICES; SPECIES-DIVERSITY; ASIAN DUST; FOOD-WEB; COMMUNITIES; ASSEMBLAGES; MANAGEMENT; DISPERSAL; INFECTION	Soil biodiversity is increasingly recognized as providing benefits to human health because it can suppress disease-causing soil organisms and provide clean air, water and food. Poor land-management practices and environmental change are, however, affecting belowground communities globally, and the resulting declines in soil biodiversity reduce and impair these benefits. Importantly, current research indicates that soil biodiversity can be maintained and partially restored if managed sustainably. Promoting the ecological complexity and robustness of soil biodiversity through improved management practices represents an underutilized resource with the ability to improve human health.	[Wall, Diana H.] Colorado State Univ, Sch Global Environm Sustainabil, Ft Collins, CO 80523 USA; [Wall, Diana H.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Nielsen, Uffe N.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 2751, Australia; [Six, Johan] ETH, Swiss Fed Inst Technol, Dept Environm Syst Sci, CH-8092 Zurich, Switzerland	Colorado State University; Colorado State University; Western Sydney University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Wall, DH (corresponding author), Colorado State Univ, Sch Global Environm Sustainabil, Ft Collins, CO 80523 USA.	diana.wall@colostate.edu	six, johan/J-5228-2015	six, johan/0000-0001-9336-4185; Nielsen, Uffe N/0000-0003-2400-7453	Directorate For Geosciences [1115245] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Abraham J, 2013, PROCESS BIOCHEM, V48, P1559, DOI 10.1016/j.procbio.2013.06.034; Alavanja MCR, 2013, CA-CANCER J CLIN, V63, P120, DOI 10.3322/caac.21170; ANDERSEN DC, 1987, Q REV BIOL, V62, P261, DOI 10.1086/415512; Anderson JO, 2012, J MED TOXICOL, V8, P166, DOI 10.1007/s13181-011-0203-1; Bailey RT, 2015, J HYDROL, V521, P341, DOI 10.1016/j.jhydrol.2014.11.079; Bardgett RD, 2014, NATURE, V515, P505, DOI 10.1038/nature13855; Bates ST, 2013, ISME J, V7, P652, DOI 10.1038/ismej.2012.147; Bender SF, 2015, J APPL ECOL, V52, P228, DOI 10.1111/1365-2664.12351; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; Brevik EC, 2015, SOIL-GERMANY, V1, P35, DOI 10.5194/soil-1-35-2015; Brevik E. C., 2012, SOILS HUMAN HLTH; Brevik EC., 2013, SOIL HORIZ, V54, P1, DOI DOI 10.2136/SH12-11-0030; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Campos-Herrera R., 2015, NEMATODE PATHOGENESI; Cary SC, 2014, NAT REV MICROBIOL, V12, P789, DOI 10.1038/nrmicro3382; Charles L, 2005, J BACTERIOL, V187, P5700, DOI 10.1128/JB.187.16.5700-5708.2005; Chauvat M, 2011, FOREST ECOL MANAG, V262, P317, DOI 10.1016/j.foreco.2011.03.037; Corbett CJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-48; Costa SR, 2012, OECOLOGIA, V170, P1053, DOI 10.1007/s00442-012-2359-z; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; de Vries Franciska T, 2013, Proc Natl Acad Sci U S A, V110, P14296, DOI 10.1073/pnas.1305198110; de Vries FT, 2012, NAT CLIM CHANGE, V2, P276, DOI [10.1038/NCLIMATE1368, 10.1038/nclimate1368]; Dominati E, 2010, ECOL ECON, V69, P1858, DOI 10.1016/j.ecolecon.2010.05.002; Epstein L, 2014, ANNU REV PHYTOPATHOL, V52, P377, DOI 10.1146/annurev-phyto-102313-045900; Evans TA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1257; Ferris H, 2015, SOIL BIOL BIOCHEM, V85, P101, DOI 10.1016/j.soilbio.2015.02.037; Ferris H, 2012, ACTA OECOL, V40, P11, DOI 10.1016/j.actao.2012.02.003; Fisher FS, 2007, ANN NY ACAD SCI, V1111, P47, DOI 10.1196/annals.1406.031; Frankenberger WT, 2001, BIOFACTORS, V14, P241, DOI 10.1002/biof.5520140130; Frey SD, 1999, SOIL BIOL BIOCHEM, V31, P573, DOI 10.1016/S0038-0717(98)00161-8; Ganz HH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002903; Garrison VH, 2003, BIOSCIENCE, V53, P469, DOI 10.1641/0006-3568(2003)053[0469:AAADFD]2.0.CO;2; Gehring CA, 2002, ECOL LETT, V5, P540, DOI 10.1046/j.1461-0248.2002.00353.x; GRAY NF, 1983, PLANT SOIL, V73, P293, DOI 10.1007/BF02197725; Haahtela T, 2012, ASIA PAC ALLERGY, V2, P275, DOI 10.5415/apallergy.2012.2.4.275; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Jeffery S, 2011, JOINT RES CTR SCI TE, P1; Johnson PTJ, 2013, NATURE, V494, P230, DOI 10.1038/nature11883; Johnson PTJ, 2012, ECOLOGY, V93, P56, DOI 10.1890/11-0636.1; Kay AB, 2000, BRIT MED BULL, V56, P843, DOI 10.1258/0007142001903481; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Khieu V., 2014, PLOS NEGL TROP DIS, V8; Khoshgoftarmanesh R., 2008, DEV USES BIOFORTIFIE; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Madden NM, 2008, ATMOS ENVIRON, V42, P3795, DOI 10.1016/j.atmosenv.2007.12.058; Matricardi PM, 2000, CLIN EXP ALLERGY, V30, P1506, DOI 10.1046/j.1365-2222.2000.00994.x; Myers SS, 2009, ANNU REV ENV RESOUR, V34, P223, DOI 10.1146/annurev.environ.033108.102650; Nguyen C, 2013, CLIN MICROBIOL REV, V26, P505, DOI 10.1128/CMR.00005-13; Nielsen UN, 2015, ANNU REV ENV RESOUR, V40, P63, DOI 10.1146/annurev-environ-102014-021257; Nkem JN, 2006, POLAR BIOL, V29, P346, DOI 10.1007/s00300-005-0061-x; Nordstrom KF, 2004, GEODERMA, V121, P157, DOI 10.1016/j.geoderma.2003.11.012; Oliver MA, 2015, EUR J SOIL SCI, V66, P257, DOI 10.1111/ejss.12216; Pappagianis D., 2013, ESSENTIALS MED GEOLO; Park JW, 2005, RESPIROLOGY, V10, P470, DOI 10.1111/j.1440-1843.2005.00728.x; Penton CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093893; Pepper IL, 2009, CRIT REV ENV SCI TEC, V39, P416, DOI 10.1080/10643380701664748; Prichard R, 2009, INFECT DIS-SER, P621, DOI 10.1007/978-1-59745-180-2_44; Quinton JN, 2010, NAT GEOSCI, V3, P311, DOI [10.1038/NGEO838, 10.1038/ngeo838]; Ramirez KS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1988; Rayu S, 2012, BIODEGRADATION, V23, P917, DOI 10.1007/s10532-012-9576-3; Rillig MC, 2006, NEW PHYTOL, V171, P41, DOI 10.1111/j.1469-8137.2006.01750.x; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Rook GAW, 2010, CLIN EXP IMMUNOL, V160, P70, DOI 10.1111/j.1365-2249.2010.04133.x; Ruokolainen L, 2015, ALLERGY, V70, P195, DOI 10.1111/all.12545; Sanchez-Moreno S, 2007, AGR ECOSYST ENVIRON, V119, P75, DOI 10.1016/j.agee.2006.06.012; Schar F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002288; Schenker M, 2000, ENVIRON HEALTH PERSP, V108, P661, DOI 10.2307/3454402; Searle CL, 2011, P NATL ACAD SCI USA, V108, P16322, DOI 10.1073/pnas.1108490108; Six J, 2006, SOIL SCI SOC AM J, V70, P555, DOI 10.2136/sssaj2004.0347; Smith KL, 2000, J CLIN MICROBIOL, V38, P3780, DOI 10.1128/JCM.38.10.3780-3784.2000; Sprigg WA, 2014, AEOLIAN RES, V14, P53, DOI 10.1016/j.aeolia.2014.03.001; Stirling G. R., 2014, Biological control of plant-parasitic nematodes: soil ecosystem management in sustainable agriculture, DOI 10.1079/9781780644158.0000; Stirling GR, 2011, PROG BIOL CONTROL, V11, P1, DOI 10.1007/978-1-4020-9648-8_1; Suzan G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005461; Tabor JA, 2011, J EXPO SCI ENV EPID, V21, P197, DOI 10.1038/jes.2009.67; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; Thiele-Bruhn S, 2012, CURR OPIN ENV SUST, V4, P523, DOI 10.1016/j.cosust.2012.06.004; Tiemann LK, 2015, ECOL LETT, V18, P761, DOI 10.1111/ele.12453; Tsiafouli MA, 2015, GLOBAL CHANGE BIOL, V21, P973, DOI 10.1111/gcb.12752; van Elsas JD, 2012, P NATL ACAD SCI USA, V109, P1159, DOI 10.1073/pnas.1109326109; van Groenigen JW, 2014, SCI REP-UK, V4, DOI 10.1038/srep06365; Wall DH, 2013, SOIL ECOLOGY AND ECOSYSTEM SERVICES, P1; Wall DH, 2015, SCIENCE, V347, P695, DOI 10.1126/science.aaa8493; Wall DH, 2010, NAT GEOSCI, V3, P297, DOI 10.1038/ngeo860; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010; World Health Organization, 2015, CONNECTING GLOBAL PR; Wu TH, 2011, P NATL ACAD SCI USA, V108, P17720, DOI 10.1073/pnas.1103824108	89	324	341	43	930	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					69	76		10.1038/nature15744	http://dx.doi.org/10.1038/nature15744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26595276				2022-12-28	WOS:000365606000050
J	Gostin, LO; DeBartolo, MC; Friedman, EA				Gostin, Lawrence O.; DeBartolo, Mary C.; Friedman, Eric A.			The International Health Regulations 10 years on: the governing framework for global health security	LANCET			English	Editorial Material									[Gostin, Lawrence O.; DeBartolo, Mary C.; Friedman, Eric A.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA.	gostin@law.georgetown.edu						[Anonymous], 2015, ASS PRESS; Centers for Disease Control and Prevention (CDC), MIDDL E RESP SYNDR M; Ebola Interim Assessment Panel, 2015, REP EB INT ASS PAN; Lucey DR, 2015, MERS KOREA WHY THIS; Smith M, 2014, EBOLA TOLL RISES UNP; The Lancet, 2014, LANCET, V384, P1321; US Department of Health and Human Services, 2014, GLOB HLTH SEC AG WOR; WHO, 2015, REP EB INT ASS PAN; WHO, 2009, SWIN INFL STAT WHO D; WHO, FREQ ASK QUEST IHR E; WHO, WHO DIR GEN ADDR G7; WHO, 2015, WHO STAT 8 M IHR EM; World Bank, 2015, PAND EM FAC FREQ ASK PAND EM FAC FREQ ASK; World Health Organization, 2009, CURR WHO PHAS PAND; World Health Organization, 2015, 2014 EB VIR DIS OUTB; World Health Organization (WHO), 2013, EM RESP FRAM	16	30	32	3	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 28	2015	386	10009					2222	2226		10.1016/S0140-6736(15)00948-4	http://dx.doi.org/10.1016/S0140-6736(15)00948-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8YW	26615327	Green Published, Bronze			2022-12-28	WOS:000365992600033
J	Jiang, XL; Shen, S; Cadwell, CR; Berens, P; Sinz, F; Ecker, AS; Patel, S; Tolias, AS				Jiang, Xiaolong; Shen, Shan; Cadwell, Cathryn R.; Berens, Philipp; Sinz, Fabian; Ecker, Alexander S.; Patel, Saumil; Tolias, Andreas S.			Principles of connectivity among morphologically defined cell types in adult neocortex	SCIENCE			English	Article							GABAERGIC INTERNEURONS; PYRAMIDAL NEURONS; VISUAL-CORTEX; RAT NEOCORTEX; INHIBITORY INTERNEURONS; SOMATOSENSORY CORTEX; CORTICAL-NEURONS; CEREBRAL-CORTEX; INTEGRATION; RECEPTORS	Since the work of Ramon y Cajal in the late 19th and early 20th centuries, neuroscientists have speculated that a complete understanding of neuronal cell types and their connections is key to explaining complex brain functions. However, a complete census of the constituent cell types and their wiring diagram in mature neocortex remains elusive. By combining octuple whole-cell recordings with an optimized avidin-biotin-peroxidase staining technique, we carried out a morphological and electrophysiological census of neuronal types in layers 1, 2/3, and 5 of mature neocortex and mapped the connectivity between more than 11,000 pairs of identified neurons. We categorized 15 types of interneurons, and each exhibited a characteristic pattern of connectivity with other interneuron types and pyramidal cells. The essential connectivity structure of the neocortical microcircuit could be captured by only a few connectivity motifs.	[Jiang, Xiaolong; Shen, Shan; Cadwell, Cathryn R.; Berens, Philipp; Sinz, Fabian; Ecker, Alexander S.; Patel, Saumil; Tolias, Andreas S.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Berens, Philipp; Ecker, Alexander S.; Tolias, Andreas S.] Bernstein Ctr Computat Neurosci, Tubingen, Germany; [Berens, Philipp] Univ Tubingen, Inst Ophthalm Res, Tubingen, Germany; [Berens, Philipp; Ecker, Alexander S.] Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany; [Berens, Philipp; Ecker, Alexander S.] Univ Tubingen, Inst Theoret Phys, Tubingen, Germany; [Ecker, Alexander S.] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	Baylor College of Medicine; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Max Planck Society	Jiang, XL (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	xiaolonj@bcm.edu; astolias@bcm.edu	Ecker, Alexander S/A-5184-2010; Cadwell, Cathryn/AAD-7800-2022; Berens, Philipp/A-5653-2009	Ecker, Alexander S/0000-0003-2392-5105; Berens, Philipp/0000-0002-0199-4727; Shen, Shan/0000-0002-9621-0314; Cadwell, Cathryn/0000-0003-1963-8285	McKnight Scholar Award; Arnold and Mabel Beckman Foundation Young Investigator Award; Deutsche Forschungsgemeinschaft (DFG) [EXC 307]; German Federal Ministry of Education and Research (BMBF; BCCN Tubingen) [FKZ 01GQ1002];  [DP1EY023176];  [DP1OD008301];  [R21EB016223];  [P30EY002520];  [T32EY07001];  [F30MH095440];  [T32GM007330];  [T32EB006350]; NATIONAL EYE INSTITUTE [DP1EY023176, P30EY002520, T32EY007001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB006350, R21EB016223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH095440] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD008301] Funding Source: NIH RePORTER	McKnight Scholar Award; Arnold and Mabel Beckman Foundation Young Investigator Award; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF; BCCN Tubingen)(Federal Ministry of Education & Research (BMBF)); ; ; ; ; ; ; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants DP1EY023176, DP1OD008301, and R21EB016223 to A.S.T.; the McKnight Scholar Award to A.S.T.; the Arnold and Mabel Beckman Foundation Young Investigator Award to A.S.T.; P30EY002520 and T32EY07001; the Deutsche Forschungsgemeinschaft (DFG, EXC 307), and the German Federal Ministry of Education and Research (BMBF; BCCN Tubingen, FKZ 01GQ1002). C.R.C. is supported by F30MH095440, T32GM007330, and T32EB006350. We thank P. Saggau and J. Reimer for help building the experiment rigs, G. Denfield for comments for the manuscript, and D. Yatsenko for help with data analysis. The electrophysiological data presented in this manuscript are stored in the laboratory computers and tabulated in the main paper and in the supplementary materials. The morphology of each neuron is preserved in the slices, and many have been digitized and stored in the laboratory computers. The data processing chain was assembled using the DataJoint library in MATLAB and Python (http://datajoint.github.com)	Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Buchanan KA, 2012, NEURON, V75, P451, DOI 10.1016/j.neuron.2012.06.017; Cauli B, 1997, J NEUROSCI, V17, P3894; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chittajallu R, 2013, NAT NEUROSCI, V16, P13, DOI 10.1038/nn.3284; Dajani D. R., 2015, AUTISM RES, Vxxx, pxxx; Garcia NVD, 2015, NAT NEUROSCI, V18, P393, DOI 10.1038/nn.3946; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; Dumitriu D, 2007, CEREB CORTEX, V17, P81, DOI 10.1093/cercor/bhj126; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hestrin S, 1996, J NEUROSCI, V16, P5290; Hu H, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00195; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Kawaguchi Y, 1996, J NEUROSCI, V16, P2701; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Le Bon-Jegoa M, 2007, FRONT NEUROSCI-SWITZ, V1, P123, DOI 10.3389/neuro.01.1.1.009.2007; Le Magueresse C, 2013, NEURON, V77, P388, DOI 10.1016/j.neuron.2013.01.011; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Menuz K, 2008, J NEUROSCI, V28, P10599, DOI 10.1523/JNEUROSCI.2732-08.2008; Meyer HS, 2011, P NATL ACAD SCI USA, V108, P16807, DOI 10.1073/pnas.1113648108; Nassarlt M, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00020; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Porter JT, 1998, EUR J NEUROSCI, V10, P3617, DOI 10.1046/j.1460-9568.1998.00367.x; Reimer J, 2014, NEURON, V84, P355, DOI 10.1016/j.neuron.2014.09.033; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Ting JT, 2014, METHODS MOL BIOL, V1183, P221, DOI 10.1007/978-1-4939-1096-0_14; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Wozny C, 2011, CEREB CORTEX, V21, P1818, DOI 10.1093/cercor/bhq257; Xiang ZX, 2003, J NEUROPHYSIOL, V89, P1278, DOI 10.1152/jn.00533.2002; Xu XM, 2009, J NEUROSCI, V29, P70, DOI 10.1523/JNEUROSCI.4104-08.2009	39	432	438	4	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264							aac9462	10.1126/science.aac9462	http://dx.doi.org/10.1126/science.aac9462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY5BJ	26612957	Green Accepted			2022-12-28	WOS:000366422600034
J	Chen, C; Buhl, E; Xu, M; Croset, V; Rees, JS; Lilley, KS; Benton, R; Hodge, JJL; Stanewsky, R				Chen, Chenghao; Buhl, Edgar; Xu, Min; Croset, Vincent; Rees, Johanna S.; Lilley, Kathryn S.; Benton, Richard; Hodge, James J. L.; Stanewsky, Ralf			Drosophila Ionotropic Receptor 25a mediates circadian clock resetting by temperature	NATURE			English	Article							GLUTAMATE RECEPTORS; SYNCHRONIZATION; CRYPTOCHROME; EXPRESSION; CHANNEL; GENE; HYGROSENSATION; PREFERENCE; MUTANTS; NEURONS	Circadian clocks are endogenous timers adjusting behaviour and physiology with the solar day(1). Synchronized circadian clocks improve fitness(2) and are crucial for our physical and mental well-being(3). Visual and non-visual photoreceptors are responsible for synchronizing circadian clocks to light(4,5), but clock-resetting is also achieved by alternating day and night temperatures with only 2-4 degrees C difference(6-8). This temperature sensitivity is remarkable considering that the circadian clock period (similar to 24 h) is largely independent of surrounding ambient temperatures(1,8). Here we show that Drosophila Ionotropic Receptor 25a (IR25a) is required for behavioural synchronization to low-amplitude temperature cycles. This channel is expressed in sensory neurons of internal stretch receptors previously implicated in temperature synchronization of the circadian clock(9). IR25a is required for temperature-synchronized clock protein oscillations in subsets of central clock neurons. Extracellular leg nerve recordings reveal temperature-and IR25a-dependent sensory responses, and IR25a misexpression confers temperature-dependent firing of heterologous neurons. We propose that IR25a is part of an input pathway to the circadian clock that detects small temperature differences. This pathway operates in the absence of known 'hot' and 'cold' sensors in the Drosophila antenna(10,11), revealing the existence of novel periphery-to-brain temperature signalling channels.	[Chen, Chenghao; Xu, Min; Stanewsky, Ralf] UCL, Dept Cell & Dev Biol, London WC1E 6DE, England; [Buhl, Edgar; Hodge, James J. L.] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Croset, Vincent; Benton, Richard] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Rees, Johanna S.; Lilley, Kathryn S.] Univ Cambridge, Dept Biochem, Cambridge Ctr Prote, Cambridge CB2 1QW, England; [Rees, Johanna S.; Lilley, Kathryn S.] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge CB2 1QW, England	University of London; University College London; University of Bristol; University of Lausanne; University of Cambridge; University of Cambridge	Chen, C (corresponding author), UCL, Dept Cell & Dev Biol, 21 Univ St, London WC1E 6DE, England.	r.stanewsky@ucl.ac.uk	Lilley, Kathryn/ABF-5787-2020; Chen, Chenghao/AAI-7478-2021; Stanewsky, Ralf/ABB-9193-2021; Buhl, Edgar/AAA-9249-2019	Lilley, Kathryn/0000-0003-0594-6543; Buhl, Edgar/0000-0003-1274-5870; Hodge, James/0000-0003-4741-2363; Rees, Johanna/0000-0003-2066-8617; Croset, Vincent/0000-0001-9696-766X; Stanewsky, Ralf/0000-0001-8238-6864; Chen, Chenghao/0000-0003-4913-4213	BBSRC [BB/H001204, BB/J0-18589/-17221]; CSC PhD fellowship; Boehringer Ingelheim Foundation Fellowship; European Research Council [205202, 615094]; Wellcome Trust [099135/Z/12/Z]; BBSRC [BB/H001204/1, BB/J017221/1, BB/J018589/1, BB/J018589/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H001204/1, BB/J018589/2, BB/J017221/1, BB/J018589/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CSC PhD fellowship; Boehringer Ingelheim Foundation Fellowship(Boehringer Ingelheim); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank P. Emery, J. Albert, J. Jepson, P. Garrity, and A. Samuel for discussions and sharing of unpublished results, J. Giebultowicz for anti-TIM antibodies, J. Albert and J. Jepson for fly stocks, C. Tardieu and R. Kavlie for help with qPCR, D. Carr for assistance with the temperature recording setup, and M. Ogueta-Gutierrez for help with figure preparations. The drawing for Fig. 4a was generated by Polygonal Tree (http://polygonaltree.co.uk/). This work was supported by BBSRC grants BB/H001204 to R.S., BB/J0-18589/-17221 to R.S. and J.J.L.H., and a CSC PhD fellowship to C.C.V.C. was supported by a Boehringer Ingelheim Foundation Fellowship. Research in R.B.'s laboratory was supported by European Research Council Starting Independent Researcher and Consolidator Grants (205202 and 615094). Mass spectrometry analysis was supported by Wellcome Trust grant 099135/Z/12/Z.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Bechtold DA, 2010, TRENDS PHARMACOL SCI, V31, P191, DOI 10.1016/j.tips.2010.01.002; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Busza A, 2007, J NEUROSCI, V27, P10722, DOI 10.1523/JNEUROSCI.2479-07.2007; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Florence TJ, 2015, NATURE, V519, P296, DOI 10.1038/nature14209; Gallio M, 2011, CELL, V144, P614, DOI 10.1016/j.cell.2011.01.028; Gentile C, 2013, CURR BIOL, V23, P185, DOI 10.1016/j.cub.2012.12.023; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Gummadova JO, 2009, J BIOL RHYTHM, V24, P353, DOI 10.1177/0748730409343890; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Hughes S, 2015, METHOD ENZYMOL, V552, P125, DOI 10.1016/bs.mie.2014.10.018; Kaneko H, 2012, CURR BIOL, V22, P1851, DOI 10.1016/j.cub.2012.08.006; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; Maguire SE, 2015, CURR OPIN INSECT SCI, V7, P71, DOI 10.1016/j.cois.2014.12.007; Ni LN, 2013, NATURE, V500, P580, DOI 10.1038/nature12390; Park JH, 1998, J BIOL RHYTHM, V13, P219, DOI 10.1177/074873098129000066; Petersen LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024531; Rees JS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002386; Ruben M, 2012, J BIOL RHYTHM, V27, P353, DOI 10.1177/0748730412455918; Rush BL, 2006, J BIOL RHYTHM, V21, P272, DOI 10.1177/0748730406290416; Rytz R, 2013, INSECT BIOCHEM MOLEC, V43, P888, DOI 10.1016/j.ibmb.2013.02.007; Saina Michael, 2013, Methods Mol Biol, V1003, P211, DOI 10.1007/978-1-62703-377-0_16; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Sehadova H, 2009, NEURON, V64, P251, DOI 10.1016/j.neuron.2009.08.026; Simoni A, 2014, SCIENCE, V343, P525, DOI 10.1126/science.1245710; Stanewsky R, 1997, J NEUROSCI, V17, P676; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106; Wilson RI, 2010, NEURON, V67, P349, DOI 10.1016/j.neuron.2010.07.022; Wolfgang W, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0959; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yoshii T, 2008, J COMP NEUROL, V508, P952, DOI 10.1002/cne.21702; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044	43	104	112	8	72	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					516	U238		10.1038/nature16148	http://dx.doi.org/10.1038/nature16148			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26580016	Green Accepted, Green Submitted			2022-12-28	WOS:000365352500048
J	Storebo, OJ; Krogh, HB; Ramstad, E; Moreira-Maia, CR; Holmskov, M; Skoog, M; Nilausen, TD; Magnusson, FL; Zwi, M; Gillies, D; Rosendal, S; Groth, C; Rasmussen, KB; Gauci, D; Kirubakaran, R; Forsbol, B; Simonsen, E; Gluud, C				Storebo, Ole Jakob; Krogh, Helle B.; Ramstad, Erica; Moreira-Maia, Carlos R.; Holmskov, Mathilde; Skoog, Maria; Nilausen, Trine Danvad; Magnusson, Frederik L.; Zwi, Morris; Gillies, Donna; Rosendal, Susanne; Groth, Camilla; Rasmussen, Kirsten Buch; Gauci, Dorothy; Kirubakaran, Richard; Forsbol, Bente; Simonsen, Erik; Gluud, Christian			Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DEFICIT HYPERACTIVITY DISORDER; DESIGN CHARACTERISTICS; COMPARATIVE EFFICACY; EMPIRICAL-EVIDENCE; INFORMATION SIZE; ADHD; MEDICATIONS; SYMPTOMS; QUALITY; RISK	STUDY QUESTION Is methylphenidate beneficial or harmful for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents? METHODS Electronic databases were searched up to February 2015 for parallel and crossover randomised clinical trials comparing methylphenidate with placebo or no intervention in children and adolescents with ADHD. Meta-analyses and trial sequential analyses (TSA) were conducted. Quality was assessed using GRADE. Teachers, parents, and observers rated ADHD symptoms and general behaviour. STUDY ANSWER AND LIMITATIONS The analyses included 38 parallel group trials (n=5111, median treatment duration 49 days) and 147 crossover trials (n=7134, 14 days). The average age across all studies was 9.7 years. The analysis suggested a beneficial effect of methylphenidate on teacher rated symptoms in 19 parallel group trials (standardised mean difference (SMD) -0.77, n=1698), corresponding to a mean difference of -9.6 points on the ADHD rating scale. There was no evidence that methylphenidate was associated with an increase in serious adverse events (risk ratio 0.98, nine trials, n=1532; TSA adjusted intervention effect RR 0.91). Methylphenidate was associated with an increased risk of non-serious adverse events (1.29, 21 trials, n=3132; TSA adjusted RR 1.29). Teacher rated general behaviour seemed to improve with methylphenidate (SMD -0.87, five trials, n=668) A change of 7 points on the child health questionnaire (CHQ) has been deemed a minimal clinically relevant difference. The change reported in a meta-analysis of three trials corresponds to a mean difference of 8.0 points on the CHQ (range 0-100 points), which suggests that methylphenidate may improve parent reported quality of life (SMD 0.61, three trials, n=514). 96.8% of trials were considered high risk of bias trials according to the Cochrane guidelines. All outcomes were assessed very low quality according to GRADE. WHAT THIS STUDY ADDS The results suggest that among children and adolescents with a diagnosis of ADHD, methylphenidate may improve teacher reported symptoms of ADHD and general behaviour and parent reported quality of life. However, given the risk of bias in the included studies, and the very low quality of outcomes, the magnitude of the effects is uncertain. Methylphenidate is associated with an increased risk of non-serious but not serious adverse events. FUNDING, COMPETING INTERESTS, DATA SHARING Region Zealand Research Foundation and Copenhagen Trial Unit. Competing interests are given in the full paper on bmj.com. Full data are available in the version of this review published in The Cochrane Library.	[Storebo, Ole Jakob; Krogh, Helle B.; Ramstad, Erica; Holmskov, Mathilde; Nilausen, Trine Danvad; Magnusson, Frederik L.; Rasmussen, Kirsten Buch; Simonsen, Erik] Psychiat Res Unit, Copenhagen, Denmark; [Storebo, Ole Jakob; Krogh, Helle B.; Ramstad, Erica; Forsbol, Bente] Child & Adolescent Psychiat Dept, Copenhagen, Region Zealand, Denmark; [Storebo, Ole Jakob] Univ Southern Denmark, Fac Hlth Sci, Dept Psychol, Copenhagen, Denmark; [Moreira-Maia, Carlos R.] Univ Fed Rio Grande do Sul, Dept Psychiat, Porto Alegre, RS, Brazil; [Skoog, Maria; Gluud, Christian] Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, Copenhagen, Denmark; [Zwi, Morris] Whittington Hlth, Islington CAMHS, London, England; [Gillies, Donna] Western Sydney Local Hlth District, Mental Hlth, Parramatta, Australia; [Rosendal, Susanne] Psychiat Ctr North Zealand, Copenhagen, Capital Region, Denmark; [Groth, Camilla] Herlev Univ Hosp, Dept Pediat, DK-2730 Herlev, Denmark; [Gauci, Dorothy] Dept Hlth, Directorate Hlth Informat & Res, Guardamangia, Malta; [Kirubakaran, Richard] Christian Med Coll & Hosp, Prof BV Moses Ctr Evidence Informed Hlth Care & H, South Asian Cochrane Network & Ctr, Vellore, Tamil Nadu, India; [Simonsen, Erik] Univ Copenhagen, Fac Hlth & Med Sci, Inst Clin Med, Copenhagen, Denmark; [Gluud, Christian] Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Cochrane Hepatobiliary Grp,Copenhagen Trial Unit, Copenhagen, Denmark	University of Southern Denmark; Universidade Federal do Rio Grande do Sul; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Christian Medical College & Hospital (CMCH) Vellore; University of Copenhagen; Rigshospitalet; University of Copenhagen	Storebo, OJ (corresponding author), Psychiat Res Unit, Copenhagen, Denmark.	ojst@regionsjaelland.dk	Magnusson, Frederik Løgstrup/AAA-1208-2022; Kirubakaran, Richard/AAI-5947-2021; Simonsen, Erik/N-6615-2014; Gluud, Christian/AAY-1027-2021; Gluud, Christian/HGB-3191-2022; Moreira-Maia, Carlos Renato/M-6980-2013	Magnusson, Frederik Løgstrup/0000-0002-7164-3535; Kirubakaran, Richard/0000-0002-5799-0303; Simonsen, Erik/0000-0002-6134-2392; Gluud, Christian/0000-0002-8861-0799; Buch Rasmussen, Kirsten/0000-0002-1033-7673; Moreira-Maia, Carlos Renato/0000-0002-1924-7105; Gillies, Donna/0000-0002-6216-4559; Gerner, Trine/0000-0002-5377-4013; Gauci, Dorothy/0000-0002-1524-584X	Region Zealand Research Foundation; Psychiatric Research Unit, Region Zealand Psychiatry, Roskilde, Denmark; Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital, Copenhagen, Denmark	Region Zealand Research Foundation; Psychiatric Research Unit, Region Zealand Psychiatry, Roskilde, Denmark; Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital, Copenhagen, Denmark	This study received funding from Region Zealand Research Foundation, Psychiatric Research Unit, Region Zealand Psychiatry, Roskilde, Denmark and the Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital, Copenhagen, Denmark.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Andrews J, 2013, J CLIN EPIDEMIOL, V66, P719, DOI 10.1016/j.jclinepi.2012.03.013; Bloch MH, 2009, J AM ACAD CHILD PSY, V48, P884, DOI 10.1097/CHI.0b013e3181b26e9f; Brok J, 2009, INT J EPIDEMIOL, V38, P287, DOI 10.1093/ije/dyn188; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; Carlson Gabrielle A, 2007, Child Adolesc Psychiatry Ment Health, V1, P10, DOI 10.1186/1753-2000-1-10; Caye A, 2013, J ATTEN DISORD; Charach A, 2013, PEDIATRICS, V131, pE1584, DOI 10.1542/peds.2012-0974; Charach A, 2011, J AM ACAD CHILD PSY, V50, P9, DOI 10.1016/j.jaac.2010.09.019; Copenhagen Trial Unit, 2011, TSA TRIAL SEQ AN 0 9; Curtin F, 2002, STAT MED, V21, P2161, DOI 10.1002/sim.1207; Efstratopoulou M, 2013, J ATTEN DISORD, V17, P437, DOI 10.1177/1087054711431698; Epstein T, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005041.pub2; Faraone Stephen V, 2006, MedGenMed, V8, P4; Faraone SV, 2010, J CLIN PSYCHIAT, V71, P754, DOI 10.4088/JCP.08m04902pur; Faraone Stephen V, 2009, P T, V34, P678; Faraone SV, 2002, J CLIN PSYCHOPHARM, V22, P468, DOI 10.1097/00004714-200210000-00005; Findling RL, 2007, J AM ACAD CHILD PSY, V46, P1445, DOI 10.1097/chi.0b013e31814b8d3b; Gluud C, 2015, COCHRANE REV GROUPS, V1; Green T, 2011, J CHILD ADOL PSYCHOP, V21, P589, DOI 10.1089/cap.2011.0042; Hanwella R, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-176; Hartman CA, 2007, J ABNORM CHILD PSYCH, V35, P536, DOI 10.1007/s10802-007-9110-y; ICH Expert Working Group, 1996, ICH HARM TRIP GUID G; Kadesjo B., 2002, ADHD HOS BAM VUXNA; Kambeitz J, 2014, PHARMACOGENOMICS J, V14, P77, DOI 10.1038/tpj.2013.9; King S, 2006, HEALTH TECHNOL ASSES, V10, P1; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Lavigne JV, 2012, J DEV BEHAV PEDIATR, V33, P336, DOI 10.1097/DBP.0b013e31824afea1; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Maia CR, 2014, J ATTEN DISORD; Martinez-Raga J, 2013, CNS DRUGS, V27, P15, DOI 10.1007/s40263-012-0019-9; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D., 2015, STATEMENT SYSTEMATIC, V4, DOI [10.1186/2046-4053-4-1, DOI 10.1186/2046-4053-4-12-S2.0-84920780781, DOI 10.14306/RENHYD.20.2.223]; Moher David, 2009, Open Med, V3, pe123; Murray DW, 2007, J CHILD ADOL PSYCHOP, V17, P605, DOI 10.1089/cap.2007.0060; National Collaborating Centre for Mental Health (UK), 2018, BR PSYCHOL SOC; Newcorn JH, 2008, AM J PSYCHIAT, V165, P721, DOI 10.1176/appi.ajp.2007.05091676; Oesterheld JR, 1998, J CHILD ADOL PSYCHOP, V8, P39, DOI 10.1089/cap.1998.8.39; Palumbo DR, 2008, J AM ACAD CHILD PSY, V47, P180, DOI 10.1097/chi.0b013e31815d9af7; Pearson DA, 2013, J CHILD ADOL PSYCHOP, V23, P337, DOI 10.1089/cap.2012.0096; Polanczyk GV, 2015, J CHILD PSYCHOL PSYC, V56, P345, DOI 10.1111/jcpp.12381; Punja S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002312; Reichow B, 2013, J AUTISM DEV DISORD, V43, P2435, DOI 10.1007/s10803-013-1793-z; Rentz AM, 2005, QUAL LIFE RES, V14, P719, DOI 10.1007/s11136-004-0832-9; Roberts I, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2463; Savovic J, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16350; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Scahill L, 2000, CHILD ADOL PSYCH CL, V9, P541; Schachter HA, 2001, CAN MED ASSOC J, V165, P1475; Schmidt S, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-58; Schroll JB, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2231; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Smith BH, 1998, EXP CLIN PSYCHOPHARM, V6, P187, DOI 10.1037/1064-1297.6.2.187; Storebo O, 2015, COCHRANE DA IN PRESS; Storebo O, 2015, E COMMUNICATION 0512; Storebo OJ, 2012, COCHRANE DB SYST REV, V5; Szobot CM, 2008, BRAZ J MED BIOL RES, V41, P250, DOI 10.1590/S0100-879X2008005000011; TAYLOR E, 1987, PSYCHOL MED, V17, P121, DOI 10.1017/S0033291700013039; Thorlund K., 2011, USER MANUAL TRIAL SE, P1, DOI DOI 10.1158/1055-9965.EPI-08-0169; Thorlund K, 2009, INT J EPIDEMIOL, V38, P276, DOI 10.1093/ije/dyn179; Tucker JD, 2009, MUTAT RES-GEN TOX EN, V677, P53, DOI 10.1016/j.mrgentox.2009.05.005; Van der Oord S, 2008, CLIN PSYCHOL REV, V28, P783, DOI 10.1016/j.cpr.2007.10.007; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Wetterslev J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-86; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; World Health Organization, 1992, ICD 10 CLASS MENT BE, DOI DOI 10.1002/1520-6505(2000)9:5%3C201::AID-EVAN2%3E3.3.CO;2-P; Zhang S, 2005, INT J METH PSYCH RES, V14, P186, DOI 10.1002/mpr.7	69	128	130	0	36	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2015	351								h5203	10.1136/bmj.h5203	http://dx.doi.org/10.1136/bmj.h5203			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX4TG	26608309	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000365692600001
J	Bohannon, J				Bohannon, John			HOW TO HIJACK A JOURNAL	SCIENCE			English	Editorial Material																			0	16	16	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2015	350	6263					903	905		10.1126/science.350.6263.903	http://dx.doi.org/10.1126/science.350.6263.903			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW4IP	26586744				2022-12-28	WOS:000364955200017
J	Adams, JU				Adams, Jill U.			Genetics: Big hopes for big data	NATURE			English	Editorial Material																		Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Liao S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0618-8	3	27	29	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					S108	S109		10.1038/527S108a	http://dx.doi.org/10.1038/527S108a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26580158	Bronze			2022-12-28	WOS:000365356800003
J	Schmidt, C				Schmidt, Charles			Immunology: Another shot at cancer	NATURE			English	Editorial Material																		Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Kim JW, 2014, ONCOLOGY-NY, V28, P15; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Mittendorf EA, 2014, ANN ONCOL, V25, P1735, DOI 10.1093/annonc/mdu211	4	5	6	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					S105	S107		10.1038/527S105a	http://dx.doi.org/10.1038/527S105a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9ZN	26580157	Bronze			2022-12-28	WOS:000365356800002
J	Gulland, A				Gulland, Anne			Palestinian doctors are barred from entering UK	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 13	2015	351								h6157	10.1136/bmj.h6157	http://dx.doi.org/10.1136/bmj.h6157			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW4HA	26566808				2022-12-28	WOS:000364950900018
J	Adigopula, S; Nsair, A				Adigopula, Sasikanth; Nsair, Ali			Left Main Coronary Artery Stent Migration	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Adigopula, Sasikanth; Nsair, Ali] Univ Calif Los Angeles, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Adigopula, S (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.	sashi.adig@gmail.com	Adigopula, Sasikanth/AAI-4618-2021						0	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2015	373	20					1957	1957		10.1056/NEJMicm1500200	http://dx.doi.org/10.1056/NEJMicm1500200			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV7IL	26559574				2022-12-28	WOS:000364445500010
J	Zhang, L				Zhang, Li			China must act decisively to eradicate the ivory trade	NATURE			English	Editorial Material									Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Beijing 100875, Peoples R China	Beijing Normal University	Zhang, L (corresponding author), Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Beijing 100875, Peoples R China.	asterzhang@bnu.edu.cn							0	5	6	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2015	527	7577					135	135		10.1038/527135a	http://dx.doi.org/10.1038/527135a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RC	26560263	Bronze			2022-12-28	WOS:000364396700008
J	Lane, R				Lane, Richard			Christopher Plowe: a leader in malaria elimination	LANCET			English	Biographical-Item									Univ Maryland, Inst Global Hlth, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Lane, R (corresponding author), Univ Maryland, Inst Global Hlth, College Pk, MD 20742 USA.								0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2015	386	10004					1617	1617		10.1016/S0140-6736(15)00542-5	http://dx.doi.org/10.1016/S0140-6736(15)00542-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU0HS	26595621				2022-12-28	WOS:000363197500014
J	Belkin, G; Linos, N; Perlman, SE; Norman, C; Bassett, MT				Belkin, Gary; Linos, Natalia; Perlman, Sharon E.; Norman, Christina; Bassett, Mary T.			A roadmap for better mental health in New York City	LANCET			English	Editorial Material									[Belkin, Gary; Norman, Christina] New York City Dept Hlth & Mental Hyg, Div Mental Hyg, Queens, NY 11101 USA; [Linos, Natalia; Bassett, Mary T.] New York City Dept Hlth & Mental Hyg, Off Commissioner, Queens, NY 11101 USA; [Perlman, Sharon E.] New York City Dept Hlth & Mental Hyg, Div Epidemiol, Queens, NY 11101 USA	New York City Department of Health & Mental Hygiene; New York City Department of Health & Mental Hygiene; New York City Department of Health & Mental Hygiene	Bassett, MT (corresponding author), New York City Dept Hlth & Mental Hyg, Off Commissioner, Queens, NY 11101 USA.	mbassett@health.nyc.gov						Center for Behavioral Health Statistics and Quality, 2015, NAT SURV DRUG US HLT; Coady MH, 2012, J URBAN HEALTH, V89, P802, DOI 10.1007/s11524-012-9683-9; Farley TA, 2009, HEALTH AFFAIR, V28, pW1098, DOI 10.1377/hlthaff.28.6.w1098; Joint Action Mental Health and Wellbeing, MENT HLTH ALL POL; McCray C, 2015, THRIVENYC MENTAL HLT; New York City Department of Health and Mental Hygiene, SOD IN; New York City Department of Health and Mental Hygiene, EP NYC INT HLTH DAT; Thorpe Lorna E, 2015, Prev Med Rep, V2, P580, DOI 10.1016/j.pmedr.2015.06.019	8	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2016	387	10015					207	208		10.1016/S0140-6736(15)00830-2	http://dx.doi.org/10.1016/S0140-6736(15)00830-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA9LQ	26621182				2022-12-28	WOS:000368130700008
J	Hirsch, M; Carli, P; Nizard, R; Riou, B; Baroudjian, B; Baubet, T; Chhor, V; Chollet-Xemard, C; Dantchev, N; Fleury, N; Fontaine, JP; Yordanov, Y; Raphael, M; Burtz, CP; Lafont, A				Hirsch, Martin; Carli, Pierre; Nizard, Remy; Riou, Bruno; Baroudjian, Barouyr; Baubet, Thierry; Chhor, Vibol; Chollet-Xemard, Charlotte; Dantchev, Nicolas; Fleury, Nadia; Fontaine, Jean-Paul; Yordanov, Youri; Raphael, Maurice; Burtz, Catherine Paugam; Lafont, Antoine		Hlth Professionals Assistance	The medical response to multisite terrorist attacks in Paris	LANCET			English	Editorial Material							DAMAGE CONTROL; RESUSCITATION		[Hirsch, Martin] AP HP, Paris, France; [Carli, Pierre] Univ Paris 05, Hop Necker Enfants Malad, SAMU Paris, Paris, France; [Nizard, Remy] Univ Paris Diderot, Hop Lariboisiere, Paris, France; [Riou, Bruno] Univ Paris 06, Hop La Pitie Salpetriere, Paris, France; [Baroudjian, Barouyr; Fontaine, Jean-Paul] Hop St Louis, Paris, France; [Baubet, Thierry] Univ Paris 13, Hop Avicenne, Paris, France; [Chhor, Vibol] Hop Europeen Georges Pompidou, Paris, France; [Chollet-Xemard, Charlotte] Hop Henri Mondor, F-94010 Creteil, France; [Dantchev, Nicolas] Hop Hotel Dieu, Paris, France; [Fleury, Nadia] Hop La Pitie Salpetriere, Paris, France; [Yordanov, Youri] Hop St Antoine, F-75571 Paris, France; [Raphael, Maurice] Hop Bicetre, Paris, France; [Burtz, Catherine Paugam] Univ Paris Diderot, Hop Beaujon, Paris, France; [Lafont, Antoine] Univ Paris 05, Hop Europeen Georges Pompidou, Paris, France	Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Lafont, A (corresponding author), Hop Europeen Georges Pompidou, Dept Cardiol, Paris, France.	antoine.lafont@inserm.fr	Nizard, Remy/R-5845-2019	Baubet, Thierry/0000-0002-4112-1592; Paugam-Burtz, Catherine/0000-0002-8168-7152				Aylwin CJ, 2006, LANCET, V368, P2219, DOI 10.1016/S0140-6736(06)69896-6; Duchesne JC, 2010, J TRAUMA, V69, P976, DOI 10.1097/TA.0b013e3181f2abc9; Gates JD, 2014, ANN SURG, V260, P960, DOI 10.1097/SLA.0000000000000914; Gutierrez de Ceballos J Peral, 2005, Crit Care Med, V33, pS107, DOI 10.1097/01.CCM.0000151072.17826.72; Jenkins DH, 2014, SHOCK, V41, P3, DOI 10.1097/SHK.0000000000000140; Katz JD, 2007, J CLIN ANESTH, V19, P152, DOI 10.1016/j.jclinane.2006.07.007; Mathieu L, 2014, INT ORTHOP, V38, P1569, DOI 10.1007/s00264-014-2305-2; RAID (Research Assistance Intervention Dissuasion) Medical Service, 2015, ANN FR MED URG, V5, P166; Regnier MA, 2012, ANESTHESIOLOGY, V117, P1276, DOI 10.1097/ALN.0b013e318273349d; Rochkind S, 2014, ACTA NEUROCHIR, V156, P1567, DOI 10.1007/s00701-014-2139-0; Tourtier JP, 2013, ANN FR ANESTH, V32, P520, DOI 10.1016/j.annfar.2013.07.012	11	183	185	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 19	2015	386	10012					2535	2538		10.1016/S0140-6736(15)01063-6	http://dx.doi.org/10.1016/S0140-6736(15)01063-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CZ1LD	26628327	Bronze			2022-12-28	WOS:000366866400028
J	Petherick, A				Petherick, Anna			Genome editing	NATURE			English	Editorial Material																			0	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					S1	S1		10.1038/528S1a	http://dx.doi.org/10.1038/528S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26630590	Bronze			2022-12-28	WOS:000365606000074
J	Stransky, N; Ghandi, M; Kryukov, GV; Garraway, LA; Lehar, J; Liu, M; Sonkin, D; Kauffmann, A; Venkatesan, K; Edelman, EJ; Riester, M; Barretina, J; Caponigro, G; Schlegel, R; Sellers, WR; Stegmeier, F; Morrissey, M; Amzallag, A; Pruteanu-Malinici, I; Haber, DA; Ramaswamy, S; Benes, CH; Menden, MP; Iorio, F; Stratton, MR; McDermott, U; Garnett, MJ; Saez-Rodriguez, J				Stransky, Nicolas; Ghandi, Mahmoud; Kryukov, Gregory V.; Garraway, Levi A.; Lehar, Joseph; Liu, Manway; Sonkin, Dmitriy; Kauffmann, Audrey; Venkatesan, Kavitha; Edelman, Elena J.; Riester, Markus; Barretina, Jordi; Caponigro, Giordano; Schlegel, Robert; Sellers, William R.; Stegmeier, Frank; Morrissey, Michael; Amzallag, Arnaud; Pruteanu-Malinici, Iulian; Haber, Daniel A.; Ramaswamy, Sridhar; Benes, Cyril H.; Menden, Michael P.; Iorio, Francesco; Stratton, Michael R.; McDermott, Ultan; Garnett, Mathew J.; Saez-Rodriguez, Julio		Drug Sensitivity Canc; Cancer Cell Line; Broad Inst; Novartis Inst Biomed Res; Genomics Drug Sensitivity; Massachusetts Gen Hosp; European Mol Biol Lab; European Bioinformatics Inst; Wellcome Trust Sanger Inst	Pharmacogenomic agreement between two cancer cell line data sets	NATURE			English	Article							DRUG-SENSITIVITY	Large cancer cell line collections broadly capture the genomic diversity of human cancers and provide valuable insight into anti-cancer drug response. Here we show substantial agreement and biological consilience between drug sensitivity measurements and their associated genomic predictors from two publicly available large-scale pharmacogenomics resources: The Cancer Cell Line Encyclopedia and the Genomics of Drug Sensitivity in Cancer databases.	[Stransky, Nicolas; Ghandi, Mahmoud; Kryukov, Gregory V.; Garraway, Levi A.; Broad Inst] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Garraway, Levi A.] Harvard Univ, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Med Oncol,Dept Med,Med Sch, Boston, MA 02115 USA; [Amzallag, Arnaud; Pruteanu-Malinici, Iulian; Haber, Daniel A.; Ramaswamy, Sridhar; Benes, Cyril H.; Massachusetts Gen Hosp] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA USA; [Lehar, Joseph; Liu, Manway; Sonkin, Dmitriy; Kauffmann, Audrey; Venkatesan, Kavitha; Edelman, Elena J.; Riester, Markus; Barretina, Jordi; Caponigro, Giordano; Schlegel, Robert; Sellers, William R.; Stegmeier, Frank; Morrissey, Michael; Novartis Inst Biomed Res] Novartis Inst Biorvlecl Res, Cambridge, MA 02139 USA; [Menden, Michael P.; Iorio, Francesco; Saez-Rodriguez, Julio] European Mol Biol Lab, European Bioinformat Inst, Hinxton CB10 1SD, England; [Iorio, Francesco; Stratton, Michael R.; McDermott, Ultan; Garnett, Mathew J.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts General Hospital; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute	Garraway, LA (corresponding author), Broad Inst MIT & Harvard, 415 Main St, Cambridge, MA 02142 USA.	Levi_Garraway@dfci.harvard.edu; CBENES@mgh.harvard.edu	Iorio, Francesco/H-3282-2019; Iorio, Francesco/H-3284-2019; Amzallag, Arnaud/Y-5802-2019; Saez-Rodriguez, Julio/H-7114-2019; Barretina, Jordi/A-7192-2013	Iorio, Francesco/0000-0001-7063-8913; Amzallag, Arnaud/0000-0001-7467-1227; Saez-Rodriguez, Julio/0000-0002-8552-8976; Ghandi, Mahmoud/0000-0003-1897-2265; Sonkin, Dmitriy/0000-0002-1649-0652; Barretina, Jordi/0000-0002-3478-4080; McDermott, Ultan/0000-0001-9032-4700; Kryukov, Gregory/0000-0002-6131-9483	Novartis Institutes for BioMedical Research; Wellcome Trust [086357, 102696]; National Institutes of Health [1U54HG006097-01]; Novartis; Dr. Miriam and Sheldon Adelson Medical Research Foundation; Slim Foundation; EMBL-EBI; Wellcome Trust Sanger Institute Post-Doctoral (ESPOD) programme; Cancer Research UK Clinician Scientist Fellowship [A16629]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006097] Funding Source: NIH RePORTER	Novartis Institutes for BioMedical Research; Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis(Novartis); Dr. Miriam and Sheldon Adelson Medical Research Foundation; Slim Foundation; EMBL-EBI; Wellcome Trust Sanger Institute Post-Doctoral (ESPOD) programme; Cancer Research UK Clinician Scientist Fellowship(Cancer Research UK); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank T. Golub, E. Lander, S. Schreiber, P. Clemons and J. Engelman for helpful discussions. This work was supported by research grants from the Novartis Institutes for BioMedical Research (CCLE; L.A.G., M.G., and G.V.K.) and by grants from the Wellcome Trust (086357 and 102696; D.A.H., M.R.S., U.M., M.J.G., A. A., C.H.B.) and the National Institutes of Health (1U54HG006097-01, A. A. and C.H.B.). L.A.G. was supported in part by grants from Novartis and the Dr. Miriam and Sheldon Adelson Medical Research Foundation. G.V.K. was supported in part by the Slim Foundation. F.I. was supported in part by the EMBL-EBI and Wellcome Trust Sanger Institute Post-Doctoral (ESPOD) programme, and U.M. was funded by a Cancer Research UK Clinician Scientist Fellowship (A16629).	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Caponigro G, 2011, NAT REV DRUG DISCOV, V10, P179, DOI 10.1038/nrd3385; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127	9	237	237	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 3	2015	528	7580					84	+		10.1038/nature15736	http://dx.doi.org/10.1038/nature15736			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX3NO	26570998	Green Accepted			2022-12-28	WOS:000365606000052
J	Ghanbarzadeh, S; Hesse, MA; Prodanovic, M; Gardner, JE				Ghanbarzadeh, Soheil; Hesse, Marc A.; Prodanovic, Masa; Gardner, James E.			Deformation-assisted fluid percolation in rock salt	SCIENCE			English	Article							INTERCONNECTED NETWORK; RECRYSTALLIZATION; WATER; PERMEABILITIES; RESISTIVITY; HALITE; BASIN; MELTS; FLOW	Deep geological storage sites for nuclear waste are commonly located in rock salt to ensure hydrological isolation from groundwater. The low permeability of static rock salt is due to a percolation threshold. However, deformation may be able to overcome this threshold and allow fluid flow. We confirm the percolation threshold in static experiments on synthetic salt samples with x-ray microtomography. We then analyze wells penetrating salt deposits in the Gulf of Mexico. The observed hydrocarbon distributions in rock salt require that percolation occurred at porosities considerably below the static threshold due to deformation-assisted percolation. Therefore, the design of nuclear waste repositories in salt should guard against deformation-driven fluid percolation. In general, static percolation thresholds may not always limit fluid flow in deforming environments.	[Ghanbarzadeh, Soheil; Prodanovic, Masa] Univ Texas Austin, Dept Petr & Geosyst Engn, Austin, TX 78712 USA; [Hesse, Marc A.; Gardner, James E.] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA; [Hesse, Marc A.] Univ Texas Austin, Inst Computat Engn & Sci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Hesse, MA (corresponding author), Univ Texas Austin, Dept Geol Sci, 1 Univ Stn, Austin, TX 78712 USA.	mhesse@jsg.utexas.edu	Hesse, Marc A/B-4914-2011; Prodanovic, Masa/AAU-9391-2021; Prodanovic, Masa/I-6810-2015; Gardner, James/H-1713-2011	Hesse, Marc A/0000-0002-2532-3274; Prodanovic, Masa/0000-0002-1335-1374; Prodanovic, Masa/0000-0002-1335-1374; 	Statoil Fellows Program at The University of Texas at Austin; NSF [EAR CMG-1025321, EAR-1348050, EAR-1258878]; Division Of Earth Sciences [1258878] Funding Source: National Science Foundation	Statoil Fellows Program at The University of Texas at Austin; NSF(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	S.G. is supported by the Statoil Fellows Program at The University of Texas at Austin. M.A.H. and J.E.G. were partially supported by NSF grants EAR CMG-1025321 and EAR-1348050, respectively. Imaging was performed at the High-Resolution X-ray Computed Tomography Facility at the Department of Geological Science, The University of Texas at Austin, which is partially supported by NSF grant EAR-1258878. Parts of image analysis was done on high-performance computing resources at Texas Advanced Computing Center. We are thankful to D. Ebrom, R. Hunsdale, and T. Loseth for providing field data and guiding their analysis. The manuscript also benefited from constructive comments by M. P. A. Jackson and R. A. Ketcham, as well as reviews from J. L. Urai and two anonymous reviewers. The authors are grateful to the Statoil Gulf Services LLC for granting permission to publish the field data. Other data are available in the manuscript as well as in the supplementary materials. The authors claim no conflicts of interest.	Bruhn D, 2000, NATURE, V403, P883, DOI 10.1038/35002558; CARTER NL, 1993, J STRUCT GEOL, V15, P1257, DOI 10.1016/0191-8141(93)90168-A; Cristescu N. D., 1998, WILEY SERIES MAT MOD, P81; Davison I, 2009, J GEOL SOC LONDON, V166, P205, DOI 10.1144/0016-76492008-064; Desbois G, 2012, CONTRIB MINERAL PETR, V163, P19, DOI 10.1007/s00410-011-0656-x; DOWNEY MW, 1984, AAPG BULL, V68, P1752; DRURY MR, 1990, TECTONOPHYSICS, V172, P235, DOI 10.1016/0040-1951(90)90033-5; Ghanbarzadeh S, 2015, J COMPUT PHYS, V297, P480, DOI 10.1016/j.jcp.2015.05.023; Ghanbarzadeh S, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.048001; Hansen F.D., 2011, SAND20110161 SAND NA; JACKSON MPA, 1986, GEOL SOC AM BULL, V97, P305, DOI 10.1130/0016-7606(1986)97<305:ESSRAD>2.0.CO;2; LAND LS, 1988, CHEM GEOL, V74, P25, DOI 10.1016/0009-2541(88)90144-1; Lewis S, 1996, GEOLOGY, V24, P431, DOI 10.1130/0091-7613(1996)024<0431:EHHODA>2.3.CO;2; Noseck U, 2015, SWISS J GEOSCI, V108, P121, DOI 10.1007/s00015-015-0183-2; Peach CJ, 2001, J GEOPHYS RES-SOL EA, V106, P13315, DOI 10.1029/2000JB900300; Schleder Z, 2005, INT J EARTH SCI, V94, P941, DOI 10.1007/s00531-005-0503-2; Schoenherr L, 2007, AAPG BULL, V91, P1541, DOI 10.1306/06200706122; Schulze O, 2001, ENG GEOL, V61, P163, DOI 10.1016/S0013-7952(01)00051-5; Shannon MC, 1998, SCIENCE, V280, P1059, DOI 10.1126/science.280.5366.1059; Shi CY, 2013, NAT GEOSCI, V6, P971, DOI [10.1038/ngeo1956, 10.1038/NGEO1956]; Stewart SA, 2007, GEOL SOC SPEC PUBL, V272, P361, DOI 10.1144/GSL.SP.2007.272.01.19; Thiemeyer N, 2015, J STRUCT GEOL, V77, P92, DOI 10.1016/j.jsg.2015.05.014; Tromans D, 2002, MINER ENG, V15, P1027, DOI 10.1016/S0892-6875(02)00213-3; URAI JL, 1983, TECTONOPHYSICS, V96, P125, DOI 10.1016/0040-1951(83)90247-0; URAI JL, 1986, NATURE, V324, P554, DOI 10.1038/324554a0; van der Marck SC, 1999, WATER RESOUR RES, V35, P595, DOI 10.1029/1998WR900062; VONBARGEN N, 1986, J GEOPHYS RES-SOLID, V91, P9261, DOI 10.1029/JB091iB09p09261; Wark DA, 1998, EARTH PLANET SC LETT, V164, P591, DOI 10.1016/S0012-821X(98)00252-0; Watanabe T, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000204; YARAMANCI U, 1994, GEOPHYS PROSPECT, V42, P229, DOI 10.1111/j.1365-2478.1994.tb00207.x; YARAMANCI U, 1992, GEOPHYS PROSPECT, V40, P85, DOI 10.1111/j.1365-2478.1992.tb00365.x	31	37	37	5	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1069	1072		10.1126/science.aac8747	http://dx.doi.org/10.1126/science.aac8747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY5BJ	26612949				2022-12-28	WOS:000366422600038
J	Kaushansky, A; Douglass, AN; Arang, N; Vigdorovich, V; Dambrauskas, N; Kain, HS; Austin, LS; Sather, DN; Kappe, SHI				Kaushansky, Alexis; Douglass, Alyse N.; Arang, Nadia; Vigdorovich, Vladimir; Dambrauskas, Nicholas; Kain, Heather S.; Austin, Laura S.; Sather, D. Noah; Kappe, Stefan H. I.			Malaria parasites target the hepatocyte receptor EphA2 for successful host infection	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; SPOROZOITES; SUSCEPTIBILITY; IMMUNITY; PROTEIN; CELLS	The invasion of a suitable host hepatocyte by mosquito-transmitted Plasmodium sporozoites is an essential early step in successful malaria parasite infection. Yet precisely how sporozoites target their host cell and facilitate productive infection remains largely unknown. We found that the hepatocyte EphA2 receptor was critical for establishing a permissive intracellular replication compartment, the parasitophorous vacuole. Sporozoites productively infected hepatocytes with high EphA2 expression, and the deletion of EphA2 protected mice from liver infection. Lack of host EphA2 phenocopied the lack of the sporozoite proteins P52 and P36. Our data suggest that P36 engages EphA2, which is likely to be a key step in establishing the permissive replication compartment.	[Kaushansky, Alexis; Douglass, Alyse N.; Arang, Nadia; Vigdorovich, Vladimir; Dambrauskas, Nicholas; Kain, Heather S.; Austin, Laura S.; Sather, D. Noah; Kappe, Stefan H. I.] Ctr Infect Dis Res, Seattle, WA 98109 USA; [Austin, Laura S.; Kappe, Stefan H. I.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR); University of Washington; University of Washington Seattle	Kaushansky, A (corresponding author), Ctr Infect Dis Res, 307 Westlake Ave North,500, Seattle, WA 98109 USA.	alexis.kaushansky@cidresearch.org; stefan.kappe@cidresearch.org	Kaushansky, Alexis/U-6695-2019	Arang, Nadia/0000-0002-8167-2188	NIH [1R01GM101183-01A1]; Transition to Independence Award [1K99AI111785-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI111785, K99AI111785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101183] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Transition to Independence Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to W. Betz for mosquito and sporozoite production. We thank the vivarium staff of the Center for Infectious Disease Research for their work with mice. This work was funded by a NIH Research Project Grant (R01) to S.H.I.K. and A.K. (grant no. 1R01GM101183-01A1). A.K. is also a recipient of a Transition to Independence Award (award no. 1K99AI111785-01A1), which partially funded this work. A.K., N.A., A.N.D., V.V., N.D., H.K., and L.S.A. performed the experiments. A.K., D.N.S., and S.H.I.K. supervised the research. A.K. and S.H.I.K. wrote the paper. A provisional U.S. patent application (application no. 62/110018) has been filed by the Center for Infectious Disease Research, covering interventions that exploit the described host-parasite interaction. The data are included in the main manuscript and in the supplementary materials.	Annoura T, 2014, FASEB J, V28, P2158, DOI 10.1096/fj.13-241570; Arredondo SA, 2012, P NATL ACAD SCI USA, V109, P6692, DOI 10.1073/pnas.1204363109; Austin LS, 2014, CELL MICROBIOL, V16, P784, DOI 10.1111/cmi.12282; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; FREVERT U, 1993, J EXP MED, V177, P1287, DOI 10.1084/jem.177.5.1287; Kappe SHI, 2010, SCIENCE, V328, P862, DOI 10.1126/science.1184785; Kaushansky A, 2015, INFECT IMMUN, V83, P39, DOI 10.1128/IAI.02230-14; Labaied M, 2007, INFECT IMMUN, V75, P3758, DOI 10.1128/IAI.00225-07; Lisabeth EM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009159; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; Rodrigues CD, 2008, CELL HOST MICROBE, V4, P271, DOI 10.1016/j.chom.2008.07.012; Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808; van Dijk MR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000853; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; VanBuskirk KM, 2009, P NATL ACAD SCI USA, V106, P13004, DOI 10.1073/pnas.0906387106; Yalaoui S, 2008, CELL HOST MICROBE, V4, P283, DOI 10.1016/j.chom.2008.07.013	16	67	67	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 27	2015	350	6264					1089	1092		10.1126/science.aad3318	http://dx.doi.org/10.1126/science.aad3318			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY5BJ	26612952	Green Accepted			2022-12-28	WOS:000366422600043
J	Coomarasamy, A; Williams, H; Truchanowicz, E; Seed, PT; Small, R; Quenby, S; Gupta, P; Dawood, F; Koot, YEM; Atik, RB; Bloemenkamp, KWM; Brady, R; Briley, AL; Cavallaro, R; Cheong, YC; Chu, JJ; Eapen, A; Ewies, A; Hoek, A; Kaaijk, EM; Koks, CAM; Li, TC; MacLean, M; Mol, BW; Moore, J; Ross, JA; Sharpe, L; Stewart, J; Vaithilingam, N; Farquharson, RG; Kilby, MD; Khalaf, Y; Goddijn, M; Regan, L; Rai, R				Coomarasamy, A.; Williams, H.; Truchanowicz, E.; Seed, P. T.; Small, R.; Quenby, S.; Gupta, P.; Dawood, F.; Koot, Y. E. M.; Atik, R. Bender; Bloemenkamp, K. W. M.; Brady, R.; Briley, A. L.; Cavallaro, R.; Cheong, Y. C.; Chu, J. J.; Eapen, A.; Ewies, A.; Hoek, A.; Kaaijk, E. M.; Koks, C. A. M.; Li, T. -C.; MacLean, M.; Mol, B. W.; Moore, J.; Ross, J. A.; Sharpe, L.; Stewart, J.; Vaithilingam, N.; Farquharson, R. G.; Kilby, M. D.; Khalaf, Y.; Goddijn, M.; Regan, L.; Rai, R.			A Randomized Trial of Progesterone in Women with Recurrent Miscarriages	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRETERM BIRTH; RISK; METAANALYSIS; SUPPORT	BACKGROUND Progesterone is essential for the maintenance of pregnancy. However, whether progesterone supplementation in the first trimester of pregnancy would increase the rate of live births among women with a history of unexplained recurrent miscarriages is uncertain. METHODS We conducted a multicenter, double-blind, placebo-controlled, randomized trial to investigate whether treatment with progesterone would increase the rates of live births and newborn survival among women with unexplained recurrent miscarriage. We randomly assigned women with recurrent miscarriages to receive twice-daily vaginal suppositories containing either 400 mg of micronized progesterone or matched placebo from a time soon after a positive urinary pregnancy test (and no later than 6 weeks of gestation) through 12 weeks of gestation. The primary outcome was live birth after 24 weeks of gestation. RESULTS A total of 1568 women were assessed for eligibility, and 836 of these women who conceived naturally within 1 year and remained willing to participate in the trial were randomly assigned to receive either progesterone (404 women) or placebo (432 women). The follow-up rate for the primary outcome was 98.8% (826 of 836 women). In an intention-to-treat analysis, the rate of live births was 65.8% (262 of 398 women) in the progesterone group and 63.3% (271 of 428 women) in the placebo group (relative rate, 1.04; 95% confidence interval [CI], 0.94 to 1.15; rate difference, 2.5 percentage points; 95% CI, -4.0 to 9.0). There were no significant between-group differences in the rate of adverse events. CONCLUSIONS Progesterone therapy in the first trimester of pregnancy did not result in a significantly higher rate of live births among women with a history of unexplained recurrent miscarriages.	[Coomarasamy, A.; Williams, H.; Truchanowicz, E.; Chu, J. J.; Eapen, A.; Kilby, M. D.] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Small, R.; Gupta, P.] Heart England NHS Fdn Trust, Birmingham, W Midlands, England; [Ewies, A.] Sandwell & West Birmingham Hosp NHS Teaching Trus, Birmingham, W Midlands, England; [Seed, P. T.] St Thomas Hosp, Kings Coll London & Kings Hlth Partners, London, England; [Brady, R.; Cavallaro, R.; Sharpe, L.; Regan, L.; Rai, R.] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp Campus, Womens Hlth Res Ctr, London, England; [Briley, A. L.] St Thomas Hosp, Kings Hlth Partners, London, England; [Ross, J. A.] Kings Coll Hosp NHS Fdn Trust, London, England; [Khalaf, Y.] Guys & St Thomas Fdn Trust, Assisted Concept Unit, London, England; [Quenby, S.] Univ Warwick, Biomed Res Unit Reprod Hlth, Warwick, England; [Dawood, F.; Farquharson, R. G.] Liverpool Womens NHS Fdn Trust, Liverpool, Merseyside, England; [Atik, R. Bender] Miscarriage Assoc, Wakefield, England; [Cheong, Y. C.] Univ Southampton, Fac Med, Princess Anne Hosp, Southampton SO9 5NH, Hants, England; [Li, T. -C.] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England; [MacLean, M.] Univ Hosp Crosshouse, Ayrshire Matern Unit, Kilmarnock, Scotland; [Moore, J.] Nottingham Univ Hosp NHS Trust, Nottingham, England; [Stewart, J.] Newcastle Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Vaithilingam, N.] Portsmouth Hosp NHS Trust, Portsmouth, Hants, England; [Koot, Y. E. M.] Univ Med Ctr Utrecht, Dept Reprod Med, Utrecht, Netherlands; [Bloemenkamp, K. W. M.] Leiden Univ, Med Ctr, Dept Obstet, Leiden, Netherlands; [Hoek, A.] Univ Groningen, Univ Med Ctr Groningen, Dept Reprod Med & Gynecol, Groningen, Netherlands; [Kaaijk, E. M.] Onze Lieve Vrouw Hosp, Dept Obstet & Gynecol, Amsterdam, Netherlands; [Goddijn, M.] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynecol, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands; [Koks, C. A. M.] Maxima Med Ctr Veldhoven, Dept Obstet & Gynecol, Veldhoven, Netherlands; [Mol, B. W.] Univ Adelaide, Sch Pediat & Reprod Hlth, Robinson Inst, Adelaide, SA, Australia	University of Birmingham; Heart of England NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; King's College Hospital NHS Foundation Trust; University of Warwick; University of Southampton; University of Sheffield; Nottingham University Hospital NHS Trust; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Portsmouth Hospitals NHS Trust; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; Onze Lieve Vrouwe Gasthuis Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Maxima Medical Center; Robinson Research Institute; University of Adelaide	Coomarasamy, A (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England.	a.coomarasamy@bham.ac.uk	Ross, Jackie A/H-2113-2013; Briley, Annette/AAZ-5305-2020; FRCPI, Mark D Kilby MB BS DSc MD FRCOG/AAW-9704-2020; Briley, Annette/N-1704-2019; Seed, Paul T/C-4435-2008	Ross, Jackie A/0000-0003-4168-6910; Briley, Annette/0000-0002-4266-920X; FRCPI, Mark D Kilby MB BS DSc MD FRCOG/0000-0001-9987-4223; Seed, Paul T/0000-0001-7904-7933; Gupta, Pratima/0000-0001-7006-9917; Goddijn, Mariette/0000-0001-9928-9673; Moore, Jonathan/0000-0002-5486-0407; Quenby, Siobhan/0000-0003-3221-5471; Chu, Justin/0000-0002-5355-9989; Li, Tin Chiu/0000-0002-0554-2031; Cheong, Ying/0000-0001-7687-4597	United Kingdom National Institute of Health Research; National Institute for Health Research [08/38/01] Funding Source: researchfish	United Kingdom National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by the United Kingdom National Institute of Health Research; PROMISE Current Controlled Trials number, ISRCTN92644181.	Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P1103, DOI 10.1016/j.fertnstert.2012.06.048; Bulletti C, 1997, HUM REPROD, V12, P1073; Carmichael SL, 2005, ARCH PEDIAT ADOL MED, V159, P957, DOI 10.1001/archpedi.159.10.957; Cicinelli E, 1998, FERTIL STERIL, V69, P471, DOI 10.1016/S0015-0282(97)00545-1; Coomarasamy Arri, 2011, BMJ, V342, pd1914, DOI 10.1136/bmj.d1914; da Fonseca EB, 2003, AM J OBSTET GYNECOL, V188, P419, DOI 10.1067/mob.2003.41; DAYA S, 1989, BRIT J OBSTET GYNAEC, V96, P275, DOI 10.1111/j.1471-0528.1989.tb02386.x; El-Zibdeh MY, 2005, J STEROID BIOCHEM, V97, P431, DOI 10.1016/j.jsbmb.2005.08.007; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; GOLDZIEHER JW, 1964, JAMA-J AM MED ASSOC, V188, P651; Kumar A, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.07.1251; LEVINE L, 1964, West J Surg Obstet Gynecol, V72, P30; Malassine A, 2003, HUM REPROD UPDATE, V9, P531, DOI 10.1093/humupd/dmg043; Nosarka S, 2005, GYNECOL OBSTET INVES, V60, P67, DOI 10.1159/000084546; Oates-Whitehead R M, 2003, Cochrane Database Syst Rev, pCD004000, DOI 10.1002/14651858.CD003511; Ozlu T, 2012, ARCH GYNECOL OBSTET, V286, P495, DOI 10.1007/s00404-012-2340-4; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Shah Duru, 2013, Indian J Endocrinol Metab, V17, P44, DOI 10.4103/2230-8210.107834; Sonntag B, 2012, CLIN ENDOCRINOL, V77, P500, DOI 10.1111/j.1365-2265.2012.04464.x; Stephenson MD, 2002, HUM REPROD, V17, P446, DOI 10.1093/humrep/17.2.446; SWYER GIM, 1953, BMJ-BRIT MED J, V1, P1073, DOI 10.1136/bmj.1.4819.1073	22	135	159	5	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 26	2015	373	22					2141	2148		10.1056/NEJMoa1504927	http://dx.doi.org/10.1056/NEJMoa1504927			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9YT	26605928	Green Published, Bronze			2022-12-28	WOS:000365354800008
J	Rockstrom, J				Rockstroem, Johan			A 'perfect' agreement in Paris is not essential	NATURE			English	Editorial Material									[Rockstroem, Johan] Earth League, London, England; [Rockstroem, Johan] Stockholm Resilience Ctr, Stockholm, Sweden	Stockholm University	Rockstrom, J (corresponding author), Earth League, London, England.	johan.rockstrom@su.se		Rockstrom, Johan/0000-0001-8988-2983					0	4	4	0	21	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 26	2015	527	7579					411	411		10.1038/527411a	http://dx.doi.org/10.1038/527411a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW9XW	26607506	Bronze			2022-12-28	WOS:000365352500005
J	Razak, F; Corsi, DJ; Slutsky, AS; Kurpad, A; Berkman, L; Laupacis, A; Subramanian, SV				Razak, Fahad; Corsi, Daniel J.; Slutsky, Arthur S.; Kurpad, Anura; Berkman, Lisa; Laupacis, Andreas; Subramanian, S. V.			Prevalence of Body Mass Index Lower Than 16 Among Women in Low- and Middle-Income Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC ENERGY DEFICIENCY; SEVERELY UNDERNOURISHED MEN; CAUSE-SPECIFIC MORTALITY; NUTRITIONAL REPLETION; INDIA; RISK; ASSOCIATION; HEALTH; ADULTS; TRIAL	IMPORTANCE Body mass index (BMI) lower than 16 is the most severe category of adult undernutrition and is associated with substantial morbidity, increased mortality, and poor maternal-fetal outcomes such as low-birth-weight newborns. Little is known about the prevalence and distribution of BMI lower than 16 in low-and middle-income countries (LMIC). OBJECTIVE To determine the prevalence and distribution of BMI lower than 16 and its change in prevalence over time in women in LMIC. DESIGN, SETTINGS, AND PARTICIPANTS Cross-sectional data analysis composed of nationally representative surveys from 1993 through 2012 from the Demographic and Health Surveys Program. Women aged 20 through 49 years from 60 LMIC (N = 500 761) and a subset of 40 countries with repeated surveys (N = 604 144) were examined. EXPOSURES Wealth was measured using a validated asset index, age was categorized in deciles, education by highest completed level (none, primary, secondary, or greater), and place of residence as urban vs rural. MAIN OUTCOMES AND MEASURES The primary outcome was BMI lower than 16. Analyses assessed the prevalence of BMI lower than 16, its association with sociodemographic factors, and change in prevalence. Logistic regression models were used to calculate odds ratios (ORs), adjusting for survey design and age structure. RESULTS Among countries examined, the pooled, weighted, and age-standardized prevalence of BMI lower than 16 was 1.8%(95% CI, 1.7% to 1.8%) with the highest prevalence in India (6.2%[95% CI, 5.9% to 6.5%]), followed by Bangladesh (3.9%[95% CI, 3.4% to 4.3%]), Madagascar (3.4%[95% CI, 2.8% to 4.0%], Timor-Leste (2.9% [95% CI, 2.4% to 3.2%]), Senegal (2.5%[95% CI, 1.9% to 3.2%]), and Sierra Leone (2.2%[95% CI, 1.3% to 3.0%]); and 6 countries had prevalences lower than 0.1% (Albania, Bolivia, Egypt, Peru, Swaziland, and Turkey). The prevalence of BMI lower than 16 in women with a secondary or higher education level was 0.51%(95% CI, 0.47% to 0.55%), and in mutually adjusted models, a less than primary education level was associated with an OR of 1.4 (95% CI, 1.2 to 1.6). The prevalence of BMI lower than 16 was 0.43%(95% CI, 0.37% to 0.48%) in the highest wealth quintile with an OR of 3.0 (95% CI, 2.4 to 3.7) in the lowest wealth quintile. Among the 24 of 39 countries with repeated surveys, there was no decrease in prevalence. In Bangladesh and India, rates were declining with an average absolute change annually of -0.52%(95% CI, -0.58% to -0.46%) in Bangladesh and -0.11% (95% CI, -0.12% to -0.10%) in India. CONCLUSIONS AND RELEVANCE Among women in 60 LMIC, the prevalence of BMI lower than 16 was 1.8%, and was associated with poverty and low education levels. Prevalence of BMI lower than 16 did not decrease over time in most countries studied.	[Razak, Fahad; Slutsky, Arthur S.; Laupacis, Andreas] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Razak, Fahad; Slutsky, Arthur S.; Laupacis, Andreas] Univ Toronto, Fac Med, Toronto, ON, Canada; [Razak, Fahad; Corsi, Daniel J.; Berkman, Lisa; Subramanian, S. V.] Harvard Univ, Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA; [Corsi, Daniel J.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Kurpad, Anura] St Johns Med Coll, Div Nutr, Bangalore, Karnataka, India	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Harvard University; Harvard T.H. Chan School of Public Health; University of Ottawa; Ottawa Hospital Research Institute; St. John's National Academy of Health Sciences; St. John's Medical College	Razak, F (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Room 364,30 Bond St, Toronto, ON M5B 1W8, Canada.	fahad.razak@mail.utoronto.ca	Slutsky, Arthur/M-3325-2019; Corsi, Daniel J/S-4689-2018	Corsi, Daniel J/0000-0001-7063-3354				Ahmad OB, AGE STANDARDIZATION; BARACNIETO M, 1979, AM J CLIN NUTR, V32, P981, DOI 10.1093/ajcn/32.5.981; BARACNIETO M, 1980, AM J CLIN NUTR, V33, P2268, DOI 10.1093/ajcn/33.11.2268; CAMPBELL P, 1994, EUR J CLIN NUTR, V48, P507; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Corsi DJ, 2012, INT J EPIDEMIOL, V41, P1602, DOI 10.1093/ije/dys184; DEVASCONCELLOS MTL, 1994, EUR J CLIN NUTR, V48, pS115; FERROLUZZI A, 1992, EUR J CLIN NUTR, V46, P173; FerroLuzzi A, 1997, AM J CLIN NUTR, V66, P1086, DOI 10.1093/ajcn/66.5.1086; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Hunter DJ, 2013, NEW ENGL J MED, V369, P1336, DOI 10.1056/NEJMra1109345; JAMES WPT, 1994, EUR J CLIN NUTR, V48, pS1; JAMES WPT, 1988, EUR J CLIN NUTR, V42, P969; Kurpad AV, 2005, PUBLIC HEALTH NUTR, V8, P1053, DOI 10.1079/PHN2005796; Loaiza E., MATERNAL NUTR STATUS; Narayan KMV, 2013, INT J EPIDEMIOL, V42, P1426, DOI 10.1093/ije/dyt082; Neuman M, 2011, AM J CLIN NUTR, V94, P1348, DOI 10.3945/ajcn.111.018127; Ortiz I, 2011, GLOBAL INEQUALITY BO; Pednekar MS, 2008, INT J EPIDEMIOL, V37, P524, DOI 10.1093/ije/dyn001; Prabhakaran D, 2013, INT J EPIDEMIOL, V42, P1431, DOI 10.1093/ije/dyt119; Razak F, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001367; Rotimi C, 1999, EUR J CLIN NUTR, V53, P734, DOI 10.1038/sj.ejcn.1600842; Rutstein S, 2008, DHS WEALTH INDEX APP, P1; SATYANARAYANA K, 1977, AM J CLIN NUTR, V30, P322, DOI 10.1093/ajcn/30.3.322; The Demographic and Health Surveys Program, SAMPL MAN; United Nations, POP DIV; Vaz M, 1996, BRIT J NUTR, V76, P9, DOI 10.1079/BJN19960005; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO, PHYS STAT US INT ANT; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	33	28	29	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	2015	314	20					2164	2171		10.1001/jama.2015.15666	http://dx.doi.org/10.1001/jama.2015.15666			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9XQ	26599184	Bronze			2022-12-28	WOS:000365351900020
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Juniors vote to strike-a profession united for the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				BMA, REM VIT SAF; Chomsky N, 2011, STAT CORP COMPL THRE; Iacobucci G, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h159; Kirkland F, 2015, GUARDIAN; Plimmer G, 2015, FT              0209; Rimmer A, 2015, BMJ CAREERS; Rimmer A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6270; Rimmer A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5624	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2015	351								h6279	10.1136/bmj.h6279	http://dx.doi.org/10.1136/bmj.h6279			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW9YA	26586693	Bronze			2022-12-28	WOS:000365352900018
J	Ravindranath, V; Dang, HM; Goya, RG; Mansour, H; Nimgaonkar, VL; Russell, VA; Xin, Y				Ravindranath, Vijayalakshmi; Dang, Hoang-Minh; Goya, Rodolfo G.; Mansour, Hader; Nimgaonkar, Vishwajit L.; Russell, Vivienne Ann; Xin, Yu			Regional research priorities in brain and nervous system disorders	NATURE			English	Review							SUB-SAHARAN AFRICA; ADOLESCENT PSYCHIATRIC-DISORDERS; ACTIVE CONVULSIVE EPILEPSY; MENTAL-HEALTH RESEARCH; AGE-OF-ONSET; LATIN-AMERICA; GLOBAL BURDEN; DEVELOPING-COUNTRIES; ALZHEIMERS-DISEASE; SUBSTANCE USE	The characteristics of neurological, psychiatric, developmental and substance-use disorders in low-and middle-income countries are unique and the burden that they have will be different from country to country. Many of the differences are explained by the wide variation in population demographics and size, poverty, conflict, culture, land area and quality, and genetics. Neurological, psychiatric, developmental and substance-use disorders that result from, or are worsened by, a lack of adequate nutrition and infectious disease still afflict much of sub-Saharan Africa, although disorders related to increasing longevity, such as stroke, are on the rise. In the Middle East and North Africa, major depressive disorders and post-traumatic stress disorder are a primary concern because of the conflict-ridden environment. Consanguinity is a serious concern that leads to the high prevalence of recessive disorders in the Middle East and North Africa and possibly other regions. The burden of these disorders in Latin American and Asian countries largely surrounds stroke and vascular disease, dementia and lifestyle factors that are influenced by genetics. Although much knowledge has been gained over the past 10 years, the epidemiology of the conditions in low-and middle-income countries still needs more research. Prevention and treatments could be better informed with more longitudinal studies of risk factors. Challenges and opportunities for ameliorating nervous-system disorders can benefit from both local and regional research collaborations. The lack of resources and infrastructure for health-care and related research, both in terms of personnel and equipment, along with the stigma associated with the physical or behavioural manifestations of some disorders have hampered progress in understanding the disease burden and improving brain health. Individual countries, and regions within countries, have specific needs in terms of research priorities.	[Ravindranath, Vijayalakshmi] Indian Inst Sci, Ctr Neurosci, Bangalore 560012, Karnataka, India; [Dang, Hoang-Minh] Vietnam Natl Univ, Hanoi 10000, Vietnam; [Goya, Rodolfo G.] Natl Univ La Plata, Inst Biochem Res, RA-1900 La Plata, Argentina; [Goya, Rodolfo G.] Natl Univ La Plata, Sch Med, RA-1900 La Plata, Argentina; [Mansour, Hader] Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Pittsburgh, PA 15213 USA; [Mansour, Hader] Mansoura Univ, Sch Med, Dept Psychiat, Mansoura 35516, Egypt; [Nimgaonkar, Vishwajit L.] Univ Pittsburgh, Dept Psychiat & Human Genet, Pittsburgh, PA 15213 USA; [Russell, Vivienne Ann] Univ Cape Town, Dept Human Biol, Fac Hlth Sci, ZA-7925 Observatory, South Africa; [Xin, Yu] Peking Univ, Inst Mental Hlth, Beijing 100191, Peoples R China	Indian Institute of Science (IISC) - Bangalore; Vietnam National University Hanoi; National University of La Plata; National University of La Plata; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Egyptian Knowledge Bank (EKB); Mansoura University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Cape Town; Peking University	Ravindranath, V (corresponding author), Indian Inst Sci, Ctr Neurosci, Bangalore 560012, Karnataka, India.	viji@cns.iisc.ernet.in			Fogarty International Center	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The authors declare no competing financial interests. Financial support for publication has been provided by the Fogarty International Center.	Agarwal S.P., 2004, MENTAL HLTH INDIAN P, P3; Al-Gazali L, 2006, BMJ-BRIT MED J, V333, P831, DOI 10.1136/bmj.38982.704931.AE; Al-Gazali L, 2014, HUM HERED, V77, P93, DOI 10.1159/000360421; Alarcon Renato D, 2003, World Psychiatry, V2, P54; Alhasnawi S, 2009, WORLD PSYCHIATRY, V8, P97; Alzheimer's Disease International, 2009, WORLD ALZH REP 2009; Ba-Diop A, 2014, LANCET NEUROL, V13, P1029, DOI 10.1016/S1474-4422(14)70114-0; Bain LE, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.120.2535; Barreto SM, 2012, INT J EPIDEMIOL, V41, P557, DOI 10.1093/ije/dys017; Bassiony MM, 2015, AM J DRUG ALCOHOL AB, V41, P206, DOI 10.3109/00952990.2015.1014959; Benamer HTS, 2009, EPILEPSIA, V50, P2301, DOI 10.1111/j.1528-1167.2009.02058.x; Birbeck GL, 2011, AM J TROP MED HYG, V85, P782, DOI 10.4269/ajtmh.2011.11-0187; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Borges G, 2008, SALUD PUBLICA MEXICO, V50, pS6; Bruno E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002480; Burneo JG, 2005, EPILEPSY RES, V66, P63, DOI 10.1016/j.eplepsyres.2005.07.002; Champagne BM, 2010, TOB CONTROL, V19, P457, DOI 10.1136/tc.2009.031666; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Correia M., 2002, 433 WDP WORLD BANK; D'Souza Manoranjan S, 2011, Addict Sci Clin Pract, V6, P4; Dans A, 2011, LANCET, V377, P680, DOI 10.1016/S0140-6736(10)61506-1; Degenhardt L, 2014, DRUG ALCOHOL REV, V33, P4, DOI 10.1111/dar.12088; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Duarte C, 2003, INT J PSYCHIAT MED, V33, P203, DOI 10.2190/4WJB-BW16-2TGE-565W; Duggan MB, 2013, AFR HEALTH SCI, V13, P613, DOI 10.4314/ahs.v13i3.14; El-Zaemey S, 2014, INT J OCCUP ENV MED, V5, P109; Espie Emmanuelle, 2009, Int J Ment Health Syst, V3, P21, DOI 10.1186/1752-4458-3-21; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Fleitlich-Bilyk B, 2004, J AM ACAD CHILD PSY, V43, P727, DOI 10.1097/01.chi.0000120021.14101.ca; Hamdi E, 2013, SUBST ABUS, V34, P97, DOI 10.1080/08897077.2012.677752; Hess AT, 2014, METAB BRAIN DIS, V29, P323, DOI 10.1007/s11011-014-9487-6; Hoare J, 2014, METAB BRAIN DIS, V29, P221, DOI 10.1007/s11011-013-9456-5; Hoffman R, 2013, EUR ADDICT RES, V19, P1, DOI 10.1159/000338285; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Hyder AA, 2009, B WORLD HEALTH ORGAN, V87, P345, DOI 10.2471/BLT.08.055798; Irving JA, 2013, SANTE MENT QUE, V38, P65, DOI 10.7202/1023990ar; Jitapunkul Sutthichai, 2001, Journal of the Medical Association of Thailand, V84, P461; KABATZINN J, 1992, AM J PSYCHIAT, V149, P936; Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8; Kerac M, 2014, SEMIN PEDIATR NEUROL, V21, P42, DOI 10.1016/j.spen.2014.01.003; Khattab A, 2012, RESP MED, V106, pS16, DOI 10.1016/S0954-6111(12)70011-2; Kitsao-Wekulo P, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00713; Knudsen EI, 2006, P NATL ACAD SCI USA, V103, P10155, DOI 10.1073/pnas.0600888103; Kulshreshtha A, 2012, NEUROEPIDEMIOLOGY, V38, P123, DOI 10.1159/000336230; Kwiatkowski MA, 2014, METAB BRAIN DIS, V29, P245, DOI 10.1007/s11011-013-9470-7; Laughton B, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18603; Lavi T, 2005, J AM ACAD CHILD PSY, V44, P1176, DOI 10.1097/01.chi.0000177325.47629.4c; Lekoubou A, 2015, J NEUROL SCI, V350, P24, DOI 10.1016/j.jns.2015.02.002; Lekoubou A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-653; Li D, 2014, ARCH GERONTOL GERIAT, V58, P1, DOI 10.1016/j.archger.2013.07.016; LINEHAN MM, 1987, B MENNINGER CLIN, V51, P261; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; [马辛 MA Xin], 2007, [中华精神科杂志, Chinese Journal of Psychiatry], V40, P100; Mac TL, 2007, LANCET NEUROL, V6, P533, DOI 10.1016/S1474-4422(07)70127-8; Mackay J, 2013, LANCET, V381, P1581, DOI 10.1016/S0140-6736(13)60854-5; Malhotra S, 2014, CHILD ADOL PSYCH MEN, V8, DOI 10.1186/1753-2000-8-22; Manjunath RB, 2013, INDIAN J PSYCHIAT, V55, pS374, DOI 10.4103/0019-5545.116314; Massey JS, 2015, NEUROPSYCHOLOGY, V29, P530, DOI 10.1037/neu0000192; Mavrodaris A, 2013, B WORLD HEALTH ORGAN, V91, P773, DOI 10.2471/BLT.13.118422; Mehndiratta MM, 2014, J NEUROL NEUROSUR PS, V85, P1308, DOI 10.1136/jnnp-2013-306992; Mejia S, 2003, INT PSYCHOGERIATR, V15, P337, DOI 10.1017/S1041610203009591; Mirkin B., 2010, POPULATION LEVELS TR; Momtazi S, 2010, CURR OPIN PSYCHIATR, V23, P221, DOI 10.1097/YCO.0b013e328338630d; Motadi SA, 2015, NUTRITION, V31, P452, DOI 10.1016/j.nut.2014.09.016; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 1997, LANCET, V349, P1347, DOI 10.1016/S0140-6736(96)07494-6; Mustapha AF, 2014, EPILEPSY BEHAV, V37, P258, DOI 10.1016/j.yebeh.2014.06.016; Ngugi AK, 2013, LANCET NEUROL, V12, P253, DOI 10.1016/S1474-4422(13)70003-6; Nitrini R, 2009, INT PSYCHOGERIATR, V21, P622, DOI 10.1017/S1041610209009430; Njuguna J, 2013, J PSYCHOACTIVE DRUGS, V45, P355, DOI 10.1080/02791072.2013.825516; Nzwalo H, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001051; Odenwald M., 2014, NEGLECTED TROPICAL D, P293, DOI DOI 10.1007/978-1-4614-8100-3_16; Okasha A, 2012, WORLD PSYCHIATRY, V11, P52, DOI 10.1016/j.wpsyc.2012.01.008; Osakwe C, 2014, EPILEPSY RES, V108, P316, DOI 10.1016/j.eplepsyres.2013.11.010; Owolabi MO, 2015, CARDIOVASC J AFR, V26, pS27, DOI 10.5830/CVJA-2015-038; Paddick SM, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19646; Padma TV, 2014, NATURE, V508, pS14, DOI 10.1038/508S14a; Pang T, 2002, BMJ-BRIT MED J, V324, P499, DOI 10.1136/bmj.324.7336.499; Paradisi I, 2008, J HUM GENET, V53, P127, DOI 10.1007/s10038-007-0227-1; Pastor P, 2003, ANN NEUROL, V54, P163, DOI 10.1002/ana.10636; Patel N. B., 2014, NEGLECTED TROPICAL D, P307, DOI DOI 10.1007/978-14614-8100-3_17; Patel V, 2000, PSYCHOL MED, V30, P743, DOI 10.1017/S0033291799002147; Preux PM, 2005, LANCET NEUROL, V4, P21, DOI 10.1016/S1474-4422(04)00963-9; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Puvanachandra P, 2008, SALUD PUBLICA MEXICO, V50, pS3; Rao NP, 2013, INDIAN J PSYCHIAT, V55, pS145, DOI 10.4103/0019-5545.105510; Razzouk D, 2010, HEALTH POLICY, V94, P211, DOI 10.1016/j.healthpol.2009.09.009; Rodriguez A, 2009, J CHILD PSYCHOL PSYC, V50, P1073, DOI 10.1111/j.1469-7610.2009.02071.x; Said-Mohamed R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1844-9; Saxena S, 2006, BRIT J PSYCHIAT, V188, P81, DOI 10.1192/bjp.bp.105.011221; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Schuurman N, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.27016; Seedat S, 2008, SOC PSYCH PSYCH EPID, V43, P889, DOI 10.1007/s00127-008-0399-9; Sepulveda J, 2014, SCIENCE, V345, P1275, DOI 10.1126/science.1257099; Shaji KS., 2010, DEMENTIA INDIA REPOR; Shaji S, 2005, BRIT J PSYCHIAT, V186, P136, DOI 10.1192/bjp.186.2.136; Sharan P, 2009, BRIT J PSYCHIAT, V195, P354, DOI 10.1192/bjp.bp.108.050187; Subodh BN, 2008, J AFFECT DISORDERS, V109, P199, DOI 10.1016/j.jad.2007.11.006; Tadmouri GO, 2006, NUCLEIC ACIDS RES, V34, pD602, DOI 10.1093/nar/gkj015; Thomas SV, 2011, ANN INDIAN ACAD NEUR, V14, P158, DOI 10.4103/0972-2327.85873; Travers KU, 2013, EXPERT REV PHARM OUT, V13, P613, DOI 10.1586/14737167.2013.838026; United Nations Office on Drugs and Crime, 2014, WORLD DRUG REP; Uthman OA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006340; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wagner RG, 2014, EPILEPSY RES, V108, P782, DOI 10.1016/j.eplepsyres.2014.01.004; Wang G, 2008, J ALZHEIMERS DIS, V15, P109; Warfa N, 2007, SOC SCI MED, V65, P309, DOI 10.1016/j.socscimed.2007.04.038; Wasay M, 2014, NAT REV NEUROL, V10, P135, DOI 10.1038/nrneurol.2014.13; Watt MH, 2014, INT J DRUG POLICY, V25, P219, DOI 10.1016/j.drugpo.2013.10.007; Whiteford HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116820; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wilmshurst JM, 2014, EPILEPSIA, V55, P1322, DOI 10.1111/epi.12602; Woldeamanuel YW, 2012, J NEUROL, V259, P1263, DOI 10.1007/s00415-011-6306-4; World Health Organization, 2007, 20067 WHO; World Health Organization, 2017, ATL COUNTR RES NEUR; Xu GL, 2013, STROKE, V44, P1775, DOI 10.1161/STROKEAHA.113.001238; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1	119	20	20	1	49	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 19	2015	527	7578					S198	S206		10.1038/nature16036	http://dx.doi.org/10.1038/nature16036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW9ZN	26580328	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000365356800017
J	Niven, DJ; Gaudet, JE; Laupland, KB; Mrklas, KJ; Roberts, DJ; Stelfox, HT				Niven, Daniel J.; Gaudet, Jonathan E.; Laupland, Kevin B.; Mrklas, Kelly J.; Roberts, Derek J.; Stelfox, Henry Thomas			Accuracy of Peripheral Thermometers for Estimating Temperature A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							INFRARED EAR THERMOMETRY; TYMPANIC MEMBRANE TEMPERATURES; PULMONARY-ARTERY CORE; BODY-TEMPERATURE; TEMPORAL-ARTERY; CRITICALLY-ILL; RECTAL TEMPERATURES; ANTIPYRETIC TREATMENT; BLADDER THERMOMETRY; SKIN TEMPERATURES	Background: Body temperature is commonly used to screen patients for infectious diseases, establish diagnoses, monitor therapy, and guide management decisions. Purpose: To determine the accuracy of peripheral thermometers for estimating core body temperature in adults and children. Data Sources: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and CINAHL Plus from inception to July 2015. Study Selection: Prospective studies comparing the accuracy of peripheral (tympanic membrane, temporal artery, axillary, or oral) thermometers with central (pulmonary artery catheter, urinary bladder, esophageal, or rectal) thermometers. Data Extraction: 2 reviewers extracted data on study characteristics, methods, and outcomes and assessed the quality of individual studies. Data Synthesis: 75 studies (8682 patients) were included. Most studies were at high or unclear risk of patient selection bias (74%) or index test bias (67%). Compared with central thermometers, peripheral thermometers had pooled 95% limits of agree-ment (random-effects meta-analysis) outside the predefined clinically acceptable range (+/- 0.5 degrees C), especially among patients with fever (-1.44 degrees C to 1.46 degrees C for adults; -1.49 degrees C to 0.43 degrees C for children) and hypothermia (-2.07 degrees C to 1.90 degrees C for adults; no data for children). For detection of fever (bivariate random-effects meta-analysis), sensitivity was low (64% [95% CI, 55% to 72%]; I-2 = 95.7%; P < 0.001) but specificity was high (96% [CI, 93% to 97%]; I-2 = 96.3%; P < 0.001). Only 1 study reported sensitivity and specificity for the detection of hypothermia. Limitations: High-quality data for some temperature measurement techniques are limited. Pooled data are associated with interstudy heterogeneity that is not fully explained by stratified and metaregression analyses. Conclusion: Peripheral thermometers do not have clinically acceptable accuracy and should not be used when accurate measurement of body temperature will influence clinical decisions. Primary Funding Source: None.	[Niven, Daniel J.; Gaudet, Jonathan E.] Peter Lougheed Ctr, Dept Crit Care Med, Calgary, AB T1Y 6J4, Canada; [Laupland, Kevin B.] Royal Inland Hosp, Dept Med, Kamloops, BC V2C 2T1, Canada; [Mrklas, Kelly J.] Foothills Med Ctr, Calgary, AB T2N 2T9, Canada; [Roberts, Derek J.] Foothills Med Ctr, Dept Crit Care Med, Calgary, AB T2N 5A1, Canada; [Stelfox, Henry Thomas] Univ Calgary, Teaching Res & Wellness Bldg, Calgary, AB T2N 4Z6, Canada	University of Calgary; University of Calgary; University of Calgary	Niven, DJ (corresponding author), Peter Lougheed Ctr, Dept Crit Care Med, 3500 26th Ave Northeast, Calgary, AB T1Y 6J4, Canada.	Daniel.niven@albertahealthservices.ca	Laupland, kevin/AAJ-6339-2020; Laupland, Kevin/AAG-3656-2020; Roberts, Derek J./L-6229-2019	Laupland, kevin/0000-0002-1205-5354; Roberts, Derek J./0000-0001-6111-6291; Stelfox, Henry/0000-0003-1231-1490	Alberta Innovates-Health Solutions; Knowledge Translation Canada Student Fellowship; Knowledge Translation Canada Training Program grants; Canadian Institutes of Health Research	Alberta Innovates-Health Solutions; Knowledge Translation Canada Student Fellowship; Knowledge Translation Canada Training Program grants; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study did not receive any specific funding from any organization. Drs. Niven and Roberts are funded through Clinician Fellowship Awards from Alberta Innovates-Health Solutions and Knowledge Translation Canada Student Fellowship and Training Program grants. Dr. Stelfox is supported by a New Investigator Award from the Canadian Institutes of Health Research and a Population Health Investigator Award from Alberta Innovates-Health Solutions.	Abdulkadir MB, 2013, PAEDIATR INT CHILD H, V33, P165, DOI 10.1179/2046905513Y.0000000066; Akinyinka OO, 2001, ANN TROP PAEDIATR, V21, P169, DOI 10.1080/02724930120058269; Allegaert Karel, 2014, Curr Ther Res Clin Exp, V76, P34, DOI 10.1016/j.curtheres.2013.11.005; Arcona S, 2001, NURS MANAG, V32, p[45, 42]; Arons MM, 1999, CRIT CARE MED, V27, P699, DOI 10.1097/00003246-199904000-00020; Attia J, 1999, JAMA-J AM MED ASSOC, V282, P175, DOI 10.1001/jama.282.2.175; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bock M, 2005, CAN J ANAESTH, V52, P1083, DOI 10.1007/BF03021609; BOR DH, 1988, J GEN INTERN MED, V3, P119, DOI 10.1007/BF02596115; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Chaturvedi Deepti, 2004, Indian Pediatr, V41, P600; Chiappini E, 2012, CLIN THER, V34, P1648, DOI 10.1016/j.clinthera.2012.06.011; Chiappini E, 2009, CLIN THER, V31, P1826, DOI 10.1016/j.clinthera.2009.08.006; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; Coburn B, 2012, JAMA-J AM MED ASSOC, V308, P502, DOI 10.1001/jama.2012.8262; Couilliet D, 1996, ANN MED INTERNE, V147, P536; Craig JV, 2000, BRIT MED J, V320, P1174, DOI 10.1136/bmj.320.7243.1174; Craig JV, 2002, LANCET, V360, P603, DOI 10.1016/S0140-6736(02)09783-0; de Naurois J, 2010, ANN ONCOL, V21, pv252, DOI 10.1093/annonc/mdq196; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; den Hertog HM, 2009, LANCET NEUROL, V8, P434, DOI 10.1016/S1474-4422(09)70051-1; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Sabatino A, 2011, LANCET, V378, P86, DOI 10.1016/S0140-6736(10)61493-6; DINARELLO CA, 1988, REV INFECT DIS, V10, P168; Dodd SR, 2006, J CLIN EPIDEMIOL, V59, P354, DOI 10.1016/j.jclinepi.2005.10.004; Draaisma J M, 1997, Ned Tijdschr Geneeskd, V141, P938; Duncan AL, 2008, AUSTRALAS EMERG NURS, V11, P130, DOI 10.1016/j.aenj.2008.05.003; Duru CO, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-86; Dwamena BA, INDEX REPEC BOCODE M; Ebell MH, 2000, JAMA-J AM MED ASSOC, V284, P2912, DOI 10.1001/jama.284.22.2912; Edelu B O, 2011, Niger Med J, V52, P207, DOI 10.4103/0300-1652.93789; Edelu BO, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-8; ERICKSON RS, 1993, CRIT CARE MED, V21, P1528, DOI 10.1097/00003246-199310000-00022; ERICKSON RS, 1994, HEART LUNG, V23, P181; Eyelade OR, 2011, J PERIANESTH NURS, V26, P151, DOI 10.1016/j.jopan.2011.03.009; FALLIS WM, 1994, HEART LUNG, V23, P300; Farnell S, 2005, J CLIN NURS, V14, P632, DOI 10.1111/j.1365-2702.2004.00916.x; Frank SM, 1997, JAMA-J AM MED ASSOC, V277, P1127, DOI 10.1001/jama.277.14.1127; Fulbrook P, 1993, Intensive Crit Care Nurs, V9, P217, DOI 10.1016/S0964-3397(05)80002-3; Fulbrook P, 1997, Intensive Crit Care Nurs, V13, P266, DOI 10.1016/S0964-3397(97)80425-9; Giuffre M, 1990, Appl Nurs Res, V3, P52; Giuliano K K, 2000, Am J Crit Care, V9, P254; Giuliano KK, 1999, CRIT CARE MED, V27, P2188, DOI 10.1097/00003246-199910000-00020; GREEN M M, 1989, Journal of Emergency Medicine, V7, P437, DOI 10.1016/0736-4679(89)90136-4; Haddadin R. B., 2007, Eastern Mediterranean Health Journal, V13, P1060; Hasper D, 2011, EMERG MED J, V28, P483, DOI 10.1136/emj.2009.090464; Hebbar Kiran, 2005, Pediatr Crit Care Med, V6, P557, DOI 10.1097/01.PCC.0000163671.69197.16; HERZOG LW, 1993, CLIN PEDIATR, V32, P142, DOI 10.1177/000992289303200303; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hooker EA, 1996, SOUTHERN MED J, V89, P230, DOI 10.1097/00007611-199602000-00016; Huber W, 2010, INTENS CARE MED, V36, pS120; ILSLEY AH, 1983, ANAESTH INTENS CARE, V11, P31, DOI 10.1177/0310057X8301100107; Jean-Mary MB, 2002, J PEDIATR-US, V141, P671, DOI 10.1067/mpd.2002.127664; Jefferies S, 2011, CRIT CARE RESUSC, V13, P194; Jirapaet K, 2000, NURSING HLTH SCI, V2, P1; Joost Mette, 2003, Ugeskr Laeger, V165, P2296; Jorgensen HS, 1996, LANCET, V348, P193, DOI 10.1016/S0140-6736(05)66135-1; Kallmunzer B, 2011, CEREBROVASC DIS, V31, P382, DOI 10.1159/000321733; Kamada Y, 1999, Masui, V48, P1121; Kastner M, 2009, J CLIN EPIDEMIOL, V62, P974, DOI 10.1016/j.jclinepi.2008.11.006; Kaul DR, 2006, J GEN INTERN MED, V21, P1184, DOI 10.1111/j.1525-1497.2006.00566.x; KHAN M N, 1990, Indian Pediatrics, V27, P807; Kimberger O, 2007, ANESTH ANALG, V105, P1042, DOI 10.1213/01.ane.0000281927.88935.e0; Kiya T, 2007, ANESTH ANALG, V105, P1688, DOI 10.1213/01.ane.0000289639.87836.79; Kocoglu H, 2002, INT J PEDIATR OTORHI, V65, P39, DOI 10.1016/S0165-5876(02)00129-5; Koennecke HC, 2001, NEUROLOGY, V57, P2301, DOI 10.1212/WNL.57.12.2301; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Langham GE, 2009, ANESTHESIOLOGY, V111, P90, DOI 10.1097/ALN.0b013e3181a864ca; Laupland KB, 2012, CLIN INFECT DIS, V54, P1064, DOI 10.1093/cid/cir1033; Laupland KB, 2012, CRIT CARE MED, V40, P145, DOI 10.1097/CCM.0b013e31822f061d; Laupland KB, 2009, CRIT CARE MED, V37, pS273, DOI 10.1097/CCM.0b013e3181aa6117; Lawson L, 2007, AM J CRIT CARE, V16, P485; Lee Gail, 2011, Adv Neonatal Care, V11, P62, DOI 10.1097/ANC.0b013e3182087d2b; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Lefrant JY, 2003, INTENS CARE MED, V29, P414, DOI 10.1007/s00134-002-1619-5; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Lodha Rakesh, 2000, Indian Journal of Pediatrics, V67, P571, DOI 10.1007/BF02758482; Mabey D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6202; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; MACKOWIAK PA, 1992, JAMA-J AM MED ASSOC, V268, P1578, DOI 10.1001/jama.268.12.1578; Massin MM, 2006, ACTA CLIN BELG, V61, P161, DOI 10.1179/acb.2006.027; Maxton FJC, 2004, J ADV NURS, V45, P214, DOI 10.1046/j.1365-2648.2003.02883.x; Mazerolle SM, 2011, J ATHL TRAINING, V46, P566; MCGOWAN JE, 1987, AM J MED, V82, P580, DOI 10.1016/0002-9343(87)90103-3; MILEWSKI A, 1991, CLIN PEDIATR, V30, P13, DOI 10.1177/0009922891030004S05; Milewski A, 1991, CLIN PEDIAT S, V30, P34; Moran JL, 2007, CRIT CARE MED, V35, P155, DOI 10.1097/01.CCM.0000250318.31453.CB; MUMA BK, 1991, ANN EMERG MED, V20, P41, DOI 10.1016/S0196-0644(05)81116-3; Myny D, 2005, SCOT MED J, V50, P15, DOI 10.1177/003693300505000106; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; NIERMAN DM, 1991, CRIT CARE MED, V19, P818, DOI 10.1097/00003246-199106000-00015; Nimah MM, 2006, PEDIATR CRIT CARE ME, V7, P48, DOI 10.1097/01.PCC.0000185476.35550.B2; Niven DJ, 2013, CRIT CARE, V17, DOI 10.1186/cc13153; Niven Daniel J, 2012, J Intensive Care Med, V27, P290, DOI 10.1177/0885066611402463; Nonose Y, 2012, ANAESTH INTENS CARE, V40, P820, DOI 10.1177/0310057X1204000510; O'Grady NP, 2008, CRIT CARE MED, V36, P1330, DOI 10.1097/CCM.0b013e318169eda9; Odinaka KK, 2014, PEDIATR EMERG CARE, V30, P867, DOI 10.1097/PEC.0000000000000289; Paes BF, 2010, ARCH DIS CHILD, V95, P974, DOI 10.1136/adc.2010.185801; Patel N, 1996, J CLIN ANESTH, V8, P462, DOI 10.1016/0952-8180(96)00103-1; Petersen MH, 1997, ACTA ANAESTH SCAND, V41, P1066, DOI 10.1111/j.1399-6576.1997.tb04837.x; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Richardson M, 2007, BRIT MED J, V334, P1163, DOI 10.1136/bmj.39218.495255.AE; Riley RD, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-3; Robinson J, 1998, CAN J ANAESTH, V45, P317, DOI 10.1007/BF03012021; ROMANO MJ, 1993, CRIT CARE MED, V21, P1181, DOI 10.1097/00003246-199308000-00018; Rotello LC, 1996, CRIT CARE MED, V24, P1501, DOI 10.1097/00003246-199609000-00012; Rubia-Rubia J, 2011, INT J NURS STUD, V48, P872, DOI 10.1016/j.ijnurstu.2010.11.003; Ryan M, 2003, CRIT CARE, V7, P221, DOI 10.1186/cc1879; Sanderson B, 2010, CRIT CARE, V14, pS111; Schmitz T, 1995, Am J Crit Care, V4, P286; Schuh S, 2004, PEDIATR EMERG CARE, V20, P736; Sehgal Arvind, 2002, Indian Journal of Pediatrics, V69, P305, DOI 10.1007/BF02723215; Shann F, 1996, ARCH PEDIAT ADOL MED, V150, P74, DOI 10.1001/archpedi.1996.02170260078013; Shin J, 2013, RESUSCITATION, V84, P810, DOI 10.1016/j.resuscitation.2012.12.023; Smitz S, 2000, J AM GERIATR SOC, V48, P63, DOI 10.1111/j.1532-5415.2000.tb03030.x; Smitz S, 2009, J CLIN NURS, V18, P451, DOI 10.1111/j.1365-2702.2008.02565.x; Stavem K, 1997, INTENS CARE MED, V23, P100, DOI 10.1007/s001340050297; Stelfox HT, 2010, BMC ANESTHESIOL, V10, DOI 10.1186/1471-2253-10-13; Sterne J. A. C., 2009, METAANALYSIS STATA U; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Suleman MI, 2002, ANESTH ANALG, V95, P67, DOI 10.1097/00000539-200207000-00012; Teller J, 2014, ACTA PAEDIATR, V103, pE80, DOI 10.1111/apa.12464; Teran CG, 2012, CHILD CARE HLTH DEV, V38, P471, DOI 10.1111/j.1365-2214.2011.01264.x; Van den Bruel A, 2010, LANCET, V375, P834, DOI 10.1016/S0140-6736(09)62000-6; Vertedor-Hurtado MV, 2009, ENFERM CLIN, V19, P115, DOI 10.1016/j.enfcli.2008.10.016; Wang K, 2013, NONCONTACT INFRARED; WHITE N, 1994, APPL NURS RES, V7, P165, DOI 10.1016/0897-1897(94)90022-1; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Williamson PR, 2002, STAT MED, V21, P2013, DOI 10.1002/sim.1158; Yalcin SS, 2010, J TROP PEDIATRICS, V56, P53, DOI 10.1093/tropej/fmp058; Yaron Michael, 1995, Journal of Emergency Medicine, V13, P617, DOI 10.1016/0736-4679(95)00065-I; Young PJ, 2012, INTENS CARE MED, V38, P437, DOI 10.1007/s00134-012-2478-3; Zengeya ST, 1996, EUR J PEDIATR, V155, P1005, DOI 10.1007/s004310050522; Zhen C, 2015, CLIN PEDIATR, V54, P114, DOI 10.1177/0009922814545492; Zhen C, 2014, CLIN PEDIATR, V53, P1158, DOI 10.1177/0009922814536774	136	127	131	1	39	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					768	+		10.7326/M15-1150	http://dx.doi.org/10.7326/M15-1150			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26571241				2022-12-28	WOS:000365746400019
J	Pindyck, T; Prochazka, AV				Pindyck, Talia; Prochazka, Allan V.			Review: Screening identifies women having intimate partner violence, but effects are unclear	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Pindyck, Talia; Prochazka, Allan V.] Denver VA Med Ctr, Aurora, CO USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Pindyck, T (corresponding author), Denver VA Med Ctr, Aurora, CO USA.							Crandall ML, 2004, J TRAUMA, V56, P906, DOI 10.1097/01.TA.0000111753.45748.E8; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Renner LM, 2012, CHILD ABUSE NEGLECT, V36, P40, DOI 10.1016/j.chiabu.2011.07.007	3	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					JC3	JC3		10.7326/ACPJC-2015-163-10-003	http://dx.doi.org/10.7326/ACPJC-2015-163-10-003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26571257				2022-12-28	WOS:000365746400004
J	Levin, LA; Le Bris, N				Levin, Lisa A.; Le Bris, Nadine			The deep ocean under climate change	SCIENCE			English	Editorial Material							SEA; BIODIVERSITY; HABITAT; SERVICES; ABYSSAL	The deep ocean absorbs vast amounts of heat and carbon dioxide, providing a critical buffer to climate change but exposing vulnerable ecosystems to combined stresses of warming, ocean acidification, deoxygenation, and altered food inputs. Resulting changes may threaten biodiversity and compromise key ocean services that maintain a healthy planet and human livelihoods. There exist large gaps in understanding of the physical and ecological feedbacks that will occur. Explicit recognition of deep-ocean climate mitigation and inclusion in adaptation planning by the United Nations Framework Convention on Climate Change (UNFCCC) could help to expand deep-ocean research and observation and to protect the integrity and functions of deep-ocean ecosystems.	[Levin, Lisa A.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Le Bris, Nadine] Univ Paris 06, Sorbonne Univ, CNRS, Lab Ecogeochim Environm Benth, F-66650 Banyuls Sur Mer, France	University of California System; University of California San Diego; Scripps Institution of Oceanography; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Levin, LA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA.	llevin@ucsd.edu	Le Bris, Nadine/E-1381-2014	Le Bris, Nadine/0000-0002-0142-4847; Levin, Lisa/0000-0002-2858-8622	Division Of Earth Sciences [1324095] Funding Source: National Science Foundation	Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Adloff F., 2015, CLIM DYN; Armstrong CW, 2012, ECOSYST SERV, V2, P2, DOI 10.1016/j.ecoser.2012.07.001; Bergmann M, 2011, DEEP-SEA RES PT I, V58, P711, DOI 10.1016/j.dsr.2011.03.007; Byrne RH, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL040999; Company JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001431; Danovaro R, 2004, ECOL LETT, V7, P821, DOI 10.1111/j.1461-0248.2004.00634.x; Gehlen M, 2014, BIOGEOSCIENCES, V11, P6955, DOI 10.5194/bg-11-6955-2014; Gilly WF, 2013, ANNU REV MAR SCI, V5, P393, DOI 10.1146/annurev-marine-120710-100849; Gjerde KM, 2013, MAR POLLUT BULL, V74, P540, DOI 10.1016/j.marpolbul.2013.07.037; Gooday AJ, 2010, MAR ECOL-EVOL PERSP, V31, P125, DOI 10.1111/j.1439-0485.2009.00348.x; Gruber N, 2011, PHILOS T R SOC A, V369, P1980, DOI 10.1098/rsta.2011.0003; Jones DOB, 2014, GLOBAL CHANGE BIOL, V20, P1861, DOI 10.1111/gcb.12480; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Lunden JJ, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00078; Marlow JJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6094; Mengerink KJ, 2014, SCIENCE, V344, P696, DOI 10.1126/science.1251458; Moffitt SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115246; Mora C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001682; Phrampus BJ, 2012, NATURE, V490, P527, DOI 10.1038/nature11528; Puig P, 2012, NATURE, V489, P286, DOI 10.1038/nature11410; Purkey SG, 2010, J CLIMATE, V23, P6336, DOI 10.1175/2010JCLI3682.1; Ramirez-Llodra E, 2010, BIOGEOSCIENCES, V7, P2851, DOI 10.5194/bg-7-2851-2010; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; Rumin-Caparros A, 2013, BIOGEOSCIENCES, V10, P3493, DOI 10.5194/bg-10-3493-2013; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; Smith CR, 2012, P ROY SOC B-BIOL SCI, V279, P1017, DOI 10.1098/rspb.2011.1496; Smith KL, 2013, P NATL ACAD SCI USA, V110, P19838, DOI 10.1073/pnas.1315447110; Stramma L, 2012, NAT CLIM CHANGE, V2, P33, DOI 10.1038/NCLIMATE1304; Stramma L, 2010, DEEP-SEA RES PT I, V57, P587, DOI 10.1016/j.dsr.2010.01.005; Thresher RE, 2015, NAT CLIM CHANGE, V5, P635, DOI 10.1038/NCLIMATE2611; Thurber AR, 2014, BIOGEOSCIENCES, V11, P3941, DOI 10.5194/bg-11-3941-2014; Yesson C, 2012, J BIOGEOGR, V39, P1278, DOI 10.1111/j.1365-2699.2011.02681.x	32	166	171	12	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					766	768		10.1126/science.aad0126	http://dx.doi.org/10.1126/science.aad0126			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW3MS	26564845				2022-12-28	WOS:000364897000032
J	Ueda, K				Ueda, Kiyoshi			To catch and smash charge on the hop	SCIENCE			English	Editorial Material							DYNAMICS; TIME		Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan	Tohoku University	Ueda, K (corresponding author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan.	ueda@tagen.tohoku.ac.jp						Allaria E, 2015, J SYNCHROTRON RADIAT, V22, P485, DOI 10.1107/S1600577515005366; Brumer P., 2003, PRINCIPLES QUANTUM C; Calegari F, 2014, SCIENCE, V346, P336, DOI 10.1126/science.1254061; Cederbaum LS, 1999, CHEM PHYS LETT, V307, P205, DOI 10.1016/S0009-2614(99)00508-4; Kraus PM, 2015, SCIENCE, V350, P790, DOI 10.1126/science.aab2160; Leone SR, 2014, NAT PHOTONICS, V8, P162, DOI 10.1038/nphoton.2014.48; Ott C, 2014, NATURE, V516, P374, DOI 10.1038/nature14026; Reduzzi M, 2015, J ELECTRON SPECTROSC, V204, P257, DOI 10.1016/j.elspec.2015.09.002; Smirnova O, 2009, NATURE, V460, P972, DOI 10.1038/nature08253; Weinkauf R, 1996, J PHYS CHEM-US, V100, P18567, DOI 10.1021/jp960926m	10	12	12	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2015	350	6262					740	741		10.1126/science.aad3982	http://dx.doi.org/10.1126/science.aad3982			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW3MS	26564834				2022-12-28	WOS:000364897000020
J	Shahlaee, A; Sridhar, J				Shahlaee, Abtin; Sridhar, Jayanth			Central Retinal-Vein Occlusion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shahlaee, Abtin; Sridhar, Jayanth] Wills Eye Hosp & Res Inst, Philadelphia, PA 19107 USA	Jefferson University	Shahlaee, A (corresponding author), Wills Eye Hosp & Res Inst, Philadelphia, PA 19107 USA.	ashahlaee@gmail.com							0	1	1	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2015	373	20							e23	10.1056/NEJMicm1501878	http://dx.doi.org/10.1056/NEJMicm1501878			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV7IL	26559596				2022-12-28	WOS:000364445500011
J	Bang, J; Spina, S; Miller, BL				Bang, Jee; Spina, Salvatore; Miller, Bruce L.			Frontotemporal dementia	LANCET			English	Article							HEXANUCLEOTIDE REPEAT EXPANSION; PROGRESSIVE SUPRANUCLEAR PALSY; LOBAR DEGENERATION; BEHAVIORAL VARIANT; ALZHEIMERS-DISEASE; BRAIN ATROPHY; RNA FOCI; NEURODEGENERATIVE DISEASES; DIAGNOSTIC-CRITERIA; LATERAL-SCLEROSIS	Frontotemporal dementia is an umbrella clinical term that encompasses a group of neurodegenerative diseases characterised by progressive deficits in behaviour, executive function, or language. Frontotemporal dementia is a common type of dementia, particularly in patients younger than 65 years. The disease can mimic many psychiatric disorders because of the prominent behavioural features. Various underlying neuropathological entities lead to the frontotemporal dementia clinical phenotype, all of which are characterised by the selective degeneration of the frontal and temporal cortices. Genetics is an important risk factor for frontotemporal dementia. Advances in clinical, imaging, and molecular characterisation have increased the accuracy of frontotemporal dementia diagnosis, thus allowing for the accurate differentiation of these syndromes from psychiatric disorders. As the understanding of the molecular basis for frontotemporal dementia improves, rational therapies are beginning to emerge.	[Bang, Jee; Spina, Salvatore; Miller, Bruce L.] Univ Calif San Francisco, Memory & Aging Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Miller, BL (corresponding author), Univ Calif San Francisco, Sch Med, Sandler Neurosci Ctr, Memory & Aging Ctr, San Francisco, CA 94158 USA.	bruce.miller@ucsf.edu		Nestor, Peter/0000-0002-5860-5921	University of California, San Francisco; Alzheimer Disease Research Center; Tau Consortium; Consortium for Frontotemporal Dementia Research; NATIONAL INSTITUTE ON AGING [T32AG023481, P01AG019724] Funding Source: NIH RePORTER	University of California, San Francisco(University of California System); Alzheimer Disease Research Center; Tau Consortium; Consortium for Frontotemporal Dementia Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	University of California, San Francisco; Alzheimer Disease Research Center; Program Project Grant; the Tau Consortium; and the Consortium for Frontotemporal Dementia Research provided funding for this report. We thank Caroline Latham and John Fesenko for their help with the rendition and editing of the illustrations. We thank William W Seeley for providing the neuropathological illustrations.	Alzheimer A, 1911, Z GESAMTE NEUROL PSY, V4, P356, DOI 10.1007/BF02866241; Asmal L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006625.pub3; Baborie A, 2011, ACTA NEUROPATHOL, V121, P365, DOI 10.1007/s00401-010-0765-z; Barker WW, 2002, ALZ DIS ASSOC DIS, V16, P203, DOI 10.1097/00002093-200210000-00001; Boxer A, 2013, ESTABLISHING THERAPE; Boxer AL, 2013, LANCET NEUROL, V12, P149, DOI 10.1016/S1474-4422(12)70320-4; Boxer AL, 2006, ARCH NEUROL-CHICAGO, V63, P81, DOI 10.1001/archneur.63.1.81; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Burrell JR, 2011, BRAIN, V134, P2582, DOI 10.1093/brain/awr195; Capell A, 2011, J NEUROSCI, V31, P1885, DOI 10.1523/JNEUROSCI.5757-10.2011; Cenik B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193433; Claassen DO, 2008, COGN BEHAV NEUROL, V21, P157, DOI 10.1097/WNN.0b013e3181864a09; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; Davies RR, 2006, ARCH NEUROL-CHICAGO, V63, P1627, DOI 10.1001/archneur.63.11.1627; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Devos SL, 2013, J NEUROSCI, V33, P12887, DOI 10.1523/JNEUROSCI.2107-13.2013; Dickson DW, 2011, PROGRESSIVE SUPRANUC; Farg MA, 2014, HUM MOL GENET, V23, P3579, DOI 10.1093/hmg/ddu068; FDA, 2008, INF HEALTHC PROF CON; Galimberti D, 2014, BIPOLAR DISORD, V16, P448, DOI 10.1111/bdi.12169; Galimberti D, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.12.004; Galimberti D, 2013, BIOL PSYCHIAT, V74, P384, DOI 10.1016/j.biopsych.2013.01.031; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; Gijselinck I, 2008, HUM MUTAT, V29, P1373, DOI 10.1002/humu.20785; Goldman JS, 2011, NEUROLOGY, V76, P475, DOI 10.1212/WNL.0b013e31820a0d13; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Hodges JR, 2003, NEUROLOGY, V61, P349, DOI 10.1212/01.WNL.0000078928.20107.52; Holm IE, 2007, J NEUROPATH EXP NEUR, V66, P884, DOI 10.1097/nen.0b013e3181567f02; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Josephs KA, 2011, ACTA NEUROPATHOL, V122, P137, DOI 10.1007/s00401-011-0839-6; Khan BK, 2012, J NEUROL NEUROSUR PS, V83, P358, DOI 10.1136/jnnp-2011-301883; Kim EJ, 2012, CEREB CORTEX, V22, P251, DOI 10.1093/cercor/bhr004; Kipps CM, 2010, CURR OPIN NEUROL, V23, P628, DOI 10.1097/WCO.0b013e3283404309; Knopman DS, 2011, J MOL NEUROSCI, V45, P330, DOI 10.1007/s12031-011-9538-y; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Lambert MA, 2014, EUR J NEUROL, V21, P563, DOI 10.1111/ene.12325; Lattante S, 2013, HUM MUTAT, V34, P812, DOI 10.1002/humu.22319; Le Ber I, 2013, REV NEUROL-FRANCE, V169, P811, DOI 10.1016/j.neurol.2013.07.014; Le Ber I, 2006, BRAIN, V129, P3051, DOI 10.1093/brain/awl288; Lebert F, 2004, DEMENT GERIATR COGN, V17, P355, DOI 10.1159/000077171; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Liu Y, 2014, MOL NEUROBIOL, V49, P386, DOI 10.1007/s12035-013-8528-1; Mackenzie IRA, 2008, BRAIN, V131, P1282, DOI 10.1093/brain/awn061; Mackenzie IRA, 2014, ACTA NEUROPATHOL, V127, P347, DOI 10.1007/s00401-013-1232-4; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P87, DOI 10.1007/s00401-011-0838-7; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V121, P207, DOI 10.1007/s00401-010-0764-0; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; Mendez MF, 2007, AM J GERIAT PSYCHIAT, V15, P84, DOI 10.1097/01.JGP.0000231744.69631.33; Mesulam MM, 2001, ANN NEUROL, V49, P425, DOI 10.1002/ana.91.abs; Miller B.L., 2009, BEHAV NEUROLOGY DEME; Miller ZA, 2013, J NEUROL NEUROSUR PS, V84, P956, DOI 10.1136/jnnp-2012-304644; Mizielinska S, 2013, ACTA NEUROPATHOL, V126, P845, DOI 10.1007/s00401-013-1200-z; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Nalbandian A, 2011, J MOL NEUROSCI, V45, P522, DOI 10.1007/s12031-011-9627-y; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Perri R, 2014, J ALZHEIMERS DIS, V39, P669, DOI 10.3233/JAD-131337; Pick A, 1892, PRAG MED WCHNSCHR, V17, P165, DOI DOI 10.1080/02687030600739463; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; REBEIZ JJ, 1968, ARCH NEUROL-CHICAGO, V18, P20, DOI 10.1001/archneur.1968.00470310034003; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rohrer JD, 2010, NEUROLOGY, V75, P2204, DOI 10.1212/WNL.0b013e318202038c; Rohrer JD, 2009, NEUROLOGY, V73, P1451, DOI 10.1212/WNL.0b013e3181bf997a; Rohrer JD, 2010, NEUROIMAGE, V53, P1070, DOI 10.1016/j.neuroimage.2009.12.088; Rosen HJ, 2002, NEUROLOGY, V58, P198, DOI 10.1212/WNL.58.2.198; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Seeley WW, 2005, NEUROLOGY, V64, P1384, DOI 10.1212/01.WNL.0000158425.46019.5C; Shankaran SS, 2008, J BIOL CHEM, V283, P1744, DOI 10.1074/jbc.M705115200; Sieben A, 2012, ACTA NEUROPATHOL, V124, P353, DOI 10.1007/s00401-012-1029-x; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Thompson SA, 2003, NEUROLOGY, V61, P1196, DOI 10.1212/01.WNL.0000091868.28557.B8; Toh H, 2011, J MOL NEUROSCI, V45, P538, DOI 10.1007/s12031-011-9569-4; Vieira Renata Teles, 2013, Clin Pract Epidemiol Ment Health, V9, P88, DOI 10.2174/1745017901309010088; Whitwell JL, 2012, BRAIN, V135, P794, DOI 10.1093/brain/aws001; Wischik CM, 2014, BIOCHEM PHARMACOL, V88, P529, DOI 10.1016/j.bcp.2013.12.008; Woolley JD, 2011, J CLIN PSYCHIAT, V72, P126, DOI 10.4088/JCP.10m06382oli; World Health Organization, 2015, DEM FACT SHEET; Yanamandra K, 2013, NEURON, V80, P402, DOI 10.1016/j.neuron.2013.07.046; Zhang Y, 2009, BRAIN, V132, P2579, DOI 10.1093/brain/awp071	83	475	488	8	88	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2015	386	10004					1672	1682		10.1016/S0140-6736(15)00461-4	http://dx.doi.org/10.1016/S0140-6736(15)00461-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU0HS	26595641	Green Accepted			2022-12-28	WOS:000363197500034
J	O'Brien, JT; Thomas, A				O'Brien, John T.; Thomas, Alan			Vascular dementia	LANCET			English	Article							WHITE-MATTER CHANGES; MILD COGNITIVE IMPAIRMENT; LATE-LIFE DEPRESSION; DOUBLE-BLIND; ELDERLY INDIVIDUALS; DIAGNOSTIC-CRITERIA; INCIDENT DEMENTIA; ALZHEIMER-DISEASE; NATURAL-HISTORY; RISK-FACTOR	Vascular dementia is one of the most common causes of dementia after Alzheimer's disease, causing around 15% of cases. However, unlike Alzheimer's disease, there are no licensed treatments for vascular dementia. Progress in the specialty has been difficult because of uncertainties over disease classification and diagnostic criteria, controversy over the exact nature of the relation between cerebrovascular pathology and cognitive impairment, and the paucity of identifiable tractable treatment targets. Although there is an established relation between vascular and degenerative Alzheimer's pathology, the mechanistic link between the two has not yet been identified. This Series paper critiques some of the key areas and controversies, summarises treatment trials so far, and makes suggestions for what progress is needed to advance our understanding of pathogenesis and thus maximise opportunities for the search for new and effective management approaches.	[O'Brien, John T.] Univ Cambridge, Dept Psychiat, Cambridge CB2 0SP, England; [Thomas, Alan] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Thomas, Alan] Newcastle Univ, Newcastle Univ Inst Ageing, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Cambridge; Newcastle University - UK; Newcastle University - UK	O'Brien, JT (corresponding author), Univ Cambridge, Dept Psychiat, Addenbrookes Hosp, Box 189,Level E4,Hills Rd, Cambridge CB2 0SP, England.	john.obrien@medschl.cam	Thomas, Alan J/G-4807-2011	O'Brien, John/0000-0002-0837-5080	Cambridge NIHR Biomedical Research Centre and Biomedical Research Unit in Dementia based at Cambridge University Hospitals NHS Foundation Trust; University of Cambridge; NIHR Biomedical Research Centre and Biomedical Research Unit in Lewy body dementia based at Newcastle-upon-Tyne Hospitals; NHS Foundation Trust; Newcastle University	Cambridge NIHR Biomedical Research Centre and Biomedical Research Unit in Dementia based at Cambridge University Hospitals NHS Foundation Trust; University of Cambridge(University of Cambridge); NIHR Biomedical Research Centre and Biomedical Research Unit in Lewy body dementia based at Newcastle-upon-Tyne Hospitals; NHS Foundation Trust; Newcastle University	The authors are supported by the Cambridge NIHR Biomedical Research Centre and Biomedical Research Unit in Dementia based at Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge; and the NIHR Biomedical Research Centre and Biomedical Research Unit in Lewy body dementia based at Newcastle-upon-Tyne Hospitals, NHS Foundation Trust, and Newcastle University. We thank our colleague Professor Raj Kalaria for leading vascular dementia research, for his great support and encouragement at all times, and for providing the figures for this paper.	Allan LM, 2011, BRAIN, V134, P3713, DOI 10.1093/brain/awr273; Amenta F, 2002, CLIN EXP HYPERTENS, V24, P697, DOI 10.1081/CEH-120015346; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Auchus AP, 2007, NEUROLOGY, V69, P448, DOI 10.1212/01.wnl.0000266625.31615.f6; Ballard C, 2008, CURR MED RES OPIN, V24, P2561, DOI 10.1185/03007990802328142 ; Ballard CG, 2004, NEUROLOGY, V63, P983, DOI 10.1212/01.WNL.0000138435.19761.93; Black S, 2003, STROKE, V34, P2323, DOI 10.1161/01.STR.0000091396.95360.E1; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Brickman AM, 2011, NEUROBIOL AGING, V32, P1588, DOI 10.1016/j.neurobiolaging.2009.10.013; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Chen N, 2013, COCHRANE DB SYST REV, V1; CHUI HC, 1992, NEUROLOGY, V42, P473, DOI 10.1212/WNL.42.3.473; de Bruijn RFAG, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0130-5; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; Deramecourt V, 2012, NEUROLOGY, V78, P1043, DOI 10.1212/WNL.0b013e31824e8e7f; Diniz BS, 2013, BRIT J PSYCHIAT, V202, P329, DOI 10.1192/bjp.bp.112.118307; Dwyer R, 2013, J ALZHEIMERS DIS, V34, P145, DOI 10.3233/JAD-121069; Erkinjuntti T, 2002, LANCET, V359, P1283, DOI 10.1016/S0140-6736(02)08267-3; Erkinjuntti T, 2000, J NEURAL TRANSM-SUPP, P23; Farooq MU, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0330-z; Fein G, 2000, NEUROLOGY, V55, P1626, DOI 10.1212/WNL.55.11.1626; Firbank MJ, 2012, BRIT J PSYCHIAT, V201, P40, DOI 10.1192/bjp.bp.111.098897; Flint J, 2014, NEURON, V81, P484, DOI [10.1016/j.neuron.2014.02.033, 10.1016/j.neuron.2014.01.027]; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forette F, 1998, LANCET, V352, P1347, DOI 10.1016/S0140-6736(98)03086-4; Gold G, 2002, AM J PSYCHIAT, V159, P82, DOI 10.1176/appi.ajp.159.1.82; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Grinberg LT, 2010, J NEUROL SCI, V299, P136, DOI 10.1016/j.jns.2010.08.055; Guekht AB, 2011, J STROKE CEREBROVASC, V20, P310, DOI 10.1016/j.jstrokecerebrovasdis.2010.01.012; Gupta M, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/430128; HACHINSKI VC, 1974, LANCET, V2, P207; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Herholz K, 2011, LANCET NEUROL, V10, P667, DOI 10.1016/S1474-4422(11)70123-5; Ho RCM, 2011, AM J GERIAT PSYCHIAT, V19, P607, DOI 10.1097/JGP.0b013e3181f17eed; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Inzitari D, 2009, BMJ-BRIT MED J, V6, pb2477; Jagtap A, 2014, BIOMAKERS GENOMIC ME, V7, P43; Jellinger KA, 2015, J NEURAL TRANSM, V122, P505, DOI 10.1007/s00702-014-1288-x; Jellinger KA, 2010, J NEUROL SCI, V299, P150, DOI 10.1016/j.jns.2010.08.038; Jorm AF, 1998, NEUROLOGY, V51, P728, DOI 10.1212/WNL.51.3.728; Kavirajan H, 2007, LANCET NEUROL, V6, P782, DOI 10.1016/S1474-4422(07)70195-3; Kua EH, 2014, PSYCHOGERIATRICS, V14, P196, DOI 10.1111/psyg.12053; Lees R, 2014, STROKE, V45, P3008, DOI 10.1161/STROKEAHA.114.005842; Liu H, 2010, J NEUROL SCI, V294, P74, DOI 10.1016/j.jns.2010.04.001; Longstreth WT, 1998, ARCH NEUROL-CHICAGO, V55, P1217, DOI 10.1001/archneur.55.9.1217; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; McGuinness B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004034.pub3; MEYER JS, 1989, J AM GERIATR SOC, V37, P549, DOI 10.1111/j.1532-5415.1989.tb05688.x; National Collaborating Centre for Mental Health, 2006, DEM SUPP PEOPL DEM T; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; O'Brien JT, 2003, LANCET NEUROL, V2, P89, DOI 10.1016/S1474-4422(03)00305-3; Orgogozo JM, 2002, STROKE, V33, P1834, DOI 10.1161/01.STR.0000020094.08790.49; Pantoni L, 2005, NEUROEPIDEMIOLOGY, V24, P51, DOI 10.1159/000081050; Pearce LA, 2014, LANCET NEUROL, V13, P1177, DOI 10.1016/S1474-4422(14)70224-8; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Perry E, 2005, NEUROLOGY, V64, P132, DOI 10.1212/01.WNL.0000148591.63727.80; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Petersen RC, 2006, J GERIATR PSYCH NEUR, V19, P147, DOI 10.1177/0891988706291085; Price CC, 2005, NEUROLOGY, V65, P376, DOI 10.1212/01.WNL.0000168877.06011.15; Rea TD, 2005, ARCH NEUROL-CHICAGO, V62, P1047, DOI 10.1001/archneur.62.7.1047; Roman GC, 2002, LANCET NEUROL, V1, P426, DOI 10.1016/S1474-4422(02)00190-4; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Roman GC, 2010, STROKE, V41, P1213, DOI 10.1161/STROKEAHA.109.570077; Sachdev P, 2014, ALZ DIS ASSOC DIS, V28, P206, DOI 10.1097/WAD.0000000000000034; Schrijvers EMC, 2012, STROKE, V43, P315, DOI 10.1161/STROKEAHA.111.628768; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Stebbins GT, 2008, STROKE, V39, P785, DOI 10.1161/STROKEAHA.107.507392; Stephan BCM, 2012, J ALZHEIMERS DIS, V29, P309, DOI 10.3233/JAD-2011-110518; Teodorczuk A, 2007, BRIT J PSYCHIAT, V191, P212, DOI 10.1192/bjp.bp.107.036756; Thal DR, 2012, EXP GERONTOL, V47, P816, DOI 10.1016/j.exger.2012.05.023; Thomas AJ, 2004, J AFFECT DISORDERS, V79, P81, DOI 10.1016/S0165-0327(02)00349-x; Thomas AJ, 2002, ARCH GEN PSYCHIAT, V59, P785, DOI 10.1001/archpsyc.59.9.785; Wentzel C, 2001, NEUROLOGY, V57, P714, DOI 10.1212/WNL.57.4.714; Wiesmann M, 2013, J CEREBR BLOOD F MET, V33, P1696, DOI 10.1038/jcbfm.2013.159; Wilcock G, 2002, INT CLIN PSYCHOPHARM, V17, P297, DOI 10.1097/00004850-200211000-00005; Wilkinson D, 2003, NEUROLOGY, V61, P479, DOI 10.1212/01.WNL.0000078943.50032.FC; World Health Organisation, 1993, ICD 10 CLASSIFICATIO; Yin YW, 2012, NEUROSCI LETT, V514, P6, DOI 10.1016/j.neulet.2012.02.031; Ylikoski R, 2007, DEMENT GERIATR COGN, V24, P73, DOI 10.1159/000103865; Zarow C, 2011, Int J Alzheimers Dis, V2011, P483972, DOI 10.4061/2011/483972; Zhuo JM, 2011, TRENDS PHARMACOL SCI, V32, P562, DOI 10.1016/j.tips.2011.05.003	84	526	565	19	118	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2015	386	10004					1698	1706		10.1016/S0140-6736(15)00463-8	http://dx.doi.org/10.1016/S0140-6736(15)00463-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU0HS	26595643				2022-12-28	WOS:000363197500036
